PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kjellbom, A; Lindgren, O; Puvaneswaralingam, S; Londahl, M; Olsen, H				Kjellbom, Albin; Lindgren, Ola; Puvaneswaralingam, Shobitha; Londahl, Magnus; Olsen, Henrik			Association Between Mortality and Levels of Autonomous Cortisol Secretion by Adrenal Incidentalomas A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							SUBCLINICAL CUSHINGS-SYNDROME; PREVALENCE; ACCURACY	Background: Autonomous cortisol secretion in patients with adrenal incidentalomas is associated with increased mortality, but detailed information about the risk associated with specific levels of autonomous cortisol secretion is not available. Objective: To measure the association between mortality and levels of autonomous cortisol secretion in patients with adrenal incidentalomas. Design: Retrospective cohort study. (ClinicalTrials.gov: NCT 03919734) Setting: Two hospitals in southern Sweden. Patients: Consecutive patients who had adrenal incidentalomas identified between 2005 and 2015 and were followed for up to 14 years. Outcome data were collected from national registers. Measurements: Patients were grouped according to plasma cortisol level after a 1-mg dexamethasone suppression test (cortisol(DST); <50, 50 to 82, 83 to 137, or >= 138 nmol/L). Results: During a median follow-up of 6.4 years, 170 of 1048 patients died. Compared with a cortisol(DST) less than 50 nmol/L, a cortisolDST of 50 to 82 nmol/L was not associated with increased mortality (hazard ratio [HR], 1.15 [95% CI, 0.78 to 1.70]). However, a cortisol(DST) of 83 to 137 nmol/L (n=119) had an HR of 2.30 (CI, 1.52 to 3.49), and a cortisol(DST) of 138 nmol/L or higher (n = 82) had an HR of 3.04 (CI, 1.86 to 4.98). Analyses using restricted cubic splines indicated that the association between cortisol(DST) and mortality was linear up to a cortisolDST of 200 nmol/L. Limitation: The results are not based on verified autonomous cortisol secretion; thus, the association may be underestimated. Conclusion: The association between mortality and cortisol(DST) increased linearly until cortisol(DST) reached 200 nmol/L. A cortisol(DST) of 83 to 137 nmol/L was associated with a 2-fold increase in mortality, and a cortisol(DST) of 138 nmol/L or higher was associated with a 3-fold increase in mortality. Additional studies should be done, and until those studies are completed some clinicians may consider these findings when deciding which patients to recommend for surgery.	[Kjellbom, Albin; Lindgren, Ola; Puvaneswaralingam, Shobitha; Londahl, Magnus; Olsen, Henrik] Skane Univ Hosp, Lund, Sweden; [Kjellbom, Albin; Lindgren, Ola; Londahl, Magnus; Olsen, Henrik] Lund Univ, Lund, Sweden	Lund University; Skane University Hospital; Lund University	Olsen, H (corresponding author), Skane Univ Hosp, Dept Endocrinol, Lasarettsgatan 15, SE-22185 Lund, Sweden.	henrik.olsen@med.lu.se	Olsen, Henrik/J-1596-2019	Olsen, Henrik/0000-0002-5351-764X; Londahl, Magnus/0000-0003-1522-3920; Vollmer, Shobitha/0000-0002-7211-087X; Kjellbom, Albin/0000-0002-4886-4807	Lisa and Johan Gronberg Foundation; Gyllenstiernska Krapperup Foundation	Lisa and Johan Gronberg Foundation; Gyllenstiernska Krapperup Foundation	By unrestricted grants from the Lisa and Johan Gronberg Foundation and the Gyllenstiernska Krapperup Foundation.	Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x; Bovio S, 2006, J ENDOCRINOL INVEST, V29, P298, DOI 10.1007/BF03344099; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Debono M, 2014, J CLIN ENDOCR METAB, V99, P4462, DOI 10.1210/jc.2014-3007; Di Dalmazi G, 2014, LANCET DIABETES ENDO, V2, P396, DOI 10.1016/S2213-8587(13)70211-0; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Elhassan YS, 2019, ANN INTERN MED, V171, P107, DOI 10.7326/M18-3630; Eller-Vainicher C, 2010, EUR J ENDOCRINOL, V163, P925, DOI 10.1530/EJE-10-0602; FASSNACHT M, 2018, EUR J ENDOCRINOL, V179, pG1, DOI DOI 10.1530/EJE-18-0608; GESKUS RB, 2011, BIOMETRICS, V67, P39, DOI DOI 10.1111/J.1541-0420.2010.01420.X; HEDELAND H, 1968, ACTA MED SCAND, V184, P211; Kumari M, 2011, J CLIN ENDOCR METAB, V96, P1478, DOI 10.1210/jc.2010-2137; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Morelli V, 2010, CLIN ENDOCRINOL, V73, P161, DOI 10.1111/j.1365-2265.2010.03794.x; Olsen H, 2015, CLIN ENDOCRINOL, V83, P762, DOI 10.1111/cen.12823; Olsen J, 2019, EUR J EPIDEMIOL, V34, P537, DOI 10.1007/s10654-018-00479-x; Patrova J, 2017, ENDOCRINE, V58, P267, DOI 10.1007/s12020-017-1400-8; Kerkvliet CP, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01277-8; Pivonello R, 2016, LANCET DIABETES ENDO, V4, P611, DOI 10.1016/S2213-8587(16)00086-3; Ragnarsson O, 2019, J CLIN ENDOCR METAB, V104, P2375, DOI 10.1210/jc.2018-02524; Rossi R, 2000, J CLIN ENDOCR METAB, V85, P1440, DOI 10.1210/jc.85.4.1440; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; Terzolo M, 2019, ANN INTERN MED, V171, P135, DOI 10.7326/M19-1482; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.2307/2336057; Ueland GA, 2020, ENDOCR CONNECT, V9, P963, DOI 10.1530/EC-20-0419; Ueland GA, 2017, EUR J ENDOCRINOL, V176, P705, DOI 10.1530/EJE-17-0078; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Vogelzangs N, 2010, J CLIN ENDOCR METAB, V95, P4959, DOI 10.1210/jc.2010-0192	29	13	13	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG	2021	174	8					1041	+		10.7326/M20-7946	http://dx.doi.org/10.7326/M20-7946			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP3IW	34029490				2022-12-28	WOS:000695277800013
J	Low, JS; Vaqueirinho, D; Mele, F; Foglierini, M; Jerak, J; Perotti, M; Jarrossay, D; Jovic, S; Perez, L; Cacciatore, R; Terrot, T; Pellanda, AF; Biggiogero, M; Garzoni, C; Ferrari, P; Ceschi, A; Lanzavecchia, A; Sallusto, F; Cassotta, A				Low, Jun Siong; Vaqueirinho, Daniela; Mele, Federico; Foglierini, Mathilde; Jerak, Josipa; Perotti, Michela; Jarrossay, David; Jovic, Sandra; Perez, Laurent; Cacciatore, Rosalia; Terrot, Tatiana; Pellanda, Alessandra Franzetti; Biggiogero, Maira; Garzoni, Christian; Ferrari, Paolo; Ceschi, Alessandro; Lanzavecchia, Antonio; Sallusto, Federica; Cassotta, Antonino			Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2	SCIENCE			English	Article								The identification of CD4(+) T cell epitopes is instrumental for the design of subunit vaccines for broad protection against coronaviruses. Here, we demonstrate in COVID-19-recovered individuals a robust CD4(+) T cell response to naturally processed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein and nucleoprotein (N), including effector, helper, and memory T cells. By characterizing 2943 S-reactive T cell clones from 34 individuals, we found that the receptor-binding domain (RBD) is highly immunogenic and that 33% of RBD-reactive clones and 94% of individuals recognized a conserved immunodominant S346-S365 region comprising nested human leukocyte antigen DR (HLA-DR)- and HLA-DP-restricted epitopes. Using pre- and post-COVID-19 samples and S proteins from endemic coronaviruses, we identified cross-reactive T cells targeting multiple S protein sites. The immunodominant and cross-reactive epitopes identified can inform vaccination strategies to counteract emerging SARS-CoV-2 variants.	[Low, Jun Siong; Vaqueirinho, Daniela; Mele, Federico; Foglierini, Mathilde; Jerak, Josipa; Perotti, Michela; Jarrossay, David; Jovic, Sandra; Perez, Laurent; Sallusto, Federica; Cassotta, Antonino] Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Cacciatore, Rosalia] Fdn IRCCS Policlin S Matteo, Dept Transfus Med & Immunohematol, Lab Immunogenet, I-27100 Pavia, Italy; [Terrot, Tatiana; Ceschi, Alessandro] Ente Osped Cantonale, Clin Trial Unit, CH-6500 Bellinzona, Switzerland; [Pellanda, Alessandra Franzetti; Biggiogero, Maira; Garzoni, Christian] Clin Luganese Moncucco, Clin Internal Med & Infect Dis, CH-6900 Lugano, Switzerland; [Ferrari, Paolo; Ceschi, Alessandro] Univ Svizzera Italiana, Fac Biomed Sci, CH-6900 Lugano, Switzerland; [Ferrari, Paolo] Ente Osped Cantonale, Dept Internal Med, CH-6500 Bellinzona, Switzerland; [Ferrari, Paolo] Univ New South Wales, Prince Wales Hosp Clin Sch, Sydney, NSW 2052, Australia; [Ceschi, Alessandro] Ente Osped Cantonale, Div Clin Pharmacol & Toxicol, Inst Pharmacol Sci Southern Switzerland, CH-6900 Lugano, Switzerland; [Ceschi, Alessandro] Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Lanzavecchia, Antonio] Natl Inst Mol Genet, I-20122 Milan, Italy; [Sallusto, Federica] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland	Universita della Svizzera Italiana; IRCCS Fondazione San Matteo; Universita della Svizzera Italiana; University of New South Wales Sydney; University of Zurich; University Zurich Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Swiss Federal Institutes of Technology Domain; ETH Zurich	Sallusto, F; Cassotta, A (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland.; Sallusto, F (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland.	federica.sallusto@irb.usi.ch; antonino.cassotta@irb.usi.ch	Cassotta, Antonino/AAW-2529-2021; Cacciatore, Rosalia/AAU-9762-2021; Perez, Laurent/ABA-4145-2021	Cassotta, Antonino/0000-0001-8674-4294; Cacciatore, Rosalia/0000-0003-4319-0206; Perez, Laurent/0000-0002-8860-7928; Ferrari, Paolo/0000-0002-9619-3104; Low, Jun Siong/0000-0002-1775-0778; Ceschi, Alessandro/0000-0002-4308-0405; Jerak, Josipa/0000-0001-5358-5055; Foglierini, Mathilde/0000-0001-7538-4262	Henry Krenter Foundation; Cariplo Foundation [2020-1374 CoVIM]; Swiss National Science Foundation [189331]; EOC research funds; Helmut Horten Foundation	Henry Krenter Foundation; Cariplo Foundation(Fondazione Cariplo); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EOC research funds; Helmut Horten Foundation	This work was supported in part by the Henry Krenter Foundation, the Cariplo Foundation (grant 2020-1374 CoVIM), the Swiss National Science Foundation (grant 189331), and by EOC research funds. F.S. and the Institute for Research in Biomedicine are supported by the Helmut Horten Foundation.	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; [Anonymous], 2021, MED, DOI DOI 10.1164/RCCM.202009-3442OC; Bacher P, 2020, IMMUNITY, V53, P1258, DOI 10.1016/j.immuni.2020.11.016; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Cassotta A, 2020, J EXP MED, V217, DOI 10.1084/jem.20200206; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Huppa JB, 2013, ADV IMMUNOL, V119, P1, DOI 10.1016/B978-0-12-407707-2.00001-1; Jaimes JA, 2020, J MOL BIOL, V432, P3309, DOI 10.1016/j.jmb.2020.04.009; Kim A, 2015, CURR OPIN IMMUNOL, V34, P9, DOI 10.1016/j.coi.2014.12.005; Knierman MD, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108454; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Low J.S., **DATA OBJECT**, DOI [10.21417/JSL2021S, DOI 10.21417/JSL2021S]; Low J. S., 2021, **DATA OBJECT**; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.1101/2020.08.11.20171843, 10.21203/rs.3.rs-57112/v1]; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; SPITS H, 1983, HYBRIDOMA, V2, P423, DOI 10.1089/hyb.1983.2.423; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100204; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988; WATSON AJ, 1983, NATURE, V304, P358, DOI 10.1038/304358a0; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JW, 2021, CSH PERSPECT MED, V11, DOI 10.1101/cshperspect.a038786	33	43	45	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2021	372	6548			SI		1336	+		10.1126/science.abg8985	http://dx.doi.org/10.1126/science.abg8985			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SY0WR	34006597	Green Published			2022-12-28	WOS:000665616000034
J	Mocumbi, AO				Mocumbi, Ana Olga			Women's cardiovascular health: shifting towards equity and justice	LANCET			English	Editorial Material							MORTALITY; DISEASE; HEART; CARE		[Mocumbi, Ana Olga] Inst Nacl Saude, Maputo 1120, Mozambique; [Mocumbi, Ana Olga] Univ Eduardo Mondlane, Maputo 1101, Mozambique	Eduardo Mondlane University	Mocumbi, AO (corresponding author), Inst Nacl Saude, Maputo 1120, Mozambique.; Mocumbi, AO (corresponding author), Univ Eduardo Mondlane, Maputo 1101, Mozambique.	amocumbi@gmail.com		Mocumbi, Ana/0000-0002-9564-2860				Bassig BA, 2020, INT J EPIDEMIOL, V49, P56, DOI 10.1093/ije/dyz158; Bond RM, 2021, CIRC-CARDIOVASC QUAL, V14, P223, DOI 10.1161/CIRCOUTCOMES.120.007643; Bots SH, SEX DIFFERENCES CORO; Bots SH, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000298; Bukhman G, 2020, LANCET, V396, P991, DOI 10.1016/S0140-6736(20)31907-3; Heemelaar S, 2020, TROP MED INT HEALTH, V25, P673, DOI 10.1111/tmi.13386; Izadnegahdar M, 2014, J WOMENS HEALTH, V23, P10, DOI 10.1089/jwh.2013.4507; Jimenez G, 2020, INT J MED INFORM, V143, DOI 10.1016/j.ijmedinf.2020.104260; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Lopez L, 2011, JT COMM J QUAL PATIE, V37, P437, DOI 10.1016/S1553-7250(11)37055-9; Mocumbi AO, 2012, HEART, V98, P450, DOI 10.1136/heartjnl-2011-301025; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Stewart S, 2011, EUR J HEART FAIL, V13, P1070, DOI 10.1093/eurjhf/hfr108; Vogel B, 2021, LANCET, V397, P2385, DOI 10.1016/S0140-6736(21)00684-X; WHO, 2019, MATERNAL MORTALITY K; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449	16	2	2	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2021	397	10292					2315	2317		10.1016/S0140-6736(21)01017-5	http://dx.doi.org/10.1016/S0140-6736(21)01017-5		JUN 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SU4QL	34010612				2022-12-28	WOS:000663124100006
J	Scheid, JF; Barnes, CO; Eraslan, B; Hudak, A; Keeffe, JR; Cosimi, LA; Brown, EM; Muecksch, F; Weisblum, Y; Zhang, ST; Delorey, T; Woolley, AE; Ghantous, F; Park, SM; Phillips, D; Tusi, B; Huey-Tubman, KE; Cohen, AA; Gnanapragasam, PNP; Rzasa, K; Hatziioanno, T; Durney, MA; Gu, XB; Tada, T; Landau, NR; West, AP; Rozenblatt-Rosen, O; Seaman, MS; Baden, LR; Graham, DB; Deguine, J; Bieniasz, PD; Regev, A; Hung, D; Bjorkman, PJ; Xavier, RJ				Scheid, Johannes F.; Barnes, Christopher O.; Eraslan, Basak; Hudak, Andrew; Keeffe, Jennifer R.; Cosimi, Lisa A.; Brown, Eric M.; Muecksch, Frauke; Weisblum, Yiska; Zhang, Shuting; Delorey, Toni; Woolley, Ann E.; Ghantous, Fadi; Park, Sung-Moo; Phillips, Devan; Tusi, Betsabeh; Huey-Tubman, Kathryn E.; Cohen, Alexander A.; Gnanapragasam, Priyanthi N. P.; Rzasa, Kara; Hatziioanno, Theodora; Durney, Michael A.; Gu, Xiebin; Tada, Takuya; Landau, Nathaniel R.; West, Anthony P., Jr.; Rozenblatt-Rosen, Orit; Seaman, Michael S.; Baden, Lindsey R.; Graham, Daniel B.; Deguine, Jacques; Bieniasz, Paul D.; Regev, Aviv; Hung, Deborah; Bjorkman, Pamela J.; Xavier, Ramnik J.			B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV	CELL			English	Article							HUMAN MONOCLONAL-ANTIBODY; RECEPTOR-BINDING DOMAIN; POTENT NEUTRALIZATION; STRUCTURAL BASIS; HIV-ANTIBODIES; CORONAVIRUS; EXPRESSION; DIFFERENTIATION; PROTECTION; DIVERSITY	Monoclonal antibodies (mAbs) are a focus in vaccine and therapeutic design to counteract severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants. Here, we combined B cell sorting with single-cell VDJ and RNA sequencing (RNA-seq) and mAb structures to characterize B cell responses against SARS-CoV-2. We show that the SARS-CoV-2-specific B cell repertoire consists of transcriptionally distinct B cell populations with cells producing potently neutralizing antibodies (nAbs) localized in two clusters that resemble memory and activated B cells. Cryo-electron microscopy structures of selected nAbs from these two clusters complexed with SARS-CoV-2 spike trimers show recognition of various receptor-binding domain (RBD) epitopes. One of these mAbs, BG10-19, locks the spike trimer in a closed conformation to potently neutralize SARS-CoV-2, the recently arising mutants B.1.1.7 and B.1.351, and SARS-CoV and cross-reacts with heterologous RBDs. Together, our results characterize transcriptional differences among SARS-CoV-2-specific B cells and uncover cross-neutralizing Ab targets that will inform immunogen and therapeutic design against coronaviruses.	[Scheid, Johannes F.; Eraslan, Basak; Hudak, Andrew; Brown, Eric M.; Zhang, Shuting; Delorey, Toni; Park, Sung-Moo; Phillips, Devan; Tusi, Betsabeh; Rzasa, Kara; Durney, Michael A.; Gu, Xiebin; Rozenblatt-Rosen, Orit; Graham, Daniel B.; Deguine, Jacques; Hung, Deborah; Xavier, Ramnik J.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Scheid, Johannes F.; Eraslan, Basak; Hudak, Andrew; Brown, Eric M.; Zhang, Shuting; Delorey, Toni; Park, Sung-Moo; Phillips, Devan; Tusi, Betsabeh; Rzasa, Kara; Durney, Michael A.; Gu, Xiebin; Rozenblatt-Rosen, Orit; Graham, Daniel B.; Deguine, Jacques; Hung, Deborah; Xavier, Ramnik J.] Harvard Univ, Cambridge, MA 02142 USA; [Scheid, Johannes F.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Scheid, Johannes F.; Brown, Eric M.; Graham, Daniel B.; Hung, Deborah; Xavier, Ramnik J.] Harvard Med Sch, Boston, MA 02114 USA; [Scheid, Johannes F.; Brown, Eric M.; Graham, Daniel B.; Hung, Deborah; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Barnes, Christopher O.; Keeffe, Jennifer R.; Huey-Tubman, Kathryn E.; Cohen, Alexander A.; Gnanapragasam, Priyanthi N. P.; West, Anthony P., Jr.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Cosimi, Lisa A.; Woolley, Ann E.; Baden, Lindsey R.] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Muecksch, Frauke; Weisblum, Yiska; Hatziioanno, Theodora; Bieniasz, Paul D.] Rockefeller Univ, Lab Mol Virol, New York, NY 10065 USA; [Delorey, Toni; Phillips, Devan; Rozenblatt-Rosen, Orit; Regev, Aviv; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Ghantous, Fadi; Seaman, Michael S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Tada, Takuya; Landau, Nathaniel R.] NYU, Dept Microbiol, Grossman Sch Med, New York, NY 10016 USA; [Bieniasz, Paul D.; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD USA; [Hung, Deborah; Xavier, Ramnik J.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Rozenblatt-Rosen, Orit; Regev, Aviv] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; California Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Rockefeller University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; New York University; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Roche Holding; Genentech	Xavier, RJ (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), Harvard Univ, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Bjorkman, PJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	bjorkman@caltech.edu; xavier@molbio.mgh.harvard.edu	Rozenblatt-Rosen, Orit/HDN-4182-2022; Tada, Takuya/GOP-1100-2022	Tada, Takuya/0000-0003-0779-9954; Hudak, Andrew/0000-0002-0241-2290; Eraslan, Basak/0000-0003-3698-8279; Weisblum, Yiska/0000-0002-9249-1745; Deguine, Jacques/0000-0001-9218-3040	NIH [P01AI138398-S1, P50 8 P50 AI150464-13, DK43351, U19 AI142784, DA046100, AI122390, AI120898]; Caltech Merkin Institute for Translational Research; George Mason University; Manton Foundation; Center for Microbiome Informatics and Therapeutics (CMIT) at Massachusetts Institute of Technology (MIT); Klarman Cell Observatory; Hanna Gray Fellowship Program from the Howard Hughes Medical Institute; Burroughs Wellcome Fund; Vilcek/Goldfarb Fellowship Endowment Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Merkin Institute for Translational Research; George Mason University; Manton Foundation; Center for Microbiome Informatics and Therapeutics (CMIT) at Massachusetts Institute of Technology (MIT); Klarman Cell Observatory; Hanna Gray Fellowship Program from the Howard Hughes Medical Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Vilcek/Goldfarb Fellowship Endowment Fund	We thank all study participants who devoted time to our research and the clinical staff. We thank Heather Kang for editorial assistance with the manuscript and figures. We thank the Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare COVID-19 biobank for support with patient samples. Wethankmembers of the Bjorkman, Xavier, and Bieniasz laboratories for helpful discussions. We thank Liat Amir-Zilberstein and Novalia Pishesha for support with sample processing and Christy Lavine (BIDMC) for assistance with pseudovirus assays. We thank Harry Gristick (Caltech) for technical assistance with SPR binding experiments and Kawther Abu Elneel and Jenna PfiffnerBorges for arranging and coordinating laboratory space during the COVID19 pandemic. We thank Patricia Rogers and Natan Pirete (Broad Institute) for support with cell sorting, Reuben Ryan Cano (Broad Institute) for help with size exclusion chromatography, and the Nussenzweig laboratory (Rockefeller University) for providing plasmids for mAbs mGO53, JB40, and ED38. We thank Pauline Hoffman, Leesa Kakutani, Yu (Erica) Lee, Jost Vielmetter, and the Caltech Beckman Institute Protein Expression Center for expression and purification of antigens and support for automated assays and Drs. Songye Chen and Andrey Malyutin (Caltech) for maintaining electron microscopes. Cell sorting was performed at the Flow Cytometry Facility of the Broad Institute, sequencing of pre-constructed DNA libraries was performed at the Genomics Platform (Broad Institute), and electron microscopy was performed in the Caltech Beckman Institute Resource Center for Transmission Electron Microscopy. We thank the Gordon and Betty Moore and Beckman Foundations for gifts to Caltech to support the Molecular Observatory (Dr. Jens Kaiser, director) and Drs. Silvia Russi, Aina Cohen, and Clyde Smith and the beamline staff at SSRL for data collection assistance. This work was supported by NIH (P01AI138398-S1 and P50 8 P50 AI150464-13 to P.J.B.; DK43351 and U19 AI142784 to R.J.X.; and DA046100, AI122390, and AI120898 to N.R.L.), the Caltech Merkin Institute for Translational Research (to P.J.B.), George Mason University Fast Grant (to P.J.B.), the Manton Foundation (to R.J.X. and A.R.), the Center for Microbiome Informatics and Therapeutics (CMIT) at Massachusetts Institute of Technology (MIT) (to R.J.X.), and the Klarman Cell Observatory. Work at the Broad Institute was supported by a gift from an anonymous donor. C.O.B was supported by the Hanna Gray Fellowship Program from the Howard Hughes Medical Institute and the Postdoctoral Enrichment Program from the Burroughs Wellcome Fund. P.D.B. is a Howard Hughes Medical Institute Investigator. A.R. was a Howard Hughes Medical Institute Investigator while doing this research. T.T. was supported by the Vilcek/Goldfarb Fellowship Endowment Fund.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arkin, 2019, SCIENCE, DOI [10.1126/science.364.6438.320, 10.1126/science.abe9728]; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Bournazos S, 2020, NAT REV IMMUNOL, V20, P633, DOI 10.1038/s41577-020-00410-0; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chao A, 2015, ECOLOGY, V96, P1189, DOI 10.1890/14-0550.1; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chen F, 2019, CURR OPIN VIROL, V34, P149, DOI 10.1016/j.coviro.2019.02.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen AA, 2021, SCIENCE, V371, P735, DOI 10.1126/science.abf6840; Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Davies N., ESTIMATED TRANSMISSI; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Dunbar J, 2014, NUCLEIC ACIDS RES, V42, pD1140, DOI 10.1093/nar/gkt1043; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Greaney Allison J, 2021, Cell Host Microbe, V29, P44, DOI [10.1101/2020.09.10.292078, 10.1016/j.chom.2020.11.007]; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Guthmiller JJ, 2020, IMMUNITY, V53, P1230, DOI 10.1016/j.immuni.2020.10.005; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hotzel I, 2012, MABS-AUSTIN, V4, P753, DOI 10.4161/mabs.22189; Horns F, 2020, CELL REP, V30, P905, DOI 10.1016/j.celrep.2019.12.063; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Hsieh Ching-Lin, 2020, bioRxiv, DOI [10.1126/science.abd0826, 10.1101/2020.05.30.125484]; Hurlburt Nicholas K, 2020, bioRxiv, DOI [10.1038/s41467-020-19231-9, 10.1101/2020.06.12.148692]; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; KREMMIDIOTIS G, 1995, CELL IMMUNOL, V161, P147, DOI 10.1006/cimm.1995.1021; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulkarni PS, 2018, VIRAL IMMUNOL, V31, P195, DOI 10.1089/vim.2017.0147; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lam JH, 2019, J IMMUNOL, V202, P351, DOI 10.4049/jimmunol.1801208; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; Li B, 2020, NAT METHODS, V17, P793, DOI 10.1038/s41592-020-0905-x; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu Yang, 2021, N Engl J Med, DOI 10.1056/NEJMc2102017; Lv Z, 2020, SCIENCE, V369, P1505, DOI 10.1126/science.abc5881; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mathew N.R., 2020, SINGLE CELL BCR TRAN; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; MOORE DS, 1985, BIOCHEM EDUC, V13, P10, DOI 10.1016/0307-4412(85)90114-1; Moroney JB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19242-6; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Muecksch Frauke, 2021, bioRxiv, DOI 10.1101/2021.03.07.434227; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Neu KE, 2019, J CLIN INVEST, V129, P93, DOI 10.1172/JCI121341; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Nouri N, 2018, BIOINFORMATICS, V34, P341, DOI 10.1093/bioinformatics/bty235; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pham-Thanh L., 2021, VIRUSES-BASEL, V13; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; Prigent J, 2018, CELL REP, V23, P2568, DOI 10.1016/j.celrep.2018.04.101; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rockx B, 2008, J VIROL, V82, P3220, DOI 10.1128/JVI.02377-07; Roy V, 2020, J IMMUNOL METHODS, V484, DOI 10.1016/j.jim.2020.112832; Rubelt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049774; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schmidt Fabian, 2020, J Exp Med, V217, DOI [10.1101/2020.06.08.140871, 10.1084/jem.20201181]; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sokal Aurelien, 2021, Cell, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Tada Takuya, 2021, bioRxiv, DOI 10.1101/2021.02.18.431897; Tada T, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108528; Tan Timothy J C, 2021, bioRxiv, DOI 10.1101/2021.01.26.428356; Tang XC, 2014, P NATL ACAD SCI USA, V111, pE2018, DOI 10.1073/pnas.1402074111; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; Teo TSP, 2021, TRANSPL INFECT DIS, V23, DOI 10.1111/tid.13516; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Verschoor CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131531; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Waickman AT, 2020, EBIOMEDICINE, V54, DOI 10.1016/j.ebiom.2020.102733; Waller F., 2005, P NATL ACAD SCI USA; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wang Zijun, 2020, bioRxiv, DOI 10.1101/2020.09.09.288555; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; West AP, 2010, J VIROL, V84, P261, DOI 10.1128/JVI.01528-09; WHO, 2018, J EXP MED, DOI [10.1101/2020.06.25.169946., 10.1155/2016/4323281]; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Wu Nicholas C, 2020, bioRxiv, DOI 10.1101/2020.07.26.222232; Yaari G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks457; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914; IMMUNITY	114	28	29	8	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3205	+		10.1016/j.cell.2021.04.032	http://dx.doi.org/10.1016/j.cell.2021.04.032		JUN 2021	41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	34015271	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000660014300012
J	Else, H				Else, Holly			OPEN-ACCESS PUBLISHER PUSHES TO EXTEND CLOUT BEYOND BIOMEDICINE	NATURE			English	News Item																			0	0	0	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					489	490		10.1038/d41586-020-01907-3	http://dx.doi.org/10.1038/d41586-020-01907-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WH1AK	33986505	Bronze			2022-12-28	WOS:000707419800010
J	Daly, M; Jones, A; Robinson, E				Daly, Michael; Jones, Andrew; Robinson, Eric			Public Trust andWillingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Daly, Michael] Maynooth Univ, Dept Psychol, 1-1-7 Educ House, Maynooth, Kildare, Ireland; [Jones, Andrew] Univ Liverpool, Dept Psychol, Liverpool, Merseyside, England; [Robinson, Eric] Univ Liverpool, Inst Populat Hlth Sci, Liverpool, Merseyside, England	Maynooth University; University of Liverpool; University of Liverpool	Daly, M (corresponding author), Maynooth Univ, Dept Psychol, 1-1-7 Educ House, Maynooth, Kildare, Ireland.	michael.a.daly@mu.ie		Jones, Andrew/0000-0001-5951-889X; Daly, Michael/0000-0003-1557-8326	Bill & Melinda Gates Foundation [U01AG054580]; National Institute on Aging - European Research Council	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute on Aging - European Research Council	The collection of the Understanding America Study (UAS) COVID-19 tracking data was supported in part by the Bill & Melinda Gates Foundation and by grant U01AG054580 from the National Institute on Aging. Dr Robinson's time was partly funded by the European Research Council.	Daly M, 2021, AM J PREV MED, V60, P766, DOI 10.1016/j.amepre.2021.01.008; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P1517, DOI 10.15585/mmwr.mm6942e1; Kapteyn A, 2020, SURV RES METHODS-GER, V14, P179, DOI 10.18148/srm/2020.v14i2.7737; Lopez L, 2021, JAMA-J AM MED ASSOC, V325, P719, DOI 10.1001/jama.2020.26443; Robinson E, 2021, VACCINE, V39, P2024, DOI 10.1016/j.vaccine.2021.02.005; Szilagyi PG, 2021, JAMA-J AM MED ASSOC, V325, P396, DOI 10.1001/jama.2020.26419	6	73	73	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2021	325	23					2397	2399		10.1001/jama.2021.8246	http://dx.doi.org/10.1001/jama.2021.8246		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SU3BJ	34028495	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000655670500001
J	Feng, RZ; Zhang, X; Murugesan, V; Holias, A; Chen, Y; Shao, YY; Walter, E; Wellala, NPN; Yan, LT; Rosso, KM; Wang, W				Feng, Ruozhu; Zhang, Xin; Murugesan, Vijayakumar; Holias, Aaron; Chen, Ying; Shao, Yuyan; Walter, Eric; Wellala, Nadeesha P. N.; Yan, Litao; Rosso, Kevin M.; Wang, Wei			Reversible ketone hydrogenation and dehydrogenation for aqueous organic redox flow batteries	SCIENCE			English	Article							ELECTROCHEMICAL OXIDATION; NEGATIVE ELECTRODE; ENERGY; COMPATIBILITY; SOLVATION; ACIDITIES; STABILITY; CAPACITY; DESIGN; WATER	Aqueous redox flow batteries with organic active materials offer an environmentally benign, tunable, and safe route to large-scale energy storage. Development has been limited to a small palette of organics that are aqueous soluble and tend to display the necessary redox reversibility within the water stability window. We show how molecular engineering of fluorenone enables the alcohol electro-oxidation needed for reversible ketone hydrogenation and dehydrogenation at room temperature without the use of a catalyst. Flow batteries based on these fluorenone derivative anolytes operate efficiently and exhibit stable long-term cycling at ambient and mildly increased temperatures in a nondemanding environment. These results expand the palette to include reversible ketone to alcohol conversion but also suggest the potential for identifying other atypical organic redox couple candidates.	[Feng, Ruozhu; Zhang, Xin; Murugesan, Vijayakumar; Holias, Aaron; Chen, Ying; Shao, Yuyan; Walter, Eric; Wellala, Nadeesha P. N.; Yan, Litao; Rosso, Kevin M.; Wang, Wei] Pacific Northwest Natl Lab, 902 Battelle Blvd, Richland, WA 99354 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Zhang, X; Wang, W (corresponding author), Pacific Northwest Natl Lab, 902 Battelle Blvd, Richland, WA 99354 USA.	xin.zhang@pnnl.gov; wei.wang@pnnl.gov	Shao, Yuyan/A-9911-2008; Wang, Wei/F-4196-2010	Shao, Yuyan/0000-0001-5735-2670; Wang, Wei/0000-0002-5453-4695; Feng, Ruozhu/0000-0003-1427-3571; Walter, Eric/0000-0003-3644-5514	US Department of Energy Office of Electricity [57558]; PNNL Laboratory Directed Research and Development project Energy Storage Materials Initiative	US Department of Energy Office of Electricity(United States Department of Energy (DOE)); PNNL Laboratory Directed Research and Development project Energy Storage Materials Initiative	This work was supported by the US Department of Energy Office of Electricity under Contract no. 57558 and PNNL Laboratory Directed Research and Development project Energy Storage Materials Initiative.	Ariche B, 2018, CAN J CHEM, V96, P1001, DOI 10.1139/cjc-2018-0032; Bianchini C, 2009, CHEM REV, V109, P4183, DOI 10.1021/cr9000995; Cantu DC, 2018, ACS CATAL, V8, P7645, DOI 10.1021/acscatal.8b00858; Chang GJ, 2018, ADV MATER, V30, DOI 10.1002/adma.201704234; Ding Y, 2018, CHEM SOC REV, V47, P69, DOI 10.1039/c7cs00569e; Duan WT, 2017, ACS ENERGY LETT, V2, P1156, DOI 10.1021/acsenergylett.7b00261; Gerken JB, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.202000340; Han KS, 2016, J PHYS CHEM C, V120, P27834, DOI 10.1021/acs.jpcc.6b09114; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Heard DM, 2020, ANGEW CHEM INT EDIT, V59, P18866, DOI 10.1002/anie.202005745; Hickey DP, 2019, J AM CHEM SOC, V141, P1382, DOI 10.1021/jacs.8b12634; HIRAYAMA M, 1987, CHEM LETT, P413, DOI 10.1246/cl.1987.413; Hollas A, 2018, NAT ENERGY, V3, P508, DOI 10.1038/s41560-018-0167-3; Huskinson B, 2014, NATURE, V505, P195, DOI 10.1038/nature12909; Inzelt G., 2013, HDB REFERENCE ELECTR, V541; Jin SJ, 2019, ACS ENERGY LETT, V4, P1342, DOI 10.1021/acsenergylett.9b00739; KALINOWSKI MK, 1966, T FARADAY SOC, V62, P926, DOI 10.1039/tf9666200926; Kamaura M, 1999, TETRAHEDRON LETT, V40, P7347, DOI 10.1016/S0040-4039(99)01506-3; Kato R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13032; Kwabi DG, 2020, CHEM REV, V120, P6467, DOI 10.1021/acs.chemrev.9b00599; Leonat L, 2013, UNIV POLITEH BUCHAR, V75, P111; Leung P, 2017, APPL ENERG, V197, P318, DOI 10.1016/j.apenergy.2017.04.023; Lin KX, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2016.102, 10.1038/NENERGY.2016.102]; Lin KX, 2015, SCIENCE, V349, P1529, DOI 10.1126/science.aab3033; Liu TB, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201501449; Luo J, 2017, NANO ENERGY, V42, P215, DOI 10.1016/j.nanoen.2017.10.057; MATTHEWS WS, 1975, J AM CHEM SOC, V97, P7006, DOI 10.1021/ja00857a010; Meister EC, 2014, HELV CHIM ACTA, V97, P1, DOI 10.1002/hlca.201300321; Mendkovich AS, 2013, RUSS CHEM B+, V62, P1668, DOI 10.1007/s11172-013-0242-7; NADJO L, 1971, J ELECTROANAL CHEM, V33, P419, DOI 10.1016/0368-1874(71)80049-7; Orita A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13230; Park M, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.80; Pezeshki AM, 2017, ELECTROCHIM ACTA, V229, P261, DOI 10.1016/j.electacta.2017.01.056; Rodriguez J., 2019, ECS Transactions, V89, P49, DOI 10.1149/08901.0049ecst; Rodriguez Jr J, 2019, ECS T, V89, P49; Shrestha A, 2020, CHEM-EUR J, V26, P5369, DOI 10.1002/chem.202000749; Sun CN, 2014, J POWER SOURCES, V248, P560, DOI 10.1016/j.jpowsour.2013.09.125; Tissandier MD, 1998, J PHYS CHEM A, V102, P7787, DOI 10.1021/jp982638r; Wang F, 2020, ACCOUNTS CHEM RES, V53, P561, DOI 10.1021/acs.accounts.9b00544; Wei XL, 2015, ANGEW CHEM INT EDIT, V54, P8684, DOI 10.1002/anie.201501443; WEINBERG NL, 1968, CHEM REV, V68, P449, DOI 10.1021/cr60254a003; Wu M, 2020, CHEM-US, V6, P1432, DOI 10.1016/j.chempr.2020.03.021; Xing XQ, 2020, J POWER SOURCES, V445, DOI 10.1016/j.jpowsour.2019.227330; Zhang X, 2013, CHEMPLUSCHEM, V78, P703, DOI 10.1002/cplu.201300123; Zu XH, 2020, ANGEW CHEM INT EDIT, V59, P22163, DOI 10.1002/anie.202009279	45	55	56	60	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					836	+		10.1126/science.abd9795	http://dx.doi.org/10.1126/science.abd9795			68	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016776				2022-12-28	WOS:000653997000041
J	McKee, M; Dunnell, K; Anderson, M; Brayne, C; Charlesworth, A; Johnston-Webber, C; Knapp, M; McGuire, A; Newton, JN; Taylor, D; Watt, RG				McKee, Martin; Dunnell, Karen; Anderson, Michael; Brayne, Carol; Charlesworth, Anita; Johnston-Webber, Charlotte; Knapp, Martin; McGuire, Alistair; Newton, John N.; Taylor, David; Watt, Richard G.			The changing health needs of the UK population	LANCET			English	Review							LIFE EXPECTANCY; PUBLIC-HEALTH; SYSTEMATIC ANALYSIS; NATURAL EXPERIMENT; GLOBAL BURDEN; ETHNIC-GROUPS; ENGLAND; PREVALENCE; MORTALITY; WALES	The demographics of the UK population are changing and so is the need for health care. In this Health Policy, we explore the current health of the population, the changing health needs, and future threats to health. Relative to other high-income countries, the UK is lagging on many health outcomes, such as life expectancy and infant mortality, and there is a growing burden of mental illness. Successes exist, such as the striking improvements in oral health, but inequalities in health persist as well. The growth of the ageing population relative to the working-age population, the rise of multimorbidity, and persistent health inequalities, particularly for preventable illness, are all issues that the National Health Service (NHS) will face in the years to come. Meeting the challenges of the future will require an increased focus on health promotion and disease prevention, involving a more concerted effort to understand and tackle the multiple social, environmental, and economic factors that lie at the heart of health inequalities. The immediate priority of the NHS will be to mitigate the wider and long-term health consequences of the COVID-19 pandemic, but it must also strengthen its resilience to reduce the impact of other threats to health, such as the UK leaving the EU, climate change, and antimicrobial resistance.	[McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Charlesworth, Anita] Hlth Fdn, London, England; [Anderson, Michael; Johnston-Webber, Charlotte; Knapp, Martin; McGuire, Alistair] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England; [Brayne, Carol] Univ Cambridge, Cambridge Publ Hlth, Cambridge, England; [Charlesworth, Anita] Univ Birmingham, Coll Social Sci, Hlth Serv Management Ctr, Birmingham, W Midlands, England; [Newton, John N.] Publ Hlth England, London, England; [Taylor, David] UCL, UCL Sch Pharm, London, England; [Watt, Richard G.] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School Economics & Political Science; University of Cambridge; University of Birmingham; Public Health England; University of London; University College London; University of London; University College London	Anderson, M (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.	m.anderson5@lse.ac.uk	Newton, John/HCH-8693-2022	Newton, John/0000-0002-5641-6457; Knapp, Martin/0000-0003-1427-0215; Brayne, Carol/0000-0001-5307-663X; Watt, Richard/0000-0001-6229-8584	LSE Knowledge and Exchange Impact (KEI) fund from the Higher Education Innovation Fund (HEIF)	LSE Knowledge and Exchange Impact (KEI) fund from the Higher Education Innovation Fund (HEIF)	Funding for the LSE-Lancet Commission on the future of the NHS was granted by the LSE Knowledge and Exchange Impact (KEI) fund, which was created using funds from the Higher Education Innovation Fund (HEIF). The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	[Anonymous], 2000, B WORLD HEALTH ORGAN, V78, P868; [Anonymous], 2013, EUROPEAN CHILD HLTH; [Anonymous], [No title captured]; [Anonymous], 2016, HIDDEN PLAIN SIGHT U; [Anonymous], 2019, DRUG REL DEATHS 2019; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Astolfi R, 2012, OECD HLTH WORKING PA, V59; Baker C., MENTAL HLTH STAT PRE; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barnsdale L, 2018, NATL DRUG RELATED DE; Bould H, 2019, LANCET, V394, P116, DOI 10.1016/S0140-6736(19)31102-X; British Medical Association, 2018, BREX INT TRAD HLTH; Bryant C, 2008, J AFFECT DISORDERS, V109, P233, DOI 10.1016/j.jad.2007.11.008; Burns A, 2015, BETTER ACCESS MENTAL; Campbell D., 2020, MILLIONS UK MISS CAN; Castleden M, 2011, J PUBLIC HEALTH-UK, V33, P369, DOI 10.1093/pubmed/fdr027; Corlett A., 2019, LIVING STANDARDS OUT; Coulmas F, 2007, ROUTL CONTEMP JPN SE, V16, P1; Cowan K, 2020, SURVEY RESULTS UNDER; Cummins I, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061145; Devakumar D, 2020, LANCET, V395, pE112, DOI 10.1016/S0140-6736(20)31371-4; Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557; Drummond C, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2704; Dubois CA, 2006, HEALTH ECON POLICY L, V1, P59, DOI 10.1017/S1744133105001027; Fahy N, 2019, LANCET, V393, P949, DOI 10.1016/S0140-6736(19)30425-8; Fahy N, 2017, LANCET, V390, P2110, DOI 10.1016/S0140-6736(17)31926-8; Fannie Mae, 2020, COV 19 NEED CONS OUT; Farmer P, 2017, THRIVING WORK REV ME; Francis-Devine B, 2020, WOMEN EC; Godlee F, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2303; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Green L, 2019, PUBLIC HLTH IMPLICAT; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Gruer L, 2016, J EPIDEMIOL COMMUN H, V70, P1251, DOI 10.1136/jech-2016-207426; Gunnell D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2608; Health and Safety Executive, 2019, WORK DAYS LOST GREAT; Hiam L, 2018, J EPIDEMIOL COMMUN H, V72, P404, DOI 10.1136/jech-2017-210401; Hiam L, 2017, J ROY SOC MED, V110, P131, DOI 10.1177/0141076817693600; Hiam L, 2017, J ROY SOC MED, V110, P153, DOI 10.1177/0141076817693599; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Horton R., 2020, COVID 19 CATASTROPHE; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Kassebaum NJ, 2017, J DENT RES, V96, P380, DOI 10.1177/0022034517693566; Kenny S., 2018, RESTRICTED CERTIFICA; Keown OP, 2014, HEALTH AFFAIR, V33, P1620, DOI 10.1377/hlthaff.2014.0383; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kingston A, 2018, AGE AGEING, V47, P374, DOI 10.1093/ageing/afx201; Kleinman ER, 2009, GERODONTOLOGY, V26, P193, DOI 10.1111/j.1741-2358.2008.00260.x; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Knai C, 2015, ADDICTION, V110, P1232, DOI 10.1111/add.12855; Knight M, 2020, PAEDIATR PERINAT EP, V34, P392, DOI 10.1111/ppe.12640; Le Quere C, 2020, NAT CLIM CHANGE, V10, P647, DOI 10.1038/s41558-020-0797-x; Leon DA, 2019, LANCET PUBLIC HEALTH, V4, pE575, DOI 10.1016/S2468-2667(19)30177-X; Loopstra R, 2016, J ROY SOC MED, V109, P109, DOI 10.1177/0141076816632215; Loopstra R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1775; Low Pay Commission, 2020, NONC ENF NAT MIN WA; Mackenbach JP, 2013, LANCET, V381, P1125, DOI 10.1016/S0140-6736(12)62082-0; Mackenbach JP, 2013, EUR J PUBLIC HEALTH, V23, P195, DOI 10.1093/eurpub/cks192; MacMahon SC., 2018, MULTIMORBIDITY PRIOR; Mansfield KE, 2020, MEDRXIV, DOI [10.1101/2020.10.29.20222174, DOI 10.1101/2020.10.29.20222174]; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; Marshall L., 2019, MORTALITY LIFE EXPEC; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; McCambridge J, 2019, TOB CONTROL, V28, P7, DOI 10.1136/tobaccocontrol-2018-054264; McKee M, 2000, B WORLD HEALTH ORGAN, V78, P803; McKee M., 2021, COVID 19 VACCINE WAR; Mckee M, 2020, NAT MED, V26, P640, DOI 10.1038/s41591-020-0863-y; McKee M, 2018, AM J PUBLIC HEALTH, V108, P1167, DOI 10.2105/AJPH.2018.304510; Mckee M, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0183-y; Mckee M, 2009, LANCET, V373, P349, DOI 10.1016/S0140-6736(09)60098-2; Ministry of Justice, 2021, DRUG REL STAT; Morgan C, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4351; Morris M, 2015, J EPIDEMIOL COMMUN H, V69, P361, DOI 10.1136/jech-2014-204210; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; NHS England, 2019, NHS LONG TERM PLAN; Nolte E, 2008, CARING PEOPLE CHRONI; Nursing and Midwifery Council, 2018, ANN REP ACC 2017 201; Office for National Statistics, 2020, COR COVID 19 REL DEA; Organisation for Economic Co-operation and Development WHO, 2003, POV HLTH PAR; Palladino R, 2016, AGE AGEING, V45, P431, DOI 10.1093/ageing/afw044; Patel P., 2020, COMMUNICATION 1023; Peres MA, 2019, LANCET, V394, P249, DOI 10.1016/S0140-6736(19)31146-8; Perou R, 2018, GEN STATUS STUDENT M; Pickard L, 2012, AGEING SOC, V32, P1147, DOI 10.1017/S0144686X11000833; Prince M., 2014, DEMENTIA UK UPDATE; Public Health England, 2018, SALT RED PROGR; Public Health England, 2018, REV REC TRENDS MORT; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; Rajan S, 2020, J LONG TERM CARE, P185, DOI [10.31389/jltc.53, DOI 10.31389/JLTC.53]; Rees PH, 2009, SOC SCI MED, V69, P1592, DOI 10.1016/j.socscimed.2009.08.015; Reeves A, 2017, HEALTH ECON, V26, P639, DOI 10.1002/hec.3336; Reeves A, 2016, AM J EPIDEMIOL, V184, P421, DOI 10.1093/aje/kww055; Rhodes D., 2018, DRUG ALCOHOL SERVICE; Richards M, 2020, NAT CANCER, V1, P565, DOI 10.1038/s43018-020-0074-y; Roberts CM, 2020, BRIT J ANAESTH, V125, P238, DOI 10.1016/j.bja.2020.06.013; Roberts CM, 2020, COVID 19 COMPLEX MUL; Roman-Urrestarazu A, 2019, HEALTH POLICY, V123, P521, DOI 10.1016/j.healthpol.2019.04.005; Royal College of Psychiatrists, 2018, SUFF SIL AG IN OLD P; Sadler K., 2018, MENTAL HLTH CHILDREN; Shah R, 2019, INT COMP HLTH WELLBE; Shen J, 2013, COMMUNITY DENT ORAL, V41, P481, DOI 10.1111/cdoe.12071; Solomi VL, 2017, CHRONIC ILLN, V13, P75, DOI 10.1177/1742395316664960; Steele JG, 2012, BRIT DENT J, V213, P523, DOI 10.1038/sj.bdj.2012.1067; Suhrcke M, 2006, BRIT MED J, V333, P1017, DOI 10.1136/bmj.38951.614144.68; Taylor-Robinson D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029424; UK Department for Work & Pensions, 2019, HOUS AV INC AN UK IN; van Schalkwyk MCI, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2307; Viner R, 2018, CHILD HLTH 2030 ENGL; Wanless, 2002, SECURING OUR FUTURE; Watt RG, 2013, BRIT DENT J, V214, P71, DOI 10.1038/sj.bdj.2013.50; WHITEHEAD M, 1991, LANCET, V338, P1059, DOI 10.1016/0140-6736(91)91911-D; WHO, 2017, SUST DEV WAL OTH REG; Wilkinson E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1626; Williams R, 2018, LANCET, V392, P2398, DOI 10.1016/S0140-6736(18)32561-3; Wohland P, 2015, ETHNIC HEALTH, V20, P341, DOI 10.1080/13557858.2014.921892; Wolfe I, 2013, LANCET, V381, P1224, DOI 10.1016/S0140-6736(12)62085-6; World Health Organization, 2008, TALL CHART HLTH SYST; Zylbersztejn A, 2018, LANCET, V391, P2008, DOI [10.1016/S0140-6736(18)30670-6, 10.1016/s0140-6736(18)30670-6]	119	6	6	5	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1979	1991		10.1016/S0140-6736(21)00229-4	http://dx.doi.org/10.1016/S0140-6736(21)00229-4		MAY 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SF1XN	33965065	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000652556000029
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Most UK adults had antibodies after one dose of AstraZeneca or Pfizer vaccine, data suggest	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], MEDRXIV, DOI [10.1101/2021.05.12.21257102v2, DOI 10.1101/2021.05.12.21257102V2]; Shrotri M, SPIKE ANTIBODY RESPO	2	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2021	373								n1274	10.1136/bmj.n1274	http://dx.doi.org/10.1136/bmj.n1274			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SL5PR	34006531	Bronze			2022-12-28	WOS:000656970600010
J	Williamson, T; Goodwin, CR; Ubel, PA				Williamson, Theresa; Goodwin, C. Rory; Ubel, Peter A.			Minority Tax Reform - Avoiding Overtaxing Minorities When We Need Them Most	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Williamson, Theresa; Goodwin, C. Rory] Duke Univ, Sch Med, Dept Neurosurg, Durham, NC USA; [Ubel, Peter A.] Duke Univ, Sch Business, Durham, NC USA; [Ubel, Peter A.] Duke Univ, Sch Publ Policy & Med, Durham, NC USA	Duke University; Duke University; Duke University	Williamson, T (corresponding author), Duke Univ, Sch Med, Dept Neurosurg, Durham, NC USA.			Ubel, Peter/0000-0001-8218-519X				Campbell KM, 2019, ACAD MED, V94, P1854, DOI 10.1097/ACM.0000000000002839; Foster KE, 2021, ANN FAM MED, V19, P66, DOI 10.1370/afm.2634; Nivet MA, 2010, J VASC SURG, V51, p53S, DOI 10.1016/j.jvs.2009.09.064; Rodriguez JE, 2021, J WOMENS HEALTH, V30, P914, DOI 10.1089/jwh.2020.8884; Rodriguez JE, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0290-9	5	20	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					1877	1879		10.1056/NEJMp2100179	http://dx.doi.org/10.1056/NEJMp2100179		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ4AW	34014047	Bronze			2022-12-28	WOS:000652579500001
J	Vallejos, JG				Vallejos, Johana Goyes			What's in a name?	SCIENCE			English	Editorial Material									[Vallejos, Johana Goyes] Univ Missouri, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Vallejos, JG (corresponding author), Univ Missouri, Columbia, MO 65211 USA.	SciCareerEditor@aaas.org							0	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					754	754		10.1126/science.372.6543.754	http://dx.doi.org/10.1126/science.372.6543.754			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SD1KE	33986182				2022-12-28	WOS:000651125300053
J	Willett, FR; Avansino, DT; Hochberg, LR; Henderson, JM; Shenoy, KV				Willett, Francis R.; Avansino, Donald T.; Hochberg, Leigh R.; Henderson, Jaimie M.; Shenoy, Krishna V.			High-performance brain-to-text communication via handwriting	NATURE			English	Article							COMPUTER INTERFACE; MOVEMENT; TETRAPLEGIA; PEOPLE; CORTEX; AREA; KNOB	Brain-computer interfaces (BCIs) can restore communication to people who have lost the ability to move or speak. So far, a major focus of BCI research has been on restoring gross motor skills, such as reaching and grasping(1-5) or point-and-click typing with a computer cursor(6,7). However, rapid sequences of highly dexterous behaviours, such as handwriting or touch typing, might enable faster rates of communication. Here we developed an intracortical BCI that decodes attempted handwriting movements from neural activity in the motor cortex and translates it to text in real time, using a recurrent neural network decoding approach. With this BCI, our study participant, whose hand was paralysed from spinal cord injury, achieved typing speeds of 90 characters per minute with 94.1% raw accuracy online, and greater than 99% accuracy offline with a general-purpose autocorrect. To our knowledge, these typing speeds exceed those reported for any other BCI, and are comparable to typical smartphone typing speeds of individuals in the age group of our participant (115 characters per minute)(8). Finally, theoretical considerations explain why temporally complex movements, such as handwriting, may be fundamentally easier to decode than point-to-point movements. Our results open a new approach for BCIs and demonstrate the feasibility of accurately decoding rapid, dexterous movements years after paralysis. A brain-computer interface enables rapid communication through neural decoding of attempted handwriting movements in a person with paralysis.	[Willett, Francis R.; Avansino, Donald T.; Shenoy, Krishna V.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Willett, Francis R.; Henderson, Jaimie M.] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA; [Willett, Francis R.; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Hochberg, Leigh R.] Providence VA Med Ctr, Rehabil R&D Serv, VA RR&D Ctr Neurorestorat & Neurotechnol, Providence, RI USA; [Hochberg, Leigh R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Hochberg, Leigh R.] Brown Univ, Carney Inst Brain Sci, Providence, RI 02912 USA; [Hochberg, Leigh R.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02115 USA; [Henderson, Jaimie M.; Shenoy, Krishna V.] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA; [Henderson, Jaimie M.; Shenoy, Krishna V.] Stanford Univ, BioX Inst, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Brown University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Stanford University; Stanford University; Stanford University; Stanford University	Willett, FR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Willett, FR (corresponding author), Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA.; Willett, FR (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.	fwillett@stanford.edu		Hochberg, Leigh/0000-0003-0261-2273; Henderson, Jaimie/0000-0002-3276-2267; Shenoy, Krishna/0000-0003-1534-9240	Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [R01 DC014034, R01 DC009899, U01 DC017844] Funding Source: Medline; NINDS NIH HHS [UH2 NS095548, U01 NS098968] Funding Source: Medline; RRD VA [I50 RX002864, I01 RX002295] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); RRD VA		Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Ajiboye AB, 2017, LANCET, V389, P1821, DOI 10.1016/S0140-6736(17)30601-3; Anumanchipalli GK, 2019, NATURE, V568, P493, DOI 10.1038/s41586-019-1119-1; Bacher D, 2015, NEUROREHAB NEURAL RE, V29, P462, DOI 10.1177/1545968314554624; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Bullard AJ, 2020, NEUROMODULATION, V23, P411, DOI 10.1111/ner.13069; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE6058, DOI 10.1073/pnas.1508080112; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Cunningham JP, 2008, J NEUROPHYSIOL, V100, P3445, DOI 10.1152/jn.90833.2008; Degenhart AD, 2020, NAT BIOMED ENG, V4, P672, DOI 10.1038/s41551-020-0542-9; Dickey AS, 2009, J NEUROPHYSIOL, V102, P1331, DOI 10.1152/jn.90920.2008; Downey JE, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aab7a0; Dyer EL, 2017, NAT BIOMED ENG, V1, P967, DOI 10.1038/s41551-017-0169-7; Eleryan Ahmed, 2014, Front Neuroeng, V7, P23, DOI 10.3389/fneng.2014.00023; Gao P., 2017, BIORXIV, DOI 10.1101/214262; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; He YZ, 2019, INT CONF ACOUST SPEE, P6381, DOI 10.1109/ICASSP.2019.8682336; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Jarosiewicz B, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7328; Makin JG, 2020, NAT NEUROSCI, V23, P575, DOI 10.1038/s41593-020-0608-8; McCane LM, 2015, CLIN NEUROPHYSIOL, V126, P2124, DOI 10.1016/j.clinph.2015.01.013; Mugler EM, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035015; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Musk E, 2019, J MED INTERNET RES, V21, DOI 10.2196/16194; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Nurmikko A, 2020, NEURON, V108, P259, DOI 10.1016/j.neuron.2020.10.015; Nuyujukian P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204566; Palin K, 2019, PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON HUMAN-COMPUTER INTERACTION WITH MOBILE DEVICES AND SERVICES (MOBILEHCI'19), DOI 10.1145/3338286.3340120; Pandarinath C, 2017, ELIFE, V6, DOI 10.7554/eLife.18554; Pels EGM, 2017, NEUROREHAB NEURAL RE, V31, P677, DOI 10.1177/1545968317714577; Sahasrabuddhe K, 2021, J NEURAL ENG, V18, DOI 10.1088/1741-2552/abd0ce; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; Sussillo D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13749; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Vansteensel MJ, 2016, NEW ENGL J MED, V375, P2060, DOI 10.1056/NEJMoa1608085; Vazquez-Guardado A, 2020, NAT NEUROSCI, V23, P1522, DOI 10.1038/s41593-020-00739-8; Willett FR, 2020, CELL, V181, P396, DOI 10.1016/j.cell.2020.02.043; Willett FR, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa5990; Williams AH, 2020, NEURON, V105, P246, DOI [10.1016/j.neuron.2019.10.020, 10.1016/j.neuron.2019.10.02]; Wolpaw JR, 2018, NEUROLOGY, V91, pE258, DOI 10.1212/WNL.0000000000005812; Xiong W., 2017, MICROSOFT 2017 CONVE; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	44	109	112	92	311	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					249	+		10.1038/s41586-021-03506-2	http://dx.doi.org/10.1038/s41586-021-03506-2			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33981047	Green Accepted			2022-12-28	WOS:000649848600018
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: FDA authorises Pfizer vaccine for children 12-15	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, TOP ST JUD PED VIR R; [Anonymous], 2021, NY TIMES; Centers for Disease Control and Prevention, 2021, COV 19 VACC US; Food and Drug Administration, 2021, COR COV 19 UPD FDA A	4	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1204	10.1136/bmj.n1204	http://dx.doi.org/10.1136/bmj.n1204			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975874	Bronze			2022-12-28	WOS:000649711400015
J	Poorman, E				Poorman, Elisabeth			The Number Needed to Prescribe - What Would It Take to Expand Access to Buprenorphine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The Number Needed to Prescribe Policies have been proposed to remove obstacles to prescribing buprenorphine to people with opioid use disorder. But a larger barrier to treatment expansion is cultural: physicians and institutions fail to treat substance use disorders as the chronic diseases they are.	[Poorman, Elisabeth] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Poorman, E (corresponding author), Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA.							CDC Health Alert Network, 2020, HAN00438 CDC; Department of Health and Human Services, 2021, HHS REL NEW BUPR PRA; Larochelle MR, 2018, ANN INTERN MED, V169, P137, DOI 10.7326/M17-3107; McBain RK, 2020, ANN INTERN MED, V172, P504, DOI 10.7326/M19-2403	4	3	3	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					1783	1784		10.1056/NEJMp2101298	http://dx.doi.org/10.1056/NEJMp2101298		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD6UF	33983689				2022-12-28	WOS:000649041600001
J	Liu, STH; Aberg, JA				Liu, Sean T. H.; Aberg, Judith A.			Convalescent plasma in patients hospitalised with COVID-19	LANCET			English	Editorial Material									[Liu, Sean T. H.; Aberg, Judith A.] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Aberg, JA (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.	judith.aberg@mssm.edu		Liu, Sean/0000-0002-3842-6838				Agarwal A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3939; Angus DC, 2020, ANN AM THORAC SOC, V17, P879, DOI 10.1513/AnnalsATS.202003-192SD; Begin P, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05235-3; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Joyner MJ, 2021, NEW ENGL J MED, V384, P1015, DOI 10.1056/NEJMoa2031893; Kenig A, 2021, CLIN IMMUNOL, V227, DOI 10.1016/j.clim.2021.108723; Li L, 2020, JAMA-J AM MED ASSOC, V324, P519, DOI 10.1001/jama.2020.13216; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Liu STH, 2020, NAT MED, V26, P1708, DOI 10.1038/s41591-020-1088-9; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; NIH, 2021, NIH HALTS TRIAL COVI; Salazar E, 2020, AM J PATHOL, V190, P1680, DOI 10.1016/j.ajpath.2020.05.014; US Food and Drug Administration, 2021, EM US AUTH AUTH ONL	13	11	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 29	2021	397	10289					2024	2025		10.1016/S0140-6736(21)01064-3	http://dx.doi.org/10.1016/S0140-6736(21)01064-3		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SK5LX	34000255	Bronze, Green Published			2022-12-28	WOS:000656257800002
J	Mok, CC				Mok, Chi Chiu			A new old treatment for lupus nephritis	LANCET			English	Editorial Material									[Mok, Chi Chiu] Tuen Mun Hosp, Dept Med, Hong Kong, Peoples R China	Tuen Mun Hospital	Mok, CC (corresponding author), Tuen Mun Hosp, Dept Med, Hong Kong, Peoples R China.	ccmok2005@yahoo.com						Fanouriakis A, 2020, ANN RHEUM DIS, V79, P713, DOI 10.1136/annrheumdis-2020-216924; Furie R, 2020, ARTHRITIS RHEUMA S10, V72; Furie R, 2020, NEW ENGL J MED, V383, P1117, DOI 10.1056/NEJMoa2001180; Li Y, 2020, CLIN PHARMACOL-ADV A, V12, P83, DOI 10.2147/CPAA.S255789; Mok CC, 2021, LANCET RHEUMATOL, V3, pE517, DOI 10.1016/S2665-9913(21)00009-6; Mok CC, 2020, ANN RHEUM DIS, V79, P1070, DOI 10.1136/annrheumdis-2020-217178; Mok CC, 2017, BEST PRACT RES CL RH, V31, P429, DOI 10.1016/j.berh.2017.09.010; Rafael-Vidal C, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031263; Rovin BH, 2021, LANCET, V397, P2070, DOI 10.1016/S0140-6736(21)00578-X; Rovin BH, 2019, KIDNEY INT, V95, P219, DOI 10.1016/j.kint.2018.08.025; Tektonidou MG, 2016, ARTHRITIS RHEUMATOL, V68, P1432, DOI 10.1002/art.39594; Zhang HT, 2017, J AM SOC NEPHROL, V28, P3671, DOI 10.1681/ASN.2017030263	12	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 29	2021	397	10289					2027	2029		10.1016/S0140-6736(21)00663-2	http://dx.doi.org/10.1016/S0140-6736(21)00663-2		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SK5LX	33971151				2022-12-28	WOS:000656257800004
J	Cantor, AG; Jungbauer, RM; McDonagh, M; Blazina, I; Marshall, NE; Weeks, C; Fu, RW; LeBlanc, ES; Chou, R				Cantor, Amy G.; Jungbauer, Rebecca M.; McDonagh, Marian; Blazina, Ian; Marshall, Nicole E.; Weeks, Chandler; Fu, Rongwei; LeBlanc, Erin S.; Chou, Roger			Counseling and Behavioral Interventions for Healthy Weight and Weight Gain in Pregnancy: Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LIFE-STYLE INTERVENTION; RANDOMIZED CONTROLLED-TRIAL; BODY-MASS INDEX; GESTATIONAL DIABETES-MELLITUS; PARTIAL MEAL REPLACEMENT; QUALITY-OF-LIFE; POSTPARTUM WEIGHT; OBESE WOMEN; PHYSICAL-ACTIVITY; RISK-FACTORS	ImportanceCounseling and active behavioral interventions to limit excess gestational weight gain (GWG) during pregnancy may improve health outcomes for women and infants. The 2009 National Academy of Medicine (NAM; formerly the Institute of Medicine) recommendations for healthy GWG vary according to prepregnancy weight category. ObjectiveTo review and synthesize the evidence on benefits and harms of behavioral interventions to promote healthy weight gain during pregnancy to inform the US Preventive Services Task Force recommendation. Data SourcesOvid MEDLINE and the Cochrane Library to March 2020, with surveillance through February 2021. Study SelectionRandomized clinical trials and nonrandomized controlled intervention studies focused on diet, exercise, and/or behavioral counseling interventions on GWG. Data Extraction and SynthesisIndependent data abstraction and study quality rating with dual review. Main Outcomes and MeasuresGestational weight-related outcomes; maternal and infant morbidity and mortality; harms. ResultsSixty-eight studies (N=25789) were included. Sixty-seven studies evaluated interventions during pregnancy, and 1 evaluated an intervention prior to pregnancy. GWG interventions were associated with reductions in risk of gestational diabetes (43 trials, n=19752; relative risk [RR], 0.87 [95% CI, 0.79 to 0.95]; absolute risk difference [ARD], -1.6%) and emergency cesarean delivery (14 trials, n=7520; RR, 0.85 [95% CI, 0.74 to 0.96]; ARD, -2.4%). There was no significant association between GWG interventions and risk of gestational hypertension, cesarean delivery, or preeclampsia. GWG interventions were associated with decreased risk of macrosomia (25 trials, n=13990; RR, 0.77 [95% CI, 0.65 to 0.92]; ARD, -1.9%) and large for gestational age (26 trials, n=13000; RR, 0.89 [95% CI, 0.80 to 0.99]; ARD, -1.3%) but were not associated with preterm birth. Intervention participants experienced reduced weight gain across all prepregnancy weight categories (55 trials, n=20090; pooled mean difference, -1.02 kg [95% CI, -1.30 to -0.75]) and demonstrated lower likelihood of GWG in excess of NAM recommendations (39 trials, n=14271; RR, 0.83 [95% CI, 0.77 to 0.89]; ARD, -7.6%). GWG interventions were associated with reduced postpartum weight retention at 12 months (10 trials, n=3957; mean difference, -0.63 kg [95% CI, -1.44 to -0.01]). Data on harms were limited. Conclusions and RelevanceCounseling and active behavioral interventions to limit GWG were associated with decreased risk of gestational diabetes, emergency cesarean delivery, macrosomia, and large for gestational age. GWG interventions were also associated with modest reductions in mean GWG and decreased likelihood of exceeding NAM recommendations for GWG. This systematic review to support the 2021 US Preventive Services Task Force Recommendation Statement on interventions for healthy weight and weight gain in pregnancy summarizes published evidence on the benefits and harms of counseling and behavioral interventions for healthy weight and gestational weight gain in adolescent and adult women who are pregnant or planning a pregnancy.	[Cantor, Amy G.; Jungbauer, Rebecca M.; McDonagh, Marian; Blazina, Ian; Weeks, Chandler; Fu, Rongwei; Chou, Roger] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Cantor, Amy G.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Cantor, Amy G.; Marshall, Nicole E.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Fu, Rongwei] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA; [LeBlanc, Erin S.] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Portland State University; Kaiser Permanente	Cantor, AG (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	cantor@ohsu.edu		Blazina, Ian/0000-0003-0164-6674; Cantor, Amy/0000-0002-4467-8484				Adane AA, 2016, INT J OBESITY, V40, P1608, DOI 10.1038/ijo.2016.140; Al Wattar BH, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002857; Altazan AD, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2196-8; Althuizen E, 2013, BJOG-INT J OBSTET GY, V120, P92, DOI 10.1111/1471-0528.12014; Alvarez-Bueno C, 2017, INT J EPIDEMIOL, V46, P1653, DOI 10.1093/ije/dyx122; American Society for Reproductive Medicine, 2019, Fertil Steril, V111, P32, DOI 10.1016/j.fertnstert.2018.12.003; [Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; [Anonymous], 2018, PROCEDURE MANUAL; [Anonymous], 2017, HD PULS EC HLTH DISP; Asbee SM, 2009, OBSTET GYNECOL, V113, P305, DOI 10.1097/AOG.0b013e318195baef; Assaf-Balut C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185873; Bacchi M, 2018, AM J HEALTH PROMOT, V32, P729, DOI 10.1177/0890117117697520; Baidal JAW, 2016, AM J PREV MED, V50, P761, DOI 10.1016/j.amepre.2015.11.012; Barakat R, 2019, BRAZ J PHYS THER, V23, P148, DOI 10.1016/j.bjpt.2018.11.005; Barakat R, 2018, EUR J OBSTET GYN R B, V224, P33, DOI 10.1016/j.ejogrb.2018.03.009; Barakat R, 2014, AM J HEALTH PROMOT, V29, P2, DOI 10.4278/ajhp.130131-QUAN-56; Barakat R, 2012, BRIT J SPORT MED, V46, P656, DOI 10.1136/bjsports-2011-090009; Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; Bogaerts AFL, 2013, INT J OBESITY, V37, P814, DOI 10.1038/ijo.2012.162; Brownfoot FC, 2016, BJOG-INT J OBSTET GY, V123, P254, DOI 10.1111/1471-0528.13735; Bruno R, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12333; Cahill AG, 2018, OBESITY, V26, P485, DOI 10.1002/oby.22070; Cantor A., 2021, AHRQ PUBLICATION; Claesson IM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-766; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Daley A J, 2015, BMC Obes, V2, P35, DOI 10.1186/s40608-015-0061-5; Daley A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030174; Daly N, 2017, OBSTET GYNECOL, V130, P1001, DOI 10.1097/AOG.0000000000002267; Deputy NP, 2018, MMWR-MORBID MORTAL W, V66, P1402, DOI 10.15585/mmwr.mm665152a3; Dodd J. M., 2014, Current Nutrition Reports, V3, P392; Dodd JM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122911; Dodd JM, 2018, INT J OBESITY, V42, P1326, DOI [10.1038/S41366-018-0019-2, 10.1038/s41366-018-0019-z]; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Epel E, 2019, INT J BEHAV MED, V26, P461, DOI 10.1007/s12529-019-09779-2; Fuemmeler BF, 2016, CHILD OBES, V12, P210, DOI 10.1089/chi.2015.0253; Gallagher D, 2018, OBESITY, V26, P578, DOI 10.1002/oby.22079; Garnaes KK, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-017-1653-5; Garnaes KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173937; Garnas Kirsti Krohn, 2016, PLoS Med, V13, pe1002079, DOI 10.1371/journal.pmed.1002079; Gesell SB, 2015, MATERN CHILD HLTH J, V19, P1842, DOI 10.1007/s10995-015-1698-x; Gray-Donald K, 2000, CAN MED ASSOC J, V163, P1247; Guelfi KJ, 2016, OBSTET GYNECOL, V128, P819, DOI 10.1097/AOG.0000000000001632; Haakstad LAH, 2011, EUR J CONTRACEP REPR, V16, P116, DOI 10.3109/13625187.2011.560307; Haire-Joshu D, 2019, OBESITY, V27, P535, DOI 10.1002/oby.22413; Harrison CL, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0134-8; Harrison CL, 2013, OBESITY, V21, P904, DOI 10.1002/oby.20163; Herring Sharon J, 2017, Prev Med Rep, V7, P119, DOI 10.1016/j.pmedr.2017.05.015; Herring SJ, 2016, OBESITY, V24, P30, DOI 10.1002/oby.21240; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffmann J, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060876; Hui A, 2012, BJOG-INT J OBSTET GY, V119, P70, DOI 10.1111/j.1471-0528.2011.03184.x; Hui AL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-331; Huvinen E, 2018, J CLIN ENDOCR METAB, V103, P1669, DOI 10.1210/jc.2017-02477; Institute of Medicine and National Research Council, 2009, WEIGHT GAIN PREGNANC; International Weight Management in Pregnancy (i-WIP) Collaborative Group, 2017, BMJ, V358, pj3119, DOI 10.1136/bmj.j3119; Aguilar-Cordero MJ, 2019, J AM PSYCHIAT NURSES, V25, P112, DOI 10.1177/1078390317753675; Kalliala I, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4511; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Kinnunen TI, 2012, EUR J CLIN NUTR, V66, P1344, DOI 10.1038/ejcn.2012.146; Koivusalo SB, 2016, DIABETES CARE, V39, P24, DOI 10.2337/dc15-0511; Kunath J, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1235-z; LeBlanc ES, 2021, AM J OBSTET GYNECOL, V224, DOI 10.1016/j.ajog.2020.07.027; LeBlanc ES, 2018, JAMA-J AM MED ASSOC, V320, P1172, DOI 10.1001/jama.2018.7777; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; MacDorman MF, 2017, OBSTET GYNECOL, V129, P811, DOI [10.1097/AOG.0000000000001968, 10.1097/aog.0000000000001968]; Magriples U, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.066; Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288; McCarthy EA, 2016, BJOG-INT J OBSTET GY, V123, P965, DOI 10.1111/1471-0528.13919; McGiveron A, 2015, J HUM NUTR DIET, V28, P29, DOI 10.1111/jhn.12240; Mitanchez D, 2018, ACTA PAEDIATR, V107, P1156, DOI 10.1111/apa.14269; Okesene-Gafa KAM, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.03.003; Olson CM, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1767-4; Patnode CD, 2017, JAMA-J AM MED ASSOC, V318, P175, DOI 10.1001/jama.2017.3303; Peaceman AM, 2018, OBESITY, V26, P1396, DOI 10.1002/oby.22250; Peccei A, 2017, OBSTET GYNECOL, V130, P423, DOI 10.1097/AOG.0000000000002134; Pelaez M, 2019, MAYO CLIN PROC, V94, P1951, DOI 10.1016/j.mayocp.2019.01.050; Perales M, 2015, ARCH MED DEPORTE, V167, P156; Petrella E, 2014, J MATERN-FETAL NEO M, V27, P1348, DOI 10.3109/14767058.2013.858318; Phelan S, 2019, OBESITY, V27, P226, DOI 10.1002/oby.22361; Phelan S, 2018, AM J CLIN NUTR, V107, P183, DOI 10.1093/ajcn/nqx043; Phelan S, 2014, AM J CLIN NUTR, V99, P302, DOI 10.3945/ajcn.113.070151; Phelan S, 2011, AM J CLIN NUTR, V93, P772, DOI 10.3945/ajcn.110.005306; Polley BA, 2002, INT J OBESITY, V26, P1494, DOI 10.1038/sj.ijo.0802130; Poorolajal J, 2016, J MATERN-FETAL NEO M, V29, P3670, DOI 10.3109/14767058.2016.1140738; Rauh K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0701-2; Rauh K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-151; Redman LM, 2017, JMIR MHEALTH UHEALTH, V5, P32, DOI 10.2196/mhealth.8228; Renault KM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.029; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Ronnberg AK, 2015, BJOG-INT J OBSTET GY, V122, P537, DOI 10.1111/1471-0528.13131; Rono K, 2018, INT J WOMENS HEALTH, V10, P493, DOI 10.2147/IJWH.S162061; Rono K, 2018, J PERINATOL, V38, P1157, DOI 10.1038/s41372-018-0178-8; Ruiz JR, 2013, MAYO CLIN PROC, V88, P1388, DOI 10.1016/j.mayocp.2013.07.020; Sagedal LR, 2017, BJOG-INT J OBSTET GY, V124, P97, DOI 10.1111/1471-0528.13862; Sagedal LR, 2017, BJOG-INT J OBSTET GY, V124, P111, DOI 10.1111/1471-0528.13863; Seneviratne SN, 2016, BJOG-INT J OBSTET GY, V123, P588, DOI 10.1111/1471-0528.13738; Senger C.A., 2017, BEHAV COUNSELING PRO; Simmons D, 2017, J CLIN ENDOCR METAB, V102, P903, DOI 10.1210/jc.2016-3455; Skouteris H, 2016, BRIT J HEALTH PSYCH, V21, P31, DOI 10.1111/bjhp.12154; Smith K, 2016, J PHYS ACT HEALTH, V13, P587, DOI 10.1123/jpah.2015-0219; Tanvig M, 2015, J CLIN ENDOCR METAB, V100, P175, DOI 10.1210/jc.2014-2675; Tanvig M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089590; Thomson JL, 2018, OBES SCI PRACT, V4, P299, DOI 10.1002/osp4.272; Thomson JL, 2016, J PREGNANCY, V2016, DOI 10.1155/2016/5703607; Tucker MJ, 2007, AM J PUBLIC HEALTH, V97, P247, DOI 10.2105/AJPH.2005.072975; Van Horn L, 2018, AM J PREV MED, V55, P603, DOI 10.1016/j.amepre.2018.06.015; Vesco KK, 2016, OBESITY, V24, P2042, DOI 10.1002/oby.21597; Vesco KK, 2014, OBESITY, V22, P1989, DOI 10.1002/oby.20831; Vinter CA, 2011, DIABETES CARE, V34, P2502, DOI 10.2337/dc11-1150; Vinter CA, 2014, ACTA OBSTET GYN SCAN, V93, P794, DOI 10.1111/aogs.12429; Willcox JC, 2017, BJOG-INT J OBSTET GY, V124, P1718, DOI 10.1111/1471-0528.14552; Wilson PWF, 2003, CIRCULATION, V108, P1537, DOI 10.1161/01.CIR.0000089506.12223.F1; Wolff S, 2008, INT J OBESITY, V32, P495, DOI 10.1038/sj.ijo.0803710	113	35	35	3	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2094	2109		10.1001/jama.2021.4230	http://dx.doi.org/10.1001/jama.2021.4230			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ6MR	34032824	Bronze			2022-12-28	WOS:000655647300024
J	Burin, G; Guimaraes, PR; Quental, TB				Burin, Gustavo; Guimaraes Jr, Paulo R.; Quental, Tiago B.			Macroevolutionary stability predicts interaction patterns of species in seed dispersal networks	SCIENCE			English	Article							BIRDS; ANGIOSPERMS; MUTUALISMS; EXTINCTION; PLANTS; SPACE	Assessing deep-time mechanisms affecting the assembly of ecological networks is key to understanding biodiversity changes on broader time scales. We combined analyses of diversification rates with interaction network descriptors from 468 bird species belonging to 29 seed dispersal networks to show that bird species that contribute most to the network structure of plant-frugivore interactions belong to lineages that show higher macroevolutionary stability. This association is stronger in warmer, wetter, less seasonal environments. We infer that the macroevolutionary sorting mechanism acts through the regional pool of species by sorting species on the basis of the available relative differences in diversification rates, rather than absolute rates. Our results illustrate how the interplay between interaction patterns and diversification dynamics may shape the organization and long-term dynamics of ecological networks.	[Burin, Gustavo; Guimaraes Jr, Paulo R.; Quental, Tiago B.] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Burin, Gustavo] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England	Universidade de Sao Paulo; Natural History Museum London	Burin, G; Quental, TB (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil.; Burin, G (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	gustavoburin@usp.br; tbquental@usp.br	Burin, Gustavo/D-8679-2016; Quental, Tiago B/C-7077-2013	Burin, Gustavo/0000-0001-7851-0666; Guimaraes Junior, Paulo Roberto/0000-0001-9161-8305; Quental, Tiago/0000-0002-4832-9468	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2014/03621-9, 2018/04821-2, 2018/14809-0, 2012/04072-3, 2018/05462-6]; CAPES	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	All authors thank FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) for funding (G.B.: grants #2014/03621-9 and #2018/04821-2; P.R.G.: grant #2018/14809-0; T.B.Q.: grants #2012/04072-3 and #2018/05462-6); G.B. also thanks CAPES for a PhD fellowship.	[Anonymous], A global phylogeny of birds; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Burin G, 2019, SYST BIOL, V68, P47, DOI 10.1093/sysbio/syy037; Burin G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11250; CaraDonna PJ, 2021, ECOL LETT, V24, P149, DOI 10.1111/ele.13623; CORLETT RT, 1994, J TROP ECOL, V10, P445, DOI 10.1017/S0266467400008129; Dehling DM, 2020, ECOLOGY, V101, DOI 10.1002/ecy.3028; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Eriksson O, 2016, BIOL REV, V91, P168, DOI 10.1111/brv.12164; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; FLEMING TH, 1987, ANNU REV ECOL SYST, V18, P91, DOI 10.1146/annurev.ecolsys.18.1.91; Fleming TH., 2013, ORNAMENTS LIFE COEVO; Fricke EC, 2020, NATURE, V585, P74, DOI 10.1038/s41586-020-2640-y; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; GILINSKY NL, 1994, PALEOBIOLOGY, V20, P445, DOI 10.1017/S0094837300012926; Gomez JM, 2012, SYST BIOL, V61, P567, DOI 10.1093/sysbio/syr127; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; Guimaraes PR, 2020, ANNU REV ECOL EVOL S, V51, P433, DOI 10.1146/annurev-ecolsys-012220-120819; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Harmon LJ, 2019, J EVOLUTION BIOL, V32, P769, DOI 10.1111/jeb.13477; Holland SM, 2019, PALEOBIOLOGY, V45, P1, DOI 10.1017/pab.2018.43; Jablonski D, 2008, EVOLUTION, V62, P715, DOI 10.1111/j.1558-5646.2008.00317.x; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kissling WD, 2009, GLOBAL ECOL BIOGEOGR, V18, P150, DOI 10.1111/j.1466-8238.2008.00431.x; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Louca S, 2020, NATURE, V580, P502, DOI 10.1038/s41586-020-2176-1; Mittelbach GG, 2015, TRENDS ECOL EVOL, V30, P241, DOI 10.1016/j.tree.2015.02.008; Nakagawa S, 2019, SYST BIOL, V68, P632, DOI 10.1093/sysbio/syy089; Nuismer SL, 2015, ECOL LETT, V18, P17, DOI 10.1111/ele.12384; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Pigot A. L., 2016, **DATA OBJECT**, DOI [10.5061/dryad.2br2b, DOI 10.5061/DRYAD.2BR2B]; Pigot AL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1597; Pires MM, 2014, OECOLOGIA, V175, P1247, DOI 10.1007/s00442-014-2971-1; Plein M, 2013, ECOLOGY, V94, P1296, DOI 10.1890/12-1213.1; Ponisio LC, 2017, ECOL LETT, V20, P1261, DOI 10.1111/ele.12821; Rabosky DL, 2019, SYST BIOL, V68, P538, DOI 10.1093/sysbio/syy079; Rabosky DL, 2015, EVOLUTION, V69, P3207, DOI 10.1111/evo.12817; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Roopnarine PD, 2019, EARTH-SCI REV, V189, P244, DOI 10.1016/j.earscirev.2018.10.014; SNOW DW, 1981, BIOTROPICA, V13, P1, DOI 10.2307/2387865; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913; Weber MG, 2014, P NATL ACAD SCI USA, V111, P16442, DOI 10.1073/pnas.1413253111; Yang SN, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00222.1; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	50	9	11	15	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					733	+		10.1126/science.abf0556	http://dx.doi.org/10.1126/science.abf0556			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986179	Green Submitted			2022-12-28	WOS:000651125300049
J	Collier, ARY; McMahan, K; Yu, JY; Tostanoski, LH; Aguayo, R; Ansel, J; Chandrashekar, A; Patel, S; Bondzie, EA; Sellers, D; Barrett, J; Sanborn, O; Wan, HH; Chang, AQ; Anioke, T; Nkolola, J; Bradshaw, C; Jacob-Dolan, C; Feldman, J; Gebre, M; Borducchi, EN; Liu, JY; Schmidt, AG; Suscovich, T; Linde, C; Alter, G; Hacker, MR; Barouch, DH				Collier, Ai-ris Y.; McMahan, Katherine; Yu, Jingyou; Tostanoski, Lisa H.; Aguayo, Ricardo; Ansel, Jessica; Chandrashekar, Abishek; Patel, Shivani; Apraku Bondzie, Esther; Sellers, Daniel; Barrett, Julia; Sanborn, Owen; Wan, Huahua; Chang, Aiquan; Anioke, Tochi; Nkolola, Joseph; Bradshaw, Connor; Jacob-Dolan, Catherine; Feldman, Jared; Gebre, Makda; Borducchi, Erica N.; Liu, Jinyan; Schmidt, Aaron G.; Suscovich, Todd; Linde, Caitlyn; Alter, Galit; Hacker, Michele R.; Barouch, Dan H.			Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VACCINATION	IMPORTANCE Pregnant women are at increased risk of morbidity and mortality from COVID-19 but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety and immunogenicity in these populations are therefore limited. OBJECTIVE To evaluate the immunogenicity of COVID-19 messenger RNA (mRNA) vaccines in pregnant and lactating women, including against emerging SARS-CoV-2 variants of concern. DESIGN, SETTING, AND PARTICIPANTS An exploratory, descriptive, prospective cohort study enrolled 103 women who received a COVID-19 vaccine from December 2020 through March 2021 and 28 women who had confirmed SARS-CoV-2 infection from April 2020 through March 2021 (the last follow-up date was March 26, 2021). This study enrolled 30 pregnant, 16 lactating, and 57 neither pregnant nor lactating women who received either the mRNA-1273 (Moderna) or BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines and 22 pregnant and 6 nonpregnant unvaccinated women with SARS-CoV-2 infection. MAIN OUTCOMES AND MEASURES SARS-CoV-2 receptor binding domain binding, neutralizing, and functional nonneutralizing antibody responses from pregnant, lactating, and nonpregnant women were assessed following vaccination. Spike-specific T-cell responses were evaluated using IFN-gamma enzyme-linked immunospot and multiparameter intracellular cytokine-staining assays. Humoral and cellular immune responses were determined against the original SARS-CoV-2 USA-WA1/2020 strain as well as against the B.1.1.7 and B.1.351 variants. RESULTS This study enrolled 103 women aged 18 to 45 years (66% non-Hispanic White) who received a COVID-19 mRNA vaccine. After the second vaccine dose, fever was reported in 4 pregnant women (14%; SD, 6%), 7 lactating women (44%; SD, 12%), and 27 nonpregnant women (52%; SD, 7%). Binding, neutralizing, and functional nonneutralizing antibody responses as well as CD4 and CD8 T-cell responses were present in pregnant, lactating, and nonpregnant women following vaccination. Binding and neutralizing antibodies were also observed in infant cord blood and breast milk. Binding and neutralizing antibody titers against the SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern were reduced, but T-cell responses were preserved against viral variants. CONCLUSION AND RELEVANCE In this exploratory analysis of a convenience sample, receipt of a COVID-19 mRNA vaccine was immunogenic in pregnant women, and vaccine-elicited antibodies were transported to infant cord blood and breast milk. Pregnant and nonpregnant women who were vaccinated developed cross-reactive antibody responses and T-cell responses against SARS-CoV-2 variants of concern.	[Collier, Ai-ris Y.; Aguayo, Ricardo; Hacker, Michele R.] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; [Collier, Ai-ris Y.; Chang, Aiquan; Jacob-Dolan, Catherine; Feldman, Jared; Gebre, Makda; Schmidt, Aaron G.; Alter, Galit; Hacker, Michele R.; Barouch, Dan H.] Harvard Med Sch, Boston, MA 02115 USA; [Collier, Ai-ris Y.; McMahan, Katherine; Yu, Jingyou; Tostanoski, Lisa H.; Ansel, Jessica; Chandrashekar, Abishek; Patel, Shivani; Apraku Bondzie, Esther; Sellers, Daniel; Barrett, Julia; Sanborn, Owen; Wan, Huahua; Chang, Aiquan; Anioke, Tochi; Nkolola, Joseph; Bradshaw, Connor; Jacob-Dolan, Catherine; Gebre, Makda; Borducchi, Erica N.; Liu, Jinyan; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Feldman, Jared; Schmidt, Aaron G.; Alter, Galit; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Suscovich, Todd; Linde, Caitlyn] SeromYx Syst Inc, Cambridge, MA USA; [Hacker, Michele R.; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Beth Israel Deaconess Medical Center	Barouch, DH (corresponding author), Ctr Virol & Vaccine Res, 330 Brookline Ave,E-CLS-1043, Boston, MA 02115 USA.	dbarouch@bidmc.harvard.edu	Hacker, Michele/ABC-5031-2021; Chandrashekar, Abishek/P-2610-2019	Chandrashekar, Abishek/0000-0001-7821-5552; Jacob-Dolan, Catherine/0000-0001-6641-0342; Tostanoski, Lisa/0000-0001-9255-5684; Gebre, Makda/0000-0001-8520-2178; Chang, Aiquan/0000-0002-9482-0979	National Institutes of Health (NIH) [CA260476]; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard; Massachusetts Consortium for Pathogen Readiness; Musk Foundation; NIH [AI146779]; Reproductive Scientist Development Program from the Eunice Kennedy Shriver National Institute of Child Health AMP; Human Development [HD000849]; BurroughsWellcome Fund [HD000849]; Multidisciplinary AIDS Training Program [AI007387]; Harvard Clinical and Translational Science Center [TR002541]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard; Massachusetts Consortium for Pathogen Readiness; Musk Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reproductive Scientist Development Program from the Eunice Kennedy Shriver National Institute of Child Health AMP; Human Development; BurroughsWellcome Fund(Burroughs Wellcome Fund); Multidisciplinary AIDS Training Program; Harvard Clinical and Translational Science Center	This study was funded by grant CA260476 from the National Institutes of Health (NIH), and grants from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard, the Massachusetts Consortium for Pathogen Readiness, and the Musk Foundation (DHB); AI146779 from the NIH (AGS); HD000849 from the Reproductive Scientist Development Program from the Eunice Kennedy Shriver National Institute of Child Health & Human Development and from BurroughsWellcome Fund (AYC), AI007387 from the Multidisciplinary AIDS Training Program (LHT), and TR002541 from the Harvard Clinical and Translational Science Center (MRH).	Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Baird JK, 2021, SARS COV 2 ANTIBODIE; Centers for Disease Control Prevention, SARS COV 2 VAR CLASS; Centers for Disease Prevention and Control, V SAF VACC HLTH CHEC; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Edlow AG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.30455; Feldman J., 2021, NAIVE HUMAN B CELLS, DOI [10.1101/2021.02.02.429458, DOI 10.1101/2021.02.02.429458]; Gee J, 2021, MMWR-MORBID MORTAL W, V70, P283, DOI 10.15585/mmwr.mm7008e3; Harvey, 2020, SSRN ELECT J, DOI [DOI 10.2139/SSRN.3780277, 10.1101/2020.12.14.422555]; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Liu Y, 2021, NEW ENGL J MED, V384, P1466, DOI 10.1056/NEJMc2102017; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Pace Ryan M, 2020, medRxiv, DOI 10.1101/2020.09.16.20196071; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rasmussen SA, 2021, JAMA-J AM MED ASSOC, V325, P1099, DOI 10.1001/jama.2021.1683; Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Winter K, 2017, CLIN INFECT DIS, V64, P9, DOI 10.1093/cid/ciw633; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284	26	162	167	10	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2021	325	23					2370	2380		10.1001/jama.2021.7563	http://dx.doi.org/10.1001/jama.2021.7563		MAY 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SU3BJ	33983379	Green Published, Bronze			2022-12-28	WOS:000650215800001
J	Hoberman, A; Preciado, D; Paradise, JL; Chi, DH; Haralam, M; Block, SL; Kearney, DH; Bhatnagar, S; Pujalt, GBM; Shope, TR; Martin, JM; Felten, DE; Kurs-Lasky, M; Liu, H; Yahner, K; Jeong, JH; Cohen, NL; Czervionke, B; Nagg, JP; Dohar, JE; Shaikh, N				Hoberman, Alejandro; Preciado, Diego; Paradise, Jack L.; Chi, David H.; Haralam, MaryAnn; Block, Stan L.; Kearney, Diana H.; Bhatnagar, Sonika; Pujalt, Gysella B. Muniz; Shope, Timothy R.; Martin, Judith M.; Felten, Daniel E.; Kurs-Lasky, Marcia; Liu, Hui; Yahner, Kristin; Jeong, Jong-Hyeon; Cohen, Norman L.; Czervionke, Brian; Nagg, Jennifer P.; Dohar, Joseph E.; Shaikh, Nader			Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVENTION; CHILDREN; INSERTION; LIFE	Background Official recommendations differ regarding tympanostomy-tube placement for children with recurrent acute otitis media. Methods We randomly assigned children 6 to 35 months of age who had had at least three episodes of acute otitis media within 6 months, or at least four episodes within 12 months with at least one episode within the preceding 6 months, to either undergo tympanostomy-tube placement or receive medical management involving episodic antimicrobial treatment. The primary outcome was the mean number of episodes of acute otitis media per child-year (rate) during a 2-year period. Results In our main, intention-to-treat analysis, the rate (+/- SE) of episodes of acute otitis media per child-year during a 2-year period was 1.48 +/- 0.08 in the tympanostomy-tube group and 1.56 +/- 0.08 in the medical-management group (P=0.66). Because 10% of the children in the tympanostomy-tube group did not undergo tympanostomy-tube placement and 16% of the children in the medical-management group underwent tympanostomy-tube placement at parental request, we conducted a per-protocol analysis, which gave corresponding episode rates of 1.47 +/- 0.08 and 1.72 +/- 0.11, respectively. Among secondary outcomes in the main analysis, results were mixed. Favoring tympanostomy-tube placement were the time to a first episode of acute otitis media, various episode-related clinical findings, and the percentage of children meeting specified criteria for treatment failure. Favoring medical management was children's cumulative number of days with otorrhea. Outcomes that did not show substantial differences included the frequency distribution of episodes of acute otitis media, the percentage of episodes considered to be severe, and antimicrobial resistance among respiratory isolates. Trial-related adverse events were limited to those included among the secondary outcomes of the trial. Conclusions Among children 6 to 35 months of age with recurrent acute otitis media, the rate of episodes of acute otitis media during a 2-year period was not significantly lower with tympanostomy-tube placement than with medical management. (Funded by the National Institute on Deafness and Other Communication Disorders and others; ClinicalTrials.gov number, .) Tympanostomy Tubes for Recurrent Acute Otitis Media This trial randomly assigned children 6 to 35 months of age who had a history of multiple episodes of acute otitis media to either undergo tympanostomy-tube placement or receive medical management. The rate of episodes of acute otitis media during a 2-year period was not substantially lower with tube placement than with medical management.	[Hoberman, Alejandro; Paradise, Jack L.; Haralam, MaryAnn; Kearney, Diana H.; Bhatnagar, Sonika; Pujalt, Gysella B. Muniz; Shope, Timothy R.; Martin, Judith M.; Kurs-Lasky, Marcia; Liu, Hui; Yahner, Kristin; Nagg, Jennifer P.; Shaikh, Nader] Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Chi, David H.; Dohar, Joseph E.] Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Dept Otolaryngol, Pittsburgh, PA USA; [Jeong, Jong-Hyeon] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Cohen, Norman L.; Czervionke, Brian] Childrens Community Pediat, Pittsburgh, PA USA; [Preciado, Diego; Felten, Daniel E.] Childrens Natl Med Ctr, Washington, DC USA; [Block, Stan L.] Kentucky Pediat & Adult Res, Bardstown, KY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's National Health System	Hoberman, A (corresponding author), UPMC Childrens Hosp Pittsburgh, Div Gen Acad Pediat, 3414 Fifth Ave, Pittsburgh, PA 15213 USA.	hoberman@chp.edu		hoberman, alejandro/0000-0001-6793-8798	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NCRR NIH HHS [UL1 RR024153] Funding Source: Medline; NIDCD NIH HHS [1 U01 DC013995-01A1, U01 DC013995] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ah-Tye C, 2001, PEDIATRICS, V107, P1251, DOI 10.1542/peds.107.6.1251; [Anonymous], 2019, PLAST RECONSTR SURG, V143, p1S; Boruk M, 2007, OTOLARYNG HEAD NECK, V136, P159, DOI 10.1016/j.otohns.2006.09.005; CASSELBRANT ML, 1992, PEDIATR INFECT DIS J, V11, P278, DOI 10.1097/00006454-199204000-00004; Cullen Karen A, 2009, Natl Health Stat Report, P1; GEBHART DE, 1981, LARYNGOSCOPE, V91, P849; GONZALEZ C, 1986, LARYNGOSCOPE, V96, P1330; Hoberman A, 2011, NEW ENGL J MED, V364, P105, DOI 10.1056/NEJMoa0912254; Johnston LC, 2004, PEDIATRICS, V114, pE58, DOI 10.1542/peds.114.1.e58; Kaleida PH, 2009, PEDIATRICS, V124, pE714, DOI 10.1542/peds.2008-2838; Kay DJ, 2001, OTOLARYNG HEAD NECK, V124, P374, DOI 10.1067/mhn.2001.113941; Kujala T, 2012, PEDIATR INFECT DIS J, V31, P565, DOI 10.1097/INF.0b013e318255ddde; Leibovitz E, 2003, PEDIATR INFECT DIS J, V22, P209, DOI 10.1097/00006454-200303000-00002; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lipsitch M, 2001, CLIN INFECT DIS, V32, P1044, DOI 10.1086/319604; McCann ME, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6459; Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V149, pS1, DOI 10.1177/0194599813487302; Rosenfeld RM, 1997, ARCH OTOLARYNGOL, V123, P1049; Samore MH, 2006, AM J EPIDEMIOL, V163, P160, DOI 10.1093/aje/kwj021; Shaikh N, 2015, PEDIATR INFECT DIS J, V34, pE41, DOI 10.1097/INF.0000000000000557	20	10	10	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					1789	1799		10.1056/NEJMoa2027278	http://dx.doi.org/10.1056/NEJMoa2027278			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD6UF	33979487	Bronze, Green Accepted			2022-12-28	WOS:000651509400007
J	Oliver, D				Oliver, David			David Oliver: Consulting on uniform while ignoring PPE failings insults NHS staff	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Carter C, 2021, COMMUNITY CARE; Conn D., 2021, GUARDIAN; Karlsson U, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3944; Lintern S, 2020, CORONAVIRUS DEATHS 1; Moore A, 2021, HLTH SERV J; National Audit Office, 2020, SUPPL PERS PROT EQ P; NHS Supply Chain, 2021, NHS SUPPL CHAIN LAUN; UK Parliament, 2020, COVID 19 GOV PROC SU; University of Greenwich, WE OWN IT PRIV UNPR	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1172	10.1136/bmj.n1172	http://dx.doi.org/10.1136/bmj.n1172			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2ZO	33980498	Bronze			2022-12-28	WOS:000651243600005
J	Ouyang, J; Yadav, T; Zhang, JM; Yang, HB; Rheinbay, E; Guo, HS; Haber, DA; Lan, L; Zou, L				Ouyang, Jian; Yadav, Tribhuwan; Zhang, Jia-Min; Yang, Haibo; Rheinbay, Esther; Guo, Hongshan; Haber, Daniel A.; Lan, Li; Zou, Lee			RNA transcripts stimulate homologous recombination by forming DR-loops	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HUMAN RAD51 PROTEIN; BINDING PROTEIN; REPAIR; PROMOTION; CHROMATIN; COMPLEX	Homologous recombination (HR) repairs DNA double-strand breaks (DSBs) in the S and G2 phases of the cell cycle(1-3). Several HR proteins are preferentially recruited to DSBs at transcriptionally active loci(4-10), but how transcription promotes HR is poorly understood. Here we develop an assay to assess the effect of local transcription on HR. Using this assay, we find that transcription stimulates HR to a substantial extent. Tethering RNA transcripts to the vicinity of DSBs recapitulates the effects of local transcription, which suggests that transcription enhances HR through RNA transcripts. Tethered RNA transcripts stimulate HR in a sequence- and orientation-dependent manner, indicating that they function by forming DNA-RNA hybrids. In contrast to most HR proteins, RAD51-associated protein 1 (RAD51AP1) only promotes HR when local transcription is active. RAD51AP1 drives the formation of R-loops in vitro and is required for tethered RNAs to stimulate HR in cells. Notably, RAD51AP1 is necessary for the DSB-induced formation of DNA-RNA hybrids in donor DNA, linking R-loops to D-loops. In vitro, RAD51AP1-generated R-loops enhance the RAD51-mediated formation of D-loops locally and give rise to intermediates that we term 'DR-loops', which contain both DNA-DNA and DNA-RNA hybrids and favour RAD51 function. Thus, at DSBs in transcribed regions, RAD51AP1 promotes the invasion of RNA transcripts into donor DNA, and stimulates HR through the formation of DR-loops.	[Ouyang, Jian; Yadav, Tribhuwan; Zhang, Jia-Min; Yang, Haibo; Rheinbay, Esther; Guo, Hongshan; Haber, Daniel A.; Lan, Li; Zou, Lee] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Yang, Haibo; Lan, Li] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Charlestown, MA USA; [Guo, Hongshan; Haber, Daniel A.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Charlestown, MA USA; [Zou, Lee] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital	Ouyang, J; Zou, L (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.; Zou, L (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA.	jouyang2@mgh.harvard.edu; zou.lee@mgh.harvard.edu		, Li/0000-0003-0383-6172; Zou, Lee/0000-0003-3094-1058; Yang, Haibo/0000-0003-3038-6453	NIH [CA197779, CA218856]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Sung, G. Legube, J. K. Joung, J. Jin and G. Gill for reagents, and N. Dyson, A. Elia and members of the L.Z. and N. Dyson laboratories for discussions. L.Z. is the James & Patricia Poitras Endowed Chair in Cancer Research. This work is supported by grants from the NIH (CA197779 and CA218856) to L.Z.	Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Chailleux C, 2014, NAT PROTOC, V9, P517, DOI 10.1038/nprot.2014.031; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/NMETH.3312, 10.1038/nmeth.3312]; Chen H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16722-7; Cohen S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02894-w; D'Alessandro G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07799-2; Daley JM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a017954; Dunlop MH, 2012, J BIOL CHEM, V287, P12343, DOI 10.1074/jbc.C112.352161; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Greene EC, 2016, J BIOL CHEM, V291, P11572, DOI 10.1074/jbc.R116.724807; Hatchi E, 2021, NATURE, V591, P665, DOI 10.1038/s41586-020-03150-2; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Kleinstiver BP, 2019, NAT BIOTECHNOL, V37, P276, DOI 10.1038/s41587-018-0011-0; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Liang FS, 2016, CELL REP, V15, P2118, DOI 10.1016/j.celrep.2016.05.007; Marnef A, 2017, J MOL BIOL, V429, P1277, DOI 10.1016/j.jmb.2017.03.024; Mazina OM, 2017, MOL CELL, V67, P19, DOI 10.1016/j.molcel.2017.05.019; McDevitt S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03483-7; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Meers C, 2020, MOL CELL, V79, P1037, DOI 10.1016/j.molcel.2020.08.011; Michelini F, 2017, NAT CELL BIOL, V19, P1400, DOI 10.1038/ncb3643; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Moquin DM, 2019, GENE DEV, V33, P75, DOI 10.1101/gad.315978.118; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Ouyang J, 2017, SCI CHINA LIFE SCI, V60, P1081, DOI 10.1007/s11427-017-9164-1; Ouyang J, 2015, MOL CELL, V57, P108, DOI 10.1016/j.molcel.2014.11.015; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sharma S, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108565; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Taylor SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02217-x; Teng YQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06586-3; Tumini E, 2021, METHODS MOL BIOL, V2153, P383, DOI 10.1007/978-1-0716-0644-5_26; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Wei LZ, 2015, P NATL ACAD SCI USA, V112, pE3495, DOI 10.1073/pnas.1507105112; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Yasuhara T, 2018, CELL, V175, P558, DOI 10.1016/j.cell.2018.08.056; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	47	35	36	5	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2021	594	7862					283	+		10.1038/s41586-021-03538-8	http://dx.doi.org/10.1038/s41586-021-03538-8		MAY 2021	34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SQ8YR	33981036	Green Accepted			2022-12-28	WOS:000650200300008
J	[Anonymous]				[Anonymous]			Foreign Letters London (Reprinted from vol 76, pg 1360, 1921)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1907	1907		10.1001/jama.2020.17930	http://dx.doi.org/10.1001/jama.2020.17930			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974028				2022-12-28	WOS:000650205000029
J	Taylor, L				Taylor, Luke			Covid-19: Investigation probes Bolsonaro's role in Brazil's failed pandemic response	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2021	373								n1181	10.1136/bmj.n1181	http://dx.doi.org/10.1136/bmj.n1181			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QT	33962975	Bronze			2022-12-28	WOS:000649708700004
J	Bohm, M; Lauder, L				Boehm, Michael; Lauder, Lucas			Blood pressure and renal denervation with ultrasound: another step forward	LANCET			English	Editorial Material							ANTIHYPERTENSIVE MEDICATIONS; UNCONTROLLED HYPERTENSION; ABSENCE		[Boehm, Michael; Lauder, Lucas] Saarland Univ, Innere Med Klin 3, Univ Klinikum Saarlandes, D-66421 Homburg, Germany	Universitatsklinikum des Saarlandes	Bohm, M (corresponding author), Saarland Univ, Innere Med Klin 3, Univ Klinikum Saarlandes, D-66421 Homburg, Germany.	michael.boehm@uks.eu						[Anonymous], KLIN INN MED 3; Azizi M, 2021, LANCET, V397, P2476, DOI 10.1016/S0140-6736(21)00788-1; Azizi M, 2018, LANCET, V391, P2335, DOI 10.1016/S0140-6736(18)31082-1; Bohm M, 2020, CLIN RES CARDIOL, V109, P289, DOI 10.1007/s00392-020-01595-z; Bohm M, 2014, CIRC RES, V115, P400, DOI 10.1161/CIRCRESAHA.115.302522; Bohm M, 2020, LANCET, V395, P1444, DOI 10.1016/S0140-6736(20)30554-7; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Kandzari DE, 2018, LANCET, V391, P2346, DOI 10.1016/S0140-6736(18)30951-6; Lauder L, 2020, NAT REV CARDIOL, V17, P614, DOI 10.1038/s41569-020-0364-1; Mahfoud F, 2020, J AM COLL CARDIOL, V75, P2879, DOI 10.1016/j.jacc.2020.04.036; Schmieder RE, 2019, CLIN RES CARDIOL, V108, P1331, DOI 10.1007/s00392-019-01468-0; Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]; Townsend RR, 2017, LANCET, V390, P2160, DOI 10.1016/S0140-6736(17)32281-X	13	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 26	2021	397	10293					2441	2443		10.1016/S0140-6736(21)00989-2	http://dx.doi.org/10.1016/S0140-6736(21)00989-2		JUN 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TA5XM	34010610				2022-12-28	WOS:000667322400005
J	Hofbauer, P; Jahnel, SM; Papai, N; Giesshammer, M; Deyett, A; Schmidt, C; Penc, M; Tavernini, K; Grdseloff, N; Meledeth, C; Ginistrelli, LC; Ctortecka, C; Salic, S; Novatchkova, M; Mendjan, S				Hofbauer, Pablo; Jahnel, Stefan M.; Papai, Nora; Giesshammer, Magdalena; Deyett, Alison; Schmidt, Clara; Penc, Mirjam; Tavernini, Katherina; Grdseloff, Nastasja; Meledeth, Christy; Ginistrelli, Lavinia Ceci; Ctortecka, Claudia; Salic, Sejla; Novatchkova, Maria; Mendjan, Sasha			Cardioids reveal self-organizing principles of human cardiogenesis	CELL			English	Article							BHLH TRANSCRIPTION FACTOR; PLURIPOTENT STEM-CELLS; CARDIOMYOCYTE PROLIFERATION; CARDIAC MICROTISSUES; HEART REGENERATION; ENDOTHELIAL-CELLS; PROGENITOR CELLS; EMBRYOS LACKING; MORPHOGENESIS; MESODERM	Organoids capable of forming tissue-like structures have transformed our ability to model human development and disease. With the notable exception of the human heart, lineage-specific self-organizing organoids have been reported for all major organs. Here, we established self-organizing cardioids from human pluripotent stem cells that intrinsically specify, pattern, and morph into chamber-like structures containing a cavity. Cardioid complexity can be controlled by signaling that instructs the separation of cardiomyocyte and endothelial layers and by directing epicardial spreading, inward migration, and differentiation. We find that cavity morphogenesis is governed by amesodermalWNT-BMP signaling axis and requires its target HAND1, a transcription factor linked to developmental heart chamber defects. Upon cryoinjury, cardioids initiated a celltype-dependent accumulation of extracellular matrix, an early hallmark of both regeneration and heart disease. Thus, human cardioids represent a powerful platform to mechanistically dissect self-organization, congenital heart defects and serve as a foundation for future translational research.	[Hofbauer, Pablo; Jahnel, Stefan M.; Papai, Nora; Giesshammer, Magdalena; Deyett, Alison; Schmidt, Clara; Penc, Mirjam; Tavernini, Katherina; Grdseloff, Nastasja; Meledeth, Christy; Ginistrelli, Lavinia Ceci; Ctortecka, Claudia; Salic, Sejla; Mendjan, Sasha] Austrian Acad Sci IMBA, Vienna BioCtr, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria; [Novatchkova, Maria] Inst Mol Pathol IMP, Vienna Bioctr 1, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Mendjan, S (corresponding author), Austrian Acad Sci IMBA, Vienna BioCtr, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	sasha.mendjan@imba.oeaw.ac.at	Mendjan, Sasha/HHN-7384-2022	Grdseloff, Nastasja/0000-0003-4417-3889; Deyett, Alison/0000-0002-0326-4613; Jahnel, Stefan/0000-0003-1147-9179; Tavernini, Katherina/0000-0003-3987-2167; Mendjan, Sasha/0000-0001-7539-3951; Meledeth, Christy/0000-0002-6056-302X	Austrian Academy of Sciences (OEAW); Research Promotion Agency (FFG)	Austrian Academy of Sciences (OEAW); Research Promotion Agency (FFG)	We thank all laboratory members for help and discussions and Katarzyna Warczok for lab management. We are grateful to the VBC Histology, EM and NGS, IMP/IMBA Core, and IMBA SCCF facilities for their services; the Allen Institute for cell lines; the Knoblich laboratory/Joshua A. Bagley for cell lines, reagents, and discussions; and Penninger laboratory/Reiner Wimmer for sharing data and reagents. We are thankful to Philip Szkokan and Steffen Hering for assisting with the FluoVolt measurements and analysis. We are thankful to the Kicheva laboratory for training on chicken embryo work. We are thankful to the Tanaka and Gerlich laboratories for sharing reagents. We are grateful to Paulina Latos, Alex Stark, Luisa Cochella, Juergen Knoblich, and Elly Tanaka for comments on the manuscript and Life Science Editors for scientific editing. This work was funded by the Austrian Academy of Sciences (OEAW) and Research Promotion Agency (FFG).	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Ali SR, 2014, CIRC RES, V115, P625, DOI 10.1161/CIRCRESAHA.115.303794; Anderson DJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03714-x; Andres-Delgado L., 2018, ACTOMYOSIN DYNAMICS, DOI [10.1101/332593, DOI 10.1101/332593]; [Anonymous], 1929, NAT COMMUN, V10; Guadix JA, 2017, STEM CELL REP, V9, P1754, DOI 10.1016/j.stemcr.2017.10.023; Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304; Birket MJ, 2015, NAT BIOTECHNOL, V33, P970, DOI 10.1038/nbt.3271; Cao JL, 2018, NAT REV CARDIOL, V15, P631, DOI 10.1038/s41569-018-0046-4; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Cui YL, 2019, CELL REP, V26, P1934, DOI 10.1016/j.celrep.2019.01.079; de Soysa TY, 2019, NATURE, V572, P120, DOI 10.1038/s41586-019-1414-x; DEHAAN RL, 1959, DEV BIOL, V1, P586, DOI 10.1016/0012-1606(59)90019-3; Devalla HD, 2015, EMBO MOL MED, V7, P394, DOI 10.15252/emmm.201404757; Doblmann J, 2019, J PROTEOME RES, V18, P535, DOI 10.1021/acs.jproteome.8b00113; Drakhlis L., 2021, NAT BIOTECHNOL, DOI [10.1038/s41587, DOI 10.1038/S41587]; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Duchemin AL, 2019, CURR OPIN GENET DEV, V57, P106, DOI 10.1016/j.gde.2019.08.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; GARCIAMARTINEZ V, 1993, DEV BIOL, V159, P706, DOI 10.1006/dbio.1993.1276; Giacomelli E, 2020, CELL STEM CELL, V26, P862, DOI 10.1016/j.stem.2020.05.004; Giacomelli E, 2017, DEVELOPMENT, V144, P1008, DOI 10.1242/dev.143438; Grossfeld P, 2019, J CARDIOVASC DEV DIS, V6, DOI 10.3390/jcdd6010010; Haack T, 2016, DEVELOPMENT, V143, P373, DOI 10.1242/dev.131425; Haubner BJ, 2016, CIRC RES, V118, P216, DOI 10.1161/CIRCRESAHA.115.307017; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hortells L, 2019, J CARDIOVASC DEV DIS, V6, DOI 10.3390/jcdd6030029; Huang XY, 2019, J BIOL CHEM, V294, P8894, DOI 10.1074/jbc.RA118.006994; Huebsch N, 2015, TISSUE ENG PART C-ME, V21, P467, DOI [10.1089/ten.tec.2014.0283, 10.1089/ten.TEC.2014.0283]; Ivanovitch K, 2017, J CARDIOVASC DEV DIS, V4, DOI 10.3390/jcdd4040020; Iyer D, 2015, DEVELOPMENT, V142, P1528, DOI 10.1242/dev.119271; Kelly RG, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015750; Kobayashi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102796; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lancaster MA, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.039347; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee JH, 2017, CELL STEM CELL, V21, P179, DOI 10.1016/j.stem.2017.07.003; Lescroart F, 2018, SCIENCE, V359, P1177, DOI 10.1126/science.aao4174; Li SR, 2004, SCIENCE, V305, P1619, DOI 10.1126/science.1098674; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Linask Kersti K., 2003, Birth Defects Research, V69, P14, DOI 10.1002/bdrc.10004; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Little MH, 2019, GENE DEV, V33, P1319, DOI 10.1101/gad.329573.119; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Ma Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8413; Majumdar U., 2021, COLD SPRING HARB PER, V13; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Meilhac SM, 2018, NAT REV CARDIOL, V15, P705, DOI 10.1038/s41569-018-0086-9; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Mills RJ, 2017, P NATL ACAD SCI USA, V114, pE8372, DOI 10.1073/pnas.1707316114; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Nakano A, 2016, BBA-MOL CELL RES, V1863, P1937, DOI 10.1016/j.bbamcr.2016.01.022; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nees SN, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036749; Neri T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09459-5; Orlova VV, 2014, NAT PROTOC, V9, P1514, DOI 10.1038/nprot.2014.102; Ortmann D, 2017, CURR OPIN GENET DEV, V46, P179, DOI 10.1016/j.gde.2017.07.004; Palpant NJ, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.153; Patsch C, 2015, NAT CELL BIOL, V17, P994, DOI 10.1038/ncb3205; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richards DJ, 2020, NAT BIOMED ENG, DOI 10.1038/s41551-020-0539-4; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Risebro CA, 2006, DEVELOPMENT, V133, P4595, DOI 10.1242/dev.02625; Roberts B, 2019, STEM CELL REP, V12, P1145, DOI 10.1016/j.stemcr.2019.03.001; Ronaldson-Bouchard K, 2018, NATURE, V556, P239, DOI 10.1038/s41586-018-0016-3; Rossi G, 2021, CELL STEM CELL, V28, P230, DOI 10.1016/j.stem.2020.10.013; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlueter J, 2018, CELL REP, V24, P1456, DOI 10.1016/j.celrep.2018.07.015; Schutgens F, 2020, ANNU REV PATHOL-MECH, V15, P211, DOI 10.1146/annurev-pathmechdis-012419-032611; Serra D, 2019, NATURE, V569, P66, DOI 10.1038/s41586-019-1146-y; Silva A.C., 2020, DEV COEMERGENCE CARD, DOI [10.1101/2020.04.30, DOI 10.1101/2020.04.30]; Strano A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107732; Sturzu AC, 2015, CIRCULATION, V132, P109, DOI 10.1161/CIRCULATIONAHA.114.011490; Tallquist MD, 2020, ANNU REV PHYSIOL, V82, P63, DOI 10.1146/annurev-physiol-021119-034527; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tang J, 2018, CIRC RES, V122, P984, DOI 10.1161/CIRCRESAHA.117.312354; Tiburcy M, 2017, CIRCULATION, V135, P1832, DOI 10.1161/CIRCULATIONAHA.116.024145; Tuveson D, 2019, SCIENCE, V364, P952, DOI 10.1126/science.aaw6985; Tyser RCV, 2021, SCIENCE, V371, P1011, DOI 10.1126/science.abb2986; Vincentz JW, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006922; Voges HK, 2017, DEVELOPMENT, V144, P1118, DOI 10.1242/dev.143966; Wang XR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08023-x; Wilsbacher L, 2016, ANNU REV PATHOL-MECH, V11, P395, DOI 10.1146/annurev-pathol-012615-044336; Wimmer RA, 2019, NATURE, V565, P505, DOI 10.1038/s41586-018-0858-8; Witty AD, 2014, NAT BIOTECHNOL, V32, P1026, DOI 10.1038/nbt.3002; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yap L, 2019, TRENDS CELL BIOL, V29, P987, DOI 10.1016/j.tcb.2019.10.001; Zaidi S, 2017, CIRC RES, V120, P923, DOI 10.1161/CIRCRESAHA.116.309140; Zhao Y, 2019, CELL, V176, P913, DOI 10.1016/j.cell.2018.11.042	101	83	87	17	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3299	+		10.1016/j.cell.2021.04.034	http://dx.doi.org/10.1016/j.cell.2021.04.034		JUN 2021	41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	34019794	Bronze, Green Submitted			2022-12-28	WOS:000660014300018
J	Pfriem, N; Hintermeier, PH; Eckstein, S; Kim, S; Liu, Q; Shi, H; Milakovic, L; Liu, YS; Haller, GL; Barath, E; Liu, Y; Lercher, JA				Pfriem, Niklas; Hintermeier, Peter H.; Eckstein, Sebastian; Kim, Sungmin; Liu, Qiang; Shi, Hui; Milakovic, Lara; Liu, Yuanshuai; Haller, Gary L.; Barath, Eszter; Liu, Yue; Lercher, Johannes A.			Role of the ionic environment in enhancing the activity of reacting molecules in zeolite pores	SCIENCE			English	Article							CATALYTIC-ACTIVITY; SI/AL RATIO; ACID SITES; CONFINEMENT; CRACKING; PATHWAYS; IMPACT; RATES	Tailoring the molecular environment around catalytically active sites allows for the enhancement of catalytic reactivity through a hitherto unexplored pathway. In zeolites, the presence of water creates an ionic environment via the formation of hydrated hydronium ions and the negatively charged framework aluminum tetrahedra. The high density of cation-anion pairs determined by the aluminum concentration of a zeolite induces a high local ionic strength that increases the excess chemical potential of sorbed and uncharged organic reactants. Charged transition states (carbocations for example) are stabilized, which reduces the energy barrier and leads to higher reaction rates. Using the intramolecular dehydration of cyclohexanol on H-MFI zeolites in water, we quantitatively show an enhancement of the reaction rate by the presence of high ionic strength as well as show potential limitations of this strategy.	[Pfriem, Niklas; Hintermeier, Peter H.; Eckstein, Sebastian; Liu, Qiang; Shi, Hui; Milakovic, Lara; Liu, Yuanshuai; Haller, Gary L.; Barath, Eszter; Liu, Yue; Lercher, Johannes A.] Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany; [Pfriem, Niklas; Hintermeier, Peter H.; Eckstein, Sebastian; Liu, Qiang; Shi, Hui; Milakovic, Lara; Liu, Yuanshuai; Haller, Gary L.; Barath, Eszter; Liu, Yue; Lercher, Johannes A.] Tech Univ Munich, Catalysis Res Ctr, Lichtenbergstr 4, D-85747 Garching, Germany; [Kim, Sungmin; Lercher, Johannes A.] Pacific Northwest Natl Lab, Inst Integrated Catalysis, POB 999, Richland, WA 99352 USA; [Liu, Qiang] Paul Scherrer Inst, Forsch Str 111, CH-5232 Villigen, Switzerland; [Shi, Hui] Yangzhou Univ, Sch Chem & Chem Engn, Siwangting Rd 180, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Yuanshuai] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Songling Rd 189, Qingdao, Peoples R China	Technical University of Munich; Technical University of Munich; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Yangzhou University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Liu, Y; Lercher, JA (corresponding author), Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany.; Liu, Y; Lercher, JA (corresponding author), Tech Univ Munich, Catalysis Res Ctr, Lichtenbergstr 4, D-85747 Garching, Germany.; Lercher, JA (corresponding author), Pacific Northwest Natl Lab, Inst Integrated Catalysis, POB 999, Richland, WA 99352 USA.	yue.liu@tum.de; johannes.lercher@tum.de	Kim, Sungmin/M-3579-2016; Liu, Yuanshuai/HHS-5154-2022	Kim, Sungmin/0000-0001-6602-1320; Liu, Yuanshuai/0000-0002-4020-7538; Liu, Yue/0000-0001-8939-0233; Eckstein, Sebastian/0000-0002-0090-2923; Milakovic, Lara/0000-0002-2580-203X	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES), Division of Chemical Sciences, Geosciences and Biosciences [FWP 47319]; DOE Office of Science and BES, Division of Chemical Sciences, Geosciences and Biosciences [DE-FG02-01ER15183]	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES), Division of Chemical Sciences, Geosciences and Biosciences(United States Department of Energy (DOE)); DOE Office of Science and BES, Division of Chemical Sciences, Geosciences and Biosciences(United States Department of Energy (DOE))	This work (J.A.L. and S.K.) was supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES), Division of Chemical Sciences, Geosciences and Biosciences (Transdisciplinary Approaches to Realize Novel Catalytic Pathways to Energy Carriers, FWP 47319). G.L.H. was supported by the DOE Office of Science and BES, Division of Chemical Sciences, Geosciences and Biosciences, under grant no. DE-FG02-01ER15183, to Yale University, Department of Chemical and Environmental Engineering.	Auroux A, 1997, TOP CATAL, V4, P71, DOI 10.1023/A:1019127919907; BARTHOMEUF D, 1984, J PHYS CHEM-US, V88, P42, DOI 10.1021/j150645a010; Bates JS, 2020, CHEM SCI, V11, P7102, DOI 10.1039/d0sc02589e; Camblor MA, 1998, J MATER CHEM, V8, P2137, DOI 10.1039/a804457k; Di Iorio JR, 2019, J CATAL, V380, P161, DOI 10.1016/j.jcat.2019.10.012; Eckstein S, 2019, ANGEW CHEM INT EDIT, V58, P3450, DOI 10.1002/anie.201812184; Eckstein S, 2017, J CATAL, V352, P329, DOI 10.1016/j.jcat.2017.06.002; Gounder R, 2009, J AM CHEM SOC, V131, P1958, DOI 10.1021/ja808292c; HAAG WO, 1984, NATURE, V309, P589, DOI 10.1038/309589a0; Janda A, 2013, J AM CHEM SOC, V135, P19193, DOI 10.1021/ja4081937; Jones AJ, 2014, J PHYS CHEM C, V118, P17787, DOI 10.1021/jp5050095; Knott BC, 2018, ACS CATAL, V8, P770, DOI 10.1021/acscatal.7b03676; Liu YS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14113; Luo WH, 2019, GREEN CHEM, V21, P3744, DOI 10.1039/c9gc01216h; Margarit VJ, 2019, ACS CATAL, V9, P5935, DOI 10.1021/acscatal.9b00763; MIRODATOS C, 1988, J CATAL, V114, P121, DOI 10.1016/0021-9517(88)90014-0; Murzin DY, 2016, CATAL SCI TECHNOL, V6, P5700, DOI 10.1039/c6cy00495d; OLSON DH, 1981, J PHYS CHEM-US, V85, P2238, DOI 10.1021/j150615a020; PARRILLO DJ, 1994, APPL CATAL A-GEN, V110, P67, DOI 10.1016/0926-860X(94)80106-1; Prodinger S, 2018, APPL CATAL B-ENVIRON, V237, P996, DOI 10.1016/j.apcatb.2018.06.065; Schallmoser S, 2014, J CATAL, V316, P93, DOI 10.1016/j.jcat.2014.05.004; Shi H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15442; STACH H, 1992, J PHYS CHEM-US, V96, P8480, DOI 10.1021/j100200a051; Tian P, 2015, ACS CATAL, V5, P1922, DOI 10.1021/acscatal.5b00007; Vermeiren W, 2009, TOP CATAL, V52, P1131, DOI 10.1007/s11244-009-9271-8; Vogt ETC, 2015, CHEM SOC REV, V44, P7342, DOI 10.1039/c5cs00376h; Wang S, 2017, J CATAL, V352, P415, DOI 10.1016/j.jcat.2017.06.012; Woolery GL, 1997, ZEOLITES, V19, P288, DOI 10.1016/S0144-2449(97)00086-9; Zhi YC, 2015, J AM CHEM SOC, V137, P15781, DOI 10.1021/jacs.5b09107	29	34	34	33	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2021	372	6545					952	+		10.1126/science.abh3418	http://dx.doi.org/10.1126/science.abh3418			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SK7YO	33958482				2022-12-28	WOS:000656432400043
J	Slomski, A				Slomski, Anita			Clear Surgical Masks Create More Positive Interactions With Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2039	2039		10.1001/jama.2021.6793	http://dx.doi.org/10.1001/jama.2021.6793			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032834				2022-12-28	WOS:000655647300006
J	Rimmer, A				Rimmer, Abi			Covid-19: Senior hospital doctors have been left with moral injury, BMA warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							SUPPORT											Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1206; Rimmer A, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1199	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2021	373								n1298	10.1136/bmj.n1298	http://dx.doi.org/10.1136/bmj.n1298			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5TH	34016638	Bronze			2022-12-28	WOS:000655596600010
J	Tauro, F				Tauro, Flavia			River basins on the edge of change Water scarcity after the Millennium Drought reveals the finite resilience of water systems	SCIENCE			English	Editorial Material							ECOSYSTEMS		[Tauro, Flavia] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, I-01100 Viterbo, Italy	Tuscia University	Tauro, F (corresponding author), Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, I-01100 Viterbo, Italy.	flavia.tauro@unitus.it						Ault TR, 2020, SCIENCE, V368, P256, DOI 10.1126/science.aaz5492; Bloschl G, 2019, HYDROLOG SCI J, V64, P1141, DOI 10.1080/02626667.2019.1620507; Caplan JS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6635; D'Odorico P, 2004, P NATL ACAD SCI USA, V101, P8848, DOI 10.1073/pnas.0401428101; Krueger EH, 2019, EARTHS FUTURE, V7, P1167, DOI 10.1029/2019EF001306; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Mishra AK, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000243; Peterson TJ, 2014, WATER RESOUR RES, V50, P2993, DOI 10.1002/2012WR013003; Peterson TJ, 2021, SCIENCE, V372, P745, DOI 10.1126/science.abd5085; Runyan CW, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009464; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Tauro F, 2018, HYDROLOG SCI J, V63, P169, DOI 10.1080/02626667.2017.1420191; van de Giesen N, 2014, WIRES WATER, V1, P341, DOI 10.1002/wat2.1034; van Dijk AIJM, 2013, WATER RESOUR RES, V49, P1040, DOI 10.1002/wrcr.20123; Walker B, 2004, ECOL SOC, V9	15	6	6	6	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					680	681		10.1126/science.abi8770	http://dx.doi.org/10.1126/science.abi8770			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SD1KE	33986165				2022-12-28	WOS:000651125300025
J	Benumof, JL				Benumof, J. L.			Management of the Difficult Airway	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRACHEAL INTUBATION; DIRECT LARYNGOSCOPY; VIDEO LARYNGOSCOPY; SOCIETY GUIDELINES; CLINICAL-PRACTICE; UNANTICIPATED DIFFICULT; EMERGENCY-DEPARTMENT; MASK VENTILATION; CARDIAC-ARREST; SUCCESS RATES	Management of the Difficult Airway Failure to establish an airway can be life-threatening. Although relatively rare, such cases tend to be underreported. Advances in visualization techniques may be helpful. Difficult intubation can often be anticipated and prepared for.	[Benumof, J. L.] Univ Bern, Bern Univ Hosp, Dept Anesthesia Spital Grabs Grabs, Bern, Switzerland; [Benumof, J. L.] Univ Bern, Bern Univ Hosp, Dept Anesthesiol & Pain Med, Bern, Switzerland; [Benumof, J. L.] Private Univ Principal Liechtenstein, Triesen, Liechtenstein	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Benumof, JL (corresponding author), Spital Grabs, Dept Anesthesia, Spitalstr 44, CH-9472 Grabs, Switzerland.	thomas.heidegger@srrws.ch						Ahmad I, 2020, ANAESTHESIA, V75, P509, DOI 10.1111/anae.14904; Amer Soc Anesthesiologists, 2013, ANESTHESIOLOGY, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; Aziz MF, 2016, ANESTHESIOLOGY, V125, P656, DOI 10.1097/ALN.0000000000001267; Aziz MF, 2016, ANESTH ANALG, V122, P740, DOI 10.1213/ANE.0000000000001084; Aziz MF, 2012, ANESTHESIOLOGY, V116, P629, DOI 10.1097/ALN.0b013e318246ea34; Aziz MF, 2011, ANESTHESIOLOGY, V114, P34, DOI 10.1097/ALN.0b013e3182023eb7; Benumof JL, 1997, ANESTHESIOLOGY, V87, P979, DOI 10.1097/00000542-199710000-00034; Bernhard M, 2015, ANESTH ANALG, V121, P1389, DOI 10.1213/ANE.0000000000000891; Brown CA, 2020, ACAD EMERG MED, V27, P100, DOI 10.1111/acem.13851; Cabrini L, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1927-3; Carayon P, 2014, BMJ QUAL SAF, V23, P196, DOI 10.1136/bmjqs-2013-001812; Collins JS, 2004, OBES SURG, V14, P1171, DOI 10.1381/0960892042386869; Cook T., 2021, CORE TOPICS AIRWAY M, P102; Cook TM, 2018, ANAESTHESIA, V73, P93, DOI 10.1111/anae.14123; Cooper RM, 2019, ANESTHESIOLOGY, V130, P833, DOI 10.1097/ALN.0000000000002555; Cooper RM, 2018, HAGBERG BENUMOFS AIR, P844; Crosby ET, 2011, ANAESTHESIA, V66, P112, DOI 10.1111/j.1365-2044.2011.06940.x; Crosby ET, 2021, CAN J ANESTH, V68, P183, DOI 10.1007/s12630-020-01846-7; De Jong A, 2018, CRIT CARE MED, V46, P532, DOI 10.1097/CCM.0000000000002925; Detsky ME, 2019, JAMA-J AM MED ASSOC, V321, P493, DOI 10.1001/jama.2018.21413; Domino KB, 2021, CAN J ANESTH, V68, P169, DOI 10.1007/s12630-020-01847-6; Duggan LV, 2011, CAN J ANESTH, V58, P560, DOI 10.1007/s12630-011-9488-4; El-Orbany M, 2011, ANESTH ANALG, V113, P103, DOI 10.1213/ANE.0b013e31821c7e9c; Eskander A, 2019, NEW ENGL J MED, V381, P1940, DOI 10.1056/NEJMra1811697; Fei M, 2017, BRIT J ANAESTH, V118, P618, DOI 10.1093/bja/aex035; Flin R, 2013, ANAESTHESIA, V68, P817, DOI 10.1111/anae.12253; Frat JP, 2019, LANCET RESP MED, V7, P303, DOI 10.1016/S2213-2600(19)30048-7; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Gadd K, 2018, BRIT J ANAESTH, V120, P1033, DOI 10.1016/j.bja.2018.02.010; Goto T, 2015, EMERG MED J, V32, P781, DOI 10.1136/emermed-2013-203473; Hagberg CA, 2018, HAGBERG BENUMOFS AIR; Han R, 2004, ANESTHESIOLOGY, V101, P267, DOI 10.1097/00000542-200407000-00059; Hasegawa K, 2012, ANN EMERG MED, V60, P749, DOI 10.1016/j.annemergmed.2012.04.005; Heidegger T, 2012, ANAESTHESIA, V67, P213, DOI 10.1111/j.1365-2044.2011.07043.x; Heidegger T, 2001, ANESTH ANALG, V92, P517; Heidegger T, 2018, HAGBERG BENUMOFS AIR, P203; Heidegger T, 2017, ANESTH ANALG, V124, P996, DOI 10.1213/ANE.0000000000001748; Higgs A, 2018, BRIT J ANAESTH, V120, P323, DOI 10.1016/j.bja.2017.10.021; Huang HB, 2017, CHEST, V152, P510, DOI 10.1016/j.chest.2017.06.012; Huitink JM, 2021, CORE TOPICS AIRWAY M, P22; Ikeda A, 2012, ANESTHESIOLOGY, V117, P487, DOI 10.1097/ALN.0b013e3182668670; Joffe AM, 2019, ANESTHESIOLOGY, V131, P818, DOI 10.1097/ALN.0000000000002815; Kaplan MB, 2006, J CLIN ANESTH, V18, P357, DOI 10.1016/j.jclinane.2006.01.002; Kerslake D, 2015, RESUSCITATION, V89, P20, DOI 10.1016/j.resuscitation.2015.01.005; Kheterpal S, 2006, ANESTHESIOLOGY, V105, P885, DOI 10.1097/00000542-200611000-00007; Kim HJ, 2019, KOREAN J ANESTHESIOL, V72, P527, DOI 10.4097/kja.19174; Kim J, 2014, RESUSCITATION, V85, P623, DOI 10.1016/j.resuscitation.2014.01.017; Kinsella SM, 2015, INT J OBSTET ANESTH, V24, P356, DOI 10.1016/j.ijoa.2015.06.008; Kleine-Brueggeney M, 2016, BRIT J ANAESTH, V116, P670, DOI 10.1093/bja/aew058; Klock P.A., 2018, HAGBERG BENUMOFS AIR, P178; Langeron O, 2000, ANESTHESIOLOGY, V92, P1229, DOI 10.1097/00000542-200005000-00009; Law JA, CAN J ANAESTH; Law JA., 2021, CORE TOPICS AIRWAY M, P38; Le Fevre PJ, 2019, ANAESTHESIA, V74, P480, DOI 10.1111/anae.14581; Levitan RM, 2011, ANN EMERG MED, V57, P240, DOI 10.1016/j.annemergmed.2010.05.035; Lim KS, 2016, BRIT J ANAESTH, V117, P828, DOI 10.1093/bja/aew368; Lindsay HA, 2018, HAGBERG ANDBENUMOFS, P328; Lodenius A, 2019, ANESTHESIOLOGY, V131, P962, DOI 10.1097/ALN.0000000000002883; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Marshall SD, 2016, ANAESTHESIA, V71, P131, DOI 10.1111/anae.13354; Marshall S, 2013, ANESTH ANALG, V117, P1162, DOI 10.1213/ANE.0b013e31829c397b; Martin LD, 2011, ANESTHESIOLOGY, V114, P42, DOI 10.1097/ALN.0b013e318201c415; Moon TS, 2019, OBES SURG, V29, P3992, DOI 10.1007/s11695-019-04077-y; Moon TS, 2019, J ANESTH, V33, P96, DOI 10.1007/s00540-018-2592-7; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; Mort TC, 2015, ANESTH ANALG, V121, P440, DOI 10.1213/ANE.0000000000000825; Mosier JM, 2015, WEST J EMERG MED, V16, P1109, DOI 10.5811/westjem.2015.8.27467; Nimmagadda U, 2017, ANESTH ANALG, V124, P507, DOI 10.1213/ANE.0000000000001589; Norris A, 2016, BRIT J ANAESTH, V117, P148, DOI 10.1093/bja/aew122; Norskov AK, 2015, ANAESTHESIA, V70, P272, DOI 10.1111/anae.12955; O'Loughlin EJ, 2017, ANAESTHESIA, V72, P835, DOI 10.1111/anae.13837; O'Sullivan E, 2011, ANAESTHESIA, V66, P331, DOI 10.1111/j.1365-2044.2011.06755.x; Odor PM, 2021, ANAESTHESIA, V76, P460, DOI 10.1111/anae.15250; Pandit JJ, 2017, ANAESTHESIA, V72, P283, DOI 10.1111/anae.13720; Popat M, 2012, ANAESTHESIA, V67, P318, DOI 10.1111/j.1365-2044.2012.07075.x; Rall M., 2015, MILLERS ANESTHESIA, P106; Rewers M, 2021, CORE TOPICS AIRWAY M, P305; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Royal College of Anaesthetists, 2011, MAJOR COMPLICATIONS; Saasouh W, 2018, BRIT J ANAESTH, V120, P1110, DOI 10.1016/j.bja.2018.01.019; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Schauble JC, 2018, ANAESTHESIST, V67, P725, DOI 10.1007/s00101-018-0492-8; Schaeuble JC, 2017, TRENDS ANAESTH CRIT, V13, P32, DOI 10.1016/tacc.2017.01.062; Schiff JH, 2014, BRIT J ANAESTH, V113, P109, DOI 10.1093/bja/aeu094; Schulz CM, 2017, ANESTHESIOLOGY, V127, P326, DOI 10.1097/ALN.0000000000001661; Scott JA, 2020, CHEST, V157, P877, DOI 10.1016/j.chest.2019.10.026; Scottish Courts and Tribunals, 2010, INQ FAT ACC INQ SCOT; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Sturgess DJ, 2017, ANAESTHESIA, V72, P248, DOI 10.1111/anae.13668; Teoh WH, 2021, CORE TOPICS AIRWAY M, P185; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; Timmermann A, 2016, BRIT J ANAESTH, V117, P5, DOI 10.1093/bja/aew107; Warters RD, 2011, ANAESTHESIA, V66, P163, DOI 10.1111/j.1365-2044.2010.06601.x; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6; Wong DT, 2019, ANESTH ANALG, V129, P1130, DOI 10.1213/ANE.0000000000003966; Yentis S, 2010, ANAESTHESIA, V65, P1, DOI 10.1111/j.1365-2044.2009.06018.x; Yentis SM, 2002, ANAESTHESIA, V57, P105, DOI 10.1046/j.0003-2409.2001.02515.x; Zhao BC, 2017, INTENS CARE MED, V43, P947, DOI 10.1007/s00134-017-4741-0	98	19	19	2	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					1836	1847		10.1056/NEJMra1916801	http://dx.doi.org/10.1056/NEJMra1916801			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD6UF	33979490				2022-12-28	WOS:000651509400011
J	Girardin, CAJ; Jenkins, S; Seddon, N; Allen, M; Lewis, SL; Wheeler, CE; Griscom, BW; Malhi, Y				Girardin, Cecile A. J.; Jenkins, Stuart; Seddon, Nathalie; Allen, Myles; Lewis, Simon L.; Wheeler, Charlotte E.; Griscom, Bronson W.; Malhi, Yadvinder			Nature-based solutions can help cool the planet - if we act now	NATURE			English	Editorial Material						Climate change; Biodiversity; Sustainability			[Girardin, Cecile A. J.] Univ Oxford, Oxford Biodivers Network, Oxford, England; [Girardin, Cecile A. J.] Nat Based Solut Initiat, Oxford, England	University of Oxford	Girardin, CAJ (corresponding author), Univ Oxford, Oxford Biodivers Network, Oxford, England.; Girardin, CAJ (corresponding author), Nat Based Solut Initiat, Oxford, England.	cecilegirardin@gmail.com						Allen M., 2020, OXFORD PRINCIPLES NE; Badola R, 2005, ENVIRON CONSERV, V32, P85, DOI 10.1017/S0376892905001967; Baldocchi D, 2019, GLOBAL CHANGE BIOL, V25, P1191, DOI 10.1111/gcb.14559; Bastin JF, 2019, SCIENCE, V365, P76, DOI 10.1126/science.aax0848; Buchner B., 2019, GLOBAL LANDSCAPE CLI; Busch J, 2019, NAT CLIM CHANGE, V9, P463, DOI 10.1038/s41558-019-0485-x; Chausson A, 2020, GLOBAL CHANGE BIOL, V26, P6134, DOI 10.1111/gcb.15310; Griscom BW, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0126; Griscom BW, 2017, P NATL ACAD SCI USA, V114, P11645, DOI 10.1073/pnas.1710465114; Heilmayr R, 2020, NAT SUSTAIN, V3, P701, DOI 10.1038/s41893-020-0547-0; Intergovernmental Panel on Climate Change, 2018, SUMMARY POLICYMAKERS; Lewis SL, 2019, NATURE, V568, P25, DOI 10.1038/d41586-019-01026-8; Roe S, 2019, NAT CLIM CHANGE, V9, P817, DOI 10.1038/s41558-019-0591-9; Scheidel A, 2018, LAND USE POLICY, V77, P9, DOI 10.1016/j.landusepol.2018.04.057; Seddon N, 2021, GLOBAL CHANGE BIOL, V27, P1518, DOI 10.1111/gcb.15513	15	44	44	25	97	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					191	194		10.1038/d41586-021-01241-2	http://dx.doi.org/10.1038/d41586-021-01241-2			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33981055	Bronze, Green Submitted			2022-12-28	WOS:000649848600006
J	Iacobucci, G				Iacobucci, Gareth			GPs should be able to delist patients who racially abuse staff, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2021	373								n1240	10.1136/bmj.n1240	http://dx.doi.org/10.1136/bmj.n1240			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SF3HS	33985994				2022-12-28	WOS:000652650700002
J	Dyer, C				Dyer, Clare			Legal reforms would allow GMC to tackle "shameful" discrimination of ethnic minority doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2021, REG HEALTHC PROF PRO; General Medical Council, 2019, FAIR REF; Norris Z., 2021, RACISM DISCRIMINATIO	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1214	10.1136/bmj.n1214	http://dx.doi.org/10.1136/bmj.n1214			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9GP	33980511				2022-12-28	WOS:000653055200005
J	King, AJ; Hudson, J; Fernie, G; Kernohan, A; Azuara-Blanco, A; Burr, J; Homer, T; Shabaninejad, H; Sparrow, JM; Garway-Heath, D; Barton, K; Norrie, J; McDonald, A; Vale, L; MacLennan, G				King, Anthony J.; Hudson, Jemma; Fernie, Gordon; Kernohan, Ashleigh; Azuara-Blanco, Augusto; Burr, Jennifer; Homer, Tara; Shabaninejad, Hosein; Sparrow, John M.; Garway-Heath, David; Barton, Keith; Norrie, John; McDonald, Alison; Vale, Luke; MacLennan, Graeme		TAGS Study Grp	Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VISUAL-FIELD LOSS; QUALITY-OF-LIFE; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; MANAGEMENT; IMPAIRMENT; PREFERENCE; SEVERITY; OUTCOMES	To determine whether primary trabeculectomy or primary medical treatment produces better outcomes in term of quality of life, clinical effectiveness, and safety in patients presenting with advanced glaucoma. DESIGN Pragmatic multicentre randomised controlled trial. SETTING 27 secondary care glaucoma departments in the UK. PARTICIPANTS 453 adults presenting with newly diagnosed advanced open angle glaucoma in at least one eye (Hodapp classification) between 3 June 2014 and 31 May 2017. INTERVENTIONS Mitomycin C augmented trabeculectomy (n=227) and escalating medical management with intraocular pressure reducing drops (n=226) MAIN OUTCOME MEASURES Primary outcome: vision specific quality of life measured with Visual Function Questionnaire-25 (VFQ-25) at 24 months. Secondary outcomes: general health status, glaucoma related quality of life, clinical effectiveness (intraocular pressure, visual field, visual acuity), and safety. RESULTS At 24 months, the mean VFQ-25 scores in the trabeculectomy and medical arms were 85.4 (SD 13.8) and 84.5 (16.3), respectively (mean difference 1.06, 95% confidence interval -1.32 to 3.43; P=0.38). Mean intraocular pressure was 12.4 (SD 4.7) mm Hg for trabeculectomy and 15.1 (4.8) mm Hg for medical management (mean difference-2.8 (-3.8 to-1.7) mm Hg; P(0.001). Adverse events occurred in 88 (39%) patients in the trabeculectomy arm and 100 (44%) in the medical management arm (relative risk 0.88, 95% confidence interval 0.66 to 1.17; P=0.37). Serious side effects were rare. CONCLUSION Primary trabeculectomy had similar quality of life and safety outcomes and achieved a lower intraocular pressure compared with primary medication. TRIAL REGISTRATION Health Technology Assessment (NIHR-HTA) Programme (project number: 12/35/38). ISRCTN registry: ISRCTN56878850.	[King, Anthony J.] Nottingham Univ Hosp, Dept Ophthalmol, Nottingham, England; [Hudson, Jemma] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Fernie, Gordon; McDonald, Alison; MacLennan, Graeme] Univ Aberdeen, Ctr Healthcare Randomised Trials CHaRT, Hlth Serv Res Unit, Aberdeen, Scotland; [Kernohan, Ashleigh; Homer, Tara; Shabaninejad, Hosein; Vale, Luke] Newcastle Univ, Populat Hlth Sci Inst, Hlth Econ Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Azuara-Blanco, Augusto] Queens Univ Belfast, Royal Victoria Hosp, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Burr, Jennifer] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Sparrow, John M.] Univ Hosp Bristol NHS Fdn Trust, Bristol Eye Hosp, Bristol, Avon, England; [Garway-Heath, David; Barton, Keith] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res NIHR, Biomed Res Ctr, London, England; [Norrie, John] Univ Edinburgh, Usher Inst, Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland	Nottingham University Hospital NHS Trust; University of Nottingham; University of Aberdeen; University of Aberdeen; Newcastle University - UK; Queens University Belfast; University of St Andrews; Bristol Eye Hospital; University of Bristol; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Edinburgh	King, AJ (corresponding author), Nottingham Univ Hosp, Dept Ophthalmol, Nottingham, England.	anthony.king@nottingham.ac.uk	ahmed, faisal/AAP-4962-2020	Sung, Velota/0000-0002-5708-2540; Kernohan, Ashleigh/0000-0002-5514-3186; Sepetis, Anastasios/0000-0002-9034-635X; Azuara-Blanco, Augusto/0000-0002-4805-9322; King, Anthony/0000-0002-3091-911X; MacLennan, Graeme/0000-0002-1039-5646; Shabaninejad, Hosein/0000-0001-9512-1398; Vale, Luke/0000-0001-8574-8429				American Academy of Ophthalmology, 2015, PRIM OP ANGL GLAUC P; Azuara-Blanco A, 2016, LANCET, V388, P1389, DOI 10.1016/S0140-6736(16)30956-4; Bhargava JS, 2006, INVEST OPHTH VIS SCI, V47, P2885, DOI 10.1167/iovs.05-1244; Boodhna T, 2015, OPHTHAL PHYSL OPT, V35, P225, DOI 10.1111/opo.12187; Burr J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004399.pub3; Burr JM, 2007, OPTOMETRY VISION SCI, V84, P797, DOI 10.1097/OPX.0b013e3181339f30; Canadian Ophthalmological Society Glaucoma Clinical Practice Guideline Expert Committee, 2009, Can J Ophthalmol, V44 Suppl 1, pS7, DOI 10.3129/cjo44s1; Candlish J, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0559-x; Damji KF, 2003, CAN J OPHTHALMOL, V38, P189, DOI 10.1016/S0008-4182(03)80060-1; Emsley R, 2010, STAT METHODS MED RES, V19, P237, DOI 10.1177/0962280209105014; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; European Glaucoma Society, 2014, TERM GUID GLAUC; Fiscella RG, 2009, PHARMACOECONOMICS, V27, P189, DOI 10.2165/00019053-200927030-00002; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Fraser S, 2001, BMJ-BRIT MED J, V322, P639, DOI 10.1136/bmj.322.7287.639; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Gazzard G, 2019, LANCET, V393, P1505, DOI 10.1016/S0140-6736(18)32213-X; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Gillespie BW, 2014, INVEST OPHTH VIS SCI, V55, P4206, DOI 10.1167/iovs.13-13683; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hodapp E, 1993, CLIN DECISION GLAUCO; King AJ, 2020, AM J OPHTHALMOL, V213, P186, DOI 10.1016/j.ajo.2020.01.026; King AJ, 2018, BRIT J OPHTHALMOL, V102, P922, DOI 10.1136/bjophthalmol-2017-310902; Kulkarni BB, 2019, BRIT J OPHTHALMOL, V103, P1850, DOI 10.1136/bjophthalmol-2018-313401; Leighton P, 2012, EYE, V26, P300, DOI 10.1038/eye.2011.279; LICHTER PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI [10.1016/S0161-6420(01)00873-9, DOI 10.1016/S0161-6420(01)00873-9]; lives Healthy, 2012, HLTH LIV HLTH PEOPL; Maier PC, 2005, BMJ-BRIT MED J, V331, P134, DOI 10.1136/bmj.38506.594977.E0; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; McKean-Cowdin R, 2008, OPHTHALMOLOGY, V115, P941, DOI 10.1016/j.ophtha.2007.08.037; McKean-Cowdin R, 2007, AM J OPHTHALMOL, V143, P1013, DOI 10.1016/j.ajo.2007.02.022; Mokhles P, 2016, J GLAUCOMA, V25, P623, DOI 10.1097/IJG.0000000000000389; National Institute for Health and Care Excellence, 2017, GLAUCOMA DIAGNOSIS M; Ng WS, 2010, BRIT J OPHTHALMOL, V94, P85, DOI 10.1136/bjo.2008.153312; Patel HY, 2013, CURR OPIN OPHTHALMOL, V24, P15, DOI 10.1097/ICU.0b013e32835ab55f; Prior M, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-72; Quartilho A, 2016, EYE, V30, P602, DOI 10.1038/eye.2015.288; Royal College of Ophthalmologists, 2015, WAY FORW GLAUC; Sotimehin AE, 2018, J GLAUCOMA, V27, P939, DOI 10.1097/IJG.0000000000001068; Stead R, 2011, CLIN EXP OPHTHALMOL, V39, P858, DOI 10.1111/j.1442-9071.2011.02574.x; Sukumar S, 2009, EYE, V23, P1038, DOI 10.1038/eye.2008.245; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429	45	10	10	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1014	10.1136/bmj.n1014	http://dx.doi.org/10.1136/bmj.n1014			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2ZO	33980505	Green Published, hybrid			2022-12-28	WOS:000651243600001
J	Kim, D; Yang, PS; You, SC; Sung, JH; Jang, E; Yu, HT; Kim, TH; Pak, HN; Lee, MH; Lip, GYH; Joung, B				Kim, Daehoon; Yang, Pil-Sung; You, Seng Chan; Sung, Jung-Hoon; Jang, Eunsun; Yu, Hee Tae; Kim, Tae-Hoon; Pak, Hui-Nam; Lee, Moon-Hyoung; Lip, Gregory Y. H.; Joung, Boyoung			Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CATHETER ABLATION; DRONEDARONE; EVENTS	OBJECTIVE To investigate whether the results of a rhythm control strategy differ according to the duration between diagnosis of atrial fibrillation and treatment initiation. DESIGN Longitudinal observational cohort study. SETTING Population based cohort from the Korean National Health Insurance Service database. PARTICIPANTS 22 635 adults with atrial fibrillation and cardiovascular conditions, newly treated with rhythm control (antiarrhythmic drugs or ablation) or rate control strategies between 28 July 2011 and 31 December 2015. MAIN OUTCOME MEASURE A composite outcome of death from cardiovascular causes, ischaemic stroke, admission to hospital for heart failure, or acute myocardial infarction. RESULTS Of the study population, 12 200 (53.9%) were male, the median age was 70, and the median follow-up duration was 2.1 years. Among patients with early treatment for atrial fibrillation (initiated within one year since diagnosis), compared with rate control, rhythm control was associated with a lower risk of the primary composite outcome (weighted incidence rate per 100 person years 7.42 in rhythm control v 9.25 in rate control; hazard ratio 0.81, 95% confidence interval 0.71 to 0.93; P=0.002). No difference in the risk of the primary composite outcome was found between rhythm and rate control (weighted incidence rate per 100 person years 8.67 in rhythm control v 8.99 in rate control; 0.97, 0.78 to 1.20; P=0.76) in patients with late treatment for atrial fibrillation (initiated after one year since diagnosis). No significant differences in safety outcomes were found between the rhythm and rate control strategies across different treatment timings. Earlier initiation of treatment was linearly associated with more favourable cardiovascular outcomes for rhythm control compared with rate control. CONCLUSIONS Early initiation of rhythm control treatment was associated with a lower risk of adverse cardiovascular outcomes than rate control treatment in patients with recently diagnosed atrial fibrillation. This association was not found in patients who had had atrial fibrillation for more than one year.	[Kim, Daehoon; Jang, Eunsun; Yu, Hee Tae; Kim, Tae-Hoon; Pak, Hui-Nam; Lee, Moon-Hyoung; Joung, Boyoung] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea; [Yang, Pil-Sung; Sung, Jung-Hoon] CHA Univ, Dept Cardiol, CHA Bundang Med Ctr, Seongnam, South Korea; [You, Seng Chan] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Lip, Gregory Y. H.] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England; [Lip, Gregory Y. H.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England	Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; University of Liverpool; Liverpool Heart & Chest Hospital	Joung, B (corresponding author), 50-1 Yonsei Ro, Seoul 03722, South Korea.	cby6908@yuhs.ac	Pak, Hui-Nam/C-4266-2015	Pak, Hui-Nam/0000-0002-3256-3620; You, Seng Chan/0000-0002-5052-6399; Kim, Tae-Hoon/0000-0003-4200-3456; Lee, Moon-Hyoung/0000-0002-7268-0741; Joung, Boyoung/0000-0001-9036-7225; Kim, Daehoon/0000-0002-9736-450X	Korean Healthcare Technology research and development project - Korean Ministry of Health and Welfare [HI15C1200, HC19C0130]; CMBYuhan research grant from the Yonsei University College of Medicine [620190124]	Korean Healthcare Technology research and development project - Korean Ministry of Health and Welfare; CMBYuhan research grant from the Yonsei University College of Medicine	This study was supported by grants from the Korean Healthcare Technology research and development project funded by the Korean Ministry of Health and Welfare (HI15C1200, HC19C0130) , and by a CMBYuhan research grant from the Yonsei University College of Medicine (620190124) . The funders of this study had no role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the manuscript for publication.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Blomstrom-Lundqvist C, 2020, EUR HEART J, DOI 10.1093/eurheartj/ehaa612; Bottle A, 2018, HEART, V104, P600, DOI [10.1136/heartjnl-2017-312183, 10.1136/heartjnl-2017-312930]; Caldeira D, 2011, EUR J INTERN MED, V22, P448, DOI 10.1016/j.ejim.2011.05.001; Camm AJ, 2016, EUR HEART J, V37, P1145, DOI 10.1093/eurheartj/ehv466; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867; Connolly SJ, 2009, CIRCULATION, V120, P1174, DOI 10.1161/CIRCULATIONAHA.109.875252; de Denus S, 2005, ARCH INTERN MED, V165, P258, DOI 10.1001/archinte.165.3.258; Desai RJ, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5657; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Ionescu-Ittu R, 2012, ARCH INTERN MED, V172, P997, DOI 10.1001/archinternmed.2012.2266; Kim D, 2020, EUR HEART J, V41, P4483, DOI 10.1093/eurheartj/ehaa726; Kim D, 2018, J AM COLL CARDIOL, V72, P1233, DOI 10.1016/j.jacc.2018.05.076; Kirchhof P, 2020, NEW ENGL J MED, V383, P1305, DOI 10.1056/NEJMoa2019422; Kumana CR, 2005, BRIT J CLIN PHARMACO, V60, P347, DOI 10.1111/j.1365-2125.2005.02449.x; Lee SS, 2017, EUR HEART J, V38, P2599, DOI 10.1093/eurheartj/ehx316; Li F, 2018, J AM STAT ASSOC, V113, P390, DOI 10.1080/01621459.2016.1260466; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Lund JL, 2015, CURR EPIDEMIOL REP, V2, P221, DOI [10.1007/s40471-015-0053-5, DOI 10.1007/S40471-015-0053-5]; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Mark DB, 2019, JAMA-J AM MED ASSOC, V321, P1275, DOI 10.1001/jama.2019.0692; Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Phillips RA, 2018, J AM COLL CARDIOL, V71, P1601, DOI 10.1016/j.jacc.2018.01.074; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Testa L, 2005, EUR HEART J, V26, P2000, DOI 10.1093/eurheartj/ehi306; Tsadok MA, 2012, CIRCULATION, V126, P2680, DOI 10.1161/CIRCULATIONAHA.112.092494; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Willems S, 2019, EUR HEART J, V40, P3793, DOI 10.1093/eurheartj/ehz782; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; You SC, 2020, JAMA-J AM MED ASSOC, V324, P1640, DOI 10.1001/jama.2020.16167	36	26	26	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n991	10.1136/bmj.n991	http://dx.doi.org/10.1136/bmj.n991			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975876	Green Published, hybrid			2022-12-28	WOS:000649711400005
J	Limb, M				Limb, Matthew			Covid-19: Don't abandon mask wearing in schools, say health experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ONS, 2021, COVID 19 SCH INF SUR	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2021	373								n1186	10.1136/bmj.n1186	http://dx.doi.org/10.1136/bmj.n1186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RA	33972361	Bronze			2022-12-28	WOS:000649709400006
J	Holt, E				Holt, Ed			Media restrictions have "cost lives"	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1695	1696						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33965074	Green Published			2022-12-28	WOS:000647813600008
J	Rimmer, A				Rimmer, Abi			Clinical negligence: Doctors and managers must learn from litigation claims, say experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Francis R., 2021, BMJ OPINION; GIRFT NHS Resolution, 2021, NHS RES LEARN LIT CL	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2021	373								n1165	10.1136/bmj.n1165	http://dx.doi.org/10.1136/bmj.n1165			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QT	33962912				2022-12-28	WOS:000649708700012
J	Anand, S; Montez-Rath, ME; Han, JL; Garcia, P; Cadden, L; Hunsader, P; Kerschmann, R; Beyer, P; Boyd, SD; Chertow, GM; Parsonnet, J				Anand, Shuchi; Montez-Rath, Maria E.; Han, Jialin; Garcia, Pablo; Cadden, LinaCel; Hunsader, Patti; Kerschmann, Russell; Beyer, Paul; Boyd, Scott D.; Chertow, Glenn M.; Parsonnet, Julie			Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATITIS-B VACCINE; CORONAVIRUS; INFECTION	Background: Assessing the evolution of SARS-CoV-2 immune response among patients receiving dialysis can define its durability in a highly clinically relevant context because patients receiving dialysis share the characteristics of persons most susceptible to SARS-CoV-2 infection. Objective: To evaluate the persistence of SARS-CoV-2 receptor-binding domain (RBD) IgG in seroprevalent patients receiving dialysis. Design: Prospective. Setting: Nationwide sample from dialysis facilities. Patients: 2215 patients receiving dialysis who had evidence of SARS-CoV-2 infection as of July 2020. Measurements: Remainder plasma from routine monthly laboratories was used to measure semiquantitative RBD IgG index value over 6 months. Results: A total of 2063 (93%) seroprevalent patients reached an assay detectable response (IgG index value >= 1). Most (n = 1323, 60%) had responses in July with index values classified as high (IgG >= 10); 1003 (76%) remained within this stratum. Adjusted median index values declined slowly but continuously (July vs. December values were 21 vs. 13; P < 0.001). The trajectory of the response did not vary by age group, sex, race/ethnicity, or diabetes status. Patients without an assay detectable response (n = 137) were more likely to be White and in the younger (18 to 44 years) or older (>= 80 years) age groups and less likely to have diabetes and hypoalbuminemia. Limitation: Lack of data on symptoms or reverse transcriptase polymerase chain reaction diagnosis, cohort of persons who survived infection, and use of a semiquantitative assay. Conclusion: Despite impaired immunity, most seropositive patients receiving dialysis maintained RBD antibody levels over 6 months. A slow and continual decline in median antibody levels over time was seen, but no indication that subgroups with impaired immunity had a shorter-lived humoral response was found.	[Anand, Shuchi; Parsonnet, Julie] Stanford Univ, Stanford, CA 94305 USA; [Montez-Rath, Maria E.; Garcia, Pablo; Boyd, Scott D.; Chertow, Glenn M.; Parsonnet, Julie] Stanford Univ, 777 Welch Rd, Palo Alto, CA 94304 USA; [Han, Jialin] Stanford Univ, Sunnyvale, CA USA; [Cadden, LinaCel; Hunsader, Patti; Kerschmann, Russell; Beyer, Paul] Ascend Clin Lab, Redwood City, CA USA	Stanford University; Stanford University; Stanford University	Anand, S (corresponding author), Stanford Univ, 777 Welch Rd, Palo Alto, CA 94304 USA.	sanand2@stanford.edu; mmrath@stanford.edu	Han, Jialin/AFQ-6523-2022	Chertow, Glenn/0000-0002-7599-0534; Garcia, Pablo/0000-0002-8482-8192; han, Jialin/0000-0001-5731-8974; Parsonnet, Julie/0000-0001-7342-5366; Montez-Rath, Maria/0000-0001-5154-2182	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK127138, K24DK085446]; Ascend Clinical Laboratories	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ascend Clinical Laboratories	By grants R01DK127138 (Dr. Anand) and K24DK085446 (Dr. Chertow) from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. Ascend Clinical Laboratories supported the remainder plasma testing for SARS-CoV-2 antibodies.	Addetia A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.02107-20; Anand S, 2020, LANCET, V396, P1335, DOI 10.1016/S0140-6736(20)32009-2; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Baumgarth N, 2020, J IMMUNOL, V205, P2342, DOI 10.4049/jimmunol.2000839; Broeders NE, 2011, CLIN J AM SOC NEPHRO, V6, P2573, DOI 10.2215/CJN.04670511; BUTI M, 1992, AM J NEPHROL, V12, P144, DOI 10.1159/000168436; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Centers for Medicare & Medicaid Services, NAT COV DET NCD GLYC; Chen XY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00301-9; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fang HC, 2002, NEPHRON, V91, P682, DOI 10.1159/000065031; Flythe JE, 2021, AM J KIDNEY DIS, V77, P190, DOI 10.1053/j.ajkd.2020.09.003; Grigoryan L, 2020, SEMIN IMMUNOL, V50, DOI 10.1016/j.smim.2020.101422; Grzelak L., 2020, SEX DIFFERENCES DECL, DOI [10.1101/2020.11.12.20230466, DOI 10.1101/2020.11.12.20230466]; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Hao L, 2007, QUANTILE REGRESSION; Hodgson SH, 2021, LANCET INFECT DIS, V21, pE26, DOI 10.1016/S1473-3099(20)30773-8; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Irsara C, 2021, CLIN CHEM LAB MED, V59, P1143, DOI 10.1515/cclm-2020-1758; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Lee WT, 2021, J INFECT DIS, V223, P47, DOI 10.1093/infdis/jiaa673; Legros V, 2021, CELL MOL IMMUNOL, V18, P318, DOI 10.1038/s41423-020-00588-2; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Ma H, 2021, SCI CHINA LIFE SCI, V64, P482, DOI 10.1007/s11427-020-1805-0; Marino MF, 2015, METRON, V73, P229, DOI 10.1007/s40300-015-0072-5; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Ng JH, 2020, KIDNEY INT, V98, P1530, DOI 10.1016/j.kint.2020.07.030; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Peces R, 1997, AM J KIDNEY DIS, V29, P239, DOI 10.1016/S0272-6386(97)90036-6; Phillips N, 2021, NATURE, V590, P382, DOI 10.1038/d41586-021-00396-2; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Poland GA, 2020, LANCET, V396, P1595, DOI 10.1016/S0140-6736(20)32137-1; Ripperger TJ, 2020, IMMUNITY, V53, P925, DOI 10.1016/j.immuni.2020.10.004; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.1101/2020.08.11.20171843, 10.21203/rs.3.rs-57112/v1]; Roltgen K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0240; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; U.S. Census Bureau American Community Survey, 2018, AM COMMUNITY SURVEY; U.S. Food and Drug Administration, EUA AUTH SER TEST PE; Vogtlander NPJ, 2004, VACCINE, V22, P2199, DOI 10.1016/j.vaccine.2003.11.046; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	44	11	11	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG	2021	174	8					1073	+		10.7326/M21-0256	http://dx.doi.org/10.7326/M21-0256			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP3IW	34000201	Green Published			2022-12-28	WOS:000695277800017
J	Bhan, N; Raj, A				Bhan, Nandita; Raj, Anita			From choice to agency in family planning services	LANCET			English	Editorial Material							REPRODUCTIVE HEALTH; ADOLESCENTS; PROGRAMS		[Bhan, Nandita; Raj, Anita] Univ Calif San Diego, Sch Med, Div Infect Dis & Global Publ Hlth, Ctr Gender Equ & Hlth, La Jolla, CA 92093 USA; [Raj, Anita] Univ Calif San Diego, Dept Educ Studies, Div Social Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Bhan, N (corresponding author), Univ Calif San Diego, Sch Med, Div Infect Dis & Global Publ Hlth, Ctr Gender Equ & Hlth, La Jolla, CA 92093 USA.	nabhan@health.ucsd.edu			Bill & Melinda Gates Foundation [INV-002967]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	We receive funding from the Bill & Melinda Gates Foundation (grant #INV-002967) and declare no other competing interests.	[Anonymous], 2012, WOMENS DEMAND REPROD; Bankole A, 2010, STUD FAMILY PLANN, V41, P117, DOI 10.1111/j.1728-4465.2010.00232.x; Bhan N, 2020, ECLINICALMEDICINE, V20; Dehlendorf C, 2018, CONTRACEPTION, V98, P4, DOI 10.1016/j.contraception.2018.03.015; Dehlendorf C, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.173; Diamond-Smith N, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0592-6; Gilliam ML, 2009, CONTRACEPTION, V79, P243, DOI 10.1016/j.contraception.2008.12.004; GSMA, 2021, CONN WOM MOB GEND GA; Hardee K, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0278-5; Hay K, 2019, LANCET, V393, P2535, DOI 10.1016/S0140-6736(19)30648-8; Hinson L, 2019, SSM-POPUL HLTH, V9, DOI 10.1016/j.ssmph.2019.100473; Holt K, 2019, STUD FAMILY PLANN, V50, P137, DOI 10.1111/sifp.12092; Levy JK, 2020, LANCET GLOB HEALTH, V8, pE225, DOI 10.1016/S2214-109X(19)30495-4; Makenzius M, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0799-1; May JF, 2017, POPUL DEV REV, V43, P308, DOI 10.1111/j.1728-4457.2016.00165.x; Morris JL, 2015, INT J GYNECOL OBSTET, V131, pS40, DOI 10.1016/j.ijgo.2015.02.006; Nalwadda G, 2019, SEX REPROD HEALTHC, V21, P15, DOI 10.1016/j.srhc.2019.05.001; Prata N, 2017, J BIOSOC SCI, V49, P713, DOI 10.1017/S0021932016000663; Scholmerich VLN, 2016, HEALTH EDUC BEHAV, V43, P246, DOI 10.1177/1090198116629442; Senderowicz L, 2019, SOC SCI MED, V239, DOI 10.1016/j.socscimed.2019.112531; Silverman JG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001723; Solo J, 2019, GLOB HEALTH-SCI PRAC, V7, P371, DOI 10.9745/GHSP-D-19-00130; Starrs AM, 2018, LANCET, V391, P2642, DOI 10.1016/S0140-6736(18)30293-9; Sudhinaraset M, 2018, STUD FAMILY PLANN, V49, P237, DOI 10.1111/sifp.12069; Taukobong HFG, 2016, HEALTH POLICY PLANN, V31, P1492, DOI 10.1093/heapol/czw074; Tilahun M, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-19; UN Department of Economic and Social Affairs Population Division, 2020, STESASERA450 UN POP; Wegner MN, 1998, INT FAM PLAN PERSPEC, V24, P38, DOI 10.2307/2991918	28	5	5	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2021	398	10295					99	101		10.1016/S0140-6736(21)00990-9	http://dx.doi.org/10.1016/S0140-6736(21)00990-9		JUL 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TG0BQ	33971154				2022-12-28	WOS:000671078800005
J	Deng, XD; Garcia-Knight, MA; Khalid, MM; Servellita, V; Wang, CDC; Morris, MK; Sotomayor-Gonzalez, A; Glasner, DR; Reyes, KR; Gliwa, AS; Reddy, NP; San Martin, CS; Federman, S; Cheng, J; Balcerek, J; Taylor, J; Streithorst, JA; Miller, S; Sreekumar, B; Chen, PY; Schulze-Gahmen, U; Taha, TY; Hayashi, JM; Simoneau, CR; Kumar, GR; McMahon, S; Lidsky, PV; Xiao, YH; Hemarajata, P; Green, NM; Espinosa, A; Kath, C; Haw, M; Bell, J; Hacker, JK; Hanson, C; Wadford, DA; Anaya, C; Ferguson, D; Frankino, PA; Shivram, H; Lareau, LF; Wyman, SK; Ott, M; Andino, R; Chiu, CY				Deng, Xianding; Garcia-Knight, Miguel A.; Khalid, Mir M.; Servellita, Venice; Wang, Candace; Morris, Mary Kate; Sotomayor-Gonzalez, Alicia; Glasner, Dustin R.; Reyes, Kevin R.; Gliwa, Amelia S.; Reddy, Nikitha P.; San Martin, Claudia Sanchez; Federman, Scot; Cheng, Jing; Balcerek, Joanna; Taylor, Jordan; Streithorst, Jessica A.; Miller, Steve; Sreekumar, Bharath; Chen, Pei-Yi; Schulze-Gahmen, Ursula; Taha, Taha Y.; Hayashi, Jennifer M.; Simoneau, Camille R.; Kumar, G. Renuka; McMahon, Sarah; Lidsky, Peter, V; Xiao, Yinghong; Hemarajata, Peera; Green, Nicole M.; Espinosa, Alex; Kath, Chantha; Haw, Monica; Bell, John; Hacker, Jill K.; Hanson, Carl; Wadford, Debra A.; Anaya, Carlos; Ferguson, Donna; Frankino, Phillip A.; Shivram, Haridha; Lareau, Liana F.; Wyman, Stacia K.; Ott, Melanie; Andino, Raul; Chiu, Charles Y.			Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant	CELL			English	Article							COVID-19; ANTIBODY; ACE2	We identified an emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples from 44 counties in California, a state in the western United States. Named B.1.427/B.1.429 to denote its two lineages, the variant emerged in May 2020 and increased from 0% to >50% of sequenced cases from September 2020 to January 2021, showing 18.6%-24% increased transmissibility relative to wild-type circulating strains. The variant carries three mutations in the spike protein, including an L452R substitution. We found 2-fold increased B.1.427/ B.1A29 viral shedding in vivo and increased L452R pseudovirus infection of cell cultures and lung organoids, albeit decreased relative to pseudoviruses carrying the N501Y mutation common to variants B.1.1.7, B.1.351, and P.1 Antibody neutralization assays revealed 4.0- to 6.7-fold and 2.0-fold decreases in neutralizing titers from convalescent patients and vaccine recipients, respectively. The increased prevalence of a more transmissible variant in California exhibiting decreased antibody neutralization warrants further investigation.	[Deng, Xianding; Servellita, Venice; Wang, Candace; Sotomayor-Gonzalez, Alicia; Glasner, Dustin R.; Reyes, Kevin R.; Gliwa, Amelia S.; Reddy, Nikitha P.; San Martin, Claudia Sanchez; Balcerek, Joanna; Taylor, Jordan; Streithorst, Jessica A.; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94158 USA; [Deng, Xianding; Servellita, Venice; Wang, Candace; Sotomayor-Gonzalez, Alicia; Glasner, Dustin R.; Reyes, Kevin R.; Gliwa, Amelia S.; Reddy, Nikitha P.; San Martin, Claudia Sanchez; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94158 USA; [Garcia-Knight, Miguel A.; Lidsky, Peter, V; Xiao, Yinghong; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Khalid, Mir M.; Cheng, Jing; Sreekumar, Bharath; Chen, Pei-Yi; Schulze-Gahmen, Ursula; Taha, Taha Y.; Hayashi, Jennifer M.; Simoneau, Camille R.; Kumar, G. Renuka; McMahon, Sarah; Ott, Melanie; Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Khalid, Mir M.; Sreekumar, Bharath; Chen, Pei-Yi; Schulze-Gahmen, Ursula; Taha, Taha Y.; Hayashi, Jennifer M.; Simoneau, Camille R.; Kumar, G. Renuka; McMahon, Sarah; Ott, Melanie] Gladstone Inst Virol, San Francisco, CA 94158 USA; [Morris, Mary Kate; Espinosa, Alex; Kath, Chantha; Haw, Monica; Bell, John; Hacker, Jill K.; Hanson, Carl; Wadford, Debra A.] Calif Dept Publ Hlth, Richmond, CA 94804 USA; [Federman, Scot] Univ Calif San Francisco, Lab Genom Res, San Francisco, CA 94158 USA; [Hemarajata, Peera; Green, Nicole M.] Los Angeles Cty Publ Hlth Labs, Downey, CA 90242 USA; [Anaya, Carlos; Ferguson, Donna] Monterey Cty Dept Publ Hlth, Monterey, CA 93906 USA; [Frankino, Phillip A.; Shivram, Haridha; Lareau, Liana F.; Wyman, Stacia K.; Ott, Melanie; Chiu, Charles Y.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Lareau, Liana F.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; California Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94158 USA.; Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94158 USA.; Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Ott, M; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Ott, M (corresponding author), Gladstone Inst Virol, San Francisco, CA 94158 USA.; Ott, M; Chiu, CY (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.	melanie.ott@gladstone.ucsf.edu; raul.andino@ucsf.edu; charles.chiu@ucsf.edu	Lidsky, Peter/AAX-7079-2021	Garcia Knight, Miguel Antonio/0000-0001-9556-3719; Lidsky, Peter/0000-0001-8976-6800; Taha, Taha/0000-0002-7344-7490; Xiao, Yinghong/0000-0002-6850-6521; Servellita, Venice/0000-0002-1745-4012; Reyes, Kevin/0000-0003-3708-444X; Wadford, Debra/0000-0002-8630-427X	US CDC Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases [6 NU50CK000539, 6 NU50CK000498]; Laboratory for Genomics Research (LGR) Excellence in Research Award; Emergent Ventures; Innovative Genomics Institute; New Frontiers in Research Fund by the Canadian Institutes of Health Research; Rodden-berry Foundation; NIH [R33-AI129455, 5DP1DA038043]	US CDC Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases; Laboratory for Genomics Research (LGR) Excellence in Research Award; Emergent Ventures; Innovative Genomics Institute; New Frontiers in Research Fund by the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Rodden-berry Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge the help from Delsy Martinez and Tyler Miyasaki at UCSF CAT core facility for genome sequencing efforts using NovaSeq. We acknowledge Maria Salas, Elizabeth Baylis, and the entire COVIDNet team at the Viral and Rickettsial Disease Laboratory of the California Department of Public Health for their support of our community viral whole-genome sequencing efforts. We thank the Whelan lab at the Washington University School of Medicine for the Vero-TMPRSS2 cells. We thank the Jackson lab at Stanford University for the A549-ACE2 cells. We thank Satish Pillai and Hannah S. Sperbert at Vitalant Research Institute (San Francisco, CA) for providing the 293T-ACE2-TMPRSS2 cells used for pseudovirus entry assays. We thank Mehrdad Arjomandi at the San Francisco Veterans Administration Medical Center for providing the clinical samples to generate the human alveolar lung organoids. We thank Dr. Kristian Andersen and his laboratory at the Scripps Research Institute for generating code (available on Github) to calculate logistic growth models of SARS-CoV-2 infection based on positive tests over time. We gratefully acknowledge the authors from the originating laboratories and the submitting laboratories who generated and shared via GISAID genetic sequence data from an additional 2,737 genomes (from samples from California collected February 1 to March 11, 2021) on which this research is based (Table S5). The findings and conclusions in this article are those of the author(s) and do not necessarily represent the views or opinions of the California Department of Public Health or the California Health and Human Services Agency. This work has been funded by US CDC Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases grants (6 NU50CK000539 to CDPH COVIDnet and 6 NU50CK000498 to Los Angeles County Public Health Laboratories), a Laboratory for Genomics Research (LGR) Excellence in Research Award (L. F.L.), a Fast Grant from Emergent Ventures (S. K.W.), the Innovative Genomics Institute (C.Y.C., M.O., L.F.L., S.K.W., P.A.F., and H.S.), the New Frontiers in Research Fund provided by the Canadian Institutes of Health Research (C.Y.C.), the Rodden-berry Foundation (M.O.), and NIH (R33-AI129455 to C.Y.C. and 5DP1DA038043 to M.O.).	Andersen K.G, 2020, OUTBREAK; Avanzato VA, 2020, CELL, V183, P1901, DOI 10.1016/j.cell.2020.10.049; Bedford T., 2021, UPDATED NEXTSTRAIN S; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Bushnell B., 2016, BBMAP SHORT READ ALI; Buss Lewis F, 2021, Science, V371, P288, DOI 10.1126/science.abe9728; Case James Brett, 2020, bioRxiv, DOI 10.1101/2020.05.18.102038; CDPH (California Department of Public Health), 2021, COVID 19 VAR 1 FOUND; CDPH (California Department of Public Health) (2021b), TRACK COVID 19 CAL; Challen R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n579; Chen JH, 2020, J MOL BIOL, V432, P5212, DOI 10.1016/j.jmb.2020.07.009; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; COVID-19 Genomics UK (COG-UK) consortiumcontact@cogconsortium.uk, 2020, Lancet Microbe, V1, pe99, DOI 10.1016/S2666-5247(20)30054-9; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Davies Nicholas G, 2021, Science, V372, DOI 10.1126/science.abg3055; Deng XD, 2020, SCIENCE, V369, P582, DOI 10.1126/science.abb9263; Drew RJ, 2020, DIAGN MICR INFEC DIS, V98, DOI 10.1016/j.diagmicrobio.2020.115130; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644Article, 10.1126/science.abh2644, 10.1101/2021.02.26.21252554]; Fontanet A, 2021, LANCET, V397, P952, DOI 10.1016/S0140-6736(21)00370-6; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1101/2021.02.14.21251704, 10.1016/j.cell.2021.04.006]; Ghazizadeh Zaniar, 2020, bioRxiv, DOI 10.1101/2020.05.12.091082; Graham, 2021, MRNA 1273 VACCINE IN, DOI [10.1101/2021.01.25, DOI 10.1101/2021.01.25]; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou Yixuan J, 2020, bioRxiv, DOI 10.1101/2020.09.28.317685; Hu J, 2021, CELL MOL IMMUNOL, V18, P1061, DOI 10.1038/s41423-021-00648-1; Jarvis, 2020, MEDRXIV, DOI [10.1126/science.abg3055, 10.1101/2020.12.24.20248822]; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kemp SA, 2021, NATURE, V592, P277, DOI 10.1038/s41586-021-03291-y; Klimstra William B, 2020, bioRxiv, DOI 10.1101/2020.06.19.154930; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lau EHY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20247-4; Leung K, 2021, EUROSURVEILLANCE, V26, P15, DOI 10.2807/1560-7917.ES.2020.26.1.2002106; Liu Yang, 2021, N Engl J Med, DOI 10.1056/NEJMc2102017; Msomi N, 2020, LANCET MICROBE, V1, pE229, DOI 10.1016/S2666-5247(20)30116-6; Naidoo Y, 2021, ESCAPE SARS COV 2 50; Neher R, 2020, GETTING STARTED GUID; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Rai B, 2021, CLIN EPIDEMIOL GLOB, V9, P157, DOI 10.1016/j.cegh.2020.08.007; Rambaut A, 2021, FIGTREE; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Servellita V., 2021, ZENODO; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Simmons, 2020, BINDING SARS COV 2 S; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; Teng SL, 2021, BRIEF BIOINFORM, V22, P1239, DOI 10.1093/bib/bbaa233; Volz E., 2021, MEDRXIV, DOI [10.1101/2020.12.30.20249034, DOI 10.1101/2020.12.30.20249034]; Wang SX, 2005, J IMMUNOL METHODS, V301, P21, DOI 10.1016/j.jim.2005.03.008; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Washburne, SCIENCE, V372; Washington Nicole L, 2021, medRxiv, DOI 10.1101/2021.02.06.21251159; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n359; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Shi Pei-Yong, 2021, Res Sq, DOI [10.1101/2021.01.07.425740, 10.21203/rs.3.rs-143532/v1]; Zhang WJ, 2021, JAMA-J AM MED ASSOC, V325, P1324, DOI 10.1001/jama.2021.1612; Zhou B, 2021, NATURE, V592, P122, DOI 10.1038/s41586-021-03361-1; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	67	245	254	6	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2021	184	13					3426	+		10.1016/j.cell.2021.04.025	http://dx.doi.org/10.1016/j.cell.2021.04.025		JUN 2021	20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SX9WL	33991487	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000665547300009
J	Stilp, F; Bereczuk, A; Berwanger, J; Mundigl, N; Richter, K; Giessibl, FJ				Stilp, Fabian; Bereczuk, Andreas; Berwanger, Julian; Mundigl, Nadine; Richter, Klaus; Giessibl, Franz J.			Very weak bonds to artificial atoms formed by quantum corrals	SCIENCE			English	Article							FORCE; MANIPULATION; WAVES	We explored the bonding properties of the quantum corral (a circle of 48 iron atoms placed on a copper surface) reported by Crommie et al. in 1993, along with variants, as an artificial atom using an atomic force microscope (AFM). The original corral geometry confines 102 electrons to 28 discrete energy states, and we found that these states can form a bond to the front atom of the AFM with an energy of about 5 millielectron volts. The measured forces are about 1/1000 of typical forces in atomically resolved AFM. The confined electrons showed covalent attraction to metal tips and Pauli repulsion to CO-terminated tips. The repulsion at close distance was evident from the response of corral states created by deliberately placing single iron atoms inside the corral. The forces scaled appropriately with a 24-atom corral.	[Stilp, Fabian; Berwanger, Julian; Mundigl, Nadine; Giessibl, Franz J.] Univ Regensburg, Inst Expt & Appl Phys, Dept Phys, D-93040 Regensburg, Germany; [Bereczuk, Andreas; Richter, Klaus] Univ Regensburg, Inst Theoret Phys, Dept Phys, D-93040 Regensburg, Germany	University of Regensburg; University of Regensburg	Giessibl, FJ (corresponding author), Univ Regensburg, Inst Expt & Appl Phys, Dept Phys, D-93040 Regensburg, Germany.	franz.giessbl@ur.de	; Giessibl, Franz/K-8022-2013	Stilp, Fabian/0000-0002-1927-9510; Giessibl, Franz/0000-0002-5585-1326; Mundigl, Nadine/0000-0003-0679-246X; Bereczuk, Andreas/0000-0003-4167-1225; Berwanger, Julian/0000-0003-1279-1658	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [314695032 SFB 1277]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, Project-ID 314695032 SFB 1277 projects A02 to F.S., J.B., N.M., and F.J.G. and A07 to A.B. and K.R.).	ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; [Anonymous], MAT METHODS ARE AVAI; [Anonymous], 2015, NONCONTACT ATOMIC FO; Bartels L, 1998, PHYS REV LETT, V80, P2004, DOI 10.1103/PhysRevLett.80.2004; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Chen C. J., 1993, INTRO SCANNING TUNNE; CROMMIE MF, 1995, PHYSICA D, V83, P98, DOI 10.1016/0167-2789(94)00254-N; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Emmrich M, 2015, SCIENCE, V348, P308, DOI 10.1126/science.aaa5329; Fiete GA, 2003, REV MOD PHYS, V75, P933, DOI 10.1103/RevModPhys.75.933; Freeney SE, 2020, SCIPOST PHYS, V9, DOI 10.21468/SciPostPhys.9.6.085; Garcia R, 2002, SURF SCI REP, V47, P197, DOI 10.1016/S0167-5729(02)00077-8; GARTLAND PO, 1972, PHYS REV LETT, V28, P738, DOI 10.1103/PhysRevLett.28.738; Giessibl FJ, 2001, APPL PHYS LETT, V78, P123, DOI 10.1063/1.1335546; Giessibl FJ, 2019, REV SCI INSTRUM, V90, DOI 10.1063/1.5052264; Gomes KK, 2012, NATURE, V483, P306, DOI 10.1038/nature10941; Gretz O, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.033094; Gross L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.086101; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Groth CW, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/6/063065; HELLER EJ, 1994, NATURE, V369, P464, DOI 10.1038/369464a0; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Huber F, 2019, SCIENCE, V366, P235, DOI 10.1126/science.aay3444; Huber F, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.4993737; KASTNER MA, 1993, PHYS TODAY, V46, P24, DOI 10.1063/1.881393; Kawai S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11559; KEVAN SD, 1983, PHYS REV LETT, V50, P526, DOI 10.1103/PhysRevLett.50.526; KEVAN SD, 1986, PHYS REV B, V34, P6713, DOI 10.1103/PhysRevB.34.6713; Khajetoorians AA, 2019, NAT REV PHYS, V1, P703, DOI 10.1038/s42254-019-0108-5; Knorr N, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.115420; LANG ND, 1970, PHYS REV B, V1, P4555, DOI 10.1103/PhysRevB.1.4555; Liebig A, 2020, NEW J PHYS, V22, DOI 10.1088/1367-2630/ab8efd; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; Moll N, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/8/083023; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Morgenstern K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.056102; Repp J, 2000, PHYS REV LETT, V85, P2981, DOI 10.1103/PhysRevLett.85.2981; Schneiderbauer M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.166102; Schuler B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.106103; Seufert K, 2013, NANO LETT, V13, P6130, DOI 10.1021/nl403459m; Stilp F., 2021, VERY WEAK BONDS ARTI, DOI [10.5283/epub.45631, DOI 10.5283/EPUB.45631]; STROSCIO JA, 1991, SCIENCE, V254, P1319, DOI 10.1126/science.254.5036.1319; Ternes M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.016802; Welker J, 2012, SCIENCE, V336, P444, DOI 10.1126/science.1219850; Weymouth AJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.226801; Yan LH, 2019, ADV PHYS-X, V4, DOI 10.1080/23746149.2019.1651672; Zangwill A., 1988, PHYS SURFACES	49	7	7	7	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2021	372	6547					1196	+		10.1126/science.abe2600	http://dx.doi.org/10.1126/science.abe2600			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SS9QN	34010141	Green Submitted			2022-12-28	WOS:000662088000026
J	Kuppalli, K; Gala, P; Cherabuddi, K; Kalantri, SP; Mohanan, M; Mukherjee, B; Pinto, L; Prakash, M; Pramesh, CS; Rathi, S; Pai, NP; Yamey, G; Pai, M				Kuppalli, Krutika; Gala, Pooja; Cherabuddi, Kartikeya; Kalantri, S. P.; Mohanan, Manoj; Mukherjee, Bhramar; Pinto, Lancelot; Prakash, Manu; Pramesh, C. S.; Rathi, Sahaj; Pai, Nitika Pant; Yamey, Gavin; Pai, Madhukar			India's COVID-19 crisis: a call for international action	LANCET			English	Editorial Material									[Kuppalli, Krutika] Med Univ South Carolina, Div Infect Dis, Charleston, SC 29425 USA; [Gala, Pooja] NYU, Dept Populat Hlth, New York, NY USA; [Cherabuddi, Kartikeya] Univ Florida, Div Infect Dis & Global Med, Gainesville, FL USA; [Kalantri, S. P.] Mahatma Gandhi Inst Med Sci, Dept Med, Sevagram, Maharashtra, India; [Mohanan, Manoj] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Yamey, Gavin] Duke Univ, Ctr Policy Impact Global Hlth, Durham, NC USA; [Pinto, Lancelot] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Prakash, Manu] Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA; [Prakash, Manu] Stanford Univ, Woods Inst Environm, Palo Alto, CA 94304 USA; [Prakash, Manu] Stanford Univ, Ctr Innovat Global Hlth, Palo Alto, CA 94304 USA; [Pramesh, C. S.] Homi Bhabha Natl Inst, Tata Mem Ctr, Mumbai, Maharashtra, India; [Rathi, Sahaj] Inst Liver & Biliary Sci, Dept Hepatol, New Delhi, India; [Pai, Nitika Pant] McGill Univ, Ctr Hlth, Div Clin Epidemiol & Infect Dis, Montreal, PQ, Canada; [Pai, Madhukar] McGill Univ, Ctr Hlth, Sch Populat & Global Hlth, Montreal, PQ, Canada	Medical University of South Carolina; New York University; State University System of Florida; University of Florida; Mahatma Gandhi Institute of Medical Sciences, Sevagram; Duke University; Duke University; University of Michigan System; University of Michigan; Stanford University; Stanford University; Stanford University; Homi Bhabha National Institute; Tata Memorial Centre (TMC); Institute of Liver & Biliary Sciences (ILBS); McGill University; McGill University	Kuppalli, K (corresponding author), Med Univ South Carolina, Div Infect Dis, Charleston, SC 29425 USA.	krutika.kuppalli@gmail.com	Cherabuddi, Kartikeya/AAD-5897-2019; Pai, Madhukar/AAX-9901-2021; Kalantri, Shriprakash/ABG-9318-2021	Cherabuddi, Kartikeya/0000-0001-7390-9053; Pai, Madhukar/0000-0003-3667-4536; Kalantri, Shriprakash/0000-0002-1633-1029; Mohanan, Manoj/0000-0001-7028-6479; Kuppalli, Krutika/0000-0002-3550-7675; Pant Pai, Nitika/0000-0002-4672-0500; Prakash, Manu/0000-0002-8046-8388				[Anonymous], 2021, FIRSTPOST       0307; [Anonymous], 2021, NEW INDIA EXPRE 0511; [Anonymous], 2021, REUTERS 0505; Bureau ET, 2021, EC TIMES        0504; Goel V, 2020, NY TIMES        0303; Horner R, 2020, CONVERSATION    0525; Institute for Health Metrics and Evaluation, 2021, COVID 19 PROJ 2021; Jamkhandikar S, 2021, REUTERS         0420; Kazmi S, 2021, EURASIA REV     0506; Office of the United States Trade Representative, 2021, COMMUNICATION   0505; Pulla P., 2021, SCIENCE, DOI [https://doi.org/10.1126/science.abj2944, DOI 10.1126/SCIENCE.ABJ2944]; Ritchie H, 2021, INDIA CORONAVIRUS PA; Siow WT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02890-x; Thakur D, 2021, STAT            0505; The Lancet COVID-19 Commission India Task Force, COUNTR WID CONT STRA; To Kelvin Kai-Wang, 2021, Clin Infect Dis, V73, pe2946, DOI 10.1093/cid/ciaa1275; WHO, 2021, NOV COR 2019 NCOV SI	17	21	21	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2021	397	10290					2132	2135		10.1016/S0140-6736(21)01121-1	http://dx.doi.org/10.1016/S0140-6736(21)01121-1		JUN 2021	5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SM8DI	34000256	Green Published, Bronze			2022-12-28	WOS:000657828600005
J	Reich, K; Teixeira, HD; de Bruin-Weller, M; Bieber, T; Soong, W; Kabashima, K; Werfel, T; Zeng, JW; Huang, XH; Hu, XF; Hendrickson, BA; Ladizinski, B; Chu, AD; Silverberg, JI				Reich, Kristian; Teixeira, Henrique D.; de Bruin-Weller, Marjolein; Bieber, Thomas; Soong, Weily; Kabashima, Kenji; Werfel, Thomas; Zeng, Jiewei; Huang, Xiaohong; Hu, Xiaofei; Hendrickson, Barbara A.; Ladizinski, Barry; Chu, Alvina D.; Silverberg, Jonathan I.			Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article							DAILY PRACTICE COHORT; DRUG SURVIVAL; MANAGEMENT; DUPILUMAB; FEATURES	Background Systemic therapies are typically combined with topical corticosteroids for the management of moderate-to-severe atopic dermatitis. Upadacitinib is an oral Janus kinase (JAK) inhibitor with greater inhibitory potency for JAK1 than JAK2, JAK3, or tyrosine kinase 2 that is being tested for atopic dermatitis. We aimed to assess the efficacy and safety of upadacitinib plus topical corticosteroids compared with placebo for the treatment of moderate-to-severe atopic dermatitis. Methods In this randomised, double-blind, placebo-controlled, phase 3 trial (AD Up) adults (aged 18-75 years) and adolescents (aged 12-17 years) with chronic atopic dermatitis that was moderate to severe (>= 10% of body surface area affected, Eczema Area and Severity Index [EASI] score of >= 16, validated Investigator's Global Assessment for atopic dermatitis [vIGA-AD] score of >= 3, and weekly average Worst Pruritus Numerical Rating Scale score of >= 4 at baseline) were enrolled at 171 clinical centres across 22 countries in the Asia-Pacific region, Europe, the Middle East, North America, and Oceania. Patients were randomly assigned (1:1:1) to receive upadacitinib 15 mg, upadacitinib 30 mg, or placebo once daily, all in combination with topical corticosteroids for 16 weeks. Randomisation was done using an interactive response technology system, stratified by baseline disease severity, geographical region, and age. Study investigators, study site personnel, and patients were masked to study treatment. The coprimary endpoints were the proportion of patients who had achieved at least a 75% reduction in EASI score from baseline (EASI-75) and the proportion of patients who had achieved a vIGA-AD response (defined as a vIGA-AD score of 0 [ clear] or 1 [almost clear] with >= 2 grades of improvement from baseline) at week 16. Efficacy was analysed in the intention-to-treat population and safety was analysed in all patients who received at least one dose of study drug. This study is registered with ClinicalTrials.gov, NCT03568318, and is active, but not recruiting. Findings Between Aug 9, 2018, and Dec 20, 2019, 901 patients were randomly assigned to receive upadacitinib 15 mg plus topical corticosteroids (n=300), upadacitinib 30 mg plus topical corticosteroids (n=297), or placebo plus topical corticosteroids (n=304). At week 16, the proportion of patients who had achieved EASI-75 was significantly higher in the upadacitinib 15 mg plus topical corticosteroid group (194 [65%] of 300 patients) and the upadacitinib 30 mg plus topical corticosteroids group (229 [77%] of 297 patients) than the placebo group (80 [26%] of 304 patients; adjusted difference in EASI-75 response rate vs placebo, 38.1% [95% CI 30.8-45.4] for the upadacitinib 15 mg group and 50.6% [43.8-57.4] for the upadacitinib 30 mg group; p<0.0001 for both doses). The proportion of patients who had achieved a vIGA-AD response at week 16 was significantly higher in the upadacitinib 15 mg plus topical corticosteroid group (119 [40%] patients) and upadacitinib 30 mg plus topical corticosteroid group (174 [59%] patients) than the placebo group (33 [11%] patients; adjusted difference in vIGA-AD response vs placebo, 28.5% [22.1-34.9] for the upadacitinib 15 mg group and 47.6% [41.1-54.0] for the upadacitinib 30 mg group; p<0.0001 for both doses). During the double-blind period, upadacitinib 15 and 30 mg were well tolerated in combination with topical corticosteroids. The most frequently reported treatment-emergent adverse events (>= 5% in any treatment group) were acne, nasopharyngitis, upper respiratory tract infection, oral herpes, elevation of blood creatine phosphokinase levels, headache, and atopic dermatitis. The incidence of acne was higher in the upadacitinib 15 mg (30 [10%] of 300 patients) and upadacitinib 30 mg (41 [14%] of 297 patients) groups than the placebo group (six [2%] of 304 patients). The incidence of adverse events leading to discontinuation of study drug (four [1%] patients in the upadacitinib 15 mg plus topical corticosteroids group, four [1%] patients in the upadacitinib 30 mg plus topical corticosteroids group, and seven [2%] patients in the placebo plus topical corticosteroids group) and serious adverse events (seven [2%] patients, four [1%] patients, and nine [3%] patients) were similar among treatment groups. No deaths were reported in any treatment group. Interpretation Upadacitinib plus topical corticosteroids was well tolerated and superior to placebo plus topical corticosteroids. Upadacitinib as combination therapy had a positive benefit-risk profile in adults and adolescents with moderate-to-severe atopic dermatitis. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Reich, Kristian] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, D-20246 Hamburg, Germany; [Teixeira, Henrique D.; Zeng, Jiewei; Huang, Xiaohong; Hu, Xiaofei; Hendrickson, Barbara A.; Ladizinski, Barry; Chu, Alvina D.] AbbVie, N Chicago, IL 60064 USA; [de Bruin-Weller, Marjolein] Univ Med Ctr Utrecht, Natl Expertise Ctr Atop Dermatitis, Dept Dermatol & Allergol, Utrecht, Netherlands; [Bieber, Thomas] Univ Hosp Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Soong, Weily] Alabama Allergy & Asthma Ctr, Birmingham, AL USA; [Soong, Weily] Clin Res Ctr Alabama, Birmingham, AL USA; [Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Werfel, Thomas] Hannover Med Sch, Div Immunodermatol & Allergy Res, Dept Dermatol & Allergy, Hannover, Germany; [Silverberg, Jonathan I.] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; AbbVie; Utrecht University; Utrecht University Medical Center; University of Bonn; Kyoto University; Hannover Medical School; George Washington University	Reich, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, D-20246 Hamburg, Germany.	k.reich@uke.de	silverberg, jonathan/ABH-2765-2021	silverberg, jonathan/0000-0003-3686-7805	AbbVie	AbbVie(AbbVie)	AbbVie.	AbbVie, 2019, RINVOQ UPD EXT REL T; Blauvelt A, 2017, LANCET, V389, P2287, DOI 10.1016/S0140-6736(17)31191-1; Damour A, 2020, CLIN REV ALLERG IMMU, V59, P1, DOI 10.1007/s12016-019-08768-3; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Guo L, 2020, J EUR ACAD DERMATOL, V34, P192, DOI 10.1111/jdv.15937; Guttman-Yassky E, 2021, LANCET, V397, P2151, DOI 10.1016/S0140-6736(21)00588-2; Guttman-Yassky E, 2020, J ALLERGY CLIN IMMUN, V145, P877, DOI 10.1016/j.jaci.2019.11.025; Halling AS, 2020, J EUR ACAD DERMATOL, V35, P275; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; He H, 2019, AM J CLIN DERMATOL, V20, P181, DOI 10.1007/s40257-018-0413-2; Hengge UR, 2006, J AM ACAD DERMATOL, V54, P1, DOI 10.1016/j.jaad.2005.01.010; Hijnen DJ, 2020, J ALLERGY CLIN IMMUN, V145, P1360, DOI 10.1016/j.jaci.2020.02.030; Nemeth T, 2020, NAT REV DRUG DISCOV, V19, P253, DOI 10.1038/s41573-019-0054-z; Parmentier JM, 2018, BMC RHEUMATOL, V2, DOI 10.1186/s41927-018-0031-x; Queeney K, 2019, ANN EUR C RHEUM MADR; Reich K, 2020, JAMA DERMATOL, V156, P1333, DOI 10.1001/jamadermatol.2020.3260; Rosmarin D, 2020, LANCET, V396, P110, DOI 10.1016/S0140-6736(20)30609-7; Shah P, 2007, J ENZYM INHIB MED CH, V22, P527, DOI 10.1080/14756360701425014; Silverberg JI, 2021, BRIT J DERMATOL, V184, P450, DOI 10.1111/bjd.19573; Silverberg JI, 2020, JAMA DERMATOL, V156, P863, DOI 10.1001/jamadermatol.2020.1406; Simpson EL, 2020, BRIT J DERMATOL, V183, P242, DOI 10.1111/bjd.18898; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Simpson E, 2020, J AM ACAD DERMATOL, V83, P839, DOI 10.1016/j.jaad.2020.04.104; Smolen JS, 2019, LANCET, V393, P2303, DOI 10.1016/S0140-6736(19)30419-2; U.S. Department of Health and Human Services, 2009, GUID IND DRUG IND LI; van der Schaft J, 2016, BRIT J DERMATOL, V175, P199, DOI 10.1111/bjd.14398; van der Schaft J, 2015, BRIT J DERMATOL, V172, P1621, DOI 10.1111/bjd.13730; van Vollenhoven R, 2020, ARTHRITIS RHEUMATOL, V72, P1607, DOI 10.1002/art.41384; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wollenberg A, 2021, BRIT J DERMATOL, V184, P437, DOI 10.1111/bjd.19574; Wollenberg A, 2003, J AM ACAD DERMATOL, V49, P198, DOI 10.1067/S0190-9622(03)00896-X	32	64	65	6	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2021	397	10290					2169	2181		10.1016/S0140-6736(21)00589-4	http://dx.doi.org/10.1016/S0140-6736(21)00589-4		JUN 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SM8DI	34023009				2022-12-28	WOS:000657828600023
J	Chakrabarti, D; Akhtar, N				Chakrabarti, Deep; Akhtar, Naseem			White Plaque on the Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chakrabarti, Deep; Akhtar, Naseem] King Georges Med Univ Lucknow, Lucknow, Uttar Pradesh, India	King George's Medical University	Akhtar, N (corresponding author), King Georges Med Univ Lucknow, Lucknow, Uttar Pradesh, India.	naseemakhtar97@gmail.com		Chakrabarti, Deep/0000-0002-9511-6844; Akhtar, Naseem/0000-0001-8724-3248					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					E75	E75		10.1056/NEJMicm2032955	http://dx.doi.org/10.1056/NEJMicm2032955			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ4AW	34010533				2022-12-28	WOS:000655474700001
J	Dijk, S				Dijk, Stijntje			A day in the life of a medical student from Portugal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dijk, Stijntje] Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Dijk, S (corresponding author), Erasmus MC, Rotterdam, Netherlands.	stijntjedijk@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2021	373								m4503	10.1136/bmj.m4503	http://dx.doi.org/10.1136/bmj.m4503			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5SO	34011518				2022-12-28	WOS:000655594700007
J	Simone, R; Javad, F; Emmett, W; Wilkins, OG; Almeida, FL; Barahona-Torres, N; Zareba-Paslawska, J; Ehteramyan, M; Zuccotti, P; Modelska, A; Siva, K; Virdi, GS; Mitchell, JS; Harley, J; Kay, VA; Hondhamuni, G; Trabzuni, D; Ryten, M; Wray, S; Preza, E; Kia, DA; Pittman, A; Ferrari, R; Manzoni, C; Lees, A; Hardy, JA; Denti, MA; Quattrone, A; Patani, R; Svenningsson, P; Warner, TT; Plagnol, V; Ule, J; de Silva, R				Simone, Roberto; Javad, Faiza; Emmett, Warren; Wilkins, Oscar G.; Almeida, Filipa Lourenco; Barahona-Torres, Natalia; Zareba-Paslawska, Justyna; Ehteramyan, Mazdak; Zuccotti, Paola; Modelska, Angelika; Siva, Kavitha; Virdi, Gurvir S.; Mitchell, Jamie S.; Harley, Jasmine; Kay, Victoria A.; Hondhamuni, Geshanthi; Trabzuni, Daniah; Ryten, Mina; Wray, Selina; Preza, Elisavet; Kia, Demis A.; Pittman, Alan; Ferrari, Raffaele; Manzoni, Claudia; Lees, Andrew; Hardy, John A.; Denti, Michela A.; Quattrone, Alessandro; Patani, Rickie; Svenningsson, Per; Warner, Thomas T.; Plagnol, Vincent; Ule, Jernej; de Silva, Rohan			MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA; TAU; GENE; AGGREGATION; PATHOLOGY; NEURONS; SINES	The human genome expresses thousands of natural antisense transcripts (NAT) that can regulate epigenetic state, transcription, RNA stability or translation of their overlapping genes(1,2). Here we describe MAPT-AS1, a brain-enriched NAT that is conserved in primates and contains an embedded mammalian-wide interspersed repeat (MIR), which represses tau translation by competing for ribosomal RNA pairing with the MAPT mRNA internal ribosome entry site(3). MAPT encodes tau, a neuronal intrinsically disordered protein (IDP) that stabilizes axonal microtubules. Hyperphosphorylated, aggregation-prone tau forms the hallmark inclusions of tauopathies(4). Mutations in MAPT cause familial frontotemporal dementia, and common variations forming the MAPT H1 haplotype are a significant risk factor in many tauopathies(5) and Parkinson's disease. Notably, expression of MAPT-AS1 or minimal essential sequences from MAPT-AS1 (including MIR) reduces-whereas silencing MAPT-AS1 expression increases-neuronal tau levels, and correlate with tau pathology in human brain. Moreover, we identified many additional NATs with embedded MIRs (MIR-NATs), which are overrepresented at coding genes linked to neurodegeneration and/or encoding IDPs, and confirmed MIR-NAT-mediated translational control of one such gene, PLCG1. These results demonstrate a key role for MAPT-AS1 in tauopathies and reveal a potentially broad contribution of MIR-NATs to the tightly controlled translation of IDPs(6), with particular relevance for proteostasis in neurodegeneration.	[Simone, Roberto; Javad, Faiza; Almeida, Filipa Lourenco; Ehteramyan, Mazdak; Kay, Victoria A.; Hondhamuni, Geshanthi; Wray, Selina; Preza, Elisavet; Lees, Andrew; Hardy, John A.; Warner, Thomas T.; de Silva, Rohan] UCL Queen Sq Inst Neurol, Reta Lila Weston Inst, London, England; [Simone, Roberto; Javad, Faiza; Almeida, Filipa Lourenco; Ehteramyan, Mazdak; Virdi, Gurvir S.; Kay, Victoria A.; Hondhamuni, Geshanthi; Kia, Demis A.; Lees, Andrew; Warner, Thomas T.; de Silva, Rohan] UCL Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, London, England; [Emmett, Warren; Plagnol, Vincent] UCL Genet Inst, London, England; [Emmett, Warren; Wilkins, Oscar G.; Mitchell, Jamie S.; Harley, Jasmine; Patani, Rickie; Ule, Jernej] UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, London, England; [Emmett, Warren] Inivata Ltd, Babraham, England; [Wilkins, Oscar G.; Virdi, Gurvir S.; Mitchell, Jamie S.; Harley, Jasmine; Patani, Rickie; Ule, Jernej] Francis Crick Inst, London, England; [Barahona-Torres, Natalia; Trabzuni, Daniah; Ryten, Mina; Wray, Selina; Preza, Elisavet; Ferrari, Raffaele; Hardy, John A.] UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zareba-Paslawska, Justyna; Svenningsson, Per] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Zuccotti, Paola; Modelska, Angelika; Siva, Kavitha; Denti, Michela A.; Quattrone, Alessandro] Dept Cellular Computat & Integrat Biol CIBIO, Trento, Italy; [Pittman, Alan] St Georges Univ London, Genet Res Ctr, Mol & Clin Sci, London, England; [Manzoni, Claudia] UCL Sch Pharm, Dept Pharmacol, London, England; [Hardy, John A.] UCL, UK Dementia Res Inst, London, England; [Hardy, John A.] Hong Kong Univ Sci & Technol, Inst Adv Study, Hong Kong, Peoples R China; [Ule, Jernej] Natl Inst Chem, Ljubljana, Slovenia	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Francis Crick Institute; University of London; University College London; Karolinska Institutet; St Georges University London; University of London; University College London; University of London; University College London; Hong Kong University of Science & Technology; National Institute of Chemistry - Slovenia	Simone, R; de Silva, R (corresponding author), UCL Queen Sq Inst Neurol, Reta Lila Weston Inst, London, England.; Simone, R; de Silva, R (corresponding author), UCL Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, London, England.	r.simone@ucl.ac.uk; r.desilva@ucl.ac.uk	Pittman, Alan/AAP-2534-2020; Svenningsson, Per JL/K-5210-2014; Denti, Michela A./ABI-4085-2020; Hardy, John/C-2451-2009; Warner, Thomas T/A-1454-2013; Patani, Rickie/J-3107-2018; Ule, Jernej/C-6315-2013; Wray, Selina/C-3682-2009	Pittman, Alan/0000-0002-8112-2987; Denti, Michela A./0000-0001-7203-7062; Hardy, John/0000-0002-3122-0423; Warner, Thomas T/0000-0001-6195-6995; Zareba-Paslawska, Justyna/0000-0001-6193-5908; Virdi, Gurvir/0000-0002-8942-0903; Patani, Rickie/0000-0002-3825-7675; Manzoni, Claudia/0000-0001-5367-4023; Barahona Torres, Natalia/0000-0002-5289-4232; Simone, Roberto/0000-0002-7722-1093; Mitchell, Jamie/0000-0002-6954-9988; Modelska, Angelika/0000-0001-6544-1024; Ule, Jernej/0000-0002-2452-4277; Wray, Selina/0000-0003-3062-7050	Reta Lila Weston Trust for Medical Research; CBD Solutions; Medical Research Council [G0501560, MR/N026004/1]; Parkinson's UK [K1212]; PSP Association; CurePSP; Brain Research UK; Alzheimer's Research UK; BBSRC LiDo PhD studentship; AgeUK PhD Studentship; NIHR Queen Square Dementia BRU; Italian Ministry of Education, University and Research Futuro in Ricerca 'Mechanisms of post-transcriptional regulation of gene expression in dementias' [RBFR-0895DC]; University of Trento PhD studentship; IBRO InEurope Short Stay grant; MRC Sudden Death Brain Bank; Francis Crick Institute from Cancer Research UK [FC001002]; Wellcome Trust [FC001002, 202903/Z/16/Z]; Wellcome Trust (4 Year Wellcome Trust Studentship); European Research Council under the European Union's Seventh Framework Programme [617837-Translate]; European Research Council under the European Union's Horizon 2020 research and innovation programme [835300-RNPdynamics]; Alzheimer's Research UK Senior Research Fellowship [ARUK-SRFEXT2020-001]; MRC Senior Clinical Fellowship [MR/S006591/1]; UK Dementia Research Institute funding from DRI Ltd - UK Medical Research Council; Alzheimer's Society; Dolby Family Fund; National Institute for Health Research University College London Hospitals Biomedical Research Centre funding; UK Medical Research Council [FC001002]	Reta Lila Weston Trust for Medical Research; CBD Solutions; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's UK(Parkinson's UK); PSP Association; CurePSP; Brain Research UK; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); BBSRC LiDo PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AgeUK PhD Studentship; NIHR Queen Square Dementia BRU; Italian Ministry of Education, University and Research Futuro in Ricerca 'Mechanisms of post-transcriptional regulation of gene expression in dementias'; University of Trento PhD studentship; IBRO InEurope Short Stay grant; MRC Sudden Death Brain Bank(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute from Cancer Research UK; Wellcome Trust(Wellcome Trust); Wellcome Trust (4 Year Wellcome Trust Studentship); European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); European Research Council under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Alzheimer's Research UK Senior Research Fellowship; MRC Senior Clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Dementia Research Institute funding from DRI Ltd - UK Medical Research Council; Alzheimer's Society; Dolby Family Fund; National Institute for Health Research University College London Hospitals Biomedical Research Centre funding; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Wilson and A. Willis for providing pRF and pRhcvF luciferase reporter vectors; P. Fratta and A. Isaacs for suggestions and comments on the manuscript, and other members of the UK Brain Expression Consortium: S. Guelfi, K. D'Sa, M. Matarin, J. Vandrovcova, A. Ramasamy, J. A. Botia, C. Smith and P. Forabosco. This work was supported by the Reta Lila Weston Trust for Medical Research for funding to T.T.W., R.d.S. and R.S.; CBD Solutions for funding to R.d.S., R.S. and P.S.); the Medical Research Council (G0501560 to R.d.S.), Parkinson's UK (K1212 to R.d.S.), PSP Association (R.d.S.), CurePSP (R.d.S.), Brain Research UK (R.d.S.), Alzheimer's Research UK to R.d.S.; a BBSRC LiDo PhD studentship to F.J.; an AgeUK PhD Studentship to V.A.K.; the NIHR Queen Square Dementia BRU to S.W., E.P. and J.A.H.; the Italian Ministry of Education, University and Research Futuro in Ricerca (RBFR-0895DC) 'Mechanisms of post-transcriptional regulation of gene expression in dementias' to M.A.D.; University of Trento PhD studentship and an IBRO InEurope Short Stay grant to K.S.; and the MRC Sudden Death Brain Bank. This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001002), the UK Medical Research Council (FC001002) and the Wellcome Trust (FC001002). This research was funded in part by the Wellcome Trust (4 Year Wellcome Trust Studentship to O.G.W.) and by the European Research Council under the European Union's Seventh Framework Programme (617837-Translate to J.U.) and under the European Union's Horizon 2020 research and innovation programme (835300-RNPdynamics to J.U.). S.W. holds a Alzheimer's Research UK Senior Research Fellowship (ARUK-SRFEXT2020-001); R.P. holds an MRC Senior Clinical Fellowship (MR/S006591/1). This work was also supported by the UK Dementia Research Institute which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK; Medical Research Council (award number MR/N026004/1 to J.A.H.), Wellcome Trust (award number 202903/Z/16/Z to J.A.H.), Dolby Family Fund to J.A.H., National Institute for Health Research University College London Hospitals Biomedical Research Centre funding to J.A.H.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Blazquez L, 2018, MOL CELL, V72, P496, DOI 10.1016/j.molcel.2018.09.033; Bottley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013030; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Coupland KG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157924; De Palma M, 2002, METHOD ENZYMOL, V346, P514; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards YJK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r50; Elkouris M, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00058; Friedman BA, 2018, CELL REP, V22, P832, DOI 10.1016/j.celrep.2017.12.066; Gilbert N, 1999, P NATL ACAD SCI USA, V96, P2869, DOI 10.1073/pnas.96.6.2869; Grubman A, 2019, NAT NEUROSCI, V22, P2087, DOI 10.1038/s41593-019-0539-4; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hall CE, 2017, CELL REP, V19, P1739, DOI 10.1016/j.celrep.2017.05.024; Holcik M, 2018, OXFORD HDB NEURONAL; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Kopec AM, 2017, J NEUROSCI METH, V280, P64, DOI 10.1016/j.jneumeth.2017.02.002; Kraushar ML, 2014, P NATL ACAD SCI USA, V111, pE3815, DOI 10.1073/pnas.1408305111; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luisier R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04373-8; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; McGlincy NJ, 2017, METHODS, V126, P112, DOI 10.1016/j.ymeth.2017.05.028; Miller JA, 2017, ELIFE, V6, DOI 10.7554/eLife.31126; Moll P, 2014, NAT METHODS, V11, P1, DOI [10.1038/nmeth.f.376, DOI 10.1038/NMETH.F.376]; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Paek KY, 2015, P NATL ACAD SCI USA, V112, P1041, DOI 10.1073/pnas.1416883112; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/NMETH.1470, 10.1038/nmeth.1470]; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Sibley CR, 2015, NATURE, V521, P371, DOI 10.1038/nature14466; SMIT AFA, 1995, NUCLEIC ACIDS RES, V23, P98, DOI 10.1093/nar/23.1.98; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sposito T, 2015, HUM MOL GENET, V24, P5260, DOI 10.1093/hmg/ddv246; Statello L, 2021, NAT REV MOL CELL BIO, V22, P96, DOI 10.1038/s41580-020-00315-9; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Tomkins JE, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00554-5; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Veo BL, 2012, RNA BIOL, V9, P1344, DOI 10.4161/rna.22181; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weingarten-Gabbay S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4939; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443; Zucchelli S, 2019, MOL NEUROBIOL, V56, P5392, DOI 10.1007/s12035-018-1465-2	72	14	14	4	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					117	+		10.1038/s41586-021-03556-6	http://dx.doi.org/10.1038/s41586-021-03556-6		MAY 2021	34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM2RM	34012113	Green Accepted, Green Submitted			2022-12-28	WOS:000652172000002
J	Kmietowicz, Z				Kmietowicz, Zosia			Chloramphenicol eye drops: GPs criticise lack of guidance over use in under 2s	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kmietowicz, Zosia] BMJ, London, England		Kmietowicz, Z (corresponding author), BMJ, London, England.							Cave James A, 2021, Drug Ther Bull, V59, P98, DOI 10.1136/dtb.2021.000001; European Medicines Agency, 2017, BOR AC BOR US EXC; Royal College of Ophthalmologists, 2021, SAF AL BOR ADD CHLOR	3	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2021	373								n1252	10.1136/bmj.n1252	http://dx.doi.org/10.1136/bmj.n1252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WX9WH	33990293				2022-12-28	WOS:000718938400001
J	Zhang, Y; Yu, JY; Wang, X; Durachko, DM; Zhang, SL; Cosgrove, DJ				Zhang, Yao; Yu, Jingyi; Wang, Xuan; Durachko, Daniel M.; Zhang, Sulin; Cosgrove, Daniel J.			Molecular insights into the complex mechanics of plant epidermal cell walls	SCIENCE			English	Article							CELLULOSE MICROFIBRILS; XYLOGLUCAN; PECTIN; DYNAMICS; NANOSCALE; POLYSACCHARIDES; ADSORPTION; VISUALIZATION; ORGANIZATION; FLEXIBILITY	Plants have evolved complex nanofibril-based cell walls to meet diverse biological and physical constraints. How strength and extensibility emerge from the nanoscale-to-mesoscale organization of growing cell walls has long been unresolved. We sought to clarify the mechanical roles of cellulose and matrix polysaccharides by developing a coarse-grained model based on polymer physics that recapitulates aspects of assembly and tensile mechanics of epidermal cell walls. Simple noncovalent binding interactions in the model generate bundled cellulose networks resembling that of primary cell walls and possessing stress-dependent elasticity, stiffening, and plasticity beyond a yield threshold. Plasticity originates from fibril-fibril sliding in aligned cellulose networks. This physical model provides quantitative insight into fundamental questions of plant mechanobiology and reveals design principles of biomaterials that combine stiffness with yielding and extensibility.	[Zhang, Yao; Yu, Jingyi; Wang, Xuan; Durachko, Daniel M.; Cosgrove, Daniel J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Zhang, Sulin] Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA; [Zhang, Sulin] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cosgrove, DJ (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.; Zhang, SL (corresponding author), Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA.; Zhang, SL (corresponding author), Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA.	suz10@psu.edu; dcosgrove@psu.edu		Yu, Jingyi/0000-0002-3380-1053; Zhang, Yao/0000-0001-9314-5820; Cosgrove, Daniel/0000-0002-4020-5786	Center for Lignocellulose Structure and Formation, an Energy Frontier Research Center - US Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001090]	Center for Lignocellulose Structure and Formation, an Energy Frontier Research Center - US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported as part of the Center for Lignocellulose Structure and Formation, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Basic Energy Sciences under award DE-SC0001090.	Adler DC, 2013, SOFT MATTER, V9, P7138, DOI 10.1039/c3sm50183c; Ali O, 2016, TRENDS PLANT SCI, V21, P398, DOI 10.1016/j.tplants.2016.01.019; Bao Y, 2014, NANOSCALE, V6, P13421, DOI 10.1039/c4nr04862h; Barthelat F, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.7; Beck DAC, 2005, BIOCHEMISTRY-US, V44, P609, DOI 10.1021/bi0486381; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bidhendi AJ, 2020, BOTANY, V98, P49, DOI 10.1139/cjb-2019-0058; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Brackey CA, 2020, NAT METHODS, V17, P767, DOI 10.1038/s41592-020-0852-6; Broedersz CP, 2014, REV MOD PHYS, V86, P995, DOI 10.1103/RevModPhys.86.995; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Chan J, 2020, CURR BIOL, V30, P941, DOI 10.1016/j.cub.2019.12.066; Chanliaud E, 1999, PLANT J, V20, P25, DOI 10.1046/j.1365-313X.1999.00571.x; Chen CJ, 2020, NAT REV MATER, V5, P642, DOI 10.1038/s41578-020-0195-z; CLELAND R, 1967, PLANTA, V74, P197, DOI 10.1007/BF00384842; Cosgrove DJ, 2018, CURR OPIN PLANT BIOL, V46, P77, DOI 10.1016/j.pbi.2018.07.016; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; DENGATE HN, 1978, STARKE, V30, P80, DOI 10.1002/star.19780300304; Doi M., 1988, THEORY POLYM DYNAMIC; Dunweg B, 1991, INT J MOD PHYS C, V2, P817, DOI 10.1142/S0129183191001037; Durachko Daniel M, 2017, Bio Protoc, V7, pe2662, DOI 10.21769/BioProtoc.2662; Eichhorn SJ, 2012, ACS MACRO LETT, V1, P1237, DOI 10.1021/mz300420k; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Hamant O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10207-y; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; Herburger K, 2020, MOL PLANT, V13, P1047, DOI 10.1016/j.molp.2020.04.011; Hu KM, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.9; Huang R, 2015, J ENG MATH, V95, P121, DOI 10.1007/s10665-014-9761-y; Huang SX, 2018, CARBOHYD POLYM, V197, P337, DOI 10.1016/j.carbpol.2018.05.091; Ingolfsson HI, 2014, WIRES COMPUT MOL SCI, V4, P225, DOI 10.1002/wcms.1169; Kafle K, 2017, CELLULOSE, V24, P3145, DOI 10.1007/s10570-017-1337-3; Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019; Kha H, 2010, PLANT PHYSIOL, V152, P774, DOI 10.1104/pp.109.146936; Kochumalayil JJ, 2014, GREEN CHEM, V16, P1904, DOI [10.1039/c3gc41823e, 10.1039/C3GC41823E]; Kohler L, 2000, PLANTA, V210, P691, DOI 10.1007/s004250050669; Koziol A, 2015, FOOD BIOPHYS, V10, P396, DOI 10.1007/s11483-015-9395-2; Kuramae R, 2014, REACT FUNCT POLYM, V85, P126, DOI 10.1016/j.reactfunctpolym.2014.06.011; Lin DH, 2018, FOOD HYDROCOLLOID, V79, P13, DOI 10.1016/j.foodhyd.2017.12.019; Lin DH, 2016, FOOD HYDROCOLLOID, V52, P57, DOI 10.1016/j.foodhyd.2015.06.004; Lipowczan M, 2018, J EXP BOT, V69, P4349, DOI 10.1093/jxb/ery237; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Morris GA, 2008, FOOD HYDROCOLLOID, V22, P1435, DOI 10.1016/j.foodhyd.2007.09.005; Morris GA, 2010, CARBOHYD POLYM, V82, P1161, DOI 10.1016/j.carbpol.2010.06.049; Muller F, 2011, BIOMACROMOLECULES, V12, P3330, DOI 10.1021/bm200881x; Neelov I, 2007, MACROMOL SYMP, V252, P140, DOI 10.1002/masy.200750614; Oehme DP, 2015, CELLULOSE, V22, P3501, DOI 10.1007/s10570-015-0778-9; Palmer JS, 2008, ACTA BIOMATER, V4, P597, DOI 10.1016/j.actbio.2007.12.007; Paniagua C, 2014, ANN BOT-LONDON, V114, P1375, DOI 10.1093/aob/mcu149; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Park YB, 2015, PLANT CELL PHYSIOL, V56, P180, DOI 10.1093/pcp/pcu204; Park YB, 2012, PLANT PHYSIOL, V158, P1933, DOI 10.1104/pp.111.192880; Patel TR, 2008, CARBOHYD POLYM, V74, P845, DOI 10.1016/j.carbpol.2008.05.006; Phyo P, 2017, PLANT PHYSIOL, V175, P1593, DOI 10.1104/pp.17.01270; Piana S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039918; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Puangsin B, 2013, INT J BIOL MACROMOL, V59, P208, DOI 10.1016/j.ijbiomac.2013.04.016; Purushotham P, 2020, SCIENCE, V369, P1089, DOI 10.1126/science.abb2978; Round AN, 2010, CARBOHYD RES, V345, P487, DOI 10.1016/j.carres.2009.12.019; Sampathkumar A, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.177964; Sampathkumar A, 2014, ELIFE, V3, DOI 10.7554/eLife.01967; Schmoller KM, 2013, NAT MATER, V12, P278, DOI 10.1038/nmat3603; Shen SP, 2004, CMES-COMP MODEL ENG, V6, P91; Smithers ET, 2019, J EXP BOT, V70, P3587, DOI 10.1093/jxb/erz253; Song JW, 2018, NATURE, V554, P224, DOI 10.1038/nature25476; TALBOTT LD, 1992, PLANT PHYSIOL, V98, P357, DOI 10.1104/pp.98.1.357; Tanaka R, 2014, CELLULOSE, V21, P1581, DOI 10.1007/s10570-014-0196-4; Thomas LH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79676-2; Usov I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8564; van Oosten ASG, 2019, NATURE, V573, P96, DOI 10.1038/s41586-019-1516-5; Vatankhah-Varnosfaderani M, 2018, SCIENCE, V359, P1509, DOI 10.1126/science.aar5308; Verger S, 2018, ELIFE, V7, DOI 10.7554/eLife.34460; Wang T, 2015, PLANT PHYSIOL, V168, P871, DOI 10.1104/pp.15.00665; Wang X, 2020, J EXP BOT, V71, P2629, DOI 10.1093/jxb/eraa059; Wang ZJ, 2019, P NATL ACAD SCI USA, V116, P5967, DOI 10.1073/pnas.1821420116; Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764; Williams MAK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021927; Wilson LA, 2021, BIOTECHNOL BIOFUELS, V14, DOI 10.1186/s13068-021-01923-z; Yang HS, 2009, POSTHARVEST BIOL TEC, V51, P391, DOI 10.1016/j.postharvbio.2008.08.009; Yang H, 2019, INTERDISCIP SCI, V11, P485, DOI 10.1007/s12539-018-0293-4; Yapo BM, 2007, CARBOHYD POLYM, V69, P426, DOI 10.1016/j.carbpol.2006.12.024; Zhang Q, 2011, CARBOHYD RES, V346, P2595, DOI 10.1016/j.carres.2011.09.007; Zhang QM, 2005, J PHYS-CONDENS MAT, V17, pS1427, DOI 10.1088/0953-8984/17/18/001; Zhang T, 2019, PLANT J, V100, P1101, DOI 10.1111/tpj.14519; Zhang Tian, 2017, Bio Protoc, V7, pe2647, DOI 10.21769/BioProtoc.2647; Zhang T, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.56; Zhang T, 2016, PLANT J, V85, P179, DOI 10.1111/tpj.13102; Zhang T, 2014, CELLULOSE, V21, P853, DOI 10.1007/s10570-013-9996-1; Zhang Y, 2019, SOFT MATTER, V15, P3807, DOI 10.1039/c8sm02277a; Zhao XH, 2014, SOFT MATTER, V10, P672, DOI 10.1039/c3sm52272e; Zhao Z, 2014, CELLULOSE, V21, P1025, DOI 10.1007/s10570-013-0041-1; Zheng YZ, 2018, PLANT J, V93, P211, DOI 10.1111/tpj.13778; Zykwinska A, 2008, CARBOHYD POLYM, V74, P957, DOI 10.1016/j.carbpol.2008.05.004; Zykwinska A, 2007, BIOMACROMOLECULES, V8, P223, DOI 10.1021/bm060292h	93	51	51	64	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					706	+		10.1126/science.abf2824	http://dx.doi.org/10.1126/science.abf2824			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986175	Green Submitted			2022-12-28	WOS:000651125300043
J	Martinez, FJ; Yow, E; Flaherty, KR; Snyder, LD; Durheim, MT; Wisniewski, SR; Sciurba, FC; Raghu, G; Brooks, MM; Kim, DY; Dilling, DF; Criner, GJ; Kim, H; Belloli, EA; Nambiar, AM; Scholand, MB; Anstrom, KJ; Noth, I				Martinez, Fernando J.; Yow, Eric; Flaherty, Kevin R.; Snyder, Laurie D.; Durheim, Michael T.; Wisniewski, Stephen R.; Sciurba, Frank C.; Raghu, Ganesh; Brooks, Maria M.; Kim, Dong-Yun; Dilling, Daniel F.; Criner, Gerard J.; Kim, Hyun; Belloli, Elizabeth A.; Nambiar, Anoop M.; Scholand, Mary Beth; Anstrom, Kevin J.; Noth, Imre		CleanUP-IPF Investigators Pulm	Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM; AZITHROMYCIN; DOXYCYCLINE; PROGRESSION; BRONCHIECTASIS; EXACERBATIONS; COTRIMOXAZOLE; PLACEBO	Key PointsQuestionDoes antimicrobial therapy in addition to usual care improve clinical outcomes in patients with idiopathic pulmonary fibrosis? FindingsIn this pragmatic randomized clinical trial that included 513 adults with idiopathic pulmonary fibrosis the addition of co-trimoxazole (trimethoprim-sulfamethoxazole) or doxycycline to usual care compared with usual care alone resulted in a rate of first nonelective respiratory hospitalization or death of 20.4 vs 18.4 events per 100 person-years, a difference that was not statistically significant. MeaningAmong adults with idiopathic pulmonary fibrosis, addition of co-trimoxazole or doxycycline compared with usual care did not significantly improve the time to nonrespiratory hospitalization or death. ImportanceAlteration in lung microbes is associated with disease progression in idiopathic pulmonary fibrosis. ObjectiveTo assess the effect of antimicrobial therapy on clinical outcomes. Design, Setting, and ParticipantsPragmatic, randomized, unblinded clinical trial conducted across 35 US sites. A total of 513 patients older than 40 years were randomized from August 2017 to June 2019 (final follow-up was January 2020). InterventionsPatients were randomized in a 1:1 allocation ratio to receive antimicrobials (n=254) or usual care alone (n=259). Antimicrobials included co-trimoxazole (trimethoprim 160 mg/sulfamethoxazole 800 mg twice daily plus folic acid 5 mg daily, n=128) or doxycycline (100 mg once daily if body weight <50 kg or 100 mg twice daily if <greater than or equal to>50 kg, n=126). No placebo was administered in the usual care alone group. Main Outcomes and MeasuresThe primary end point was time to first nonelective respiratory hospitalization or all-cause mortality. ResultsAmong the 513 patients who were randomized (mean age, 71 years; 23.6% women), all (100%) were included in the analysis. The study was terminated for futility on December 18, 2019. After a mean follow-up time of 13.1 months (median, 12.7 months), a total of 108 primary end point events occurred: 52 events (20.4 events per 100 patient-years [95% CI, 14.8-25.9]) in the usual care plus antimicrobial therapy group and 56 events (18.4 events per 100 patient-years [95% CI, 13.2-23.6]) in the usual care group, with no significant difference between groups (adjusted HR, 1.04 [95% CI, 0.71-1.53; P=.83]. There was no statistically significant interaction between the effect of the prespecified antimicrobial agent (co-trimoxazole vs doxycycline) on the primary end point (adjusted HR, 1.15 [95% CI 0.68-1.95] in the co-trimoxazole group vs 0.82 [95% CI, 0.46-1.47] in the doxycycline group; P=.66). Serious adverse events occurring at 5% or greater among those treated with usual care plus antimicrobials vs usual care alone included respiratory events (16.5% vs 10.0%) and infections (2.8% vs 6.6%); adverse events of special interest included diarrhea (10.2% vs 3.1%) and rash (6.7% vs 0%). Conclusions and RelevanceAmong adults with idiopathic pulmonary fibrosis, the addition of co-trimoxazole or doxycycline to usual care, compared with usual care alone, did not significantly improve time to nonelective respiratory hospitalization or death. These findings do not support treatment with these antibiotics for the underlying disease. Trial RegistrationClinicalTrials.gov Identifier: NCT02759120 This clinical trial investigates whether the addition of antimicrobial treatments co-trimoxazole or doxycycline to usual care improves outcomes among patients with idiopathic pulmonary fibrosis better than usual care alone.	[Martinez, Fernando J.] New York Presbyterian Hosp, Weill Cornell Med, New York, NY USA; [Yow, Eric; Snyder, Laurie D.; Durheim, Michael T.; Anstrom, Kevin J.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Flaherty, Kevin R.; Belloli, Elizabeth A.] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Durheim, Michael T.] Oslo Univ Hosp, Rikshosp, Dept Resp Med, Oslo, Norway; [Wisniewski, Stephen R.; Sciurba, Frank C.; Brooks, Maria M.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Raghu, Ganesh] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Kim, Dong-Yun] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Dilling, Daniel F.] Loyola Univ, Med Ctr, Div Pulm & Crit Care Med, 2160 S 1st Ave, Maywood, IL 60153 USA; [Criner, Gerard J.] Temple Univ, Lewis Katz Sch Med, Dept Thorac Med & Surg, Philadelphia, PA 19122 USA; [Kim, Hyun] Univ Minnesota, Div Pulm & Crit Care Med, Minneapolis, MN USA; [Nambiar, Anoop M.] Univ Texas Hlth San Antonino, Div Pulm & Crit Care Med, San Antonio, TX USA; [Scholand, Mary Beth] Univ Utah, Div Pulm & Crit Care Med, Salt Lake City, UT USA; [Noth, Imre] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA	Cornell University; NewYork-Presbyterian Hospital; Duke University; University of Michigan System; University of Michigan; University of Oslo; National Hospital Norway; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Loyola University Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Minnesota System; University of Minnesota Twin Cities; Utah System of Higher Education; University of Utah; University of Virginia	Martinez, FJ (corresponding author), 1305 York Ave,POB 96,Room Y-1059, New York, NY 10021 USA.	fjm2003@med.cornell.edu	Nambiar, Anoop M./P-5319-2017; Sciurba, Frank/AAZ-9339-2021; Dilling, Daniel/E-2967-2019	Nambiar, Anoop M./0000-0003-2778-0433; sciurba, frank/0000-0001-7468-2225; Dilling, Daniel/0000-0002-9723-510X; Snyder, Laurie/0000-0002-5962-2184; Mooney, Joshua/0000-0002-4687-194X; DiSanto-Rose, Maria/0000-0003-2250-291X				Altenburg J, 2013, JAMA-J AM MED ASSOC, V309, P1251, DOI 10.1001/jama.2013.1937; [Anonymous], 2016, QUALITYMETRIC HLTH O; Anstrom KJ, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1326-1; Bhattacharyya P, 2009, LUNG INDIA, V26, P81, DOI 10.4103/0970-2113.53231; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Collard HR, 2015, EUR RESPIR J, V46, P243, DOI 10.1183/09031936.00200614; Collard HR, 2014, CHEST, V146, P1256, DOI 10.1378/chest.14-0492; de Andrade J, 2015, CHEST, V148, P1034, DOI 10.1378/chest.14-2889; Dickson RP, 2019, AM J RESP CRIT CARE, V200, P1544, DOI 10.1164/rccm.201903-0680LE; Eakin EG, 1998, CHEST, V113, P619, DOI 10.1378/chest.113.3.619; Gibson KF, 2018, JAMA-J AM MED ASSOC, V319, P2275, DOI 10.1001/jama.2018.6225; Gosens R, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02320-2019; Grewal I, 2006, SOC SCI MED, V62, P1891, DOI 10.1016/j.socscimed.2005.08.023; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Ho JMW, 2011, CAN MED ASSOC J, V183, P1851, DOI 10.1503/cmaj.111152; Huang Y, 2017, AM J RESP CRIT CARE, V196, P208, DOI 10.1164/rccm.201607-1525OC; Knippenberg S, 2015, THORAX, V70, P636, DOI 10.1136/thoraxjnl-2014-206420; Krempaska K, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1275-8; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Macaluso C, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00628-2018; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Mishra A, 2011, LUNG INDIA, V28, P174, DOI 10.4103/0970-2113.83972; Molyneaux PL, 2017, AM J RESP CRIT CARE, V195, P1640, DOI 10.1164/rccm.201607-1408OC; Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC; O'Dwyer DN, 2019, AM J RESP CRIT CARE, V199, P1127, DOI 10.1164/rccm.201809-1650OC; Paterniti MO, 2017, ANN AM THORAC SOC, V14, P1395, DOI 10.1513/AnnalsATS.201606-458OC; Ramsheh MY, 2020, THORAX, V75, P8, DOI 10.1136/thoraxjnl-2019-213485; Segal LN, 2017, THORAX, V72, P13, DOI 10.1136/thoraxjnl-2016-208599; Serisier DJ, 2013, JAMA-J AM MED ASSOC, V309, P1260, DOI 10.1001/jama.2013.2290; Shulgina L, 2013, THORAX, V68, P155, DOI 10.1136/thoraxjnl-2012-202403; Smith K, 2005, CLIN THER, V27, P1329, DOI 10.1016/j.clinthera.2005.09.005; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson AM, 2020, JAMA-J AM MED ASSOC, V324, P2282, DOI 10.1001/jama.2020.22960	35	15	16	4	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1841	1851		10.1001/jama.2021.4956	http://dx.doi.org/10.1001/jama.2021.4956			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974018	Green Published, Bronze			2022-12-28	WOS:000650205000013
J	Qasim, SE; Fried, I; Jacobs, J				Qasim, Salman E.; Fried, Itzhak; Jacobs, Joshua			Phase precession in the human hippocampus and entorhinal cortex	CELL			English	Article							PLACE CELLS; SINGLE-NEURON; GRID CELLS; THETA OSCILLATIONS; GAMMA OSCILLATIONS; POWER SPECTRA; FREQUENCY; SPACE; CODE; DYNAMICS	Knowing where we are, where we have been, and where we are going is critical to many behaviors, including navigation and memory. One potential neuronal mechanism underlying this ability is phase precession, in which spatially tuned neurons represent sequences of positions by activating at progressively earlier phases of local network theta oscillations. Based on studies in rodents, researchers have hypothesized that phase precession may be a general neural pattern for representing sequential events for learning and memory. By recording human single-neuron activity during spatial navigation, we show that spatially tuned neurons in the human hippocampus and entorhinal cortex exhibit phase precession. Furthermore, beyond the neural representation of locations, we show evidence for phase precession related to specific goal states. Our findings thus extend theta phase precession to humans and suggest that this phenomenon has a broad functional role for the neural representation of both spatial and non-spatial information.	[Qasim, Salman E.; Jacobs, Joshua] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Fried, Itzhak] Univ Calif Los Angeles, Dept Neurol Surg, Los Angeles, CA 90095 USA	Columbia University; University of California System; University of California Los Angeles	Jacobs, J (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	joshua.jacobs@columbia.edu	Qasim, Salman Ehtesham/AFT-9122-2022; Jacobs, Joshua/E-9500-2013	Qasim, Salman Ehtesham/0000-0001-8739-5962; Jacobs, Joshua/0000-0003-1807-6882	National Institute of Mental Health [R01-MH104606]; National Science Foundation [BCS-1724243]; National Institute of Neurological Disorders and Stroke [R01-NS033221, R01-NS084017]; National Science Foundation Graduate Research Fellowship [DGE 1644869]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	We are grateful to the patients for participating in our study. We thank Kamran Diba, Sam McKenzie, Jonathan Miller, Andrew Watrous, Tom Donoghue, and Melina Tsitsiklis for helpful comments and suggestions. We would like to thank Gyorgy Buzsaki for making his rat CA1 data publicly available. This work was supported by the National Institute of Mental Health (R01-MH104606 to J.J.), the National Science Foundation (BCS-1724243 to J.J.), the National Institute of Neurological Disorders and Stroke (R01-NS033221, R01-NS084017 to I.F.), and National Science Foundation Graduate Research Fellowship (DGE 1644869 to S.E.Q.).	Aghajan ZM, 2015, NAT NEUROSCI, V18, P121, DOI 10.1038/nn.3884; Aronov D, 2017, NATURE, V543, P719, DOI 10.1038/nature21692; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brown TI, 2016, SCIENCE, V352, P1323, DOI 10.1126/science.aaf0784; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Bush D, 2020, HIPPOCAMPUS, V30, P745, DOI 10.1002/hipo.23199; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Buzsaki G, 2018, TRENDS COGN SCI, V22, P853, DOI 10.1016/j.tics.2018.07.006; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Cole S, 2019, J NEUROPHYSIOL, V122, P849, DOI 10.1152/jn.00273.2019; Courellis HS, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000546; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Donoghue T, 2020, NAT NEUROSCI, V23, P1655, DOI 10.1038/s41593-020-00744-x; Dvorak D, 2014, J NEUROSCI METH, V225, P42, DOI 10.1016/j.jneumeth.2014.01.002; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Eliav T, 2018, CELL, V175, P1119, DOI 10.1016/j.cell.2018.09.017; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Goyal A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15670-6; GREENSTEIN YJ, 1988, BRAIN RES, V438, P331, DOI 10.1016/0006-8993(88)91358-3; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hebb Donald O., 1949, ORG BEHAV; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Howard LR, 2014, CURR BIOL, V24, P1331, DOI 10.1016/j.cub.2014.05.001; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jacobs J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0304; Jacobs J, 2013, NAT NEUROSCI, V16, P1188, DOI 10.1038/nn.3466; Jacobs J, 2010, TRENDS COGN SCI, V14, P162, DOI 10.1016/j.tics.2010.01.005; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Jaramillo J, 2017, CURR OPIN NEUROBIOL, V43, P130, DOI 10.1016/j.conb.2017.02.006; Jeewajee A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0532; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Jutras MJ, 2013, P NATL ACAD SCI USA, V110, P13144, DOI 10.1073/pnas.1302351110; Kempter R, 2012, J NEUROSCI METH, V207, P113, DOI 10.1016/j.jneumeth.2012.03.007; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; Kim SM, 2012, J NEUROSCI, V32, P11539, DOI 10.1523/JNEUROSCI.5942-11.2012; Lenck-Santini PP, 2008, J NEUROSCI, V28, P6773, DOI 10.1523/JNEUROSCI.5329-07.2008; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; MacKAY DONALD M., 1952, BULL MATH BIOPHYS, V14, P127, DOI 10.1007/BF02477711; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Meshulam L, 2017, NEURON, V96, P1178, DOI 10.1016/j.neuron.2017.10.027; Middleton SJ, 2018, NAT NEUROSCI, V21, P996, DOI 10.1038/s41593-018-0163-8; Miller JF, 2015, CURR BIOL, V25, P1080, DOI 10.1016/j.cub.2015.02.045; Mizuseki K., 2013, Multiple single unit recordings from different rat hippocampal and entorhinal regions while the animals were performing multiple behavioral tasks; Mizuseki K, 2009, MULTIUNIT RECORDINGS; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Monaco JD, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006741; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Niediek J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166598; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Perktold J, 2010, P 9 PYTH SCI C ED S; Petersen PC, 2020, NEURON, V107, P731, DOI 10.1016/j.neuron.2020.05.023; Qasim SE, 2019, NAT NEUROSCI, V22, P2078, DOI 10.1038/s41593-019-0523-z; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Ravassard P, 2013, SCIENCE, V340, P1342, DOI 10.1126/science.1232655; Reifenstein E.T., 2020, SYNAPTIC LEARNING RU, DOI [10.1101/2020.04.13.039826, DOI 10.1101/2020.04.13.039826]; Reifenstein E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100638; Reifenstein ET, 2012, P NATL ACAD SCI USA, V109, P6301, DOI 10.1073/pnas.1109599109; Robinson NTM, 2017, NEURON, V94, P677, DOI 10.1016/j.neuron.2017.04.003; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Russell S.J., 2010, ARTIFICIAL INTELLIGE; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Safaryan K., 2020, ENHANCED HIPPOCAMPAL, DOI [10.1101/2020.06.29.178186, DOI 10.1101/2020.06.29.178186]; Schlesiger MI, 2015, NAT NEUROSCI, V18, P1123, DOI 10.1038/nn.4056; Schultheiss NW, 2020, BEHAV NEUROSCI, V134, P529, DOI 10.1037/bne0000409; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Skaggs WE, 1993, ADV NEURAL INFORM PR, V5, P1030, DOI DOI 10.1109/PROC.1977.10559; Souza BC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08609-3; STEWART M, 1991, BRAIN RES, V538, P59, DOI 10.1016/0006-8993(91)90376-7; Takahashi M, 2014, J NEUROPHYSIOL, V111, P1601, DOI 10.1152/jn.00395.2013; Terada S, 2017, NEURON, V94, P1248, DOI 10.1016/j.neuron.2017.05.024; Tingley D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar3230; Tingley D, 2015, J NEUROSCI, V35, P2992, DOI 10.1523/JNEUROSCI.4432-14.2015; Tingley D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00174; Umbach G, 2020, P NATL ACAD SCI USA, V117, P28463, DOI 10.1073/pnas.2013250117; Valdez AB, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016001; van der Meer MAA, 2011, J NEUROSCI, V31, P2843, DOI 10.1523/JNEUROSCI.4869-10.2011; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wang MN, 2020, SCIENCE, V370, P247, DOI 10.1126/science.abb4151; Watrous AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.32554; Watrous AJ, 2013, HIPPOCAMPUS, V23, P656, DOI 10.1002/hipo.22124; Wikenheiser AM, 2015, NAT NEUROSCI, V18, P289, DOI 10.1038/nn.3909; Wutz A, 2018, P NATL ACAD SCI USA, V115, P1346, DOI 10.1073/pnas.1713318115; Zanos S, 2012, J NEUROPHYSIOL, V107, P1808, DOI 10.1152/jn.00663.2011	114	26	26	9	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3242	+		10.1016/j.cell.2021.04.017	http://dx.doi.org/10.1016/j.cell.2021.04.017		JUN 2021	24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	33979655	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000660014300014
J	Chen, XZ; Yin, XT; Li, JB; Wu, ZH; Qi, YL; Wang, XX; Liu, WD; Xu, YH				Chen, Xizi; Yin, Xiaotong; Li, Jiabei; Wu, Zihan; Qi, Yilun; Wang, Xinxin; Liu, Weida; Xu, Yanhui			Structures of the human Mediator and Mediator-bound preinitiation complex	SCIENCE			English	Article							RNA-POLYMERASE-II; TERMINAL REPEAT DOMAIN; CDK-ACTIVATING KINASE; CRYSTAL-STRUCTURE; TAIL MODULE; TRANSCRIPTION; INITIATION; SUBUNIT; ARCHITECTURE; PROMOTER	The 1.3-megadalton transcription factor IID (TFIID) is required for preinitiation complex (PIC) assembly and RNA polymerase II (Pol II)-mediated transcription initiation on almost all genes. The 26-subunit Mediator stimulates transcription and cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the Pol II C-terminal domain (CTD). We determined the structures of human Mediator in the Tail module-extended (at near-atomic resolution) and Tail-bent conformations and structures of TFIID-based PICMediator (76 polypeptides, similar to 4.1 megadaltons) in four distinct conformations. PIC-Mediator assembly induces concerted reorganization (Head-tilting and Middle-down) of Mediator and creates a Head-Middle sandwich, which stabilizes two CTD segments and brings CTD to CDK7 for phosphorylation; this suggests a CTD-gating mechanism favorable for phosphorylation. The TFIID-based PIC architecture modulates Mediator organization and TFIIH stabilization, underscoring the importance of TFIID in orchestrating PIC-Mediator assembly.	[Chen, Xizi; Yin, Xiaotong; Li, Jiabei; Wu, Zihan; Qi, Yilun; Wang, Xinxin; Liu, Weida; Xu, Yanhui] Fudan Univ, Shanghai Canc Ctr, Inst Biomed Sci, State Key Lab Genet Engn,Shanghai Key Lab Radiat, Shanghai, Peoples R China; [Chen, Xizi; Yin, Xiaotong; Li, Jiabei; Wu, Zihan; Qi, Yilun; Wang, Xinxin; Liu, Weida; Xu, Yanhui] Fudan Univ, Shanghai Key Lab Med Epigenet, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Xu, Yanhui] Minist Sci & Technol China, Int Colab Med Epigenet & Metab, Beijing, Peoples R China; [Xu, Yanhui] Fudan Univ, Sch Basic Med Sci, Dept Syst Biol Med, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Xu, Yanhui] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Human Phenome Inst, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Ministry of Science and Technology, China; Fudan University; Fudan University	Xu, YH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Inst Biomed Sci, State Key Lab Genet Engn,Shanghai Key Lab Radiat, Shanghai, Peoples R China.; Xu, YH (corresponding author), Fudan Univ, Shanghai Key Lab Med Epigenet, Shanghai Med Coll, Shanghai 200032, Peoples R China.; Xu, YH (corresponding author), Minist Sci & Technol China, Int Colab Med Epigenet & Metab, Beijing, Peoples R China.; Xu, YH (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Syst Biol Med, Shanghai Med Coll, Shanghai 200032, Peoples R China.; Xu, YH (corresponding author), Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Human Phenome Inst, Shanghai 200433, Peoples R China.	xuyh@fudan.edu.cn		Wu, Zihan/0000-0002-2451-5231; Qi, Yilun/0000-0002-0851-8782; Chen, Xizi/0000-0002-4120-104X; Xu, Yanhui/0000-0002-1408-5178				Abdella R, 2021, SCIENCE, V372, P52, DOI 10.1126/science.abg3074; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Ansari SA, 2012, EMBO J, V31, P44, DOI 10.1038/emboj.2011.362; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XZ, 2021, SCIENCE, V372, P480, DOI 10.1126/science.aba8490; Chen ZL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11337-z; Coin F, 2006, MOL CELL, V21, P215, DOI 10.1016/j.molcel.2005.10.024; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Combe CW, 2015, MOL CELL PROTEOMICS, V14, P1137, DOI 10.1074/mcp.O114.042259; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; DeLano W.L, PYMOL MOL GRAPHICS S; DEVAULT A, 1995, EMBO J, V14, P5027, DOI 10.1002/j.1460-2075.1995.tb00185.x; Donczew R, 2020, ELIFE, V9, DOI 10.7554/eLife.50109; Donczew R, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00448-17; El Khattabi L, 2019, CELL, V178, P1145, DOI 10.1016/j.cell.2019.07.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; FISHER RP, 1995, CELL, V83, P47, DOI 10.1016/0092-8674(95)90233-3; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Fujiwara R, 2019, METHODS, V159, P82, DOI 10.1016/j.ymeth.2019.03.016; Greber BJ, 2019, ELIFE, V8, DOI 10.7554/eLife.44771; Grimm M, 2015, NUCLEIC ACIDS RES, V43, pW362, DOI 10.1093/nar/gkv463; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Ito M, 2002, EMBO J, V21, P3464, DOI 10.1093/emboj/cdf348; Jaeger MG, 2020, NAT GENET, V52, P719, DOI 10.1038/s41588-020-0635-0; Jeronimo C, 2017, TRENDS CELL BIOL, V27, P765, DOI 10.1016/j.tcb.2017.07.001; Jeronimo C, 2016, MOL CELL, V64, P455, DOI 10.1016/j.molcel.2016.09.002; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kaufmann R, 2010, AM J HUM GENET, V87, P667, DOI 10.1016/j.ajhg.2010.09.016; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Lim MK, 2007, J MOL BIOL, V374, P9, DOI 10.1016/j.jmb.2007.09.013; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malik S, 2005, MOL CELL BIOL, V25, P2117, DOI 10.1128/MCB.25.6.2117-2129.2005; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Monte D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05967-y; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Nozawa K, 2017, NATURE, V545, P248, DOI 10.1038/nature22328; Peruzzini R, 2016, BIOMOL NMR ASSIGN, V10, P233, DOI 10.1007/s12104-016-9673-z; Petrenko N, 2017, ELIFE, V6, DOI [10.7554/eLife.28447, 10.7554/eLife.32061]; Petrenko N, 2016, MOL CELL, V64, P443, DOI 10.1016/j.molcel.2016.09.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Reeves WM, 2003, MOL CELL BIOL, V23, P349, DOI 10.1128/MCB.23.1.349-358.2003; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Robinson PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08719; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sakurai H, 1996, P NATL ACAD SCI USA, V93, P9488, DOI 10.1073/pnas.93.18.9488; Sakurai H, 2000, J BIOL CHEM, V275, P37251, DOI 10.1074/jbc.M004364200; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schiano C, 2014, BBA-GENE REGUL MECH, V1839, P444, DOI 10.1016/j.bbagrm.2014.04.012; Schilbach S, 2017, NATURE, V551, P204, DOI 10.1038/nature24282; Schubert HL, 2013, P NATL ACAD SCI USA, V110, P3345, DOI 10.1073/pnas.1215379110; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Sogaard TMM, 2007, J BIOL CHEM, V282, P14113, DOI 10.1074/jbc.M701345200; Soutourina J, 2018, NAT REV MOL CELL BIO, V19, P262, DOI 10.1038/nrm.2017.115; Spaeth JM, 2011, SEMIN CELL DEV BIOL, V22, P776, DOI 10.1016/j.semcdb.2011.07.024; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Tsai KL, 2017, NATURE, V544, P196, DOI 10.1038/nature21393; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wang XJ, 2014, CELL RES, V24, P796, DOI 10.1038/cr.2014.64; Warfield L, 2017, MOL CELL, V68, P118, DOI 10.1016/j.molcel.2017.08.014; Wong KH, 2014, MOL CELL, V54, P601, DOI 10.1016/j.molcel.2014.03.024; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2; Zhang HQ, 2021, MOL CELL, V81, P1781, DOI 10.1016/j.molcel.2021.01.022; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao HY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21601-w; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	104	31	31	12	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2021	372	6546					1055	+	eabg0635	10.1126/science.abg0635	http://dx.doi.org/10.1126/science.abg0635			63	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM5NE	33958484				2022-12-28	WOS:000657651200040
J	Rovin, BH; Teng, YKO; Ginzler, EM; Arriens, C; Caster, DJ; Romero-Diaz, J; Gibson, K; Kaplan, J; Lisk, L; Navarra, S; Parikh, SV; Randhawa, S; Solomons, N; Huizinga, RB				Rovin, Brad H.; Teng, Y. K. Onno; Ginzler, Ellen M.; Arriens, Cristina; Caster, Dawn J.; Romero-Diaz, Juanita; Gibson, Keisha; Kaplan, Joshua; Lisk, Laura; Navarra, Sandra; Parikh, Samir V.; Randhawa, Simrat; Solomons, Neil; Huizinga, Robert B.			Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial	LANCET			English	Article							MYCOPHENOLATE-MOFETIL; INDUCTION TREATMENT; INTRAVENOUS CYCLOPHOSPHAMIDE; TACROLIMUS; CYTOSKELETON; THERAPY	Background Voclosporin, a novel calcineurin inhibitor approved for the treatment of adults with lupus nephritis, improved complete renal response rates in patients with lupus nephritis in a phase 2 trial. This study aimed to evaluate the efficacy and safety of voclosporin for the treatment of lupus nephritis. Methods This multicentre, double-blind, randomised phase 3 trial was done in 142 hospitals and clinics across 27 countries. Patients with a diagnosis of systemic lupus erythematosus with lupus nephritis according to the American College of Rheumatology criteria, and a kidney biopsy within 2 years that showed class III, IV, or V (alone or in combination with class III or IV) were eligible. Patients were randomly assigned (1: 1) to oral voclosporin (23.7 mg twice daily) or placebo, on a background of mycophenolate mofetil (1 g twice daily) and rapidly tapered low-dose oral steroids, by use of an interactive web response system. The primary endpoint was complete renal response at 52 weeks defined as a composite of urine protein creatinine ratio of 0.5 mg/mg or less, stable renal function (defined as estimated glomerular filtration rate [eGFR] >= 60 mL/min/1.73 m(2) or no confirmed decrease from baseline in eGFR of >20%), no administration of rescue medication, and no more than 10 mg prednisone equivalent per day for 3 or more consecutive days or for 7 or more days during weeks 44 through 52, just before the primary endpoint assessment. Safety was also assessed. Efficacy analysis was by intention-to-treat and safety analysis by randomised patients receiving at least one dose of study treatment. The trial is registered with ClinicalTrials.gov, NCT03021499. Findings Between April 13, 2017, and Oct 10, 2019, 179 patients were assigned to the voclosporin group and 178 to the placebo group. The primary endpoint of complete renal response at week 52 was achieved in significantly more patients in the voclosporin group than in the placebo group (73 [41%] of 179 patients vs 40 [23%] of 178 patients; odds ratio 2.65; 95% CI 1.64-4.27; p<0.0001). The adverse event profile was balanced between the two groups; serious adverse events occurred in 37 (21%) of 178 in the voclosporin group and 38 (21%) of 178 patients in the placebo group. The most frequent serious adverse event involving infection was pneumonia, occurring in 7 (4%) patients in the voclosporin group and in 8 (4%) patients in the placebo group. A total of six patients died during the study or study follow-up period (one [<1%] patient in the voclosporin group and five [3%] patients in the placebo group). None of the events leading to death were considered by the investigators to be related to the study treatments. Interpretation Voclosporin in combination with MMF and low-dose steroids led to a clinically and statistically superior complete renal response rate versus MMF and low-dose steroids alone, with a comparable safety profile. This finding is an important advancement in the treatment of patients with active lupus nephritis. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Rovin, Brad H.; Parikh, Samir V.] Ohio State Univ, Wexner Med Ctr, Dept Nephrol, Columbus, OH 43210 USA; [Teng, Y. K. Onno] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Ginzler, Ellen M.] SUNY Downstate Hlth Sci Univ, Dept Med, Brooklyn, NY USA; [Arriens, Cristina] Oklahoma Med Res Fdn, Dept Arthrit & Clin Immunol, Rheumatol, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Caster, Dawn J.] Univ Louisville, Sch Med, Dept Med, Div Nephrol & Hypertens, Louisville, KY 40292 USA; [Romero-Diaz, Juanita] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; [Gibson, Keisha] UNC Kidney Ctr, Dept Med, Chapel Hill, NC USA; [Kaplan, Joshua] Rutgers State Univ, Dept Med, Newark, NJ USA; [Lisk, Laura; Randhawa, Simrat; Solomons, Neil] Aurinia Pharmaceut, Clin Dev, Victoria, BC, Canada; [Huizinga, Robert B.] Aurinia Pharmaceut, Res, Victoria, BC V8Z 7X8, Canada; [Navarra, Sandra] Univ Santo Tomas, Manila, Philippines; [Navarra, Sandra] St Lukes Med Ctr, Manila, Philippines	University System of Ohio; Ohio State University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Oklahoma Medical Research Foundation; University of Louisville; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Rutgers State University Newark; Rutgers State University New Brunswick; University of Santo Tomas; Saint Lukes Medical Center - Philippines	Huizinga, RB (corresponding author), Aurinia Pharmaceut, Res, Victoria, BC V8Z 7X8, Canada.	rhuizinga@auriniapharma.com	Teng, Yoe Kie Onno/S-1765-2019	Teng, Yoe Kie Onno/0000-0001-9920-2195; Huizinga, Robert/0000-0001-8703-7655	Aurinia Pharmaceuticals	Aurinia Pharmaceuticals	The study and publication were funded by Aurinia Pharmaceuticals. We thank all AURORA 1 investigators, study site coordinators, and patients who participated in this study. We also thank Matt Truman, study statistician; the following members of the Drug Safety Monitoring Board: Arif Khwaja, James Sawyer, and Ed Vital; and the following members of the Clinical Endpoints Committee: Ian Bruce, Daniel Cattran, Teun van Gelder, Colin Hayward, and Md Yuzaiful Md Yusof. The manuscript was drafted by Rachelle Steele (MedEvent Partners, London, UK) and managed by Vanessa Birardi (Aurinia, Rockville, MD, USA).	Al Sawah S, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000066; Appel GB, 2009, J AM SOC NEPHROL, V20, P1103, DOI 10.1681/ASN.2008101028; Bao H, 2008, J AM SOC NEPHROL, V19, P2001, DOI 10.1681/ASN.2007121272; Busque S, 2011, AM J TRANSPLANT, V11, P2675, DOI 10.1111/j.1600-6143.2011.03763.x; Chen W, 2011, AM J KIDNEY DIS, V57, P235, DOI 10.1053/j.ajkd.2010.08.036; Chen YE, 2008, CLIN J AM SOC NEPHRO, V3, P46, DOI 10.2215/CJN.03280807; Contreras G, 2006, KIDNEY INT, V69, P1846, DOI 10.1038/sj.ki.5000243; Dall'Era M, 2019, LUPUS, V28, P591, DOI 10.1177/0961203319842924; Dall'Era M, 2015, ARTHRITIS RHEUMATOL, V67, P1305, DOI 10.1002/art.39026; Davidson JE, 2018, J RHEUMATOL, V45, P671, DOI 10.3899/jrheum.161554; Dooley MA, 1997, KIDNEY INT, V51, P1188, DOI 10.1038/ki.1997.162; Fanouriakis A, 2019, ANN RHEUM DIS, V78, P736, DOI 10.1136/annrheumdis-2019-215089; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Furie R, 2020, NEW ENGL J MED, V383, P1117, DOI 10.1056/NEJMoa2001180; Hoskova L, 2017, PHYSIOL RES, V66, P167, DOI 10.33549/physiolres.933332; Kolic J, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa162; Li X, 2012, NEPHROL DIAL TRANSPL, V27, P1467, DOI 10.1093/ndt/gfr484; Liu ZH, 2015, ANN INTERN MED, V162, P18, DOI 10.7326/M14-1030; Mahajan A, 2020, LUPUS, V29, P1011, DOI 10.1177/0961203320932219; Mathieson PW, 2012, CLIN KIDNEY J, V5, P498, DOI 10.1093/ckj/sfs153; Parikh SV, 2020, AM J KIDNEY DIS, V76, P265, DOI 10.1053/j.ajkd.2019.10.017; Rovin B, 2020, KIDNEY INT REP, V5, pS352; Rovin BH, 2019, KIDNEY INT, V95, P219, DOI 10.1016/j.kint.2018.08.025; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Ruiz-Irastorza G, 2014, AUTOIMMUN REV, V13, P206, DOI 10.1016/j.autrev.2013.10.013; Tamirou F, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2015-000123; Tamirou F, 2016, ANN RHEUM DIS, V75, P526, DOI 10.1136/annrheumdis-2014-206897; van Gelder T, 2022, NEPHROL DIAL TRANSPL, V37, P917, DOI 10.1093/ndt/gfab022; Wakamatsu A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12679; Wang S, 2012, LUPUS, V21, P1025, DOI 10.1177/0961203312448105; Zavada J, 2010, LUPUS, V19, P1281, DOI 10.1177/0961203310371155; Zeher M, 2011, LUPUS, V20, P1484, DOI 10.1177/0961203311418269	32	105	105	3	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 29	2021	397	10289					2070	2080		10.1016/S0140-6736(21)00578-X	http://dx.doi.org/10.1016/S0140-6736(21)00578-X		MAY 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK5LX	33971155				2022-12-28	WOS:000656257800025
J	Davidson, KW; Barry, MJ; Mangione, CM; Cabana, M; Caughey, AB; Davis, EM; Donahue, KE; Doubeni, CA; Krist, AH; Kubik, M; Li, L; Ogedegbe, G; Pbert, L; Silverstein, M; Simon, M; Stevermer, J; Tseng, CW; Wong, JB				Davidson, Karina W.; Barry, Michael J.; Mangione, Carol M.; Cabana, Michael; Caughey, Aaron B.; Davis, Esa M.; Donahue, Katrina E.; Doubeni, Chyke A.; Krist, Alex H.; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Pbert, Lori; Silverstein, Michael; Simon, Melissa; Stevermer, James; Tseng, Chien-Wen; Wong, John B.		US Preventive Serv Task Force	Behavioral Counseling Interventions for Healthy Weight and Weight Gain in Pregnancy: US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LIFE-STYLE INTERVENTION; OBESITY; WOMEN; OVERWEIGHT; ADULTS; TRIAL	ImportanceThe prevalence of overweight and obesity is increasing among persons of childbearing age and pregnant persons. In 2015, almost half of all persons began pregnancy with overweight (24%) or obesity (24%). Reported rates of overweight and obesity are higher among Black, Alaska Native/American Indian, and Hispanic women and lower among White and Asian women. Excess weight at the beginning of pregnancy and excess gestational weight gain have been associated with adverse maternal and infant health outcomes such as a large for gestational age infant, cesarean delivery, or preterm birth. ObjectiveThe USPSTF commissioned a systematic review to evaluate the benefits and harms of behavioral counseling interventions to prevent adverse health outcomes associated with obesity during pregnancy and to evaluate intermediate outcomes, including excess gestational weight gain. This is a new recommendation. PopulationPregnant adolescents and adults in primary care settings. Evidence AssessmentThe USPSTF concludes with moderate certainty that behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy have a moderate net benefit for pregnant persons. RecommendationThe USPSTF recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy. (B recommendation) This 2021 Recommendation Statement from the US Preventive Services Task Force recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy (B recommendation).	[Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davis, Esa M.] Univ Pittsburgh, Pittsburgh, PA USA; [Donahue, Katrina E.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, MN USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Kubik, Martha] George Mason Univ, Fairfax, VA 22030 USA; [Li, Li] Univ Virginia, Charlottesville, VA USA; [Ogedegbe, Gbenga] NYU, New York, NY USA; [Pbert, Lori] Univ Massachusetts, Med Sch, Worcester, MA 01605 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa] Northwestern Univ, Chicago, IL 60611 USA; [Stevermer, James] Univ Missouri, Columbia, MO 65211 USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Cabana, Michael] Albert Einstein Coll Med, New York, NY USA	Northwell Health; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; Virginia Commonwealth University; George Mason University; University of Virginia; New York University; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Northwestern University; University of Missouri System; University of Missouri Columbia; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University; Yeshiva University	Davidson, KW (corresponding author), Feinstein Inst Med Res, 130 E 59th St,Ste 14C, New York, NY 10032 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010				Al Wattar BH, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002857; Altazan AD, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2196-8; American Academy of Pediatrics and American College of, 2017, GUID PER CAR, V8th; American College of Obstetricians and Gynecologists, 2019, Obstet Gynecol, V133, pe51, DOI 10.1097/AOG.0000000000003025; American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P210, DOI http://10.1097/01.AOG.0000425668.87506.4c; American Society for Reproductive Medicine, 2019, Fertil Steril, V111, P32, DOI 10.1016/j.fertnstert.2018.12.003; [Anonymous], 2015, Obstet Gynecol, V126, pe112, DOI 10.1097/AOG.0000000000001211; [Anonymous], 2014, Obstet Gynecol, V123, P726, DOI 10.1097/01.AOG.0000444457.29401.a0; [Anonymous], BOD MASS IND BMI; Assaf-Balut C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185873; Bacchi M, 2018, AM J HEALTH PROMOT, V32, P729, DOI 10.1177/0890117117697520; Barakat R, 2019, BRAZ J PHYS THER, V23, P148, DOI 10.1016/j.bjpt.2018.11.005; Bogaerts AFL, 2013, INT J OBESITY, V37, P814, DOI 10.1038/ijo.2012.162; Branum Amy M, 2016, Natl Vital Stat Rep, V65, P1; Bruno R, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12333; Cahill AG, 2018, OBESITY, V26, P485, DOI 10.1002/oby.22070; Cantor A., 2021, AHRQ PUBLICATION; Cantor AG, 2021, JAMA-J AM MED ASSOC, V325, P2094, DOI 10.1001/jama.2021.4230; Community Preventive Services Task Force, PREGN HLTH EX PROGR; Community Preventive Services Task Force (CPSTF), CPSTF FIND OB; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P1163, DOI 10.1001/jama.2018.13022; Deputy NP, 2018, MMWR-MORBID MORTAL W, V66, P1402, DOI 10.15585/mmwr.mm665152a3; Gallagher D, 2018, OBESITY, V26, P578, DOI 10.1002/oby.22079; Grossman DC, 2017, JAMA-J AM MED ASSOC, V318, P167, DOI 10.1001/jama.2017.7171; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Institute of Medicine and National Research Council, 2009, WEIGHT GAIN PREGNANC; Krist AH, 2020, JAMA-J AM MED ASSOC, V324, P2069, DOI 10.1001/jama.2020.21749; Moyer VA, 2014, ANN INTERN MED, V160, P414, DOI 10.7326/M13-2905; Phelan S, 2018, AM J CLIN NUTR, V107, P183, DOI 10.1093/ajcn/nqx043; Phelan S, 2011, AM J CLIN NUTR, V93, P772, DOI 10.3945/ajcn.110.005306; Procedure Manual, PROC MAN; Rauh K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-151; Renault KM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.029; Ronnberg AK, 2015, BJOG-INT J OBSTET GY, V122, P537, DOI 10.1111/1471-0528.13131; Ruiz JR, 2013, MAYO CLIN PROC, V88, P1388, DOI 10.1016/j.mayocp.2013.07.020; Sagedal LR, 2017, BJOG-INT J OBSTET GY, V124, P97, DOI 10.1111/1471-0528.13862; Stuebe A, 2018, OBSTET GYNECOL, V131, pE140, DOI 10.1097/AOG.0000000000002633	37	23	23	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2087	2093		10.1001/jama.2021.6949	http://dx.doi.org/10.1001/jama.2021.6949			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032823	Bronze			2022-12-28	WOS:000655647300023
J	Kirenga, BJ; Byakika-Kibwika, P				Kirenga, Bruce J.; Byakika-Kibwika, Pauline			Excess COVID-19 mortality among critically ill patients in Africa Comment	LANCET			English	Editorial Material									[Kirenga, Bruce J.] Makerere Univ, Lung Inst, Kampala, Uganda; [Kirenga, Bruce J.; Byakika-Kibwika, Pauline] Makerere Univ, Dept Med, Kampala, Uganda	Makerere University; Makerere University	Kirenga, BJ (corresponding author), Makerere Univ, Lung Inst, Kampala, Uganda.; Kirenga, BJ (corresponding author), Makerere Univ, Dept Med, Kampala, Uganda.	brucekirenga@yahoo.co.uk						Biccard BM, 2021, LANCET, V397, P1885, DOI 10.1016/S0140-6736(21)00441-4; Burki T, 2021, LANCET, V397, P462, DOI 10.1016/S0140-6736(21)00298-1; Daniel O, 2020, J PAN AFR THORAC SOC, V2, P4; Dubowitz G, 2010, WORLD J SURG, V34, P438, DOI 10.1007/s00268-009-0229-6; Institute of Health Metrics and Evaluation, 2021, COVID 19 PROJ GLOB; Mwananyanda L, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n334; UK Government, 2021, NERVTAG PAP COVID 19; Worm A, 2017, IMPROVED STATUS MED IMPROVED STATUS MED	8	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1860	1861						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF1XN	34022973	Bronze, Green Published			2022-12-28	WOS:000652556000002
J	Jaklevic, MC				Jaklevic, Mary Chris			The Push for Earlier Bariatric Surgery for Adolescents With Severe Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2021	325	22					2241	2242		10.1001/jama.2021.7912	http://dx.doi.org/10.1001/jama.2021.7912		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS1CN	34014255				2022-12-28	WOS:000652631700002
J	Mallapaty, S				Mallapaty, Smriti			WHAT CHINA'S MARS ROVER WILL DO NEXT	NATURE			English	News Item																			0	6	6	3	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					323	324		10.1038/d41586-021-01301-7	http://dx.doi.org/10.1038/d41586-021-01301-7			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE2PC	33990784	Bronze			2022-12-28	WOS:000651914000004
J	Mehta, SJ; Day, SC; Norris, AH; Sung, J; Reitz, C; Wollack, C; Snider, CK; Shaw, PA; Asch, DA				Mehta, Shivan J.; Day, Susan C.; Norris, Anne H.; Sung, Jessica; Reitz, Catherine; Wollack, Colin; Snider, Christopher K.; Shaw, Pamela A.; Asch, David A.			Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HCV GENOTYPE 1; PERSONS BORN; PREVENTIVE SERVICES; VIRUS-INFECTION; TRENDS; RATES; IMPLEMENTATION; IDENTIFICATION; SOFOSBUVIR; POWER	OBJECTIVE To evaluate whether opt out framing, messaging incorporating behavioral science concepts, or electronic communication increases the uptake of hepatitis C virus (HCV) screening in patients born between 1945 and 1965. DESIGN Pragmatic randomized controlled trial. SETTING 43 primary care practices from one academic health system (Philadelphia, PA, USA) between April 2019 and May 2020. PARTICIPANTS Patients born between 1945 and 1965 with no history of screening and at least two primary care visits in the two years before the enrollment period. INTERVENTIONS This multilevel trial was divided into two studies. Substudy A included 1656 eligible patients of 17 primary care clinicians who were randomized in a 1:1 ratio to a mailed letter about HCV screening (letter only), or a similar letter with a laboratory order for HCV screening (letter+order). Substudy B included the remaining 19 837 eligible patients followed by 417 clinicians. Active electronic patient portal users were randomized 1:5 to receive a mailed letter about HCV screening (letter), or an electronic patient portal message with similar content (patient portal); inactive patient portal users were mailed a letter. In a factorial design, patients in substudy B were also randomized 1:1 to receive standard content (usual care), or content based on principles of social norming, anticipated regret, reciprocity, and commitment (behavioral content). MAIN OUTCOME MEASURES Proportion of patients who completed HCV testing within four months. RESULTS 21 303 patients were included in the intention-to-treat analysis. Among the 1642 patients in substudy A, 19.2% (95% confidence interval 16.5% to 21.9%) completed screening in the letter only arm and 43.1% (39.7% to 46.4%) in the letter+order arm (P<0.001). Among the 19 661 patients in substudy B, 14.6% (13.9% to 15.3%) completed screening with usual care content and 13.6% (13.0% to 14.3%) with behavioral science content (P=0.06). Among active patient portal users, 17.8% (16.0% to 19.5%) completed screening after receiving a letter and 13.8% (13.1% to 14.5%) after receiving a patient portal message (P<0.001). CONCLUSIONS Opt out framing and effort reduction by including a signed laboratory order with outreach increased screening for HCV. Behavioral science messaging content did not increase uptake, and mailed letters achieved a greater response rate than patient portal messages.	[Mehta, Shivan J.; Day, Susan C.; Norris, Anne H.; Sung, Jessica; Reitz, Catherine; Asch, David A.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mehta, Shivan J.; Sung, Jessica; Reitz, Catherine; Snider, Christopher K.; Asch, David A.] Univ Penn, Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA; [Wollack, Colin] Univ Penn, Informat Serv, Penn Med, Philadelphia, PA 19104 USA; [Shaw, Pamela A.] Univ Penn, Dept Clin Epidemiol Biostat & Informat, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Mehta, SJ (corresponding author), 14-174 PCAM South Tower,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	mehta@pennmedicine.upenn.edu			University of Pennsylvania Health System [K08CA234326]; National Cancer Institute of the National Institutes of Health	University of Pennsylvania Health System; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This trial was funded by the University of Pennsylvania Health System. SJM's time was supported by grant No K08CA234326 from the National Cancer Institute of the National Institutes of Health. The funders had no involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Asch DA, 2017, NEW ENGL J MED, V377, P1412, DOI 10.1056/NEJMp1707991; Balkissoon CJ, 2019, J COMMUN HEALTH, V44, P1055, DOI 10.1007/s10900-019-00680-3; Beste LA, 2015, GASTROENTEROLOGY, V149, P1471, DOI 10.1053/j.gastro.2015.07.056; Buist DSM, 2017, PREV MED, V102, P49, DOI 10.1016/j.ypmed.2017.06.028; Chapman GB, 2010, JAMA-J AM MED ASSOC, V304, P43, DOI 10.1001/jama.2010.892; de Martel C, 2015, HEPATOLOGY, V62, P1190, DOI 10.1002/hep.27969; Dirmaier J, 2007, J CLIN EPIDEMIOL, V60, P1263, DOI 10.1016/j.jclinepi.2007.04.006; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Flanigan CA, 2017, MMWR-MORBID MORTAL W, V66, P1023, DOI 10.15585/mmwr.mm6638a3; Fowler FJ, 2019, HEALTH SERV RES, V54, P714, DOI 10.1111/1475-6773.13109; Halpern SD, 2007, NEW ENGL J MED, V357, P1340, DOI 10.1056/NEJMsb071595; Hepatitis C Screening Act, 2016, PENNSYLVANIA GEN ASS; Horwitz LI, 2019, NEW ENGL J MED, V381, P1175, DOI 10.1056/NEJMsb1900856; Jemal A, 2017, AM J PREV MED, V53, pE31, DOI 10.1016/j.amepre.2017.01.033; KAHNEMAN D, 1991, J ECON PERSPECT, V5, P193, DOI 10.1257/jep.5.1.193; Kasting ML, 2018, CANCER EPIDEM BIOMAR, V27, P503, DOI 10.1158/1055-9965.EPI-17-0855; Kruger DL, 2017, HEALTH PROMOT PRACT, V18, P283, DOI 10.1177/1524839916661495; Kube S, 2012, AM ECON REV, V102, P1644, DOI 10.1257/aer.102.4.1644; Levin TR, 2011, EPIDEMIOL REV, V33, P101, DOI 10.1093/epirev/mxr007; Linas BP, 2014, AM J MED, V127, P398, DOI 10.1016/j.amjmed.2014.01.012; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Mehta SJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10305; Mehta SJ, 2018, AM J GASTROENTEROL, V113, P1848, DOI 10.1038/s41395-018-0151-3; Mehta SJ, 2016, JAMA CARDIOL, V1, P847, DOI 10.1001/jamacardio.2016.2374; Mehta SJ, 2014, CLIN GASTROENTEROL H, V12, P711, DOI 10.1016/j.cgh.2014.02.022; Milkman KL, 2011, P NATL ACAD SCI USA, V108, P10415, DOI 10.1073/pnas.1103170108; Montoy JCC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6895; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Omland Lars Haukali, 2013, Clin Epidemiol, V5, P163, DOI 10.2147/CLEP.S43926; Roberts K, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m322; Sahlqvist S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-62; Sandberg T, 2009, BRIT J SOC PSYCHOL, V48, P221, DOI 10.1348/014466608X347001; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Schwartz J, 2014, PSYCHOL SCI, V25, P538, DOI 10.1177/0956797613510950; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Singal AG, 2017, JAMA-J AM MED ASSOC, V318, P806, DOI 10.1001/jama.2017.11389; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Tsay CJ, 2020, J CLIN TRANSL HEPATO, V8, P25, DOI 10.14218/JCTH.2019.00059; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; US Preventive Serv Task Force, 2020, JAMA-J AM MED ASSOC, V323, P970, DOI 10.1001/jama.2020.1123; Yartel AK, 2018, HEPATOLOGY, V67, P524, DOI 10.1002/hep.29548; Yeboah-Korang A, 2018, J TRANSL INTERN MED, V6, P82, DOI 10.2478/jtim-2018-0012	43	6	6	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2021	373								n1022	10.1136/bmj.n1022	http://dx.doi.org/10.1136/bmj.n1022			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SL5PR	34006604	Green Published, hybrid			2022-12-28	WOS:000656970600002
J	Ogata, H; Fukagawa, M; Hirakata, H; Kagimura, T; Fukushima, M; Akizawa, T				Ogata, Hiroaki; Fukagawa, Masafumi; Hirakata, Hideki; Kagimura, Tatsuo; Fukushima, Masanori; Akizawa, Tadao		LANDMARK Invest	Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY CALCIFICATION; PHOSPHATE BINDERS; DIALYSIS OUTCOMES; PRACTICE PATTERNS; VASCULAR CALCIFICATION; MORTALITY RISK; SEVELAMER; ASSOCIATION; PROGRESSION; JAPAN	Key PointsQuestionDoes lanthanum carbonate-based treatment without calcium-based phosphate binders reduce cardiovascular events compared with calcium carbonate-based treatment in patients with hyperphosphatemia undergoing hemodialysis? FindingsIn this open-label randomized clinical trial that included 2135 patients undergoing hemodialysis with at least 1 risk factor for vascular calcification, there was no significant difference in composite cardiovascular events between lanthanum carbonate-based treatment with and without calcium-based phosphate binders after a median follow-up of 3.16 years (4.80 vs 4.30 per 100 person-years). MeaningLanthanum carbonate-based treatment without calcium-based phosphate binders did not significantly reduce the composite outcome of cardiovascular events in patients with hyperphosphatemia undergoing hemodialysis. ImportanceAmong patients with hyperphosphatemia undergoing dialysis, it is unclear whether non-calcium-based phosphate binders are more effective than calcium-based binders for reducing cardiovascular events. ObjectiveTo determine whether lanthanum carbonate reduces cardiovascular events compared with calcium carbonate in patients with hyperphosphatemia at risk of vascular calcification undergoing hemodialysis. Design, Setting, and ParticipantsOpen-label, randomized, parallel-group clinical trial with blinded end point adjudication performed in 2374 patients with chronic kidney disease from 273 hemodialysis facilities in Japan. Eligible patients had hyperphosphatemia and 1 or more risk factors for vascular calcification (ie, >= 65 years, postmenopausal, diabetes). Enrollment occurred from November 2011 to July 2014; follow-up ended June 2018. InterventionsPatients were randomized to receive either lanthanum carbonate (n=1154) or calcium carbonate (n=1155) and titrated to achieve serum phosphate levels of between 3.5 mg/dL and 6.0 mg/dL. Main Outcomes and MeasuresThe primary outcome was a composite cardiovascular event (cardiovascular death, nonfatal myocardial infarction or stroke, unstable angina, transient ischemic attack, or hospitalization for heart failure or ventricular arrhythmia). Secondary outcomes included overall survival, secondary hyperparathyroidism-free survival, hip fracture-free survival, and adverse events. ResultsAmong 2309 randomized patients (median age, 69 years; 40.5% women), 1851 (80.2%) completed the trial. After a median follow-up of 3.16 years, cardiovascular events occurred in 147 of 1063 patients in the lanthanum calcium group and 134 of 1072 patients in the calcium carbonate group (incidence rate, 4.80 vs 4.30 per 100 person-years; difference 0.50 per 100 person-years [95% CI, -0.57 to 1.56]; hazard ratio [HR], 1.11 [95%, CI, 0.88 to 1.41], P=.37). There were no significant differences in all-cause death (difference, 0.43 per 100 person-years [95% CI, -0.63 to 1.49]; HR, 1.10 [95% CI, 0.88 to 1.37]; P=.42) or hip fracture (difference, 0.10 per 100 person-years [95% CI, -0.26 to 0.47]; HR, 1.21 [95% CI, 0.62 to 2.35]; P=.58). The lanthanum carbonate group had an increased risk of cardiovascular death (difference, 0.61 per 100 person-years [95% CI, 0.02 to 1.21]; HR, 1.51 [95% CI, 1.01 to 2.27]; P=.045) and secondary hyperparathyroidism (difference, 1.34 [95% CI, 0.49 to 2.19]; HR, 1.62 [95% CI, 1.19 to 2.20]; P=.002). Adverse events occurred in 282 (25.7%) in the lanthanum carbonate group and 259 (23.4%) in the calcium carbonate groups. Conclusions and RelevanceAmong patients undergoing hemodialysis with hyperphosphatemia and at least 1 vascular calcification risk factor, treatment of hyperphosphatemia with lanthanum carbonate compared with calcium carbonate did not result in a significant difference in composite cardiovascular events. However, the event rate was low, and the findings may not apply to patients at higher risk. Trial RegistrationClinicalTrials.gov Identifier: NCT01578200; UMIN Clinical Trial Registry Identifier: UMIN000006815 This clinical trial compared cardiovascular events among patients receiving hemodialysis with at least at 1 risk factor for vascular calcification and treated with a calcium-free phosphate binder, lanthanum carbonate, or calcium carbonate	[Ogata, Hiroaki] Showa Univ, Northern Yokohama Hosp, Dept Internal Med, Div Nephrol,Tsuzuki Ku, Chigasaki Chuo 35-1, Yokohama, Kanagawa 2248503, Japan; [Fukagawa, Masafumi] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa, Japan; [Hirakata, Hideki] Fukuoka Renal Clin, Chuo Ku, Fukuoka, Japan; [Kagimura, Tatsuo; Fukushima, Masanori] Fdn Biomed Res & Innovat Kobe, Translat Res Ctr Med Innovat, Chuo Ku, Kobe, Hyogo, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol,Shinagawa Ku, Tokyo, Japan	Showa University; Tokai University; Showa University	Ogata, H (corresponding author), Showa Univ, Northern Yokohama Hosp, Dept Internal Med, Div Nephrol,Tsuzuki Ku, Chigasaki Chuo 35-1, Yokohama, Kanagawa 2248503, Japan.	ogatah@med.showa-u.ac.jp	Ogata, Hiroaki/A-7946-2011	Ogata, Hiroaki/0000-0002-0046-5575	Bayer Yakuhin Ltd.	Bayer Yakuhin Ltd.	This trial was funded by Bayer Yakuhin Ltd.	Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Block GA, 2005, KIDNEY INT, V68, P1815, DOI 10.1111/j.1523-1755.2005.00600.x; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Chertow GM, 2004, NEPHROL DIAL TRANSPL, V19, P1489, DOI 10.1093/ndt/gfh125; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Cozzolino M, 2018, NEPHROL DIAL TRANSPL, V33, P28, DOI 10.1093/ndt/gfy174; Di Iorio B, 2013, AM J KIDNEY DIS, V62, P771, DOI 10.1053/j.ajkd.2013.03.023; Di Iorio B, 2012, CLIN J AM SOC NEPHRO, V7, P487, DOI 10.2215/CJN.03820411; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Hruska KA, 2008, KIDNEY INT, V74, P148, DOI 10.1038/ki.2008.130; Jovanovich A, 2020, AM J KIDNEY DIS, V75, P453, DOI 10.1053/j.ajkd.2019.08.008; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Kumssa DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep10974; Masakane I., 2018, RENAL REPLACE THER, V4, DOI [10.1186/s41100-018-0149-8, DOI 10.1186/S41100-018-0149-8]; McGovern AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074996; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Ogata H., 2017, J AM SOC NEPHROL, V28, pB7; Ogata H, 2017, CLIN EXP NEPHROL, V21, P531, DOI 10.1007/s10157-016-1310-8; Ohtake T, 2013, J CARDIOVASC PHARM T, V18, P439, DOI 10.1177/1074248413486355; Peter WLS, 2008, AM J KIDNEY DIS, V51, P445, DOI 10.1053/j.ajkd.2007.12.002; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Robinson BM, 2016, LANCET, V388, P294, DOI 10.1016/S0140-6736(16)30448-2; Ruospo M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006023.pub3; Spoendlin J, 2019, JAMA INTERN MED, V179, P741, DOI 10.1001/jamainternmed.2019.0045; Stirnadel-Farrant HA, 2019, KIDNEY INT REP, V4, P864, DOI 10.1016/j.ekir.2019.03.016; Suki WN, 2007, KIDNEY INT, V72, P1130, DOI 10.1038/sj.ki.5002466; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Zhang CH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008664	33	15	16	3	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1946	1954		10.1001/jama.2021.4807	http://dx.doi.org/10.1001/jama.2021.4807			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003226	Green Published, Bronze			2022-12-28	WOS:000652675100009
J	Gonsalves, G; Yamey, G				Gonsalves, Gregg; Yamey, Gavin			The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								An intellectual property waiver alone will not solve the covid-19 vaccine access challenge, other steps will be needed.	[Gonsalves, Gregg] Yale Sch Publ Hlth, Publ Hlth Modeling Unit, New Haven, CT 06510 USA; [Gonsalves, Gregg] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Yamey, Gavin] Duke Univ, Ctr Policy Impact Global Hlth, Duke Global Hlth Inst, Durham, NC USA	Yale University; Yale University; Duke University	Gonsalves, G (corresponding author), Yale Sch Publ Hlth, Publ Hlth Modeling Unit, New Haven, CT 06510 USA.; Gonsalves, G (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.	gregg.gonsalves@yale.edu						[Anonymous], 2021, BBC NEWS 0503; [Anonymous], NEW YORK TIMES; Byanyima W, 2021, GUARDIAN 0129	3	15	16	3	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2021	373								n1249	10.1136/bmj.n1249	http://dx.doi.org/10.1136/bmj.n1249			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9HR	34001498	Bronze			2022-12-28	WOS:000653058000005
J	Markewitz, RDH; Dargvainiene, J				Markewitz, Robert D. H.; Dargvainiene, Justina			Mitotic and Apoptotic Figures on a Peripheral-Blood Smear	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Markewitz, Robert D. H.; Dargvainiene, Justina] Univ Hosp Schleswig Holstein, Inst Clin Chem, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Markewitz, RDH (corresponding author), Univ Hosp Schleswig Holstein, Inst Clin Chem, Kiel, Germany.	robert.markewitz@uksh.de	Markewitz, Robert/AAB-2074-2022	Markewitz, Robert/0000-0003-1676-1085					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					1942	1942		10.1056/NEJMicm2033085	http://dx.doi.org/10.1056/NEJMicm2033085		MAY 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ4AW	34014049				2022-12-28	WOS:000652577700001
J	Fish, L; Khoroshkin, M; Navickas, A; Garcia, K; Culbertson, B; Hanisch, B; Zhang, S; Nguyen, HCB; Soto, LM; Dermit, M; Mardakheh, FK; Molina, H; Alarcon, C; Najafabadi, HS; Goodarzi, H				Fish, Lisa; Khoroshkin, Matvei; Navickas, Albertas; Garcia, Kristle; Culbertson, Bruce; Hanisch, Benjamin; Zhang, Steven; Nguyen, Hoang C. B.; Soto, Larisa M.; Dermit, Maria; Mardakheh, Faraz K.; Molina, Henrik; Alarcon, Claudio; Najafabadi, Hamed S.; Goodarzi, Hani			A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elements	SCIENCE			English	Article							BREAST-CANCER METASTASIS; COMPUTATIONAL PLATFORM; PROTEIN INTERACTIONS; ANALYSIS REVEALS; U2 SNRNP; BINDING; MECHANISMS; SPECIFICITY; STABILITY; DISCOVERY	Aberrant alternative splicing is a hallmark of cancer, yet the underlying regulatory programs that control this process remain largely unknown. Here, we report a systematic effort to decipher the RNA structural code that shapes pathological splicing during breast cancer metastasis. We discovered a previously unknown structural splicing enhancer that is enriched near cassette exons with increased inclusion in highly metastatic cells. We show that the spliceosomal protein small nuclear ribonucleoprotein polypeptide A' (SNRPA1) interacts with these enhancers to promote cassette exon inclusion. This interaction enhances metastatic lung colonization and cancer cell invasion, in part through SNRPA1-mediated regulation of PLEC alternative splicing, which can be counteracted by splicing modulating morpholinos. Our findings establish a noncanonical regulatory role for SNRPA1 as a prometastatic splicing enhancer in breast cancer.	[Fish, Lisa; Khoroshkin, Matvei; Navickas, Albertas; Garcia, Kristle; Culbertson, Bruce; Hanisch, Benjamin; Zhang, Steven; Goodarzi, Hani] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Fish, Lisa; Khoroshkin, Matvei; Navickas, Albertas; Garcia, Kristle; Culbertson, Bruce; Hanisch, Benjamin; Zhang, Steven; Goodarzi, Hani] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA; [Fish, Lisa; Khoroshkin, Matvei; Navickas, Albertas; Garcia, Kristle; Culbertson, Bruce; Hanisch, Benjamin; Zhang, Steven; Goodarzi, Hani] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Fish, Lisa; Khoroshkin, Matvei; Navickas, Albertas; Garcia, Kristle; Culbertson, Bruce; Hanisch, Benjamin; Zhang, Steven; Goodarzi, Hani] Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94158 USA; [Nguyen, Hoang C. B.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Soto, Larisa M.; Najafabadi, Hamed S.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0C7, Canada; [Soto, Larisa M.; Najafabadi, Hamed S.] McGill Genome Ctr, Montreal, PQ H3A 0G1, Canada; [Dermit, Maria; Mardakheh, Faraz K.] Queen Mary Univ London, Ctr Canc Cell & Mol Biol, Barts Canc Inst, London EC1M 6BQ, England; [Molina, Henrik] Rockefeller Univ, Proteome Resource Ctr, New York, NY 10065 USA; [Alarcon, Claudio] Yale Univ, Dept Pharmacol, Sch Med, New Haven, CT 06520 USA; [Alarcon, Claudio] Yale Univ, Yale Canc Biol Inst, West Haven, CT 06516 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; McGill University; University of London; Queen Mary University London; Rockefeller University; Yale University; Yale University	Goodarzi, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.; Goodarzi, H (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA.; Goodarzi, H (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.; Goodarzi, H (corresponding author), Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94158 USA.	hani.goodarzi@ucsf.edu		Morales Soto, Larisa/0000-0003-4801-8309; Navickas, Albertas/0000-0003-0016-2643; Fish, Lisa/0000-0001-9184-0512; Dermit, Maria/0000-0002-6287-8367; Bui Nguyen, Hoang/0000-0001-6975-3084; Culbertson, Bruce/0000-0002-1489-1348; Khoroshkin, Matvei/0000-0002-1744-6792; Garcia, Kristle/0000-0002-9868-8397; Goodarzi, Hani/0000-0002-9648-8949	NIH [R00CA194077, R01CA240984, T32CA108462-15]; ACS [130920-RSG-17-114-01-RMC]; CIHR [PJT-155966, PJT-173317]; UCSF Breast Oncology Program; DoD PRCRP Horizon Award [W81XWH-19-1-0594]; HHMI medical research fellowship; MRC career development award [MR/P009417/1]; UCSF Helen Diller Family Comprehensive Cancer Center Breast Oncology Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); CIHR(Canadian Institutes of Health Research (CIHR)); UCSF Breast Oncology Program; DoD PRCRP Horizon Award; HHMI medical research fellowship; MRC career development award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCSF Helen Diller Family Comprehensive Cancer Center Breast Oncology Program	This work was supported by grants from the NIH (R00CA194077 and R01CA240984) and ACS (130920-RSG-17-114-01-RMC) to H.G. and grants from CIHR (PJT-155966 and PJT-173317) and resource allocations from Compute Canada to H.S.N. This research was also supported by funding from the UCSF Breast Oncology Program (the content is solely the responsibility of the authors). L.F. was supported by NIH training grant T32CA108462-15. A.N. was supported by DoD PRCRP Horizon Award W81XWH-19-1-0594. S.Z. was supported by an HHMI medical research fellowship. H.S.N. holds a CIHR Canada Research Chair. M.D. and F.K.M. were supported by an MRC career development award to F.K.M. (MR/P009417/1). This research was also supported by funding from the UCSF Helen Diller Family Comprehensive Cancer Center Breast Oncology Program.	Alajati A, 2013, CANCER RES, V73, P5320, DOI 10.1158/0008-5472.CAN-12-3186; Anastasi S, 2016, SEMIN CELL DEV BIOL, V50, P115, DOI 10.1016/j.semcdb.2015.10.001; Anczukow O, 2016, RNA, V22, P1285, DOI 10.1261/rna.057919.116; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Bemmo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011981; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; BOELENS WC, 1993, CELL, V72, P881, DOI 10.1016/0092-8674(93)90577-D; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Butter F, 2009, P NATL ACAD SCI USA, V106, P10626, DOI 10.1073/pnas.0812099106; Calabrese C, 2020, NATURE, V578, P129, DOI 10.1038/s41586-020-1970-0; Climente-Gonzalez H, 2017, CELL REP, V20, P2215, DOI 10.1016/j.celrep.2017.08.012; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Dermit M, 2020, DEV CELL, V55, P298, DOI 10.1016/j.devcel.2020.10.006; Dorman SN, 2014, SCI REP-UK, V4, DOI 10.1038/srep07063; Dvinge H, 2018, FEBS LETT, V592, P2987, DOI 10.1002/1873-3468.13119; El Marabti E, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00080; Fica SM, 2017, NAT STRUCT MOL BIOL, V24, P791, DOI 10.1038/nsmb.3463; Fish L, 2019, MOL CELL, V75, P967, DOI 10.1016/j.molcel.2019.06.001; Goodarzi H, 2014, NATURE, V513, P256, DOI 10.1038/nature13466; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Guenther UP, 2013, NATURE, V502, P385, DOI 10.1038/nature12543; Harvey SE, 2018, RNA, V24, P1326, DOI 10.1261/rna.066712.118; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; Kastner B, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032417; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Ke H, 2018, P NATL ACAD SCI USA, V115, pE3426, DOI 10.1073/pnas.1714573115; Ketema M, 2015, MOL BIOL CELL, V26, P2402, DOI 10.1091/mbc.E15-01-0043; Khoroshkin M., 2021, ZENODO; Khoroshkin M, 2021, GOODARZILAB PYTEISER, DOI [10.5281/zenodo.4533306, DOI 10.5281/ZENODO.4533306]; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Li DH, 2018, TRENDS PHARMACOL SCI, V39, P982, DOI 10.1016/j.tips.2018.09.001; Litterman AJ, 2019, GENOME RES, V29, P896, DOI 10.1101/gr.242552.118; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marzese DM, 2018, CLIN EXP METASTAS, V35, P393, DOI 10.1007/s10585-018-9905-y; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Mercer TR, 2015, GENOME RES, V25, P290, DOI 10.1101/gr.182899.114; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Ramanathan M, 2018, NAT METHODS, V15, P207, DOI [10.1038/NMETH.4601, 10.1038/nmeth.4601]; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Shiraishi Y, 2018, GENOME RES, V28, P1111, DOI 10.1101/gr.231951.117; Siegel MB, 2018, J CLIN INVEST, V128, P1371, DOI 10.1172/JCI96153; Siegfried Z, 2018, CURR OPIN GENET DEV, V48, P16, DOI 10.1016/j.gde.2017.10.001; Smith CC, 2019, NAT REV CANCER, V19, P465, DOI 10.1038/s41568-019-0162-4; Smola MJ, 2016, P NATL ACAD SCI USA, V113, P10322, DOI 10.1073/pnas.1600008113; Song XW, 2018, SEMIN CELL DEV BIOL, V75, P13, DOI 10.1016/j.semcdb.2017.09.018; Tanikawa M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.70; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Urbanski LM, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1476; Urdaneta EC, 2020, METHODS, V178, P72, DOI 10.1016/j.ymeth.2019.09.013; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Williams SG, 2014, BIOCHEMISTRY-US, V53, P3727, DOI 10.1021/bi500438e; Winkler J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18794-x; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; Xu YL, 2014, GENE DEV, V28, P1191, DOI 10.1101/gad.241968.114; Yoneyama MS, 2014, EUR J CELL BIOL, V93, P157, DOI 10.1016/j.ejcb.2014.03.002; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]; Zubradt M, 2017, NAT METHODS, V14, P75, DOI [10.1038/nmeth.4057, 10.1038/NMETH.4057]	66	9	9	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					702	+	abc7531	10.1126/science.abc7531	http://dx.doi.org/10.1126/science.abc7531			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986153	Green Accepted			2022-12-28	WOS:000651125300039
J	Su, ZL; Dutta, A				Su, Zhangli; Dutta, Anindya			De-stressing the T cells in need Protection of transfer RNAs from fragmentation avoids overstressing T cells	SCIENCE			English	Editorial Material							SCHLAFEN; FAMILY		[Su, Zhangli; Dutta, Anindya] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham	Dutta, A (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA.	duttaa@uab.edu		Su, Zhangli/0000-0001-6495-3351; Dutta, Anindya/0000-0002-4319-0073	National Institutes of Health [R01 AR067712]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work in the authors' laboratory is supported by R01 AR067712 from the National Institutes of Health.	Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Franchina DG, 2018, TRENDS IMMUNOL, V39, P489, DOI 10.1016/j.it.2018.01.005; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Ross SH, 2018, ANNU REV IMMUNOL, V36, P411, DOI 10.1146/annurev-immunol-042617-053352; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Su ZL, 2020, ANNU REV GENET, V54, P47, DOI 10.1146/annurev-genet-022620-101840; Su ZL, 2019, J BIOL CHEM, V294, P16930, DOI 10.1074/jbc.RA119.009272; Wolf T, 2020, NAT IMMUNOL, V21, P927, DOI 10.1038/s41590-020-0714-5; Yang JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03544-x; Ye CX, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-017-0002-5; Yue T., 2021, SCIENCE, V372	13	0	0	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					683	684		10.1126/science.abi7265	http://dx.doi.org/10.1126/science.abi7265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SD1KE	33986167				2022-12-28	WOS:000651125300027
J	Wallner, A; Froehlich, MB; Hotchkis, MAC; Kinoshita, N; Paul, M; Martschini, M; Pavetich, S; Tims, SG; Kivel, N; Schumann, D; Honda, M; Matsuzaki, H; Yamagata, T				Wallner, A.; Froehlich, M. B.; Hotchkis, M. A. C.; Kinoshita, N.; Paul, M.; Martschini, M.; Pavetich, S.; Tims, S. G.; Kivel, N.; Schumann, D.; Honda, M.; Matsuzaki, H.; Yamagata, T.			Fe-60 and Pu-244 deposited on Earth constrain the r-process yields of recent nearby supernovae	SCIENCE			English	Article							SOLAR-SYSTEM; FALLOUT RADIONUCLIDES; INTERSTELLAR DUST; HEAVY-ELEMENTS; MASSIVE STARS; AMS; ABUNDANCES; PLUTONIUM; ORIGIN; NUCLEOSYNTHESIS	Half of the chemical elements heavier than iron are produced by the rapid neutron capture process (r-process). The sites and yields of this process are disputed, with candidates including some types of supernovae (SNe) and mergers of neutron stars. We search for two isotopic signatures in a sample of Pacific Ocean crust-iron-60 (Fe-60) (half-life, 2.6 million years), which is predominantly produced in massive stars and ejected in supernova explosions, and plutonium-244 (Pu-244) (half-life, 80.6 million years), which is produced solely in r-process events. We detect two distinct influxes of 60Fe to Earth in the last 10 million years and accompanying lower quantities of Pu-244. The Pu-244/Fe-60 influx ratios are similar for both events. The Pu-244 influx is lower than expected if SNe dominate r-process nucleosynthesis, which implies some contribution from other sources.	[Wallner, A.; Froehlich, M. B.; Martschini, M.; Pavetich, S.; Tims, S. G.] Australian Natl Univ, Res Sch Phys, Dept Nucl Phys, Canberra, ACT 2601, Australia; [Wallner, A.] Helmholtz Zentrum Dresden Rossendorf, Inst Ion Beam Phys & Mat Res, D-01328 Dresden, Germany; [Hotchkis, M. A. C.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW 2234, Australia; [Kinoshita, N.] Shimizu Corp, Inst Technol, Tokyo 1358530, Japan; [Paul, M.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Kivel, N.; Schumann, D.] Paul Scherrer Inst, Dept Nucl Energy & Safety, Lab Radiochem, CH-5232 Villigen, Switzerland; [Honda, M.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Matsuzaki, H.; Yamagata, T.] Univ Tokyo, Univ Museum, Micro Anal Lab, Tandem Accelerator, Tokyo 1130032, Japan; [Martschini, M.] Univ Vienna, Vienna Envirorm Res Accelerator Lab, Fac Phys, A-1090 Vienna, Austria; [Honda, M.] Japan Atom Energy Agcy, Nucl Sci Res Inst, Tokai, Ibaraki, Japan	Australian National University; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Australian Nuclear Science & Technology Organisation; Shimizu Corporation; Hebrew University of Jerusalem; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Tsukuba; University of Tokyo; University of Vienna; Japan Atomic Energy Agency	Wallner, A (corresponding author), Australian Natl Univ, Res Sch Phys, Dept Nucl Phys, Canberra, ACT 2601, Australia.; Wallner, A (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Ion Beam Phys & Mat Res, D-01328 Dresden, Germany.	anton.wallner@hzdr.de	Froehlich, Michaela/AAV-2272-2021; Wallner, Anton/G-1480-2011; Martschini, Martin/ABC-1253-2020; Tims, Stephen/P-6505-2015	Froehlich, Michaela/0000-0002-1938-8119; Wallner, Anton/0000-0003-2804-3670; Martschini, Martin/0000-0002-6661-0624; Kinoshita, Norikazu/0000-0001-9135-483X; Hotchkis, Michael/0000-0003-2321-0222; Tims, Stephen/0000-0001-6014-0126; Paul, Michael/0000-0002-4121-8597; Honda, Maki/0000-0002-9548-1745; Pavetich, Stefan/0000-0001-8014-0545	Australian Research Council's Discovery scheme [DP140100136, DP180100495, DP180100496]; Japan Society for the Promotion of Science (JSPS) KAKENHI [17K05722]; Australian government	Australian Research Council's Discovery scheme(Australian Research Council); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Australian government(Australian GovernmentCGIAR)	A.W., M.B. F., M. P., M.M., and S.P. were supported by the Australian Research Council's Discovery scheme, project numbers DP140100136, DP180100495, and DP180100496. N.Kin. was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grant no. 17K05722. We also acknowledge financial support from the Australian government for the Heavy Ion Accelerator Facility at ANU and for the Centre for Accelerator Science at ANSTO through the National Collaborative Research Infrastructure Strategy (NCRIS).	Abbott R., 2021, ASTROPHYS J, V913, pL7, DOI [10.3847/2041-8213/abe949, DOI 10.3847/2041-8213/AC5C5B]; Altobelli N, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010772; Altobelli N, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009874; [Anonymous], MAT METHODS ARE AVAI; Arnould M, 2007, PHYS REP, V450, P97, DOI 10.1016/j.physrep.2007.06.002; Athanassiadou T, 2011, NEW ASTRON, V16, P229, DOI 10.1016/j.newast.2010.09.007; Bartos I, 2019, NATURE, V569, P85, DOI 10.1038/s41586-019-1113-7; Beech M, 2011, ASTROPHYS SPACE SCI, V336, P287, DOI 10.1007/s10509-011-0873-9; Binns WR, 2016, SCIENCE, V352, P677, DOI 10.1126/science.aad6004; BOURLES D, 1989, GEOCHIM COSMOCHIM AC, V53, P443, DOI 10.1016/0016-7037(89)90395-5; BOWEN VT, 1980, EARTH PLANET SC LETT, V49, P411, DOI 10.1016/0012-821X(80)90083-7; Breitschwerdt D, 2016, NATURE, V532, P73, DOI 10.1038/nature17424; Brennecka GA, 2010, SCIENCE, V327, P449, DOI 10.1126/science.1180871; Chmeleff J, 2010, NUCL INSTRUM METH B, V268, P192, DOI 10.1016/j.nimb.2009.09.012; Clayton DD, 2011, LECT NOTES PHYS, V812, P25, DOI 10.1007/978-3-642-12698-7_2; Cote B, 2021, SCIENCE, V371, P945, DOI 10.1126/science.aba1111; Cowan JJ, 2021, REV MOD PHYS, V93, DOI 10.1103/RevModPhys.93.015002; Dauphas N, 2005, NATURE, V435, P1203, DOI 10.1038/nature03645; Dauphas N, 2005, NUCL PHYS A, V758, p757C, DOI 10.1016/j.nuclphysa.2005.05.136; Dittmann BA, 2015, NUCL INSTRUM METH B, V361, P327, DOI 10.1016/j.nimb.2015.04.030; Dwek E, 1998, ASTROPHYS J, V501, P643, DOI 10.1086/305829; Ellis J, 1996, ASTROPHYS J, V470, P1227, DOI 10.1086/177945; Feige J, 2012, PUBL ASTRON SOC AUST, V29, P109, DOI 10.1071/AS11070; Feige J, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.221103; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; Fields BD, 2020, P NATL ACAD SCI USA, V117, P21008, DOI 10.1073/pnas.2013774117; FIELDS PR, 1970, SCIENCE, V167, P499, DOI 10.1126/science.167.3918.499; Fifield LK, 2010, NUCL INSTRUM METH B, V268, P858, DOI 10.1016/j.nimb.2009.10.049; Fimiani L, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.151104; Fitoussi C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.121101; Frisch PC, 2009, SPACE SCI REV, V146, P235, DOI 10.1007/s11214-009-9502-0; Froehlich MB, 2016, J ENVIRON RADIOACTIV, V165, P197, DOI 10.1016/j.jenvrad.2016.09.015; Fry BJ, 2020, ASTROPHYS J, V894, DOI 10.3847/1538-4357/ab86bf; Fry BJ, 2016, ASTROPHYS J, V827, DOI 10.3847/0004-637X/827/1/48; Fry BJ, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/71; Gall C, 2014, NATURE, V511, P326, DOI 10.1038/nature13558; Gehrels N, 2003, ASTROPHYS J, V585, P1169, DOI 10.1086/346127; Goriely S, 2016, MON NOT R ASTRON SOC, V459, P4174, DOI 10.1093/mnras/stw946; Goto KT, 2014, GEOCHIM COSMOCHIM AC, V146, P43, DOI 10.1016/j.gca.2014.10.003; Hotchkis MAC, 2019, NUCL INSTRUM METH B, V438, P70, DOI 10.1016/j.nimb.2018.07.029; Hotokezaka K, 2015, NAT PHYS, V11, P1042, DOI [10.1038/NPHYS3574, 10.1038/nphys3574]; Jakopic R., 2014, EUROPEAN COMMISSION; Ji AP, 2016, NATURE, V531, P610, DOI 10.1038/nature17425; Kachelriess M, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.181103; Kasen D, 2017, NATURE, V551, P80, DOI 10.1038/nature24453; Kelley JM, 1999, SCI TOTAL ENVIRON, V238, P483, DOI 10.1016/S0048-9697(99)00160-6; Ketterer ME, 2008, SPECTROCHIM ACTA B, V63, P719, DOI 10.1016/j.sab.2008.04.018; Knie K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.171103; Knie K, 1999, PHYS REV LETT, V83, P18, DOI 10.1103/PhysRevLett.83.18; Koll D, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.072701; Korschinek G, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.031101; Korschinek G, 2010, NUCL INSTRUM METH B, V268, P187, DOI 10.1016/j.nimb.2009.09.020; Korschinek G., 1996, RADIOCARBON, V38, P68; Kutschera W, 2013, INT J MASS SPECTROM, V349, P203, DOI 10.1016/j.ijms.2013.05.023; Lachner J, 2020, NUCL INSTRUM METH B, V467, P146, DOI 10.1016/j.nimb.2019.11.047; Lachner J, 2010, APPL RADIAT ISOTOPES, V68, P979, DOI 10.1016/j.apradiso.2010.01.043; LATTIMER JM, 1976, ASTROPHYS J, V210, P549, DOI 10.1086/154860; Li A., 2005, Journal of Physics: Conference Series, V6, P229, DOI 10.1088/1742-6596/6/1/028; Limongi M, 2006, ASTROPHYS J, V647, P483, DOI 10.1086/505164; LIVINGSTON HD, 1983, NATURE, V303, P228, DOI 10.1038/303228a0; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Ludwig P, 2016, P NATL ACAD SCI USA, V113, P9232, DOI 10.1073/pnas.1601040113; Lugaro M, 2014, SCIENCE, V345, P650, DOI 10.1126/science.1253338; Mann I, 2010, ANNU REV ASTRON ASTR, V48, P173, DOI 10.1146/annurev-astro-081309-130846; Martschini M, 2019, NUCL INSTRUM METH B, V438, P141, DOI 10.1016/j.nimb.2018.05.039; Matsuura M, 2011, SCIENCE, V333, P1258, DOI 10.1126/science.1205983; Matsuzaki H, 2015, NUCL INSTRUM METH B, V361, P63, DOI 10.1016/j.nimb.2015.05.032; Miller KA, 2018, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00418; Mor R, 2019, ASTRON ASTROPHYS, V624, DOI 10.1051/0004-6361/201935105; PAUL M, 1989, NUCL INSTRUM METH A, V277, P418, DOI 10.1016/0168-9002(89)90771-7; Paul M, 2007, J RADIOANAL NUCL CH, V272, P243, DOI 10.1007/s10967-007-0508-3; Paul M, 2001, ASTROPHYS J, V558, pL133, DOI 10.1086/323617; Pol N, 2020, RES NOTES AAS, V4, P22, DOI DOI 10.3847/2515-5172/AB7307; Qian YZ, 2003, PROG PART NUCL PHYS, V50, P153, DOI 10.1016/S0146-6410(02)00178-3; Raisbeck G, 2007, NUCL INSTRUM METH B, V259, P673, DOI 10.1016/j.nimb.2007.01.205; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; Rosswog S, 2017, CLASSICAL QUANT GRAV, V34, DOI 10.1088/1361-6382/aa68a9; Rugel G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.072502; Schumann D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219039; SEGL M, 1984, NATURE, V309, P540, DOI 10.1038/309540a0; Steier P, 2013, NUCL INSTRUM METH B, V294, P160, DOI 10.1016/j.nimb.2012.06.017; Steier P, 2010, NUCL INSTRUM METH B, V268, P1045, DOI 10.1016/j.nimb.2009.10.094; Svensmark H, 2012, MON NOT R ASTRON SOC, V423, P1234, DOI 10.1111/j.1365-2966.2012.20953.x; Synal HA, 2013, INT J MASS SPECTROM, V349, P192, DOI 10.1016/j.ijms.2013.05.008; Thielemann FK, 2011, PROG PART NUCL PHYS, V66, P346, DOI 10.1016/j.ppnp.2011.01.032; Timmes FX, 1997, ASTROPHYS J, V481, pL81, DOI 10.1086/310662; Tims SG, 2013, NUCL INSTRUM METH B, V294, P636, DOI 10.1016/j.nimb.2012.07.010; Tissot FLH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501400; Vockenhuber C, 2013, NUCL INSTRUM METH B, V294, P382, DOI 10.1016/j.nimb.2012.01.014; Wallner A, 2020, P NATL ACAD SCI USA, V117, P21873, DOI 10.1073/pnas.1916769117; Wallner A, 2016, NATURE, V532, P69, DOI 10.1038/nature17196; Wallner A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6956; Wallner A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.041101; Wallner A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.192501; Wallner C, 2004, NEW ASTRON REV, V48, P145, DOI 10.1016/j.newar.2003.11.020; Wallner C, 2000, NUCL INSTRUM METH B, V172, P333, DOI 10.1016/S0168-583X(00)00138-5; Wanajo S, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/1/L6; Wang W, 2007, ASTRON ASTROPHYS, V469, P1005, DOI 10.1051/0004-6361:20066982; Wasserburg GJ, 2006, NUCL PHYS A, V777, P5, DOI 10.1016/j.nuclphysa.2005.07.015; Westphal AJ, 2014, SCIENCE, V345, P786, DOI 10.1126/science.1252496; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237	104	18	18	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					742	+		10.1126/science.aax3972	http://dx.doi.org/10.1126/science.aax3972			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986180				2022-12-28	WOS:000651125300051
J	Malina, D				Malina, Debra			Deconstructing Inequities - Transparent Values in Measurement and Analytic Choices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH; EQUITY; RACE	Deconstructing Inequities An important step in addressing racism as a U.S. public health crisis is accurate measurement of progress necessary to hold ourselves collectively accountable. Public Health Critical Race Praxis provides guiding principles for analyzing myriad health equity challenges.	[Malina, Debra] Univ Wisconsin, Populat Hlth Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Malina, D (corresponding author), Univ Wisconsin, Populat Hlth Inst, Madison, WI 53706 USA.			Pollock, Elizabeth/0000-0003-0405-6151				American Public Health Association, 2021, RAC IS PUBL HLTH CRI; Asada Y., 2007, HLTH INEQUALITY MORA; Blacksher E, 2018, AM J BIOETHICS, V18, P3, DOI 10.1080/15265161.2018.1513585; Bobo LD, 2004, CHANGING TERRAIN OF RACE AND ETHNICITY, P13; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; Braveman P., 2017, WHAT IS HLTH EQUITY; Brown L.T., 2021, BLACK BUTTERFLY HARM; Cho S, 2013, SIGNS, V38, P785, DOI 10.1086/669608; Collins P.H., 1999, BLACK FEMINIST THOUG, VRevised, 10th Anniv., 2nd ed.).; Duran D, 2019, AM J PUBLIC HEALTH, V109, pS25, DOI 10.2105/AJPH.2019.304952; Ford CL, 2010, AM J PUBLIC HEALTH, V100, pS30, DOI 10.2105/AJPH.2009.171058; Gennuso KP, 2019, AM J PREV MED, V57, P585, DOI 10.1016/j.amepre.2019.06.018; Givens ML, 2020, HEALTH EQUITY, V4, P446, DOI 10.1089/heq.2020.0013; Gramlich John, 2019, GAP NUMBER BLACKS WH; Harper S, 2010, MILBANK Q, V88, P4, DOI 10.1111/j.1468-0009.2010.00587.x; Hartman L., 2020, STATES REPORTING COV; Hayes-Greene D., 2018, GROUNDWATER APPROACH; Kawachi I, 2002, J EPIDEMIOL COMMUN H, V56, P647, DOI 10.1136/jech.56.9.647; Keppel Kenneth, 2005, Vital Health Stat 2, P1; Kindig D, 2017, JAMA-J AM MED ASSOC, V317, P467, DOI 10.1001/jama.2016.19435; Lowery Wesley, 2016, WASHINGTON POST; Marchand S, 1998, MILBANK Q, V76, P449, DOI 10.1111/1468-0009.00098; Maybank A., 2020, NEW YORK TIMES; National Association for the Advancement of Colored People, CRIM JUST FACT SHEET; National Center for Health Statistics, 2021, PROV DEATH COUNTS CO; National Collaborative for Health Equity Texas Health Institute and VCU Center on Society and Health, MEAS ADV HLTH OPP TH; Speer PW., 2020, DEV COMMUNITY POWER; We All Count, DAT EQ FRAM; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; Zimmerman FJ, 2019, PUBLIC HEALTH, V175, P68, DOI 10.1016/j.puhe.2019.06.008	30	5	5	3	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					1861	1865		10.1056/NEJMms2035717	http://dx.doi.org/10.1056/NEJMms2035717			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD6UF	33979494	Bronze			2022-12-28	WOS:000651509400015
J	Pearson, H				Pearson, Helen			HOW COVID BROKE THE EVIDENCE PIPELINE	NATURE			English	News Item						SARS-CoV-2; Medical research; Health care; Virology		The pandemic stress-tested the way the world produces evidence - and revealed all the flaws.										Carley S, 2020, EMERG MED J, V37, P572, DOI 10.1136/emermed-2020-210098; Chalmers I, 1989, EFFECTIVE CARE PREGN; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71	5	31	32	1	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					182	185		10.1038/d41586-021-01246-x	http://dx.doi.org/10.1038/d41586-021-01246-x			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SB2RT	33981057	Bronze			2022-12-28	WOS:000649848600005
J	Ravindran, S				Ravindran, Sandeep			SMARTPHONE APPS TEST AND TRACK INFECTIOUS DISEASES	NATURE			English	Editorial Material						SARS-CoV-2; Epidemiology; Developing world; Technology	AMPLIFICATION	The prevalence, power and portability of smartphones make them valuable tools for pathogen monitoring and citizen science. The prevalence, power and portability of smartphones make them valuable tools for pathogen monitoring and citizen science.										Azhar M., 2020, PREPRINT MEDRXIV, DOI [10.1101/2020.09.13.20193581, DOI 10.1101/2020.09.13.20193581]; Chung S, 2021, NAT PROTOC, V16, P1452, DOI 10.1038/s41596-020-00460-7; Fozouni P, 2021, CELL, V184, P323, DOI 10.1016/j.cell.2020.12.001; Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9; Ganguli A, 2020, P NATL ACAD SCI USA, V117, P22727, DOI 10.1073/pnas.2014739117; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Rader B, 2021, LANCET DIGIT HEALTH, V3, pE148, DOI 10.1016/S2589-7500(20)30293-4; Sousa LB, 2020, SCI TOTAL ENVIRON, V704, DOI 10.1016/j.scitotenv.2019.135349; Sudre CH, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01292-y; Varsavsky T, 2021, LANCET PUBLIC HEALTH, V6, pE21, DOI 10.1016/S2468-2667(20)30269-3	10	3	3	3	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					302	303		10.1038/d41586-021-01253-y	http://dx.doi.org/10.1038/d41586-021-01253-y			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA0DY	33972778	Bronze			2022-12-28	WOS:000648971600003
J	Schiereck, SS; Constantinople, CM				Schiereck, Shannon S.; Constantinople, Christine M.			Tracking self-performance in the prefrontal cortex: It's layered	CELL			English	Editorial Material								In this issue of Cell, Spellman and colleagues record and manipulate the activity of neurons in the medial prefrontal cortex of mice performing a task in which they must pay attention to different stimuli. They show that this brain region is important for monitoring the animals' performance, and neurons that appear to contribute to behavior reside in deep cortical layers.	[Schiereck, Shannon S.; Constantinople, Christine M.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Constantinople, CM (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	cmc472@nyu.edu						Bissonette GB, 2013, BEHAV BRAIN RES, V250, P91, DOI 10.1016/j.bbr.2013.04.037; Brown VJ, 2016, CURR TOP BEHAV NEURO, V28, P363, DOI 10.1007/7854_2015_5002; Hirokawa J, 2019, NATURE, V576, P446, DOI 10.1038/s41586-019-1816-9; Hyman JM, 2017, NEURON, V95, P447, DOI 10.1016/j.neuron.2017.06.021; Marton TF, 2018, J NEUROSCI, V38, P2569, DOI 10.1523/JNEUROSCI.1728-17.2018; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nakayama H, 2018, J NEUROSCI, V38, P4490, DOI 10.1523/JNEUROSCI.3537-17.2018; Otis JM, 2017, NATURE, V543, P103, DOI 10.1038/nature21376; Radnikow G, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00001; Spellman T., 2021, CELL; Tremblay R, 2016, NEURON, V91, P260, DOI 10.1016/j.neuron.2016.06.033; Wimmer RD, 2015, NATURE, V526, P705, DOI 10.1038/nature15398	12	0	0	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2534	2536		10.1016/j.cell.2021.04.030	http://dx.doi.org/10.1016/j.cell.2021.04.030		MAY 2021	4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33989547	Bronze			2022-12-28	WOS:000652830800003
J	Mao, C; Liu, XG; Zhang, YL; Lei, G; Yan, YL; Lee, H; Koppula, P; Wu, SQ; Zhuang, L; Fang, BL; Poyurovsky, MV; Olszewski, K; Gan, BY				Mao, Chao; Liu, Xiaoguang; Zhang, Yilei; Lei, Guang; Yan, Yuelong; Lee, Hyemin; Koppula, Pranavi; Wu, Shiqi; Zhuang, Li; Fang, Bingliang; Poyurovsky, Masha V.; Olszewski, Kellen; Gan, Boyi			DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer	NATURE			English	Article							MULTICENTER PHASE-II; BREQUINAR SODIUM; CELL-DEATH; INHIBITION; MITOCHONDRIA; METABOLISM; CHECKPOINT; EXPRESSION; GROWTH; TRIAL	Ferroptosis, a form of regulated cell death that is induced by excessive lipid peroxidation, is a key tumour suppression mechanism(1-4). Glutathione peroxidase 4 (GPX4)(5,6) and ferroptosis suppressor protein 1 (FSP1)(7,8) constitute two major ferroptosis defence systems. Here we show that treatment of cancer cells with GPX4 inhibitors results in acute depletion of N-carbamoyl-l-aspartate, a pyrimidine biosynthesis intermediate, with concomitant accumulation of uridine. Supplementation with dihydroorotate or orotate-the substrate and product of dihydroorotate dehydrogenase (DHODH)-attenuates or potentiates ferroptosis induced by inhibition of GPX4, respectively, and these effects are particularly pronounced in cancer cells with low expression of GPX4 (GPX4(low)). Inactivation of DHODH induces extensive mitochondrial lipid peroxidation and ferroptosis in GPX4(low) cancer cells, and synergizes with ferroptosis inducers to induce these effects in GPX4(high) cancer cells. Mechanistically, DHODH operates in parallel to mitochondrial GPX4 (but independently of cytosolic GPX4 or FSP1) to inhibit ferroptosis in the mitochondrial inner membrane by reducing ubiquinone to ubiquinol (a radical-trapping antioxidant with anti-ferroptosis activity). The DHODH inhibitor brequinar selectively suppresses GPX4(low) tumour growth by inducing ferroptosis, whereas combined treatment with brequinar and sulfasalazine, an FDA-approved drug with ferroptosis-inducing activity, synergistically induces ferroptosis and suppresses GPX4(high) tumour growth. Our results identify a DHODH-mediated ferroptosis defence mechanism in mitochondria and suggest a therapeutic strategy of targeting ferroptosis in cancer treatment.	[Mao, Chao; Liu, Xiaoguang; Zhang, Yilei; Lei, Guang; Yan, Yuelong; Lee, Hyemin; Koppula, Pranavi; Wu, Shiqi; Zhuang, Li; Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Koppula, Pranavi; Gan, Boyi] Univ Texas MD Anderson UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Poyurovsky, Masha V.; Olszewski, Kellen] Kadmon Corp LLC, New York, NY 10016 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gan, BY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.; Gan, BY (corresponding author), Univ Texas MD Anderson UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA.; Olszewski, K (corresponding author), Kadmon Corp LLC, New York, NY 10016 USA.	kellen@kadmon.com; bgan@mdanderson.org	Zhang, Yilei/I-8997-2014; Gan, Boyi/HDM-4206-2022; Koppula, Pranavi/P-7226-2019	Zhang, Yilei/0000-0003-1407-0301; Koppula, Pranavi/0000-0002-7567-1891; Lei, Guang/0000-0002-3282-0666; Gan, Boyi/0000-0001-8884-6040; Yan, Yuelong/0000-0001-8495-6445; LIU, XIAOGUANG/0000-0001-6977-5128; , chao/0000-0002-8685-8539	Institutional Research Fund from The University of Texas MD Anderson Cancer Center; National Institutes of Health [R01CA181196, R01CA190370, R01CA244144, R01CA247992]; University of Texas MD Anderson Cancer Center Moon Shots Program; Specialized Program of Research Excellence (SPORE) [CA070907]; National Institutes of Health Cancer Center Support Grant [P30CA016672]	Institutional Research Fund from The University of Texas MD Anderson Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center Moon Shots Program; Specialized Program of Research Excellence (SPORE); National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We apologize to the colleagues whose relevant work cannot be cited here owing to space limitations. This research was supported by Institutional Research Fund from The University of Texas MD Anderson Cancer Center, and grants R01CA181196, R01CA190370, R01CA244144, R01CA247992 from the National Institutes of Health (to B.G.). PDX generation and annotation were supported by the University of Texas MD Anderson Cancer Center Moon Shots Program, and Specialized Program of Research Excellence (SPORE) grant CA070907. This research was also supported by the National Institutes of Health Cancer Center Support Grant P30CA016672 to The University of Texas MD Anderson Cancer Center.	Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Arai M, 1996, BIOCHEM BIOPH RES CO, V227, P433, DOI 10.1006/bbrc.1996.1525; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Bersuker K, 2019, NATURE, V575, P688, DOI 10.1038/s41586-019-1705-2; Chauhan AS, 2019, FASEB J, V33, P2957, DOI 10.1096/fj.201801225R; Dai FY, 2017, P NATL ACAD SCI USA, V114, P3192, DOI 10.1073/pnas.1619588114; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2019, NATURE, V575, P693, DOI 10.1038/s41586-019-1707-0; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Fang JX, 2013, BIOSCIENCE REP, V33, P217, DOI 10.1042/BSR20120097; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601; Heinrich P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36293-4; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Koppula P, 2021, PROTEIN CELL, V12, P599, DOI 10.1007/s13238-020-00789-5; Koppula P, 2017, J BIOL CHEM, V292, P14240, DOI 10.1074/jbc.M117.798405; Lang XT, 2019, CANCER DISCOV, V9, P1673, DOI 10.1158/2159-8290.CD-19-0338; Lee H, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0461-8; Lee H, 2016, ONCOTARGET, V7, P19134, DOI 10.18632/oncotarget.8102; Lei G, 2020, CELL RES, V30, P146, DOI 10.1038/s41422-019-0263-3; Lin A, 2014, ONCOGENE, V33, P3183, DOI 10.1038/onc.2013.273; Lin AF, 2014, CANCER RES, V74, P1682, DOI 10.1158/0008-5472.CAN-13-1729; Liu XG, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0496-x; Liu XW, 2016, CELL CYCLE, V15, P3471, DOI 10.1080/15384101.2016.1249545; Liu XW, 2016, NAT CELL BIOL, V18, P431, DOI 10.1038/ncb3328; MAROUN J, 1993, CANCER CHEMOTH PHARM, V32, P64, DOI 10.1007/BF00685878; Nagase M, 2018, J CLIN BIOCHEM NUTR, V63, P205, DOI 10.3164/jcbn.17-131; NATALE R, 1992, ANN ONCOL, V3, P659, DOI 10.1093/oxfordjournals.annonc.a058298; PETERS GJ, 1990, CANCER RES, V50, P4644; Prime TA, 2012, FREE RADICAL BIO MED, V53, P544, DOI 10.1016/j.freeradbiomed.2012.05.033; Shimada K, 2016, NAT CHEM BIOL, V12, P497, DOI [10.1038/NCHEMBIO.2079, 10.1038/nchembio.2079]; Soula M, 2020, NAT CHEM BIOL, V16, P1351, DOI 10.1038/s41589-020-0613-y; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Trnka J, 2008, FREE RADICAL BIO MED, V44, P1406, DOI 10.1016/j.freeradbiomed.2007.12.036; URBA S, 1992, CANCER CHEMOTH PHARM, V31, P167, DOI 10.1007/BF00685106; Vasan K, 2020, CELL METAB, V32, P341, DOI 10.1016/j.cmet.2020.06.019; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Ye LF, 2020, ACS CHEM BIOL, V15, P469, DOI 10.1021/acschembio.9b00939; Zhang Y, 2019, CELL CHEM BIOL, V26, P623, DOI 10.1016/j.chembiol.2019.01.008; Zhang YL, 2020, CANCER RES, V80, P2243, DOI 10.1158/0008-5472.CAN-19-3580; Zhang YL, 2019, CELL CYCLE, V18, P773, DOI 10.1080/15384101.2019.1597506; Zhang YL, 2018, NAT CELL BIOL, V20, P1181, DOI 10.1038/s41556-018-0178-0; Zou Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09277-9	47	220	225	123	442	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					586	+		10.1038/s41586-021-03539-7	http://dx.doi.org/10.1038/s41586-021-03539-7		MAY 2021	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SS9XG	33981038	Green Accepted			2022-12-28	WOS:000650200300009
J	Rodriguez-Hernandez, M; Pilato, TC; Yerdon, KA; Kysel, IM; Taki, F; Yale-Loehr, S; Kaur, G; Burke, AE; Koscal, N				Rodriguez-Hernandez, Merlys; Pilato, Tara C.; Yerdon, Kayleigh A.; Kysel, Ian M.; Taki, Faten; Yale-Loehr, Stephen; Kaur, Gunisha; Burke, Alison E.; Koscal, Natalie			Detained	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pilato, Tara C.] Weill Cornell Med Coll, New York, NY USA; [Taki, Faten; Kaur, Gunisha] Weill Cornell Med, Dept Anesthesiol, New York, NY USA; [Yerdon, Kayleigh A.; Kysel, Ian M.; Yale-Loehr, Stephen] Cornell Law Sch, Ithaca, NY USA	Cornell University; Cornell University; Cornell University									0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					1785	1787		10.1056/NEJMp2032690	http://dx.doi.org/10.1056/NEJMp2032690		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD6UF	33983690				2022-12-28	WOS:000649040900001
J	Limb, M				Limb, Matthew			Covid-19: Early stage cancer diagnoses fell by third in first lockdown	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Cancer Registration and Analysis Service, 19 RAP CANC REG TREA	1	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2021	373								n1179	10.1136/bmj.n1179	http://dx.doi.org/10.1136/bmj.n1179			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QT	33962972	Bronze			2022-12-28	WOS:000649708700001
J	Cheng, YF; Ma, N; Witt, C; Rapp, S; Wild, PS; Andreae, MO; Poschl, U; Su, H				Cheng, Yafang; Ma, Nan; Witt, Christian; Rapp, Steffen; Wild, Philipp S.; Andreae, Meinrat O.; Poschl, Ulrich; Su, Hang			Face masks effectively limit the probability of SARS-CoV-2 transmission	SCIENCE			English	Article							SURFACE CONTAMINATION; AIRBORNE TRANSMISSION; SURGICAL MASK; INFECTION; AEROSOL; MODEL; AIR	Y Airborne transmission by droplets and aerosols is important for the spread of viruses. Face masks are a well-established preventive measure, but their effectiveness for mitigating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is still under debate. We show that variations in mask efficacy can be explained by different regimes of virus abundance and are related to population-average infection probability and reproduction number. For SARS-CoV-2, the viral load of infectious individuals can vary by orders of magnitude. We find that most environments and contacts are under conditions of low virus abundance (virus-limited), where surgical masks are effective at preventing virus spread. More-advanced masks and other protective equipment are required in potentially virus-rich indoor environments, including medical centers and hospitals. Masks are particularly effective in combination with other preventive measures like ventilation and distancing.	[Cheng, Yafang; Andreae, Meinrat O.; Poschl, Ulrich; Su, Hang] Max Planck Inst Chem, D-55128 Mainz, Germany; [Ma, Nan] Jinan Univ, Inst Environm & Climate Res, Guangzhou 511443, Guangdong, Peoples R China; [Witt, Christian] Charite Univ Med Berlin, Dept Outpatient Pneumol, Campus Charite Mitte, D-10117 Berlin, Germany; [Witt, Christian] Charite Univ Med Berlin, Inst Physiol, Campus Charite Mitte, D-10117 Berlin, Germany; [Rapp, Steffen; Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55131 Mainz, Germany; [Andreae, Meinrat O.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Andreae, Meinrat O.] King Saud Univ, Dept Geol & Geophys, Riyadh 11451, Saudi Arabia; [Su, Hang] Shanghai Acad Environm Sci, State Environm Protect Key Lab Format & Prevent U, Shanghai 200233, Peoples R China	Max Planck Society; Jinan University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz; University of California System; University of California San Diego; Scripps Institution of Oceanography; King Saud University	Cheng, YF; Su, H (corresponding author), Max Planck Inst Chem, D-55128 Mainz, Germany.	yafang.cheng@mpic.de; h.su@mpic.de	Cheng, Yafang/F-9362-2010; Andreae, Meinrat O./B-1068-2008; Pöschl, Ulrich/A-6263-2010; Su, Hang/A-6226-2010	Cheng, Yafang/0000-0003-4912-9879; Andreae, Meinrat O./0000-0003-1968-7925; Pöschl, Ulrich/0000-0003-1412-3557; Su, Hang/0000-0003-4889-1669; Wild, Philipp/0000-0003-4413-9752	Max Planck Society (MPG)	Max Planck Society (MPG)(Max Planck Society)	The authors would like to thank the reviewers for their very helpful feedback. This study was supported by the Max Planck Society (MPG).	Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Bake B, 2019, RESP RES, V20, DOI 10.1186/s12931-019-0970-9; Bourouiba L, 2020, JAMA-J AM MED ASSOC, V323, P1837, DOI 10.1001/jama.2020.4756; Brooks JT, 2020, JAMA-J AM MED ASSOC, V324, P635, DOI 10.1001/jama.2020.13107; Bundgaard H, 2021, ANN INTERN MED, V174, P335, DOI 10.7326/M20-6817; Burrows SM, 2014, ATMOS CHEM PHYS, V14, P13601, DOI 10.5194/acp-14-13601-2014; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Chia PY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16670-2; Chu DK., 2020, LANCET, V395, P1973, DOI [DOI 10.1111/irv.12369, DOI 10.1016/S0140-6736(20)31142-9]; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; Grinshpun SA, 2009, J OCCUP ENVIRON HYG, V6, P593, DOI 10.1080/15459620903120086; Haas CN, 2014, QUANTITATIVE MICROBIAL RISK ASSESSMENT, 2ND EDITION, P1, DOI 10.1002/9781118910030; Holmgren H, 2010, J AEROSOL SCI, V41, P439, DOI 10.1016/j.jaerosci.2010.02.011; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Jacot D, 2020, MICROBES INFECT, V22, P617, DOI 10.1016/j.micinf.2020.08.004; Johansson MA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35057; Lednicky JA, 2020, AEROSOL AIR QUAL RES, V20, P1167, DOI [10.4209/aaqr.2020.05.0202, 10.4209/aaqr.2020.02.0202]; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Oberg T, 2008, AM J INFECT CONTROL, V36, P276, DOI 10.1016/j.ajic.2007.07.008; Prather KA, 2020, SCIENCE, V370, P303, DOI 10.1126/science.abf0521; Rasmussen AL, 2020, NEW ENGL J MED, V383, P2092, DOI 10.1056/NEJMc2030886; Roberts A, 2005, J VIROL, V79, P503, DOI 10.1128/JVI.79.1.503-511.2005; Santarpia JL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69286-3; Su H., 2021, FACE MASKS EFFECTIVE, DOI [10.17617/3.5d, DOI 10.17617/3.5D]; van den Driessche P, 2008, LECT NOTES MATH, V1945, P159; Watanabe T, 2010, RISK ANAL, V30, P1129, DOI 10.1111/j.1539-6924.2010.01427.x; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001; Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117	31	88	88	23	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2021	372	6549					1439	+		10.1126/science.abg6296	http://dx.doi.org/10.1126/science.abg6296			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SY4KW	34016743	Green Published, Green Submitted			2022-12-28	WOS:000665860000047
J	Flynn, RA; Pedram, K; Malaker, SA; Batista, PJ; Smith, BAH; Johnson, AG; George, BM; Majzoub, K; Villalta, PW; Carette, JE; Bertozzi, CR				Flynn, Ryan A.; Pedram, Kayvon; Malaker, Stacy A.; Batista, Pedro J.; Smith, Benjamin A. H.; Johnson, Alex G.; George, Benson M.; Majzoub, Karim; Villalta, Peter W.; Carette, Jan E.; Bertozzi, Carolyn R.			Small RNAs are modified with N-glycans and displayed on the surface of living cells	CELL			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SIALIC-ACID; Y RNAS; GLYCOSYLATION; EXPRESSION; ANTIBODIES; SIGLECS; BINDING; DSRNA; AUTOANTIBODIES	Glycans modify lipids and proteins to mediate inter- and intramolecular interactions across all domains of life. RNA is not thought to be a major target of glycosylation. Here, we challenge this view with evidence that mammals use RNA as a third scaffold for glycosylation. Using a battery of chemical and biochemical approaches, we found that conserved small noncoding RNAs bear sialylated glycans. These "glycoRNAs'' were present in multiple cell types and mammalian species, in cultured cells, and in vivo. GlycoRNA assembly depends on canonical N-glycan biosynthetic machinery and results in structures enriched in sialic acid and fucose. Analysis of living cells revealed that the majority of glycoRNAs were present on the cell surface and can interact with anti-dsRNA antibodies and members of the Siglec receptor family. Collectively, these findings suggest the existence of a direct interface between RNA biology and glycobiology, and an expanded role for RNA in extracellular biology.	[Flynn, Ryan A.; Pedram, Kayvon; Malaker, Stacy A.; Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Batista, Pedro J.] NCI, Lab Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Smith, Benjamin A. H.] Stanford Univ, Dept Chem & Syst Biol & ChEM H, Stanford, CA USA; [Johnson, Alex G.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA USA; [George, Benson M.] Stanford Univ, Dept Canc Biol, Stanford, CA USA; [Majzoub, Karim; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Majzoub, Karim] Univ Montpellier, CNRS, IGMM, Montpellier, France; [Villalta, Peter W.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Villalta, Peter W.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Bertozzi, Carolyn R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Flynn, Ryan A.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Flynn, Ryan A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; Stanford University; Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; Stanford University; Harvard University; Boston Children's Hospital; Harvard University	Flynn, RA; Bertozzi, CR (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Bertozzi, CR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Flynn, RA (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.; Flynn, RA (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	ryan.flynn@childrens.harvard.edu; bertozzi@stanford.edu		Carette, Jan/0000-0002-5187-8070; Majzoub, Karim/0000-0001-7345-6840; Smith, Benjamin/0000-0001-8802-416X; Malaker, Stacy/0000-0003-2382-5067; Batista, Pedro/0000-0003-1055-2354; Johnson, Alexander/0000-0002-4040-9797; Flynn, Ryan/0000-0001-5013-0442; Villalta, Peter/0000-0002-0067-3083	NIH S10 Shared Instrument Grants [S10RR025518-01, 1S10OD026831-01]; NCI [P30CA077598]; Damon Runyon Cancer Research Foundation [DRG-2286-17]; Burroughs Wellcome Fund Career Award for Medical Scientists; NIH [R01 CA200423-17, R01 AI141970]; Stanford Medical Scientist Training Program; NIH F30 Predoctoral Fellowship [F30CA232541]; National Institute of General Medical Sciences F32 Postdoctoral Fellowship [F32-GM126663-01]; National Science Foundation Graduate Research Fellowship (NSF GRF) [DGE-114747]; NSF-GRF/Stanford Graduate Fellowship/Stanford ChEM-H Chemistry/Biology Interface Predoctoral Training Program; Intramural Research Program of the NIH, National Cancer Institute; Center for Cancer Research of the United States of America	NIH S10 Shared Instrument Grants; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Medical Scientist Training Program; NIH F30 Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences F32 Postdoctoral Fellowship; National Science Foundation Graduate Research Fellowship (NSF GRF)(National Science Foundation (NSF)); NSF-GRF/Stanford Graduate Fellowship/Stanford ChEM-H Chemistry/Biology Interface Predoctoral Training Program; Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research of the United States of America	We thank Phillip Sharp, Robert Spitale, Eliezer Calo, Steven Banik, and the Bertozzi Group members for critical discussion. We also thank Hannah Long, Ulla Gerling-Driessen, and Cheen Ang for help with human ES cell culture, Caitlyn Miller for synthesis of 9Az sialic acid, Dean Felsher for the TALL 4188 cells, Melissa Gray for expression and purification of VC-Sialidase, Sam Wattrus for help with confocal imaging, and Edgar Henriquez for help doing the cell sorting and FACS analysis. Cell sorting and FACS analysis was performed on an instrument in the Shared FACS Facility obtained using NIH S10 Shared Instrument Grants S10RR025518-01 and 1S10OD026831-01. Mass spectrometry was performed in the Analytical Biochemistry Shared Resource, Masonic Cancer Center, University of Minnesota, supported in part by NCI (P30CA077598). This work utilized the computational resources of the NIH HPC Biowulf cluster (https://hpc.nih.gov/).This work was supported by grants from Damon Runyon Cancer Research Foundation (DRG-2286-17 to R.A.F.), Burroughs Wellcome Fund Career Award for Medical Scientists (to R.A.F.), NIH (R01 CA200423-17 to C.R.B. and R01 AI141970 to J.E.C.), Stanford Medical Scientist Training Program and NIH F30 Predoctoral Fellowship (F30CA232541 to B.A.H.S), National Institute of General Medical Sciences F32 Postdoctoral Fellowship (F32-GM126663-01 to S.A.M.), National Science Foundation Graduate Research Fellowship (NSF GRF) (DGE-114747 to A.G.J.), and NSF-GRF/Stanford Graduate Fellowship/Stanford ChEM-H Chemistry/Biology Interface Predoctoral Training Program (to K.P.). P.J.B. is supported by the Intramural Research Program of the NIH, National Cancer Institute, and Center for Cancer Research of the United States of America.	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; Ahlin E, 2012, LUPUS, V21, P586, DOI 10.1177/0961203311434938; Aizawa S, 2016, AUTOPHAGY, V12, P565, DOI 10.1080/15548627.2016.1145325; Angata T, 2014, GLYCOBIOLOGY, V24, P785, DOI 10.1093/glycob/cwu043; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bar DZ, 2018, NAT METHODS, V15, P127, DOI 10.1038/nmeth.4533; Barkal AA, 2019, NATURE, V572, P392, DOI 10.1038/s41586-019-1456-0; Beckmann BM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10127; BLANCO F, 1991, CLIN EXP IMMUNOL, V86, P66; Boccitto M, 2019, CRIT REV BIOCHEM MOL, V54, P133, DOI 10.1080/10409238.2019.1608902; Bond MR, 2011, BIOCONJUGATE CHEM, V22, P1811, DOI 10.1021/bc2002117; Bonin M, 2000, RNA, V6, P563, DOI 10.1017/S1355838200992318; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chang PV, 2009, ANGEW CHEM INT EDIT, V48, P4030, DOI 10.1002/anie.200806319; Chang YC, 2020, ADV EXP MED BIOL, V1204, P197, DOI 10.1007/978-981-15-1580-4_8; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Christov CP, 2006, MOL CELL BIOL, V26, P6993, DOI 10.1128/MCB.01060-06; Cummings R.D., 2015, ESSENTIALS GLYCOBIOL, P435; Duan ST, 2020, ANNU REV IMMUNOL, V38, P365, DOI 10.1146/annurev-immunol-102419-035900; Duffy Erin E, 2016, Curr Protoc Chem Biol, V8, P234, DOI 10.1002/cpch.12; Eakin AJ, 2016, PROTEOM CLIN APPL, V10, P635, DOI 10.1002/prca.201500069; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Fazal FM, 2019, CELL, V178, P473, DOI 10.1016/j.cell.2019.05.027; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Flores R, 2019, CELL MOL IMMUNOL, V16, P154, DOI 10.1038/cmi.2017.160; Flynn RA, 2016, NAT PROTOC, V11, P273, DOI 10.1038/nprot.2016.011; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Fraschilla I, 2017, IMMUNOL REV, V276, P178, DOI 10.1111/imr.12526; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Gagnon KT, 2014, NAT PROTOC, V9, P2045, DOI 10.1038/nprot.2014.135; GAHMBERG CG, 1982, EUR J BIOCHEM, V122, P581; Gao C, 2019, CELL CHEM BIOL, V26, P535, DOI 10.1016/j.chembiol.2019.01.002; Gardiner TJ, 2009, RNA, V15, P1375, DOI 10.1261/rna.1472009; GOLAN TD, 1992, J CLIN INVEST, V90, P1067, DOI 10.1172/JCI115922; Gray M., 2019, TARGETED DESIALYLATI, DOI [10. 26434/chemrxiv.8187146, DOI 10.26434/CHEMRXIV.8187146]; Gray MA, 2020, NAT CHEM BIOL, V16, P1376, DOI 10.1038/s41589-020-0622-x; Han JH, 2014, EUR J IMMUNOL, V44, P215, DOI 10.1002/eji.201343714; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Huang N, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02145-6; Hudak JE, 2014, NAT CHEM BIOL, V10, P69, DOI [10.1038/NCHEMBIO.1388, 10.1038/nchembio.1388]; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jandus C, 2014, J CLIN INVEST, V124, P1810, DOI 10.1172/JCI65899; KASAI H, 1976, J AM CHEM SOC, V98, P5044, DOI 10.1021/ja00432a071; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Koczera P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081278; Kohn M, 2013, BIOMOLECULES, V3, P143, DOI 10.3390/biom3010143; KOSA RE, 1993, BIOCHEM BIOPH RES CO, V190, P914, DOI 10.1006/bbrc.1993.1136; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; Kowalski MP, 2015, INT J BIOCHEM CELL B, V66, P20, DOI 10.1016/j.biocel.2015.07.003; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Laubli H, 2014, J BIOL CHEM, V289, P33481, DOI 10.1074/jbc.M114.593129; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Malaker SA, 2019, P NATL ACAD SCI USA, V116, P7278, DOI 10.1073/pnas.1813020116; Manya H, 2016, J BIOL CHEM, V291, P24618, DOI 10.1074/jbc.M116.751917; Marchand V, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010013; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Mateer E, 2019, JOVE-J VIS EXP, DOI 10.3791/59095; McConkey E.H., 1967, METHODS ENZYMOLOGY A, V12, P620; Mockl L, 2019, DEV CELL, V50, P57, DOI 10.1016/j.devcel.2019.04.035; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Muller J, 2015, J IMMUNOL, V195, P51, DOI 10.4049/jimmunol.1403139; Nachtergaele S., 2017, RNA BIOL, V14, P156, DOI [DOI 10.2135/cropsci2007.04.0191, DOI 10.1080/15476286.2016.1267096]; Nguyen TA, 2019, J IMMUNOL, V202, P3483, DOI 10.4049/jimmunol.1801369; OKADA N, 1977, NUCLEIC ACIDS RES, V4, P415, DOI 10.1093/nar/4.2.415; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Qin W, 2018, ANGEW CHEM INT EDIT, V57, P1817, DOI 10.1002/anie.201711710; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reily C, 2019, NAT REV NEPHROL, V15, P346, DOI 10.1038/s41581-019-0129-4; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Schumann B., 2019, CHEM PRECISION GLYCO, DOI [10.1101/669861, DOI 10.1101/669861]; Schumann B, 2020, MOL CELL, V78, P824, DOI 10.1016/j.molcel.2020.03.030; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Sorrentino S, 2010, FEBS LETT, V584, P2194, DOI 10.1016/j.febslet.2010.04.018; Stanczak MA, 2018, J CLIN INVEST, V128, P4912, DOI 10.1172/JCI120612; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Thornhill SI, 2017, RHEUMATOLOGY, V56, P1025, DOI 10.1093/rheumatology/kew498; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willer T, 2014, ELIFE, V3, DOI 10.7554/eLife.03941; Woo CM, 2015, NAT METHODS, V12, P561, DOI 10.1038/nmeth.3366; Xiao H, 2016, P NATL ACAD SCI USA, V113, P10304, DOI 10.1073/pnas.1608069113; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]; Zhou Y, 2019, ANGEW CHEM INT EDIT, V58, P11763, DOI 10.1002/anie.201905949	103	121	124	74	241	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3109	+	e22	10.1016/j.cell.2021.04.023	http://dx.doi.org/10.1016/j.cell.2021.04.023		JUN 2021	38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	34004145	Bronze, Green Accepted			2022-12-28	WOS:000660014300006
J	Guttman-Yassky, E; Teixeira, HD; Simpson, EL; Papp, KA; Pangan, AL; Blauvelt, A; Thaci, D; Chu, CY; Hong, HCH; Katoh, N; Paller, AS; Calimlim, B; Gu, YH; Hu, XF; Liu, M; Yang, Y; Liu, J; Tenorio, AR; Chu, AD; Irvine, AD				Guttman-Yassky, Emma; Teixeira, Henrique D.; Simpson, Eric L.; Papp, Kim A.; Pangan, Aileen L.; Blauvelt, Andrew; Thaci, Diamant; Chu, Chia-Yu; Hong, H. Chih-Ho; Katoh, Norito; Paller, Amy S.; Calimlim, Brian; Gu, Yihua; Hu, Xiaofei; Liu, Meng; Yang, Yang; Liu, John; Tenorio, Allan R.; Chu, Alvina D.; Irvine, Alan D.			Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double- blind, randomised controlled phase 3 trials	LANCET			English	Article							BURDEN	Background Upadacitinib is an oral Janus kinase (JAK) inhibitor with greater inhibitory potency for JAK1 than JAK2, JAK3, and tyrosine kinase 2. We aimed to assess the efficacy and safety of upadacitinib compared with placebo for the treatment of moderate-to-severe atopic dermatitis. Methods Measure Up 1 and Measure Up 2 were replicate multicentre, randomised, double-blind, placebo-controlled, phase 3 trials; Measure Up 1 was done at 151 clinical centres in 24 countries across Europe, North and South America, Oceania, and the Asia-Pacific region; and Measure Up 2 was done at 154 clinical centres in 23 countries across Europe, North America, Oceania, and the Asia-Pacific region. Eligible patients were adolescents (aged 12-17 years) and adults (aged 18-75 years) with moderate-to-severe atopic dermatitis (>= 10% of body surface area affected by atopic dermatitis, Eczema Area and Severity Index [EASI] score of >= 16, validated Investigator's Global Assessment for Atopic Dermatitis [vIGA-AD] score of >= 3, and Worst Pruritus Numerical Rating Scale score of >= 4). Patients were randomly assigned (1:1:1) using an interactive response technology system to receive upadacitinib 15 mg, upadacitinib 30 mg, or placebo once daily for 16 weeks, stratified by baseline disease severity, geographical region, and age. Coprimary endpoints were the proportion of patients who had achieved at least a 75% improvement in EASI score from baseline (EASI-75) and the proportion of patients who had achieved a vIGA-AD response (defined as a vIGA-AD score of 0 [clear] or 1 [almost clear] with >= 2 grades of reduction from baseline) at week 16. Efficacy was analysed in the intention-to-treat population and safety was analysed in all randomly assigned patients who received at least one dose of study drug. These trials are registered with ClinicalTrials.gov, NCT03569293 (Measure Up 1) and NCT03607422 (Measure Up 2), and are both active but not recruiting. Findings Between Aug 13, 2018, and Dec 23, 2019, 847 patients were randomly assigned to upadacitinib 15 mg (n=281), upadacitinib 30 mg (n=285), or placebo (n=281) in the Measure Up 1 study. Between July 27, 2018, and Jan 17, 2020, 836 patients were randomly assigned to upadacitinib 15 mg (n=276), upadacitinib 30 mg (n=282), or placebo ( n=278) in the Measure Up 2 study. At week 16, the coprimary endpoints were met in both studies (all p< 0.0001). The proportion of patients who had achieved EASI-75 at week 16 was significantly higher in the upadacitinib 15 mg (196 [70%] of 281 patients) and upadacitinib 30 mg (227 [80%] of 285 patients) groups than the placebo group (46 [16%] of 281 patients) in Measure Up 1 (adjusted difference in EASI-75 response rate vs placebo, 53.3% [95% CI 46.4-60.2] for the upadacitinib 15 mg group; 63.4% [57.1-69.8] for the upadacitinib 30 mg group) and Measure Up 2 (166 [60%] of 276 patients in the upadacitinib 15 mg group and 206 [73%] of 282 patients in the upadacitinib 30 mg group vs 37 [13%] of 278 patients in the placebo group; adjusted difference in EASI-75 response rate vs placebo, 46.9% [39.9-53. 9] for the upadacitinib 15 mg group; 59.6% [53.1-66.2] for the upadacitinib 30 mg group). The proportion of patients who achieved a vIGA-AD response at week 16 was significantly higher in the upadacitinib 15 mg (135 [48%] patients) and upadacitinib 30 mg ( 177 [62%] patients) groups than the placebo group (24 [8%] patients) in Measure Up 1 (adjusted difference in vIGA- AD response rate vs placebo, 39.8% [33.2-46.4] for the upadacitinib 15 mg group; 53.6% [47.2-60.0] for the upadacitinib 30 mg group) and Measure Up 2 (107 [39%] patients in the upadacitinib 15 mg group and 147 [52%] patients in the upadacitinib 30 mg group vs 13 [5%] patients in the placebo group; adjusted difference in vIGA-AD response rate vs placebo, 34.0% [27.8-40.2] for the upadacitinib 15 mg group; 47.4% [41.0-53.7] for the upadacitinib 30 mg group). Both upadacitinib doses were well tolerated. The incidence of serious adverse events and adverse events leading to study drug discontinuation were similar among groups. The most frequently reported treatment-emergent adverse events were acne (19 [7%] of 281 patients in the upadacitinib 15 mg group, 49 [17%] of 285 patients in the upadacitinib 30 mg group, and six [2%] of 281 patients in the placebo group in Measure Up 1; 35 [13%] of 276 patients in the upadacitinib 15 mg group, 41 [15%] of 282 patients in the upadacitinib 30 mg group, and six [2%] of 278 patients in the placebo group in Measure Up 2), upper respiratory tract infection (25 [9%] patients, 38 [13%] patients, and 20 [7%] patients; 19 [7%] patients, 17 [16%] patients, and 12 [4%] patients), nasopharyngitis (22 [8%] patients, 33 [12%] patients, and 16 [6%] patients; 16 [6%] patients, 18 [6%] patients, and 13 [5%] patients), headache (14 [5%] patients, 19 [7%] patients, and 12 [ 4%] patients; 18 [7%] patients, 20 [7%] patients, and 11 [4%] patients), elevation in creatine phosphokinase levels (16 [6%] patients, 16 [6%] patients, and seven [3%] patients; nine [3%] patients, 12 [4%] patients, and five [2%] patients), and atopic dermatitis (nine [3%] patients, four [1%] patients, and 26 [9%] patients; eight [3%] patients, four [1%] patients, and 26 [9%] patients). Interpretation Monotherapy with upadacitinib might be an effective treatment option and had a positive benefit-risk profile in adolescents and adults with moderate-to-severe atopic dermatitis. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Guttman-Yassky, Emma] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Guttman-Yassky, Emma] Icahn Sch Med Mt Sinai, Lab Inflammatory Skin Dis, New York, NY 10029 USA; [Teixeira, Henrique D.; Pangan, Aileen L.; Calimlim, Brian; Gu, Yihua; Hu, Xiaofei; Liu, Meng; Yang, Yang; Liu, John; Tenorio, Allan R.; Chu, Alvina D.] AbbVie, N Chicago, IL 60064 USA; [Simpson, Eric L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Papp, Kim A.; Hong, H. Chih-Ho] Prob Med Res, Waterloo, ON, Canada; [Papp, Kim A.] K Papp Clin Res, Waterloo, ON, Canada; [Blauvelt, Andrew] Oregon Med Res Ctr, Portland, OR USA; [Thaci, Diamant] Univ Lubeck, Comprehens Ctr Inflammat Med, Lubeck, Germany; [Chu, Chia-Yu] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Chu, Chia-Yu] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Hong, H. Chih-Ho] Dr Chih Ho Hong Med, Surrey, BC, Canada; [Hong, H. Chih-Ho] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada; [Katoh, Norito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kyoto, Japan; [Paller, Amy S.] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Irvine, Alan D.] Univ Dublin, Trinity Coll Dublin, Med Clin, Dublin, Ireland; [Irvine, Alan D.] St James Hosp, Wellcome HRB Clin Res Facil, Dublin, Ireland	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; AbbVie; Oregon Health & Science University; University of Lubeck; National Taiwan University; National Taiwan University Hospital; National Taiwan University; University of British Columbia; Kyoto Prefectural University of Medicine; Northwestern University; Feinberg School of Medicine; Trinity College Dublin; Trinity College Dublin	Irvine, AD (corresponding author), Univ Dublin, Trinity Coll Dublin, Med Clin, Dublin 2, Ireland.	irvinea@tcd.ie	Thaci, Diamant/AAE-7310-2022; Irvine, Alan D/A-3982-2008	Irvine, Alan D/0000-0002-9048-2044; CHU, CHIA-YU/0000-0002-9370-3279	AbbVie	AbbVie(AbbVie)	AbbVie.	AbbVie, 2019, RINVOQ UPD EXT REL T; Andersen YMF, 2017, J AM ACAD DERMATOL, V76, P274, DOI 10.1016/j.jaad.2016.08.047; Cork MJ, 2020, J DERMATOL TREAT, V31, P801, DOI 10.1080/09546634.2019.1655137; Damsky W, 2017, J AM ACAD DERMATOL, V76, P736, DOI 10.1016/j.jaad.2016.12.005; Drucker AM, 2017, ALLERGY ASTHMA PROC, V38, P3, DOI 10.2500/aap.2017.38.4005; Feldman SR, 2006, CLIN DERMATOL, V24, P229, DOI 10.1016/j.clindermatol.2005.09.003; Ferreira S, 2020, AM J CLIN DERMATOL, V21, P783, DOI 10.1007/s40257-020-00548-6; Gerdes S, 2020, J DERMATOL TREAT, V31, P470, DOI 10.1080/09546634.2020.1746734; Gooderham MJ, 2019, JAMA DERMATOL, V155, P1371, DOI 10.1001/jamadermatol.2019.2855; Guttman-Yassky E, 2020, J ALLERGY CLIN IMMUN, V145, P877, DOI 10.1016/j.jaci.2019.11.025; Guttman-Yassky E, 2019, J AM ACAD DERMATOL, V80, P913, DOI 10.1016/j.jaad.2018.01.018; Harrington R, 2020, J INFLAMM RES, V13, P519, DOI 10.2147/JIR.S219586; Hengge UR, 2006, J AM ACAD DERMATOL, V54, P1, DOI 10.1016/j.jaad.2005.01.010; Howell MD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02342; Kaufman BP, 2018, EXP DERMATOL, V27, P340, DOI 10.1111/exd.13514; Langan SM, 2020, LANCET, V396, P345, DOI 10.1016/S0140-6736(20)31286-1; Nader A, 2020, J CLIN PHARMACOL, V60, P528, DOI 10.1002/jcph.1550; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Phan K, 2021, J DERMATOL TREAT, V32, P345, DOI 10.1080/09546634.2019.1657224; Reich K, 2021, LANCET, V397, P2169, DOI 10.1016/S0140-6736(21)00589-4; Retzler J, 2019, QUAL LIFE RES, V28, P2373, DOI 10.1007/s11136-019-02174-0; Ronnstad ATM, 2018, J AM ACAD DERMATOL, V79, P448, DOI 10.1016/j.jaad.2018.03.017; Schmitt J, 2016, J ALLERGY CLIN IMMUN, V137, P130, DOI 10.1016/j.jaci.2015.06.029; Shreberk-Hassidim Rony, 2017, J Am Acad Dermatol, V76, P745, DOI 10.1016/j.jaad.2016.12.004; Silverberg JI, 2021, BRIT J DERMATOL, V184, P888, DOI 10.1111/bjd.19457; Silverberg JI, 2020, JAMA DERMATOL, V156, P863, DOI 10.1001/jamadermatol.2020.1406; Silverberg JI, 2017, DERMATOL CLIN, V35, P283, DOI 10.1016/j.det.2017.02.002; Simpson EL, 2020, BRIT J DERMATOL, V183, P242, DOI 10.1111/bjd.18898; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Simpson E, 2020, J AM ACAD DERMATOL, V83, P839, DOI 10.1016/j.jaad.2020.04.104; Simpson EL, 2020, LANCET, V396, P255, DOI 10.1016/S0140-6736(20)30732-7; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wollenberg A, 2003, J AM ACAD DERMATOL, V49, P198, DOI 10.1067/S0190-9622(03)00896-X	34	76	78	2	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2021	397	10290					2151	2168		10.1016/S0140-6736(21)00588-2	http://dx.doi.org/10.1016/S0140-6736(21)00588-2		JUN 2021	18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SM8DI	34023008				2022-12-28	WOS:000657828600022
J	Christoffersen, M; Tybjaerg-Hansen, A				Christoffersen, Mette; Tybjaerg-Hansen, Anne			Targeting IL-6 in patients at high cardiovascular risk	LANCET			English	Editorial Material							HEMODIALYSIS; MORTALITY		[Christoffersen, Mette; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Mol Genet Sect, DK-2100 Copenhagen, Denmark; [Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Tybjaerg-Hansen, A (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Mol Genet Sect, DK-2100 Copenhagen, Denmark.; Tybjaerg-Hansen, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark.	anne.tybjaerg.hansen@regionh.dk	Christoffersen, Mette/AFE-8953-2022					Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Cai TX, 2018, JAMA CARDIOL, V3, P849, DOI 10.1001/jamacardio.2018.2287; Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105; Kronenberg F, 2014, CLIN EXP NEPHROL, V18, P234, DOI 10.1007/s10157-013-0875-8; O'Donoghue ML, 2019, CIRCULATION, V139, P1483, DOI 10.1161/CIRCULATIONAHA.118.037184; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2021, LANCET, V397, P2060, DOI 10.1016/S0140-6736(21)00520-1; Ridker PM, 2019, CIRC RES, V124, P437, DOI 10.1161/CIRCRESAHA.118.313129; Spoto B, 2015, CLIN J AM SOC NEPHRO, V10, P232, DOI 10.2215/CJN.07000714; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9	10	3	3	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 29	2021	397	10289					2025	2027		10.1016/S0140-6736(21)00985-5	http://dx.doi.org/10.1016/S0140-6736(21)00985-5		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SK5LX	34015339				2022-12-28	WOS:000656257800003
J	Shen, H; Yang, M; Li, SY; Zhang, J; Peng, B; Wang, CH; Chang, Z; Ong, JN; Du, P				Shen, Hui; Yang, Min; Li, Shiyu; Zhang, Jing; Peng, Bing; Wang, Chunhui; Chang, Zai; Ong, Jennie; Du, Peng			Mouse totipotent stem cells captured and maintained through spliceosomal repression	CELL			English	Article							U1 SNRNP; GENE-EXPRESSION; R-PACKAGE; DERIVATION; ESTABLISHMENT; PRINCIPLES; LANDSCAPE; ALIGNER	Since establishment of the first embryonic stem cells (ESCs), in vitro culture of totipotent cells functionally and molecularly comparable with in vivo blastomeres with embryonic and extraembryonic developmental potential has been a challenge. Here we report that spliceosomal repression in mouse ESCs drives a pluripotent-to-totipotent state transition. Using the splicing inhibitor pladienolide B, we achieve stable in vitro culture of totipotent ESCs comparable at molecular levels with 2- and 4-cell blastomeres, which we call totipotent blastomere-like cells (TBLCs). Mouse chimeric assays combined with single-cell RNA sequencing (scRNA-seq) demonstrate that TBLCs have a robust bidirectional developmental capability to generate multiple embryonic and extraembryonic cell lineages. Mechanically, spliceosomal repression causes widespread splicing inhibition of pluripotent genes, whereas totipotent genes, which contain few short introns, are efficiently spliced and transcriptionally activated. Our study provides a means for capturing and maintaining totipotent stem cells.	[Shen, Hui; Yang, Min; Li, Shiyu; Peng, Bing; Wang, Chunhui; Ong, Jennie; Du, Peng] Peking Univ, Sch Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Shen, Hui; Li, Shiyu; Peng, Bing; Ong, Jennie; Du, Peng] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Zhang, Jing; Chang, Zai] Tsinghua Univ, Sch Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Tsinghua University	Du, P (corresponding author), Peking Univ, Sch Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China.; Du, P (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	pengdu@pku.edu.cn		Yang, Min/0000-0002-1471-3330; Shen, Hui/0000-0003-3219-0008	National Key Research and Development Program of China [2019YFA0110000]	National Key Research and Development Program of China	We thank Drs. Frederick Alt (Harvard Medical School/Boston Children's Hospital), Robert Blelloch (University of California, San Francisco), Austin Smith (University of Cambridge), Wei Li (Institute of Zoology, Chinese Academy of Sciences), and Yangming Wang (Peking University) for kindly providing mouse TC1 ESCs, mouse ESCs with mCherry-pri-miR-290, mouse ESCs with Rex1-GFP, and mouse C57 ESCs with GFP and OCT4-GFP, respectively. We thank the flow cytometry core at the National Center for Protein Sciences at Peking University for technical help and the Core Facilities of Life Sciences, Peking University, for assistance with confocal microscopy and 10x Genomics SC Chromium. We are grateful to the Imaging Core Facility, the State Key Laboratory of Membrane Biology, and the Technology Center for Protein Sciences at Tsinghua University for assistance with confocal microscopy. We appreciate the support from Beijing Vitalstar Biotechnology regarding mouse embryo microinjection and transplantation. This work was supported by a grant from the National Key Research and Development Program of China (2019YFA0110000 to P.D.).	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Baker CL, 2018, CELL STEM CELL, V22, P25, DOI 10.1016/j.stem.2017.12.011; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boroviak T, 2017, DEVELOPMENT, V144, P175, DOI 10.1242/dev.145177; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Choi YJ, 2017, SCIENCE, V355, DOI 10.1126/science.aag1927; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Du P, 2018, CELL STEM CELL, V22, P851, DOI 10.1016/j.stem.2018.04.021; Du P, 2015, CELL, V162, P885, DOI 10.1016/j.cell.2015.07.008; Eckersley-Maslin MA, 2016, CELL REP, V17, P179, DOI 10.1016/j.celrep.2016.08.087; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hupalowska A, 2018, CELL, V175, P1902, DOI 10.1016/j.cell.2018.11.027; Inoue D, 2019, NATURE, V574, P432, DOI 10.1038/s41586-019-1646-9; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koh PW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.109; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwasnieski JC, 2019, GENOME RES, V29, P1188, DOI 10.1101/gr.242164.118; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mascetti VL, 2016, CELL STEM CELL, V19, P163, DOI 10.1016/j.stem.2016.07.018; Muller F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1664-9; Posfai E, 2021, NAT CELL BIOL, V23, DOI 10.1038/s41556-020-00609-2; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Terrones D, 2018, NAT GENET, V50, P106, DOI 10.1038/s41588-017-0016-5; Rossant J, 2017, CELL STEM CELL, V20, P18, DOI 10.1016/j.stem.2016.12.004; Seiler M, 2018, CELL REP, V23, P282, DOI 10.1016/j.celrep.2018.01.088; Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245; Shuai SM, 2019, NATURE, V574, P712, DOI 10.1038/s41586-019-1651-z; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suzuki H, 2019, NATURE, V574, P707, DOI 10.1038/s41586-019-1650-0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang JQ, 2018, CELL, V175, P1887, DOI 10.1016/j.cell.2018.11.039; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wu JY, 2018, NATURE, V557, P256, DOI 10.1038/s41586-018-0080-8; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yagi M, 2017, NATURE, V548, P224, DOI 10.1038/nature23286; Yagi S, 2017, PLACENTA, V49, P68, DOI 10.1016/j.placenta.2016.11.013; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang J, 2017, NATURE, V550, P393, DOI 10.1038/nature24052; Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005; Yin YF, 2020, NATURE, V580, P147, DOI 10.1038/s41586-020-2105-3; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhao T, 2018, CELL STEM CELL, V23, P31, DOI 10.1016/j.stem.2018.05.025	64	38	39	14	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					2843	+		10.1016/j.cell.2021.04.020	http://dx.doi.org/10.1016/j.cell.2021.04.020		MAY 2021	37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	33991488	Bronze			2022-12-28	WOS:000656965600006
J	Taylor, L				Taylor, Luke			Covid-19: Researchers find higher than expected reinfections with P.1 variant among the Brazilian Amazon	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644Article, 10.1126/science.abh2644, 10.1101/2021.02.26.21252554]; Prete CA, 2021, MEDRXIV, DOI [10.1101/2021.05.10.21256644, DOI 10.1101/2021.05.10.21256644]; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5	3	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2021	373								n1353	10.1136/bmj.n1353	http://dx.doi.org/10.1136/bmj.n1353			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WT9WF	34035005				2022-12-28	WOS:000716206500001
J	Turner, JS; Kim, W; Kalaidina, E; Goss, CW; Rauseo, AM; Schmitz, AJ; Hansen, L; Haile, A; Klebert, MK; Pusic, I; O'Halloran, JA; Presti, RM; Ellebedy, AH				Turner, Jackson S.; Kim, Wooseob; Kalaidina, Elizaveta; Goss, Charles W.; Rauseo, Adriana M.; Schmitz, Aaron J.; Hansen, Lena; Haile, Alem; Klebert, Michael K.; Pusic, Iskra; O'Halloran, Jane A.; Presti, Rachel M.; Ellebedy, Ali H.			SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans	NATURE			English	Article							NEUTRALIZING ANTIBODIES; IMMUNITY	Long-lived bone marrow plasma cells (BMPCs) are a persistent and essential source of protective antibodies(1-7). Individuals who have recovered from COVID-19 have a substantially lower risk of reinfection with SARS-CoV-2(8-10). Nonetheless, it has been reported that levels of anti-SARS-CoV-2 serum antibodies decrease rapidly in the first few months after infection, raising concerns that long-lived BMPCs may not be generated and humoral immunity against SARS-CoV-2 may be short-lived(11-13). Here we show that in convalescent individuals who had experienced mild SARS-CoV-2 infections (n = 77), levels of serum anti-SARS-CoV-2 spike protein (S) antibodies declined rapidly in the first 4 months after infection and then more gradually over the following 7 months, remaining detectable at least 11 months after infection. Anti-S antibody titres correlated with the frequency of S-specific plasma cells in bone marrow aspirates from 18 individuals who had recovered from COVID-19 at 7 to 8 months after infection. S-specific BMPCs were not detected in aspirates from 11 healthy individuals with no history of SARS-CoV-2 infection. We show that S-binding BMPCs are quiescent, which suggests that they are part of a stable compartment. Consistently, circulating resting memory B cells directed against SARS-CoV-2 S were detected in the convalescent individuals. Overall, our results indicate that mild infection with SARS-CoV-2 induces robust antigen-specific, long-lived humoral immune memory in humans.	[Turner, Jackson S.; Kim, Wooseob; Schmitz, Aaron J.; Hansen, Lena; Ellebedy, Ali H.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Kalaidina, Elizaveta] Washington Univ, Sch Med, Dept Internal Med, Div Allergy & Immunol, St Louis, MO 63110 USA; [Goss, Charles W.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Rauseo, Adriana M.; O'Halloran, Jane A.; Presti, Rachel M.] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; [Hansen, Lena] Univ Bergen, Dept Clin Sci, Influenza Ctr, Bergen, Norway; [Haile, Alem; Klebert, Michael K.] Washington Univ, Sch Med, Clin Trials Unit, St Louis, MO USA; [Pusic, Iskra] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ellebedy, Ali H.] Washington Univ, Sch Med, Ctr Vaccines & Immun Microbial Pathogens, St Louis, MO 63130 USA; [Ellebedy, Ali H.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63130 USA; [Ellebedy, Ali H.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Bergen; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ellebedy, AH (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Ellebedy, AH (corresponding author), Washington Univ, Sch Med, Ctr Vaccines & Immun Microbial Pathogens, St Louis, MO 63130 USA.; Ellebedy, AH (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63130 USA.; Ellebedy, AH (corresponding author), Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63130 USA.	ellebedy@wustl.edu	Goss, Charles W/R-7296-2019	Rauseo, Adriana/0000-0001-9555-2550; Schmitz, Aaron/0000-0002-8077-6751; Kim, Wooseob/0000-0002-9199-1000	National Institute of Allergy and Infectious Diseases (NIAID) [U01AI141990, 1U01AI150747]; NIAID Centers of Excellence for Influenza Research and Surveillance [HHSN272201400006C, HHSN272201400008C]; NIAID Collaborative Influenza Vaccine Innovation Centers contract [75N93019C00051]; NIAID [5T32CA009547]; Norwegian Research Council [271160]; National Graduate School in Infection Biology and Antimicrobials [249062]; NIH-National Center for Advancing Translational Sciences [UL1 TR002345]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID Centers of Excellence for Influenza Research and Surveillance; NIAID Collaborative Influenza Vaccine Innovation Centers contract; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Norwegian Research Council(Research Council of NorwayEuropean Commission); National Graduate School in Infection Biology and Antimicrobials; NIH-National Center for Advancing Translational Sciences	We thank the donors for providing specimens; T. Lei for assistance with preparing specimens; and L. Kessels, A. J. Winingham, the staff of the Infectious Diseases Clinical Research Unit at Washington University School of Medicine and the nursing team of the bone marrow biopsy suite at Washington University School of Medicine and Barnes Jewish Hospital for sample collection and providing care for donors. The SARS-CoV-2 S and RBD protein expression plasmids were provided by F. Krammer. The Ellebedy laboratory was supported by National Institute of Allergy and Infectious Diseases (NIAID) grants U01AI141990 and 1U01AI150747, NIAID Centers of Excellence for Influenza Research and Surveillance contracts HHSN272201400006C and HHSN272201400008C and NIAID Collaborative Influenza Vaccine Innovation Centers contract 75N93019C00051. J.S.T. was supported by NIAID 5T32CA009547. L.H. was supported by Norwegian Research Council grant 271160 and National Graduate School in Infection Biology and Antimicrobials grant 249062. This study used samples obtained from the Washington University School of Medicine's COVID-19 biorepository, which is supported by the NIH-National Center for Advancing Translational Sciences grant UL1 TR002345. The content is solely the responsibility of the authors and does not necessarily represent the view of the NIH. The WU353, WU367 and WU368 studies were reviewed and approved by the Washington University Institutional Review Board (approval nos. 202003186, 202009100 and 202012081, respectively).	Alsoussi WB, 2020, J IMMUNOL, V205, P915, DOI 10.4049/jimmunol.2000583; BENNER R, 1974, IMMUNOLOGY, V26, P247; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chen YZ, 2020, CELL, V183, P1496, DOI 10.1016/j.cell.2020.10.051; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Davis CW, 2020, SCIENCE, V370, P237, DOI 10.1126/science.aaz8432; Davis CW, 2019, CELL, V177, P1566, DOI 10.1016/j.cell.2019.04.036; Edridge AWD, 2020, NAT MED, V26, P1691, DOI 10.1038/s41591-020-1083-1; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Houlihan CF, 2020, LANCET, V396, pE6, DOI 10.1016/S0140-6736(20)31484-7; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Isho B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe5511; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Mei HE, 2015, BLOOD, V125, P1739, DOI 10.1182/blood-2014-02-555169; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Pritz T, 2015, EUR J IMMUNOL, V45, P738, DOI 10.1002/eji.201444878; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.1101/2020.08.11.20171843, 10.21203/rs.3.rs-57112/v1]; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; TURESSON I, 1976, ACTA MED SCAND, V199, P293; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y; Wang K, 2021, CLIN INFECT DIS, V73, pE531, DOI 10.1093/cid/ciaa1143	35	222	224	6	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 15	2021	595	7867					421	+		10.1038/s41586-021-03647-4	http://dx.doi.org/10.1038/s41586-021-03647-4		MAY 2021	12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS3DA	34030176	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000662148700001
J	Iacobucci, G				Iacobucci, Gareth			General practices in deprived areas should get extra "levelling up" funding, says report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Fisher R, WHAT SHOULD GOVT PRI	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2021	373								n1305	10.1136/bmj.n1305	http://dx.doi.org/10.1136/bmj.n1305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7ZT	34020964				2022-12-28	WOS:000656435600006
J	Limb, M				Limb, Matthew			UK campaigners mount legal challenge over US takeover of GP surgeries	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n519	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2021	373								n1321	10.1136/bmj.n1321	http://dx.doi.org/10.1136/bmj.n1321			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7ZT	34020963				2022-12-28	WOS:000656435600016
J	Kilgo, D				Kilgo, Danielle			Media bias delegitimizes Black-rights protesters	NATURE			English	Editorial Material									[Kilgo, Danielle] Univ Minnesota, Journalism Divers & Equal, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kilgo, D (corresponding author), Univ Minnesota, Journalism Divers & Equal, Minneapolis, MN 55455 USA.	dkilgo@umn.edu		Brown, Danielle/0000-0001-7637-8964					0	3	3	2	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					315	315		10.1038/d41586-021-01314-2	http://dx.doi.org/10.1038/d41586-021-01314-2			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SE7VT	34012088	Bronze			2022-12-28	WOS:000652278400003
J	Oliver, D				Oliver, David			David Oliver: Squaring the circle on ward visiting	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						NHS England, 2021, VIS HEALTHC INP SETT; Oliver D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n832	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2021	373								n1241	10.1136/bmj.n1241	http://dx.doi.org/10.1136/bmj.n1241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5SO	34011564	Bronze			2022-12-28	WOS:000655594700002
J	Saddawi-Konefka, D; Brown, A; Eisenhart, I; Hicks, K; Barrett, E; Gold, JA				Saddawi-Konefka, Daniel; Brown, Ariel; Eisenhart, Isabella; Hicks, Katharine; Barrett, Eileen; Gold, Jessica A.			Consistency Between State Medical License Applications and Recommendations Regarding Physician Mental Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study examines the consistency of medical license applications with recommendations from the Federation of State Medical Boards on physician wellness and burnout.	[Saddawi-Konefka, Daniel] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Ariel; Eisenhart, Isabella; Hicks, Katharine] Emotional PPE Project Inc, 15 Univ Rd, Arlington, MA 02474 USA; [Barrett, Eileen] Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA; [Gold, Jessica A.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA	Harvard University; Massachusetts General Hospital; University of New Mexico; Washington University (WUSTL)	Brown, A (corresponding author), Emotional PPE Project Inc, 15 Univ Rd, Arlington, MA 02474 USA.	ariel@emotionalppe.org						Aaronson AL, 2018, ACAD PSYCHIATR, V42, P469, DOI 10.1007/s40596-017-0881-3; Dutheil F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226361; Dyrbye LN, 2017, MAYO CLIN PROC, V92, P1486, DOI 10.1016/j.mayocp.2017.06.020; Federation of State Medical Boards, 2018, PHYS WELLNESS BURNOU; Jaklevic MC, 2021, JAMA-J AM MED ASSOC, V325, P420, DOI 10.1001/jama.2020.25689; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976	6	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					2017	2018		10.1001/jama.2021.2275	http://dx.doi.org/10.1001/jama.2021.2275			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003231	Bronze, Green Published			2022-12-28	WOS:000652675100016
J	Shen, PC; Su, C; Lin, YX; Chou, AS; Cheng, CC; Park, JH; Chiu, MH; Lu, AY; Tang, HL; Tavakoli, MM; Pitner, G; Ji, X; Cai, ZY; Mao, NN; Wang, JT; Tung, VC; Li, J; Bokor, J; Zettl, A; Wu, CI; Palacios, T; Li, LJ; Kong, J				Shen, Pin-Chun; Su, Cong; Lin, Yuxuan; Chou, Ang-Sheng; Cheng, Chao-Ching; Park, Ji-Hoon; Chiu, Ming-Hui; Lu, Ang-Yu; Tang, Hao-Ling; Tavakoli, Mohammad Mahdi; Pitner, Gregory; Ji, Xiang; Cai, Zhengyang; Mao, Nannan; Wang, Jiangtao; Tung, Vincent; Li, Ju; Bokor, Jeffrey; Zettl, Alex; Wu, Chih-, I; Palacios, Tomas; Li, Lain-Jong; Kong, Jing			Ultralow contact resistance between semimetal and monolayer semiconductors	NATURE			English	Article							MOS2 TRANSISTORS; METAL CONTACTS; BARRIER	Advanced beyond-silicon electronic technology requires both channel materials and also ultralow-resistance contacts to be discovered(1,2). Atomically thin two-dimensional semiconductors have great potential for realizing high-performance electronic devices(1,3). However, owing to metal-induced gap states (MIGS)(4-7), energy barriers at the metal-semiconductor interface-which fundamentally lead to high contact resistance and poor current-delivery capability-have constrained the improvement of two-dimensional semiconductor transistors so far(2,8,9). Here we report ohmic contact between semimetallic bismuth and semiconducting monolayer transition metal dichalcogenides (TMDs) where the MIGS are sufficiently suppressed and degenerate states in the TMD are spontaneously formed in contact with bismuth. Through this approach, we achieve zero Schottky barrier height, a contact resistance of 123 ohm micrometres and an on-state current density of 1,135 microamps per micrometre on monolayer MoS2; these two values are, to the best of our knowledge, the lowest and highest yet recorded, respectively. We also demonstrate that excellent ohmic contacts can be formed on various monolayer semiconductors, including MoS2, WS2 and WSe2. Our reported contact resistances are a substantial improvement for two-dimensional semiconductors, and approach the quantum limit. This technology unveils the potential of high-performance monolayer transistors that are on par with state-of-the-art three-dimensional semiconductors, enabling further device downscaling and extending Moore's law. Electric contacts of semimetallic bismuth on monolayer semiconductors are shown to suppress metal-induced gap states and thus have very low contact resistance and a zero Schottky barrier height.	[Shen, Pin-Chun; Lin, Yuxuan; Park, Ji-Hoon; Chiu, Ming-Hui; Lu, Ang-Yu; Tang, Hao-Ling; Tavakoli, Mohammad Mahdi; Ji, Xiang; Cai, Zhengyang; Mao, Nannan; Wang, Jiangtao; Palacios, Tomas; Kong, Jing] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Su, Cong; Zettl, Alex] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Su, Cong; Zettl, Alex] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Su, Cong; Bokor, Jeffrey; Zettl, Alex] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA USA; [Su, Cong; Li, Ju] MIT, Dept Nucl Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lin, Yuxuan; Bokor, Jeffrey] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Cheng, Chao-Ching; Lu, Ang-Yu; Tang, Hao-Ling; Li, Lain-Jong] Taiwan Semicond Mfg Co TSMC, Corp Res, Hsinchu, Taiwan; [Chou, Ang-Sheng; Wu, Chih-, I] Natl Taiwan Univ, Grad Inst Photon & Optoelect, Taipei, Taiwan; [Chiu, Ming-Hui; Tang, Hao-Ling; Tung, Vincent] King Abdullah Univ Sci & Technol KAUST, Phys Sci & Engn Div, Thuwal, Saudi Arabia; [Pitner, Gregory] Taiwan Semicond Mfg Co TSMC, Corp Res, San Jose, CA USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; Taiwan Semiconductor Manufacturing Company; National Taiwan University; King Abdullah University of Science & Technology; Taiwan Semiconductor Manufacturing Company	Shen, PC; Kong, J (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.; Li, LJ (corresponding author), Taiwan Semicond Mfg Co TSMC, Corp Res, Hsinchu, Taiwan.	pcshenc@tsmc.com; lanceli1@hku.hk; jingkong@mit.edu	Li, Lain-Jong/D-5244-2011; Lin, Yuxuan/GQP-7493-2022; Lu, Ang-Yu/GYD-5095-2022; cai, zhengyang/ABE-6950-2021; Li, Ju/A-2993-2008; lin, yuxuan/HHC-4044-2022; Chiu, Ming-Hui/J-3830-2018	Li, Lain-Jong/0000-0002-4059-7783; Lu, Ang-Yu/0000-0002-4031-0156; Li, Ju/0000-0002-7841-8058; Chiu, Ming-Hui/0000-0003-3753-8149; Lin, Yuxuan/0000-0003-0638-2620				Akinwande D, 2019, NATURE, V573, P507, DOI 10.1038/s41586-019-1573-9; Allain A, 2015, NAT MATER, V14, P1195, DOI 10.1038/nmat4452; [Anonymous], 2017, INT ROADMAP DEVICES; Cao ZH, 2020, APPL PHYS LETT, V116, DOI 10.1063/1.5094890; Chakraborty B, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.161403; Chee SS, 2019, ADV MATER, V31, DOI 10.1002/adma.201804422; Chhowalla M, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats2016.52; Cui X, 2017, NANO LETT, V17, P4781, DOI 10.1021/acs.nanolett.7b01536; Das S, 2013, NANO LETT, V13, P100, DOI 10.1021/nl303583v; English CD, 2016, INT EL DEVICES MEET, DOI 10.1109/IEDM.2016.7838355; English CD, 2016, NANO LETT, V16, P3824, DOI 10.1021/acs.nanolett.6b01309; Fiori G, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4840175; Gao J, 2016, ADV MATER, V28, P9735, DOI 10.1002/adma.201601104; Ghani T, 2003, 2003 IEEE INTERNATIONAL ELECTRON DEVICES MEETING, TECHNICAL DIGEST, P978; Guimaraes MHD, 2016, ACS NANO, V10, P6392, DOI 10.1021/acsnano.6b02879; Jung Y, 2019, NAT ELECTRON, V2, P187, DOI 10.1038/s41928-019-0245-y; Kang JH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031005; Kim C, 2017, ACS NANO, V11, P1588, DOI 10.1021/acsnano.6b07159; Kim JJ, 2013, IEEE T ELECTRON DEV, V60, P3683, DOI 10.1109/TED.2013.2281857; Kim S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2018; Kobayashi M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3065990; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kwon J, 2017, NANOSCALE, V9, P6151, DOI 10.1039/c7nr01501a; Li SL, 2014, ACS NANO, V8, P12836, DOI 10.1021/nn506138y; Liu W, 2013, NANO LETT, V13, P1983, DOI 10.1021/nl304777e; Liu Y, 2018, NATURE, V557, P696, DOI 10.1038/s41586-018-0129-8; Liu Y, 2016, NANO LETT, V16, P6337, DOI 10.1021/acs.nanolett.6b02713; Liu YY, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600069; LOUIE SG, 1976, PHYS REV B, V13, P2461, DOI 10.1103/PhysRevB.13.2461; McClellan CJ, 2021, ACS NANO, V15, P1587, DOI 10.1021/acsnano.0c09078; Michail A, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4948357; Moe YA, 2018, ACS APPL MATER INTER, V10, P40246, DOI 10.1021/acsami.8b13241; Nagao T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.105501; NGUYEN LD, 1989, IEEE T ELECTRON DEV, V36, P2243, DOI 10.1109/16.40906; Nishimura T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789701; Nourbakhsh A, 2016, NANO LETT, V16, P7798, DOI 10.1021/acs.nanolett.6b03999; Qian XF, 2014, SCIENCE, V346, P1344, DOI 10.1126/science.1256815; Razavieh A, 2019, IEEE T NANOTECHNOL, V18, P999, DOI 10.1109/TNANO.2019.2942456; SIMMONS JG, 1963, J APPL PHYS, V34, P1793, DOI 10.1063/1.1702682; Smets Q, 2019, INT EL DEVICES MEET, DOI 10.1109/IEDM19573.2019.8993650; Smithe KKH, 2017, ACS NANO, V11, P8456, DOI 10.1021/acsnano.7b04100; Smithe KKH, 2017, 2D MATER, V4, DOI 10.1088/2053-1583/4/1/011009; Sotthewes K, 2019, J PHYS CHEM C, V123, P5411, DOI 10.1021/acs.jpcc.8b10971; Sze S. M., 2006, PHYS SEMICONDUCTOR D; TERSOFF J, 1984, PHYS REV LETT, V52, P465, DOI 10.1103/PhysRevLett.52.465; Thompson S, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P61, DOI 10.1109/IEDM.2002.1175779; Tung RT, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4858400; Vilan A, 2000, NATURE, V404, P166, DOI 10.1038/35004539; Wang Q, 2020, J MATER CHEM C, V8, P3113, DOI 10.1039/c9tc06331e; Wang Y, 2019, NATURE, V568, P70, DOI 10.1038/s41586-019-1052-3; Yang L, 2015, 2015 73RD ANNUAL DEVICE RESEARCH CONFERENCE (DRC), P237, DOI 10.1109/DRC.2015.7175655; Yang LM, 2014, NANO LETT, V14, P6275, DOI 10.1021/nl502603d; Yeh CH, 2019, INT EL DEVICES MEET; Yue D, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201807338; Zhong HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21786	55	197	197	190	607	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					211	+		10.1038/s41586-021-03472-9	http://dx.doi.org/10.1038/s41586-021-03472-9			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33981050	Green Submitted			2022-12-28	WOS:000649848600011
J	Kohn, DB; Booth, C; Shaw, KL; Xu-Bayford, J; Garabedian, E; Trevisan, V; Carbonaro-Sarracino, DA; Soni, K; Terrazas, D; Snell, K; Ikeda, A; Leon-Rico, D; Moore, TB; Buckland, KF; Shah, AJ; Gilmour, KC; De Oliveira, S; Rivat, C; Crooks, GM; Izotova, N; Tse, J; Adams, S; Shupien, S; Ricketts, H; Davila, A; Uzowuru, C; Icreverzi, A; Barman, P; Fernandez, BC; Hollis, RP; Coronel, M; Yu, A; Chun, KM; Casas, CE; Zhang, R; Arduini, S; Lynn, F; Kudari, M; Spezzi, A; Zahn, M; Heimke, R; Labik, I; Parrott, R; Buckley, RH; Reeves, L; Cornetta, K; Sokolic, R; Hershfield, M; Schmidt, M; Candotti, F; Malech, HL; Thrasher, AJ; Gaspar, HB				Kohn, D. B.; Booth, C.; Shaw, K. L.; Xu-Bayford, J.; Garabedian, E.; Trevisan, V.; Carbonaro-Sarracino, D. A.; Soni, K.; Terrazas, D.; Snell, K.; Ikeda, A.; Leon-Rico, D.; Moore, T. B.; Buckland, K. F.; Shah, A. J.; Gilmour, K. C.; De Oliveira, S.; Rivat, C.; Crooks, G. M.; Izotova, N.; Tse, J.; Adams, S.; Shupien, S.; Ricketts, H.; Davila, A.; Uzowuru, C.; Icreverzi, A.; Barman, P.; Fernandez, B. Campo; Hollis, R. P.; Coronel, M.; Yu, A.; Chun, K. M.; Casas, C. E.; Zhang, R.; Arduini, S.; Lynn, F.; Kudari, M.; Spezzi, A.; Zahn, M.; Heimke, R.; Labik, I.; Parrott, R.; Buckley, R. H.; Reeves, L.; Cornetta, K.; Sokolic, R.; Hershfield, M.; Schmidt, M.; Candotti, F.; Malech, H. L.; Thrasher, A. J.; Gaspar, H. B.			Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; COMBINED IMMUNE-DEFICIENCY; STEM-CELL TRANSPLANTATION; HEMATOPOIETIC STEM; MOLECULAR-BASIS; VECTOR; EXPRESSION; EFFICACY; UPDATE; ADA	Background Severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency (ADA-SCID) is a rare and life-threatening primary immunodeficiency. Methods We treated 50 patients with ADA-SCID (30 in the United States and 20 in the United Kingdom) with an investigational gene therapy composed of autologous CD34+ hematopoietic stem and progenitor cells (HSPCs) transduced ex vivo with a self-inactivating lentiviral vector encoding human ADA. Data from the two U.S. studies (in which fresh and cryopreserved formulations were used) at 24 months of follow-up were analyzed alongside data from the U.K. study (in which a fresh formulation was used) at 36 months of follow-up. Results Overall survival was 100% in all studies up to 24 and 36 months. Event-free survival (in the absence of reinitiation of enzyme-replacement therapy or rescue allogeneic hematopoietic stem-cell transplantation) was 97% (U.S. studies) and 100% (U.K. study) at 12 months; 97% and 95%, respectively, at 24 months; and 95% (U.K. study) at 36 months. Engraftment of genetically modified HSPCs persisted in 29 of 30 patients in the U.S. studies and in 19 of 20 patients in the U.K. study. Patients had sustained metabolic detoxification and normalization of ADA activity levels. Immune reconstitution was robust, with 90% of the patients in the U.S. studies and 100% of those in the U.K. study discontinuing immunoglobulin-replacement therapy by 24 months and 36 months, respectively. No evidence of monoclonal expansion, leukoproliferative complications, or emergence of replication-competent lentivirus was noted, and no events of autoimmunity or graft-versus-host disease occurred. Most adverse events were of low grade. Conclusions Treatment of ADA-SCID with ex vivo lentiviral HSPC gene therapy resulted in high overall and event-free survival with sustained ADA expression, metabolic correction, and functional immune reconstitution. (Funded by the National Institutes of Health and others; ClinicalTrials.gov numbers, NCT01852071, NCT02999984, and NCT01380990.) Gene Therapy for Adenosine Deaminase Deficiency Fifty patients in the United States and the United Kingdom underwent HSCT with CD34+ cells transduced with a replication-defective lentivirus bearing ADA. At 24 months, all the patients were alive, and event-free survival was 96.7% among the U.S. patients and 95% among the U.K. patients. Only two patients did not have persistent engraftment. No viable virus or abnormal proliferations were noted.	[Kohn, D. B.; Shaw, K. L.; Carbonaro-Sarracino, D. A.; Terrazas, D.; Davila, A.; Icreverzi, A.; Barman, P.; Fernandez, B. Campo; Hollis, R. P.; Coronel, M.; Yu, A.; Chun, K. M.; Casas, C. E.; Zhang, R.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 3163 Terasaki Life Sci Bldg, Los Angeles, CA 90095 USA; [Kohn, D. B.; Moore, T. B.; De Oliveira, S.; Shupien, S.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA USA; [Crooks, G. M.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Kohn, D. B.; Crooks, G. M.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Tse, J.] Ronald Reagan UCLA Med Ctr, Dept Pharmaceut Serv, Los Angeles, CA USA; [Shah, A. J.] Stanford Sch Med, Palo Alto, CA USA; [Booth, C.; Xu-Bayford, J.; Trevisan, V.; Soni, K.; Snell, K.; Leon-Rico, D.; Buckland, K. F.; Gilmour, K. C.; Rivat, C.; Izotova, N.; Ricketts, H.; Uzowuru, C.; Thrasher, A. J.; Gaspar, H. B.] UCL, Great Ormond St Inst Child Hlth, London, England; [Booth, C.; Xu-Bayford, J.; Trevisan, V.; Soni, K.; Snell, K.; Leon-Rico, D.; Buckland, K. F.; Gilmour, K. C.; Rivat, C.; Izotova, N.; Adams, S.; Ricketts, H.; Uzowuru, C.; Thrasher, A. J.; Gaspar, H. B.] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Carbonaro-Sarracino, D. A.; Lynn, F.; Kudari, M.; Spezzi, A.; Gaspar, H. B.] Orchard Therapeut Europe, London, England; [Malech, H. L.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Garabedian, E.; Sokolic, R.; Candotti, F.] NHGRI, NIH, Bethesda, MD 20892 USA; [Ikeda, A.] Cure 4 Kids Fdn, Las Vegas, NV USA; [Reeves, L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Cornetta, K.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Parrott, R.; Buckley, R. H.; Hershfield, M.] Duke Univ, Durham, NC USA; [Candotti, F.] Lausanne Univ Hosp, Div Immunol & Allergy, Lausanne, Switzerland; [Candotti, F.] Univ Lausanne, Lausanne, Switzerland; [Zahn, M.; Heimke, R.; Labik, I.; Schmidt, M.] GeneWerk, Heidelberg, Germany; [Zahn, M.; Schmidt, M.] German Canc Res Ctr, Heidelberg, Germany; [Zahn, M.; Schmidt, M.] Natl Ctr Tumor Dis, Heidelberg, Germany	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; Stanford University; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cincinnati Children's Hospital Medical Center; Indiana University System; Indiana University Bloomington; Duke University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Kohn, DB (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 3163 Terasaki Life Sci Bldg, Los Angeles, CA 90095 USA.	dkohn1@mednet.ucla.edu	De Oliveira, Satiro/D-8860-2014	De Oliveira, Satiro/0000-0002-8181-7316; Shaw, Kit/0000-0002-1293-8050; Buckland, Karen/0000-0001-6989-2228; shah, ami/0000-0001-5700-6188; TREVISAN, VALENTINA/0000-0002-9566-4971	California Institute for Regenerative Medicine [CL1-00505, CLIN2-09339, FA1-00613, AC1-07675] Funding Source: Medline; Medical Research Council [MR/K015427/1, G80248] Funding Source: Medline; National Institute of Allergy and Infectious Diseases [Intramural program] Funding Source: Medline; NHGRI NIH HHS [Intramural program] Funding Source: Medline; NHLBI NIH HHS [Gene Therapy Resource Program [GTRP] Request for S, 75N92019D00018, NHLBI Contract No. 75N92019D00018, P01 HL073104] Funding Source: Medline; NIAID NIH HHS [U01 AI100801] Funding Source: Medline; NIH HHS [2P01 HL073104, U01 AI100801] Funding Source: Medline; University College London [AC1-07675] Funding Source: Medline; Wellcome Trust Funding Source: Medline	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University College London(General Electric); Wellcome Trust(Wellcome Trust)		Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; [Anonymous], 2016, STRIMVELIS; [Anonymous], 2017, EBMTESID GUIDELINES; [Anonymous], 2020, ORCHARD STATEMENT ST; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Booth C, 2009, BIOL-TARGETS THER, V3, P349; Carbonaro DA, 2014, MOL THER, V22, P607, DOI 10.1038/mt.2013.265; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chan B, 2005, CLIN IMMUNOL, V117, P133, DOI 10.1016/j.clim.2005.07.006; Cicalese MP, 2016, BLOOD, V128, P45, DOI 10.1182/blood-2016-01-688226; Eichler F, 2017, NEW ENGL J MED, V377, P1630, DOI 10.1056/NEJMoa1700554; Ferrua F, 2019, LANCET HAEMATOL, V6, pE239, DOI 10.1016/S2352-3026(19)30021-3; Ferrua F, 2010, CURR OPIN ALLERGY CL, V10, P551, DOI 10.1097/ACI.0b013e32833fea85; Gaspar HB, 2009, BLOOD, V114, P3524, DOI 10.1182/blood-2009-06-189209; Griffith LM, 2009, J ALLERGY CLIN IMMUN, V124, P1152, DOI 10.1016/j.jaci.2009.10.022; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Haddad E, 1998, BLOOD, V91, P3646; Hassan A, 2012, BLOOD, V120, P3615, DOI 10.1182/blood-2011-12-396879; Hershfield MS, 1998, SEMIN HEMATOL, V35, P291; HIRSCHHORN R, 1995, CLIN IMMUNOL IMMUNOP, V76, pS219, DOI 10.1016/S0090-1229(95)90288-0; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kohn DB, 2020, MOL THER, V28, P554; Kohn DB, 2020, NAT MED, V26, P200, DOI 10.1038/s41591-019-0735-5; Kohn DB, 2019, J ALLERGY CLIN IMMUN, V143, P852, DOI 10.1016/j.jaci.2018.08.024; Kuo CY, 2020, J CLIN IMMUNOL, V40, P1124, DOI 10.1007/s10875-020-00857-9; Kuo CY, 2018, J CLIN IMMUNOL, V38, P342; Marktel S, 2019, NAT MED, V25, P234, DOI 10.1038/s41591-018-0301-6; Montiel-Equihua CA, 2012, MOL THER, V20, P1400, DOI 10.1038/mt.2012.50; MURAOKA T, 1990, ANAL BIOCHEM, V187, P268, DOI 10.1016/0003-2697(90)90455-I; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; Sauer AV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00265; Sessa M, 2016, LANCET, V388, P476, DOI 10.1016/S0140-6736(16)30374-9; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Thompson AA, 2018, NEW ENGL J MED, V378, P1479, DOI 10.1056/NEJMoa1705342; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	36	44	45	2	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2021	384	21					2002	2013		10.1056/NEJMoa2027675	http://dx.doi.org/10.1056/NEJMoa2027675		MAY 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SY1GA	33974366	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-28	WOS:000649467400001
J	Shah, A; Pereira, P; Tuma, P				Shah, Amar; Pereira, Penny; Tuma, Paula			Quality improvement at times of crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shah, Amar] East London NHS Fdn Trust, London, England; [Shah, Amar] Royal Coll Psychiatrists, London, England; [Shah, Amar] Univ Leicester, Leicester, Leics, England; [Pereira, Penny] Hlth Fdn, London, England; [Tuma, Paula] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil	University of Leicester; Hospital Israelita Albert Einstein	Shah, A (corresponding author), East London NHS Fdn Trust, London, England.; Shah, A (corresponding author), Royal Coll Psychiatrists, London, England.; Shah, A (corresponding author), Univ Leicester, Leicester, Leics, England.	amarshah@nhs.net						BENNETT B, 2015, QUAL PROG, V48, P36; Dixon-Woods Mary, 2016, Future Hosp J, V3, P191, DOI 10.7861/futurehosp.3-3-191; East London NHS Foundation Trust, 2020, TRUST; Fitzsimons J, 2021, INT J QUAL HEALTH C, V33, DOI 10.1093/intqhc/mzaa051; Gilbert AW, 2020, BMJ OPEN QUAL, V9, DOI 10.1136/bmjoq-2020-000985; Health Foundation, UNDERSTANDING; Hill M, 2020, INSIGHT; Mondoux S, 2020, CAN J EMERG MED, V22, P422, DOI 10.1017/cem.2020.386; Perla RJ, 2021, INT J QUAL HEALTH C, V33, DOI 10.1093/intqhc/mzaa069; Sansaver J., 2020, HLTH SERV J; Shah A, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l189; Staines A, 2021, INT J QUAL HEALTH C, V33, DOI [10.1093/intqhc/mzaa050, DOI 10.1093/intqhc/mzaa050]	12	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n928	10.1136/bmj.n928	http://dx.doi.org/10.1136/bmj.n928			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SB0RU	33975873	Green Published, hybrid			2022-12-28	WOS:000649711400008
J	Chang, D; Liu, JR; Fang, B; Xu, Z; Li, Z; Liu, YL; Brassart, L; Guo, F; Gao, WW; Gao, C				Chang, Dan; Liu, Jingran; Fang, Bo; Xu, Zhen; Li, Zheng; Liu, Yilun; Brassart, Laurence; Guo, Fan; Gao, Weiwei; Gao, Chao			Reversible fusion and fission of graphene oxide-based fibers	SCIENCE			English	Article							CAPILLARY MENISCUS INTERACTION; MICROPILLAR ARRAYS; LIQUID-CRYSTALS; DEPOSITION; NETWORKS	Stimuli-responsive fusion and fission are widely observed in both bio-organizations and artificial molecular assemblies. However, the design of a system with structure and property persistence during repeated fusion and fission remains challenging. We show reversible fusion and fission of wet-spun graphene oxide (GO) fibers, in which a number of macroscopic fibers can fuse into a thicker one and can also separate into original individual fibers under stimulation of solvents. The dynamic geometrical deformation of GO fiber shells, caused by solvent evaporation and infiltration, is the key to the reversible fusion-fission cycles. This principle is extended to implement flexible transitions between complex fiber assemblies and the inclusion or expulsion of guest compounds.	[Chang, Dan; Fang, Bo; Xu, Zhen; Li, Zheng; Guo, Fan; Gao, Weiwei; Gao, Chao] Zhejiang Univ, Dept Polymer Sci & Engn, MOE Key Lab Macromol Synth & Functionalizat, Key Lab Adsorpt & Separat Mat & Technol Zhejiang, Hangzhou 310027, Peoples R China; [Liu, Jingran; Liu, Yilun] Xi An Jiao Tong Univ, State Key Lab Strength & Vibrat Mech Struct, Sch Aerosp, Xian 710049, Peoples R China; [Brassart, Laurence] Monash Univ, Dept Mat Sci & Engn, Clayton, Vic 3800, Australia; [Brassart, Laurence] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England	Zhejiang University; Xi'an Jiaotong University; Monash University; University of Oxford	Li, Z; Gao, C (corresponding author), Zhejiang Univ, Dept Polymer Sci & Engn, MOE Key Lab Macromol Synth & Functionalizat, Key Lab Adsorpt & Separat Mat & Technol Zhejiang, Hangzhou 310027, Peoples R China.; Liu, YL (corresponding author), Xi An Jiao Tong Univ, State Key Lab Strength & Vibrat Mech Struct, Sch Aerosp, Xian 710049, Peoples R China.	lizheng_zju@zju.edu.cn; yilunliu@mail.edu.cn; chaogao@zju.edu.cn	liu, yi/GXE-9662-2022; Gao, Weiwei/K-4727-2018; Li, Zheng/I-6538-2016	Gao, Weiwei/0000-0002-8111-3095; xu, zhen/0000-0003-1352-9176; Li, Zheng/0000-0002-8760-7205; Fang, Bo/0000-0002-8356-6901	National Key R&D Program of China [2016YFA0200200]; National Natural Science Foundation of China [52090030, 51533008, 51703194, 11890674, 51873191]; Hundred Talents Program of Zhejiang University [188020*194231701/113]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of Zhejiang University	This work was funded by the National Key R&D Program of China (grant 2016YFA0200200), the National Natural Science Foundation of China (grants 52090030, 51533008, 51703194, 11890674, and 51873191), and the Hundred Talents Program of Zhejiang University (grant 188020*194231701/113).	Brassart L, 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4601590, DOI 10.5281/ZENODO.4601590]; Cai HH, 2013, SOFT MATTER, V9, P11398, DOI 10.1039/c3sm52439f; Chandra D, 2010, ACCOUNTS CHEM RES, V43, P1080, DOI 10.1021/ar100001a; Chandra D, 2009, LANGMUIR, V25, P10430, DOI 10.1021/la901722g; Cheng HH, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201703096; El-Kady MF, 2012, SCIENCE, V335, P1326, DOI 10.1126/science.1216744; Fang B, 2020, ADV MATER, V32, DOI 10.1002/adma.201902664; Fang X, 2014, ADV MATER, V26, P1694, DOI 10.1002/adma.201305241; Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792; Gao W, 2011, NAT NANOTECHNOL, V6, P496, DOI [10.1038/NNANO.2011.110, 10.1038/nnano.2011.110]; Huang Y, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.245413; Huther A, 2004, FLUID PHASE EQUILIBR, V219, P231, DOI 10.1016/j.fluid.2003.08.002; Jensen P, 1999, REV MOD PHYS, V71, P1695, DOI 10.1103/RevModPhys.71.1695; Kang MK, 2010, SOFT MATTER, V6, P5736, DOI 10.1039/c0sm00335b; Kim J, 2012, ACCOUNTS CHEM RES, V45, P1356, DOI 10.1021/ar300047s; KRALCHEVSKY PA, 1992, J COLLOID INTERF SCI, V151, P79, DOI 10.1016/0021-9797(92)90239-I; Li XM, 2011, LANGMUIR, V27, P12164, DOI 10.1021/la202380g; Li Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13684; Liu YJ, 2016, ADV MATER, V28, P7941, DOI 10.1002/adma.201602444; Luo C, 2018, ADV MATER, V30, DOI 10.1002/adma.201706229; Medhekar NV, 2010, ACS NANO, V4, P2300, DOI 10.1021/nn901934u; MENGER FM, 1992, J AM CHEM SOC, V114, P5862, DOI 10.1021/ja00040a059; Poulin P, 2016, P NATL ACAD SCI USA, V113, P11088, DOI 10.1073/pnas.1605121113; Presolski S, 2018, ANGEW CHEM INT EDIT, V57, P16713, DOI 10.1002/anie.201809979; Rharbi Y, 2014, LANGMUIR, V30, P7947, DOI 10.1021/la501465v; Shillcock JC, 2005, NAT MATER, V4, P225, DOI 10.1038/nmat1333; Sugimoto Y, 2013, CARBON, V57, P416, DOI 10.1016/j.carbon.2013.02.014; Sugimoto Y, 2012, CARBON, V50, P2860, DOI 10.1016/j.carbon.2012.02.053; Tanaka M, 2005, J PHYS-CONDENS MAT, V17, pS649, DOI 10.1088/0953-8984/17/9/022; Tian QS, 2017, NANOSCALE, V9, P12335, DOI 10.1039/c7nr03895j; Wang CC, 2015, NANO RES, V8, P2143, DOI 10.1007/s12274-014-0685-7; Wen YY, 2017, ADV MATER, V29, DOI 10.1002/adma.201702831; Xu Z, 2014, ACCOUNTS CHEM RES, V47, P1267, DOI 10.1021/ar4002813; Xu Z, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1583; Yao YG, 2018, SCIENCE, V359, P1489, DOI 10.1126/science.aan5412; Zhao XL, 2017, ACS NANO, V11, P9663, DOI 10.1021/acsnano.7b03480; Zhou YF, 2005, J AM CHEM SOC, V127, P10468, DOI 10.1021/ja0505696; Zhou YF, 2005, ANGEW CHEM INT EDIT, V44, P3223, DOI 10.1002/anie.200462622	38	32	32	56	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					614	+		10.1126/science.abb6640	http://dx.doi.org/10.1126/science.abb6640			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958473	Green Submitted			2022-12-28	WOS:000649103500042
J	Crecelius, A				Crecelius, Anne			From professor to patient X	SCIENCE			English	Editorial Material									[Crecelius, Anne] Univ Dayton, Dayton, OH 45469 USA	University of Dayton	Crecelius, A (corresponding author), Univ Dayton, Dayton, OH 45469 USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					654	654		10.1126/science.372.6542.654	http://dx.doi.org/10.1126/science.372.6542.654			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA2AW	33958478				2022-12-28	WOS:000649103500050
J	Khan, FZ; Tritschler, T; Kahn, SR; Rodger, MA				Khan, Faizan; Tritschler, Tobias; Kahn, Susan R.; Rodger, Marc A.			Venous thromboembolism	LANCET			English	Review							DEEP-VEIN THROMBOSIS; CATHETER-DIRECTED THROMBOLYSIS; SUSPECTED PULMONARY-EMBOLISM; HEMATOLOGY 2018 GUIDELINES; EMERGENCY-DEPARTMENT PATIENTS; DIRECT ORAL ANTICOAGULANTS; RULE-OUT CRITERIA; D-DIMER; AMERICAN SOCIETY; 1ST EPISODE	Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism, is a chronic illness that affects nearly 10 million people every year worldwide. Strong provoking risk factors for venous thromboembolism include major surgery and active cancer, but most events are unprovoked. Diagnosis requires a sequential work-up that combines assessment of clinical pretest probability for venous thromboembolism using a clinical score (eg, Wells score), D-dimer testing, and imaging. Venous thromboembolism can be considered excluded in patients with both a non-high clinical pretest probability and normal D-dimer concentrations. When required, ultrasonography should be done for a suspected deep vein thrombosis and CT or ventilation-perfusion scintigraphy for a suspected pulmonary embolism. Direct oral anticoagulants (DOACs) are the first-line treatment for almost all patients with venous thromboembolism (including those with cancer). After completing 3-6 months of initial treatment, anticoagulation can be discontinued in patients with venous thromboembolism provoked by a major transient risk factor. Patients whose long-term risk of recurrent venous thromboembolism outweighs the long-term risk of major bleeding, such as those with active cancer or men with unprovoked venous thromboembolism, should receive indefinite anticoagulant treatment. Pharmacological venous thromboembolism prophylaxis is generally warranted in patients undergoing major orthopaedic or cancer surgery. Ongoing research is focused on improving diagnostic strategies for suspected deep vein thrombosis, comparing different DOACs, developing safer anticoagulants, and further individualising approaches for the prevention and management of venous thromboembolism.	[Khan, Faizan] Univ Ottawa, Ottawa Hosp Res Inst, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Khan, Faizan; Rodger, Marc A.] Univ Ottawa, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Tritschler, Tobias] Univ Ottawa, Ottawa Hosp Res Inst, Dept Med, Ottawa, ON, Canada; [Tritschler, Tobias] Univ Bern, Bern Univ Hosp, Dept Gen Internal Med, Inselspital, Bern, Switzerland; [Khan, Faizan; Rodger, Marc A.] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [Kahn, Susan R.] Jewish Gen Hosp, Lady Davis Inst, Div Internal Med, Montreal, PQ, Canada; [Kahn, Susan R.] Jewish Gen Hosp, Lady Davis Inst, Div Clin Epidemiol, Montreal, PQ, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Bern; University Hospital of Bern; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University	Rodger, MA (corresponding author), McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada.	marc.rodger@mcgill.ca	Tritschler, Tobias/ABH-1772-2021	Tritschler, Tobias/0000-0002-8775-0511; , Faizan/0000-0001-7570-0755	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	All authors are investigators of the CanVECTOR Network; the Network receives grant funding from the Canadian Institutes of Health Research (CDT-142654). FK holds the Frederick Banting and Charles Best doctoral research scholarship from the Canadian Institutes of Health Research.	Ageno W, 2015, LANCET HAEMATOL, V2, pE474, DOI 10.1016/S2352-3026(15)00190-8; Agnelli G, 2020, NEW ENGL J MED, V382, P1599, DOI 10.1056/NEJMoa1915103; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Anand SS, 1998, JAMA-J AM MED ASSOC, V279, P1094, DOI 10.1001/jama.279.14.1094; Anderson DR, 2018, NEW ENGL J MED, V378, P699, DOI 10.1056/NEJMoa1712746; Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Anderson DR, 2019, BLOOD ADV, V3, P3898, DOI 10.1182/bloodadvances.2019000975; Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Azirar S, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004177.pub2; Barco S, 2020, LANCET RESP MED, V8, P277, DOI 10.1016/S2213-2600(19)30354-6; Barco S, 2016, THROMB HAEMOSTASIS, V115, P800, DOI 10.1160/TH15-08-0670; Bates SM, 2018, BLOOD ADV, V2, P3317, DOI 10.1182/bloodadvances.2018024802; Bates SM, 2012, CHEST, V141, pE351S, DOI 10.1378/chest.11-2299; Bikdeli B, 2019, JAMA-J AM MED ASSOC, V322, P574, DOI 10.1001/jama.2019.8594; Boonyawat K, 2017, J THROMB HAEMOST, V15, P1322, DOI 10.1111/jth.13701; Bourjeily G, 2010, LANCET, V375, P500, DOI 10.1016/S0140-6736(09)60996-X; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Byrnes JR, 2017, BLOOD, V130, P1795, DOI 10.1182/blood-2017-03-745349; Carrier M, 2019, NEW ENGL J MED, V380, P711, DOI 10.1056/NEJMoa1814468; Carrier M, 2017, HEMATOL-AM SOC HEMAT, P237, DOI 10.1182/asheducation-2017.1.237; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Castellucci LA, 2014, JAMA-J AM MED ASSOC, V312, P1122, DOI 10.1001/jama.2014.10538; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; Chan N, 2020, LANCET, V396, P1767, DOI 10.1016/S0140-6736(20)32439-9; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2017, THROMB HAEMOSTASIS, V117, P57, DOI 10.1160/TH15-08-0686; Cohen H, 2016, LANCET HAEMATOL, V3, pE426, DOI 10.1016/S2352-3026(16)30079-5; Connors JM, 2017, NEW ENGL J MED, V377, P1177, DOI 10.1056/NEJMra1700365; Couturaud F, 2002, BLOOD COAGUL FIBRIN, V13, P241, DOI 10.1097/00001721-200204000-00010; Couturaud F, 2019, HAEMATOLOGICA, V104, DOI 10.3324/haematol.2018.210971; Couturaud F, 2015, JAMA-J AM MED ASSOC, V314, P31, DOI 10.1001/jama.2015.7046; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Diaz J A, 2013, J Vasc Surg Venous Lymphat Disord, V1, DOI 10.1016/j.jvsv.2012.12.002; Douma RA, 2010, NAT REV CARDIOL, V7, P585, DOI 10.1038/nrcardio.2010.106; Dronkers CEA, 2017, J THROMB HAEMOST, V15, P2270, DOI 10.1111/jth.13805; Dronkers CEA, 2017, J THROMB HAEMOST, V15, P1040, DOI 10.1111/jth.13654; Ende-Verhaar YM, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01792-2016; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Farfan M, 2016, THROMB RES, V141, P163, DOI 10.1016/j.thromres.2016.03.029; Farge D, 2019, LANCET ONCOL, V20, pE566, DOI 10.1016/S1470-2045(19)30336-5; Freund Y, 2018, JAMA-J AM MED ASSOC, V319, P559, DOI 10.1001/jama.2017.21904; Galanaud JP, 2020, J THROMB HAEMOST, V18, P857, DOI 10.1111/jth.14728; Galanaud JP, 2018, THROMB RES, V164, P100, DOI 10.1016/j.thromres.2017.07.026; Garcia D, 2013, BLOOD, V122, P817, DOI 10.1182/blood-2013-04-496257; Geersing GJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1340; Geersing GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2990; Geersing GJ, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6564; Gibson NS, 2008, THROMB HAEMOSTASIS, V99, P229, DOI 10.1160/TH07-05-0321; Goel R, 2018, JAMA SURG, V153, P826, DOI 10.1001/jamasurg.2018.1565; Grosse SD, 2016, THROMB RES, V137, P3, DOI 10.1016/j.thromres.2015.11.033; Ha JT, 2019, ANN INTERN MED, V171, P181, DOI 10.7326/M19-0087; HAEGER K, 1969, ANGIOLOGY, V20, P219, DOI 10.1177/000331976902000406; Haig Y, 2016, LANCET HAEMATOL, V3, pE64, DOI 10.1016/S2352-3026(15)00248-3; Hao QK, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004437.pub5; Heit JA, 2017, BLOOD, V130, P109, DOI 10.1182/blood-2016-12-758995; Heit JA, 2015, NAT REV CARDIOL, V12, P464, DOI 10.1038/nrcardio.2015.83; Iorio A, 2010, ARCH INTERN MED, V170, P1710, DOI 10.1001/archinternmed.2010.367; Kahn SR, 2009, J THROMB HAEMOST, V7, P884, DOI 10.1111/j.1538-7836.2009.03339.x; Kahn SR, 2020, RES PRACT THROMB HAE, V4, P366, DOI 10.1002/rth2.12323; Kahn SR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024444; Kahn SR, 2017, CHEST, V151, P1058, DOI 10.1016/j.chest.2016.11.030; Kahn SR, 2014, LANCET, V383, P880, DOI 10.1016/S0140-6736(13)61902-9; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kearon C, 2016, J THROMB HAEMOST, V14, P1480, DOI 10.1111/jth.13336; Kearon C, 2010, J THROMB HAEMOST, V8, P2313, DOI 10.1111/j.1538-7836.2010.03991.x; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 2020, BLOOD, V135, P317, DOI 10.1182/blood.2019002364; Kearon C, 2019, NEW ENGL J MED, V381, P2125, DOI 10.1056/NEJMoa1909159; Kearon C, 2018, BLOOD, V131, P2151, DOI 10.1182/blood-2017-09-805689; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Keller K, 2020, EUR HEART J, V41, P522, DOI 10.1093/eurheartj/ehz236; Key NS, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.01461; Khan F, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4363; Khan F, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2344; Khorana AA, 2019, NEW ENGL J MED, V380, P720, DOI 10.1056/NEJMoa1814630; Khorana AA, 2018, J THROMB HAEMOST, V16, P1891, DOI 10.1111/jth.14219; Khorana AA, 2008, ARCH INTERN MED, V168, P2377, DOI 10.1001/archinte.168.21.2377; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Klok FA, 2008, ARCH INTERN MED, V168, P2131, DOI 10.1001/archinte.168.19.2131; Klok FA, 2020, BLOOD, V135, P724, DOI 10.1182/blood.2019001605; Konstantinides SV, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01647-2019; Koupenova M, 2018, CIRC RES, V122, P337, DOI 10.1161/CIRCRESAHA.117.310795; Kraaijpoel N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228788; Kraaijpoel N, 2019, BLOOD, V133, P291, DOI 10.1182/blood-2018-08-835595; Kunutsor SK, 2017, EUR HEART J, V38, P1608, DOI 10.1093/eurheartj/ehx107; Kunutsor SK, 2017, LANCET HAEMATOL, V4, pE83, DOI 10.1016/S2352-3026(16)30184-3; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Le Gal G, 2006, THROMB HAEMOSTASIS, V95, P963, DOI 10.1160/TH06-03-0158; Lim W, 2018, BLOOD ADV, V2, P3226, DOI 10.1182/bloodadvances.2018024828; Lindstrom S, 2019, BLOOD, V134, P1645, DOI 10.1182/blood.2019000435; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Lyman GH, 2021, BLOOD ADV, V5, P927, DOI 10.1182/bloodadvances.2020003442; Mackman N, 2012, J CLIN INVEST, V122, P2331, DOI 10.1172/JCI60229; Marshall A, 2020, J THROMB HAEMOST, V18, P905, DOI 10.1111/jth.14752; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Matharu GS, 2020, JAMA INTERN MED, V180, P376, DOI 10.1001/jamainternmed.2019.6108; Mazzolai L, 2018, EUR HEART J, V39, P4208, DOI 10.1093/eurheartj/ehx003; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Miranda S, 2020, J THROMB HAEMOST, V18, P926, DOI 10.1111/jth.14720; Mulder FI, 2020, BLOOD, V136, P1433, DOI 10.1182/blood.2020005819; National Institute for Health and Care Excellence, 2019, VEN THROMB 16S RED R; National Institute for Health and Care Excellence (NICE), 2020, VEN THROMB DIS DIAGN; Notten P, 2020, LANCET HAEMATOL, V7, pE40, DOI 10.1016/S2352-3026(19)30209-1; Ordi-Ros J, 2019, ANN INTERN MED, V171, P685, DOI 10.7326/M19-0291; Ortel TL, 2020, BLOOD ADV, V4, P4693, DOI 10.1182/bloodadvances.2020001830; Othieno R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003076.pub3; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Pengo V, 2018, BLOOD, V132, P1365, DOI 10.1182/blood-2018-04-848333; Piran S, 2013, THROMB RES, V132, P515, DOI 10.1016/j.thromres.2013.08.012; Posch F, 2015, THROMB RES, V136, P582, DOI 10.1016/j.thromres.2015.07.011; Rabinovich A, 2018, BLOOD, V131, P2215, DOI 10.1182/blood-2018-01-785956; Raskob GE, 2014, THROMB RES, V134, P931, DOI 10.1016/j.thromres.2014.08.014; Raskob GE, 2018, NEW ENGL J MED, V378, P615, DOI 10.1056/NEJMoa1711948; Righini M, 2009, J THROMB HAEMOST, V7, P406, DOI 10.1111/j.1538-7836.2008.03264.x; Righini M, 2019, J THROMB HAEMOST, V17, P507, DOI 10.1111/jth.14387; Righini M, 2018, ANN INTERN MED, V169, P766, DOI 10.7326/M18-1670; Righini M, 2016, LANCET HAEMATOL, V3, pE556, DOI 10.1016/S2352-3026(16)30131-4; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Roach REJ, 2014, CIRCULATION, V129, P51, DOI 10.1161/CIRCULATIONAHA.113.004768; Robert-Ebadi H, 2017, THROMB RES, V149, P48, DOI 10.1016/j.thromres.2016.11.009; Robertson L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001100.pub4; Rodger MA, 2019, THROMB RES, V180, P105, DOI 10.1016/j.thromres.2019.06.017; Rodger MA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1065; Rodger MA, 2018, BLOOD ADV, V2, P3081, DOI 10.1182/bloodadvances.2018020230; Rodrigues JD, 2016, J THROMB HAEMOST, V14, P1765, DOI 10.1111/jth.13407; Roy PM, 2017, J THROMB HAEMOST, V15, P685, DOI 10.1111/jth.13629; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Saeed MJ, 2017, JAMA INTERN MED, V177, P1861, DOI 10.1001/jamainternmed.2017.5960; Schunemann HJ, 2020, LANCET HAEMATOL, V7, pE746, DOI 10.1016/S2352-3026(20)30293-3; Schunemann HJ, 2018, BLOOD ADV, V2, P3198, DOI 10.1182/bloodadvances.2018022954; Shalhoub J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1309; Siegal DM, 2021, CARDIOVASC RES, V117, P576, DOI 10.1093/cvr/cvaa044; Singh B, 2013, EMERG MED J, V30, P701, DOI 10.1136/emermed-2012-201730; Sista AK, 2018, THROMB RES, V164, P157, DOI 10.1016/j.thromres.2017.06.017; Stein PD, 2010, AM J MED, V123, P426, DOI 10.1016/j.amjmed.2009.09.037; Subbiah R, 2016, LANCET HAEMATOL, V3, pE293, DOI 10.1016/S2352-3026(16)30017-5; Tagalakis V, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.024; Thalin C, 2019, ARTERIOSCL THROM VAS, V39, P1724, DOI 10.1161/ATVBAHA.119.312463; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; Tritschler T, 2018, JAMA-J AM MED ASSOC, V320, P1583, DOI 10.1001/jama.2018.14346; van Dam LF, 2020, BLOOD, V135, P1377, DOI 10.1182/blood.2019004114; van der Hulle T, 2017, LANCET, V390, P289, DOI 10.1016/S0140-6736(17)30885-1; van der Hulle T, 2016, CHEST, V149, P1245, DOI 10.1016/j.chest.2015.10.069; van der Hulle T, 2015, HAEMATOLOGICA, V100, P188, DOI 10.3324/haematol.2014.112896; van der Pol LM, 2019, NEW ENGL J MED, V380, P1139, DOI 10.1056/NEJMoa1813865; van Es N, 2016, ANN INTERN MED, V165, P253, DOI 10.7326/M16-0031; van Es N, 2014, BLOOD, V124, P1968, DOI [10.1182/blood-2014-04571232, 10.1182/blood-2014-04-571232]; van Montfoort ML, 2013, ARTERIOSCL THROM VAS, V33, P147, DOI 10.1161/ATVBAHA.112.300498; Vedantham S, 2017, NEW ENGL J MED, V377, P2240, DOI 10.1056/NEJMoa1615066; Wang KL, 2019, HEART, V105, P545, DOI 10.1136/heartjnl-2018-313617; Wang TF, 2020, BLOOD, V135, P904, DOI 10.1182/blood.2019003528; Wang TF, 2019, J THROMB HAEMOST, V17, P1772, DOI 10.1111/jth.14564; Weitz JI, 2017, NEW ENGL J MED, V376, P1211, DOI 10.1056/NEJMoa1700518; Weitz JI, 2020, BLOOD, V135, P351, DOI 10.1182/blood.2019000919; Weitz JI, 2020, JAMA-J AM MED ASSOC, V323, P130, DOI 10.1001/jama.2019.20687; Wells PS, 2018, ANN INTERN MED, V168, P131, DOI 10.7326/M17-0291; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Young AM, 2018, J CLIN ONCOL, V36, P2017, DOI 10.1200/JCO.2018.78.8034; Zondag W, 2011, J THROMB HAEMOST, V9, P1500, DOI 10.1111/j.1538-7836.2011.04388.x	164	57	63	28	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2021	398	10294					64	77		10.1016/S0140-6736(20)32658-1	http://dx.doi.org/10.1016/S0140-6736(20)32658-1		JUL 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TC9PM	33984268				2022-12-28	WOS:000668969500030
J	Kuehn, BM				Kuehn, Bridget M.			Massive Costs of the US Opioid Epidemic in Lives and Dollars	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2040	2040		10.1001/jama.2021.7464	http://dx.doi.org/10.1001/jama.2021.7464			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032821				2022-12-28	WOS:000655647300011
J	Uyeki, TM; Wentworth, DE; Jernigan, DB				Uyeki, Timothy M.; Wentworth, David E.; Jernigan, Daniel B.			Influenza Activity in the US During the 2020-2021 Season	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Uyeki, Timothy M.; Wentworth, David E.; Jernigan, Daniel B.] US Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Uyeki, TM (corresponding author), US Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd NE,Mailstop H24-7, Atlanta, GA 30329 USA.	tmu0@cdc.gov						Merckx J, 2017, ANN INTERN MED, V167, P394, DOI 10.7326/M17-0848; Mott JA, 2021, INFLUENZA OTHER RESP, V15, P415, DOI 10.1111/irv.12844; Olsen SJ, 2020, MMWR-MORBID MORTAL W, V69, P1305, DOI 10.15585/mmwr.mm6937a6; Sovann LY, 2021, INT J INFECT DIS, V103, P352, DOI 10.1016/j.ijid.2020.11.178; Stowe J, 2021, INT J EPIDEMIOL, V50, P1124, DOI 10.1093/ije/dyab081; Uyeki TM, 2019, CLIN INFECT DIS, V68, pE1, DOI [10.1093/cid/ciy866, 10.1093/cid/ciy874]; Vaughn VM, 2021, CLIN INFECT DIS, V72, pE533, DOI 10.1093/cid/ciaa1239; WHO, 2021, RECOMMENDED COMPOSIT; Xiao JY, 2020, EMERG INFECT DIS, V26, P967, DOI 10.3201/eid2605.190994	9	10	10	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2021	325	22					2247	2248		10.1001/jama.2021.6125	http://dx.doi.org/10.1001/jama.2021.6125		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS1CN	34028492				2022-12-28	WOS:000655670500003
J	Zarocostas, J				Zarocostas, John			What next for a COVID-19 intellectual property waiver?	LANCET			English	Editorial Material								The USA has backed a waiver for intellectual property related to COVID-19 vaccines. What happens next? John Zarocostas reports from Geneva.											0	13	14	5	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1871	1872						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF1XN	34022975	hybrid, Green Published			2022-12-28	WOS:000652556000008
J	Sen, A				Sen, Ananya			The problem with 'follow your dream'	SCIENCE			English	Editorial Material									[Sen, Ananya] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Sen, A (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA.	SciCareerEditor@aaas.org							0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					874	874		10.1126/science.372.6544.874	http://dx.doi.org/10.1126/science.372.6544.874			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016783				2022-12-28	WOS:000653997000049
J	Hoeffel, G; Debroas, G; Roger, A; Rossignol, R; Gouilly, J; Laprie, C; Chasson, L; Barbon, PV; Balsamo, A; Reynders, A; Moqrich, A; Ugolini, S				Hoeffel, Guillaume; Debroas, Guilhaume; Roger, Anais; Rossignol, Rafaelle; Gouilly, Jordi; Laprie, Caroline; Chasson, Lionel; Barbon, Pierre-Vincent; Balsamo, Anais; Reynders, Ana; Moqrich, Aziz; Ugolini, Sophie			Sensory neuron-derived TAFA4 promotes macrophage tissue repair functions	NATURE			English	Article							FETAL MONOCYTES; DENDRITIC CELLS; SKIN; ORIGINS; PROTEIN; IL-10; PAIN	Inflammation is a defence response to tissue damage that requires tight regulation in order to prevent impaired healing. Tissue-resident macrophages have a key role in tissue repair(1), but the precise molecular mechanisms that regulate the balance between inflammatory and pro-repair macrophage responses during healing remain poorly understood. Here we demonstrate a major role for sensory neurons in promoting the tissue-repair function of macrophages. In a sunburn-like model of skin damage in mice, the conditional ablation of sensory neurons expressing the G alpha(i)-interacting protein (GINIP) results in defective tissue regeneration and in dermal fibrosis. Elucidation of the underlying molecular mechanisms revealed a crucial role for the neuropeptide TAFA4, which is produced in the skin by C-low threshold mechanoreceptors-a subset of GINIP(+) neurons. TAFA4 modulates the inflammatory profile of macrophages directly in vitro. In vivo studies in Tafa4-deficient mice revealed that TAFA4 promotes the production of IL-10 by dermal macrophages after UV-induced skin damage. This TAFA4-IL-10 axis also ensures the survival and maintenance of IL-10(+)TIM4(+) dermal macrophages, reducing skin inflammation and promoting tissue regeneration. These results reveal a neuroimmune regulatory pathway driven by the neuropeptide TAFA4 that promotes the anti-inflammatory functions of macrophages and prevents fibrosis after tissue damage, and could lead to new therapeutic perspectives for inflammatory diseases.	[Hoeffel, Guillaume; Debroas, Guilhaume; Roger, Anais; Rossignol, Rafaelle; Gouilly, Jordi; Laprie, Caroline; Chasson, Lionel; Barbon, Pierre-Vincent; Balsamo, Anais; Ugolini, Sophie] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Reynders, Ana; Moqrich, Aziz] Aix Marseille Univ, CNRS, IBDM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Hoeffel, G; Ugolini, S (corresponding author), Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.	hoeffel@ciml.univ-mrs.fr; ugolini@ciml.univ-mrs.fr	Hoeffel, Guillaume/ABG-4881-2021	Hoeffel, Guillaume/0000-0002-2534-4972; Roger, Anais/0000-0003-4872-3171	European Research Council under the European Union [648768]; Agence Nationnale de la Recherche [ANR-14-CE14-0009-01]; Fondation pour la Recherche Medicale [ECO201906009090]; INSERM; CNRS; Aix-Marseille University; Marseille-Immunopole	European Research Council under the European Union(European Research Council (ERC)); Agence Nationnale de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Marseille-Immunopole	We thank V. Feuillet for reading the manuscript and for comments and discussions, B. Escaliere for statistical insights, J. Galluso for mouse breeding and genotyping, and M. Lucattelli and L. Zitvogel for providing Fpr1-knockout bone marrow cells. We thank S. Memet and J. P. Gorvel for providing the IL-10<SUP>GFP/GFP</SUP> mice and S. Sarrazin and M. Sieweke for providing the CX3CR1<SUP>CreERT2</SUP>:R26-YFP mice. We thank the Centre d'Immunologie de Marseille-Luminy (CIML) mouse house and core cytometry, imaging and histology facilities. The S.U. laboratory received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program, under grant agreement no. 648768; from the Agence Nationnale de la Recherche (no. ANR-14-CE14-0009-01); and from the Fondation pour la Recherche Medicale (no. ECO201906009090). This work was also supported by institutional grants from INSERM, CNRS, Aix-Marseille University and Marseille-Immunopole to the CIML.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; Eming SA, 2007, AM J PATHOL, V170, P188, DOI 10.2353/ajpath.2007.060370; Gaillard S, 2014, NEURON, V84, P123, DOI 10.1016/j.neuron.2014.08.056; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Hoeffel G, 2018, CELL IMMUNOL, V330, P5, DOI 10.1016/j.cellimm.2018.01.001; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; La Russa F, 2019, J INVEST DERMATOL, V139, P1936, DOI 10.1016/j.jid.2019.01.037; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lopes DM, 2016, CNS NEUROSCI THER, V22, P118, DOI 10.1111/cns.12444; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Pinho-Ribeiro FA, 2018, CELL, V173, P1083, DOI 10.1016/j.cell.2018.04.006; Reber LL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92900; Renthal W, 2020, NEURON, V108, P128, DOI 10.1016/j.neuron.2020.07.026; Reynders A, 2015, CELL REP, V10, P1007, DOI 10.1016/j.celrep.2015.01.022; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Serhan N, 2019, NAT IMMUNOL, V20, P1435, DOI 10.1038/s41590-019-0493-z; Sharma N, 2020, NATURE, V577, P392, DOI 10.1038/s41586-019-1900-1; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tang YT, 2004, GENOMICS, V83, P727, DOI 10.1016/j.ygeno.2003.10.006; Urien L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43493; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Wang WY, 2015, CELL MOL IMMUNOL, V12, P615, DOI 10.1038/cmi.2014.61; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	41	36	36	13	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					94	+		10.1038/s41586-021-03563-7	http://dx.doi.org/10.1038/s41586-021-03563-7		MAY 2021	29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM2RM	34012116	Green Submitted			2022-12-28	WOS:000652172000005
J	Otten, EG; Werner, E; Crespillo-Casado, A; Boyle, KB; Dharamdasani, V; Pathe, C; Santhanam, B; Randow, F				Otten, Elsje G.; Werner, Emma; Crespillo-Casado, Ana; Boyle, Keith B.; Dharamdasani, Vimisha; Pathe, Claudio; Santhanam, Balaji; Randow, Felix			Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection	NATURE			English	Article							MOYAMOYA-DISEASE; SELECTIVE AUTOPHAGY; RESTRICTS; CELLS; CYTOSOL; HOST	Ubiquitylation is a widespread post-translational protein modification in eukaryotes and marks bacteria that invade the cytosol as cargo for antibacterial autophagy(1-3). The identity of the ubiquitylated substrate on bacteria is unknown. Here we show that the ubiquitin coat on Salmonella that invade the cytosol is formed through the ubiquitylation of a non-proteinaceous substrate, the lipid A moiety of bacterial lipopolysaccharide (LPS), by the E3 ubiquitin ligase ring finger protein 213 (RNF213). RNF213 is a risk factor for moyamoya disease(4,5), which is a progressive stenosis of the supraclinoid internal carotid artery that causes stroke (especially in children)(6,7). RNF213 restricts the proliferation of cytosolic Salmonella and is essential for the generation of the bacterial ubiquitin coat, both directly (through the ubiquitylation of LPS) and indirectly (through the recruitment of LUBAC, which is a downstream E3 ligase that adds M1-linked ubiquitin chains onto pre-existing ubiquitin coats(8)). In cells that lack RNF213, bacteria do not attract ubiquitin-dependent autophagy receptors or induce antibacterial autophagy. The ubiquitylation of LPS on Salmonella that invade the cytosol requires the dynein-like core of RNF213, but not its RING domain. Instead, ubiquitylation of LPS relies on an RZ finger in the E3 shell. We conclude that ubiquitylation extends beyond protein substrates and that ubiquitylation of LPS triggers cell-autonomous immunity, and we postulate that non-proteinaceous substances other than LPS may also become ubiquitylated.	[Otten, Elsje G.; Werner, Emma; Crespillo-Casado, Ana; Boyle, Keith B.; Dharamdasani, Vimisha; Pathe, Claudio; Santhanam, Balaji; Randow, Felix] MRC Lab Mol Biol, Cambridge, England; [Randow, Felix] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England; [Santhanam, Balaji] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Santhanam, Balaji] St Jude Childrens Res Hosp, Ctr Data Driven Discovery, 332 N Lauderdale St, Memphis, TN 38105 USA	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Otten, EG; Randow, F (corresponding author), MRC Lab Mol Biol, Cambridge, England.; Randow, F (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England.	gotten@mrc-lmb.cam.ac.uk; randow@mrc-lmb.cam.ac.uk		Otten, Elsje/0000-0002-8716-3560	Boehringer Ingelheim Trust; MRC [U105170648]; Wellcome Trust [WT104752MA]	Boehringer Ingelheim Trust(Boehringer Ingelheim); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank F. Begum, S. Peak Chew and M. Shekel of the LMB mass spectrometry facility for analysing samples; D. Morito for providing RNF213 cDNA; and C. Gladkova and A. von der Malsburg for advice. This work was supported by a PhD fellowship from the Boehringer Ingelheim Trust to V.D., and by grants from the MRC (U105170648) and the Wellcome Trust (WT104752MA) to F.R.	Ahel J, 2020, ELIFE, V9, DOI 10.7554/eLife.56185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banh RS, 2016, NAT CELL BIOL, V18, P803, DOI 10.1038/ncb3376; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Engstrom P, 2019, NAT MICROBIOL, V4, P2538, DOI 10.1038/s41564-019-0583-6; Fiskin E, 2016, MOL CELL, V62, P967, DOI 10.1016/j.molcel.2016.04.015; Franco LH, 2017, CELL HOST MICROBE, V21, P59, DOI [10.1016/j.chom.2017.08.005, 10.1016/j.chom.2016.11.002]; Glover JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077222; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Liu WY, 2012, NEUROL MED-CHIR, V52, P299, DOI 10.2176/nmc.52.299; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; Morito D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04442; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Noad J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.63; Ogawa M, 2011, CELL HOST MICROBE, V9, P376, DOI 10.1016/j.chom.2011.04.010; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Piccolis M, 2019, MOL CELL, V74, P32, DOI 10.1016/j.molcel.2019.01.036; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Randow Felix, 2006, Subcell Biochem, V40, P383; Santos JC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16889-z; Schaible U. E., 2009, INTRACELLULAR NICHES; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sugihara M, 2019, J CELL BIOL, V218, P949, DOI 10.1083/jcb.201712120; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; van Wijk SJL, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.66; Wandel MP, 2020, NAT IMMUNOL, V21, P880, DOI 10.1038/s41590-020-0697-2; Wang Y, 2019, NAT CELL BIOL, V21, P1346, DOI 10.1038/s41556-019-0416-0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	45	66	68	22	89	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					111	+		10.1038/s41586-021-03566-4	http://dx.doi.org/10.1038/s41586-021-03566-4		MAY 2021	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM2RM	34012115	Green Accepted			2022-12-28	WOS:000652172000003
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: GPs deserve better than this micromanagement	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Bostock N, GP              0325; NHS England, 2021, UPD STAND OP PROC SO; Philpotts E, 2021, PULSE	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2021	373								n1256	10.1136/bmj.n1256	http://dx.doi.org/10.1136/bmj.n1256			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SL5PR	34006523	Bronze			2022-12-28	WOS:000656970600007
J	Shepherd, A				Shepherd, Alison			Doctors shine light on legal fight against PPE contracts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2021	373								n1259	10.1136/bmj.n1259	http://dx.doi.org/10.1136/bmj.n1259			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SL5PR	34006501	Bronze			2022-12-28	WOS:000656970600001
J	Ahmadlou, M; Houba, JHW; van Vierbergen, JFM; Giannouli, M; Gimenez, GA; van Weeghel, C; Darbanfouladi, M; Shirazi, MY; Dziubek, J; Kacem, M; de Winter, F; Heimel, JA				Ahmadlou, Mehran; Houba, Janou H. W.; van Vierbergen, Jacqueline F. M.; Giannouli, Maria; Gimenez, Geoffrey-Alexander; van Weeghel, Christiaan; Darbanfouladi, Maryam; Shirazi, Maryam Yasamin; Dziubek, Julia; Kacem, Mejdy; de Winter, Fred; Heimel, J. Alexander			A cell type-specific cortico-subcortical brain circuit for investigatory and novelty-seeking behavior	SCIENCE			English	Article							ZONA INCERTA; GABAERGIC NEURONS; VISUAL-CORTEX; CURIOSITY; MODULATION; PSYCHOLOGY	Exploring the physical and social environment is essential for understanding the surrounding world. We do not know how novelty-seeking motivation initiates the complex sequence of actions that make up investigatory behavior. We found in mice that inhibitory neurons in the medial zona incerta (ZIm), a subthalamic brain region, are essential for the decision to investigate an object or a conspecific. These neurons receive excitatory input from the prelimbic cortex to signal the initiation of exploration. This signal is modulated in the ZIm by the level of investigatory motivation. Increased activity in the ZIm instigates deep investigative action by inhibiting the periaqueductal gray region. A subpopulation of inhibitory ZIm neurons expressing tachykinin 1 (TAC1) modulates the investigatory behavior.	[Ahmadlou, Mehran; Houba, Janou H. W.; van Vierbergen, Jacqueline F. M.; Giannouli, Maria; Gimenez, Geoffrey-Alexander; van Weeghel, Christiaan; Darbanfouladi, Maryam; Shirazi, Maryam Yasamin; Dziubek, Julia; Kacem, Mejdy; Heimel, J. Alexander] Netherlands Inst Neurosci, Cort Struct & Funct Grp, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands; [de Winter, Fred] Netherlands Inst Neurosci, Lab Neuroregenerat, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands; [Ahmadlou, Mehran; Dziubek, Julia] UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, 25 Howland St, London W1T 4JG, England	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of London; University College London	Ahmadlou, M; Heimel, JA (corresponding author), Netherlands Inst Neurosci, Cort Struct & Funct Grp, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.; Ahmadlou, M (corresponding author), UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, 25 Howland St, London W1T 4JG, England.	m.ahmadlou@nin.knaw.nl	De Winter, Fred/AAZ-8671-2020	De Winter, Fred/0000-0002-3042-2429; Ahmadlou, Mehran/0000-0003-4688-2064; Houba, Janou/0000-0001-7902-132X; Dziubek, Julia/0000-0002-4313-512X; van Vierbergen, Jacqueline/0000-0002-5741-3119; Darbanfouladi, Maryam/0000-0003-4993-3509; Kacem, Mejdy/0000-0001-6913-4187; Gimenez, Geoffrey-Alexander/0000-0003-2838-8708	Dr. J. L. Dobberke Foundation; Onderzoekfonds KNAW-instituten, ronde 2019	Dr. J. L. Dobberke Foundation; Onderzoekfonds KNAW-instituten, ronde 2019	We thank J. Coppens, A. de Groot, R. Hamelink, M. Heemskerk, S. Hofer, H. Kessels, M. Oomstee, S. Super, J. van Veldhuijzen, M. Verhage, N. van der Wal, and J. Verhaagen. Funding: This work was supported by the Dr. J. L. Dobberke Foundation. F.d.W. was supported by Onderzoekfonds KNAW-instituten, ronde 2019.	Ahmadlou M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06389-6; Ahmadlou M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7773; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bardo MT, 1996, BEHAV BRAIN RES, V77, P23, DOI 10.1016/0166-4328(95)00203-0; BERLYNE DE, 1966, SCIENCE, V153, P25, DOI 10.1126/science.153.3731.25; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chou XL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03581-6; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004; Inamura N, 2011, DEV NEUROSCI-BASEL, V33, P118, DOI 10.1159/000328974; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/nmeth.2281, 10.1038/NMETH.2281]; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Kang MJ, 2009, PSYCHOL SCI, V20, P963, DOI 10.1111/j.1467-9280.2009.02402.x; Kidd C, 2015, NEURON, V88, P449, DOI 10.1016/j.neuron.2015.09.010; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kolmac C, 1999, ANAT EMBRYOL, V199, P265, DOI 10.1007/s004290050227; Li YQ, 2020, NATURE, V583, P819, DOI 10.1038/s41586-020-2504-5; Liang B, 2018, NEURON, V100, P700, DOI 10.1016/j.neuron.2018.08.043; Liu K, 2017, NATURE, V548, P582, DOI 10.1038/nature23663; LOEWENSTEIN G, 1994, PSYCHOL BULL, V116, P75, DOI 10.1037/0033-2909.116.1.75; Mahn M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06511-8; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mitrofanis J, 2005, NEUROSCIENCE, V130, P1, DOI 10.1016/j.neuroscience.2004.08.017; Murugan M, 2017, CELL, V171, P1663, DOI 10.1016/j.cell.2017.11.002; ROMANOWSKI CAJ, 1985, J ANAT, V143, P75; Shang CP, 2019, NAT NEUROSCI, V22, P909, DOI 10.1038/s41593-019-0405-4; Sommeijer JP, 2017, NAT NEUROSCI, V20, P1715, DOI 10.1038/s41593-017-0002-3; Spielberger CD., 1994, CURIOSITY EXPLORATOR, P221; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tovote P, 2016, NATURE, V534, P206, DOI 10.1038/nature17996; Venkataraman A, 2019, P NATL ACAD SCI USA, V116, P9072, DOI 10.1073/pnas.1820541116; Wang XY, 2019, ELIFE, V8, DOI 10.7554/eLife.42728; Zhang XB, 2017, SCIENCE, V356, P853, DOI 10.1126/science.aam7100; Zhao ZD, 2019, NAT NEUROSCI, V22, P921, DOI 10.1038/s41593-019-0404-5; Zhou M, 2018, NAT NEUROSCI, V21, P1515, DOI 10.1038/s41593-018-0248-4	38	19	19	16	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					704	+	abe9681	10.1126/science.abe9681	http://dx.doi.org/10.1126/science.abe9681			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986154	Green Submitted			2022-12-28	WOS:000651125300041
J	Gibbons, MD; Mendoza, DP; Waheed, A; Barshak, MB; Villalba, JA				Gibbons, Michael D.; Mendoza, Dexter P.; Waheed, Anem; Barshak, Miriam B.; Villalba, Julian A.			Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BABESIOSIS; DIAGNOSIS; PERSISTENT; ADULT; SCORE	A Woman with Fever and Pancytopenia A 64-year-old woman with multiple sclerosis was admitted with fever and pancytopenia after a 7-month illness that began with nausea and fatigue. CT revealed splenomegaly; FDG-PET revealed uptake in the spleen and bone marrow throughout the axial and appendicular skeleton. A diagnostic test result was received.	[Gibbons, Michael D.] Newton Wellesley Hosp, Dept Med, Newton, MA 02462 USA; [Mendoza, Dexter P.] Massachusetts Gen Hosp, Dept Radiol, 32 Fruit St, Boston, MA 02114 USA; [Waheed, Anem; Barshak, Miriam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Mendoza, Dexter P.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Waheed, Anem; Barshak, Miriam B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Villalba, Julian A.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Newton Wellesley Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gibbons, MD (corresponding author), Newton Wellesley Hosp, Dept Med, Newton, MA 02462 USA.		Villalba, Julian/AAK-4222-2020; Waheed, Anem/GXA-0429-2022	Villalba, Julian/0000-0001-9230-8747; 				ABDALLA SH, 1990, BLOOD CELLS, V16, P401; Akel T, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0179-z; Austin A, 2019, AM J HEMATOL, V94, P378, DOI 10.1002/ajh.25324; Bowen JL, 2006, NEW ENGL J MED, V355, P2217, DOI 10.1056/NEJMra054782; Dawson MA, 2005, INTERN MED J, V35, P626, DOI 10.1111/j.1445-5994.2005.00912.x; Debaugnies F, 2016, AM J CLIN PATHOL, V145, P862, DOI [10.1093/AJCP/AQW076, 10.1093/ajcp/aqw076]; Fardet L, 2014, ARTHRITIS RHEUMATOL, V66, P2613, DOI 10.1002/art.38690; Gesundheit B, 2006, J PEDIAT HEMATOL ONC, V28, P194, DOI 10.1097/01.mph.0000200672.77667.56; Hayden A, 2017, BLOOD ADV, V1, P2529, DOI 10.1182/bloodadvances.2017012310; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Iolascon A, 2020, BLOOD, V136, P1274, DOI 10.1182/blood.2019000948; Kennedy-Snodgrass C, 2019, AM J HEMATOL, V94, P379, DOI 10.1002/ajh.25364; Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; MARCHAND A, 1980, JAMA-J AM MED ASSOC, V243, P1909, DOI 10.1001/jama.243.19.1909; Marsh RA, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01902; RUEBUSH TK, 1977, NEW ENGL J MED, V297, P825, DOI 10.1056/NEJM197710132971511; Sanchez E, 2016, JAMA-J AM MED ASSOC, V315, P1767, DOI 10.1001/jama.2016.2884	18	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					1849	1857		10.1056/NEJMcpc2100275	http://dx.doi.org/10.1056/NEJMcpc2100275			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD6UF	33979492				2022-12-28	WOS:000651509400013
J	Wise, J				Wise, Jacqui			Covid-19: Global response was too slow and leadership absent, report finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Independent Panel for Pandemic Preparedness and Response, 2021, COV 19 MAKE IT LAST	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2021	373								n1234	10.1136/bmj.n1234	http://dx.doi.org/10.1136/bmj.n1234			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3HS	33985967	Bronze			2022-12-28	WOS:000652650700009
J	Bunduc, CM; Fahrenkamp, D; Wald, J; Ummels, R; Bitter, W; Houben, ENG; Marlovits, TC				Bunduc, Catalin M.; Fahrenkamp, Dirk; Wald, Jiri; Ummels, Roy; Bitter, Wilbert; Houben, Edith N. G.; Marlovits, Thomas C.			Structure and dynamics of a mycobacterial type VII secretion system	NATURE			English	Article							PROTEIN; EVOLUTION; COMPONENT; COMPLEX; MODEL	Mycobacterium tuberculosis is the cause of one of the most important infectious diseases in humans, which leads to 1.4 million deaths every year(1). Specialized protein transport systems-known as type VII secretion systems (T7SSs)-are central to the virulence of this pathogen, and are also crucial for nutrient and metabolite transport across the mycobacterial cell envelope(2,3). Here we present the structure of an intact T7SS inner-membrane complex of M. tuberculosis. We show how the 2.32-MDa ESX-5 assembly, which contains 165 transmembrane helices, is restructured and stabilized as a trimer of dimers by the MycP(5) protease. A trimer of MycP(5) caps a central periplasmic dome-like chamber that is formed by three EccB(5) dimers, with the proteolytic sites of MycP(5) facing towards the cavity. This chamber suggests a central secretion and processing conduit. Complexes without MycP(5) show disruption of the EccB(5) periplasmic assembly and increased flexibility, which highlights the importance of MycP(5) for complex integrity. Beneath the EccB(5)-MycP(5) chamber, dimers of the EccC(5) ATPase assemble into three bundles of four transmembrane helices each, which together seal the potential central secretion channel. Individual cytoplasmic EccC(5) domains adopt two distinctive conformations that probably reflect different secretion states. Our work suggests a previously undescribed mechanism of protein transport and provides a structural scaffold to aid in the development of drugs against this major human pathogen.	[Bunduc, Catalin M.; Fahrenkamp, Dirk; Wald, Jiri; Marlovits, Thomas C.] Ctr Struct Syst Biol, Hamburg, Germany; [Bunduc, Catalin M.; Fahrenkamp, Dirk; Wald, Jiri; Marlovits, Thomas C.] Univ Med Ctr Hamburg Eppendorf, Inst Struct & Syst Biol, Hamburg, Germany; [Bunduc, Catalin M.; Fahrenkamp, Dirk; Wald, Jiri; Marlovits, Thomas C.] Deutsch Elektron Synchrotron DESY, Hamburg, Germany; [Bitter, Wilbert; Houben, Edith N. G.] Vrije Univ Amsterdam, Amsterdam Inst Mol & Life Sci, Mol Microbiol Sect, Amsterdam, Netherlands; [Ummels, Roy; Bitter, Wilbert] Amsterdam UMC, Amsterdam Infect & Immun Inst, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Vrije Universiteit Amsterdam; University of Amsterdam	Marlovits, TC (corresponding author), Ctr Struct Syst Biol, Hamburg, Germany.; Marlovits, TC (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Struct & Syst Biol, Hamburg, Germany.; Marlovits, TC (corresponding author), Deutsch Elektron Synchrotron DESY, Hamburg, Germany.	marlovits@marlovitslab.org	Wald, Jiri/AAX-1215-2021; Bitter, W/CAJ-5778-2022; Houben, Edith N.G./B-2110-2015	Houben, Edith N.G./0000-0002-8805-2002; Bitter, Wilbert/0000-0001-8347-6511; Wald, Jiri/0000-0002-1539-6488; Marlovits, Thomas/0000-0001-8106-4038	Behorde fur Wissenschaft, Forschung und Gleichstellung of the city of Hamburg at the Institute of Structural and Systems Biology at the University Medical Center Hamburg-Eppendorf (UKE); DESY (German Electron Synchrotron Center); University of Hamburg; University Medical Center Hamburg-Eppendorf; DFG [INST152/772-1, 152/774-1, 152/775-1, 152/776-1, 152/777-1 FUGG]; VIDI grant from the Netherlands Organization of Scientific Research [864.12.006]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [101030373]	Behorde fur Wissenschaft, Forschung und Gleichstellung of the city of Hamburg at the Institute of Structural and Systems Biology at the University Medical Center Hamburg-Eppendorf (UKE); DESY (German Electron Synchrotron Center); University of Hamburg; University Medical Center Hamburg-Eppendorf; DFG(German Research Foundation (DFG)); VIDI grant from the Netherlands Organization of Scientific Research; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa)	We thank all members of the laboratories of T.C.M., E.N.G.H. and W.B. for their support of this project; W. Lugmayr for scientific IT support; L. Ciccarelli for initial cryo-EM analysis of the M. tuberculosis ESX-5 complex; and T. Croll for his support with ISOLDE. High-performance computing was possible through access to the HPC at DESY/Hamburg. Cryo-EM data collection was performed at the Cryo-EM Facility at CSSB. This project was supported by funds available to T.C.M. through the Behorde fur Wissenschaft, Forschung und Gleichstellung of the city of Hamburg at the Institute of Structural and Systems Biology at the University Medical Center Hamburg-Eppendorf (UKE). The laboratory of T.C.M. is supported by DESY (German Electron Synchrotron Center). The cryo-EM facility is supported by the University of Hamburg, the University Medical Center Hamburg-Eppendorf and DFG grant numbers INST152/772-1, 152/774-1, 152/775-1, 152/776-1 and 152/777-1 FUGG. This work received funding by a VIDI grant (864.12.006; to C.M.B. and E.N.G.H.) from the Netherlands Organization of Scientific Research. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 101030373 (to C.M.B.).	[Anonymous], 2015, PYMOL MOL GRAPHICS S; Beckham KSH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.47; Bunduc CM, 2020, ANNU REV MICROBIOL, V74, P315, DOI 10.1146/annurev-micro-012420-081657; Bunduc CM, 2020, MOL MICROBIOL, V114, P66, DOI 10.1111/mmi.14496; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Famelis N, 2019, NATURE, V576, P321, DOI 10.1038/s41586-019-1633-1; Groschel MI, 2016, NAT REV MICROBIOL, V14, P677, DOI 10.1038/nrmicro.2016.131; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Poweleit N, 2019, ELIFE, V8, DOI 10.7554/eLife.52983; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenberg OS, 2015, CELL, V161, P501, DOI 10.1016/j.cell.2015.03.040; Rybniker J, 2014, CELL HOST MICROBE, V16, P538, DOI 10.1016/j.chom.2014.09.008; Sanchez-Garcia R, 2020, PREPRINT, DOI [10.1101/2020.06.12.148296, DOI 10.1101/2020.06.12.148296]; Solomonson M, 2013, J BIOL CHEM, V288, P17782, DOI 10.1074/jbc.M113.462036; Terwilliger TC, 2020, NAT METHODS, V17, P923, DOI 10.1038/s41592-020-0914-9; van Winden VJC, 2020, J MOL BIOL, V432, P1265, DOI 10.1016/j.jmb.2019.12.040; van Winden VJC, 2019, J BIOL CHEM, V294, P4806, DOI 10.1074/jbc.RA118.007090; van Winden VJC, 2016, MBIO, V7, DOI 10.1128/mBio.01471-16; Wagner' JM, 2016, BMC STRUCT BIOL, V16, DOI [10.1186/s12900-016-0056-6, 10.1186/S12900-016-0056-6]; Wagner JM, 2013, J STRUCT BIOL, V184, P115, DOI 10.1016/j.jsb.2013.09.022; Wagner T, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0790-y; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; World Health Organization (WHO), 2019, TUBERCULOSIS; Xie XQ, 2016, ACTA CRYSTALLOGR F, V72, P139, DOI 10.1107/S2053230X16000212; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081	32	13	13	2	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					445	+		10.1038/s41586-021-03517-z	http://dx.doi.org/10.1038/s41586-021-03517-z		MAY 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE2PC	33981042	Green Published, hybrid			2022-12-28	WOS:000650174400004
J	Aspvall, K; Andersson, E; Melin, K; Norlin, L; Eriksson, V; Vigerland, S; Jolstedt, M; Silverberg-Morse, M; Wallin, L; Sampaio, F; Feldman, I; Bottai, M; Lenhard, F; Mataix-Cols, D; Serlachius, E				Aspvall, Kristina; Andersson, Erik; Melin, Karin; Norlin, Lisa; Eriksson, Viktor; Vigerland, Sarah; Jolstedt, Maral; Silverberg-Moerse, Maria; Wallin, Lena; Sampaio, Filipa; Feldman, Inna; Bottai, Matteo; Lenhard, Fabian; Mataix-Cols, David; Serlachius, Eva			Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCALE; RELIABILITY; INTERVIEW; VALIDITY; VERSION; OCD	Key PointsQuestionIs internet-delivered cognitive behavioral therapy (CBT) implemented in a stepped-care model noninferior to in-person CBT for children and adolescents with obsessive-compulsive disorder? FindingsIn this randomized, noninferiority clinical trial, 152 children and adolescents with obsessive-compulsive disorder were treated with an internet-delivered CBT program followed by traditional in-person CBT if necessary vs in-person CBT alone. After 6 months, the mean Children's Yale-Brown Obsessive-Compulsive Scale score was 11.57 in those treated with internet-delivered CBT vs 10.57 in those treated with in-person CBT, a difference that met the noninferiority criterion of 4 points. MeaningTreating children and adolescents with obsessive-compulsive disorder with an internet intervention followed by traditional face-to-face therapy if necessary was noninferior to in-person therapy alone. ImportanceIn most countries, young people with obsessive-compulsive disorder have limited access to specialist cognitive behavioral therapy (CBT), a first-line treatment. ObjectiveTo investigate whether internet-delivered CBT implemented in a stepped-care model is noninferior to in-person CBT for pediatric obsessive-compulsive disorder. Design, Setting and ParticipantsA randomized clinical noninferiority trial conducted at 2 specialist child and adolescent mental health clinics in Sweden. Participants included 152 individuals aged 8 to 17 years with obsessive-compulsive disorder. Enrollment began in October 2017 and ended in May 2019. Follow-up ended in April 2020. InterventionsParticipants randomized to the stepped-care group (n=74) received internet-delivered CBT for 16 weeks. Nonresponders at the 3-month follow-up were then offered a course of traditional face-to-face treatment. Participants randomized to the control group (n=78) immediately received in-person CBT for 16 weeks. Nonresponders at the 3-month follow-up received additional face-to-face treatment. Main Outcomes and MeasuresThe primary outcome was the masked assessor-rated Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) score at the 6-month follow-up. The scale includes 10 items rated from 0(no symptoms) to 4(extreme symptoms), yielding a total score range of 0 to 40, with higher scores indicating greater severity. Assessors were masked to treatment allocation at pretreatment, posttreatment, 3-month follow-up, and 6-month follow-up assessments. The predefined noninferiority margin was 4 points on the CY-BOCS. ResultsAmong the 152 randomized participants (mean age, 13.4 years; 94 [62%] females), 151 (99%) completed the trial. At the 3-month follow-up, 34 participants (46%) in the stepped-care group and 23 (30%) in the in-person CBT group were nonresponders. At the 6-month follow-up, the CY-BOCS score was 11.57 points in the stepped-care group vs 10.57 points in the face-to-face treatment group, corresponding to an estimated mean difference of 0.91 points ([1-sided 97.5% CI, -infinity to 3.28]; P for noninferiority=.02). Increased anxiety (30%-36%) and depressive symptoms (20%-28%) were the most frequently reported adverse events in both groups. There were 2 unrelated serious adverse events (1 in each group). Conclusions and RelevanceAmong children and adolescents with obsessive-compulsive disorder, treatment with an internet-delivered CBT program followed by in-person CBT if necessary compared with in-person CBT alone resulted in a noninferior difference in symptoms at the 6-month follow-up. Further research is needed to understand the durability and generalizability of these findings. Trial RegistrationClinicalTrials.gov Identifier: NCT03263546 This noninferiority trial compares the effects of an internet-delivered cognitive behavioral therapy (CBT) program followed by traditional in-person CBT if necessary vs in-person CBT alone on symptoms of obsessive compulsive disorder (OCD) in children and adolescents.	[Aspvall, Kristina; Vigerland, Sarah; Jolstedt, Maral; Lenhard, Fabian; Mataix-Cols, David; Serlachius, Eva] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Solna, Sweden; [Aspvall, Kristina; Eriksson, Viktor; Vigerland, Sarah; Jolstedt, Maral; Silverberg-Moerse, Maria; Mataix-Cols, David; Serlachius, Eva] Stockholm Hlth Care Serv, Stockholm, Region Stockhol, Sweden; [Andersson, Erik] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden; [Melin, Karin] Univ Gothenburg, Inst Hlth & Care Sci, Sahlgrenska Acad, Gothenburg, Sweden; [Melin, Karin; Norlin, Lisa; Wallin, Lena] Sahlgrens Univ Hosp, Dept Child & Adolescent Psychiat, Gothenburg, Region Vastra G, Sweden; [Wallin, Lena] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Sampaio, Filipa; Feldman, Inna] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Bottai, Matteo] Karolinska Inst, Div Biostat, Inst Environm Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Uppsala University; Karolinska Institutet	Aspvall, K (corresponding author), Child & Adolescent Psychiat Res Ctr, Gavlegatan 22, SE-11330 Stockholm, Sweden.	kristina.aspvall@ki.se		Melin, Karin/0000-0002-3297-7735				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Angold A, 1995, INT J METHOD PSYCH, V5, P237; [Anonymous], 2005, GUIDELINE CHOICE NON; Aspvall K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13810; Aspvall K, 2020, INTERNET INTERV, V20, DOI 10.1016/j.invent.2020.100308; Aspvall K, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-2450-7; Aspvall K, 2018, BJPSYCH OPEN, V4, P106, DOI 10.1192/bjo.2018.10; Babiano-Espinosa L, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1166-6; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Fawcett EJ, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.19r13085; Fernandez de la Cruz L, 2017, MOL PSYCHIATR, V22, P1626, DOI 10.1038/mp.2016.115; Fineberg NA, 2019, EUR NEUROPSYCHOPHARM, V29, P549, DOI 10.1016/j.euroneuro.2019.02.002; Geller DA, 2012, J AM ACAD CHILD PSY, V51, P98, DOI 10.1016/j.jaac.2011.09.019; Goodwin R, 2002, ACTA PSYCHIAT SCAND, V106, P143, DOI 10.1034/j.1600-0447.2002.01221.x; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; Isomura K, 2018, BIOL PSYCHIAT, V84, P324, DOI 10.1016/j.biopsych.2017.12.003; Jassi A, 2020, CHILD PSYCHIAT HUM D, V51, P453, DOI 10.1007/s10578-020-00956-z; Jolstedt M, 2018, LANCET CHILD ADOLESC, V2, P792, DOI 10.1016/S2352-4642(18)30275-X; Lenhard F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015246; Lenhard F, 2017, J AM ACAD CHILD PSY, V56, P10, DOI 10.1016/j.jaac.2016.09.515; Lenhard F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100773; Lovell K, 2006, BMJ-BRIT MED J, V333, P883, DOI 10.1136/bmj.38940.355602.80; Mataix-Cols D, 2006, COMPR PSYCHIAT, V47, P243, DOI 10.1016/j.comppsych.2005.11.007; Mataix-Cols D, 2016, WORLD PSYCHIATRY, V15, P80, DOI 10.1002/wps.20299; Ost LG, 2016, J ANXIETY DISORD, V43, P58, DOI 10.1016/j.janxdis.2016.08.003; Perez-Vigil A, 2019, PSYCHOL MED, V49, P1015, DOI 10.1017/S0033291718001691; Perez-Vigil A, 2018, JAMA PSYCHIAT, V75, P47, DOI 10.1001/jamapsychiatry.2017.3523; Pinto A, 2006, J CLIN PSYCHIAT, V67, P703, DOI 10.4088/JCP.v67n0503; Pinto A, 2013, J OBSESS-COMPULS REL, V2, P457, DOI 10.1016/j.jocrd.2012.06.001; Rubin D.B., 1975, ETS RES B SER, V1, P1, DOI [10.1002/j.2333-8504.1975.tb01053.x, DOI 10.1002/J.2333-8504.1975.TB01053.X]; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Skarphedinsson G, 2015, J CHILD ADOL PSYCHOP, V25, P574, DOI 10.1089/cap.2015.0041; Stevens K, 2011, APPL HEALTH ECON HEA, V9, P157, DOI 10.2165/11587350-000000000-00000; Taylor S, 2011, CLIN PSYCHOL REV, V31, P1083, DOI 10.1016/j.cpr.2011.06.007; Turner CM, 2014, J AM ACAD CHILD PSY, V53, P1298, DOI 10.1016/j.jaac.2014.09.012; Uher R, 2008, J ANXIETY DISORD, V22, P979, DOI 10.1016/j.janxdis.2007.10.001	39	11	11	3	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1863	1873		10.1001/jama.2021.3839	http://dx.doi.org/10.1001/jama.2021.3839			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SB7YR	33974020	Green Published, Bronze			2022-12-28	WOS:000650205000015
J	Dyer, C				Dyer, Clare			Opportunities to prevent children dying from asthma are being missed, says safety watchdog	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Healthcare Safety Investigation Branch, 2021, MAN CHRON ASTHM CHIL; Royal College of Physicians, 2014, NAT REV ASTHM DEATHS; Shah R, 2019, INT COMPARISONS HLTH	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2021	373								n1180	10.1136/bmj.n1180	http://dx.doi.org/10.1136/bmj.n1180			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QT	33962971				2022-12-28	WOS:000649708700005
J	Nguyen, TP; Easley, AD; Kang, NA; Khan, S; Lim, SM; Rezenom, YH; Wang, SY; Tran, DK; Fan, JW; Letteri, RA; He, X; Su, L; Yu, CH; Lutkenhaus, JL; Wooley, KL				Nguyen, Tan P.; Easley, Alexandra D.; Kang, Nari; Khan, Sarosh; Lim, Soon-Mi; Rezenom, Yohannes H.; Wang, Shaoyang; Tran, David K.; Fan, Jingwei; Letteri, Rachel A.; He, Xun; Su, Lu; Yu, Cheng-Han; Lutkenhaus, Jodie L.; Wooley, Karen L.			Polypeptide organic radical batteries	NATURE			English	Article							LITHIUM-ION BATTERY; ELECTROLYTE-TYPE; POLYMER; MOIETIES	In only a few decades, lithium-ion batteries have revolutionized technologies, enabling the proliferation of portable devices and electric vehicles(1), with substantial benefits for society. However, the rapid growth in technology has highlighted the ethical and environmental challenges of mining lithium, cobalt and other mineral ore resources, and the issues associated with the safe usage and non-hazardous disposal of batteries(2). Only a small fraction of lithium-ion batteries are recycled, further exacerbating global material supply of strategic elements(3-5). A potential alternative is to use organic-based redox-active materials(6-8) to develop rechargeable batteries that originate from ethically sourced, sustainable materials and enable on-demand deconstruction and reconstruction. Making such batteries is challenging because the active materials must be stable during operation but degradable at end of life. Further, the degradation products should be either environmentally benign or recyclable for reconstruction into a new battery. Here we demonstrate a metal-free, polypeptide-based battery, in which viologens and nitroxide radicals are incorporated as redox-active groups along polypeptide backbones to function as anode and cathode materials, respectively. These redox-active polypeptides perform as active materials that are stable during battery operation and subsequently degrade on demand in acidic conditions to generate amino acids, other building blocks and degradation products. Such a polypeptide-based battery is a first step to addressing the need for alternative chemistries for green and sustainable batteries in a future circular economy. An environmentally friendly, all-organic radical battery is demonstrated, in which redox-active polypeptides perform as both cathode and anode materials, with a metal-free organic electrolyte.	[Nguyen, Tan P.; Khan, Sarosh; Lim, Soon-Mi; Rezenom, Yohannes H.; Tran, David K.; Fan, Jingwei; Letteri, Rachel A.; He, Xun; Su, Lu; Yu, Cheng-Han; Lutkenhaus, Jodie L.; Wooley, Karen L.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Easley, Alexandra D.; Kang, Nari; Wooley, Karen L.] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA; [Wang, Shaoyang; Lutkenhaus, Jodie L.; Wooley, Karen L.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Lutkenhaus, JL; Wooley, KL (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.; Wooley, KL (corresponding author), Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.; Lutkenhaus, JL; Wooley, KL (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.	jodie.lutkenhaus@tamu.edu; wooley@chem.tamu.edu	Wooley, Karen L/D-4399-2015; Wooley, Karen/AAX-2259-2020; Lim, Soon Mi/O-3976-2014	Wooley, Karen L/0000-0003-4086-384X; Wooley, Karen/0000-0003-4086-384X; Su, Lu/0000-0001-8207-756X; Lim, Soon Mi/0000-0002-7186-4629; Easley, Alexandra/0000-0001-5680-6431				Bard A.J., 2000, ELECTROCHEMICAL METH; BELSHAW PJ, 1990, SYNTHETIC COMMUN, V20, P3157, DOI 10.1080/00397919008051540; Bugnon L, 2007, CHEM MATER, V19, P2910, DOI 10.1021/cm063052h; Coates GW, 2020, NAT REV MATER, V5, P501, DOI 10.1038/s41578-020-0190-4; Deming TJ, 2016, CHEM REV, V116, P786, DOI 10.1021/acs.chemrev.5b00292; Deming TJ, 2010, NAT MATER, V9, P535, DOI 10.1038/nmat2789; Elsabahy M, 2013, J MATER CHEM B, V1, P5241, DOI [10.1039/C3TB20668H, 10.1039/c3tb20668h]; Engler AC, 2009, ANGEW CHEM INT EDIT, V48, P9334, DOI 10.1002/anie.200904070; Esquivel JP, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201700275; Fan JW, 2014, POLYM CHEM-UK, V5, P3977, DOI 10.1039/c4py00628c; Friebe C, 2019, CHEMSUSCHEM, V12, P4093, DOI 10.1002/cssc.201901545; Galbo J. P., 1994, US patent, Patent No. [5374729A, 5374729]; Hansen KA, 2020, CHEMSUSCHEM, V13, P2386, DOI 10.1002/cssc.201903529; Hatakeyama-Sato K, 2018, ADV MATER, V30, DOI 10.1002/adma.201800900; Hiejima T, 2013, MACROMOLECULES, V46, P1713, DOI 10.1021/ma302256c; Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924; Ibe T, 2010, CHEM COMMUN, V46, P3475, DOI 10.1039/c002797a; Janoschka T, 2015, NATURE, V527, P78, DOI 10.1038/nature15746; Janoschka T, 2013, ADV ENERGY MATER, V3, P1025, DOI 10.1002/aenm.201300036; Janoschka T, 2012, ADV MATER, V24, P6397, DOI 10.1002/adma.201203119; Joo Y, 2018, SCIENCE, V359, P1391, DOI 10.1126/science.aao7287; Kim J, 2017, JOULE, V1, P739, DOI 10.1016/j.joule.2017.08.018; Koshika K, 2010, GREEN CHEM, V12, P1573, DOI 10.1039/b926296b; Koshika K, 2009, MACROMOL CHEM PHYS, V210, P1989, DOI 10.1002/macp.200900257; Lalatsa A, 2012, J CONTROL RELEASE, V161, P523, DOI 10.1016/j.jconrel.2012.04.046; Lopez J, 2019, NAT REV MATER, V4, P312, DOI 10.1038/s41578-019-0103-6; Lutkenhaus J, 2018, SCIENCE, V359, P1334, DOI 10.1126/science.aat1298; Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b; Muench S, 2016, CHEM REV, V116, P9438, DOI 10.1021/acs.chemrev.6b00070; Nkulu CBL, 2018, NAT SUSTAIN, V1, P495, DOI 10.1038/s41893-018-0139-4; Oka K, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201805858; Olivetti EA, 2017, JOULE, V1, P229, DOI 10.1016/j.joule.2017.08.019; Otaki M, 2019, MACROMOLECULES, V52, P3199, DOI 10.1021/acs.macromol.9b00274; Qu JQ, 2008, CHEM-EUR J, V14, P3250, DOI 10.1002/chem.200800021; Qu JQ, 2007, J POLYM SCI POL CHEM, V45, P5431, DOI 10.1002/pola.22288; Sano N, 2013, ACS APPL MATER INTER, V5, P1355, DOI 10.1021/am302647w; Shpilevaya I, 2014, ELECTROANAL, V26, P2088, DOI 10.1002/elan.201400310; Suga T, 2011, ADV MATER, V23, P751, DOI 10.1002/adma.201003525; Suga T, 2009, ADV MATER, V21, P1627, DOI 10.1002/adma.200803073; Tomlinson EP, 2014, MACROMOLECULES, V47, P6145, DOI 10.1021/ma5014572; Turcheniuk K, 2018, NATURE, V559, P467, DOI 10.1038/d41586-018-05752-3; Vlad A, 2015, CHEMSUSCHEM, V8, P1692, DOI 10.1002/cssc.201500246; Wang SY, 2020, CHEMSUSCHEM, V13, P2371, DOI 10.1002/cssc.201903554; Wild A, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201601415; Zeng XL, 2014, CRIT REV ENV SCI TEC, V44, P1129, DOI 10.1080/10643389.2013.763578; Zhang K, 2016, POLYM CHEM-UK, V7, P5589, DOI 10.1039/c6py00996d	46	81	80	111	410	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					61	+		10.1038/s41586-021-03399-1	http://dx.doi.org/10.1038/s41586-021-03399-1			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RY0YD	33953410	Green Submitted			2022-12-28	WOS:000647642900012
J	Yu, QH; Kilik, U; Holloway, EM; Tsai, YH; Harmel, C; Wu, A; Wu, JH; Czerwinski, M; Childs, CJ; He, ZS; Capeling, MM; Huang, S; Glass, IA; Higgins, PDR; Treutlein, B; Spence, JR; Camp, JG				Yu, Qianhui; Kilik, Umut; Holloway, Emily M.; Tsai, Yu-Hwai; Harmel, Christoph; Wu, Angeline; Wu, Joshua H.; Czerwinski, Michael; Childs, Charlie J.; He, Zhisong; Capeling, Meghan M.; Huang, Sha; Glass, Ian A.; Higgins, Peter D. R.; Treutlein, Barbara; Spence, Jason R.; Camp, J. Gray			Charting human development using a multi-endodermal organ atlas and organoid models	CELL			English	Article							HUMAN INTESTINAL ORGANOIDS; PLURIPOTENT STEM-CELLS; IN-VITRO; OVERLAPPING FUNCTIONS; PROGENITOR CELLS; CDX2; EXPRESSION; DIFFERENTIATION; GENERATION; MOUSE	Organs are composed of diverse cell types that traverse transient states during organogenesis. To interrogate this diversity during human development, we generate a single-cell transcriptome atlas from multiple developing endodermal organs of the respiratory and gastrointestinal tract. We illuminate cell states, transcription factors, and organ-specific epithelial stem cell and mesenchyme interactions across lineages. We implement the atlas as a high-dimensional search space to benchmark human pluripotent stem cell (hPSC)-derived intestinal organoids (HIOs) under multiple culture conditions. We show that HIOs recapitulate reference cell states and use HIOs to reconstruct the molecular dynamics of intestinal epithelium and mesenchyme emergence. We show that the mesenchyme-derived niche cue NRG1 enhances intestinal stem cell maturation in vitro and that the homeobox transcription factor CDX2 is required for regionalization of intestinal epithelium and mesenchyme in humans. This work combines cell atlases and organoid technologies to understand how human organ development is orchestrated.	[Yu, Qianhui; Kilik, Umut; Harmel, Christoph; Camp, J. Gray] Inst Mol & Clin Ophthalmol Basel, CH-4031 Basel, Switzerland; [Kilik, Umut; Harmel, Christoph; Camp, J. Gray] Univ Basel, Dept Ophthalmol, CH-4031 Basel, Switzerland; [Holloway, Emily M.; Childs, Charlie J.; Spence, Jason R.] Univ Michigan, Dept Cell & Dev Biol, Med Sch, Ann Arbor, MI 48109 USA; [Tsai, Yu-Hwai; Wu, Angeline; Wu, Joshua H.; Czerwinski, Michael; Huang, Sha; Higgins, Peter D. R.; Spence, Jason R.] Univ Michigan, Dept Internal Med, Gastroenterol, Med Sch, Ann Arbor, MI 48109 USA; [He, Zhisong; Treutlein, Barbara] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Glass, Ian A.] Univ Washington, Dept Pediat, Genet Med, Seattle, WA 98195 USA; [Capeling, Meghan M.; Spence, Jason R.] Univ Michigan, Dept Biomed Engn, Coll Engn, Ann Arbor, MI 48109 USA	University of Basel; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan	Camp, JG (corresponding author), Inst Mol & Clin Ophthalmol Basel, CH-4031 Basel, Switzerland.; Camp, JG (corresponding author), Univ Basel, Dept Ophthalmol, CH-4031 Basel, Switzerland.; Spence, JR (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Med Sch, Ann Arbor, MI 48109 USA.; Spence, JR (corresponding author), Univ Michigan, Dept Internal Med, Gastroenterol, Med Sch, Ann Arbor, MI 48109 USA.; Treutlein, B (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.; Spence, JR (corresponding author), Univ Michigan, Dept Biomed Engn, Coll Engn, Ann Arbor, MI 48109 USA.	barbara.treutlein@bsse.ethz.ch; spencejr@med.umich.edu; grayson.camp@iob.ch		Wu, Joshua/0000-0002-2575-4912; Kilik, Umut/0000-0001-6386-8294; Capeling, Meghan/0000-0003-0310-123X	Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation [CZF2019-002440]; European Research Council [803441, 758877, 874606]; Swiss National Science Foundation [310030_84795, 310030_192604]; National Center of Competence in Research Molecular Systems Engineering; Intestinal Stem Cell Consortium [U01DK103141]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Heart, Lung, and Blood Institute (NHLBI) [R01HL119215]; NIAID Novel Alternative Model Systems for Enteric Diseases (NAMSED) Consortium [U19AI116482]; NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [5R24HD000836]; Training in Basic and Translational Digestive Sciences training grant (NIH-NIDDK) [5T32DK094775]; Cellular Biotechnology Training Program training grant (NIH-NIGMS) [2T32GM008353]; Ruth L. Kirschstein Predoctoral Individual National Research Service Award (NIH-NHLBI) [F31HL146162]; Training Program in Organogenesis (NIH-NICHD) [T32 HD007505]; University of Michigan Center for Gastrointestinal Research (UMCGR) (NIDDK) [5P30DK034933]	Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research Molecular Systems Engineering; Intestinal Stem Cell Consortium; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID Novel Alternative Model Systems for Enteric Diseases (NAMSED) Consortium; NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Training in Basic and Translational Digestive Sciences training grant (NIH-NIDDK); Cellular Biotechnology Training Program training grant (NIH-NIGMS); Ruth L. Kirschstein Predoctoral Individual National Research Service Award (NIH-NHLBI); Training Program in Organogenesis (NIH-NICHD); University of Michigan Center for Gastrointestinal Research (UMCGR) (NIDDK)	We thank the Camp and Treutlein labs for helpful discussions, Marc Perea and Mendurim Rahshiti of IOB-IT for support hosting the GutTubeR data browser, and D-BSSE IT Services for computational support. We thank Judy Opp and the University of Michigan Advanced Genomics Core for expertise regarding operation of the 10X Chromium single-cell capture platform and sequencing. We would also like to thank the University of Washington Laboratory of Developmental Biology staff for supporting this project. J.G.C., J.R.S., and B.T. are supported by grant CZF2019-002440 from the Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation. J.G.C. is supported by the European Research Council (Anthropoid-803441) and the Swiss National Science Foundation (project grant 310030_84795). B.T. is supported by the European Research Council (Organomics-758877 and Braintime-874606), the Swiss National Science Foundation (project grant 310030_192604), and the National Center of Competence in Research Molecular Systems Engineering. J.R.S. is supported by the Intestinal Stem Cell Consortium (U01DK103141), a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the National Institute of Allergy and Infectious Diseases (NIAID). J.R.S. is also supported by the National Heart, Lung, and Blood Institute (NHLBI; R01HL119215) and the NIAID Novel Alternative Model Systems for Enteric Diseases (NAMSED) Consortium (U19AI116482). I.A.G. and the University of Washington Laboratory of Developmental Biology were supported by NIH award 5R24HD000836 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). E.M.H. was supported by a Training in Basic and Translational Digestive Sciences training grant (NIH-NIDDK 5T32DK094775), a Cellular Biotechnology Training Program training grant (NIH-NIGMS 2T32GM008353), and the Ruth L. Kirschstein Predoctoral Individual National Research Service Award (NIH-NHLBI F31HL146162). M.C. was supported by the Training Program in Organogenesis (NIH-NICHD T32 HD007505). Additional support was provided by the University of Michigan Center for Gastrointestinal Research (UMCGR) (NIDDK 5P30DK034933).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Aoki R, 2016, CELL MOL GASTROENTER, V2, P175, DOI 10.1016/j.jcmgh.2015.12.004; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Camp JG, 2019, SCIENCE, V365, P1401, DOI 10.1126/science.aax6648; Campa CC, 2019, NAT METHODS, V16, P887, DOI 10.1038/s41592-019-0508-6; Cao JY, 2020, SCIENCE, V370, P808, DOI 10.1126/science.aba7721; Capeling M, 2020, METHOD CELL BIOL, V159, P143, DOI 10.1016/bs.mcb.2020.03.007; Capeling MM, 2019, STEM CELL REP, V12, P381, DOI 10.1016/j.stemcr.2018.12.001; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cowan CS, 2020, CELL, V182, P1623, DOI 10.1016/j.cell.2020.08.013; Du AP, 2012, DEV BIOL, V365, P175, DOI 10.1016/j.ydbio.2012.02.024; Dusing MR, 2010, PHYSIOL GENOMICS, V42, P115, DOI 10.1152/physiolgenomics.00017.2010; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Edgar LG, 2001, DEV BIOL, V229, P71, DOI 10.1006/dbio.2000.9977; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Ehrman LA, 2001, DEV DYNAM, V221, P412, DOI 10.1002/dvdy.1151; El-Hashash AHK, 2011, DEV BIOL, V353, P242, DOI 10.1016/j.ydbio.2011.02.031; Elmentaite R, 2020, DEV CELL, V55, P771, DOI 10.1016/j.devcel.2020.11.010; Faas L, 2009, DEV DYNAM, V238, P835, DOI 10.1002/dvdy.21901; Fawkner-Corbett D, 2021, CELL, V184, P810, DOI 10.1016/j.cell.2020.12.016; Finkbeiner SR, 2015, BIOL OPEN, V4, P1462, DOI 10.1242/bio.013235; Finkbeiner SR, 2015, STEM CELL REP, V4, P1140, DOI 10.1016/j.stemcr.2015.04.010; Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12; Forbester JL, 2015, INFECT IMMUN, V83, P2926, DOI 10.1128/IAI.00161-15; Fujii M, 2018, CELL STEM CELL, V23, P787, DOI 10.1016/j.stem.2018.11.016; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gaunt SJ, 2008, DEVELOPMENT, V135, P2511, DOI 10.1242/dev.015909; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Han L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17968-x; Han XP, 2020, NATURE, V581, P303, DOI 10.1038/s41586-020-2157-4; He ZS, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02147-4; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Hill DR, 2017, ELIFE, V6, DOI 10.7554/eLife.29132; Holloway EM, 2021, CELL STEM CELL, V28, P568, DOI 10.1016/j.stem.2020.11.008; Holloway EM, 2020, DEV CELL, V54, P516, DOI 10.1016/j.devcel.2020.07.023; Homan KA, 2019, NAT METHODS, V16, P255, DOI 10.1038/s41592-019-0325-y; Hu H, 2019, NUCLEIC ACIDS RES, V47, pD33, DOI 10.1093/nar/gky822; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Ihida-Stansbury K, 2004, CIRC RES, V94, P1507, DOI 10.1161/01.RES.0000130656.72424.20; Ihida-Stansbury K, 2015, PULM CIRC, V5, P382, DOI 10.1086/681272; Jard T, 2020, CELL STEM CELL, V27, P646, DOI 10.1016/j.stem.2020.06.021; Josephson R, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-28; Kanton S, 2019, NATURE, V574, P418, DOI 10.1038/s41586-019-1654-9; Kechele DO, 2019, CURR OPIN CELL BIOL, V61, P92, DOI 10.1016/j.ceb.2019.07.009; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Kumar N, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.172189; Le T.L., 2021, J CLIN INVEST, V131; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Leslie JL, 2015, INFECT IMMUN, V83, P138, DOI 10.1128/IAI.02561-14; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lu K, 2013, DEV BIOL, V382, P110, DOI 10.1016/j.ydbio.2013.07.019; Matera I, 2021, CLIN GENET, V99, P430, DOI 10.1111/cge.13895; Matsuo Y, 1999, Hum Cell, V12, P149; McCarthy N, 2020, NAT CELL BIOL, V22, P1033, DOI 10.1038/s41556-020-0567-z; McCarthy N, 2020, CELL STEM CELL, V26, P391, DOI 10.1016/j.stem.2020.01.008; McCracken KW, 2017, NATURE, V541, P182, DOI 10.1038/nature21021; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Miller AJ, 2020, DEV CELL, V53, P117, DOI 10.1016/j.devcel.2020.01.033; Miller AJ, 2019, NAT PROTOC, V14, P518, DOI 10.1038/s41596-018-0104-8; Miller AJ, 2018, STEM CELL REP, V10, P101, DOI 10.1016/j.stemcr.2017.11.012; Miura S, 2017, CELL STEM CELL, V21, P456, DOI 10.1016/j.stem.2017.08.020; Moor AE, 2018, CELL, V175, P1156, DOI 10.1016/j.cell.2018.08.063; Munera JO, 2017, CELL STEM CELL, V21, P51, DOI 10.1016/j.stem.2017.05.020; Nikolic MZ, 2017, ELIFE, V6, DOI [10.7554/eLife.26575, 10.7554/eLife.26575.001]; Nitzan M, 2019, NATURE, V576, P132, DOI 10.1038/s41586-019-1773-3; O'Connell AE, 2018, AM J HUM GENET, V103, P131, DOI 10.1016/j.ajhg.2018.05.007; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Poling HM, 2018, NAT BIOMED ENG, V2, P429, DOI 10.1038/s41551-018-0243-9; Rodansky ES, 2015, EXP MOL PATHOL, V98, P346, DOI 10.1016/j.yexmp.2015.03.033; Rossi G, 2018, NAT REV GENET, V19, P671, DOI 10.1038/s41576-018-0051-9; Santos AJM, 2018, TRENDS CELL BIOL, V28, P1062, DOI 10.1016/j.tcb.2018.08.001; Schlieve CR, 2017, STEM CELL REP, V9, P883, DOI 10.1016/j.stemcr.2017.07.017; Shacham-Silverberg V, 2020, METHOD CELL BIOL, V159, P1, DOI 10.1016/bs.mcb.2020.04.009; Shoshkes-Carmel M, 2018, NATURE, V557, P242, DOI 10.1038/s41586-018-0084-4; Sidar B, 2019, LAB CHIP, V19, P3552, DOI 10.1039/c9lc00653b; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Steiner Calen A, 2021, Inflamm Bowel Dis, V27, P303, DOI 10.1093/ibd/izaa169; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Stzepourginski I, 2017, P NATL ACAD SCI USA, V114, pE506, DOI 10.1073/pnas.1620059114; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugawara S, 2014, J BIOSCI BIOENG, V117, P525, DOI 10.1016/j.jbiosc.2013.10.009; Taylor DM, 2019, DEV CELL, V49, P10, DOI 10.1016/j.devcel.2019.03.001; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Trisno SL, 2018, CELL STEM CELL, V23, P501, DOI 10.1016/j.stem.2018.08.008; Tsai YH, 2017, DEVELOPMENT, V144, P1045, DOI 10.1242/dev.138453; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Wang GC, 2019, NAT IMMUNOL, V20, P1494, DOI 10.1038/s41590-019-0500-4; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Weinreb C, 2018, BIOINFORMATICS, V34, P1246, DOI 10.1093/bioinformatics/btx792; Wells JM, 2014, DEVELOPMENT, V141, P752, DOI 10.1242/dev.097386; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Workman MJ, 2017, NAT MED, V23, P49, DOI 10.1038/nm.4233; Wu HJ, 2018, CELL STEM CELL, V23, P869, DOI 10.1016/j.stem.2018.10.010; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Young T, 2009, CURR TOP DEV BIOL, V88, P235, DOI 10.1016/S0070-2153(09)88008-3; Zhang YJ, 2021, EUR J HUM GENET, V29, P998, DOI 10.1038/s41431-021-00812-1; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	112	23	23	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3281	+		10.1016/j.cell.2021.04.028	http://dx.doi.org/10.1016/j.cell.2021.04.028		JUN 2021	40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	34019796	Green Published, hybrid			2022-12-28	WOS:000660014300017
J	Ridker, PM; Devalaraja, M; Baeres, FMM; Engelmann, MDM; Hovingh, GK; Ivkovic, M; Lo, L; Kling, D; Pergola, P; Raj, D; Libby, P; Davidson, M				Ridker, Paul M.; Devalaraja, Matt; Baeres, Florian M. M.; Engelmann, Mads D. M.; Hovingh, G. Kees; Ivkovic, Milana; Lo, Larry; Kling, Douglas; Pergola, Pablo; Raj, Dominic; Libby, Peter; Davidson, Michael		RESCUE Investigators	IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial	LANCET			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; INTERLEUKIN-6 RECEPTOR; KIDNEY-FUNCTION; INFLAMMATION; MORTALITY; HEMODIALYSIS; ALBUMINURIA; ASSOCIATION; CANAKINUMAB	Background IL-6 has emerged as a pivotal factor in atherothrombosis. Yet, the safety and efficacy of IL-6 inhibition among individuals at high atherosclerotic risk but without a systemic inflammatory disorder is unknown. We therefore addressed whether ziltivekimab, a fully human monoclonal antibody directed against the IL-6 ligand, safely and effectively reduces biomarkers of inflammation and thrombosis among patients with high cardiovascular risk. We focused on individuals with elevated high-sensitivity CRP and chronic kidney disease, a group with substantial unmet clinical need in whom previous studies in inflammation inhibition have shown efficacy for cardiovascular event reduction. Methods RESCUE is a randomised, double-blind, phase 2 trial done at 40 clinical sites in the USA. Inclusion criteria were age 18 years or older, moderate to severe chronic kidney disease, and high-sensitivity CRP of at least 2 mg/L. Participants were randomly allocated (1:1:1:1) to subcutaneous administration of placebo or ziltivekimab 7.5 mg, 15 mg, or 30 mg every 4 weeks up to 24 weeks. The primary outcome was percentage change from baseline in high-sensitivity CRP after 12 weeks of treatment with ziltivekimab compared with placebo, with additional biomarker and safety data collected over 24 weeks of treatment. Primary analyses were done in the intention-to-treat population. Safety was assessed in all patients who received at least one dose of assigned treatment. The trial is registered with ClinicalTrials.gov, NCT03926117. Findings Between June 17, 2019, and Jan 14, 2020, 264 participants were enrolled into the trial, of whom 66 were randomly assigned to each of the four treatment groups. At 12 weeks after randomisation, median high-sensitivity CRP levels were reduced by 77% for the 7.5 mg group, 88% for the 15 mg group, and 92% for the 30 mg group compared with 4% for the placebo group. As such, the median pairwise differences in percentage change in high-sensitivity CRP between the ziltivekimab and placebo groups, after aligning for strata, were -66.2% for the 7.5 mg group, -77.7% for the 15 mg group, and -87.8% for the 30 mg group (all p<0.0001). Effects were stable over the 24-week treatment period. Dose-dependent reductions were also observed for fibrinogen, serum amyloid A, haptoglobin, secretory phospholipase A2, and lipoprotein(a). Ziltivekimab was well tolerated, did not affect the total cholesterol to HDL cholesterol ratio, and there were no serious injection-site reactions, sustained grade 3 or 4 neutropenia or thrombocytopenia. Interpretation Ziltivekimab markedly reduced biomarkers of inflammation and thrombosis relevant to atherosclerosis. On the basis of these data, a large-scale cardiovascular outcomes trial will investigate the effect of ziltivekimab in patients with chronic kidney disease, increased high-sensitivity CRP, and established cardiovascular disease. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Ridker, Paul M.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; [Ridker, Paul M.; Libby, Peter] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Devalaraja, Matt; Kling, Douglas; Davidson, Michael] Corvidia Therapeut, Waltham, MA USA; [Baeres, Florian M. M.; Engelmann, Mads D. M.; Hovingh, G. Kees; Ivkovic, Milana] Novo Nordisk, Bagsvaerd, Denmark; [Pergola, Pablo] Renal Associates, San Antonio, TX USA; [Raj, Dominic] George Washington Univ, Div Kidney Dis & Hypertens, Washington, DC USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; George Washington University	Ridker, PM (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA.	pridker@bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X	Corvidia Therapeutics (Waltham, MA, USA)	Corvidia Therapeutics (Waltham, MA, USA)	This trial was sponsored by Corvidia Therapeutics (Waltham, MA, USA) with subsequent input from Novo Nordisk, Bagsvaerd, Denmark.	Akita K, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00084; Amdur RL, 2016, CLIN J AM SOC NEPHRO, V11, P1546, DOI 10.2215/CJN.13121215; Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Cai TX, 2018, JAMA CARDIOL, V3, P849, DOI 10.1001/jamacardio.2018.2287; Fanola CL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005637; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; Held C, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005077; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kleveland O, 2016, EUR HEART J, V37, P2406, DOI 10.1093/eurheartj/ehw171; Krane V, 2009, AM J KIDNEY DIS, V54, P902, DOI 10.1053/j.ajkd.2009.06.029; Libby P, 2018, INT J CARDIOL, V259, P213, DOI 10.1016/j.ijcard.2018.02.062; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; LOPPNOW H, 1989, CELL IMMUNOL, V122, P493, DOI 10.1016/0008-8749(89)90095-6; LOPPNOW H, 1990, J CLIN INVEST, V85, P731, DOI 10.1172/JCI114498; Muller N, 2015, J LIPID RES, V56, P1034, DOI 10.1194/jlr.P052209; Nidorf SM, 2020, NEW ENGL J MED, V383, P1838, DOI 10.1056/NEJMoa2021372; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2020, EUR HEART J, V41, P2153, DOI 10.1093/eurheartj/ehz542; Ridker PM, 2019, CIRC RES, V124, P437, DOI 10.1161/CIRCRESAHA.118.313129; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Ridker PM, 2018, EUR HEART J, V39, P3499, DOI 10.1093/eurheartj/ehy310; Ridker PM, 2018, J AM COLL CARDIOL, V71, P2405, DOI 10.1016/j.jacc.2018.03.490; Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3; Ridker PM, 2016, CIRC RES, V118, P145, DOI 10.1161/CIRCRESAHA.115.306656; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Spoto B, 2015, CLIN J AM SOC NEPHRO, V10, P232, DOI 10.2215/CJN.07000714; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tardif JC, 2019, NEW ENGL J MED, V381, P2497, DOI 10.1056/NEJMoa1912388; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9	33	98	99	12	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 29	2021	397	10289					2060	2069		10.1016/S0140-6736(21)00520-1	http://dx.doi.org/10.1016/S0140-6736(21)00520-1		MAY 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK5LX	34015342				2022-12-28	WOS:000656257800024
J	Wan, YH; Anastasakis, DG; Rodriguez, J; Palangat, M; Gudla, P; Zaki, G; Tandon, M; Pegoraro, G; Chow, CC; Hafner, M; Larson, DR				Wan, Yihan; Anastasakis, Dimitrios G.; Rodriguez, Joseph; Palangat, Murali; Gudla, Prabhakar; Zaki, George; Tandon, Mayank; Pegoraro, Gianluca; Chow, Carson C.; Hafner, Markus; Larson, Daniel R.			Dynamic imaging of nascent RNA reveals general principles of transcription dynamics and stochastic splice site selection	CELL			English	Article							WIDE IDENTIFICATION; HUMAN GENOME; R PACKAGE; KINETICS; BINDING; INTRON; INFORMATION; RECOGNITION; ELONGATION; DROSOPHILA	The activities of RNA polymerase and the spliceosome are responsible for the heterogeneity in the abundance and isoform composition of mRNA in human cells. However, the dynamics of these megadalton enzymatic complexes working in concert on endogenous genes have not been described. Here, we establish a quasi-genome-scale platform for observing synthesis and processing kinetics of single nascent RNA molecules in real time. We find that all observed genes show transcriptional bursting. We also observe large kinetic variation in intron removal for single introns in single cells, which is inconsistent with deterministic splice site selection. Transcriptome-wide footprinting of the U2AF complex, nascent RNA profiling, long-read sequencing, and lariat sequencing further reveal widespread stochastic recursive splicing within introns. We propose and validate a unified theoretical model to explain the general features of transcription and pervasive stochastic splice site selection.	[Wan, Yihan; Palangat, Murali; Gudla, Prabhakar; Tandon, Mayank; Pegoraro, Gianluca; Larson, Daniel R.] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Anastasakis, Dimitrios G.; Hafner, Markus] NIAMSD, Bethesda, MD 20892 USA; [Rodriguez, Joseph] NIEHS, Durham, NC USA; [Chow, Carson C.] NIDDK, Lab Biol Modeling, Bethesda, MD 20892 USA; [Zaki, George] Frederick Natl Lab Canc Res, Biomed Informat & Data Sci Directorate, Frederick, MD USA; [Tandon, Mayank] Frederick Natl Lab Canc Res, Adv Biomed Computat Sci, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Larson, DR (corresponding author), NCI, Ctr Canc Res, Bethesda, MD 20892 USA.; Hafner, M (corresponding author), NIAMSD, Bethesda, MD 20892 USA.	markus.hafner@nih.gov; dan.larson@nih.gov	Larson, Daniel R/B-9829-2008; Rodriguez, Joseph/I-9277-2014	Larson, Daniel R/0000-0001-9253-3055; Wan, Yihan/0000-0003-4272-0340; Rodriguez, Joseph/0000-0002-6017-1376; Anastasakis, Dimitrios/0000-0003-2306-275X	Biowulf; High-Performance Computing Group; Center for Information Technology; Intramural Research Program of the NIH	Biowulf; High-Performance Computing Group; Center for Information Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Pleiss and B. Fair for discussions and designing primers for detecting splicing intermediates; S. Mount and B.X. Wang for bioinformatic discussions and analysis of the nascent RNA sequencing data; J. R. Hogg for insightful discussions on NMD pathway and poison exons; and R. Casellas, I. Eperon, and A. Raj for comments on the manuscript. We thank X. Wu, B. Tran, J. Shetti, K. Talsania, and Y. Zhao from the CCR Sequencing Facility. This work was supported by Biowulf, the High-Performance Computing Group, and the Center for Information Technology. This research was funded by the Intramural Research Program of the NIH.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Attig J, 2016, ELIFE, V5, DOI 10.7554/eLife.19545; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Burke JE, 2018, CELL, V173, P1014, DOI 10.1016/j.cell.2018.03.020; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen WJ, 2018, CELL, V173, P1031, DOI 10.1016/j.cell.2018.03.062; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Coulon A, 2014, ELIFE, V3, DOI 10.7554/eLife.03939; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Dietz C, 2016, ADV ANAT EMBRYOL CEL, V219, P179, DOI 10.1007/978-3-319-28549-8_7; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drexler HL, 2020, MOL CELL, V77, P985, DOI 10.1016/j.molcel.2019.11.017; Duff MO, 2015, NATURE, V521, P376, DOI 10.1038/nature14475; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Gazzoli I, 2016, RNA BIOL, V13, P290, DOI 10.1080/15476286.2015.1125074; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; Herzel L, 2018, GENOME RES, V28, P1008, DOI 10.1101/gr.232025.117; Herzel L, 2017, NAT REV MOL CELL BIO, V18, P637, DOI 10.1038/nrm.2017.63; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Joseph B, 2018, NAT STRUCT MOL BIOL, V25, P365, DOI 10.1038/s41594-018-0052-6; Kelly S, 2015, NUCLEIC ACIDS RES, V43, P4721, DOI 10.1093/nar/gkv386; Khodor YL, 2012, RNA, V18, P2174, DOI 10.1261/rna.034090.112; Koster J, 2018, BIOINFORMATICS, V34, P3600, DOI 10.1093/bioinformatics/bty350; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Larson DR, 2013, ELIFE, V2, DOI 10.7554/eLife.00750; Lee TH, 2009, J PHYS CHEM B, V113, P11535, DOI 10.1021/jp903831z; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Montero P, 2014, J STAT SOFTW, V62, P1; Moore MJ, 2000, NAT STRUCT BIOL, V7, P14, DOI 10.1038/71207; Oesterreich FC, 2016, CELL, V165, P372, DOI 10.1016/j.cell.2016.02.045; Pai A.A., 2017, BIORXIV, DOI [10.1101/107995, DOI 10.1101/107995]; Palangat M, 2019, GENE DEV, V33, P482, DOI 10.1101/gad.319590.118; Pandya-Jones A, 2013, RNA, V19, P811, DOI 10.1261/rna.039081.113; Rabani M, 2014, CELL, V159, P1698, DOI 10.1016/j.cell.2014.11.015; Radle B, 2013, JOVE-J VIS EXP, DOI 10.3791/50195; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez J, 2019, CELL, V176, P213, DOI 10.1016/j.cell.2018.11.026; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Russo J, 2017, METHODS, V120, P39, DOI 10.1016/j.ymeth.2017.02.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shcherbakova I, 2013, CELL REP, V5, P151, DOI 10.1016/j.celrep.2013.08.026; Sibley CR, 2015, NATURE, V521, P371, DOI 10.1038/nature14466; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; So BR, 2019, MOL CELL, V76, P590, DOI 10.1016/j.molcel.2019.08.007; Soille P., 1999, MORPHOLOGICAL IMAGE, DOI 10.1007/978-3-662-05088-0; Taggart AJ, 2017, GENOME RES, V27, P639, DOI 10.1101/gr.202820.115; Tang AD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15171-6; Tani H, 2012, RNA BIOL, V9, P1370, DOI 10.4161/rna.22360; Tardaguila M, 2018, GENOME RES, V28, P396, DOI 10.1101/gr.222976.117; The Bioconductor Dev Team, 2014, BSGENOME HSAP UCSC H; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wagih O, 2017, BIOINFORMATICS, V33, P3645, DOI 10.1093/bioinformatics/btx469; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Windhager L, 2012, GENOME RES, V22, P2031, DOI 10.1101/gr.131847.111; Wohland T, 2001, BIOPHYS J, V80, P2987, DOI 10.1016/S0006-3495(01)76264-9; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Xiao MS, 2019, NUCLEIC ACIDS RES, V47, P8755, DOI 10.1093/nar/gkz576; Xu HS, 2019, NAT METHODS, V16, P55, DOI 10.1038/s41592-018-0258-x; Zhang SY, 2018, CELL, V172, P952, DOI 10.1016/j.cell.2018.02.019; Zhang SY, 2021, SCIENCE, V371, P305, DOI 10.1126/science.abf1870; Zhang XO, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007579; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZJ, 2016, GENE DEV, V30, P2106, DOI 10.1101/gad.285395.116	76	28	29	9	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					2878	+		10.1016/j.cell.2021.04.012	http://dx.doi.org/10.1016/j.cell.2021.04.012		MAY 2021	38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	33979654	Green Accepted, Bronze			2022-12-28	WOS:000656965600008
J	Rubin, R				Rubin, Rita			Free, At-Home Rapid SARS-CoV-2 Tests	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2038	2038		10.1001/jama.2021.7585	http://dx.doi.org/10.1001/jama.2021.7585			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032842	Bronze			2022-12-28	WOS:000655647300004
J	Rubin, R				Rubin, Rita			Allergic Reactions to mRNA Vaccines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2038	2038		10.1001/jama.2021.6941	http://dx.doi.org/10.1001/jama.2021.6941			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032844	Bronze			2022-12-28	WOS:000655647300003
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... mixed messages	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Transport, 2021, RED AMB GREEN LIST R; Dunhill L, 2021, CLAIMS HLTH SYSTEM L; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1276; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1195	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2021	373								n1318	10.1136/bmj.n1318	http://dx.doi.org/10.1136/bmj.n1318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7ZT	34021005				2022-12-28	WOS:000656435600014
J	Daugherty, SE; Guo, YL; Heath, K; Dasmarinas, MC; Jubilo, KG; Samranvedhya, J; Lipsitch, M; Cohen, K				Daugherty, Sarah E.; Guo, Yinglong; Heath, Kevin; Dasmarinas, Micah C.; Jubilo, Karol Giuseppe; Samranvedhya, Jirapat; Lipsitch, Marc; Cohen, Ken			Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COVID-19; COMPLICATIONS; INFLUENZA	OBJECTIVE To evaluate the excess risk and relative hazards for developing incident clinical sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. DESIGN Retrospective cohort study. SETTING Three merged data sources from a large United States health plan: a large national administrative claims database, an outpatient laboratory testing database, and an inpatient hospital admissions database. PARTICIPANTS Individuals aged 18-65 with continuous enrollment in the health plan from January 2019 to the date of a diagnosis of SARS-CoV-2 infection. Three comparator groups, matched by propensity score, to individuals infected with SARS-CoV-2: a 2020 comparator group, an historical 2019 comparator group, and an historical comparator group with viral lower respiratory tract illness. MAIN OUTCOME MEASURES More than 50 clinical sequelae after the acute phase of SARS-CoV-2 infection (defined as the date of first SARS-CoV-2 diagnosis (index date) plus 21 days) were identified using ICD-10 (international classification of diseases, 10th revision) codes. Excess risk in the four months after acute infection and hazard ratios with Bonferroni corrected 95% confidence intervals were calculated. RESULTS 14% of adults aged <= 65 who were infected with SARS-CoV-2 (27 074 of 193 113) had at least one new type of clinical sequelae that required medical care after the acute phase of the illness, which was 4.95% higher than in the 2020 comparator group. The risk for specific new sequelae attributable to SARS-Cov-2 infection after the acute phase, including chronic respiratory failure, cardiac arrythmia, hypercoagulability, encephalopathy, peripheral neuropathy, amnesia (memory difficulty), diabetes, liver test abnormalities, myocarditis, anxiety, and fatigue, was significantly greater than in the three comparator groups (2020, 2019, and viral lower respiratory tract illness groups) (all P<0.001). Significant risk differences because of SARS-CoV-2 infection ranged from 0.02 to 2.26 per 100 people (all P<0.001), and hazard ratios ranged from 1.24 to 25.65 compared with the 2020 comparator group. CONCLUSIONS The results indicate the excess risk of developing new clinical sequelae after the acute phase of SARS-CoV-2 infection, including specific types of sequelae less commonly seen in other viral illnesses. Although individuals who were older, had pre-existing conditions, and were admitted to hospital because of covid-19 were at greatest excess risk, younger adults (aged <= 50), those with no pre-existing conditions, or those not admitted to hospital for covid-19 also had an increased risk of developing new clinical sequelae. The greater risk for incident sequelae after the acute phase of SARS-CoV-2 infection is relevant for healthcare planning.	[Daugherty, Sarah E.; Guo, Yinglong; Dasmarinas, Micah C.; Jubilo, Karol Giuseppe; Samranvedhya, Jirapat; Cohen, Ken] UnitedHealth Grp, OptumLabs, Minneapolis, MN 55440 USA; [Heath, Kevin; Cohen, Ken] OptumCare, Minneapolis, MN USA; [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Optum; UnitedHealth Group Incorporated; Harvard University; Harvard T.H. Chan School of Public Health	Daugherty, SE (corresponding author), UnitedHealth Grp, OptumLabs, Minneapolis, MN 55440 USA.	SarahDaugherty@uhg.com		Lipsitch, Marc/0000-0003-1504-9213	OptumLabs, the research and development arm of UnitedHealth Group	OptumLabs, the research and development arm of UnitedHealth Group	The study was funded by OptumLabs, the research and development arm of UnitedHealth Group, and the authors SED, KC, KH, YG, MCD, KGJ, and JS are full time employees at UnitedHealth Group. UnitedHealth Group, the organization, was not involved in determining the details of the study design, analysis plan, interpretation of data, or writing of the report.	Agency for Healthcare Research and Quality, 2008, CREAT NEW RAC ETHN C; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Azaroff LS, 2002, AM J PUBLIC HEALTH, V92, P1421, DOI 10.2105/AJPH.92.9.1421; Bhatla A, 2020, HEART RHYTHM, V17, P1439, DOI 10.1016/j.hrthm.2020.06.016; Bonow RO, 2020, JAMA-J AM MED ASSOC, V324, P1131, DOI 10.1001/jama.2020.15088; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Chopra V, 2021, ANN INTERN MED, V174, P576, DOI 10.7326/M20-5661; Chow EJ, 2020, ANN INTERN MED, V173, P605, DOI 10.7326/M20-1509; Crabb BT, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17703; Cunningham JW, 2021, JAMA INTERN MED, V181, P379, DOI 10.1001/jamainternmed.2020.5313; Davis HE, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101019; Dennis A, 2020, BMJ, DOI [10.1101/2020.10.14.20212555, DOI 10.1101/2020.10.14.20212555, 10.1101/ 2020.10.14.20212555]; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Hill JB, 2020, BLOOD ADV, V4, P5373, DOI 10.1182/bloodadvances.2020003083; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Josephson SA, 2020, JAMA-J AM MED ASSOC, V324, P1139, DOI 10.1001/jama.2020.14254; Kassambara A, 2020, **DATA OBJECT**; Lau ST, 2005, INT J CARDIOL, V100, P167, DOI 10.1016/j.ijcard.2004.06.022; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Leung TYM, 2020, EMERG MICROBES INFEC, V9, P2190, DOI 10.1080/22221751.2020.1825914; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Logue JK, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0830; Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740; Moreno-Perez O, 2021, J INFECTION, V82, P378, DOI 10.1016/j.jinf.2021.01.004; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Rogers JP, 2020, LANCET PSYCHIAT, V7, P611, DOI 10.1016/S2215-0366(20)30203-0; Sathish T, 2021, DIABETES OBES METAB, V23, P870, DOI 10.1111/dom.14269; SCHAEFER RL, 1984, COMMUN STAT-THEOR M, V13, P99, DOI 10.1080/03610928408828664; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sellers SA, 2017, INFLUENZA OTHER RESP, V11, P372, DOI 10.1111/irv.12470; Sudre CH, 2020, ATTRIBUTES PREDICTOR, DOI [10.1101/2020.10.19.20214494, DOI 10.1101/2020.10.19.20214494, 10.19.20214494]; Taquet M, 2021, LANCET PSYCHIAT, V8, P130, DOI 10.1016/S2215-0366(20)30462-4; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]; Therneau TM, 2020, **DATA OBJECT**; van den Borst B, 2021, CLIN INFECT DIS, V73, pE1089, DOI 10.1093/cid/ciaa1750; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Winkelmayer WC, 2020, JAMA-J AM MED ASSOC, V324, P1137, DOI 10.1001/jama.2020.16779; Wu Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09536-z; Ye MX, 2020, BRAIN BEHAV IMMUN, V88, P945, DOI [10.1016/j.bbi.2020.04.017, 10.1016/J.bbi.2020.04.017]; Yu CM, 2006, POSTGRAD MED J, V82, P140, DOI 10.1136/pgmj.2005.037515	45	105	107	7	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2021	373								n1098	10.1136/bmj.n1098	http://dx.doi.org/10.1136/bmj.n1098			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5SO	34011492	hybrid, Green Published			2022-12-28	WOS:000655594700013
J	Iacobucci, G				Iacobucci, Gareth			BMA demands urgent meeting with health secretary over GP appointments row	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1251; NHS England, 2021, LETT UPD STAND OP PR	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2021	373								n1276	10.1136/bmj.n1276	http://dx.doi.org/10.1136/bmj.n1276			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SL5PR	34006502				2022-12-28	WOS:000656970600004
J	Jaklevic, MC				Jaklevic, Mary Chris			Point-of-Care Test for Sexually Transmitted Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1932	1932		10.1001/jama.2021.7164	http://dx.doi.org/10.1001/jama.2021.7164			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003235				2022-12-28	WOS:000652675100018
J	Haas, EJ; Angulo, FJ; McLaughlin, JM; Anis, E; Singer, SR; Khan, F; Brooks, N; Smaja, M; Mircus, G; Pan, KJ; Southern, J; Swerdlow, DL; Jodar, L; Levy, Y; Alroy-Preis, S				Haas, Eric J.; Angulo, Frederick J.; McLaughlin, John M.; Anis, Emilia; Singer, Shepherd R.; Khan, Farid; Brooks, Nati; Smaja, Meir; Mircus, Gabriel; Pan, Kaijie; Southern, Jo; Swerdlow, David L.; Jodar, Luis; Levy, Yeheskel; Alroy-Preis, Sharon			Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data	LANCET			English	Article								Background Following the emergency use authorisation of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the Ministry of Health (MoH) launched a campaign to immunise the 6.5 million residents of Israel aged 16 years and older. We estimated the real-world effectiveness of two doses of BNT162b2 against a range of SARS-CoV-2 outcomes and to evaluate the nationwide public-health impact following the widespread introduction of the vaccine. Methods We used national surveillance data from the first 4 months of the nationwide vaccination campaign to ascertain incident cases of laboratory-confirmed SARS-CoV-2 infections and outcomes, as well as vaccine uptake in residents of Israel aged 16 years and older. Vaccine effectiveness against SARS-CoV-2 outcomes (asymptomatic infection, symptomatic infection, and COVID-19-related hospitalisation, severe or critical hospitalisation, and death) was calculated on the basis of incidence rates in fully vaccinated individuals (defined as those for whom 7 days had passed since receiving the second dose of vaccine) compared with rates in unvaccinated individuals (who had not received any doses of the vaccine), with use of a negative binomial regression model adjusted for age group (16-24, 25-34, 35-44, 45-54, 55-64, 65-74, 75-84, and >= 85 years), sex, and calendar week. The proportion of spike gene target failures on PCR test among a nationwide convenience-sample of SARS-CoV-2-positive specimens was used to estimate the prevelance of the B.1.1.7 variant. Findings During the analysis period (Jan 24 to April 3, 2021), there were 232 268 SARS-CoV-2 infections, 7694 COVID-19 hospitalisations, 4481 severe or critical COVID-19 hospitalisations, and 1113 COVID-19 deaths in people aged 16 years or older. By April 3, 2021, 4 714 932 (72.1%) of 6 538 911 people aged 16 years and older were fully vaccinated with two doses of BNT162b2. Adjusted estimates of vaccine effectiveness at 7 days or longer after the second dose were 95.3% (95% CI 94.9-95.7; incidence rate 91.5 per 100 000 person-days in unvaccinated vs 3.1 per 100 000 person-days in fully vaccinated individuals) against SARS-CoV-2 infection, 91.5% (90.7-92.2; 40.9 vs 1.8 per 100 000 person-days) against asymptomatic SARS-CoV-2 infection, 97.0% (96.7-97.2; 32.5 vs 0.8 per 100 000 person-days) against symptomatic COVID-19, 97.2% (96.8-97.5; 4.6 vs 0.3 per 100 000 person-days) against COVID-19-related hospitalisation, 97.5% (97.1-97.8; 2.7 vs 0.2 per 100 000 person-days) against severe or critical COVID-19-related hospitalisation, and 96.7% (96.0-97.3; 0.6 vs 0.1 per 100 000 person-days) against COVID-19-related death. In all age groups, as vaccine coverage increased, the incidence of SARS-CoV-2 outcomes declined. 8006 of 8472 samples tested showed a spike gene target failure, giving an estimated prevalence of the B.1.1.7 variant of 94.5% among SARS-CoV-2 infections. Interpretation Two doses of BNT162b2 are highly effective across all age groups (>= 16 years, including older adults aged >= 85 years) in preventing symptomatic and asymptomatic SARS-CoV-2 infections and COVID-19-related hospitalisations, severe disease, and death, including those caused by the B.1.1.7 SARS-CoV-2 variant. There were marked and sustained declines in SARS-CoV-2 incidence corresponding to increasing vaccine coverage. These findings suggest that COVID-19 vaccination can help to control the pandemic. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Haas, Eric J.; Anis, Emilia; Singer, Shepherd R.; Alroy-Preis, Sharon] Israel Minist Hlth, Publ Hlth Serv, IL-9101002 Jerusalem, Israel; [Haas, Eric J.] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Angulo, Frederick J.; McLaughlin, John M.; Khan, Farid; Pan, Kaijie; Southern, Jo; Swerdlow, David L.; Jodar, Luis] Pfizer, Collegeville, PA USA; [Anis, Emilia; Singer, Shepherd R.] Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth, Jerusalem, Israel; [Brooks, Nati; Smaja, Meir] Israel Minist Hlth, Informat Technol Dept, Jerusalem, Israel; [Mircus, Gabriel] Pfizer Pharmaceut Israel, Herzliyya, Israel; [Levy, Yeheskel] Israel Minist Hlth, Jerusalem, Israel	Ben Gurion University; Pfizer; Hebrew University of Jerusalem; Pfizer	Alroy-Preis, S (corresponding author), Israel Minist Hlth, Publ Hlth Serv, IL-9101002 Jerusalem, Israel.	sharon.alroy@moh.gov.il	Haas, Eric/HGB-7336-2022; Haas, Eric/AFM-6358-2022	Haas, Eric/0000-0002-4605-6566; 				Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Angulo FJ, 2020, JAMA-J AM MED ASSOC, V323, P2247, DOI 10.1001/jama.2020.7872; Ayyub R, 2020, UK COVID 19 VARIANT; Britton A, 2021, MMWR-MORBID MORTAL W, V70, P396, DOI 10.15585/mmwr.mm7011e3; Chodick G., 2021, EFFECTIVENESS 1 DOSE, DOI [10.1101/2021.01.27.21250612, DOI 10.1101/2021.01.27.21250612, 10.1101/2021.01.27.21250612v1]; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Hall VJ, 2021, LANCET, V397, P1725, DOI 10.1016/S0140-6736(21)00790-X; Israel Ministry of Health, COVID 19 DAT; Jackson ML, 2013, AM J EPIDEMIOL, V178, P1327, DOI 10.1093/aje/kwt124; Moore JP, 2021, JAMA-J AM MED ASSOC, V325, P821, DOI 10.1001/jama.2021.1114; Moustsen-Helms I.R., 2021, MEDRXIV, DOI [10.1101/2021.03.08.21252200, DOI 10.1101/2021.03.08.21252200]; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; National Institutes of Health, COVID 19 TREATM GUID; National Insurance Institute of Israel, CALC KEY DISTR HLTH; PHE, 2020, INV NOV SARS COV 2 V, P1; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; UCLA Institute for Digital Research and Education, REGR MOD COUNT DAT; Vasileiou E, 2021, LANCET, V397, P1646, DOI 10.1016/S0140-6736(21)00677-2; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Worldometer, COVID 19 COR PAND; Zhang XY, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1441-7; Zuckerman NS, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12080854	24	747	751	12	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2021	397	10287					1819	1829		10.1016/S0140-6736(21)00947-8	http://dx.doi.org/10.1016/S0140-6736(21)00947-8		MAY 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD0HD	33964222	Green Published, Bronze			2022-12-28	WOS:000651041900028
J	Saunders, KO; Lee, E; Parks, R; Martinez, DR; Li, DP; Chen, HY; Edwards, RJ; Gobeil, S; Barr, M; Mansouri, K; Alam, SM; Sutherland, LL; Cai, FP; Sanzone, AM; Berry, M; Manne, K; Bock, KW; Minai, M; Nagata, BM; Kapingidza, AB; Azoitei, M; Tse, LV; Scobey, TD; Spreng, RL; Rountree, RW; DeMarco, CT; Denny, TN; Woods, CW; Petzold, EW; Tang, JJ; Oguin, TH; Sempowski, GD; Gagne, M; Douek, DC; Tomai, MA; Fox, CB; Seder, R; Wiehe, K; Weissman, D; Pardi, N; Golding, H; Khurana, S; Acharya, P; Andersen, H; Lewis, MG; Moore, IN; Montefiori, DC; Baric, RS; Haynes, BF				Saunders, Kevin O.; Lee, Esther; Parks, Robert; Martinez, David R.; Li, Dapeng; Chen, Haiyan; Edwards, Robert J.; Gobeil, Sophie; Barr, Maggie; Mansouri, Katayoun; Alam, S. Munir; Sutherland, Laura L.; Cai, Fangping; Sanzone, Aja M.; Berry, Madison; Manne, Kartik; Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; Kapingidza, Anyway B.; Azoitei, Mihai; Tse, Longping V.; Scobey, Trevor D.; Spreng, Rachel L.; Rountree, R. Wes; DeMarco, C. Todd; Denny, Thomas N.; Woods, Christopher W.; Petzold, Elizabeth W.; Tang, Juanjie; Oguin, Thomas H., III; Sempowski, Gregory D.; Gagne, Matthew; Douek, Daniel C.; Tomai, Mark A.; Fox, Christopher B.; Seder, Robert; Wiehe, Kevin; Weissman, Drew; Pardi, Norbert; Golding, Hana; Khurana, Surender; Acharya, Priyamvada; Andersen, Hanne; Lewis, Mark G.; Moore, Ian N.; Montefiori, David C.; Baric, Ralph S.; Haynes, Barton F.			Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses	NATURE			English	Article							RECEPTOR-BINDING DOMAIN; LENGTH INFECTIOUS CDNA; NANOPARTICLE VACCINES; REVERSE GENETICS; SARS; RESPONSES	Betacoronaviruses caused the outbreaks of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome, as well as the current pandemic of SARS coronavirus 2 (SARS-CoV-2)(1-4). Vaccines that elicit protective immunity against SARS-CoV-2 and betacoronaviruses that circulate in animals have the potential to prevent future pandemics. Here we show that the immunization of macaques with nanoparticles conjugated with the receptor-binding domain of SARS-CoV-2, and adjuvanted with 3M-052 and alum, elicits cross-neutralizing antibody responses against bat coronaviruses, SARS-CoV and SARS-CoV-2 (including the B.1.1.7, P.1 and B.1.351 variants). Vaccination of macaques with these nanoparticles resulted in a 50% inhibitory reciprocal serum dilution (ID50) neutralization titre of 47,216 (geometric mean) for SARS-CoV-2, as well as in protection against SARS-CoV-2 in the upper and lower respiratory tracts. Nucleoside-modified mRNAs that encode a stabilized transmembrane spike or monomeric receptor-binding domain also induced cross-neutralizing antibody responses against SARS-CoV and bat coronaviruses, albeit at lower titres than achieved with the nanoparticles. These results demonstrate that current mRNA-based vaccines may provide some protection from future outbreaks of zoonotic betacoronaviruses, and provide a multimeric protein platform for the further development of vaccines against multiple (or all) betacoronaviruses.	[Saunders, Kevin O.; Lee, Esther; Parks, Robert; Li, Dapeng; Chen, Haiyan; Edwards, Robert J.; Gobeil, Sophie; Barr, Maggie; Mansouri, Katayoun; Alam, S. Munir; Sutherland, Laura L.; Cai, Fangping; Sanzone, Aja M.; Berry, Madison; Manne, Kartik; Kapingidza, Anyway B.; Azoitei, Mihai; Spreng, Rachel L.; Rountree, R. Wes; DeMarco, C. Todd; Denny, Thomas N.; Woods, Christopher W.; Oguin, Thomas H., III; Sempowski, Gregory D.; Wiehe, Kevin; Acharya, Priyamvada; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Saunders, Kevin O.; Acharya, Priyamvada; Montefiori, David C.] Duke Univ, Dept Surg, Durham, NC 27708 USA; [Saunders, Kevin O.; Haynes, Barton F.] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA; [Saunders, Kevin O.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Lee, Esther; Parks, Robert; Li, Dapeng; Chen, Haiyan; Edwards, Robert J.; Gobeil, Sophie; Barr, Maggie; Mansouri, Katayoun; Alam, S. Munir; Sutherland, Laura L.; Cai, Fangping; Sanzone, Aja M.; Berry, Madison; Manne, Kartik; Kapingidza, Anyway B.; Azoitei, Mihai; Spreng, Rachel L.; Rountree, R. Wes; DeMarco, C. Todd; Denny, Thomas N.; Woods, Christopher W.; Oguin, Thomas H., III; Sempowski, Gregory D.; Wiehe, Kevin; Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Martinez, David R.; Tse, Longping V.; Scobey, Trevor D.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; Moore, Ian N.] NIAID, Infect Dis Pathogenesis Sect, Comparat Med Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Woods, Christopher W.; Petzold, Elizabeth W.] Duke Univ, Med Ctr, Ctr Appl Genom & Precis Med, Durham, NC USA; [Tang, Juanjie; Golding, Hana; Khurana, Surender] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res CBER, Silver Spring, MD USA; [Gagne, Matthew; Douek, Daniel C.; Seder, Robert] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Tomai, Mark A.] 3M Co, Corp Res Mat Lab, St Paul, MN 55144 USA; [Fox, Christopher B.] Infect Dis Res Inst, Seattle, WA USA; [Weissman, Drew; Pardi, Norbert] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Andersen, Hanne; Lewis, Mark G.] BIOQUAL, Rockville, MD USA	Duke University; Duke University; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); 3M; University of Pennsylvania; BIOQUAL Inc.	Saunders, KO; Haynes, BF (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.; Saunders, KO (corresponding author), Duke Univ, Dept Surg, Durham, NC 27708 USA.; Saunders, KO; Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA.; Saunders, KO (corresponding author), Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.; Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA.	kevin.saunders@duke.edu; barton.haynes@duke.edu	martinez, david/GQI-0849-2022; Tang, Juanjie/AGW-9966-2022; Chen, Haiyan/HGB-6216-2022; Li, Dapeng/F-9611-2017	Li, Dapeng/0000-0002-8131-5914; Edwards, Robert/0000-0003-4446-1194; Elyard, Hanne/0000-0003-1103-9608; Spreng, Rachel/0000-0003-1254-0760; Oguin, Thomas/0000-0001-8959-4025; Saunders, Kevin/0000-0001-7399-7954; Acharya, Priyamvada/0000-0002-0089-277X; gobeil, sophie/0000-0002-0057-2477; Sempowski, Gregory/0000-0003-0391-6594	Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH [SARS-CoV-2, USA-WA1/2020, NR-52281]; State of North Carolina; federal CARES Act; NIH, NIAID, DAIDS [AI142596]; Ting Tsung & Wei Fong Chao Foundation [R01AI157155, U54 CA260543]; North Carolina Policy Collaboratory at the University of North Carolina at Chapel Hill; North Carolina Coronavirus Relief Fund; NIH [F32 AI152296]; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award; NIH NIAID [T32 AI007151]; NIH/NIAD [UC6AI058607]; DOD/DARPA [HR0011-17-2-0069]	Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH; State of North Carolina; federal CARES Act; NIH, NIAID, DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ting Tsung & Wei Fong Chao Foundation; North Carolina Policy Collaboratory at the University of North Carolina at Chapel Hill; North Carolina Coronavirus Relief Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Postdoctoral Enrichment Program Award(Burroughs Wellcome Fund); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOD/DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We thank V. Gee-Lai, M. Deyton, C. McDanal, B. Watts and K. Cronin for technical assistance; E. Donahue for program management and assistance with manuscript preparation; P. J. C. Lin and Y. K. Tam from Acuitas Therapeutics for providing lipid nanoparticles; J. Harrison, A. Granados, A. Goode, A. Cook, A. Dodson, K. Steingrebe, B. Bart, L. Pessaint, A. VanRy, D. Valentin, A. Strasbaugh and M. Cabus for assistance with macaque studies; and S. O'Connor and J. J. Baczenas at the Department of Pathology and Laboratory Medicine (University of Wisconsin-Madison) for sequencing support. The following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-CoV-2, isolate USA-WA1/2020, NR-52281. This work was supported by a grant from the State of North Carolina with funds from the federal CARES Act, by funds from NIH, NIAID, DAIDS grant AI142596 (B.F.H.), by support from the Ting Tsung & Wei Fong Chao Foundation (B.F.H.), by grant R01AI157155 (R.S.B.) and by grant U54 CA260543 (R.S.B.). This project was also supported by the North Carolina Policy Collaboratory at the University of North Carolina at Chapel Hill with funding from the North Carolina Coronavirus Relief Fund established and appropriated by the North Carolina General Assembly. This study was also supported by funding from an NIH F32 AI152296, a Burroughs Wellcome Fund Postdoctoral Enrichment Program Award, and was previously supported by an NIH NIAID T32 AI007151 (all three awarded to D.R.M.). COVID-19 sample processing was performed in the Duke Regional Biocontainment Laboratory, which received partial support for construction from the NIH/NIAD (UC6AI058607; G.D.S.) with support from a cooperative agreement with DOD/DARPA (HR0011-17-2-0069; G.D.S.).	Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bangaru S, 2020, SCIENCE, V370, P1089, DOI 10.1126/science.abe1502; Berry JD, 2004, J VIROL METHODS, V120, P87, DOI 10.1016/j.jviromet.2004.04.009; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Burton DR, 2020, CELL HOST MICROBE, V27, P695, DOI 10.1016/j.chom.2020.04.022; Cele S., 2021, MEDRXIV, DOI [10.1101/2021.01.26.21250224, DOI 10.1101/2021.01.26.21250224]; Cohen AA, 2021, SCIENCE, V371, P735, DOI 10.1126/science.abf6840; Coleman Christopher M, 2015, Curr Protoc Microbiol, V37, DOI 10.1002/9780471729259.mc15e02s37; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faria N., 2021, GENOMIC CHARACTERISA, DOI 10.1093/cid/ciaa1864; Fox CB, 2016, J CONTROL RELEASE, V244, P98, DOI 10.1016/j.jconrel.2016.11.011; Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2externalicon, 10.15585/mmwr.mm7003e2]; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Hsieh Ching-Lin, 2020, bioRxiv, DOI [10.1126/science.abd0826, 10.1101/2020.05.30.125484]; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kint J, 2015, METHODS MOL BIOL, V1282, P89, DOI 10.1007/978-1-4939-2438-7_9; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Laczko D, 2020, IMMUNITY, V53, P724, DOI 10.1016/j.immuni.2020.07.019; Lassauniere R., 2020, SARS COV 2 SPIKE MUT; Leung K, 2021, EUROSURVEILLANCE, V26, P15, DOI 10.2807/1560-7917.ES.2020.26.1.2002106; Li Dapeng, 2021, bioRxiv, DOI 10.1101/2020.12.31.424729; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Liu Hejun, 2020, bioRxiv, DOI [10.1016/j.immuni.2020.10.023, 10.1101/2020.08.02.233536]; Liu L, 2022, IEEE T KNOWL DATA EN, V34, P2293, DOI [10.1109/TKDE.2020.3004939, 10.1101/2020.06.17.153486]; Ma XC, 2020, IMMUNITY, V53, P1315, DOI 10.1016/j.immuni.2020.11.015; Menachery VD, 2017, CURR OPIN VIROL, V23, P1, DOI 10.1016/j.coviro.2017.01.002; Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113; Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Nakamura T, 2018, BIOINFORMATICS, V34, P2490, DOI 10.1093/bioinformatics/bty121; Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608; Saunders KO, 2019, SCIENCE, V366, P1215, DOI 10.1126/science.aay7199; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Tegally H, 2021, NAT MED, V27, P440, DOI 10.1038/s41591-021-01255-3; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Walls Alexandra C, 2020, Cell, V183, P1367, DOI [10.1101/2020.08.11.247395, 10.1016/j.cell.2020.10.043]; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu K., 2021, MRNA 1273 VACCINE IN; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhou TQ, 2020, CELL REP, V33, DOI [10.1101/2020.06.22.166033, 10.1016/j.celrep.2020.108322]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zost Seth J, 2020, bioRxiv, DOI 10.1101/2020.05.22.111005	66	100	100	7	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 24	2021	594	7864					553	+		10.1038/s41586-021-03594-0	http://dx.doi.org/10.1038/s41586-021-03594-0		MAY 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX5MA	33971664	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000657239200001
J	Sjoberg, S; Malmiga, G; Nord, A; Andersson, A; Backman, J; Tarka, M; Willemoes, M; Thorup, K; Hansson, B; Alerstam, T; Hassequist, D				Sjoberg, Sissel; Malmiga, Gintaras; Nord, Andreas; Andersson, Arne; Backman, Johan; Tarka, Maja; Willemoes, Mikkel; Thorup, Kasper; Hansson, Bengt; Alerstam, Thomas; Hassequist, Dennis			Extreme altitudes during diurnal flights in a nocturnal songbird migrant	SCIENCE			English	Article							MIGRATION; WIND	Billions of nocturnally migrating songbirds fly across oceans and deserts on their annual journeys. Using multisensor data loggers, we show that great reed warblers (Acrocephalus arundinaceus) regularly prolong their otherwise strictly nocturnal flights into daytime when crossing the Mediterranean Sea and the Sahara Desert. Unexpectedly, when prolonging their flights, they climbed steeply at dawn, from a mean of 2394 meters above sea level to reach extreme cruising altitudes (mean 5367 and maximum 6267 meters above sea level) during daytime flights. This previously unknown behavior of using exceedingly high flight altitudes when migrating during daytime could be caused by diel variation in ambient temperature, winds, predation, vision range, and solar radiation. Our finding of this notable behavior provides new perspectives on constraints in bird flight and might help to explain the evolution of nocturnal migration.	[Sjoberg, Sissel; Nord, Andreas; Andersson, Arne; Backman, Johan; Tarka, Maja; Willemoes, Mikkel; Hansson, Bengt; Alerstam, Thomas; Hassequist, Dennis] Lund Univ, Dept Biol, Lund, Sweden; [Sjoberg, Sissel; Thorup, Kasper] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Globe Inst, Copenhagen, Denmark; [Malmiga, Gintaras] Nat Res Ctr, Vilnius, Lithuania	Lund University; University of Copenhagen; Nature Research Center - Lithuania	Sjoberg, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.; Sjoberg, S (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Globe Inst, Copenhagen, Denmark.	sissel.sjoberg@biol.lu.se	Thorup, Kasper/A-4835-2013; Hansson, Bengt/L-8874-2013; Tarka, Maja/L-8065-2013; Willemoes, Mikkel/J-9391-2012	Thorup, Kasper/0000-0002-0320-0601; Nord, Andreas/0000-0001-6170-689X; Hansson, Bengt/0000-0001-6694-8169; Andersson, Arne/0000-0002-1363-4403; Malmiga, Gintaras/0000-0003-2925-6918; Sjoberg, Sissel/0000-0002-1392-7441; Alerstam, Thomas/0000-0001-5329-4514; Tarka, Maja/0000-0001-9651-1101; Willemoes, Mikkel/0000-0001-9363-6304	European Union's Horizon 2020 research and innovation program (Marie Sklodowska Curie grant) [751692]; European Union's Horizon 2020 research and innovation program (ERC) [742646]; Danish National Research Foundation [DNRF96]; Swedish Research Council [621-2016-689, 2016-04391, 2020-03976, 349-2007-8690]; Birgit and Hellmuth Hertz Foundation/Royal Physiographic Society of Lund [2017-39034]; Lunds Djurskyddsfond	European Union's Horizon 2020 research and innovation program (Marie Sklodowska Curie grant); European Union's Horizon 2020 research and innovation program (ERC); Danish National Research Foundation(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission); Birgit and Hellmuth Hertz Foundation/Royal Physiographic Society of Lund; Lunds Djurskyddsfond	This project received funding from the European Union's Horizon 2020 research and innovation program (Marie Sklodowska Curie grant 751692 to S.S., ERC Advanced grant 742646 to D.H.), the Danish National Research Foundation (grant DNRF96 to the Center for Macroecology, Evolution and Climate), the Swedish Research Council [consolidator grant 621-2016-689 to B.H., research grants 2016-04391 and 2020-03976 to D.H., and Linnaeus grant 349-2007-8690 to the Center for Animal Movement research (CAnMove), Lund University], the Birgit and Hellmuth Hertz Foundation/Royal Physiographic Society of Lund (grant 2017-39034 to A.N.), and Lunds Djurskyddsfond.	Backman J, 2017, J AVIAN BIOL, V48, P309, DOI 10.1111/jav.01068; Bowlin MS, 2015, AUK, V132, P808, DOI 10.1642/AUK-15-33.1; Bruderer B, 2018, J ORNITHOL, V159, P315, DOI 10.1007/s10336-017-1506-z; BRYANT DM, 1983, IBIS, V125, P313, DOI 10.1111/j.1474-919X.1983.tb03117.x; Guillemette M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0386; Hijmans Robert J, 2019, CRAN; Kemp MU, 2012, METHODS ECOL EVOL, V3, P65, DOI 10.1111/j.2041-210X.2011.00138.x; Kolecek J, 2016, J AVIAN BIOL, V47, P756, DOI 10.1111/jav.00929; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Liechti F, 1998, J AVIAN BIOL, V29, P561, DOI 10.2307/3677176; Liechti F, 2000, AUK, V117, P205, DOI 10.1642/0004-8038(2000)117[0205:PMFABP]2.0.CO;2; Liechti F, 2018, MOV ECOL, V6, DOI 10.1186/s40462-018-0137-1; Lisovski S, 2012, METHODS ECOL EVOL, V3, P1055, DOI 10.1111/j.2041-210X.2012.00248.x; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Malmiga G, 2021, J AVIAN BIOL, V52, DOI 10.1111/jav.02549; Mellone U, 2013, J AVIAN BIOL, V44, P417, DOI 10.1111/j.1600-048X.2013.00139.x; Ouwehand J, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1060; QGIS.org, 2020, OP SOURC GEOSP FDN P, DOI [10.26131/IRSA525, DOI 10.26131/IRSA525]; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rydell J, 2020, CAN J ZOOL, V98, P149, DOI 10.1139/cjz-2019-0182; Seidel DJ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005526; Senner NR, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0569; Sjoberg S, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01821; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; TORREBUENO JR, 1978, J EXP BIOL, V75, P231; Voigt CC, 2011, P ROY SOC B-BIOL SCI, V278, P2311, DOI 10.1098/rspb.2010.2290; WALLACE JM, 1969, MON WEATHER REV, V97, P446, DOI 10.1175/1520-0493(1969)097<0446:DWVSTK>2.3.CO;2; Wolf BO, 2000, AM ZOOL, V40, P575, DOI 10.1668/0003-1569(2000)040[0575:TROTPI]2.0.CO;2; Xirouchakis SM, 2019, J RAPTOR RES, V53, P56, DOI 10.3356/JRR-17-94	29	11	12	5	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					646	+		10.1126/science.abe7291	http://dx.doi.org/10.1126/science.abe7291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958477				2022-12-28	WOS:000649103500049
J	DeConto, RM; Pollard, D; Alley, RB; Velicogna, I; Gasson, E; Gomez, N; Sadai, S; Condron, A; Gilford, DM; Ashe, EL; Kopp, RE; Li, DW; Dutton, A				DeConto, Robert M.; Pollard, David; Alley, Richard B.; Velicogna, Isabella; Gasson, Edward; Gomez, Natalya; Sadai, Shaina; Condron, Alan; Gilford, Daniel M.; Ashe, Erica L.; Kopp, Robert E.; Li, Dawei; Dutton, Andrea			The Paris Climate Agreement and future sea-level rise from Antarctica	NATURE			English	Article							ICE-SHEET RETREAT; GLACIAL ISOSTATIC-ADJUSTMENT; RAPID BEDROCK UPLIFT; VISCOELASTIC RESPONSE; SYSTEM MODEL; SURFACE; GREENLAND; SHELVES; DRIVEN; EARTH	An observationally calibrated ice sheet-shelf model suggests that global warming of 3 degrees C will trigger rapid Antarctic ice loss, contributing about 0.5 cm per year of sea-level rise by 2100. The Paris Agreement aims to limit global mean warming in the twenty-first century to less than 2 degrees Celsius above preindustrial levels, and to promote further efforts to limit warming to 1.5 degrees Celsius(1). The amount of greenhouse gas emissions in coming decades will be consequential for global mean sea level (GMSL) on century and longer timescales through a combination of ocean thermal expansion and loss of land ice(2). The Antarctic Ice Sheet (AIS) is Earth's largest land ice reservoir (equivalent to 57.9 metres of GMSL)(3), and its ice loss is accelerating(4). Extensive regions of the AIS are grounded below sea level and susceptible to dynamical instabilities(5-8) that are capable of producing very rapid retreat(8). Yet the potential for the implementation of the Paris Agreement temperature targets to slow or stop the onset of these instabilities has not been directly tested with physics-based models. Here we use an observationally calibrated ice sheet-shelf model to show that with global warming limited to 2 degrees Celsius or less, Antarctic ice loss will continue at a pace similar to today's throughout the twenty-first century. However, scenarios more consistent with current policies (allowing 3 degrees Celsius of warming) give an abrupt jump in the pace of Antarctic ice loss after around 2060, contributing about 0.5 centimetres GMSL rise per year by 2100-an order of magnitude faster than today(4). More fossil-fuel-intensive scenarios(9) result in even greater acceleration. Ice-sheet retreat initiated by the thinning and loss of buttressing ice shelves continues for centuries, regardless of bedrock and sea-level feedback mechanisms(10-12) or geoengineered carbon dioxide reduction. These results demonstrate the possibility that rapid and unstoppable sea-level rise from Antarctica will be triggered if Paris Agreement targets are exceeded.	[DeConto, Robert M.; Sadai, Shaina; Li, Dawei] Univ Massachusetts Amherst, Dept Geosci, Amherst, MA 01003 USA; [Pollard, David; Alley, Richard B.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Alley, Richard B.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Velicogna, Isabella] Univ Calif Irvine, Earth Syst Sci, Irvine, CA USA; [Gasson, Edward] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [Gomez, Natalya] McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ, Canada; [Condron, Alan] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Gilford, Daniel M.; Ashe, Erica L.; Kopp, Robert E.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA; [Li, Dawei] Shanghai Jiao Tong Univ, Sch Oceanog, Shanghai, Peoples R China; [Dutton, Andrea] Univ Wisconsin Madison, Dept Geosci, Madison, WI USA	University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Irvine; University of Bristol; McGill University; Woods Hole Oceanographic Institution; Rutgers State University New Brunswick; Shanghai Jiao Tong University; University of Wisconsin System; University of Wisconsin Madison	DeConto, RM (corresponding author), Univ Massachusetts Amherst, Dept Geosci, Amherst, MA 01003 USA.	deconto@geo.umass.edu	; Dutton, Andrea/A-2506-2008	Ashe, Erica/0000-0002-7445-6321; Dutton, Andrea/0000-0002-3836-119X; Condron, Alan/0000-0002-7337-1713; Li, Dawei/0000-0002-4886-9173; Gilford, Daniel/0000-0003-2422-0887; , Shaina/0000-0002-6723-6531				A G, 2013, GEOPHYS J INT, V192, P557, DOI 10.1093/gji/ggs030; An L, 2017, GEOPHYS RES LETT, V44, P3728, DOI 10.1002/2017GL073245; Antonov J.I., 2013, WORLD OCEAN ATLAS 20; ATKINSON BK, 1984, J GEOPHYS RES, V89, P4077, DOI 10.1029/JB089iB06p04077; Austermann J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700457; Banwell AF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08522-5; Barletta VR, 2018, SCIENCE, V360, P1335, DOI 10.1126/science.aao1447; Bassis JN, 2012, P ROY SOC A-MATH PHY, V468, P913, DOI 10.1098/rspa.2011.0422; Bell RE, 2017, NATURE, V544, P344, DOI 10.1038/nature22048; Benn DI, 2007, EARTH-SCI REV, V82, P143, DOI 10.1016/j.earscirev.2007.02.002; Bindschadler RA, 2013, J GLACIOL, V59, P195, DOI 10.3189/2013JoG12J125; Capron E, 2014, QUATERNARY SCI REV, V103, P116, DOI 10.1016/j.quascirev.2014.08.018; Clark PU, 2020, NATURE, V577, P660, DOI 10.1038/s41586-020-1931-7; Clerc F, 2019, GEOPHYS RES LETT, V46, P12108, DOI 10.1029/2019GL084183; Cook CP, 2013, NAT GEOSCI, V6, P765, DOI [10.1038/ngeo1889, 10.1038/NGEO1889]; Dahl-Jensen D, 2013, NATURE, V493, P489, DOI 10.1038/nature11789; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Dumitru OA, 2019, NATURE, V574, P233, DOI 10.1038/s41586-019-1543-2; Dutton A, 2015, QUATERNARY SCI REV, V107, P182, DOI 10.1016/j.quascirev.2014.10.025; Edwards TL, 2019, NATURE, V566, P58, DOI 10.1038/s41586-019-0901-4; Fawcett AA, 2015, SCIENCE, V350, P1168, DOI 10.1126/science.aad5761; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Furst JJ, 2016, NAT CLIM CHANGE, V6, P479, DOI [10.1038/NCLIMATE2912, 10.1038/nclimate2912]; Gilford DM, 2020, J GEOPHYS RES-EARTH, V125, DOI 10.1029/2019JF005418; Goelzer H, 2016, CLIM PAST, V12, P2195, DOI 10.5194/cp-12-2195-2016; Golledge NR, 2019, NATURE, V566, P65, DOI 10.1038/s41586-019-0889-9; Gomez N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9798; Grant GR, 2019, NATURE, V574, P237, DOI 10.1038/s41586-019-1619-z; Gudmundsson GH, 2013, CRYOSPHERE, V7, P647, DOI 10.5194/tc-7-647-2013; Heeszel DS, 2016, J GEOPHYS RES-SOL EA, V121, P1758, DOI 10.1002/2015JB012616; Helsen MM, 2013, CLIM PAST, V9, P1773, DOI 10.5194/cp-9-1773-2013; Holland PR, 2008, J CLIMATE, V21, P2558, DOI 10.1175/2007JCLI1909.1; Hurrell JW, 2013, B AM METEOROL SOC, V94, P1339, DOI 10.1175/BAMS-D-12-00121.1; Ivins ER, 2013, J GEOPHYS RES-SOL EA, V118, P3126, DOI 10.1002/jgrb.50208; Jenkins A, 2018, NAT GEOSCI, V11, P733, DOI 10.1038/s41561-018-0207-4; Joughin I, 2020, CRYOSPHERE, V14, P211, DOI 10.5194/tc-14-211-2020; Joughin I, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002110; Khazendar A, 2019, NAT GEOSCI, V12, P277, DOI 10.1038/s41561-019-0329-3; Munneke PK, 2014, J GLACIOL, V60, P205, DOI 10.3189/2014JoG13J183; Lai CY, 2020, NATURE, V584, P574, DOI 10.1038/s41586-020-2627-8; Larour E, 2019, SCIENCE, V364, P969, DOI 10.1126/science.aav7908; Le Brocq A. M., 2010, EARTH SYST SCI DATA, V2, P247, DOI [10.5194/essd-2-247-2010, DOI 10.5194/essd-2-247-2010, DOI 10.5194/ESSD-2-247-2010]; Lenaerts JTM, 2016, CLIM DYNAM, V47, P1367, DOI 10.1007/s00382-015-2907-4; Ma Y, 2017, GEOPHYS RES LETT, V44, P1369, DOI 10.1002/2016GL071560; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mengel M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02985-8; Milillo P, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3433; Morelli A, 2004, GLOBAL PLANET CHANGE, V42, P155, DOI 10.1016/j.gloplacha.2003.12.005; Morlighem M, 2020, NAT GEOSCI, V13, P132, DOI 10.1038/s41561-019-0510-8; Nicholl JAL, 2012, NAT GEOSCI, V5, P901, DOI [10.1038/ngeo1622, 10.1038/NGEO1622]; Nick FM, 2010, J GLACIOL, V56, P781, DOI 10.3189/002214310794457344; Nield GA, 2014, EARTH PLANET SC LETT, V397, P32, DOI 10.1016/j.epsl.2014.04.019; Pal JS, 2007, B AM METEOROL SOC, V88, P1395, DOI 10.1175/BAMS-88-9-1395; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Parizek BR, 2019, GEOLOGY, V47, P449, DOI 10.1130/G45880.1; Pattyn F, 2017, CRYOSPHERE, V11, P1851, DOI 10.5194/tc-11-1851-2017; Pollard D, 2012, GEOSCI MODEL DEV, V5, P1273, DOI 10.5194/gmd-5-1273-2012; Pollard D, 2012, CRYOSPHERE, V6, P953, DOI 10.5194/tc-6-953-2012; Pollard D, 2018, GEOSCI MODEL DEV, V11, P5149, DOI 10.5194/gmd-11-5149-2018; Pollard D, 2017, J GEOPHYS RES-EARTH, V122, P2124, DOI 10.1002/2017JF004371; Pollard D, 2016, GEOSCI MODEL DEV, V9, P1697, DOI 10.5194/gmd-9-1697-2016; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Powell E, 2020, J CLIMATE, V33, P443, DOI 10.1175/JCLI-D-19-0479.1; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Robel AA, 2019, GEOPHYS RES LETT, V46, P12092, DOI 10.1029/2019GL084397; Robel AA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14596; Rohling EJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12874-3; Sadai S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1169; Scambos TA, 2011, ANN GLACIOL, V52, P74, DOI 10.3189/172756411799096204; Schlemm T, 2019, CRYOSPHERE, V13, P2475, DOI 10.5194/tc-13-2475-2019; Schmidtko S, 2014, SCIENCE, V346, P1227, DOI 10.1126/science.1256117; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Seroussi H, 2020, CRYOSPHERE, V14, P3033, DOI 10.5194/tc-14-3033-2020; Seroussi H, 2018, CRYOSPHERE, V12, P3085, DOI 10.5194/tc-12-3085-2018; Shepherd A, 2018, NATURE, V558, P219, DOI 10.1038/s41586-018-0179-y; Shields CA, 2016, GEOPHYS RES LETT, V43, P7767, DOI 10.1002/2016GL069476; Trusel LD, 2015, NAT GEOSCI, V8, P927, DOI [10.1038/ngeo2563, 10.1038/NGEO2563]; Tsai CY, 2020, CLIM DYNAM, V55, P1875, DOI 10.1007/s00382-020-05354-8; Tsai VC, 2015, J GLACIOL, V61, P205, DOI 10.3189/2015JoG14J221; UNFCCC, 2015, AD PAR AGR FCCC CP 2; van Wessem JM, 2014, CRYOSPHERE, V8, P125, DOI 10.5194/tc-8-125-2014; VAUGHAN DG, 1993, J GLACIOL, V39, P255, DOI 10.3189/S0022143000015926; Velicogna I, 2014, GEOPHYS RES LETT, V41, P8130, DOI 10.1002/2014GL061052; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]; Whitehouse PL, 2012, GEOPHYS J INT, V190, P1464, DOI 10.1111/j.1365-246X.2012.05557.x; Zhao C, 2017, EARTH PLANET SC LETT, V473, P164, DOI 10.1016/j.epsl.2017.06.002	87	69	71	56	115	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					83	+		10.1038/s41586-021-03427-0	http://dx.doi.org/10.1038/s41586-021-03427-0			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RY0YD	33953408				2022-12-28	WOS:000647642900015
J	Sirleaf, EJ; Clark, H				Sirleaf, Ellen Johnson; Clark, Helen			Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic	LANCET			English	Editorial Material									[Sirleaf, Ellen Johnson] Ellen Johnson Sirleaf Presidential Ctr Women & De, Monrovia, Liberia; [Clark, Helen] Helen Clark Fdn, Auckland, New Zealand		Clark, H (corresponding author), Helen Clark Fdn, Auckland, New Zealand.	singhsu@ipppr.org						Furceri D., 2020, VOX 0508; Independent Panel for Pandemic Preparedness and Response, COVID 19 MAK IT LAST, P2021; Independent Panel for Pandemic Preparedness and Response, OUTBR BEC PAND DEF M, P2021; Pereznieto P., SOCIAL COSTS COVID 1, P2021	4	37	38	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2021	398	10295					101	103		10.1016/S0140-6736(21)01095-3	http://dx.doi.org/10.1016/S0140-6736(21)01095-3		JUL 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TG0BQ	33991477	Green Accepted, Bronze			2022-12-28	WOS:000671078800006
J	Vervoort, SJ; Welsh, SA; Devlin, JR; Barbieri, E; Knight, DA; Offley, S; Bjelosevic, S; Costacurta, M; Todorovski, I; Kearney, CJ; Sandow, JJ; Fan, Z; Blyth, B; McLeod, V; Vissers, JHA; Pavic, K; Martin, B; Gregory, G; Demosthenous, E; Zethoven, M; Kong, IY; Hawkins, ED; Hogg, SJ; Kelly, MJ; Newbold, A; Simpson, KJ; Kauko, O; Harvey, KF; Ohlmeyer, M; Westermarck, J; Gray, N; Gardini, A; Johnstone, RW				Vervoort, Stephin J.; Welsh, Sarah A.; Devlin, Jennifer R.; Barbieri, Elisa; Knight, Deborah A.; Offley, Sarah; Bjelosevic, Stefan; Costacurta, Matteo; Todorovski, Izabela; Kearney, Conor J.; Sandow, Jarrod J.; Fan, Zheng; Blyth, Benjamin; McLeod, Victoria; Vissers, Joseph H. A.; Pavic, Karolina; Martin, Ben P.; Gregory, Gareth; Demosthenous, Elena; Zethoven, Magnus; Kong, Isabella Y.; Hawkins, Edwin D.; Hogg, Simon J.; Kelly, Madison J.; Newbold, Andrea; Simpson, Kaylene J.; Kauko, Otto; Harvey, Kieran F.; Ohlmeyer, Michael; Westermarck, Jukka; Gray, Nathanael; Gardini, Alessandro; Johnstone, Ricky W.			The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer	CELL			English	Article							PROTEIN PHOSPHATASE 2A; P-TEFB; INTEGRATOR COMPLEX; ELONGATION COMPLEX; GENE-EXPRESSION; PAUSE RELEASE; SEQ DATA; RNA; ACTIVATION; PROMOTER	Gene expression by RNA polymerase II (RNAPII) is tightly controlled by cyclin-dependent kinases (CDKs) at discrete checkpoints during the transcription cycle. The pausing checkpoint following transcription initiation is primarily controlled by CDK9. We discovered that CDK9-mediated, RNAPII-driven transcription is functionally opposed by a protein phosphatase 2A (PP2A) complex that is recruited to transcription sites by the Integrator complex subunit INTS6. PP2A dynamically antagonizes phosphorylation of key CDK9 substrates including DSIF and RNAPII-CTD. Loss of INTS6 results in resistance to tumor cell death mediated by CDK9 inhibition, decreased turnover of CDK9 phospho-substrates, and amplification of acute oncogenic transcriptional responses. Pharmacological PP2A activation synergizes with CDK9 inhibition to kill both leukemic and solid tumor cells, providing therapeutic benefit in vivo. These data demonstrate that fine control of gene expression relies on the balance between kinase and phosphatase activity throughout the transcription cycle, a process dysregulated in cancer that can be exploited therapeutically.	[Vervoort, Stephin J.; Devlin, Jennifer R.; Knight, Deborah A.; Bjelosevic, Stefan; Costacurta, Matteo; Todorovski, Izabela; Kearney, Conor J.; Fan, Zheng; Blyth, Benjamin; McLeod, Victoria; Vissers, Joseph H. A.; Martin, Ben P.; Gregory, Gareth; Demosthenous, Elena; Zethoven, Magnus; Hogg, Simon J.; Kelly, Madison J.; Newbold, Andrea; Simpson, Kaylene J.; Harvey, Kieran F.; Johnstone, Ricky W.] Peter MacCallum Canc Ctr, Melbourne, Vic 3000, Australia; [Vervoort, Stephin J.; Devlin, Jennifer R.; Knight, Deborah A.; Bjelosevic, Stefan; Costacurta, Matteo; Todorovski, Izabela; Kearney, Conor J.; Fan, Zheng; Vissers, Joseph H. A.; Martin, Ben P.; Gregory, Gareth; Hogg, Simon J.; Kelly, Madison J.; Newbold, Andrea; Harvey, Kieran F.; Johnstone, Ricky W.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Welsh, Sarah A.; Barbieri, Elisa; Offley, Sarah; Gardini, Alessandro] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Welsh, Sarah A.] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA; [Offley, Sarah] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Sandow, Jarrod J.; Kong, Isabella Y.; Hawkins, Edwin D.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3010, Australia; [Vissers, Joseph H. A.] Univ Melbourne, Ctr Canc Res, Parkville, Vic 3010, Australia; [Vissers, Joseph H. A.] Univ Melbourne, Dept Clin Pathol, Parkville, Vic 3010, Australia; [Pavic, Karolina; Kauko, Otto; Westermarck, Jukka] Univ Turku, Turku Biosci Ctr, FI-20014 Turku, Finland; [Pavic, Karolina; Kauko, Otto; Westermarck, Jukka] Abo Akad Univ, FI-20014 Turku, Finland; [Pavic, Karolina; Kauko, Otto; Westermarck, Jukka] Univ Turku, Inst Biomed, FI-20014 Turku, Finland; [Gregory, Gareth] Monash Univ, Sch Clin Sci Monash Hlth, Clayton, Vic 3168, Australia; [Harvey, Kieran F.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3168, Australia; [Harvey, Kieran F.] Monash Univ, Biomed Discovery Inst, Clayton, Vic 3168, Australia; [Ohlmeyer, Michael] Mt Sinai Sch Med, New York, NY 10029 USA; [Ohlmeyer, Michael] Atux Iskay LLC, Plainsboro, NJ 08536 USA; [Gray, Nathanael] Dana Farber Canc Inst, Boston, MA 02215 USA; [Sandow, Jarrod J.; Kong, Isabella Y.; Hawkins, Edwin D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Turku; Abo Akademi University; University of Turku; Monash University; Monash University; Monash University; Icahn School of Medicine at Mount Sinai; Harvard University; Dana-Farber Cancer Institute; University of Melbourne	Vervoort, SJ; Johnstone, RW (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic 3000, Australia.; Vervoort, SJ; Johnstone, RW (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia.; Gardini, A (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	stephin-vervoort@petermac.org; agardini@wistar.org; ricky.johnstone@petermac.org	Hogg, Simon/AFL-2783-2022; Vervoort, Stephin/AAP-7854-2020; Costacurta, Matteo/AAB-8004-2022; Westermarck, Jukka/AAL-6464-2020; Costacurta, Matteo/GYA-2599-2022; Harvey, Kieran/AAD-5268-2022; Johnstone, Ricky/H-3748-2014	Westermarck, Jukka/0000-0001-7478-3018; Costacurta, Matteo/0000-0003-4605-7427; Vervoort, Stephin/0000-0001-7459-126X; WELSH, SARAH A./0000-0003-2251-1111; Blyth, Benjamin/0000-0003-4754-6249; Kong, Isabella/0000-0002-7480-4525; Bjelosevic, Stefan/0000-0002-3012-9273; Johnstone, Ricky/0000-0001-7053-9237; Devlin, Jennifer/0000-0002-2933-6240; Offley, Sarah/0000-0002-4902-333X	Cancer Council Victoria; National Health and Medical Research Council of Australia (NHMRC); The Kids' Cancer Project; American Cancer Society [RSG18-157-01-DMC]; G. Harold & Leila Y. Mathers Foundation; NIH [R01 HL141326, T32-GM071339]; Emerson Collective Cancer Research Fund; Ovarian Cancer Research Alliance; Rubicon fellowship (NWO) [019.161LW.017]; NHMRC EL1 fellowship [GNT1178339]; Kids' Cancer Project; Early Career Seed Grant from the Victorian Cancer Agency (VCA); Cancer Council of Victoria (CCV); NHMRC [APP1078220]; Academy of Finland [294850]; Finnish Cancer Foundation; Finnish Cultural Foundation; Australian Cancer Research Foundation (ACRF); University of Melbourne Collaborative Research Infrastructure Program; PMCC Foundation	Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); The Kids' Cancer Project; American Cancer Society(American Cancer Society); G. Harold & Leila Y. Mathers Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerson Collective Cancer Research Fund; Ovarian Cancer Research Alliance; Rubicon fellowship (NWO); NHMRC EL1 fellowship(National Health and Medical Research Council (NHMRC) of Australia); Kids' Cancer Project; Early Career Seed Grant from the Victorian Cancer Agency (VCA); Cancer Council of Victoria (CCV)(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Australian Cancer Research Foundation (ACRF); University of Melbourne Collaborative Research Infrastructure Program; PMCC Foundation	We thank members of the Johnstone and Gardini laboratories, the Translational Research Laboratory, the Victorian Centre for Functional Genomics (VCFG), Molecular Genomics Core and the Flow Cytometry Core Facilities at the Peter MacCallum Cancer Center (PMCC), the Proteomics Facility at the Walter and Eliza Hall Institute, and the Genomics Core and the Proteomics Core at The Wistar Institute (P30-CA010815) for their technical expertise and for providing reagents. We thank Prof. Robert Fisher for providing phosphoSpt5 antibodies. Illustrations were made with BioRender.com. R.W.J. was supported by the Cancer Council Victoria, National Health and Medical Research Council of Australia (NHMRC) and The Kids' Cancer Project. The Gardini laboratory (A.G.) was supported the American Cancer Society (RSG18-157-01-DMC), the G. Harold & Leila Y. Mathers Foundation (A.G.), the NIH (R01 HL141326), the Emerson Collective Cancer Research Fund, and the Ovarian Cancer Research Alliance. S.J.V. was supported by a Rubicon fellowship (NWO, 019.161LW.017), NHMRC EL1 fellowship (GNT1178339), and The Kids' Cancer Project. S.A.W. was supported by a training grant from NIH (T32-GM071339). J.R.D. was supported by an Early Career Seed Grant from the Victorian Cancer Agency (VCA). S.J.H. was supported by a Postdoctoral Fellowship from the Cancer Council of Victoria (CCV). K.F.H. was supported by a NHMRC Senior Research Fellowship (APP1078220). J.W. and K.P. were supported by Academy of Finland (294850) and Finnish Cancer Foundation. K.P. was supported by Finnish Cultural Foundation. The VCFG ACRF Translational Reverse Phase Protein Array platform (K.J.S.) is funded by the Australian Cancer Research Foundation (ACRF), University of Melbourne Collaborative Research Infrastructure Program, and the PMCC Foundation. The PMCC Foundation and ACRF provide generous support for equipment and core facilities.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Akama-Garren EH, 2016, SCI REP-UK, V6, DOI 10.1038/srep16836; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Baker A, 2016, CANCER RES, V76, P1158, DOI 10.1158/0008-5472.CAN-15-1070; Barbieri E, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108373; Barbieri E, 2018, MOL CELL, V71, P103, DOI 10.1016/j.molcel.2018.05.031; Bassett AR, 2014, BIOL OPEN, V3, P42, DOI 10.1242/bio.20137120; Beckedorff F, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107917; Bots M, 2014, BLOOD, V123, P1341, DOI 10.1182/blood-2013-03-488114; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen FX, 2018, NAT REV MOL CELL BIO, V19, P464, DOI 10.1038/s41580-018-0010-5; Chen FX, 2015, CELL, V162, P1003, DOI 10.1016/j.cell.2015.07.042; Chou J, 2020, CANCER DISCOV, V10, P351, DOI 10.1158/2159-8290.CD-19-0528; Cidado J, 2020, CLIN CANCER RES, V26, P922, DOI 10.1158/1078-0432.CCR-19-1853; Clark AR, 2019, PHARMACOL THERAPEUT, V201, P181, DOI 10.1016/j.pharmthera.2019.05.016; Core L, 2019, GENE DEV, V33, P960, DOI 10.1101/gad.325142.119; Cortazar MA, 2019, MOL CELL, V76, P896, DOI 10.1016/j.molcel.2019.09.031; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eaton JD, 2020, GENE DEV, V34, P132, DOI 10.1101/gad.332833.119; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Egan B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166438; Elrod ND, 2019, MOL CELL, V76, P738, DOI 10.1016/j.molcel.2019.10.034; Filleur S, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-28; Fowle H, 2019, ADV CANCER RES, V144, P55, DOI 10.1016/bs.acr.2019.03.009; Fujinaga K, 2020, MOLECULES, V25, DOI 10.3390/molecules25040838; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gardini A, 2014, MOL CELL, V56, P128, DOI 10.1016/j.molcel.2014.08.004; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Grallert A, 2015, NATURE, V517, P94, DOI 10.1038/nature14019; Gregersen LH, 2019, CELL, V177, P1797, DOI 10.1016/j.cell.2019.04.038; Gregory GP, 2015, LEUKEMIA, V29, P1437, DOI 10.1038/leu.2015.10; Gressel S, 2017, ELIFE, V6, DOI 10.7554/eLife.29736; Haesen D, 2016, CANCER RES, V76, P5719, DOI 10.1158/0008-5472.CAN-15-3342; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hashiguchi T, 2019, MOL CANCER THER, V18, P1520, DOI 10.1158/1535-7163.MCT-18-1023; He LY, 2018, METHODS MOL BIOL, V1711, P351, DOI 10.1007/978-1-4939-7493-1_17; Huang KL, 2020, MOL CELL, V80, P345, DOI 10.1016/j.molcel.2020.08.016; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeronimo C, 2016, J MOL BIOL, V428, P2607, DOI 10.1016/j.jmb.2016.02.006; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kastrinsky DB, 2015, BIOORGAN MED CHEM, V23, P6528, DOI 10.1016/j.bmc.2015.07.007; Kauko O, 2020, J BIOL CHEM, V295, P4194, DOI 10.1074/jbc.RA119.011265; Kauko O, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1093; Kearney CJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3451; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lai F, 2015, NATURE, V525, P399, DOI 10.1038/nature14906; Laitem C, 2015, NAT STRUCT MOL BIOL, V22, P396, DOI 10.1038/nsmb.3000; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leonard D, 2020, CELL, V181, P688, DOI 10.1016/j.cell.2020.03.038; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H., 2013, PREPRINT, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li J, 2015, HEMATOLOGY, V20, P377, DOI 10.1179/1607845414Y.0000000214; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martin RD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093354; Mayer A, 2017, CURR OPIN CELL BIOL, V46, P72, DOI 10.1016/j.ceb.2017.03.002; Mayfield JE, 2016, BBA-PROTEINS PROTEOM, V1864, P372, DOI 10.1016/j.bbapap.2016.01.007; Merisaari J., 2020, MONOTHERAPY EFFICACY; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morita K, 2020, CELL, V181, P702, DOI 10.1016/j.cell.2020.03.051; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Parua PK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18173-6; Parua PK, 2018, NATURE, V558, P460, DOI 10.1038/s41586-018-0214-z; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Riemondy Kent A, 2017, F1000Res, V6, P1025, DOI 10.12688/f1000research.11997.1; Rienzo M, 2016, BBA-GENE REGUL MECH, V1859, P1269, DOI 10.1016/j.bbagrm.2016.07.008; Roeder RG, 2019, NAT STRUCT MOL BIOL, V26, P783, DOI 10.1038/s41594-019-0287-x; Ropke A, 2005, ONCOGENE, V24, P6667, DOI 10.1038/sj.onc.1208824; Rubtsova MP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38297-6; Sangodkar J, 2017, J CLIN INVEST, V127, P2081, DOI 10.1172/JCI89548; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sanso M, 2016, GENE DEV, V30, P117, DOI 10.1101/gad.269589.115; Sen I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13931-7; Shih IM, 2011, AM J PATHOL, V178, P1442, DOI 10.1016/j.ajpath.2011.01.009; Skaar JR, 2009, J CELL BIOL, V187, P25, DOI 10.1083/jcb.200907026; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tatomer DC, 2019, GENE DEV, V33, P1525, DOI 10.1101/gad.330167.119; Therneau T.M., 2018, PACKAGE SURVIVAL ANA; Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; Westermarck J, 2020, CELL, V181, P514, DOI 10.1016/j.cell.2020.04.005; Wu TZ, 2020, J MED CHEM, V63, P13228, DOI 10.1021/acs.jmedchem.0c00744; Xu YW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15741; Yang L, 2017, METHODS MOL BIOL, V1487, P113, DOI 10.1007/978-1-4939-6424-6_8; Ye T, 2014, METHODS MOL BIOL, V1150, P141, DOI 10.1007/978-1-4939-0512-6_8; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338; Yue JY, 2020, GENE DEV, V34, P637, DOI 10.1101/gad.333864.119; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng H, 2020, SCIENCE, V370, P1059, DOI 10.1126/science.abb5872; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	107	27	27	9	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3143	+	e32	10.1016/j.cell.2021.04.022	http://dx.doi.org/10.1016/j.cell.2021.04.022		JUN 2021	52	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	34004147	Bronze, Green Accepted			2022-12-28	WOS:000660014300008
J	Slomski, A				Slomski, Anita			Upadacitinib Noninferior to Adalimumab for Psoriatic Arthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2039	2039		10.1001/jama.2021.7716	http://dx.doi.org/10.1001/jama.2021.7716			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032833				2022-12-28	WOS:000655647300007
J	Faisal, AA				Faisal, A. Aldo			Putting touch into action	SCIENCE			English	Editorial Material							GRASP		[Faisal, A. Aldo] Imperial Coll, Brain & Behav Lab, London, England; [Faisal, A. Aldo] Imperial Coll, Dept Bioengn, London, England; [Faisal, A. Aldo] Imperial Coll, Dept Comp, London, England; [Faisal, A. Aldo] Imperial Coll, UK Res & Innovat UKRI Ctr Doctoral Training Healt, London, England; [Faisal, A. Aldo] Med Res Council MRC London Inst Med Sci, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Faisal, AA (corresponding author), Imperial Coll, Brain & Behav Lab, London, England.; Faisal, AA (corresponding author), Imperial Coll, Dept Bioengn, London, England.; Faisal, AA (corresponding author), Imperial Coll, Dept Comp, London, England.; Faisal, AA (corresponding author), Imperial Coll, UK Res & Innovat UKRI Ctr Doctoral Training Healt, London, England.; Faisal, AA (corresponding author), Med Res Council MRC London Inst Med Sci, London, England.	a.faisal@imperial.ac.uk	Faisal, Aldo/A-2367-2009	Faisal, Aldo/0000-0003-0813-7207	UKRI Turing AI Fellowship [EP/V025449/1]	UKRI Turing AI Fellowship(UK Research & Innovation (UKRI))	A.A.F. acknowledges his UKRI Turing AI Fellowship (EP/V025449/1).	Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Bensmaia SJ, 2014, NAT REV NEUROSCI, V15, P313, DOI 10.1038/nrn3724; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Callier T, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/5/056010; Dahiya R, 2019, P IEEE, V107, P247, DOI 10.1109/JPROC.2018.2890729; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; Flesher SN, 2021, SCIENCE, V372, P831, DOI 10.1126/science.abd0380; Flesher SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8083; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Makin TR, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0014; Raspopovic S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006820; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820	13	0	0	3	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					791	792		10.1126/science.abi7262	http://dx.doi.org/10.1126/science.abi7262			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016768				2022-12-28	WOS:000653997000025
J	Langezaal, LCM; van der Hoeven, EJRJ; Mont'Alverne, FJA; de Carvalho, JJF; Lima, FO; Dippel, DWJ; van der Lugt, A; Lo, RTH; Boiten, J; Nijeholt, GJLA; Staals, J; van Zwam, WH; Nederkoorn, PJ; Majoie, CBLM; Gerber, JC; Mazighi, M; Piotin, M; Zini, A; Vallone, S; Hofmeijer, J; Martins, SO; Nolte, CH; Szabo, K; Dias, FA; Abud, DG; Wermer, MJH; Remmers, MJM; Schneider, H; Rueckert, CM; de Laat, KF; Yoo, AJ; van Doormaal, PJ; van Es, ACGM; Emmer, BJ; Michel, P; Puetz, V; Audebert, HJ; Pontes-Neto, OM; Vos, JA; Kappelle, LJ; Algra, A; Schonewille, WJ				Langezaal, L. C. M.; van der Hoeven, Erik J. R. J.; Mont'Alverne, Francisco J. A.; de Carvalho, Joao J. F.; Lima, Fabricio O.; Dippel, Diederik W. J.; van der Lugt, Aad; Lo, Rob T. H.; Boiten, Jelis; Lycklama a Nijeholt, Geert J.; Staals, Julie; van Zwam, Wim H.; Nederkoorn, Paul J.; Majoie, Charles B. L. M.; Gerber, Johannes C.; Mazighi, Mikael; Piotin, Michel; Zini, Andrea; Vallone, Stefano; Hofmeijer, Jeannette; Martins, Sheila O.; Nolte, Christian H.; Szabo, Kristina; Dias, Francisco A.; Abud, Daniel G.; Wermer, Marieke J. H.; Remmers, Michel J. M.; Schneider, Hauke; Rueckert, Christina M.; de Laat, Karlijn F.; Yoo, Albert J.; van Doormaal, Pieter-Jan; van Es, Adriaan C. G. M.; Emmer, Bart J.; Michel, Patrik; Puetz, Volker; Audebert, Heinrich J.; Pontes-Neto, Octavio M.; Vos, Jan-Albert; Kappelle, L. Jaap; Algra, Ale; Schonewille, Wouter J.		BASICS Study Grp	Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISCHEMIC-STROKE; INTRAARTERIAL; THROMBECTOMY; TRIAL	Background The effectiveness of endovascular therapy in patients with stroke caused by basilar-artery occlusion has not been well studied. Methods We randomly assigned patients within 6 hours after the estimated time of onset of a stroke due to basilar-artery occlusion, in a 1:1 ratio, to receive endovascular therapy or standard medical care. The primary outcome was a favorable functional outcome, defined as a score of 0 to 3 on the modified Rankin scale (range, 0 to 6, with 0 indicating no disability, 3 indicating moderate disability, and 6 indicating death) at 90 days. The primary safety outcomes were symptomatic intracranial hemorrhage within 3 days after the initiation of treatment and mortality at 90 days. Results A total of 300 patients were enrolled (154 in the endovascular therapy group and 146 in the medical care group). Intravenous thrombolysis was used in 78.6% of the patients in the endovascular group and in 79.5% of those in the medical group. Endovascular treatment was initiated at a median of 4.4 hours after stroke onset. A favorable functional outcome occurred in 68 of 154 patients (44.2%) in the endovascular group and 55 of 146 patients (37.7%) in the medical care group (risk ratio, 1.18; 95% confidence interval [CI], 0.92 to 1.50). Symptomatic intracranial hemorrhage occurred in 4.5% of the patients after endovascular therapy and in 0.7% of those after medical therapy (risk ratio, 6.9; 95% CI, 0.9 to 53.0); mortality at 90 days was 38.3% and 43.2%, respectively (risk ratio, 0.87; 95% CI, 0.68 to 1.12). Conclusions Among patients with stroke from basilar-artery occlusion, endovascular therapy and medical therapy did not differ significantly with respect to a favorable functional outcome, but, as reflected by the wide confidence interval for the primary outcome, the results of this trial may not exclude a substantial benefit of endovascular therapy. Larger trials are needed to determine the efficacy and safety of endovascular therapy for basilar-artery occlusion. (Funded by the Dutch Heart Foundation and others; BASICS ClinicalTrials.gov number, NCT01717755; Netherlands Trial Register number, NL2500.) Endovascular Therapy for Basilar-Artery Stroke In a randomized trial involving 300 patients with basilar-artery stroke, endovascular thrombectomy was not significantly different from medical therapy with respect to a favorable functional outcome (modified Rankin scale score of 0 to 3) at 90 days, but a clinically significant benefit could not be excluded.	[Langezaal, L. C. M.; van der Hoeven, Erik J. R. J.; Vos, Jan-Albert] St Antonius Hosp, Dept Radiol, Nieuwegein, Netherlands; [Schonewille, Wouter J.] St Antonius Hosp, Dept Neurol, Nieuwegein, Netherlands; [Dippel, Diederik W. J.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [van der Lugt, Aad; van Doormaal, Pieter-Jan] Erasmus Univ, Med Ctr, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [Lo, Rob T. H.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Kappelle, L. Jaap] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [Kappelle, L. Jaap] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr, Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Algra, Ale] Univ Utrecht, Utrecht, Netherlands; [de Laat, Karlijn F.] Haaglanden Med Ctr, The Hague, Netherlands; [de Laat, Karlijn F.] Haga Hosp, Dept Neurol, The Hague, Netherlands; [Staals, Julie] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [van Zwam, Wim H.] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, Maastricht, Netherlands; [Majoie, Charles B. L. M.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [van Doormaal, Pieter-Jan] Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Majoie, Charles B. L. M.; Emmer, Bart J.] Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Hofmeijer, Jeannette] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands; [Hofmeijer, Jeannette] Univ Twente, Dept Clin Neurophysiol, Enschede, Netherlands; [Wermer, Marieke J. H.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [van Es, Adriaan C. G. M.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Mont'Alverne, Francisco J. A.] Hosp Geral Fortaleza, Intervent Neuroradiol Serv, Fortaleza, Ceara, Brazil; [de Carvalho, Joao J. F.; Lima, Fabricio O.] Hosp Geral Fortaleza, Neurol Serv, Fortaleza, Ceara, Brazil; [Martins, Sheila O.] Univ Fed Rio Grande do Sul, Dept Neurol, Porto Alegre, RS, Brazil; [Martins, Sheila O.] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Dias, Francisco A.; Pontes-Neto, Octavio M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Stroke Serv, Neurol Div,Dept Neurosci & Behav Sci, Sao Paulo, Brazil; [Abud, Daniel G.] Univ Sao Paulo, Ribeirao Preto Med Sch, Intervent Neuroradiol Serv, Dept Med Imaging Hematol & Oncol, Sao Paulo, Brazil; [Gerber, Johannes C.] Univ Hosp Carl Gustav Carus, Dresden Neurovasc Ctr, Inst Neuroradiol, Dresden, Germany; [Puetz, Volker] Univ Hosp Carl Gustav Carus, Dresden Neurovasc Ctr, Dept Neurol, Dresden, Germany; [Schneider, Hauke] Tech Univ Dresden, Med Fak Carl Gustav Carus, Dresden, Germany; [Nolte, Christian H.; Audebert, Heinrich J.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Nolte, Christian H.; Audebert, Heinrich J.] Charite Univ Med Berlin, Ctr Stroke Res, Berlin, Germany; [Szabo, Kristina] Heidelberg Univ, Dept Neurol, Univ Med Ctr Mannheim, Med Fac Mannheim, Mannheim, Germany; [Rueckert, Christina M.] Univ Paris, Dept Neurol, Oberschwabenklin Ravensburg, Paris, France; [Michel, Patrik] Univ Paris, Dept Neurol, Rothschild Fdn Hosp, INSERM Unite 1148, Paris, France; [Zini, Andrea] IRCCS Ist Sci Neurol Bologna, Dept Neurol, Maggiore Hosp, Bologna, Italy; [Zini, Andrea] IRCCS Ist Sci Neurol Bologna, Stroke Ctr, Maggiore Hosp, Bologna, Italy; [Vallone, Stefano] Modena Univ Hosp, Osped Civile S AgostinoEstense, Dept Neurosci, Neuroradiol Unit, Modena, Italy; [Yoo, Albert J.] Texas Stroke Inst, Ft Worth, TX USA; [Michel, Patrik] Univ Lausanne Hosp, Neurol Serv, Stroke Ctr, Lausanne, Switzerland	St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Haaglanden Medical Center; Haga Hospital; Maastricht University; Maastricht University; Maastricht University; University of Amsterdam; University of Amsterdam; Rijnstate Hospital; University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade de Sao Paulo; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; UDICE-French Research Universities; Universite Paris Cite; Fondation Adolphe de Rothschild; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Schonewille, WJ (corresponding author), St Antonius Hosp, Dept Neurol, Nieuwegein, Netherlands.	w.schonewille@antoniusziekenhuis.nl	Nolte, Christian/AAA-2651-2022; Pontes-Neto, Octavio Marques/G-4294-2012; Zini, Andrea/K-1136-2014; Gerber, Johannes/U-4918-2019	Nolte, Christian/0000-0001-5577-1775; Pontes-Neto, Octavio Marques/0000-0003-0317-843X; Zini, Andrea/0000-0003-1486-4507; Gerber, Johannes/0000-0001-7465-8700; Majoie, Charles/0000-0002-7600-9568; Schneider, Hauke/0000-0002-9641-0922; Audebert, Heinrich J./0000-0002-4785-0366; Erdur, Hebun/0000-0001-5383-9625; Emmer, Bart/0000-0001-8462-4037; Martens, Jasper/0000-0002-9418-4503				Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; HACKE W, 1988, STROKE, V19, P1216, DOI 10.1161/01.STR.19.10.1216; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Knol MJ, 2012, CAN MED ASSOC J, V184, P895, DOI 10.1503/cmaj.101715; Lindsberg PJ, 2006, STROKE, V37, P922, DOI 10.1161/01.STR.0000202582.29510.6b; Liu XF, 2020, LANCET NEUROL, V19, P115, DOI 10.1016/S1474-4422(19)30395-3; Macleod MR, 2005, CEREBROVASC DIS, V20, P12, DOI 10.1159/000086121; Mattle Heinrich P, 2011, Lancet Neurol, V10, P1002, DOI 10.1016/S1474-4422(11)70229-0; Meinel TR, 2019, J NEUROINTERV SURG, V11, P1174, DOI 10.1136/neurintsurg-2018-014516; Mocco J, 2016, STROKE, V47, P2331, DOI 10.1161/STROKEAHA.116.013372; Puetz V, 2008, STROKE, V39, P2485, DOI 10.1161/STROKEAHA.107.511162; Reinink H, 2021, JAMA NEUROL, V78, P208, DOI 10.1001/jamaneurol.2020.3745; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Schonewille WJ, 2009, LANCET NEUROL, V8, P724, DOI 10.1016/S1474-4422(09)70173-5; van der Hoeven EJRJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-200; von Kummer R, 2015, STROKE, V46, P2981, DOI 10.1161/STROKEAHA.115.010049; ZEUMER H, 1983, AM J NEURORADIOL, V4, P401	19	119	127	7	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					1910	1920		10.1056/NEJMoa2030297	http://dx.doi.org/10.1056/NEJMoa2030297			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ4AW	34010530	Green Published, Bronze			2022-12-28	WOS:000655474700010
J	Taylor, L				Taylor, Luke			Covid-19: How the Brazil variant took hold of South America	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												lukestephentaylor@gmail.com						Andrade RD, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3032; Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644Article, 10.1126/science.abh2644, 10.1101/2021.02.26.21252554]; Hitchings MDT., 2021, LANCET REG HLTH AM, V1, DOI 10.1101/2021.04.07.21255081; Pan-American Health Organisation, 2021, DIR WARNS VACC AL WI; Taylor L, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1181; Taylor L, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1023; Taylor L, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n879; Taylor L, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n394; Taylor L, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3575; Werner F, ALARM BELLS BRAZILS	10	6	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2021	373								n1227	10.1136/bmj.n1227	http://dx.doi.org/10.1136/bmj.n1227			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5TH	34016644	Bronze			2022-12-28	WOS:000655596600001
J	[Anonymous]				[Anonymous]			Life on a Space Ship	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1961, JAMA, V176, P606	1	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					2022	2022		10.1001/jama.2020.17942	http://dx.doi.org/10.1001/jama.2020.17942			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003232				2022-12-28	WOS:000652675100017
J	Komaroff, AL				Komaroff, Anthony L.			Does Sleep Flush Wastes From the Brain?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CENTRAL-NERVOUS-SYSTEM		[Komaroff, Anthony L.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Komaroff, AL (corresponding author), Brigham & Womens Hosp, 1620 Tremont St, Boston, MA 02120 USA.	komaroff@hms.harvard.edu						Da Mesquita S, 2021, NATURE, V593, P255, DOI 10.1038/s41586-021-03489-0; Fultz NE, 2019, SCIENCE, V366, P628, DOI 10.1126/science.aax5440; Holth JK, 2019, SCIENCE, V363, P880, DOI 10.1126/science.aav2546; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Nedergaard M, 2020, SCIENCE, V370, P50, DOI 10.1126/science.abb8739; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; Shokri-Kojori E, 2018, P NATL ACAD SCI USA, V115, P4483, DOI 10.1073/pnas.1721694115; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	9	3	3	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2021	325	21					2153	2154		10.1001/jama.2021.5631	http://dx.doi.org/10.1001/jama.2021.5631		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UK2NJ	33999096				2022-12-28	WOS:000652627900002
J	Romero-Brufau, S; Chopra, A; Ryu, AJ; Gel, E; Raskar, R; Kremers, W; Anderson, KS; Subramanian, J; Krishnamurthy, B; Singh, A; Pasupathy, K; Dong, Y; O'Horo, JC; Wilson, WR; Mitchell, O; Kingsley, TC				Romero-Brufau, Santiago; Chopra, Ayush; Ryu, Alex J.; Gel, Esma; Raskar, Ramesh; Kremers, Walter; Anderson, Karen S.; Subramanian, Jayakumar; Krishnamurthy, Balaji; Singh, Abhishek; Pasupathy, Kalyan; Dong, Yue; O'Horo, John C.; Wilson, Walter R.; Mitchell, Oscar; Kingsley, Thomas C.			Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To estimate population health outcomes with delayed second dose versus standard schedule of SARS-CoV-2 mRNA vaccination. DEsIGN Simulation agent based modeling study. SETTING Simulated population based on real world US county. PARTICIPANTs The simulation included 100 000 agents, with a representative distribution of demographics and occupations. Networks of contacts were established to simulate potentially infectious interactions though occupation, household, and random interactions. INTERVENTIONs Simulation of standard covid-19 vaccination versus delayed second dose vaccination prioritizing the first dose. The simulation runs were replicated 10 times. Sensitivity analyses included first dose vaccine efficacy of 50%, 60%, 70%, 80%, and 90% after day 12 post-vaccination; vaccination rate of 0.1%, 0.3%, and 1% of population per day; assuming the vaccine prevents only symptoms but not asymptomatic spread (that is, non-sterilizing vaccine); and an alternative vaccination strategy that implements delayed second dose for people under 65 years of age, but not until all those above this age have been vaccinated. MAIN OUTCOME MEAsUREs Cumulative covid-19 mortality, cumulative SARS-CoV-2 infections, and cumulative hospital admissions due to covid-19 over 180 days. REsULTs Over all simulation replications, the median cumulative mortality per 100 000 for standard dosing versus delayed second dose was 226 v 179, 233 v 207, and 235 v 236 for 90%, 80%, and 70% first dose efficacy, respectively. The delayed second dose strategy was optimal for vaccine efficacies at or above 80% and vaccination rates at or below 0.3% of the population per day, under both sterilizing and non sterilizing vaccine assumptions, resulting in absolute cumulative mortality reductions between 26 and 47 per 100 000. The delayed second dose strategy for people under 65 performed consistently well under all vaccination rates tested. CONCLUsIONs A delayed second dose vaccination strategy, at least for people aged under 65, could result in reduced cumulative mortality under certain conditions.	[Romero-Brufau, Santiago; Ryu, Alex J.; O'Horo, John C.; Wilson, Walter R.; Kingsley, Thomas C.] Mayo Clin, Dept Med, Rochester, MN 55902 USA; [Romero-Brufau, Santiago] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Chopra, Ayush; Raskar, Ramesh; Singh, Abhishek] MIT, Media Lab, Cambridge, MA 02139 USA; [Gel, Esma; Anderson, Karen S.] Arizona State Univ, Sch Life Sci, Phoenix, AZ USA; [Kremers, Walter; Pasupathy, Kalyan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Subramanian, Jayakumar; Krishnamurthy, Balaji] Adobe Inc Noidia, Media & Data Sci Res Lab, Noida, UP, India; [Dong, Yue] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA; [Mitchell, Oscar] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Mayo Clinic; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Arizona State University; Arizona State University-Downtown Phoenix; Mayo Clinic; Mayo Clinic; University of Pennsylvania	Kingsley, TC (corresponding author), Mayo Clin, Dept Med, Rochester, MN 55902 USA.	Kingsley.Thomas@mayo.edu	O'Horo, John C/N-8681-2013; Romero-Brufau, Santiago/I-4758-2015	O'Horo, John C/0000-0002-0880-4498; Krishnamurthy, Balaji/0000-0002-0366-2427; Chopra, Ayush/0000-0002-4070-4139; Subramanian, Jayakumar/0000-0003-4621-2677; Gel, Esma/0000-0003-0472-4762; Romero-Brufau, Santiago/0000-0002-9922-0083				Abueg M, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00422-7; Aguerre IM, 2019, DISABIL REHABIL, V41, P2538, DOI 10.1080/09638288.2018.1471741; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; [Anonymous], 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMclde2101987; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Baric RS, 2020, NEW ENGL J MED, V383, P2684, DOI 10.1056/NEJMcibr2032888; Bonanad C, 2020, J AM MED DIR ASSOC, V21, P915, DOI 10.1016/j.jamda.2020.05.045; Centers for Disease Control and Prevention, 2021, COVID 19 VACC US; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Doria-Rose N, 2021, NEW ENGL J MED, V384, P2259, DOI 10.1056/NEJMc2103916; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Holder J., 2021, TRACKING CORONAVIRUS; Iacobucci Gareth, 2021, BMJ, V372, pn18, DOI 10.1136/bmj.n18; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Koh HK, 2021, JAMA-J AM MED ASSOC, V325, P133, DOI 10.1001/jama.2020.25381; Lee K, 2009, GLOB INST, P1; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n158; Moghadas SM, 2021, MEDRXIV, V2021; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Our World in Data, 2021, DAIL COVID 19 VACC D; Paltiel AD, 2021, HEALTH AFFAIR, V40, P42, DOI 10.1377/hlthaff.2020.02054; Pfizer, 2021, PFIZER BIONTECH CONF; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Post N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244126; Sharma O, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.585354; Skowronski DM, 2021, NEW ENGL J MED, V384, P1576, DOI 10.1056/NEJMc2036242; So AD, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4750; Stokel-Walker C, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n99; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; Tuite AR, 2021, ANN INTERN MED, V174, P570, DOI 10.7326/M20-8137; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1	33	29	29	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1087	10.1136/bmj.n1087	http://dx.doi.org/10.1136/bmj.n1087			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9GP	33980718	Green Published, hybrid			2022-12-28	WOS:000653055200001
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Doctors feel under pressure to work extra shifts unpaid, survey shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal College of Nursing, 2020, BUILD BETT FUT NURS	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2021	373								n1189	10.1136/bmj.n1189	http://dx.doi.org/10.1136/bmj.n1189			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RA	33972269	Bronze			2022-12-28	WOS:000649709400003
J	Nasar, S				Nasar, Saima			The art of medicine Patrolling race and the UK's medical borders	LANCET			English	Editorial Material									[Nasar, Saima] Univ Bristol, Dept Hist, Bristol BS8 1TB, Avon, England	University of Bristol	Nasar, S (corresponding author), Univ Bristol, Dept Hist, Bristol BS8 1TB, Avon, England.	saima.nasar@bristol.ac.uk							0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1702	1703						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33965078				2022-12-28	WOS:000647813600013
J	Couger, MB; Roy, SW; Anderson, N; Gozashti, L; Pirro, S; Millward, LS; Kim, M; Kilburn, D; Liu, KJ; Wilson, TM; Epps, CW; Dizney, L; Ruedas, LA; Campbell, P				Couger, Matthew B.; Roy, Scott W.; Anderson, Noelle; Gozashti, Landen; Pirro, Stacy; Millward, Lindsay S.; Kim, Michelle; Kilburn, Duncan; Liu, Kelvin J.; Wilson, Todd M.; Epps, Clinton W.; Dizney, Laurie; Ruedas, Luis A.; Campbell, Polly			Sex chromosome transformation and the origin of a male-specific X chromosome in the creeping vole	SCIENCE			English	Article							Y-CHROMOSOMES; GENE STRUCTURE; SRY GENE; EVOLUTION; GENOME; SEQUENCE; MICROTUS; INACTIVATION; CHROMATIN; PATTERNS	The mammalian sex chromosome system (XX female/XY male) is ancient and highly conserved. The sex chromosome karyotype of the creeping vole (Microtus oregoni) represents a long-standing anomaly, with an X chromosome that is unpaired in females (X0) and exclusively maternally transmitted. We produced a highly contiguous male genome assembly, together with short-read genomes and transcriptomes for both sexes. We show that M. oregoni has lost an independently segregating Y chromosome and that the male-specific sex chromosome is a second X chromosome that is largely homologous to the maternally transmitted X. Both maternally inherited and male-specific sex chromosomes carry fragments of the ancestral Y chromosome. Consequences of this recently transformed sex chromosome system include Y-like degeneration and gene amplification on the male-specific X, expression of ancestral Y-linked genes in females, and X inactivation of the male-specific chromosome in male somatic cells. The genome of M. oregoni elucidates the processes that shape the gene content and dosage of mammalian sex chromosomes and exemplifies a rare case of plasticity in an ancient sex chromosome system.	[Couger, Matthew B.] Brigham & Womens Hosp, Dept Thorac Surg, Boston, MA 02115 USA; [Roy, Scott W.] San Francisco State Univ, Dept Biol, San Francisco, CA 94117 USA; [Roy, Scott W.; Anderson, Noelle] Univ Calif Merced, Dept Mol & Cell Biol, Merced, CA 95343 USA; [Gozashti, Landen] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Gozashti, Landen] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Pirro, Stacy] Iridian Genomes Inc, Bethesda, MD 20817 USA; [Millward, Lindsay S.; Epps, Clinton W.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97330 USA; [Kim, Michelle; Kilburn, Duncan; Liu, Kelvin J.] Circulomics Inc, Baltimore, MD 21202 USA; [Wilson, Todd M.] US Forest Serv, PNW Res Stn, Corvallis, OR 97331 USA; [Dizney, Laurie] Univ Portland, Dept Biol, Portland, OR 97203 USA; [Ruedas, Luis A.] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Ruedas, Luis A.] Portland State Univ, Museum Nat Hist, Portland, OR 97207 USA; [Campbell, Polly] Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA	Harvard University; Brigham & Women's Hospital; California State University System; San Francisco State University; University of California System; University of California Merced; Harvard University; Harvard University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; University of Portland; Portland State University; Portland State University; University of California System; University of California Riverside	Campbell, P (corresponding author), Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA.	polly.campbell@ucr.edu	Epps, Clinton/AAX-3971-2021; Liu, Kelvin/F-5432-2010	Epps, Clinton/0000-0001-6577-1840; Gozashti, Landen/0000-0001-6023-3138; Pirro, Stacy/0000-0002-5642-4203; Wilson, Todd M/0000-0002-6031-957X; Couger, Matthew/0000-0003-3692-1613; Liu, Kelvin/0000-0002-1164-582X; Millward, Lindsay/0000-0002-9624-9833	National Science Foundation [MCB 1616878, IOS 1558109]; University of California, Riverside; National Institutes of Health [R44GM134994]	National Science Foundation(National Science Foundation (NSF)); University of California, Riverside(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Science Foundation IOS 1558109 and start-up funds from the University of California, Riverside (P.C.), National Science Foundation MCB 1616878 (S.W.R.), and National Institutes of Health R44GM134994 (K.J.L.).	Acosta MJ, 2010, SEX DEV, V4, P336, DOI 10.1159/000319195; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Balaton BP, 2016, TRENDS GENET, V32, P348, DOI 10.1016/j.tig.2016.03.007; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Bickhart DM, 2017, NAT GENET, V49, P643, DOI 10.1038/ng.3802; Bryant DM, 2017, CELL REP, V18, P762, DOI 10.1016/j.celrep.2016.12.063; Bull J.J., 1983, EVOLUTION SEX DETERM; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charlesworth B, 2001, HEREDITY, V86, P387, DOI 10.1046/j.1365-2540.2001.00803.x; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Close RA, 2015, CURR BIOL, V25, P2137, DOI 10.1016/j.cub.2015.06.047; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Deng XX, 2014, NAT REV GENET, V15, P367, DOI 10.1038/nrg3687; do Valle IF, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1190-7; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edge P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12493-y; Fink S, 2010, SYST BIOL, V59, P548, DOI 10.1093/sysbio/syq042; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Giger JM, 2009, EXP PHYSIOL, V94, P1163, DOI 10.1113/expphysiol.2009.049692; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregoire MC, 2018, CELL MOL LIFE SCI, V75, P2859, DOI 10.1007/s00018-018-2769-0; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hoff KJ, 2013, NUCLEIC ACIDS RES, V41, pW123, DOI 10.1093/nar/gkt418; Hughes JF, 2015, ANNU REV GENET, V49, P507, DOI 10.1146/annurev-genet-112414-055311; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; HURST LD, 1991, GENETICS, V128, P841; Jain C, 2020, BIORXIV, V2020, DOI [DOI 10.1101/2020.11.01.363887, 10.1101/2020.11.01.363887]; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Jimenez R, 2013, SEX DEV, V7, P147, DOI 10.1159/000338768; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitano J, 2012, ENVIRON BIOL FISH, V94, P549, DOI 10.1007/s10641-011-9853-8; KONICEK BW, 1995, DNA CELL BIOL, V14, P961, DOI 10.1089/dna.1995.14.961; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulikova T, 2004, NUCLEIC ACIDS RES, V32, pD27, DOI 10.1093/nar/gkh120; Kuroiwa A, 2010, CHROMOSOMA, V119, P519, DOI 10.1007/s00412-010-0275-8; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; LIBBUS BL, 1988, CYTOGENET CELL GENET, V47, P181, DOI 10.1159/000132544; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Lin FQ, 2012, P NATL ACAD SCI USA, V109, P11752, DOI 10.1073/pnas.1201816109; Mank JE, 2009, SEX DEV, V3, P60, DOI 10.1159/000223071; Marchal JA, 2008, GENOMICS, V91, P142, DOI 10.1016/j.ygeno.2007.10.010; MATTHEY R, 1958, EXPERIENTIA, V14, P240, DOI 10.1007/BF02159178; MATTHEY R, 1956, EXPERIENTIA, V12, P337, DOI 10.1007/BF02165337; MODI WS, 1987, SYST ZOOL, V36, P109, DOI 10.2307/2413264; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Mulugeta E, 2016, GENOME RES, V26, P1202, DOI 10.1101/gr.201665.115; Murata C, 2016, CHROMOSOME RES, V24, P407, DOI 10.1007/s10577-016-9531-y; Musser GG, 2005, MAMMAL SPECIES WORLD, P955; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Nishimura O, 2017, BIOINFORMATICS, V33, P3635, DOI 10.1093/bioinformatics/btx445; Nurk S, 2020, GENOME RES, V30, P1291, DOI 10.1101/gr.263566.120; OHNO S., 1963, CYTOGENETICS [BASEL], V2, P232, DOI 10.1159/000129781; Ohno S., 1966, CHROMOSOMES TODAY, V1, P182; Ohno S., 1964, 2 INT C NEW YORK, P40; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Pessia E, 2012, P NATL ACAD SCI USA, V109, P5346, DOI 10.1073/pnas.1116763109; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Printzlau F, 2017, J NEUROSCI RES, V95, P311, DOI 10.1002/jnr.23951; Roach MJ, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2485-7; Roco AS, 2015, P NATL ACAD SCI USA, V112, pE4752, DOI 10.1073/pnas.1505291112; Rodrigues N, 2016, HEREDITY, V117, P25, DOI 10.1038/hdy.2016.22; Sheardown SA, 1997, GENE, V203, P159, DOI 10.1016/S0378-1119(97)00507-6; Shendure J, 2015, SCIENCE, V349, P1478, DOI 10.1126/science.aaa9119; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Skinner BM, 2016, GENOME RES, V26, P130, DOI 10.1101/gr.188839.114; Spies N, 2017, NAT METHODS, V14, P915, DOI [10.1038/NMETH.4366, 10.1038/nmeth.4366]; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Weirick T, 2015, BIOINFORMATICS, V31, P3537, DOI 10.1093/bioinformatics/btv410; Weisenfeld NI, 2017, GENOME RES, V27, P757, DOI 10.1101/gr.214874.116; White M. J. D., 1957, P ZOOL CALC MOOK MAM, V113-114; White M. J. D, 1957, P ZOOL CALCUTTA MOOK, V113-114; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	92	5	5	6	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					592	+		10.1126/science.abg7019	http://dx.doi.org/10.1126/science.abg7019			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958470				2022-12-28	WOS:000649103500039
J	Kauffman, MJ; Cagnacci, F; Chamaille-Jammes, S; Hebblewhite, M; Hopcraft, JGC; Merkle, JA; Mueller, T; Mysterud, A; Peters, W; Roettger, C; Steingisser, A; Meacham, JE; Abera, K; Adamczewski, J; Aikens, EO; Bartlam-Brooks, H; Bennitt, E; Berger, J; Boyd, C; Cote, SD; Debeffe, L; Dekrout, AS; Dejid, N; Donadio, E; Dziba, L; Fagan, WF; Fischer, C; Focardi, S; Fryxell, JM; Fynn, RWS; Geremia, C; Gonzalez, BA; Gunn, A; Gurarie, E; Heurich, M; Hilty, J; Hurley, M; Johnson, A; Joly, K; Kaczensky, P; Kendall, CJ; Kochkarev, P; Kolpaschikov, L; Kowalczyk, R; van Langevelde, F; Li, BV; Lobora, AL; Loison, A; Madiri, TH; Mallon, D; Marchand, P; Medellin, RA; Meisingset, E; Merrill, E; Middleton, AD; Monteith, KL; Morjan, M; Morrison, TA; Mumme, S; Naidoo, R; Novaro, A; Ogutu, JO; Olson, KA; Oteng-Yeboah, A; Ovejero, RJA; Owen-Smith, N; Paasivaara, A; Packer, C; Panchenko, D; Pedrotti, L; Plumptre, AJ; Rolandsen, CM; Said, S; Salemgareyev, A; Savchenko, A; Savchenko, P; Sawyer, H; Selebatso, M; Skroch, M; Solberg, E; Stabach, JA; Strand, O; Suitor, MJ; Tachiki, Y; Trainor, A; Tshipa, A; Virani, MZ; Vynne, C; Ward, S; Wittemyer, G; Xu, WJ; Zuther, S				Kauffman, Matthew J.; Cagnacci, Francesca; Chamaille-Jammes, Simon; Hebblewhite, Mark; Hopcraft, J. Grant C.; Merkle, Jerod A.; Mueller, Thomas; Mysterud, Atle; Peters, Wibke; Roettger, Christiane; Steingisser, Alethea; Meacham, James E.; Abera, Kasahun; Adamczewski, Jan; Aikens, Ellen O.; Bartlam-Brooks, Hattie; Bennitt, Emily; Berger, Joel; Boyd, Charlotte; Cote, Steeve D.; Debeffe, Lucie; Dekrout, Andrea S.; Dejid, Nandintsetseg; Donadio, Emiliano; Dziba, Luthando; Fagan, William F.; Fischer, Claude; Focardi, Stefano; Fryxell, John M.; Fynn, Richard W. S.; Geremia, Chris; Gonzalez, Benito A.; Gunn, Anne; Gurarie, Elie; Heurich, Marco; Hilty, Jodi; Hurley, Mark; Johnson, Aran; Joly, Kyle; Kaczensky, Petra; Kendall, Corinne J.; Kochkarev, Pavel; Kolpaschikov, Leonid; Kowalczyk, Rafal; van Langevelde, Frank; Li, Binbin V.; Lobora, Alex L.; Loison, Anne; Madiri, Tinaapi H.; Mallon, David; Marchand, Pascal; Medellin, Rodrigo A.; Meisingset, Erling; Merrill, Evelyn; Middleton, Arthur D.; Monteith, Kevin L.; Morjan, Malik; Morrison, Thomas A.; Mumme, Steffen; Naidoo, Robin; Novaro, Andres; Ogutu, Joseph O.; Olson, Kirk A.; Oteng-Yeboah, Alfred; Ovejero, Ramiro J. A.; Owen-Smith, Norman; Paasivaara, Antti; Packer, Craig; Panchenko, Danila; Pedrotti, Luca; Plumptre, Andrew J.; Rolandsen, Christer M.; Said, Sonia; Salemgareyev, Albert; Savchenko, Aleksandr; Savchenko, Piotr; Sawyer, Hall; Selebatso, Moses; Skroch, Matthew; Solberg, Erling; Stabach, Jared A.; Strand, Olav; Suitor, Michael J.; Tachiki, Yasuyuki; Trainor, Anne; Tshipa, Arnold; Virani, Munir Z.; Vynne, Carly; Ward, Stephanie; Wittemyer, George; Xu, Wenjing; Zuther, Steffen			Mapping out a future for ungulate migrations	SCIENCE			English	Editorial Material									[Kauffman, Matthew J.] Univ Wyoming, US Geol Survey, Wyoming Cooperat Fish & Wildlife Res Unit, Dept Zool & Physiol, Laramie, WY 82071 USA; [Cagnacci, Francesca; Mumme, Steffen] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, I-38010 San Michele All Adige, Italy; [Chamaille-Jammes, Simon] Univ Paul Valery Montpellier 3, CEFE, Univ Montpellier, CNRS,EPHE,IRD, Montpellier, France; [Chamaille-Jammes, Simon] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Pretoria, South Africa; [Chamaille-Jammes, Simon] LTSER France, Zone Atelier Hwange, Hwange Natl Pk,Bag 62, Dete, Zimbabwe; [Hebblewhite, Mark] Univ Montana, Franke Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Wildlife Biol Program, Missoula, MT 59812 USA; [Hopcraft, J. Grant C.; Morrison, Thomas A.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland; [Merkle, Jerod A.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Mueller, Thomas; Dejid, Nandintsetseg] Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Senckenberganlage 25, D-60325 Frankfurt, Germany; [Mueller, Thomas] Goethe Univ Frankfurt, Dept Biol Sci, D-60323 Frankfurt, Germany; [Mysterud, Atle] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, POB 1066 Blindern, NO-0316 Oslo, Norway; [Peters, Wibke] Bavarian State Inst Forestry, Dept Conservat Biodivers & Wildlife Management, D-85354 Freising Weihenstephan, Germany; [Peters, Wibke] Tech Univ Munich, Wildlife Biol & Management Unit, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany; [Roettger, Christiane; Dekrout, Andrea S.; Medellin, Rodrigo A.; Oteng-Yeboah, Alfred] Secretariat Convent Conservat Migratory Species W, D-53113 Bonn, Germany; [Steingisser, Alethea; Meacham, James E.] Univ Oregon, Dept Geog, InfoGraph Lab, Eugene, OR 97403 USA; [Abera, Kasahun] German Tech Cooperat GIZ, Biodivers & Forestry Programme Ethiopia, Addis Ababa, Ethiopia; [Adamczewski, Jan] Govt Northwest Terr, Environm & Nat Resources, Wildlife Div, Yellowknife, NT X1A 2L9, Canada; [Aikens, Ellen O.] Max Planck Inst Anim Behav, Dept Migrat, D-78315 Radolfzell am Bodensee, Germany; [Aikens, Ellen O.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Aikens, Ellen O.] Univ Konstanz, Ctr Adv Study Collect Behav, D-78468 Constance, Germany; [Bartlam-Brooks, Hattie] Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Bennitt, Emily; Fynn, Richard W. S.] Univ Botswana, Okavango Res Inst, Maun, Botswana; [Berger, Joel; Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Berger, Joel] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Boyd, Charlotte] Int Union Conservat Nat, North Amer Off, Washington, DC 20009 USA; [Cote, Steeve D.] Caribou Ungava, Dept Biol, Quebec City, PQ G1V 0A6, Canada; [Cote, Steeve D.] Univ Laval, Ctr Etud Nord, Quebec City, PQ G1V 0A6, Canada; [Debeffe, Lucie] Univ Toulouse, INRAE, CEFS, F-31326 Castanet Tolosan, France; [Donadio, Emiliano] Fdn Rewilding Argentina, Estn La Ascens, RA-9041 Los Antiguos, Santa Cruz, Argentina; [Dziba, Luthando] South African Natl Pk, Conservat Serv, ZA-0001 Pretoria, South Africa; [Dziba, Luthando] Nelson Mandela Univ, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Fagan, William F.; Gurarie, Elie] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Fischer, Claude] Univ Appl Sci Western Switzerland, Dept Nat Management, CH-1274 Jussey, Switzerland; [Focardi, Stefano] CNR, Ist Sistemi Complessi, I-50019 Sesto Fiorentino, Italy; [Fryxell, John M.] Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Dept Zool, Guelph, ON N1G 2WI, Canada; [Geremia, Chris] Yellowstone Ctr Resources, Mammoth Hot Springs, WY 82190 USA; [Gonzalez, Benito A.] Univ Chile, Lab Ecol Vida Silvestre, Fac Ciencias Forestales & Conservac Nat, Santiago, Chile; [Gunn, Anne] Circum Arctic Rangifer Monitoring & Assessment, Salt Spring Isl, BC V8K 1V1, Canada; [Heurich, Marco] Bavarian Forest Natl Pk, Dept Visitor Management & Natl Pk Monitoring, D-94481 Grafenau, Germany; [Heurich, Marco] Albert Ludwigs Univ Freiburg, Chair Wildlife Ecol & Management, D-79106 Freiburg, Germany; [Hilty, Jodi] Yellowstone Yukon Conservat Initiat, Canmore, AB T1W 1P6, Canada; [Hurley, Mark] Idaho Dept Fish & Game, Boise, ID 83712 USA; [Johnson, Aran] Southern Ute Indian Tribe, Div Wildlife Resource Management, Ignacio, CO 81137 USA; [Joly, Kyle] Natl Pk Serv, Arctic Inventory & Monitoring Network, Gates Arctic Natl Pk & Preserve, Fairbanks, AK USA; [Kaczensky, Petra; Rolandsen, Christer M.; Solberg, Erling; Strand, Olav] Norwegian Inst Nat Res NINA, NO-7485 Trondheim, Norway; [Kaczensky, Petra] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria; [Kaczensky, Petra] Inland Norway Univ Appl Sci, Dept Forestry & Wildlife Management, NO-2480 Koppang, Norway; [Kendall, Corinne J.] North Carolina Zoo Dept Conservat Educ & Sci, 4401 Zoo Pkwy, Asheboro, NC 27205 USA; [Kochkarev, Pavel] Cent Siberia Nat Reserve Tsentralnosibirsky, Krasnoyarsk 648368, Russia; [Kolpaschikov, Leonid] Fed State Budgetary Inst Reserves Taimyr, Norilsk 663305, Russia; [Kowalczyk, Rafal] Polish Acad Sci, Mammal Res Inst, PL-17230 Bialowieza, Poland; [van Langevelde, Frank] Wageningen Univ & Res, Wildlife Ecol & Conservat Grp, NL-6708 PB Wageningen, Netherlands; [Li, Binbin V.] Duke Kunshan Univ, Environm Res Ctr, Kunshan 215316, Jiangsu, Peoples R China; [Lobora, Alex L.] Tanzania Wildlife Res Inst, Directorate Res Dev & Coordinat, POB 661, Arusha, Tanzania; [Loison, Anne] Univ Savoie Mt Blanc, Univ Grenoble Alpes, CNRS, LECA, Grenoble, France; [Madiri, Tinaapi H.] Hwange Natl Pk, Zimbabwe Parks & Wildlife Management, Matabeleland North, Zimbabwe; [Mallon, David] Manchester Metropolitan Univ, Dept Nat Sci, Manchester M1 5GD, Lancs, England; [Mallon, David] IUCN Species Survival Commiss, Gland, Switzerland; [Marchand, Pascal] Off Francais Biodivers, Direct Rech & Appui Sci, Unite Ongules Sauvages, F-34990 Les Portes Du Soleil, Juvignac, France; [Medellin, Rodrigo A.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Meisingset, Erling] Norwegian Inst Bioecon Res, Dept Forestry & Forestry Resources, NO-6630 Tingvoll, Norway; [Merrill, Evelyn] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Middleton, Arthur D.; Xu, Wenjing] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94709 USA; [Monteith, Kevin L.] Univ Wyoming, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Haub Sch Environm & Nat Resources, Laramie, WY 82072 USA; [Morjan, Malik] Minist Wildlife Conservat & Tourism, Jebel Lemon, Juba, South Sudan; [Morjan, Malik] Univ Juba, Sch Nat Resources & Environm Studies, Dept Environm Studies, Juba, South Sudan; [Mumme, Steffen] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Naidoo, Robin] WWF US, 1250 24th St NW, Washington, DC 20037 USA; [Novaro, Andres] Univ Comahue, Inst Invest Biodiversidad & Medioambiente INIBIOM, Consejo Nacl Invest Cient CONICET, RA-8371 Neuquen, Argentina; [Novaro, Andres] Wildlife Conservat Soc Argentina, RA-8371 Neuquen, Argentina; [Ogutu, Joseph O.] Univ Hohenheim, Inst Crop Sci, Biostat Unit, D-70599 Stuttgart, Germany; [Ogutu, Joseph O.] Nelson Mandela African Inst Sci & Technol NM AIST, Arusha, Tanzania; [Olson, Kirk A.] Wildlife Conservat Soc, Mongolia Country Program, Ulaanbaatar 14200, Mongolia; [Oteng-Yeboah, Alfred] Council Sci & Ind Res Ghana, Forestry Commiss Ghana, Wildlife Div, Accra, Ghana; [Ovejero, Ramiro J. A.] Univ Nacl Tucuman, Inst Ecol Reg, Consejo Nacl Invest Cient CONICET, CCT CONICET TUCUMAN, San Miguel De Tucuman, Argentina; [Ovejero, Ramiro J. A.] Fac Ciencias, Lab Ecol Conductual, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Ovejero, Ramiro J. A.] Univ Austral Chile UACH, Comis Nacl Invest Cient & Tecnol CONICYT, Valdivia, Chile; [Owen-Smith, Norman] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, ZA-2050 Johannesburg, South Africa; [Paasivaara, Antti] Nat Resources Inst Finland, FI-00790 Helsinki, Finland; [Packer, Craig] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Panchenko, Danila] Russian Acad Sci, Karelian Res Ctr, Inst Biol, Petrozavodsk 185910, Russia; [Pedrotti, Luca] Stelvio Natl Pk, I-23032 Bormio, SO, Italy; [Plumptre, Andrew J.] BirdLife Int, Key Biodivers Area Secretariat, Cambridge CB2 3QZ, England; [Said, Sonia] Direct Rech & Appui Sci, Off Francais Biodivers, F-01330 Montfort, Birieux, France; [Salemgareyev, Albert] Assoc Conservat Biodivers Kazakhstan, Nur Sultan 010000, Kazakhstan; [Savchenko, Aleksandr; Savchenko, Piotr] Siberian Fed Univ, Inst Ecol & Geog, Dept Wildlife Resource Studies & Reserve Manageme, Krasnoyarsk 660041, Russia; [Sawyer, Hall] Western EcoSyst Technol Inc, Laramie, WY 82072 USA; [Selebatso, Moses] Kalahari Res & Conservat Trust, Gaborone, Botswana; [Skroch, Matthew] Pew Charitable Trusts, Portland, OR 97201 USA; [Stabach, Jared A.] Smithsonian Natl Zoo & Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA; [Suitor, Michael J.] Environm Yukon, Fish & Wildlife Branch, Dawson City, YT Y0B 1G0, Canada; [Tachiki, Yasuyuki] Rakuno Gakuen Univ, Ebetsu, Hokkaido 0698501, Japan; [Trainor, Anne] Nature Conservancy, Africa Program, Cincinnati, OH 45221 USA; [Tshipa, Arnold] Wilderness Safaris, Victoria, Zimbabwe; [Tshipa, Arnold] Natl Univ Sci & Technol, Dept Forestry Resources & Wildlife Management, Ascot, Bulawayo, Zimbabwe; [Virani, Munir Z.] Peregrine Fund, Boise, ID 83709 USA; [Vynne, Carly] Osprey Insights, Seattle, WA 98115 USA; [Ward, Stephanie; Zuther, Steffen] Frankfurt Zool Soc, Altyn Dala Conservat Initiat, D-60316 Frankfurt, Germany	United States Department of the Interior; United States Geological Survey; University of Wyoming; Fondazione Edmund Mach; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Pretoria; University of Montana System; University of Montana; University of Glasgow; University of Wyoming; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; University of Oslo; Technical University of Munich; University of Oregon; Max Planck Society; University of Konstanz; University of Konstanz; University of London; University of London Royal Veterinary College; University of Botswana; Colorado State University; Wildlife Conservation Society; Laval University; INRAE; Nelson Mandela University; University System of Maryland; University of Maryland College Park; University of Applied Sciences & Arts Western Switzerland; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); University of Guelph; Universidad de Chile; University of Freiburg; United States Department of the Interior; Norwegian Institute Nature Research; University of Veterinary Medicine Vienna; Inland Norway University of Applied Sciences; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Wageningen University & Research; Duke Kunshan University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Manchester Metropolitan University; Office Francais de la Biodiversite OFB; Universidad Nacional Autonoma de Mexico; Norwegian Institute of Bioeconomy Research; University of Alberta; University of California System; University of California Berkeley; University of Wyoming; Sapienza University Rome; World Wildlife Fund; Universidad Nacional del Comahue; University Hohenheim; Universidad Nacional de Tucuman; Universidad Austral de Chile; University of Witwatersrand; Natural Resources Institute Finland (Luke); University of Minnesota System; University of Minnesota Twin Cities; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS; BirdLife International; Office Francais de la Biodiversite OFB; Association for the Conservation of Biodiversity of Kazakhstan; Siberian Federal University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Rakuno Gakuen University; National University of Science & Technology - Zimbabwe	Kauffman, MJ (corresponding author), Univ Wyoming, US Geol Survey, Wyoming Cooperat Fish & Wildlife Res Unit, Dept Zool & Physiol, Laramie, WY 82071 USA.	mkauffm1@uwyo.edu	Wittemyer, George/AFQ-1840-2022; Heurich, Marco/O-4653-2014; Bennitt, Emily/AAB-6032-2020; Cagnacci, Francesca/L-7377-2013; hebblewhite, mark/G-6164-2013; Hebblewhite, Mark/AAI-8101-2020; Panchenko, Danila/A-9616-2014; Aikens, Ellen/AAT-4481-2020; Merkle, Jerod A/ABB-5431-2021; Stabach, Jared/AEX-9187-2022	Heurich, Marco/0000-0003-0051-2930; Cagnacci, Francesca/0000-0002-4954-9980; Hebblewhite, Mark/0000-0001-5382-1361; Panchenko, Danila/0000-0003-1955-4196; Aikens, Ellen/0000-0003-0827-3006; Merkle, Jerod A/0000-0003-0100-1833; Stabach, Jared/0000-0002-7896-1237; Fischer, Claude/0000-0002-1818-6179; SAID, Sonia/0000-0003-1485-8297; Li, Binbin/0000-0001-6188-7512; Kaczensky, Petra/0000-0001-5428-1176; Rolandsen, Christer Moe/0000-0002-5628-0385; Bartlam-Brooks, Hattie/0000-0002-1507-1712; Mumme, Steffen/0000-0002-3671-4596; Donadio, Emiliano/0000-0001-5257-4100; Kowalczyk, Rafal/0000-0001-7264-2158	Knobloch Family Foundation; George B. Storer Foundation; Bole and Klingenstein Foundation; European Union [641918]; French 'Agence Nationale de la Recherche' [ANR-16-CE02-0001-01]; German Federal Ministry of Education and Research (MORESTEP) [01LC1710A, 01LC1820A]; German Research Foundation [257734638]; Hawk Mountain Sanctuary; NASA [NNX15AW71A]; NSF LTREB [1556248]; NSF [DBI1915347, DEB-9903416, DEB-0343960, DEB-1020479]; Peregrine Fund, Princeton University; Robert Bosch Foundation	Knobloch Family Foundation; George B. Storer Foundation; Bole and Klingenstein Foundation(Klingenstein Philanthropies); European Union(European Commission); French 'Agence Nationale de la Recherche'(French National Research Agency (ANR)); German Federal Ministry of Education and Research (MORESTEP); German Research Foundation(German Research Foundation (DFG)); Hawk Mountain Sanctuary; NASA(National Aeronautics & Space Administration (NASA)); NSF LTREB(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Peregrine Fund, Princeton University; Robert Bosch Foundation	The GIUM is financially supported by the Knobloch Family Foundation, George B. Storer Foundation, and the Bole and Klingenstein Foundation. Field studies funded by European Union's Horizon 2020 research and innovation program #641918 (AfricanBioServices), French 'Agence Nationale de la Recherche' #ANR-16-CE02-0001-01, German Federal Ministry of Education and Research (MORESTEP, #01LC1710A and #01LC1820A), German Research Foundation (Grant #257734638), Hawk Mountain Sanctuary, NASA #NNX15AW71A, NSF LTREB #1556248, NSF DBI1915347, NSF DEB-9903416, NSF DEB-0343960, NSF DEB-1020479, The Peregrine Fund, Princeton University, and the Robert Bosch Foundation.	Aikens EO, 2020, GLOBAL CHANGE BIOL, V26, P4215, DOI 10.1111/gcb.15169; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Berger J, 2014, CONSERV BIOL, V28, P1142, DOI 10.1111/cobi.12327; Cunsolo A, 2020, AM IMAGO, V77, P31, DOI 10.1353/aim.2020.0002; Davidson SC, 2020, SCIENCE, V370, P712, DOI 10.1126/science.abb7080; Dinerstein E, 2017, BIOSCIENCE, V67, P534, DOI 10.1093/biosci/bix014; Fischer C., 2017, Schweizerische Zeitschrift fur Forstwesen, V168, P299, DOI 10.3188/szf.2017.0299; Hamilton K., 2008, DECISION NOTICE FIND; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hilty J., 2020, GUIDELINES CONSERVIN, DOI [10.2305/IUCN.CH.2020.PAG.30.en, DOI 10.2305/IUCN.CH.2020.PAG.30.EN]; Jesmer BR, 2018, SCIENCE, V361, P1023, DOI 10.1126/science.aat0985; Kassahun A., 2019, THESIS; Kauffman M. J., 2018, WILD MIGRATIONS ATLA; Kendall CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083470; Kremen C, 2018, SCIENCE, V362, DOI 10.1126/science.aau6020; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Naidoo R, 2016, ORYX, V50, P138, DOI 10.1017/S0030605314000222; Nandintsetseg D, 2019, J APPL ECOL, V56, P1916, DOI 10.1111/1365-2664.13380; Ogutu J.O., 2013, OPEN CONSERVATION BI, V7; Ogutu J.O, 2014, OPEN ECOLOGY J, V7; Owen-Smith N, 2012, WILDLIFE CONSERVATIO, P153, DOI DOI 10.7208/9780226074641-008; Poole KG, 2010, ARCTIC, V63, P414; Said MY, 2016, J NAT CONSERV, V34, P151, DOI 10.1016/j.jnc.2016.10.005; Sawyer H, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1534; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; WGFD (Wyoming Game and Fish Department), 2016, UNG MIGR CORR STRAT	27	30	33	11	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					566	+		10.1126/science.abf0998	http://dx.doi.org/10.1126/science.abf0998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA2AW	33958460	Green Submitted			2022-12-28	WOS:000649103500022
J	Angel, Y; Spitzer, A; Henig, O; Saiag, E; Sprecher, E; Padova, H; Ben-Ami, R				Angel, Yoel; Spitzer, Avishay; Henig, Oryan; Saiag, Esther; Sprecher, Eli; Padova, Hagit; Ben-Ami, Ronen			Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								This cohort study estimates the association between Pfizer-BioNTech BNT162b2 vaccination and symptomatic and asymptomatic SARS-CoV-2 infections among health care workers more than 7 days after receipt of a second vaccine dose. Question What is the association between receipt of the Pfizer-BioNTech BNT162b2 vaccine and the incidence of symptomatic and asymptomatic SARS-CoV-2 infection among health care workers? Findings In this retrospective cohort study conducted in Tel Aviv, Israel, that included 6710 health care workers who underwent periodic testing for SARS-CoV-2 infection, vaccination with the BNT162b2 vaccine was associated with an adjusted incidence rate ratio of 0.03 for symptomatic infection and 0.14 for asymptomatic infection more than 7 days after the second dose. Both incidence rate ratios were statistically significant. Meaning Receipt of the BNT162b2 vaccine was significantly associated with lower incidence of symptomatic and asymptomatic SARS-CoV-2 infection among health care workers. Importance Randomized clinical trials have provided estimates of the effectiveness of the BNT162b2 vaccine against symptomatic SARS-CoV-2 infection, but its effect on asymptomatic infections remains unclear. Objective To estimate the association of vaccination with the Pfizer-BioNTech BNT162b2 vaccine with symptomatic and asymptomatic SARS-CoV-2 infections among health care workers. Design, Setting, and Participants This was a single-center, retrospective cohort study conducted at a tertiary medical center in Tel Aviv, Israel. Data were collected on symptomatic and asymptomatic SARS-CoV-2 infections confirmed via polymerase chain reaction (PCR) tests in health care workers undergoing regular screening with nasopharyngeal swabs between December 20, 2020, and February 25, 2021. Logistic regression was used to calculate incidence rate ratios (IRRs) comparing the incidence of infection between fully vaccinated and unvaccinated participants, controlling for demographics and the number of PCR tests performed. Exposures Vaccination with the BNT162b2 vaccine vs unvaccinated status was ascertained from the employee health database. Full vaccination was defined as more than 7 days after receipt of the second vaccine dose. Main Outcomes and Measures The primary outcome was the regression-adjusted IRR for symptomatic and asymptomatic SARS-CoV-2 infection of fully vaccinated vs unvaccinated health care workers. The secondary outcomes included IRRs for partially vaccinated health care workers (days 7-28 after first dose) and for those considered as late fully vaccinated (>21 days after second dose). Results A total of 6710 health care workers (mean [SD] age, 44.3 [12.5] years; 4465 [66.5%] women) were followed up for a median period of 63 days; 5953 health care workers (88.7%) received at least 1 dose of the BNT162b2 vaccine, 5517 (82.2%) received 2 doses, and 757 (11.3%) were not vaccinated. Vaccination was associated with older age compared with those who were not vaccinated (mean age, 44.8 vs 40.7 years, respectively) and male sex (31.4% vs 17.7%). Symptomatic SARS-CoV-2 infection occurred in 8 fully vaccinated health care workers and 38 unvaccinated health care workers (incidence rate, 4.7 vs 149.8 per 100 000 person-days, respectively, adjusted IRR, 0.03 [95% CI, 0.01-0.06]). Asymptomatic SARS-CoV-2 infection occurred in 19 fully vaccinated health care workers and 17 unvaccinated health care workers (incidence rate, 11.3 vs 67.0 per 100 000 person-days, respectively, adjusted IRR, 0.14 [95% CI, 0.07-0.31]). The results were qualitatively unchanged by the propensity score sensitivity analysis. Conclusions and Relevance Among health care workers at a single center in Tel Aviv, Israel, receipt of the BNT162b2 vaccine compared with no vaccine was associated with a significantly lower incidence of symptomatic and asymptomatic SARS-CoV-2 infection more than 7 days after the second dose. Findings are limited by the observational design.	[Angel, Yoel] Tel Aviv Sourasky Med Ctr, Dept Phys Affairs, Tel Aviv, Israel; [Angel, Yoel; Spitzer, Avishay; Henig, Oryan; Saiag, Esther; Sprecher, Eli; Padova, Hagit; Ben-Ami, Ronen] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Spitzer, Avishay] Tel Aviv Sourasky Med Ctr, Dept Oncol, Tel Aviv, Israel; [Spitzer, Avishay] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Henig, Oryan; Ben-Ami, Ronen] Tel Aviv Sourasky Med Ctr, Dept Infect Dis & Infect Control, Tel Aviv, Israel; [Saiag, Esther] Tel Aviv Sourasky Med Ctr, Dept Informat Syst & Operat, Tel Aviv, Israel; [Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Res Dev Dept, Tel Aviv, Israel; [Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Dermatol, Tel Aviv, Israel; [Padova, Hagit] Tel Aviv Sourasky Med Ctr, Dept Patient Safety, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Ben-Ami, R (corresponding author), Tel Aviv Sourasky Med Ctr, Weizmann 6, IL-6423906 Tel Aviv, Israel.	ronenba@tlvmc.gov.il		Angel, Yoel/0000-0002-2243-6601; Ben-Ami, Ronen/0000-0003-0628-0798; Spitzer, Avishay/0000-0001-6551-9338				Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Benenson S, 2021, NEW ENGL J MED, V384, P1775, DOI 10.1056/NEJMc2101951; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Desai RJ, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5657; Israel Ministry of Health, ISR COVID 19 DAT; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Lee S, 2020, JAMA INTERN MED, V180, P1447, DOI 10.1001/jamainternmed.2020.3862; Mascola JR., 2021, JAMA-J AM MED ASSOC, V325, P1261, DOI [10.1001/jama.2021.2088, DOI 10.1001/jama.2021.2088]; Munitz A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100264; Nogrady B, 2020, NATURE, V587, P534, DOI 10.1038/d41586-020-03141-3; Ooi EE, 2020, LANCET INFECT DIS, V20, P996, DOI 10.1016/S1473-3099(20)30460-6; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rosen B, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00440-6; Roser M., CORONAVIRUS PANDEMIC; Singanayagam A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.32.2001483; US Food and Drug Agency, 2021, EM US AUTH PFIZ BION; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	18	113	115	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2021	325	24					2457	2465		10.1001/jama.2021.7152	http://dx.doi.org/10.1001/jama.2021.7152		MAY 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD7ZK	33956048	Green Published, Bronze			2022-12-28	WOS:000647844100001
J	Tang, L; Hijano, DR; Gaur, AH; Geiger, TL; Neufeld, EJ; Hoffman, JM; Hayden, RT				Tang, Li; Hijano, Diego R.; Gaur, Aditya H.; Geiger, Terrence L.; Neufeld, Ellis J.; Hoffman, James M.; Hayden, Randall T.			Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.	[Tang, Li] St Jude Childrens Res Hosp, Dept Biostat, 262 Danny Thomas Pl,Mail Stop 768, Memphis, TN 38105 USA; [Hijano, Diego R.; Gaur, Aditya H.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Geiger, Terrence L.; Hayden, Randall T.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Neufeld, Ellis J.] St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Hoffman, James M.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Tang, L (corresponding author), St Jude Childrens Res Hosp, Dept Biostat, 262 Danny Thomas Pl,Mail Stop 768, Memphis, TN 38105 USA.	li.tang@stjude.org	Neufeld, Ellis J./F-9331-2011; Hijano, Diego/N-2665-2018	Neufeld, Ellis J./0000-0001-8092-6281; Hijano, Diego/0000-0002-2903-666X	American Lebanese Syrian Associated Charities (ALSAC)	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported in part by the American Lebanese Syrian Associated Charities (ALSAC).	Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Centers for Disease Control and Prevention, 2021, WHAT HEALTHC PERS NE; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; HIGHTOWER AW, 1988, B WORLD HEALTH ORGAN, V66, P99; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; State of Tennessee Health Department, COVID 19 VACC PLAN	6	46	47	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2021	325	24					2500	2502		10.1001/jama.2021.6564	http://dx.doi.org/10.1001/jama.2021.6564		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD7ZK	33956050	Green Published, Bronze			2022-12-28	WOS:000647844100002
J	Lu, MY; Chen, TY; Williamson, DFK; Zhao, M; Shady, M; Lipkova, J; Mahmood, F				Lu, Ming Y.; Chen, Tiffany Y.; Williamson, Drew F. K.; Zhao, Melissa; Shady, Maha; Lipkova, Jana; Mahmood, Faisal			AI-based pathology predicts origins for cancers of unknown primary	NATURE			English	Article							PRIMARY SITE	Cancer of unknown primary (CUP) origin is an enigmatic group of diagnoses in which the primary anatomical site of tumour origin cannot be determined(1,2). This poses a considerable challenge, as modern therapeutics are predominantly specific to the primary tumour(3). Recent research has focused on using genomics and transcriptomics to identify the origin of a tumour(4-9). However, genomic testing is not always performed and lacks clinical penetration in low-resource settings. Here, to overcome these challenges, we present a deep-learning-based algorithm-Tumour Origin Assessment via Deep Learning (TOAD)-that can provide a differential diagnosis for the origin of the primary tumour using routinely acquired histology slides. We used whole-slide images of tumours with known primary origins to train a model that simultaneously identifies the tumour as primary or metastatic and predicts its site of origin. On our held-out test set of tumours with known primary origins, the model achieved a top-1 accuracy of 0.83 and a top-3 accuracy of 0.96, whereas on our external test set it achieved top-1 and top-3 accuracies of 0.80 and 0.93, respectively. We further curated a dataset of 317 cases of CUP for which a differential diagnosis was assigned. Our model predictions resulted in concordance for 61% of cases and a top-3 agreement of 82%. TOAD can be used as an assistive tool to assign a differential diagnosis to complicated cases of metastatic tumours and CUPs and could be used in conjunction with or in lieu of ancillary tests and extensive diagnostic work-ups to reduce the occurrence of CUP.	[Lu, Ming Y.; Chen, Tiffany Y.; Williamson, Drew F. K.; Zhao, Melissa; Shady, Maha; Lipkova, Jana; Mahmood, Faisal] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lu, Ming Y.; Chen, Tiffany Y.; Williamson, Drew F. K.; Shady, Maha; Lipkova, Jana; Mahmood, Faisal] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA; [Lu, Ming Y.; Shady, Maha; Lipkova, Jana; Mahmood, Faisal] Dana Farber Canc Inst, Canc Data Sci Program, Boston, MA 02115 USA; [Shady, Maha] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Mahmood, F (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.; Mahmood, F (corresponding author), Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA.; Mahmood, F (corresponding author), Dana Farber Canc Inst, Canc Data Sci Program, Boston, MA 02115 USA.	faisalmahmood@bwh.harvard.edu	; Mahmood, Faisal/C-1021-2015	Williamson, Drew/0000-0003-1745-8846; Lu, Ming Yang/0000-0003-0009-9699; Chen, Tiffany/0000-0003-2546-2941; Mahmood, Faisal/0000-0001-7587-1562	BWH Pathology, NIH NIGMS [R35GM138216]; Google Cloud Research Grant; Nvidia GPU Grant Program; NIH Biomedical Informatics and Data Science Research Training Program [NIH NLM T15LM007092]	BWH Pathology, NIH NIGMS; Google Cloud Research Grant(Google Incorporated); Nvidia GPU Grant Program; NIH Biomedical Informatics and Data Science Research Training Program	We thank A. Bruce for scanning internal cohorts of histology slides of patients at BWH; J. Wang, M. Barbieri, K. Bronstein, L. Cirelli and E. Askeland for querying the BWH slide database and retrieving archival slides; C. Li for assistance with EMRs and Research Patient Data Registry (RPDR); M. Bragg, T. Mellen, T. A. Mages and S. Zimmet for administrative support; Z. Noor for developing the interactive demo website; and K. Tung of Boston Children's Hospital for anatomical illustrations. This work was supported in part by internal funds from BWH Pathology, NIH NIGMS R35GM138216 (F.M.), Google Cloud Research Grant and Nvidia GPU Grant Program. M.S. was additionally supported by the NIH Biomedical Informatics and Data Science Research Training Program, NIH NLM T15LM007092. The content is solely the responsibility of the authors and does not reflect the official views of the National Institute of Health, National Institute of General Medical Sciences or the National Library of Medicine.	Campanella G, 2019, NAT MED, V25, P1301, DOI 10.1038/s41591-019-0508-1; Chen PHC, 2019, NAT MED, V25, P1453, DOI 10.1038/s41591-019-0539-7; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Estrella JS, 2011, AM J SURG PATHOL, V35, P563, DOI 10.1097/PAS.0b013e318211b3d2; Graham S, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101563; Grewal JK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2597; Handorf CR, 2013, AM J SURG PATHOL, V37, P1067, DOI 10.1097/PAS.0b013e31828309c4; Hayashi H, 2020, JAMA ONCOL, V6, P1931, DOI 10.1001/jamaoncol.2020.4643; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hollon TC, 2020, NAT MED, V26, P52, DOI 10.1038/s41591-019-0715-9; Ilse M, 2018, PR MACH LEARN RES, V80; Jiao W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13825-8; Jurmeister P, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8513; Kalra S, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0238-2; Kather JN, 2019, NAT MED, V25, P1054, DOI 10.1038/s41591-019-0462-y; Kerr SE, 2012, CLIN CANCER RES, V18, P3952, DOI 10.1158/1078-0432.CCR-12-0920; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liu Y, 2022, NAT PROD RES, V36, P1757, DOI 10.1080/14786419.2020.1815740; Lu MY, 2021, NAT BIOMED ENG, V5, P555, DOI 10.1038/s41551-020-00682-w; Massard C, 2011, NAT REV CLIN ONCOL, V8, P701, DOI 10.1038/nrclinonc.2011.158; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Ouyang DV, 2020, NATURE, V580, P252, DOI 10.1038/s41586-020-2145-8; Penson A, 2020, JAMA ONCOL, V6, P84, DOI 10.1001/jamaoncol.2019.3985; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Rassy E, 2020, NAT REV CLIN ONCOL, V17, P541, DOI 10.1038/s41571-020-0359-1; Rassy E, 2019, CANCER EPIDEMIOL, V61, P139, DOI 10.1016/j.canep.2019.06.006; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; SHEAHAN K, 1993, AM J CLIN PATHOL, V99, P729, DOI 10.1093/ajcp/99.6.729; Shen YF, 2021, BRIEF BIOINFORM, V22, P2106, DOI 10.1093/bib/bbaa031; Varadhachary GR, 2014, NEW ENGL J MED, V371, P757, DOI 10.1056/NEJMra1303917; Yosinski J, 2014, ADV NEUR IN, V27; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhao Y, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103030	35	87	88	25	101	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					106	+		10.1038/s41586-021-03512-4	http://dx.doi.org/10.1038/s41586-021-03512-4		MAY 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM2RM	33953404	Green Submitted			2022-12-28	WOS:000647555000002
J	Suchorski, Y; Zeininger, J; Buhr, S; Raab, M; Stoger-Pollach, M; Bernardi, J; Gronbeck, H; Rupprechter, G				Suchorski, Y.; Zeininger, J.; Buhr, S.; Raab, M.; Stoeger-Pollach, M.; Bernardi, J.; Gronbeck, H.; Rupprechter, G.			Resolving multifrequential oscillations and nanoscale interfacet communication in single-particle catalysis	SCIENCE			English	Article							OXYGEN-INDUCED RECONSTRUCTION; FIELD-ION MICROSCOPY; CO OXIDATION; IN-SITU; HYDROGEN-OXIDATION; SURFACE-REACTIONS; WATER FORMATION; NANOPARTICLES; RH; PLATINUM	In heterogeneous catalysis research, the reactivity of individual nanofacets of single particles is typically not resolved. We applied in situ field electron microscopy to the apex of a curved rhodium crystal (radius of 650 nanometers), providing high spatial (similar to 2 nanometers) and time resolution (similar to 2 milliseconds) of oscillatory catalytic hydrogen oxidation, to image adsorbed species and reaction fronts on the individual facets. Using ionized water as the imaging species, the active sites were directly imaged with field ion microscopy. The catalytic behavior of differently structured nanofacets and the extent of coupling between them were monitored individually. We observed limited interfacet coupling, entrainment, frequency locking, and reconstruction-induced collapse of spatial coupling. The experimental results are backed up by microkinetic modeling of time-dependent oxygen species coverages and oscillation frequencies.	[Suchorski, Y.; Zeininger, J.; Buhr, S.; Raab, M.; Rupprechter, G.] TU Wien, Inst Mat Chem, Getreidemarkt 9, A-1060 Vienna, Austria; [Stoeger-Pollach, M.; Bernardi, J.] TU Wien, Univ Serv Ctr Transmiss Electron Microscopy, Wiedner Hauptstr 8-10, A-1040 Vienna, Austria; [Gronbeck, H.] Chalmers Univ Technol, Dept Phys, S-41296 Gothenburg, Sweden; [Gronbeck, H.] Chalmers Univ Technol, Competence Ctr Catalysis, S-41296 Gothenburg, Sweden	Technische Universitat Wien; Technische Universitat Wien; Chalmers University of Technology; Chalmers University of Technology	Rupprechter, G (corresponding author), TU Wien, Inst Mat Chem, Getreidemarkt 9, A-1060 Vienna, Austria.	guenther.rupprechter@tuwien.ac.at	Rupprechter, Günther/ABE-8023-2020	Rupprechter, Günther/0000-0002-8040-1677; Raab, Maximilian/0000-0002-5390-6290; Bernardi, Johannes/0000-0002-4626-9246; Gronbeck, Henrik/0000-0002-8709-2889; Stoger-Pollach, Michael/0000-0002-5450-4621	Austrian Science Fund (FWF) [P 32772-N, SFB F45 FOXSI]; Swedish Research Council [2020-05191]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Austrian Science Fund (FWF) (P 32772-N and SFB F45 FOXSI) and by the Swedish Research Council (2020-05191).	Adibi PTZ, 2016, ACS NANO, V10, P5063, DOI 10.1021/acsnano.5b07861; Barroo C., 2018, ENCY INTERFACIAL CHE, V2.1, P251; Barroo C, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.144501; Beben J, 2003, PROG SURF SCI, V74, P3, DOI 10.1016/j.progsurf.2003.08.002; Bodega PS, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/3/061; Datler M, 2016, CATAL LETT, V146, P1867, DOI 10.1007/s10562-016-1824-4; de Bocarme TV, 2006, TOP CATAL, V39, P111, DOI 10.1007/s11244-006-0044-3; de Bocarme TV, 2004, SURF INTERFACE ANAL, V36, P522, DOI 10.1002/sia.1698; Dery S, 2018, TOP CATAL, V61, P923, DOI 10.1007/s11244-018-0931-4; Ebenstein Y, 2002, APPL PHYS LETT, V80, P4033, DOI 10.1063/1.1482785; Ernst N, 1996, INT J MASS SPECTROM, V152, P185, DOI 10.1016/0168-1176(95)04332-2; Ertl G., 1990, ADV CATAL, V37, P213; Ertl G, 2008, ANGEW CHEM INT EDIT, V47, P3524, DOI 10.1002/anie.200800480; GOMER R, 1990, REP PROG PHYS, V53, P917, DOI 10.1088/0034-4885/53/7/002; Good R. H., 1956, HDB PHYS, P176, DOI [10.1007/978-3-642-45844-6_2, DOI 10.1007/978-3-642-45844-6]; GORODETSKII V, 1994, NATURE, V370, P276, DOI 10.1038/370276a0; GORODETSKII V, 1994, APPL SURF SCI, V76, P129, DOI 10.1016/0169-4332(94)90333-6; GORODETSKII VV, 1981, SURF SCI, V105, P299, DOI 10.1016/0039-6028(81)90163-1; Gorodetskii VV, 2005, CATAL TODAY, V105, P183, DOI 10.1016/j.cattod.2005.03.082; Grass ME, 2008, ANGEW CHEM INT EDIT, V47, P8893, DOI 10.1002/anie.200803574; GREGORATTI L, 1995, SURF SCI, V340, P205, DOI 10.1016/0039-6028(95)00695-8; Hansen TW, 2013, ACCOUNTS CHEM RES, V46, P1720, DOI 10.1021/ar3002427; Hansen TW, 2001, SCIENCE, V294, P1508, DOI 10.1126/science.1064399; HOOGERS G, 1993, SURF SCI, V286, P306, DOI 10.1016/0039-6028(93)90414-F; HORN FJM, 1967, IND ENG CHEM PROC DD, V6, P21, DOI 10.1021/i260021a005; IMBIHL R, 1995, CHEM REV, V95, P697, DOI 10.1021/cr00035a012; Klikovits J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.266104; Krefting D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178301; Lassenberger A, 2017, CHEM MATER, V29, P4511, DOI 10.1021/acs.chemmater.7b01207; Li YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00603-7; Liu YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12634; McEwen JS, 2008, CHEM PHYS LETT, V452, P133, DOI 10.1016/j.cplett.2007.12.031; McEwen JS, 2010, SURF SCI, V604, P1353, DOI 10.1016/j.susc.2010.04.007; McEwen JS, 2009, J PHYS CHEM C, V113, P17045, DOI 10.1021/jp901975w; McEwen JS, 2009, P NATL ACAD SCI USA, V106, P3006, DOI 10.1073/pnas.0811941106; Medvedev VK, 1998, LANGMUIR, V14, P6151, DOI 10.1021/la980603c; Medvedev VK, 1996, SURF SCI, V364, pL540, DOI 10.1016/0039-6028(96)00729-7; MERTENS F, 1993, J CHEM PHYS, V99, P8668, DOI 10.1063/1.465590; MURRAY PW, 1993, PHYS REV B, V47, P12976, DOI 10.1103/PhysRevB.47.12976; Neagu D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9120; Nolte P, 2008, SCIENCE, V321, P1654, DOI 10.1126/science.1160845; Plodinec M, 2020, ACS CATAL, V10, P3183, DOI 10.1021/acscatal.9b03692; Reske R, 2014, J AM CHEM SOC, V136, P6978, DOI 10.1021/ja500328k; Spiel C, 2015, ULTRAMICROSCOPY, V159, P178, DOI 10.1016/j.ultramic.2015.05.012; Suchorski Y, 2006, SURF SCI, V600, P1579, DOI 10.1016/j.susc.2005.11.060; Suchorski Y, 1998, SURF SCI, V401, P392, DOI 10.1016/S0039-6028(98)00043-0; SUCHORSKI Y, 1995, PROG SURF SCI, V48, P121, DOI 10.1016/0079-6816(95)93420-C; Suchorski Y., 2021, ZENODO; Suchorski Y., 2021, ZENODO, DOI [10.5281/zenodo.4709843, DOI 10.5281/ZENODO.4709843]; Suchorski Y, 2007, TOP CATAL, V46, P201, DOI 10.1007/s11244-007-0330-8; Suchorski Y, 2019, J PHYS CHEM C, V123, P4217, DOI 10.1021/acs.jpcc.8b11421; Suchorski Y, 2018, NAT MATER, V17, P519, DOI 10.1038/s41563-018-0080-y; Suchorski Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03007-3; Suchorski Y, 2017, ADSORPTION, V23, P217, DOI 10.1007/s10450-016-9824-7; Suchorski Y, 2016, SURF SCI, V643, P52, DOI 10.1016/j.susc.2015.05.021; Verheij LK, 1998, SURF SCI, V416, P37, DOI 10.1016/S0039-6028(98)00498-1; VOSS C, 1993, APPL SURF SCI, V67, P142, DOI 10.1016/0169-4332(93)90306-V; Winkler P., NAT COMMUN, V12, P69, DOI [10.1038/s41467-020- 20377-9 Medline, DOI 10.1038/S41467-020-20377-9MEDLINE]; Wolff J, 2001, SCIENCE, V294, P134, DOI 10.1126/science.1063597; ZUMMALLEN MP, 1993, J PHYS CHEM-US, V97, P625, DOI 10.1021/j100105a016	60	10	10	9	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2021	372	6548			SI		1314	+		10.1126/science.abf8107	http://dx.doi.org/10.1126/science.abf8107			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SY0WR	34016741	Bronze			2022-12-28	WOS:000665616000029
J	Gong, M; Wang, SY; Zha, C; Chen, MC; Huang, HL; Wu, YL; Zhu, QL; Zhao, YW; Li, SW; Guo, SJ; Qian, HR; Ye, YS; Chen, FS; Ying, C; Yu, JL; Fan, DJ; Wu, DC; Su, H; Deng, H; Rong, H; Zhang, KL; Cao, SR; Lin, J; Xu, Y; Sun, LH; Guo, C; Li, N; Liang, FT; Bastidas, VM; Nemoto, K; Munro, WJ; Huo, YH; Lu, CY; Peng, CZ; Zhu, XB; Pan, JW				Gong, Ming; Wang, Shiyu; Zha, Chen; Chen, Ming-Cheng; Huang, He-Liang; Wu, Yulin; Zhu, Qingling; Zhao, Youwei; Li, Shaowei; Guo, Shaojun; Qian, Haoran; Ye, Yangsen; Chen, Fusheng; Ying, Chong; Yu, Jiale; Fan, Daojin; Wu, Dachao; Su, Hong; Deng, Hui; Rong, Hao; Zhang, Kaili; Cao, Sirui; Lin, Jin; Xu, Yu; Sun, Lihua; Guo, Cheng; Li, Na; Liang, Futian; Bastidas, V. M.; Nemoto, Kae; Munro, W. J.; Huo, Yong-Heng; Lu, Chao-Yang; Peng, Cheng-Zhi; Zhu, Xiaobo; Pan, Jian-Wei			Quantum walks on a programmable two-dimensional 62-qubit superconducting processor	SCIENCE			English	Article								Quantum walks are the quantum mechanical analog of classical random walks and an extremely powerful tool in quantum simulations, quantum search algorithms, and even for universal quantum computing. In our work, we have designed and fabricated an 8-by-8 two-dimensional square superconducting qubit array composed of 62 functional qubits. We used this device to demonstrate high-fidelity single- and two-particle quantum walks. Furthermore, with the high programmability of the quantum processor, we implemented a Mach-Zehnder interferometer where the quantum walker coherently traverses in two paths before interfering and exiting. By tuning the disorders on the evolution paths, we observed interference fringes with single and double walkers. Our work is a milestone in the field, bringing future larger-scale quantum applications closer to realization for noisy intermediate-scale quantum processors.	[Gong, Ming; Wang, Shiyu; Zha, Chen; Chen, Ming-Cheng; Huang, He-Liang; Wu, Yulin; Zhu, Qingling; Zhao, Youwei; Li, Shaowei; Guo, Shaojun; Qian, Haoran; Ye, Yangsen; Chen, Fusheng; Ying, Chong; Yu, Jiale; Fan, Daojin; Wu, Dachao; Su, Hong; Deng, Hui; Rong, Hao; Zhang, Kaili; Cao, Sirui; Lin, Jin; Xu, Yu; Sun, Lihua; Guo, Cheng; Li, Na; Liang, Futian; Huo, Yong-Heng; Lu, Chao-Yang; Peng, Cheng-Zhi; Zhu, Xiaobo; Pan, Jian-Wei] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Gong, Ming; Wang, Shiyu; Zha, Chen; Chen, Ming-Cheng; Huang, He-Liang; Wu, Yulin; Zhu, Qingling; Zhao, Youwei; Li, Shaowei; Guo, Shaojun; Qian, Haoran; Ye, Yangsen; Chen, Fusheng; Ying, Chong; Yu, Jiale; Fan, Daojin; Wu, Dachao; Su, Hong; Deng, Hui; Rong, Hao; Zhang, Kaili; Cao, Sirui; Lin, Jin; Xu, Yu; Sun, Lihua; Guo, Cheng; Li, Na; Liang, Futian; Huo, Yong-Heng; Lu, Chao-Yang; Peng, Cheng-Zhi; Zhu, Xiaobo; Pan, Jian-Wei] Univ Sci & Technol China, Dept Modem Phys, Hefei 230026, Anhui, Peoples R China; [Gong, Ming; Wang, Shiyu; Zha, Chen; Chen, Ming-Cheng; Huang, He-Liang; Wu, Yulin; Zhu, Qingling; Zhao, Youwei; Li, Shaowei; Guo, Shaojun; Qian, Haoran; Ye, Yangsen; Chen, Fusheng; Ying, Chong; Yu, Jiale; Fan, Daojin; Wu, Dachao; Su, Hong; Deng, Hui; Rong, Hao; Zhang, Kaili; Cao, Sirui; Lin, Jin; Xu, Yu; Sun, Lihua; Guo, Cheng; Li, Na; Liang, Futian; Huo, Yong-Heng; Lu, Chao-Yang; Peng, Cheng-Zhi; Zhu, Xiaobo; Pan, Jian-Wei] Univ Sci & Technol China, CAS Ctr Excellence Quantum Informat & Quantum Phy, Shanghai Branch, Shanghai 201315, Peoples R China; [Gong, Ming; Wang, Shiyu; Zha, Chen; Chen, Ming-Cheng; Huang, He-Liang; Wu, Yulin; Zhu, Qingling; Zhao, Youwei; Li, Shaowei; Guo, Shaojun; Qian, Haoran; Ye, Yangsen; Chen, Fusheng; Ying, Chong; Yu, Jiale; Fan, Daojin; Wu, Dachao; Su, Hong; Deng, Hui; Rong, Hao; Zhang, Kaili; Cao, Sirui; Lin, Jin; Xu, Yu; Sun, Lihua; Guo, Cheng; Li, Na; Liang, Futian; Huo, Yong-Heng; Lu, Chao-Yang; Peng, Cheng-Zhi; Zhu, Xiaobo; Pan, Jian-Wei] Shanghai Res Ctr Quantum Sci, Shanghai 201315, Peoples R China; [Bastidas, V. M.; Munro, W. J.] NTT Basic Res Labs & Res Ctr Theoret Quantum Phys, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan; [Nemoto, Kae; Munro, W. J.] Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Zhu, XB; Pan, JW (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.; Zhu, XB; Pan, JW (corresponding author), Univ Sci & Technol China, Dept Modem Phys, Hefei 230026, Anhui, Peoples R China.; Zhu, XB; Pan, JW (corresponding author), Univ Sci & Technol China, CAS Ctr Excellence Quantum Informat & Quantum Phy, Shanghai Branch, Shanghai 201315, Peoples R China.; Zhu, XB; Pan, JW (corresponding author), Shanghai Res Ctr Quantum Sci, Shanghai 201315, Peoples R China.	xbzhu16@ustc.edu.cn; pan@ustc.edu.cn	Huo, Yongheng/AAQ-4930-2020; Munro, William/A-8453-2011; Huo, Yongheng/C-1916-2016; Lu, Chao-Yang/D-8481-2011; cao, sirui/GSO-1557-2022; Nemoto, Kae/A-8833-2011; Liang, Futian/ABH-3046-2021; Chen, Ming-Cheng/AAN-9647-2020; Gong, Ming/I-3223-2016; Pan, Jian-Wei/A-2332-2010	Huo, Yongheng/0000-0002-0310-3078; Munro, William/0000-0003-1835-2250; Huo, Yongheng/0000-0002-0310-3078; Lu, Chao-Yang/0000-0002-8227-9177; Liang, Futian/0000-0001-9843-0559; Gong, Ming/0000-0002-5534-2177; Bastidas, Victor M./0000-0001-8091-7860; Huang, He-Liang/0000-0002-5121-3028; Pan, Jian-Wei/0000-0002-6100-5142; Zhu, Qingling/0000-0002-0925-9903	National Key R&D Program of China [2017YFA0304300]; Chinese Academy of Sciences; Technology Committee of Shanghai Municipality; National Science Foundation of China [11905217, 11774326]; Shanghai Municipal Science and Technology Major Project [2019SHZDZX01]; Natural Science Foundation of Shanghai [19ZR1462700]; Key-Area Research and Development Program of Guangdong Provice [2020B0303030001]; Japanese MEXT Quantum Leap Flagship Program (MEXT Q-LEAP) [JPMXS0118069605]; Anhui Initiative in Quantum Information Technologies	National Key R&D Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Technology Committee of Shanghai Municipality; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Major Project; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Key-Area Research and Development Program of Guangdong Provice; Japanese MEXT Quantum Leap Flagship Program (MEXT Q-LEAP); Anhui Initiative in Quantum Information Technologies	This research was supported by the National Key R&D Program of China (grant 2017YFA0304300), the Chinese Academy of Sciences, Anhui Initiative in Quantum Information Technologies, Technology Committee of Shanghai Municipality, National Science Foundation of China (grants 11905217 and 11774326), Shanghai Municipal Science and Technology Major Project (grant 2019SHZDZX01), Natural Science Foundation of Shanghai (grant 19ZR1462700), and Key-Area Research and Development Program of Guangdong Provice (grant 2020B0303030001). This work was also supported in part by the Japanese MEXT Quantum Leap Flagship Program (MEXT Q-LEAP), grant JPMXS0118069605.	AHARONOV Y, 1993, PHYS REV A, V48, P1687, DOI 10.1103/PhysRevA.48.1687; Arute F, 2019, NATURE, V574, P505, DOI 10.1038/s41586-019-1666-5; Aspuru-Guzik A, 2012, NAT PHYS, V8, P285, DOI [10.1038/NPHYS2253, 10.1038/nphys2253]; Burrell CK, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.052319; Chen C, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.100502; Cheneau M, 2012, NATURE, V481, P484, DOI 10.1038/nature10748; Childs A.M., 2003, P 35 ACM S THEOR COM, DOI [10.1145/780542.780552, DOI 10.1145/780542.780552]; Childs AM, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.022314; Childs AM., 2003, P 35 ANN ACM S THEOR, ppp 59; Childs AM, 2013, SCIENCE, V339, P791, DOI 10.1126/science.1229957; Childs AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.180501; Foxen B, 2018, QUANTUM SCI TECHNOL, V3, DOI 10.1088/2058-9565/aa94fc; Foxen B, 2017, SCI TECH-BEL, V3; Karski M, 2009, SCIENCE, V325, P174, DOI 10.1126/science.1174436; Lahini Y, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.011603; Lambert N, 2013, NAT PHYS, V9, P10, DOI [10.1038/nphys2474, 10.1038/NPHYS2474]; LIEB EH, 1972, COMMUN MATH PHYS, V28, P251, DOI 10.1007/BF01645779; Mulken O, 2011, PHYS REP, V502, P37, DOI 10.1016/j.physrep.2011.01.002; Peruzzo A, 2010, SCIENCE, V329, P1500, DOI 10.1126/science.1193515; Ramasesh VV, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.130501; Rohde PP, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.022332; Ryan CA, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.062317; Schmitz H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.090504; Shenvi N, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.052307; Takasu Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba9255; Tulsi A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.012310; Underwood MS, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.052314; Vahidpour M., 2017, ARXIV170802226PHYSIC; Vahidpour M., 2017, ARXIV170802226; Yan ZG, 2019, SCIENCE, V364, P753, DOI 10.1126/science.aaw1611; Zahringer F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.100503; Zhong HS, 2020, SCIENCE, V370, P1460, DOI 10.1126/science.abe8770	32	82	84	21	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2021	372	6545					948	+		10.1126/science.abg7812	http://dx.doi.org/10.1126/science.abg7812			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SK7YO	33958483	Green Submitted			2022-12-28	WOS:000656432400042
J	He, CX				He, Cynthia X.			Defense Against Numbness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[He, Cynthia X.] UCSF Weill Inst Neurosci, Dept Psychiat & Behav Sci, San Francisco, CA USA		He, CX (corresponding author), 401 Parnassus Ave,RTP Box 0984, San Francisco, CA 94143 USA.	cynthia.he@ucsf.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2047	2048		10.1001/jama.2021.7137	http://dx.doi.org/10.1001/jama.2021.7137			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032826	Bronze			2022-12-28	WOS:000655647300016
J	McKee, M				McKee, Martin			What went wrong in the UK's covid-19 response?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKee, Martin] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), London Sch Hyg & Trop Med, London, England.	Martin.McKee@lshtm.ac.uk						McKee M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2052	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2021	373								n1309	10.1136/bmj.n1309	http://dx.doi.org/10.1136/bmj.n1309			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK9UC	34031098	Bronze			2022-12-28	WOS:000656562600002
J	Guzik, P; Drahus, M				Guzik, Piotr; Drahus, Michal			Gaseous atomic nickel in the coma of interstellar comet 2I/Borisov	NATURE			English	Article							EMISSION; SPECTRUM; SPECTROSCOPY; SOLAR; GAS	On 31 August 2019, an interstellar comet was discovered as it passed through the Solar System (2I/Borisov). On the basis of initial imaging observations, 2I/Borisov seemed to be similar to ordinary Solar System comets(1,2)-an unexpected characteristic given the multiple peculiarities of the only known previous interstellar visitor, 1I/'Oumuamua(3-6). Spectroscopic investigations of 2I/Borisov identified the familiar cometary emissions from CN (refs. (7-9)), C-2 (ref. (10)), O i (ref. (11)), NH2 (ref. (12)), OH (ref. (13)), HCN (ref. (14)) and CO (refs. (14,15)), revealing a composition similar to that of carbon monoxide-rich Solar System comets. At temperatures greater than 700 kelvin, comets also show metallic vapours that are produced by the sublimation of metal-rich dust grains(16). Observation of gaseous metals had until very recently(17) been limited to bright sunskirting and sungrazing comets(18-20) and giant star-plunging exocomets(21). Here we report spectroscopic observations of atomic nickel vapour in the cold coma of 2I/Borisov at a heliocentric distance of 2.322 astronomical units-equivalent to an equilibrium temperature of 180 kelvin. Nickel in 2I/Borisov seems to originate from a short-lived nickel-containing molecule with a lifetime of 340(-200)(+260) seconds at 1 astronomical unit and is produced at a rate of 0.9 +/- 0.3 x 10(22) atoms per second, or 0.002 per cent relative to OH and 0.3 per cent relative to CN. The detection of gas-phase nickel in the coma of 2I/Borisov is in line with the recent identification of this atom-as well as iron-in the cold comae of Solar System comets(17).	[Guzik, Piotr; Drahus, Michal] Jagiellonian Univ, Astron Observ, Krakow, Poland	Jagiellonian University	Guzik, P; Drahus, M (corresponding author), Jagiellonian Univ, Astron Observ, Krakow, Poland.	piotr.guzik@doctoral.uj.edu.pl; drahus@oa.uj.edu.pl	Guzik, Piotr/B-1313-2016	Guzik, Piotr/0000-0002-5019-4056	ESO [0104.C-0933(B)]; National Science Centre of Poland through ETIUDA scholarship [2020/36/T/ST9/00596]; SONATA BIS [2016/22/E/ST9/00109]; Polish Ministry of Science and Higher Education [DIR/WK/2018/12]	ESO; National Science Centre of Poland through ETIUDA scholarship; SONATA BIS; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	We thank K. Rusek for help with proposal writing, M. Ratajczak and M. Gromadzki for introducing us to X-shooter data reduction, and P. Kozyra for discussion on nickel-containing molecules. This work is based on observations collected at the ESO under ESO programme 0104.C-0933(B). We thank the ESO staff for support. We are also grateful for support from the National Science Centre of Poland through ETIUDA scholarship no. 2020/36/T/ST9/00596 to P.G. and SONATA BIS grant no. 2016/22/E/ST9/00109 to M.D., and we acknowledge support from the Polish Ministry of Science and Higher Education through grant no. DIR/WK/2018/12.	AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Bannister M. T., 2020, INTERSTELLAR COMET 2; CHOCHOL D, 1983, ASTROPHYS SPACE SCI, V91, P71, DOI 10.1007/BF00650215; Cochran AL, 2002, ASTROPHYS J, V576, pL165, DOI 10.1086/343763; Cochran AL, 2018, ASTROPHYS J LETT, V854, DOI 10.3847/2041-8213/aaab57; Combi MR, 2004, SPACE SCI S, P523; de Leon J, 2020, MON NOT R ASTRON SOC, V495, P2053, DOI 10.1093/mnras/staa1190; Drahus M, 2018, NAT ASTRON, V2, P407, DOI 10.1038/s41550-018-0440-1; Feldman PD, 2004, SPACE SCI S, P425; Fitzsimmons A, 2019, ASTROPHYS J LETT, V885, DOI 10.3847/2041-8213/ab49fc; Flynn GJ, 2006, SCIENCE, V314, P1731, DOI 10.1126/science.1136141; Fraser WC, 2018, NAT ASTRON, V2, P383, DOI 10.1038/s41550-018-0398-z; Fulle M, 2007, ASTROPHYS J, V661, pL93, DOI 10.1086/518719; GOLDBERG RA, 1973, SCIENCE, V180, P294, DOI 10.1126/science.180.4083.294; Guzik P, 2020, NAT ASTRON, V4, P53, DOI 10.1038/s41550-019-0931-8; Haser L., 1957, B ACAD ROY SCI BELGI, V43, P740; Hoeijmakers HJ, 2020, ASTRON ASTROPHYS, V641, DOI 10.1051/0004-6361/202038365; Huebner WF, 2015, PLANET SPACE SCI, V106, P11, DOI 10.1016/j.pss.2014.11.022; Ivezic Z, 2019, ASTROPHYS J, V873, DOI 10.3847/1538-4357/ab042c; Jehin E., 2020, CBET 4719 COMET 2I 2; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; Kareta T, 2020, ASTROPHYS J LETT, V889, DOI 10.3847/2041-8213/ab6a08; Kiefer F, 2019, ASTRON ASTROPHYS, V621, DOI 10.1051/0004-6361/201834274; Kim SJ, 2003, ICARUS, V166, P157, DOI 10.1016/j.icarus.2003.07.003; Lin HW, 2020, ASTROPHYS J LETT, V889, DOI 10.3847/2041-8213/ab6bd9; Manfroid J, 2021, NATURE, V593, P372, DOI 10.1038/s41586-021-03435-0; McKay AJ, 2020, ASTROPHYS J LETT, V889, DOI 10.3847/2041-8213/ab64ed; Micheli M, 2018, NATURE, V559, P223, DOI 10.1038/s41586-018-0254-4; Opitom C, 2019, ASTRON ASTROPHYS, V624, DOI 10.1051/0004-6361/201834357; PECK ER, 1972, J OPT SOC AM, V62, P958, DOI 10.1364/JOSA.62.000958; PRESTON GW, 1967, ASTROPHYS J, V147, P718, DOI 10.1086/149049; Prialnik D, 2004, SPACE SCI S, P359; Rubin M, 2019, MON NOT R ASTRON SOC, V489, P594, DOI 10.1093/mnras/stz2086; SLAUGHTE.CD, 1969, ASTRON J, V74, P929, DOI 10.1086/110884; Swings P., 1941, LICK OBS B, V19, P131; VALK JH, 1992, ASTROPHYS J, V388, P621, DOI 10.1086/171179; Vanderburg A, 2015, NATURE, V526, P546, DOI 10.1038/nature15527; Wasson J. T, 1974, METEORITES, P11; Xu S, 2017, ASTROPHYS J LETT, V836, DOI 10.3847/2041-8213/836/1/L7; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	46	6	6	1	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					375	+		10.1038/s41586-021-03485-4	http://dx.doi.org/10.1038/s41586-021-03485-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE7VT	34012084	Green Accepted			2022-12-28	WOS:000652278400014
J	Kamil, JP				Kamil, Jeremy P.			Virus variants: GISAID policies incentivize surveillance in global south	NATURE			English	Letter									[Kamil, Jeremy P.] Louisiana State Univ Hlth Shreveport, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Kamil, JP (corresponding author), Louisiana State Univ Hlth Shreveport, Shreveport, LA 71105 USA.	jeremy.kamil@lsuhs.edu						LOTEMPIO J, 2020, SCI DIPLOM, V9, P47	1	2	2	3	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					341	341		10.1038/d41586-021-01310-6	http://dx.doi.org/10.1038/d41586-021-01310-6			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE2PC	34007076	Bronze			2022-12-28	WOS:000651914000012
J	Yousefzadeh, MJ; Flores, RR; Zhu, Y; Schmiechen, ZC; Brooks, RW; Trussoni, CE; Cui, YX; Angelini, L; Lee, KA; McGowan, SJ; Burrack, AL; Wang, D; Dong, Q; Lu, AP; Sano, T; O'Kelly, RD; McGuckian, CA; Kato, JI; Bank, MP; Wade, EA; Pillai, SPS; Klug, J; Ladiges, WC; Burd, CE; Lewis, SE; LaRusso, NF; Vo, NV; Wang, YS; Kelley, EE; Huard, J; Stromnes, IM; Robbins, PD; Niedernhofer, LJ				Yousefzadeh, Matthew J.; Flores, Rafael R.; Zhu, Yi; Schmiechen, Zoe C.; Brooks, Robert W.; Trussoni, Christy E.; Cui, Yuxiang; Angelini, Luise; Lee, Kyoo-A; McGowan, Sara J.; Burrack, Adam L.; Wang, Dong; Dong, Qing; Lu, Aiping; Sano, Tokio; O'Kelly, Ryan D.; McGuckian, Collin A.; Kato, Jonathan I.; Bank, Michael P.; Wade, Erin A.; Pillai, Smitha P. S.; Klug, Jenna; Ladiges, Warren C.; Burd, Christin E.; Lewis, Sara E.; LaRusso, Nicholas F.; Vo, Nam V.; Wang, Yinsheng; Kelley, Eric E.; Huard, Johnny; Stromnes, Ingunn M.; Robbins, Paul D.; Niedernhofer, Laura J.			An aged immune system drives senescence and ageing of solid organs	NATURE			English	Article							T-CELLS; IN-VIVO; BIOMARKER; EXPRESSION; PHENOTYPE	Ageing of the immune system, or immunosenescence, contributes to the morbidity and mortality of the elderly(1,2). To define the contribution of immune system ageing to organism ageing, here we selectively deleted Ercc1, which encodes a crucial DNA repair protein(3,4), in mouse haematopoietic cells to increase the burden of endogenous DNA damage and thereby senescence(5-7) in the immune system only. We show that Vav-iCre(+/-);Ercc1(-/fl) mice were healthy into adulthood, then displayed premature onset of immunosenescence characterized by attrition and senescence of specific immune cell populations and impaired immune function, similar to changes that occur during ageing in wild-type mice(8-10). Notably, non-lymphoid organs also showed increased senescence and damage, which suggests that senescent, aged immune cells can promote systemic ageing. The transplantation of splenocytes from Vav-iCre(+/-);Ercc1(-/fl) or aged wild-type mice into young mice induced senescence intrans, whereas the transplantation of young immune cells attenuated senescence. The treatment of Vav-iCre(+/-);Ercc1(-/fl) mice with rapamycin reduced markers of senescence in immune cells and improved immune function(11,12). These data demonstrate that an aged, senescent immune system has a causal role in driving systemic ageing and therefore represents a key therapeutic target to extend healthy ageing.	[Yousefzadeh, Matthew J.; Flores, Rafael R.; Angelini, Luise; Lee, Kyoo-A; McGowan, Sara J.; O'Kelly, Ryan D.; McGuckian, Collin A.; Robbins, Paul D.; Niedernhofer, Laura J.] Univ Minnesota, Inst Biol Aging & Metab, Minneapolis, MN 55455 USA; [Yousefzadeh, Matthew J.; Flores, Rafael R.; Angelini, Luise; Lee, Kyoo-A; McGowan, Sara J.; O'Kelly, Ryan D.; McGuckian, Collin A.; Robbins, Paul D.; Niedernhofer, Laura J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Zhu, Yi] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA; [Schmiechen, Zoe C.; Burrack, Adam L.; Stromnes, Ingunn M.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Brooks, Robert W.; Sano, Tokio; Kato, Jonathan I.; Bank, Michael P.; Wade, Erin A.] Scripps Res Inst, Dept Mol Med, Jupiter, FL USA; [Trussoni, Christy E.; LaRusso, Nicholas F.] Mayo Clin, Div Gastroenterol, Ctr Cell Signaling Gastroenterol, Rochester, MN USA; [Cui, Yuxiang; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Wang, Dong; Dong, Qing; Vo, Nam V.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Lu, Aiping; Huard, Johnny] Univ Texas Hlth Sci Ctr Houston, Dept Orthoped Surg, McGovern Med Sch, Houston, TX 77030 USA; [Pillai, Smitha P. S.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Klug, Jenna; Ladiges, Warren C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Burd, Christin E.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Burd, Christin E.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Lewis, Sara E.; Kelley, Eric E.] West Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute; Mayo Clinic; University of California System; University of California Riverside; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; West Virginia University	Robbins, PD; Niedernhofer, LJ (corresponding author), Univ Minnesota, Inst Biol Aging & Metab, Minneapolis, MN 55455 USA.; Robbins, PD; Niedernhofer, LJ (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	probbins@umn.edu; lniedern@umn.edu	Wang, Yin/HCI-9352-2022	Trussoni, Christy/0000-0002-4247-076X; Zhu, Yi/0000-0002-3876-3156	National Institutes of Health (NIH) [P01 AG043376, RO1 AG063543, R56 AG059676, U19 AG056278, P01 AG062413, R56 AG058543, R01 AG044376]; Glenn Foundation; Irene Diamond Fund/American Federation on Aging Research Postdoctoral Transition Award	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; Irene Diamond Fund/American Federation on Aging Research Postdoctoral Transition Award	This work was supported by the National Institutes of Health (NIH) grants P01 AG043376 (P.D.R., L.J.N., E.E.K., J.H.), RO1 AG063543 (L.J.N.), R56 AG059676 (L.J.N.), U19 AG056278 (P.D.R., L.J.N., W.C.L.), P01 AG062413 (P.D.R., L.J.N.), R56 AG058543 (W.C.L.), R01 AG044376 (N.V.V.) and the Glenn Foundation (L.J.N., C.E.B.). M.J.Y. is supported by The Irene Diamond Fund/American Federation on Aging Research Postdoctoral Transition Award. Mass cytometry and panel design were performed by S. Farwana and K. D. Pavelko at the Mayo Clinic Immune Monitoring Core. We thank J. Zhao, C. Bukata, K. Melos and M. Calubag for their assistance in measuring senescence. All mouse illustrations were made with BioRender.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Argyropoulos CP, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00073; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Bumgardner SA, 2018, EXP GERONTOL, V104, P9, DOI 10.1016/j.exger.2018.01.010; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Cho JS, 2013, STEM CELLS, V31, P511, DOI 10.1002/stem.1261; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713; Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039; Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Ladiges W, 2016, PATHOBIOL AGING AGE, V6, DOI 10.3402/pba.v6.31478; Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Mannick JB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1564; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Nasto LA, 2013, MECH AGEING DEV, V134, P35, DOI 10.1016/j.mad.2012.11.002; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Olshansky SJ, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025940; Pettan-Brewer C, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7202; Pinti M, 2016, EUR J IMMUNOL, V46, P2286, DOI 10.1002/eji.201546178; Robinson AR, 2018, REDOX BIOL, V17, P259, DOI 10.1016/j.redox.2018.04.007; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Siegemund S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124661; St Sauver JL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006413; Su Y, 2012, J BIOL CHEM, V287, P21846, DOI 10.1074/jbc.M111.337899; Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vicente R, 2016, AGING CELL, V15, P400, DOI 10.1111/acel.12455; Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Yousefzadeh MJ, 2019, METHODS MOL BIOL, V1896, P203, DOI 10.1007/978-1-4939-8931-7_17; Yousefzadeh MJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12706; Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036; Zhao Jing, 2017, Curr Protoc Cytom, V79, DOI 10.1002/cpcy.16; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	41	120	121	46	141	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					100	+		10.1038/s41586-021-03547-7	http://dx.doi.org/10.1038/s41586-021-03547-7		MAY 2021	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM2RM	33981041	Green Accepted			2022-12-28	WOS:000650200300001
J	Snyder, RA				Snyder, Rebecca A.			How do I know if I am a good mother?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Snyder, Rebecca A.] East Carolina Univ, Brody Sch Med, Dept Surg, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Snyder, RA (corresponding author), East Carolina Univ, Div Surg Oncol, Brody Sch Med, 600 Moye Blvd,Surg Oncol Ste,4S-24, Greenville, NC 27834 USA.	snyderre19@ecu.edu						Snyder RA, 2020, JAMA-J AM MED ASSOC, V324, P1611, DOI 10.1001/jama.2020.20407; Snyder RA, 2020, JAMA-J AM MED ASSOC, V323, P215, DOI 10.1001/jama.2019.21664; Wilson K, 2019, NOTHING SEE HERE	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1837	1838		10.1001/jama.2021.6271	http://dx.doi.org/10.1001/jama.2021.6271			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974015				2022-12-28	WOS:000650205000011
J	Wu, Y; Levis, B; Sun, Y; He, C; Krishnan, A; Neupane, D; Bhandari, PM; Negeri, Z; Benedetti, A; Thombs, BD				Wu, Yin; Levis, Brooke; Sun, Ying; He, Chen; Krishnan, Ankur; Neupane, Dipika; Bhandari, Parash Mani; Negeri, Zelalem; Benedetti, Andrea; Thombs, Brett D.		DEPRESsion Screenin	Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTERNATIONAL DIAGNOSTIC INTERVIEW; PATIENT-DATA; RECOMMENDATIONS; RELIABILITY; PREVALENCE; VALIDITY; OUTCOMES; QUALITY; ADULTS; MINI	To evaluate the accuracy of the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) to screen for major depression among people with physical health problems. DESIGN Systematic review and individual participant data meta-analysis. DATA SOURCES Medline, Medline In-Process and Other Non-Indexed Citations, PsycInfo, and Web of Science (from inception to 25 October 2018). REVIEW METHODS Eligible datasets included HADS-D scores and major depression status based on a validated diagnostic interview. Primary study data and study level data extracted from primary reports were combined. For HADS-D cut-off thresholds of 5-15, a bivariate random effects meta-analysis was used to estimate pooled sensitivity and specificity, separately, in studies that used semi-structured diagnostic interviews (eg, Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders), fully structured interviews (eg, Composite International Diagnostic Interview), and the Mini International Neuropsychiatric Interview. One stage meta regression was used to examine whether accuracy was associated with reference standard categories and the characteristics of participants. Sensitivity analyses were done to assess whether including published results from studies that did not provide raw data influenced the results. RESULTS Individual participant data were obtained from 101 of 168 eligible studies (60%; 25 574 participants (72% of eligible participants), 2549 with major depression). Combined sensitivity and specificity was maximised at a cut-off value of seven or higher for semi-structured interviews, fully structured interviews, and the Mini International Neuropsychiatric Interview. Among studies with a semi-structured interview (57 studies, 10 664 participants, 1048 with major depression), sensitivity and specificity were 0.82 (95% confidence interval 0.76 to 0.87) and 0.78 (0.74 to 0.81) for a cut-off value of seven or higher, 0.74 (0.68 to 0.79) and 0.84 (0.81 to 0.87) fora cut-off value of eight or higher, and 0.44 (0.38 to 0.51) and 0.95 (0.93 to 0.96) for a cut-off value of 11 or higher. Accuracy was similar across reference standards and subgroups and when published results from studies that did not contribute data were included. CONCLUSIONS When screening for major depression, a HADS-D cut-off value of seven or higher maximised combined sensitivity and specificity. A cut-off value of eight or higher generated similar combined sensitivity and specificity but was less sensitive and more specific. To identify medically ill patients with depression with the HADS-D, lower cut-off values could be used to avoid false negatives and higher cut-off values to reduce false positives and identify people with higher symptom levels. TRIAL REGISTRATION PROSPERO CRD42015016761.	[Wu, Yin; Sun, Ying; He, Chen; Krishnan, Ankur; Neupane, Dipika; Bhandari, Parash Mani; Negeri, Zelalem; Thombs, Brett D.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Wu, Yin; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Levis, Brooke] Keele Univ, Ctr Prognosis Res, Sch Primary Community & Social Care Med, Keele, Staffs, England; [Benedetti, Andrea; Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Benedetti, Andrea] McGill Univ, Resp Epidemiol & Clin Res Unit, Ctr Hlth, Montreal, PQ, Canada; [Benedetti, Andrea; Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Biomed Eth Unit, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; Keele University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Thombs, BD (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Biomed Eth Unit, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	Wu, Yin/AFR-0274-2022; Gilbody, Simon/AAY-3720-2021; Julião, Miguel/G-3868-2014; Patten, Scott/B-4434-2011; Strobel, Natalie/O-9174-2014	Gilbody, Simon/0000-0002-8236-6983; Julião, Miguel/0000-0001-9283-5045; Patten, Scott/0000-0001-9871-4041; Strobel, Natalie/0000-0002-2962-5704; Thombs, Brett D./0000-0002-5644-8432; Jenewein, Josef/0000-0003-4271-918X; Rieckmann, Nina/0000-0002-6870-451X; , Gemma/0000-0001-8931-4513	Canadian Institutes of Health Research (CIHR) [KRS-140045, PCG155468]; Fonds de recherche du QuebecSante (FRQ-S); Faculty of Medicine, McGill University; Research Institute of the McGill University Health Centre; FRQ-S researcher salary award; Tier 1 Canada Research Chair; Vanier Canada Graduate Scholarship; University of Calgary Cumming School of Medicine; Hotchkiss Brain Institute; Alberta Innovates; CIHR [THC135234]; Crohn's and Colitis Canada; Research Manitoba Chair; Bingham Chair in Gastroenterology; Waugh Family Chair in Multiple Sclerosis; Research Council of Lithuania [LIG03/2011]; National Science Council, Taiwan [NSC 962314B182A090MY2]; Waikato Clinical School, University of Auckland; Waikato Medical Research Foundation; Waikato Respiratory Research Fund; Catalan Agency for Health Technology Assessment and Research [102/19/2004]; Promoting Psychological Research and Training on HealthDisparities Issues at Ethnic MinorityServing Institutions Grants (ProDIGs) from the American Psychological Association; Research Grant "Ramon CarrilloArturo Ofiativa for Multicentric Studies" (2015) from the commission "Salud Investiga" of the Ministry of Health and Social Action of Argentina [1853]; Birmingham and Solihull Mental Health Foundation Trust; German Federal Ministry of Education and Research [01GY1155A, 01GY1150]; Maastricht University; Multiple Sclerosis Society of Canada; Drummond Foundation; Department of Psychiatry, University Health Network; Japanese Ministry of Health, Labour, and Welfare [11-2, 9-31]; Japanese Ministry of Education, Culture, Sports, Science, and Technology; European Commission DG Health and Consumer Protection (University of Ferrara) [SI2.307317 2000CVGG2026]; University of Ferrara; Fondazione Cassa di Risparmio di Ferrara; Federal Ministry of Education and Research; Federation of German Pension Insurance Institutes; Medical Faculty of the University of Heidelberg [175/2000]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [20090087344]; Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea [A102065]; Kathleen Cuningham Foundation (National Breast Cancer Foundation); Cancer Council of Victoria; National Health and Medical Research Council; Bethlehem Griffiths Research Foundation; medical faculty of the University of Heidelberg, Germany [121/2000]; Instituto de Salud Carlos III [EO PI08/90869, FISE08/00268]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [PFB12/2007]; Fondo Nacional de Desarrolo Cientifico y Tecnologico (FONDECYT) [1110849]; Japanese Ministry of Health, Labour, and Welfare through Research on Psychiatric and Neurological Disease and Mental Health [16190501, 19230701, 20300701]; German Cancer Aid within the psychosocial oncology funding priority program [107465]; French Society of Dermatology; University Hospital of Saint Etienne; Australian Government National Health and Medical Research Council program grant; NHMRC Program [1073041]; Scottish Home and Health Department; Ministry of Health of Spain [PI040418]; Transport Accident Commission Grant; Instituto de Investigacion Hospital 12 de Octubre (i+12); British Geriatric Society, Scotland; Research Council of Norway; NHS Lothian NeuroOncology Endowment Fund; PRONEX Program (NENASC Project); PPSUS Program of Fundacao de Amparo a esquisa e Inovacao do Estado de Santa Catarina (FAPESC); National Science and Technology Institute for Translational Medicine (INCTTM); Universiti Sains Malaysia; University of Sydney Cancer Research Fund; IDEA grants from the Canadian Prostate Cancer Research Initiative; Canadian Breast Cancer Research Alliance; German Federal Ministry for Education and Research [01ZZ0106, 7DZAIQTX]; University of Leipzig [formel. 1-57]; Federal Ministry of Education and Research (BMBF); Western and Central Melbourne Integrated Cancer Service; University of Melbourne; Medical Research Council, UK; Chest Heart and Stroke, Scotland; Government of Western Australia, Department of Health [G1000794]; CNPq, Brazil; Fapemig, Brazil; FAPEMIG [APq-03539-13]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig) [APq-03539-13]; Hungarian Research Council [ETT 395]; Melbourne Health; Kaohsiung Chang Gung Memorial Hospital, Taiwan [CMRPG8A0581, CMRPG891321]; Victorian Health Promotion Foundation [91-0095]; National Health and Medical Research Council [628582, 299831, 251638, 509103, 1026265, 009367, 1104438]; Alberta Health Services; Health Solutions; Health Foundation Limburg; Adriana van RinsumPonsen Stichting; Irish Cancer Society [CRP08GAL]; Freiburg/Bad Saeckingen Rehabilitation Research Network [01 GD 9802/4]; Stroke Association; Medical Research Council; Catalonia Government [DURSI 2009SGR1119]; Federal Ministry of Education and Research [BMBF 01GY1154]; Hunter Medical Research Institute	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du QuebecSante (FRQ-S); Faculty of Medicine, McGill University; Research Institute of the McGill University Health Centre; FRQ-S researcher salary award; Tier 1 Canada Research Chair(Canada Research Chairs); Vanier Canada Graduate Scholarship; University of Calgary Cumming School of Medicine; Hotchkiss Brain Institute; Alberta Innovates; CIHR(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Canada; Research Manitoba Chair; Bingham Chair in Gastroenterology; Waugh Family Chair in Multiple Sclerosis; Research Council of Lithuania(Research Council of Lithuania (LMTLT)); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Waikato Clinical School, University of Auckland; Waikato Medical Research Foundation; Waikato Respiratory Research Fund; Catalan Agency for Health Technology Assessment and Research; Promoting Psychological Research and Training on HealthDisparities Issues at Ethnic MinorityServing Institutions Grants (ProDIGs) from the American Psychological Association; Research Grant "Ramon CarrilloArturo Ofiativa for Multicentric Studies" (2015) from the commission "Salud Investiga" of the Ministry of Health and Social Action of Argentina; Birmingham and Solihull Mental Health Foundation Trust; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Maastricht University; Multiple Sclerosis Society of Canada; Drummond Foundation; Department of Psychiatry, University Health Network; Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Commission DG Health and Consumer Protection (University of Ferrara); University of Ferrara; Fondazione Cassa di Risparmio di Ferrara(Fondazione Carife); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Federation of German Pension Insurance Institutes; Medical Faculty of the University of Heidelberg; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(National Research Foundation of Korea); Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea; Kathleen Cuningham Foundation (National Breast Cancer Foundation); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bethlehem Griffiths Research Foundation; medical faculty of the University of Heidelberg, Germany; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo Nacional de Desarrolo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Japanese Ministry of Health, Labour, and Welfare through Research on Psychiatric and Neurological Disease and Mental Health; German Cancer Aid within the psychosocial oncology funding priority program; French Society of Dermatology; University Hospital of Saint Etienne; Australian Government National Health and Medical Research Council program grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); Scottish Home and Health Department; Ministry of Health of Spain(Spanish Government); Transport Accident Commission Grant; Instituto de Investigacion Hospital 12 de Octubre (i+12); British Geriatric Society, Scotland; Research Council of Norway(Research Council of Norway); NHS Lothian NeuroOncology Endowment Fund; PRONEX Program (NENASC Project); PPSUS Program of Fundacao de Amparo a esquisa e Inovacao do Estado de Santa Catarina (FAPESC); National Science and Technology Institute for Translational Medicine (INCTTM); Universiti Sains Malaysia(Universiti Sains Malaysia); University of Sydney Cancer Research Fund(University of Sydney); IDEA grants from the Canadian Prostate Cancer Research Initiative; Canadian Breast Cancer Research Alliance; German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); University of Leipzig; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Western and Central Melbourne Integrated Cancer Service; University of Melbourne(University of Melbourne); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chest Heart and Stroke, Scotland; Government of Western Australia, Department of Health; CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapemig, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Hungarian Research Council; Melbourne Health; Kaohsiung Chang Gung Memorial Hospital, Taiwan; Victorian Health Promotion Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alberta Health Services; Health Solutions; Health Foundation Limburg; Adriana van RinsumPonsen Stichting; Irish Cancer Society; Freiburg/Bad Saeckingen Rehabilitation Research Network; Stroke Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Catalonia Government; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Hunter Medical Research Institute	Funding: The study was funded by the Canadian Institutes of Health Research (CIHR, KRS-140045 and PCG155468) .YW and BL were supported by Fonds de recherche du QuebecSante (FRQ-S) Postdoctoral Training Fellowships. DN was supported by GR Caverhill Fellowship from the Faculty of Medicine, McGill University. PMB was supported by a studentship from the Research Institute of the McGill University Health Centre. AB was supported by a FRQ-S researcher salary award. BDT was supported by a Tier 1 Canada Research Chair. DBR was supported by a Vanier Canada Graduate Scholarship. The primary studies by Scott et al, Amoozegar et al, and Prisnie et al were supported by the University of Calgary Cumming School of Medicine, Alberta Health Services, and the Hotchkiss Brain Institute. SBP was supported by a Senior Health Scholar Award from Alberta Innovates, Health Solutions. The primary study by Marrie et al was supported by the CIHR (THC135234) , Crohn's and Colitis Canada, a Research Manitoba Chair, and the Waugh Family Chair in Multiple Sclerosis (to RAM) . The primary study by Bernstein et al was supported by the CIHR (THC-135234) and Crohn's and Colitis Canada. CNB was supported in part by the Bingham Chair in Gastroenterology. RAM was supported by the Waugh Family Chair in Multiple Sclerosis and the Research Manitoba Chair. The primary study by Butnoriene et al was supported by a grant from the Research Council of Lithuania (LIG03/2011) . Jurate Butnoriene, PhD, who did the data collection and analysis as part of her PhD thesis for the primary study by Butnoriene et al, passed away and could not participate in this project. Dr Robertas Bunevicius, MD, PhD (1958-2016) was the principal investigator of the primary studies by Butnoriene et al and Bunevicius et al, but passed away and could not participate in this project. The primary study by Chen et al was supported by the National Science Council, Taiwan (NSC 962314B182A090MY2) . The primary study by Cheung et al was supported by the Waikato Clinical School, University of Auckland, the Waikato Medical Research Foundation and the Waikato Respiratory Research Fund. The primary study by CostaRequena et al was supported by the Catalan Agency for Health Technology Assessment and Research (No 102/19/2004) . The primary study by Cukor et al was supported in part by a Promoting Psychological Research and Training on HealthDisparities Issues at Ethnic MinorityServing Institutions Grants (ProDIGs) awarded to DC from the American Psychological Association. The primary study by De la Torre et al was supported by a Research Grant "Ramon CarrilloArturo Ofiativa for Multicentric Studies" (2015) from the commission "Salud Investiga" of the Ministry of Health and Social Action of Argentina (grant No 1853) . The primary study by De Souza et al was supported by Birmingham and Solihull Mental Health Foundation Trust. The primary study by Dorow et al was supported by the German Federal Ministry of Education and Research (grant/award No 01GY1155A) . The primary study by Douven et al was supported by Maastricht University, Health Foundation Limburg and the Adriana van RinsumPonsen Stichting. The primary study by Honarmand et al was supported by a grant from the Multiple Sclerosis Society of Canada. The primary study by Fischer et al was supported as part of the RECODEHF study by the German Federal Ministry of Education and Research (01GY1150) . The primary study by Gagnon et al was supported by the Drummond Foundation and the Department of Psychiatry, University Health Network.; The primary study by Akechi et al was supported in part by a GrantinAid for Cancer Research (11-2) from the Japanese Ministry of Health, Labour, and Welfare and a GrantinAid for Young Scientists (B) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. The primary study by Kugaya et al was supported in part by a GrantinAid for Cancer Research (9-31) and the SecondTerm Comprehensive 10year Strategy for Cancer Control from the Japanese Ministry of Health, Labour, and Welfare. The primary study Ryan et al was supported by the Irish Cancer Society (grant CRP08GAL) . The primary study by Grassi et al was supported by the European Commission DG Health and Consumer Protection (agreement with the University of FerraraSI2.307317 2000CVGG2026) , the University of Ferrara, and the Fondazione Cassa di Risparmio di Ferrara. The primary study by Harter et al was supported by the Federal Ministry of Education and Research, the Federation of German Pension Insurance Institutes, and the Freiburg/Bad Saeckingen Rehabilitation Research Network (grant 01 GD 9802/4) . The primary study by Keller et al was supported by the Medical Faculty of the University of Heidelberg (grant No 175/2000) . The primary study by Kang et al was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (20090087344) , and was supported by a grant of the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea (A102065) . The primary study by Jang et al was supported by a grant from the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea. The primary study by Love et al (2004) was supported by the Kathleen Cuningham Foundation (National Breast Cancer Foundation) , the Cancer Council of Victoria and the National Health and Medical Research Council. The primary study by Love et al (2002) was supported by a grant from the Bethlehem Griffiths Research Foundation. The primary study by Lowe et al was supported by the medical faculty of the University of Heidelberg, Germany (project 121/2000) . The primary study by Navines et al was supported in part by grants from the Instituto de Salud Carlos III (EO PI08/90869) and (PSIGEN-VHC Study: FISE08/00268) . The primary study by Massardo et al was supported by Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) grant No PFB12/2007 and Fondo Nacional de Desarrolo Cientifico y Tecnologico (FONDECYT; grant No 1110849) . The primary study by Matsuoka et al was supported by the Japanese Ministry of Health, Labour, and Welfare through Research on Psychiatric and Neurological Disease and Mental Health (16190501, 19230701, and 20300701) . The primary study by Hartung et al was supported by the German Cancer Aid within the psychosocial oncology funding priority program (grant No 107465) . The primary study by Consoli et al was supported by grants from the French Society of Dermatology and the University Hospital of Saint Etienne. The primary study by McFarlane et al was supported by an Australian Government National Health and Medical Research Council program grant. MLO was supported by grants from NHMRC Program (1073041) during the conduct of the study. The primary study by O'Rourke et al was supported by the Scottish Home and Health Department, Stroke Association, and Medical Research Council. The primary study by SanchezGistau et al was supported by a grant from the Ministry of Health of Spain (PI040418) and in part by the Catalonia Government, DURSI 2009SGR1119.; The primary study by Gould et al was supported by the Transport Accident Commission Grant. The primary study by BayonPerez et al was supported by a grant from the Instituto de Investigacion Hospital 12 de Octubre (i+12) . FP was an investigator from the Intensification of Research Activity Program of the Instituto de Investigacion Hospital 12 de Octubre (i+12) during the conduct of the study. The primary study by Lees et al was supported by a "startup" research grant from the British Geriatric Society, Scotland. The primary study by Reme et al was supported by the Research Council of Norway. The primary study by Rooney et al was supported by the NHS Lothian NeuroOncology Endowment Fund. The primary study by Schwarzbold et al was supported by PRONEX Program (NENASC Project) and PPSUS Program of Fundacao de Amparo a esquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCTTM) . The primary study by Azah et al was supported by Universiti Sains Malaysia. The primary studies bysupported by Malaysia. primary by Patel et al (2010 and 2011) were supported by the University of Sydney Cancer Research Fund. The primary study by Simard et al was supported by IDEA grants from the Canadian Prostate Cancer Research Initiative and the Canadian Breast Cancer Research Alliance, as well as a studentship from the CIHR. The primary study by Singer et al (2009) was supported by a grant from the German Federal Ministry for Education and Research (No 01ZZ0106) . The primary study by Singer et al (2008) was supported by grants from the German Federal Ministry for Education and Research (No 7DZAIQTX) and of the University of Leipzig (No formel. 1-57). The primary study by Meyer et al was supported by the Federal Ministry of Education and Research (BMBF). The primary study by Stafford et al (2014) was supported in part by seed funding from the Western and Central Melbourne Integrated Cancer Service. The primary study by Stafford et al (2007) was supported by the University of Melbourne. The primary study by Stone et al was supported by the Medical Research Council, UK and Chest Heart and Stroke, Scotland. The primary study by Phan et al was supported by the Government of Western Australia, Department of Health (grant No G1000794). The primary study by de Oliveira et al was supported by CNPq and Fapemig, Brazil. The primary study by Pedroso et al (2018) was supported by FAPEMIG (APq-03539-13). The primary study by Pedroso et al (2016) was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig) (APq-03539-13). The primary study by Tiringer et al was supported by the Hungarian Research Council (ETT 395). The primary study by Tschorn et al is part of the study "CDCare-Supply of patients with coronary artery disease and comorbid depression: a patient oriented needs analysis." CDCare was funded by the Federal Ministry of Education and Research (BMBF; 01GY1154). The primary study by Turner et al was supported by a bequest from Jennie Thomas through Hunter Medical Research Institute. The primary study by Walterfang et al was supported by Melbourne Health. The primary study by Lee et al (2017) was supported by a grant from the Kaohsiung Chang Gung Memorial Hospital, Taiwan (CMRPG8A0581). The primary study by Lee et al (2016) was supported by a grant from Kaohsiung Chang Gung Memorial Hospital, Taiwan (CMRPG891321).; The primary study by Sia et al (PIs: Pasco and Williams) was supported by the Victorian Health Promotion Foundation (ID 91-0095) and the National Health and Medical Research Council (ID 628582; 299831; 251638; 509103; 1026265; 009367; 1104438). No other authors reported funding for primary studies or for their work on this study. No funder had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; [Anonymous], 2013, DIAGNOSTIC STAT MANU, V5; [Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; [Anonymous], 1987, DIAGNOSTIC STAT MANU; [Anonymous], 1994, DIAGNOSTIC STAT MANU; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Brugha TS, 1999, PSYCHOL MED, V29, P1013, DOI 10.1017/S0033291799008880; Brugha TS, 2001, PSYCHOL MED, V31, P1001, DOI 10.1017/S0033291701004184; Clarke DM, 1998, PSYCHOSOMATICS, V39, P318, DOI 10.1016/S0033-3182(98)71320-9; Dickens C, 2001, RHEUMATOLOGY, V40, P1327, DOI 10.1093/rheumatology/40.12.1327; Duhoux A, 2013, J AFFECT DISORDERS, V151, P265, DOI 10.1016/j.jad.2013.05.097; Duhoux A, 2009, SOC PSYCH PSYCH EPID, V44, P385, DOI 10.1007/s00127-008-0444-8; Endicott J, 1987, Acta Psychiatr Belg, V87, P361; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Fann JR, 2008, GEN HOSP PSYCHIAT, V30, P112, DOI 10.1016/j.genhosppsych.2007.10.008; First M.B., 2016, STRUCTURED CLIN INTE; Gilbody S, 2006, BMJ-BRIT MED J, V332, P1027, DOI 10.1136/bmj.332.7548.1027; Harter M, 2010, DTSCH ARZTEBL INT, V107, P700, DOI 10.3238/arztebl.2010.0700; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Joffres M, 2013, CAN MED ASSOC J, V185, P775, DOI 10.1503/cmaj.130403; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Levis B, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4022; Levis B, 2019, INT J METH PSYCH RES, V28, DOI 10.1002/mpr.1803; Levis B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1476; Levis B, 2018, BRIT J PSYCHIAT, V212, P377, DOI 10.1192/bjp.2018.54; Levis B, 2017, AM J EPIDEMIOL, V185, P954, DOI 10.1093/aje/kww191; Macaskill P, 2010, COCHRANE HDB SYSTEMA, V1st; Meader N, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613151; Mitchell AJ, 2010, J AFFECT DISORDERS, V126, P335, DOI 10.1016/j.jad.2010.01.067; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mojtabai R, 2013, PSYCHOTHER PSYCHOSOM, V82, P161, DOI 10.1159/000345968; Mojtabai R, 2011, HEALTH AFFAIR, V30, P1434, DOI 10.1377/hlthaff.2010.1024; National Institute for Clinical Excellence, 2004, IMPROVING SUPPORTIVE; National Institute for Clinical Excellence, 2010, DEPRESSION ADULTS CH; National Institute for Health and Care Excellence, 2011, DEPRESSION ADULTS QU; Nosen E, 2008, HDB RES METHODS ABNO, P109; Palmer SC, 2003, J PSYCHOSOM RES, V54, P279, DOI 10.1016/S0022-3999(02)00640-2; PRESS-Peer Review of Electronic Search Strategies, 2016, 2015 GUIDELINE EXPLA; R Core Team, 2018, R LANG ENV STAT COMP; Rice DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150067; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Riley RD, 2008, STAT MED, V27, P6111, DOI 10.1002/sim.3441; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; RStudio Team, 2020, RSTUDIO INTEGRATED D; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Salameh JP, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2632; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Thombs BD, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011913; Thombs BD, 2016, INT J METH PSYCH RES, V25, P145, DOI 10.1002/mpr.1504; Thombs BD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1253; Thombs BD, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-13; Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035; Thombs BD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4825; Vodermaier A, 2011, SUPPORT CARE CANCER, V19, P1899, DOI 10.1007/s00520-011-1251-4; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; World Health Organization, 1994, SCHEDULES CLIN ASSES; Wu Y, 2020, PSYCHOTHER PSYCHOSOM, V90, P28, DOI 10.1159/000509283; Wu Y, 2020, J PSYCHOSOM RES, V129, DOI 10.1016/j.jpsychores.2019.109892; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	65	31	31	3	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2021	373								n972	10.1136/bmj.n972	http://dx.doi.org/10.1136/bmj.n972			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SB0RA	33972268	Green Published, hybrid			2022-12-28	WOS:000649709400002
J	Devi, S				Devi, Sharmila			COVID-19 surge threatens health in the Gaza strip	LANCET			English	Editorial Material																			0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1698	1698						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33965076	Green Published, Bronze			2022-12-28	WOS:000647813600010
J	Witmer, LM				Witmer, Lawrence M.			Making sense of dinosaurs and birds	SCIENCE			English	Editorial Material									[Witmer, Lawrence M.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA	University System of Ohio; Ohio University	Witmer, LM (corresponding author), Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA.	witmerl@ohio.edu						Cau A, 2018, B SOC PALEONTOL ITAL, V57, P1, DOI 10.4435/BSPI.2018.01; Choiniere JN, 2021, SCIENCE, V372, P610, DOI 10.1126/science.abe7941; Davies TG, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0194; Hanson M, 2021, SCIENCE, V372, P601, DOI 10.1126/science.abb4305; Neenan JM, 2017, CURR BIOL, V27, P3852, DOI 10.1016/j.cub.2017.10.069; R Core Team, 2018, R LANG ENV STAT COMP; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Senter P, 2005, PALEOBIOLOGY, V31, P373, DOI 10.1666/0094-8373(2005)031[0373:FITSFO]2.0.CO;2; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6	11	0	0	3	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					575	576		10.1126/science.abi5697	http://dx.doi.org/10.1126/science.abi5697			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA2AW	33958465				2022-12-28	WOS:000649103500027
J	Tsukui, T; Iguchi, S				Tsukui, Takafumi; Iguchi, Satoru			Spiral morphology in an intensely star-forming disk galaxy more than 12 billion years ago	SCIENCE			English	Article							SUPERMASSIVE BLACK-HOLE; MOLECULAR GAS; ROTATION CURVES; WISDOM PROJECT; LINE EMISSION; ANGULAR-MOMENTUM; DARK-MATTER; MASS; BULGE; KINEMATICS	Spiral galaxies have distinct internal structures, including a stellar bulge, a disk, and spiral arms. It is unknown when in cosmic history these structures formed. In this study, we analyzed observations of BRI 1335-0417, an intensely star-forming galaxy in the distant Universe, at a redshift of 4.41. The [C II] gas kinematics shows a steep velocity rise near the galaxy center and has a two-armed spiral morphology, which extends from about 2 to 5 kiloparsecs in radius. We interpret these features as due to a central compact structure such as a bulge, a rotating gas disk, and either spiral arms or tidal tails. These features had formed within 1.4 billion years after the Big Bang, long before the peak of cosmic star formation.	[Tsukui, Takafumi; Iguchi, Satoru] SOKENDAI Grad Univ Adv Studies, Dept Astron Sci, 2-21-1 Osawa, Mitaka, Tokyo, Japan; [Tsukui, Takafumi; Iguchi, Satoru] Natl Inst Nat Sci, Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Tsukui, T (corresponding author), SOKENDAI Grad Univ Adv Studies, Dept Astron Sci, 2-21-1 Osawa, Mitaka, Tokyo, Japan.; Tsukui, T (corresponding author), Natl Inst Nat Sci, Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo, Japan.	t.tsukui@grad.nao.ac.jp		Tsukui, Takafumi/0000-0002-1499-6377; Iguchi, Satoru/0000-0002-7191-2301	Department of Astronomical Science, the Graduate University for Advanced Studies, SOKENDAI	Department of Astronomical Science, the Graduate University for Advanced Studies, SOKENDAI	T.T was partially supported by Overseas Travel Fund for Students (2019) of the Department of Astronomical Science, the Graduate University for Advanced Studies, SOKENDAI.	Baba J, 2015, MON NOT R ASTRON SOC, V454, P2954, DOI 10.1093/mnras/stv2220; Bennett CL, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/135; Binney J., 2008, GALACTIC DYNAMICS; Briggs D. S., 1995, BAAS, V27, P1444; Bruce VA, 2014, MON NOT R ASTRON SOC, V444, P1001, DOI 10.1093/mnras/stu1478; Burkert A, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/2/214; Burkert A, 2010, ASTROPHYS J, V725, P2324, DOI 10.1088/0004-637X/725/2/2324; Cappellari M, 2017, MON NOT R ASTRON SOC, V466, P798, DOI 10.1093/mnras/stw3020; Carilli CL, 2002, ASTRON J, V123, P1838, DOI 10.1086/339306; Dame T. M., 2011, ARXIV11011499ASTROPH; Davis TA, 2017, MON NOT R ASTRON SOC, V468, P4675, DOI 10.1093/mnras/stw3217; Davis TA, 2013, NATURE, V494, P328, DOI 10.1038/nature11819; Dawson S, 2003, ASTRON J, V125, P1236, DOI 10.1086/367792; de Vaucouleurs G., 1948, ANN DAP, V11, P247; Dekel A, 2014, MON NOT R ASTRON SOC, V438, P1870, DOI 10.1093/mnras/stt2331; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Dobbs C, 2014, PUBL ASTRON SOC AUST, V31, DOI 10.1017/pasa.2014.31; Driver SP, 2006, MON NOT R ASTRON SOC, V368, P414, DOI 10.1111/j.1365-2966.2006.10126.x; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; FREEMAN KC, 1970, ASTROPHYS J, V160, P811, DOI 10.1086/150474; Gadotti DA, 2009, MON NOT R ASTRON SOC, V393, P1531, DOI 10.1111/j.1365-2966.2008.14257.x; Genzel R, 2017, NATURE, V543, P397, DOI 10.1038/nature21685; Genzel R, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/75; Graham AW, 2005, PUBL ASTRON SOC AUST, V22, P118, DOI 10.1071/AS05001; Green AW, 2010, NATURE, V467, P684, DOI 10.1038/nature09452; Guilloteau S, 1997, ASTRON ASTROPHYS, V328, pL1; Gullberg B, 2018, ASTROPHYS J, V859, DOI 10.3847/1538-4357/aabe8c; Hodge JA, 2019, ASTROPHYS J, V876, DOI 10.3847/1538-4357/ab1846; Iguchi S, 2005, PUBL ASTRON SOC JPN, V57, P643, DOI 10.1093/pasj/57.4.643; Jones GC, 2017, ASTROPHYS J, V850, DOI 10.3847/1538-4357/aa8df2; Jones GC, 2016, ASTROPHYS J, V830, DOI 10.3847/0004-637X/830/2/63; KATZ N, 1991, ASTROPHYS J, V377, P365, DOI 10.1086/170367; KENT SM, 1986, ASTRON J, V91, P1301, DOI 10.1086/114106; Kohandel M, 2019, MON NOT R ASTRON SOC, V487, P3007, DOI 10.1093/mnras/stz1486; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Krajnovic D, 2006, MON NOT R ASTRON SOC, V366, P787, DOI 10.1111/j.1365-2966.2005.09902.x; Lang P, 2017, ASTROPHYS J, V840, DOI 10.3847/1538-4357/aa6d82; Lang P, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/11; Lange R, 2016, MON NOT R ASTRON SOC, V462, P1470, DOI 10.1093/mnras/stw1495; Law DR, 2012, NATURE, V487, P338, DOI 10.1038/nature11256; Lelli F, 2021, SCIENCE, V371, P713, DOI 10.1126/science.abc1893; Lu NY, 2018, ASTROPHYS J, V864, DOI 10.3847/1538-4357/aad3c9; Lynden-Bell D, 1965, MNRAS, V130, P97, DOI DOI 10.1093/MNRAS/130.2.97; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; McMullin JP, 2007, ASTR SOC P, V376, P127; Mejia-Restrepo JE, 2018, NAT ASTRON, V2, P63, DOI 10.1038/s41550-017-0305-z; Mitzkus M, 2017, MON NOT R ASTRON SOC, V464, P4789, DOI 10.1093/mnras/stw2677; Neeleman M, 2020, NATURE, V581, P269, DOI 10.1038/s41586-020-2276-y; Noordermeer E, 2008, MON NOT R ASTRON SOC, V385, P1359, DOI 10.1111/j.1365-2966.2008.12837.x; North EV, 2019, MON NOT R ASTRON SOC, V490, P319, DOI 10.1093/mnras/stz2598; Peng CY, 2010, ASTRON J, V139, P2097, DOI 10.1088/0004-6256/139/6/2097; Pineda JL, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321188; PUERARI I, 1992, ASTRON ASTROPHYS SUP, V93, P469; Remijan A., 2020, ALMA TECHNICALHANDBO; Ren J., 2020, MON NOT R ASTRON SOC, V499, P3399; Riechers DA, 2008, ASTROPHYS J LETT, V686, pL9, DOI 10.1086/592834; Rizzo F, 2020, NATURE, V584, P201, DOI 10.1038/s41586-020-2572-6; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Schulze A, 2014, MON NOT R ASTRON SOC, V438, P3422, DOI 10.1093/mnras/stt2457; Shields GA, 2006, ASTROPHYS J, V641, P683, DOI 10.1086/500542; Smith MD, 2019, MON NOT R ASTRON SOC, V485, P4359, DOI 10.1093/mnras/stz625; Sofue Y, 2003, PUBL ASTRON SOC JPN, V55, P59, DOI 10.1093/pasj/55.1.59; Sofue Y, 2009, PUBL ASTRON SOC JPN, V61, P227, DOI 10.1093/pasj/61.2.227; Spilker JS, 2020, ASTROPHYS J, V905, DOI 10.3847/1538-4357/abc47f; Tacchella S, 2015, SCIENCE, V348, P314, DOI 10.1126/science.1261094; Tadaki K, 2018, NATURE, V560, P613, DOI 10.1038/s41586-018-0443-1; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; van den Bosch RCE, 2009, MON NOT R ASTRON SOC, V398, P1117, DOI 10.1111/j.1365-2966.2009.15177.x; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; Wagg J, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/71; Wagg J, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/201015424; Wisnioski E, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/209; Wuyts S, 2016, ASTROPHYS J, V831, DOI 10.3847/0004-637X/831/2/149; Yuan TT, 2017, ASTROPHYS J, V850, DOI 10.3847/1538-4357/aa951d; Zanella A, 2018, MON NOT R ASTRON SOC, V481, P1976, DOI 10.1093/mnras/sty2394	75	7	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2021	372	6547					1201	+		10.1126/science.abe9680	http://dx.doi.org/10.1126/science.abe9680			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SS9QN	34016739	Bronze, Green Submitted			2022-12-28	WOS:000662088000027
J	Asarnow, D; Wang, B; Lee, WH; Hu, YY; Huang, CW; Faust, B; Ng, PML; Ngoh, EZX; Bohn, M; Bulkley, D; Pizzorno, A; Ary, B; Tan, HC; Lee, CY; Minhat, RA; Terrier, O; Soh, MK; Teo, FJ; Yeap, YYC; Seah, SGK; Chan, CEZ; Connelly, E; Young, NJ; Maurer-Stroh, S; Renia, L; Hanson, BJ; Rosa-Calatrava, M; Manglik, A; Cheng, YF; Craik, CS; Wang, CI				Asarnow, Daniel; Wang, Bei; Lee, Wen-Hsin; Hu, Yuanyu; Huang, Ching-Wen; Faust, Bryan; Ng, Patricia Miang Lon; Ngoh, Eve Zi Xian; Bohn, Markus; Bulkley, David; Pizzorno, Andres; Ary, Beatrice; Tan, Hwee Ching; Lee, Chia Yin; Minhat, Rabiatul Adawiyah; Terrier, Olivier; Soh, Mun Kuen; Teo, Frannie Jiuyi; Yeap, Yvonne Yee Chin; Seah, Shirley Gek Kheng; Chan, Conrad En Zuo; Connelly, Emily; Young, Nicholas J.; Maurer-Stroh, Sebastian; Renia, Laurent; Hanson, Brendon John; Rosa-Calatrava, Manuel; Manglik, Aashish; Cheng, Yifan; Craik, Charles S.; Wang, Cheng-, I			Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia	CELL			English	Article							CRYO-EM; VISUALIZATION; CORONAVIRUS; DENSITY; MODEL	Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is initiated by binding of the viral Spike protein to host receptor angiotensin-converting enzyme 2 (ACE2), followed by fusion of viral and host membranes. Although antibodies that block this interaction are in emergency use as early coronavirus disease 2019 (COVID-19) therapies, the precise determinants of neutralization potency remain unknown. We discovered a series of antibodies that potently block ACE2 binding but exhibit divergent neutralization efficacy against the live virus. Strikingly, these neutralizing antibodies can inhibit or enhance Spike-mediated membrane fusion and formation of syncytia, which are associated with chronic tissue damage in individuals with COVID-19. As revealed by cryoelectron microscopy, multiple structures of Spike-antibody complexes have distinct binding modes that not only block ACE2 binding but also alter the Spike protein conformational cycle triggered by ACE2 binding. We show that stabilization of different Spike conformations leads to modulation of Spike-mediated membrane fusion with profound implications for COVID-19 pathology and immunity.	[Asarnow, Daniel; Faust, Bryan; Bulkley, David; Cheng, Yifan] Univ Calif San Francisco UCSF, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Wang, Bei; Lee, Wen-Hsin; Hu, Yuanyu; Huang, Ching-Wen; Ng, Patricia Miang Lon; Ngoh, Eve Zi Xian; Tan, Hwee Ching; Lee, Chia Yin; Minhat, Rabiatul Adawiyah; Soh, Mun Kuen; Teo, Frannie Jiuyi; Yeap, Yvonne Yee Chin; Renia, Laurent; Wang, Cheng-, I] ASTAR, Singapore Immunol Network, Immunos, 8A Biomed Grove, Singapore 138648, Singapore; [Asarnow, Daniel; Faust, Bryan; Bohn, Markus; Bulkley, David; Ary, Beatrice; Manglik, Aashish; Cheng, Yifan; Craik, Charles S.] QBI COVID 19 Res Grp QCRG, San Francisco, CA 94143 USA; [Bohn, Markus; Ary, Beatrice; Connelly, Emily; Young, Nicholas J.; Manglik, Aashish; Craik, Charles S.] Univ Calif San Francisco UCSF, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Pizzorno, Andres; Terrier, Olivier; Rosa-Calatrava, Manuel] Univ Claude Bernard Lyon 1, Univ Lyon, CIRI, Team VirPath,INSERM U1111,CNRS,UMR5308,ENS Lyon, F-69007 Lyon, France; [Seah, Shirley Gek Kheng; Chan, Conrad En Zuo; Hanson, Brendon John] DSO Natl Labs, Biol Def Program, 27 Med Dr, Singapore 117510, Singapore; [Maurer-Stroh, Sebastian] ASTAR, Bioinformat Inst, Matrix, 30 Biopolis St, Singapore 138671, Singapore; [Maurer-Stroh, Sebastian; Renia, Laurent] ASTAR, Infect Dis Labs ID Labs, Immunos, 8A Biomed Grove, Singapore 138648, Singapore; [Maurer-Stroh, Sebastian] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117558, Singapore; [Rosa-Calatrava, Manuel] Univ Claude Bernard Lyon 1, Univ Lyon, Fac Med RTH Laennec, VirNext, Lyon, France; [Manglik, Aashish] UCSF, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Cheng, Yifan] UCSF, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); A*STAR Infectious Disease Labs (ID Labs); National University of Singapore; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Cheng, YF (corresponding author), Univ Calif San Francisco UCSF, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Wang, CI (corresponding author), ASTAR, Singapore Immunol Network, Immunos, 8A Biomed Grove, Singapore 138648, Singapore.; Manglik, A; Cheng, YF; Craik, CS (corresponding author), QBI COVID 19 Res Grp QCRG, San Francisco, CA 94143 USA.; Manglik, A; Craik, CS (corresponding author), Univ Calif San Francisco UCSF, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.; Manglik, A (corresponding author), UCSF, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.; Cheng, YF (corresponding author), UCSF, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	aashish.manglik@ucsf.edu; ycheng@ucsf.edu; charles.craik@ucsf.edu; wang_chengi@immunol.a-star.edu.sg	Wang, Bei/GYR-3359-2022; Renia, Laurent/E-2117-2011; Terrier, Olivier/B-6301-2009; Maurer-Stroh, Sebastian/Q-9476-2019	Wang, Bei/0000-0002-3112-7341; Renia, Laurent/0000-0003-0349-1557; Terrier, Olivier/0000-0001-9393-7684; Maurer-Stroh, Sebastian/0000-0003-0813-9640; Faust, Bryan/0000-0002-4126-6409; Asarnow, Daniel/0000-0001-7870-5308; Rosa-calatrava, Manuel/0000-0002-7559-9527; Cheng, Yifan/0000-0001-9535-0369; Hu, Yuanyu/0000-0001-5457-4331; Bohn, Markus-Frederik/0000-0002-0369-1922; Connelly, Emily J/0000-0003-0732-1627	Biomedical Research Council (BMRC); A* CCLERATE GAP fund from the Agency of Science, Technology and Research (A* STAR, Singapore) [ACCL/19-GAP064-R20H-I]; NMRC [COVID19RF-004]; National Institutes of Health [P50AI150476, S10 S10OD020054, S10OD021741]; UCSF COVID-19 Response Fund; Allen Company; Sandler Foundation; Emergent Ventures at the Mercatus Center, George Mason University; INSERM REACTing (Research & Action Emerging Infectious Diseases); CNRS; Institut Merieux	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); A* CCLERATE GAP fund from the Agency of Science, Technology and Research (A* STAR, Singapore)(Agency for Science Technology & Research (A*STAR)); NMRC(National Medical Research Council, Singapore); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF COVID-19 Response Fund; Allen Company; Sandler Foundation; Emergent Ventures at the Mercatus Center, George Mason University; INSERM REACTing (Research & Action Emerging Infectious Diseases); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Merieux	We thank Prof. Yee-Joo Tan (Department of Microbiology, NUS; Institute of Molecular and Cell Biology, A*STAR) who kindly provided CHO-ACE2 cells. We also thank Wong Pui San and Chye De Ho in the BSL 3 facility (DSO National Laboratories) as well as Dr. Pei Yin Lim and Siti Nazihah Mohd Salleh (Singapore Immunology Network) for technical assistance. We thank Prof. Jason McLellan (University of Texas at Austin) for the prefusion S ectodomain and Prof. Joseph DeRisi, Prof. Robert Fletterick (UCSF), and Dr. John Pak (CZI Biohub, San Francisco) for helpful discussions. This work was supported by core research grants provided to the Singapore Immunology Network by the Biomedical Research Council (BMRC) and the A* CCLERATE GAP fund (ACCL/19-GAP064-R20H-I) from the Agency of Science, Technology and Research (A* STAR, Singapore) (to C.-I.W.). S.M.-S. was supported by NMRC grant COVID19RF-004. Support was also provided by National Institutes of Health grants P50AI150476 (to C.S.C. and Y.C.), S10 S10OD020054 (to Y.C.), and S10OD021741 (to Y.C.). This work was supported by the UCSF COVID-19 Response Fund, a grant from Allen & Company, and supporters of the UCSF Program for Breakthrough Biomedical Research (PBBR), which was established with support from the Sandler Foundation (to C.S.C., Y.C., and A.M.). Additional support was provided by a fast grant from Emergent Ventures at the Mercatus Center, George Mason University (to C.S.C.). Y.C. is an Investigator of the Howard Hughes Medical Institute. Additional support was provided by INSERM REACTing (Research & Action Emerging Infectious Diseases), CNRS, and Institut Me ' rieux (Me ' rieux research grant) (to A.P., O.T., and M.R.-C.).	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Benton DJ, 2020, NATURE, V588, DOI 10.1038/s41586-020-2772-0; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Burton DR, 2001, CURR TOP MICROBIOL, V260, P109; Bussani R, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103104; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020; FLAMAND A, 1993, VIROLOGY, V194, P302, DOI 10.1006/viro.1993.1261; Frenzel A, 2017, TRANSFUS MED HEMOTH, V44, P312, DOI 10.1159/000479633; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goh AXH, 2014, MABS-AUSTIN, V6, P764, DOI 10.4161/mabs.28614; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang K, 2010, J VIROL, V84, P8132, DOI 10.1128/JVI.02699-09; Huo JD, 2020, CELL HOST MICROBE, V28, P445, DOI [10.1016/j.chom.2020.06.010, 10.1016/j.chom.2020.07.002]; Jay S., 2021, NATURE PORTFOLIO, DOI [10.21203/rs.3.rs-95587/v1, DOI 10.21203/RS.3.RS-95587/V1]; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Lescure FX., 2020, LANCET INFECT DIS, V20, P697; Liu Hejun, 2020, bioRxiv, DOI [10.1016/j.immuni.2020.10.023, 10.1101/2020.08.02.233536]; Lou Y., 2020, CROSS NEUTRALIZATION, DOI [10.1101/2020.06.06.137513, DOI 10.1101/2020.06.06.137513]; Lu RM, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-019-0592-z; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McNamara PS, 2002, BRIT MED BULL, V61, P13, DOI 10.1093/bmb/61.1.13; Musarrat F, 2020, J MED VIROL, V92, P2087, DOI 10.1002/jmv.25985; Ng OW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102415; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Pizzorno A, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100059; Punjani A, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107702; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Saphire EO, 2018, CELL, V174, P938, DOI 10.1016/j.cell.2018.07.033; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Sylwester A, 1997, J IMMUNOL, V158, P3996; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; Vaughan TJ, 1998, NAT BIOTECHNOL, V16, P535, DOI 10.1038/nbt0698-535; Vauquelin G, 2013, BRIT J PHARMACOL, V168, P1771, DOI 10.1111/bph.12106; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Wan JK, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107918; Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wrapp D, 2020, CELL, V181, P1004, DOI 10.1016/j.cell.2020.04.031; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Yurkovetskiy Leonid, 2020, bioRxiv, DOI [10.1016/j.cell.2020.09.032, 10.1101/2020.07.04.187757]; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou GY, 2020, INT J BIOL SCI, V16, P1718, DOI 10.7150/ijbs.45123; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	65	35	35	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3192	+		10.1016/j.cell.2021.04.033	http://dx.doi.org/10.1016/j.cell.2021.04.033		JUN 2021	29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	33974910	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000660014300011
J	Liu, YZ; Mattar, MG; Behrens, TEJ; Daw, ND; Dolan, RJ				Liu, Yunzhe; Mattar, Marcelo G.; Behrens, Timothy E. J.; Daw, Nathaniel D.; Dolan, Raymond J.			Experience replay is associated with efficient nonlocal learning	SCIENCE			English	Article							HIPPOCAMPAL PLACE CELLS; THETA OSCILLATIONS; REVERSE REPLAY; SEQUENCES; PREDICTION; SUBSTRATE; CHOICES; FUTURE; STATE	To make effective decisions, people need to consider the relationship between actions and outcomes. These are often separated by time and space. The neural mechanisms by which disjoint actions and outcomes are linked remain unknown. One promising hypothesis involves neural replay of nonlocal experience. Using a task that segregates direct from indirect value learning, combined with magnetoencephalography, we examined the role of neural replay in human nonlocal learning. After receipt of a reward, we found significant backward replay of nonlocal experience, with a 160-millisecond state-to-state time lag, which was linked to efficient learning of action values. Backward replay and behavioral evidence of nonlocal learning were more pronounced for experiences of greater benefit for future behavior. These findings support nonlocal replay as a neural mechanism for solving complex credit assignment problems during learning.	[Liu, Yunzhe; Dolan, Raymond J.] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, IDG McGovem Inst Brain Res, Beijing, Peoples R China; [Liu, Yunzhe] Chinese Inst Brain Res, Beijing, Peoples R China; [Liu, Yunzhe; Dolan, Raymond J.] UCL, London Ctr Computat Psychiat & Ageing Res, Max Planck Univ Coll, London, England; [Liu, Yunzhe; Behrens, Timothy E. J.; Dolan, Raymond J.] UCL, Wellcome Ctr Human Neuroimaging, London, England; [Mattar, Marcelo G.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA; [Behrens, Timothy E. J.] Univ Oxford, Wellcome Ctr Integrat Neuroimaging, Oxford, England; [Daw, Nathaniel D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Daw, Nathaniel D.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Dolan, Raymond J.] Univ Med Berlin, Dept Psychiat, Campus Charite Mitte, Berlin, Germany	Beijing Normal University; University of London; University College London; University of London; University College London; University of California System; University of California San Diego; University of Oxford; Princeton University; Princeton University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Liu, YZ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, IDG McGovem Inst Brain Res, Beijing, Peoples R China.; Liu, YZ (corresponding author), Chinese Inst Brain Res, Beijing, Peoples R China.; Liu, YZ (corresponding author), UCL, London Ctr Computat Psychiat & Ageing Res, Max Planck Univ Coll, London, England.; Liu, YZ (corresponding author), UCL, Wellcome Ctr Human Neuroimaging, London, England.	yunzhe.liu@bnu.edu.cn		Mattar, Marcelo G/0000-0003-3303-2490; Liu, Yunzhe/0000-0003-0836-9403; Daw, Nathaniel/0000-0001-5029-1430; Behrens, Timothy/0000-0003-0048-1177; Dolan, Ray/0000-0001-9356-761X	Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; Wellcome Trust Investigator Award [098362/Z/12/Z]; Lundbeck Visiting Professorship [R290-20182804]; Wellcome Trust Senior Research Fellowship [104765/Z/14/Z]; Principal Research Fellowship [219525/Z/19/Z]; James S. McDonnell Foundation [JSMF220020372]; NSF, part of the CRCNS program [IIS-1822571]; Newton International Fellowship of the Royal Society [181426]	Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; Wellcome Trust Investigator Award(Wellcome Trust); Lundbeck Visiting Professorship; Wellcome Trust Senior Research Fellowship(Wellcome Trust); Principal Research Fellowship; James S. McDonnell Foundation; NSF, part of the CRCNS program; Newton International Fellowship of the Royal Society	Supported by the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (Y.L.); a Wellcome Trust Investigator Award (098362/Z/12/Z) (R.J.D.); a Lundbeck Visiting Professorship (R290-20182804) to the Danish Research Centre for Magnetic Resonance (R.J.D.); a Wellcome Trust Senior Research Fellowship (104765/Z/14/Z) and a Principal Research Fellowship (219525/Z/19/Z), together with a James S. McDonnell Foundation Award (JSMF220020372) (T.E.J.B.); NSF grant IIS-1822571, part of the CRCNS program (N.D.D. and M.G.M.); and a Newton International Fellowship of the Royal Society (grant 181426) (M.G.M.).	Agarwal G, 2014, SCIENCE, V344, P626, DOI 10.1126/science.1250444; Ambrose RE, 2016, NEURON, V91, P1124, DOI 10.1016/j.neuron.2016.07.047; Barron HC, 2020, CELL, V183, P228, DOI 10.1016/j.cell.2020.08.035; Bush D, 2020, HIPPOCAMPUS, V30, P745, DOI 10.1002/hipo.23199; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; de Lavilleon G, 2015, NAT NEUROSCI, V18, P493, DOI 10.1038/nn.3970; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Doll BB, 2015, NAT NEUROSCI, V18, P767, DOI 10.1038/nn.3981; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Eliav T, 2018, CELL, V175, P1119, DOI 10.1016/j.cell.2018.09.017; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gomperts SN, 2015, ELIFE, V4, DOI 10.7554/eLife.05360; Gridchyn I, 2020, NEURON, V106, P291, DOI 10.1016/j.neuron.2020.01.021; Hauser TU, 2017, P NATL ACAD SCI USA, V114, pE7395, DOI 10.1073/pnas.1705643114; Herweg NA, 2020, TRENDS COGN SCI, V24, P208, DOI 10.1016/j.tics.2019.12.006; Igata H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2011266118; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Kay K, 2020, CELL, V180, P552, DOI 10.1016/j.cell.2020.01.014; Kurth-Nelson Z, 2016, NEURON, V91, P194, DOI 10.1016/j.neuron.2016.05.028; Kurth-Nelson Z, 2015, ELIFE, V4, DOI 10.7554/eLife.04919; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; Liu Y., 2020, 066407 BIORXIV; Liu YZ, 2019, CELL, V178, P640, DOI 10.1016/j.cell.2019.06.012; Mattar MG, 2018, NAT NEUROSCI, V21, P1609, DOI 10.1038/s41593-018-0232-z; Mattout J, 2006, NEUROIMAGE, V30, P753, DOI 10.1016/j.neuroimage.2005.10.037; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Momennejad I, 2018, ELIFE, V7, DOI 10.7554/eLife.32548; MOORE AW, 1993, MACH LEARN, V13, P103, DOI 10.1023/A:1022635613229; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Olafsdottir HF, 2015, ELIFE, V4, DOI 10.7554/eLife.06063; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Russek EM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005768; Schuck NW, 2019, SCIENCE, V364, P1254, DOI 10.1126/science.aaw5181; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Singer AC, 2013, NEURON, V77, P1163, DOI 10.1016/j.neuron.2013.01.027; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Sutton R.S., 1991, SIGART B, V2, P160, DOI [10.1145/122344.122377, DOI 10.1145/122344.122377]; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Vidaurre D, 2019, CEREB CORTEX, V29, P863, DOI 10.1093/cercor/bhy290; Vikbladh OM, 2019, NEURON, V102, P683, DOI 10.1016/j.neuron.2019.02.014; Wang MN, 2020, SCIENCE, V370, P247, DOI 10.1126/science.abb4151; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wimmer GE, 2020, NAT NEUROSCI, V23, P1025, DOI 10.1038/s41593-020-0649-z; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252	52	25	25	10	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					807	+	eabf1357	10.1126/science.abf1357	http://dx.doi.org/10.1126/science.abf1357			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016753	Green Submitted, Green Accepted			2022-12-28	WOS:000653997000035
J	Mahase, E				Mahase, Elisabeth			Covid-19: Advocates urge India's prime minister to remove barriers to vaccine production and access	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], NEW YORK TIMES; Oxfam India, 2021, PEOPL COV 19 VACC IN; Oxfam India Forum for Medical Ethics Society, 2021, END PEOPL VACC IND C	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2021	373								n1297	10.1136/bmj.n1297	http://dx.doi.org/10.1136/bmj.n1297			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5TH	34016646	Bronze			2022-12-28	WOS:000655596600002
J	Bollu, T; Ito, BS; Whitehead, SC; Kardon, B; Redd, J; Liu, MH; Goldberg, JH				Bollu, Tejapratap; Ito, Brendan S.; Whitehead, Samuel C.; Kardon, Brian; Redd, James; Liu, Mei Hong; Goldberg, Jesse H.			Cortex-dependent corrections as the tongue reaches for and misses targets	NATURE			English	Article							VISUAL FEEDBACK; MOTOR; MOVEMENT; MECHANISMS; HAND; ACCURACY; CIRCUITS; DYNAMICS; BEHAVIOR; ONLINE	Precise tongue control is necessary for drinking, eating and vocalizing(1-3). However, because tongue movements are fast and difficult to resolve, neural control of lingual kinematics remains poorly understood. Here we combine kilohertz-frame-rate imaging and a deep-learning-based neural network to resolve 3D tongue kinematics in mice drinking from a water spout. Successful licks required corrective submovements that-similar to online corrections during primate reaches(4-11)-occurred after the tongue missed unseen, distant or displaced targets. Photoinhibition of anterolateral motor cortex impaired corrections, which resulted in hypometric licks that missed the spout. Neural activity in anterolateral motor cortex reflected upcoming, ongoing and past corrective submovements, as well as errors in predicted spout contact. Although less than a tenth of a second in duration, a single mouse lick exhibits the hallmarks of online motor control associated with a primate reach, including cortex-dependent corrections after misses.	[Bollu, Tejapratap; Ito, Brendan S.; Whitehead, Samuel C.; Kardon, Brian; Redd, James; Liu, Mei Hong; Goldberg, Jesse H.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Goldberg, JH (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jessehgoldberg@gmail.com		Kardon, Brian/0000-0003-0140-9919; Goldberg, Jesse/0000-0003-0422-8902; Bollu, Tejapratap/0000-0002-4945-3962	NIH [DP2 HD087952]; Dystonia Medical Research Foundation; Pew Charitable Trust; Klingenstein Neuroscience Foundation; NSF Graduate Research Fellowship Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dystonia Medical Research Foundation; Pew Charitable Trust; Klingenstein Neuroscience Foundation(Klingenstein Philanthropies); NSF Graduate Research Fellowship Program(National Science Foundation (NSF))	We thank J. Fetcho, M. Warden, N. Hogan, C. Pandarinath and members of the laboratory of J.H.G. for comments on the manuscript, and B. Bari, A. Finkelstein, N. Prasad and J. Walker for technical advice. Funding to J.H.G. was provided by the NIH (grant no. DP2 HD087952), the Dystonia Medical Research Foundation, the Pew Charitable Trust, J. Sheng and the Klingenstein Neuroscience Foundation. Funding to B.S.I. was provided by the NSF Graduate Research Fellowship Program.	Allen WE, 2017, NEURON, V94, P891, DOI 10.1016/j.neuron.2017.04.017; Ames KC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10772-2; Ames KC, 2014, NEURON, V81, P438, DOI 10.1016/j.neuron.2013.11.003; Arce-McShane FI, 2014, J NEUROSCI, V34, P5985, DOI 10.1523/JNEUROSCI.4367-13.2014; Archambault PS, 2011, J NEUROSCI, V31, P742, DOI 10.1523/JNEUROSCI.2623-10.2011; Beatus T, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0075; Chartier J, 2018, NEURON, V98, P1042, DOI 10.1016/j.neuron.2018.04.031; Coddington LT, 2018, NAT NEUROSCI, V21, P1563, DOI 10.1038/s41593-018-0245-7; Crochet S, 2019, TRENDS NEUROSCI, V42, P66, DOI 10.1016/j.tins.2018.08.011; de Groot JH, 2004, P ROY SOC B-BIOL SCI, V271, P761, DOI 10.1098/rspb.2003.2637; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Dickey AS, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00051; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; ELLIOTT D, 1987, Q J EXP PSYCHOL-A, V39, P541, DOI 10.1080/14640748708401802; Gaffield MA, 2017, J NEUROSCI, V37, P4751, DOI 10.1523/JNEUROSCI.0534-17.2017; GEORGOPOULOS AP, 1983, EXP BRAIN RES, V49, P327; Ghez Claude, 1995, P549; Goard MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.13764; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Harper CJ, 2013, P NATL ACAD SCI USA, V110, P8852, DOI 10.1073/pnas.1222726110; Hayar A, 2006, J NEUROSCI METH, V153, P203, DOI 10.1016/j.jneumeth.2005.10.023; Heath M, 2003, MOTOR CONTROL, V7, P346; Khan MA, 2003, J MOTOR BEHAV, V35, P285, DOI 10.1080/00222890309602141; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Li N, 2015, NATURE, V519, P51, DOI 10.1038/nature14178; Mcelvain LE, 2018, NEUROSCIENCE, V368, P152, DOI 10.1016/j.neuroscience.2017.08.034; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; MEGAW ED, 1974, BRAIN RES, V71, P425, DOI 10.1016/0006-8993(74)90986-X; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; OConnor D.H., 2020, FUNCTIONAL CORTICAL, DOI [10.1101/783050, DOI 10.1101/783050]; Olshausen BA, 2003, J COGNITIVE NEUROSCI, V15, P154, DOI 10.1162/089892903321107891; Pruszynski JA, 2016, CURR BIOL, V26, P788, DOI 10.1016/j.cub.2016.01.027; Reis PM, 2010, SCIENCE, V330, P1231, DOI 10.1126/science.1195421; Rico-Guevara A, 2011, P NATL ACAD SCI USA, V108, P9356, DOI 10.1073/pnas.1016944108; Rohrer B, 2002, J NEUROSCI, V22, P8297; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sauerbrei BA, 2020, NATURE, V577, P386, DOI 10.1038/s41586-019-1869-9; SPIJKERS WAC, 1994, J MOTOR BEHAV, V26, P283, DOI 10.1080/00222895.1994.9941684; Svoboda K, 2018, CURR OPIN NEUROBIOL, V49, P33, DOI 10.1016/j.conb.2017.10.023; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Wei JK, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2020.0449; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Westwood DA, 2003, J MOTOR BEHAV, V35, P127, DOI 10.1080/00222890309602128; WOODS JW, 1964, J NEUROPHYSIOL, V27, P635, DOI 10.1152/jn.1964.27.4.635	46	10	10	7	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					82	+		10.1038/s41586-021-03561-9	http://dx.doi.org/10.1038/s41586-021-03561-9		MAY 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SM2RM	34012117	Green Accepted			2022-12-28	WOS:000652172000006
J	Schwab, T				Schwab, Tim			How Wellcome's opaque fossil fuel investments harm its global health mission	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												timschwab2020@gmail.com						Abbasi K, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m167; [Anonymous], 2015, GUARDIAN; Bill & Melinda Gates Foundation Trust, 2019, 990 PF TAX FIL US IN; Erickson P, 2017, NAT ENERGY, V2, DOI 10.1038/s41560-017-0009-8; Farrar J., 2015, GUARDIAN        0325; Fossil Fuel Divest Harvard, 2021, COMPL ATT GEN HEAL; Honarvar Afshin Jon, 2011, GUARDIAN        0325; Howard, 2015, GUARDIAN        1013; Nauman B, 2019, FINANCIAL TIMES 0917; Remedios, 2021, WBUR            0315; US Securities and Exchange Commission, HI CRUSH INC FORM 10; Vohra K, 2021, ENVIRON RES, V195, DOI 10.1016/j.envres.2021.110754; Weissman, 2013, ATLANTIC; Wellcome Trust, 2020, OUR COMM TACKL RAC W; Wellcome Trust, 2018, 990 T TAX FIL US INT; Wellcome Trust, WHAT IS PLANET HLTH; Wellcome Trust, 2020, 990 T TAX FIL US INT	17	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2021	373								n1202	10.1136/bmj.n1202	http://dx.doi.org/10.1136/bmj.n1202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5SO	34011493	hybrid, Green Published			2022-12-28	WOS:000655594700009
J	Moberly, T				Moberly, Tom			BMJ appeal raises 60 pound 000 for the Independent Food Aid Network	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2021	373								n1141	10.1136/bmj.n1141	http://dx.doi.org/10.1136/bmj.n1141			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9HX	33990292	Bronze			2022-12-28	WOS:000653058600013
J	Popov, I				Popov, Inna			Is chiral crystal shape inherited or acquired? Reaction kinetics drives chiral nanocrystal formation from helically bonded tellurium atoms	SCIENCE			English	Editorial Material									[Popov, Inna] Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, IL-9190410 Jerusalem, Israel	Hebrew University of Jerusalem	Popov, I (corresponding author), Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, IL-9190410 Jerusalem, Israel.	innap@savion.huji.ac.il			Hebrew University Center for Nanoscience and Nanotechnology	Hebrew University Center for Nanoscience and Nanotechnology	The author acknowledges the financial support of the Hebrew University Center for Nanoscience and Nanotechnology.	Ben-Moshe A, 2021, SCIENCE, V372, P729, DOI 10.1126/science.abf9645; Ben-Moshe A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5302; Collet A, 1995, NATO ADV SCI INST SE, V473, P91; Escaig B, 1974, J PHYS C, V35; Feringa BL, 2001, SCIENCE, V292, P2021, DOI 10.1126/science.1062070; FRIEDMAN L, 1971, SCIENCE, V172, P1044, DOI 10.1126/science.172.3987.1044; Hentschel M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602735; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Pasteur L., 1848, ANN CHIM PHYS, V24, P442; Shtukenberg AG, 2014, ANGEW CHEM INT EDIT, V53, P672, DOI 10.1002/anie.201301223	10	1	1	13	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					688	688		10.1126/science.abh1213	http://dx.doi.org/10.1126/science.abh1213			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SD1KE	33986170				2022-12-28	WOS:000651125300030
J	Torjesen, I				Torjesen, Ingrid			Academic journal is criticised for publishing special issue funded by tobacco industry	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, AM J HLTH BEHAV, P4; Feeley J., 2020, BLOOMBERG; Rosenblatt J, 2021, BLOOMBERG	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2021	373								n1247	10.1136/bmj.n1247	http://dx.doi.org/10.1136/bmj.n1247			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9HX	33990316				2022-12-28	WOS:000653058600007
J	Leshem, E; Wilder-Smith, A				Leshem, Eyal; Wilder-Smith, Annelies			COVID-19 vaccine impact in Israel and a way out of the pandemic	LANCET			English	Editorial Material									[Leshem, Eyal] Chaim Sheba Med Ctr, IL-52621 Ramatgan, Israel; [Leshem, Eyal] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Wilder-Smith, Annelies] Heidelberg Univ, Heidelberg Global Hlth Inst, Heidelberg, Germany	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of London; London School of Hygiene & Tropical Medicine; Ruprecht Karls University Heidelberg	Leshem, E (corresponding author), Chaim Sheba Med Ctr, IL-52621 Ramatgan, Israel.; Leshem, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	eyal.leshem@sheba.health.gov.il						[Anonymous], 2021, LANCET, V397, P941, DOI 10.1016/S0140-6736(21)00617-6; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Hall VJ, 2021, LANCET, V397, P1725, DOI 10.1016/S0140-6736(21)00790-X; Israel Ministry of Health, COVID 19 DAIL SIT RE; Kustin T, 2021, NAT MED, V27, P1379, DOI 10.1038/s41591-021-01413-7; Leshem E, 2021, LANCET, V397, P1685, DOI 10.1016/S0140-6736(21)00870-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rosen B, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00440-6; Vasileiou E, 2021, LANCET, V397, P1646, DOI 10.1016/S0140-6736(21)00677-2; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; World Health Organization, EV COVID 19 VACC EFF; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8	12	34	34	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2021	397	10287					1783	1785		10.1016/S0140-6736(21)01018-7	http://dx.doi.org/10.1016/S0140-6736(21)01018-7		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD0HD	33964221	Bronze, Green Published			2022-12-28	WOS:000651041900004
J	Syn, NL; Cummings, DE; Wang, LZ; Lin, DJ; Zhao, JJ; Loh, M; Koh, ZJ; Chew, CA; Loo, YE; Tai, BC; Kim, G; So, JBY; Kaplan, LM; Dixon, JB; Shabbir, A				Syn, Nicholas L.; Cummings, David E.; Wang, Louis Z.; Lin, Daryl J.; Zhao, Joseph J.; Loh, Marie; Koh, Zong Jie; Chew, Claire Alexandra; Loo, Ying Ern; Tai, Bee Choo; Kim, Guowei; So, Jimmy Bok-Yan; Kaplan, Lee M.; Dixon, John B.; Shabbir, Asim			Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants	LANCET			English	Article							INDIVIDUAL PATIENT DATA; Y GASTRIC BYPASS; PRACTICE GUIDELINES; SLEEVE GASTRECTOMY; HEART-FAILURE; WEIGHT-LOSS; OPEN-LABEL; ALL-CAUSE; OBESITY; MORTALITY	Background Metabolic-bariatric surgery delivers substantial weight loss and can induce remission or improvement of obesity-related risks and complications. However, more robust estimates of its effect on long-term mortality and life expectancy-especially stratified by pre-existing diabetes status-are needed to guide policy and facilitate patient counselling. We compared long-term survival outcomes of severely obese patients who received metabolic-bariatric surgery versus usual care. Methods We did a prespecified one-stage meta-analysis using patient-level survival data reconstructed from prospective controlled trials and high-quality matched cohort studies. We searched PubMed, Scopus, and MEDLINE (via Ovid) for randomised trials, prospective controlled studies, and matched cohort studies comparing all-cause mortality after metabolic-bariatric surgery versus non-surgical management of obesity published between inception and Feb 3, 2021. We also searched grey literature by reviewing bibliographies of included studies as well as review articles. Shared-frailty (ie, random-effects) and stratified Cox models were fitted to compare all-cause mortality of adults with obesity who underwent metabolic-bariatric surgery compared with matched controls who received usual care, taking into account clustering of participants at the study level. We also computed numbers needed to treat, and extrapolated life expectancy using Gompertz proportional-hazards modelling. The study protocol is prospectively registered on PROSPERO, number CRD42020218472. Findings Among 1470 articles identified, 16 matched cohort studies and one prospective controlled trial were included in the analysis. 7712 deaths occurred during 1.2 million patient-years. In the overall population consisting 174 772 participants, metabolic-bariatric surgery was associated with a reduction in hazard rate of death of 49.2% (95% CI 46.3-51.9, p<0.0001) and median life expectancy was 6.1 years (95% CI 5.2-6.9) longer than usual care. In subgroup analyses, both individuals with (hazard ratio 0.409, 95% CI 0.370-0.453, p<0.0001) or without (0.704, 0.588-0.843, p<0.0001) baseline diabetes who underwent metabolic-bariatric surgery had lower rates of all-cause mortality, but the treatment effect was considerably greater for those with diabetes (between-subgroup I-2 95.7%, p<0.0001). Median life expectancy was 9.3 years (95% CI 7.1-11.8) longer for patients with diabetes in the surgery group than the non-surgical group, whereas the life expectancy gain was 5.1 years (2.0-9.3) for patients without diabetes. The numbers needed to treat to prevent one additional death over a 10-year time frame were 8.4 (95% CI 7.8-9.1) for adults with diabetes and 29.8 (21.2-56.8) for those without diabetes. Treatment effects did not appear to differ between gastric bypass, banding, and sleeve gastrectomy (I-2 3.4%, p=0.36). By leveraging the results of this meta-analysis and other published data, we estimated that every 1.0% increase in metabolic-bariatric surgery utilisation rates among the global pool of metabolic-bariatric candidates with and without diabetes could yield 5.1 million and 6.6 million potential life-years, respectively. Interpretation Among adults with obesity, metabolic-bariatric surgery is associated with substantially lower all-cause mortality rates and longer life expectancy than usual obesity management. Survival benefits are much more pronounced for people with pre-existing diabetes than those without. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Syn, Nicholas L.; Wang, Louis Z.; Lin, Daryl J.; Zhao, Joseph J.; Koh, Zong Jie; Chew, Claire Alexandra; Loo, Ying Ern; Tai, Bee Choo; Kim, Guowei; So, Jimmy Bok-Yan; Shabbir, Asim] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Syn, Nicholas L.; Tai, Bee Choo] Saw Swee Hock Sch Publ Hlth, Biostat & Modelling Domain, Singapore, Singapore; [Cummings, David E.] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Div Metab Endocrinol & Nutr, UW Med Diabet Inst,Dept Med, Seattle, WA 98195 USA; [Cummings, David E.] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Weight Management Program, Seattle, WA 98195 USA; [Wang, Louis Z.] Singapore Gen Hosp, SingHlth Internal Med Residency Programme, Singapore, Singapore; [Loh, Marie] Imperial Colkge London, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Loh, Marie] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Koh, Zong Jie; Chew, Claire Alexandra; Kim, Guowei; So, Jimmy Bok-Yan] Natl Univ Hlth Syst, Univ Surg Cluster, Dept Surg, Singapore 119228, Singapore; [Tai, Bee Choo] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Tai, Bee Choo] Natl Univ Hlth Syst, Singapore, Singapore; [Kaplan, Lee M.] Massachusetts Gen Hosp, Obes Metab & Nutr Inst, Boston, MA 02114 USA; [Kaplan, Lee M.] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA; [Kaplan, Lee M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Dixon, John B.] Swinburne Univ Technol, Iverson Hlth Innovat Res Inst, Melbourne, Vic, Australia	National University of Singapore; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Singapore General Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; National University of Singapore; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Swinburne University of Technology	Shabbir, A (corresponding author), Natl Univ Hlth Syst, Univ Surg Cluster, Dept Surg, Singapore 119228, Singapore.	cfsasim@nus.edu.sg	Zhao, Joseph J/AGD-3384-2022; Syn, Nicholas/A-3770-2017	Syn, Nicholas/0000-0002-6343-176X; So, Jimmy, Bok-Yan/0000-0002-9772-7905; Chew, Claire/0000-0002-4435-6127; Zhao, Joseph J/0000-0002-2002-5390; Lin, Daryl/0000-0002-3799-1843				Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Adams TD, 2017, NEW ENGL J MED, V377, P1143, DOI 10.1056/NEJMoa1700459; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS100, DOI 10.2337/dc21-S008; Aminian A, 2020, ANN SURG, V272, P639, DOI 10.1097/SLA.0000000000004369; Aminian A, 2019, JAMA-J AM MED ASSOC, V322, P1271, DOI 10.1001/jama.2019.14231; Aminian A, 2019, DIABETES OBES METAB, V21, P2058, DOI 10.1111/dom.13765; [Anonymous], 2020, NEPHROL DIAL TRANSPL, DOI DOI 10.1186/S12882-020-1708-0; Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415; Arterburn DE, 2015, JAMA-J AM MED ASSOC, V313, P62, DOI 10.1001/jama.2014.16968; Batterham RL, 2016, DIABETES CARE, V39, P893, DOI 10.2337/dc16-0145; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/s2213-8587(18)30288-2, 10.1016/S2213-8587(18)30288-2]; Bowden J, 2011, RES SYNTH METHODS, V2, P150, DOI 10.1002/jrsm.45; Busetto L, 2007, SURG OBES RELAT DIS, V3, P496, DOI 10.1016/j.soard.2007.06.003; Carlsson LMS, 2020, NEW ENGL J MED, V383, P1535, DOI 10.1056/NEJMoa2002449; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Ceriani V, 2019, INT J OBESITY, V43, P1147, DOI 10.1038/s41366-018-0244-5; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Davies M, 2021, LANCET, V397, P971, DOI 10.1016/S0140-6736(21)00213-0; de Jong VMT, 2020, RES SYNTH METHODS, V11, P148, DOI 10.1002/jrsm.1384; Debray TPA, 2013, STAT MED, V32, P3158, DOI 10.1002/sim.5732; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dicker D, 2021, OBES SURG, V31, P755, DOI 10.1007/s11695-020-05068-0; Dixon JB, 2011, SURG OBES RELAT DIS, V7, P433, DOI 10.1016/j.soard.2011.05.013; Dixon JB, 2016, SURG OBES RELAT DIS, V12, P1171, DOI 10.1016/j.soard.2015.11.027; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Doumouras AG, 2020, ANN INTERN MED, V173, P694, DOI 10.7326/M19-3925; Eliasson B, 2015, LANCET DIABETES ENDO, V3, P847, DOI 10.1016/S2213-8587(15)00334-4; Fisher DP, 2018, JAMA-J AM MED ASSOC, V320, P1570, DOI 10.1001/jama.2018.14619; Freeman SC, 2020, J CLIN EPIDEMIOL, V124, P94, DOI 10.1016/j.jclinepi.2020.05.010; Furer A, 2020, LANCET DIABETES ENDO, V8, P216, DOI 10.1016/S2213-8587(20)30019-X; Ghosh-Swaby OR, 2020, LANCET DIABETES ENDO, V8, P418, DOI 10.1016/S2213-8587(20)30038-3; Gloy VL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5934; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Guidry CA, 2015, AM J SURG, V209, P463, DOI 10.1016/j.amjsurg.2014.10.009; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Hassinger TE, 2018, SURG OBES RELAT DIS, V14, P1133, DOI 10.1016/j.soard.2018.03.032; Himpens J, 2019, 4 IFSO GLOBAL REGIST; Hofso D, 2019, LANCET DIABETES ENDO, V7, P912, DOI 10.1016/S2213-8587(19)30344-4; Hoskuldsdottir G, 2020, DIABETES CARE, V43, P3079, DOI 10.2337/dc20-0388; Ikramuddin S, 2018, JAMA-J AM MED ASSOC, V319, P266, DOI 10.1001/jama.2017.20813; Jayedi A, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3324; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Kelly AS, 2020, NEW ENGL J MED, V382, P2117, DOI 10.1056/NEJMoa1916038; Koh ZJ, 2020, SURG OBES RELAT DIS, V16, P1442, DOI 10.1016/j.soard.2020.05.029; Lent MR, 2017, DIABETES CARE, V40, P1379, DOI 10.2337/dc17-0519; Lingvay I, 2019, LANCET DIABETES ENDO, V7, P834, DOI 10.1016/S2213-8587(19)30311-0; Mechanick JI, 2013, OBESITY, V21, pS1, DOI 10.1002/oby.20461; Mensah GA, 2019, J AM COLL CARDIOL, V74, P2529, DOI 10.1016/j.jacc.2019.10.009; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moussa O, 2020, EUR HEART J, V41, P2660, DOI 10.1093/eurheartj/ehaa069; Murray CJL, 2020, LANCET, V396, P1223, DOI 10.1016/S0140-6736(20)30752-2; O'Neil PM, 2018, LANCET, V392, P637, DOI 10.1016/S0140-6736(18)31773-2; Ostlund MP, 2011, BRIT J SURG, V98, P811, DOI 10.1002/bjs.7416; Papadimitropoulou K, 2020, RES SYNTH METHODS, V11, P780, DOI 10.1002/jrsm.1434; Pearson-Stuttard J, 2021, LANCET DIABETES ENDO, V9, P165, DOI 10.1016/S2213-8587(20)30431-9; Pearson-Stuttard J, 2018, LANCET DIABETES ENDO, V6, pE6, DOI [10.1016/S2213-8587(18)30150-5, 10.1016/S2213-8587(17)30366-2, 10.1016/52213-8587(17)30366-2, 10.1016/s2213-8587(17)30366-2]; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Pontiroli AE, 2020, ACTA DIABETOL, V57, P323, DOI 10.1007/s00592-019-01433-3; Pontiroli AE, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0801-1; Pontiroli AE, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0347-z; Prabhakaran D, 2018, LANCET GLOB HEALTH, V6, pE1339, DOI 10.1016/S2214-109X(18)30407-8; Pratley RE, 2018, LANCET DIABETES ENDO, V6, P275, DOI 10.1016/S2213-8587(18)30024-X; Reges O, 2018, JAMA-J AM MED ASSOC, V319, P279, DOI 10.1001/jama.2017.20513; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rubino F, 2020, LANCET DIABETES ENDO, V8, P374, DOI 10.1038/s41591-020-0803-x; Schauer PR, 2017, NEW ENGL J MED, V376, P641, DOI 10.1056/NEJMoa1600869; Schauer PR, 2016, DIABETES CARE, V39, P902, DOI 10.2337/dc16-0382; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Sheetz KH, 2020, JAMA SURG, V155, P581, DOI 10.1001/jamasurg.2020.0829; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Smith CT, 2005, STAT MED, V24, P1307, DOI 10.1002/sim.2050; Song Y, 2020, RES SYNTH METHODS, V11, P594, DOI 10.1002/jrsm.1406; Srivastava G, 2018, NAT REV ENDOCRINOL, V14, P12, DOI 10.1038/nrendo.2017.122; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Syn NL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5123; Syn NL, 2020, ANN SURG, V272, P253, DOI 10.1097/SLA.0000000000003672; Teo YH, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019463; Thereaux J, 2019, LANCET DIABETES ENDO, V7, P786, DOI 10.1016/S2213-8587(19)30191-3; Wadden TA, 2021, JAMA-J AM MED ASSOC, V325, P1403, DOI 10.1001/jama.2021.1831; Wei YH, 2017, STATA J, V17, P786, DOI 10.1177/1536867X1701700402; Wells G., NEWCASTLE OTTAWA SCA; Wilding JPH, 2021, NEW ENGL J MED, V384, P989, DOI 10.1056/NEJMoa2032183; Yabe D, 2020, LANCET DIABETES ENDO, V8, P392, DOI 10.1016/S2213-8587(20)30074-7; Yeo C, 2021, OBES SURG, V31, P949, DOI 10.1007/s11695-020-05094-y; Yeo C, 2019, OBES REV, V20, P1759, DOI 10.1111/obr.12940; Zannad F, 2020, LANCET, V396, P819, DOI 10.1016/S0140-6736(20)31824-9	90	82	85	6	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2021	397	10287					1830	1841		10.1016/S0140-6736(21)00591-2	http://dx.doi.org/10.1016/S0140-6736(21)00591-2		MAY 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD0HD	33965067				2022-12-28	WOS:000651041900029
J	Zegarra-Ruiz, DF; Kim, DV; Norwood, K; Kim, M; Wu, WJH; Saldana-Morales, FB; Hill, AA; Majumdar, S; Orozco, S; Bell, R; Round, JL; Longman, RS; Egawa, T; Bettini, ML; Diehl, GE				Zegarra-Ruiz, Daniel F.; Kim, Dasom V.; Norwood, Kendra; Kim, Myunghoo; Wu, Wan-Jung H.; Saldana-Morales, Fatima B.; Hill, Andrea A.; Majumdar, Shubhabrata; Orozco, Stephanie; Bell, Rickesha; Round, June L.; Longman, Randy S.; Egawa, Takeshi; Bettini, Matthew L.; Diehl, Gretchen E.			Thymic development of gut-microbiota-specific T cells	NATURE			English	Article							IMMUNOLOGICAL-TOLERANCE; MONONUCLEAR PHAGOCYTES; FLUORESCENT PROTEIN; NEGATIVE SELECTION; ESCHERICHIA-COLI; DENDRITIC CELLS; RNA; REPERTOIRE; LINEAGE; MOUSE	Humans and their microbiota have coevolved a mutually beneficial relationship in which the human host provides a hospitable environment for the microorganisms and the microbiota provides many advantages for the host, including nutritional benefits and protection from pathogen infection(1). Maintaining this relationship requires a careful immune balance to contain commensal microorganisms within the lumen while limiting inflammatory anti-commensal responses(1,2). Antigen-specific recognition of intestinal microorganisms by T cells has previously been described(3,4). Although the local environment shapes the differentiation of effector cells(3-5) it is unclear how microbiota-specific T cells are educated in the thymus. Here we show that intestinal colonization in early life leads to the trafficking of microbial antigens from the intestine to the thymus by intestinal dendritic cells, which then induce the expansion of microbiota-specific T cells. Once in the periphery, microbiota-specific T cells have pathogenic potential or can protect against related pathogens. In this way, the developing microbiota shapes and expands the thymic and peripheral T cell repertoire, allowing for enhanced recognition of intestinal microorganisms and pathogens.	[Zegarra-Ruiz, Daniel F.; Kim, Dasom V.; Wu, Wan-Jung H.; Saldana-Morales, Fatima B.; Diehl, Gretchen E.] Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA; [Kim, Dasom V.; Diehl, Gretchen E.] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Norwood, Kendra; Kim, Myunghoo; Diehl, Gretchen E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Wu, Wan-Jung H.; Majumdar, Shubhabrata] Baylor Coll Med, Program Immunol, Houston, TX 77030 USA; [Saldana-Morales, Fatima B.] Baylor Coll Med, Neurosci Program, Houston, TX 77030 USA; [Hill, Andrea A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Majumdar, Shubhabrata; Orozco, Stephanie; Bell, Rickesha; Round, June L.; Bettini, Matthew L.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; [Longman, Randy S.] Weill Cornell Med, Dept Med, Div Gastroenterol & Hepatol, New York, NY USA; [Longman, Randy S.] Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY USA; [Longman, Randy S.] Weill Cornell Med, Jill Roberts Ctr Inflammatory Bowel Dis, New York, NY USA; [Egawa, Takeshi] Washington Univ, Dept Pathol, Sch Med St Louis, St Louis, MO 63130 USA; [Kim, Myunghoo] Pusan Natl Univ, Dept Anim Sci, Pusan, South Korea	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah; Cornell University; Cornell University; Cornell University; Saint Louis University; Washington University (WUSTL); Pusan National University	Diehl, GE (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.; Diehl, GE (corresponding author), Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA.; Diehl, GE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Bettini, ML (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA.	Matt.Bettini@path.utah.edu; Diehlg1@mskcc.org		Wu, Wan-Jung/0000-0002-3028-9146; Saldana Morales, Fatima/0000-0001-5192-5722; Zegarra Ruiz, Daniel/0000-0003-0752-7238	NIH [R01AI136963, R01AI125264, R01DK114456, R01AI130152, R01 DK114252, P30 CA125123, S10 RR024574]; Kleberg Foundation; Kenneth Rainin Foundation; Leukemia and Lymphoma Society Scholar Award; Cytometry and Cell Sorting Core at Baylor College of Medicine; CPRIT Core Facility Support Award [CPRIT-RP180672]; Cancer Center Grant [P30 CA125123]; Mouse Embryonic Stem Cell Core at Baylor College of Medicine; NIAID [HHSN272201300006C]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kleberg Foundation; Kenneth Rainin Foundation; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Cytometry and Cell Sorting Core at Baylor College of Medicine; CPRIT Core Facility Support Award; Cancer Center Grant; Mouse Embryonic Stem Cell Core at Baylor College of Medicine; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01AI136963 (G.E.D. and M.L.B.), R01AI125264 (G.E.D.), R01DK114456 (M.L.B.), R01AI130152 (T.E.) and R01 DK114252 (R.S.L.); the Kleberg Foundation (G.E.D. and M.L.B); the Kenneth Rainin Foundation (G.E.D.); the Leukemia and Lymphoma Society Scholar Award (T.E.); and the Cytometry and Cell Sorting Core at Baylor College of Medicine, with funding from the CPRIT Core Facility Support Award (CPRIT-RP180672) and the NIH (P30 CA125123 and S10 RR024574) and with the assistance of J. M. Sederstrom. We thank the Baylor College of Medicine Genetically Engineered Mouse Core supported by the Cancer Center Grant (P30 CA125123); the Mouse Embryonic Stem Cell Core at Baylor College of Medicine; D. Littman and C.-S. Hsieh for critical reading of the manuscript; N. Ajami for advice on 16S; and the NIH Tetramer Facility, which is supported by contract HHSN272201300006C from the NIAID.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Boehm T, 2013, NAT REV IMMUNOL, V13, P831, DOI 10.1038/nri3534; Buchan A, 2009, APPL ENVIRON MICROB, V75, P7542, DOI 10.1128/AEM.00814-09; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chern EC, 2011, LETT APPL MICROBIOL, V52, P298, DOI 10.1111/j.1472-765X.2010.03001.x; Chopp LB, 2020, IMMUNITY, V53, P1182, DOI 10.1016/j.immuni.2020.10.024; Chu HH, 2010, J IMMUNOL, V185, P4705, DOI 10.4049/jimmunol.1002276; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; DIPADOVA FE, 1993, INFECT IMMUN, V61, P3863, DOI 10.1128/IAI.61.9.3863-3872.1993; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Hadeiba H, 2013, EUR J IMMUNOL, V43, P1425, DOI 10.1002/eji.201243192; Hashimoto K, 2002, GENESIS, V32, P152, DOI 10.1002/gene.10056; Hogquist KA, 2015, J IMMUNOL, V195, P1351, DOI 10.4049/jimmunol.1501050; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kim M, 2018, IMMUNITY, V49, P151, DOI 10.1016/j.immuni.2018.05.009; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kotov Dmitri I, 2019, Curr Protoc Immunol, V125, pe75, DOI 10.1002/cpim.75; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Leech JM, 2019, CELL HOST MICROBE, V26, P795, DOI 10.1016/j.chom.2019.10.007; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; Owen DL, 2019, NAT IMMUNOL, V20, P195, DOI 10.1038/s41590-018-0289-6; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Viladomiu M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9655; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Zegarra-Ruiz DF, 2019, CELL HOST MICROBE, V25, P113, DOI 10.1016/j.chom.2018.11.009	44	40	42	6	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 17	2021	594	7863					413	+		10.1038/s41586-021-03531-1	http://dx.doi.org/10.1038/s41586-021-03531-1		MAY 2021	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SU1FZ	33981034	Green Accepted			2022-12-28	WOS:000650200300005
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK offers under 40s alternative to AstraZeneca vaccine to boost confidence	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2021	373								n1185	10.1136/bmj.n1185	http://dx.doi.org/10.1136/bmj.n1185			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RA	33972259	Bronze			2022-12-28	WOS:000649709400004
J	Tsanni, A				Tsanni, Abdullahi			Covid-19: Africa scrambles to increase genomic testing capacity as variants spread	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												abdullahitsanni@gmail.com						Adepoju P, 2021, LANCET MICROBE, V2, pE139, DOI 10.1016/S2666-5247(21)00065-3; Hayward A, 2021, BMJ BLOGS; Ihekweazu C, 2020, 1 AFR SARS COV 2 GEN; Jerving S, 2021, QUARTER WORLDS COUNT; Nigeria Centre for Disease Control, 2021, STAT VAR SARS COV 2; WHO, 2021, NEW COV 19 VAR FUEL	6	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2021	373								n1122	10.1136/bmj.n1122	http://dx.doi.org/10.1136/bmj.n1122			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QT	33962965	Bronze			2022-12-28	WOS:000649708700011
J	Sheng, F; Hua, CQ; Cheng, M; Hu, J; Sun, XK; Tao, Q; Lu, HZ; Lu, YH; Zhong, MZ; Watanabe, K; Taniguchi, T; Xia, QL; Xu, ZA; Zheng, Y				Sheng, Feng; Hua, Chenqiang; Cheng, Man; Hu, Jie; Sun, Xikang; Tao, Qian; Lu, Hengzhe; Lu, Yunhao; Zhong, Mianzeng; Watanabe, Kenji; Taniguchi, Takashi; Xia, Qinglin; Xu, Zhu-An; Zheng, Yi			Rashba valleys and quantum Hall states in few-layer black arsenic	NATURE			English	Article							2-DIMENSIONAL ELECTRON; PHOSPHORUS; PHASE	Exciting phenomena may emerge in non-centrosymmetric two-dimensional electronic systems when spin-orbit coupling (SOC)(1) interplays dynamically with Coulomb interactions(2,3), band topology(4,5) and external modulating forces(6-8). Here we report synergetic effects between SOC and the Stark effect in centrosymmetric few-layer black arsenic, which manifest as particle-hole asymmetric Rashba valley formation and exotic quantum Hall states that are reversibly controlled by electrostatic gating. The unusual findings are rooted in the puckering square lattice of black arsenic, in which heavy 4p orbitals form a Brillouin zone-centred Gamma valley with p(z) symmetry, coexisting with doubly degenerate D valleys of p(x) origin near the time-reversal-invariant momenta of the X points. When a perpendicular electric field breaks the structure inversion symmetry, strong Rashba SOC is activated for the p(x) bands, which produces spin-valley-flavoured D-+/- valleys paired by time-reversal symmetry, whereas Rashba splitting of the Gamma valley is constrained by the p(z) symmetry. Intriguingly, the giant Stark effect shows the same p(x)-orbital selectiveness, collectively shifting the valence band maximum of the D-+/- Rashba valleys to exceed the Gamma Rashba top. Such an orchestrating effect allows us to realize gate-tunable Rashba valley manipulations for two-dimensional hole gases, hallmarked by unconventional even-to-odd transitions in quantum Hall states due to the formation of a flavour-dependent Landau level spectrum. For two-dimensional electron gases, the quantization of the Gamma Rashba valley is characterized by peculiar density-dependent transitions in the band topology from trivial parabolic pockets to helical Dirac fermions. Two-dimensional electronic systems in few-layer black arsenic show gate-tunable Rashba bands with unique spin-valley flavours and unconventional quantum Hall states due to synergetic spin-orbit coupling and the Stark effect.	[Sheng, Feng; Hua, Chenqiang; Cheng, Man; Hu, Jie; Sun, Xikang; Tao, Qian; Lu, Hengzhe; Lu, Yunhao; Xu, Zhu-An; Zheng, Yi] Zhejiang Univ, Zhejiang Prov Key Lab Quantum Technol & Device, Dept Phys, Hangzhou, Peoples R China; [Zhong, Mianzeng; Xia, Qinglin] Cent South Univ, Hunan Key Lab Nanophoton & Devices, Sch Phys & Elect, Changsha, Peoples R China; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Xu, Zhu-An; Zheng, Yi] Zhejiang Univ, State Key Lab Silicon Mat, Hangzhou, Peoples R China	Zhejiang University; Central South University; National Institute for Materials Science; Zhejiang University	Xu, ZA; Zheng, Y (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Quantum Technol & Device, Dept Phys, Hangzhou, Peoples R China.; Xia, QL (corresponding author), Cent South Univ, Hunan Key Lab Nanophoton & Devices, Sch Phys & Elect, Changsha, Peoples R China.; Xu, ZA; Zheng, Y (corresponding author), Zhejiang Univ, State Key Lab Silicon Mat, Hangzhou, Peoples R China.	qlxia@csu.edu.cn; zhuan@zju.edu.cn; phyzhengyi@zju.edu.cn	Watanabe, Kenji/ABB-2135-2021; ZHENG, Yi Steve/E-9515-2011	Watanabe, Kenji/0000-0003-3701-8119; ZHENG, Yi Steve/0000-0002-9487-1151; sheng, feng/0000-0003-0846-6238; Zhong, MianZeng/0000-0003-0343-5248				Bawden L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500495; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Carvalho A, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.61; Chen YB, 2018, ADV MATER, V30, DOI 10.1002/adma.201800754; Feng Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12805-2; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Ishizaka K, 2011, NAT MATER, V10, P521, DOI [10.1038/NMAT3051, 10.1038/nmat3051]; Kammhuber J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00315-y; Khoo KH, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.201401; Kim J, 2015, SCIENCE, V349, P723, DOI 10.1126/science.aaa6486; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Klimes J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/2/022201; KOELLING DD, 1977, J PHYS C SOLID STATE, V10, P3107, DOI 10.1088/0022-3719/10/16/019; Kooi BJ, 2020, ADV MATER, V32, DOI 10.1002/adma.201908302; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Li LK, 2016, NAT NANOTECHNOL, V11, P592, DOI [10.1038/nnano.2016.42, 10.1038/NNANO.2016.42]; Li LK, 2014, NAT NANOTECHNOL, V9, P372, DOI [10.1038/NNANO.2014.35, 10.1038/nnano.2014.35]; Li X, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.066803; Liu YP, 2017, NANO LETT, V17, P1970, DOI 10.1021/acs.nanolett.6b05381; Long G, 2016, NANO LETT, V16, P7768, DOI 10.1021/acs.nanolett.6b03951; Manchon A, 2015, NAT MATER, V14, P871, DOI [10.1038/NMAT4360, 10.1038/nmat4360]; Movva HCP, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.247701; Murakawa H, 2013, SCIENCE, V342, P1490, DOI 10.1126/science.1242247; Ramasubramaniam A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.205325; Seki S, 2012, SCIENCE, V336, P198, DOI 10.1126/science.1214143; Shoenberg D., 1984, MAGNETIC OSCILLATION; Shportko K, 2008, NAT MATER, V7, P653, DOI 10.1038/nmat2226; Sun J, 2018, NANO LETT, V18, P6144, DOI 10.1021/acs.nanolett.8b01799; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wang Z, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041020; Wang Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02566-1; Winkler R, 2003, SPRINGER TRACTS MOD, V191, P1, DOI 10.1007/b13586; Xia FN, 2019, NAT REV PHYS, V1, P306, DOI 10.1038/s42254-019-0043-5; Xu SG, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.067702; Xu Y, 2014, NAT PHYS, V10, P956, DOI [10.1038/NPHYS3140, 10.1038/nphys3140]; Yang FY, 2018, NANO LETT, V18, P6611, DOI 10.1021/acs.nanolett.8b03267; Zomer PJ, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4886096	40	12	11	29	169	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					56	+		10.1038/s41586-021-03449-8	http://dx.doi.org/10.1038/s41586-021-03449-8			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RY0YD	33953409	Green Submitted			2022-12-28	WOS:000647642900011
J	Farooqi, S				Farooqi, Sadaf			Putting a brake on hunger	SCIENCE			English	Editorial Material							OBESITY; MC4R; MUTATIONS; VARIANTS		[Farooqi, Sadaf] Addenbrookes Hosp, Wellcome MRC Inst Metab Sci, Box 289, Cambridge, England	Addenbrooke's Hospital; University of Cambridge	Farooqi, S (corresponding author), Addenbrookes Hosp, Wellcome MRC Inst Metab Sci, Box 289, Cambridge, England.	isf20@cam.ac.uk			Wellcome Trust [207462/Z/17/Z]; National Institute for Health Research Cambridge Biomedical Research Centre; Fondation Botnar; Bernard Wolfe Health Neuroscience Endowment	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Fondation Botnar; Bernard Wolfe Health Neuroscience Endowment	I.S.F. was supported by the Wellcome Trust (207462/Z/17/Z), the National Institute for Health Research Cambridge Biomedical Research Centre, Fondation Botnar,and the Bernard Wolfe Health Neuroscience Endowment and wishes to thank members of her research team for their contributions.I.S.F has consulted for a number of companies seeking to target MC4R and design weight loss treatments.	Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Brouwers B, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108862; Clement K, 2020, LANCET DIABETES ENDO, V8, P960, DOI 10.1016/S2213-8587(20)30364-8; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Friedman JM, 2019, NAT METAB, V1, P754, DOI 10.1038/s42255-019-0095-y; Gautron L, 2015, CELL, V161, P133, DOI 10.1016/j.cell.2015.02.023; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Israeli H, 2021, SCIENCE, V372, P808, DOI 10.1126/science.abf7958; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lotta LA, 2019, CELL, V177, P597, DOI 10.1016/j.cell.2019.03.044; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Wade K. H, 2020, MEDRXIV, DOI [10.1101/2020.10.30.20220467, DOI 10.1101/2020.10.30.20220467]; Yeo G. S. H, 2021, MOL METAB, V48; Yu J, 2020, SCIENCE, V368, P428, DOI 10.1126/science.aaz8995	15	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					792	793		10.1126/science.abi8942	http://dx.doi.org/10.1126/science.abi8942			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016769				2022-12-28	WOS:000653997000026
J	O'Connor, LMJ; Pollock, LJ; Renaud, J; Verhagen, W; Verburg, PH; Lavorel, S; Maiorano, L; Thuiller, W				O'Connor, Louise M. J.; Pollock, Laura J.; Renaud, Julien; Verhagen, Willem; Verburg, Peter H.; Lavorel, Sandra; Maiorano, Luigi; Thuiller, Wilfried			Balancing conservation priorities for nature and for people in Europe	SCIENCE			English	Article							MAPPING ECOSYSTEM SERVICES; LAND-USE; POLLINATION SERVICES; PROTECTED AREAS; 2000 NETWORK; BIODIVERSITY; DEMAND	There is an urgent need to protect key areas for biodiversity and nature's contributions to people (NCP). However, different values of nature are rarely considered together in conservation planning. Here, we explore potential priority areas in Europe for biodiversity (all terrestrial vertebrates) and a set of cultural and regulating NCP while considering demand for these NCP. We quantify the spatial overlap between these priorities and their performance in representing different values of nature. We show that different priorities rarely coincide, except in certain irreplaceable ecosystems. Notably, priorities for biodiversity better represent NCP than the reverse. Theoretically, protecting an extra 5% of land has the potential to double conservation gains for biodiversity while also maintaining some essential NCP, leading to co-benefits for both nature and people.	[O'Connor, Louise M. J.; Pollock, Laura J.; Renaud, Julien; Lavorel, Sandra; Thuiller, Wilfried] Univ Grenoble Alpes, Univ Savoie Mt Blanc, CNRS, LECA,Lab Ecol Alpine, F-38000 Grenoble, France; [Pollock, Laura J.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Verhagen, Willem; Verburg, Peter H.] Vrije Univ Amsterdam, Environm Geog Grp, Inst Environm Studies, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [Verhagen, Willem] Univ Denver, Frederick S Pardee Ctr Int Futures, Josef Korbel Sch Int Studies, Denver, CO 80208 USA; [Verburg, Peter H.] Swiss Fed Res Inst WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland; [Maiorano, Luigi] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; McGill University; Vrije Universiteit Amsterdam; University of Denver; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Sapienza University Rome	O'Connor, LMJ (corresponding author), Univ Grenoble Alpes, Univ Savoie Mt Blanc, CNRS, LECA,Lab Ecol Alpine, F-38000 Grenoble, France.	louise.mj.oconnor@gmail.com	Maiorano, Luigi/AFR-6582-2022; Thuiller, Wilfried/G-3283-2010; Verburg, Peter/A-8469-2010; Verhagen, Willem/K-9503-2013	Maiorano, Luigi/0000-0002-2957-8979; Thuiller, Wilfried/0000-0002-5388-5274; Verburg, Peter/0000-0002-6977-7104; O'Connor, Louise/0000-0002-6671-9144; Verhagen, Willem/0000-0002-9394-0741	Belmont Forum; BiodivERsA; Agence Nationale pour la Recherche (FutureWeb) [ANR-18-EBI4-0009]; Dutch Research Council (FutureWeb) [E10005]	Belmont Forum; BiodivERsA; Agence Nationale pour la Recherche (FutureWeb)(French National Research Agency (ANR)); Dutch Research Council (FutureWeb)	This research was funded through the 2017-2018 Belmont Forum and BiodivERsA joint call for research proposals, under the BiodivScen ERA-Net COFUND program, and with the funding organizations Agence Nationale pour la Recherche (FutureWeb, ANR-18-EBI4-0009) and the Dutch Research Council (FutureWeb, grant E10005).	[Anonymous], Materials andmethods are available in the supplementarymaterials.; [Anonymous], MAT METHODS ARE AVAI; Arneth A, 2020, P NATL ACAD SCI USA, V117, P30882, DOI 10.1073/pnas.2009584117; Bolam FC, 2021, CONSERV LETT, V14, DOI 10.1111/conl.12762; Brauman KA, 2020, P NATL ACAD SCI USA, V117, P32799, DOI 10.1073/pnas.2010473117; Bubeck P, 2011, NAT HAZARD EARTH SYS, V11, P3293, DOI 10.5194/nhess-11-3293-2011; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; De Palma A, 2015, J APPL ECOL, V52, P1567, DOI 10.1111/1365-2664.12524; Dee LE, 2019, TRENDS ECOL EVOL, V34, P746, DOI 10.1016/j.tree.2019.03.010; Diaz S, 2018, SCIENCE, V359, P270, DOI 10.1126/science.aap8826; Dinerstein E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2869; Eastwood A, 2016, ECOSYST SERV, V17, P152, DOI 10.1016/j.ecoser.2015.12.001; Ficetola GF, 2015, DIVERS DISTRIB, V21, P302, DOI 10.1111/ddi.12296; Girardello M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41342-7; Grundstrom M, 2014, ENVIRON POLLUT, V189, P73, DOI 10.1016/j.envpol.2014.02.026; Heberling JM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018093118; Hocking DJ, 2014, HERPETOL CONSERV BIO, V9, P1; Kujala H, 2018, METHODS ECOL EVOL, V9, P2249, DOI 10.1111/2041-210X.13084; Kukkala AS, 2016, BIOL CONSERV, V198, P193, DOI 10.1016/j.biocon.2016.04.016; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Lavalle C., 2015, LF511 NO2 REMOVAL UR; Lavorel S, 2020, ECOSYST SERV, V45, DOI 10.1016/j.ecoser.2020.101155; Lehtomaki J, 2013, ENVIRON MODELL SOFTW, V47, P128, DOI 10.1016/j.envsoft.2013.05.001; Lehtomuki J., 2016, RUNNING ZONATION PLA; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Louette G, 2011, J NAT CONSERV, V19, P224, DOI 10.1016/j.jnc.2011.02.001; Mace GM, 2018, NAT SUSTAIN, V1, P448, DOI 10.1038/s41893-018-0130-0; Maiorano L, 2015, CONSERV BIOL, V29, P986, DOI 10.1111/cobi.12535; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; Maiorano L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074989; Mammola S, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.2166; Mateo-Tomas P, 2017, GLOBAL ECOL BIOGEOGR, V26, P1459, DOI 10.1111/geb.12673; Maxwell SL, 2020, NATURE, V586, P217, DOI 10.1038/s41586-020-2773-z; Moilanen A., 2014, USER MANUAL; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; OConnor L., 2021, Spatial priorities for vertebrate species and nature's contributions to people in Europe, Version 1, DOI [10.34894/TCNKPJ, DOI 10.34894/TCNKPJ]; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pascual U, 2017, CURR OPIN ENV SUST, V26-27, P7, DOI 10.1016/j.cosust.2016.12.006; Pearson RG, 2016, TRENDS ECOL EVOL, V31, P366, DOI 10.1016/j.tree.2016.02.005; Pereira L. M., 2020, PEOPLE NAT, V2, P1172, DOI DOI 10.1002/PAN3.10146; Pereira LM, 2020, PEOPLE NAT, V2, P1172, DOI 10.1002/pan3.10146; Pollock LJ, 2020, TRENDS ECOL EVOL, V35, P1119, DOI 10.1016/j.tree.2020.08.015; Pollock LJ, 2017, NATURE, V546, P141, DOI 10.1038/nature22368; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; Purvis A, 2020, NAT ECOL EVOL, V4, P768, DOI 10.1038/s41559-020-1181-y; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Roquet C, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.5102670fff8aa5c918e78f5592790e48; Schleicher J, 2019, NAT SUSTAIN, V2, P1094, DOI 10.1038/s41893-019-0423-y; Schulp CJE, 2014, ECOL ECON, V105, P292, DOI 10.1016/j.ecolecon.2014.06.018; Schulp CJE, 2014, ECOL INDIC, V36, P131, DOI 10.1016/j.ecolind.2013.07.014; Schulp CJE, 2008, AGR ECOSYST ENVIRON, V127, P251, DOI 10.1016/j.agee.2008.04.010; Strassburg BBN, 2020, NATURE, V586, P724, DOI 10.1038/s41586-020-2784-9; Sturck J, 2014, ECOL INDIC, V38, P198, DOI 10.1016/j.ecolind.2013.11.010; Tieskens KF, 2017, LAND USE POLICY, V62, P29, DOI 10.1016/j.landusepol.2016.12.001; van Berkel DB, 2011, LAND USE POLICY, V28, P447, DOI 10.1016/j.landusepol.2010.09.002; Verhagen W, 2017, CONSERV BIOL, V31, P860, DOI 10.1111/cobi.12872; Verkerk PJ, 2018, REG ENVIRON CHANGE, V18, P817, DOI 10.1007/s10113-016-1055-7; Xu WH, 2017, P NATL ACAD SCI USA, V114, P1601, DOI 10.1073/pnas.1620503114; Zulian G, 2013, LAND-BASEL, V2, P472, DOI 10.3390/land2030472	60	10	10	18	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					856	+		10.1126/science.abc4896	http://dx.doi.org/10.1126/science.abc4896			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016780	Green Published			2022-12-28	WOS:000653997000046
J	Tiacci, E; De Carolis, L; Simonetti, E; Capponi, M; Ambrosetti, A; Lucia, E; Antolino, A; Pulsoni, A; Ferrari, S; Zinzani, PL; Ascani, S; Perriello, VM; Rigacci, L; Gaidano, G; Della Seta, R; Frattarelli, N; Falcucci, P; Foa, R; Visani, G; Zaja, F; Falini, B				Tiacci, Enrico; De Carolis, Luca; Simonetti, Edoardo; Capponi, Monia; Ambrosetti, Achille; Lucia, Eugenio; Antolino, Agostino; Pulsoni, Alessandro; Ferrari, Samantha; Zinzani, Pier L.; Ascani, Stefano; Perriello, Vincenzo M.; Rigacci, Luigi; Gaidano, Gianluca; Della Seta, Roberta; Frattarelli, Natalia; Falcucci, Paolo; Foa, Robin; Visani, Giuseppe; Zaja, Francesco; Falini, Brunangelo			Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; BRAF INHIBITION; PHASE-II; CLADRIBINE; IMMUNOHISTOCHEMISTRY; ERADICATION; MANAGEMENT; MUTATIONS; DIAGNOSIS	BRAF Inhibition plus Rituximab in Hairy-Cell Leukemia The rare indolent B-cell cancer hairy-cell leukemia is often driven by activating BRAF mutations. BRAF inhibition induces responses, but relapse is common when therapy stops. The addition of rituximab (anti-CD20 antibody) to vemurafenib led to a complete response in 26 of 30 patients (87%) with relapsed or refractory disease; 78% were progression-free at 3 years. Background Hairy-cell leukemia (HCL) is a CD20+ indolent B-cell cancer in which a BRAF V600E kinase-activating mutation plays a pathogenetic role. In clinical trials involving patients with refractory or relapsed HCL, the targeting of BRAF V600E with the oral BRAF inhibitor vemurafenib led to a response in 91% of the patients; 35% of the patients had a complete response. However, the median relapse-free survival was only 9 months after treatment was stopped. Methods In a phase 2, single-center, academic trial involving patients with refractory or relapsed HCL, we assessed the safety and efficacy of vemurafenib (960 mg, administered twice daily for 8 weeks) plus concurrent and sequential rituximab (375 mg per square meter of body-surface area, administered for 8 doses over a period of 18 weeks). The primary end point was a complete response at the end of planned treatment. Results Among the 30 enrolled patients with HCL, the median number of previous therapies was 3. A complete response was observed in 26 patients (87%) in the intention-to-treat population. All the patients who had HCL that had been refractory to chemotherapy (10 patients) or rituximab (5) and all those who had previously been treated with BRAF inhibitors (7) had a complete response. Thrombocytopenia resolved after a median of 2 weeks, and neutropenia after a median of 4 weeks. Of the 26 patients with a complete response, 17 (65%) were cleared of minimal residual disease (MRD). Progression-free survival among all 30 patients was 78% at a median follow-up of 37 months; relapse-free survival among the 26 patients with a response was 85% at a median follow-up of 34 months. In post hoc analyses, MRD negativity and no previous BRAF inhibitor treatment correlated with longer relapse-free survival. Toxic effects, mostly of grade 1 or 2, were those that had previously been noted for these agents. Conclusions In this small study, a short, chemotherapy-free, nonmyelotoxic regimen of vemurafenib plus rituximab was associated with a durable complete response in most patients with refractory or relapsed HCL. (Funded by the European Research Council and others; HCL-PG03 EudraCT number, .)	[Tiacci, Enrico; De Carolis, Luca; Simonetti, Edoardo; Capponi, Monia; Ascani, Stefano; Perriello, Vincenzo M.; Falini, Brunangelo] Univ Perugia, Osped S Maria Misericordia, Inst Hematol, Perugia, Italy; [Tiacci, Enrico; De Carolis, Luca; Simonetti, Edoardo; Capponi, Monia; Ascani, Stefano; Perriello, Vincenzo M.; Falini, Brunangelo] Univ Perugia, Dept Med, Perugia, Italy; [Ambrosetti, Achille] Univ Verona, Dept Med, Sect Hematol, Verona, Italy; [Lucia, Eugenio] Osped Cosenza, Hematol Unit, Cosenza, Italy; [Antolino, Agostino] Maria Paterno Arezzo Hosp, Dept Transfus Med SIMMT, Hematol Unit, Ragusa, Italy; [Pulsoni, Alessandro; Foa, Robin] Sapienza Univ Rome, Hematol Unit, Dep Translat & Precis Med, Rome, Italy; [Rigacci, Luigi] AO San Camillo Forlanini, Hematol & Stem Cell Transplant Unit, Rome, Italy; [Ferrari, Samantha] Spedali Civili Brescia, Dept Hematol, Brescia, Italy; [Zinzani, Pier L.] Univ Bologna, Ist Emarol Seragnoli, IRCCS Azienda Osped Univ Bologna, Bologna, Italy; [Zinzani, Pier L.] Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy; [Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy; [Della Seta, Roberta] Osped Carrara, Hematol Unit, Carrara, Italy; [Frattarelli, Natalia] Osped Frosinone, Hematol Unit, Frosinone, Italy; [Falcucci, Paolo] Osped Ronciglione, Hematol Unit, Viterbo, Italy; [Visani, Giuseppe] Osped Pesaro, Hematol Unit, Pesaro, Italy; [Zaja, Francesco] Azienda Sanitaria Univ Integrara Osped Maggiore, Hematol Unit, Trieste, Italy	Hospital Santa Maria della Misericordia; University of Perugia; University of Perugia; University of Verona; Civile M.P. Arezzo Hospital; Sapienza University Rome; Azienda Ospedaliera San Camillo-Forlanini; Hospital Spedali Civili Brescia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; University of Eastern Piedmont Amedeo Avogadro	Tiacci, E; Falini, B (corresponding author), Osped S Maria Misericordia, Ctr Ric Ematooncol, Blocco R,Piano 2,Piazzale Menghini 8, I-06132 Perugia, Italy.	enrico.tiacci@unipg.it; brunangelo.falini@unipg.it	Gaidano, Gianluca/AAW-2773-2021	Gaidano, Gianluca/0000-0002-4681-0151	Associazione Italiana per la Ricerca sul Cancro [IG-14447 to ET, grant Metastasis/5-per-mille no. 21198 to BF and R] Funding Source: Medline; Fondation ARC pour la Recherche sur le Cancer [Leopold Griffuel Prize 2015 to BF] Funding Source: Medline; Leukemia and Lymphoma Society [Scholarship in Clinical Research 2030-14 to ET] Funding Source: Medline; Ministero della Salute [RF-2016-02362264 to ET] Funding Source: Medline; Hairy Cell Leukemia Foundation [grant 2016 to ET and BF] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Ministero della Salute(Ministry of Health, Italy); Hairy Cell Leukemia Foundation		Benz R, 2020, BLOOD ADV, V4, P3699, DOI 10.1182/bloodadvances.2020002160; Bohn JP, 2019, AM J HEMATOL, V94, pE180, DOI 10.1002/ajh.25474; Brown NA, 2015, AM J CLIN PATHOL, V143, P89, DOI 10.1309/AJCPDN4Q1JTFGCFC; Chakraborty R, 2020, COLD SPRING HARB PER; Chihara D, 2020, J CLIN ONCOL, V38, P1527, DOI 10.1200/JCO.19.02250; Chihara D, 2016, BRIT J HAEMATOL, V174, P760, DOI 10.1111/bjh.14129; Dietrich S, 2016, BLOOD, V127, P2847, DOI 10.1182/blood-2015-11-680074; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Else M, 2015, BEST PRACT RES CL HA, V28, P217, DOI 10.1016/j.beha.2015.09.004; Falini B, 2019, HEMATOL ONCOL, V37, P30, DOI 10.1002/hon.2594; Falini B, 2016, BLOOD, V128, P1918, DOI 10.1182/blood-2016-07-418434; Glenthoj A, 2021, EUR J HAEMATOL, V106, P72, DOI 10.1111/ejh.13519; Grever MR, 2017, BLOOD, V129, P553, DOI 10.1182/blood-2016-01-689422; Grever MR, 2010, BLOOD, V115, P21, DOI 10.1182/blood-2009-06-195370; Grever MR, LEUKEMIA; Gupta GK, 2020, AM J CLIN PATHOL, V153, P322, DOI 10.1093/ajcp/aqz171; Kreitman RJ, 2018, LEUKEMIA, V32, P1768, DOI 10.1038/s41375-018-0210-1; Kreitman RJ, 2018, BLOOD, V131, P2331, DOI 10.1182/blood-2017-09-803072; Lee LYW, 2020, LANCET ONCOL, V21, P1309, DOI 10.1016/S1470-2045(20)30442-3; Maitre E, 2019, AM J HEMATOL, V94, P1413, DOI 10.1002/ajh.25653; Nieva J, 2003, BLOOD, V102, P810, DOI 10.1182/blood-2003-01-0014; Ortiz-Maldonado V, 2018, BRIT J HAEMATOL, V183, P127, DOI 10.1111/bjh.14900; Paillassa J, 2020, BLOOD CANCER J, V10, DOI 10.1038/s41408-020-0328-z; Pettirossi V, 2015, BLOOD, V125, P1207, DOI 10.1182/blood-2014-10-603100; Raspadori D, 1999, LEUKEMIA, V13, P1254, DOI 10.1038/sj.leu.2401476; Rosenberg JD, 2014, BLOOD, V123, P177, DOI 10.1182/blood-2013-06-508754; Sarid N, 2015, BRIT J HAEMATOL, V171, P784, DOI 10.1111/bjh.13767; Shenoi DP, 2019, BLOOD ADV, V3, P116, DOI 10.1182/bloodadvances.2018027466; Sigal DS, 2010, BLOOD, V115, P1893, DOI 10.1182/blood-2009-10-251645; Tiacci E, 2015, NEW ENGL J MED, V373, P1733, DOI 10.1056/NEJMoa1506583; Tiacci E, 2006, NAT REV CANCER, V6, P437, DOI 10.1038/nrc1888; Tiacci E, 2021, LEUKEMIA, V35, P3314, DOI 10.1038/s41375-021-01210-8; Tiacci E, 2017, J CLIN ONCOL, V35, P1002, DOI 10.1200/JCO.2016.71.1556; Tiacci E, 2013, HAEMATOLOGICA, V98, P635, DOI 10.3324/haematol.2012.078071; Tiacci E, 2012, BLOOD, V119, P192, DOI 10.1182/blood-2011-08-371179; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Vergote V, 2014, ANN HEMATOL, V93, P2087, DOI 10.1007/s00277-014-2104-2	38	32	33	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					1810	1823		10.1056/NEJMoa2031298	http://dx.doi.org/10.1056/NEJMoa2031298			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD6UF	33979489	Green Published, Bronze			2022-12-28	WOS:000651509400009
J	Yu, J; Rao, P; Clark, S; Mitra, J; Ha, T; Gouaux, E				Yu, Jie; Rao, Prashant; Clark, Sarah; Mitra, Jaba; Ha, Taekjip; Gouaux, Eric			Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition	NATURE			English	Article							CRYO-EM; SYNAPTIC-TRANSMISSION; SUBUNIT COMPOSITION; CORNICHON PROTEINS; RECOMBINANT AMPA; TARP GAMMA-8; EXPRESSION; COMPLEXES; VISUALIZATION; REFINEMENT	AMPA-selective glutamate receptors mediate the transduction of signals between the neuronal circuits of the hippocampus(1). The trafficking, localization, kinetics and pharmacology of AMPA receptors are tuned by an ensemble of auxiliary protein subunits, which are integral membrane proteins that associate with the receptor to yield bona fide receptor signalling complexes(2). Thus far, extensive studies of recombinant AMPA receptor-auxiliary subunit complexes using engineered protein constructs have not been able to faithfully elucidate the molecular architecture of hippocampal AMPA receptor complexes. Here we obtain mouse hippocampal, calcium-impermeable AMPA receptor complexes using immunoaffinity purification and use single-molecule fluorescence and cryo-electron microscopy experiments to elucidate three major AMPA receptor-auxiliary subunit complexes. The GluA1-GluA2, GluA1-GluA2-GluA3 and GluA2-GluA3 receptors are the predominant assemblies, with the auxiliary subunits TARP-gamma 8 and CNIH2-SynDIG4 non-stochastically positioned at the B'/D' and A'/C' positions, respectively. We further demonstrate how the receptor-TARP-gamma 8 stoichiometry explains the mechanism of and submaximal inhibition by a clinically relevant, brain-region-specific allosteric inhibitor.	[Yu, Jie; Rao, Prashant; Clark, Sarah; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Mitra, Jaba] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL USA; [Mitra, Jaba; Ha, Taekjip] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Baltimore, MD USA; [Ha, Taekjip] Johns Hopkins Univ, Dept Biophys, Baltimore, MD USA; [Ha, Taekjip] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Ha, Taekjip] Howard Hughes Med Inst, Baltimore, MD USA; [Gouaux, Eric] Howard Hughes Med Inst, Portland, OR 97219 USA	Oregon Health & Science University; University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.; Gouaux, E (corresponding author), Howard Hughes Med Inst, Portland, OR 97219 USA.	gouauxe@ohsu.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Mitra, Jaba/0000-0001-6569-6203; Rao, Prashant/0000-0003-0132-5571	NIH [U24GM129547]; EMSL, a DOE Office of Science User Facility - Office of Biological and Environmental Research [grid.436923.9]; NIGMS [R35GM122569]; NINDS [R01NS038631]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMSL, a DOE Office of Science User Facility - Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Pacific Northwest Cryo-EM Center (PNCC) and OHSU MMC for microscope use, D. Cawley, P. Streeter, Y. Zhong and N. Sheldon for generating antibodies, A. Goehring for mouse dissections, M. Mayer for his guidance and advice on electrophysiology experiments, J. Elferich for help writing SiMPull processing scripts, S. Chen for help initiating the project, L. Vaskalis for assistance with figures, F. Jalali-Yazdi and H. Owen for help with manuscript preparation and R. Nicoll and members of the Gouaux laboratory for discussions. PNCC is supported by NIH grant U24GM129547 and accessed through EMSL (grid.436923.9), a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research. T.H. and J.M. were supported by the NIGMS grant R35GM122569. This work was supported by the NINDS grant R01NS038631 to E.G. T.H. and E.G. are investigators of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of National Institutes of Health.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; [Anonymous], 2020, PYMOL MOL GRAPHICS S; Baranovic J, 2016, BIOPHYS J, V110, P896, DOI 10.1016/j.bpj.2015.12.033; Biedermann J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2012843118; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Boudkkazi S, 2014, NEURON, V82, P848, DOI 10.1016/j.neuron.2014.03.031; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Carrillo E, 2020, J GEN PHYSIOL, V152, DOI 10.1085/jgp.201912451; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Diering GH, 2018, NEURON, V100, P314, DOI 10.1016/j.neuron.2018.10.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Gill MB, 2012, EUR J NEUROSCI, V35, P182, DOI 10.1111/j.1460-9568.2011.07948.x; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Harmel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030681; Herguedas B, 2019, SCIENCE, V364, P352, DOI 10.1126/science.aav9011; Herring BE, 2013, NEURON, V77, P1083, DOI 10.1016/j.neuron.2013.01.017; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jacobi E, 2017, CURR OPIN NEUROBIOL, V45, P32, DOI 10.1016/j.conb.2017.03.001; Jain A, 2012, NAT PROTOC, V7, P445, DOI 10.1038/nprot.2011.452; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Kamalova A, 2021, J PHYSIOL-LONDON, V599, P453, DOI 10.1113/JP278701; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kirk LM, 2016, J COMP NEUROL, V524, P2266, DOI 10.1002/cne.23945; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Maher MP, 2016, J PHARMACOL EXP THER, V357, P394, DOI 10.1124/jpet.115.231712; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matt L, 2018, CELL REP, V22, P2246, DOI 10.1016/j.celrep.2018.02.026; Morise J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145101; Nakagawa T, 2019, SCIENCE, V366, P1259, DOI 10.1126/science.aay2783; Penn AC, 2017, NATURE, V549, P384, DOI 10.1038/nature23658; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Sultan Faraz A, 2013, Bio Protoc, V3; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Troyano-Rodriguez E, 2019, MOL CELL NEUROSCI, V98, P155, DOI 10.1016/j.mcn.2019.06.008; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Zhao Y, 2019, SCIENCE, V364, P355, DOI 10.1126/science.aaw8250; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	58	22	22	3	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 17	2021	594	7863					448	+		10.1038/s41586-021-03540-0	http://dx.doi.org/10.1038/s41586-021-03540-0		MAY 2021	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SU1FZ	33981040	Green Accepted			2022-12-28	WOS:000650200300006
J	Li, SY; Vandvik, PO; Lytvyn, L; Guyatt, GH; Palmer, SC; Rodriguez-Gutierrez, R; Foroutan, F; Agoritsas, T; Siemieniuk, RAC; Walsh, M; Frere, L; Tunnicliffe, DJ; Nagler, EV; Manja, V; Asvold, BO; Jha, V; Vermandere, M; Gariani, K; Zhao, Q; Ren, Y; Cartwright, EJ; Gee, P; Wickes, A; Ferns, L; Wright, R; Li, L; Hao, QK; Mustafa, RA				Li, Sheyu; Vandvik, Per Olav; Lytvyn, Lyubov; Guyatt, Gordon H.; Palmer, Suetonia C.; Rodriguez-Gutierrez, Rene; Foroutan, Farid; Agoritsas, Thomas; Siemieniuk, Reed A. C.; Walsh, Michael; Frere, Lawrie; Tunnicliffe, David J.; Nagler, Evi, V; Manja, Veena; Asvold, Bjorn Olav; Jha, Viveekanand; Vermandere, Mieke; Gariani, Karim; Zhao, Qian; Ren, Yan; Cartwright, Emma Jane; Gee, Patrick; Wickes, Alan; Ferns, Linda; Wright, Robin; Li, Ling; Hao, Qiukui; Mustafa, Reem A.			SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INDIVIDUAL PARTICIPANT DATA; RISK EQUATIONS; COMPLICATIONS; ASSOCIATION; CONSENSUS; VALIDATION; OUTCOMES	CLINICAL QUESTION What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with type 2 diabetes at different risk for cardiovascular and kidney outcomes? CURRENT PRACTICE Clinical decisions about treatment of type 2 diabetes have been led by glycaemic control for decades. SGLT-2 inhibitors and GLP-1 receptor agonists are traditionally used in people with elevated glucose level after metformin treatment. This has changed through trials demonstrating atherosclerotic cardiovascular disease (CVD) and chronic kidney disease (CKD) benefits independent of medications' glucose-lowering potential. RECOMMENDATIONS The guideline panel issued risk-stratified recommendations concerning the use of SGLT-2 inhibitors or GLP-1 receptor agonists in adults with type 2 diabetes Three or fewer cardiovascular risk factors without established CVD or CKD: Weak recommendation against starting SGLT-2 inhibitors or GLP-1 receptor agonists. More than three cardiovascular risk factors without established CVD or CKD: Weak recommendation for starting SGLT-2 inhibitors and weak against starting GLP-1 receptor agonists. Established CVD or CKD: Weak recommendation for starting SGLT-2 inhibitors and GLP-1 receptor agonists. Established CVD and CKD: Strong recommendation for starting SGLT-2 inhibitors and weak recommendation for starting GLP-1 receptor agonists. For those committed to further reducing their risk for CVD and CKD outcomes: Weak recommendation for starting SGLT-2 inhibitors rather than GLP-1 receptor agonists. HOW THIS GUIDELINE WAS CREATED An international panel including patients, clinicians, and methodologists created these recommendations following standards for trustworthy guidelines and using the GRADE approach. The panel applied an individual patient perspective. THE EVIDENCE A linked systematic review and network meta-analysis (764 randomised trials included 421346 participants) of benefits and harms found that SGLT-2 inhibitors and GLP-1 receptor agonists generally reduce overall death, and incidence of myocardial infarctions, and end-stage kidney disease or kidney failure (moderate to high certainty evidence). These medications exert different effects on stroke, hospitalisations for heart failure, and key adverse events in different subgroups. Absolute effects of benefit varied widely based on patients' individual risk (for example, from five fewer deaths in the lowest risk to 48 fewer deaths in the highest risk, for 1000 patients treated over five years). A prognosis review identified 14 eligible risk prediction models, one of which (RECODe) informed most baseline risk estimates in evidence summaries to underpin the risk-stratified recommendations. Concerning patients' values and preferences, the recommendations were supported by evidence from a systematic review of published literature, a patient focus group study, a practical issues summary, and a guideline panel survey. UNDERSTANDING THE RECOMMENDATION We stratified the recommendations by the levels of risk for CVD and CKD and systematically considered the balance of benefits, harms, other considerations, and practical issues for each risk group. The strong recommendation for SGLT-2 inhibitors in patients with CVD and CKD reflects what the panel considered to be a clear benefit. For all other adults with type 2 diabetes, the weak recommendations reflect what the panel considered to be a finer balance between benefits, harms, and burdens of treatment options. Clinicians using the guideline can identify their patient's individual risk for cardiovascular and kidney outcomes using credible risk calculators such as RECODe. Interactive evidence summaries and decision aids may support well informed treatment choices, including shared decision making.	[Li, Sheyu; Ren, Yan] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Peoples R China; [Li, Sheyu; Li, Ling] Sichuan Univ, Chinese Evidence Based Med Ctr, Cochrane China Ctr, West China Hosp, Chengdu, Peoples R China; [Li, Sheyu; Li, Ling] Sichuan Univ, MAGIC China Ctr, West China Hosp, Chengdu, Peoples R China; [Vandvik, Per Olav] Univ Oslo, Oslo, Norway; [Vandvik, Per Olav] MAGIC Evidence Ecosyst Fdn, Oslo, Norway; [Lytvyn, Lyubov; Guyatt, Gordon H.; Siemieniuk, Reed A. C.; Walsh, Michael; Hao, Qiukui; Mustafa, Reem A.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Guyatt, Gordon H.; Siemieniuk, Reed A. C.; Walsh, Michael] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Palmer, Suetonia C.] Univ Otago, Dept Med, Christchurch, New Zealand; [Rodriguez-Gutierrez, Rene] Univ Autonoma Nuevo Leon, Plataforma INVEST Med UANL KER Unit KER Unit Mexi, Subdirecc Invest, Monterrey 64460, Mexico; [Rodriguez-Gutierrez, Rene] Mayo Clin, Knowledge & Evaluat Res Unit Endocrinol, Rochester, MN 55905 USA; [Rodriguez-Gutierrez, Rene] Univ Autonoma Nuevo Leon, Div Endocrinol, Dept Internal Med, Univ Hosp Dr Jose E Gonzalez, Monterrey 64460, Mexico; [Foroutan, Farid] Ted Rogers Ctr Heart Res, Toronto, ON, Canada; [Agoritsas, Thomas; Gariani, Karim] Geneva Univ Hosp, Serv Endocrinol Diabet Nutr & Patient Therapeut E, Geneva, Switzerland; [Frere, Lawrie] Newbridge Surg, Bath, Avon, England; [Tunnicliffe, David J.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Tunnicliffe, David J.] Childrens Hosp Westmead, Ctr Kidney Res, Sydney, Australia; [Nagler, Evi, V] Ghent Univ Hosp, Renal Div, Ghent, Belgium; [Manja, Veena] Univ Calif Davis, Davis, CA 95616 USA; [Asvold, Bjorn Olav] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Endocrinol, Med Clin, Trondheim, Norway; [Asvold, Bjorn Olav] Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Dept Publ Hlth & Nursing, NTNU, Trondheim, Norway; [Jha, Viveekanand] UNSW, George Inst Global Hlth, Sydney, NSW, Australia; Imperial Coll, Sch Publ Hlth, London, England; [Jha, Viveekanand] Manipal Acad Higher Educ, Prasanna Sch Publ Hlth, Manipal, India; [Vermandere, Mieke] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Zhao, Qian] Sichuan Univ, Int Med Ctr, Ward Gen Practice, West China Hosp, Chengdu, Peoples R China; [Gee, Patrick] iAdvocate Inc, Chesterfield, VA USA; [Hao, Qiukui] Sichuan Univ, West China Hosp, Ctr Gerontol & Geriatr, Natl Clin Res Ctr Geriatr, Chengdu, Peoples R China; [Mustafa, Reem A.] Univ Kansas, Dept Internal Med, Div Nephrol & Hypertens, Kansas City, KS 64110 USA	Sichuan University; Sichuan University; Sichuan University; University of Oslo; McMaster University; McMaster University; University of Otago; Universidad Autonoma de Nuevo Leon; Mayo Clinic; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; University of Geneva; University of Sydney; University of Sydney; Ghent University; Ghent University Hospital; University of California System; University of California Davis; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Imperial College London; Manipal Academy of Higher Education (MAHE); KU Leuven; Sichuan University; Sichuan University; University of Kansas	Hao, QK; Mustafa, RA (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Hao, QK (corresponding author), Sichuan Univ, West China Hosp, Ctr Gerontol & Geriatr, Natl Clin Res Ctr Geriatr, Chengdu, Peoples R China.; Mustafa, RA (corresponding author), Univ Kansas, Dept Internal Med, Div Nephrol & Hypertens, Kansas City, KS 64110 USA.	haoqiukui@gmail.com; rmustafa@kumc.edu	Li, Sheyu/O-3242-2016	Li, Sheyu/0000-0003-0060-0287; Zhao, Qian/0000-0002-9540-5726; Jha, Vivekanand/0000-0002-8015-9470; Tunnicliffe, David J./0000-0003-3270-3475; Walsh, Michael/0000-0001-8292-2014	1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University [ZYGD18022]	1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University	This guideline was funded by the 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (grant number ZYGD18022) .	Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS111, DOI 10.2337/dc21-S009; Basu S, 2018, DIABETES CARE, V41, P586, DOI 10.2337/dc17-2002; Basu S, 2017, LANCET DIABETES ENDO, V5, P788, DOI 10.1016/S2213-8587(17)30221-8; Bersoff-Matcha SJ, 2019, ANN INTERN MED, V170, P764, DOI 10.7326/M19-0085; Bommer C, 2018, DIABETES CARE, V41, P963, DOI 10.2337/dc17-1962; Buchan TA, 2021, HEART, V107, P1962, DOI 10.1136/heartjnl-2021-319243; [中华医学会糖尿病学分会 Chinese Diabetes Society], 2020, [中华糖尿病杂志, Chinese Journal of Diabetes Mellitus], V12, P369; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Cosentino F., 2020, EUR HEART J, V41, P255, DOI [10.1093/eurheartj/ehz486, DOI 10.1093/eurheartj/ehz486]; Das SR, 2020, J AM COLL CARDIOL, V76, P1117, DOI 10.1016/j.jacc.2020.05.037; Einarson TR, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0728-6; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Garber AJ, 2020, ENDOCR PRACT, V26, P107, DOI 10.4158/CS-2019-0472; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2019, LANCET, V394, P121, DOI 10.1016/S0140-6736(19)31149-3; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hirji I, 2012, J DIABETES COMPLICAT, V26, P501, DOI 10.1016/j.jdiacomp.2012.06.012; Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group, 2020, Kidney Int, V98, pS1, DOI 10.1016/j.kint.2020.06.019; Li L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2366; Liu JL, 2020, DIABETES OBES METAB, V22, P1619, DOI 10.1111/dom.14075; Lupsa BC, 2018, DIABETOLOGIA, V61, P2118, DOI 10.1007/s00125-018-4663-6; Marx N, 2020, DIABETES STOFFWECH H, V29, P164, DOI 10.1016/j.diabres.2020.108092; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; National Institute for Health and Care Excellence, 2020, NICE GUID; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Palmer SC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4573; Palmer SC, 2016, JAMA-J AM MED ASSOC, V316, P313, DOI 10.1001/jama.2016.9400; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Rodriguez-Gutierrez R, BMJ OPEN; Rodriguez-Gutierrez R, 2016, CIRC-CARDIOVASC QUAL, V9, P504, DOI 10.1161/CIRCOUTCOMES.116.002901; RODRIGUEZGUTIERREZ, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L5887; SIEMIENIUK RA, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/BMJ.I5191; Steenkamp DW, 2013, CURR DIABETES REP, V13, P130, DOI 10.1007/s11892-012-0342-z; Ueda P, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4365; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X; Zhang Y, 2019, J CLIN EPIDEMIOL, V111, P83, DOI 10.1016/j.jclinepi.2018.05.011; Zheng SL, 2018, JAMA-J AM MED ASSOC, V319, P1580, DOI 10.1001/jama.2018.3024; Zhou YL, 2021, CHINESE MED J-PEKING, V134, P1317, DOI 10.1097/CM9.0000000000001407; Zhu JH, 2020, LANCET DIABETES ENDO, V8, P192, DOI 10.1016/S2213-8587(19)30422-X	40	28	28	5	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1091	10.1136/bmj.n1091	http://dx.doi.org/10.1136/bmj.n1091			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975892	Green Published, Bronze			2022-12-28	WOS:000649711400010
J	O'Dowd, A				O'Dowd, Adrian			Supporting teams through the pandemic: nephrologist Reza Motazed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1039	10.1136/bmj.n1039	http://dx.doi.org/10.1136/bmj.n1039			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975855	Bronze			2022-12-28	WOS:000649711400012
J	de Lepinay, LM; Ockeloen-Korppi, CF; Woolley, MJ; Sillanpaa, MA				de Lepinay, Laure Mercier; Ockeloen-Korppi, Caspar F.; Woolley, Matthew J.; Sillanpaa, Mika A.			Quantum mechanics-free subsystem with mechanical oscillators	SCIENCE			English	Article							EVADING MEASUREMENT; ENTANGLEMENT; MOTION; NOISE; FORCE	Quantum mechanics sets a limit for the precision of continuous measurement of the position of an oscillator. We show how it is possible to measure an oscillator without quantum back-action of the measurement by constructing one effective oscillator from two physical oscillators. We realize such a quantum mechanics-free subsystem using two micromechanical oscillators, and show the measurements of two collective quadratures while evading the quantum back-action by 8 decibels on both of them, obtaining a total noise within a factor of 2 of the full quantum limit. This facilitates the detection of weak forces and the generation and measurement of nonclassical motional states of the oscillators. Moreover, we directly verify the quantum entanglement of the two oscillators by measuring the Duan quantity 1.4 decibels below the separability bound.	[de Lepinay, Laure Mercier; Ockeloen-Korppi, Caspar F.; Sillanpaa, Mika A.] Aalto Univ, QTF Ctr Excellence, Dept Appl Phys, FI-00076 Aalto, Finland; [Woolley, Matthew J.] UNSW Canberra, Sch Engn & Informat Technol, Canberra, ACT 2600, Australia; [Ockeloen-Korppi, Caspar F.] IQM Finland Oy, Keilaranta 19, Espoo 02150, Finland	Aalto University; University of New South Wales Sydney	Sillanpaa, MA (corresponding author), Aalto Univ, QTF Ctr Excellence, Dept Appl Phys, FI-00076 Aalto, Finland.	mika.sillanpaa@aalto.fi	Sillanpaa, Mika/A-3554-2013; de Lépinay, Laure Mercier/ABH-4084-2020	de Lépinay, Laure Mercier/0000-0001-9938-5825	ARC Centre for Engineered Quantum Systems [CE170100009]; AFOSR through the Asian Office of Aerospace Research and Development (AOARD) [FA 2386-18-1-4026]; Academy of Finland [308290, 307757, 312057]; European Research Council [615755-CAVITYQPD]; Aalto Centre for Quantum Engineering; Academy of Finland Centre of Excellence program [336810]; European Union [732894]	ARC Centre for Engineered Quantum Systems(Australian Research Council); AFOSR through the Asian Office of Aerospace Research and Development (AOARD); Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); Aalto Centre for Quantum Engineering; Academy of Finland Centre of Excellence program(Academy of Finland); European Union(European Commission)	Supported by ARC Centre for Engineered Quantum Systems (CE170100009) and AFOSR FA 2386-18-1-4026 through the Asian Office of Aerospace Research and Development (AOARD) (M.J.W.) and by the Academy of Finland (contracts 308290, 307757, 312057), the European Research Council (615755-CAVITYQPD), and the Aalto Centre for Quantum Engineering. The work was performed as part of the Academy of Finland Centre of Excellence program (project 336810). We acknowledge funding from the European Union's Horizon 2020 research and innovation program under grant agreement 732894 (FETPRO HOT).	Anetsberger G, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.061804; Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; Caniard T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.110801; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Duan LM, 2000, PHYS REV LETT, V84, P2722, DOI 10.1103/PhysRevLett.84.2722; Kotler S, 2021, SCIENCE, V372, P622, DOI 10.1126/science.abf2998; Lei CU, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.100801; Mason D, 2019, NAT PHYS, V15, P745, DOI 10.1038/s41567-019-0533-5; Moller CB, 2017, NATURE, V547, P191, DOI 10.1038/nature22980; Motazedifard A, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/7/073040; Ockeloen-Korppi CF, 2018, NATURE, V556, P478, DOI 10.1038/s41586-018-0038-x; Ockeloen-Korppi CF, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.140401; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; Reid MD, 2009, REV MOD PHYS, V81, P1727, DOI 10.1103/RevModPhys.81.1727; Riedinger R, 2018, NATURE, V556, P473, DOI 10.1038/s41586-018-0036-z; Schreppler S, 2014, SCIENCE, V344, P1486, DOI 10.1126/science.1249850; Shomroni I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10024-3; Suh J, 2014, SCIENCE, V344, P1262, DOI 10.1126/science.1253258; Tan HT, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.033829; Tan SM, 1999, PHYS REV A, V60, P2752, DOI 10.1103/PhysRevA.60.2752; Teufel JD, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.013602; Teufel JD, 2011, NATURE, V471, P204, DOI 10.1038/nature09898; Teufel JD, 2009, NAT NANOTECHNOL, V4, P820, DOI [10.1038/NNANO.2009.343, 10.1038/nnano.2009.343]; Thomas RA, 2021, NAT PHYS, V17, P228, DOI 10.1038/s41567-020-1031-5; Tsang M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031016; Tsang M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.123601; Wang YD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.253601; Woolley MJ, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.063805; Woolley MJ, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063846; Zhang KY, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043632	31	38	38	4	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					625	+		10.1126/science.abf5389	http://dx.doi.org/10.1126/science.abf5389			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958476	Green Submitted			2022-12-28	WOS:000649103500045
J	Koo, BK; Kang, J; Park, KW; Rhee, TM; Yang, HM; Won, KB; Rha, SW; Bae, JW; Lee, NH; Hur, SH; Yoon, J; Park, TH; Kim, BS; Lim, SW; Cho, YH; Jeon, DW; Kim, SH; Han, JK; Shin, ES; Kim, HS				Koo, Bon-Kwon; Kang, Jeehoon; Park, Kyung Woo; Rhee, Tae-Min; Yang, Han-Mo; Won, Ki-Bum; Rha, Seung-Woon; Bae, Jang-Whan; Lee, Nam Ho; Hur, Seung-Ho; Yoon, Junghan; Park, Tae-Ho; Kim, Bum Soo; Lim, Sang Wook; Cho, Yoon Haeng; Jeon, Dong Woon; Kim, Sang-Hyun; Han, Jung-Kyu; Shin, Eun-Seok; Kim, Hyo-Soo		HOST-EXAM Investigators	Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial	LANCET			English	Article							DUAL ANTIPLATELET THERAPY; ARTERY-DISEASE; FOCUSED UPDATE; ASSOCIATION; GUIDELINES; INHIBITOR; BENEFIT	Background Optimal antiplatelet monotherapy during the chronic maintenance period in patients who undergo coronary stenting is unknown. We aimed to compare head to head the efficacy and safety of aspirin and clopidogrel monotherapy in this population. Methods We did an investigator-initiated, prospective, randomised, open-label, multicentre trial at 37 study sites in South Korea. We enrolled patients aged at least 20 years who maintained dual antiplatelet therapy without clinical events for 6-18 months after percutaneous coronary intervention with drug-eluting stents (DES). We excluded patients with any ischaemic and major bleeding complications. Patients were randomly assigned (1:1) to receive a monotherapy agent of clopidogrel 75 mg once daily or aspirin 100 mg once daily for 24 months. The primary endpoint was a composite of all-cause death, non-fatal myocardial infarction, stroke, readmission due to acute coronary syndrome, and Bleeding Academic Research Consortium (BARC) bleeding type 3 or greater, in the intention-to-treat population. This trial is registered with ClinicalTrials.gov, NCT02044250. Findings Between March 26, 2014, and May 29, 2018, we enrolled 5530 patients. 5438 (98.3%) patients were randomly assigned to either the clopidogrel group (2710 [49.8%]) or to the aspirin group (2728 [50.2%]). Ascertainment of the primary endpoint was completed in 5338 (98.2%) patients. During 24-month follow-up, the primary outcome occurred in 152 (5.7%) patients in the clopidogrel group and 207 (7.7%) in the aspirin group (hazard ratio 0.73 [95% CI 0.59-0.90]; p=0.0035). Interpretation Clopidogrel monotherapy, compared with aspirin monotherapy during the chronic maintenance period after percutaneous coronary intervention with DES significantly reduced the risk of the composite of all-cause death, non-fatal myocardial infarction, stroke, readmission due to acute coronary syndrome, and BARC bleeding type 3 or greater. In patients requiring indefinite antiplatelet monotherapy after percutaneous coronary intervention, clopidogrel monotherapy was superior to aspirin monotherapy in preventing future adverse clinical events. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Koo, Bon-Kwon; Kang, Jeehoon; Park, Kyung Woo; Rhee, Tae-Min; Yang, Han-Mo; Han, Jung-Kyu] Seoul Natl Univ Hosp, Cardiol Ctr, Dept Internal Med, Seoul, South Korea; [Won, Ki-Bum; Shin, Eun-Seok] Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea; [Rha, Seung-Woon] Korea Univ, Guro Hosp, Seoul, South Korea; [Bae, Jang-Whan] Chungbuk Natl Univ Hosp, Dept Internal Med, Cheongju, South Korea; [Lee, Nam Ho] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Hur, Seung-Ho] Keimyung Univ Dongsan Hosp, Dept Internal Med, Daegu, South Korea; [Yoon, Junghan] Yonsei Univ, Dept Internal Med, Wonju Severance Christian Hosp, Wonju, South Korea; [Park, Tae-Ho] Dong A Univ Hosp, Dept Internal Med, Busan, South Korea; [Kim, Bum Soo] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea; [Lim, Sang Wook] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Seongnam, South Korea; [Cho, Yoon Haeng] Soonchunhyang Univ, Dept Internal Med, Bucheon Hosp, Bucheon, South Korea; [Jeon, Dong Woon] Natl Hlth Insurance Serv Ilsan Hosp, Dept Internal Med, Goyang, South Korea; [Kim, Sang-Hyun] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Hyo-Soo] Seoul Natl Univ Hosp, Cardiovasc Ctr, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Ulsan University Hospital; Korea University; Korea University Medicine (KU Medicine); Chungbuk National University; Chungbuk National University Hospital; Hallym University; Keimyung University; Yonsei University; Dong A University; Sungkyunkwan University (SKKU); Samsung Medical Center; Pochon Cha University; Soonchunhyang University; National Health Insurance Service; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, HS (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, Dept Internal Med, Seoul, South Korea.	hyosoo@snu.ac.kr	Rha, Seung-Woon/AGE-5810-2022	Rha, Seung-Woon/0000-0001-9456-9852; Kim, Sang-Hyun/0000-0001-8026-1582	ChongKunDang; SamJin; HanMi; DaeWoong; South Korea Ministry of Health and Welfare	ChongKunDang; SamJin; HanMi; DaeWoong; South Korea Ministry of Health and Welfare	ChongKunDang, SamJin, HanMi, DaeWoong, and the South Korea Ministry of Health and Welfare.	Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bhatt DL, 2002, AM J CARDIOL, V90, P625, DOI 10.1016/S0002-9149(02)02567-5; Bhatt DL, 2001, CIRCULATION, V103, P363; Bowman L, 2018, NEW ENGL J MED, V379, P1529, DOI 10.1056/NEJMoa1804988; Chiarito M, 2020, LANCET, V395, P1487, DOI 10.1016/S0140-6736(20)30315-9; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Gaziano JM, 2018, LANCET, V392, P1036, DOI 10.1016/S0140-6736(18)31924-X; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Giacoppo D, 2021, EUR HEART J, V42, P308, DOI 10.1093/eurheartj/ehaa739; Kang J, 2018, KOREAN CIRC J, V48, P537, DOI 10.4070/kcj.2018.0166; Kim BK, 2020, JAMA-J AM MED ASSOC, V323, P2407, DOI 10.1001/jama.2020.7580; Kim HS, 2020, LANCET, V396, P1079, DOI 10.1016/S0140-6736(20)31791-8; Lee H, 2017, AM HEART J, V185, P17, DOI 10.1016/j.ahj.2016.12.001; Lemesle G, 2016, CARDIOLOGY, V134, P11, DOI 10.1159/000442706; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Lim WH, 2016, THROMB HAEMOSTASIS, V116, P78, DOI 10.1160/TH15-12-0931; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; McNeil JJ, 2018, NEW ENGL J MED, V379, P1519, DOI 10.1056/NEJMoa1803955; McNeil JJ, 2018, NEW ENGL J MED, V379, P1509, DOI 10.1056/NEJMoa1805819; Neumann FJ, 2019, EUR HEART J, V40, P79, DOI 10.1093/eurheartj/ehy855; Park TK, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.002816; Ringleb PA, 2004, STROKE, V35, P528, DOI 10.1161/01.STR.0000110221.54366.49; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2011, OBSTET GYNECOL SURV, V66, P222, DOI 10.1097/OGX.0b013e318225cec2; Sim DS, 2020, KOREAN CIRC J, V50, P120, DOI 10.4070/kcj.2019.0166; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Valgimigli M, 2018, EUR HEART J, V39, P187, DOI 10.1093/eurheartj/ehx768	27	67	69	4	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 26	2021	397	10293					2487	2496		10.1016/S0140-6736(21)01063-1	http://dx.doi.org/10.1016/S0140-6736(21)01063-1		JUN 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TA5XM	34010616				2022-12-28	WOS:000667322400031
J	Obradovic, A; Chowdhury, N; Haake, SM; Ager, C; Wang, V; Vlahos, L; Guo, XZV; Aggen, DH; Rathmell, WK; Jonasch, E; Johnson, JE; Roth, M; Beckermann, KE; Rini, BI; McKiernan, J; Califano, A; Drake, CG				Obradovic, Aleksandar; Chowdhury, Nivedita; Haake, Scott M.; Ager, Casey; Wang, Vinson; Vlahos, Lukas; Guo, Xinzheng, V; Aggen, David H.; Rathmell, W. Kimryn; Jonasch, Eric; Johnson, Joyce E.; Roth, Marc; Beckermann, Kathryn E.; Rini, Brian, I; McKiernan, James; Califano, Andrea; Drake, Charles G.			Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages	CELL			English	Article							CANCER; NETWORK; TREM2; INFERENCE; TARGET; CD70	Clear cell renal carcinoma (ccRCC) is a heterogeneous disease with a variable post-surgical course. To assemble a comprehensive ccRCC tumor microenvironment (TME) atlas, we performed single-cell RNA sequencing (scRNA-seq) of hematopoietic and non-hematopoietic subpopulations from tumor and tumor-adjacent tissue of treatment-naive ccRCC resections. We leveraged the VIPER algorithm to quantitate single-cell protein activity and validated this approach by comparison to flow cytometry. The analysis identified key TME subpopulations, as well as their master regulators and candidate cell-cell interactions, revealing clinically relevant populations, undetectable by gene-expression analysis. Specifically, we uncovered a tumor-specific macrophage subpopulation characterized by upregulation of TREM2/APOE/C1Q, validated by spatially resolved, quantitative multispectral immunofluorescence. In a large clinical validation cohort, these markers were significantly enriched in tumors from patients who recurred following surgery. The study thus identifies TREM2/APOE/C1Q-positive macrophage infiltration as a potential prognostic biomarker for ccRCC recurrence, as well as a candidate therapeutic target.	[Obradovic, Aleksandar; Chowdhury, Nivedita; Ager, Casey; Guo, Xinzheng, V; Aggen, David H.; Drake, Charles G.] Columbia Univ, Columbia Ctr Translat Immunol CCTI, Irving Med Ctr CUMC, New York, NY 10032 USA; [Wang, Vinson; McKiernan, James; Drake, Charles G.] Herbert Irving Comprehens Canc Ctr HICC, Dept Urol, New York, NY 10032 USA; [Obradovic, Aleksandar; Vlahos, Lukas; Califano, Andrea] HICC, Dept Syst Biol, New York, NY 10032 USA; [Chowdhury, Nivedita; Califano, Andrea] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [McKiernan, James; Califano, Andrea; Drake, Charles G.] Columbia Univ, HICC, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Califano, Andrea] JP Sulzberger Columbia Genome Ctr, New York, NY 10032 USA; [Rathmell, W. Kimryn; Jonasch, Eric; Johnson, Joyce E.; Roth, Marc; Beckermann, Kathryn E.; Rini, Brian, I] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Haake, Scott M.] MD Anderson Canc Ctr, Houston, TX USA; [Aggen, David H.] MSKCC, Div Solid Tumor Oncol, New York, NY 10065 USA	Columbia University; Johns Hopkins University; Columbia University; Columbia University; Columbia University; Columbia University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center	Drake, CG (corresponding author), Columbia Univ, Columbia Ctr Translat Immunol CCTI, Irving Med Ctr CUMC, New York, NY 10032 USA.; Drake, CG (corresponding author), Herbert Irving Comprehens Canc Ctr HICC, Dept Urol, New York, NY 10032 USA.; Califano, A (corresponding author), HICC, Dept Syst Biol, New York, NY 10032 USA.; Califano, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA.; Califano, A; Drake, CG (corresponding author), Columbia Univ, HICC, New York, NY 10032 USA.; Califano, A (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.; Califano, A (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA.; Califano, A (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA.; Califano, A (corresponding author), JP Sulzberger Columbia Genome Ctr, New York, NY 10032 USA.	ac2248@cumc.columbia.edu; cgd2139@columbia.edu	Guo, Xinzheng Victor/ABG-2980-2021; Chowdhury, Nivedita/ABH-3806-2020	Guo, Xinzheng Victor/0000-0003-0499-9870; Chowdhury, Nivedita/0000-0001-7327-3067; Obradovic, Aleksandar/0000-0002-8009-0186; Haake, Scott/0000-0003-3455-0791; Vlahos, Lukas/0000-0002-4083-6924	National Cancer Institute's Office of Cancer Genomics Cancer Target Discovery and Development (CTD2) initiative; National Institutes of Health (NIH) [R01 CA127153, 1P50CA58236-15, P30CA006973]; CUMC institutional funds; NIH [R35CA197745, U01DA217858, S10 OD012351, S10 OD021764]; NIH grant R38 grant [CA231577]; DOD/CDMRP award [W81XWH-17-10309, CA160728];  [P30CA013696]	National Cancer Institute's Office of Cancer Genomics Cancer Target Discovery and Development (CTD2) initiative; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CUMC institutional funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant R38 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD/CDMRP award; 	This work was supported by the National Cancer Institute's Office of Cancer Genomics Cancer Target Discovery and Development (CTD2) initiative. The results published here are based in whole or in part upon data generated by Cancer Target Discovery and Development (CTD2) Network (https://ocg.cancer.gov/programs/ctd2/data-portal) established by the National Cancer Institute's Office of Cancer Genomics. This research was also supported by National Institutes of Health (NIH) grants R01 CA127153, 1P50CA58236-15, and P30CA006973 and CUMC institutional funds to C.G.D.; by NIH grants R35CA197745, U01DA217858, S10 OD012351, and S10 OD021764 to A.C. and by NIH grant R38 grant CA231577 to D.H.A. The independent validation RNA-seq dataset was supported by DOD/CDMRP award W81XWH-17-10309 under proposal CA160728. The P30CA013696 Cancer Center grant supports of the Flow Cytometry Core at HICCC Siu-Hong-Ho and Luke Caisheng assisted with FACS sorting.	Alvarez M.J., 2018, DARWIN ONCOTARGET ON; Alvarez MJ, 2018, NAT GENET, V50, P979, DOI 10.1038/s41588-018-0138-4; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Arik D, 2017, PATHOL ONCOL RES, V23, P409, DOI 10.1007/s12253-016-0128-8; Arumugam K, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108474; Barkal AA, 2019, NATURE, V572, P392, DOI 10.1038/s41586-019-1456-0; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Becht E, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1049804; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chao JL, 2018, J IMMUNOL, V200, P415, DOI 10.4049/jimmunol.1701188; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Chung W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15081; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Ding HX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03843-3; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dutta A, 2016, SCIENCE, V352, P1576, DOI 10.1126/science.aad9512; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Farber NJ, 2017, TRANSL CANCER RES, V6, P620, DOI 10.21037/tcr.2017.05.19; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Hsieh JJ, 2018, J CLIN ONCOL, V36, P3533, DOI 10.1200/JCO.2018.79.2549; Jacobs J, 2015, PHARMACOL THERAPEUT, V155, P1, DOI 10.1016/j.pharmthera.2015.07.007; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Jilaveanu LB, 2012, HUM PATHOL, V43, P1394, DOI 10.1016/j.humpath.2011.10.014; Katzenelenbogen Y, 2020, CELL, V182, P872, DOI 10.1016/j.cell.2020.06.032; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Koul H, 2011, AM J CANCER RES, V1, P240; Lachmann A, 2016, BIOINFORMATICS, V32, P2233, DOI 10.1093/bioinformatics/btw216; Li XT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13157; Lizio M, 2019, NUCLEIC ACIDS RES, V47, pD752, DOI 10.1093/nar/gky1099; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Martens JHA, 2013, HAEMATOLOGICA, V98, P1487, DOI 10.3324/haematol.2013.094243; Ramirez A., 2015, ALZHEIMERS DEMENT, V11, P500; Roumenina LT, 2019, CANCER IMMUNOL RES, V7, P1091, DOI 10.1158/2326-6066.CIR-18-0891; Roussos P, 2015, ALZHEIMERS DEMENT, V11, P1163, DOI 10.1016/j.jalz.2014.10.013; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sanchez-Gastaldo A, 2017, CANCER TREAT REV, V60, P77, DOI 10.1016/j.ctrv.2017.08.010; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Talos F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14662; Tan HS, 2017, ONCOTARGET, V8, P76189, DOI 10.18632/oncotarget.19198; Turajlic S, 2017, LANCET ONCOL, V18, P1009, DOI 10.1016/S1470-2045(17)30516-8; Vargas FA, 2017, IMMUNITY, V46, P577, DOI 10.1016/j.immuni.2017.03.013; Wang XQ, 2016, ONCOTARGET, V7, P2354, DOI 10.18632/oncotarget.6221; Yao YA, 2016, ONCOTARGET, V7, P29620, DOI 10.18632/oncotarget.8813; Zeleke TZ., NETWORK BASED ASSESS, DOI [10.1101/2020.04.23.20066928, DOI 10.1101/2020.04.23.20066928]; ZHENG GX, 2017, NATURE, V0008	50	34	35	8	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					2988	+		10.1016/j.cell.2021.04.038	http://dx.doi.org/10.1016/j.cell.2021.04.038		MAY 2021	34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	34019793	Green Accepted, Bronze			2022-12-28	WOS:000656965600015
J	Roquilly, A; Moyer, JD; Huet, O; Lasocki, S; Cohen, B; Dahyot-Fizelier, C; Chalard, K; Seguin, P; Jeantrelle, C; Vermeersch, V; Gaillard, T; Cinotti, R; Latte, DDD; Mahe, PJ; Vourc'h, M; Martin, FP; Chopin, A; Lerebourg, C; Flet, L; Chiffoleau, A; Feuillet, F; Asehnoune, K				Roquilly, Antoine; Moyer, Jean Denis; Huet, Olivier; Lasocki, Sigismond; Cohen, Benjamin; Dahyot-Fizelier, Claire; Chalard, Kevin; Seguin, Philippe; Jeantrelle, Caroline; Vermeersch, Veronique; Gaillard, Thomas; Cinotti, Raphael; Latte, Dominique Demeure Dit; Mahe, Pierre Joachim; Vourc'h, Mickael; Martin, Florian Pierre; Chopin, Alice; Lerebourg, Celine; Flet, Laurent; Chiffoleau, Anne; Feuillet, Fanny; Asehnoune, Karim		Atlanrea Study Grp; Soc Francaise Anesthesie Reanima	Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients With Traumatic Brain Injury: The COBI Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THERAPY; ASSOCIATION; MODERATE; HYPERNATREMIA; EPIDEMIOLOGY; MULTICENTER; RELIABILITY; GUIDELINES; MANAGEMENT; MORTALITY	Key PointsQuestionWhat is the effect of continuous infusion of hypertonic saline solution in patients with traumatic brain injury? FindingsIn this randomized clinical trial that included 370 adults with moderate to severe traumatic brain injury, treatment with continuous infusion of 20% hypertonic saline vs standard care resulted in an odds ratio for better neurological outcomes (based on the Extended Glasgow Outcome Scale) of 1.02 after 6 months; this was not statistically significant. MeaningAmong patients with moderate to severe traumatic brain injury, treatment with continuous infusion of 20% hypertonic saline compared with standard care did not result in a significantly better neurological status at 6 months. ImportanceFluid therapy is an important component of care for patients with traumatic brain injury, but whether it modulates clinical outcomes remains unclear. ObjectiveTo determine whether continuous infusion of hypertonic saline solution improves neurological outcome at 6 months in patients with traumatic brain injury. Design, Setting, and ParticipantsMulticenter randomized clinical trial conducted in 9 intensive care units in France, including 370 patients with moderate to severe traumatic brain injury who were recruited from October 2017 to August 2019. Follow-up was completed in February 2020. InterventionsAdult patients with moderate to severe traumatic brain injury were randomly assigned to receive continuous infusion of 20% hypertonic saline solution plus standard care (n=185) or standard care alone (controls; n=185). The 20% hypertonic saline solution was administered for 48 hours or longer if patients remained at risk of intracranial hypertension. Main Outcomes and MeasuresThe primary outcome was Extended Glasgow Outcome Scale (GOS-E) score (range, 1-8, with lower scores indicating worse functional outcome) at 6 months, obtained centrally by blinded assessors and analyzed with ordinal logistic regression adjusted for prespecified prognostic factors (with a common odds ratio [OR] >1.0 favoring intervention). There were 12 secondary outcomes measured at multiple time points, including development of intracranial hypertension and 6-month mortality. ResultsAmong 370 patients who were randomized (median age, 44 [interquartile range, 27-59] years; 77 [20.2%] women), 359 (97%) completed the trial. The adjusted common OR for the GOS-E score at 6 months was 1.02 (95% CI, 0.71-1.47; P=.92). Of the 12 secondary outcomes, 10 were not significantly different. Intracranial hypertension developed in 62 (33.7%) patients in the intervention group and 66 (36.3%) patients in the control group (absolute difference, -2.6% [95% CI, -12.3% to 7.2%]; OR, 0.80 [95% CI, 0.51-1.26]). There was no significant difference in 6-month mortality (29 [15.9%] in the intervention group vs 37 [20.8%] in the control group; absolute difference, -4.9% [95% CI, -12.8% to 3.1%]; hazard ratio, 0.79 [95% CI, 0.48-1.28]). Conclusions and RelevanceAmong patients with moderate to severe traumatic brain injury, treatment with continuous infusion of 20% hypertonic saline compared with standard care did not result in a significantly better neurological status at 6 months. However, confidence intervals for the findings were wide, and the study may have had limited power to detect a clinically important difference. Trial RegistrationClinicalTrials.gov Identifier: NCT03143751 This clinical trial conducted in France explores whether continuous infusion of hypertonic saline solution improves neurological outcome at 6 months in patients with traumatic brain injury.	[Roquilly, Antoine; Cinotti, Raphael; Latte, Dominique Demeure Dit; Mahe, Pierre Joachim; Vourc'h, Mickael; Martin, Florian Pierre; Chopin, Alice; Lerebourg, Celine; Asehnoune, Karim] Univ Nantes, Serv Anesthesie Reanimat Chirurg, CHU Nantes, Pole Anesthesie Reanimat,Hotel Dieu, Nantes, France; [Moyer, Jean Denis; Jeantrelle, Caroline] Beaujon Hosp, AP HP Nord, Dept Anesthesiol & Crit Care, DMU Parabol, Paris, France; [Huet, Olivier; Vermeersch, Veronique] CHU Brest, Anesthesia & Intens Care Unit, Brest, France; [Lasocki, Sigismond; Gaillard, Thomas] CHU Angers, Anesthesia & Intens Care Unit, Angers, France; [Cohen, Benjamin] CHU Tours, Anesthesia & Intens Care Unit, Tours, France; [Dahyot-Fizelier, Claire] CHU Potiers, Anesthesia & Intens Care Unit, Poitiers, France; [Chalard, Kevin] CHU Montpellier, Anesthesia & Intens Care Unit, Montpellier, France; [Seguin, Philippe] CHU Rennes, Anesthesia & Intens Care Unit, Rennes, France; [Flet, Laurent] CHU Nantes, Hotel Dieu, Serv Pharm, Nantes, France; [Chiffoleau, Anne] CHU Nantes, Dept Promot, DRCI, Cellule Vigilances, Nantes, France; [Feuillet, Fanny] CHU Nantes, DRCI, Plateforme Methodol & Biostat, Nantes, France; [Feuillet, Fanny] Univ Nantes, Univ Tours, INSERM, SPHERE U1246, Nantes, France	Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Brest; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Tours; Universite de Montpellier; CHU de Montpellier; CHU Rennes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite de Tours	Roquilly, A (corresponding author), CHU Nantes, Hotel Dieu HME, Serv Anesthesie Reanimat Chirurg, 5 Allee Lile Gloriette, F-4400 Nantes, France.	antoine.roquilly@chu-nantes.fr	Seguin, Philippe/P-9487-2019; FLET, Laurent/X-1192-2019	Seguin, Philippe/0000-0002-7774-4257; FLET, Laurent/0000-0001-8305-7085; MARTIN, Florian/0000-0002-5968-5484				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; Bouzat P, 2016, ANESTHESIOLOGY, V125, P346, DOI 10.1097/ALN.0000000000001165; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Darmon M, 2010, NEPHROL DIAL TRANSPL, V25, P2510, DOI 10.1093/ndt/gfq067; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Hauer EM, 2011, CRIT CARE MED, V39, P1766, DOI 10.1097/CCM.0b013e318218a390; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Roquilly A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018035; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Rowland MJ, 2020, LANCET NEUROL, V19, P208, DOI 10.1016/S1474-4422(20)30003-X; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tan SKR, 2016, CAN J ANESTH, V63, P664, DOI 10.1007/s12630-016-0633-y; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; Udy AA, 2013, CRIT CARE, V17, DOI 10.1186/cc12544; Wagner I, 2011, STROKE, V42, P1540, DOI 10.1161/STROKEAHA.110.609479; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	40	26	28	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2056	2066		10.1001/jama.2021.5561	http://dx.doi.org/10.1001/jama.2021.5561			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032829	Green Published, Bronze			2022-12-28	WOS:000655647300020
J	[Anonymous]				[Anonymous]			The Social Responsibilities of Modern Medicine (Reprint from vol 76, pg 1477-1483, 1921)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2122	2122		10.1001/jama.2020.17954	http://dx.doi.org/10.1001/jama.2020.17954			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032840				2022-12-28	WOS:000655647300029
J	James, N; Lee, N; Horton, R				James, Nick; Lee, Naomi; Horton, Richard			Announcing the Lancet Commission on Prostate Cancer Comment	LANCET			English	Editorial Material									[James, Nick] Inst Canc Res, Div Radiotherapy & Imaging, London SW3 6JB, England; [Lee, Naomi; Horton, Richard] The Lancet, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	James, N (corresponding author), Inst Canc Res, Div Radiotherapy & Imaging, London SW3 6JB, England.	nick.james@icr.ac.uk		James, Nicholas/0000-0002-7314-8204				Abbafati C, 2020, LANCET, V396, P1135, DOI 10.1016/S0140-6736(20)31404-5; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Ferlay J, 2020, GLOBAL CANC OBSERVAT; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; James N, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20530; National Prostate Cancer Audit, 2021, RES NPCA PROSP AUD E; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660	7	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1865	1866		10.1016/S0140-6736(21)01020-5	http://dx.doi.org/10.1016/S0140-6736(21)01020-5		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SF1XN	33991476				2022-12-28	WOS:000652556000005
J	Cifu, AS				Cifu, Adam S.			A Place of Memory and Learning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a primary care physician describes a binder in which he keeps the face sheet, cards, obituaries, and notes on the patients who died while in his care-a memory book that marks the arc of his career and the impermanence of life.	[Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Leriche R., 1951, BIBLIOTH QUE PHILOSO	1	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1939	1940		10.1001/jama.2021.6691	http://dx.doi.org/10.1001/jama.2021.6691			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003222				2022-12-28	WOS:000652675100006
J	Kuehn, BM				Kuehn, Bridget M.			WHO Calls for Stronger Primary Care in the Postpandemic World	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1931	1931		10.1001/jama.2021.7216	http://dx.doi.org/10.1001/jama.2021.7216			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003215				2022-12-28	WOS:000652675100023
J	Kitzman, DW; Whellan, DJ; Duncan, P; Pastva, AM; Mentz, RJ; Reeves, GR; Nelson, MB; Chen, HY; Upadhya, B; Reed, SD; Espeland, MA; Hewston, L; O'Connor, CM				Kitzman, Dalane W.; Whellan, David J.; Duncan, Pamela; Pastva, Amy M.; Mentz, Robert J.; Reeves, Gordon R.; Nelson, M. Benjamin; Chen, Haiying; Upadhya, Bharathi; Reed, Shelby D.; Espeland, Mark A.; Hewston, LeighAnn; O'Connor, Christopher M.			Physical Rehabilitation for Older Patients Hospitalized for Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC REHABILITATION; PERFORMANCE-MEASURES; OUTCOMES; ASSOCIATION; THERAPY; RESPONSIVENESS; INTERVENTION; MANAGEMENT; STATEMENT; EFFICACY	BACKGROUND Older patients who are hospitalized for acute decompensated heart failure have high rates of physical frailty, poor quality of life, delayed recovery, and frequent rehospitalizations. Interventions to address physical frailty in this population are not well established. METHODS We conducted a multicenter, randomized, controlled trial to evaluate a transitional, tailored, progressive rehabilitation intervention that included four physical-function domains (strength, balance, mobility, and endurance). The intervention was initiated during, or early after, hospitalization for heart failure and was continued after discharge for 36 outpatient sessions. The primary outcome was the score on the Short Physical Performance Battery (total scores range from 0 to 12, with lower scores indicating more severe physical dysfunction) at 3 months. The secondary outcome was the 6-month rate of rehospitalization for any cause. RESULTS A total of 349 patients underwent randomization; 175 were assigned to the rehabilitation intervention and 174 to usual care (control). At baseline, patients in each group had markedly impaired physical function, and 97% were frail or prefrail; the mean number of coexisting conditions was five in each group. Patient retention in the intervention group was 82%, and adherence to the intervention sessions was 67%. After adjustment for baseline Short Physical Performance Battery score and other baseline characteristics, the least-squares mean (+/- SE) score on the Short Physical Performance Battery at 3 months was 8.3 +/- 0.2 in the intervention group and 6.9 +/- 0.2 in the control group (mean between-group difference, 1.5; 95% confidence interval [CI], 0.9 to 2.0; P<0.001). At 6 months, the rates of rehospitalization for any cause were 1.18 in the intervention group and 1.28 in the control group (rate ratio, 0.93; 95% CI, 0.66 to 1.19). There were 21 deaths (15 from cardiovascular causes) in the intervention group and 16 deaths (8 from cardiovascular causes) in the control group. The rates of death from any cause were 0.13 and 0.10, respectively (rate ratio, 1.17; 95% CI, 0.61 to 2.27). CONCLUSIONS In a diverse population of older patients who were hospitalized for acute decompensated heart failure, an early, transitional, tailored, progressive rehabilitation intervention that included multiple physical-function domains resulted in greater improvement in physical function than usual care.	[Kitzman, Dalane W.; Nelson, M. Benjamin; Upadhya, Bharathi] Wake Forest Sch Med, Dept Internal Med, Sect Cardiovasc Med, 1 Med Ctr Blvd, Winston Salem, NC 27157 USA; [Kitzman, Dalane W.; Espeland, Mark A.] Wake Forest Sch Med, Sect Gerontol & Geriatr Med, Dept Internal Med, 1 Med Ctr Blvd, Winston Salem, NC 27157 USA; [Duncan, Pamela] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Chen, Haiying; Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat & Data Sci, Winston Salem, NC 27101 USA; [Pastva, Amy M.] Duke Univ, Sch Med, Dept Orthoped Surg, Doctor Phys Therapy Div, Durham, NC USA; [Mentz, Robert J.] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA; [Reed, Shelby D.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA; [Reeves, Gordon R.] Novant Hlth Heart & Vasc Inst, Charlotte, NC USA; [Whellan, David J.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Med, Philadelphia, PA 19107 USA; [Hewston, LeighAnn] Thomas Jefferson Univ, Jefferson Coll Rehabil Sci, Dept Phys Therapy, Philadelphia, PA 19107 USA; [O'Connor, Christopher M.] Inova Heart & Vasc Inst, Fairfax, VA USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Duke University; Duke University; Duke University; Jefferson University; Jefferson University; Inova Fairfax Hospital	Kitzman, DW (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Cardiovasc Med, 1 Med Ctr Blvd, Winston Salem, NC 27157 USA.; Kitzman, DW (corresponding author), Wake Forest Sch Med, Sect Gerontol & Geriatr Med, Dept Internal Med, 1 Med Ctr Blvd, Winston Salem, NC 27157 USA.	dkitzman@wakehealth.edu	Pastva, Amy/AAG-4332-2022; Mentz, Robert/AAV-4758-2021; Pastva, Amy/AFK-5944-2022	Pastva, Amy/0000-0002-0891-745X; Pastva, Amy/0000-0002-0891-745X; Mentz, Robert/0000-0002-3222-1719	National Institutes of Health [R01AG045551, R01AG18915, P30AG021332, P30AG028716, U24AG059624]; Oristano Family Fund at Wake Forest School of Medicine	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oristano Family Fund at Wake Forest School of Medicine	Supported by research grants from the National Institutes of Health (R01AG045551, R01AG18915, P30AG021332, P30AG028716, and U24AG059624), the Kermit Glenn Phillips II Chair in Cardiovascular Medicine, and the Oristano Family Fund at Wake Forest School of Medicine.	Acanfora D, 2016, INT J CARDIOL, V225, P313, DOI 10.1016/j.ijcard.2016.10.026; Alahdab MT, 2009, J CARD FAIL, V15, P130, DOI 10.1016/j.cardfail.2008.10.006; [Anonymous], 2018, BIG DATA RES, V11, piii, DOI 10.1016/S2214-5796(18)30058-3; [Anonymous], 2017, CIRC-HEART FAIL, V10, ps1; Babu Abraham Samuel, 2011, Heart Views, V12, P99, DOI 10.4103/1995-705X.95064; Cheng RK, 2014, AM HEART J, V168, P721, DOI 10.1016/j.ahj.2014.07.008; Chiarantini D, 2010, J CARD FAIL, V16, P390, DOI 10.1016/j.cardfail.2010.01.004; Contrepois K, 2020, CELL, V181, P1112, DOI 10.1016/j.cell.2020.04.043; Davies EJ, 2010, EUR J HEART FAIL, V12, P706, DOI 10.1093/eurjhf/hfq056; Faber MJ, 2006, ARCH PHYS MED REHAB, V87, P885, DOI 10.1016/j.apmr.2006.04.005; Fleg JL, 2018, JACC-HEART FAIL, V6, P153, DOI 10.1016/j.jchf.2017.12.012; Fleg JL, 2015, CIRC-HEART FAIL, V8, P209, DOI 10.1161/CIRCHEARTFAILURE.113.001420; Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457; Forman DE, 2017, CIRCULATION, V135, pE894, DOI 10.1161/CIR.0000000000000483; Forman DE, 2012, J AM COLL CARDIOL, V60, P2653, DOI 10.1016/j.jacc.2012.08.1010; Giallauria F, 2010, J GERONTOL A-BIOL, V65, P1353, DOI 10.1093/gerona/glq138; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Huusko J, 2020, ESC HEART FAIL, V7, P2406, DOI 10.1002/ehf2.12792; Johnson TJ, 2012, J CARD FAIL, V18, P246, DOI 10.1016/j.cardfail.2011.12.005; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Lorenzo M, 2020, EUR J INTERN MED, V81, P78, DOI 10.1016/j.ejim.2020.05.017; Mudge AM, 2018, JACC-HEART FAIL, V6, P143, DOI 10.1016/j.jchf.2017.11.016; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Pandey A, 2019, JACC-HEART FAIL, V7, P1079, DOI 10.1016/j.jchf.2019.10.003; Pastva AM, 2018, CONTEMP CLIN TRIALS, V64, P118, DOI 10.1016/j.cct.2017.10.014; Pavasini R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0763-7; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Reeves GR, 2017, JACC-HEART FAIL, V5, P359, DOI 10.1016/j.jchf.2016.12.019; Reeves GR, 2017, AM HEART J, V185, P130, DOI 10.1016/j.ahj.2016.12.012; Reeves GR, 2016, AM J CARDIOL, V117, P1953, DOI 10.1016/j.amjcard.2016.03.046; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Scrutinio D, 2012, J CARDIOPULM REHABIL, V32, P71, DOI 10.1097/HCR.0b013e31823be124; Soubra R, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1354362; Spertus JA, 2008, QUAL LIFE RES, V17, P291, DOI 10.1007/s11136-007-9302-5; Volpato S, 2011, J GERONTOL A-BIOL, V66, P89, DOI 10.1093/gerona/glq167; Wang W, 2017, COMPUT METH PROG BIO, V138, P23, DOI 10.1016/j.cmpb.2016.10.003; Witham MD, 2012, CIRC-HEART FAIL, V5, P209, DOI 10.1161/CIRCHEARTFAILURE.111.963132; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; 2019, BRAIN STIMUL MAR, V12, pe0080	40	111	113	11	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2021	385	3					203	216		10.1056/NEJMoa2026141	http://dx.doi.org/10.1056/NEJMoa2026141		MAY 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM6AG	33999544	Green Accepted, Bronze			2022-12-28	WOS:000652592000001
J	Cowper, A				Cowper, Andy			What doctors need to know about the Greensill scandal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cowper, Andy] Hlth Policy Insight, London, England		Cowper, A (corresponding author), Hlth Policy Insight, London, England.	andycowper@hotmail.com							0	2	2	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2021	373								n1245	10.1136/bmj.n1245	http://dx.doi.org/10.1136/bmj.n1245			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9HX	33990341				2022-12-28	WOS:000653058600006
J	Klitzman, R				Klitzman, Robert			Disclosure of Presidential Health Information-Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Klitzman, Robert] Columbia Univ, New York, NY USA	Columbia University	Klitzman, R (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Joseph L Mailman Sch Publ Hlth, 1051 Riverside Dr,15, New York, NY 10032 USA.	rlk2@cumc.columbia.edu						Klitzman R, 2021, JAMA-J AM MED ASSOC, V325, P25, DOI 10.1001/jama.2020.23476; US Air Force, MED STAND DIR MSD; US Air Force, AIR FORC WAIV GUID D	3	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1904	+		10.1001/jama.2021.3345	http://dx.doi.org/10.1001/jama.2021.3345			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974022				2022-12-28	WOS:000650205000026
J	Mefford, JT; Akbashev, AR; Kang, MK; Bentley, CL; Gent, WE; Deng, HTD; Alsem, DH; Yu, YS; Salmon, NJ; Shapiro, DA; Unwin, PR; Chueh, WC				Mefford, J. Tyler; Akbashev, Andrew R.; Kang, Minkyung; Bentley, Cameron L.; Gent, William E.; Deng, Haitao D.; Alsem, Daan Hein; Yu, Young-Sang; Salmon, Norman J.; Shapiro, David A.; Unwin, Patrick R.; Chueh, William C.			Correlative operando microscopy of oxygen evolution electrocatalysts	NATURE			English	Article							QUARTZ-CRYSTAL MICROBALANCE; WATER OXIDATION; OXIDES; ELECTROLYSIS; STABILITY; HYDROXIDE; DYNAMICS; BEHAVIOR; STATE	Transition metal (oxy)hydroxides are promising electrocatalysts for the oxygen evolution reaction(1-3). The properties of these materials evolve dynamically and heterogeneously(4) with applied voltage through ion insertion redox reactions, converting materials that are inactive under open circuit conditions into active electrocatalysts during operation(5). The catalytic state is thus inherently far from equilibrium, which complicates its direct observation. Here, using a suite of correlative operando scanning probe and X-ray microscopy techniques, we establish a link between the oxygen evolution activity and the local operational chemical, physical and electronic nanoscale structure of single-crystalline beta-Co(OH)(2) platelet particles. At pre-catalytic voltages, the particles swell to form an alpha-CoO(2)H(1.5 center dot)0.5H(2)O-like structure-produced through hydroxide intercalation-in which the oxidation state of cobalt is +2.5. Upon increasing the voltage to drive oxygen evolution, interlayer water and protons de-intercalate to form contracted beta-CoOOH particles that contain Co3+ species. Although these transformations manifest heterogeneously through the bulk of the particles, the electrochemical current is primarily restricted to their edge facets. The observed Tafel behaviour is correlated with the local concentration of Co3+ at these reactive edge sites, demonstrating the link between bulk ion-insertion and surface catalytic activity. Mapping the operational chemical, physical and electronic structure of an oxygen evolution electrocatalyst at the nanoscale links the properties of the material with the observed oxygen evolution activity.	[Mefford, J. Tyler; Akbashev, Andrew R.; Gent, William E.; Deng, Haitao D.; Chueh, William C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Mefford, J. Tyler; Akbashev, Andrew R.; Chueh, William C.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Kang, Minkyung; Bentley, Cameron L.; Unwin, Patrick R.] Univ Warwick, Dept Chem, Coventry, W Midlands, England; [Alsem, Daan Hein; Salmon, Norman J.] Hummingbird Sci, Lacey, WA USA; [Yu, Young-Sang; Shapiro, David A.] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Warwick; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Mefford, JT; Chueh, WC (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.; Mefford, JT; Chueh, WC (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.	tmefford@stanford.edu; wchueh@stanford.edu		Bentley, Cameron/0000-0001-7867-6068; Kang, Minkyung/0000-0003-3248-8496; Gent, William/0000-0001-7663-3988; Deng, Haitao/0000-0003-3225-4219; Mefford, Tyler/0000-0003-4965-4147; Akbashev, Andrew/0000-0003-1573-1773; Yu, Young-Sang/0000-0002-0545-9019				Bajdich M, 2013, J AM CHEM SOC, V135, P13521, DOI 10.1021/ja405997s; Bentley CL, 2019, ANAL CHEM, V91, P84, DOI 10.1021/acs.analchem.8b05235; Bentley CL, 2017, J AM CHEM SOC, V139, P16813, DOI 10.1021/jacs.7b09355; Bergmann A, 2018, NAT CATAL, V1, P711, DOI 10.1038/s41929-018-0141-2; BERNARD P, 1991, ELECTROCHIM ACTA, V36, P743, DOI 10.1016/0013-4686(91)85166-5; Burke MS, 2015, CHEM MATER, V27, P7549, DOI 10.1021/acs.chemmater.5b03148; Burke MS, 2015, J AM CHEM SOC, V137, P3638, DOI 10.1021/jacs.5b00281; Cherepanova S, 2016, ACTA CRYSTALLOGR A, V72, P651, DOI 10.1107/S2053273316014868; Dau H, 2010, CHEMCATCHEM, V2, P724, DOI 10.1002/cctc.201000126; Deng J, 2017, NANO LETT, V17, P6922, DOI 10.1021/acs.nanolett.7b03313; Dette C, 2019, ACS APPL MATER INTER, V11, P5590, DOI 10.1021/acsami.8b02796; Doyle AD, 2017, CATAL LETT, V147, P1533, DOI 10.1007/s10562-017-2010-z; Gerken JB, 2011, J AM CHEM SOC, V133, P14431, DOI 10.1021/ja205647m; Hall DS, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2014.0792; Hong WT, 2015, ENERG ENVIRON SCI, V8, P1404, DOI 10.1039/c4ee03869j; KAMACHI M, 2011, CORROS REV, V29, P73; Kanan MW, 2010, J AM CHEM SOC, V132, P13692, DOI 10.1021/ja1023767; Kuai CG, 2020, NAT CATAL, V3, P743, DOI 10.1038/s41929-020-0496-z; LI FB, 1992, J ELECTROANAL CHEM, V335, P345, DOI 10.1016/0022-0728(92)80253-Z; Lim J, 2016, SCIENCE, V353, P566, DOI 10.1126/science.aaf4914; Liu SY, 2016, J ELECTROCHEM SOC, V163, pA150, DOI 10.1149/2.0331602jes; Ma RZ, 2006, INORG CHEM, V45, P3964, DOI 10.1021/ic052108r; McAlpin JG, 2010, J AM CHEM SOC, V132, P6882, DOI 10.1021/ja1013344; Mefford JT, 2020, ENERG ENVIRON SCI, V13, P622, DOI 10.1039/c9ee02697e; Mefford JT, 2019, J PHYS CHEM C, V123, P18783, DOI 10.1021/acs.jpcc.9b03589; Mefford JT, 2021, REPLICATION DATA COR; Risch M, 2015, ENERG ENVIRON SCI, V8, P661, DOI 10.1039/c4ee03004d; Stevens MB, 2019, NANO RES, V12, P2288, DOI 10.1007/s12274-019-2391-y; Toma FM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12012; Wahab OJ, 2020, CURR OPIN ELECTROCHE, V22, P120, DOI 10.1016/j.coelec.2020.04.018; Young MJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39052-1	31	133	133	66	276	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					67	+		10.1038/s41586-021-03454-x	http://dx.doi.org/10.1038/s41586-021-03454-x			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RY0YD	33953412				2022-12-28	WOS:000647642900013
J	Lane, R				Lane, Richard			Roxana Mehran: driving force in women's cardiovascular health	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2021	397	10292					2326	2326		10.1016/S0140-6736(21)01100-4	http://dx.doi.org/10.1016/S0140-6736(21)01100-4		JUN 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SU4QL	34010614				2022-12-28	WOS:000663124100010
J	Menon, U; Gentry-Maharaj, A; Burnell, M; Singh, N; Ryan, A; Karpinskyj, C; Carlino, G; Taylor, J; Massingham, SK; Raikou, M; Kalsi, JK; Woolas, R; Manchanda, R; Arora, R; Casey, L; Dawnay, A; Dobbs, S; Leeson, S; Mould, T; Seif, MW; Sharma, A; Williamson, K; Liu, YL; Fallowfield, L; McGuire, AJ; Campbell, S; Skates, SJ; Jacobs, IJ; Parmar, M				Menon, Usha; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Singh, Naveena; Ryan, Andy; Karpinskyj, Chloe; Carlino, Giulia; Taylor, Julie; Massingham, Susan K.; Raikou, Maria; Kalsi, Jatinderpal K.; Woolas, Robert; Manchanda, Ranjit; Arora, Rupali; Casey, Laura; Dawnay, Anne; Dobbs, Stephen; Leeson, Simon; Mould, Tim; Seif, Mourad W.; Sharma, Aarti; Williamson, Karin; Liu, Yiling; Fallowfield, Lesley; McGuire, Alistair J.; Campbell, Stuart; Skates, Steven J.; Jacobs, Ian J.; Parmar, Mahesh			Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial	LANCET			English	Article							RISK; ALGORITHM; PROSTATE; WOMEN; LUNG	Background Ovarian cancer continues to have a poor prognosis with the majority of women diagnosed with advanced disease. Therefore, we undertook the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) to determine if population screening can reduce deaths due to the disease. We report on ovarian cancer mortality after long-term follow-up in UKCTOCS. Methods In this randomised controlled trial, postmenopausal women aged 50-74 years were recruited from 13 centres in National Health Service trusts in England, Wales, and Northern Ireland. Exclusion criteria were bilateral oophorectomy, previous ovarian or active non-ovarian malignancy, or increased familial ovarian cancer risk. The trial management system confirmed eligibility and randomly allocated participants in blocks of 32 using computer generated random numbers to annual multimodal screening (MMS), annual transvaginal ultrasound screening (USS), or no screening, in a 1:1:2 ratio. Follow-up was through national registries. The primary outcome was death due to ovarian or tubal cancer (WHO 2014 criteria) by June 30, 2020. Analyses were by intention to screen, comparing MMS and USS separately with no screening using the versatile test. Investigators and participants were aware of screening type, whereas the outcomes review committee were masked to randomisation group. This study is registered with ISRCTN, 22488978, and ClinicalTrials.gov, NCT00058032. Findings Between April 17, 2001, and Sept 29, 2005, of 1 243 282 women invited, 202 638 were recruited and randomly assigned, and 202 562 were included in the analysis: 50 625 (25.0%) in the MMS group, 50 623 (25.0%) in the USS group, and 101 314 (50.0%) in the no screening group. At a median follow-up of 16.3 years (IQR 15.1-17.3), 2055 women were diagnosed with tubal or ovarian cancer: 522 (1.0%) of 50 625 in the MMS group, 517 (1.0%) of 50623 in the USS group, and 1016 (1.0%) of 101 314 in the no screening group. Compared with no screening, there was a 47.2% (95% CI 19.7 to 81.1) increase in stage I and 24.5% (-41.8 to -2.0) decrease in stage IV disease incidence in the MMS group. Overall the incidence of stage I or II disease was 39.2% (95% CI 16.1 to 66.9) higher in the MMS group than in the no screening group, whereas the incidence of stage III or IV disease was 10.2% (-21.3 to 2.4) lower. 1206 women died of the disease: 296 (0.6%) of 50 625 in the MMS group, 291 (0.6%) of 50 623 in the USS group, and 619 (0.6%) of 101 314 in the no screening group. No significant reduction in ovarian and tubal cancer deaths was observed in the MMS (p=0.58) or USS (p=0.36) groups compared with the no screening group. Interpretation The reduction in stage III or IV disease incidence in the MMS group was not sufficient to translate into lives saved, illustrating the importance of specifying cancer mortality as the primary outcome in screening trials. Given that screening did not significantly reduce ovarian and tubal cancer deaths, general population screening cannot be recommended. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Menon, Usha; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Ryan, Andy; Karpinskyj, Chloe; Carlino, Giulia; Massingham, Susan K.; Parmar, Mahesh] UCL, MRC Clin Trials Unit, Inst Clin Trials & Methodol, London WC1V 6LJ, England; [Taylor, Julie] UCL, Clin Epidemiol, Inst Hlth Informat, London, England; [Kalsi, Jatinderpal K.; Jacobs, Ian J.] UCL, Dept Womens Canc, Inst Womens Hlth, London, England; [Singh, Naveena; Casey, Laura] Barts Hlth NHS Trust, Dept Cellular Pathol, London, England; [Dawnay, Anne] Barts Hlth NHS Trust, Dept Clin Biochem, London, England; [Manchanda, Ranjit] Barts Hlth NHS Trust, Dept Gynaecol Oncol, London, England; [Raikou, Maria; McGuire, Alistair J.] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England; [Raikou, Maria] Univ Piraeus, Dept Econ, Athens, Greece; [Woolas, Robert] Queen Alexandra Hosp, Dept Gynaecol Oncol, Portsmouth, Hants, England; [Manchanda, Ranjit] Queen Mary Univ London, Wolfson Inst Prevent Med, CRUK Barts Canc Ctr, London, England; [Arora, Rupali] Univ Coll London Hosp NHS Trust, Dept Cellular Pathol, London, England; [Mould, Tim] Univ Coll London Hosp NHS Trust, Dept Gynaecol Oncol, London, England; [Dobbs, Stephen] Belfast City Hosp, Dept Gynaecol Oncol, Belfast, Antrim, North Ireland; [Leeson, Simon] Ysbyty Gwynedd, Dept Obstet & Gynaecol, Bangor, Gwynedd, Wales; [Seif, Mourad W.] St Marys Hosp, Div Gynaecol & Canc Sci, Manchester, Lancs, England; [Sharma, Aarti] Univ Hosp Wales, Dept Obstet & Gynaecol, Cardiff, S Glam, Wales; [Williamson, Karin] Nottingham City Hosp, Dept Gynaecol Oncol, Nottingham, England; [Liu, Yiling; Skates, Steven J.] Massachusetts Gen Hosp, Dept Med, MGH Biostat, Boston, MA 02114 USA; [Skates, Steven J.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Fallowfield, Lesley] Univ Sussex, Brighton & Sussex Med Sch, Sussex Hlth Outcomes Res & Educ Canc, SHORE C, Brighton, E Sussex, England; [Campbell, Stuart] Create Hlth, London, England; [Jacobs, Ian J.] Univ New South Wales, Dept Womens Hlth, Sydney, NSW, Australia	Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; University College London; University of London; University College London; Barts Health NHS Trust; Barts Health NHS Trust; Barts Health NHS Trust; University of London; London School Economics & Political Science; University of Piraeus; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of London; Queen Mary University London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Belfast City Hospital; University of Manchester; Cardiff University; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Brighton; University of Sussex; University of New South Wales Sydney	Menon, U (corresponding author), UCL, MRC Clin Trials Unit, Inst Clin Trials & Methodol, London WC1V 6LJ, England.	u.menon@ucl.ac.uk	Liu, Yiling/GVS-4553-2022; Manchanda, Ranjit/AEP-0906-2022	Manchanda, Ranjit/0000-0003-3381-5057; Liu, Yiling/0000-0002-0387-8973; Menon, Usha/0000-0003-3708-1732	National Institute for Health Research; Eve Appeal; Cancer Research UK	National Institute for Health Research(National Institute for Health Research (NIHR)); Eve Appeal; Cancer Research UK(Cancer Research UK)	National Institute for Health Research, Cancer Research UK, and The Eve Appeal.	Blyuss O, 2018, CLIN CANCER RES, V24, P4726, DOI 10.1158/1078-0432.CCR-18-0208; Brown PO, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000114; Burnell M, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05125-8; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; CAMPBELL S, 1989, BMJ-BRIT MED J, V299, P1363, DOI 10.1136/bmj.299.6712.1363; Cancer Research UK, 2018, OV CANC SURV STAT; Daya D, 2014, WHO CLASSIFICATION T, P92; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Dilley J, 2015, INT J GYNECOL CANCER, V25, P423; JACOBS I, 1988, LANCET, V1, P268; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Kalsi JK, 2021, TRIALS, V22, DOI 10.1186/s13063-020-04968-x; Karrison TG, 2016, STATA J, V16, P678, DOI 10.1177/1536867X1601600308; Kobayashi H, 2008, INT J GYNECOL CANCER, V18, P414, DOI 10.1111/j.1525-1438.2007.01035.x; Meinhold-Heerlein I, 2016, ARCH GYNECOL OBSTET, V293, P695, DOI 10.1007/s00404-016-4035-8; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; MENON U, 2008, BMJ BRIT MED J, V337; Menon U, 2009, 2 INT M PREV SCREEN; Menon U, 2015, J CLIN ONCOL, V33, P2062, DOI 10.1200/JCO.2014.59.4945; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Pinsky PF, 2016, GYNECOL ONCOL, V143, P270, DOI 10.1016/j.ygyno.2016.08.334; Rosenthal AN, 2017, J CLIN ONCOL, V35, P1411, DOI 10.1200/JCO.2016.69.9330; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Skates SJ, 2001, J AM STAT ASSOC, V96, P429, DOI 10.1198/016214501753168145; Skates SJ, 2017, CLIN CANCER RES, V23, P3628, DOI 10.1158/1078-0432.CCR-15-2750; STRAUSS GM, 1995, CHEST, V107, pS270, DOI 10.1378/chest.107.6_Supplement.270S; Tabar L, 2015, BREAST J, V21, P13, DOI 10.1111/tbj.12354; Tavassoli FA, 2003, TUMORS BREAST FEMALE; UKCTOCS, 2020, PROT UK COLL TRIAL O; van Nagell JR, 2018, OBSTET GYNECOL, V132, P1091, DOI 10.1097/AOG.0000000000002921	32	111	112	7	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2021	397	10290					2182	2193		10.1016/S0140-6736(21)00731-5	http://dx.doi.org/10.1016/S0140-6736(21)00731-5		JUN 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SM8DI	33991479	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000657828600024
J	Hu, B; Liu, TL				Hu, Bo; Liu, T. Leo			Tanking up energy through atypical charging	SCIENCE			English	Editorial Material							FLOW; STABILITY		[Hu, Bo; Liu, T. Leo] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Liu, TL (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	leo.liu@usu.edu			National Science Foundation [1847674]; Utah State University faculty start-up	National Science Foundation(National Science Foundation (NSF)); Utah State University faculty start-up	The authors acknowledge funding support from the National Science Foundation (CareerAward, grant 1847674) and a Utah State University faculty start-up.	Ding Y, 2018, CHEM SOC REV, V47, P69, DOI 10.1039/c7cs00569e; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Eisenstein O, 2013, NEW J CHEM, V37, P21, DOI 10.1039/c2nj40659d; Feng RZ, 2021, SCIENCE, V372, P836, DOI 10.1126/science.abd9795; Hu B, 2017, J AM CHEM SOC, V139, P1207, DOI 10.1021/jacs.6b10984; Ji YL, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201900039; Leung P, 2017, APPL ENERG, V197, P318, DOI 10.1016/j.apenergy.2017.04.023; Luo JA, 2019, ACS ENERGY LETT, V4, P2220, DOI 10.1021/acsenergylett.9b01332; Luo J, 2019, JOULE, V3, P149, DOI 10.1016/j.joule.2018.10.010; Luo J, 2017, NANO ENERGY, V42, P215, DOI 10.1016/j.nanoen.2017.10.057; Park M, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.80; Rodriguez J., 2019, ECS Transactions, V89, P49, DOI 10.1149/08901.0049ecst; Winsberg J, 2017, ANGEW CHEM INT EDIT, V56, P686, DOI 10.1002/anie.201604925	13	8	8	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					788	789		10.1126/science.abi5911	http://dx.doi.org/10.1126/science.abi5911			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016766				2022-12-28	WOS:000653997000023
J	Dunnavant, J; Justinvil, D; Colwell, C				Dunnavant, Justin; Justinvil, Delande; Colwell, Chip			Craft an African American Graves Protection and Repatriation Act	NATURE			English	Editorial Material									[Dunnavant, Justin] Vanderbilt Univ, Dept Anthropol, Hist Archaeol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Justinvil, Delande] Amer Univ, Dept Anthropol, Washington, DC 20016 USA; [Justinvil, Delande] Natl Museum Nat Hist, Washington, DC 20560 USA	Vanderbilt University; American University; Smithsonian Institution; Smithsonian National Museum of Natural History	Dunnavant, J (corresponding author), Vanderbilt Univ, Dept Anthropol, Hist Archaeol, 221 Kirkland Hall, Nashville, TN 37235 USA.	justin.p.dunnavant@vanderbilt.edu; dj6541a@american.edu; chip@sapiens.org						Abu-Jamous B, 2012, IEEE INT WORKS MACH; [Anonymous], 2018, IDENTIFIED SKELETAL; Blakey M., 1998, TRANSFORM ANTHROPOL, V7, P53, DOI [10.1525/tran.1998.7.1.53, DOI 10.1525/tran.1998.7.1.53]; Blakey ML, 2020, CURR ANTHROPOL, V61, pS183, DOI 10.1086/710357; Blakey ML, 2008, EVALUATING MULTIPLE NARRATIVES, P17, DOI 10.1007/978-0-387-71825-5_2; Challis B. C., 1968, CHEM AMINO GROUP; Clinton CK, 2021, AM J PHYS ANTHROPOL, V175, P339, DOI 10.1002/ajpa.24171; Colwell Chip, 2017, PLUNDERED SKULLS STO; Davidson JamesM., 2007, INT J HIST ARCHAEOLO, V11, P193; Fox K, 2019, NATURE, V572, P581, DOI 10.1038/d41586-019-02516-5; Gates E., 2017, U VIRGINIA MAGAZINE, V106; HARRINGTON SPM, 1993, ARCHAEOLOGY, V46, P28; Hassan A.A., 2007, J SULFUR CHEM, V28, P211, DOI DOI 10.1080/17415990701230596; Jones A., 2021, SAPIENS; Lang PT, 2010, PROTEIN SCI, V19, P1420, DOI 10.1002/pro.423; Mor-Cohen R, 2016, ANTIOXID REDOX SIGN, V24, P16, DOI 10.1089/ars.2014.6149; Nelson A., 2016, SOCIAL LIFE DNA; Owens D.C, 2017, MED BONDAGE MED BONDAGE; Rainville L, 2009, J FIELD ARCHAEOL, V34, P196, DOI 10.1179/009346909791071005; Rankin-Hill L. M., 2016, NEW DIRECTIONS BIOCU, P133, DOI DOI 10.1002/9781118962954.CH7; Sawyer D. T., 1991, OXYGEN CHEM; Skloot R., 2011, IMMORTAL LIFE HENRIE; TALLBEAR KIM, 2013, NATIVE AM DNA; Watkins RJ, 2020, HIST ARCHAEOL, V54, P17, DOI 10.1007/s41636-019-00224-5; Wensien M, 2021, NATURE, V593, P460, DOI 10.1038/s41586-021-03513-3	26	11	11	3	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					337	344		10.1038/d41586-021-01320-4	http://dx.doi.org/10.1038/d41586-021-01320-4			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SE7VT	34012089	Bronze			2022-12-28	WOS:000652278400008
J	Kim, JH; Constantin, T; Simonetti, M; Llaveria, J; Sheikh, NS; Leonori, D				Kim, Ji Hye; Constantin, Timothee; Simonetti, Marco; Llaveria, Josep; Sheikh, Nadeem S.; Leonori, Daniele			A radical approach for the selective C-H borylation of azines	NATURE			English	Article							ELECTRON-SPIN RESONANCE; BORANE; FUNCTIONALIZATION; REGIOSELECTIVITY; ELECTROPHILICITY; NUCLEOPHILICITY; HETEROCYCLES; COMPLEXES; CATALYSIS; BONDS	Selective borylation of azines-nitrogen-containing aromatic heterocycles used in the synthesis of many pharmaceuticals-is made possible by forming a radical from an aminoborane using a photocatalyst. Boron functional groups are often introduced in place of aromatic carbon-hydrogen bonds to expedite small-molecule diversification through coupling of molecular fragments(1-3). Current approaches based on transition-metal-catalysed activation of carbon-hydrogen bonds are effective for the borylation of many (hetero)aromatic derivatives(4,5) but show narrow applicability to azines (nitrogen-containing aromatic heterocycles), which are key components of many pharmaceutical and agrochemical products(6). Here we report an azine borylation strategy using stable and inexpensive amine-borane(7) reagents. Photocatalysis converts these low-molecular-weight materials into highly reactive boryl radicals(8) that undergo efficient addition to azine building blocks. This reactivity provides a mechanistically alternative tactic for sp(2) carbon-boron bond assembly, where the elementary steps of transition-metal-mediated carbon-hydrogen bond activation and reductive elimination from azine-organometallic intermediates are replaced by a direct, Minisci(9)-style, radical addition. The strongly nucleophilic character of the amine-boryl radicals enables predictable and site-selective carbon-boron bond formation by targeting the azine's most activated position, including the challenging sites adjacent to the basic nitrogen atom. This approach enables access to aromatic sites that elude current strategies based on carbon-hydrogen bond activation, and has led to borylated materials that would otherwise be difficult to prepare. We have applied this process to the introduction of amine-borane functionalities to complex and industrially relevant products. The diversification of the borylated azine products by mainstream cross-coupling technologies establishes aromatic amino-boranes as a powerful class of building blocks for chemical synthesis.	[Kim, Ji Hye; Constantin, Timothee; Simonetti, Marco; Leonori, Daniele] Univ Manchester, Dept Chem, Manchester, Lancs, England; [Llaveria, Josep] Janssen Res & Dev, Discovery Chem, Toledo, Spain; [Sheikh, Nadeem S.] King Faisal Univ, Coll Sci, Dept Chem, Al Hasa, Saudi Arabia	University of Manchester; King Faisal University	Leonori, D (corresponding author), Univ Manchester, Dept Chem, Manchester, Lancs, England.	daniele.leonori@manchester.ac.uk		Constantin, Timothee/0000-0001-5376-1557; Llaveria Cros, Josep/0000-0003-2260-3657; Leonori, Daniele/0000-0002-7692-4504	EPSRC [EP/P004997/1]; European Research Council [758427]; Marie Curie Actions [842422]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Marie Curie Actions(European Commission)	D.L. thanks the EPSRC for a fellowship (EP/P004997/1) and the European Research Council for a research grant (758427); J.H.K. thanks Marie Curie Actions for a fellowship (842422). The Chemical Capabilities team of Janssen Research and Development (Toledo) is acknowledged for technical support.	BABAN JA, 1984, J CHEM SOC PERK T 2, P1717, DOI 10.1039/p29840001717; BABAN JA, 1985, J CHEM SOC PERK T 2, P1723, DOI 10.1039/p29850001723; Bietti M, 2018, ANGEW CHEM INT EDIT, V57, P16618, DOI 10.1002/anie.201804929; Blakemore D., 2016, SYNTHETIC METHODS DR, V1, P1; Blakemore DC, 2018, NAT CHEM, V10, P383, DOI 10.1038/s41557-018-0021-z; Bonet A, 2014, NAT CHEM, V6, P584, DOI [10.1038/NCHEM.1971, 10.1038/nchem.1971]; Brow DG, 2016, J MED CHEM, V59, P4443, DOI 10.1021/acs.jmedchem.5b01409; Brown DG, 2015, J MED CHEM, V58, P2390, DOI 10.1021/jm501894t; Chotana GA, 2005, J AM CHEM SOC, V127, P10539, DOI 10.1021/ja0428309; Chu QL, 2009, CHEM-EUR J, V15, P12937, DOI 10.1002/chem.200902450; Cook XAF, 2021, ANGEW CHEM INT EDIT, V60, P11068, DOI 10.1002/anie.202010631; Cox PA, 2017, J AM CHEM SOC, V139, P13156, DOI 10.1021/jacs.7b07444; Curran DP, 2011, ANGEW CHEM INT EDIT, V50, P10294, DOI 10.1002/anie.201102717; Dai W, 2020, J AM CHEM SOC, V142, P6261, DOI 10.1021/jacs.0c00490; Davis HJ, 2016, J AM CHEM SOC, V138, P12759, DOI 10.1021/jacs.6b08164; De Vleeschouwer F, 2007, ORG LETT, V9, P2721, DOI 10.1021/ol071038k; Dick GR, 2012, ANGEW CHEM INT EDIT, V51, P2667, DOI 10.1002/anie.201108608; Duncton MAJ, 2011, MEDCHEMCOMM, V2, P1135, DOI 10.1039/c1md00134e; Furuya T, 2008, ANGEW CHEM INT EDIT, V47, P5993, DOI 10.1002/anie.200802164; Garattini E, 2013, EXPERT OPIN DRUG DIS, V8, P641, DOI 10.1517/17460441.2013.788497; GILES JRM, 1983, J CHEM SOC PERK T 2, P743, DOI 10.1039/p29830000743; Hall DG, 2005, BORONIC ACIDS: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS AND MEDICINE, P1, DOI 10.1002/3527606548.ch1; Hioe J, 2010, CHEM-EUR J, V16, P6861, DOI 10.1002/chem.200903395; ISHIYAMA T, 1995, J ORG CHEM, V60, P7508, DOI 10.1021/jo00128a024; Jin J, 2015, ANGEW CHEM INT EDIT, V54, P1565, DOI 10.1002/anie.201410432; Kuninobu Y, 2015, ANGEW CHEM INT EDIT, V54, P10263, DOI 10.1002/anie.201505335; Lalevee J, 2008, MACROMOLECULES, V41, P9057, DOI 10.1021/ma8018848; Larsen MA, 2014, J AM CHEM SOC, V136, P4287, DOI 10.1021/ja412563e; Li JQ, 2015, SCIENCE, V347, P1221, DOI 10.1126/science.aaa5414; Mills HA, 2020, J AM CHEM SOC, V142, P4586, DOI 10.1021/jacs.0c00300; MINISCI F, 1986, J ORG CHEM, V51, P476, DOI 10.1021/jo00354a012; Mkhalid IAI, 2006, ANGEW CHEM INT EDIT, V45, P489, DOI 10.1002/anie.200503047; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Molloy JJ, 2017, CHEM SCI, V8, P1551, DOI 10.1039/c6sc04014d; Preshlock SM, 2013, ANGEW CHEM INT EDIT, V52, P12915, DOI 10.1002/anie.201306511; Proctor RSJ, 2019, ANGEW CHEM INT EDIT, V58, P13666, DOI 10.1002/anie.201900977; Roberts BP, 1999, CHEM SOC REV, V28, P25, DOI 10.1039/a804291h; Roughley SD, 2011, J MED CHEM, V54, P3451, DOI 10.1021/jm200187y; Sadler SA, 2014, ORG BIOMOL CHEM, V12, P7318, DOI 10.1039/c4ob01565g; Sheeller B, 2001, J CHEM SOC PERK T 2, P480, DOI 10.1039/b009494n; Staubitz A, 2010, CHEM REV, V110, P4023, DOI 10.1021/cr100105a; Taniguchi T, 2019, EUR J ORG CHEM, V2019, P6308, DOI 10.1002/ejoc.201901010; Taylor RD, 2014, J MED CHEM, V57, P5845, DOI 10.1021/jm4017625; Tehfe MA, 2011, POLYM CHEM-UK, V2, P625, DOI 10.1039/c0py00296h; Ueng SH, 2008, J AM CHEM SOC, V130, P10082, DOI 10.1021/ja804150k; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; West MJ, 2019, CHEM REV, V119, P12491, DOI 10.1021/acs.chemrev.9b00491; Wu C, 2017, J ORG CHEM, V82, P2898, DOI 10.1021/acs.joc.6b02849; Yang LC, 2019, J AM CHEM SOC, V141, P7972, DOI 10.1021/jacs.9b03138	49	24	24	20	122	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 29	2021	595	7869					677	+		10.1038/s41586-021-03637-6	http://dx.doi.org/10.1038/s41586-021-03637-6		MAY 2021	8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TR2SM	34015802	Green Submitted			2022-12-28	WOS:000675383600001
J	Skokowa, J				Skokowa, Julia			Circumventing Mutation to Nix Neutropenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Skokowa, Julia] Univ Tubingen Hosp, Dept Oncol Hematol Clin Immunol & Rheumatol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Skokowa, J (corresponding author), Univ Tubingen Hosp, Dept Oncol Hematol Clin Immunol & Rheumatol, Tubingen, Germany.		Skokowa, Julia/AAU-3622-2021	Skokowa, Julia/0000-0002-4399-2324				BONILLA MA, 1989, NEW ENGL J MED, V320, P1574, DOI 10.1056/NEJM198906153202402; Nasri M, 2020, HAEMATOLOGICA, V105, P598, DOI 10.3324/haematol.2019.221804; Tran NT, 2020, MOL THER, V28, P2621, DOI 10.1016/j.ymthe.2020.08.004; Rao S, 2021, CELL STEM CELL; Skokowa J, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.32	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					1956	1958		10.1056/NEJMcibr2102952	http://dx.doi.org/10.1056/NEJMcibr2102952			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ4AW	34010536				2022-12-28	WOS:000655474700017
J	Ross, IR				Ross, Ian R.			Through the Fog	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Through the Fog Faced with a delirious patient whose life story resembles his own, a physician finds a way to break through the fog. How often have we treated patients with delirium without understanding how it was affecting them as people?	[Ross, Ian R.] John Cochran Vet Affairs Med Ctr, Gen Med Serv, St Louis, MO 63106 USA		Ross, IR (corresponding author), John Cochran Vet Affairs Med Ctr, Gen Med Serv, St Louis, MO 63106 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					1882	1883		10.1056/NEJMp2033891	http://dx.doi.org/10.1056/NEJMp2033891		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ4AW	34014048				2022-12-28	WOS:000652581300001
J	Dionne-Odom, JN; White, DB				Dionne-Odom, J. Nicholas; White, Douglas B.			Reconceptualizing How to Support Surrogates Making Medical Decisions for Critically Ill Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dionne-Odom, J. Nicholas] Univ Alabama Birmingham, Sch Nursing, 1720 Second Ave S,NB 485J, Birmingham, AL 35294 USA; [White, Douglas B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Program Eth & Decis Making Crit Illness, Pittsburgh, PA USA	University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dionne-Odom, JN (corresponding author), Univ Alabama Birmingham, Sch Nursing, 1720 Second Ave S,NB 485J, Birmingham, AL 35294 USA.	dionneod@uab.edu		Dionne-Odom, James/0000-0001-6764-0254	NIH [K24HL148314]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded in part by NIH grant K24HL148314 (Dr White).	Bibas L, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7229; Cox CE, 2019, ANN INTERN MED, V170, P285, DOI 10.7326/M18-2335; Dionne-Odom JN, 2015, NURS OUTLOOK, V63, P331, DOI 10.1016/j.outlook.2014.10.004; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Lerner JS, 2015, ANNU REV PSYCHOL, V66, P799, DOI 10.1146/annurev-psych-010213-115043; MARKS G, 1987, PSYCHOL BULL, V102, P72, DOI 10.1037/0033-2909.102.1.72; RobertWood Johnson Foundation, 2018, DISCR AM FIN SUMM; Tunney RJ, 2015, PERSPECT PSYCHOL SCI, V10, P880, DOI 10.1177/1745691615598508; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; White DB, 2018, NEW ENGL J MED, V378, P2365, DOI 10.1056/NEJMoa1802637	10	7	7	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2021	325	21					2147	2148		10.1001/jama.2021.6445	http://dx.doi.org/10.1001/jama.2021.6445		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UK2NJ	33988689				2022-12-28	WOS:000650215600001
J	He, Y; Wang, YQ; Liu, BC; Helmling, C; Susac, L; Cheng, R; Zhou, ZH; Feigon, J				He, Yao; Wang, Yaqiang; Liu, Baocheng; Helmling, Christina; Susac, Lukas; Cheng, Ryan; Zhou, Z. Hong; Feigon, Juli			Structures of telomerase at several steps of telomere repeat synthesis	NATURE			English	Article							TEMPLATE-BOUNDARY DEFINITION; REVERSE-TRANSCRIPTASE; PROTEIN TPP1; RNA-BINDING; PROCESSIVITY; HOLOENZYME; DOMAIN; SUBUNIT; MODEL; MOTIF	Telomerase is unique among the reverse transcriptases in containing a noncoding RNA (known as telomerase RNA (TER)) that includes a short template that is used for the processive synthesis of G-rich telomeric DNA repeats at the 3' ends of most eukaryotic chromosomes(1). Telomerase maintains genomic integrity, and its activity or dysregulation are critical determinants of human longevity, stem cell renewal and cancer progression(2,3). Previous cryo-electron microscopy structures have established the general architecture, protein components and stoichiometries of Tetrahymena and human telomerase, but our understandings of the details of DNA-protein and RNA-protein interactions and of the mechanisms and recruitment involved remain limited(4-6). Here we report cryo-electron microscopy structures of active Tetrahymena telomerase with telomeric DNA at different steps of nucleotide addition. Interactions between telomerase reverse transcriptase (TERT), TER and DNA reveal the structural basis of the determination of the 5' and 3' template boundaries, handling of the template-DNA duplex and separation of the product strand during nucleotide addition. The structure and binding interface between TERT and telomerase protein p50 (a homologue of human TPP1(7,8)) define conserved interactions that are required for telomerase activation and recruitment to telomeres. Telomerase La-related protein p65 remodels several regions of TER, bridging the 5' and 3' ends and the conserved pseudoknot to facilitate assembly of the TERT-TER catalytic core.	[He, Yao; Wang, Yaqiang; Liu, Baocheng; Helmling, Christina; Susac, Lukas; Cheng, Ryan; Feigon, Juli] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [He, Yao; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Feigon, J (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Zhou, ZH (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	hong.zhou@ucla.edu; feigon@mbi.ucla.edu	Zhou, Z Hong/HDN-0747-2022	Wang, Yaqiang/0000-0002-6822-4778; Zhou, Hong/0000-0002-8373-4717; He, Yao/0000-0002-1368-6422	NIH [1S10RR23057, 1S10OD018111, U24GM116792, R35GM131901, GM071940]; NSF [MCB2016540, DBI-1338135, DMR-1548924]; UCLA; NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy programme [U24 GM129541]; National Center for CryoEM Access and Training (NCCAT); Simons Electron Microscopy Center located at the New York Structural Biology Center - NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy programme [U24 GM129539]; Simons Foundation [SF349247]; NY State Assembly	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); UCLA; NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy programme; National Center for CryoEM Access and Training (NCCAT); Simons Electron Microscopy Center located at the New York Structural Biology Center - NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy programme; Simons Foundation; NY State Assembly	This work was supported by NIH R35GM131901 and NSF MCB2016540 grants to J.F. and NIH grant GM071940 to Z.H.Z. We acknowledge use of instruments at the Electron Imaging Center for Nanomachines supported by UCLA and by instrumentation grants from NIH (1S10RR23057, 1S10OD018111 and U24GM116792) and NSF (DBI-1338135 and DMR-1548924). Some preliminary data were collected at the Stanford-SLAC Cryo-EM Center (S2C2) supported by the NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy programme (U24 GM129541) and National Center for CryoEM Access and Training (NCCAT) and the Simons Electron Microscopy Center located at the New York Structural Biology Center, supported by the NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy programme (U24 GM129539), and by grants from the Simons Foundation (SF349247) and NY State Assembly. We thank D. Weisman for help with illustration of Fig. 5.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akiyama BM, 2013, J BIOL CHEM, V288, P22141, DOI 10.1074/jbc.M113.452425; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Berman AJ, 2011, NAT STRUCT MOL BIOL, V18, P1371, DOI 10.1038/nsmb.2174; Blackburn EH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003558; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cash DD, 2017, NUCLEIC ACIDS RES, V45, P482, DOI 10.1093/nar/gkw1153; Chan H, 2017, ANNU REV BIOPHYS, V46, P199, DOI 10.1146/annurev-biophys-062215-011140; Chu TW, 2016, MOL CELL BIOL, V36, P210, DOI 10.1128/MCB.00746-15; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Grill S, 2018, CELL REP, V22, P1132, DOI 10.1016/j.celrep.2018.01.012; Harkisheimer M, 2013, STRUCTURE, V21, P1870, DOI 10.1016/j.str.2013.08.013; Holohan B, 2015, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3093-4; Hong K, 2013, MOL CELL BIOL, V33, P3962, DOI 10.1128/MCB.00792-13; Hu XC, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108568; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Jansson LI, 2019, P NATL ACAD SCI USA, V116, P9350, DOI 10.1073/pnas.1814777116; Jansson LI, 2015, NAT STRUCT MOL BIOL, V22, P883, DOI 10.1038/nsmb.3101; Jiang JS, 2018, CELL, V173, P1179, DOI 10.1016/j.cell.2018.04.038; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kotik-Kogan O, 2008, STRUCTURE, V16, P852, DOI 10.1016/j.str.2008.02.021; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lim CJ, 2021, NAT REV MOL CELL BIO, V22, P283, DOI 10.1038/s41580-021-00328-y; Lue NF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6762; Maraia RJ, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1430; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Miller MC, 2002, P NATL ACAD SCI USA, V99, P6585, DOI 10.1073/pnas.102024699; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Patrick EM, 2020, NAT CHEM BIOL, V16, P801, DOI 10.1038/s41589-020-0478-0; Petrov A, 2013, METHOD ENZYMOL, V530, P315, DOI 10.1016/B978-0-12-420037-1.00017-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Prathapam R, 2005, NAT STRUCT MOL BIOL, V12, P252, DOI 10.1038/nsmb900; Richards RJ, 2006, NUCLEIC ACIDS RES, V34, P816, DOI 10.1093/nar/gkj481; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schaich MA, 2020, ELIFE, V9, DOI 10.7554/eLife.55438; Shastry S, 2018, NUCLEIC ACIDS RES, V46, P3088, DOI 10.1093/nar/gky117; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; Singh M, 2012, MOL CELL, V47, P16, DOI 10.1016/j.molcel.2012.05.018; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Tesmer VM, 2019, P NATL ACAD SCI USA, V116, P26505, DOI 10.1073/pnas.1911912116; Nguyen THD, 2018, NATURE, V557, P190, DOI 10.1038/s41586-018-0062-x; Upton HE, 2017, J BIOL CHEM, V292, P217, DOI 10.1074/jbc.M116.763664; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang MH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16234-4; Wang YQ, 2020, P NATL ACAD SCI USA, V117, P31078, DOI 10.1073/pnas.2011684117; Wang YQ, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032383; Wu RA, 2017, ANNU REV BIOCHEM, V86, P439, DOI 10.1146/annurev-biochem-061516-045019; Wu RA, 2017, EMBO J, V36, P1908, DOI 10.15252/embj.201796887; Xie MY, 2010, NUCLEIC ACIDS RES, V38, P1982, DOI 10.1093/nar/gkp1198; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Yang W, 2015, NAT STRUCT MOL BIOL, V22, P844, DOI 10.1038/nsmb.3098; Zeng ZX, 2011, P NATL ACAD SCI USA, V108, P20357, DOI 10.1073/pnas.1113624108; Zhang Y, 2013, P NATL ACAD SCI USA, V110, P5457, DOI 10.1073/pnas.1217733110; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	71	17	17	6	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					454	+		10.1038/s41586-021-03529-9	http://dx.doi.org/10.1038/s41586-021-03529-9		MAY 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE2PC	33981033	Green Accepted			2022-12-28	WOS:000650174400003
J	Kuehn, BM				Kuehn, Bridget M.			Even Partial COVID-19 Vaccination Protects Nursing Home Residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1826	1826		10.1001/jama.2021.5968	http://dx.doi.org/10.1001/jama.2021.5968			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974012	Bronze			2022-12-28	WOS:000650205000005
J	Sotos, JG				Sotos, John G.			Disclosure of Presidential Health Information	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sotos, John G.] 855 El Camino Real,Ste 13A 243, Palo Alto, CA 94301 USA		Sotos, JG (corresponding author), 855 El Camino Real,Ste 13A 243, Palo Alto, CA 94301 USA.	jama2021@sotos.com						Klitzman R, 2021, JAMA-J AM MED ASSOC, V325, P25, DOI 10.1001/jama.2020.23476; Sotos J, 2020, WASHINGTON POST; US Air Force, AIR FORC WAIV GUID D; USAF Air Force Office of the Surgeon General (SG3/5P), 2017, MED STAND DIR	4	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1903	+		10.1001/jama.2021.3338	http://dx.doi.org/10.1001/jama.2021.3338			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974024				2022-12-28	WOS:000650205000025
J	Zarocostas, J				Zarocostas, John			UK makes massive global health cuts	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1697	1697						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33965075				2022-12-28	WOS:000647813600009
J	Coleman, GA; Davin, AA; Mahendrarajah, TA; Szantho, LL; Spang, A; Hugenholtz, P; Szollosi, GJ; Williams, TA				Coleman, Gareth A.; Davin, Adrian A.; Mahendrarajah, Tara A.; Szantho, Lenard L.; Spang, Anja; Hugenholtz, Philip; Szollosi, Gergely J.; Williams, Tom A.			A rooted phylogeny resolves early bacterial evolution	SCIENCE			English	Article							LATERAL GENE-TRANSFER; TREE; ANCIENT; LIFE; GENOMES; PROTEIN; CLASSIFICATION; TRANSITION; ALGORITHM; ORIGINS	A rooted bacterial tree is necessary to understand early evolution, but the position of the root is contested. Here, we model the evolution of 11,272 gene families to identify the root, extent of horizontal gene transfer (HGT), and the nature of the last bacterial common ancestor (LBCA). Our analyses root the tree between the major clades Terrabacteria and Gracilicutes and suggest that LBCA was a free-living flagellated, rod-shaped double-membraned organism. Contrary to recent proposals, our analyses reject a basal placement of the Candidate Phyla Radiation, which instead branches sister to Chloroflexota within Terrabacteria. While most gene families (92%) have evidence of HGT, overall, two-thirds of gene transmissions have been vertical, suggesting that a rooted tree provides a meaningful frame of reference for interpreting bacterial evolution.	[Coleman, Gareth A.; Williams, Tom A.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England; [Davin, Adrian A.; Hugenholtz, Philip] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Mahendrarajah, Tara A.; Spang, Anja] Royal Netherlands Inst Sea Res, NIOZ, Dept Marine Microbiol & Biogeochem, NL-1790 AB Den Burg, Netherlands; [Szantho, Lenard L.; Szollosi, Gergely J.] Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; [Szantho, Lenard L.; Szollosi, Gergely J.] Lendulet Evolutionary Genom Res Grp, MTA ELTE, H-1117 Budapest, Hungary; [Spang, Anja] Uppsala Univ, Dept Cell & Mol Biol, SE-75123 Uppsala, Sweden; [Szollosi, Gergely J.] Ctr Ecol Res, Inst Evolut, H-1121 Budapest, Hungary	University of Bristol; University of Queensland; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Eotvos Lorand University; Uppsala University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research	Williams, TA (corresponding author), Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England.; Hugenholtz, P (corresponding author), Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.; Szollosi, GJ (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary.; Szollosi, GJ (corresponding author), Lendulet Evolutionary Genom Res Grp, MTA ELTE, H-1117 Budapest, Hungary.; Szollosi, GJ (corresponding author), Ctr Ecol Res, Inst Evolut, H-1121 Budapest, Hungary.	p.hugenholtz@uq.edu.au; ssolo@elte.hu; tom.a.williams@bristol.ac.uk	Szollosi, Gergely/AAG-5760-2019; Hugenholtz, Philip/AAD-9138-2019	Szollosi, Gergely/0000-0002-8556-845X; Hugenholtz, Philip/0000-0001-5386-7925; Coleman, Gareth/0000-0003-2642-8278; Mahendrarajah, Tara/0000-0001-7032-6581; Williams, Tom/0000-0003-1072-0223; Szantho, Lenard Lajos/0000-0003-3363-2488; Spang, Anja/0000-0002-6518-8556	Royal Society Research Grant; Royal Society University Research Fellowship; NERC [NE/P00251X/1]; European Research Council under the European Union [714774, GINOP-2.3.2.-15-201600057]; Swedish Research Council (VR) [2016-03559]; NWO-I foundation of the Netherlands Organisation for Scientific Research (WISE fellowship); Australian Research Council Laureate Fellowship [FL150100038]	Royal Society Research Grant(Royal Society of London); Royal Society University Research Fellowship(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council under the European Union(European Research Council (ERC)); Swedish Research Council (VR)(Swedish Research Council); NWO-I foundation of the Netherlands Organisation for Scientific Research (WISE fellowship); Australian Research Council Laureate Fellowship(Australian Research Council)	G.A.C. is supported by a Royal Society Research Grant to T.A.W. T.A.W. is supported by a Royal Society University Research Fellowship and NERC grant NE/P00251X/1. G.J.Sz. received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program under grant agreement 714774 and grant GINOP-2.3.2.-15-201600057. A.S. is supported by the Swedish Research Council (VR starting grant 2016-03559 to A.S.) and the NWO-I foundation of the Netherlands Organisation for Scientific Research (WISE fellowship to A.S.). A.A.D. and P.H. are supported by an Australian Research Council Laureate Fellowship (grant FL150100038).	Adam PS, 2018, P NATL ACAD SCI USA, V115, pE1166, DOI 10.1073/pnas.1716667115; Alvarez-Ponce D, 2013, P NATL ACAD SCI USA, V110, pE1594, DOI 10.1073/pnas.1211371110; Antunes LCS, 2016, ELIFE, V5, DOI 10.7554/eLife.14589; Aramaki T, 2020, BIOINFORMATICS, V36, P2251, DOI 10.1093/bioinformatics/btz859; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Beam JP, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01848; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bocchetta M, 2000, J MOL EVOL, V50, P366, DOI 10.1007/s002399910040; Borrel G, 2016, GENOME BIOL EVOL, V8, P1706, DOI 10.1093/gbe/evw114; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; BROWN JR, 1995, P NATL ACAD SCI USA, V92, P2441, DOI 10.1073/pnas.92.7.2441; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Castelle CJ, 2018, NAT REV MICROBIOL, V16, P629, DOI 10.1038/s41579-018-0076-2; Castelle CJ, 2018, CELL, V172, P1181, DOI 10.1016/j.cell.2018.02.016; Castelle CJ, 2015, CURR BIOL, V25, P690, DOI 10.1016/j.cub.2015.01.014; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; Chauve, 2017, BIORXIV, DOI [10.1101/127548., DOI 10.1101/127548]; Coleman G, 2020, FIGSHARE; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Dagan T, 2007, P NATL ACAD SCI USA, V104, P870, DOI 10.1073/pnas.0606318104; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; Davin AA, 2020, BIOINFORMATICS, V36, P1286, DOI 10.1093/bioinformatics/btz710; Davin AA, 2018, NAT ECOL EVOL, V2, P904, DOI 10.1038/s41559-018-0525-3; Dombrowski N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17408-w; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Emms DM, 2017, MOL BIOL EVOL, V34, P3267, DOI 10.1093/molbev/msx259; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Galperin MY, 2019, BRIEF BIOINFORM, V20, P1063, DOI 10.1093/bib/bbx117; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; Gouy R, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0329; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Humphries S., 2020, 202008202603 BIORXIV; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Katz LA, 2012, SYST BIOL, V61, P653, DOI 10.1093/sysbio/sys026; Koonin EV, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0087; Koonin EV, 2014, ANTON LEEUW INT J G, V106, P27, DOI 10.1007/s10482-014-0169-5; Krupovic M, 2019, NAT REV MICROBIOL, V17, P449, DOI 10.1038/s41579-019-0205-6; Lake JA, 2009, NATURE, V460, P967, DOI 10.1038/nature08183; Lake JA, 2009, PHILOS T R SOC B, V364, P2177, DOI 10.1098/rstb.2009.0035; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Megrian D, 2020, MOL MICROBIOL, V113, P659, DOI 10.1111/mmi.14469; Meheust R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12171-z; Mukherjee S, 2017, NAT BIOTECHNOL, V35, P676, DOI 10.1038/nbt.3886; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Puigbo P, 2010, GENOME BIOL EVOL, V2, P745, DOI 10.1093/gbe/evq062; Raymann K, 2015, P NATL ACAD SCI USA, V112, P6670, DOI 10.1073/pnas.1420858112; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Sanchez-Andrea I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18906-7; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Sela I, 2016, P NATL ACAD SCI USA, V113, P11399, DOI 10.1073/pnas.1614083113; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Skophammer RG, 2007, MOL BIOL EVOL, V24, P1761, DOI 10.1093/molbev/msm096; Sousa FL, 2016, BBA-BIOENERGETICS, V1857, P1027, DOI 10.1016/j.bbabio.2016.04.284; Sousa FL, 2014, BBA-BIOENERGETICS, V1837, P964, DOI 10.1016/j.bbabio.2014.02.001; Susko E, 2007, MOL BIOL EVOL, V24, P2139, DOI 10.1093/molbev/msm144; Szollosi GJ, 2013, SYST BIOL, V62, P901, DOI 10.1093/sysbio/syt054; Szollosi GJ, 2013, SYST BIOL, V62, P386, DOI 10.1093/sysbio/syt003; Szollosi GJ, 2012, P NATL ACAD SCI USA, V109, P17513, DOI 10.1073/pnas.1202997109; Taib N, 2020, NAT ECOL EVOL, V4, P1661, DOI 10.1038/s41559-020-01299-7; Tocheva EI, 2016, NAT REV MICROBIOL, V14, P535, DOI 10.1038/nrmicro.2016.85; Wang HC, 2018, SYST BIOL, V67, P216, DOI 10.1093/sysbio/syx068; WEISS MC, 2016, NAT MICROBIOL, V1, P16116, DOI [DOI 10.1038/NMICROBIOL.2016.116, 10.1038/nmicrobiol.2016.116]; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Williams TA, 2017, P NATL ACAD SCI USA, V114, pE4602, DOI 10.1073/pnas.1618463114; Zhang C, 2017, LECT N BIOINFORMAT, V10562, P53, DOI 10.1007/978-3-319-67979-2_4; Zhaxybayeva O, 2005, PROTOPLASMA, V227, P53, DOI 10.1007/s00709-005-0135-1; Zhu QY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13443-4; Zwaenepoel A, 2019, MOL BIOL EVOL, V36, P1384, DOI 10.1093/molbev/msz088	88	28	28	16	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					588	+	abe0511	10.1126/science.abe0511	http://dx.doi.org/10.1126/science.abe0511			74	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958449	Green Submitted, Green Published			2022-12-28	WOS:000649103500035
J	Pineles, BL; Goodman, KE; Pineles, L; O'Hara, LM; Nadimpalli, G; Magder, LS; Baghdadi, JD; Parchem, JG; Harris, AD				Pineles, Beth L.; Goodman, Katherine E.; Pineles, Lisa; O'Hara, Lyndsay M.; Nadimpalli, Gita; Magder, Laurence S.; Baghdadi, Jonathan D.; Parchem, Jacqueline G.; Harris, Anthony D.			In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19	ANNALS OF INTERNAL MEDICINE			English	Letter									[Pineles, Beth L.; Parchem, Jacqueline G.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA; [Goodman, Katherine E.; Pineles, Lisa; O'Hara, Lyndsay M.; Nadimpalli, Gita; Magder, Laurence S.; Baghdadi, Jonathan D.; Harris, Anthony D.] Univ Maryland, Sch Med, 10 South Pine St,MSTF 330, Baltimore, MD 21201 USA	University of Texas System; University of Texas Health Science Center Houston; University System of Maryland; University of Maryland Baltimore	Harris, AD (corresponding author), Univ Maryland, Sch Med, 10 South Pine St,MSTF 330, Baltimore, MD 21201 USA.	aharris@som.umaryland.edu	Parchem, Jacqueline/AHE-3147-2022; Parchem, Jacqueline/HDN-4962-2022	Parchem, Jacqueline/0000-0002-4795-3488; Pineles, Lisa/0000-0002-2377-5971; Goodman, Katherine/0000-0003-2851-775X; Nadimpalli, Gita/0000-0002-6283-1032; Pineles, Beth/0000-0002-0450-2943				Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Kadri SS, 2020, JAMA-J AM MED ASSOC, V324, P2553, DOI 10.1001/jama.2020.20323; Knight M., 2021, FEMALES HOSP SARS CO; Metz TD, 2021, OBSTET GYNECOL, V137, P571, DOI 10.1097/AOG.0000000000004339	5	12	12	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG	2021	174	8					1186	+		10.7326/M21-0974	http://dx.doi.org/10.7326/M21-0974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP3IW	33971101	Green Published			2022-12-28	WOS:000695277800039
J	Brouwers, S; Sudano, I; Kokubo, Y; Sulaica, EM				Brouwers, Sofie; Sudano, Isabella; Kokubo, Yoshihiro; Sulaica, Elisabeth M.			Arterial hypertension	LANCET			English	Review							SYSTOLIC BLOOD-PRESSURE; RESISTANT HYPERTENSION; UNCONTROLLED HYPERTENSION; RENAL DENERVATION; MILLION ADULTS; AIR-POLLUTION; GLOBAL BURDEN; TASK-FORCE; ASSOCIATION; PREVENTION	Arterial hypertension is the most important contributor to the global burden of disease; however, disease control remains poor. Although the diagnosis of hypertension is still based on office blood pressure, confirmation with out-of-office blood pressure measurements (ie, ambulatory or home monitoring) is strongly recommended. The definition of hypertension differs throughout various guidelines, but the indications for antihypertensive therapy are relatively similar. Lifestyle adaptation is absolutely key in non-pharmacological treatment. Pharmacologically, angiotens-inconverting enzyme inhibitors or angiotensin receptor blockers, calcium channel blockers, and diuretics are the first-line agents, with advice for the use of single-pill combination therapy by most guidelines. As a fourth-line agent, spironolactone should be considered. The rapidly evolving field of device-based therapy, especially renal denervation, will further broaden therapeutic options. Despite being a largely controllable condition, the actual rates of awareness, treatment, and control of hypertension are disappointingly low. Further improvements throughout the process of patient screening, diagnosis, treatment, and follow-up need to be urgently addressed.	[Brouwers, Sofie] OLV Hosp Aalst, Dept Cardiol, Cardiovasc Ctr Aalst, B-9300 Aalst, Belgium; [Brouwers, Sofie] Vrije Univ Brussel, Fac Med & Pharm, Dept Expt Pharmacol, Brussels, Belgium; [Sudano, Isabella] Univ Zurich, Univ Zurich Hosp, Univ Heart Ctr, Cardiol, Zurich, Switzerland; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Kokubo, Yoshihiro] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Sulaica, Elisabeth M.] Univ Houston, Coll Pharm, Pharm Practice & Translat Res, Houston, TX 77030 USA	Cardiovascular Center Aalst; Vrije Universiteit Brussel; University of Zurich; University Zurich Hospital; National Cerebral & Cardiovascular Center - Japan; University of Glasgow; University of Houston System; University of Houston	Brouwers, S (corresponding author), OLV Hosp Aalst, Dept Cardiol, Cardiovasc Ctr Aalst, B-9300 Aalst, Belgium.	sofie.brouwers@olvz-aalst.be			Intramural Research Fund for the National Cerebral and Cardiovascular Center, Osaka, Japan [20-4-9]	Intramural Research Fund for the National Cerebral and Cardiovascular Center, Osaka, Japan	We thank H Zekollari for the fruitful discussions and help with the design of figure 2. YK is supported by the Intramural Research Fund for the National Cerebral and Cardiovascular Center (20-4-9), Osaka, Japan.	[Anonymous], 2018, ESC TXB CARDIOVASCUL; [Anonymous], 2018, ESC TXB CARDIOVASCUL; Baker WL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005686; Bangalore S, 2017, AM J MED, V130, P707, DOI 10.1016/j.amjmed.2017.01.004; Beaney T, 2020, HYPERTENSION, V76, P333, DOI 10.1161/HYPERTENSIONAHA.120.14874; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Blood Pressure Lowering Treatment Trialists' Collaboration, LANCET, V397, P1625; Bohm M, 2020, LANCET, V395, P1444, DOI 10.1016/S0140-6736(20)30554-7; Bozkurt B, 2020, J CARD FAIL, V26, P370, DOI 10.1016/j.cardfail.2020.04.013; Bromfield SG, 2014, J CLIN HYPERTENS, V16, P270, DOI 10.1111/jch.12281; Brouwers S, 2013, EUR HEART J, V34, P654; Burnier M, 2013, HYPERTENSION, V62, P218, DOI 10.1161/HYPERTENSIONAHA.113.00687; Campbell NRC, 2020, J CLIN HYPERTENS, V22, P1754, DOI 10.1111/jch.14017; Carey RM, 2018, HYPERTENSION, V72, pE53, DOI 10.1161/HYP.0000000000000084; Carey RM, 2018, J AM COLL CARDIOL, V72, P1278, DOI 10.1016/j.jacc.2018.07.008; Chow CK, 2017, LANCET, V389, P1035, DOI 10.1016/S0140-6736(17)30260-X; Colhoun HM, 1998, J HUM HYPERTENS, V12, P91, DOI 10.1038/sj.jhh.1000558; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; de Abajo FJ, 2020, LANCET, V395, P1705, DOI 10.1016/S0140-6736(20)31030-8; Delgado J, 2018, JAMA INTERN MED, V178, P93, DOI 10.1001/jamainternmed.2017.7023; Drummond GR, 2019, NAT REV IMMUNOL, V19, P517, DOI 10.1038/s41577-019-0160-5; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; ESC, 2020, POS STAT ESC COUNC H; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Evangelou E, 2018, NAT GENET, V50, P1412, DOI 10.1038/s41588-018-0205-x; Falkner B, 2020, HYPERTENSION, V75, P1142, DOI 10.1161/HYPERTENSIONAHA.119.14059; Ferdinand KC, 2019, CIRCULATION, V140, P138, DOI 10.1161/CIRCULATIONAHA.119.040070; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Fuks KB, 2017, EUR HEART J, V38, P983, DOI 10.1093/eurheartj/ehw413; Furuhashi M, 2020, HYPERTENS RES, V43, P837, DOI 10.1038/s41440-020-0478-1; GBD 2017 Collaborators, 2018, LANCET, V392, P1923, DOI 10.1016/S0140-6736(18)32225-6; Gibbs J, 2021, J HYPERTENS, V39, P23, DOI 10.1097/HJH.0000000000002604; Groenland EH, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-1024-x; Haikerwal A, 2020, HYPERTENSION, V75, P211, DOI 10.1161/HYPERTENSIONAHA.119.13780; Hardy ST, 2017, JAMA CARDIOL, V2, P653, DOI 10.1001/jamacardio.2017.0652; Heusser K, 2020, HYPERTENSION, V75, P257, DOI 10.1161/HYPERTENSIONAHA.119.13925; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Irigoyen MC, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0642-9; Ji HW, 2020, JAMA CARDIOL, V5, P255, DOI 10.1001/jamacardio.2019.5306; Kanda T, 2020, HYPERTENS RES, V43, P859, DOI 10.1038/s41440-020-0451-z; Kandzari DE, 2020, HYPERTENSION, V76, P1410, DOI 10.1161/HYPERTENSIONAHA.120.15745; Kandzari DE, 2018, LANCET, V391, P2346, DOI 10.1016/S0140-6736(18)30951-6; Kario K, 2018, HYPERTENSION, V71, P375, DOI 10.1161/HYPERTENSIONAHA.117.10238; Keeley EC, 2020, J CLIN HYPERTENS, V22, P1987, DOI 10.1111/jch.14037; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kokubo Y, 2019, ENVIRON HEALTH PREV, V24, DOI 10.1186/s12199-019-0771-2; Kostis JB, 2005, ARCH INTERN MED, V165, P1637, DOI 10.1001/archinte.165.14.1637; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lederle FA, 2016, ANN INTERN MED, V165, P663, DOI 10.7326/M16-1208; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lobo MD, 2015, LANCET, V385, P1634, DOI 10.1016/S0140-6736(14)62053-5; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Lopaschuk GD, 2020, JACC-BASIC TRANSL SC, V5, P632, DOI 10.1016/j.jacbts.2020.02.004; Lu JP, 2017, LANCET, V390, P2549, DOI [10.1016/S0140-6736(17)32478-9, 10.1016/s0140-6736(17)32478-9]; Lu XM, 2019, HYPERTENSION, V74, P697, DOI 10.1161/HYPERTENSIONAHA.119.13273; Ma Y, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002933; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Marques FZ, 2018, NAT REV CARDIOL, V15, P20, DOI 10.1038/nrcardio.2017.120; McMullan CJ, 2013, CLIN J AM SOC NEPHRO, V8, P731, DOI 10.2215/CJN.10131012; Medina D, 2020, CLIN AUTON RES, V30, P393, DOI 10.1007/s10286-020-00720-2; Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621; Mehta N, 2020, JAMA CARDIOL, V5, P1020, DOI 10.1001/jamacardio.2020.1855; Munzel T, 2017, EUR HEART J, V38, P550, DOI 10.1093/eurheartj/ehw269; Aguilera EM, 2020, CARDIOVASC RES, V116, P28, DOI 10.1093/cvr/cvz201; Myers MG, 2010, HYPERTENSION, V55, P195, DOI 10.1161/HYPERTENSIONAHA.109.141879; Niiranen TJ, 2018, JAMA CARDIOL, V3, P427, DOI 10.1001/jamacardio.2018.0250; Noubiap JJ, 2017, LANCET PUBLIC HEALTH, V2, pE375, DOI 10.1016/S2468-2667(17)30123-8; Ojji DB, 2019, NEW ENGL J MED, V380, P2429, DOI 10.1056/NEJMoa1901113; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Padwal R, 2019, J HYPERTENS, V37, P1737, DOI 10.1097/HJH.0000000000002112; Parati G, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0743-0; Pellegrini D, 2020, HYPERTENS RES, V43, P621, DOI 10.1038/s41440-020-0422-4; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Picone DS, 2020, J CLIN HYPERTENS, V22, P2167, DOI 10.1111/jch.14065; Picone DS, 2020, HYPERTENSION, V75, P1593, DOI 10.1161/HYPERTENSIONAHA.120.14719; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Rea F, 2018, HYPERTENSION, V72, P846, DOI 10.1161/HYPERTENSIONAHA.118.11308; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; Rodriguez-Iturbe B, 2017, PHYSIOL REV, V97, P1127, DOI 10.1152/physrev.00031.2016; Salvetti M, 2019, HYPERTENSION, V73, P736, DOI 10.1161/HYPERTENSIONAHA.118.12187; Satoh M, 2019, HYPERTENSION, V73, P52, DOI 10.1161/HYPERTENSIONAHA.118.11635; Sega R, 2002, HYPERTENSION, V39, P710, DOI 10.1161/hy0202.104376; Sharman JE, 2019, J HUM HYPERTENS, V33, P89, DOI 10.1038/s41371-018-0122-6; Sinnott SJ, 2017, EUR J PREV CARDIOL, V24, P228, DOI 10.1177/2047487316675194; Son M, 2020, HYPERTENSION, V76, P742, DOI 10.1161/HYPERTENSIONAHA.120.15464; Stergiou GS, 2021, J HYPERTENS, V39, P1293, DOI 10.1097/HJH.0000000000002843; Sulaica EM, 2020, MAYO CLIN PROC, V95, P1955, DOI 10.1016/j.mayocp.2020.01.014; Townsend RR, 2017, LANCET, V390, P2160, DOI 10.1016/S0140-6736(17)32281-X; Unger T, 2020, J HYPERTENS, V38, P982, DOI 10.1097/HJH.0000000000002453; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; Vallianou NG, 2020, J CARDIOVASC MED, V21, P83, DOI 10.2459/JCM.0000000000000900; van der Wardt V, 2017, J HYPERTENS, V35, P1742, DOI 10.1097/HJH.0000000000001405; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Williams B, 2015, LANCET, V386, P2059, DOI 10.1016/S0140-6736(15)00257-3; Wohlfahrt P, 2019, J HYPERTENS, V37, pE67, DOI 10.1097/01.hjh.0000571024.24398.08; World Health Assembly, 2018, DIGITAL HLTH 0526; World Health Organization, 2019, REC DIG INT HLTH SYT; Wright JT, 2005, JAMA-J AM MED ASSOC, V293, P1595, DOI 10.1001/jama.293.13.1595; Zhang YY, 2019, J AM COLL CARDIOL, V74, P330, DOI 10.1016/j.jacc.2019.03.529	105	32	32	3	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2021	398	10296					249	261		10.1016/S0140-6736(21)00221-X	http://dx.doi.org/10.1016/S0140-6736(21)00221-X		JUL 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TK6UV	34019821				2022-12-28	WOS:000674291900024
J	Spertus, JA; Fine, JT; Elliott, P; Ho, CY; Olivotto, J; Saberi, S; Li, WY; Dolan, C; Reaney, M; Sehnert, AJ; Jacoby, D				Spertus, John A.; Fine, Jennifer T.; Elliott, Perry; Ho, Carolyn Y.; Olivotto, Jacopo; Saberi, Sara; Li, Wanying; Dolan, Chantal; Reaney, Matthew; Sehnert, Amy J.; Jacoby, Daniel			Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article							HEART-FAILURE; HIGH-RISK; QUESTIONNAIRE; HOSPITALIZATION; MANAGEMENT; DIAGNOSIS; THERAPY	Background Improving symptoms is a primary treatment goal in patients with obstructive hypertrophic cardiomyopathy. Currently available pharmacological options for hypertrophic cardiomyopathy are not disease-specific and are often inadequate or poorly tolerated. We aimed to assess the effect of mavacamten, a first-in-class cardiac myosin inhibitor, on patients' health status-ie, symptoms, physical and social function, and quality of life. Methods We did a health status analysis of EXPLORER-HCM, a phase 3, double-blind, randomised, placebo-controlled trial. The study took place at 68 clinical cardiovascular centres in 13 countries. Adult patients (>= 18 years) with symptomatic obstructive hypertrophic cardiomyopathy (gradient >= 50 mm Hg and New York Heart Association class II-III) were randomly assigned (1:1) to mavacamten or placebo for 30 weeks, followed by an 8-week washout period. Both patients and staff were masked to study treatment. The primary outcome for this secondary analysis was the Kansas City Cardiomyopathy Questionnaire (KCCQ), a well validated disease-specific measure of patients' health status. It was administered at baseline and weeks 6, 12, 18, 30 (end of treatment), and 38 (end of study). Changes from baseline to week 30 in KCCQ overall summary (OS) score and all subscales were analysed using mixed model repeated measures. This study is registered with ClinicalTrials.gov, NCT03470545. Findings Between May 30, 2018, and July 12, 2019, 429 adults were assessed for eligibility, of whom 251 (59%) were enrolled and randomly assigned. Of 123 patients randomly assigned to mavacamten, 92 (75%) completed the KCCQ at baseline and week 30 and of the 128 patients randomly assigned to placebo 88 (69%) completed the KCCQ at baseline and week 30. At 30 weeks, the change in KCCQ-OS score was greater with mavacamten than placebo (mean score 14.9 [SD 15.8] vs 5.4 [13.7]; difference +9.1 [95% CI 5.5-12.8]; p<0.0001), with similar benefits across all KCCQ subscales. The proportion of patients with a very large change (KCCQ-OS >= 20 points) was 36% (33 of 92) in the mavacamten group versus 15% (13 of 88) in the placebo group, with an estimated absolute difference of 21% (95% CI 8.8-33.4) and number needed to treat of five (95% CI 3-11). These gains returned to baseline after treatment was stopped. Interpretation Mavacamten markedly improved the health status of patients with symptomatic obstructive hypertrophic cardiomyopathy compared with placebo, with a low number needed to treat for marked improvement. Given that the primary goals of treatment are to improve symptoms, physical and social function, and quality of life, mavacamten represents a new potential strategy for achieving these goals.	[Spertus, John A.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64098 USA; [Spertus, John A.] Univ Missouri, Kansas City, MO 64110 USA; [Fine, Jennifer T.; Li, Wanying; Sehnert, Amy J.] MyoKan Lia, Brisbane, CA USA; [Elliott, Perry] UCL, Ctr Heart Muscle Dis, Inst Cardiovasc Sci, London, England; [Ho, Carolyn Y.] Brigham & Womens Hosp, Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Olivotto, Jacopo] Azienda Osped Univ Careggi, Cardiomyopathy Unit, Florence, Italy; [Saberi, Sara] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Dolan, Chantal] CMD Consulting, Sandy, UT USA; [Reaney, Matthew] IQVIA, Patient Ctr Endpoints, Reading, Berks, England; [Jacoby, Daniel] Yale Univ, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT USA	Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of London; University College London; Harvard University; Brigham & Women's Hospital; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Michigan System; University of Michigan; IQVIA; Yale University	Spertus, JA (corresponding author), St Lukes Mid Amer Heart Inst, Kansas City, MO 64098 USA.	spertusj@umkc.edu	Elliott, Perry/AAR-3430-2020; Spertus, John/ABD-3075-2021	Elliott, Perry/0000-0003-3383-3984; 	MyoKardia, a Bristol Myers Squibb company	MyoKardia, a Bristol Myers Squibb company	MyoKardia, a Bristol Myers Squibb company.	Arnold SV, 2020, J AM COLL CARDIOL, V75, P2099, DOI 10.1016/j.jacc.2020.03.002; Chan PS, 2009, CIRCULATION, V119, P398, DOI 10.1161/CIRCULATIONAHA.108.820472; de Cano SF, 2016, CATHETER CARDIO INTE, V88, P953, DOI 10.1002/ccd.26430; Dreyer RP, 2016, QUAL LIFE RES, V25, P2213, DOI 10.1007/s11136-016-1267-9; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Flynn KE, 2012, AM HEART J, V163, P88, DOI 10.1016/j.ahj.2011.09.027; Food and Drug Administration, 2019, TREATM HEART FAIL EN; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Greene SJ, 2018, J AM COLL CARDIOL, V72, P351, DOI 10.1016/j.jacc.2018.04.070; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Heidenreich PA, 2006, J AM COLL CARDIOL, V47, P752, DOI 10.1016/j.jacc.2005.11.021; Heidenreich PA, 2020, J AM COLL CARDIOL, V76, P2527, DOI 10.1016/j.jacc.2020.07.023; Ho CY, 2021, CIRCULATION, V143, P295, DOI 10.1161/CIRCULATIONAHA.120.050608; Ho CY, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.006853; Huff CM, 2013, QUAL LIFE RES, V22, P647, DOI 10.1007/s11136-012-0182-y; Khalil J, 2017, ANN CARDIOTHORAC SUR, V6, P337, DOI 10.21037/acs.2017.07.09; Kosiborod M, 2007, CIRCULATION, V115, P1975, DOI 10.1161/CIRCULATIONAHA.106.670901; Kosiborod MN, 2020, CIRCULATION, V141, P90, DOI 10.1161/CIRCULATIONAHA.119.044138; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059; Maron BJ, 2018, NEW ENGL J MED, V379, P655, DOI 10.1056/NEJMra1710575; Maurer MS, 2018, NEW ENGL J MED, V379, P1007, DOI 10.1056/NEJMoa1805689; Olivotto I, 2020, LANCET, V396, P759, DOI 10.1016/S0140-6736(20)31792-X; Ommen SR, 2020, CIRCULATION, V142, pe533, DOI 10.1161/CIR.0000000000000938; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Papadakis M, 2020, LANCET, V396, P736, DOI 10.1016/S0140-6736(20)31793-1; Pokharel Y, 2017, JAMA CARDIOL, V2, P1315, DOI 10.1001/jamacardio.2017.3983; Rastegar H, 2017, ANN CARDIOTHORAC SUR, V6, P353, DOI 10.21037/acs.2017.07.07; Reynolds MR, 2012, J AM COLL CARDIOL, V60, P548, DOI 10.1016/j.jacc.2012.03.075; Solomon SD, 2019, NEW ENGL J MED, V381, P1609, DOI 10.1056/NEJMoa1908655; Soto GE, 2004, CIRCULATION, V110, P546, DOI 10.1161/01.CIR.0000136991.85540.A9; Spertus J, 2005, AM HEART J, V150, P707, DOI 10.1016/j.ahj.2004.12.010; Spertus JA, 2020, J AM COLL CARDIOL, V76, P2379, DOI 10.1016/j.jacc.2020.09.542; Teerlink JR, 2021, NEW ENGL J MED, V384, P105, DOI 10.1056/NEJMoa2025797; US FDA, 2020, CLIN OUTC ASS COA QU; US Food and Drug Administration, 2020, FDA2018D1893; Zaiser E, 2020, J PATIENT-REP OUTCOM, V4, DOI 10.1186/s41687-020-00269-8	38	29	30	4	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 26	2021	397	10293					2467	2475		10.1016/S0140-6736(21)00763-7	http://dx.doi.org/10.1016/S0140-6736(21)00763-7		JUN 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TA5XM	34004177	Green Submitted			2022-12-28	WOS:000667322400029
J	Hansen, JM; de Jong, MF; Wu, Q; Zhang, LS; Heisler, DB; Alto, LT; Alto, NM				Hansen, Justin M.; de Jong, Maarten F.; Wu, Qi; Zhang, Li-Shu; Heisler, David B.; Alto, Laura T.; Alto, Neal M.			Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions	CELL			English	Article							INNATE LYMPHOID-CELLS; GASDERMIN D; SHIGELLA EFFECTOR; PROTEIN FAMILY; ACTIVATION; PYROPTOSIS; SECRETION; REVEALS; ASTHMA; DEATH	Gasdermin B (GSDMB) belongs to a large family of pore-forming cytolysins that execute inflammatory cell death programs. While genetic studies have linked GSDMB polymorphisms to human disease, its function in the immunological response to pathogens remains poorly understood. Here, we report a dynamic host-pathogen conflict between GSDMB and the IpaH7.8 effector protein secreted by enteroinvasive Shigella flexneri. We show that IpaH7.8 ubiquitinates and targets GSDMB for 26S proteasome destruction. This virulence strategy protects Shigella from the bacteriocidic activity of natural killer cells by suppressing granzyme-A-mediated activation of GSDMB. In contrast to the canonical function of most gasdermin family members, GSDMB does not inhibit Shigella by lysing host cells. Rather, it exhibits direct microbiocidal activity through recognition of phospholipids found on Gram-negative bacterialmembranes. These findings place GSDMB as a central executioner of intracellular bacterial killing and reveal a mechanism employed by pathogens to counteract this host defense system.	[Hansen, Justin M.; de Jong, Maarten F.; Wu, Qi; Zhang, Li-Shu; Heisler, David B.; Alto, Laura T.; Alto, Neal M.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Alto, NM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	neal.alto@UTSouthwestern.edu	Heisler, David/AAU-2189-2020	Heisler, David/0000-0002-6482-4215	National Institutes of Health [AI083359, 5T32AI007520]; Welch Foundation [I-1704]; Burroughs Welcome Fund [1011019]; Howard Hughes Medical Institute; Simons Foundation Faculty Scholars Program [55108499]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Burroughs Welcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation Faculty Scholars Program	We would like to thank Dr. Kim Orth, Dr. Michael Reese, Dr. Vanessa Sperandio, Dr. Zixu Liu, Benjamin Kocsis, and members of the Alto laboratory for helpful discussions. We thank the UT Southwestern Medical Center Proteomics Core and Electron Microscopy Core Facilities for assistance with aspects of experimental design and execution. This research was supported by the National Institutes of Health (grant AI083359 to N.M.A. and 5T32AI007520 to D.B.H.), the Welch Foundation (grant I-1704), the Burroughs Welcome Fund (grant 1011019), and the Howard Hughes Medical Institute and Simons Foundation Faculty Scholars Program (grant 55108499).	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; ALLAOUI A, 1993, MOL MICROBIOL, V7, P59, DOI 10.1111/j.1365-2958.1993.tb01097.x; Ashida H, 2007, MOL MICROBIOL, V63, P680, DOI 10.1111/j.1365-2958.2006.05547.x; Bond PJ, 2004, MOL MEMBR BIOL, V21, P151, DOI 10.1080/0968760410001699169; Bos MP, 2004, CURR OPIN MICROBIOL, V7, P610, DOI 10.1016/j.mib.2004.10.011; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Carl-Mcgrath S, 2008, PATHOLOGY, V40, P13, DOI 10.1080/00313020701716250; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chao KL, 2017, P NATL ACAD SCI USA, V114, pE1128, DOI 10.1073/pnas.1616783114; Chen Q, 2019, J MOL CELL BIOL, V11, P496, DOI 10.1093/jmcb/mjy056; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Das S, 2016, P NATL ACAD SCI USA, V113, P13132, DOI 10.1073/pnas.1610433113; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong MF, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.84, 10.1038/nmicrobiol.2016.84]; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dotiwala F, 2017, CELL, V171, P1125, DOI 10.1016/j.cell.2017.10.004; Dotiwala F, 2015, JOVE-J VIS EXP, DOI 10.3791/52911; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hitchen PG, 2002, MOL MICROBIOL, V44, P1637, DOI 10.1046/j.1365-2958.2002.02990.x; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keszei AFA, 2014, MOL CELL BIOL, V34, P362, DOI 10.1128/MCB.01360-13; Khalil IA, 2018, LANCET INFECT DIS, V18, P1229, DOI [10.1016/S1473-3099(18)30475-4, 10.1016/s1473-3099(18)30475-4]; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kuang SY, 2017, P NATL ACAD SCI USA, V114, P10642, DOI 10.1073/pnas.1708194114; Li P, 2017, NATURE, V551, P378, DOI 10.1038/nature24467; Liu J, 2003, METHODS MOL BIOL, P163; Liu X, 2020, ANNU REV IMMUNOL, V38, P455, DOI 10.1146/annurev-immunol-111319-023800; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Malik-Kale P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038732; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mitchell P.S., 2020, NAIP NLRC4 DEFICIENT, V2016; O'Connor HF, 2015, EMBO REP, V16, P1699, DOI 10.15252/embr.201540620; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Panda SK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00861; Peng W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213423; Perelman SS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006102; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Piro AS, 2017, MBIO, V8, DOI 10.1128/mBio.01979-17; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Richardson RB, 2018, NAT MICROBIOL, V3, P1214, DOI 10.1038/s41564-018-0244-1; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi PL, 2015, BIOCHEM J, V468, P325, DOI 10.1042/BJ20150204; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Spycher BD, 2012, J ALLERGY CLIN IMMUN, V130, P503, DOI 10.1016/j.jaci.2012.06.002; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Suzuki S, 2018, EMBO REP, V19, P89, DOI 10.15252/embr.201643841; Suzuki S, 2014, P NATL ACAD SCI USA, V111, pE4254, DOI 10.1073/pnas.1324021111; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Tulah AS, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-100; Walch M, 2014, CELL, V157, P1309, DOI 10.1016/j.cell.2014.03.062; Wandel MP, 2017, CELL HOST MICROBE, V22, P507, DOI 10.1016/j.chom.2017.09.007; Watson JL, 2019, MBIO, V10, DOI 10.1128/mBio.02654-19; Yu J, 2011, PEDIATR PULM, V46, P701, DOI 10.1002/ppul.21424; Zhang ZB, 2021, CANCER IMMUNOL RES, V9, P2, DOI 10.1158/2326-6066.CIR-20-0525; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517; Zychlinsky A, 1996, INFECT IMMUN, V64, P5357, DOI 10.1128/IAI.64.12.5357-5365.1996; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	77	40	40	5	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3178	+	e18	10.1016/j.cell.2021.04.036	http://dx.doi.org/10.1016/j.cell.2021.04.036		JUN 2021	32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	34022140	Green Accepted, Bronze			2022-12-28	WOS:000660014300010
J	Kajala, K; Gouran, M; Shaar-Moshe, L; Mason, GA; Rodriguez-Medina, J; Kawa, D; Pauluzzi, G; Reynoso, M; Canto-Pastor, A; Manzano, C; Lau, V; Artur, MAS; West, DA; Gray, SB; Borowsky, AT; Moore, BP; Yao, AI; Morimoto, KW; Bajic, M; Formentin, E; Nirmal, NA; Rodriguez, A; Pasha, A; Deal, RB; Kliebenstein, DJ; Hvidsten, TR; Provart, NJ; Sinha, NR; Runcie, DE; Bailey-Serres, J; Brady, SM				Kajala, Kaisa; Gouran, Mona; Shaar-Moshe, Lidor; Mason, G. Alex; Rodriguez-Medina, Joel; Kawa, Dorota; Pauluzzi, Germain; Reynoso, Mauricio; Canto-Pastor, Alex; Manzano, Concepcion; Lau, Vincent; Artur, Mariana A. S.; West, Donnelly A.; Gray, Sharon B.; Borowsky, Alexander T.; Moore, Bryshal P.; Yao, Andrew, I; Morimoto, Kevin W.; Bajic, Marko; Formentin, Elide; Nirmal, Niba A.; Rodriguez, Alan; Pasha, Asher; Deal, Roger B.; Kliebenstein, Daniel J.; Hvidsten, Torgeir R.; Provart, Nicholas J.; Sinha, Neelima R.; Runcie, Daniel E.; Bailey-Serres, Julia; Brady, Siobhan M.			Innovation, conservation, and repurposing of gene function in root cell type development	CELL			English	Article							TRANSCRIPTION FACTORS; ARABIDOPSIS ROOTS; READ ALIGNMENT; EXPRESSION MAP; PLANT; STRESS; SEQ; IDENTIFICATION; HOURGLASS; REVEALS	Plant species have evolved myriads of solutions, including complex cell type development and regulation, to adapt to dynamic environments. To understand this cellular diversity, we profiled tomato root cell type translatomes. Using xylem differentiation in tomato, examples of functional innovation, repurposing, and conservation of transcription factors are described, relative to the model plant Arabidopsis. Repurposing and innovation of genes are further observed within an exodermis regulatory network and illustrate its function. Comparative translatome analyses of rice, tomato, and Arabidopsis cell populations suggest increased expression conservation of root meristems compared with other homologous populations. In addition, the functions of constitutively expressed genes are more conserved than those of cell type/tissue-enriched genes. These observations suggest that higher order properties of cell type and pan-cell type regulation are evolutionarily conserved between plants and animals.	[Kajala, Kaisa; Gouran, Mona; Shaar-Moshe, Lidor; Mason, G. Alex; Rodriguez-Medina, Joel; Kawa, Dorota; Canto-Pastor, Alex; Manzano, Concepcion; West, Donnelly A.; Gray, Sharon B.; Morimoto, Kevin W.; Nirmal, Niba A.; Rodriguez, Alan; Sinha, Neelima R.; Brady, Siobhan M.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Kajala, Kaisa; Gouran, Mona; Shaar-Moshe, Lidor; Mason, G. Alex; Rodriguez-Medina, Joel; Kawa, Dorota; Canto-Pastor, Alex; Manzano, Concepcion; Gray, Sharon B.; Yao, Andrew, I; Morimoto, Kevin W.; Nirmal, Niba A.; Rodriguez, Alan; Brady, Siobhan M.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Kajala, Kaisa; Artur, Mariana A. S.; Bailey-Serres, Julia] Univ Utrecht, Inst Environm Biol, Plant Ecophysiol, NL-3584 Utrecht, Netherlands; [Gouran, Mona] Univ Calif Davis, Plant Biol Grad Grp, Davis, CA 95616 USA; [Rodriguez-Medina, Joel; West, Donnelly A.] Univ Calif Davis, Integrat Genet & Genom Grad Grp, Davis, CA 95616 USA; [Pauluzzi, Germain; Reynoso, Mauricio; Borowsky, Alexander T.; Formentin, Elide; Bailey-Serres, Julia] Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Reynoso, Mauricio] FCE UNLP CONICET, IBBM, RA-1900 La Plata, Argentina; [Lau, Vincent; Pasha, Asher; Provart, Nicholas J.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Dept Cell & Syst Biol, 25 Willcocks St, Toronto, ON M5S 3B2, Canada; [Moore, Bryshal P.] Ft Valley State Univ, Ft Valley, GA 31030 USA; [Yao, Andrew, I] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Bajic, Marko; Deal, Roger B.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Formentin, Elide] Univ Padua, Dept Biol, Padua, Italy; [Kliebenstein, Daniel J.; Runcie, Daniel E.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Hvidsten, Torgeir R.] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, N-1432 As, Norway	University of California System; University of California Davis; University of California System; University of California Davis; Utrecht University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Riverside; University of Toronto; University System of Georgia; Fort Valley State University; University of California System; University of California Davis; Emory University; University of Padua; University of California System; University of California Davis; Norwegian University of Life Sciences	Brady, SM (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.; Brady, SM (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	sbrady@ucdavis.edu	Hvidsten, Torgeir R./A-3409-2009; Kajala, Kaisa/E-8345-2011; Silva Artur, Mariana Aline/M-4774-2019; Silva Artur, Mariana Aline/GWD-1378-2022; Brady, Siobhan/AAY-1729-2021; Moore, Bryshal/HGU-0066-2022	Hvidsten, Torgeir R./0000-0001-6097-2539; Kajala, Kaisa/0000-0001-6483-7473; Silva Artur, Mariana Aline/0000-0002-6832-2407; Moore, Bryshal/0000-0002-8159-5127; Mason, Grace/0000-0002-4273-3793; Pasha, Asher/0000-0002-9315-0520; Canto-Pastor, Alex/0000-0001-8571-1116; Morimoto, Kevin/0000-0002-9690-0411; Manzano, Concepcion/0000-0003-1592-5068; Kawa, Dorota/0000-0002-4227-1621	HHMI [55108506]; NSF PGRP [IOS-1306848, IOS-123824, IOS-1856749, IOS-1810468, IOS-1907088]; US-Norway Fulbright Foundation; SKR Postdoctoral Fellowship; MSCA RI Fellowship [790057]; UC-MEXUS/CONACYT; NSF [DGE1922642, IOS-1558900]; NSF MCB [1906486]; SDA NIFA Hatch [CA-D-PLS7033-H]; Michael Smith Foreign Studies Supplement; NSERC [OG-128]; MSCA Global Fellowship [655406]; USDA NIFA Hatch [1010469]; BARD [FI-570-2018]; PABGAP grant - UCOP/UC-HBCU Initiative	HHMI(Howard Hughes Medical Institute); NSF PGRP(National Science Foundation (NSF)NSF - Office of the Director (OD)); US-Norway Fulbright Foundation; SKR Postdoctoral Fellowship; MSCA RI Fellowship; UC-MEXUS/CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSF(National Science Foundation (NSF)); NSF MCB(National Science Foundation (NSF)); SDA NIFA Hatch; Michael Smith Foreign Studies Supplement; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); MSCA Global Fellowship; USDA NIFA Hatch; BARD(US-Israel Binational Science Foundation); PABGAP grant - UCOP/UC-HBCU Initiative	We would like to thank H. Masson, R.M. Sanz, A. Gothberg, S. Vitales, J. Zheng, K. Zumstein, and B. Waring for experimental assistance; T. Demura, E. Kellogg, and K. Bubb for discussion; A. Hay for seed; and P. Benfey, N. Geldner, L. Strader, and J. Harada for manuscript critique. Funding was as follows: S.M.B. by HHMI 55108506; S.B.G. by NSF PGRP IOS-1306848; R.B.D., N.R.S., J.B.-S., and S.M.B. by NSF PGRP IOS-123824 and IOS-1856749; J.B.-S. and A.T.B. by NSF PGRP IOS-1810468; T.R.H. by the US-Norway Fulbright Foundation; K.K. by an SKR Postdoctoral Fellowship and MSCA RI Fellowship 790057; J.R.-M. by UC-MEXUS/CONACYT; A.T.B. by NSF DGE1922642; D.J.K. by NSF MCB 1906486 and SDA NIFA Hatch CA-D-PLS7033-H; V.L. by a Michael Smith Foreign Studies Supplement; V.L. and N.J.P. by an NSERC and OG-128; C.M. by MSCA Global Fellowship 655406; G.A.M. by NSF PGRP IOS-1907088; D.E.R. by USDA NIFA Hatch 1010469; L.S.-M. by BARD FI-570-2018; N.R.S. by NSF IOS-1558900; and B.P.M. by the PABGAP grant, funded by the UCOP/UC-HBCU Initiative.	Agarwal PK, 2017, J EXP BOT, V68, P2135, DOI 10.1093/jxb/erx118; Alam T, 2020, GENOME RES, V30, P951, DOI 10.1101/gr.255679.119; Alexandre CM, 2018, MOL BIOL EVOL, V35, P837, DOI 10.1093/molbev/msx326; [Anonymous], NUCLEIC ACIDS RES, V43, pD234; Armand T, 2019, ANN BOT-LONDON, V124, P1091, DOI 10.1093/aob/mcz113; Barberon M, 2016, CELL, V164, P447, DOI 10.1016/j.cell.2015.12.021; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; BRUNDRETT MC, 1988, PROTOPLASMA, V146, P133, DOI 10.1007/BF01405922; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Chen J, 2019, GENOME RES, V29, P53, DOI 10.1101/gr.237636.118; Chung WY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-46; Coego A, 2014, PLANT J, V77, P944, DOI 10.1111/tpj.12443; Cridge AG, 2016, ANN BOT-LONDON, V117, P833, DOI 10.1093/aob/mcw024; Cruickshank T, 2008, EVOL DEV, V10, P583, DOI 10.1111/j.1525-142X.2008.00273.x; Davidson E, 2005, P NATL ACAD SCI USA, V102, P4935, DOI 10.1073/pnas.0502024102; de Mendiburu F., 2019, AGRICOLAE STAT PROCE; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; Denyer T, 2019, DEV CELL, V48, P840, DOI 10.1016/j.devcel.2019.02.022; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Dong ZB, 2020, P NATL ACAD SCI USA, V117, P20908, DOI 10.1073/pnas.2005014117; Douglas SJ, 2002, PLANT CELL, V14, P547, DOI 10.1105/tpc.010391; Drost HG, 2015, MOL BIOL EVOL, V32, P1221, DOI 10.1093/molbev/msv012; Du H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11037; DUBOULE D, 1994, DEVELOPMENT, P135; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Endo H, 2015, PLANT CELL PHYSIOL, V56, P242, DOI 10.1093/pcp/pcu134; Franco-Zorrilla JM, 2017, BBA-GENE REGUL MECH, V1860, P21, DOI 10.1016/j.bbagrm.2016.05.001; Gaudinier A, 2018, NATURE, V563, P259, DOI 10.1038/s41586-018-0656-3; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gilad Yoav, 2015, F1000Res, V4, P121, DOI 10.12688/f1000research.6536.1; Gu X, 2005, P NATL ACAD SCI USA, V102, P707, DOI 10.1073/pnas.0409186102; Hay A, 2006, DEVELOPMENT, V133, P3955, DOI 10.1242/dev.02545; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henry S, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01139; Iyer-Pascuzzi AS, 2011, DEV CELL, V21, P770, DOI 10.1016/j.devcel.2011.09.009; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jean-Baptiste K, 2019, PLANT CELL, V31, P993, DOI 10.1105/tpc.18.00785; Kadota K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-294; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kenrick P, 2014, PLANT PHYSIOL, V166, P570, DOI 10.1104/pp.114.244517; Kim WC, 2014, PLANT MOL BIOL, V85, P589, DOI 10.1007/s11103-014-0205-x; Klie Sebastian, 2012, Frontiers in Genetics, V3, P115, DOI 10.3389/fgene.2012.00115; Konishi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2621; Kosma DK, 2014, PLANT J, V80, P216, DOI 10.1111/tpj.12624; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Lahmy S, 2007, PLANT J, V50, P615, DOI 10.1111/j.1365-313X.2007.03072.x; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee MH, 2019, EMBO J, V38, DOI 10.15252/embj.2019101948; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li S, 2016, DEV CELL, V39, P508, DOI 10.1016/j.devcel.2016.10.012; Li XW, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00377; Li YX, 2018, PLANT CELL, V30, P466, DOI 10.1105/tpc.17.00380; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Lux A, 2005, ANN BOT-LONDON, V96, P989, DOI 10.1093/aob/mci266; Madden T., 2013, NCBI HDB; Maher KA, 2018, PLANT CELL, V30, P15, DOI 10.1105/tpc.17.00581; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Mi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046128; Miyashima S, 2011, DEVELOPMENT, V138, P2303, DOI 10.1242/dev.060491; Mustroph A, 2014, PLANT CELL ENVIRON, V37, P2366, DOI 10.1111/pce.12282; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Namyslov J, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020201; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; Ogawa D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1279; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Ou Y, 2016, CELL RES, V26, P686, DOI 10.1038/cr.2016.63; Panda C, 2020, PLANT J, V102, P1281, DOI 10.1111/tpj.14701; Parry G, 2013, J EXP BOT, V64, P833, DOI 10.1093/jxb/ers289; Patel RV, 2012, PLANT J, V71, P1038, DOI 10.1111/j.1365-313X.2012.05055.x; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; PERUMALLA CJ, 1990, BOT J LINN SOC, V103, P93, DOI 10.1111/j.1095-8339.1990.tb00176.x; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quint M, 2012, NATURE, V490, P98, DOI 10.1038/nature11394; Raff R. A., 2012, SHAPE LIFE GENES DEV; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; RAVEN JA, 1993, BIOL REV, V68, P337, DOI 10.1111/j.1469-185X.1993.tb00735.x; Reynoso MA, 2019, SCIENCE, V365, P1291, DOI 10.1126/science.aax8862; Reynoso MA, 2018, PLANT PHYSIOL, V176, P270, DOI 10.1104/pp.17.00688; Reynoso MA, 2015, METHODS MOL BIOL, V1284, P185, DOI 10.1007/978-1-4939-2444-8_9; Rishmawi L, 2014, PLANT PHYSIOL, V165, P186, DOI 10.1104/pp.113.233775; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robbins NE, 2014, PLANT PHYSIOL, V166, P551, DOI 10.1104/pp.114.244871; Robischon M, 2011, PLANT PHYSIOL, V155, P1214, DOI 10.1104/pp.110.167007; Rokas A., 2011, CURR PROTOC MOL BIOL, V96, P19; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Ron M, 2013, PLANT PHYSIOL, V162, P755, DOI 10.1104/pp.113.217802; Ryu KH, 2019, PLANT PHYSIOL, V179, P1444, DOI 10.1104/pp.18.01482; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schreiber L, 2005, PLANT SOIL, V269, P333, DOI 10.1007/s11104-004-0721-6; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shulse CN, 2019, CELL REP, V27, P2241, DOI 10.1016/j.celrep.2019.04.054; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; stlund G., 2015, INPARANOID 8 ORTHOLO; Sullivan AM, 2014, CELL REP, V8, P2015, DOI 10.1016/j.celrep.2014.08.019; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Toal TW, 2018, G3-GENES GENOM GENET, V8, P3841, DOI 10.1534/g3.118.200540; Townsley BT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00366; Trim galore Krueger F, 2015, WRAPPER TOOL CUTADAP, V516, P517; Truernit E, 2006, PLANT MOL BIOL, V60, P1, DOI 10.1007/s11103-005-1673-9; Turco GM, 2019, CELL REP, V28, P342, DOI 10.1016/j.celrep.2019.06.041; Turner S., 2012, BIOINFORMATICS, V29, P15, DOI [10.3410/ f.717961569.793464455, DOI 10.3410/F.717961569.793464455]; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Urbanczyk-Wochniak E, 2006, PLANT MOL BIOL, V60, P773, DOI 10.1007/s11103-005-5772-4; Ursache R, 2018, PLANT J, V93, P399, DOI 10.1111/tpj.13784; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woerlen N, 2017, PLANTA, V245, P1079, DOI 10.1007/s00425-017-2663-2; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhao DY, 2017, G3-GENES GENOM GENET, V7, P203, DOI 10.1534/g3.116.036020	133	19	19	7	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3333	+		10.1016/j.cell.2021.04.024	http://dx.doi.org/10.1016/j.cell.2021.04.024		JUN 2021	35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	34010619	hybrid, Green Published			2022-12-28	WOS:000660014300020
J	Yao, ZZ; van Velthoven, CTJ; Nguyen, TN; Goldy, J; Sedeno-Cortes, AE; Baftizadeh, F; Bertagnolli, D; Casper, T; Chiang, MG; Crichton, K; Ding, SL; Fong, O; Garren, E; Glandon, A; Gouwens, NW; Gray, J; Graybuck, LT; Hawrylycz, MJ; Hirschstein, D; Kroll, M; Lathia, K; Lee, C; Levi, B; McMillen, D; Mok, S; Pham, T; Ren, QZ; Rimorin, C; Shapovalova, N; Sulc, J; Sunkin, SM; Tieu, M; Torkelson, A; Tung, H; Ward, K; Dee, N; Smith, KA; Tasic, B; Zeng, HK				Yao, Zizhen; van Velthoven, Cindy T. J.; Thuc Nghi Nguyen; Goldy, Jeff; Sedeno-Cortes, Adriana E.; Baftizadeh, Fahimeh; Bertagnolli, Darren; Casper, Tamara; Chiang, Megan; Crichton, Kirsten; Ding, Song-Lin; Fong, Olivia; Garren, Emma; Glandon, Alexandra; Gouwens, Nathan W.; Gray, James; Graybuck, Lucas T.; Hawrylycz, Michael J.; Hirschstein, Daniel; Kroll, Matthew; Lathia, Kanan; Lee, Changkyu; Levi, Boaz; McMillen, Delissa; Mok, Stephanie; Thanh Pham; Ren, Qingzhong; Rimorin, Christine; Shapovalova, Nadiya; Sulc, Josef; Sunkin, Susan M.; Tieu, Michael; Torkelson, Amy; Tung, Herman; Ward, Katelyn; Dee, Nick; Smith, Kimberly A.; Tasic, Bosiljka; Zeng, Hongkui			A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation	CELL			English	Article							SPATIALLY-RESOLVED TRANSCRIPTOMICS; HIERARCHICAL ORGANIZATION; EVOLUTION; CORTEX; INTERNEURONS; NEOCORTEX; ANATOMY; DRIVER; LINES; CA3	The isocortex and hippocampal formation (HPF) in the mammalian brain play critical roles in perception, cognition, emotion, and learning. We profiled similar to 1.3 million cells covering the entire adult mouse isocortex and HPF and derived a transcriptomic cell-type taxonomy revealing a comprehensive repertoire of glutamatergic and GABAergic neuron types. Contrary to the traditional view of HPF as having a simpler cellular organization, we discover a complete set of glutamatergic types in HPF homologous to all major subclasses found in the six-layered isocortex, suggesting that HPF and the isocortex share a common circuit organization. We also identify large-scale continuous and graded variations of cell types along isocortical depth, across the isocortical sheet, and in multiple dimensions in hippocampus and subiculum. Overall, our study establishes a molecular architecture of the mammalian isocortex and hippocampal formation and begins to shed light on its underlying relationship with the development, evolution, connectivity, and function of these two brain structures.	[Yao, Zizhen; van Velthoven, Cindy T. J.; Thuc Nghi Nguyen; Goldy, Jeff; Sedeno-Cortes, Adriana E.; Baftizadeh, Fahimeh; Bertagnolli, Darren; Casper, Tamara; Chiang, Megan; Crichton, Kirsten; Ding, Song-Lin; Fong, Olivia; Garren, Emma; Glandon, Alexandra; Gouwens, Nathan W.; Gray, James; Graybuck, Lucas T.; Hawrylycz, Michael J.; Hirschstein, Daniel; Kroll, Matthew; Lathia, Kanan; Lee, Changkyu; Levi, Boaz; McMillen, Delissa; Mok, Stephanie; Thanh Pham; Ren, Qingzhong; Rimorin, Christine; Shapovalova, Nadiya; Sulc, Josef; Sunkin, Susan M.; Tieu, Michael; Torkelson, Amy; Tung, Herman; Ward, Katelyn; Dee, Nick; Smith, Kimberly A.; Tasic, Bosiljka; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98109 USA	Allen Institute for Brain Science	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA 98109 USA.	hongkuiz@alleninstitute.org	huang, dezhi/ABC-6566-2021	Chiang, Megan/0000-0002-7306-3016; Ding, Song-Lin/0000-0002-7072-5272; Nguyen, Thuc Nghi/0000-0002-6466-5883	The National Eye Institute [R01EY023173]; National Institute of Mental Health [U01MH105982, U19MH114830]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Allen Institute for Brain Science; National Institutes of Health (NIH)	The National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Allen Institute for Brain Science; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to the Transgenic Colony Management, Neurosurgery & Behavior, Lab Animal Services, Molecular Biology, and Histology teams at the Allen Institute for technical support. We thank Christof Koch, Ed Lein, and Allan Jones for their support and leadership. We thank Charles Gerfen for providing several Cre driver lines, Raj Awatramani for providing Th-P2AFlpO line, Ian Wickersham for providing RVDGL-Cre, and Miguel Chillon Rodrigues for providing CAV-Cre. The research was funded by multiple grant awards from institutes under the National Institutes of Health (NIH), including award number R01EY023173 from The National Eye Institute, U01MH105982 from the National Institute of Mental Health and Eunice Kennedy Shriver National Institute of Child Health and Human Development, and U19MH114830 from the National Institute of Mental Health to H.Z. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH and its subsidiary institutes. This work was also supported by the Allen Institute for Brain Science. The authors thank the Allen Institute founder, Paul G. Allen, for his vision, encouragement, and support.	Bienkowski MS, 2018, NAT NEUROSCI, V21, P1628, DOI 10.1038/s41593-018-0241-y; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cadwell CR, 2019, NEURON, V103, P980, DOI 10.1016/j.neuron.2019.07.009; Cembrowski MS, 2019, NAT REV NEUROSCI, V20, P193, DOI 10.1038/s41583-019-0125-5; Cembrowski MS, 2018, ELIFE, V7, DOI 10.7554/eLife.37701; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Chatterjee S, 2018, NAT NEUROSCI, V21, P638, DOI 10.1038/s41593-018-0091-7; Chawla MK, 2018, HIPPOCAMPUS, V28, P178, DOI 10.1002/hipo.22820; Close JL, 2021, NAT METHODS, V18, P23, DOI 10.1038/s41592-020-01040-z; COOGAN TA, 1993, J NEUROSCI, V13, P3749; D'Souza RD, 2016, ELIFE, V5, DOI 10.7554/eLife.19332; Daigle TL, 2018, CELL, V174, P465, DOI 10.1016/j.cell.2018.06.035; Ding SL, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107648; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Economo MN, 2018, NATURE, V563, P79, DOI 10.1038/s41586-018-0642-9; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferrante M, 2017, CEREB CORTEX, V27, P3186, DOI 10.1093/cercor/bhw143; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Frazer S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14219; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gergues MM, 2020, NAT NEUROSCI, V23, P1444, DOI 10.1038/s41593-020-0705-8; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Gouwens NW, 2020, CELL, V183, P935, DOI 10.1016/j.cell.2020.09.057; Graybuck L.T., 2021, NEURON; Harris JA, 2019, NATURE, V575, P195, DOI 10.1038/s41586-019-1716-z; Harris KD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006387; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hrvatin S, 2018, NAT NEUROSCI, V21, P120, DOI 10.1038/s41593-017-0029-5; Hu JS, 2017, DEVELOPMENT, V144, P3867, DOI 10.1242/dev.132852; Larsson L, 2021, NAT METHODS, V18, P15, DOI 10.1038/s41592-020-01038-7; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leao RN, 2012, NAT NEUROSCI, V15, P1524, DOI 10.1038/nn.3235; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lim L, 2018, NEURON, V100, P294, DOI 10.1016/j.neuron.2018.10.009; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markov NT, 2014, J COMP NEUROL, V522, P225, DOI 10.1002/cne.23458; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [10.21105/joss.00861, DOI 10.21105/JOSS.00861]; Miller JA, 2020, ELIFE, V9, DOI 10.7554/eLife.59928; Minatohara K, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00078; Miyoshi G, 2015, J NEUROSCI, V35, P12869, DOI 10.1523/JNEUROSCI.1164-15.2015; Moser EI, 2017, NAT NEUROSCI, V20, P1448, DOI 10.1038/nn.4653; Nilssen ES, 2019, HIPPOCAMPUS, V29, P1238, DOI 10.1002/hipo.23145; Niquille M, 2018, ELIFE, V7, DOI 10.7554/eLife.32017; NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; Peng H., 2020, BRAIN WIDE SINGLE NE; Pessoa L, 2019, NEUROSCI BIOBEHAV R, V107, P296, DOI 10.1016/j.neubiorev.2019.09.021; Poulin JF, 2018, NAT NEUROSCI, V21, P1260, DOI 10.1038/s41593-018-0203-4; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rubin AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077339; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Scala F, 2021, NATURE, V598, P144, DOI 10.1038/s41586-020-2907-3; Scharfman HE, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00106; Siegle JH, 2021, NATURE, V592, P86, DOI 10.1038/s41586-020-03171-x; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Svensson V, 2020, BIOINFORMATICS, V36, P3418, DOI 10.1093/bioinformatics/btaa169; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Tosches MA, 2019, CURR OPIN NEUROBIOL, V56, P199, DOI 10.1016/j.conb.2019.04.009; Tremblay R, 2016, NEURON, V91, P260, DOI 10.1016/j.neuron.2016.06.033; Van Essen DC, 2018, NEURON, V99, P640, DOI 10.1016/j.neuron.2018.07.002; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Wang QX, 2020, CELL, V181, P936, DOI 10.1016/j.cell.2020.04.007; Yao Z., 2020, INTEGRATED TRANSCRIP; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yuan M, 2017, ELIFE, V6, DOI 10.7554/eLife.21105; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85; Zhuang XW, 2021, NAT METHODS, V18, P18, DOI 10.1038/s41592-020-01037-8	79	114	114	8	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3222	+		10.1016/j.cell.2021.04.021	http://dx.doi.org/10.1016/j.cell.2021.04.021		JUN 2021	46	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	34004146	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000660014300013
J	Hatfield, PW; Gaffney, JA; Anderson, GJ; Ali, S; Antonelli, L; du Pree, SB; Citrin, J; Fajardo, M; Knapp, P; Kettle, B; Kustowski, B; MacDonald, MJ; Mariscal, D; Martin, ME; Nagayama, T; Palmer, CAJ; Peterson, JL; Rose, S; Ruby, JJ; Shneider, C; Streeter, MJV; Trickey, W; Williams, B				Hatfield, Peter W.; Gaffney, Jim A.; Anderson, Gemma J.; Ali, Suzanne; Antonelli, Luca; du Pree, Suzan Basegmez; Citrin, Jonathan; Fajardo, Marta; Knapp, Patrick; Kettle, Brendan; Kustowski, Bogdan; MacDonald, Michael J.; Mariscal, Derek; Martin, Madison E.; Nagayama, Taisuke; Palmer, Charlotte A. J.; Peterson, J. Luc; Rose, Steven; Ruby, J. J.; Shneider, Carl; Streeter, Matt J., V; Trickey, Will; Williams, Ben			The data-driven future of high-energy-density physics	NATURE			English	Article							INERTIAL CONFINEMENT FUSION; BAYESIAN-INFERENCE; SPACE WEATHER; LASER; COMPRESSION; FACILITY; SIMULATIONS; PERFORMANCE; INTERIORS; PETAWATT	High-energy-density physics is the field of physics concerned with studying matter at extremely high temperatures and densities. Such conditions produce highly nonlinear plasmas, in which several phenomena that can normally be treated independently of one another become strongly coupled. The study of these plasmas is important for our understanding of astrophysics, nuclear fusion and fundamental physics-however, the nonlinearities and strong couplings present in these extreme physical systems makes them very difficult to understand theoretically or to optimize experimentally. Here we argue that machine learning models and data-driven methods are in the process of reshaping our exploration of these extreme systems that have hitherto proved far too nonlinear for human researchers. From a fundamental perspective, our understanding can be improved by the way in which machine learning models can rapidly discover complex interactions in large datasets. From a practical point of view, the newest generation of extreme physics facilities can perform experiments multiple times a second (as opposed to approximately daily), thus moving away from human-based control towards automatic control based on real-time interpretation of diagnostic data and updates of the physics model. To make the most of these emerging opportunities, we suggest proposals for the community in terms of research design, training, best practice and support for synthetic diagnostics and data analysis.	[Hatfield, Peter W.; Rose, Steven] Univ Oxford, Clarendon Lab, Pk Rd, Oxford, England; [Gaffney, Jim A.; Anderson, Gemma J.; Ali, Suzanne; Kustowski, Bogdan; MacDonald, Michael J.; Mariscal, Derek; Martin, Madison E.; Peterson, J. Luc] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Antonelli, Luca; Trickey, Will] Univ York, York Plasma Inst, Dept Phys, York, N Yorkshire, England; [du Pree, Suzan Basegmez] Natl Inst Subat Phys, Nikhef, Amsterdam, Netherlands; [Citrin, Jonathan] DIFFER Dutch Inst Fundamental Energy Res, Eindhoven, Netherlands; [Fajardo, Marta] Inst Super Tecn, Inst Plasmas & Fusao Nucl, Lisbon, Portugal; [Knapp, Patrick; Nagayama, Taisuke] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA; [Kettle, Brendan; Rose, Steven; Streeter, Matt J., V] Imperial Coll London, London, England; [Palmer, Charlotte A. J.] Queens Univ Belfast, Sch Math & Phys, Belfast, Antrim, North Ireland; [Ruby, J. J.] Univ Rochester, Lab Laser Energet, Rochester, NY USA; [Shneider, Carl] Dutch Natl Ctr Math & Comp Sci CWI, Amsterdam, Netherlands; [Williams, Ben] AWE Plc, Reading, Berks, England	University of Oxford; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of York - UK; FOM National Institute for Subatomic Physics; Universidade de Lisboa; Instituto Superior Tecnico; United States Department of Energy (DOE); Sandia National Laboratories; Imperial College London; Queens University Belfast; University of Rochester	Hatfield, PW (corresponding author), Univ Oxford, Clarendon Lab, Pk Rd, Oxford, England.; Gaffney, JA; Anderson, GJ (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	peter.hatfiel.d@physics.ox.ac.uk; gaffney3@llnl.gov; anderson276@llnl.gov	Anderson, Gemma J./AAM-8627-2021; Fajardo, Marta/AAO-9798-2020; Shneider, Carl/D-9636-2016; Antonelli, Luca/C-1003-2015	Anderson, Gemma J./0000-0002-4169-5553; Fajardo, Marta/0000-0003-2133-2365; Kettle, Brendan/0000-0003-4424-4448; Palmer, Charlotte/0000-0002-3762-0380; Hatfield, Peter/0000-0002-3065-457X; Shneider, Carl/0000-0002-3689-6959; Nagayama, Taisuke/0000-0001-9114-6977; Ali, Suzanne Jihad/0000-0003-1823-3788; Antonelli, Luca/0000-0003-0694-948X; Basegmez du Pree, Suzan/0000-0003-1599-6974; Rose, Steven/0000-0001-6808-6355				Albertsson K, 2018, J PHYS CONF SER, V1085, DOI 10.1088/1742-6596/1085/2/022008; Amorin C, 2019, STAT ANAL DATA MIN, V12, P505, DOI 10.1002/sam.11437; Anirudh R, 2020, P NATL ACAD SCI USA, V117, P9741, DOI 10.1073/pnas.1916634117; [Anonymous], 2019, LULI2000 USER GUIDE; Atzeni S, 2004, PHYS INERTIAL FUSION; Badziak J, 2018, J PHYS CONF SER, V959, DOI 10.1088/1742-6596/959/1/012001; Bailey JE, 2015, NATURE, V517, P56, DOI 10.1038/nature14048; Bambi C, 2018, ANN PHYS-BERLIN, V530, DOI 10.1002/andp.201700430; Bellinger EP, 2016, ASTROPHYS J, V830, DOI 10.3847/0004-637X/830/1/31; Bobra MG, 2016, ASTROPHYS J, V821, DOI 10.3847/0004-637X/821/2/127; Boehly TR, 1997, OPT COMMUN, V133, P495, DOI 10.1016/S0030-4018(96)00325-2; Borne K. D., 2009, REVOLUTION ASTRONOMY; Brunton S. L., 2019, DATA DRIVEN SCI ENG, DOI [10.1017/9781108380690, DOI 10.1017/9781108380690]; Campbell EM, 1999, PLASMA PHYS CONTR F, V41, pB39, DOI 10.1088/0741-3335/41/12B/303; Campi C, 2019, ASTROPHYS J, V883, DOI 10.3847/1538-4357/ab3c26; Camporeale E, 2019, SPACE WEATHER, V17, P1166, DOI 10.1029/2018SW002061; Camporeale E., 2020, J GEOPHYS RES, V125, DOI [10.1029/2019JA027684, DOI 10.1029/2019JA027684]; Camporeale E, 2017, J GEOPHYS RES-SPACE, V122, P10910, DOI 10.1002/2017JA024383; Celliers PM, 2018, SCIENCE, V361, P677, DOI 10.1126/science.aat0970; CERN, 2017, CERNBROCHURE2017002E; Chardin J, 2019, MON NOT R ASTRON SOC, V490, P1055, DOI 10.1093/mnras/stz2605; Chen Y, 2019, SPACE WEATHER, V17, P1404, DOI 10.1029/2019SW002214; Colvin J., 2013, EXTREME PHYS; Coughlin MW, 2019, MON NOT R ASTRON SOC, V489, pL91, DOI 10.1093/mnrasl/slz133; Dann SJD, 2019, PHYS REV ACCEL BEAMS, V22, DOI 10.1103/PhysRevAccelBeams.22.041303; Danson CN, 2019, HIGH POWER LASER SCI, V7, DOI 10.1017/hpl.2019.36; de Souza RS, 2019, PHYS REV C, V99, DOI 10.1103/PhysRevC.99.014619; Dimonte G, 2020, PHYS PLASMAS, V27, DOI 10.1063/1.5143887; Eastwood JP, 2017, RISK ANAL, V37, P206, DOI 10.1111/risa.12765; European XFEL, FACTAND FIG; Falcon RE, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/214; Feng J, 2020, HIGH ENERG DENS PHYS, V36, DOI 10.1016/j.hedp.2020.100753; Fleming SW, 2020, PHYS TODAY, V73, P46, DOI 10.1063/PT.3.4523; Fournier K., 2019, LLNLTR785259; Freidberg J.P., 2008, PLASMA PHYS FUSION E; Gaffney JA, 2013, HIGH ENERG DENS PHYS, V9, P457, DOI 10.1016/j.hedp.2013.04.012; Gaffney JA, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073032; Gaffney J. A, 2020, JAG INERTIAL CONFINE; Gaffney JA, 2019, PHYS PLASMAS, V26, DOI 10.1063/1.5108667; Glinsky M. E., 2019, PHYS PLASMAS, V27; Gotzfried J, 2018, NUCL INSTRUM METH A, V909, P286, DOI 10.1016/j.nima.2018.02.110; Gomez MR, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.155003; Gopalaswamy V, 2019, NATURE, V565, P581, DOI 10.1038/s41586-019-0877-0; Gould O, 2019, PHYS REV A, V99, DOI 10.1103/PhysRevA.99.052120; Graziani F., 2014, LECT NOTES COMPUTATI, V96; Hatfield PW, 2019, PHYS PLASMAS, V26, DOI 10.1063/1.5091985; Hatfield P, 2020, IEEE T PLASMA SCI, V48, P14, DOI 10.1109/TPS.2019.2944416; He ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8156; Hidding B, 2019, PHILOS T R SOC A, V377, DOI 10.1098/rsta.2019.0215; Hidding B, 2019, PLASMA WAKEFIELD ACC; Hsu A, 2020, PHYS PLASMAS, V27, DOI 10.1063/1.5130585; Humbird KD, 2020, IEEE T PLASMA SCI, V48, P61, DOI 10.1109/TPS.2019.2955098; Humbird KD, 2019, IEEE T NEUR NET LEAR, V30, P1286, DOI 10.1109/TNNLS.2018.2869694; Huppenkothen D, 2017, MON NOT R ASTRON SOC, V466, P2364, DOI 10.1093/mnras/stw3190; Hurricane OA, 2016, J PHYS CONF SER, V717, DOI 10.1088/1742-6596/717/1/012005; Inceoglu F, 2018, ASTROPHYS J, V861, DOI 10.3847/1538-4357/aac81e; Joshi C, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/045003; Kasim MF, 2019, PHYS PLASMAS, V26, DOI 10.1063/1.5125979; Kasim M.F., 2020, BUILDING HIGH ACCURA; Kates-Harbeck J, 2019, NATURE, V568, P526, DOI 10.1038/s41586-019-1116-4; KIRILLOV GA, 1990, LASER PART BEAMS, V8, P827, DOI 10.1017/S0263034600009198; Kirschner J, 2019, PR MACH LEARN RES, V97; Kluth G, 2020, PHYS PLASMAS, V27, DOI 10.1063/5.0006784; Knapp P., 2018, SAND20181698PE663774; Kong X, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aac7a8; Kustowski B, 2020, IEEE T PLASMA SCI, V48, P46, DOI 10.1109/TPS.2019.2948339; Lamb K., 2019, 2 WORKSH MACH LEARN; Lang M, 2019, SPACE WEATHER, V17, P59, DOI 10.1029/2018SW001857; Lin ZQ, 1999, FUSION ENG DES, V44, P61, DOI 10.1016/S0920-3796(98)00308-1; Linac Coherent Light Source, LCLS 2 DES PERF; LINDL JD, 1998, INERTIAL CONFINEMENT; Lochner M, 2016, ASTROPHYS J SUPPL S, V225, DOI 10.3847/0067-0049/225/2/31; Bernal JL, 2018, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2018/07/002; Lyons L., 2013, DISCOVERING SIGNIFIC; MacDonald MJ, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4960502; Maier AR, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.031039; Martin ME, 2018, HIGH ENERG DENS PHYS, V26, P26, DOI 10.1016/j.hedp.2017.12.001; Meneghini O, 2017, NUCL FUSION, V57, DOI 10.1088/1741-4326/aa7776; Millot M, 2018, NAT PHYS, V14, P297, DOI 10.1038/s41567-017-0017-4; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Moses EI, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/1/012003; Nagayama T, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.235001; Nora R, 2017, STAT ANAL DATA MIN, V10, P230, DOI 10.1002/sam.11344; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; Osthus D, 2019, SIAM-ASA J UNCERTAIN, V7, P604, DOI 10.1137/17M1158860; Palaniyappan S, 2020, PHYS PLASMAS, V27, DOI 10.1063/1.5144608; Pasian F, 2012, PROC SPIE, V8451, DOI 10.1117/12.926026; Peterson JL, 2017, PHYS PLASMAS, V24, DOI 10.1063/1.4977912; Peterson J. L., 2019, MERLIN ENABLING MACH; Raghu M, 2020, SURVEY DEEP LEARNING; Reichstein M, 2019, NATURE, V566, P195, DOI 10.1038/s41586-019-0912-1; Remington BA, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4930134; Roodman A., 2003, P C STAT PROBL PART; Rose SJ, 2004, CONTEMP PHYS, V45, P109, DOI 10.1080/00107510310001631704; Roso L., 2018, EPJ WEB C, V167, P01001, DOI [10.1051/epjconf/201816701001, DOI 10.1051/EPJCONF/201816701001]; Rowlinson A, 2019, ASTRON COMPUT, V27, P111, DOI 10.1016/j.ascom.2019.03.003; Sarma R, 2020, J GEOPHYS RES-SPACE, V125, DOI 10.1029/2019JA027618; Saumon D, 2004, ASTROPHYS J, V609, P1170, DOI 10.1086/421257; Schramm U, 2017, J PHYS CONF SER, V874, DOI 10.1088/1742-6596/874/1/012028; Shalloo RJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20245-6; Sivia D., DATA ANAL BAYESIAN T; Slutz SA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.025003; Smith RF, 2014, NATURE, V511, P330, DOI 10.1038/nature13526; Spears BK, 2018, PHYS PLASMAS, V25, DOI 10.1063/1.5020791; Streeter MJV, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5027297; Sturm C, 2011, PHYS PART NUCLEI LET, V8, P865, DOI 10.1134/S1547477111080140; Thayer J, 2017, ADV STRUCT CHEM IMAG, V3, DOI 10.1186/s40679-016-0037-7; The National Space Weather Program Strategic Plan, 1995, CMP301995; Trines R., 2019, CLF ANN REPORT 2017; Tzeferacos P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02953-2; van de Plassche KL, 2020, PHYS PLASMAS, V27, DOI 10.1063/1.5134126; Wang WM, 2018, P NATL ACAD SCI USA, V115, P9911, DOI 10.1073/pnas.1809649115; Wang ZH, 2020, IEEE T PLASMA SCI, V48, P1, DOI 10.1109/TPS.2019.2961571; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Yabashi M, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7060604; Yang C., 2019, LLNLTR799958; Zhang ZX, 2020, HIGH POWER LASER SCI, V8, DOI 10.1017/hpl.2020.3; Zhao Z., 2019, P LINAC2018 BEIJ; Zhelavskaya I.S., 2018, MACH LEARN TECH SP W, P301, DOI DOI 10.1016/B978-0-12-811788-0.00012-3; Zhelavskaya IS, 2017, J GEOPHYS RES-SPACE, V122, P11227, DOI 10.1002/2017JA024406; Zheng W, 2018, NUCL FUSION, V58, DOI 10.1088/1741-4326/aaad17; Zheng WG, 2016, HIGH POWER LASER SCI, V4, DOI 10.1017/hpl.2016.20	125	20	19	17	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					351	361		10.1038/s41586-021-03382-w	http://dx.doi.org/10.1038/s41586-021-03382-w			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE7VT	34012079	Green Submitted, Green Accepted			2022-12-28	WOS:000652278400011
J	Liu, Y; Hu, MG; Nichols, MA; Yang, DZ; Xie, DQ; Guo, H; Ni, KK				Liu, Yu; Hu, Ming-Guang; Nichols, Matthew A.; Yang, Dongzheng; Xie, Daiqian; Guo, Hua; Ni, Kang-Kuen			Precision test of statistical dynamics with state-to-state ultracold chemistry	NATURE			English	Article							HIGH-RESOLUTION SPECTROSCOPY; LOG-DERIVATIVE METHOD; ELECTRONIC-STATE; ION; COLLISIONS; MOLECULES; RB-2; RB2	Chemical reactions represent a class of quantum problems that challenge both the current theoretical understanding and computational capabilities(1). Reactions that occur at ultralow temperatures provide an ideal testing ground for quantum chemistry and scattering theories, because they can be experimentally studied with unprecedented control(2), yet display dynamics that are highly complex(3). Here we report the full product state distribution for the reaction 2KRb -> K-2 + Rb-2. Ultracold preparation of the reactants allows us complete control over their initial quantum degrees of freedom, whereas state-resolved, coincident detection of both products enables the probability of scattering into each of the 57 allowed rotational state-pairs to be measured. Our results show an overall agreement with a state-counting model based on statistical theory(4-6), but also reveal several deviating state-pairs. In particular, we observe a strong suppression of population in the state-pair closest to the exoergicity limit as a result of the long-range potential inhibiting the escape of products. The completeness of our measurements provides a benchmark for quantum dynamics calculations beyond the current state of the art.	[Liu, Yu; Hu, Ming-Guang; Nichols, Matthew A.; Ni, Kang-Kuen] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Liu, Yu; Hu, Ming-Guang; Nichols, Matthew A.; Ni, Kang-Kuen] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Liu, Yu; Hu, Ming-Guang; Nichols, Matthew A.; Ni, Kang-Kuen] Harvard MIT Ctr Ultracold Atoms, Cambridge, MA 02139 USA; [Yang, Dongzheng; Xie, Daiqian] Nanjing Univ, Sch Chem & Chem Engn, Inst Theoret & Computat Chem, Nanjing, Peoples R China; [Guo, Hua] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA; [Liu, Yu] NIST, Time & Frequency Div, Boulder, CO 80305 USA	Harvard University; Harvard University; Harvard University; Nanjing University; University of New Mexico; National Institute of Standards & Technology (NIST) - USA	Liu, Y; Ni, KK (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Liu, Y; Ni, KK (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Liu, Y; Ni, KK (corresponding author), Harvard MIT Ctr Ultracold Atoms, Cambridge, MA 02139 USA.; Liu, Y (corresponding author), NIST, Time & Frequency Div, Boulder, CO 80305 USA.	yu.liu-1@colorado.edu; ni@chemistry.harvard.edu	Guo, Hua/J-2685-2014; HU, MING-GUANG/J-8379-2017	Guo, Hua/0000-0001-9901-053X; Nichols, Matthew/0000-0002-6686-0252; Yang, Dongzheng/0000-0002-8567-1051; HU, MING-GUANG/0000-0002-7728-7500; Liu, Yu/0000-0002-5228-1997	DOE Young Investigator Program [DE-SC0019020]; David and Lucile Packard Foundation; Arnold O. Beckman Postdoctoral Fellowship in Chemical Instrumentation; National Natural Science Foundation of China [21733006]; Army Research Office [W911NF-19-1-0283]	DOE Young Investigator Program(United States Department of Energy (DOE)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Arnold O. Beckman Postdoctoral Fellowship in Chemical Instrumentation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Army Research Office	We thank L. Zhu for experimental assistance; T. Rosenband, G. Quemener, W. Cairncross, E. Heller and M. Soley for discussions; T. Karman for providing the code for state-counting; J. Huang for ab initio calculations; and L. Liu for a critical reading of the manuscript. This work is supported by the DOE Young Investigator Program (DE-SC0019020) and the David and Lucile Packard Foundation. M. A.N. is supported by the Arnold O. Beckman Postdoctoral Fellowship in Chemical Instrumentation. D.Y. and D.X. acknowledge support from the National Natural Science Foundation of China (grant numbers 21733006). H.G. thanks the Army Research Office (W911NF-19-1-0283) for funding.	Aldegunde J, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013401; AMIOT C, 1995, J CHEM PHYS, V103, P3350, DOI 10.1063/1.470245; AMIOT C, 1990, J CHEM PHYS, V93, P8591, DOI 10.1063/1.459246; Amiot C, 1997, CHEM PHYS LETT, V274, P91, DOI 10.1016/S0009-2614(97)00634-9; Balakrishnan N, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4964096; Balucani N, 2006, J PHYS CHEM A, V110, P817, DOI 10.1021/jp054928v; Brouard M, 2002, J PHYS CHEM A, V106, P3629, DOI 10.1021/jp015530b; Brumer P, 2000, J CHEM PHYS, V113, P2053, DOI 10.1063/1.482014; Byrd JN, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.010502; CALDWELL CD, 1980, CHEM PHYS, V54, P21, DOI 10.1016/0301-0104(80)80031-0; Clary DC, 2008, P NATL ACAD SCI USA, V105, P12649, DOI 10.1073/pnas.0800088105; Continetti RE, 2001, ANNU REV PHYS CHEM, V52, P165, DOI 10.1146/annurev.physchem.52.1.165; DIXIT SN, 1988, PHYS REV A, V37, P4220, DOI 10.1103/PhysRevA.37.4220; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Falke S, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2375120; GERICKE KH, 1988, PHYS REV LETT, V60, P561, DOI 10.1103/PhysRevLett.60.561; Gonzalez-Martinez ML, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.052716; Gregory PD, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.163402; Guo MY, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.041044; Hu MG, 2019, SCIENCE, V366, P1111, DOI 10.1126/science.aay9531; Hu MG, 2021, NAT CHEM, V13, P435, DOI 10.1038/s41557-020-00610-0; Johnson BR, 1973, CHEM PHYS, V2, P381, DOI 10.1016/0301-0104(73)80013-8; JOHNSON BR, 1973, J COMPUT PHYS, V13, P445, DOI 10.1016/0021-9991(73)90049-1; Julienne PS, 2009, FARADAY DISCUSS, V142, P361, DOI 10.1039/b820917k; Kendrick BK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8918; Lee SK, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4903856; LIGHT JC, 1967, DISCUSS FARADAY SOC, P14, DOI 10.1039/df9674400014; Lin JJ, 2003, SCIENCE, V300, P966, DOI 10.1126/science.1083672; Liu KP, 2007, PHYS CHEM CHEM PHYS, V9, P17, DOI 10.1039/b614801h; Liu Y, 2020, NAT PHYS, V16, P1132, DOI 10.1038/s41567-020-0968-8; MANOLOPOULOS DE, 1986, J CHEM PHYS, V85, P6425, DOI 10.1063/1.451472; Meyer ER, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.042707; Nesbitt DJ, 2012, CHEM REV, V112, P5062, DOI 10.1021/cr300208b; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Ni KK, 2010, NATURE, V464, P1324, DOI 10.1038/nature08953; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Quemener G, 2012, CHEM REV, V112, P4949, DOI 10.1021/cr300092g; Rivero-Santamaria A, 2011, PHYS CHEM CHEM PHYS, V13, P8136, DOI 10.1039/c0cp02662j; Rui J, 2017, NAT PHYS, V13, P699, DOI [10.1038/nphys4095, 10.1038/NPHYS4095]; Sun ZG, 2008, J AM CHEM SOC, V130, P14962, DOI 10.1021/ja8068616; Tarbutt MR, 2018, CONTEMP PHYS, V59, P356, DOI 10.1080/00107514.2018.1576338; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; Vredenborg A, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2949142; Wasserman L., 2004, ALL STAT CONCISE COU, V26; Wolf J, 2017, SCIENCE, V358, P921, DOI 10.1126/science.aan8721; Yang DZ, 2020, J CHEM PHYS, V152, DOI 10.1063/5.0014805; Yang DZ, 2020, J PHYS CHEM LETT, V11, P2605, DOI 10.1021/acs.jpclett.0c00518; Yang H, 2019, SCIENCE, V363, P261, DOI 10.1126/science.aau5322	59	27	27	14	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					379	+		10.1038/s41586-021-03459-6	http://dx.doi.org/10.1038/s41586-021-03459-6			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE7VT	34012086	Green Submitted			2022-12-28	WOS:000652278400015
J	Schmid, CP; Weigl, L; Grossing, P; Junk, V; Gorini, C; Schlauderer, S; Ito, S; Meierhofer, M; Hofmann, N; Afanasiev, D; Crewse, J; Kokh, KA; Tereshchenko, OE; Gudde, J; Evers, F; Wilhelm, J; Richter, K; Hofer, U; Huber, R				Schmid, C. P.; Weigl, L.; Groessing, P.; Junk, V; Gorini, C.; Schlauderer, S.; Ito, S.; Meierhofer, M.; Hofmann, N.; Afanasiev, D.; Crewse, J.; Kokh, K. A.; Tereshchenko, O. E.; Guedde, J.; Evers, F.; Wilhelm, J.; Richter, K.; Hoefer, U.; Huber, R.			Tunable non-integer high-harmonic generation in a topological insulator	NATURE			English	Article							SURFACE; STATES; BLOCH	When intense lightwaves accelerate electrons through a solid, the emerging high-order harmonic (HH) radiation offers key insights into the material(1-11). Sub-optical-cycle dynamics-such as dynamical Bloch oscillations(2-5), quasiparticle collisions(6,12), valley pseudospin switching(13) and heating of Dirac gases(10)-leave fingerprints in the HH spectra of conventional solids. Topologically non-trivial matter(14,15) with invariants that are robust against imperfections has been predicted to support unconventional HH generation(16-20). Here we experimentally demonstrate HH generation in a three-dimensional topological insulator-bismuth telluride. The frequency of the terahertz driving field sharply discriminates between HH generation from the bulk and from the topological surface, where the unique combination of long scattering times owing to spin-momentum locking(17) and the quasi-relativistic dispersion enables unusually efficient HH generation. Intriguingly, all observed orders can be continuously shifted to arbitrary non-integer multiples of the driving frequency by varying the carrier-envelope phase of the driving field-in line with quantum theory. The anomalous Berry curvature warranted by the non-trivial topology enforces meandering ballistic trajectories of the Dirac fermions, causing a hallmark polarization pattern of the HH emission. Our study provides a platform to explore topology and relativistic quantum physics in strong-field control, and could lead to non-dissipative topological electronics at infrared frequencies.	[Schmid, C. P.; Weigl, L.; Schlauderer, S.; Meierhofer, M.; Hofmann, N.; Afanasiev, D.; Huber, R.] Univ Regensburg, Inst Expt & Appl Phys, Regensburg, Germany; [Groessing, P.; Junk, V; Gorini, C.; Crewse, J.; Evers, F.; Wilhelm, J.; Richter, K.] Univ Regensburg, Inst Theoret Phys, Regensburg, Germany; [Ito, S.; Guedde, J.; Hoefer, U.] Philipps Univ Marburg, Dept Phys, Marburg, Germany; [Kokh, K. A.] VS Sobolev Inst Geol & Mineral SB RAS, Novosibirsk, Russia; [Kokh, K. A.; Tereshchenko, O. E.] Novosibirsk State Univ, Novosibirsk, Russia; [Tereshchenko, O. E.] AV Rzhanov Inst Semicond Phys SB RAS, Novosibirsk, Russia; [Gorini, C.] Univ Paris Saclay, SPEC, CNRS, CEA, Gif Sur Yvette, France	University of Regensburg; University of Regensburg; Philipps University Marburg; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Rzhanov Institute of Semiconductor Physics, Siberian Branch, Russian Academy of Sciences; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Huber, R (corresponding author), Univ Regensburg, Inst Expt & Appl Phys, Regensburg, Germany.; Wilhelm, J; Richter, K (corresponding author), Univ Regensburg, Inst Theoret Phys, Regensburg, Germany.	jan.wilhelm@ur.de; klaus.richter@ur.de; rupert.huber@ur.de	Afanasiev, Dmytro/ABG-3148-2021; Huber, Rupert/N-4126-2018; Gorini, Cosimo/N-7818-2013	Huber, Rupert/0000-0001-6617-9283; Gorini, Cosimo/0000-0002-3197-8322; Meierhofer, Manuel/0000-0001-6719-9913; Wilhelm, Jan/0000-0001-8678-8246; Junk, Vanessa/0000-0003-1675-8548; Evers, Ferdinand/0000-0003-1343-1662; Afanasiev, Dmytro/0000-0001-6726-3479				AUSTIN IG, 1958, P PHYS SOC LOND, V72, P545, DOI 10.1088/0370-1328/72/4/309; Banks HB, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.041042; Bauer D, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.177401; Baykusheva D, 2021, PHYS REV A, V103, DOI 10.1103/PhysRevA.103.023101; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Braun L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13259; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Cheng B, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.117402; Chin AH, 2001, PHYS REV LETT, V86, P3292, DOI 10.1103/PhysRevLett86.3292; Floss I, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.011401; Garg M, 2016, NATURE, V538, P359, DOI 10.1038/nature19821; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Giorgianni F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11421; Gradhand M, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/21/213202; Hafez HA, 2018, NATURE, V561, P507, DOI 10.1038/s41586-018-0508-1; Higuchi T, 2017, NATURE, V550, P224, DOI 10.1038/nature23900; Hohenleutner M, 2015, NATURE, V523, P572, DOI 10.1038/nature14652; Huard S. S., 1997, POLARIZATION LIGHT; Junginger F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.147403; Junk V, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.134302; KANE EO, 1959, J PHYS CHEM SOLIDS, V12, P181, DOI 10.1016/0022-3697(60)90035-4; Kira M., 2012, SEMICONDUCTOR QUANTU; Kokh KA, 2014, CRYSTENGCOMM, V16, P581, DOI 10.1039/c3ce42026d; Kruckl V, 2013, WAVE PACKETS MESOSCO; Kuroda K, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.076801; Lange C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.227401; Langer F, 2018, NATURE, V557, P76, DOI 10.1038/s41586-018-0013-6; Langer F, 2016, NATURE, V533, P225, DOI 10.1038/nature17958; Liu CX, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045122; Luu TT, 2015, NATURE, V521, P498, DOI 10.1038/nature14456; Mahmood F, 2016, NAT PHYS, V12, P306, DOI 10.1038/NPHYS3609; McIver JW, 2020, NAT PHYS, V16, P38, DOI 10.1038/s41567-019-0698-y; Michiardi M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.075105; Mikhailov SA, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/27002; Reimann J, 2018, NATURE, V562, P396, DOI 10.1038/s41586-018-0544-x; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Sell A, 2008, OPT LETT, V33, P2767, DOI 10.1364/OL.33.002767; Silva REF, 2019, NAT PHOTONICS, V13, P849, DOI 10.1038/s41566-019-0516-1; Sivis M, 2017, SCIENCE, V357, P303, DOI 10.1126/science.aan2395; Luu TT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03397-4; Vampa G, 2015, NATURE, V522, P462, DOI 10.1038/nature14517; Wilhelm J, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.125419; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Yoshikawa N, 2017, SCIENCE, V356, P736, DOI 10.1126/science.aam8861	45	40	41	13	97	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					385	+		10.1038/s41586-021-03466-7	http://dx.doi.org/10.1038/s41586-021-03466-7			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE7VT	34012087	Green Published			2022-12-28	WOS:000652278400016
J	Winn, M; Rowlinson, M; Wang, FH; Bering, L; Francis, D; Levy, C; Micklefield, J				Winn, Michael; Rowlinson, Michael; Wang, Fanghua; Bering, Luis; Francis, Daniel; Levy, Colin; Micklefield, Jason			Discovery, characterization and engineering of ligases for amide synthesis	NATURE			English	Article							AMINO-ACID; ACTIVATING ENZYMES; CARBOXYLIC-ACIDS; BOND FORMATION; CORONATINE; CONTAINS; TRANSAMIDATION; BIOSYNTHESIS; CULTURES; CLUSTER	Coronatine and related bacterial phytotoxins are mimics of the hormone jasmonyI-l-isoleucine (JA-Ile), which mediates physiologically important plant signalling pathways(1-4). Coronatine-like phytotoxins disrupt these essential pathways and have potential in the development of safer, more selective herbicides. Although the biosynthesis of coronatine has been investigated previously, the nature of the enzyme that catalyses the crucial coupling of coronafacic acid to amino acids remains unknown(1,2). Here we characterize a family of enzymes, coronafacic acid ligases (CfaLs), and resolve their structures. We found that CfaL can also produce JA-Ile, despite low similarity with the Jar1 enzyme that is responsible for ligation of JA and l-Ile in plants(5). This suggests that Jar1 and CfaL evolved independently to catalyse similar reactions-Jar1 producing a compound essential for plant development(4,5), and the bacterial ligases producing analogues toxic to plants. We further demonstrate how CfaL enzymes can be used to synthesize a diverse array of amides, obviating the need for protecting groups. Highly selective kinetic resolutions of racemic donor or acceptor substrates were achieved, affording homochiral products. We also used structure-guided mutagenesis to engineer improved CfaL variants. Together, these results show that CfaLs can deliver a wide range of amides for agrochemical, pharmaceutical and other applications.	[Winn, Michael; Rowlinson, Michael; Wang, Fanghua; Bering, Luis; Francis, Daniel; Levy, Colin; Micklefield, Jason] Univ Manchester, Manchester Inst Biotechnol, Dept Chem, Manchester, Lancs, England; [Wang, Fanghua] South China Univ Technol, Sch Food Sci & Engn, Guangzhou, Peoples R China	University of Manchester; South China University of Technology	Micklefield, J (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Dept Chem, Manchester, Lancs, England.	jason.micklefield@manchester.ac.uk		Levy, Colin/0000-0002-9724-310X	BBSRC [BB/K002341/1, BB/N023536/1]; Syngenta; China Scholarship Council [201806155100]; Deutsche Forschungsgemeinschaft (DFG) [BE 7054/1]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Syngenta(Syngenta); China Scholarship Council(China Scholarship Council); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank the BBSRC (grants BB/K002341/1 and BB/N023536/1) and Syngenta for funding. F.W. was supported by the China Scholarship Council (grant no. 201806155100) and L.B. was funded by the Deutsche Forschungsgemeinschaft (DFG, grant BE 7054/1). The Michael Barber Centre for Collaborative Mass Spectrometry provided access to MS instrumentation. We also thank J. Vincent and N. Mulholland (Syngenta) for helpful discussions in the early stages of the project, and N. J. Turner (University of Manchester) for kindly providing the CHU plasmid. We also thank Diamond Light Source for beamtime access on i03 and i04-1 (proposal mx17773-56 and 76).	Al-Zoubi RM, 2008, ANGEW CHEM INT EDIT, V47, P2876, DOI 10.1002/anie.200705468; Allen CL, 2012, ANGEW CHEM INT EDIT, V51, P1383, DOI 10.1002/anie.201107348; Andexer JN, 2015, CHEMBIOCHEM, V16, P380, DOI 10.1002/cbic.201402550; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Bignell DRD, 2010, MOL PLANT MICROBE IN, V23, P161, DOI 10.1094/MPMI-23-2-0161; Boras B., 2020, PREPRINT, DOI [10.1101/2020.09.12.293498v3, DOI 10.1101/2020.09.12.293498V3]; BOTTINI R, 1989, PLANT PHYSIOL, V90, P45, DOI 10.1104/pp.90.1.45; CHEN CS, 1982, J AM CHEM SOC, V104, P7294, DOI 10.1021/ja00389a064; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Fyans JK, 2015, MOL PLANT MICROBE IN, V28, P443, DOI 10.1094/MPMI-09-14-0255-R; Goswami A, 2015, MOL BIOSYST, V11, P338, DOI 10.1039/c4mb00627e; Hara R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21408-8; Jervis PJ, 2020, SOFT MATTER, V16, P10001, DOI 10.1039/d0sm01198c; Kelly WL, 2007, BIOCHEMISTRY-US, V46, P359, DOI 10.1021/bi061930j; Krause T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11732; Littleson MM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03443-1; Mitchell RE, 1998, PHYTOCHEMISTRY, V49, P1579, DOI 10.1016/S0031-9422(98)00279-9; MITCHELL RE, 1986, J GEN MICROBIOL, V132, P1503; Nocek BP, 2018, ACS CATAL, V8, P10746, DOI 10.1021/acscatal.8b03151; Noda H, 2017, NAT CHEM, V9, P571, DOI [10.1038/NCHEM.2708, 10.1038/nchem.2708]; PARRY RJ, 1991, J AM CHEM SOC, V113, P1849, DOI 10.1021/ja00005a069; Parry RJ, 1996, J AM CHEM SOC, V118, P703, DOI 10.1021/ja9536330; Pattabiraman VR, 2011, NATURE, V480, P471, DOI 10.1038/nature10702; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; Petchey M, 2018, ANGEW CHEM INT EDIT, V57, P11584, DOI 10.1002/anie.201804592; Philpott HK, 2018, GREEN CHEM, V20, P3426, DOI 10.1039/c8gc01697f; Rangaswamy V, 1998, P NATL ACAD SCI USA, V95, P15469, DOI 10.1073/pnas.95.26.15469; Rangaswamy V, 1997, FEMS MICROBIOL LETT, V154, P65, DOI 10.1111/j.1574-6968.1997.tb12625.x; Sabatini MT, 2019, NAT CATAL, V2, P10, DOI 10.1038/s41929-018-0211-5; Sabatini MT, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701028; Scheidt K, 2010, NATURE, V465, P1020, DOI 10.1038/4651020a; Schuler G, 2004, FEBS LETT, V563, P17, DOI 10.1016/S0014-5793(04)00239-X; Sheldon RA, 2007, BIOCHEM SOC T, V35, P1583, DOI 10.1042/BST0351583; Shockey JM, 2003, PLANT PHYSIOL, V132, P1065, DOI 10.1104/pp.103.020552; Slawiak M, 2009, EUR J PLANT PATHOL, V124, P353, DOI 10.1007/s10658-008-9418-7; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stephenson NA, 2009, J AM CHEM SOC, V131, P10003, DOI 10.1021/ja8094262; Strieter ER, 2009, J AM CHEM SOC, V131, P2113, DOI 10.1021/ja8077945; Strohmeier GA, 2019, CHEM-EUR J, V25, P6119, DOI 10.1002/chem.201901147; Stuhlsatz-Krouper SM, 1998, J BIOL CHEM, V273, P28642, DOI 10.1074/jbc.273.44.28642; Tao T, 2001, ORG LETT, V3, P3045; Tiwari AD, 2014, ORG BIOMOL CHEM, V12, P7238, DOI 10.1039/c4ob01281j; ULLRICH M, 1994, J BACTERIOL, V176, P7574, DOI 10.1128/JB.176.24.7574-7586.1994; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Winn M, 2020, CURR OPIN CHEM BIOL, V55, P77, DOI 10.1016/j.cbpa.2019.12.004; Wood AJL, 2017, ANGEW CHEM INT EDIT, V56, P14498, DOI 10.1002/anie.201707918; Zhang LL, 2020, J MED CHEM, V63, P4562, DOI 10.1021/acs.jmedchem.9b01828; Zhou HJ, 2009, J MED CHEM, V52, P3028, DOI 10.1021/jm801329v	49	13	13	25	105	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					391	+		10.1038/s41586-021-03447-w	http://dx.doi.org/10.1038/s41586-021-03447-w			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE7VT	34012085	Bronze			2022-12-28	WOS:000652278400017
J	Cao, Z; Aharonian, FA; An, Q; Axikegu; Bai, LX; Bai, YX; Bao, YW; Bastieri, D; Bi, XJ; Bi, YJ; Cai, H; Cai, JT; Cao, Z; Chang, J; Chang, JF; Chang, XC; Chen, BM; Chen, J; Chen, L; Chen, L; Chen, L; Chen, MJ; Chen, ML; Chen, QH; Chen, SH; Chen, SZ; Chen, TL; Chen, XL; Chen, Y; Cheng, N; Cheng, YD; Cui, SW; Cui, XH; Cui, YD; Dai, BZ; Dai, HL; Dai, ZG; Danzengluobu; della Volpe, D; Piazzoli, BD; Dong, XJ; Fan, JH; Fan, YZ; Fan, ZX; Fang, J; Fang, K; Feng, CF; Feng, L; Feng, SH; Feng, YL; Gao, B; Gao, CD; Gao, Q; Gao, W; Ge, MM; Geng, LS; Gong, GH; Gou, QB; Gu, MH; Guo, JG; Guo, XL; Guo, YQ; Guo, YY; Han, YA; He, HH; He, HN; He, JC; He, SL; He, XB; He, Y; Heller, M; Hor, YK; Hou, C; Hou, X; Hu, HB; Hu, S; Hu, SC; Hu, XJ; Huang, DH; Huang, QL; Huang, WH; Huang, XT; Huang, ZC; Ji, F; Ji, XL; Jia, HY; Jiang, K; Jiang, ZJ; Jin, C; Kuleshov, D; Levochkin, K; Li, BB; Li, C; Li, C; Li, F; Li, HB; Li, HC; Li, HY; Li, J; Li, K; Li, WL; Li, X; Li, X; Li, XR; Li, Y; Li, YZ; Li, Z; Li, Z; Liang, EW; Liang, YF; Lin, SJ; Liu, B; Liu, C; Liu, D; Liu, H; Liu, HD; Liu, J; Liu, JL; Liu, JS; Liu, JY; Liu, MY; Liu, RY; Liu, SM; Liu, W; Liu, YN; Liu, ZX; Long, WJ; Lu, R; Lv, HK; Ma, BQ; Ma, LL; Ma, XH; Mao, JR; Masood, A; Mitthumsiri, W; Montaruli, T; Nan, YC; Pang, BY; Pattarakijwanich, P; Pei, ZY; Qi, MY; Ruffolo, D; Rulev, V; Saiz, A; Shao, L; Shchegolev, O; Sheng, XD; Shi, JR; Song, HC; Stenkin, YV; Stepanov, V; Sun, QN; Sun, XN; Sun, ZB; Tam, PHT; Tang, ZB; Tian, WW; Wang, BD; Wang, C; Wang, H; Wang, HG; Wang, JC; Wang, JS; Wang, LP; Wang, LY; Wang, RN; Wang, W; Wang, W; Wang, XG; Wang, XJ; Wang, XY; Wang, YD; Wang, YJ; Wang, YP; Wang, Z; Wang, Z; Wang, ZH; Wang, ZX; Wei, DM; Wei, JJ; Wei, YJ; Wen, T; Wu, CY; Wu, HR; Wu, S; Wu, WX; Wu, XF; Xi, SQ; Xia, J; Xia, JJ; Xiang, GM; Xiao, G; Xiao, HB; Xin, GG; Xin, YL; Xing, Y; Xu, DL; Xu, RX; Xue, L; Yan, DH; Yang, CW; Yang, FF; Yang, JY; Yang, LL; Yang, MJ; Yang, RZ; Yang, SB; Yao, YH; Yao, ZG; Ye, YM; Yin, LQ; Yin, N; You, XH; You, ZY; Yu, YH; Yuan, Q; Zeng, HD; Zeng, TX; Zeng, W; Zeng, ZK; Zha, M; Zhai, XX; Zhang, BB; Zhang, HM; Zhang, HY; Zhang, JL; Zhang, JW; Zhang, L; Zhang, L; Zhang, LX; Zhang, PF; Zhang, PP; Zhang, R; Zhang, SR; Zhang, SS; Zhang, X; Zhang, XP; Zhang, Y; Zhang, Y; Zhang, YF; Zhang, YL; Zhao, B; Zhao, J; Zhao, L; Zhao, LZ; Zhao, SP; Zheng, F; Zheng, Y; Zhou, B; Zhou, H; Zhou, JN; Zhou, P; Zhou, R; Zhou, XX; Zhu, CG; Zhu, FR; Zhu, H; Zhu, KJ; Zuo, X				Cao, Zhen; Aharonian, F. A.; An, Q.; Axikegu; Bai, L. X.; Bai, Y. X.; Bao, Y. W.; Bastieri, D.; Bi, X. J.; Bi, Y. J.; Cai, H.; Cai, J. T.; Cao, Zhe; Chang, J.; Chang, J. F.; Chang, X. C.; Chen, B. M.; Chen, J.; Chen, L.; Chen, Liang; Chen, Long; Chen, M. J.; Chen, M. L.; Chen, Q. H.; Chen, S. H.; Chen, S. Z.; Chen, T. L.; Chen, X. L.; Chen, Y.; Cheng, N.; Cheng, Y. D.; Cui, S. W.; Cui, X. H.; Cui, Y. D.; Dai, B. Z.; Dai, H. L.; Dai, Z. G.; Danzengluobu; della Volpe, D.; Piazzoli, B. D' Ettorre; Dong, X. J.; Fan, J. H.; Fan, Y. Z.; Fan, Z. X.; Fang, J.; Fang, K.; Feng, C. F.; Feng, L.; Feng, S. H.; Feng, Y. L.; Gao, B.; Gao, C. D.; Gao, Q.; Gao, W.; Ge, M. M.; Geng, L. S.; Gong, G. H.; Gou, Q. B.; Gu, M. H.; Guo, J. G.; Guo, X. L.; Guo, Y. Q.; Guo, Y. Y.; Han, Y. A.; He, H. H.; He, H. N.; He, J. C.; He, S. L.; He, X. B.; He, Y.; Heller, M.; Hor, Y. K.; Hou, C.; Hou, X.; Hu, H. B.; Hu, S.; Hu, S. C.; Hu, X. J.; Huang, D. H.; Huang, Q. L.; Huang, W. H.; Huang, X. T.; Huang, Z. C.; Ji, F.; Ji, X. L.; Jia, H. Y.; Jiang, K.; Jiang, Z. J.; Jin, C.; Kuleshov, D.; Levochkin, K.; Li, B. B.; Li, Cong; Li, Cheng; Li, F.; Li, H. B.; Li, H. C.; Li, H. Y.; Li, J.; Li, K.; Li, W. L.; Li, X.; Li, Xin; Li, X. R.; Li, Y.; Li, Y. Z.; Li, Zhe; Li, Zhuo; Liang, E. W.; Liang, Y. F.; Lin, S. J.; Liu, B.; Liu, C.; Liu, D.; Liu, H.; Liu, H. D.; Liu, J.; Liu, J. L.; Liu, J. S.; Liu, J. Y.; Liu, M. Y.; Liu, R. Y.; Liu, S. M.; Liu, W.; Liu, Y. N.; Liu, Z. X.; Long, W. J.; Lu, R.; Lv, H. K.; Ma, B. Q.; Ma, L. L.; Ma, X. H.; Mao, J. R.; Masood, A.; Mitthumsiri, W.; Montaruli, T.; Nan, Y. C.; Pang, B. Y.; Pattarakijwanich, P.; Pei, Z. Y.; Qi, M. Y.; Ruffolo, D.; Rulev, V.; Saiz, A.; Shao, L.; Shchegolev, O.; Sheng, X. D.; Shi, J. R.; Song, H. C.; Stenkin, Yu. V.; Stepanov, V.; Sun, Q. N.; Sun, X. N.; Sun, Z. B.; Tam, P. H. T.; Tang, Z. B.; Tian, W. W.; Wang, B. D.; Wang, C.; Wang, H.; Wang, H. G.; Wang, J. C.; Wang, J. S.; Wang, L. P.; Wang, L. Y.; Wang, R. N.; Wang, W.; Wang, W.; Wang, X. G.; Wang, X. J.; Wang, X. Y.; Wang, Y. D.; Wang, Y. J.; Wang, Y. P.; Wang, Zheng; Wang, Zhen; Wang, Z. H.; Wang, Z. X.; Wei, D. M.; Wei, J. J.; Wei, Y. J.; Wen, T.; Wu, C. Y.; Wu, H. R.; Wu, S.; Wu, W. X.; Wu, X. F.; Xi, S. Q.; Xia, J.; Xia, J. J.; Xiang, G. M.; Xiao, G.; Xiao, H. B.; Xin, G. G.; Xin, Y. L.; Xing, Y.; Xu, D. L.; Xu, R. X.; Xue, L.; Yan, D. H.; Yang, C. W.; Yang, F. F.; Yang, J. Y.; Yang, L. L.; Yang, M. J.; Yang, R. Z.; Yang, S. B.; Yao, Y. H.; Yao, Z. G.; Ye, Y. M.; Yin, L. Q.; Yin, N.; You, X. H.; You, Z. Y.; Yu, Y. H.; Yuan, Q.; Zeng, H. D.; Zeng, T. X.; Zeng, W.; Zeng, Z. K.; Zha, M.; Zhai, X. X.; Zhang, B. B.; Zhang, H. M.; Zhang, H. Y.; Zhang, J. L.; Zhang, J. W.; Zhang, L.; Zhang, Li; Zhang, L. X.; Zhang, P. F.; Zhang, P. P.; Zhang, R.; Zhang, S. R.; Zhang, S. S.; Zhang, X.; Zhang, X. P.; Zhang, Yong; Zhang, Yi; Zhang, Y. F.; Zhang, Y. L.; Zhao, B.; Zhao, J.; Zhao, L.; Zhao, L. Z.; Zhao, S. P.; Zheng, F.; Zheng, Y.; Zhou, B.; Zhou, H.; Zhou, J. N.; Zhou, P.; Zhou, R.; Zhou, X. X.; Zhu, C. G.; Zhu, F. R.; Zhu, H.; Zhu, K. J.; Zuo, X.			Ultrahigh-energy photons up to 1.4 petaelectronvolts from 12 gamma-ray Galactic sources	NATURE			English	Article							STAR-FORMING COMPLEX; PULSAR-WIND; MILKY-WAY; MOLECULAR CLOUDS; SUPERNOVA; RADIATION; TEV; REMNANT; NEBULA; DISTANCES	The extension of the cosmic-ray spectrum beyond 1 petaelectronvolt (PeV; 10(15) electronvolts) indicates the existence of the so-called PeVatrons-cosmic-ray factories that accelerate particles to PeV energies. We need to locate and identify such objects to find the origin of Galactic cosmic rays(1). The principal signature of both electron and proton PeVatrons is ultrahigh-energy (exceeding 100 TeV) gamma radiation. Evidence of the presence of a proton PeVatron has been found in the Galactic Centre, according to the detection of a hard-spectrum radiation extending to 0.04 PeV (ref. (2)). Although gamma-rays with energies slightly higher than 0.1 PeV have been reported from a few objects in the Galactic plane(3-6), unbiased identification and in-depth exploration of PeVatrons requires detection of gamma-rays with energies well above 0.1 PeV. Here we report the detection of more than 530 photons at energies above 100 teraelectronvolts and up to 1.4 PeV from 12 ultrahigh-energy gamma-ray sources with a statistical significance greater than seven standard deviations. Despite having several potential counterparts in their proximity, including pulsar wind nebulae, supernova remnants and star-forming regions, the PeVatrons responsible for the ultrahigh-energy gamma-rays have not yet been firmly localized and identified (except for the Crab Nebula), leaving open the origin of these extreme accelerators.	[Cao, Zhen; Bai, Y. X.; Bi, X. J.; Bi, Y. J.; Chang, J. F.; Chang, X. C.; Chen, L.; Chen, M. J.; Chen, M. L.; Chen, S. H.; Chen, S. Z.; Chen, X. L.; Cheng, N.; Cheng, Y. D.; Dai, H. L.; Piazzoli, B. D' Ettorre; Dong, X. J.; Fan, Z. X.; Fang, K.; Feng, S. H.; Gao, B.; Geng, L. S.; Gou, Q. B.; Gu, M. H.; Guo, J. G.; Guo, Y. Q.; Guo, Y. Y.; He, H. H.; He, J. C.; Hou, C.; Hu, H. B.; Hu, S. C.; Huang, Q. L.; Ji, F.; Ji, X. L.; Jin, C.; Li, Cong; Li, F.; Li, H. B.; Li, H. C.; Li, K.; Li, X. R.; Li, Y. Z.; Li, Zhe; Liu, C.; Liu, J.; Liu, J. Y.; Liu, W.; Lv, H. K.; Ma, L. L.; Ma, X. H.; Qi, M. Y.; Sheng, X. D.; Shi, J. R.; Wang, B. D.; Wang, L. Y.; Wang, X. J.; Wang, Y. D.; Wang, Y. J.; Wang, Y. P.; Wang, Zheng; Wei, Y. J.; Wu, C. Y.; Wu, H. R.; Wu, S.; Xiao, G.; Yang, F. F.; Yang, M. J.; Yao, Z. G.; Yin, L. Q.; You, X. H.; You, Z. Y.; Zeng, T. X.; Zeng, Z. K.; Zha, M.; Zhai, X. X.; Zhang, S. S.; Zhang, X. P.; Zhang, Yong; Zhang, Yi; Zhang, Y. L.; Zhao, J.; Zhou, B.; Zhu, K. J.; Zuo, X.] Chinese Acad Sci, Inst High Energy Phys, Key Lab Particle Astrophys, Beijing, Peoples R China; [Cao, Zhen; Bai, Y. X.; Bi, X. J.; Bi, Y. J.; Chang, J. F.; Chang, X. C.; Chen, L.; Chen, M. J.; Chen, M. L.; Chen, S. H.; Chen, S. Z.; Chen, X. L.; Cheng, N.; Cheng, Y. D.; Dai, H. L.; Piazzoli, B. D' Ettorre; Dong, X. J.; Fan, Z. X.; Fang, K.; Feng, S. H.; Gao, B.; Geng, L. S.; Gou, Q. B.; Gu, M. H.; Guo, J. G.; Guo, Y. Q.; Guo, Y. Y.; He, H. H.; He, J. C.; Hou, C.; Hu, H. B.; Hu, S. C.; Huang, Q. L.; Ji, F.; Ji, X. L.; Jin, C.; Li, Cong; Li, F.; Li, H. B.; Li, H. C.; Li, K.; Li, X. R.; Li, Y. Z.; Li, Zhe; Liu, C.; Liu, J.; Liu, J. Y.; Liu, W.; Lv, H. K.; Ma, L. L.; Ma, X. H.; Qi, M. Y.; Sheng, X. D.; Shi, J. R.; Wang, B. D.; Wang, L. Y.; Wang, X. J.; Wang, Y. D.; Wang, Y. J.; Wang, Y. P.; Wang, Zheng; Wei, Y. J.; Wu, C. Y.; Wu, H. R.; Wu, S.; Xiao, G.; Yang, F. F.; Yang, M. J.; Yao, Z. G.; Yin, L. Q.; You, X. H.; You, Z. Y.; Zeng, T. X.; Zeng, Z. K.; Zha, M.; Zhai, X. X.; Zhang, S. S.; Zhang, X. P.; Zhang, Yong; Zhang, Yi; Zhang, Y. L.; Zhao, J.; Zhou, B.; Zhu, K. J.; Zuo, X.] Chinese Acad Sci, Inst High Energy Phys, Expt Phys Div, Beijing, Peoples R China; [Cao, Zhen; Bai, Y. X.; Bi, X. J.; Bi, Y. J.; Chang, J. F.; Chang, X. C.; Chen, L.; Chen, M. J.; Chen, M. L.; Chen, S. H.; Chen, S. Z.; Chen, X. L.; Cheng, N.; Cheng, Y. D.; Dai, H. L.; Piazzoli, B. D' Ettorre; Dong, X. J.; Fan, Z. X.; Fang, K.; Feng, S. H.; Gao, B.; Geng, L. S.; Gou, Q. B.; Gu, M. H.; Guo, J. G.; Guo, Y. Q.; Guo, Y. Y.; He, H. H.; He, J. C.; Hou, C.; Hu, H. B.; Hu, S. C.; Huang, Q. L.; Ji, F.; Ji, X. L.; Jin, C.; Li, Cong; Li, F.; Li, H. B.; Li, H. C.; Li, K.; Li, X. R.; Li, Y. Z.; Li, Zhe; Liu, C.; Liu, J.; Liu, J. Y.; Liu, W.; Lv, H. K.; Ma, L. L.; Ma, X. H.; Qi, M. Y.; Sheng, X. D.; Shi, J. R.; Wang, B. D.; Wang, L. Y.; Wang, X. J.; Wang, Y. D.; Wang, Y. J.; Wang, Y. P.; Wang, Zheng; Wei, Y. J.; Wu, C. Y.; Wu, H. R.; Wu, S.; Xiao, G.; Yang, F. F.; Yang, M. J.; Yao, Z. G.; Yin, L. Q.; You, X. H.; You, Z. Y.; Zeng, T. X.; Zeng, Z. K.; Zha, M.; Zhai, X. X.; Zhang, S. S.; Zhang, X. P.; Zhang, Yong; Zhang, Yi; Zhang, Y. L.; Zhao, J.; Zhou, B.; Zhu, K. J.; Zuo, X.] Chinese Acad Sci, Inst High Energy Phys, Comp Ctr, Beijing, Peoples R China; [Cao, Zhen; Bai, Y. X.; Bi, X. J.; Bi, Y. J.; Chang, J. F.; Chang, X. C.; Chen, L.; Chen, M. J.; Chen, M. L.; Chen, S. H.; Chen, S. Z.; Chen, X. L.; Cheng, N.; Cheng, Y. D.; Dai, H. L.; Dong, X. J.; Fan, Z. X.; Fang, K.; Feng, S. H.; Gao, B.; Geng, L. S.; Gou, Q. B.; Gu, M. H.; Guo, J. G.; Guo, Y. Q.; Guo, Y. Y.; He, H. H.; He, J. C.; Hou, C.; Hu, H. B.; Hu, S. C.; Huang, Q. L.; Ji, F.; Ji, X. L.; Jin, C.; Li, Cong; Li, F.; Li, H. B.; Li, H. C.; Li, K.; Li, X. R.; Li, Y. Z.; Li, Zhe; Liu, C.; Liu, J.; Liu, J. Y.; Liu, W.; Lv, H. K.; Ma, L. L.; Ma, X. H.; Qi, M. Y.; Sheng, X. D.; Shi, J. R.; Wang, B. D.; Wang, L. Y.; Wang, X. J.; Wang, Y. D.; Wang, Y. J.; Wang, Y. P.; Wang, Zheng; Wei, Y. J.; Wu, C. Y.; Wu, H. R.; Wu, S.; Xiao, G.; Yang, F. F.; Yang, M. J.; Yao, Z. G.; Yin, L. Q.; You, X. H.; You, Z. Y.; Zeng, T. X.; Zeng, Z. K.; Zha, M.; Zhai, X. X.; Zhang, S. S.; Zhang, X. P.; Zhang, Yong; Zhang, Y. L.; Zhao, J.; Zhou, B.; Zhu, K. J.; Zuo, X.] TIANFU Cosm Ray Res Ctr, Chengdu, Sichuan, Peoples R China; [Cao, Zhen; Bi, X. J.; Chen, L.; Chen, S. H.; Chen, X. L.; Guo, J. G.; Guo, Y. Y.; He, H. H.; He, J. C.; Hu, H. B.; Hu, S. C.; Jin, C.; Li, Y. Z.; Tian, W. W.; Wang, Y. P.; Wei, Y. J.; Xiang, G. M.; You, Z. Y.; Zeng, Z. K.; Zhu, K. J.] Univ Chinese Acad Sci, Beijing, Peoples R China; [Aharonian, F. A.] Dublin Inst Adv Studies, Dublin, Ireland; [Aharonian, F. A.] Max Planck Inst Nucl Phys, Heidelberg, Germany; [An, Q.; Cao, Zhe; Chang, J. F.; Chen, M. L.; Gu, M. H.; Jiang, K.; Li, Cheng; Li, F.; Li, J.; Li, X.; Tang, Z. B.; Wang, Zheng; Yang, F. F.; Zeng, T. X.; Zhao, L.; Zhu, K. J.] State Key Lab Particle Detect & Elect, Beijing, Peoples R China; [An, Q.; Cao, Zhe; Jiang, K.; Li, Cheng; Li, H. Y.; Li, X.; Liu, B.; Tang, Z. B.; Xia, J.; Yang, R. Z.; Zhang, R.; Zhao, L.] Univ Sci & Technol China, Hefei, Peoples R China; [Axikegu; Chen, Long; Chen, Q. H.; Guo, X. L.; He, Y.; Huang, D. H.; Huang, Z. C.; Jia, H. Y.; Li, Xin; Liu, H.; Long, W. J.; Masood, A.; Pang, B. Y.; Sun, Q. N.; Wang, H.; Wang, R. N.; Wu, W. X.; Xi, S. Q.; Xia, J. J.; Xin, Y. L.; Zhang, Y. F.; Zhao, B.; Zheng, Y.; Zhou, X. X.; Zhu, F. R.] Southwest Jiaotong Univ, Sch Phys Sci & Technol, Chengdu, Peoples R China; [Axikegu; Chen, Long; Chen, Q. H.; Guo, X. L.; He, Y.; Huang, D. H.; Huang, Z. C.; Jia, H. Y.; Li, Xin; Liu, H.; Long, W. J.; Masood, A.; Pang, B. Y.; Sun, Q. N.; Wang, H.; Wang, R. N.; Wu, W. X.; Xi, S. Q.; Xia, J. J.; Xin, Y. L.; Zhang, Y. F.; Zhao, B.; Zheng, Y.; Zhou, X. X.; Zhu, F. R.] Southwest Jiaotong Univ, Sch Informat Sci & Technol, Chengdu, Peoples R China; [Bai, L. X.; Chen, J.; Hu, S.; Li, Y.; Liu, Z. X.; Wang, Z. H.; Yang, C. W.; Yao, Y. H.; Zhang, J. W.; Zhou, R.] Sichuan Univ, Coll Phys, Chengdu, Peoples R China; [Bao, Y. W.; Chen, Y.; Dai, Z. G.; Liu, R. Y.; Wang, X. Y.; Zhang, B. B.; Zhang, H. M.; Zhang, X.; Zhou, P.] Nanjing Univ, Sch Astron & Space Sci, Nanjing, Peoples R China; [Bastieri, D.; Cai, J. T.; Fan, J. H.; He, S. L.; Pei, Z. Y.; Wang, H. G.; Xiao, H. B.; Zhang, L. X.] Guangzhou Univ, Ctr Astrophys, Guangzhou, Peoples R China; [Cai, H.; Li, J.; Wang, W.; Xin, G. G.] Wuhan Univ, Sch Phys & Technol, Wuhan, Peoples R China; [Chang, J.; Dai, H. L.; Fan, Y. Z.; Feng, L.; Feng, Y. L.; Guo, Y. Y.; He, H. N.; Li, H. Y.; Liu, S. M.; Wei, D. M.; Wei, J. J.; Wu, X. F.; Xia, J.; Yuan, Q.; Zeng, H. D.; Zhang, R.; Zhang, Yi; Zhao, S. P.] Chinese Acad Sci, Key Lab Dark Matter & Space Astron, Purple Mt Observ, Nanjing, Peoples R China; [Chen, B. M.; Cui, S. W.; Li, B. B.; Shao, L.; Zhang, L.; Zhang, P. P.; Zhang, S. R.; Zhao, L. Z.] Hebei Normal Univ, Shijiazhuang, Hebei, Peoples R China; [Chen, Liang; Xiang, G. M.; Xing, Y.; Zhou, J. N.] Chinese Acad Sci, Shanghai Astron Observ, Key Lab Res Galaxies & Cosmol, Shanghai, Peoples R China; [Chen, T. L.; Danzengluobu; Gao, Q.; Liu, M. Y.] Tibet Univ, Minist Educ, Key Lab Cosm Rays, Lhasa, Tibet, Peoples R China; [Cui, X. H.; Tian, W. W.; Zhang, J. L.; Zhu, H.] Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China; [Cui, Y. D.; He, X. B.; Hor, Y. K.; Lin, S. J.; Liu, J. S.; Tam, P. H. T.; Wang, W.; Yang, J. Y.; Yang, L. L.] Sun Yat Sen Univ, Sch Phys & Astron, Zhuhai, Peoples R China; [Cui, Y. D.; He, X. B.; Hor, Y. K.; Lin, S. J.; Liu, J. S.; Tam, P. H. T.; Wang, W.; Yang, J. Y.; Yang, L. L.] Sun Yat Sen Univ, Sch Phys Guangzhou, Zhuhai, Peoples R China; [Dai, B. Z.; Fang, J.; Ge, M. M.; Jiang, Z. J.; Lu, R.; Wang, Z. X.; Wen, T.; Yang, S. B.; Zeng, W.; Zhang, Li; Zhang, P. F.] Yunnan Univ, Sch Phys & Astron, Kunming, Yunnan, Peoples R China; [della Volpe, D.; Heller, M.; Montaruli, T.] Univ Geneva, Dept Phys Nucl & Corpusculaire, Fac Sci, Geneva, Switzerland; [Piazzoli, B. D' Ettorre] Univ Napoli Federico II, Complesso Univ Monte St Angelo, Dipartimento Fis, Naples, Italy; [Feng, C. F.; Gao, C. D.; Gao, W.; Huang, W. H.; Huang, X. T.; Li, W. L.; Liu, D.; Nan, Y. C.; Wang, L. P.; Xue, L.; Yin, N.; Yu, Y. H.; Zhang, H. Y.; Zhao, S. P.; Zhu, C. G.] Shandong Univ, Inst Frontier & Interdisciplinary Sci, Qingdao, Peoples R China; [Gong, G. H.; Hu, X. J.; Liu, Y. N.; Ye, Y. M.] Tsinghua Univ, Dept Engn Phys, Beijing, Peoples R China; [Han, Y. A.; Liu, H. D.] Zhengzhou Univ, Sch Phys & Microelect, Zhengzhou, Peoples R China; [Hou, X.; Mao, J. R.; Wang, J. C.; Yan, D. H.] Chinese Acad Sci, Yunnan Observ, Kunming, Yunnan, Peoples R China; [Kuleshov, D.; Levochkin, K.; Rulev, V.; Shchegolev, O.; Stenkin, Yu. V.; Stepanov, V.] Russian Acad Sci, Inst Nucl Res, Moscow, Russia; [Li, Zhuo; Ma, B. Q.; Song, H. C.; Xu, R. X.] Peking Univ, Sch Phys, Beijing, Peoples R China; [Liang, E. W.; Liang, Y. F.; Sun, X. N.; Wang, X. G.] Guangxi Univ, Sch Phys Sci & Technol, Nanning, Peoples R China; [Liu, J. L.; Wang, J. S.; Wang, Zhen; Xu, D. L.; Zhou, H.] Shanghai Jiao Tong Univ, Tsung Dao Lee Inst, Shanghai, Peoples R China; [Liu, J. L.; Wang, J. S.; Wang, Zhen; Xu, D. L.; Zhou, H.] Shanghai Jiao Tong Univ, Sch Phys & Astron, Shanghai, Peoples R China; [Mitthumsiri, W.; Pattarakijwanich, P.; Ruffolo, D.; Saiz, A.] Mahidol Univ, Dept Phys, Fac Sci, Bangkok, Thailand; [Shchegolev, O.; Stenkin, Yu. V.] Moscow Inst Phys & Technol, Moscow, Russia; [Sun, Z. B.; Wang, C.; Zheng, F.] Chinese Acad Sci, Natl Space Sci Ctr, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Dublin Institute for Advanced Studies; Max Planck Society; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Southwest Jiaotong University; Southwest Jiaotong University; Sichuan University; Nanjing University; Guangzhou University; Wuhan University; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Hebei Normal University; Chinese Academy of Sciences; Shanghai Astronomical Observatory, CAS; Tibet University; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Sun Yat Sen University; Sun Yat Sen University; Yunnan University; University of Geneva; University of Naples Federico II; Shandong University; Tsinghua University; Zhengzhou University; Chinese Academy of Sciences; Yunnan Astronomical Observatory, NAOC, CAS; Russian Academy of Sciences; Institute for Nuclear Research of the Russian Academy of Sciences; Peking University; Guangxi University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Mahidol University; Moscow Institute of Physics & Technology; Chinese Academy of Sciences; National Space Science Center, CAS	Cao, Z; Chen, SZ (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Key Lab Particle Astrophys, Beijing, Peoples R China.; Cao, Z; Chen, SZ (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Expt Phys Div, Beijing, Peoples R China.; Cao, Z; Chen, SZ (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Comp Ctr, Beijing, Peoples R China.; Cao, Z; Chen, SZ (corresponding author), TIANFU Cosm Ray Res Ctr, Chengdu, Sichuan, Peoples R China.; Cao, Z (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Aharonian, FA (corresponding author), Dublin Inst Adv Studies, Dublin, Ireland.; Aharonian, FA (corresponding author), Max Planck Inst Nucl Phys, Heidelberg, Germany.; Yang, RZ (corresponding author), Univ Sci & Technol China, Hefei, Peoples R China.; Liu, RY (corresponding author), Nanjing Univ, Sch Astron & Space Sci, Nanjing, Peoples R China.	caozh@ihep.ac.cn; felix.aharonian@mpi-hd.mpg.de; chensz@ihep.ac.cn; ryliu@nju.edu.cn; yangrz@ustc.edu.cn	bi, xiaojun/CAF-6323-2022; Feng, Li/G-2100-2015; Kuleshov, Denis/Q-8731-2017; liu, yi/GXE-9662-2022	Cao, Zhen/0000-0002-4858-6130; Lv, Hongkui/0000-0002-7779-3630; Kuleshov, Denis/0000-0001-7326-3029; Aharonian, Felix/0000-0003-1157-3915	National Key R&D programme of China [2018YFA0404201, 2018YFA0404202, 2018YFA0404203, 2018YFA0404204]; NSFC [12022502, 11905227, U1931112, 11635011, 11761141001, U2031105]; Thailand Science Research and Innovation [RTA6280002]; Chengdu Management Committee of Tianfu New Area	National Key R&D programme of China; NSFC(National Natural Science Foundation of China (NSFC)); Thailand Science Research and Innovation; Chengdu Management Committee of Tianfu New Area	This work is supported in China by National Key R&D programme of China under grants 2018YFA0404201, 2018YFA0404202, 2018YFA0404203 and 2018YFA0404204 and by NSFC (grant numbers 12022502, 11905227, U1931112, 11635011, 11761141001 and U2031105), and in Thailand by RTA6280002 from Thailand Science Research and Innovation. We thank all staff members who work year-round at the LHAASO site at 4,400 m above sea level to maintain the detector and keep the electricity power supply and other components of the experiment operating smoothly. We are grateful to Chengdu Management Committee of Tianfu New Area for constant financial support to research with LHAASO data.	Abdalla H, 2018, ASTRON ASTROPHYS, V612, DOI 10.1051/0004-6361/201732098; Abdollahi S, 2020, ASTROPHYS J SUPPL S, V247, DOI 10.3847/1538-4365/ab6bcb; Abeysekara AU, 2021, NAT ASTRON, V5, P465, DOI 10.1038/s41550-021-01318-y; Abeysekara AU, 2017, SCIENCE, V358, P911, DOI 10.1126/science.aan4880; Abramowski A, 2016, NATURE, V531, P476, DOI 10.1038/nature17147; Acciari VA, 2020, ASTRON ASTROPHYS, V635, DOI 10.1051/0004-6361/201936899; Acero F, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/77; Aguilar M, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.231102; Aharonian F, 2021, CHINESE PHYS C, V45, DOI 10.1088/1674-1137/abd01b; Aharonian F, 2004, ASTROPHYS J, V614, P897, DOI 10.1086/423931; Aharonian F, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/9/096901; Aharonian FA, 1996, ASTRON ASTROPHYS, V309, P917; Aharonian F, 2019, NAT ASTRON, V3, P561, DOI 10.1038/s41550-019-0724-0; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert A, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.021102; Aloisio R, 2018, MULTIPLE MESSENGERS; Amenomori M, 2021, NAT ASTRON, V5, P460, DOI 10.1038/s41550-020-01294-9; Amenomori M, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.051101; Azimlu M, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/4/123; Bartoli B, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/27; Bartoli B, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/110; Bykov AM, 2020, SPACE SCI REV, V216, DOI 10.1007/s11214-020-00663-0; Cao Z, 2010, CHINESE PHYS C, V34, P249, DOI 10.1088/1674-1137/34/2/018; CESARSKY CJ, 1983, SPACE SCI REV, V36, P173, DOI 10.1007/BF00167503; CRONIN JW, 1993, ANNU REV NUCL PART S, V43, P883; Dame TM, 2001, ASTROPHYS J, V547, P792, DOI 10.1086/318388; DOWNES AJB, 1980, ASTRON ASTROPHYS, V92, P47; Fleysher R, 2004, ASTROPHYS J, V603, P355, DOI 10.1086/381384; Gabici S, 2007, ASTROPHYS J, V665, pL131, DOI 10.1086/521047; Gelfand JD, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/30; Giacinti G, 2020, ASTRON ASTROPHYS, V636, DOI 10.1051/0004-6361/201936505; Gotthelf EV, 2011, ASTROPHYS J LETT, V729, DOI 10.1088/2041-8205/729/2/L16; GOULD RJ, 1966, PHYS REV LETT, V16, P252, DOI 10.1103/PhysRevLett.16.252; He HH, 2018, RADIAT DETECT TECHNO, V2, DOI 10.1007/s41605-018-0037-3; Kafexhiu E, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.123014; Khangulyan D, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/100; Kirichenko A, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/1/17; Kothes R, 2001, ASTROPHYS J, V560, P236, DOI 10.1086/322511; Linden T, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.103016; Liu RY, 2020, MON NOT R ASTRON SOC, V494, P2618, DOI 10.1093/mnras/staa911; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Moskalenko IV, 2006, ASTROPHYS J, V640, pL155, DOI 10.1086/503524; Paredes JM, 2009, ASTRON ASTROPHYS, V507, P241, DOI 10.1051/0004-6361/200912448; Popescu CC, 2017, MON NOT R ASTRON SOC, V470, P2539, DOI 10.1093/mnras/stx1282; Ranasinghe S, 2018, MON NOT R ASTRON SOC, V477, P2230, DOI 10.1093/mnras/sty817; Rygl KLJ, 2012, ASTRON ASTROPHYS, V539, DOI [10.1051/0004-6361/201118211, 10.1051/0004-6361/20111821]; Shan SS, 2018, ASTROPHYS J SUPPL S, V238, DOI 10.3847/1538-4365/aae07a; Sudoh T, 2019, PHYS REV D, V100, DOI 10.1103/PhysRevD.100.043016; Yang J, 2006, CHINESE J ASTRON AST, V6, P210, DOI 10.1088/1009-9271/6/2/8; Zhang B, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/89; Zirakashvili VN, 2007, ASTRON ASTROPHYS, V465, P695, DOI 10.1051/0004-6361:20066494	51	115	123	29	109	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					33	+		10.1038/s41586-021-03498-z	http://dx.doi.org/10.1038/s41586-021-03498-z		MAY 2021	16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM2RM	34002091				2022-12-28	WOS:000651348600001
J	Qiu, XT; Hanage, WP; Taylor, BP				Qiu, Xueting; Hanage, William P.; Taylor, Bradford P.			Coming to America: Genomic surveillance and how B.1.1.7 arrived in the US	CELL			English	Editorial Material							TRANSMISSION	In this issue of Cell, Washington et al. and Alpert et al. demonstrate the value of genomic surveillance when studying the introduction of the B.1.1.7 variant to the US and illustrate the challenge that results from the lack of good sampling strategies.	[Qiu, Xueting; Hanage, William P.; Taylor, Bradford P.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Qiu, XT (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.	xuetingqiu@hsph.harvard.edu	Hanage, Bill/CAF-1813-2022		National Institute of General Medical Sciences of the National Institutes of Health [U54GM088558]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI128344]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	X.Q. and W.P.H. were supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number U54GM088558. W.P.H. and B.P.T. were supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI128344. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alpert T, 2021, CELL, V184, P2595, DOI 10.1016/j.cell.2021.03.061; CDC, 2021, COVID DAT TRACK PROP; CDC, 2021, SARS COV 2 VAR CLASS; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; De Oliveira T., 2021, MEDRXIV, DOI [10.1101/2021.03.30.21254323, DOI 10.1101/2021.03.30.21254323]; GISAID, 2021, GISAID HCOV19 VAR SU; Maxmen A, 2021, NATURE, V592, P336, DOI 10.1038/d41586-021-00908-0; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Vavrek D., 2021, GENOMIC SURV SCAL IS, DOI [10.1101/2021.01.12.21249613, DOI 10.1101/2021.01.12.21249613]; Washington NL, 2021, CELL, V184, P2587, DOI 10.1016/j.cell.2021.03.052; White House, 2021, FACT SHEET BID ADM A	11	0	0	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2532	2534		10.1016/j.cell.2021.04.031	http://dx.doi.org/10.1016/j.cell.2021.04.031		MAY 2021	3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33989546	Bronze, Green Published			2022-12-28	WOS:000652830800002
J	Buechler, MB; Pradhan, RN; Krishnamurty, AT; Cox, C; Calviello, AK; Wang, AW; Yang, YA; Tam, L; Caothien, R; Roose-Girma, M; Modrusan, Z; Arron, JR; Bourgon, R; Muller, S; Turley, SJ				Buechler, Matthew B.; Pradhan, Rachana N.; Krishnamurty, Akshay T.; Cox, Christian; Calviello, Aslihan Karabacak; Wang, Amber W.; Yang, Yeqing Angela; Tam, Lucinda; Caothien, Roger; Roose-Girma, Merone; Modrusan, Zora; Arron, Joseph R.; Bourgon, Richard; Muller, Soren; Turley, Shannon. J.			Cross-tissue organization of the fibroblast lineage	NATURE			English	Article							SEQUENCING REVEALS; GENE-EXPRESSION; STROMAL NICHE; CELL; MYOFIBROBLASTS; POPULATIONS	Fibroblasts are non-haematopoietic structural cells that define the architecture of organs, support the homeostasis of tissue-resident cells and have key roles in fibrosis, cancer, autoimmunity and wound healing(1). Recent studies have described fibroblast heterogeneity within individual tissues(1). However, the field lacks a characterization of fibroblasts at single-cell resolution across tissues in healthy and diseased organs. Here we constructed fibroblast atlases by integrating single-cell transcriptomic data from about 230,000 fibroblasts across 17 tissues, 50 datasets, 11 disease states and 2 species. Mouse fibroblast atlases and a Dpt(IRESCreERT2) knock-in mouse identified two universal fibroblast transcriptional subtypes across tissues. Our analysis suggests that these cells can serve as a reservoir that can yield specialized fibroblasts across a broad range of steady-state tissues and activated fibroblasts in disease. Comparison to an atlas of human fibroblasts from perturbed states showed that fibroblast transcriptional states are conserved between mice and humans, including universal fibroblasts and activated phenotypes associated with pathogenicity in human cancer, fibrosis, arthritis and inflammation. In summary, a cross-species and pan-tissue approach to transcriptomics at single-cell resolution has identified key organizing principles of the fibroblast lineage in health and disease.	[Buechler, Matthew B.; Pradhan, Rachana N.; Krishnamurty, Akshay T.; Cox, Christian; Calviello, Aslihan Karabacak; Wang, Amber W.; Yang, Yeqing Angela; Tam, Lucinda; Caothien, Roger; Roose-Girma, Merone; Modrusan, Zora; Arron, Joseph R.; Bourgon, Richard; Muller, Soren; Turley, Shannon. J.] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Bourgon, R; Muller, S; Turley, SJ (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	rbourgon@gmail.com; muller.soren@gene.com; turley.shannon@gene.com	Muller, Soren/AFK-6577-2022; Muller, Soren/AAG-4846-2022	Krishnamurty, Akshay/0000-0001-5382-1417; Buechler, Matthew/0000-0003-1902-622X; Yang, Angela/0000-0002-9868-7431; Pradhan, Rachana/0000-0001-7352-8111; Muller, Soren/0000-0001-9490-5270	Genentech	Genentech(Roche HoldingGenentech)	We thank members of the Turley laboratory and individuals in the bioinformatics department for discussions; C. Dominguez for experimental assistance; S. Lianoglou, Y. Senbabaoglu and N. Lounsbury for bioinformatics assistance; facility staff at Genentech for vivarium maintenance and core facility assistance; and Turley laboratory members and A. Berkley for their careful review of this manuscript. This work was supported by Genentech.	Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Bellomo A, 2020, IMMUNITY, V53, P127, DOI 10.1016/j.immuni.2020.06.008; Bharat A, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abe4282; Boyd DF, 2020, NATURE, V587, P466, DOI 10.1038/s41586-020-2877-5; Buechler MB, 2020, IMMUNITY, V52, P578, DOI 10.1016/j.immuni.2020.03.015; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Buechler MB, 2018, SEMIN IMMUNOL, V35, P48, DOI 10.1016/j.smim.2017.11.001; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burl RB, 2018, CELL METAB, V28, P300, DOI 10.1016/j.cmet.2018.05.025; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Dahlgren MW, 2019, TRENDS IMMUNOL, V40, P877, DOI 10.1016/j.it.2019.08.002; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; Davidson S, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107628; Dell'Orso S, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174177; Dobie R, 2019, CELL REP, V29, P1832, DOI 10.1016/j.celrep.2019.10.024; Dominguez CX, 2020, CANCER DISCOV, V10, P232, DOI 10.1158/2159-8290.CD-19-0644; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Emblom-Callahan MC, 2010, GENOMICS, V96, P134, DOI 10.1016/j.ygeno.2010.04.005; Gao X, 2019, BIOINFORMATICS, V35, P3038, DOI 10.1093/bioinformatics/btz024; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guerrero-Juarez CF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08247-x; Habermann AC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1972; Hepler C, 2018, ELIFE, V7, DOI 10.7554/eLife.39636; Hinz B, 2020, NAT REV RHEUMATOL, V16, P11, DOI 10.1038/s41584-019-0324-5; Ho DE, 2011, J STAT SOFTW, V42; Tran HTN, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-019-1850-9; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Koga, 2018, J EXP MED, V278; Koliaraki V, 2020, NAT IMMUNOL, V21, P974, DOI 10.1038/s41590-020-0741-2; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Krausgruber T, 2020, NATURE, V583, P296, DOI 10.1038/s41586-020-2424-4; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maurer C, 2019, GUT, V68, P1034, DOI 10.1136/gutjnl-2018-317706; Maynard A, 2020, CELL, V182, P1232, DOI 10.1016/j.cell.2020.07.017; McCarthy N, 2020, CELL STEM CELL, V26, P391, DOI 10.1016/j.stem.2020.01.008; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501; Micheli, 2020, SINGLE CELL TRANSCRI, DOI 10.1101/801266; Newman RJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv600; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Perez-Shibayama C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb7066; Peyser R, 2019, AM J RESP CELL MOL, V61, P74, DOI 10.1165/rcmb.2018-0313OC; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Saunders T. L., 2011, ISTT MANUAL; Schubert M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02391-6; Schwalie PC, 2018, NATURE, V559, P103, DOI 10.1038/s41586-018-0226-8; Scott RW, 2019, CELL STEM CELL, V25, P797, DOI 10.1016/j.stem.2019.11.004; Sitnik KM, 2016, CELL REP, V14, P2375, DOI 10.1016/j.celrep.2016.02.033; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Soliman H, 2020, CELL STEM CELL, V26, P205, DOI 10.1016/j.stem.2019.12.008; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Tsukui T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15647-5; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Wei KV, 2020, NATURE, V582, P259, DOI 10.1038/s41586-020-2222-z; Wirka RC, 2019, NAT MED, V25, P1280, DOI 10.1038/s41591-019-0512-5; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	81	130	129	16	175	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					575	+		10.1038/s41586-021-03549-5	http://dx.doi.org/10.1038/s41586-021-03549-5		MAY 2021	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SS9XG	33981032	Bronze			2022-12-28	WOS:000650200300007
J	Wise, J				Wise, Jacqui			Diabetes: BMI cut-offs designed to trigger action are too high for some ethnic populations, say researchers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															National Institute for Health Research	National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the National Institute for Health Research.	Caleyachetty R, 2021, LANCET DIABETES ENDO, V9, P419, DOI 10.1016/S2213-8587(21)00088-7; Cummings D, 2021, LANCET DIABETES ENDO; National Institute for Health and Care Excellence, 2013, PUBL HLTH GUID	3	2	2	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1217	10.1136/bmj.n1217	http://dx.doi.org/10.1136/bmj.n1217			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9GP	33980497				2022-12-28	WOS:000653055200008
J	Adepoju, P				Adepoju, Paul			Fear and stigma remain in survivors of Africa's Ebola epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adepojupaul@gmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2021	373								n1167	10.1136/bmj.n1167	http://dx.doi.org/10.1136/bmj.n1167			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RA	33972236				2022-12-28	WOS:000649709400007
J	DeMerle, K; Angus, DC; Seymour, CW				DeMerle, Kimberley; Angus, Derek C.; Seymour, Christopher W.			Precision Medicine for COVID-19 Phenotype Anarchy or Promise Realized?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[DeMerle, Kimberley; Angus, Derek C.; Seymour, Christopher W.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Dept Crit Care Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Seymour, CW (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, 3550 Terrace St,Scaife Hall 639, Pittsburgh, PA 15261 USA.; Seymour, CW (corresponding author), Univ Pittsburgh, Sch Med, Dept Emergency Med, Clin Res Invest & Syst Modeling Acute Illness CRI, 3550 Terrace St,Scaife Hall 639, Pittsburgh, PA 15261 USA.	seymourcw@upmc.edu			NIH [R35GM119519]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by the NIH (Dr Seymour, R35GM119519).	Challen R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n579; Dorward DA, 2021, AM J RESP CRIT CARE, V203, P192, DOI 10.1164/rccm.202008-3265OC; Kox M, 2020, JAMA-J AM MED ASSOC, V324, P1565, DOI 10.1001/jama.2020.17052; Lauring AS, 2021, JAMA-J AM MED ASSOC, V325, P529, DOI 10.1001/jama.2020.27124; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y	7	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2041	2042		10.1001/jama.2021.5248	http://dx.doi.org/10.1001/jama.2021.5248		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	33961002	Bronze			2022-12-28	WOS:000647843300001
J	Chiarito, M; Stefanini, GG				Chiarito, Mauro; Stefanini, Giulio G.			Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties	LANCET			English	Editorial Material							ASPIRIN; METAANALYSIS		[Chiarito, Mauro; Stefanini, Giulio G.] Humanitas Univ, Dept Biomed Sci, I-20090 Pieve Emanuele Milan, Italy; [Chiarito, Mauro; Stefanini, Giulio G.] Humanitas Res Hosp IRCCS, Rozzano Milan, Italy	Humanitas University	Chiarito, M (corresponding author), Humanitas Univ, Dept Biomed Sci, I-20090 Pieve Emanuele Milan, Italy.; Chiarito, M (corresponding author), Humanitas Res Hosp IRCCS, Rozzano Milan, Italy.	mauro.chiarito@humanitas.it	Chiarito, Mauro/AAC-6819-2022; Stefanini, Giulio/GZG-4754-2022	Chiarito, Mauro/0000-0002-9333-2658; Stefanini, Giulio/0000-0002-3558-6967				[Anonymous], 1988, J AM COLL CARDIOL, V12, pA3; CAO D, 2021, EUR HEART J, V42, P339, DOI DOI 10.1093/EURHEARTJ/EHAA824; Capodanno D, 2018, NAT REV CARDIOL, V15, P480, DOI 10.1038/s41569-018-0049-1; Chiarito M, 2020, LANCET, V395, P1487, DOI 10.1016/S0140-6736(20)30315-9; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Koo BK, 2021, LANCET, V397, P2487, DOI 10.1016/S0140-6736(21)01063-1; Palmerini T, 2015, LANCET, V385, P2371, DOI 10.1016/S0140-6736(15)60263-X; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; Wallentin L, 2009, EUR HEART J, V30, P1964, DOI 10.1093/eurheartj/ehp296	10	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 26	2021	397	10293					2443	2444		10.1016/S0140-6736(21)01120-X	http://dx.doi.org/10.1016/S0140-6736(21)01120-X		JUN 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TA5XM	34010615				2022-12-28	WOS:000667322400006
J	Prasad, SB; Atherton, JJ				Prasad, Sandhir B.; Atherton, John J.			Quality first in obstructive hypertrophic cardiomyopathy	LANCET			English	Editorial Material							MAVACAMTEN		[Prasad, Sandhir B.; Atherton, John J.] Royal Brisbane & Womens Hosp, Dept Cardiol, Herston, Qld 4029, Australia; [Prasad, Sandhir B.; Atherton, John J.] Univ Queensland, Fac Med, Herston, Qld 4029, Australia; [Prasad, Sandhir B.] Griffith Univ, Sch Med, Brisbane, Qld, Australia; [Atherton, John J.] Queensland Univ Technol, Fac Hlth, Brisbane, Qld, Australia	Royal Brisbane & Women's Hospital; University of Queensland; Griffith University; Queensland University of Technology (QUT)	Atherton, JJ (corresponding author), Royal Brisbane & Womens Hosp, Dept Cardiol, Herston, Qld 4029, Australia.; Atherton, JJ (corresponding author), Univ Queensland, Fac Med, Herston, Qld 4029, Australia.; Atherton, JJ (corresponding author), Queensland Univ Technol, Fac Hlth, Brisbane, Qld, Australia.	john.atherton@health.qld.gov.au	Atherton, John J/B-9994-2011	Atherton, John J/0000-0003-2271-578X				Cardiovascular news, 2020, CARDIOVASCULAR NEWS; Cox S, 1997, HEART, V78, P182, DOI 10.1136/hrt.78.2.182; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Geske JB, 2011, JACC-CARDIOVASC INTE, V4, P704, DOI 10.1016/j.jcin.2011.02.014; Ho CY, 2020, J AM COLL CARDIOL, V75, P2649, DOI 10.1016/j.jacc.2020.03.064; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron MS, 2006, CIRCULATION, V114, P2232, DOI 10.1161/CIRCULATIONAHA.106.644682; Olivotto I, 2020, LANCET, V396, P759, DOI 10.1016/S0140-6736(20)31792-X; Ommen SR, 2020, CIRCULATION, V142, pe533, DOI 10.1161/CIR.0000000000000938; Spertus JA, LANCET, V2021, DOI [10.1016/S0140-6736(21)00898-9, DOI 10.1016/S0140-6736(21)00898-9]; Sweeting J, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000484; Younger J, 2020, HEART LUNG CIRC, V29, P556, DOI 10.1016/j.hlc.2019.12.005	13	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 26	2021	397	10293					2440	2441		10.1016/S0140-6736(21)00898-9	http://dx.doi.org/10.1016/S0140-6736(21)00898-9		JUN 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TA5XM	34004178				2022-12-28	WOS:000667322400004
J	Poteat, TC; Logie, CH; van der Merwe, LA				Poteat, Tonia C.; Logie, Carmen H.; van der Merwe, Leigh Ann			Advancing LGBTQI health research	LANCET			English	Editorial Material									[Poteat, Tonia C.] Univ North Carolina Chapel Hill, Dept Social Med, Chapel Hill, NC 27599 USA; [Logie, Carmen H.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [van der Merwe, Leigh Ann] Feminist Collect Transgender Women Afr, Social Hlth Empowerment, East London, South Africa	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Toronto	Poteat, TC (corresponding author), Univ North Carolina Chapel Hill, Dept Social Med, Chapel Hill, NC 27599 USA.	tonia_poteat@med.unc.edu						Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Beyrer C, 2002, LANCET, V360, P246, DOI 10.1016/S0140-6736(02)09465-5; Festersen C. H., 2018, Eurohealth, V24, P41; Flanders CE, 2019, J SEX RES, V56, P1115, DOI 10.1080/00224499.2018.1563042; Gahagan J, 2017, J HOMOSEXUAL, V64, P95, DOI 10.1080/00918369.2016.1172893; Gilmour H, 2019, HEALTH REP, V30, P3, DOI [10.25318/82-003-x201901100001, 10.25318/82-003-x201901100001-eng]; Hatzenbuehler ML, 2016, PEDIATR CLIN N AM, V63, P985, DOI 10.1016/j.pcl.2016.07.003; Jorge JC, 2021, GLOB PUBLIC HEALTH, V16, P679, DOI 10.1080/17441692.2019.1706759; Logie CH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17392; Mendos L. R., 2020, STATE SPONSORED HOMO; Mongelli F., 2019, MINORITY STRESS MENT; National Academies of Sciences Engineering and Medicine, 2020, UND WELL BEING LGBT; Perry NS, 2021, LGBT HEALTH, V8, P169, DOI 10.1089/lgbt.2020.0379; Poteat T, 2016, JAIDS-J ACQ IMM DEF, V72, pS210, DOI 10.1097/QAI.0000000000001087; The Global Forum on MSM HIV OutRight Action International, 2017, AG 2030 LGBTI HLTH W; UN Human Rights Council, 2011, 17 19 HUM RIGHTS SEX	16	13	13	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 29	2021	397	10289					2031	2033		10.1016/S0140-6736(21)01057-6	http://dx.doi.org/10.1016/S0140-6736(21)01057-6		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SK5LX	33992129				2022-12-28	WOS:000656257800006
J	Huttlin, EL; Bruckner, RJ; Navarrete-Perea, J; Cannon, JR; Baltier, K; Gebreab, F; Gygi, MP; Thornock, A; Zarraga, G; Tam, S; Szpyt, J; Gassaway, BM; Panov, A; Parzen, H; Fu, SP; Golbazi, A; Maenpaa, E; Stricker, K; Thakurta, SG; Zhang, T; Rad, R; Pan, J; Nusinow, DP; Paulo, JA; Schweppe, DK; Vaites, LP; Harper, JW; Gygi, SP				Huttlin, Edward L.; Bruckner, Raphael J.; Navarrete-Perea, Jose; Cannon, Joe R.; Baltier, Kurt; Gebreab, Fana; Gygi, Melanie P.; Thornock, Alexandra; Zarraga, Gabriela; Tam, Stanley; Szpyt, John; Gassaway, Brandon M.; Panov, Alexandra; Parzen, Hannah; Fu, Sipei; Golbazi, Arvene; Maenpaa, Eila; Stricker, Keegan; Thakurta, Sanjukta Guha; Zhang, Tian; Rad, Ramin; Pan, Joshua; Nusinow, David P.; Paulo, Joao A.; Schweppe, Devin K.; Vaites, Laura Pontano; Harper, J. Wade; Gygi, Steven P.			Dual proteome-scale networks reveal cell-specific remodeling of the human interactome	CELL			English	Article							COMPLEX; ORGANIZATION; MAP; PHOSPHORYLATION; IDENTIFICATION; ESSENTIALITY; COMPENDIUM; EXPRESSION; LANDSCAPE; LETHALITY	Thousands of interactions assemble proteins into modules that impart spatial and functional organization to the cellular proteome. Through affinity-purification mass spectrometry, we have created two proteome-scale, cell-line-specific interaction networks. The first, BioPlex 3.0, results from affinity purification of 10,128 human proteins-half the proteome-in 293T cells and includes 118,162 interactions among 14,586 proteins. The second results from 5,522 immunoprecipitations in HCT116 cells. These networks model the interactome whose structure encodes protein function, localization, and complex membership. Comparison across cell lines validates thousands of interactions and reveals extensive customization. Whereas shared interactions reside in core complexes and involve essential proteins, cell-specific interactions link these complexes, "rewiring'' subnetworks within each cell's interactome. Interactions covary among proteins of shared function as the proteome remodels to produce each cell's phenotype. Viewable interactively online through BioPlexExplorer, these networks define principles of proteome organization and enable unknown protein characterization.	[Huttlin, Edward L.; Bruckner, Raphael J.; Navarrete-Perea, Jose; Cannon, Joe R.; Baltier, Kurt; Gebreab, Fana; Gygi, Melanie P.; Thornock, Alexandra; Zarraga, Gabriela; Tam, Stanley; Szpyt, John; Gassaway, Brandon M.; Panov, Alexandra; Parzen, Hannah; Fu, Sipei; Golbazi, Arvene; Maenpaa, Eila; Stricker, Keegan; Thakurta, Sanjukta Guha; Zhang, Tian; Rad, Ramin; Nusinow, David P.; Paulo, Joao A.; Schweppe, Devin K.; Vaites, Laura Pontano; Harper, J. Wade; Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Pan, Joshua] Broad Inst, Cambridge, MA 02142 USA; [Bruckner, Raphael J.] Arrakis Therapeut, Waltham, MA 02451 USA; [Cannon, Joe R.] Merck, West Point, PA 19486 USA; [Baltier, Kurt] IQ Prote, Cambridge, MA 02139 USA; [Zarraga, Gabriela] Vor Biopharma, Cambridge, MA 02142 USA; [Tam, Stanley] Rubius Therapeut, Cambridge, MA 02139 USA; [Parzen, Hannah] RPS North Amer, South Kingstown, RI 02879 USA; [Nusinow, David P.] Pfizer, Cambridge, MA 02139 USA; [Schweppe, Devin K.] Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pfizer; University of Washington; University of Washington Seattle	Huttlin, EL; Harper, JW; Gygi, SP (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	edward_huttlin@hms.harvard.edu; wade_harper@hms.harvard.edu; steven_gygi@hms.harvard.edu	Gassaway, Brandon Mark/AAU-7548-2021	Gassaway, Brandon Mark/0000-0002-6102-2356; Pan, Joshua/0000-0002-7745-1497; Huttlin, Edward/0000-0002-1822-1173	NIH [U24 HG006673]; Biogen; Google Ventures; Third Rock Ventures	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biogen(Biogen); Google Ventures(Google Incorporated); Third Rock Ventures	We thank Marc Vidal and David Hill for ORFeome 8.1 and acknowledge the Nikon Imaging Center (Harvard Medical School) for imaging support. This work was supported by the NIH (U24 HG006673 to S.P.G., J.W.H., and E.L.H.) and Biogen (S.P.G. and J.W.H.) as well as Google Ventures and Third Rock Ventures (S.P.G., J.W.H, and E.L.H.).	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Boldt K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11491; Burmeister T, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-6; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Dana JM, 2019, NUCLEIC ACIDS RES, V47, pD482, DOI 10.1093/nar/gky1114; Dempster J.M., 2019, EXTRACTING BIOL INSI; Drew K., 2020, HU MAP 2 0 INT OV 15, DOI [10.1101/2020.09.15.298216, DOI 10.1101/2020.09.15.298216]; Drew K, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167490; Ecco G, 2017, DEVELOPMENT, V144, P2719, DOI 10.1242/dev.132605; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Erickson BK, 2019, J PROTEOME RES, V18, P1299, DOI 10.1021/acs.jproteome.8b00899; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P6070, DOI 10.1093/nar/gkw523; Franz M, 2018, NUCLEIC ACIDS RES, V46, pW60, DOI 10.1093/nar/gky311; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Giurgiu M, 2019, NUCLEIC ACIDS RES, V47, pD559, DOI 10.1093/nar/gky973; Go C. D., 2019, PROXIMITY BIOTINYLAT, DOI [10.1101/796391v1, 10.1101/796391, DOI 10.1101/796391]; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Greber BJ, 2019, ELIFE, V8, DOI 10.7554/eLife.44771; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Heusel M, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188438; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liebeskind BJ, 2016, GENOME BIOL EVOL, V8, P1812, DOI 10.1093/gbe/evw113; Luck K, 2020, NATURE, V580, P402, DOI 10.1038/s41586-020-2188-x; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Navarrete-Perea J, 2018, J PROTEOME RES, V17, P2226, DOI 10.1021/acs.jproteome.8b00217; Nusinow DP, 2020, CELL, V180, P387, DOI 10.1016/j.cell.2019.12.023; Ori A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0912-5; Orre LM, 2019, MOL CELL, V73, P166, DOI 10.1016/j.molcel.2018.11.035; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Pan J, 2018, CELL SYST, V6, P555, DOI 10.1016/j.cels.2018.04.011; Paulo JA, 2016, J AM SOC MASS SPECTR, V27, P1620, DOI 10.1007/s13361-016-1434-9; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pratt D, 2015, CELL SYST, V1, P302, DOI 10.1016/j.cels.2015.10.001; Qin Y., 2020, BIORXIV, DOI [10.1101/2020.06.21.163709, DOI 10.1101/2020.06.21.163709]; R Core Team, 2011, R LANG ENV STAT COMP; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Romanov N, 2019, CELL, V177, P1308, DOI 10.1016/j.cell.2019.03.015; Rosenberger G, 2020, CELL SYST, V11, P589, DOI 10.1016/j.cels.2020.11.006; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ryan CJ, 2017, CELL SYST, V5, P399, DOI 10.1016/j.cels.2017.09.011; Rzechorzek NJ, 2020, NUCLEIC ACIDS RES, V48, P6980, DOI 10.1093/nar/gkaa429; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sehnal D., 2018, MOLVA EUROVIS P, V18, P29; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stacey RG, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5139-2; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Takahashi K, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208769; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Topalis D, 2013, ANTIVIR RES, V97, P122, DOI 10.1016/j.antiviral.2012.11.007; Treiber T, 2017, MOL CELL, V66, P270, DOI 10.1016/j.molcel.2017.03.014; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Tzavlaki K, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030487; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wainberg M., 2019, GENOME WIDE ALMANAC, DOI [10.1101/827071, DOI 10.1101/827071]; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wang DX, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188503; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Werner A, 2015, NATURE, V525, P523, DOI 10.1038/nature14978; Wu J, 2018, CELL, V175, P1393, DOI 10.1016/j.cell.2018.10.003; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Youn JY, 2018, MOL CELL, V69, P517, DOI 10.1016/j.molcel.2017.12.020; Zhang JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6059	96	117	117	15	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					3022	+		10.1016/j.cell.2021.04.011	http://dx.doi.org/10.1016/j.cell.2021.04.011		MAY 2021	47	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	33961781	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000656965600017
J	Bodilsen, J; Nielsen, PB; Sogaard, M; Dalager-Pedersen, M; Speiser, LOZ; Yndigegn, T; Nielsen, H; Larsen, TB; Skjoth, F				Bodilsen, Jacob; Nielsen, Peter Bronnum; Sogaard, Mette; Dalager-Pedersen, Michael; Speiser, Lasse Ole Zacho; Yndigegn, Troels; Nielsen, Henrik; Larsen, Torben Bjerregaard; Skjoth, Flemming			Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYSTEM	OBJECTIVE To determine the incidence of hospital admissions and associated mortality rates for non-covid medical conditions during the covid-19 pandemic. DESIGN Nationwide, population based cohort study. SETTING Denmark from 13 March 2019 to 27 January 2021. PARTICIPANTS All Danish residents >1 year of age. MAIN OUTCOMES MEASURES Population based healthcare registries that encompass the entire Danish population were used to compare hospital admission and mortality rates during the covid-19 pandemic (from 11 March 2020 to 27 January 2021) with the prepandemic baseline data (from 13 March 2019 to 10 March 2020). Hospital admissions were categorised as covid-19 when patients were assigned a diagnosis code for covid-19 within five days of admission. All patients were followed until migration, death, or end of followup, whichever came first. Rate ratios for hospital admissions were computed using Poisson regression and were directly standardised using the Danish population on 1 January 2019 as reference. 30 day mortality rate ratios were examined by Cox regression, adjusted for age and sex, and covid-19 diagnosis was used as a competing risk. RESULTS 5 753 179 residents were identified during 567.8 million person weeks of observation, with 1 113 705 hospital admissions among 675 447 people. Compared with the prepandemic baseline period (mean hospital admission rate 204.1 per 100 000/ week), the overall hospital admission rate for noncovid-19 conditions decreased to 142.8 per 100 000/ week (rate ratio 0.70, 95% confidence interval 0.66 to 0.74) after the first national lockdown, followed by a gradual return to baseline levels until the second national lockdown when it decreased to 158.3 per 100 000/week (0.78, 0.73 to 0.82). This pattern was mirrored for most major diagnosis groups except for non-covid-19 respiratory diseases, nervous system diseases, cancer, heart failure, sepsis, and noncovid-19 respiratory infections, which remained lower throughout the study period. Overall 30 day mortality rates were higher during the first national lockdown (mortality rate ratio 1.28, 95% confidence interval 1.23 to 1.32) and the second national lockdown (1.20, 1.16 to 1.24), and these results were similar across most major diagnosis groups. For non-covid-19 respiratory diseases, cancer, pneumonia, and sepsis, the 30 day mortality rate ratios were also higher between lockdown periods. CONCLUSIONS Hospital admissions for all major non-covid-19 disease groups decreased during national lockdowns compared with the prepandemic baseline period. Additionally, mortality rates were higher overall and for patients admitted to hospital with conditions such as respiratory diseases, cancer, pneumonia, and sepsis. Increased attention towards management of serious non-covid-19 medical conditions is warranted.	[Bodilsen, Jacob; Dalager-Pedersen, Michael; Nielsen, Henrik] Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark; [Nielsen, Peter Bronnum; Sogaard, Mette; Larsen, Torben Bjerregaard; Skjoth, Flemming] Aalborg Univ, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Nielsen, Peter Bronnum; Sogaard, Mette; Larsen, Torben Bjerregaard] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Speiser, Lasse Ole Zacho] Aarhus Univ Hosp, Dept Radiol, Aarhus, Denmark; [Yndigegn, Troels] Lund Univ Hosp, Dept Cardiol, Lund, Sweden; [Nielsen, Henrik] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Skjoth, Flemming] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital; Aarhus University; Lund University; Skane University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital	Bodilsen, J (corresponding author), Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark.	jacob.bodilsen@rn.dk		Dalager-Pedersen, Michael/0000-0002-3220-2526; Bodilsen, Jacob/0000-0002-7398-814X; Nielsen, Peter Bronnum/0000-0003-2922-6970; Sogaard, Mette/0000-0002-2830-4968				Baldi E, 2020, NEW ENGL J MED, V383, P496, DOI 10.1056/NEJMc2010418; Baum A, 2020, JAMA-J AM MED ASSOC, V324, P96, DOI 10.1001/jama.2020.9972; Bhambhvani HP, 2021, JAMA INTERN MED, V181, P272, DOI 10.1001/jamainternmed.2020.3982; Bilinski A, 2020, JAMA-J AM MED ASSOC, V324, P2100, DOI 10.1001/jama.2020.20717; Blecker S, 2021, JAMA INTERN MED, V181, P269, DOI 10.1001/jamainternmed.2020.3978; Danish Board of Health, 2021, COVID 19 STAT MAN DE; De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166; De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409; DeJong C, 2021, JAMA INTERN MED, V181, P274, DOI 10.1001/jamainternmed.2020.4016; Dore B, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1711; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Garcia S, 2020, J AM COLL CARDIOL, V75, P2871, DOI 10.1016/j.jacc.2020.04.011; Kansagra AP, 2020, NEW ENGL J MED, V383, P400, DOI 10.1056/NEJMc2014816; Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0; Lai AG, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-043828; Lee LYW, 2020, LANCET, V395, P1919, DOI 10.1016/S0140-6736(20)31173-9; Mayor S, 2020, LANCET ONCOL, V21, P633, DOI 10.1016/S1470-2045(20)30240-0; Nelson B, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1544; Reilev M, 2020, INT J EPIDEMIOL, V49, P1468, DOI 10.1093/ije/dyaa140; Rinkel LA, 2021, J NEUROL, V268, P403, DOI 10.1007/s00415-020-10069-1; Rosenbaum L, 2020, NEW ENGL J MED, V382, P2368, DOI 10.1056/NEJMms2009984; Schmidt M, 2019, CLIN EPIDEMIOL, V11, P563, DOI 10.2147/CLEP.S179083; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Sokolski M, 2021, AM J MED, V134, P482, DOI 10.1016/j.amjmed.2020.08.043; Solomon MD, 2020, NEW ENGL J MED, V383, P691, DOI 10.1056/NEJMc2015630; The Danish Board of Health (Danish), 2021, GEN PRACT DENM MON A; The Danish Board of Health (Danish), 2021, COVID 19 MON AKT SUN; UK Coronavirus Canc, 2020, LANCET ONCOL, V21, P622, DOI 10.1016/S1470-2045(20)30230-8; Vestergaard LS, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.26.2001214; Weinberger DM, 2020, JAMA INTERN MED, V180, P1336, DOI 10.1001/jamainternmed.2020.3391; World Health Organization, 2020, WHO REL GUID HELP CO	32	53	54	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2021	373								n1135	10.1136/bmj.n1135	http://dx.doi.org/10.1136/bmj.n1135			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK9UC	34035000	Green Published, hybrid			2022-12-28	WOS:000656562600003
J	Biccard, BM; Miller, M; Michell, WL; Thomson, D; Ademuyiwa, A; Aniteye, E; Calligaro, G; Chaibou, MS; Dhufera, HT; Elfagieh, M; Elfiky, M; Elhadi, M; Fawzy, M; Fredericks, D; Gebre, M; Bayih, AG; Hardy, A; Joubert, I; Kifle, F; Kluyts, HL; Macleod, KDM; Mekonnen, Z; Mer, M; Morais, A; Msosa, V; Mulwafu, W; Ndonga, A; Ngumi, Z; Omigbodun, A; Owoo, C; Paruk, F; Piercy, JL; Scribante, J; Seman, Y; Taylor, EH; van Straaten, DEA; Gopalan, PD				Biccard, Bruce M.; Miller, Malcolm; Michell, William L.; Thomson, David; Ademuyiwa, Adesoji; Aniteye, Ernest; Calligaro, Greg; Chaibou, Maman Sani; Dhufera, Hailu Tamiru; Elfagieh, Mohamed; Elfiky, Mahmoud; Elhadi, Muhammed; Fawzy, Maher; Fredericks, David; Gebre, Meseret; Bayih, Abebe Genetu; Hardy, Anneli; Joubert, Ivan; Kifle, Fitsum; Kluyts, Hyla-Louise; Macleod, Kieran D. M.; Mekonnen, Zelalem; Mer, Mervyn; Morais, Atilio; Msosa, Vanessa; Mulwafu, Wakisa; Ndonga, Andrew; Ngumi, Zipporah; Omigbodun, Akinyinka; Owoo, Christian; Paruk, Fathima; Piercy, Jenna L.; Scribante, Juan; Seman, Yakob; Taylor, Elliott H.; van Straaten, Dawid E. A.; Gopalan, P. Dean		African COVID-19 Critical Care	Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study	LANCET			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; SEPSIS; SOFA	Background There have been insufficient data for African patients with COVID-19 who are critically ill. The African COVID-19 Critical Care Outcomes Study (ACCCOS) aimed to determine which resources, comorbidities, and critical care interventions are associated with mortality in this patient population. Methods The ACCCOS study was a multicentre, prospective, observational cohort study in adults (aged 18 years or older) with suspected or confirmed COVID-19 infection who were referred to intensive care or high-care units in 64 hospitals in ten African countries (ie, Egypt, Ethiopia, Ghana, Kenya, Libya, Malawi, Mozambique, Niger, Nigeria, and South Africa). The primary outcome was in-hospital mortality censored at 30 days. We studied the factors (ie, human and facility resources, patient comorbidities, and critical care interventions) that were associated with mortality in these adult patients. This study is registered on ClinicalTrials.gov, NCT04367207. Findings From May to December, 2020, 6779 patients were referred to critical care. Of these, 3752 (55.3%) patients were admitted and 3140 (83.7%) patients from 64 hospitals in ten countries participated (mean age 55.6 years; 1890 [60.6%] of 3118 participants were male). The hospitals had a median of two intensivists (IQR 1-4) and pulse oximetry was available to all patients in 49 (86%) of 57 sites. In-hospital mortality within 30 days of admission was 48.2% (95% CI 46.4-50.0; 1483 of 3077 patients). Factors that were independently associated with mortality were increasing age per year (odds ratio 1.03; 1.02-1.04); HIV/AIDS (1.91; 1.31-2.79); diabetes (1.25; 1.01-1.56); chronic liver disease (3.48; 1.48-8.18); chronic kidney disease (1.89; 1.28-2.78); delay in admission due to a shortage of resources (2.14; 1.42-3.22); quick sequential organ failure assessment score at admission ( for one factor [1.44; 1.01-2.04], for two factors [2.0; 1.33-2.99], and for three factors [3.66, 2.12-6.33]); respiratory support (high flow oxygenation [2.72; 1.46-5.08]; continuous positive airway pressure [3.93; 2.13-7.26]; invasive mechanical ventilation [15.27; 8.51-27.37]); cardiorespiratory arrest within 24 h of admission (4.43; 2.25-8.73); and vasopressor requirements (3.67; 2.77-4.86). Steroid therapy was associated with survival (0.55; 0.37-0.81). There was no difference in outcome associated with female sex (0.86; 0.69-1.06). Interpretation Mortality in critically ill patients with COVID-19 is higher in African countries than reported from studies done in Asia, Europe, North America, and South America. Increased mortality was associated with insufficient critical care resources, as well as the comorbidities of HIV/AIDS, diabetes, chronic liver disease, and kidney disease, and severity of organ dysfunction at admission. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Biccard, Bruce M.] Univ Cape Town, Groote Schuur Hosp, Dept Anaesthesia & Perioperat Med, Fac Hlth Sci, Cape Town, South Africa; [Miller, Malcolm; Thomson, David; Piercy, Jenna L.] Univ Cape Town, Groote Schuur Hosp, Div Crit Care, Dept Anaesthesia & Perioperat Med,Fac Hlth Sci, Cape Town, South Africa; [Michell, William L.] Univ Cape Town, Div Crit Care, Dept Anaesthesia & Perioperat Med, Groote Schuur Hosp, Cape Town, South Africa; [Michell, William L.] Univ Cape Town, Dept Surg, Fac Hlth Sci, Cape Town, South Africa; [Ademuyiwa, Adesoji] Univ Lagos, Dept Surg, Coll Med, Surg Paediat & Surg Epidemiol, Lagos, Nigeria; [Ademuyiwa, Adesoji] Lagos Univ Teaching Hosp, Lagos, Nigeria; [Aniteye, Ernest] Korle Bu Teaching Hosp, Accra, Ghana; [Aniteye, Ernest] Univ Ghana, Med Sch, Accra, Ghana; [Calligaro, Greg] Univ Cape Town, Div Pulmonol, Dept Med, Ctr Lung Infect & Immun, Cape Town, South Africa; [Calligaro, Greg] Univ Cape Town, UCT Lung Inst, Cape Town, South Africa; [Calligaro, Greg] Univ Cape Town, South African MRC UCT Ctr Study Antimicrobial Res, Cape Town, South Africa; [Chaibou, Maman Sani] Natl Hosp Niamey, Dept Anesthesiol Intens Care & Emergency, Niamey, Niger; [Dhufera, Hailu Tamiru] Minist Hlth, Med Serv Directorate Gen, Addis Ababa, Ethiopia; [Elfagieh, Mohamed] NCI, Misrata, Libya; [Elfiky, Mahmoud] Cairo Univ, Kasr Ainy Fac Med, Ali Ibrahim St, Cairo 11432, Egypt; [Elhadi, Muhammed] Univ Tripoli, Fac Med, Univ Rd, Tripoli 13275, Libya; [Fawzy, Maher] Cairo Univ, Anesthesia ICU & Pain Management, Fac Med, Cairo, Egypt; [Fredericks, David] Univ Cape Town, Groote Schuur Hosp, Dept Crit Care Med, Fac Hlth Sci, Cape Town, South Africa; [Gebre, Meseret; Bayih, Abebe Genetu; Macleod, Kieran D. M.] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Hardy, Anneli] Univ Cape Town, Dept Stat Sci, Fac Sci, Cape Town, South Africa; [Joubert, Ivan] Univ Cape Town, Groote Schuur Hosp, Dept Anaesthesia & Perioperat Med, Fac Hlth Sci,Crit Care,Div Crit Care, Cape Town, South Africa; [Kifle, Fitsum] Debre Berhan Univ, Debre Berhan Comprehens Specialized Hosp, Coll Med, Dept Anaesthesia, Debre Berhan, Ethiopia; [Kluyts, Hyla-Louise] Sefako Makgatho Hlth Sci Univ, Dept Anaesthesiol, Ga Rankuwa, South Africa; [Macleod, Kieran D. M.] Glasgow Royal Infirm, Glasgow, Lanark, Scotland; [Mer, Mervyn] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Div Crit Care, Dept Med, Johannesburg, South Africa; [Mer, Mervyn] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Div Pulmonol, Dept Med, Johannesburg, South Africa; [Morais, Atilio] Hosp Cent Maputo, Dept Cirurgias, Ave Eduardo Mondlane, Maputo, Mozambique; [Msosa, Vanessa] Kamuzu Cent Hosp, POB 149, Lilongwe, Malawi; [Mulwafu, Wakisa] Coll Med, Private Bag 360, Blantyre, Malawi; [Ndonga, Andrew] Mater Misericordiae Univ Hosp, Nairobi, Kenya; [Ngumi, Zipporah] Univ Nairobi, Dept Anaesthesia, Sch Med, Nairobi, Kenya; [Omigbodun, Akinyinka] Univ Ibadan, Coll Med, Obstet & Gynaecol, Ibadan, Nigeria; [Owoo, Christian] Univ Ghana, Korle Bu Teaching Hosp, Med Sch, Accra, Ghana; [Owoo, Christian] Univ Ghana, Med Ctr, Accra, Ghana; [Paruk, Fathima] Univ Pretoria, Steve Biko Acad Hosp, Dept Crit Care, Fac Hlth Sci, Pretoria, South Africa; [Scribante, Juan] Univ Witwatersrand, Sch Clin Med, Dept Anaesthesiol, Fac Hlth Sci, Johannesburg, South Africa; [Seman, Yakob] Med Serv, Minist Hlth, Addis Ababa, Ethiopia; [Taylor, Elliott H.] Univ Oxford, Oxford Univ Global Surg Grp, Nuffield Dept Surg Sci, Oxford, England; [Taylor, Elliott H.] Univ Cape Town, Global Surg Div, Dept Surg, Cape Town, South Africa; [van Straaten, Dawid E. A.] Safe Surg South Africa NPC, 5 14th St, ZA-2193 Parkhurst, Gauteng, South Africa; [Gopalan, P. Dean] Univ KwaZulu Natal, Sch Clin Med, Anaesthesiol Crit Care, Durban, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Lagos; University of Ghana; University of Cape Town; University of Cape Town; University of Cape Town; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; University of Cape Town; University of Cape Town; University of Cape Town; Sefako Makgatho Health Sciences University; University of Glasgow; University of Witwatersrand; University of Witwatersrand; University of Malawi; University of Nairobi; University of Ibadan; University of Ghana; University of Ghana; University of Pretoria; University of Witwatersrand; University of Oxford; University of Cape Town; University of Kwazulu Natal	Biccard, BM (corresponding author), Univ Cape Town, Dept Anaesthesia & Perioperat Med, ZA-7925 Cape Town, South Africa.; Biccard, BM (corresponding author), Groote Schuur Hosp, Dept Anaesthesia & Perioperat Med, ZA-7935 Cape Town, South Africa.	bruce.biccard@uct.ac.za	Azzam, Ahmed Y./ABB-1522-2020; Thomson, David/AAQ-9471-2021; Gamal, Mahmoud/AAE-8872-2022; Alhadi, Abdulmueti/ABD-1650-2020; Dhufera, Hailu Tamiru/AAY-4102-2021; Paruk, Fathima/AAO-1864-2021; Alhadi, Abdulmueti/ABG-3342-2020; Sayed, Islam/ABA-5823-2021; Miller, Malcolm/AAR-5783-2021; Elfiky, Mahmoud/B-1569-2015; Tawheed, Ahmed/ABA-4816-2020; Awad, Ahmed/AAE-1778-2021; Elhadi, Muhammed/AAU-5641-2020; Owoo, Christian/ABD-3254-2021; Ibrahim, Sanusi Mohammed/AAE-6044-2022; Elmehrath, Ahmed O./B-5557-2019; El-Kassas, Mohamed/F-8306-2019	Azzam, Ahmed Y./0000-0002-4256-0159; Thomson, David/0000-0003-2433-3611; Gamal, Mahmoud/0000-0003-0704-4228; Alhadi, Abdulmueti/0000-0002-6335-1057; Dhufera, Hailu Tamiru/0000-0002-5697-140X; Paruk, Fathima/0000-0002-6549-0106; Sayed, Islam/0000-0003-0844-4215; Miller, Malcolm/0000-0001-6137-7723; Elfiky, Mahmoud/0000-0003-1820-8603; Tawheed, Ahmed/0000-0002-9382-8733; Awad, Ahmed/0000-0001-6647-1866; Elhadi, Muhammed/0000-0001-6406-4212; Owoo, Christian/0000-0003-2279-1432; Ibrahim, Sanusi Mohammed/0000-0003-2937-3452; Ghozy, Sherief/0000-0001-5629-3023; Kifle Belachew, Fitsum/0000-0002-1849-9415; Omigbodun, Akinyinka/0000-0002-6377-9299; Gebremedhin, Yemane/0000-0001-7134-5856; Bouhuwaish, Ahmad/0000-0001-7182-1277; Kluyts, Hyla-Louise/0000-0002-9917-1330; Smith, Michelle Terry Dolores/0000-0002-6954-153X; Rheeder, Paul/0000-0002-1573-4985; Abdelgalil, Mahmoud Shaban/0000-0002-7325-0129; Abdelwahab, Omar Ahmed/0000-0001-8266-0245; Elmehrath, Ahmed O./0000-0002-2943-4975; , Mahmoud/0000-0002-4779-4632; Yesuf, Elias Ali/0000-0003-0281-5564; El-Kassas, Mohamed/0000-0002-3396-6894; Calligaro, Gregory/0000-0001-7324-0775; Scribante, Juan/0000-0002-2221-5024	Critical Care Society of Southern Africa	Critical Care Society of Southern Africa	The ACCCOS was partially supported by a grant from the Critical Care Society of Southern Africa.	Armstrong RA, 2020, ANAESTHESIA, V75, P1340, DOI 10.1111/anae.15201; Ayebale ET, 2020, SOUTH AFR J ANAESTH, V26, P162, DOI 10.36303/SAJAA.2020.26.3.2431; Barbaro RP, 2020, LANCET, V396, P1071, DOI 10.1016/S0140-6736(20)32008-0; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Biccard BM, 2020, AFRICAN MULTICENTRE; Biccard BM, 2018, LANCET, V391, P1589, DOI [10.1016/S0140-6736(18)30001-1, 10.1016/s0140-6736(18)30001-1]; Biswas M, 2021, INTERVIROLOGY, V64, P36, DOI 10.1159/000512592; Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385; Conradie A, 2018, BRIT J ANAESTH, V121, P813, DOI 10.1016/j.bja.2018.06.013; Costenaro P, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2155; Gupta M, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00159-y; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4; Liu SJ, 2020, AM J EMERG MED, V38, P2074, DOI 10.1016/j.ajem.2020.07.019; Nguyen YL, 2015, CHEST, V148, P79, DOI 10.1378/chest.14-2195; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; R Development Core Team, 2009, R LANG ENV STAT COMP; Ritchie H, 2020, MORTALITY RISK COVID; Rubin DB, 1987, MULTIPLE IMPUTATION; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Skinner DL, 2017, SAMJ S AFR MED J, V107, P411, DOI [10.7196/SAMJ.2017.v107i5.11455, 10.7196/samj.2017.v107i5.11455]; Starke KR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165974; Taylor EH, 2020, SOUTH AFR J ANAESTH, V26, P116, DOI 10.36303/SAJAA.2020.26.3.2428; Tzotzos SJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03240-7; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	28	54	54	10	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1885	1894						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF1XN	34022988	Green Published, Bronze			2022-12-28	WOS:000652556000024
J	Jani, AB; Schreibmann, E; Goyal, S; Halkar, R; Hershatter, B; Rossi, PJ; Shelton, JW; Patel, PR; Xu, KM; Goodman, M; Master, VA; Joshi, SS; Kucuk, O; Carthon, BC; Bilen, MA; Abiodun-Ojo, OA; Akintayo, AA; Dhere, VR; Schuster, DM				Jani, Ashesh B.; Schreibmann, Eduard; Goyal, Subir; Halkar, Raghuveer; Hershatter, Bruce; Rossi, Peter J.; Shelton, Joseph W.; Patel, Pretesh R.; Xu, Karen M.; Goodman, Mark; Master, Viraj A.; Joshi, Shreyas S.; Kucuk, Omer; Carthon, Bradley C.; Bilen, Mehmet A.; Abiodun-Ojo, Olayinka A.; Akintayo, Akinyemi A.; Dhere, Vishal R.; Schuster, David M.			F-18-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial	LANCET			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RADICAL PROSTATECTOMY; ADJUVANT RADIOTHERAPY; INITIAL FINDINGS; TARGET VOLUME; RADIATION; THERAPY; DEFINITION; RECURRENCE; IMPACT	Background Molecular imaging is increasingly used to guide treatment decisions and planning in prostate cancer. We aimed to evaluate the role of F-18-fluciclovine-PET/CT in improving cancer control compared with conventional imaging (bone scan and either CT or MRI) alone for salvage postprostatectomy radiotherapy. Methods In EMPIRE-1, a single-centre, open-label, phase 2/3 randomised controlled trial, patients with prostate cancer with detectable PSA after prostatectomy and negative conventional imaging (no extrapelvic or bone findings) were randomly assigned in a 1:1 ratio to radiotherapy directed by conventional imaging alone or to conventional imaging plus F-18-fluciclovine-PET/CT. Computer-generated randomisation was stratified by PSA concentration, adverse pathology indicators, and androgen deprivation therapy intent. In the F-18-fluciclovine-PET/CT group, radiotherapy decisions were rigidly determined by PET findings, which were also used for target delineation. The primary endpoint was 3 year event-free survival, with events defined as biochemical or clinical recurrence or progression, or initiation of systemic therapy, using univariate and multivariable analyses in patients who received radiotherapy. This trial is registered with ClinicalTrials.gov, NCT01666808 and is closed to new participants. Findings From Sept 18, 2012, to March 4, 2019, 165 patients were randomly assigned, with median follow-up of 3.52 years (95% CI 2.98-3.95). PET findings resulted in four patients in the F-18-fluciclovine-PET/CT group having radiotherapy aborted; these patients were excluded from survival analyses. Median survival was not reached (95% CI 35.2-not reached; 33% of 81 patients had events) in the conventional imaging group compared with not reached (95% CI not reached-not reached; 20% of 76 patients) in the F-18-fluciclovine-PET/CT group, and 3 year event-free survival was 63.0% (95% CI 49.2-74.0) in the conventional imaging group versus 75.5% (95% CI 62.5-84.6) for F-18-fluciclovine-PET/CT (difference 12.5; 95% CI 4.3-20.8; p=0.0028). In adjusted analyses, study group (hazard ratio 2.04 [95% CI 1.06-3.93], p=0.0327) was significantly associated with event-free survival. Toxicity was similar in both study groups, with the most common adverse events being late urinary frequency or urgency (37 [46%] of 81 patients in the conventional imaging group and 31 [41%] of 76 in the PET group), and acute diarrhoea (11 [14%] in the conventional imaging group and 16 [21%] in the PET group). Interpretation Inclusion of F-18-fluciclovine-PET into postprostatectomy radiotherapy decision making and planning significantly improved survival free from biochemical recurrence or persistence. Integration of novel PET radiotracers into radiotherapy decisions and planning for prostate cancer patients warrants further study.	[Jani, Ashesh B.; Schreibmann, Eduard; Hershatter, Bruce; Rossi, Peter J.; Shelton, Joseph W.; Patel, Pretesh R.; Xu, Karen M.; Dhere, Vishal R.] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Goyal, Subir] Emory Univ, Biostat Shared Resource, Winship Canc Inst, Atlanta, GA 30322 USA; [Kucuk, Omer; Carthon, Bradley C.; Bilen, Mehmet A.] Emory Univ, Dept Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Halkar, Raghuveer; Goodman, Mark; Abiodun-Ojo, Olayinka A.; Akintayo, Akinyemi A.; Schuster, David M.] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Master, Viraj A.; Joshi, Shreyas S.] Emory Univ, Dept Urol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University	Jani, AB (corresponding author), Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA.	abjani@emory.edu	Akintayo, Akinyemi/AGO-5887-2022; Abiodun-Ojo, Olayinka/GMW-7572-2022; Abiodun-Ojo, Olayinka/ABB-6698-2021	Akintayo, Akinyemi/0000-0002-6864-350X; Abiodun-Ojo, Olayinka/0000-0003-1811-0155; 	National Institutes of Health/National Cancer Institute; Winship Cancer Institute of Emory University; Blue Earth Diagnostics	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Winship Cancer Institute of Emory University; Blue Earth Diagnostics	National Institutes of Health/National Cancer Institute, Blue Earth Diagnostics, and Winship Cancer Institute of Emory University.	Abiodun-Ojo OA, 2021, J NUCL MED, V62, P1089, DOI 10.2967/jnumed.120.256784; Akin-Akintayo O, 2018, EUR J RADIOL, V102, P1, DOI 10.1016/j.ejrad.2018.02.006; Andriole GL, 2019, J UROLOGY, V201, P322, DOI 10.1016/j.juro.2018.08.050; Bolla M, 2012, LANCET, V380, P2018, DOI 10.1016/S0140-6736(12)61253-7; Calais J, 2019, LANCET ONCOL, V20, P1286, DOI 10.1016/S1470-2045(19)30415-2; Carrie C, 2019, LANCET ONCOL, V20, P1740, DOI 10.1016/S1470-2045(19)30486-3; Emmett L, 2020, J NUCL MED, V61, P866, DOI 10.2967/jnumed.119.235028; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Jani AB, 2003, LANCET, V361, P1045, DOI 10.1016/S0140-6736(03)12833-4; Jani AB, 2017, J NUCL MED, V58, P412, DOI 10.2967/jnumed.116.176057; Kane CJ, 2003, UROLOGY, V61, P607, DOI 10.1016/S0090-4295(02)02411-1; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Kneebone A, 2020, LANCET ONCOL, V21, P1331, DOI 10.1016/S1470-2045(20)30456-3; Mason BR, 2019, J NATL COMPR CANC NE, V17, P506, DOI 10.6004/jnccn.2019.7306; Michalski JM, 2010, INT J RADIAT ONCOL, V76, P361, DOI 10.1016/j.ijrobp.2009.02.006; Odewole OA, 2016, EUR J NUCL MED MOL I, V43, P1773, DOI 10.1007/s00259-016-3383-8; Parker CC, 2020, LANCET, V396, P1413, DOI 10.1016/S0140-6736(20)31553-1; Pernthaler B, 2019, CLIN NUCL MED, V44, pE566, DOI 10.1097/RLU.0000000000002703; Pollack A, 2018, AM SOC RAD ONC ASTR; Sargos P, 2020, LANCET ONCOL, V21, P1341, DOI 10.1016/S1470-2045(20)30454-X; Scarsbrook AF, 2020, INT J RADIAT ONCOL, V107, P316, DOI 10.1016/j.ijrobp.2020.01.050; Hegemann NSS, 2020, CANCERS, V12, DOI 10.3390/cancers12113395; Schreibmann E, 2016, INT J RADIAT ONCOL, V96, P206, DOI 10.1016/j.ijrobp.2016.04.023; Schuster DM, 2014, J UROLOGY, V191, P1446, DOI 10.1016/j.juro.2013.10.065; Shipley WU, 2017, NEW ENGL J MED, V376, P417, DOI 10.1056/NEJMoa1607529; Swanson GP, 2008, J UROLOGY, V180, P2453, DOI 10.1016/j.juro.2008.08.037; Tendulkar RD, 2016, J CLIN ONCOL, V34, P3648, DOI 10.1200/JCO.2016.67.9647; Vale CL, 2020, LANCET, V396, P1422, DOI 10.1016/S0140-6736(20)31952-8; Wiegel T, 2014, EUR UROL, V66, P243, DOI 10.1016/j.eururo.2014.03.011	30	42	42	2	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1895	1904						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF1XN	33971152	Green Accepted			2022-12-28	WOS:000652556000025
J	Fan, QT; Yan, LH; Tripp, MW; Krejci, O; Dimosthenous, S; Kachel, SR; Chen, MY; Foster, AS; Koert, U; Liljeroth, P; Gottfried, JM				Fan, Qitang; Yan, Linghao; Tripp, Matthias W.; Krejci, Ondrej; Dimosthenous, Stavrina; Kachel, Stefan R.; Chen, Mengyi; Foster, Adam S.; Koert, Ulrich; Liljeroth, Peter; Gottfried, J. Michael			Biphenylene network: A nonbenzenoid carbon allotrope	SCIENCE			English	Article							ON-SURFACE SYNTHESIS; ARMCHAIR GRAPHENE NANORIBBONS; NANOGRAPHENES; PLANAR	The quest for planar sp(2)-hybridized carbon allotropes other than graphene, such as graphenylene and biphenylene networks, has stimulated substantial research efforts because of the materials' predicted mechanical, electronic, and transport properties. However, their syntheses remain challenging given the lack of reliable protocols for generating nonhexagonal rings during the in-plane tiling of carbon atoms. We report the bottom-up growth of an ultraflat biphenylene network with periodically arranged four-, six-, and eight-membered rings of sp(2)-hybridized carbon atoms through an on-surface interpolymer dehydrofluorination (HF-zipping) reaction. The characterization of this biphenylene network by scanning probe methods reveals that it is metallic rather than a dielectric. We expect the interpolymer HF-zipping method to complement the toolbox for the synthesis of other nonbenzenoid carbon allotropes.	[Fan, Qitang; Tripp, Matthias W.; Kachel, Stefan R.; Chen, Mengyi; Koert, Ulrich; Gottfried, J. Michael] Philipps Univ Marburg, Dept Chem, D-35032 Marburg, Germany; [Yan, Linghao; Krejci, Ondrej; Dimosthenous, Stavrina; Foster, Adam S.; Liljeroth, Peter] Aalto Univ, Dept Appl Phys, FI-00076 Aalto, Finland; [Foster, Adam S.] Kanazawa Univ, Nano Life Sci Inst WPI NanoLSI, Kakumamachi, Kanazawa, Ishikawa 9204192, Japan	Philipps University Marburg; Aalto University; Kanazawa University	Gottfried, JM (corresponding author), Philipps Univ Marburg, Dept Chem, D-35032 Marburg, Germany.; Liljeroth, P (corresponding author), Aalto Univ, Dept Appl Phys, FI-00076 Aalto, Finland.	peter.liljeroth@aalto.fi; michael.gotttried@chemie.uni-marburg.de	Yan, Linghao/S-8584-2017; Foster, Adam/E-1275-2012; Krejčí, Ondřej/G-5918-2014; Gottfried, Michael/ABB-1089-2021; Liljeroth, Peter/A-5594-2009; Fan, Qitang/G-8205-2015	Yan, Linghao/0000-0002-4860-8096; Foster, Adam/0000-0001-5371-5905; Krejčí, Ondřej/0000-0002-4948-4312; Liljeroth, Peter/0000-0003-1253-8097; Fan, Qitang/0000-0002-2629-6212; Dimosthenous, Stavrina/0000-0002-6199-5094; Kachel, Stefan Renato/0000-0003-0323-2440	Deutsche Forschungsgemeinschaft [223848855-SFB1083, GO1812/2-1]; State of Hessen (LOEWE Focus Group PriOSS); European Research Council (ERC-2017-AdG) [788185]; Academy of Finland [318995, 320555, 311012, 314882]; Alexander von Humboldt Foundation; European Union [839242, 845060]; World Premier International Research Center Initiative (WPI), MEXT, Japan	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); State of Hessen (LOEWE Focus Group PriOSS); European Research Council (ERC-2017-AdG); Academy of Finland(Academy of Finland); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Union(European Commission); World Premier International Research Center Initiative (WPI), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the Deutsche Forschungsgemeinschaft through projects 223848855-SFB1083 and GO1812/2-1; the State of Hessen (LOEWE Focus Group PriOSS); the European Research Council (ERC-2017-AdG no. 788185); the Academy of Finland (Academy professor funding nos. 318995 and 320555 and project nos. 311012 and 314882); an Alexander von Humboldt Foundation research fellowship for postdoctoral researchers (Q.F.); the European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie Actions Individual Fellowship nos. 839242 and 845060) (L.Y. and O.K.); and the World Premier International Research Center Initiative (WPI), MEXT, Japan (A.S.F.).	Amsharov KY, 2012, J ORG CHEM, V77, P5445, DOI 10.1021/jo300783y; BALABAN AT, 1989, COMPUT MATH APPL, V17, P397, DOI 10.1016/0898-1221(89)90170-3; BALABAN AT, 1968, REV ROUM CHIM, V13, P231; Basagni A, 2015, J AM CHEM SOC, V137, P1802, DOI 10.1021/ja510292b; Bitzek E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170201; Blum V, 2009, COMPUT PHYS COMMUN, V180, P2175, DOI 10.1016/j.cpc.2009.06.022; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Chen M, 2014, J PHYS CHEM C, V118, P6820, DOI 10.1021/jp4121468; Chen ZP, 2020, ADV MATER, V32, DOI 10.1002/adma.202001893; Clair S, 2019, CHEM REV, V119, P4717, DOI 10.1021/acs.chemrev.8b00601; Crespi VH, 1996, PHYS REV B, V53, P13303, DOI 10.1103/PhysRevB.53.R13303; de la Torre B, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.166001; Deniz O, 2017, NANO LETT, V17, P2197, DOI 10.1021/acs.nanolett.6b04727; Fan Q, 2019, J AM CHEM SOC, V141, P17713, DOI 10.1021/jacs.9b08060; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Han D, 2020, J PHYS CHEM C, V124, P5248, DOI 10.1021/acs.jpcc.0c00018; Hapala P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.226101; Hapala P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085421; Heyd J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2204597; Hieulle J, 2018, NANO LETT, V18, P418, DOI 10.1021/acs.nanolett.7b04309; Hirsch A, 2010, NAT MATER, V9, P868, DOI 10.1038/nmat2885; Hou ICY, 2020, J AM CHEM SOC, V142, P10291, DOI 10.1021/jacs.0c03635; Hudspeth MA, 2010, ACS NANO, V4, P4565, DOI 10.1021/nn100758h; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kaiser K, 2019, SCIENCE, V365, P1299, DOI 10.1126/science.aay1914; Karaush NN, 2014, CHEM PHYS LETT, V612, P229, DOI 10.1016/j.cplett.2014.08.025; Klein BP, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.011030; Kolmer M, 2019, SCIENCE, V363, P57, DOI 10.1126/science.aav4954; Kolmer M, 2020, SCIENCE, V369, P571, DOI 10.1126/science.abb8880; Krejci O, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.045407; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Lherbier A., 2018, PHYS REV MATER, V2; Liu JZ, 2019, J AM CHEM SOC, V141, P12011, DOI 10.1021/jacs.9b04718; Liu MZ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15646; Maiti B, 2019, J MATER CHEM C, V7, P3881, DOI 10.1039/c8tc06517a; Merino-Diez N, 2017, ACS NANO, V11, P11661, DOI 10.1021/acsnano.7b06765; Mishra S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04144-5; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Rizzo DJ, 2018, NATURE, V560, P204, DOI 10.1038/s41586-018-0376-8; Ruffieux P, 2016, NATURE, V531, P489, DOI 10.1038/nature17151; Sanchez-Sanchez C, 2019, CHEM-EUR J, V25, P12074, DOI 10.1002/chem.201901410; Schlutter F, 2014, ANGEW CHEM INT EDIT, V53, P1538, DOI 10.1002/anie.201309324; Steiner AK, 2017, ANGEW CHEM INT EDIT, V56, P14732, DOI 10.1002/anie.201707272; Tyutyulkov N, 1997, CHEM PHYS LETT, V272, P111, DOI 10.1016/S0009-2614(97)00465-X; Urgel JI, 2020, ANGEW CHEM INT EDIT, V59, P13281, DOI 10.1002/anie.202001939; Wang SY, 2017, NANO LETT, V17, P4277, DOI 10.1021/acs.nanolett.7b01244; Wang WH, 2011, J AM CHEM SOC, V133, P13264, DOI 10.1021/ja204956b; Wang ZH, 2015, NANO LETT, V15, P6182, DOI 10.1021/acs.nanolett.5b02512; Xu T, 2018, WOODH PUB SER ELECT, P137, DOI 10.1016/B978-0-08-102053-1.00005-3	50	115	115	50	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					852	+		10.1126/science.abg4509	http://dx.doi.org/10.1126/science.abg4509			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016779	Green Accepted			2022-12-28	WOS:000653997000045
J	Rimmer, A				Rimmer, Abi			Covid-19: Offer staff military-style mental health support, say healthcare leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Greenberg N, 2021, OCCUP MED-OXFORD, V71, P62, DOI 10.1093/occmed/kqaa220	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2021	373								n1292	10.1136/bmj.n1292	http://dx.doi.org/10.1136/bmj.n1292			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ5TH	34016604	Bronze			2022-12-28	WOS:000655596600007
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on... calorie labelling	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2021, MED CAL LAB OUT OF H; Department of Health and Social Care, 2021, CAL LAB MEN BE INTR	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2021	373								n1255	10.1136/bmj.n1255	http://dx.doi.org/10.1136/bmj.n1255			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9HX	33990352				2022-12-28	WOS:000653058600004
J	Morawska, L; Allen, J; Bahnfleth, W; Bluyssen, PM; Boerstra, A; Buonanno, G; Cao, JJ; Dancer, SJ; Floto, A; Franchimon, F; Greenhalgh, T; Haworth, C; Hogeling, J; Isaxon, C; Jimenez, JL; Kurnitski, J; Li, YG; Loomans, M; Marks, G; Marr, LC; Mazzarella, L; Melikov, AK; Miller, S; Milton, DK; Nazaroff, W; Nielsen, PV; Noakes, C; Peccia, J; Prather, K; Querol, X; Sekhar, C; Seppanen, O; Tanabe, S; Tang, JW; Tellier, R; Tham, KW; Wargocki, P; Wierzbicka, A; Yao, MS				Morawska, Lidia; Allen, Joseph; Bahnfleth, William; Bluyssen, Philomena M.; Boerstra, Atze; Buonanno, Giorgio; Cao, Junji; Dancer, Stephanie J.; Floto, Andres; Franchimon, Francesco; Greenhalgh, Trisha; Haworth, Charles; Hogeling, Jaap; Isaxon, Christina; Jimenez, Jose L.; Kurnitski, Jarek; Li, Yuguo; Loomans, Marcel; Marks, Guy; Marr, Linsey C.; Mazzarella, Livio; Melikov, Arsen Krikor; Miller, Shelly; Milton, Donald K.; Nazaroff, William; Nielsen, Peter V.; Noakes, Catherine; Peccia, Jordan; Prather, Kim; Querol, Xavier; Sekhar, Chandra; Seppanen, Olli; Tanabe, Shin-ichi; Tang, Julian W.; Tellier, Raymond; Tham, Kwok Wai; Wargocki, Pawel; Wierzbicka, Aneta; Yao, Maosheng			A paradigm shift to combat indoor respiratory infection Building ventilation systems must get much better	SCIENCE			English	Editorial Material							HEALTH		[Morawska, Lidia] Queensland Univ Technol, Int Lab Air Qual & Heath, Brisbane, Qld, Australia; [Morawska, Lidia] Univ Surrey, Fac Engn & Phys Sci, Dept Civil & Environm Engn, Global Ctr Clean Air Res GCARE, Guildford GU2 7XH, Surrey, England; [Allen, Joseph] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Cambridge, MA USA; [Bahnfleth, William] Penn State Univ, Dept Architectural Engn, University Pk, PA 16802 USA; [Bluyssen, Philomena M.] Delft Univ Technol, Fac Architecture & Built Environm, Delft, Netherlands; [Boerstra, Atze] REHVA Federat European Heating Ventilat & Air Con, New Delhi, India; [Boerstra, Atze] BBA Binnenmilieu, The Hague, Netherlands; [Boerstra, Atze] Delft Univ Technol, Delft, Netherlands; [Buonanno, Giorgio] Univ Cassino & Southern Lazio, Dept Civil & Mech Engn, Cassino, Italy; [Cao, Junji] Chinese Acad Sci, Inst Atmospher Phys, Beijing, Peoples R China; [Dancer, Stephanie J.] Edinburgh Napier Univ, Edinburgh, Midlothian, Scotland; [Dancer, Stephanie J.] NHS Lanarkshire, Bothwell, Scotland; [Floto, Andres] Univ Cambridge, Dept Med, Cambridge, England; [Franchimon, Francesco] Franchimon ICM, South Holland, Netherlands; [Greenhalgh, Trisha] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Haworth, Charles] Univ Cambridge, Royal Papworth Hosp, Cambridge Ctr Lung Infect, Cambridge, England; [Haworth, Charles] Univ Cambridge, Dept Med, Cambridge, England; [Hogeling, Jaap] ISSO Int Project, Int Stand ISSO, Rotterdam, Netherlands; [Isaxon, Christina; Wierzbicka, Aneta] Lund Univ, Ergon & Aerosol Technol, Lund, Sweden; [Jimenez, Jose L.] Univ Colorado, Dept Chem, Boulder, CO 80309 USA; [Jimenez, Jose L.] Univ Colorado, Cooperat Inst Res Environm Sci CIRES, Boulder, CO 80309 USA; [Kurnitski, Jarek] Tallinn Univ Technol, REHVA Technol & Res Comm, Tallinn, Estonia; [Li, Yuguo] Univ Hong Kong, Dept Mech Engn, Pokfulam, Hong Kong, Peoples R China; [Loomans, Marcel] Eindhoven Univ Technol TUe, Dept Built Environm, Eindhoven, Netherlands; [Marks, Guy] Univ New South Wales UNSW, Ctr Air Qual Res & Evaluat CAR, Sydney, NSW, Australia; [Marr, Linsey C.] Virginia Tech, Civil & Environm Engn, Blacksburg, VA USA; [Mazzarella, Livio] Politecn Milan, AiCARR, Milan, Italy; [Melikov, Arsen Krikor; Wargocki, Pawel] Tech Univ Denmark, Dept Civil Engn, Int Ctr Indoor Environm & Energy, Lyngby, Denmark; [Miller, Shelly] Univ Colorado, Mech Engn, Boulder, CO 80309 USA; [Milton, Donald K.] Univ Maryland, Sch Publ Hlth, Environm Hlth, College Pk, MD 20742 USA; [Nazaroff, William] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Nielsen, Peter V.] Aalborg Univ, Dept Civil Engn, Fac Sci & Engn, Aalborg, Denmark; [Noakes, Catherine] Univ Leeds, Sch Civil Engn, Leeds, W Yorkshire, England; [Peccia, Jordan] Yale Univ, Environm Engn, New Haven, CT 06520 USA; [Prather, Kim] Univ Calif San Diego, NSF Ctr Aerosol Impacts Chem Environm CAICE, San Diego, CA USA; [Querol, Xavier] Spanish Natl Res Council, Dept Geosci, Inst Environm Assessment & Water Res, Barcelona, Spain; [Sekhar, Chandra] Natl Univ Singapore, Dept Bldg, Singapore, Singapore; [Seppanen, Olli] Aalto Univ, Espoo, Finland; [Tanabe, Shin-ichi] Waseda Univ, Dept Architecture, Tokyo, Japan; [Tang, Julian W.] Univ Leicester, Resp Sci, Leicester, Leics, England; [Tellier, Raymond] McGill Univ, Dept Med, Montreal, PQ, Canada; [Tellier, Raymond] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Tham, Kwok Wai] Natl Univ Singapore, Dept Bldg, Singapore, Singapore; [Yao, Maosheng] Peking Univ, Coll Environm Sci & Engn, Beijing, Peoples R China	Queensland University of Technology (QUT); University of Surrey; Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Delft University of Technology; Delft University of Technology; University of Cassino; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Edinburgh Napier University; University of Cambridge; University of Oxford; Papworth Hospital; University of Cambridge; University of Cambridge; Lund University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Tallinn University of Technology; University of Hong Kong; Eindhoven University of Technology; University of New South Wales Sydney; Virginia Polytechnic Institute & State University; Polytechnic University of Milan; Technical University of Denmark; University of Colorado System; University of Colorado Boulder; University System of Maryland; University of Maryland College Park; University of California System; University of California Berkeley; Aalborg University; University of Leeds; Yale University; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); National University of Singapore; Aalto University; Waseda University; University of Leicester; McGill University; University of Calgary; National University of Singapore; Peking University	Morawska, L (corresponding author), Queensland Univ Technol, Int Lab Air Qual & Heath, Brisbane, Qld, Australia.; Morawska, L (corresponding author), Univ Surrey, Fac Engn & Phys Sci, Dept Civil & Environm Engn, Global Ctr Clean Air Res GCARE, Guildford GU2 7XH, Surrey, England.	l.morawska@qut.edu	Nazaroff, William W/C-4106-2008; Junji, Cao/D-3259-2014; Boerstra, Atze/GLV-4759-2022; Jimenez, Jose L/A-5294-2008; Greenhalgh, Trisha/B-1825-2015; Querol, Xavier/E-2800-2014; Marks, Guy B./F-5058-2013; Wierzbicka, Aneta/AAD-1860-2019; Tanabe, Shin-ichi/A-2041-2011; Prather, Kim/A-3892-2008; Wargocki, Pawel/AAZ-9496-2021; Morawska, Lidia/B-4140-2011; Tham, Kwok Wai/B-6541-2009; Sekhar, Chandra/F-3253-2017	Nazaroff, William W/0000-0001-5645-3357; Junji, Cao/0000-0003-1000-7241; Boerstra, Atze/0000-0002-4887-4343; Jimenez, Jose L/0000-0001-6203-1847; Greenhalgh, Trisha/0000-0003-2369-8088; Querol, Xavier/0000-0002-6549-9899; Marks, Guy B./0000-0002-8976-8053; Wierzbicka, Aneta/0000-0002-0678-7161; Tanabe, Shin-ichi/0000-0002-2947-1645; Prather, Kim/0000-0003-3048-9890; Wargocki, Pawel/0000-0003-3865-3560; Morawska, Lidia/0000-0002-0594-9683; Bahnfleth, William/0000-0001-5749-6543; Melikov, Arsen Krikor/0000-0003-0200-6046; Tham, Kwok Wai/0000-0002-2957-1152; Sekhar, Chandra/0000-0002-0814-8662				American National Standards Institute; American Society of Heating Refrigerating and Air-Conditioning Engineers; American Society for Health Care Engineering, 2021, 1702021 ANSIASHRAEAS; Buonanno G, 2020, ENVIRON INT, V145, DOI 10.1016/j.envint.2020.106112; Castillo JC, 2021, SCIENCE, V371, P1107, DOI 10.1126/science.abg0889; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Fisk WJ, 1997, INDOOR AIR, V7, P158, DOI 10.1111/j.1600-0668.1997.t01-1-00002.x; Greenhalgh T, 2021, LANCET, V397, P1603, DOI 10.1016/S0140-6736(21)00869-2; Lee K, 2009, GLOB INST, P1; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832; Putri WCWS, 2018, VACCINE, V36, P3960, DOI 10.1016/j.vaccine.2018.05.057; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Wargocki P., 2016, REHVA GUIDEBOOK; Watanabe T, 2012, RISK ANAL, V32, P555, DOI 10.1111/j.1539-6924.2011.01680.x; World Health Organization, 2010, GUID IND AIR QUAL SE	14	93	94	17	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					689	+		10.1126/science.abg2025	http://dx.doi.org/10.1126/science.abg2025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SD1KE	33986171	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000651125300031
J	Yue, T; Zhan, XM; Zhang, DW; Jain, RC; Wang, KW; Choi, JH; Misawa, T; Su, LJ; Quan, JX; Hildebrand, S; Xu, DR; Li, XH; Turer, E; Sun, L; Moresco, EMY; Beutler, B				Yue, Tao; Zhan, Xiaoming; Zhang, Duanwu; Jain, Ruchi; Wang, Kuan-Wen; Choi, Jin Huk; Misawa, Takuma; Su, Lijing; Quan, Jiexia; Hildebrand, Sara; Xu, Darui; Li, Xiaohong; Turer, Emre; Sun, Lei; Moresco, Eva Marie Y.; Beutler, Bruce			SLFN2 protection of tRNAs from stress-induced cleavage is essential for T cell-mediated immunity	SCIENCE			English	Article							ANGIOGENIN; ACTIVATION; PROTEIN; GENE; GROWTH; DIFFERENTIATION; INTERLEUKIN-2; PROLIFERATION; RIBONUCLEASE; TRANSLATION	Reactive oxygen species (ROS) increase in activated T cells because of metabolic activity induced to support T cell proliferation and differentiation. We show that these ROS trigger an oxidative stress response that leads to translation repression. This response is countered by Schlafen 2 (SLFN2), which directly binds transfer RNAs (tRNAs) to protect them from cleavage by the ribonuclease angiogenin. T cell-specific SLFN2 deficiency results in the accumulation of tRNA fragments, which inhibit translation and promote stress-granule formation. Interleukin-2 receptor beta (IL-2R beta) and IL-2R gamma fail to be translationally up-regulated after T cell receptor stimulation, rendering SLFN2-deficient T cells insensitive to interleukin-2's mitogenic effects. SLFN2 confers resistance against the ROS-mediated translation-inhibitory effects of oxidative stress normally induced by T cell activation, permitting the robust protein synthesis necessary for T cell expansion and immunity.	[Yue, Tao; Zhan, Xiaoming; Zhang, Duanwu; Jain, Ruchi; Wang, Kuan-Wen; Choi, Jin Huk; Misawa, Takuma; Su, Lijing; Quan, Jiexia; Hildebrand, Sara; Xu, Darui; Li, Xiaohong; Turer, Emre; Sun, Lei; Moresco, Eva Marie Y.; Beutler, Bruce] Univ Texas Southwestern Med Ctr, Ctr Genet Host Def, Dallas, TX 75390 USA; [Turer, Emre] Univ Texas Southwestern Med Ctr, Dept Internal Med, Div Gastroenterol, Dallas, TX 75390 USA; [Zhang, Duanwu] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Zhang, Duanwu; Sun, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Misawa, Takuma] RIKEN, Lab Immune Cell Syst, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Sun, Lei] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai 201100, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Fudan University; Fudan University; RIKEN; Fudan University	Beutler, B (corresponding author), Univ Texas Southwestern Med Ctr, Ctr Genet Host Def, Dallas, TX 75390 USA.	bruce.beutler@utsouthwestern.edu	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	Moresco, Eva Marie/0000-0002-2049-7291; Zhang, Duanwu/0000-0003-2946-846X; Su, Lijing/0000-0003-1533-0988; Hildebrand, Sara/0000-0002-5534-3604; Zhan, Xiaoming/0000-0003-2045-5259	National Institutes of Health [U19 AI100627, R01 AI125581]; Lyda Hill Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lyda Hill Foundation	This work was supported by National Institutes of Health grants U19 AI100627 and R01 AI125581 to B.B. and by the Lyda Hill Foundation.	Araki K, 2017, NAT IMMUNOL, V18, P1046, DOI 10.1038/ni.3795; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Choi JH, 2017, P NATL ACAD SCI USA, V114, pE1196, DOI 10.1073/pnas.1621258114; Coughlin DJ, 2009, RNA BIOL, V6, P195, DOI 10.4161/rna.6.2.8050; Eleftheriadis T, 2016, EXP THER MED, V12, P3471, DOI 10.3892/etm.2016.3786; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Fletcher SJ, 2018, RNA, V24, P939, DOI 10.1261/rna.066415.118; Franchina DG, 2018, TRENDS IMMUNOL, V39, P489, DOI 10.1016/j.it.2018.01.005; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Torres AG, 2019, P NATL ACAD SCI USA, V116, P8451, DOI 10.1073/pnas.1821120116; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Goncalves KA, 2016, CELL, V166, P894, DOI 10.1016/j.cell.2016.06.042; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Hidmark AS, 2006, J VIROL, V80, P7100, DOI 10.1128/JVI.02579-05; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; immuni, 2012, IMMUNITY, V46, P675, DOI [10.1016/ j.immuni.2017.03.019; pmid: 28423341, DOI 10.1016/J.IMMUNI.2017.03.019;PMID:28423341]; Ito D, 2015, J IMMUNOL, V195, P934, DOI 10.4049/jimmunol.1403038; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Iyer S, 2013, FEBS J, V280, P302, DOI 10.1111/febs.12071; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li LD, 2012, NAT STRUCT MOL BIOL, V19, P824, DOI 10.1038/nsmb.2337; Li MQ, 2018, NAT STRUCT MOL BIOL, V25, P1047, DOI 10.1038/s41594-018-0142-5; Lian GJ, 2018, ELIFE, V7, DOI 10.7554/eLife.36158; Lin YZ, 2016, VIROLOGY, V495, P112, DOI 10.1016/j.virol.2016.04.024; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Mak TW, 2017, IMMUNITY, V46, P675, DOI 10.1016/j.immuni.2017.03.019; Mami L, 2016, J AM SOC NEPHROL, V27, P863, DOI 10.1681/ASN.2015020196; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; molcel, 2011, CELL, V138, P215, DOI [10.1016/j.cell.2009.07.001; pmid: 1963216, DOI 10.1016/J.CELL.2009.07.001;PMID:1963216]; Morales-Perez CL, 2016, STRUCTURE, V24, P797, DOI 10.1016/j.str.2016.03.004; NAKAGAWA K, INT IMMUNOL; Nakagawa K, 2018, INT IMMUNOL, V30, P69, DOI 10.1093/intimm/dxx079; Nobile V, 1996, P NATL ACAD SCI USA, V93, P4331, DOI 10.1073/pnas.93.9.4331; Omar I, 2016, ONCOTARGET, V7, P39396, DOI 10.18632/oncotarget.9818; Pizzo E, 2013, J CELL SCI, V126, P4308, DOI 10.1242/jcs.134551; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Ricciardi S, 2018, CELL METAB, V28, P895, DOI 10.1016/j.cmet.2018.08.009; Ross SH, 2018, ANNU REV IMMUNOL, V36, P411, DOI 10.1146/annurev-immunol-042617-053352; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Saikia M, 2015, J BIOL CHEM, V290, P29761, DOI 10.1074/jbc.R115.694661; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; Schimmel P, 2018, NAT REV MOL CELL BIO, V19, P45, DOI 10.1038/nrm.2017.77; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; SHAPIRO R, 1986, BIOCHEMISTRY-US, V25, P3527, DOI 10.1021/bi00360a008; She J, 2018, NATURE, V556, P130, DOI 10.1038/nature26139; Silberstein L, 2016, CELL STEM CELL, V19, P530, DOI 10.1016/j.stem.2016.07.004; Su ZL, 2019, J BIOL CHEM, V294, P16930, DOI 10.1074/jbc.RA119.009272; Thomas SP, 2018, RNA, V24, P1018, DOI 10.1261/rna.065516.117; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Wang KW, 2019, P NATL ACAD SCI USA, V116, P11380, DOI 10.1073/pnas.1901407116; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yang JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03544-x; Yu WH, 2017, CELL, V171, P849, DOI 10.1016/j.cell.2017.10.005; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	68	19	19	9	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					703	+	aba4220	10.1126/science.aba4220	http://dx.doi.org/10.1126/science.aba4220			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986151	Green Accepted			2022-12-28	WOS:000651125300040
J	Dyer, C				Dyer, Clare			GP who altered patient's notes to deflect complaint is struck off	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2021	373								n1237	10.1136/bmj.n1237	http://dx.doi.org/10.1136/bmj.n1237			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3HS	33985975				2022-12-28	WOS:000652650700005
J	[Anonymous]				[Anonymous]			Seven days in medicine: 5-11 May 2021	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Anderson M, 2021, LANCET, V397, P1915, DOI 10.1016/S0140-6736(21)00232-4; King's Fund, 2021, SOC CAR 360; NHS Digital, 2021, GEN PRACT WORKF 31 M	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2021	373								n1192	10.1136/bmj.n1192	http://dx.doi.org/10.1136/bmj.n1192			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3HN	33985960				2022-12-28	WOS:000652650200002
J	Finkel, Y; Gluck, A; Nachshon, A; Winkler, R; Fisher, T; Rozman, B; Mizrahi, O; Lubelsky, Y; Zuckerman, B; Slobodin, B; Yahalom-Ronen, Y; Tamir, H; Ulitsky, I; Israely, T; Paran, N; Schwartz, M; Stern-Ginossar, N				Finkel, Yaara; Gluck, Avi; Nachshon, Aharon; Winkler, Roni; Fisher, Tal; Rozman, Batsheva; Mizrahi, Orel; Lubelsky, Yoav; Zuckerman, Binyamin; Slobodin, Boris; Yahalom-Ronen, Yfat; Tamir, Hadas; Ulitsky, Igor; Israely, Tomer; Paran, Nir; Schwartz, Michal; Stern-Ginossar, Noam			SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis	NATURE			English	Article							GENE-EXPRESSION; RNA; TRANSLATION	The coronavirus SARS-CoV-2 is the cause of the ongoing pandemic of COVID-19(1). Coronaviruses have developed a variety of mechanisms to repress host mRNA translation to allow the translation of viral mRNA, and concomitantly block the cellular innate immune response(2,3). Although several different proteins of SARS-CoV-2 have previously been implicated in shutting off host expression(4-7), a comprehensive picture of the effects of SARS-CoV-2 infection on cellular gene expression is lacking. Here we combine RNA sequencing, ribosome profiling and metabolic labelling of newly synthesized RNA to comprehensively define the mechanisms that are used by SARS-CoV-2 to shut off cellular protein synthesis. We show that infection leads to a global reduction in translation, but that viral transcripts are not preferentially translated. Instead, we find that infection leads to the accelerated degradation of cytosolic cellular mRNAs, which facilitates viral takeover of the mRNA pool in infected cells. We reveal that the translation of transcripts that are induced in response to infection (including innate immune genes) is impaired. We demonstrate this impairment is probably mediated by inhibition of nuclear mRNA export, which prevents newly transcribed cellular mRNA from accessing ribosomes. Overall, our results uncover a multipronged strategy that is used by SARS-CoV-2 to take over the translation machinery and to suppress host defences.	[Finkel, Yaara; Gluck, Avi; Nachshon, Aharon; Winkler, Roni; Fisher, Tal; Rozman, Batsheva; Mizrahi, Orel; Schwartz, Michal; Stern-Ginossar, Noam] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel; [Lubelsky, Yoav; Zuckerman, Binyamin; Ulitsky, Igor] Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel; [Slobodin, Boris] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Yahalom-Ronen, Yfat; Tamir, Hadas; Israely, Tomer; Paran, Nir] Israel Inst Biol Chem & Environm Sci, Dept Infect Dis, Ness Ziona, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Schwartz, M; Stern-Ginossar, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel.	michalsc@weizmann.ac.il; noam.stern-ginossar@weizmann.ac.il	Ulitsky, Igor/HCH-7453-2022	Ulitsky, Igor/0000-0003-0555-6561; Finkel, Yaara/0000-0002-3843-2357; Lubelsky, Yoav/0000-0001-6127-1152; Zuckerman, Binyamin/0000-0002-6216-011X; Mizrahi, Orel/0000-0003-2189-5731; Gluck, Avi/0000-0002-6403-2955	Weizmann Corona Response Fund; European Research Council [CoG-2019-864012]	Weizmann Corona Response Fund; European Research Council(European Research Council (ERC)European Commission)	We thank members of the laboratory of N.S.-G. for providing valuable feedback; N. Krogan for the SARS-CoV-2 ORF expression plasmids; G. Jona and Weizmann Bacteriology and Genomic Repository Units for technical assistance; members of the virology research group at the IIBR for their contribution and support; and S. Weiss for biosafety guidance. This study was supported by a research grant from Weizmann Corona Response Fund. Work in the laboratory of N.S.-G. is supported by a European Research Council consolidator grant (CoG-2019-864012). N.S.-G. is an incumbent of the Skirball Career Development Chair in New Scientists and is a member of the European Molecular Biology Organization (EMBO) Young Investigator Program.	Addetia A, 2021, MBIO, V12, DOI 10.1128/mBio.00065-21; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Carlevaro-Fita J, 2019, MOL CELL, V73, P869, DOI 10.1016/j.molcel.2019.02.008; Del Valle D.M., 2020, NAT MED, V26, P1636, DOI DOI 10.1038/s41591-020-1051-9; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fields AP, 2015, MOL CELL, V60, P816, DOI 10.1016/j.molcel.2015.11.013; Finkel Yaara, 2021, Nature, V589, P125, DOI 10.1038/s41586-020-2739-1; Finkel Y, 2020, ELIFE, V9, DOI 10.7554/eLife.50960; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Herzog VA, 2017, NAT METHODS, V14, P1198, DOI [10.1038/NMETH.4435, 10.1038/nmeth.4435]; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Irigoyen N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005473; Jurges C, 2018, BIOINFORMATICS, V34, P218, DOI 10.1093/bioinformatics/bty256; Jungreis I, 2021, VIROLOGY, V558, P145, DOI 10.1016/j.virol.2021.02.013; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Lokugamage KG, 2015, J VIROL, V89, P10970, DOI 10.1128/JVI.01352-15; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Nakagawa K, 2016, ADV VIRUS RES, V96, P165, DOI 10.1016/bs.aivir.2016.08.001; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Rao Shilpa, 2021, bioRxiv, DOI 10.1101/2020.09.13.295493; Ribero MS, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008737; Schubert K, 2020, NAT STRUCT MOL BIOL, V27, P959, DOI 10.1038/s41594-020-0511-8; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; Tidu A, 2021, RNA, V27, P253, DOI 10.1261/rna.078121.120; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Wolff G, 2020, SCIENCE, V369, P1395, DOI 10.1126/science.abd3629; Yahalom-Ronen Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20228-7; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zuckerman B, 2020, MOL CELL, V79, P251, DOI 10.1016/j.molcel.2020.05.013	35	67	68	2	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2021	594	7862					240	+		10.1038/s41586-021-03610-3	http://dx.doi.org/10.1038/s41586-021-03610-3		MAY 2021	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SQ8YR	33979833	Bronze			2022-12-28	WOS:000657238000001
J	Iacobucci, G				Iacobucci, Gareth			Government should commit to making GP premises carbon neutral by 2030, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1228	10.1136/bmj.n1228	http://dx.doi.org/10.1136/bmj.n1228			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9GP	33980540				2022-12-28	WOS:000653055200006
J	Scales, D; Gorman, J; Jamieson, KH				Scales, David; Gorman, Jack; Jamieson, Kathleen H.			The Covid-19 Infodemic - Applying the Epidemiologic Model to Counter Misinformation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Scales, David] Weill Cornell Med Coll, Div Gen Internal Med, New York, NY 10065 USA; [Scales, David; Gorman, Jack] Critica, Bronx, NY 10463 USA; [Jamieson, Kathleen H.] Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA	Cornell University; University of Pennsylvania	Scales, D (corresponding author), Weill Cornell Med Coll, Div Gen Internal Med, New York, NY 10065 USA.; Scales, D (corresponding author), Critica, Bronx, NY 10463 USA.			Scales, David/0000-0001-5727-7148				Benkler Y., 2018, NETWORK PROPAGANDA M; Gagneur A, 2018, VACCINE, V36, P6553, DOI 10.1016/j.vaccine.2017.10.049; Pluviano S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181640; Romer D, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113356; Walter N, 2018, COMMUN MONOGR, V85, P423, DOI 10.1080/03637751.2018.1467564	5	31	31	5	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2021	385	8					678	681		10.1056/NEJMp2103798	http://dx.doi.org/10.1056/NEJMp2103798		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UB8VQ	33979506	Bronze			2022-12-28	WOS:000649817800001
J	Kuehn, BM				Kuehn, Bridget M.			Vaccine Dramatically Reduces HPV Infection Among Young Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1826	1826		10.1001/jama.2021.6597	http://dx.doi.org/10.1001/jama.2021.6597			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974011				2022-12-28	WOS:000650205000006
J	Dyer, O				Dyer, Owen			Covid-19: Study claims real global deaths are twice official figures	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Institute for Health Metrics and Evaluation, 2021, EST TOT MORT COV 19; Institute for Health Metrics and Evaluation, 2021, COV 19 RES BRIEF US; Institute for Health Metrics and Evaluation, 2021, COV 19 RES BRIEF IND; Institute for Health Metrics and Evaluation, 2021, COV 19 RES BRIEF UK; Institute for Health Metrics and Evaluation, 2021, COV 19 RES BRIEF GLO; Woolf SH, 2021, JAMA-J AM MED ASSOC, V325, P1786, DOI 10.1001/jama.2021.5199	6	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2021	373								n1188	10.1136/bmj.n1188	http://dx.doi.org/10.1136/bmj.n1188			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RA	33972234	Bronze			2022-12-28	WOS:000649709400008
J	Bocchi, VD; Conforti, P; Vezzoli, E; Besusso, D; Cappadona, C; Lischetti, T; Galimberti, M; Ranzani, V; Bonnal, RJP; De Simone, M; Rossetti, G; He, XL; Kamimoto, K; Espuny-Camacho, I; Faedo, A; Gervasoni, F; Vuono, R; Morris, SA; Chen, J; Felsenfeld, D; Pavesi, G; Barker, RA; Pagani, M; Cattaneo, E				Bocchi, Vittoria Dickinson; Conforti, Paola; Vezzoli, Elena; Besusso, Dario; Cappadona, Claudio; Lischetti, Tiziana; Galimberti, Maura; Ranzani, Valeria; Bonnal, Raoul J. P.; De Simone, Marco; Rossetti, Grazisa; He, Xiaoling; Kamimoto, Kenji; Espuny-Camacho, Ira; Faedo, Andrea; Gervasoni, Federica; Vuono, Romina; Morris, Samantha A.; Chen, Jian; Felsenfeld, Dan; Pavesi, Giulio; Barker, Roger A.; Pagani, Massimiliano; Cattaneo, Elena			The coding and long noncoding single-cell atlas of the developing human fetal striatum	SCIENCE			English	Article							EXPRESSION; RNAS; ANNOTATION; REVEALS; TRANSCRIPTION; LANDSCAPE; INFERENCE	Deciphering how the human striatum develops is necessary for understanding the diseases that affect this region. To decode the transcriptional modules that regulate this structure during development, we compiled a catalog of 1116 long intergenic noncoding RNAs (lincRNAs) identified de novo and then profiled 96,789 single cells from the early human fetal striatum. We found that D1 and D2 medium spiny neurons (D1- and D2-MSNs) arise from a common progenitor and that lineage commitment is established during the postmitotic transition, across a pre-MSN phase that exhibits a continuous spectrum of fate determinants. We then uncovered cell type-specific gene regulatory networks that we validated through in silico perturbation. Finally, we identified human-specific lincRNAs that contribute to the phylogenetic divergence of this structure in humans. This work delineates the cellular hierarchies governing MSN lineage commitment.	[Bocchi, Vittoria Dickinson; Conforti, Paola; Vezzoli, Elena; Besusso, Dario; Cappadona, Claudio; Lischetti, Tiziana; Galimberti, Maura; Espuny-Camacho, Ira; Faedo, Andrea; Pavesi, Giulio; Cattaneo, Elena] Univ Milan, Dipartimento Biosci, Milan, Italy; [Bocchi, Vittoria Dickinson; Conforti, Paola; Vezzoli, Elena; Besusso, Dario; Cappadona, Claudio; Lischetti, Tiziana; Galimberti, Maura; Ranzani, Valeria; Bonnal, Raoul J. P.; De Simone, Marco; Rossetti, Grazisa; Espuny-Camacho, Ira; Faedo, Andrea; Gervasoni, Federica; Pagani, Massimiliano; Cattaneo, Elena] Ist Nazl Genet Mol, Milan, Italy; [He, Xiaoling; Vuono, Romina; Barker, Roger A.] Univ Cambridge, WT MRC Cambridge Stem Cell Inst, Cambridge, England; [He, Xiaoling; Vuono, Romina; Barker, Roger A.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Kamimoto, Kenji; Morris, Samantha A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Kamimoto, Kenji; Morris, Samantha A.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Kamimoto, Kenji; Morris, Samantha A.] Washington Univ, Ctr Regenerat Med, Sch Med, St Louis, MO 63110 USA; [Gervasoni, Federica; Pagani, Massimiliano] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy; [Chen, Jian; Felsenfeld, Dan] CHDI Fdn, CHDI Management, New York, NY USA; [Vezzoli, Elena] Univ Milan, Dept Biomed Sci Hlth, I-20133 Milan, Italy; [Cappadona, Claudio] Humanitas Univ, Dept Biomed Sci, I-20090 Milan, Italy; [Bonnal, Raoul J. P.; Rossetti, Grazisa; Gervasoni, Federica; Pagani, Massimiliano] IFOM FIRC Inst Mol Oncol, Milan, Italy; [De Simone, Marco] Cedars Sinai Med Ctr, Dept Radiat Oncol, Los Angeles, CA 90048 USA; [Espuny-Camacho, Ira] Univ Liege, GIGA Stem Cells, Quartier Hop 15, B-4000 Liege, Belgium; [Faedo, Andrea] Axxam, OpenZone, I-20091 Milan, Italy; [Vuono, Romina] Univ Kent, Medway Sch Pharm, Chatham, Kent, England	University of Milan; University of Cambridge; University of Cambridge; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Milan; University of Milan; Humanitas University; IFOM - FIRC Institute of Molecular Oncology; Cedars Sinai Medical Center; University of Liege; University of Greenwich; University of Kent	Cattaneo, E (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.; Pagani, M; Cattaneo, E (corresponding author), Ist Nazl Genet Mol, Milan, Italy.; Pagani, M (corresponding author), Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy.; Pagani, M (corresponding author), IFOM FIRC Inst Mol Oncol, Milan, Italy.	massimiliano.pagani@unimi.it; elena.cattaneo@unimi.it	Pavesi, Giulio/AAB-3230-2022; Cappadona, Claudio/AAB-6261-2022; rossetti, grazisa/C-3722-2015	Cappadona, Claudio/0000-0003-3301-2967; Bocchi, Vittoria Dickinson/0000-0002-0541-0151; rossetti, grazisa/0000-0001-6361-311X; Kamimoto, Kenji/0000-0003-3541-4353; Faedo, Andrea/0000-0002-2227-0656; Besusso, Dario/0000-0001-9793-9644; Vuono, Romina/0000-0002-5162-3422; Vezzoli, Elena/0000-0002-3342-3451; Ranzani, Valeria/0000-0002-0602-5335; Lischetti, Tiziana/0000-0003-2459-0263; Bonnal, Raoul/0000-0002-2123-6536; Espuny Camacho, Ira/0000-0002-2356-2159; Gervasoni, Federica/0000-0002-0873-7563; Pagani, Massimiliano/0000-0002-7017-9304	CHDI Foundation [JSC A11103]; European Union [602278, 874758]; NIHR funding of the Biomedical Research Centre; Wellcome Trust [203151/Z/16/Z]	CHDI Foundation; European Union(European Commission); NIHR funding of the Biomedical Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was conducted with collaboration and funding from CHDI Foundation (JSC A11103), a nonprofit biomedical research organization exclusively dedicated to developing therapeutics that will substantially improve the life of individuals affected by HD, to E.C. This study was also supported by the European Union funded projects NeurostemcellRepair (FP7, GA no. 602278, 2013-17) and NSC-Reconstruct (H2020, GA no. 874758, 2020-23) to E.C. and R.A.B. The fetal tissue collection in Cambridge is supported by NIHR funding of the Biomedical Research Centre and by the Wellcome Trust 203151/Z/16/Z.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Barnat M, 2020, SCIENCE, V369, P787, DOI 10.1126/science.aax3338; Bastian M, 2009, INT AAAI C WEBL SOC; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Fan XY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz2978; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Grillner S, 2013, J PHYSIOL-LONDON, V591, P5425, DOI 10.1113/jphysiol.2012.246660; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kamimoto K., 2020, CELLORACLE DISSECTIN; Kelly SM, 2018, NEURON, V99, P345, DOI 10.1016/j.neuron.2018.06.021; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin-Ibanez R, 2010, J COMP NEUROL, V518, P329, DOI 10.1002/cne.22215; Mele M, 2017, GENOME RES, V27, P27, DOI 10.1101/gr.214205.116; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; Onorati M, 2014, NAT NEUROSCI, V17, P1804, DOI 10.1038/nn.3860; Pai ELL, 2020, ELIFE, V9, DOI 10.7554/eLife.54903; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Raghanti MA, 2016, J COMP NEUROL, V524, P2117, DOI 10.1002/cne.23937; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wolf FA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1663-x; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Wucher V, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1306; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhang QQ, 2016, CELL REP, V16, P1431, DOI 10.1016/j.celrep.2016.06.090; Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zhu JC, 2007, PLOS COMPUT BIOL, V3, P2498, DOI 10.1371/journal.pcbi.0030247	47	18	17	5	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					591	+	eabf5759	10.1126/science.abf5759	http://dx.doi.org/10.1126/science.abf5759			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958447	Green Submitted, Green Published			2022-12-28	WOS:000649103500038
J	Iacobucci, G				Iacobucci, Gareth			European regulators urged to crack down on missing clinical trial results	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		EU Trials Tracker, U AMST EU CLIN TRIAL; EU Trials Tracker, WHOS NOT SHAR EU CLI; Transpari MED, CLIN TRIAL TRANSP BE; Transpari MED, 2020, 100 CLIN TRIALS INV; TranspariMED, AUSTR RAP PROGR CLIN; TranspariMED, 2020, HALF COVID TRIALS EU; TranspariMED, CLIN TRIALS DENM PHA; TranspariMED, 2021, FDA ISS FINES HIDD C	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2021	373								n1169	10.1136/bmj.n1169	http://dx.doi.org/10.1136/bmj.n1169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YV	33958386				2022-12-28	WOS:000651241700003
J	Vogel, B; Acevedo, M; Appelman, Y; Merz, CNB; Chieffo, A; Figtree, GA; Guerrero, M; Kunadian, V; Lam, CSP; Maas, AHEM; Mihailidou, AS; Olszanecka, A; Poole, JE; Saldarriaga, C; Saw, J; Zuhlke, L; Mehran, R				Vogel, Birgit; Acevedo, Monica; Appelman, Yolande; Merz, C. Noel Bairey; Chieffo, Alaide; Figtree, Gemma A.; Guerrero, Mayra; Kunadian, Vijay; Lam, Carolyn S. P.; Maas, Angela H. E. M.; Mihailidou, Anastasia S.; Olszanecka, Agnieszka; Poole, Jeanne E.; Saldarriaga, Clara; Saw, Jacqueline; Zuhlke, Liesl; Mehran, Roxana			The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030	LANCET			English	Review							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISSECTION; RHEUMATIC HEART-DISEASE; SUDDEN CARDIAC DEATH; ST-SEGMENT-ELEVATION; MECHANICAL CIRCULATORY SUPPORT; INTIMATE PARTNER VIOLENCE; MITRAL-VALVE-REPLACEMENT; SEX-BASED DIFFERENCES; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS	Cardiovascular disease is the leading cause of death in women. Decades of grassroots campaigns have helped to raise awareness about the impact of cardiovascular disease in women, and positive changes affecting women and their health have gained momentum. Despite these efforts, there has been stagnation in the overall reduction of cardiovascular disease burden for women in the past decade. Cardiovascular disease in women remains understudied, under-recognised, underdiagnosed, and undertreated. This Commission summarises existing evidence and identifies knowledge gaps in research, prevention, treatment, and access to care for women. Recommendations from an international team of experts and leaders in the field have been generated with a clear focus to reduce the global burden of cardiovascular disease in women by 2030. This Commission represents the first effort of its kind to connect stakeholders, to ignite global awareness of sex-related and gender-related disparities in cardiovascular disease, and to provide a springboard for future research.	[Vogel, Birgit; Mehran, Roxana] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Acevedo, Monica] Pontificia Univ Catolica Chile, Fac Med, Div Enfermedades Cardiovasc, Santiago, Chile; [Appelman, Yolande] Vrije Univ Amsterdam Med Ctr, Amsterdam UMC, Amsterdam, Netherlands; [Merz, C. Noel Bairey] Cedars Sinai Med Ctr, Smidt Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA; [Chieffo, Alaide] IRCCS San Raffaele Sci Inst, Intervent Cardiol Unit, Milan, Italy; [Figtree, Gemma A.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Guerrero, Mayra] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA; [Kunadian, Vijay] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Kunadian, Vijay] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Ctr Cardiothorac, Newcastle Upon Tyne, Tyne & Wear, England; [Lam, Carolyn S. P.] Natl Heart Ctr Singapore, Singapore, Singapore; [Lam, Carolyn S. P.] Duke Natl Univ Singapore, Cardiovasc Sci Acad Clin Programme, Singapore, Singapore; [Maas, Angela H. E. M.] Radboud Univ Nijmegen, Med Ctr, Dept Womens Cardiac Hlth, Nijmegen, Netherlands; [Mihailidou, Anastasia S.] Royal North Shore Hosp, Northern Sydney Local Hlth Dist, Sydney, NSW, Australia; [Mihailidou, Anastasia S.] Kolling Inst, Cardiovasc & Hormonal Res Lab, Sydney, NSW, Australia; [Mihailidou, Anastasia S.] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Olszanecka, Agnieszka] Jagiellonian Univ Med Coll, Fac Med, Dept Cardiol Intervent Electrocardiol & Hypertens, Krakow, Poland; [Poole, Jeanne E.] Univ Washington, Med Ctr, Div Cardiol, Seattle, WA 98195 USA; [Saldarriaga, Clara] Univ Antioquia, Clin CardioVID, Dept Cardiol, Medellin, Colombia; [Saldarriaga, Clara] Univ Antioquia, Clin CardioVID, Heart Failure Clin, Medellin, Colombia; [Saw, Jacqueline] Vancouver Gen Hosp, Div Cardiol, Vancouver, BC, Canada; [Zuhlke, Liesl] Univ Cape Town, Red Cross Childrens & Groote Schuur Hosp, Dept Paediat, Div Paediat, Cape Town, South Africa; [Zuhlke, Liesl] Univ Cape Town, Red Cross Childrens & Groote Schuur Hosp, Dept Med, Div Paediat, Cape Town, South Africa; [Zuhlke, Liesl] Univ Cape Town, Red Cross Childrens & Groote Schuur Hosp, Dept Paediat, Div Adult Cardiol, Cape Town, South Africa; [Zuhlke, Liesl] Univ Cape Town, Red Cross Childrens & Groote Schuur Hosp, Dept Med, Div Adult Cardiol, Cape Town, South Africa	Icahn School of Medicine at Mount Sinai; Pontificia Universidad Catolica de Chile; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Cedars Sinai Medical Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Sydney; Mayo Clinic; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust; National Heart Centre Singapore; National University of Singapore; Radboud University Nijmegen; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Macquarie University; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Washington; University of Washington Seattle; Universidad de Antioquia; Universidad de Antioquia; University of British Columbia; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Mehran, R (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	roxana.mehran@mountsinai.org	Acevedo, Monica/GSI-9787-2022; Mehran, Roxana/ABF-4160-2021; Zühlke, Liesl Joanna/AAZ-9723-2021; Lam, Carolyn SP/ABD-6810-2021	Acevedo, Monica/0000-0002-7989-6633; Zühlke, Liesl Joanna/0000-0003-3961-2760; Lam, Carolyn SP/0000-0003-1903-0018	Abbott Vascular; Abiomed; Amgen; AstraZeneca; Bristol Myers Squibb; CSL Behring; Janssen; Medtronic; Orbus Neich; Philips; Sanofi	Abbott Vascular(Abbott Laboratories); Abiomed; Amgen(Amgen); AstraZeneca(AstraZeneca); Bristol Myers Squibb(Bristol-Myers Squibb); CSL Behring; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medtronic(Medtronic); Orbus Neich; Philips; Sanofi	The Commission was supported financially by grants from Abbott Vascular, Abiomed, Amgen, AstraZeneca, Bristol Myers Squibb, CSL Behring, Janssen, Medtronic, Orbus Neich, Philips, and Sanofi, who had no role in study design, data collection, data analysis, data interpretation, or writing of this Commission article. The funds were used towards the planning, development, and public launch of the Commission article. None of the authors were paid for their work on the Commission.	Abdulla I, 2006, INTERN MED J, V36, P414, DOI 10.1111/j.1445-5994.2006.01095.x; Abi-Gerges N, 2004, FUND CLIN PHARMACOL, V18, P139, DOI 10.1111/j.1472-8206.2004.00230.x; Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Adler NE, 2010, ANN NY ACAD SCI, V1186, P5, DOI 10.1111/j.1749-6632.2009.05337.x; Akhter N, 2009, AM HEART J, V157, P141, DOI 10.1016/j.ahj.2008.08.012; Akoum N, 2018, EUROPACE, V20, P1086, DOI 10.1093/europace/eux260; Al-Khatib Sana M, 2018, Circulation, V138, pe272, DOI 10.1161/CIR.0000000000000549; Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; Alabas OA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007123; Alasnag M, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-0828-0; Alastuey I, 2013, REP PRACT ONCOL RADI, V18, pS179; Alkema Leontine, 2016, Lancet, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; American College of Cardiology and American Heart Association, ASCVD RISK EST; Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Anand SS, 2006, INT J EPIDEMIOL, V35, P1239, DOI 10.1093/ije/dyl163; Andersson HB, 2018, EUR HEART J, V39, P102, DOI 10.1093/eurheartj/ehx491; [Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; [Anonymous], 2019, Obstet Gynecol, V133, pe128, DOI 10.1097/AOG.0000000000003072; [Anonymous], 2021, COVID 19 SEX DIS DAT; Apostolakis S, 2013, CHEST, V144, P1555, DOI 10.1378/chest.13-0054; Appelman Y, 2015, ATHEROSCLEROSIS, V241, P211, DOI 10.1016/j.atherosclerosis.2015.01.027; Argacha JF, 2018, TRENDS CARDIOVAS MED, V28, P112, DOI 10.1016/j.tcm.2017.07.013; Armenian SH, 2017, J CLIN ONCOL, V35, P893, DOI 10.1200/JCO.2016.70.5400; Arnao V, 2016, INT J STROKE, V11, P287, DOI 10.1177/1747493016632245; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]; Arora S, 2019, CIRCULATION, V139, P1047, DOI 10.1161/CIRCULATIONAHA.118.037137; Arshad A, 2011, J AM COLL CARDIOL, V57, P814, DOI 10.1016/j.jacc.2010.06.061; Australian Commission on Safety and Quality in Health Care and Australian Institute of Health and Welfare, 2018, 3 AUSTR ATL HEALTHC; Australian Institute of Health and Welfare, 2007, AB TORR STRAT ISL HL; Australian Institute of Health and Welfare, 2019, IND SOC IN CARD DIS; Australian Institute of Health and Welfare, 2018, AB TORR STRAT ISL AD; Australian Institute of Health and Welfare, 2020, ASTHMA; Australian Institute of Health and Welfare, 2019, HLTH AUSTR FEM; Azibani Feriel, 2018, Curr Heart Fail Rep, V15, P297, DOI 10.1007/s11897-018-0404-x; Backholer K, 2017, J EPIDEMIOL COMMUN H, V71, P550, DOI 10.1136/jech-2016-207890; Bahrami H, 2008, J AM COLL CARDIOL, V51, P1775, DOI 10.1016/j.jacc.2007.12.048; Bainey KR, 2018, INT J CARDIOL, V264, P12, DOI 10.1016/j.ijcard.2018.04.004; Barajas-Martinez H, 2009, CARDIOVASC RES, V81, P82, DOI 10.1093/cvr/cvn255; Barakat K, 2000, AM HEART J, V140, P740, DOI 10.1067/mhj.2000.110089; Bartus K, 2013, J AM COLL CARDIOL, V62, P108, DOI 10.1016/j.jacc.2012.06.046; Bateman BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036171; Bates ER, 2011, CIRCULATION, V124, P355, DOI 10.1161/CIRCULATIONAHA.110.974204; Bellettiere J, 2019, CIRCULATION, V139, P1036, DOI 10.1161/CIRCULATIONAHA.118.035312; Belton S, 2018, AUST NZ J OBSTET GYN, V58, P425, DOI 10.1111/ajo.12744; Beltrame JF, 2017, EUR HEART J, V38, P2565, DOI 10.1093/eurheartj/ehv351; Bentley-Lewis R, 2011, ENDOCRIN METAB CLIN, V40, P433, DOI 10.1016/j.ecl.2011.01.009; Bergau L, 2014, J ELECTROCARDIOL, V47, P869, DOI 10.1016/j.jelectrocard.2014.08.007; Berkman ND, 2010, J HEALTH COMMUN, V15, P9, DOI 10.1080/10810730.2010.499985; Berry GJ, 2005, PEDIATR BLOOD CANCER, V44, P630, DOI 10.1002/pbc.20346; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Bleiweis R, 2020, BASIC FACTS WOMEN PO; Blom MT, 2019, EUR HEART J, V40, P3824, DOI 10.1093/eurheartj/ehz297; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Borges N, 2018, RAD INDUCED CAD INCI; BORTONE AS, 1989, CIRCULATION, V79, P516, DOI 10.1161/01.CIR.79.3.516; Bourdrel T, 2017, ARCH CARDIOVASC DIS, V110, P634, DOI 10.1016/j.acvd.2017.05.003; Bozdag G, 2016, HUM REPROD, V31, P2841, DOI 10.1093/humrep/dew218; Brar SS, 2007, AM J CARDIOL, V100, P302, DOI 10.1016/j.amjcard.2007.02.092; Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103; Breiding MJ, 2008, ANN EPIDEMIOL, V18, P538, DOI 10.1016/j.annepidem.2008.02.005; Brennan JM, 2019, J AM COLL CARDIOL, V73, P1207, DOI 10.1016/S0735-1097(19)31814-5; Brindis CD, 2018, CLIN CARDIOL, V41, P173, DOI 10.1002/clc.22896; Burki TK, 2017, LANCET RESP MED, V5, P470, DOI 10.1016/S2213-2600(17)30160-1; Bush RL, 2008, J SURG RES, V145, P313, DOI 10.1016/j.jss.2007.03.022; Calabria B, 2018, MED J AUSTRALIA, V209, P35, DOI 10.5694/mja17.00897; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Cameron D, 2017, LANCET, V389, P1195, DOI 10.1016/S0140-6736(16)32616-2; Canobbio MM, 2017, CIRCULATION, V135, pE50, DOI 10.1161/CIR.0000000000000458; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Ceia F, 2002, EUR J HEART FAIL, V4, P531, DOI 10.1016/S1388-9842(02)00034-X; Cenko E, 2019, J AM COLL CARDIOL, V74, P2379, DOI 10.1016/j.jacc.2019.08.1047; Cenko E, 2018, JAMA INTERN MED, V178, P632, DOI 10.1001/jamainternmed.2018.0514; Cenko E, 2016, INT J CARDIOL, V222, P1110, DOI 10.1016/j.ijcard.2016.07.211; Champney KP, 2009, HEART, V95, P895, DOI 10.1136/hrt.2008.155804; Chandrasekhar J, 2016, J AM COLL CARDIOL, V68, P2733, DOI 10.1016/j.jacc.2016.10.041; Chang AY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194030; Cheng C, 2015, AUST NZ J PUBL HEAL, V39, P309, DOI 10.1111/1753-6405.12341; Cheng YJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005633; Cheung AM, 2008, J OBSTET GYNAECOL CA, V30, P332, DOI 10.1016/S1701-2163(16)32802-X; Chomistek AK, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.117.008234, 10.1161/jaha.117.008234]; Chou AY, 2016, CAN J CARDIOL, V32, P554, DOI 10.1016/j.cjca.2016.01.009; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Clouston SAP, 2017, AGE AGEING, V46, P493, DOI 10.1093/ageing/afw229; Collet Jean-Philippe, 2021, Eur Heart J, V42, P1289, DOI [10.1093/eurheartj/ehaa575, 10.15829/1560-4071-2021-4418]; Conen D, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00003; Cook NL, 2009, CIRCULATION, V119, P2463, DOI 10.1161/CIRCULATIONAHA.108.825133; Costa-Hong VA, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0855-8; Coughtrie AL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016627; Crousillat DR, 2019, HEART FAIL CLIN, V15, P77, DOI 10.1016/j.hfc.2018.08.008; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Curtis AB, 2005, AM HEART J, V149, P645, DOI 10.1016/j.ahj.2004.09.038; Curtis KM, 2006, CONTRACEPTION, V73, P179, DOI 10.1016/j.contraception.2005.08.005; Curtis LH, 2007, JAMA-J AM MED ASSOC, V298, P1517, DOI 10.1001/jama.298.13.1517; Daan NMP, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.08.001; Davis MB, 2020, J AM COLL CARDIOL, V75, P207, DOI 10.1016/j.jacc.2019.11.014; de Jong M, 2020, DIABETES CARE, V43, P2050, DOI 10.2337/dc19-2363; De Luca L, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004202; Denollet J, 2010, J AFFECT DISORDERS, V120, P105, DOI 10.1016/j.jad.2009.04.013; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Diederichs C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208303; Ding EL, 2007, ARCH INTERN MED, V167, P905, DOI 10.1001/archinte.167.9.905; Dodson JA, 2012, CIRC-CARDIOVASC QUAL, V5, P298, DOI 10.1161/CIRCOUTCOMES.112.966077; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Durante Alessandro, 2015, J Clin Med Res, V7, P379, DOI 10.14740/jocmr2122w; Eaton CB, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002883; Ebong I, 2020, J WOMENS HEALTH, V29, P891, DOI 10.1089/jwh.2019.8125; Eitel I, 2012, CIRC-CARDIOVASC IMAG, V5, P119, DOI 10.1161/CIRCIMAGING.111.965467; Elkayam U, 2019, CLIN CARDIOL, V42, P974, DOI 10.1002/clc.23249; Elkayam U, 2014, J AM COLL CARDIOL, V64, P1629, DOI 10.1016/j.jacc.2014.07.961; Elkayam U, 2014, CIRCULATION, V129, P1695, DOI 10.1161/CIRCULATIONAHA.113.002054; Emdin CA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h7013; Eschenhagen T, 2011, EUR J HEART FAIL, V13, P1, DOI 10.1093/eurjhf/hfq213; European Society of Cardiology, SPONT COR ART DISS S; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Farley TMM, 1998, J EPIDEMIOL COMMUN H, V52, P775, DOI 10.1136/jech.52.12.775; Farrell SR, 2010, AM J PHYSIOL-HEART C, V299, pH36, DOI 10.1152/ajpheart.00299.2010; Ford TJ, 2020, JACC-CARDIOVASC INTE, V13, P33, DOI 10.1016/j.jcin.2019.11.001; Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]; Fowkes FGR, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.179; Fox CS, 2006, J AM SOC NEPHROL, V17, P521, DOI 10.1681/ASN.2005060627; Fox CS, 2003, CIRCULATION, V107, P1492, DOI 10.1161/01.CIR.0000058168.26163.BC; Fuchs C, 2010, HEART, V96, P539, DOI 10.1136/hrt.2009.186650; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Gabet A, 2017, EUR HEART J, V38, P1060, DOI 10.1093/eurheartj/ehx097; Gaede L, 2019, CLIN RES CARDIOL, V108, P61, DOI 10.1007/s00392-018-1312-5; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Garfield C., 2009, DEVELOPMENTAL BEHAV, P94; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Gebreab SY, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001553; Gemmati D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103474; Gerber Y, 2015, JAMA INTERN MED, V175, P996, DOI 10.1001/jamainternmed.2015.0924; Gerdts E, 2008, HYPERTENSION, V51, P1109, DOI 10.1161/HYPERTENSIONAHA.107.107474; Ghadri JR, 2016, HEART FAIL CLIN, V12, P597, DOI 10.1016/j.hfc.2016.06.010; Ghanbari H, 2009, ARCH INTERN MED, V169, P1500, DOI 10.1001/archinternmed.2009.255; Ghisi GLD, 2018, PATIENT EDUC COUNS, V101, P177, DOI 10.1016/j.pec.2017.09.002; Gili S, 2019, EUR HEART J, V40, P2142, DOI 10.1093/eurheartj/ehz170; Gimenez MR, 2020, CIRC-CARDIOVASC INTE, V13, DOI 10.1161/CIRCINTERVENTIONS.119.008537; Giudicessi JR, 2020, MAYO CLIN PROC, V95, P1213, DOI 10.1016/j.mayocp.2020.03.024; Goette A, 2017, HEART RHYTHM, V14, pE3, DOI 10.1016/j.hrthm.2016.05.028; Gorgui J, 2014, CAN J CARDIOL, V30, P774, DOI 10.1016/j.cjca.2014.01.007; Greenberg KL, 2019, EUR J PREV CARDIOL, V26, P1762, DOI 10.1177/2047487319853900; Greendale GA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124865; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/S0140-6736(18)31310-2, 10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94]; Grodzinsky A, 2015, EUR HEART J-QUAL CAR, V1, P92, DOI 10.1093/ehjqcco/qcv014; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guerrero M, 2021, JACC-CARDIOVASC INTE, V14, P830, DOI 10.1016/j.jcin.2021.01.052; Guerrero M, 2020, CIRC-CARDIOVASC INTE, V13, DOI 10.1161/CIRCINTERVENTIONS.119.008425; Guerrero M, 2018, J AM COLL CARDIOL, V71, P1841, DOI 10.1016/j.jacc.2018.02.054; Guerrero M, 2016, JACC-CARDIOVASC INTE, V9, P1361, DOI 10.1016/j.jcin.2016.04.022; Guh JY, 2007, AM J CLIN NUTR, V85, P1229, DOI 10.1093/ajcn/85.5.1229; Guo YT, 2015, CHEST, V147, P109, DOI 10.1378/chest.14-0321; Gupta SS, 2018, APPETITE, V120, P679, DOI 10.1016/j.appet.2017.10.007; Haghikia A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0366-9; Hamood R, 2019, J CARDIOL, V73, P280, DOI 10.1016/j.jjcc.2018.10.009; Hao YC, 2019, CIRCULATION, V139, P1776, DOI 10.1161/CIRCULATIONAHA.118.037655; Hare DL, 2020, HEART LUNG CIRC, V29, P401, DOI 10.1016/j.hlc.2019.03.009; Hart JE, 2014, CIRCULATION, V130, P1474, DOI 10.1161/CIRCULATIONAHA.114.011489; Haukilahti MAE, 2019, CIRCULATION, V139, P1012, DOI 10.1161/CIRCULATIONAHA.118.037702; Hayashi M, 2015, CIRC RES, V116, P1887, DOI 10.1161/CIRCRESAHA.116.304521; Hayes SN, 2018, CIRCULATION, V137, pE523, DOI 10.1161/CIR.0000000000000564; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Heidari Shirin, 2016, Res Integr Peer Rev, V1, P2, DOI 10.1186/s41073-016-0007-6; Helviz Y, 2019, INTENS CARE MED, V45, P278, DOI 10.1007/s00134-018-5487-z; Henkin S, 2016, HEART, V102, P876, DOI 10.1136/heartjnl-2015-308645; Hilfiker-Kleiner D, 2017, EUR J HEART FAIL, V19, P1723, DOI 10.1002/ejhf.808; Hilfiker-Kleiner D, 2017, EUR HEART J, V38, P2671, DOI 10.1093/eurheartj/ehx355; Hilfiker-Kleiner D, 2015, EUR HEART J, V36, P1090, DOI 10.1093/eurheartj/ehv009; Hirsch AT, 2007, CIRCULATION, V116, P2086, DOI 10.1161/CIRCULATIONAHA.107.725101; Hirsch AT, 2012, CIRCULATION, V125, P1449, DOI 10.1161/CIR.0b013e31824c39ba; Ho JE, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.003116; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029; Honigberg MC, 2019, JAMA-J AM MED ASSOC, V322, P2411, DOI 10.1001/jama.2019.19191; Huded Chetan P, 2018, J Am Coll Cardiol, V71, P2122, DOI 10.1016/j.jacc.2018.02.039; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hung MY, 2010, EUR J CLIN INVEST, V40, P1094, DOI 10.1111/j.1365-2362.2010.02360.x; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Institute for Health Metrics and Evaluation, CARD DIS FEM AGR STA; Institute for Health Metrics and Evaluation, 2019, GBD 2019 DEATHS PER; Institute for Health Metrics and Evaluation U. o. W, 2022, GBD RES TOOL; Isogai T, 2019, INT HEART J, V60, P503, DOI 10.1536/ihj.18-729; Jackson AM, 2020, EUR HEART J-QUAL CAR, V6, P156, DOI 10.1093/ehjqcco/qcz040; Jackson EA, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.030; Jain AK, 2011, AM SURGEON, V77, P844; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Jefferis BJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-382; Jelani QU, 2018, CURR ATHEROSCLER REP, V20, DOI 10.1007/s11883-018-0742-x; Jenkins KR, 2014, WOMEN HEALTH, V54, P15, DOI 10.1080/03630242.2013.858098; Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331; Jha MK, 2019, J AM COLL CARDIOL, V73, P1827, DOI 10.1016/j.jacc.2019.01.041; Ji HW, 2020, JAMA CARDIOL, V5, P255, DOI 10.1001/jamacardio.2019.5306; Jin XR, 2020, CIRCULATION, V141, P540, DOI 10.1161/CIRCULATIONAHA.119.043594; Jochmann N, 2005, EUR HEART J, V26, P1585, DOI 10.1093/eurheartj/ehi397; Jones E, 2012, TRENDS CARDIOVAS MED, V22, P161, DOI 10.1016/j.tcm.2012.07.014; Jordan S, 2011, INTERN MED J, V41, P722, DOI 10.1111/j.1445-5994.2011.02536.x; Joseph SM, 2016, J INTERV CARDIOL, V29, P248, DOI 10.1111/joic.12298; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kaczmarek I, 2013, THORAC CARDIOV SURG, V61, P29, DOI 10.1055/s-0032-1331467; Kamphuis Carlijn B M, 2012, BMC Public Health, V12, P1045, DOI 10.1186/1471-2458-12-1045; Kang SH, 2012, AM J CARDIOL, V109, P787, DOI 10.1016/j.amjcard.2011.11.006; Kang WY, 2011, INT J CARDIOL, V146, P207, DOI 10.1016/j.ijcard.2009.07.001; Kapral MK, 2005, STROKE, V36, P809, DOI 10.1161/01.STR.0000157662.09551.e5; Kassebaum NJ, 2014, LANCET, V384, P2209, DOI 10.1016/S0140-6736(14)62425-9; Kassim NA, 2017, J CARDIOL, V69, P195, DOI 10.1016/j.jjcc.2016.02.022; Kaul P, 2013, AM HEART J, V165, P379, DOI 10.1016/j.ahj.2012.12.005; Kaul P, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.016; Kengne AP, 2019, LANCET GLOB HEALTH, V7, pE980, DOI 10.1016/S2214-109X(19)30293-1; Kerpen K, 2019, ARCH CARDIOVASC DIS, V112, P187, DOI 10.1016/j.acvd.2018.10.002; Khariton Y, 2018, JACC-HEART FAIL, V6, P465, DOI 10.1016/j.jchf.2018.02.002; Khuddus MA, 2010, J INTERV CARDIOL, V23, P511, DOI 10.1111/j.1540-8183.2010.00598.x; Khush KK, 2018, J HEART LUNG TRANSPL, V37, P1155, DOI 10.1016/j.healun.2018.07.022; Kim LK, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003704; Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425; Kodali S, 2016, ANN INTERN MED, V164, P377, DOI 10.7326/M15-0121; Kok HS, 2006, J AM COLL CARDIOL, V47, P1976, DOI 10.1016/j.jacc.2005.12.066; Kolte D, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000590; Kong MH, 2011, J AM COLL CARDIOL, V57, P794, DOI 10.1016/j.jacc.2010.09.064; Kosmidou I, 2017, EUR HEART J, V38, P1656, DOI 10.1093/eurheartj/ehx159; Kramer CK, 2019, DIABETOLOGIA, V62, P905, DOI 10.1007/s00125-019-4840-2; Kunadian V, 2020, EUR HEART J, V41, P3504, DOI 10.1093/eurheartj/ehaa503; Kurowski V, 2007, CHEST, V132, P809, DOI 10.1378/chest.07-0608; Kutner M., 2006, NCES 2006 483; Lai YH, 2017, J AM COLL CARDIOL, V69, P2876, DOI 10.1016/j.jacc.2017.04.016; Lam CSP, 2019, EUR HEART J, V40, P3859, DOI 10.1093/eurheartj/ehz835; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Lane DA, 2009, THROMB HAEMOSTASIS, V101, P802, DOI 10.1160/TH09-02-0106; Lang C, 2017, STROKE, V48, P778, DOI 10.1161/STROKEAHA.116.015900; Lanza GA, 2010, CIRCULATION, V121, P2317, DOI 10.1161/CIRCULATIONAHA.109.900191; Lawson CA, 2019, LANCET PUBLIC HEALTH, V4, pE406, DOI 10.1016/S2468-2667(19)30108-2; Lee MO, 2012, ARTERIOSCL THROM VAS, V32, P343, DOI 10.1161/ATVBAHA.111.237651; Lee MS, 2013, AM J CARDIOL, V112, P1688, DOI 10.1016/j.amjcard.2013.07.031; Lefebvre KM, 2015, VASC MED, V20, P51, DOI 10.1177/1358863X14565373; Legato MJ, 2016, JAMA-J AM MED ASSOC, V316, P1865, DOI 10.1001/jama.2016.13995; Leifheit-Limson EC, 2015, J AM COLL CARDIOL, V66, P1949, DOI 10.1016/j.jacc.2015.08.859; Leon LJ, 2019, CIRCULATION, V140, P1050, DOI 10.1161/CIRCULATIONAHA.118.038080; Leone O, 2004, EUR HEART J, V25, P1237, DOI 10.1016/j.ehj.2004.04.007; Lesperance F, 2002, CIRCULATION, V105, P1049, DOI 10.1161/hc0902.104707; Lichtman JH, 2015, CIRC-CARDIOVASC QUAL, V8, pS31, DOI 10.1161/CIRCOUTCOMES.114.001612; Lilyasari O, 2020, FRONT SURG, V7, DOI 10.3389/fsurg.2020.00047; Linde C, 2018, EUROPACE, V20, P1565, DOI 10.1093/europace/euy067; Linde C, 2018, EUR J HEART FAIL, V20, P780, DOI 10.1002/ejhf.1133; Linde C, 2015, EUROPACE, V17, P424, DOI 10.1093/europace/euu205; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lloyd-Jones DM, 2019, J AM COLL CARDIOL, V73, P3153, DOI 10.1016/j.jacc.2018.11.005; Lloyd-Williams F, 2003, J CLIN EPIDEMIOL, V56, P1157, DOI 10.1016/S0895-4356(03)00205-1; Lo RC, 2014, J VASC SURG, V59, P409, DOI 10.1016/j.jvs.2013.07.114; Lopez AD, 2019, INT J EPIDEMIOL, V48, P1815, DOI 10.1093/ije/dyz143; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Lovell M, 2009, CAN J CARDIOL, V25, P39, DOI 10.1016/S0828-282X(09)70021-2; Loyaga-Rendon RY, 2014, CIRC-HEART FAIL, V7, P300, DOI 10.1161/CIRCHEARTFAILURE.113.000721; Lundberg GP, 2019, MENOPAUSE HORMONE TH; Luzier AB, 1999, CLIN PHARMACOL THER, V66, P594, DOI 10.1053/cp.1999.v66.103400001; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Lyon AR, 2016, EUR J HEART FAIL, V18, P8, DOI 10.1002/ejhf.424; Maas AHEM, 2019, MATURITAS, V124, P68, DOI 10.1016/j.maturitas.2019.03.021; MacFadden DR, 2012, ANN INTERN MED, V156, P195, DOI 10.7326/0003-4819-156-3-201202070-00007; Mahmoud KD, 2013, EUR HEART J-ACUTE CA, V2, P166, DOI 10.1177/2048872613481449; Manrique-Garcia E, 2011, J EPIDEMIOL COMMUN H, V65, P301, DOI 10.1136/jech.2009.104075; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855; Mason SA, 2009, BIOCHEM BIOPH RES CO, V388, P565, DOI 10.1016/j.bbrc.2009.08.050; Matthews KA, 2017, STROKE, V48, P70, DOI 10.1161/STROKEAHA.116.014743; Matthews KA, 2009, J AM COLL CARDIOL, V54, P2366, DOI 10.1016/j.jacc.2009.10.009; McDermott MM, 2003, J AM GERIATR SOC, V51, P222, DOI 10.1046/j.1532-5415.2003.51061.x; McGrady M, 2012, HEART, V98, P1562, DOI 10.1136/heartjnl-2012-302229; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; McMurray JJV, 2020, CIRCULATION, V141, P338, DOI 10.1161/CIRCULATIONAHA.119.044491; McNamara DM, 2015, J AM COLL CARDIOL, V66, P905, DOI 10.1016/j.jacc.2015.06.1309; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; de Chazal HM, 2018, J AM COLL CARDIOL, V72, P1955, DOI 10.1016/j.jacc.2018.07.072; Mehta S, 2017, INDIAN HEART J, V69, pS1, DOI 10.1016/j.ihj.2016.12.020; Melberg T, 2013, AM HEART J, V166, P839, DOI 10.1016/j.ahj.2013.07.034; Melloni C, 2010, CIRC-CARDIOVASC QUAL, V3, P135, DOI 10.1161/CIRCOUTCOMES.110.868307; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Merkatz R B, 1998, J Obstet Gynecol Neonatal Nurs, V27, P78, DOI 10.1111/j.1552-6909.1998.tb02594.x; Merz CNB, 2017, J AM COLL CARDIOL, V70, P123, DOI 10.1016/j.jacc.2017.05.024; Merz CNB, 2017, CIRCULATION, V135, P1075, DOI 10.1161/CIRCULATIONAHA.116.024534; Merz CNB, 2016, J WOMENS HEALTH, V25, P875, DOI 10.1089/jwh.2015.5441; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Miller SM, 2019, ANN VASC SURG, V58, P54, DOI 10.1016/j.avsg.2019.01.006; Minissian MB, 2018, CIRCULATION, V137, P865, DOI 10.1161/CIRCULATIONAHA.117.031403; Mocumbi AO, 2016, CARDIOVASC J AFR, V27, P84, DOI 10.5830/CVJA-2016-018; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82; Mosca L, 2010, CIRC-CARDIOVASC QUAL, V3, P120, DOI 10.1161/CIRCOUTCOMES.109.915538; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; MOSSERI M, 1986, CIRCULATION, V74, P964, DOI 10.1161/01.CIR.74.5.964; Myerburg RJ, 2012, CIRCULATION, V125, P1043, DOI 10.1161/CIRCULATIONAHA.111.023846; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Najjar RS, 2018, CLIN CARDIOL, V41, P1062, DOI 10.1002/clc.23027; Nakashima T, 2016, INT J CARDIOL, V207, P341, DOI 10.1016/j.ijcard.2016.01.188; NANNA MG, 2019, CIRC-CARDIOVASC QUAL, V12, DOI DOI 10.1161/CIRCOUTCOMES.118.005562; National Collaborating Centre for Infectious Diseases, 2015, UNDERSTANDING MEASUR; National Institutes of Health, 2015, CONS SEX BIOL VAR NI; Navar-Boggan AM, 2015, J AM COLL CARDIOL, V65, P1633, DOI 10.1016/j.jacc.2015.02.025; Newby DE, 2015, EUR HEART J, V36, P83, DOI 10.1093/eurheartj/ehu458; Newton TL, 2005, BIOL PSYCHOL, V70, P121, DOI 10.1016/j.biopsycho.2004.12.003; Nguyen LL, 2007, J VASC SURG, V46, P1191, DOI 10.1016/j.jvs.2007.07.053; Nguyen LL, 2009, CIRCULATION, V119, P123, DOI 10.1161/CIRCULATIONAHA.108.810341; Nielsen PB, 2018, CIRCULATION, V137, P832, DOI 10.1161/CIRCULATIONAHA.117.029081; Nishiguchi T, 2016, EUR HEART J-ACUTE CA, V5, P263, DOI 10.1177/2048872613504310; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Noone AM, 2018, SEER CANC STAT REV 1; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; O'Neil A, 2018, CIRCULATION, V137, P854, DOI 10.1161/CIRCULATIONAHA.117.028595; O'Neil A, 2016, J AFFECT DISORDERS, V196, P117, DOI 10.1016/j.jad.2016.02.029; Ohkuma T, 2019, DIABETOLOGIA, V62, P1550, DOI 10.1007/s00125-019-4926-x; Okello E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043917; Olie V, 2020, EUR J PUBLIC HEALTH, V30, P380, DOI 10.1093/eurpub/ckz171; Ong P, 2018, INT J CARDIOL, V250, P16, DOI 10.1016/j.ijcard.2017.08.068; Packer DL, 2019, JAMA-J AM MED ASSOC, V321, P1261, DOI 10.1001/jama.2019.0693; Packer M, 2020, NEW ENGL J MED, V383, P1413, DOI 10.1056/NEJMoa2022190; Padro T, 2020, CARDIOVASC RES, V116, P741, DOI 10.1093/cvr/cvaa003; Pagidipati NJ, 2016, NAT REV CARDIOL, V13, P471, DOI 10.1038/nrcardio.2016.89; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Parekh Ameeta, 2011, Expert Rev Clin Pharmacol, V4, P453, DOI 10.1586/ecp.11.29; Pasupathy S, 2015, CIRCULATION, V131, P861, DOI 10.1161/CIRCULATIONAHA.114.011201; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2901; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Pelletier R, 2016, J AM COLL CARDIOL, V67, P127, DOI 10.1016/j.jacc.2015.10.067; Perez MV, 2019, NEW ENGL J MED, V381, P1909, DOI 10.1056/NEJMoa1901183; Pessel C, 2014, SEMIN PERINATOL, V38, P273, DOI 10.1053/j.semperi.2014.04.016; Peters SAE, 2020, NEUROLOGY, V95, pE2715, DOI 10.1212/WNL.0000000000010982; Peters SAE, 2018, HEART, V104, P1069, DOI 10.1136/heartjnl-2017-312289; Peters SAE, 2018, J AM COLL CARDIOL, V71, P1729, DOI 10.1016/j.jacc.2018.02.032; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Peterson Eric D, 2004, Am J Geriatr Cardiol, V13, P11, DOI 10.1111/j.1076-7460.2004.01709.x; Phan HT, 2019, STROKE, V50, P2299, DOI 10.1161/STROKEAHA.118.024437; Phan HT, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003436; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1016/j.atherosclerosis.2016.05.037, 10.1177/2047487316653709]; Piers LS, 2003, EUR J CLIN NUTR, V57, P956, DOI 10.1038/sj.ejcn.1601630; Planer D, 2014, CIRC-CARDIOVASC INTE, V7, P285, DOI 10.1161/CIRCINTERVENTIONS.113.000606; Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Prasad M, 2015, AM J CARDIOL, V115, P1672, DOI 10.1016/j.amjcard.2015.03.011; Prata J, 2014, CARDIOL REV, V22, P25, DOI 10.1097/CRD.0b013e31829e852b; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Proietti M, 2015, EUR HEART J-CARDIOVA, V1, P150, DOI 10.1093/ehjcvp/pvv012; Qasim H, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006353; Randolph TC, 2017, AM HEART J, V189, P48, DOI 10.1016/j.ahj.2017.04.001; Rankin JS, 2006, J THORAC CARDIOV SUR, V131, P547, DOI 10.1016/j.jtcvs.2005.10.041; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rashid HNZ, 2016, INT J CARDIOL, V202, P336, DOI 10.1016/j.ijcard.2015.09.072; Rawshani A, 2018, LANCET, V392, P477, DOI 10.1016/S0140-6736(18)31506-X; Redford S, 2018, WHAT DATA SOURCES GO; Redfors B, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001995; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Regitz-Zagrosek V, 2018, EUR HEART J, V39, P3165, DOI 10.1093/eurheartj/ehy340; Reid JM, 2008, STROKE, V39, P1090, DOI 10.1161/STROKEAHA.107.495143; Reimers AK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223928; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Retnakaran R, 2018, DIABETES RES CLIN PR, V145, P193, DOI 10.1016/j.diabres.2018.04.008; Reynolds HR, 2021, CIRCULATION, V143, P624, DOI 10.1161/CIRCULATIONAHA.120.052008; Reynolds HR, 2020, JAMA CARDIOL, V5, P773, DOI 10.1001/jamacardio.2020.0822; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Roffi M, 2013, EUR HEART J-ACUTE CA, V2, P342, DOI 10.1177/2048872613490382; Romond EH, 2012, J CLIN ONCOL, V30, P3792, DOI 10.1200/JCO.2011.40.0010; Roos-Hesselink J, 2019, EUR HEART J, V40, P3848, DOI 10.1093/eurheartj/ehz136; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Rossello X, 2019, EUR J PREV CARDIOL, V26, P1534, DOI 10.1177/2047487319846715; Rossello X, 2020, EUR J HEART FAIL, V22, P834, DOI 10.1002/ejhf.1740; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Roth GA, 2015, CIRCULATION, V132, P1270, DOI 10.1161/CIRCULATIONAHA.115.016021; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Russo AM, 2021, CIRCULATION, V143, P661, DOI 10.1161/CIRCULATIONAHA.120.051558; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Santema BT, 2019, LANCET, V394, P1254, DOI 10.1016/S0140-6736(19)31792-1; Sarma AA, 2019, J AM COLL CARDIOL, V74, P3013, DOI 10.1016/j.jacc.2019.09.065; Sattar N, 2019, CIRCULATION, V139, P2228, DOI 10.1161/CIRCULATIONAHA.118.037885; Savji N, 2018, JACC-HEART FAIL, V6, P701, DOI 10.1016/j.jchf.2018.05.018; Saw J, 2019, EUR HEART J, V40, P1188, DOI 10.1093/eurheartj/ehz007; Saw J, 2017, J AM COLL CARDIOL, V70, P1148, DOI 10.1016/j.jacc.2017.06.053; Saw J, 2016, J AM COLL CARDIOL, V68, P297, DOI 10.1016/j.jacc.2016.05.034; Saw J, 2014, CIRC-CARDIOVASC INTE, V7, P645, DOI 10.1161/CIRCINTERVENTIONS.114.001760; Saw J, 2014, CAN J CARDIOL, V30, P814, DOI 10.1016/j.cjca.2014.01.011; Saw J, 2013, CAN J CARDIOL, V29, P1027, DOI 10.1016/j.cjca.2012.12.018; Saw J, 2013, JACC-CARDIOVASC INTE, V6, P44, DOI 10.1016/j.jcin.2012.08.017; Schoenfeld SR, 2016, ANN RHEUM DIS, V75, P1315, DOI 10.1136/annrheumdis-2015-207714; Schrage B, 2019, CIRCULATION, V140, P1530, DOI 10.1161/CIRCULATIONAHA.119.043012; Schultz WM, 2018, CIRCULATION, V137, P2166, DOI 10.1161/CIRCULATIONAHA.117.029652; Schumacher HC, 2007, ANN EMERG MED, V50, P99, DOI 10.1016/j.annemergmed.2007.01.021; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Scott-Storey KA, 2013, J CARDIOVASC NURS, V28, pE1, DOI 10.1097/JCN.0b013e318279e372; Sever P, 2021, EUR J PREV CARDIOL, V28, P805, DOI 10.1177/2047487320902750; Sharma Garima, 2020, JACC Case Rep, V2, P1407, DOI 10.1016/j.jaccas.2020.04.027; Sharma JB, 2018, INDIAN HEART J, V70, P685, DOI 10.1016/j.ihj.2018.01.018; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Shaw LJ, 2006, CIRCULATION, V114, P894, DOI 10.1161/CIRCULATIONAHA.105.609990; Shaw LJ, 2017, J AM COLL CARDIOL, V70, P373, DOI 10.1016/j.jacc.2017.05.051; Shekelle PG, 2003, J AM COLL CARDIOL, V41, P1529, DOI 10.1016/S0735-1097(03)00262-6; Sigvant B, 2007, J VASC SURG, V45, P1185, DOI 10.1016/j.jvs.2007.02.004; Simmons A, 2012, REV CARDIOVASC MED, V13, pE37, DOI 10.3909/ricm0589; Singal A, 2021, CIRCULATION, V143, DOI 10.1161/circ.143.suppl_1.P011; Singh SM, 2016, J CARDIOVASC ELECTR, V27, P1259, DOI 10.1111/jce.13051; Sliwa K, 2020, JACC-HEART FAIL, V8, P100, DOI 10.1016/j.jchf.2019.09.001; Sliwa K, 2018, EUR J HEART FAIL, V20, P951, DOI 10.1002/ejhf.1178; Sliwa K, 2016, LANCET, V387, P2072, DOI 10.1016/S0140-6736(16)30391-9; Sliwa K, 2014, HEART, V100, P1967, DOI 10.1136/heartjnl-2014-306199; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; Sliwa K, 2010, CIRCULATION, V121, P1465, DOI 10.1161/CIRCULATIONAHA.109.901496; Sliwa K, 2010, EUR HEART J, V31, P719, DOI 10.1093/eurheartj/ehp530; Smilowitz NR, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003443; Smith EE, 2017, CLIN SCI, V131, P1059, DOI 10.1042/CS20160607; Song HK, 2008, ANN THORAC SURG, V85, P2040, DOI 10.1016/j.athoracsur.2008.02.082; Song PG, 2019, LANCET GLOB HEALTH, V7, pE1020, DOI 10.1016/S2214-109X(19)30255-4; Spagnolo PA, 2020, ANN INTERN MED, V173, P385, DOI 10.7326/M20-1941; Sredhar K, 2013, AM J EPIDEMIOL INFEC, V1, P34; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P1313, DOI 10.1056/NEJM198811173192004; Stapel B, 2017, EUR HEART J, V38, P349, DOI 10.1093/eurheartj/ehw086; Stecker EC, 2014, CIRC-ARRHYTHMIA ELEC, V7, P212, DOI 10.1161/CIRCEP.113.001034; Steinberg ZL, 2017, J AM COLL CARDIOL, V69, P2681, DOI 10.1016/j.jacc.2017.03.605; Stene LE, 2013, J WOMENS HEALTH, V22, P250, DOI 10.1089/jwh.2012.3920; Stringhini S, 2018, INT J EPIDEMIOL, V47, P36, DOI 10.1093/ije/dyx106; Sy F, 2013, AM J CARDIOL, V112, P479, DOI 10.1016/j.amjcard.2013.04.010; Tamis-Holland JE, 2019, CIRCULATION, V139, pE891, DOI 10.1161/CIR.0000000000000670; Taqueti VR, 2018, J AM COLL CARDIOL, V72, P2625, DOI 10.1016/j.jacc.2018.09.042; Taylor C, 2017, J CLIN ONCOL, V35, P1641, DOI 10.1200/JCO.2016.72.0722; Taylor CJ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l223; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Tepper NK, 2018, J WOMENS HEALTH, V27, P413, DOI 10.1089/jwh.2018.6985; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Timpka S, 2018, EUR J EPIDEMIOL, V33, P1003, DOI 10.1007/s10654-018-0429-1; Tsadok MA, 2015, HEART RHYTHM, V12, P1979, DOI [10.1016/j.hrthm.20l5.06.029, 10.1016/j.hrthm.2015.06.029]; Turner-McGrievy GM, 2015, NUTRITION, V31, P350, DOI 10.1016/j.nut.2014.09.002; Tweet MS, 2017, J AM COLL CARDIOL, V70, P426, DOI 10.1016/j.jacc.2017.05.055; Tzikas A, 2016, EUROINTERVENTION, V11, P1170, DOI 10.4244/EIJY15M01_06; Udell JA, 2018, CLIN CARDIOL, V41, P758, DOI 10.1002/clc.22938; Udell JA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004319; UN Sustainable Development Goals, GOAL 3 ENSURE HLTH L; UN Women, PROGR WORLDS WOM 201; UN Women, SHAD PAN VIOL WOM DU; UN Women, SDG 3 ENS HEALTH LIV; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2018, CIRCULATION, V137, P794, DOI 10.1161/CIRCULATIONAHA.117.030849; van Hagen IM, 2018, CIRCULATION, V137, P806, DOI 10.1161/CIRCULATIONAHA.117.032561; Varma N, 2014, HEART RHYTHM, V11, P1139, DOI 10.1016/j.hrthm.2014.04.001; Vassileva CM, 2013, ANN THORAC SURG, V96, P1367, DOI 10.1016/j.athoracsur.2013.04.055; Vidyasagaran AL, 2016, EUR J PREV CARDIOL, V23, P1970, DOI 10.1177/2047487316654026; Dantas APV, 2012, EXP DIABETES RES, DOI 10.1155/2012/570598; Voigt K, 2017, PUBLIC HEALTH ETH-UK, V10, P244, DOI 10.1093/phe/phx012; von Dadelszen P, 2017, OBSTET MED, V10, P5, DOI 10.1177/1753495X16686287; Vouyouka AG, 2010, J VASC SURG, V52, P1196, DOI 10.1016/j.jvs.2010.05.106; Walli-Attaei M, 2020, LANCET, V396, P97, DOI 10.1016/S0140-6736(20)30543-2; Watkins DA, 2017, NEW ENGL J MED, V377, P713, DOI 10.1056/NEJMoa1603693; Wedekind H, 2006, HERZ, V31, P339, DOI 10.1007/s00059-006-2822-x; Wei J, 2017, AM HEART J, V191, P30, DOI 10.1016/j.ahj.2017.06.005; Wenger NK, 2018, J AM COLL CARDIOL, V71, P1797, DOI 10.1016/j.jacc.2018.02.033; Wheeler A, 2013, AM J CARDIOL, V112, P656, DOI 10.1016/j.amjcard.2013.04.042; WHO, 2004, LANCET, V363, P902; Wilkinson C, 2019, HEART, V105, P516, DOI 10.1136/heartjnl-2018-313959; Wilsgaard T, 2000, ARCH INTERN MED, V160, P2847, DOI 10.1001/archinte.160.18.2847; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Wise LA, 2002, J EPIDEMIOL COMMUN H, V56, P851, DOI 10.1136/jech.56.11.851; Wissenberg M, 2014, RESUSCITATION, V85, P1212, DOI 10.1016/j.resuscitation.2014.06.008; Wolters FJ, 2019, ARTERIOSCL THROM VAS, V39, P1542, DOI 10.1161/ATVBAHA.119.311908; Wong SC, 2001, J AM COLL CARDIOL, V38, P1395, DOI 10.1016/S0735-1097(01)01581-9; Wright EN, 2019, PREV MED, V121, P47, DOI 10.1016/j.ypmed.2019.01.016; Wright EN, 2021, J INTERPERS VIOLENCE, V36, pNP6643, DOI 10.1177/0886260518816324; Xu X, 2017, PSYCHOSOM MED, V79, P50, DOI 10.1097/PSY.0000000000000429; Xu Z, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2015.11.005; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Yandrapalli S, 2019, J AM COLL CARDIOL, V73, P573, DOI 10.1016/j.jacc.2018.10.084; Yoon SH, 2019, EUR HEART J, V40, P441, DOI 10.1093/eurheartj/ehy590; Young L, 2019, HEART, V105, P1656, DOI 10.1136/heartjnl-2018-314268; Yusuf S, 2021, NEW ENGL J MED, V384, P216, DOI 10.1056/NEJMoa2028220; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177; Zafar F, 2017, JACC-HEART FAIL, V5, P123, DOI 10.1016/j.jchf.2016.09.009; Zamorano J, 2016, EUR HEART J-CARD IMG, V17, P9, DOI 10.1093/ehjci/jev282; Zareba W, 2011, CIRCULATION, V123, P1061, DOI 10.1161/CIRCULATIONAHA.110.960898; Zhang WZ, 2013, CARDIOVASC J AFR, V24, P28, DOI 10.5830/CVJA-2012-076; Zhang Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35773-x; Zhao D, 2018, J AM COLL CARDIOL, V71, P2555, DOI 10.1016/j.jacc.2018.01.083; Zhao LQ, 2016, ONCOTARGET, V7, P33715, DOI 10.18632/oncotarget.9553; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zhou YQ, 2017, GYNECOL ENDOCRINOL, V33, P904, DOI 10.1080/09513590.2017.1347779; Zhu DS, 2019, LANCET PUBLIC HEALTH, V4, pE553, DOI 10.1016/S2468-2667(19)30155-0; Zuhlke L, 2016, CARDIOVASC J AFR, V27, P79, DOI 10.5830/CVJA-2016-017; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449; Zuhlke L, 2016, CIRCULATION, V134, P1456, DOI 10.1161/CIRCULATIONAHA.116.024769; Zuhlke Liesl J, 2017, Curr Treat Options Cardiovasc Med, V19, P15, DOI 10.1007/s11936-017-0513-y; Zuhlke LJ, 2013, GLOB HEART, V8, P235, DOI 10.1016/j.gheart.2013.08.009; Adeboye B, 2012, CARDIOVASC J AFR, V23, P512, DOI 10.5830/CVJA-2012-040; African Tobacco Control Alliance, 2016, BIG TOB TIN TARG TOB; Alegre-Diaz J, 2016, NEW ENGL J MED, V375, P1961, DOI 10.1056/NEJMoa1605368; Alshahrani H, 2014, EUR J CARDIOVASC NUR, V13, P399, DOI 10.1177/1474515113507159; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Balfour PC, 2016, J LAT O PSYCHOL, V4, P98, DOI 10.1037/lat0000056; Barcelo A, 2006, LANCET, V368, P625, DOI 10.1016/S0140-6736(06)69223-4; Barreto SM, 2012, INT J EPIDEMIOL, V41, P557, DOI 10.1093/ije/dys017; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Bhalla V, 2006, SMJ Singapore Medical Journal, V47, P841; Cappuccio FP, 2016, INTERN EMERG MED, V11, P299, DOI 10.1007/s11739-016-1423-9; Carnethon MR, 2017, CIRCULATION, V136, pE393, DOI 10.1161/CIR.0000000000000534; Castro A, 2015, REV PANAM SALUD PUBL, V38, P96; CDC, 2020, NAT DIAB STAT REP 20; Centres for Disease Control and Prevention, HUS 2018 TREND TABL; Champagne BM, 2010, TOB CONTROL, V19, P457, DOI 10.1136/tc.2009.031666; Choi HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178334; Cresswell JA, 2016, TROP MED INT HEALTH, V21, P879, DOI 10.1111/tmi.12713; Dewi FS., 2010, GLOBAL HEALTH ACTION, V3, P3; DuMonthier A., 2017, STATUS BLACK WOMEN U; Escobedo J, 2009, DIABETIC MED, V26, P864, DOI 10.1111/j.1464-5491.2009.02795.x; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Eurostat, 2020, TOB CONS STAT 2014; Forster T, 2018, HLTH INEQUALITIES EU; Go AS, 2014, CIRCULATION, V129, P28; Gomez-Olive FX, 2017, GLOB HEART, V12, P81, DOI 10.1016/j.gheart.2017.01.007; Grace C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1931; Green S., 2017, VIOLENCE BLACK WOMEN; Gudmundsdottir H, 2012, THER ADV CHRONIC DIS, V3, P137, DOI 10.1177/2040622312438935; Gupta R, 2018, INDIAN HEART J, V70, P802, DOI 10.1016/j.ihj.2017.11.011; Heron Melonie, 2016, Natl Vital Stat Rep, V65, P1; Kandala NB, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-018-0907-9; Klasen S, 2009, FEM ECON, V15, P91, DOI 10.1080/13545700902893106; Kochanek Kenneth D, 2019, Natl Vital Stat Rep, V68, P1; Lecours N, 2016, REV PANAM SALUD PUBL, V40, P202; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Macia E, 2017, CARDIOVASC J AFR, V28, P324, DOI [10.5830/CVJA-2017-034, 10.5830/cvja-2017-034]; Martiniuk ALC, 2007, J HYPERTENS, V25, P73, DOI 10.1097/HJH.0b013e328010775f; Maziak W, 2009, INT J PUBLIC HEALTH, V54, P349, DOI 10.1007/s00038-009-0061-7; Mehta R, 2016, J LIPID RES, V57, P2115, DOI 10.1194/jlr.R072231; Ministry of Health of Chile, 2017, NAT HLTH SURV 2016 2; Mobaraki A. E. H., 2010, Eastern Mediterranean Health Journal, V16, P113; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Movsisyan NK, 2020, ANN GLOB HEALTH, V86, DOI 10.5334/aogh.2713; Muncan B, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0109-4; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; Naing C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002417; Ngwenya Nomusa A., 2017, Curationis, V40, P1, DOI 10.4102/curationis.v40i1.1662; Oertelt-Prigione S, 2020, ECLINICALMEDICINE, V20, DOI 10.1016/j.eclinm.2020.100305; Otang-Mbeng W, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0098-9; Pan American Health Organization and WHO, MORT AM; Rabanal KS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016819; Rajadurai J, 2012, NAT REV CARDIOL, V9, P464, DOI 10.1038/nrcardio.2012.59; Roudi-Fahimi F, 2006, AL RAIDA, V23-24, P4; Saldarriaga Clara, 2016, Rev. Colomb. Cardiol., V23, P163, DOI 10.1016/j.rccar.2015.07.005; Santos RD, 2011, J CLIN LIPIDOL, V5, P124, DOI 10.1016/j.jacl.2011.02.006; Singapore Heart Foundation, 2020, WOMEN HEART DIS; Sliwa K, 2011, EUR HEART J, V32, P61; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Sliwa K, 2010, HEART, V96, P1878, DOI 10.1136/hrt.2010.206938; Smedley B.D, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Stewart S, 2008, CIRCULATION, V118, P2360, DOI 10.1161/CIRCULATIONAHA.108.786244; Tao LC, 2015, INT J CLIN EXP MED, V8, P1611; Tejero ME, 2010, NUTR METAB CARDIOVAS, V20, P405, DOI 10.1016/j.numecd.2010.02.005; Tibazarwa K, 2009, INT J CARDIOL, V132, P233, DOI 10.1016/j.ijcard.2007.11.067; US Department of Health and Human Services-Health Resources and Services Administration, 2011, WOM HLTH US 2011; US National Center for Chronic Disease Prevention and Health Promotion, 2015, 2004 SURG GEN REP HL; WHO, 2008, HLTH PROM MOR PHYS; WHO, 2015, EMP WOM FAC CHALL TO; WHO, 2009, WHO STAT INF SYST WH; WHO, 2017, GLOB HLTH OBS DAT RE; WHO, 2015, NONC DIS THEIR RISK; WHO, 2020, EUR HLTH INF GAT TOB; Wilson N, 2010, HEART LUNG CIRC, V19, P282, DOI 10.1016/j.hlc.2010.02.021; Woodward M, 2011, WOMENS HEALTH, V7, P305, DOI [10.2217/WHE.11.25, 10.2217/whe.11.25]; World Health Organization, GLOB HLTH OBS DAT RE	577	134	139	39	83	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2021	397	10292					2385	2438		10.1016/S0140-6736(21)00684-X	http://dx.doi.org/10.1016/S0140-6736(21)00684-X		JUN 2021	54	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SU4QL	34010613				2022-12-28	WOS:000663124100026
J	Cui, C; Chakraborty, K; Tang, XA; Zhou, GL; Schoenfelt, KQ; Becker, KM; Hoffman, A; Chang, YF; Blank, A; Reardon, CA; Kenny, HA; Vaisar, T; Lengyel, E; Greene, G; Becker, L				Cui, Chang; Chakraborty, Kasturi; Tang, Xu Anna; Zhou, Guolin; Schoenfelt, Kelly Q.; Becker, Kristen M.; Hoffman, Alexandria; Chang, Ya-Fang; Blank, Ariane; Reardon, Catherine A.; Kenny, Hilary A.; Vaisar, Tomas; Lengyel, Ernst; Greene, Geoffrey; Becker, Lev			Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis	CELL			English	Article							PORCINE PANCREATIC ELASTASE; HUMAN-LEUKOCYTE; HISTONE H1; INHIBITION; EXPRESSION; PHENOTYPE; MECHANISM; MIGRATION; ADHESION; BINDING	Cancer cell genetic variability and similarity to host cells have stymied development of broad anti-cancer therapeutics. Our innate immune system evolved to clear genetically diverse pathogens and limit host toxicity; however, whether/how innate immunity can produce similar effects in cancer is unknown. Here, we show that human, but not murine, neutrophils release catalytically active neutrophil elastase (ELANE) to kill many cancer cell types while sparing non-cancer cells. ELANE proteolytically liberates the CD95 death domain, which interacts with histone H1 isoforms to selectively eradicate cancer cells. ELANE attenuates primary tumor growth and produces a CD8(+)T cell-mediated abscopal effect to attack distant metastases. Porcine pancreatic elastase (ELANE homolog) resists tumor-derived protease inhibitors and exhibits markedly improved therapeutic efficacy. Altogether, our studies suggest that ELANE kills genetically diverse cancer cells with minimal toxicity to non-cancer cells, raising the possibility of developing it as a broad anti-cancer therapy.	[Cui, Chang; Kenny, Hilary A.; Lengyel, Ernst; Greene, Geoffrey; Becker, Lev] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Cui, Chang; Chakraborty, Kasturi; Tang, Xu Anna; Zhou, Guolin; Schoenfelt, Kelly Q.; Becker, Kristen M.; Hoffman, Alexandria; Chang, Ya-Fang; Blank, Ariane; Reardon, Catherine A.; Greene, Geoffrey; Becker, Lev] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Hoffman, Alexandria; Becker, Lev] Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA; [Kenny, Hilary A.; Lengyel, Ernst] Univ Chicago, Dept Obstet & Gynecol, Sect Gynecol Oncol, Chicago, IL 60637 USA; [Vaisar, Tomas] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Lengyel, Ernst; Greene, Geoffrey; Becker, Lev] Univ Chicago, Comprehens Canc Ctr, Chicago, IL 60637 USA; [Lengyel, Ernst; Greene, Geoffrey; Becker, Lev] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Washington; University of Washington Seattle; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Chicago	Becker, L (corresponding author), Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA.; Becker, L (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.; Becker, L (corresponding author), Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA.; Becker, L (corresponding author), Univ Chicago, Comprehens Canc Ctr, Chicago, IL 60637 USA.; Becker, L (corresponding author), Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA.	levb@uchicago.edu	Chakraborty, Kasturi/AAT-1122-2020	Chakraborty, Kasturi/0000-0002-0635-9028	Ludwig Fund for Cancer Research; Virginia and D.K. Ludwig Fund for Cancer Research; University of Chicago Medicine Comprehensive Cancer Center Janet D. Rowley Discovery Fund; University of Chicago Cancer Research Foundation J. Clifford Moos Award; Ruth Bruch Triple Negative Breast Cancer Research Award; Women's Board Faculty Research Startup Funds and Ben May Department Startup Funds; Bernice Goldblatt Scholarship; Schmidt Science Fellowship; Rhodes Trust	Ludwig Fund for Cancer Research; Virginia and D.K. Ludwig Fund for Cancer Research; University of Chicago Medicine Comprehensive Cancer Center Janet D. Rowley Discovery Fund; University of Chicago Cancer Research Foundation J. Clifford Moos Award; Ruth Bruch Triple Negative Breast Cancer Research Award; Women's Board Faculty Research Startup Funds and Ben May Department Startup Funds; Bernice Goldblatt Scholarship; Schmidt Science Fellowship; Rhodes Trust	We thank the healthy blood donors and patients for their collaboration, Ani Solanki for assistance with tail vein injections, Dr. Anna Dembo for providing MMTV-PyMT mice, Dr. Payal Tiwari for initial guidance on human tissue processing, Drs. Xiaoyang Wu and Cynthia Li for providing murine primary keratinocytes, and numerous University of Chicago professors (see STAR Methods) for generously providing us with cancer cell lines. This work was supported by the Ludwig Fund for Cancer Research (L.B.), the Virginia and D.K. Ludwig Fund for Cancer Research (G.G.), University of Chicago Medicine Comprehensive Cancer Center Janet D. Rowley Discovery Fund (L.B.), University of Chicago Cancer Research Foundation J. Clifford Moos Award (L.B.), Ruth Bruch Triple Negative Breast Cancer Research Award (G.G.), and Women's Board Faculty Research Startup Funds and Ben May Department Startup Funds (L.B.). C.C. was supported by a Bernice Goldblatt Scholarship. K.C. was supported by a Schmidt Science Fellowship, in partnership with the Rhodes Trust.	Becker L, 2010, CELL METAB, V11, P125, DOI 10.1016/j.cmet.2010.01.003; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Catalfamo M, 2003, CURR OPIN IMMUNOL, V15, P522, DOI 10.1016/S0952-7915(03)00114-6; Chang YH, 2012, MOL CELL PROTEOMICS, V11, P1320, DOI 10.1074/mcp.M112.017384; Chawla A, 2016, CANCER IMMUNOL IMMUN, V65, P741, DOI 10.1007/s00262-016-1841-6; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Colom B, 2015, IMMUNITY, V42, P1075, DOI 10.1016/j.immuni.2015.05.010; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; Dudani JS, 2018, ANNU REV CANC BIOL, V2, P353, DOI 10.1146/annurev-cancerbio-030617-050549; Eng JK, 2015, J AM SOC MASS SPECTR, V26, P1865, DOI 10.1007/s13361-015-1179-x; Eruslanov EB, 2017, TRENDS CANCER, V3, P149, DOI 10.1016/j.trecan.2016.12.006; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Fricker M, 2014, EXPERT OPIN DRUG DIS, V9, P629, DOI 10.1517/17460441.2014.909805; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kerros C, 2017, J BIOL CHEM, V292, P10295, DOI 10.1074/jbc.M116.773051; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kraunsoe JAE, 1996, BIOCHEMISTRY-US, V35, P9090, DOI 10.1021/bi953013b; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Kuhns Douglas B, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.im0723s111; Lee W, 2019, J EXP MED, V216, P176, DOI 10.1084/jem.20181170; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Mittendorf EA, 2012, CANCER RES, V72, P3153, DOI 10.1158/0008-5472.CAN-11-4135; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ngwa W, 2018, NAT REV CANCER, V18, P313, DOI 10.1038/nrc.2018.6; ORTWERTH BJ, 1994, CURR EYE RES, V13, P561, DOI 10.3109/02713689408999889; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Powell DR, 2016, TRENDS IMMUNOL, V37, P41, DOI 10.1016/j.it.2015.11.008; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Sato S, 2012, PATHOL INT, V62, P84, DOI 10.1111/j.1440-1827.2011.02755.x; Scaffidi P, 2016, BBA-GENE REGUL MECH, V1859, P533, DOI 10.1016/j.bbagrm.2015.09.008; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Shen MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098259; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Torrent M, 2008, BIOCHEMISTRY-US, V47, P3544, DOI 10.1021/bi702065b; Ungefroren H, 2001, J CELL SCI, V114, P2735; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Yan J, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/15384101.2014.950163; Yan N, 2003, NAT STRUCT BIOL, V10, P983, DOI 10.1038/nsb1203-983; YOUNG JD, 1986, NATURE, V321, P613, DOI 10.1038/321613a0	50	45	46	15	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3163	+	e21	10.1016/j.cell.2021.04.016	http://dx.doi.org/10.1016/j.cell.2021.04.016		JUN 2021	36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	33964209	Bronze			2022-12-28	WOS:000660014300009
J	Faust, JS; Du, CA; Mayes, KD; Li, SX; Lin, ZQ; Barnett, ML; Krumholz, HM				Faust, Jeremy S.; Du, Chengan; Mayes, Katherine Dickerson; Li, Shu-Xia; Lin, Zhenqiu; Barnett, Michael L.; Krumholz, Harlan M.			Mortality From Drug Overdoses, Homicides, Unintentional Injuries, Motor Vehicle Crashes, and Suicides During the Pandemic, March-August 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Faust, Jeremy S.] Brigham & Womens Hosp, Dept Emergency Med, 10 Vining St, Boston, MA 02115 USA; [Du, Chengan; Krumholz, Harlan M.] Yale Univ, Sch Med, Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Mayes, Katherine Dickerson] Harvard Affiliated Emergency Med Residency, Boston, MA USA; [Li, Shu-Xia; Lin, Zhenqiu] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Barnett, Michael L.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Faust, JS (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 10 Vining St, Boston, MA 02115 USA.	jsfaust@gmail.com	Barnett, Michael/AAF-4017-2019	Barnett, Michael/0000-0002-4884-6609	NCATS NIH HHS [UL1 TR001863] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		FBI, 2020, OV PREL UN CRIM REP; Holland KM, 2021, JAMA PSYCHIAT, V78, P372, DOI 10.1001/jamapsychiatry.2020.4402; Huskamp HA, 2020, JAMA-J AM MED ASSOC, V324, P2440, DOI 10.1001/jama.2020.21512; National Center for Health Statistics, MONTHL COUNTS DEATHS; National Highway Traffic Safety Administration, 2016, BEHAV RES	5	34	34	4	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2021	326	1					84	87		10.1001/jama.2021.8012	http://dx.doi.org/10.1001/jama.2021.8012		MAY 2021	5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG4UV	34019096	Green Published, Bronze			2022-12-28	WOS:000652627800001
J	Shi, WF; Gao, GF				Shi, Weifeng; Gao, George F.			Emerging H5N8 avian influenza viruses	SCIENCE			English	Editorial Material							OUTBREAKS		[Shi, Weifeng] Shandong First Med Univ & Shandong Acad Med Sci, Sch Publ Hlth, Jinan 250000, Peoples R China; [Shi, Weifeng] Shandong First Med Univ & Shandong Acad Med Sci, Key Lab Etiol & Epidemiol Emerging Infect Dis Uni, Tai An 271000, Shandong, Peoples R China; [Gao, George F.] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Microbiology, CAS	Shi, WF (corresponding author), Shandong First Med Univ & Shandong Acad Med Sci, Sch Publ Hlth, Jinan 250000, Peoples R China.; Shi, WF (corresponding author), Shandong First Med Univ & Shandong Acad Med Sci, Key Lab Etiol & Epidemiol Emerging Infect Dis Uni, Tai An 271000, Shandong, Peoples R China.	shiwf@ioz.ac.cn; gaof@im.ac.cn	Gao, George Fu/ABD-5229-2021		National Science and Technology Major Project [2018ZX10101004]; Taishan Scholars Program of Shandong Province; Academic Promotion Programme of Shandong First Medical University [2019QL006]	National Science and Technology Major Project; Taishan Scholars Program of Shandong Province; Academic Promotion Programme of Shandong First Medical University	This work was supported by National Science and Technology Major Project (2018ZX10101004) and theAcademic Promotion Programme of Shandong First Medical University (2019QL006).W.S. is supported by the Taishan Scholars Program of Shandong Province.	Bi YH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19671-3; Bi YH, 2016, CELL HOST MICROBE, V20, P810, DOI 10.1016/j.chom.2016.10.022; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Isoda N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12121439; Li YB, 2020, EMERG INFECT DIS, V26, P2956, DOI 10.3201/eid2612.201201; Lycett SJ, 2016, SCIENCE, V354, P213, DOI 10.1126/science.aaf8852; The WorldOrganisation for Animal Health (OIE), 2020, UPD AV INFL AN TYP H; WHO, 2020, CUM NUMB CONF HUM CA; WHO, 2021, HUM INF AV INFL H5N8; World Health Organization, 2021, INFL UPD 388; World Health Organization (WHO), 2011, EV AS H5 HEM; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yamaji R, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2099; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455	15	30	31	10	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					784	786		10.1126/science.abg6302	http://dx.doi.org/10.1126/science.abg6302			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SH2WJ	34016764				2022-12-28	WOS:000653997000021
J	Kim, LHY; Saleh, C; Whalen-Browne, A; O'Byrne, PM; Chu, DK				Kim, Lisa H. Y.; Saleh, Carol; Whalen-Browne, Anna; O'Byrne, Paul M.; Chu, Derek K.			Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-LIFE; LUNG-FUNCTION; TIOTROPIUM; GRADE; VALIDATION; TRIALS; GLYCOPYRRONIUM; EXACERBATIONS; QUESTIONNAIRE; INDACATEROL	IMPORTANCE The benefits and harms of adding long-acting muscarinic antagonists (LAMAs) to inhaled corticosteroids (ICS) and long-acting beta(2)-agonists (LABAs) for moderate to severe asthma remain unclear. OBJECTIVE To systematically synthesize the outcomes and adverse events associated with triple therapy (ICS, LABA, and LAMA) vs dual therapy (ICS plus LABA) in children and adults with persistent uncontrolled asthma. DATA SOURCES MEDLINE, Embase, CENTRAL, ICTRP, FDA, and EMA databases from November 2017, to December 8, 2020, without language restriction. STUDY SELECTION Two investigators independently selected randomized clinical trials (RCTs) comparing triple vs dual therapy in patients with moderate to severe asthma. DATA EXTRACTION AND SYNTHESIS Two reviewers independently extracted data and assessed risk of bias. Random-effects meta-analyses, including individual patient-level exacerbation data, were used. The GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach was used to assess certainty (quality) of the evidence. MAIN OUTCOMES AND MEASURES Severe exacerbations, asthma control (measured using the Asthma Control Questionnaire [ACQ-7], a 7-item list with each item ranging from 0 [totally controlled] to 6 [severely uncontrolled]; minimal important difference, 0.5), quality of life (measured using the Asthma-related Quality of Life [AQLQ] tool; score range, 1 [severely impaired] to 7 [no impairment]; minimal important difference, 0.5), mortality, and adverse events. RESULTS Twenty RCTs using 3 LAMA types that enrolled 11 894 children and adults (mean age, 52 years [range, 9-71 years]; 57.7% female) were included. High-certainty evidence showed that triple therapy vs dual therapy was significantly associated with a reduction in severe exacerbation risk (9 trials [9932 patients]; 22.7% vs 27.4%; risk ratio, 0.83 [95% CI, 0.77 to 0.90]) and an improvement in asthma control (14 trials [11 230 patients]; standardized mean difference [SMD], -0.06 [95% CI, -0.10 to -0.02]; mean difference in ACQ-7 scale, -0.04 [95% CI, -0.07 to -0.01]). There were no significant differences in asthma-related quality of life (7 trials [5247 patients]; SMD, 0.05 [95% CI, -0.03 to 0.13]; mean difference in AQLQ score, 0.05 [95% CI, -0.03 to 0.13]; moderate-certainty evidence) or mortality (17 trials [11 595 patients]; 0.12% vs 0.12%; risk ratio, 0.96 [95% CI, 0.33 to 2.75]; high-certainty evidence) between dual and triple therapy. Triple therapy was significantly associated with increased dry mouth and dysphonia (10 trials [7395 patients]; 3.0% vs 1.8%; risk ratio, 1.65 [95% CI, 1.14 to 2.38]; high-certainty evidence), but treatment-related and serious adverse events were not significantly different between groups (moderate-certainty evidence). CONCLUSIONS AND RELEVANCE Among children (aged 6 to 18 years) and adults with moderate to severe asthma, triple therapy, compared with dual therapy, was significantly associated with fewer severe asthma exacerbations and modest improvements in asthma control without significant differences in quality of life or mortality.	[Kim, Lisa H. Y.; Saleh, Carol; Whalen-Browne, Anna; O'Byrne, Paul M.; Chu, Derek K.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Chu, Derek K.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, New Zealand; [Chu, Derek K.] Res Inst St Joes Hamilton, Hamilton, ON, Canada	McMaster University	Chu, DK (corresponding author), McMaster Univ, Med Ctr, Dept Med, Div Clin Immunol & Allergy, 1280 Main St W,Room 3V41, Hamilton, ON L8S 4K1, Canada.; Chu, DK (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, 1280 Main St W,Room 3V41, Hamilton, ON L8S 4K1, Canada.	chudk@mcmaster.ca	T, E/HII-8943-2022	Chu, Derek/0000-0001-8269-4496				Akl EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057132; Akl EA, 2012, J CLIN EPIDEMIOL, V65, P262, DOI 10.1016/j.jclinepi.2011.04.015; Anderson WC, 2019, ANN ALLERG ASTHMA IM, V122, P367, DOI 10.1016/j.anai.2019.01.018; Aziz-Ur-Rehman A, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0190-0; Blais CM, 2016, RESP MED, V118, P96, DOI 10.1016/j.rmed.2016.07.017; Buels Kalmia S, 2012, Handb Exp Pharmacol, P317, DOI 10.1007/978-3-642-23274-9_14; Buhl R, 2020, RESP MED, V162, DOI 10.1016/j.rmed.2019.105859; Canonica GW, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2018.12.001; Cloutier MM, 2020, J ALLERGY CLIN IMMUN, V146, P1217, DOI 10.1016/j.jaci.2020.10.003; Cloutier MM, 2020, JAMA-J AM MED ASSOC, V324, P2301, DOI 10.1001/jama.2020.21974; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Dechartres A, 2014, JAMA-J AM MED ASSOC, V312, P623, DOI 10.1001/jama.2014.8166; Donohue JF, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0223-3; Global initiative for Asthma, 2020, GLOB STRAT ASTHM MAN; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Griffiths B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000060.pub2; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P173, DOI 10.1016/j.jclinepi.2012.08.001; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Hamelmann E, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01100-2016; Hoshino M, 2019, J ASTHMA, V56, P995, DOI 10.1080/02770903.2018.1514047; Institute for Clinical and Economic Review, 2018, BIOL THER TREATM AST; Ishiura Y, 2020, INT J CHRONIC OBSTR, V15, P269, DOI 10.2147/COPD.S231004; Ishiura Y, 2019, INT J CLIN PHARM TH, V57, P384, DOI 10.5414/CP203382; Jabbal S, 2017, CLIN EXP ALLERGY, V47, P1239, DOI 10.1111/cea.12972; Jabbal S, 2020, CLIN EXP ALLERGY, V50, P1140, DOI 10.1111/cea.13702; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kerstjens HAM, 2020, LANCET RESP MED, V8, P1000, DOI 10.1016/S2213-2600(20)30190-9; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Kerstjens HAM, 2011, J ALLERGY CLIN IMMUN, V128, P308, DOI 10.1016/j.jaci.2011.04.039; Kew KM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011721.pub2; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Kirkland SW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001284.pub2; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lee LA, 2021, LANCET RESP MED, V9, P69, DOI 10.1016/S2213-2600(20)30389-1; Lefebvre P, 2015, J ALLERGY CLIN IMMUN, V136, P1488, DOI 10.1016/j.jaci.2015.07.046; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Heart Lung and Blood Institute, 2014, NEEDS ASS REP POT UP; Ohta K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124109; Pearl Therapeutics, 2020, PEARL THERAPEUTICS E; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Rodrigo GJ, 2017, PEDIAT ALLERG IMM-UK, V28, P573, DOI 10.1111/pai.12759; Santanello NC, 1999, EUR RESPIR J, V14, P23, DOI 10.1034/j.1399-3003.1999.14a06.x; Santesso N, 2020, J CLIN EPIDEMIOL, V119, P126, DOI 10.1016/j.jclinepi.2019.10.014; Schandelmaier S, 2020, CAN MED ASSOC J, V192, pE901, DOI 10.1503/cmaj.200077; Sobieraj DM, 2018, JAMA-J AM MED ASSOC, V319, P1485, DOI 10.1001/jama.2018.2769; Sobieraj DM, 2018, JAMA-J AM MED ASSOC, V319, P1473, DOI 10.1001/jama.2018.2757; Suruki RY, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0409-3; Szefler SJ, 2017, J ALLERGY CLIN IMMUN, V140, P1277, DOI 10.1016/j.jaci.2017.01.014; Tepper RS, 2012, J ALLERGY CLIN IMMUN, V129, pS65, DOI 10.1016/j.jaci.2011.12.986; Thorlund K, 2011, RES SYNTH METHODS, V2, P188, DOI 10.1002/jrsm.46; Virchow JC, 2019, LANCET, V394, P1737, DOI 10.1016/S0140-6736(19)32215-9; Waljee AK, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1415; Wang K, 2015, INT J CLIN EXP MED, V8, P19476; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Watz H, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01349-5; Wei YH, 2017, STATA J, V17, P786, DOI 10.1177/1536867X1701700402; YATES DH, 1995, AM J RESP CRIT CARE, V152, P1170, DOI 10.1164/ajrccm.152.4.7551366; Yoshida M, 2017, PULM PHARMACOL THER, V42, P7, DOI 10.1016/j.pupt.2016.11.004; Yoshida M, 2013, PULM PHARMACOL THER, V26, P159, DOI 10.1016/j.pupt.2012.09.007; Zhang L, 2018, MED SCI MONITOR, V24, P944, DOI 10.12659/MSM.907950; Zheng YY, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4388	71	12	13	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2021	325	24					2466	2479		10.1001/jama.2021.7872	http://dx.doi.org/10.1001/jama.2021.7872		MAY 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD7ZK	34009257	Bronze, Green Published			2022-12-28	WOS:000652629500001
J	Mahase, E				Mahase, Elisabeth			Covid-19: Poor links between NHS and social care weakened England's response, says NAO	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Audit Office, 2021, IN LEARN GOV RESP CO	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2021	373								n1279	10.1136/bmj.n1279	http://dx.doi.org/10.1136/bmj.n1279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5SO	34011497	Bronze			2022-12-28	WOS:000655594700005
J	Rossmann, MP; Hoi, K; Chan, V; Abraham, BJ; Yang, S; Mullahoo, J; Papanastasiou, M; Wang, Y; Elia, I; Perlin, JR; Hagedorn, EJ; Hetzel, S; Weigert, R; Vyas, S; Nag, PP; Sullivan, LB; Warren, CR; Dorjsuren, B; Greig, EC; Adatto, I; Cowan, CA; Schreiber, SL; Young, RA; Meissner, A; Haigis, MC; Hekimi, S; Carr, SA; Zon, LI				Rossmann, Marlies P.; Hoi, Karen; Chan, Victoria; Abraham, Brian J.; Yang, Song; Mullahoo, James; Papanastasiou, Malvina; Wang, Ying; Elia, Ilaria; Perlin, Julie R.; Hagedorn, Elliott J.; Hetzel, Sara; Weigert, Raha; Vyas, Sejal; Nag, Partha P.; Sullivan, Lucas B.; Warren, Curtis R.; Dorjsuren, Bilguujin; Greig, Eugenia Custo; Adatto, Isaac; Cowan, Chad A.; Schreiber, Stuart L.; Young, Richard A.; Meissner, Alexander; Haigis, Marcia C.; Hekimi, Siegfried; Carr, Steven A.; Zon, Leonard, I			Cell-specific transcriptional control of mitochondrial metabolism by TIF1 gamma drives erythropoiesis	SCIENCE			English	Article							DIHYDROOROTATE DEHYDROGENASE; HEMATOPOIESIS; COMPLEX; PROTEIN; DEFICIENCY; ONTOGENY	Transcription and metabolism both influence cell function, but dedicated transcriptional control of metabolic pathways that regulate cell fate has rarely been defined. We discovered, using a chemical suppressor screen, that inhibition of the pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase (DHODH) rescues erythroid differentiation in bloodless zebrafish moonshine (mon) mutant embryos defective for transcriptional intermediary factor 1 gamma (tif1 gamma). This rescue depends on the functional link of DHODH to mitochondrial respiration. The transcription elongation factor TIF1 gamma directly controls coenzyme Q (CoQ) synthesis gene expression. Upon tif1 gamma loss, CoQ levels are reduced, and a high succinate/alpha-ketoglutarate ratio leads to increased histone methylation. A CoQ analog rescues mon's bloodless phenotype. These results demonstrate that mitochondrial metabolism is a key output of a lineage transcription factor that drives cell fate decisions in the early blood lineage.	[Rossmann, Marlies P.; Hoi, Karen; Chan, Victoria; Dorjsuren, Bilguujin; Greig, Eugenia Custo; Adatto, Isaac; Meissner, Alexander; Zon, Leonard, I] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 01238 USA; [Rossmann, Marlies P.; Hoi, Karen; Chan, Victoria; Yang, Song; Perlin, Julie R.; Hagedorn, Elliott J.; Dorjsuren, Bilguujin; Greig, Eugenia Custo; Adatto, Isaac; Zon, Leonard, I] Harvard Med Sch, Stem Cell Program, Boston, MA 02115 USA; [Rossmann, Marlies P.; Hoi, Karen; Chan, Victoria; Yang, Song; Perlin, Julie R.; Hagedorn, Elliott J.; Dorjsuren, Bilguujin; Greig, Eugenia Custo; Adatto, Isaac; Zon, Leonard, I] Harvard Med Sch, Div Hematol Oncol, Boston Childrens Hosp, Boston, MA 02115 USA; [Rossmann, Marlies P.; Hoi, Karen; Chan, Victoria; Yang, Song; Perlin, Julie R.; Hagedorn, Elliott J.; Dorjsuren, Bilguujin; Greig, Eugenia Custo; Adatto, Isaac; Zon, Leonard, I] Harvard Med Sch, Dana Farber Canc Inst, Howard Hughes Med Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Abraham, Brian J.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Mullahoo, James; Papanastasiou, Malvina; Nag, Partha P.; Schreiber, Stuart L.; Meissner, Alexander; Carr, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wang, Ying; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Elia, Ilaria; Vyas, Sejal; Haigis, Marcia C.] Harvard Med Sch, Dept Cell Biol, Blavatn Inst, Boston, MA 02115 USA; [Hetzel, Sara; Weigert, Raha; Meissner, Alexander] Max Planck Inst Mol Genet, Dept Genome Regulat, D-14195 Berlin, Germany; [Sullivan, Lucas B.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; [Warren, Curtis R.; Cowan, Chad A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Abraham, Brian J.] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Warren, Curtis R.] Boehringer Ingelheirn Pharmaceut Inc, Cardiometab Dis Res, Ridgefield, CT 06877 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; McGill University; Harvard University; Harvard Medical School; Max Planck Society; Fred Hutchinson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts Institute of Technology (MIT); St Jude Children's Research Hospital; Boehringer Ingelheim	Zon, LI (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 01238 USA.; Zon, LI (corresponding author), Harvard Med Sch, Stem Cell Program, Boston, MA 02115 USA.; Zon, LI (corresponding author), Harvard Med Sch, Div Hematol Oncol, Boston Childrens Hosp, Boston, MA 02115 USA.; Zon, LI (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Howard Hughes Med Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA.	leonard.zon@enders.tch.harvard.edu	Rossmann, Marlies/AAJ-1943-2021; Abraham, Brian/C-2230-2019	Rossmann, Marlies/0000-0003-2056-6792; Mullahoo, James/0000-0002-5469-4066; Abraham, Brian/0000-0001-8085-3027; Sullivan, Lucas/0000-0002-6745-8222	National Heart, Lung, and Blood Institute [4R01HL048801, 5P01HL032262, 5U01HL134812, 1P01HL131477]; National Institute of Diabetes and Digestive and Kidney Diseases [1U54DK110805, 3R24DK092760]; Harvard Catalyst; Canadian Institutes of Health Research [FDN0159916]; National Cancer Institute [5R01CA213062]; National Institute of General Medical Sciences [R35GM127045]; National Human Genome Research Institute [U54-HG008097]; Cancer Research Institute; American Lebanese Syrian Associated Charities	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Catalyst; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cancer Research Institute; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by the National Heart, Lung, and Blood Institute (grants 4R01HL048801, 5P01HL032262, 5U01HL134812, and 1P01HL131477 to L.I.Z.); the National Institute of Diabetes and Digestive and Kidney Diseases (grants 1U54DK110805 and 3R24DK092760 to L.I.Z.); Harvard Catalyst (L.I.Z.); the Canadian Institutes of Health Research (foundation grant FDN0159916 to S.H. and Y.W.); the National Cancer Institute (grant 5R01CA213062 to M.C.H.); the National Institute of General Medical Sciences (grant R35GM127045 to S.L.S.); the National Human Genome Research Institute (grant U54-HG008097 to M.P.); the Cancer Research Institute (I.E.); and the American Lebanese Syrian Associated Charities (B.J.A.).	Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anso E, 2017, NAT CELL BIOL, V19, P614, DOI 10.1038/ncb3529; Aucagne R, 2011, J CLIN INVEST, V121, P2361, DOI 10.1172/JCI45213; Bai X, 2013, DEV BIOL, V373, P422, DOI 10.1016/j.ydbio.2012.10.008; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baron MH, 2013, STEM CELLS, V31, P849, DOI 10.1002/stem.1342; Brownlie A, 2003, DEV BIOL, V255, P48, DOI 10.1016/S0012-1606(02)00041-6; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cabezas-Wallscheid N, 2017, CELL, V169, P807, DOI 10.1016/j.cell.2017.04.018; Cao XW, 2020, CELL REP, V30, P4152, DOI 10.1016/j.celrep.2020.03.001; Carvalho L, 2010, TRENDS CELL BIOL, V20, P586, DOI 10.1016/j.tcb.2010.06.009; CASEY AC, 1973, CANCER RES, V33, P1183; CHEN JJ, 1976, ARCH BIOCHEM BIOPHYS, V176, P82, DOI 10.1016/0003-9861(76)90143-0; Donati S, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1396; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Guijas C, 2018, NAT BIOTECHNOL, V36, P316, DOI 10.1038/nbt.4101; Gusic M, 2020, AM J HUM GENET, V106, P102, DOI 10.1016/j.ajhg.2019.12.005; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Islam MS, 2018, ANNU REV BIOCHEM, V87, P585, DOI 10.1146/annurev-biochem-061516-044724; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lensch MW, 2004, CURR TOP DEV BIOL, V60, P127; LIEBERMAN I, 1953, BIOCHIM BIOPHYS ACTA, V12, P223, DOI 10.1016/0006-3002(53)90141-3; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Madak JT, 2019, PHARMACOL THERAPEUT, V195, P111, DOI 10.1016/j.pharmthera.2018.10.012; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; O'Donnell EF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013128; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ransom DG, 2004, PLOS BIOL, V2, P1188, DOI 10.1371/journal.pbio.0020237; Ransom DG, 1996, DEVELOPMENT, V123, P311; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rossmann Marlies P, 2013, Cold Spring Harb Protoc, V2013, P625, DOI 10.1101/pdb.prot067116; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Stachura DL, 2006, BLOOD, V107, P87, DOI 10.1182/blood-2005-07-2740; Stefely JA, 2017, TRENDS BIOCHEM SCI, V42, P824, DOI 10.1016/j.tibs.2017.06.008; Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174; Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2016, TRENDS CELL BIOL, V26, P367, DOI 10.1016/j.tcb.2015.12.007; Wang Y, 2013, HUM MOL GENET, V22, P4768, DOI 10.1093/hmg/ddt330; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLIAMSON RA, 1995, J BIOL CHEM, V270, P22467, DOI 10.1074/jbc.270.38.22467; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	60	13	13	6	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					716	+		10.1126/science.aaz2740	http://dx.doi.org/10.1126/science.aaz2740			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986176	Green Submitted, Green Accepted			2022-12-28	WOS:000651125300045
J	Garcia, D				Garcia, Denise			Stop the emerging AI cold war	NATURE			English	Editorial Material									[Garcia, Denise] Northeastern Univ, Boston, MA 02115 USA; [Garcia, Denise] Int Comm Robot Arms Control, Boston, MA 02115 USA	Northeastern University	Garcia, D (corresponding author), Northeastern Univ, Boston, MA 02115 USA.; Garcia, D (corresponding author), Int Comm Robot Arms Control, Boston, MA 02115 USA.	d.garcia@northeastern.edu							0	2	2	3	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					169	169		10.1038/d41586-021-01244-z	http://dx.doi.org/10.1038/d41586-021-01244-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA6OC	33976428	Bronze			2022-12-28	WOS:000649420400001
J	Kmietowicz, Z				Kmietowicz, Zosia			Covid-19: Caution urged while lockdown eases in England because of vaccine success	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, SUMMARY FURTHER MODE; Ismail S.A., EFFECTIVENESS BNT162; Lopez Bernal J., EFFECTIVENESS BNT162	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1203	10.1136/bmj.n1203	http://dx.doi.org/10.1136/bmj.n1203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975884	Bronze			2022-12-28	WOS:000649711400009
J	Prats-Uribe, A; Sena, AG; Lai, LNYH; Ahmed, WU; Alghoul, H; Alser, O; Alshammari, TM; Areia, C; Carter, W; Casajust, P; Dawoud, D; Golozar, A; Jonnagaddala, J; Mehta, PP; Gong, MC; Morales, DR; Nyberg, F; Posada, JD; Recalde, M; Roel, E; Shah, K; Shah, NH; Schilling, LM; Subbian, V; Vizcaya, D; Zhang, L; Zhang, Y; Zhu, H; Liu, L; Cho, J; Lynch, KE; Matheny, ME; You, SC; Rijnbeek, PR; Hripcsak, G; Lane, JCE; Burn, E; Reich, C; Suchard, MA; Duarte-Salles, T; Kostka, K; Ryan, PB; Prieto-Alhambra, D				Prats-Uribe, Albert; Sena, Anthony G.; Lai, Lana Yin Hui; Ahmed, Waheed-Ul-Rahman; Alghoul, Heba; Alser, Osaid; Alshammari, Thamir M.; Areia, Carlos; Carter, William; Casajust, Paula; Dawoud, Dalia; Golozar, Asieh; Jonnagaddala, Jitendra; Mehta, Paras P.; Gong, Mengchun; Morales, Daniel R.; Nyberg, Fredrik; Posada, Jose D.; Recalde, Martina; Roel, Elena; Shah, Karishma; Shah, Nigam H.; Schilling, Lisa M.; Subbian, Vignesh; Vizcaya, David; Zhang, Lin; Zhang, Ying; Zhu, Hong; Liu, Li; Cho, Jaehyeong; Lynch, Kristine E.; Matheny, Michael E.; You, Seng Chan; Rijnbeek, Peter R.; Hripcsak, George; Lane, Jennifer C. E.; Burn, Edward; Reich, Christian; Suchard, Marc A.; Duarte-Salles, Talita; Kostka, Kristin; Ryan, Patrick B.; Prieto-Alhambra, Daniel			Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital with covid-19 across three continents. DESIGN Multinational network cohort study. SETTING Hospital electronic health records from the United States, Spain, and China, and nationwide claims data from South Korea. PARTICIPANTS 303 264 patients admitted to hospital with covid-19 from January 2020 to December 2020. MAIN OUTCOME MEASURES Prescriptions or dispensations of any drug on or 30 days after the date of hospital admission for covid-19. RESULTS Of the 303 264 patients included, 290 131 were from the US, 7599 from South Korea, 5230 from Spain, and 304 from China. 3455 drugs were identified. Common repurposed drugs were hydroxychloroquine (used in from <5 (<2%) patients in China to 2165 (85.1%) in Spain), azithromycin (from 15 (4.9%) in China to 1473 (57.9%) in Spain), combined lopinavir and ritonavir (from 156 (<2%) in the VA-OMOP US to 2,652 (34.9%) in South Korea and 1285 (50.5%) in Spain), and umifenovir (0% in the US, South Korea, and Spain and 238 (78.3%) in China). Use of adjunctive drugs varied greatly, with the five most used treatments being enoxaparin, fluoroquinolones, ceftriaxone, vitamin D, and corticosteroids. Hydroxychloroquine use increased rapidly from March to April 2020 but declined steeply in May to June and remained low for the rest of the year. The use of dexamethasone and corticosteroids increased steadily during 2020. CONCLUSIONS Multiple drugs were used in the first few months of the covid-19 pandemic, with substantial geographical and temporal variation. Hydroxychloroquine, azithromycin, lopinavir-ritonavir, and umifenovir (in China only) were the most prescribed repurposed drugs. Antithrombotics, antibiotics, H2 receptor antagonists, and corticosteroids were often used as adjunctive treatments. Research is needed on the comparative risk and benefit of these treatments in the management of covid-19.	[Prats-Uribe, Albert; Burn, Edward; Prieto-Alhambra, Daniel] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Pharmaco & Device Epidemiol, Oxford, England; [Sena, Anthony G.; Ryan, Patrick B.] Janssen Res & Dev, Titusville, NJ 08560 USA; [Sena, Anthony G.; Rijnbeek, Peter R.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Lai, Lana Yin Hui] Univ Manchester, Sch Med Sci, Div Canc Sci, Manchester, Lancs, England; [Ahmed, Waheed-Ul-Rahman; Shah, Karishma; Lane, Jennifer C. E.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Ahmed, Waheed-Ul-Rahman] Univ Exeter, Coll Med & Hlth, Exeter, Devon, England; [Alghoul, Heba] Islamic Univ Gaza, Fac Med, Gaza City, Palestine; [Alser, Osaid] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Alshammari, Thamir M.] Riyadh Elm Univ, Coll Pharm, Riyadh, Saudi Arabia; [Areia, Carlos] Univ Oxford, Nuffield Dept Clin Neurosci, Crit Care Res Grp, Oxford, England; [Carter, William; Schilling, Lisa M.] Univ Colorado Anschutz Med Campus, Aurora, CO USA; [Casajust, Paula] Trial Form Support, Real World Evidence, Barcelona, Spain; [Dawoud, Dalia] Cairo Univ, Fac Pharm, Cairo, Egypt; [Dawoud, Dalia] Natl Inst Hlth & Care Excellence, London, England; [Golozar, Asieh] Regeneron Pharmaceut, Tarrytown, NY USA; [Golozar, Asieh] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Jonnagaddala, Jitendra] UNSW Sydney, Sch Populat Hlth, Sydney, NSW, Australia; [Mehta, Paras P.] Univ Arizona, Coll Med, Tucson, AZ USA; [Gong, Mengchun; Zhang, Ying] DHC Technol, Beijing, Peoples R China; [Morales, Daniel R.] Univ Dundee, Div Populat Hlth & Genom, Dundee, Scotland; [Morales, Daniel R.] Univ Southern Denmark, Dept Publ Hlth, Odense, Denmark; [Nyberg, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Inst Med, Gothenburg, Sweden; [Posada, Jose D.; Shah, Nigam H.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Recalde, Martina; Roel, Elena; Burn, Edward; Duarte-Salles, Talita] Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain; [Recalde, Martina; Roel, Elena] Univ Autonoma Barcelona, Barcelona, Spain; [Subbian, Vignesh] Univ Arizona, Coll Engn, Tucson, AZ USA; [Vizcaya, David] Bayer Pharmaceut, St Joan Despi, Spain; [Zhang, Lin] Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Beijing, Peoples R China; [Zhang, Lin] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Zhu, Hong; Liu, Li] Southern Med Univ, Nanfang Univ, Guangzhou, Peoples R China; [Cho, Jaehyeong] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, South Korea; [Lynch, Kristine E.] VA Salt Lake City Healthcare Syst, VA Informat & Comp Infrastruct, Salt Lake City, UT USA; [Lynch, Kristine E.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Matheny, Michael E.] Tennessee Valley Healthcare Syst, VA Informat & Comp Infrastruct, VA Med Ctr, Nashville, TN USA; [Matheny, Michael E.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [You, Seng Chan] Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul, South Korea; [Hripcsak, George] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Reich, Christian; Kostka, Kristin] IQVIA, Cambridge, MA USA; [Suchard, Marc A.] Univ Calif Los Angeles, UCLA Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA; [Kostka, Kristin] Northeastern Univ, OHDSI Ctr, Roux Inst, Portland, ME USA; [Ryan, Patrick B.] Columbia Univ, Irving Med Ctr, New York, NY 10032 USA	University of Oxford; Johnson & Johnson; Janssen Pharmaceuticals; Erasmus University Rotterdam; Erasmus MC; University of Manchester; University of Oxford; University of Exeter; Harvard University; Harvard Medical School; Massachusetts General Hospital; Riyadh Elm University; University of Oxford; University of Colorado System; University of Colorado Anschutz Medical Campus; Egyptian Knowledge Bank (EKB); Cairo University; National Institute for Health & Care Excellence; Regeneron; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of New South Wales Sydney; University of Arizona; University of Dundee; University of Southern Denmark; University of Gothenburg; Stanford University; Autonomous University of Barcelona; University of Arizona; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Melbourne; Southern Medical University - China; Ajou University; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Yonsei University; Yonsei University Health System; Columbia University; IQVIA; University of California System; University of California Los Angeles; Columbia University; NewYork-Presbyterian Hospital	Ryan, PB (corresponding author), Janssen Res & Dev, Titusville, NJ 08560 USA.; Ryan, PB (corresponding author), Columbia Univ, Irving Med Ctr, New York, NY 10032 USA.	ryan@ohdsi.org	Gong, Mengchun/GYQ-8802-2022; Alser, Osaid/P-5509-2017; ZHANG, LIN/GYD-9123-2022; Ryan, Patrick/HDO-1133-2022; jiang, yu/HGU-0029-2022; Posada, Jose/AAB-5284-2022; Roel, Elena/AAG-4664-2021; Zhang, Lin/L-5132-2019; Posada, Jose David/GQA-4607-2022; Gong, Mengchun/ABC-8370-2021	Gong, Mengchun/0000-0001-8197-6643; Alser, Osaid/0000-0001-6743-803X; Posada, Jose/0000-0003-3864-0241; Roel, Elena/0000-0002-1964-3546; Zhang, Lin/0000-0002-2064-8440; Posada, Jose David/0000-0003-3864-0241; You, Seng Chan/0000-0002-5052-6399; Casajust, Paula/0000-0003-2733-5436; Nyberg, Fredrik/0000-0003-0892-5668; Ahmed, Waheed-Ul-Rahman/0000-0003-0880-0355; Areia, Carlos/0000-0002-4668-7069; Lane, Jennifer/0000-0002-1729-8654; Prieto-Alhambra, Daniel/0000-0002-3950-6346				A.Montgomery, 2020, medRxiv, DOI 10.1101/2020.07.15.20151852; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], KOREA COVID 19 CENTR; Arshad S, 2020, INT J INFECT DIS, V97, P396, DOI 10.1016/j.ijid.2020.06.099; Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bhopal R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n742; Centers for Disease Control and Prevention, 2019, INT CLIN GUID MAN PA; Chen FF, 2020, J CRIT CARE, V60, P32, DOI 10.1016/j.jcrc.2020.07.003; Dagens A, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1936; Datta S, 2020, ARXIV200310534; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Github, 2018, OHDSI COMMONDATAMODE; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Johns Hopkins University, 2021, COVID 19 DASHB CTR S; Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379; Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31324-6, 10.1016/S0140-6736(20)31180-6]; Ministerio de Sanitarias (Madrid), 2020, TECHN DOC CLIN MAN; National Health Commission of China, 2020, DIAGN TREATM PROT PA; Prieto-Alhambra Daniel, 2021, Res Sq, DOI 10.21203/rs.3.rs-279400/v1; Rho Yeunsook, 2021, J Prev Med Public Health, V54, P8, DOI 10.3961/jpmph.20.616; Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2; Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019; Shang LH, 2020, LANCET, V395, P683, DOI 10.1016/S0140-6736(20)30361-5; Societa Italiana di Malattie Infettive e Tropicali, 2020, THER SUPP CAR GUID P; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Subbian V, 2021, J AM MED INFORM ASSN, V28, P184, DOI 10.1093/jamia/ocaa188; Thachil J, 2020, J THROMB HAEMOST, V18, P1023, DOI 10.1111/jth.14810; Thorlund K, 2020, LANCET DIGIT HEALTH, V2, pE286, DOI 10.1016/S2589-7500(20)30086-8; United States Food and Drug Administration, 2020, COR COVID 19 UPD FDA; Voss EA, 2015, J AM MED INFORM ASSN, V22, P553, DOI 10.1093/jamia/ocu023; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n433; World Health Organization, 2020, SOLIDARITY; Xu P, 2020, MICROBES INFECT, V22, P200, DOI 10.1016/j.micinf.2020.05.012; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405	38	20	20	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1038	10.1136/bmj.n1038	http://dx.doi.org/10.1136/bmj.n1038			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975825	Green Published, hybrid			2022-12-28	WOS:000649711400004
J	Busse, JW; Kansagara, DL; Lin, K; O'Gurek, D; Qaseem, A				Busse, Jason W.; Kansagara, Devan L.; Lin, Kenneth; O'Gurek, David; Qaseem, Amir			Nonpharmacologic and Pharmacologic Management of Acute Pain From Non-Low Back, Musculoskeletal Injuries in Adults RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Busse, Jason W.] McMaster Univ, Hamilton, ON, Canada; [Busse, Jason W.] Chron Pain Ctr Excellence Canadian Vet, Hamilton, ON, Canada; [Kansagara, Devan L.] Portland VA Med Ctr, Portland, OR USA; [Lin, Kenneth] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [O'Gurek, David] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA USA	McMaster University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; American College of Physicians	Busse, JW (corresponding author), McMaster Univ, Hamilton, ON, Canada.; Busse, JW (corresponding author), Chron Pain Ctr Excellence Canadian Vet, Hamilton, ON, Canada.		Busse, Jason/CAH-3696-2022	Busse, Jason/0000-0002-0178-8712; Qaseem, Amir/0000-0001-6866-7985				Busse JW, 2020, ANN INTERN MED, V173, P730, DOI 10.7326/M19-3601; Qaseem A, 2020, ANN INTERN MED, V173, P739, DOI 10.7326/M19-3602	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					733	733		10.7326/L21-0061	http://dx.doi.org/10.7326/L21-0061			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33999673				2022-12-28	WOS:000652604800049
J	Rivas-Prado, L; Morales-Ortega, A; Allodi-de la Hoz, S; Bernal-Bello, D				Rivas-Prado, Luis; Morales-Ortega, Alejandro; Allodi-de la Hoz, Sonia; Bernal-Bello, David			Hyperparathyroidism shows its hand: findings of osteitis fibrosa cystica	LANCET			English	Editorial Material									[Rivas-Prado, Luis; Morales-Ortega, Alejandro; Bernal-Bello, David] Hosp Univ Fuenlabrada, Dept Internal Med, Madrid 28942, Spain; [Allodi-de la Hoz, Sonia] Hosp Univ Fuenlabrada, Dept Radiol, Madrid, Spain	Hospital Universitario Fuenlabrada; Hospital Universitario Fuenlabrada	Rivas-Prado, L (corresponding author), Hosp Univ Fuenlabrada, Dept Internal Med, Madrid 28942, Spain.	luis.rivas@salud.madrid.org	Bernal-Bello, David/AAY-7047-2021	Bernal-Bello, David/0000-0002-6887-1676; Rivas Prado, Luis/0000-0003-0200-0883; Morales-Ortega, Alejandro/0000-0002-8110-4498					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1914	1914						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF1XN	34022989				2022-12-28	WOS:000652556000027
J	Charlesworth, A; Anderson, M; Donaldson, C; Johnson, P; Knapp, M; McGuire, A; McKee, M; Mossialos, E; Smith, P; Street, A; Woods, M				Charlesworth, Anita; Anderson, Michael; Donaldson, Cam; Johnson, Paul; Knapp, Martin; McGuire, Alistair; McKee, Martin; Mossialos, Elias; Smith, Peter; Street, Andrew; Woods, Michael			What is the right level of spending needed for health and care in the UK?	LANCET			English	Review							SOCIAL-ISOLATION; LIFE EXPECTANCY; UNITED-STATES; INCOME; INEQUALITIES; LONELINESS; MORTALITY; COUNTRIES; ENGLAND; TRENDS	The health and care sector plays a valuable role in improving population health and societal wellbeing, protecting people from the financial consequences of illness, reducing health and income inequalities, and supporting economic growth. However, there is much debate regarding the appropriate level of funding for health and care in the UK. In this Health Policy paper, we look at the economic impact of the COVID-19 pandemic and historical spending in the UK and comparable countries, assess the role of private spending, and review spending projections to estimate future needs. Public spending on health has increased by 3.7% a year on average since the National Health Service (NHS) was founded in 1948 and, since then, has continued to assume a larger share of both the economy and government expenditure. In the decade before the ongoing pandemic started, the rate of growth of government spending for the health and care sector slowed. We argue that without average growth in public spending on health of at least 4% per year in real terms, there is a real risk of degradation of the NHS, reductions in coverage of benefits, increased inequalities, and increased reliance on private financing. A similar, if not higher, level of growth in public spending on social care is needed to provide high standards of care and decent terms and conditions for social care staff, alongside an immediate uplift in public spending to implement long-overdue reforms recommended by the Dilnot Commission to improve financial protection. COVID-19 has highlighted major issues in the capacity and resilience of the health and care system. We recommend an independent review to examine the precise amount of additional funds that are required to better equip the UK to withstand further acute shocks and major threats to health.	[Charlesworth, Anita] Hlth Fdn, London, England; [Charlesworth, Anita] Univ Birmingham, Coll Social Sci, Hlth Serv Management Ctr, Birmingham, W Midlands, England; [Anderson, Michael; Knapp, Martin; McGuire, Alistair; Mossialos, Elias; Street, Andrew; Woods, Michael] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England; [Donaldson, Cam] Glasgow Caledonian Univ, Social Business & Hlth, Glasgow, Lanark, Scotland; [Johnson, Paul] Inst Fiscal Studies, London, England; [McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Smith, Peter] Imperial Coll London, Ctr Hlth Econ & Policy Innovat, London, England; [Smith, Peter] Univ York, Ctr Hlth Econ, York, N Yorkshire, England	University of Birmingham; University of London; London School Economics & Political Science; Glasgow Caledonian University; University of London; London School Economics & Political Science; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of York - UK	Anderson, M (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.	m.anderson5@lse.ac.uk	Mossialos, Elias/ABE-1301-2021	Smith, Peter/0000-0003-0058-7588; Knapp, Martin/0000-0003-1427-0215; Street, Andrew David/0000-0002-2540-0364	LSE Knowledge and Exchange Impact (KEI) fund from the Higher Education Innovation Fund	LSE Knowledge and Exchange Impact (KEI) fund from the Higher Education Innovation Fund	Funding for the LSE-Lancet Commission on the future of the NHS was granted by the LSE Knowledge and Exchange Impact (KEI) fund, which was created using funds from the Higher Education Innovation Fund	Aiyar MS, 2016, IMPACT WORKFORCE AGI; Anderson M, 2021, LANCET, V397, P1992, DOI 10.1016/S0140-6736(21)00231-2; [Anonymous], 2020, DEATHS INV COVID 19; [Anonymous], **DATA OBJECT**; [Anonymous], 2020, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.M577; Asaria M, 2016, J EPIDEMIOL COMMUN H, V70, P990, DOI 10.1136/jech-2016-207447; Baicker K, 2018, JAMA-J AM MED ASSOC, V319, P986, DOI 10.1001/jama.2018.1152; BAUMOL WJ, 1993, P AM PHILOS SOC, V137, P612; Baumol WJ, 1968, PERFORMING ARTS EC D; Bloom D., 2003, DEMOGRAPHIC DIVIDEND; Bloom DE, 2019, HLTH EC GROWTH RECON; Bloom N, 2012, AM ECON REV, V102, P167, DOI 10.1257/aer.102.1.167; Blundell J, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620942589; Bradley EH, 2011, BMJ QUAL SAF, V20, P826, DOI 10.1136/bmjqs.2010.048363; British Medical Association, 2019, IND SECT PROV NHS RE; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Castelli A., 2019, PRODUCTIVITY ENGLISH; Cervellati M, 2013, ECONOMETRICA, V81, P2055, DOI 10.3982/ECTA11169; Chatzakou D, 2017, PROCEEDINGS OF THE 2017 ACM WEB SCIENCE CONFERENCE (WEBSCI '17), P13, DOI 10.1145/3091478.3091487; Claxton K, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19140; Colombier C., 2013, 125 FIFO; Courtin E, 2017, HEALTH SOC CARE COMM, V25, P799, DOI 10.1111/hsc.12311; CULYER AJ, 1971, OXFORD ECON PAP, V23, P189, DOI 10.1093/oxfordjournals.oep.a041190; Darzi A., 2018, LORD DARZI REV HLTH; Dixon J, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4301; Emerson C, 2020, OUTLOOK PUBLIC FINAN; Figueras Josep., 2012, HLTH SYSTEMS HLTH WE, DOI DOI 10.1371/journal.pone.0070231; Foubister T, 2006, PRIVATE MED INSURANC; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; Garrow V., 2016, PRESENTEEISM REV CUR; Gutacker N, 2018, HEALTH ECON, V27, pE13, DOI 10.1002/hec.3554; HM Revenues and Customs, 2019, HMRC TAX REC NAT INS; HM Treasury, 2019, PUBL EXP STAT AN 201; International Monetary Fund, 2020, POL REC; James C, 2017, INCLUSIVE GROWTH HLT; Jayawardana S, 2019, EUR HEART J-QUAL CAR, V5, P195, DOI 10.1093/ehjqcco/qcz022; Johansson A, 2013, LONG TERM GROWTH SCE; Kanabar R, 2015, J ECON AGEING, V6, P123, DOI 10.1016/j.jeoa.2015.05.002; Keep M., 2020, BARNETT FORMULA; Kelly E, 2020, J HEALTH ECON, V73, DOI 10.1016/j.jhealeco.2020.102353; King D, 2005, HEALTH SERV RES, V40, P195, DOI 10.1111/j.1475-6773.2005.00349.x; Kraindler J., 2019, BRIEFING FAILING CAP; Kraindley J, 2018, FALSE EC ANAL NHS FU; Kumar S, 2002, AM ECON REV, V92, P527, DOI 10.1257/00028280260136381; Lee T, 2018, SECURING FUTURE FUND; Leon DA, 2019, LANCET PUBLIC HEALTH, V4, pE575, DOI 10.1016/S2468-2667(19)30177-X; Lomas J, 2019, VALUE HEALTH, V22, P995, DOI 10.1016/j.jval.2019.04.1926; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; Martin S, 2008, J HEALTH ECON, V27, P826, DOI 10.1016/j.jhealeco.2007.12.002; McKee M, 2021, LANCET, V397, P1979, DOI 10.1016/S0140-6736(21)00229-4; McKenna H., 2017, TERENCE MCKENNA HALL; Miller H., 2016, CHANGING COMPOSITION; Mossialos E, 2018, LANCET, V391, P1001, DOI 10.1016/S0140-6736(18)30574-9; National Records of Scotland, DEATHS INV COR COVID; NHS England, 2019, TECHN GUID ALL FORM; Nolte E, 2011, HEALTH POLICY, V103, P47, DOI 10.1016/j.healthpol.2011.08.002; Northern Ireland Statistics and Research Agency, WEEKLY DEATHS; Nuffield Trust Health Foundation King's Fund, 2017, AUT BUDG JOINT STAT; O'Dowd NC, 2018, CAN PEOPLE AFFORD PA; OECD, 2015, FISCAL SUSTAINABILIT; OECD Eurostate and World Health Organization, 2017, SYST HLTH ACC 2011; Office for Budget Responsibility, 2019, FISC RISKS REP; Office for Budget Responsibility, 2021, EC FISC OUTL MARCH 2; Office for Budget Responsibility, 2016, FISC SUST PUBL SPEND; Office for Budget Responsibility, 2017, DRIV RIS HLTH SPEND; Office for Budget Responsibility, 2019, EC FISC OUTL MARCH 2; Office for Budget Responsibility, 2018, FISC SUST REP JUL 20; Office for National Statistics, 2015, AD HLTH GREAT BRIT 2; Office for National Statistics, 2020, PUBL SERV PROD TOT U; Office for National Statistics, 2015, EXP HEALTHC UK 2013; Office for National Statistics, 2020, HEALTHC EXP UK HLTH; Organisation for Economic Co-operation and Development, 2013, PUBL SPEND HLTH LONG; Organisation for Economic Co-operation and Development, 2020, TAX FISC POL RESP CO; Palloni A, 2009, SOC SCI MED, V68, P1574, DOI 10.1016/j.socscimed.2009.02.009; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Parkin E, 2020, NHS CHARGES; Phillips D., 2018, CHANGES COUNCILS ADU; Rajan S, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2360; Richards M, 2020, NAT CANCER, V1, P565, DOI 10.1038/s43018-020-0074-y; Ryan M, 1995, Qual Health Care, V4, P207, DOI 10.1136/qshc.4.3.207; Sheikh A, 2021, LANCET DIGIT HEALTH, V3, pE383, DOI 10.1016/S2589-7500(21)00005-4; Sorenson C, 2013, CLINICOECONOMIC OUTC, V5, P223, DOI 10.2147/CEOR.S39634; Stoye G, 2019, RECENT TRENDS INDEPE; Tetlow G, 2018, UNDERSTANDING EC IMP; The Conservative and Unionist Party, 2019, OUR PLAN CONS MAN 20; The King's Fund, 2018, DOES PUBL SEE TAX RI; Thomson S, 2019, CAN PEOPLE AFFORD PA; UK Government, 2018, PRIM MIN SETS OUT 5; UK Government, 2019, PM ANN EXTR 1 8 BILL; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; van Doorslaer E, 2006, CAN MED ASSOC J, V174, P177, DOI 10.1503/cmaj.050584; van Doorslaer E, 1999, J HEALTH ECON, V18, P291, DOI 10.1016/S0167-6296(98)00043-5; Wagstaff A, 2018, LANCET GLOB HEALTH, V6, pE169, DOI [10.1016/S2214-109X(17)30486-2, 10.1016/s2214-109x(17)30486-2, 10.1016/S2214-109X(17)30429-1]; Watt T, 2018, SOCIAL CARE FUNDING; WHITEHEAD M, 1991, LANCET, V338, P1059, DOI 10.1016/0140-6736(91)91911-D; Wittenberg R, 2018, PROJECTIONS DEMAND E; Wood C, 2017, GOOD RETIREMENT PUBL; Woodward R, 2009, GLOB INST, V35, P1	99	7	7	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					2012	2022		10.1016/S0140-6736(21)00230-0	http://dx.doi.org/10.1016/S0140-6736(21)00230-0		MAY 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SF1XN	33965068	Green Published, Green Accepted			2022-12-28	WOS:000652556000031
J	Evans, DK; Jakiela, P; Knauer, HA				Evans, David K.; Jakiela, Pamela; Knauer, Heather A.			The impact of early childhood interventions on mothers	SCIENCE			English	Editorial Material							RANDOMIZED-CONTROLLED-TRIAL; CASH TRANSFER PROGRAM; HOME-VISITING INTERVENTION; PRIMARY-HEALTH-CARE; MATERNAL DEPRESSION; PRESCHOOL-CHILDREN; PARENTING PROGRAM; YOUNG-CHILDREN; MENTAL-HEALTH; COGNITIVE-DEVELOPMENT		[Evans, David K.] Ctr Global Dev, Washington, DC USA; [Jakiela, Pamela] Williams Coll, Dept Econ, Williamstown, MA 01267 USA; [Knauer, Heather A.] Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA	Williams College; University of Michigan System; University of Michigan	Jakiela, P (corresponding author), Williams Coll, Dept Econ, Williamstown, MA 01267 USA.	pj5@williams.edu		Evans, David/0000-0001-5413-9284	Hewlett Foundation; Bill & Melinda Gates Foundation	Hewlett Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	We thank Echidna Giving,the Hewlett Foundation, and the Bill & Melinda Gates Foundation for financing this project. Authors are listed alphabetically.A. Mendez Acosta provided extensive research assistance. E. Galasso,M. O'Donnell, and O. Ozier provided helpful comments. All errors are our own.	Abdullah ASM, 2005, ADDICTION, V100, P1731, DOI 10.1111/j.1360-0443.2005.01231.x; Frances EAA, 2013, SOC SCI MED, V97, P250, DOI 10.1016/j.socscimed.2013.06.020; Adams KP, 2018, WORLD DEV, V107, P138, DOI 10.1016/j.worlddev.2018.02.025; Adubra L, 2019, AM J CLIN NUTR, V110, P1476, DOI 10.1093/ajcn/nqz238; Ali NS, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-57; Alsan M, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3175; Andrew A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002556; Aracena M, 2009, J HEALTH PSYCHOL, V14, P878, DOI 10.1177/1359105309340988; Araujo C., 2015, EARLY YEARS CHILD WE; Attanasio O., 2019, PUBLIC CHILDCA UNPUB; Attanasio O., 2018, W25059 NAT BUR EC RE, DOI [10.3386/w25059, DOI 10.3386/W25059]; Atukunda P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071561; Ayiasi RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153051; Baird J, 2011, SOC SCI MED, V72, P1948, DOI 10.1016/j.socscimed.2010.04.038; Baker-Henningham H, 2005, ARCH DIS CHILD, V90, P1230, DOI 10.1136/adc.2005.073015; Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Baqui AH, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020406; Baranov V, 2020, AM ECON REV, V110, P824, DOI 10.1257/aer.20180511; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bass JK, 2017, AIDS, V31, P1877, DOI 10.1097/QAD.0000000000001563; Bennett D, 2018, ECON J, V128, pF545, DOI 10.1111/ecoj.12549; Berlinski S, 2007, LABOUR ECON, V14, P665, DOI 10.1016/j.labeco.2007.01.003; Berlinski S, 2011, ECON DEV CULT CHANGE, V59, P313, DOI 10.1086/657124; Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7; Boivin MJ, 2017, J DEV BEHAV PEDIATR, V38, P753, DOI 10.1097/dbp.0000000000000510; Bonfrer I, 2014, SOC SCI MED, V123, P96, DOI 10.1016/j.socscimed.2014.11.004; Bonilla J, 2017, WORLD DEV, V95, P55, DOI 10.1016/j.worlddev.2017.02.017; Boo FL, 2019, ECONOMIA, V19, P169, DOI 10.1353/eco.2019.0005; Brahm P, 2016, FAM PRACT, V33, P226, DOI 10.1093/fampra/cmv071; Cahyadi N, 2020, AM ECON J-ECON POLIC, V12, P88, DOI 10.1257/pol.20190245; Camacho A, 2013, ECON DEV CULT CHANGE, V61, P633, DOI 10.1086/669263; Carneiro P., 2019, PARENTAL BELIEFS INV, P50; Carneiro P.M., 2019, IMPACTS MULTIFACETED; Cascio EU, 2009, J HUM RESOUR, V44, P140, DOI 10.1353/jhr.2009.0034; Cespedes J, 2013, AM J MED, V126, P27, DOI 10.1016/j.amjmed.2012.04.045; Chang SM, 2015, PEDIATRICS, V136, P272, DOI 10.1542/peds.2015-0119; Chomat AM, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0744-z; Clark S, 2019, DEMOGRAPHY, V56, P1247, DOI 10.1007/s13524-019-00793-3; Cooper PJ, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b974; Crookston BT, 2007, MATERN CHILD NUTR, V3, P10, DOI 10.1111/j.1740-8709.2007.00074.x; Diaz M., 2016, CASHING ED HOMES CHI; Doyle K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192756; Edmond KM, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2327-2; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Fasanghari M, 2019, J EDUC HEALTH PROMOT, V8, DOI 10.4103/jehp.jehp_202_17; Feldman BS, 2009, STUD FAMILY PLANN, V40, P51, DOI 10.1111/j.1728-4465.2009.00186.x; Fenn B, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002305; Fernald LCH, 2011, SOC SCI MED, V72, P1437, DOI 10.1016/j.socscimed.2011.03.005; FIrdy S. B, 2009, MOTHERS OTHERS EVOLU; Fitzsimons E, 2016, J DEV ECON, V122, P113, DOI 10.1016/j.jdeveco.2016.05.002; Frongillo EA, 2017, J NUTR, V147, P256, DOI 10.3945/jn.116.240861; Galasso E, 2019, LANCET GLOB HEALTH, V7, pE1257, DOI 10.1016/S2214-109X(19)30317-1; Gao YQ, 2014, INT J ENV RES PUB HE, V11, P6780, DOI 10.3390/ijerph110706780; Gertler P, 2014, SCIENCE, V344, P998, DOI 10.1126/science.1251178; Giles J, 2015, J DEV ECON, V114, P97, DOI 10.1016/j.jdeveco.2014.12.001; Grijalva-Eternod CS, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002684; Halim D., 2021, PRESCHOOL AVAILABILI, DOI 10.1086/714439; Hamadani JD, 2019, LANCET GLOB HEALTH, V7, pE366, DOI 10.1016/S2214-109X(18)30535-7; Handa S, 2016, HEALTH ECON, V25, P225, DOI 10.1002/hec.3136; Haushofer J, 2016, Q J ECON, V131, P1973, DOI 10.1093/qje/qjw025; Hojman A., 2019, COST EFFECTIVE PUBLI; Husain N, 2017, ASIAN J PSYCHIATR, V29, P63, DOI 10.1016/j.ajp.2017.03.010; John HB, 2018, EARLY HUM DEV, V123, P17, DOI 10.1016/j.earlhumdev.2018.07.001; Kalinauskiene L, 2009, CHILD CARE HLTH DEV, V35, P613, DOI 10.1111/j.1365-2214.2009.00962.x; Kandpal E, 2016, J NUTR, V146, P1793, DOI 10.3945/jn.116.233684; Khan Muhammad Amir, 2018, BJGP Open, V2, pbjgpopen18X101593, DOI 10.3399/bjgpopen18X101593; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Kurniawati, 2019, COMPR CHILD ADOLES N, V42, P252, DOI 10.1080/24694193.2019.1594457; Lachman JM, 2017, CHILD ABUSE NEGLECT, V72, P338, DOI 10.1016/j.chiabu.2017.08.014; Lancy, 2014, ANTHR CHILDHOOD CHER; le Roux IM, 2013, AIDS, V27, P1461, DOI 10.1097/QAD.0b013e3283601b53; leckman J. J. I., 1974, C3687 NAT BUR EC RES; Leung C, 2017, J CHILD FAM STUD, V26, P2865, DOI 10.1007/s10826-017-0790-9; Levere M., 2016, 22640 NBER; Lewycka S, 2013, LANCET, V381, P1721, DOI 10.1016/S0140-6736(12)61959-X; Luby SP, 2018, LANCET GLOB HEALTH, V6, pE302, DOI 10.1016/S2214-109X(17)30490-4; Ly CT, 2006, EUR J CLIN NUTR, V60, P265, DOI 10.1038/sj.ejcn.1602311; Macours K, 2012, AM ECON J-APPL ECON, V4, P247, DOI 10.1257/app.4.2.247; Martinez S., 2017, Policy Research Working Paper - World Bank; McConnell M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0914-z; Milani HS, 2017, J RES MED SCI, V22, DOI 10.4103/jrms.JRMS_319_17; Mirmolaei ST, 2014, INT J PREVENTIVE MED, V5, P61; Morris J, 2012, AM J ORTHOPSYCHIAT, V82, P349, DOI 10.1111/j.1939-0025.2012.01168.x; Murray L, 2016, DEV MED CHILD NEUROL, V58, P270, DOI 10.1111/dmcn.12873; Nahar B, 2015, CHILD CARE HLTH DEV, V41, P483, DOI 10.1111/cch.12176; Natali L, 2018, SSM-POPUL HLTH, V4, P225, DOI 10.1016/j.ssmph.2018.02.002; Osaki K, 2019, J PUBLIC HEALTH-UK, V41, P170, DOI 10.1093/pubmed/fdx175; Ozler B, 2018, J DEV ECON, V133, P448, DOI 10.1016/j.jdeveco.2018.04.004; Paxson C, 2010, ECON DEV CULT CHANGE, V59, P187, DOI 10.1086/655458; Peterman A, 2018, HEALTH ECON, V27, P622, DOI 10.1002/hec.3588; Prado EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032519; Rahman A, 2009, CHILD CARE HLTH DEV, V35, P56, DOI 10.1111/j.1365-2214.2008.00897.x; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Richardson RA, 2018, SOC SCI MED, V217, P32, DOI 10.1016/j.socscimed.2018.09.061; Rockers PC, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002555; Rockers PC, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000104; Rosero J., 2011, TINBERGEN I DISCUSSI, DOI [10.2139/ssrn.1898566, DOI 10.2139/SSRN.1898566]; Rotheram-Borus MJ, 2019, J CONSULT CLIN PSYCH, V87, P551, DOI 10.1037/ccp0000408; Rotheram-Borus MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084867; Schlossman N, 2017, FOOD NUTR BULL, V38, P275, DOI 10.1177/0379572117700754; Sener DK, 2016, CHILD YOUTH SERV REV, V64, P82, DOI 10.1016/j.childyouth.2016.03.007; Shrestha S, 2016, MIDWIFERY, V42, P21, DOI 10.1016/j.midw.2016.09.006; Singla DR, 2015, LANCET GLOB HEALTH, V3, pE458, DOI 10.1016/S2214-109X(15)00099-6; Sumargi A, 2015, CHILD PSYCHIAT HUM D, V46, P749, DOI 10.1007/s10578-014-0517-8; Tomlinson M, 2016, PREV SCI, V17, P937, DOI 10.1007/s11121-016-0676-x; Vance G, 2014, HEALTH POLICY PLANN, V29, P359, DOI 10.1093/heapol/czt022; Waiswa P, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.24584; Wang Y, 2015, INT J ENV RES PUB HE, V12, P692, DOI 10.3390/ijerph120100692; Ward CL, 2020, J CHILD PSYCHOL PSYC, V61, P503, DOI 10.1111/jcpp.13129; Yanagisawa S, 2015, HEALTH POLICY PLANN, V30, P1184, DOI 10.1093/heapol/czu133; Yilmaz G, 2006, CHILD CARE HLTH DEV, V32, P73, DOI 10.1111/j.1365-2214.2006.00570.x; Yousafzai AK, 2016, LANCET GLOB HEALTH, V4, pE548, DOI 10.1016/S2214-109X(16)30100-0; Yousafzai AK, 2015, PEDIATRICS, V135, pE1247, DOI 10.1542/peds.2014-2335; Zhang ZY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200519	114	8	8	8	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					794	+		10.1126/science.abg0132	http://dx.doi.org/10.1126/science.abg0132			55	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SH2WJ	34016770				2022-12-28	WOS:000653997000027
J	Knudsen, AB; Rutter, CM; Peterse, EFP; Lietz, AP; Seguin, CL; Meester, RGS; Perdue, LA; Lin, JS; Siegel, RL; Doria-Rose, VP; Feuer, EJ; Zauber, AG; Kuntz, KM; Lansdorp-Vogelaar, I				Knudsen, Amy B.; Rutter, Carolyn M.; Peterse, Elisabeth F. P.; Lietz, Anna P.; Seguin, Claudia L.; Meester, Reinier G. S.; Perdue, Leslie A.; Lin, Jennifer S.; Siegel, Rebecca L.; Doria-Rose, V. Paul; Feuer, Eric J.; Zauber, Ann G.; Kuntz, Karen M.; Lansdorp-Vogelaar, Iris			Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							COST-EFFECTIVENESS; YOUNG-ADULTS; COLONOSCOPY; RISK; INFORM; RECOMMENDATIONS; SIGMOIDOSCOPY; ADENOMAS; ACCURACY; IMPACT	IMPORTANCE The US Preventive Services Task Force (USPSTF) is updating its 2016 colorectal cancer screening recommendations. OBJECTIVE To provide updated model-based estimates of the benefits, burden, and harms of colorectal cancer screening strategies and to identify strategies that may provide an efficient balance of life-years gained (LYG) from screening and colonoscopy burden to inform the USPSTF. DESIGN, SETTING, AND PARTICIPANTS Comparative modeling study using 3 microsimulation models of colorectal cancer screening in a hypothetical cohort of 40-year-old US individuals at average risk of colorectal cancer. EXPOSURES Screening from ages 45, 50, or 55 years to ages 70, 75, 80, or 85 years with fecal immunochemical testing (FIT), multitarget stool DNA testing, flexible sigmoidoscopy alone or with FIT, computed tomography colonography, or colonoscopy. All persons with an abnormal noncolonoscopy screening test result were assumed to undergo follow-up colonoscopy. Screening intervals varied by test. Full adherence with all procedures was assumed. MAIN OUTCOME AND MEASURES Estimated LYG relative to no screening (benefit), lifetime number of colonoscopies (burden), number of complications from screening (harms), and balance of incremental burden and benefit (efficiency ratios). Efficient strategies were those estimated to require fewer additional colonoscopies per additional LYG relative to other strategies. RESULTS Estimated LYG from screening strategies ranged from 171 to 381 per 1000 40-year-olds. Lifetime colonoscopy burden ranged from 624 to 6817 per 1000 individuals, and screening complications ranged from 5 to 22 per 1000 individuals. Among the 49 strategies that were efficient options with all 3 models, 41 specified screening beginning at age 45. No single age to end screening was predominant among the efficient strategies, although the additional LYG from continuing screening after age 75 were generally small. With the exception of a 5-year interval for computed tomography colonography, no screening interval predominated among the efficient strategies for each modality. Among the strategies highlighted in the 2016 USPSTF recommendation, lowering the age to begin screening from 50 to 45 years was estimated to result in 22 to 27 additional LYG, 161 to 784 additional colonoscopies, and 0.1 to 2 additional complications per 1000 persons (ranges are across screening strategies, based on mean estimates across models). Assuming full adherence, screening outcomes and efficient strategies were similar by sex and race and across 3 scenarios for population risk of colorectal cancer. CONCLUSIONS AND RELEVANCE This microsimulation modeling analysis suggests that screening for colorectal cancer with stool tests, endoscopic tests, or computed tomography colonography starting at age 45 years provides an efficient balance of colonoscopy burden and life-years gained.	[Knudsen, Amy B.; Lietz, Anna P.; Seguin, Claudia L.] Massachusetts Gen Hosp, Inst Technol Assessment, 101 Merrimac St,Ste 1010, Boston, MA 02114 USA; [Knudsen, Amy B.] Harvard Med Sch, Boston, MA 02115 USA; [Rutter, Carolyn M.] RAND Corp, Santa Monica, CA USA; [Peterse, Elisabeth F. P.; Meester, Reinier G. S.; Lansdorp-Vogelaar, Iris] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Peterse, Elisabeth F. P.] OPEN Hlth, Rotterdam, Netherlands; [Lietz, Anna P.] Columbia Univ, Sch Nursing, New York, NY USA; [Perdue, Leslie A.; Lin, Jennifer S.] Kaiser Permanente, Kaiser Permanente Evidence Based Practice Ctr, Portland, OR USA; [Perdue, Leslie A.; Lin, Jennifer S.] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA; [Siegel, Rebecca L.] Amer Canc Soc, Atlanta, GA 30329 USA; [Doria-Rose, V. Paul; Feuer, Eric J.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Kuntz, Karen M.] Univ Minnesota, Sch Publ Hlth, Dept Hlth Policy & Management, Minneapolis, MN USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; RAND Corporation; Erasmus University Rotterdam; Erasmus MC; Columbia University; Kaiser Permanente; Kaiser Permanente; American Cancer Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; University of Minnesota System; University of Minnesota Twin Cities	Knudsen, AB (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, 101 Merrimac St,Ste 1010, Boston, MA 02114 USA.	amy.knudsen@mgh.harvard.edu	Rutter, Carolyn/AAZ-3677-2021	Seguin, Claudia/0000-0002-1076-5563	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, via the Kaiser Permanente Evidence-based Practice Center (EPC) [HHSA-290-2015-00007-I-EPC5]; National Cancer Institute [U01CA199335, U01CA253913]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, via the Kaiser Permanente Evidence-based Practice Center (EPC); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded under contract HHSA-290-2015-00007-I-EPC5, Task Order 8, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, via the Kaiser Permanente Evidence-based Practice Center (EPC), under a contract to support the US Preventive Services Task Force (USPSTF). Drs Knudsen, Rutter, Peterse, Meester, Zauber, Kuntz, and Lansdorp-Vogelaar and Mss Lietz and Seguin were also supported in part by grants U01CA199335 and U01CA253913 from the National Cancer Institute.	[Anonymous], 2019, SEER STAT DAT INC SE; [Anonymous], 2019, CANC TRENDS PROGR RE; Arias Elizabeth, 2019, Natl Vital Stat Rep, V68, P1; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Blasi PR., 2021, AHRQ PUBLICATION 20; Butterly LF, 2021, AM J GASTROENTEROL, V116, P171, DOI 10.14309/ajg.0000000000000820; DeYoreo M, 2020, MED DECIS MAKING, V40, P1034, DOI 10.1177/0272989X20961095; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Greuter MJE, 2016, CANCER EPIDEM BIOMAR, V25, P135, DOI 10.1158/1055-9965.EPI-15-0592; Gupta S, 2020, AM J GASTROENTEROL, V115, P415, DOI 10.14309/ajg.0000000000000544; Hubbard RA, 2013, CANCER EPIDEM BIOMAR, V22, P1612, DOI 10.1158/1055-9965.EPI-13-0254; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Imperiale TF, 2018, GASTROENTEROLOGY, V155, P1776, DOI 10.1053/j.gastro.2018.08.020; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Knudsen AB., 2021, AHRQ PUBLICATION 20; Knudsen AB, 2016, JAMA-J AM MED ASSOC, V315, P2595, DOI 10.1001/jama.2016.6828; Kuntz KM, 2011, MED DECIS MAKING, V31, P530, DOI 10.1177/0272989X11408730; Mark DH, 2002, JAMA-J AM MED ASSOC, V287, P2428, DOI 10.1001/jama.287.18.2428; Meester RGS, 2018, CANCER-AM CANCER SOC, V124, P2974, DOI 10.1002/cncr.31542; Montminy EM, 2021, ANN INTERN MED, V174, P157, DOI 10.7326/M20-0068; MORSON B, 1974, P ROY SOC MED, V67, P451, DOI 10.1177/00359157740676P115; Naber SK, 2018, GASTROENTEROLOGY, V154, P105, DOI 10.1053/j.gastro.2017.09.021; Peterse EFP, 2018, CANCER-AM CANCER SOC, V124, P2964, DOI 10.1002/cncr.31543; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rundle AG, 2008, GASTROENTEROLOGY, V134, P1311, DOI 10.1053/j.gastro.2008.02.032; Rutter CM, 2021, CANCER EPIDEM BIOMAR, V30, P3, DOI 10.1158/1055-9965.EPI-19-1537; Rutter CM, 2019, ANN APPL STAT, V13, P2189, DOI [10.1214/19-AOAS1279, 10.1214/19-aoas1279]; Rutter CM, 2016, MED DECIS MAKING, V36, P604, DOI 10.1177/0272989X15622642; Rutter CM, 2013, JNCI-J NATL CANCER I, V105, P1806, DOI 10.1093/jnci/djt299; Schroy PC, 2013, ANN INTERN MED, V159, P13, DOI 10.7326/0003-4819-159-1-201307020-00004; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Siegel RL, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw322; van der Meulen MP, 2016, CANCER-AM CANCER SOC, V122, P1680, DOI 10.1002/cncr.29952; van Hees F, 2014, JAMA INTERN MED, V174, P1568, DOI 10.1001/jamainternmed.2014.3889; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Weissfeld JL, 2005, JNCI-J NATL CANCER I, V97, P989, DOI 10.1093/jnci/dji175	36	54	58	5	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1998	2011		10.1001/jama.2021.5746	http://dx.doi.org/10.1001/jama.2021.5746			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003219	Bronze, Green Accepted			2022-12-28	WOS:000652675100013
J	Whitlock, EL; Diaz-Ramirez, LG; Smith, AK; Boscardin, WJ; Covinsky, KE; Avidan, MS; Glymour, MM				Whitlock, Elizabeth L.; Diaz-Ramirez, L. Grisell; Smith, Alexander K.; Boscardin, W. John; Covinsky, Kenneth E.; Avidan, Michael S.; Glymour, M. Maria			Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults Undergoing Coronary Revascularization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OFF-PUMP; ON-PUMP; SURGERY; OUTCOMES; HEALTH; DAMAGE; RISK	Key PointsQuestionAmong older adults undergoing coronary revascularization, is the type of procedure (coronary artery bypass grafting [CABG] or percutaneous coronary intervention [PCI]) associated with differences in memory decline over time? FindingsIn this retrospective cohort study of 1680 US older adults, the change in the rate of memory decline from pre- to postprocedure was not significantly different for those undergoing CABG vs PCI. MeaningThere was no significant difference in the change in the rate of memory decline after CABG compared with PCI in a cohort of older adults. ImportanceIt is uncertain whether coronary artery bypass grafting (CABG) is associated with cognitive decline in older adults compared with a nonsurgical method of coronary revascularization (percutaneous coronary intervention [PCI]). ObjectiveTo compare the change in the rate of memory decline after CABG vs PCI. Design, Setting, and ParticipantsRetrospective cohort study of community-dwelling participants in the Health and Retirement Study, who underwent CABG or PCI between 1998 and 2015 at age 65 years or older. Data were modeled for up to 5 years preceding and 10 years following revascularization or until death, drop out, or the 2016-2017 interview wave. The date of final follow-up was November 2017. ExposuresCABG (including on and off pump) or PCI, ascertained from Medicare fee-for-service billing records. Main Outcomes and MeasuresThe primary outcome was a summary measure of cognitive test scores and proxy cognition reports that were performed biennially in the Health and Retirement Study, referred to as memory score, normalized as a z score (ie, mean of 0, SD of 1 in a reference population of adults aged >= 72 years). Memory score was analyzed using multivariable linear mixed-effects models, with a prespecified subgroup analysis of on-pump and off-pump CABG. The minimum clinically important difference was a change of 1 SD of the population-level rate of memory decline (0.048 memory units/y). ResultsOf 1680 participants (mean age at procedure, 75 years; 41% female), 665 underwent CABG (168 off pump) and 1015 underwent PCI. In the PCI group, the mean rate of memory decline was 0.064 memory units/y (95% CI, 0.052 to 0.078) before the procedure and 0.060 memory units/y (95% CI, 0.048 to 0.071) after the procedure (within-group change, 0.004 memory units/y [95% CI, -0.010 to 0.018]). In the CABG group, the mean rate of memory decline was 0.049 memory units/y (95% CI, 0.033 to 0.065) before the procedure and 0.059 memory units/y (95% CI, 0.047 to 0.072) after the procedure (within-group change, -0.011 memory units/y [95% CI, -0.029 to 0.008]). The between-group difference-in-differences estimate for memory decline for PCI vs CABG was 0.015 memory units/y (95% CI, -0.008 to 0.038; P=.21). There was statistically significant increase in the rate of memory decline after off-pump CABG compared with after PCI (difference-in-differences: mean increase in the rate of decline of 0.046 memory units/y [95% CI, 0.008 to 0.084] after off-pump CABG), but not after on-pump CABG compared with PCI (difference-in-differences: mean slowing of decline of 0.003 memory units/y [95% CI, -0.024 to 0.031] after on-pump CABG). Conclusions and RelevanceAmong older adults undergoing coronary revascularization with CABG or PCI, the type of revascularization procedure was not significantly associated with differences in the change of rate of memory decline. This cohort study compares the change in the rate of memory decline after coronary artery bypass grafting (CABG) vs percutaneous coronary intervention (PCI) in older adults.	[Whitlock, Elizabeth L.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Box 0648,521 Parnassus Ave,Floor 04, San Francisco, CA 94143 USA; [Diaz-Ramirez, L. Grisell; Smith, Alexander K.; Boscardin, W. John; Covinsky, Kenneth E.] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Smith, Alexander K.] San Francisco VA Med Ctr, Geriatr Palliat & Extended Care Serv, San Francisco, CA USA; [Boscardin, W. John; Glymour, M. Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Avidan, Michael S.] Washington Univ, Dept Anesthesiol, St Louis, MO 63110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Washington University (WUSTL)	Whitlock, EL (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Box 0648,521 Parnassus Ave,Floor 04, San Francisco, CA 94143 USA.	elizabeth.whitlock@ucsf.edu	Whitlock, Elizabeth L./N-1860-2014	Whitlock, Elizabeth L./0000-0002-6868-4301	National Institute on Aging of the National Institutes of Health [P30AG044281, R03AG059822, R01AG057751, K24AG068312]; National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR001879]; Foundation for Anesthesia Education and Research	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Foundation for Anesthesia Education and Research	Funding was provided by the National Institute on Aging (grant P30AG044281 to Drs Whitlock, Smith, Boscardin, and Covinsky and Ms Diaz-Ramirez; grant R03AG059822 to Dr Whitlock and Ms Diaz-Ramirez; and grants R01AG057751 and K24AG068312 to Dr Smith) and the National Center for Advancing Translational Sciences (grant KL2TR001879 to Dr Whitlock and Ms Diaz-Ramirez), both of the National Institutes of Health, and the Foundation for Anesthesia Education and Research (to Dr Whitlock).	Benedetto U, 2017, J THORAC DIS, V9, P5085, DOI 10.21037/jtd.2017.11.10; BRANTHWAITE MA, 1972, THORAX, V27, P748, DOI 10.1136/thx.27.6.748; Cigolle CT, 2009, J AM GERIATR SOC, V57, P830, DOI 10.1111/j.1532-5415.2009.02225.x; Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X; Diegeler A, 2019, CIRCULATION, V139, P1865, DOI 10.1161/CIRCULATIONAHA.118.035857; Evered L, 2018, BRIT J ANAESTH, V121, P1005, DOI 10.1016/j.bja.2017.11.087; Evered L, 2011, ANESTH ANALG, V112, P1179, DOI 10.1213/ANE.0b013e318215217e; Evered LA, 2016, ANESTHESIOLOGY, V125, P62, DOI 10.1097/ALN.0000000000001143; Figueroa JF, 2019, JAMA CARDIOL, V4, P265, DOI 10.1001/jamacardio.2019.0007; Gianattasio KZ, 2020, EPIDEMIOLOGY, V31, P126, DOI 10.1097/EDE.0000000000001101; Krause Bryan M, 2019, BMJ, V366, pl4466, DOI 10.1136/bmj.l4466; Kuzma E, 2017, ALZ DIS ASSOC DIS, V31, P120, DOI 10.1097/WAD.0000000000000191; Lamy A, 2013, NEW ENGL J MED, V368, P1179, DOI 10.1056/NEJMoa1301228; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Marden JR, 2017, ALZ DIS ASSOC DIS, V31, P48, DOI 10.1097/WAD.0000000000000182; Marden JR, 2016, ALZ DIS ASSOC DIS, V30, P195, DOI 10.1097/WAD.0000000000000137; Matlock DD, 2013, JAMA-J AM MED ASSOC, V310, P155, DOI 10.1001/jama.2013.7837; Nadelson MR, 2014, BRIT J ANAESTH, V112, P440, DOI 10.1093/bja/aet420; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Selnes OA, 2009, ANN THORAC SURG, V88, P445, DOI 10.1016/j.athoracsur.2009.04.061; Shroyer AL, 2017, NEW ENGL J MED, V377, P623, DOI 10.1056/NEJMoa1614341; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Singh-Manoux A, 2010, AGE, V32, P509, DOI 10.1007/s11357-010-9147-7; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; SOTANIEMI KA, 1980, J NEUROL NEUROSUR PS, V43, P127, DOI 10.1136/jnnp.43.2.127; Vable AM, 2018, J EPIDEMIOL COMMUN H, V72, P1162, DOI 10.1136/jech-2018-210771; Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405; van Dijk D, 2007, JAMA-J AM MED ASSOC, V297, P701, DOI 10.1001/jama.297.7.701; Wang QY, 2014, CEREBROVASC DIS, V37, P235, DOI 10.1159/000357557; Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717; Whitlock EL, 2019, ANN THORAC SURG, V107, P1119, DOI 10.1016/j.athoracsur.2018.10.021; Whitlock EL, 2017, JAMA INTERN MED, V177, P1146, DOI 10.1001/jamainternmed.2017.1622; Wu Q, 2013, ALZ DIS ASSOC DIS, V27, P207, DOI 10.1097/WAD.0b013e31826cfe90	33	16	16	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1955	1964		10.1001/jama.2021.5150	http://dx.doi.org/10.1001/jama.2021.5150			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003225	Green Published, Bronze			2022-12-28	WOS:000652675100010
J	Lutters, B; Schlich, T				Lutters, Bart; Schlich, Thomas			The art of medicine Facts and values in the history of spina bifida	LANCET			English	Editorial Material									[Lutters, Bart] Univ Med Ctr Utrecht, Dept Med Human, NL-3584 CX Utrecht, Netherlands; [Schlich, Thomas] McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada	Utrecht University; Utrecht University Medical Center; McGill University	Schlich, T (corresponding author), McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada.	thomas.schlich@mcgill.ca							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2021	397	10287					1800	1801						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD0HD	33992133				2022-12-28	WOS:000651041900011
J	Dutta, U; Maiti, S; Bhattacharya, T; Maiti, D				Dutta, Uttam; Maiti, Sudip; Bhattacharya, Trisha; Maiti, Debabrata			Arene diversification through distal C(sp(2))-H functionalization	SCIENCE			English	Review							C-H FUNCTIONALIZATION; CATALYZED ORTHO-ARYLATION; DIRECTING GROUP; NONCOVALENT INTERACTIONS; BOND FUNCTIONALIZATION; LIGAND; ACTIVATION; BORYLATION; ALKYLATION; OLEFINATION	Transition metal-catalyzed aryl C-H activation is a powerful synthetic tool as it offers step and atom-economical routes to site-selective functionalization. Compared with proximal ortho-C-H activation, distal (meta- and/or para-) C-H activation remains more challenging due to the inaccessibility of these sites in the formation of energetically favorable organometallic pretransition states. Directing the catalyst toward the distal C-H bonds requires judicious template engineering and catalyst design, as well as prudent choice of ligands. This review aims to summarize the recent elegant discoveries exploiting directing group assistance, transient mediators or traceless directors, noncovalent interactions, and catalyst and/or ligand selection to control distal C-H activation.	[Dutta, Uttam; Maiti, Sudip; Bhattacharya, Trisha; Maiti, Debabrata] Indian Inst Technol, Mumbai 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Maiti, D (corresponding author), Indian Inst Technol, Mumbai 400076, Maharashtra, India.	dmaiti@iitb.ac.in	; Maiti, Debabrata/K-5112-2012	Dutta, Uttam/0000-0001-7056-5865; Maiti, Debabrata/0000-0001-8353-1306	SERB India [CRG/2018/003951]; UGC-India	SERB India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); UGC-India(University Grants Commission, India)	This work was supported by SERB India (CRG/2018/003951) and research fellowships from UGC-India (to S.M. and T.B.).	Achar TK, 2019, ANGEW CHEM INT EDIT, V58, P10353, DOI 10.1002/anie.201904608; Ackermann L, 2011, ORG LETT, V13, P1875, DOI 10.1021/ol200366n; Bag S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21633-2; Bag S, 2020, J AM CHEM SOC, V142, P12453, DOI 10.1021/jacs.0c05223; Bag S, 2017, ANGEW CHEM INT EDIT, V56, P12538, DOI 10.1002/anie.201706360; Bag S, 2017, ANGEW CHEM INT EDIT, V56, P3182, DOI 10.1002/anie.201611360; Bag S, 2015, J AM CHEM SOC, V137, P11888, DOI 10.1021/jacs.5b06793; Ball LT, 2012, SCIENCE, V337, P1644, DOI 10.1126/science.1225709; Barlow HL, 2017, ORG LETT, V19, P6662, DOI 10.1021/acs.orglett.7b03387; Bastidas JRM, 2019, J AM CHEM SOC, V141, P15483, DOI 10.1021/jacs.9b08464; Beer P. D., 1999, SUPRAMOLECULAR CHEM; Bera M, 2017, ANGEW CHEM INT EDIT, V56, P5272, DOI 10.1002/anie.201701579; Bera M, 2016, ACS CATAL, V6, P3575, DOI 10.1021/acscatal.6b00675; Bera M, 2015, ANGEW CHEM INT EDIT, V54, P8515, DOI 10.1002/anie.201503112; Bera M, 2014, ORG LETT, V16, P5760, DOI 10.1021/ol502823c; Berger F, 2019, NATURE, V567, P223, DOI 10.1038/s41586-019-0982-0; Bisht R, 2018, ANGEW CHEM INT EDIT, V57, P15762, DOI 10.1002/anie.201809929; Bisht R, 2016, J AM CHEM SOC, V138, P84, DOI 10.1021/jacs.5b11683; Boursalian GB, 2016, NAT CHEM, V8, P810, DOI [10.1038/NCHEM.2529, 10.1038/nchem.2529]; Boursalian GB, 2013, J AM CHEM SOC, V135, P13278, DOI 10.1021/ja4064926; Brasche G, 2008, ORG LETT, V10, P2207, DOI 10.1021/ol800619c; Cambeiro XC, 2013, ANGEW CHEM INT EDIT, V52, P1781, DOI 10.1002/anie.201209007; Catellani M, 2008, ACCOUNTS CHEM RES, V41, P1512, DOI 10.1021/ar800040u; Chen H, 2019, ACS CATAL, V9, P1979, DOI 10.1021/acscatal.8b04639; Chen H, 2018, ANGEW CHEM INT EDIT, V57, P2497, DOI 10.1002/anie.201712235; Cheng GL, 2017, ANGEW CHEM INT EDIT, V56, P8183, DOI 10.1002/anie.201704411; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Chu L, 2015, ACS CENTRAL SCI, V1, P394, DOI 10.1021/acscentsci.5b00312; Ciana CL, 2011, ANGEW CHEM INT EDIT, V50, P458, DOI 10.1002/anie.201004703; CLARK GR, 1994, INORG CHIM ACTA, V220, P261, DOI 10.1016/0020-1693(94)03877-5; Cornella J, 2011, ANGEW CHEM INT EDIT, V50, P9429, DOI 10.1002/anie.201103720; Coudret C, 1998, CHEM COMMUN, P663, DOI 10.1039/a709101j; Davis HJ, 2017, ANGEW CHEM INT EDIT, V56, P13351, DOI 10.1002/anie.201708967; Davis HJ, 2016, J AM CHEM SOC, V138, P12759, DOI 10.1021/jacs.6b08164; de Azambuja F, 2020, NAT CHEM, V12, P489, DOI 10.1038/s41557-020-0428-1; Dey A, 2019, ANGEW CHEM INT EDIT, V58, P10820, DOI 10.1002/anie.201812116; Ding QP, 2017, J AM CHEM SOC, V139, P417, DOI 10.1021/jacs.6b11097; Dong Z, 2015, J AM CHEM SOC, V137, P5887, DOI 10.1021/jacs.5b02809; Duong HA, 2011, ANGEW CHEM INT EDIT, V50, P463, DOI 10.1002/anie.201004704; Dutta U, 2020, ANGEW CHEM INT EDIT, V59, P20831, DOI 10.1002/anie.202005664; Dutta U, 2019, CHEM SCI, V10, P7426, DOI 10.1039/c9sc01824g; Dutta U, 2017, ACS CATAL, V7, P3162, DOI 10.1021/acscatal.7b00247; Fan ZL, 2016, J AM CHEM SOC, V138, P8470, DOI 10.1021/jacs.6b03402; Fang LZ, 2017, J AM CHEM SOC, V139, P10702, DOI 10.1021/jacs.7b03296; Farmer ME, 2018, ACS CATAL, V8, P7362, DOI 10.1021/acscatal.8b01599; Genov GR, 2020, SCIENCE, V367, P1246, DOI 10.1126/science.aba1120; Han J, 2016, CHEM COMMUN, V52, P6903, DOI 10.1039/c6cc02384c; Hartwig JF, 2016, ACS CENTRAL SCI, V2, P281, DOI 10.1021/acscentsci.6b00032; Hofmann N, 2013, J AM CHEM SOC, V135, P5877, DOI 10.1021/ja401466y; Hoque ME, 2017, J AM CHEM SOC, V139, P7745, DOI 10.1021/jacs.7b04490; Hull KL, 2007, J AM CHEM SOC, V129, P11904, DOI 10.1021/ja074395z; Ishiyama T, 2002, ANGEW CHEM INT EDIT, V41, P3056, DOI 10.1002/1521-3773(20020816)41:16<3056::AID-ANIE3056>3.0.CO;2-#; Knowles RR, 2010, P NATL ACAD SCI USA, V107, P20678, DOI 10.1073/pnas.1006402107; Korvorapun K, 2020, ACS CATAL, V10, P435, DOI 10.1021/acscatal.9b04592; Kuninobu Y, 2015, NAT CHEM, V7, P712, DOI [10.1038/NCHEM.2322, 10.1038/nchem.2322]; Lee S, 2013, J AM CHEM SOC, V135, P18778, DOI 10.1021/ja4107034; Leitch JA, 2017, CHEM SOC REV, V46, P7145, DOI 10.1039/c7cs00496f; Leitch JA, 2017, ANGEW CHEM INT EDIT, V56, P15131, DOI 10.1002/anie.201708961; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Li B, 2017, ORG LETT, V19, P3950, DOI 10.1021/acs.orglett.7b01529; Li G, 2017, ORG LETT, V19, P2682, DOI 10.1021/acs.orglett.7b00885; Li GC, 2017, ANGEW CHEM INT EDIT, V56, P6874, DOI 10.1002/anie.201702686; Li GB, 2017, ACS CATAL, V7, P4138, DOI 10.1021/acscatal.7b01072; Li J, 2015, J AM CHEM SOC, V137, P13894, DOI 10.1021/jacs.5b08435; Li MH, 2019, ORG LETT, V21, P540, DOI 10.1021/acs.orglett.8b03871; Li Q, 2017, CHEM-EUR J, V23, P11519, DOI 10.1002/chem.201703054; Li SD, 2019, ANGEW CHEM INT EDIT, V58, P18502, DOI 10.1002/anie.201910691; Li SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10443; Liu LY, 2019, CHEM-EUR J, V25, P2199, DOI 10.1002/chem.201805772; Luo JF, 2014, J AM CHEM SOC, V136, P4109, DOI 10.1021/ja500457s; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Maji A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06018-2; Maji A, 2017, ANGEW CHEM INT EDIT, V56, P14903, DOI 10.1002/anie.201708449; Maji A, 2016, CHEM SCI, V7, P3147, DOI 10.1039/c5sc04060d; Mihai MT, 2019, J AM CHEM SOC, V141, P15477, DOI 10.1021/jacs.9b07267; Mihai MT, 2018, CHEM SOC REV, V47, P149, DOI 10.1039/c7cs00637c; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Modak A, 2016, CHEM COMMUN, V52, P13916, DOI 10.1039/c6cc08302a; Nakao Y, 2010, J AM CHEM SOC, V132, P13666, DOI 10.1021/ja106514b; Naksomboon K, 2019, J AM CHEM SOC, V141, P6719, DOI 10.1021/jacs.9b01908; Okumura S, 2016, J AM CHEM SOC, V138, P14699, DOI 10.1021/jacs.6b08767; Paterson AJ, 2017, ORG BIOMOL CHEM, V15, P5993, DOI 10.1039/c7ob01192j; Paterson AJ, 2015, CHEM COMMUN, V51, P12807, DOI 10.1039/c5cc03951g; Patra T, 2016, ANGEW CHEM INT EDIT, V55, P7751, DOI 10.1002/anie.201601999; Patra T, 2016, CHEM COMMUN, V52, P2027, DOI 10.1039/c5cc09446a; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Porey S, 2020, J AM CHEM SOC, V142, P3762, DOI 10.1021/jacs.9b10646; Ramakrishna K, 2019, ANGEW CHEM INT EDIT, V131, P13946, DOI [DOI 10.1002/ANGE.201907544, 10.1002/ange.201907544]; Romero NA, 2015, SCIENCE, V349, P1326, DOI 10.1126/science.aac9895; Ruan ZX, 2017, ANGEW CHEM INT EDIT, V56, P2045, DOI 10.1002/anie.201611595; Saidi O, 2011, J AM CHEM SOC, V133, P19298, DOI 10.1021/ja208286b; Saito Y, 2015, J AM CHEM SOC, V137, P5193, DOI 10.1021/jacs.5b02052; Sasmal S, 2020, CHEM COMMUN, V56, P7100, DOI 10.1039/d0cc02851g; SCHWARZ H, 1989, ACCOUNTS CHEM RES, V22, P282, DOI 10.1021/ar00164a004; Shi H, 2020, NAT CHEM, V12, P399, DOI 10.1038/s41557-020-0424-5; Shi H, 2018, NATURE, V558, P581, DOI 10.1038/s41586-018-0220-1; Smith B. M, 2007, ADV ORGANIC CHEM REA; Tang RY, 2014, NATURE, V507, P215, DOI 10.1038/nature12963; Teskey CJ, 2015, ANGEW CHEM INT EDIT, V54, P11677, DOI 10.1002/anie.201504390; Toste FD, 2017, ACCOUNTS CHEM RES, V50, P609, DOI 10.1021/acs.accounts.6b00613; Wagner GK, 2003, J ORG CHEM, V68, P4527, DOI 10.1021/jo026619w; Wan L, 2013, J AM CHEM SOC, V135, P18056, DOI 10.1021/ja410760f; Wang JC, 2019, CHEM REV, V119, P7478, DOI 10.1021/acs.chemrev.9b00079; Wang P, 2017, NATURE, V551, P489, DOI 10.1038/nature24632; Wang P, 2016, J AM CHEM SOC, V138, P9269, DOI 10.1021/jacs.6b04966; Wang XC, 2015, NATURE, V519, P334, DOI 10.1038/nature14214; Wang XG, 2019, J AM CHEM SOC, V141, P13914, DOI 10.1021/jacs.9b06608; Wang XS, 2011, J AM CHEM SOC, V133, P13864, DOI 10.1021/ja206572w; Xu HJ, 2017, J AM CHEM SOC, V139, P2200, DOI 10.1021/jacs.6b13269; Yang GQ, 2014, J AM CHEM SOC, V136, P10807, DOI 10.1021/ja505737x; Yang LC, 2019, J AM CHEM SOC, V141, P7972, DOI 10.1021/jacs.9b03138; Yang YF, 2014, J AM CHEM SOC, V136, P344, DOI 10.1021/ja410485g; Yeung CS, 2010, CHEM SCI, V1, P331, DOI 10.1039/c0sc00231c; Yu QZ, 2015, ANGEW CHEM INT EDIT, V54, P15284, DOI 10.1002/anie.201507100; Yuan CC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03341-6; Zhang ZP, 2017, NATURE, V543, P538, DOI 10.1038/nature21418; Zhao D, 2019, CHEM-US, V5, P97, DOI 10.1016/j.chempr.2018.09.027	117	107	106	62	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					701	+	abd5992	10.1126/science.abd5992	http://dx.doi.org/10.1126/science.abd5992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986152				2022-12-28	WOS:000651125300038
J	Sun, YZ; Rahbani, JF; Jedrychowski, MP; Riley, CL; Vidoni, S; Bogoslavski, D; Hu, B; Dumesic, PA; Zeng, X; Wang, AB; Knudsen, NH; Kim, CR; Marasciullo, A; Millan, JL; Chouchani, ET; Kazak, L; Spiegelman, BM				Sun, Yizhi; Rahbani, Janane F.; Jedrychowski, Mark P.; Riley, Christopher L.; Vidoni, Sara; Bogoslavski, Dina; Hu, Bo; Dumesic, Phillip A.; Zeng, Xing; Wang, Alex B.; Knudsen, Nelson H.; Kim, Caroline R.; Marasciullo, Anthony; Millan, Jose L.; Chouchani, Edward T.; Kazak, Lawrence; Spiegelman, Bruce M.			Mitochondrial TNAP controls thermogenesis by hydrolysis of phosphocreatine	NATURE			English	Article							DIET-INDUCED THERMOGENESIS; BROWN ADIPOSE-TISSUE; NONSPECIFIC ALKALINE-PHOSPHATASE; ABSOLUTE QUANTIFICATION; ENERGY-EXPENDITURE; GENE-EXPRESSION; BEIGE; GLUCOSE; OBESITY; DEPLETION	Adaptive thermogenesis has attracted much attention because of its ability to increase systemic energy expenditure and to counter obesity and diabetes(1-3). Recent data have indicated that thermogenic fat cells use creatine to stimulate futile substrate cycling, dissipating chemical energy as heat(4,5). This model was based on the super-stoichiometric relationship between the amount of creatine added to mitochondria and the quantity of oxygen consumed. Here we provide direct evidence for the molecular basis of this futile creatine cycling activity in mice. Thermogenic fat cells have robust phosphocreatine phosphatase activity, which is attributed to tissue-nonspecific alkaline phosphatase (TNAP). TNAP hydrolyses phosphocreatine to initiate a futile cycle of creatine dephosphorylation and phosphorylation. Unlike in other cells, TNAP in thermogenic fat cells is localized to the mitochondria, where futile creatine cycling occurs. TNAP expression is powerfully induced when mice are exposed to cold conditions, and its inhibition in isolated mitochondria leads to a loss of futile creatine cycling. In addition, genetic ablation of TNAP in adipocytes reduces whole-body energy expenditure and leads to rapid-onset obesity in mice, with no change in movement or feeding behaviour. These data illustrate the critical role of TNAP as a phosphocreatine phosphatase in the futile creatine cycle.	[Sun, Yizhi; Jedrychowski, Mark P.; Riley, Christopher L.; Vidoni, Sara; Bogoslavski, Dina; Hu, Bo; Dumesic, Phillip A.; Zeng, Xing; Wang, Alex B.; Knudsen, Nelson H.; Kim, Caroline R.; Marasciullo, Anthony; Chouchani, Edward T.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Sun, Yizhi; Jedrychowski, Mark P.; Riley, Christopher L.; Vidoni, Sara; Hu, Bo; Dumesic, Phillip A.; Zeng, Xing; Wang, Alex B.; Knudsen, Nelson H.; Chouchani, Edward T.; Spiegelman, Bruce M.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Rahbani, Janane F.; Kazak, Lawrence] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Rahbani, Janane F.; Kazak, Lawrence] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Millan, Jose L.] Sanford Childrens Hlth Res Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; McGill University; McGill University; Sanford Burnham Prebys Medical Discovery Institute	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Spiegelman, BM (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Chouchani, Edward T./HCH-3775-2022	Rahbani, Janane/0000-0003-4598-4683				Allan C, 2012, NAT METHODS, V9, P245, DOI [10.1038/NMETH.1896, 10.1038/nmeth.1896]; Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.bi.54.070185.004151; Buchet R, 2013, METHODS MOL BIOL, V1053, P27, DOI 10.1007/978-1-62703-562-0_3; Carobbio S, 2019, BBA-MOL CELL BIOL L, V1864, P37, DOI 10.1016/j.bbalip.2018.05.013; Chen WW, 2017, NAT PROTOC, V12, P2215, DOI 10.1038/nprot.2017.104; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Chouchani ET, 2019, CELL METAB, V29, P27, DOI 10.1016/j.cmet.2018.11.002; CLARK MG, 1973, NATURE, V245, P99, DOI 10.1038/245099a0; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Foster BL, 2017, J DENT RES, V96, P81, DOI 10.1177/0022034516663633; GETTINS P, 1985, J BIOL CHEM, V260, P2875; Haarhaus M, 2017, NAT REV NEPHROL, V13, P429, DOI 10.1038/nrneph.2017.60; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429; Kazak L, 2019, NAT METAB, V1, P360, DOI 10.1038/s42255-019-0035-x; Kazak L, 2017, CELL METAB, V26, P660, DOI 10.1016/j.cmet.2017.08.009; Kazak L, 2017, P NATL ACAD SCI USA, V114, P7981, DOI 10.1073/pnas.1705406114; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kiffer-Moreira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089374; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; KLEIN S, 1990, J CLIN INVEST, V86, P1403, DOI 10.1172/JCI114854; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Leitner BP, 2017, P NATL ACAD SCI USA, V114, P8649, DOI 10.1073/pnas.1705287114; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Long JZ, 2016, CELL, V166, P424, DOI 10.1016/j.cell.2016.05.071; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30030; Newsholme E A, 1976, Biochem Soc Symp, P61; Pinkerton AB, 2018, BIOORG MED CHEM LETT, V28, P31, DOI 10.1016/j.bmcl.2017.11.024; Rahbani JF, 2021, NATURE, V590, DOI 10.1038/s41586-021-03221-y; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Roh HC, 2018, CELL METAB, V27, P1121, DOI 10.1016/j.cmet.2018.03.005; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharabi K, 2017, CELL, V169, P148, DOI 10.1016/j.cell.2017.03.001; SHULMAN GI, 1985, J CLIN INVEST, V76, P757, DOI 10.1172/JCI112032; Springer Matthew L, 2002, Curr Protoc Hum Genet, VChapter 13, DOI 10.1002/0471142905.hg1304s31; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Vendelin M, 2004, BIOPHYS J, V87, P696, DOI 10.1529/biophysj.103.036210; WOLFE RR, 1987, NEW ENGL J MED, V317, P403, DOI 10.1056/NEJM198708133170702; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zeng X, 2019, NATURE, V569, P229, DOI 10.1038/s41586-019-1156-9	52	26	26	7	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					580	+		10.1038/s41586-021-03533-z	http://dx.doi.org/10.1038/s41586-021-03533-z		MAY 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT9IE	33981039	Green Accepted			2022-12-28	WOS:000650200300004
J	Howard, S				Howard, Sally			Experimental treatments risk further medicalisation of menopause	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; WOMEN					sal@sallyhoward.net						Akahori T, 2019, CLIN MED INSIGHTS-RE, V13, DOI 10.1177/1179558119848007; Collaborative Grp Hormonal Factors, 2019, LANCET, V394, P1159, DOI 10.1016/S0140-6736(19)31709-X; Donnez J, 2006, HUM REPROD UPDATE, V12, P519, DOI 10.1093/humupd/dml032; Hickey M, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5101; Hipp HS, 2016, MENOPAUSE, V23, P993, DOI 10.1097/GME.0000000000000658; Martin RM, 2010, J PUBLIC HEALTH-UK, V32, P555, DOI 10.1093/pubmed/fdq021; National Institute for Health and Care Excellence, 2019, MEN DIAGN MAN; North American Menopause Society, 2010, MEN PRACT CLIN GUID; Peacock K, 2020, MENOPAUSE; Prague JK, 2018, MENOPAUSE, V25, P862, DOI 10.1097/GME.0000000000001090; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Women's Health Concern, 2017, NEW SURV HIGHL IMP M	12	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n992	10.1136/bmj.n992	http://dx.doi.org/10.1136/bmj.n992			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975866				2022-12-28	WOS:000649711400014
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... travel traffic lights	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Transport, 2021, RED AMB GREEN LIST R; Savage M, 2021, GUARDIAN; Shendruk A, 2021, QUARTZ          0423	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2021	373								n1195	10.1136/bmj.n1195	http://dx.doi.org/10.1136/bmj.n1195			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RA	33972310	Bronze			2022-12-28	WOS:000649709400005
J	Cavazza, T; Takeda, Y; Politi, AZ; Aushev, M; Aldag, P; Baker, C; Choudhary, M; Bucevicius, J; Lukinavicius, G; Elder, K; Blayney, M; Lucas-Hahn, A; Niemann, H; Herbert, M; Schuh, M				Cavazza, Tommaso; Takeda, Yuko; Politi, Antonio Z.; Aushev, Magomet; Aldag, Patrick; Baker, Clara; Choudhary, Meenakshi; Bucevicius, Jonas; Lukinavicius, Grazvydas; Elder, Kay; Blayney, Martyn; Lucas-Hahn, Andrea; Niemann, Heiner; Herbert, Mary; Schuh, Melina			Parental genome unification is highly error-prone in mammalian embryos	CELL			English	Article							NUCLEAR-PORE COMPLEX; MICROTUBULE ORGANIZATION; PREIMPLANTATION DEVELOPMENT; CHROMOSOMAL-ABNORMALITIES; SPATIAL SEPARATION; MOUSE EMBRYO; STAGE; FERTILIZATION; CENTROSOME; CLEAVAGE	Most human embryos are aneuploid. Aneuploidy frequently arises during the early mitotic divisions of the embryo, but its origin remains elusive. Human zygotes that cluster their nucleoli at the pronuclear interface are thought to be more likely to develop into healthy euploid embryos. Here, we show that the parental genomes cluster with nucleoli in each pronucleus within human and bovine zygotes, and clustering is required for the reliable unification of the parental genomes after fertilization. During migration of intact pronuclei, the parental genomes polarize toward each other in a process driven by centrosomes, dynein, microtubules, and nuclear pore complexes. The maternal and paternal chromosomes eventually cluster at the pronuclear interface, in direct proximity to each other, yet separated. Parental genome clustering ensures the rapid unification of the parental genomes on nuclear envelope breakdown. However, clustering often fails, leading to chromosome segregation errors and micronuclei, incompatible with healthy embryo development.	[Cavazza, Tommaso; Politi, Antonio Z.; Bucevicius, Jonas; Lukinavicius, Grazvydas; Schuh, Melina] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Takeda, Yuko; Aushev, Magomet; Herbert, Mary] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Biosci Inst, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; [Aldag, Patrick; Lucas-Hahn, Andrea; Niemann, Heiner] Friedrich Loeffler Inst, Inst Farm Anim Genet, Biotechnol, D-31535 Neustadt, Germany; [Baker, Clara; Elder, Kay; Blayney, Martyn] Bourn Hall Clin, Cambridge CB23 2TN, England; [Choudhary, Meenakshi; Herbert, Mary] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Fertil Ctr Life, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; [Niemann, Heiner] Hannover Med Sch, Clin Gastroenterol, Hepatol, Endocrinol TwinCore, D-30625 Hannover, Germany	Max Planck Society; Newcastle University - UK; Friedrich Loeffler Institute; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Hannover Medical School	Schuh, M (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	melina.schuh@mpibpc.mpg.de	Lukinavicius, Grazvydas/H-9799-2017; Cavazza, Tommaso/AAB-8296-2022	Lukinavicius, Grazvydas/0000-0002-7176-1793; Cavazza, Tommaso/0000-0003-2544-5340; Aushev, Magomet/0000-0002-1348-6404; Elder, Kay/0000-0003-3510-8268; Politi, Antonio/0000-0003-4788-0933; Herbert, Mary/0000-0002-8488-2770	Wellcome Human Developmental Biology Initiative (HDBI) [215116/Z/18/Z]; Wellcome Centre grant [203105/Z/16/Z]; Max Planck Society; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [EXC 2067/1-390729940, SCHU 3047/1-1]	Wellcome Human Developmental Biology Initiative (HDBI); Wellcome Centre grant; Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	We thank L. Pieper and M.W. Kriesten (Westfleisch SCE mbH, Hamm, Germany) for enabling this research by donating bovine ovaries; the MPI-BPC drivers for collecting ovaries; M. Daniel (MPI-BPC) for assistance in coordinating ovary collection; J. Uraji and K. Menelaou (MPI-BPC) for help in providing the human embryo videos; N. Sharma, C. So, A. Webster (MPI-BPC), and A. Zielinska (Imperial College, London, UK) for technical advice; S. Munro (LMB, Cambridge, UK), A. Musacchio (MPI-Molecular Physiology, Dortmund, Germany), and J. Ellenberg (EMBL, Heidelberg, Germany) for plasmids; V. Cordes (MPI-BPC) for antibodies; Z. Holubcova (Department of Histology and Embryology, Masaryk University, Czech Republic) for discussions about human zygotes; M.E. Torres-Padilla (IES, Munich, Germany) for discussion about Nup98; the Bioimaging Unit (Newcastle University, UK), the Livecell imaging facility (MPI-BPC), and P. Lenart (MPI-BPC) for discussion and support; C. Thomas (MPI-BPC), L. Wartosch (MPI-BPC), and Life Science Editors for critical comments on the manuscript; members of the Schuh lab for discussions. The work on human zygotes was funded by the Wellcome Human Developmental Biology Initiative (HDBI; 215116/Z/18/Z) and a Wellcome Centre grant (203105/Z/16/Z). The research leading to these results received financial support from the Max Planck Society and Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy (EXC 2067/1-390729940) and a DFG Leibniz Prize (SCHU 3047/1-1) to M.S.	Arlucea J, 1998, J STRUCT BIOL, V124, P51, DOI 10.1006/jsbi.1998.4054; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Benkhalifa M, 2005, PRENATAL DIAG, V25, P894, DOI 10.1002/pd.1230; Bernal-Ulloa SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150264; Bolkova J, 2016, INT J DEV BIOL, V60, P5, DOI 10.1387/ijdb.150222cl; Bone CR, 2016, J CELL SCI, V129, P1951, DOI 10.1242/jcs.179788; Brevini TAL, 2012, THERIOGENOLOGY, V77, P766, DOI 10.1016/j.theriogenology.2011.11.010; Brooks K.E., 2020, BIORXIV; Bucevicius J, 2019, CHEM SCI, V10, P1962, DOI 10.1039/c8sc05082a; Capelson M., 2018, NUCL ARCHITECTURE DY, V2, P369; Chia G, 2017, NAT CELL BIOL, V19, P282, DOI 10.1038/ncb3485; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Coskun Serdar, 2003, Reprod Biomed Online, V7, P86; Coticchio G, 2018, HUM REPROD, V33, P23, DOI 10.1093/humrep/dex344; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Daigneault BW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25964-x; Destouni A, 2016, GENOME RES, V26, P567, DOI 10.1101/gr.200527.115; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dozortsev D, 2000, FERTIL STERIL, V73, P366, DOI 10.1016/S0015-0282(99)00491-4; Egli D, 2018, NATURE, V560, pE5, DOI 10.1038/s41586-018-0379-5; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Ellenberg J., 2020, 342154 BIORXIV, V2020, DOI [10.1101/2020.10.16.342154, DOI 10.1101/2020.10.16.342154]; Faramarzi A, 2018, GYNECOL ENDOCRINOL, V34, P248, DOI 10.1080/09513590.2017.1388365; Fishman EL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04678-8; Ford E., 2020, BIORXIV2020200720172, DOI [10.1101/2020.07.17.208744, DOI 10.1101/2020.07.17.208744]; Fragouli E, 2013, HUM GENET, V132, P1001, DOI 10.1007/s00439-013-1309-0; Fritz B, 2001, EUR J HUM GENET, V9, P539, DOI 10.1038/sj.ejhg.5200669; Gamiz P, 2003, HUM REPROD, V18, P2413, DOI 10.1093/humrep/deg458; Gerri C, 2020, ANNU REV CELL DEV BI, V36, P411, DOI 10.1146/annurev-cellbio-022020-024900; Gerri C, 2020, NATURE, V587, P443, DOI 10.1038/s41586-020-2759-x; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Hu DJK, 2013, CELL, V154, P1300, DOI 10.1016/j.cell.2013.08.024; Human Fertilisation and Embryology Authority, 2018, HFEA COD PRACT; Ibarra A, 2015, GENE DEV, V29, P337, DOI 10.1101/gad.256495.114; Inoue A, 2014, NAT STRUCT MOL BIOL, V21, P609, DOI 10.1038/nsmb.2839; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kim NH, 1996, BIOL REPROD, V54, P1397, DOI 10.1095/biolreprod54.6.1397; Klare K, 2015, J CELL BIOL, V210, P11, DOI 10.1083/jcb.201412028; Kort DH, 2016, HUM REPROD, V31, P312, DOI 10.1093/humrep/dev281; Kuznetsov NV, 2002, CHROMOSOMA, V111, P236, DOI 10.1007/s00412-002-0208-2; Lee A, 2017, J ASSIST REPROD GEN, V34, P15, DOI 10.1007/s10815-016-0845-7; Legland D, 2016, BIOINFORMATICS, V32, P3532, DOI 10.1093/bioinformatics/btw413; Lequarre AS, 2003, BIOL REPROD, V69, P1707, DOI 10.1095/biolreprod.103.017178; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003308; Lightfoot DA, 2006, DEV BIOL, V289, P384, DOI 10.1016/j.ydbio.2005.11.001; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lindeman RE, 2012, CURR BIOL, V22, P843, DOI 10.1016/j.cub.2012.03.058; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Mayer W, 2000, J CELL BIOL, V148, P629, DOI 10.1083/jcb.148.4.629; McCoy RC, 2017, TRENDS GENET, V33, P448, DOI 10.1016/j.tig.2017.04.001; McCoy RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005601; Meriano J, 2004, REPROD BIOMED ONLINE, V9, P511, DOI 10.1016/S1472-6483(10)61635-5; Milo R., 2016, CELL BIOL NUMBERS; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Minn IL, 2009, MOL BIOL CELL, V20, P4586, DOI 10.1091/mbc.E08-10-1034; NAVARA CS, 1994, DEV BIOL, V162, P29, DOI 10.1006/dbio.1994.1064; Ottolini CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09693-1; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Payne C, 2003, J CELL SCI, V116, P4727, DOI 10.1242/jcs.00784; Perez-Garrastachu M, 2017, NUCLEUS-PHILA, V8, P515, DOI 10.1080/19491034.2017.1320001; Popken J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124619; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt U, 2018, LECT NOTES COMPUT SC, V11071, P265, DOI 10.1007/978-3-030-00934-2_30; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Scott Lynette, 2003, Reprod Biomed Online, V6, P201; Shibuya H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004821; Simmet K, 2018, P NATL ACAD SCI USA, V115, P2770, DOI 10.1073/pnas.1718833115; So C, 2019, SCIENCE, V364, P1252, DOI 10.1126/science.aat9557; Sood V, 2014, CURR OPIN GENET DEV, V25, P43, DOI 10.1016/j.gde.2013.11.018; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Tavenard R, 2020, J MACH LEARN RES, V21; Team RC., 2013, R LANG ENV STAT COMP; Tesarik J, 1999, HUM REPROD, V14, P1318, DOI 10.1093/humrep/14.5.1318; Thomas C, 2021, BIOCHEM SOC T, V49, P107, DOI 10.1042/BST20200043; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; van de Werken C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6868; van Echten-Arends J, 2011, HUM REPROD UPDATE, V17, P620, DOI 10.1093/humupd/dmr014; VanBlerkom J, 1995, HUM REPROD UPDATE, V1, P429, DOI 10.1093/humupd/1.5.429; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vazquez-Diez C, 2019, CURR BIOL, V29, P865, DOI 10.1016/j.cub.2018.12.042; Vera-Rodriguez M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8601; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Zeng XH, 2018, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00121; Zenker J, 2017, SCIENCE, V357, P925, DOI 10.1126/science.aam9335; Zuccaro MV, 2020, CELL, V183, P1650, DOI 10.1016/j.cell.2020.10.025	95	32	32	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					2860	+		10.1016/j.cell.2021.04.013	http://dx.doi.org/10.1016/j.cell.2021.04.013		MAY 2021	40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	33964210	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000656965600007
J	Slomski, A				Slomski, Anita			Patients Favor Surgical Repair of Ruptured ACL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2039	2039		10.1001/jama.2021.7718	http://dx.doi.org/10.1001/jama.2021.7718			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032832				2022-12-28	WOS:000655647300008
J	Razai, MS; Chaudhry, UAR; Doerholt, K; Bauld, L; Majeed, A				Razai, Mohammad S.; Chaudhry, Umar A. R.; Doerholt, Katja; Bauld, Linda; Majeed, Azeem			Covid-19 vaccination hesitancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Razai, Mohammad S.; Chaudhry, Umar A. R.] St George Univ London, Populat Hlth Res Inst, London, England; [Doerholt, Katja] St Georges Univ Hosp NHS Fdn Trust, London, England; [Bauld, Linda] Univ Edinburgh, Coll Med & Vet Med, Usher Inst, Edinburgh, Midlothian, Scotland; [Majeed, Azeem] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England	St Georges University London; University of Edinburgh; Imperial College London	Razai, MS (corresponding author), St George Univ London, Populat Hlth Res Inst, London, England.	mrazai@sgul.ac.uk		Razai, Mohammad Sharif/0000-0002-6671-5557; Majeed, Azeem/0000-0002-2357-9858				Allegretti A, 2021, GUARDIAN 1013; [Anonymous], SEASONAL INFLUENZA V; Arede M, 2019, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00381; Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401; British Medical Association, 2021, COVID 19 COMM DIFF G; Centers for Disease Control and Prevention, 2021, VACC SAF MON; Dahir A.L., 2021, NEW YORK TIMES; de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0; Duffy B., 2020, CORONAVIRUS VACCINE; European Centre for Disease Prevention and Control, 2017, CAT INT ADDR VACC HE; Hesitancy WSWGDwV, 2014, STRATEGIES ADDRESSIN; Institute of Global Health Innovation Imperial College London., 2021, COVID 19 GLOB ATT CO; Jain A, 2017, VACCINE, V35, P2315, DOI 10.1016/j.vaccine.2017.03.013; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lewandowsky S, 2021, COVID 19 VACCINE COM; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Majeed A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4654; Mangtani P, 2005, PREV MED, V41, P545, DOI 10.1016/j.ypmed.2005.02.001; Martin CA, 2021, ASS DEMOGRAPHIC OCCU, DOI [10.1101/2021.02.11.21251548, DOI 10.1101/2021.02.11.21251548]; Mills M., 2020, COVID 19 VACCINE DEP; Office for National Statistics, 2021, COR VACC RAT PEOPL 7; Office For National Statistics, 2021, COR SOC IMP GREAT BR; Peterson P, 2019, PUBLIC HEALTH REP, V134, P241, DOI 10.1177/0033354919834579; Razai MS, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n513; Razai MS, 2021, BMJ OPINION; Ritchie H., 2021, OUR WORLD DATA; Robertson E, 2021, BRAIN BEHAV IMMUN, V94, P41, DOI 10.1016/j.bbi.2021.03.008; Robinson E., 2020, INT ESTIMATES INTEND, DOI [10.1101/2020.11.27.20239970, 10.1101/2020.12.01.20241729]; Tull K., 2014, 672 K4D I DEV STUD, DOI 00.12413/14747; UK Government, 2020, PUBL HLTH MESS COMM; UK Government, 2021, UK COVID 19 VACC UPT; UK Government Scientific Advisory Group for Emergencies, 2020, FACTORS INFLUENCING; UK Health Security Agency, 2021, COVID 19 INF; Williams Nia, 2011, JRSM Short Rep, V2, P81, DOI 10.1258/shorts.2011.011112; World Health Organization, 2021, COR DIS COVID 19 VAC; World Health Organization (WHO), 2019, TUBERCULOSIS; YouGov, 2021, EUR NOW SEE ASTRAZEN	38	109	109	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2021	373								n1138	10.1136/bmj.n1138	http://dx.doi.org/10.1136/bmj.n1138			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5TH	34016653	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000655596600008
J	Scholten, RC; Jandt, R; Miller, EA; Rogers, BM; Veraverbeke, S				Scholten, Rebecca C.; Jandt, Randi; Miller, Eric A.; Rogers, Brendan M.; Veraverbeke, Sander			Overwintering fires in boreal forests	NATURE			English	Article							WILDFIRE; ALGORITHM; PATTERNS; IGNITION; SYSTEM; CANADA; ALASKA; AREA	Forest fires are usually viewed within the context of a single fire season, in which weather conditions and fuel supply can combine to create conditions favourable for fire ignition-usually by lightning or human activity-and spread(1-3). But some fires exhibit 'overwintering' behaviour, in which they smoulder through the non-fire season and flare up in the subsequent spring(4,5). In boreal (northern) forests, deep organic soils favourable for smouldering(6), along with accelerated climate warming(7), may present unusually favourable conditions for overwintering. However, the extent of overwintering in boreal forests and the underlying factors influencing this behaviour remain unclear. Here we show that overwintering fires in boreal forests are associated with hot summers generating large fire years and deep burning into organic soils, conditions that have become more frequent in our study areas in recent decades. Our results are based on an algorithm with which we detect overwintering fires in Alaska, USA, and the Northwest Territories, Canada, using field and remote sensing datasets. Between 2002 and 2018, overwintering fires were responsible for 0.8 per cent of the total burned area; however, in one year this amounted to 38 per cent. The spatiotemporal predictability of overwintering fires could be used by fire management agencies to facilitate early detection, which may result in reduced carbon emissions and firefighting costs.	[Scholten, Rebecca C.; Veraverbeke, Sander] Vrije Univ Amsterdam, Fac Sci, Amsterdam, Netherlands; [Jandt, Randi] Univ Alaska, Alaska Fire Sci Consortium, Fairbanks, AK USA; [Miller, Eric A.] Alaska Fire Serv, Bur Land Management, Ft Wainwright, AK USA; [Rogers, Brendan M.] Woodwell Climate Res Ctr, Falmouth, MA USA	Vrije Universiteit Amsterdam; University of Alaska System; University of Alaska Fairbanks	Scholten, RC (corresponding author), Vrije Univ Amsterdam, Fac Sci, Amsterdam, Netherlands.	r.c.scholten@vu.nl	; Veraverbeke, Sander/H-2301-2012	Jandt, Randi/0000-0001-8471-792X; Veraverbeke, Sander/0000-0003-1362-5125; Rogers, Brendan/0000-0001-6711-8466; Scholten, Rebecca Christine/0000-0002-0144-0572; Miller, Eric/0000-0002-2021-2612	Netherlands Organization for Scientific Research (NWO) through a Vidi grant (Fires Pushing Trees North); National Aeronautics and Space Administration (NASA) Arctic-Boreal Vulnerability Experiment (ABoVE) [NNX15AU56A]	Netherlands Organization for Scientific Research (NWO) through a Vidi grant (Fires Pushing Trees North)(Netherlands Organization for Scientific Research (NWO)); National Aeronautics and Space Administration (NASA) Arctic-Boreal Vulnerability Experiment (ABoVE)	We would like to thank C. Van Der Horn and G. Branson (Alaska Interagency Coordination Center), and M. Coyle (Forest Management Division, Department of Environment and Natural Resources, Government of the Northwest Territories), for providing ground truth data on overwintering fires. We wish to thank Environment and Climate Change Canada for their generous permission to use Canadian Lightning Detection Network data, and the Bureau of Land Management, Alaska Fire Service, for providing cost information. We thank NASA JPL's Snow Data Center for making their MODSCAG data available. This work was funded by the Netherlands Organization for Scientific Research (NWO) through a Vidi grant (Fires Pushing Trees North) awarded to S.V. B.M.R. acknowledges support from the National Aeronautics and Space Administration (NASA) Arctic-Boreal Vulnerability Experiment (ABoVE; NNX15AU56A).	Adams W. H., 2016, ROLE FIRE ALASKA TAI; Alaska Division of Forestry, 2020, STAT FOR MON HOT SPO; Alaska Interagency Coordination Center, 2010, 2010 AL FIR STAT; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Baber C., 2019, ALASKA STATEWIDE ANN; Beaudoin A, 2018, CAN J FOREST RES, V48, P85, DOI 10.1139/cjfr-2017-0184; Beaudoin A., 2017, SPECIES COMPOSITION, DOI [10.23687/ec9-2659-1c29-4ddb-87a2-6aced147a990, DOI 10.23687/EC9E2659-1C29-4DDB-87A2-6ACED147A990, DOI 10.23687/EC9-2659-1C29-4DDB-87A2-6ACED147A990]; Bieniek PA, 2020, J APPL METEOROL CLIM, V59, P1139, DOI 10.1175/JAMC-D-19-0209.1; Burrows WR, 2010, ATMOS OCEAN, V48, P177, DOI 10.3137/AO1118.2010; Calef MP, 2008, EARTH INTERACT, V12, DOI 10.1175/2007EI220.1; Canadian Council on Ecological Areas (CCEA), 2016, CAN EC; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Coops NC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197218; Dai CL, 2018, GEOPHYS RES LETT, V45, P3107, DOI 10.1002/2018GL077379; Dean JF, 2018, REV GEOPHYS, V56, P207, DOI 10.1002/2017RG000559; Dowdy AJ, 2012, J APPL METEOROL CLIM, V51, P2025, DOI 10.1175/JAMC-D-11-0219.1; Duncan BW, 2010, CAN J FOREST RES, V40, P286, DOI 10.1139/X09-193; Farukh M.A., 2012, J NATURAL DISASTER S, V33, P71, DOI [10.2328/jnds.33.71, DOI 10.2328/JNDS.33.71]; Flannigan MD, 2016, CLIMATIC CHANGE, V134, P59, DOI 10.1007/s10584-015-1521-0; Flannigan M, 2013, FOREST ECOL MANAG, V294, P54, DOI 10.1016/j.foreco.2012.10.022; Gallant AL, 1995, 1567 USGS; Giglio L, 2016, REMOTE SENS ENVIRON, V178, P31, DOI 10.1016/j.rse.2016.02.054; Government of Yukon, 2018, CORP SPAT WAR; Hansen MC, 2003, EARTH INTERACT, V7; Hoy EE, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/095001; Hugelius G, 2013, EARTH SYST SCI DATA, V5, P3, DOI 10.5194/essd-5-3-2013; Irannezhad M, 2020, SCIENCE, V369, P1171, DOI 10.1126/science.abe1739; Jandt R. R., 2019, OPPORTUNITIES APPL R; Johnstone JF, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3129; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Kane ES, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000458; Kasischke E. S., 2006, ALASKAS CHANGING BOR, P285; Kasischke ES, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001707; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Kochtubajda B, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016080; Kochtubajda B., 2016, P 24 INT LIGHTN DET, P1; Larjavaara M, 2005, AGR FOREST METEOROL, V132, P171, DOI 10.1016/j.agrformet.2005.07.005; Pettinari ML, 2016, BIOGEOSCIENCES, V13, P2061, DOI 10.5194/bg-13-2061-2016; McCarty JL, 2020, NAT GEOSCI, V13, P658, DOI 10.1038/s41561-020-00645-5; Mekonnen ZA, 2019, NAT PLANTS, V5, P952, DOI 10.1038/s41477-019-0495-8; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Miyanishi K, 2002, CAN J FOREST RES, V32, P1285, DOI [10.1139/x02-051, 10.1139/X02-051]; Morin P., 2016, GEOPH RES ABSTR, V18; Ottmar RD, 2007, CAN J FOREST RES, V37, P2383, DOI 10.1139/X07-077; Overland JE, 2014, EARTHS FUTURE, V2, P68, DOI 10.1002/2013EF000162; Painter TH, 2009, REMOTE SENS ENVIRON, V113, P868, DOI 10.1016/j.rse.2009.01.001; Podur J, 2010, ECOL MODEL, V221, P1301, DOI 10.1016/j.ecolmodel.2010.01.013; Porter C, 2018, **DATA OBJECT**, DOI [10.7910/DVN/OHHUKH, DOI 10.7910/DVN/OHHUKH]; Post E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw9883; Rein G, 2008, WIT TRANS ECOL ENVIR, V119, P183, DOI 10.2495/FIVA080191; Rein G, 2013, FIRE PHENOMENA EARTH, P15, DOI [DOI 10.1002/9781118529539.CH2, 10.1002/9781118529539.CH2]; Riccardi CL, 2007, CAN J FOREST RES, V37, P2394, DOI 10.1139/X07-143; Rittger K., 2013, ADV WATER RESOUR, V51, P367, DOI [DOI 10.1016/j.advwatres.2012.03.002, DOI 10.1016/J.ADVWATRES.2012.03.002]; Schroeder W, 2014, REMOTE SENS ENVIRON, V143, P85, DOI 10.1016/j.rse.2013.12.008; Sedano F, 2014, BIOGEOSCIENCES, V11, P3739, DOI 10.5194/bg-11-3739-2014; Statistics Canada, 2016, ROAD NETW FIL 2010; Stocks BJ, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000484; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Turetsky MR, 2015, NAT GEOSCI, V8, P11, DOI [10.1038/NGEO2325, 10.1038/ngeo2325]; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Tymstra C, 2020, PROG DISASTER SCI, V5, DOI 10.1016/j.pdisas.2019.100045; USDA Forest Service USFS-USDI and NASF, 2003, LARG FIR COST RED AC; Veraverbeke S, 2015, BIOGEOSCIENCES, V12, P3579, DOI 10.5194/bg-12-3579-2015; Veraverbeke S., 2020, **DATA OBJECT**; Veraverbeke S, 2017, NAT CLIM CHANGE, V7, P529, DOI [10.1038/nclimate3329, 10.1038/NCLIMATE3329]; Veraverbeke S, 2014, INT J WILDLAND FIRE, V23, P655, DOI 10.1071/WF13015; Wagner C. E. van, 1987, Forestry Technical Report - Canadian Forestry Service; Walker XJ, 2019, NATURE, V572, P520, DOI 10.1038/s41586-019-1474-y; Walker XJ, 2018, INT J WILDLAND FIRE, V27, P125, DOI 10.1071/WF17095; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wiggins E. B., ATMOS CHEM PHYS; Xiao JF, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/044003	74	28	28	13	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					399	+		10.1038/s41586-021-03437-y	http://dx.doi.org/10.1038/s41586-021-03437-y			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE7VT	34012083	Green Submitted			2022-12-28	WOS:000652278400018
J	Martin, S; Sandberg, ES; Shumer, DE				Martin, Simona; Sandberg, Elizabeth S.; Shumer, Daniel E.			Criminalization of Gender-Affirming Care - Interfering with Essential Treatment for Transgender Children and Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Criminalization of Gender-Affirming Care Arkansas recently passed a law making it illegal for clinicians to provide gender-affirming treatment to children and adolescents with gender dysphoria. This legislation and similar bills could threaten the health, well-being, and survival of transgender young people.										Baker KE, 2021, J ENDOCR SOC, V5, DOI 10.1210/jendso/bvab011; de Vries ALC, 2014, PEDIATRICS, V134, P696, DOI 10.1542/peds.2013-2958; de Vries ALC, 2012, J HOMOSEXUAL, V59, P301, DOI 10.1080/00918369.2012.653300; Johns MM, 2019, MMWR-MORBID MORTAL W, V68, P67, DOI 10.15585/mmwr.mm6803a3; Turban JL, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-1725	5	2	2	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2021	385	7					579	581		10.1056/NEJMp2106314	http://dx.doi.org/10.1056/NEJMp2106314		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UA7BM	34010528				2022-12-28	WOS:000653202400001
J	Davidson, KW; Barry, MJ; Mangione, CM; Cabana, M; Caughey, AB; Davis, EM; Donahue, KE; Doubeni, CA; Krist, AH; Kubik, M; Li, L; Ogedegbe, G; Owens, DK; Pbert, L; Silverstein, M; Stevermer, J; Tseng, CW; Wong, JB				Davidson, Karina W.; Barry, Michael J.; Mangione, Carol M.; Cabana, Michael; Caughey, Aaron B.; Davis, Esa M.; Donahue, Katrina E.; Doubeni, Chyke A.; Krist, Alex H.; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Owens, Douglas K.; Pbert, Lori; Silverstein, Michael; Stevermer, James; Tseng, Chien-Wen; Wong, John B.		US Preventive Servi	Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MORTALITY; STATISTICS; RISK	ImportanceColorectal cancer is the third leading cause of cancer death for both men and women, with an estimated 52980 persons in the US projected to die of colorectal cancer in 2021. Colorectal cancer is most frequently diagnosed among persons aged 65 to 74 years. It is estimated that 10.5% of new colorectal cancer cases occur in persons younger than 50 years. Incidence of colorectal cancer (specifically adenocarcinoma) in adults aged 40 to 49 years has increased by almost 15% from 2000-2002 to 2014-2016. In 2016, 26% of eligible adults in the US had never been screened for colorectal cancer and in 2018, 31% were not up to date with screening. ObjectiveTo update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for colorectal cancer in adults 40 years or older. The review also examined whether these findings varied by age, sex, or race/ethnicity. In addition, as in 2016, the USPSTF commissioned a report from the Cancer Intervention and Surveillance Modeling Network Colorectal Cancer Working Group to provide information from comparative modeling on how estimated life-years gained, colorectal cancer cases averted, and colorectal cancer deaths averted vary by different starting and stopping ages for various screening strategies. PopulationAsymptomatic adults 45 years or older at average risk of colorectal cancer (ie, no prior diagnosis of colorectal cancer, adenomatous polyps, or inflammatory bowel disease; no personal diagnosis or family history of known genetic disorders that predispose them to a high lifetime risk of colorectal cancer [such as Lynch syndrome or familial adenomatous polyposis]). Evidence AssessmentThe USPSTF concludes with high certainty that screening for colorectal cancer in adults aged 50 to 75 years has substantial net benefit. The USPSTF concludes with moderate certainty that screening for colorectal cancer in adults aged 45 to 49 years has moderate net benefit. The USPSTF concludes with moderate certainty that screening for colorectal cancer in adults aged 76 to 85 years who have been previously screened has small net benefit. Adults who have never been screened for colorectal cancer are more likely to benefit. RecommendationThe USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years. (A recommendation) The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years. (B recommendation) The USPSTF recommends that clinicians selectively offer screening for colorectal cancer in adults aged 76 to 85 years. Evidence indicates that the net benefit of screening all persons in this age group is small. In determining whether this service is appropriate in individual cases, patients and clinicians should consider the patient's overall health, prior screening history, and preferences. (C recommendation) This 2021 Recommendation Statement from the US Preventive Services Task Force recommends screening for colorectal cancer in all adults aged 50 to 75 years (A recommendation), screening for colorectal cancer in adults aged 45 to 49 years (B recommendation), and that clinicians selectively offer screening for colorectal cancer in adults aged 76 to 85 years (C recommendation).	[Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Cabana, Michael] Albert Einstein Coll Med, New York, NY USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davis, Esa M.] Univ Pittsburgh, Pittsburgh, PA USA; [Donahue, Katrina E.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, MN USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kubik, Martha] George Mason Univ, Fairfax, VA 22030 USA; [Li, Li] Univ Virginia, Charlottesville, VA USA; [Ogedegbe, Gbenga] NYU, New York, NY USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Pbert, Lori] Univ Massachusetts, Sch Med, Worcester, MA USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Stevermer, James] Univ Missouri, Columbia, MO USA	Northwell Health; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Yeshiva University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; Virginia Commonwealth University; George Mason University; University of Virginia; New York University; Stanford University; University of Massachusetts System; University of Massachusetts Worcester; Boston University; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University; University of Missouri System; University of Missouri Columbia	Davidson, KW (corresponding author), Feinstein Inst Med Res, 130 E 59th St,Ste 14C, New York, NY 10032 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	[Anonymous], COLONOSCOPY; [Anonymous], VIRT COL; [Anonymous], FEC OCC BLOOD TEST F; [Anonymous], CANC STAT FACTS COL; [Anonymous], FEC IMM TEST FIT; [Anonymous], CLIN PREV SERV REC C; [Anonymous], SEER STAT DATABASE I; [Anonymous], COL CANC SCREEN TEST; [Anonymous], 2018, PROC MAN; [Anonymous], PDQ COL CANC TREATM; [Anonymous], COLOSSIANS; [Anonymous], QUICK FACTS COL CANC; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Chiu HM, 2015, CANCER-AM CANCER SOC, V121, P3221, DOI 10.1002/cncr.29462; Cooper GS, 2018, CANCER-AM CANCER SOC, V124, P3876, DOI 10.1002/cncr.31660; Doubeni CA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv229; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Garcia-Albeniz X, 2017, ANN INTERN MED, V166, P18, DOI 10.7326/M16-0758; Howlader NR, 2020, BREAST CANCER RES TR, V182, P739, DOI 10.1007/s10549-020-05738-8; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Joseph DA, 2020, MMWR-MORBID MORTAL W, V69, P253, DOI 10.15585/mmwr.mm6910a1; Knudsen AB, 2021, AHRQ PUBLICATION, V20-05271-EF-2; Knudsen AB, 2021, JAMA-J AM MED ASSOC, V325, P1998, DOI 10.1001/jama.2021.5746; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Lin JS, 2021, JAMA-J AM MED ASSOC, V325, P1978, DOI 10.1001/jama.2021.4417; Lin JS., 2021, AHRQ PUBLICATION, V20-05271-EF-1; Lowery JT, 2016, CANCER-AM CANCER SOC, V122, P2633, DOI 10.1002/cncr.30080; Miller EA, 2019, LANCET GASTROENTEROL, V4, P101, DOI 10.1016/S2468-1253(18)30358-3; Montminy EM, 2021, ANN INTERN MED, V174, P157, DOI 10.7326/M20-0068; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Qaseem A, 2019, ANN INTERN MED, V171, P643, DOI 10.7326/M19-0642; Rex DK, 2017, GASTROINTEST ENDOSC, V86, P18, DOI 10.1016/j.gie.2017.04.003; Rutter CM, 2021, CANCER EPIDEM BIOMAR, V30, P3, DOI 10.1158/1055-9965.EPI-19-1537; Rutter CM, 2013, JNCI-J NATL CANCER I, V105, P1806, DOI 10.1093/jnci/djt299; Scholefield JH, 2012, GUT, V61, P1036, DOI 10.1136/gutjnl-2011-300774; SEER*Explorer, COL RECT CANC US 5 Y; Shaukat A, 2021, AM J GASTROENTEROL, V116, P458, DOI 10.14309/ajg.0000000000001122; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Siegel RL, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw322; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Virostko J, 2019, CANCER-AM CANCER SOC, V125, P3828, DOI 10.1002/cncr.32347; Wolf AMD, 2018, CA-CANCER J CLIN, V68, P250, DOI 10.3322/caac.21457; Xu, 2019, US LIFE TABLES 2017	44	158	161	45	126	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1965	1977		10.1001/jama.2021.6238	http://dx.doi.org/10.1001/jama.2021.6238			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003218	hybrid			2022-12-28	WOS:000652675100011
J	Moorthy, V; Binka, F				Moorthy, Vasee; Binka, Fred			R21/Matrix-M: a second malaria vaccine?	LANCET			English	Editorial Material									[Moorthy, Vasee] WHO, Div Sci, Dept Res Hlth, Geneva, Switzerland; [Binka, Fred] Univ Hlth & Allied Sci, Sch Publ Hlth, Ho, Ghana	World Health Organization	Moorthy, V (corresponding author), WHO, Div Sci, Dept Res Hlth, Geneva, Switzerland.	moorthyv@who.int		Moorthy, Vasee/0000-0002-6535-2854				Chitnis CE, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03491-3; Datoo MS, 2021, LANCET, V397, P1809, DOI 10.1016/S0140-6736(21)00943-0; Moorthy Vasee, 2007, Vaccine, V25, P5115, DOI 10.1016/j.vaccine.2007.01.085; WHO, 2021, WHO MAL FACTSH; WHO, 2021, WORLD MAL DAY 2021 W; WHO, 2014, PREF PROD CHAR MAL V	6	4	4	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2021	397	10287					1782	1783		10.1016/S0140-6736(21)01065-5	http://dx.doi.org/10.1016/S0140-6736(21)01065-5		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD0HD	33964224				2022-12-28	WOS:000651041900003
J	Rimmer, A				Rimmer, Abi			Covid-19: BMA demands better psychological support for trainees	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1199	10.1136/bmj.n1199	http://dx.doi.org/10.1136/bmj.n1199			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SB0RU	33975856	Bronze			2022-12-28	WOS:000649711400013
J	[Anonymous]				[Anonymous]			Pharmacotherapy for Postmenopausal Osteoporosis (Reprinted from Medical Letter on Drugs and Therapeutics, vol 62, pg 105-112, 2020)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Qaseem A, 2017, ANN INTERN MED, V166, P818, DOI 10.7326/M15-1361; Solomon DH, 2014, J BONE MINER RES, V29, P1929, DOI 10.1002/jbmr.2202; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269	3	1	1	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1888	1889		10.1001/jama.2020.13841	http://dx.doi.org/10.1001/jama.2020.13841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974021				2022-12-28	WOS:000650205000018
J	Hanson, M; Hoffman, EA; Norell, MA; Bhullar, BAS				Hanson, Michael; Hoffman, Eva A.; Norell, Mark A.; Bhullar, Bhart-Anjan S.			The early origin of a birdlike inner ear and the evolution of dinosaurian movement and vocalization	SCIENCE			English	Article							AVIAN BODY PLAN; PHYLOGENETIC-RELATIONSHIPS; GEOGRAPHIC-VARIATION; FOSSIL EVIDENCE; CHELONIA-MYDAS; BEHAVIOR; ANATOMY; THEROPOD; REPTILES; SKULL	Reptiles, including birds, exhibit a range of behaviorally relevant adaptations that are reflected in changes to the structure of the inner ear. These adaptations include the capacity for flight and sensitivity to high-frequency sound. We used three-dimensional morphometric analyses of a large sample of extant and extinct reptiles to investigate inner ear correlates of locomotor ability and hearing acuity. Statistical analyses revealed three vestibular morphotypes, best explained by three locomotor categories-quadrupeds, bipeds and simple fliers (including bipedal nonavialan dinosaurs), and high-maneuverability fliers. Troodontids fall with Archaeopteryx among the extant low-maneuverability fliers. Analyses of cochlear shape revealed a single instance of elongation, on the stem of Archosauria. We suggest that this transformation coincided with the origin of both high-pitched juvenile location, alarm, and hatching-synchronization calls and adult responses to them.	[Hanson, Michael; Bhullar, Bhart-Anjan S.] Yale Univ, Dept Earth & Planetary Sci, New Haven, CT 06520 USA; [Hanson, Michael; Bhullar, Bhart-Anjan S.] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA; [Hoffman, Eva A.; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Yale University; Yale University; American Museum of Natural History (AMNH)	Bhullar, BAS (corresponding author), Yale Univ, Dept Earth & Planetary Sci, New Haven, CT 06520 USA.; Bhullar, BAS (corresponding author), Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA.	bhart-anjan.bhullar@yale.edu		Hoffman, Eva/0000-0001-9894-5341	Department of Earth and Planetary Sciences at Yale University; Yale Institute for Biospheric Studies; American Museum of Natural History; National Science Foundation	Department of Earth and Planetary Sciences at Yale University; Yale Institute for Biospheric Studies; American Museum of Natural History; National Science Foundation(National Science Foundation (NSF))	B.-A.S.B. and M.H. were funded by the Department of Earth and Planetary Sciences at Yale University and the Yale Institute for Biospheric Studies. M.A.N. and E.A.H. were funded by the American Museum of Natural History and the National Science Foundation.	Adams D.C., 2019, GEOMORPH SOFTWARE GE; Adams DC, 2016, METHODS ECOL EVOL, V7, P565, DOI 10.1111/2041-210X.12511; Agnolin FL, 2019, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00252; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; American Museum of Natural History (AMNH),, 2007, DIV PAL CAT NUMB FR; [Anonymous], 2019, AUT MAYA 2019; [Anonymous], CORNELL LAB ORNITHOL; [Anonymous], 2019, VGSTUDIO MAX 3 3; [Anonymous], MAT METHODS ARE AVAI; Balanoff AM, 2016, J ANAT, V229, P173, DOI 10.1111/joa.12378; Balanoff AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113559; Bardua C, 2019, INTEGR ORGANISM BIOL, V1, DOI 10.1093/iob/obz016; Bennett G., 1835, BLUM T ZOOL SOC LOND, V1, P229, DOI [10.1111/j.1096-3642.1835.tb00622.x, DOI 10.1111/J.1096-3642.1835.TB00622.X]; Bennett G., 1835, T ZOOL SOC LOND, V1, P229; Benson RBJ, 2017, J ANAT, V231, P990, DOI 10.1111/joa.12726; Benson RBJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1780; Benton MJ, 2012, P GEOLOGIST ASSOC, V123, P210, DOI 10.1016/j.pgeola.2011.07.004; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Bhullar B.A, 2021, **DATA OBJECT**, DOI [10.5061/dryad.866t1g1q4, DOI 10.5061/DRYAD.866T1G1Q4]; Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L; Bonke R, 2015, NORTH-WEST J ZOOL, V11, P151; BRATTSTROM BH, 1973, J MAMMAL, V54, P50, DOI 10.2307/1378872; BrittanPowell EF, 1997, J COMP PSYCHOL, V111, P226; Bromham L, 2002, EVOLUTION, V56, P1921; Brown EE, 2020, PALAEONTOLOGY, V63, P255, DOI 10.1111/pala.12454; Brown P. E., 1984, **DROPPED REF**, V10, P1150; Brua RB, 2002, OX ORN SER, V13, P88; Brusatte SL, 2014, CURR BIOL, V24, P2386, DOI 10.1016/j.cub.2014.08.034; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Burbrink FT, 2020, SYST BIOL, V69, P502, DOI 10.1093/sysbio/syz062; Burch SH, 2014, J ANAT, V225, P271, DOI 10.1111/joa.12216; BUXTON L, 1978, E AFR WILDL J, V16, P201; CAMPBELL HW, 1973, ZOOLOGICA-NEW YORK, V58, P1; Caputo Vincenzo, 1999, Russian Journal of Herpetology, V6, P23; Carabajal AP, 2012, ANAT REC, V295, P2141, DOI 10.1002/ar.22572; CASE TJ, 1978, AM NAT, V112, P861, DOI 10.1086/283328; Cau A, 2018, B SOC PALEONTOL ITAL, V57, P1, DOI 10.4435/BSPI.2018.01; Cerio DG, 2019, PEERJ, V7, DOI 10.7717/peerj.7355; Chatterjee S., 2004, GEOLOGICAL SOC AM SP, DOI 10.1130/0-8137-2376-0.1; Chiappe L. M., 2002, MESOZOIC BIRDS HEADS; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Cignoni P, 2008, EUR IT CHAPT C EUR A, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Clarke JA, 2016, NATURE, V538, P502, DOI 10.1038/nature19852; Clemente CJ, 2004, AUST J ZOOL, V52, P487, DOI 10.1071/ZO04026; Codorniu L, 2016, PEERJ, V4, DOI 10.7717/peerj.2311; Collins JT., 2009, STANDARD COMMON CURR, V6th ed; Crawford NG, 2015, MOL PHYLOGENET EVOL, V83, P250, DOI 10.1016/j.ympev.2014.10.021; CROWLEY SR, 1983, ANIM BEHAV, V31, P1055, DOI 10.1016/S0003-3472(83)80012-8; Daza JD, 2017, J HERPETOL, V51, P330, DOI 10.1670/16-162; De Queiroz K, 2020, PHYLONYMS COMPANION; de Queiroz SA, 2011, TURK J ZOOL, V35, P103, DOI 10.3906/zoo-0904-21; Digby A., 2013, THESIS VICTORIA U WE; Digital Morphology Group, DIG MORPH; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; EISENBERG J F, 1975, Zeitschrift fuer Tierpsychologie, V37, P379; Ellrott Christian, 2010, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V3, P347; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Evans H. E., 1993, HDB AVIAN ANATOMY NO, P585; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2016, PEERJ, V4, DOI 10.7717/peerj.1778; Ezcurra MD, 2013, GEOL SOC SPEC PUBL, V379, P9, DOI 10.1144/SP379.11; Fabbri M, 2017, NAT ECOL EVOL, V1, P1543, DOI 10.1038/s41559-017-0288-2; Feldman A, 2016, GLOBAL ECOL BIOGEOGR, V25, P187, DOI 10.1111/geb.12398; Ferrara C. R., 2014, BIOCOMMUNICATION ANI, P261, DOI DOI 10.1007/978-94-007-7414-8; Fitch WT., 2006, ENCY LANGUAGE LINGUI, V2, P115, DOI DOI 10.1016/B0-08-044854-2/00821-X; FRANKENBERG E, 1974, Journal of Herpetology, V8, P59, DOI 10.2307/1563077; Gadow H., 1902, NOVIT ZOOL, V9, P169; GAILEY J, 1973, CONDOR, V75, P60, DOI 10.2307/1366535; Galton Peter M., 2010, Revue de Paleobiologie, V29, P341; GANS C, 1976, P NATL ACAD SCI USA, V73, P4244, DOI 10.1073/pnas.73.11.4244; GANS C, 1973, AM ZOOL, V13, P1195; Gauthier JA, 2011, B PEABODY MUS NAT HI, V52, P107, DOI 10.3374/014.052.0102; Georgi JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058517; Gill F., 2019, IOC WORLD BIRD LIST, DOI [10.14344/IOC.ML.9.2, DOI 10.14344/IOC.ML.9.2, 10.14344/IOC. ML.9.2]; GILLINGHAM JC, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P5; Giret N, 2012, ACTA ETHOL, V15, P39, DOI 10.1007/s10211-011-0106-9; Gleich O, 2004, SPR HDB AUD, V22, P224; Gold MEL, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1312-0; Goodrich E.S., 1958, STUDIES STRUCTURE DE; Goolsby E. W., 2019, RPHYLOPARS PHYLOGENE; GOW C E, 1975, Palaeontologia Africana, V18, P89; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Grohe C, 2016, J ANAT, V228, P366, DOI 10.1111/joa.12421; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartdegen RW, 2001, CONT HERPETOLOGY, V2001, P1; Haycock CA, 1997, J AFR EARTH SCI, V24, P79, DOI 10.1016/S0899-5362(97)00028-6; Hays GC, 2002, CAN J ZOOL, V80, P1299, DOI 10.1139/Z02-110; Henderson DM, 2010, J VERTEBR PALEONTOL, V30, P768, DOI 10.1080/02724631003758334; Herrel A, 2009, COPEIA, P727, DOI 10.1643/CG-08-136; Holtz TR, 2018, CURR BIOL, V28, pR941, DOI 10.1016/j.cub.2018.07.014; Iijima M, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171774; Iverson JB, 1997, HERPETOLOGICA, V53, P96; Iwaniuk AN, 2010, CAN J ZOOL, V88, P855, DOI 10.1139/Z10-051; Jacobs Hans J., 2009, Sauria, V31, P5; Jarvis ED, 2007, J ORNITHOL, V148, pS35, DOI 10.1007/s10336-007-0243-0; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jessop TS, 2002, HORM BEHAV, V41, P357, DOI 10.1006/hbeh.2002.1775; JOLLIE M. T., 1960, ACTA ZOOL [STOCKHOLM], V41, P1; JURISEVIC MA, 1994, EMU, V94, P141, DOI 10.1071/MU9940141; KAMEZAKI N, 1995, J HERPETOL, V29, P51, DOI 10.2307/1565085; Khand Yo., 2000, Developments in Palaeontology and Stratigraphy, V17, P49; Kimball RT, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11070109; Klingenberg CP, 2008, EVOL BIOL, V35, P186, DOI 10.1007/s11692-008-9029-4; KNOWLTON VY, 1967, J MORPHOL, V121, P179, DOI 10.1002/jmor.1051210302; Koay G, 2002, HEARING RES, V171, P96, DOI 10.1016/S0378-5955(02)00458-6; Krings M, 2018, ZOOLOGY, V126, P82, DOI 10.1016/j.zool.2017.11.010; Labra A, 2013, COPEIA, P206, DOI 10.1643/CE-12-026; Lang J.W., 1987, P273; Lautenschlager S, 2016, PEERJ, V4, DOI 10.7717/peerj.2251; Leahey LG, 2015, PEERJ, V3, DOI 10.7717/peerj.1475; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Li ZH, 2014, AUK, V131, P335, DOI 10.1642/AUK-13-245.1; Longrich NR, 2009, CRETACEOUS RES, V30, P239, DOI 10.1016/j.cretres.2008.07.005; Lu JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4788; Luo ZX, 2011, P ROY SOC B-BIOL SCI, V278, P28, DOI 10.1098/rspb.2010.1148; Lynx Edicions, INT BIRD COLL IBC; Maddison WP., 2019, CHROMASEQ MESQUITE P; Manley G. A., 2004, **DROPPED REF**, V22; MARCELLINI D, 1977, AM ZOOL, V17, P251; Marki PZ, 2017, MOL PHYLOGENET EVOL, V107, P516, DOI 10.1016/j.ympev.2016.12.021; MATTHEWS L. HARRISON, 1929, DISCOVERY REPTS GOVERNMENT DEPENDENCIES FALKLAND ISL, V1, P561; Mayr G, 2003, J ORNITHOL, V144, P157, DOI 10.1007/BF02465644; Mayr G, 2018, ZOOMORPHOLOGY, V137, P457, DOI 10.1007/s00435-018-0410-2; Middleton KM, 2000, ZOOL J LINN SOC-LOND, V128, P149; MILTON TH, 1979, COPEIA, P481, DOI 10.2307/1443226; Moore JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158496; Morando M, 2014, ZOOL SCR, V43, P249, DOI 10.1111/zsc.12052; Neenan JM, 2017, CURR BIOL, V27, P3852, DOI 10.1016/j.cub.2017.10.069; Nesbitt SJ, 2017, NATURE, V544, P484, DOI 10.1038/nature22037; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; NORTHCOTE EM, 1979, IBIS, V121, P74, DOI 10.1111/j.1474-919X.1979.tb05016.x; Olson VA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0401; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; OUBOTER P E, 1990, Amphibia-Reptilia, V11, P419, DOI 10.1163/156853890X00104; Palci A, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170685; Phillips AG, 2020, BIOL J LINN SOC, V129, P543, DOI 10.1093/biolinnean/blz198; Pianka E., 1986, ECOLOGY NATURAL HIST; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Qin ZC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48148-7; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Reddy S, 2017, SYST BIOL, V66, P857, DOI 10.1093/sysbio/syx041; Richtsmeier JT, 2013, ACTA NEUROPATHOL, V125, P469, DOI 10.1007/s00401-013-1104-y; Riede T, 2016, EVOLUTION, V70, DOI 10.1111/evo.12988; Rodenwald P. G., 2020, BIRDS OF THE WORLD; Rumpf M., 2010, OPEN ORNITHOL J, V3, P141, DOI DOI 10.2174/1874453201003010141; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Santos S. S., 2018, COMUN SCI, V9, P575; Sargatal J., 2020, BIRDS OF THE WORLD, DOI DOI 10.2173/BOW.GRRWOO1.01; Schachner ER, 2017, J ANAT, V231, P835, DOI 10.1111/joa.12722; Schaefer Florian, 2016, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V9, P267; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlager S., 2017, STAT SHAPE DEFORMATI, P217; Schulte JA, 2000, BIOL J LINN SOC, V69, P75, DOI 10.1006/bijl.1999.0346; Senter P, 2005, PALEOBIOLOGY, V31, P373, DOI 10.1666/0094-8373(2005)031[0373:FITSFO]2.0.CO;2; Senter P, 2008, J HERPETOL, V42, P354, DOI 10.1670/07-150.1; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sobral G, 2016, SPRINGER HANDB AUDIT, V59, P285, DOI 10.1007/978-3-319-46661-3_10; Sobral G, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160072; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P3; Stocker MR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46028; STRAHL SD, 1988, IBIS, V130, P483, DOI 10.1111/j.1474-919X.1988.tb02714.x; Szabo M.J, 2013, NZ BIRDS ONLINE; Thorbjarnarson JB, 1996, HERPETOLOGICA, V52, P8; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2012, B AM MUS NAT HIST, P5; Tyack PL, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2018.0406; Vaughan T. A., 2011, MAMMALOGY; Vergne AL, 2009, BIOL REV, V84, P391, DOI 10.1111/j.1469-185X.2009.00079.x; Vergne AL, 2008, CURR BIOL, V18, pR513, DOI 10.1016/j.cub.2008.04.011; Vidal N, 2009, CR BIOL, V332, P129, DOI 10.1016/j.crvi.2008.07.010; Videler J.J., 2006, AVIAN FLIGHT; Villain AS, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150497; Vitousek MN, 2007, BIOL LETTERS, V3, P632, DOI 10.1098/rsbl.2007.0443; Vitt LJ, 2014, LIZARD ECOLOGY HIST; Voeten DFAE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03296-8; Walsh S. A., 2013, SPRINGER HDB AUDITOR, V49, P227; Walsh SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067176; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Wang X, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0622; WEEKS SE, 1973, ZOOLOGICA-NEW YORK, V58, P13; Wever E. G., 1978, THE REPTILE EAR; Wiley D. F, 2006, LANDMARK 3 6; Wilms Thomas M., 2009, Bonner Zoologische Beitraege, V56, P55; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; WORTHY TH, 1994, NEW ZEAL J ZOOL, V21, P113, DOI 10.1080/03014223.1994.9517981; Yang LM, 2019, DEV DYNAM, V248, P88, DOI 10.1002/dvdy.24664; Yonezawa T, 2017, CURR BIOL, V27, P68, DOI 10.1016/j.cub.2016.10.029; Young B. A., 2013, **DROPPED REF**, V49, P323; Young BA, 2003, Q REV BIOL, V78, P303, DOI 10.1086/377052; Zaaf A, 2001, ZOOMORPHOLOGY, V121, P45, DOI 10.1007/s004350100044; Zelenitsky DK, 2011, P ROY SOC B-BIOL SCI, V278, P3625, DOI 10.1098/rspb.2011.0238; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009	196	10	10	3	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					601	+		10.1126/science.abb4305	http://dx.doi.org/10.1126/science.abb4305			248	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958471				2022-12-28	WOS:000649103500040
J	Flesher, SN; Downey, JE; Weiss, JM; Hughes, CL; Herrera, AJ; Tyler-Kabara, EC; Boninger, ML; Collinger, JL; Gaunt, RA				Flesher, Sharlene N.; Downey, John E.; Weiss, Jeffrey M.; Hughes, Christopher L.; Herrera, Angelica J.; Tyler-Kabara, Elizabeth C.; Boninger, Michael L.; Collinger, Jennifer L.; Gaunt, Robert A.			A brain-computer interface that evokes tactile sensations improves robotic arm control	SCIENCE			English	Article							CORTICAL CONTROL; MOTOR; PERFORMANCE; REPRESENTATION; RESTORATION; STIMULATION; TETRAPLEGIA; EXPERIENCE; PRIORITIES	Prosthetic arms controlled by a brain-computer interface can enable people with tetraplegia to perform functional movements. However, vision provides limited feedback because information about grasping objects is best relayed through tactile feedback. We supplemented vision with tactile percepts evoked using a bidirectional brain-computer interface that records neural activity from the motor cortex and generates tactile sensations through intracortical microstimulation of the somatosensory cortex. This enabled a person with tetraplegia to substantially improve performance with a robotic limb; trial times on a clinical upper-limb assessment were reduced by half, from a median time of 20.9 to 10.2 seconds. Faster times were primarily due to less time spent attempting to grasp objects, revealing that mimicking known biological control principles results in task performance that is closer to able-bodied human abilities.	[Flesher, Sharlene N.; Downey, John E.; Weiss, Jeffrey M.; Hughes, Christopher L.; Herrera, Angelica J.; Boninger, Michael L.; Collinger, Jennifer L.; Gaunt, Robert A.] Univ Pittsburgh, Rehab Neural Engn Labs, Pittsburgh, PA 15260 USA; [Flesher, Sharlene N.; Downey, John E.; Hughes, Christopher L.; Herrera, Angelica J.; Boninger, Michael L.; Collinger, Jennifer L.; Gaunt, Robert A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Flesher, Sharlene N.; Downey, John E.; Hughes, Christopher L.; Herrera, Angelica J.; Collinger, Jennifer L.; Gaunt, Robert A.] Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; [Downey, John E.] Univ Chicago, Dept Organismal Biol, Chicago, IL 60637 USA; [Weiss, Jeffrey M.; Boninger, Michael L.; Collinger, Jennifer L.; Gaunt, Robert A.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Tyler-Kabara, Elizabeth C.] Univ Texas Austin, Dept Neurosurg, Austin, TX 78712 USA; [Boninger, Michael L.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Boninger, Michael L.; Collinger, Jennifer L.] VA Ctr Excellence, Dept Vet Affairs, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Austin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Collinger, JL; Gaunt, RA (corresponding author), Univ Pittsburgh, Rehab Neural Engn Labs, Pittsburgh, PA 15260 USA.; Collinger, JL; Gaunt, RA (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Collinger, JL; Gaunt, RA (corresponding author), Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA.; Collinger, JL; Gaunt, RA (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.; Collinger, JL (corresponding author), VA Ctr Excellence, Dept Vet Affairs, Pittsburgh, PA 15260 USA.	rag53@pitt.edu	Hughes, Christopher/ABB-2765-2021; heflin, jade/AAC-9223-2022; Downey, John/AAF-3837-2020; Tyler-Kabara, Elizabeth/H-4930-2013	Hughes, Christopher/0000-0001-9257-8659; Downey, John/0000-0002-2992-2848; Boninger, Michael/0000-0001-6966-919X; Collinger, Jennifer/0000-0002-4517-5395; Weiss, Jeffrey/0000-0003-1332-674X; Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Herrera, Angelica/0000-0003-2310-5908	Defense Advanced Research Projects Agency (DARPA); Space and Naval Warfare Systems Center Pacific (SSC Pacific) [N66001-16-C-4051]; Revolutionizing Prosthetics program [N66001-10-C-4056]; NSF Graduate Research Fellowship [DGE-1247842]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Space and Naval Warfare Systems Center Pacific (SSC Pacific); Revolutionizing Prosthetics program; NSF Graduate Research Fellowship(National Science Foundation (NSF))	This material is based upon work supported by the Defense Advanced Research Projects Agency (DARPA) and Space and Naval Warfare Systems Center Pacific (SSC Pacific) under contract no. N66001-16-C-4051 and the Revolutionizing Prosthetics program (contract no. N66001-10-C-4056). S.N.F. was supported by an NSF Graduate Research Fellowship under grant number DGE-1247842. The views, opinions, and/or findings contained in this article are those of the authors and should not be interpreted as representing the official views or policies of DARPA, SSC Pacific, or the US government.	Ajiboye AB, 2017, LANCET, V389, P1821, DOI 10.1016/S0140-6736(17)30601-3; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Collinger JL, 2013, J REHABIL RES DEV, V50, P145, DOI 10.1682/JRRD.2011.11.0213; Dadarlat MC, 2015, NAT NEUROSCI, V18, P138, DOI 10.1038/nn.3883; Delhaye BP, 2018, COMPR PHYSIOL, V8, P1575, DOI 10.1002/cphy.c170033; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Downey JE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17222-3; Flesher SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8083; Graczyk EL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26952-x; Graczyk EL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5187; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hughes C., 2020, BRAIN COMPUTER INTER, V168, P168; Johannes MS, 2011, J HOPKINS APL TECH D, V30, P207; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1992, EXP BRAIN RES, V89, P181, DOI 10.1007/BF00229015; Klaes C, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056024; Lee B, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00024; Loomis J. M., 2012, Assistive Technology for Blindness and Low Vision; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Monzee J, 2003, J NEUROPHYSIOL, V89, P672, DOI 10.1152/jn.00434.2001; *NAT SPIN CORD INJ, 2018, FACTS FIG GLANC; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Pandarinath C, 2017, ELIFE, V6, DOI 10.7554/eLife.18554; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Raspopovic S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006820; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; Salas MA, 2018, ELIFE, V7, DOI 10.7554/eLife.32904; Schiefer M, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016001; Sombeck JT, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab5cf3; Stronks HC, 2015, BRAIN RES, V1624, P140, DOI 10.1016/j.brainres.2015.06.033; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wang W, 2007, J NEUROPHYSIOL, V97, P4258, DOI 10.1152/jn.01180.2006; Weiss JM, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/aae748; Wendelken S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0320-4; Wodlinger B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016011; Yozbatiran N, 2008, NEUROREHAB NEURAL RE, V22, P78, DOI 10.1177/1545968307305353	40	71	71	97	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					831	+	abd0380	10.1126/science.abd0380	http://dx.doi.org/10.1126/science.abd0380			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016775	Green Accepted, Green Submitted			2022-12-28	WOS:000653997000040
J	Jaklevic, MC				Jaklevic, Mary Chris			Reprocessed Urological Endoscopes Tied to Infection Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1932	1932		10.1001/jama.2021.6754	http://dx.doi.org/10.1001/jama.2021.6754			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003236				2022-12-28	WOS:000652675100019
J	Jones, WS; Mulder, H; Wruck, LM; Pencina, MJ; Kripalani, S; Munoz, D; Crenshaw, DL; Effron, MB; Re, RN; Gupta, K; Anderson, RD; Pepine, CJ; Handberg, EM; Manning, BR; Jain, SK; Girotra, S; Riley, D; DeWalt, DA; Whittle, J; Goldberg, YH; Roger, VL; Hess, R; Benziger, CP; Farrehi, P; Zhou, L; Ford, DE; Haynes, K; VanWormer, JJ; Knowlton, KU; Kraschnewski, JL; Polonsky, TS; Fintel, DJ; Ahmad, FS; McClay, JC; Campbell, JR; Bell, DS; Fonarow, GC; Bradley, SM; Paranjape, A; Roe, MT; Robertson, HR; Curtis, LH; Sharlow, AG; Berdan, LG; Hammill, BG; Harris, DF; Qualls, LG; Marquis-Gravel, G; Modrow, MF; Marcus, GM; Carton, TW; Nauman, E; Waitman, LR; Kho, AM; Shenkman, EA; McTigue, KM; Kaushal, R; Masoudi, FA; Antman, EM; Davidson, DR; Edgley, K; Merritt, JG; Brown, LS; Zemon, DN; McCormick, TE; Alikhaani, JD; Gregoire, KC; Rothman, RL; Harrington, RA; Hernandez, AF				Jones, W. S.; Mulder, H.; Wruck, L. M.; Pencina, M. J.; Kripalani, S.; Munoz, D.; Crenshaw, D. L.; Effron, M. B.; Re, R. N.; Gupta, K.; Anderson, R. D.; Pepine, C. J.; Handberg, E. M.; Manning, B. R.; Jain, S. K.; Girotra, S.; Riley, D.; DeWalt, D. A.; Whittle, J.; Goldberg, Y. H.; Roger, V. L.; Hess, R.; Benziger, C. P.; Farrehi, P.; Zhou, L.; Ford, D. E.; Haynes, K.; VanWormer, J. J.; Knowlton, K. U.; Kraschnewski, J. L.; Polonsky, T. S.; Fintel, D. J.; Ahmad, F. S.; McClay, J. C.; Campbell, J. R.; Bell, D. S.; Fonarow, G. C.; Bradley, S. M.; Paranjape, A.; Roe, M. T.; Robertson, H. R.; Curtis, L. H.; Sharlow, A. G.; Berdan, L. G.; Hammill, B. G.; Harris, D. F.; Qualls, L. G.; Marquis-Gravel, G.; Modrow, M. F.; Marcus, G. M.; Carton, T. W.; Nauman, E.; Waitman, L. R.; Kho, A. M.; Shenkman, E. A.; McTigue, K. M.; Kaushal, R.; Masoudi, F. A.; Antman, E. M.; Davidson, D. R.; Edgley, K.; Merritt, J. G.; Brown, L. S.; Zemon, D. N.; McCormick, T. E., III; Alikhaani, J. D.; Gregoire, K. C.; Rothman, R. L.; Harrington, R. A.; Hernandez, A. F.		ADAPTABLE Team	Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Early Access							ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROME; SECONDARY PREVENTION; ASSOCIATION; GUIDELINE; PATTERNS; OUTCOMES; THERAPY; UPDATE	BACKGROUND The appropriate dose of aspirin to lower the risk of death, myocardial infarction, and stroke and to minimize major bleeding in patients with established atherosclerotic cardiovascular disease is a subject of controversy. METHODS Using an open-label, pragmatic design, we randomly assigned patients with established atherosclerotic cardiovascular disease to a strategy of 81 mg or 325 mg of aspirin per day. The primary effectiveness outcome was a composite of death from any cause, hospitalization for myocardial infarction, or hospitalization for stroke, assessed in a time-to-event analysis. The primary safety outcome was hospitalization for major bleeding, also assessed in a time-to-event analysis. RESULTS A total of 15,076 patients were followed for a median of 26.2 months (interquartile range [IQR], 19.0 to 34.9). Before randomization, 13,537 (96.0% of those with available information on previous aspirin use) were already taking aspirin, and 85.3% of these patients were previously taking 81 mg of daily aspirin. Death, hospitalization for myocardial infarction, or hospitalization for stroke occurred in 590 patients (estimated percentage, 7.28%) in the 81-mg group and 569 patients (estimated percentage, 7.51%) in the 325-mg group (hazard ratio, 1.02; 95% confidence interval [CI], 0.91 to 1.14). Hospitalization for major bleeding occurred in 53 patients (estimated percentage, 0.63%) in the 81-mg group and 44 patients (estimated percentage, 0.60%) in the 325-mg group (hazard ratio, 1.18; 95% CI, 0.79 to 1.77). Patients assigned to 325 mg had a higher incidence of dose switching than those assigned to 81 mg (41.6% vs. 7.1%) and fewer median days of exposure to the assigned dose (434 days [IQR, 139 to 737] vs. 650 days [IQR, 415 to 922]). CONCLUSIONS In this pragmatic trial involving patients with established cardiovascular disease, there was substantial dose switching to 81 mg of daily aspirin and no significant differences in cardiovascular events or major bleeding between patients assigned to 81 mg and those assigned to 325 mg of aspirin daily.	[Jones, W. S.; Mulder, H.; Wruck, L. M.; Pencina, M. J.; Roe, M. T.; Robertson, H. R.; Curtis, L. H.; Sharlow, A. G.; Berdan, L. G.; Hammill, B. G.; Harris, D. F.; Qualls, L. G.; Marquis-Gravel, G.; Hernandez, A. F.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [DeWalt, D. A.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Zhou, L.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Kripalani, S.; Munoz, D.; Crenshaw, D. L.; Rothman, R. L.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Effron, M. B.; Re, R. N.] Ochsner Hlth, New Orleans, LA USA; [Carton, T. W.; Nauman, E.] Louisiana Publ Hlth Inst, New Orleans, LA USA; [Gupta, K.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Anderson, R. D.; Pepine, C. J.; Handberg, E. M.; Manning, B. R.; Shenkman, E. A.] Univ Florida, Gainesville, FL USA; [Jain, S. K.; McTigue, K. M.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Kraschnewski, J. L.] Penn State Coll Med, Hershey, PA USA; [Paranjape, A.] Temple Univ, Philadelphia, PA 19122 USA; [Girotra, S.; Riley, D.] Univ Iowa, Iowa City, IA USA; [Whittle, J.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [VanWormer, J. J.] Marshfield Clin Res Inst, Marshfield, WI USA; [Goldberg, Y. H.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Kaushal, R.] Weill Cornell Med, New York, NY USA; [Kaushal, R.] New York Presbyterian Hosp, New York, NY USA; [Roger, V. L.] Mayo Clin, Rochester, MN USA; [Benziger, C. P.] Essentia Hlth Heart & Vasc Ctr, Duluth, MN USA; [Bradley, S. M.] Allina Hlth, Minneapolis, MN USA; [Bradley, S. M.] Minneapolis Heart Inst, Minneapolis, MN USA; [Hess, R.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Knowlton, K. U.] Intermt Med Ctr Heart Inst, Salt Lake City, UT USA; [Farrehi, P.] Univ Michigan, Ann Arbor, MI 48109 USA; [Ford, D. E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Haynes, K.] HealthCore, Wilmington, DE USA; [Polonsky, T. S.] Univ Chicago Med, Chicago, IL USA; [Fintel, D. J.; Ahmad, F. S.; Kho, A. M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [McClay, J. C.; Campbell, J. R.] Univ Nebraska Med Ctr, Omaha, NE USA; [Bell, D. S.; Fonarow, G. C.] Univ Calif Los Angeles, Los Angeles, CA USA; [Modrow, M. F.; Marcus, G. M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Harrington, R. A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Waitman, L. R.] Univ Missouri, Sch Med, Columbia, MO USA; [Masoudi, F. A.] Univ Colorado, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Antman, E. M.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center; Vanderbilt University; University of Kansas; University of Kansas Medical Center; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Iowa; Medical College of Wisconsin; Yeshiva University; Albert Einstein College of Medicine; Cornell University; NewYork-Presbyterian Hospital; Mayo Clinic; Allina Health System; Minneapolis Heart Institute Foundation; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; University of Michigan System; University of Michigan; Johns Hopkins University; Northwestern University; Feinberg School of Medicine; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; Stanford University; University of Missouri System; University of Missouri Columbia; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jones, WS (corresponding author), Duke Univ Hlth Syst, Div Cardiol, DUMC 3330, Durham, NC 27710 USA.	schuyler.jones@duke.edu	Effron, Mark B./P-9300-2015; Roger, Veronique/AAV-5951-2020; Bradley, Steven/AID-7839-2022; Sandu, Oana/AAH-4771-2019	Effron, Mark B./0000-0003-4050-5030; Sandu, Oana/0000-0002-4198-7249; Girotra, Saket/0000-0002-4784-4513; Whittle, Jeff/0000-0002-9544-838X; Rothman, Russsell/0000-0002-1506-3990; Shenkman, Elizabeth/0000-0003-4903-1804; Pepine, Carl/0000-0002-6011-681X; Marcus, Gregory/0000-0001-5197-7696; Clariday, Laura/0000-0001-5291-2982	PCORI Award [ASP-1502-27029]	PCORI Award(Patient-Centered Outcomes Research Institute - PCORI)	Supported by a PCORI Award (ASP-1502-27029).	Ahmad FS, 2020, CIRC-CARDIOVASC QUAL, V13, P355, DOI 10.1161/CIRCOUTCOMES.119.006292; Amsterdam EA, 2014, CIRCULATION, V130, P2354, DOI 10.1161/CIR.0000000000000133; Bowman L, 2018, NEW ENGL J MED, V379, P1529, DOI 10.1056/NEJMoa1804988; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Fishman E, 2018, CONT CLIN TRIAL COMM, V12, P154, DOI 10.1016/j.conctc.2018.11.001; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Gaziano JM, 2018, LANCET, V392, P1036, DOI 10.1016/S0140-6736(18)31924-X; Hall HM, 2014, CIRC-CARDIOVASC QUAL, V7, P701, DOI 10.1161/CIRCOUTCOMES.113.000822; Hernandez AF, 2015, ANN INTERN MED, V163, P635, DOI 10.7326/M15-1460; Kohli P, 2014, J AM COLL CARDIOL, V63, P225, DOI 10.1016/j.jacc.2013.09.023; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Mahaffey KW, 2014, AM J CARDIOL, V113, P936, DOI 10.1016/j.amjcard.2013.11.052; Marquis-Gravel G, 2020, JAMA CARDIOL, V5, P598, DOI 10.1001/jamacardio.2020.0116; Marquis-Gravel G, 2019, CIRCULATION, V140, P1115, DOI 10.1161/CIRCULATIONAHA.119.040205; McNeil JJ, 2018, NEW ENGL J MED, V379, P1509, DOI 10.1056/NEJMoa1805819; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Okunrintemi V, 2020, CIRCULATION, V142; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Xian Y, 2015, CIRCULATION, V132, P174, DOI 10.1161/CIRCULATIONAHA.114.014992	21	57	58	5	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMoa2102137	http://dx.doi.org/10.1056/NEJMoa2102137		MAY 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2GY	33999548	Bronze			2022-12-28	WOS:000652580700001
J	Bello, C; Barreto, E				Bello, Carolina; Barreto, Elisa			The footprint of evolution in seed dispersal interactions The evolutionary stability of fruit-eating birds is linked to their role in dispersing seeds	SCIENCE			English	Editorial Material							CONSEQUENCES		[Bello, Carolina; Barreto, Elisa] Swiss Fed Res Inst WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland; [Barreto, Elisa] Univ Fed Goias UFG, Lab Ecol Teor & Sintese, Goiania, Go, Brazil	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Universidade Federal de Goias	Bello, C (corresponding author), Swiss Fed Res Inst WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland.	carolina.bello@wsl.ch	Bello, Carolina/J-8714-2013	Bello, Carolina/0000-0001-6351-4998	European Research Council under the European Union [787638]; Swiss National Science Foundation [173342]	European Research Council under the European Union(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We acknowledge funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (grant 787638) and the Swiss National Science Foundation (grant 173342),both awarded to C.Graham.We thank D. Karger for valuable comments.	Burin G, 2021, SCIENCE, V372, P733, DOI 10.1126/science.abf0556; CaraDonna PJ, 2021, ECOL LETT, V24, P149, DOI 10.1111/ele.13623; Chamberlain S, 2014, J ECOL, V102, P1234, DOI 10.1111/1365-2745.12293; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Eriksson O, 2016, BIOL REV, V91, P168, DOI 10.1111/brv.12164; Fleming TH, 2011, ACTA OECOL, V37, P521, DOI 10.1016/j.actao.2011.01.016; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Jordano P, 2011, BIOL LETTERS, V7, P321, DOI 10.1098/rsbl.2010.0986; Jordano Pedro, 2010, Evolution Education and Outreach, V3, P40; Louca S, 2020, NATURE, V580, P502, DOI 10.1038/s41586-020-2176-1; Peralta G, 2016, FUNCT ECOL, V30, P1917, DOI 10.1111/1365-2435.12669; Plein M, 2013, ECOLOGY, V94, P1296, DOI 10.1890/12-1213.1; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Rumeu B, 2019, OECOLOGIA, V190, P605, DOI 10.1007/s00442-019-04434-9; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x	15	0	0	8	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					682	683		10.1126/science.abi8160	http://dx.doi.org/10.1126/science.abi8160			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SD1KE	33986166	Green Accepted			2022-12-28	WOS:000651125300026
J	Karron, RA				Karron, Ruth A.			Preventing respiratory syncytial virus (RSV) disease in children After many decades, promising strategies for RSV immunization are on the horizon	SCIENCE			English	Editorial Material							INFECTION; INFANTS; RISK		[Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Karron, RA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD 21205 USA.	rkarron@jhu.edu			NIH [HHS 272200900010C]; Sanofi-Pasteur; Bill and Melinda Gates Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi-Pasteur; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Thoughtful review of the manuscript by A. Moscona and B. Graham is gratefully acknowledged. The author has received funding from the NIH (HHS 272200900010C), SanofiPasteur, and the Bill and Melinda Gates Foundation.	Britton PN, 2020, LANCET CHILD ADOLESC, V4, pE42, DOI 10.1016/S2352-4642(20)30307-2; CHANOCK R, 1957, AM J HYG, V66, P291, DOI 10.1093/oxfordjournals.aje.a119902; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Griffin MP, 2020, NEW ENGL J MED, V383, P415, DOI 10.1056/NEJMoa1913556; Karron RA, 2021, AM J RESP CRIT CARE, V203, P594, DOI 10.1164/rccm.202005-1660OC; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Liang B, 2020, J VIROL, V94, DOI 10.1128/JVI.00175-20; Madhi SA, 2020, NEW ENGL J MED, V383, P426, DOI 10.1056/NEJMoa1908380; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; O'Brien KL, 2019, LANCET, V394, P757, DOI 10.1016/S0140-6736(19)30721-4; Ruckwardt TJ, 2019, IMMUNITY, V51, P429, DOI 10.1016/j.immuni.2019.08.007; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Zar HJ, 2020, LANCET GLOB HEALTH, V8, pE1316, DOI 10.1016/S2214-109X(20)30251-5	14	11	11	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					686	687		10.1126/science.abf9571	http://dx.doi.org/10.1126/science.abf9571			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SD1KE	33986169				2022-12-28	WOS:000651125300029
J	Zaaijer, S; Capes-Davis, A				Zaaijer, Sophie; Capes-Davis, Amanda			Ancestry matters: Building inclusivity into preclinical study design Comment	CELL			English	Editorial Material								Human cell lines (CLs) are key assets for biomedicine but lack ancestral diversity. Here, we explore why genetic diversity among cell-based models is essential for making preclinical research more equitable and widely translatable. We lay out practical actions that can be taken to improve inclusivity in study design.	[Zaaijer, Sophie] Cornell Tech, New York, NY 10044 USA; [Zaaijer, Sophie] FIND Genom, New York, NY 10029 USA; [Capes-Davis, Amanda] Univ Sydney, Childrens Med Res Inst, CellBank Australia, Westmead, NSW, Australia	Children's Medical Research Institute - Australia; University of Sydney	Zaaijer, S (corresponding author), Cornell Tech, New York, NY 10044 USA.; Zaaijer, S (corresponding author), FIND Genom, New York, NY 10029 USA.	sophie@cornell.edu		Capes-Davis, Amanda/0000-0003-4184-6339	FIND Genomics Inc.; Jacobs Technion-Cornell Institute; Elisha M. Friedman Postdoctoral Fellowship; Cell Bank Australia; Children's Medical Research Institute (CMRI); International Cell Line Authentication Committee (ICLAC)	FIND Genomics Inc.; Jacobs Technion-Cornell Institute; Elisha M. Friedman Postdoctoral Fellowship; Cell Bank Australia; Children's Medical Research Institute (CMRI); International Cell Line Authentication Committee (ICLAC)	We thank Simon (Niels) Groen, PhD and Tyler Joseph for helpful discussions and help with editing the manuscript. S.Z. is supported by FIND Genomics Inc., the Jacobs Technion-Cornell Institute, and the Elisha M. Friedman Postdoctoral Fellowship. A.C.D. has received support for writing and data analysis from FIND Genomics Inc. and acknowledges additional funding and support from CellBank Australia, Children's Medical Research Institute (CMRI), and the International Cell Line Authentication Committee (ICLAC). The authors acknowledge many excellent studies on warfarin, CLs, GWAS, and genetic diversity that could not be cited in this commentary due to space limitations.	Beaton A, 2017, GENET MED, V19, P345, DOI 10.1038/gim.2016.111; Choudhury A, 2020, NATURE, V586, P741, DOI 10.1038/s41586-020-2859-7; Dutil J, 2019, CANCER RES, V79, P1263, DOI 10.1158/0008-5472.CAN-18-2747; Harlemon M, 2020, CANCER RES, V80, P2956, DOI 10.1158/0008-5472.CAN-19-2165; Kessler MD, 2019, CANCER-AM CANCER SOC, V125, P2076, DOI 10.1002/cncr.32020; Li J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-52; Mulshine JL, 2020, J CELL BIOCHEM, V121, P3986, DOI 10.1002/jcb.29564; Perera MA, 2013, LANCET, V382, P790, DOI 10.1016/S0140-6736(13)60681-9; Research America, 2017, CLIN TRIALS SURV DAT; Sirugo G, 2019, CELL, V177, P26, DOI 10.1016/j.cell.2019.02.048; Sodeke SO, 2019, J HEALTH CARE POOR U, V30, P1, DOI 10.1353/hpu.2019.0109; Valdez P., 2020, RIGOR REPRODUCIBILIT; van der Meer D, 2019, NUCLEIC ACIDS RES, V47, pD923, DOI 10.1093/nar/gky872; Weinstein JN, 2012, NATURE, V483, P544, DOI 10.1038/483544a; Zhong YZ, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008662	15	5	5	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2525	2531		10.1016/j.cell.2021.03.041	http://dx.doi.org/10.1016/j.cell.2021.03.041		MAY 2021	7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33989545	Bronze			2022-12-28	WOS:000652830800001
J	Munro, C				Munro, Clara			Nearly 700 anaesthetists have training interrupted after cuts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Munro, Clara/0000-0002-9607-8587				Health Education England, SPEC TRAIN COMP RAT; Rimmer A, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5042; Royal College of Anaesthetists, COST TRAIN; Royal College of Anaesthetists, 2020, MED WORKF CENS REP 2; Royal College of Anaesthetists, 2021, TRAIN CURR UPD; Royal College of Anaesthetists, 2021, AN NAT RECR 2021 APP	6	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1213	10.1136/bmj.n1213	http://dx.doi.org/10.1136/bmj.n1213			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9HD	33980503				2022-12-28	WOS:000653056600001
J	Araya, R; Menezes, PR; Claro, HG; Brandt, LR; Daley, KL; Quayle, J; Diez-Canseco, F; Peters, TJ; Cruz, DV; Toyama, M; Aschar, S; Hidalgo-Padilla, L; Martins, H; Cavero, V; Rocha, T; Scotton, G; Lopes, IFD; Begale, M; Mohr, DC; Miranda, JJ				Araya, Ricardo; Menezes, Paulo Rossi; Claro, Heloisa Garcia; Brandt, Lena R.; Daley, Kate L.; Quayle, Julieta; Diez-Canseco, Francisco; Peters, Tim J.; Cruz, Daniela Vera; Toyama, Mauricio; Aschar, Suzana; Hidalgo-Padilla, Liliana; Martins, Hellen; Cavero, Victoria; Rocha, Thais; Scotton, George; de Almeida Lopes, Ivan F.; Begale, Mark; Mohr, David C.; Jaime Miranda, J.			Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MIDDLE-INCOME COUNTRIES; PRIMARY-CARE; MENTAL-DISORDERS; HEALTH; PREVENTION; SANTIAGO; CHILE; INDIA; PHQ-9	Key PointsQuestionWhat is the effect of a behavioral activation digital intervention delivered over a 6-week period on depressive symptoms among patients with comorbid hypertension or diabetes in Brazil and Peru? FindingsIn 2 randomized clinical trials conducted separately in SAo Paulo, Brazil (880 participants), and Lima, Peru (432 participants), a significantly greater proportion of participants who received the digital intervention, compared with enhanced usual care, experienced at least a 50% reduction in depressive symptoms at 3 months (40.7% vs 28.6% in Brazil; [odds ratio, 1.6]; 52.7% vs 34.1% in Peru [odds ratio, 2.1]), although the differences were no longer statistically significant at 6 months. MeaningA digital intervention for patients with depressive symptoms and comorbid hypertension or diabetes significantly improved depressive symptoms at 3 months compared with enhanced usual care in Peru and Brazil, but the effects were not sustained at 6 months in either of the 2 trials. ImportanceDepression is a leading contributor to disease burden globally. Digital mental health interventions can address the treatment gap in low- and middle-income countries, but the effectiveness in these countries is unknown. ObjectiveTo investigate the effectiveness of a digital intervention in reducing depressive symptoms among people with diabetes and/or hypertension. Design, Setting, and ParticipantsParticipants with clinically significant depressive symptoms (Patient Health Questionnaire-9 [PHQ-9] score >= 10) who were being treated for hypertension and/or diabetes were enrolled in a cluster randomized clinical trial (RCT) at 20 sites in SAo Paulo, Brazil (N=880; from September 2016 to September 2017; final follow-up, April 2018), and in an individual-level RCT at 7 sites in Lima, Peru (N=432; from January 2017 to September 2017; final follow-up, March 2018). InterventionsAn 18-session, low-intensity, digital intervention was delivered over 6 weeks via a provided smartphone, based on behavioral activation principles, and supported by nurse assistants (n=440 participants in 10 clusters in SAo Paulo; n=217 participants in Lima) vs enhanced usual care (n=440 participants in 10 clusters in SAo Paulo; n=215 participants in Lima). Main Outcomes and MeasuresThe primary outcome was a reduction of at least 50% from baseline in PHQ-9 scores (range, 0-27; higher score indicates more severe depression) at 3 months. Secondary outcomes included a reduction of at least 50% from baseline PHQ-9 scores at 6 months. ResultsAmong 880 patients cluster randomized in Brazil (mean age, 56.0 years; 761 [86.5%] women) and 432 patients individually randomized in Peru (mean age, 59.7 years; 352 [81.5%] women), 807 (91.7%) in Brazil and 426 (98.6%) in Peru completed at least 1 follow-up assessment. The proportion of participants in SAo Paulo with a reduction in PHQ-9 score of at least 50% at 3-month follow-up was 40.7% (159/391 participants) in the digital intervention group vs 28.6% (114/399 participants) in the enhanced usual care group (difference, 12.1 percentage points [95% CI, 5.5 to 18.7]; adjusted odds ratio [OR], 1.6 [95% CI, 1.2 to 2.2]; P=.001). In Lima, the proportion of participants with a reduction in PHQ-9 score of at least 50% at 3-month follow-up was 52.7% (108/205 participants) in the digital intervention group vs 34.1% (70/205 participants) in the enhanced usual care group (difference, 18.6 percentage points [95% CI, 9.1 to 28.0]; adjusted OR, 2.1 [95% CI, 1.4 to 3.2]; P<.001). At 6-month follow-up, differences across groups were no longer statistically significant. Conclusions and RelevanceIn 2 RCTs of patients with hypertension or diabetes and depressive symptoms in Brazil and Peru, a digital intervention delivered over a 6-week period significantly improved depressive symptoms at 3 months when compared with enhanced usual care. However, the magnitude of the effect was small in the trial from Brazil and the effects were not sustained at 6 months. Trial RegistrationClinicalTrials.gov: NCT02846662 (SAo Paulo) and NCT03026426 (Lima) These randomized clinical trials compare the effects of smartphone app-delivered mini-sessions to treat depression vs enhanced usual care on depressive symptoms among patients with hypertension or diabetes in Brazil and Peru.	[Araya, Ricardo] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Global Mental Hlth, London, England; [Menezes, Paulo Rossi; Claro, Heloisa Garcia; Daley, Kate L.; Quayle, Julieta; Cruz, Daniela Vera; Aschar, Suzana; Martins, Hellen; Rocha, Thais; Scotton, George] Univ Sao Paulo, Populat Mental Hlth Res Ctr, Sao Paulo, Brazil; [Menezes, Paulo Rossi] Univ Sao Paulo, Dept Prevent Med, Fac Med, Sao Paulo, Brazil; [Claro, Heloisa Garcia] Univ Estadual Campinas, Sch Nursing, Campinas, Brazil; [Brandt, Lena R.; Diez-Canseco, Francisco; Toyama, Mauricio; Hidalgo-Padilla, Liliana; Cavero, Victoria; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Peters, Tim J.] Univ Bristol, Bristol Med Sch, Fac Hlth Sci, Bristol, Avon, England; [de Almeida Lopes, Ivan F.] Fed Univ ABC, Engn Modeling & Appl Social Sci Ctr CECS, Santo Andre, SP, Brazil; [Begale, Mark; Mohr, David C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Ctr Behav Intervent Technol, Chicago, IL 60611 USA; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru	University of London; King's College London; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidad Peruana Cayetano Heredia; University of Bristol; Universidade Federal do ABC (UFABC); Northwestern University; Feinberg School of Medicine; Universidad Peruana Cayetano Heredia	Araya, R (corresponding author), Kings Coll London, Ctr Global Mental Hlth, Five De Crespigny Pk, London SE5 8AF, England.; Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, Ctr Excelencia Enfermedades Cron, Av Armendariz 445, Lima 18, Peru.	ricardo.araya@kcl.ac.uk; jaime.miranda@upch.pe	Claro, Heloísa Garcia/J-3911-2014; Santos, Daniela Vera Cruz/AAO-9042-2020; Menezes, Paulo R/C-9985-2010; Menezes, Paulo/AAM-3529-2021; de Almeida Lopes Fernandes, Ivan Filipe/E-6869-2015	Claro, Heloísa Garcia/0000-0003-1504-7074; Santos, Daniela Vera Cruz/0000-0002-8285-2519; Menezes, Paulo R/0000-0001-6330-3314; Menezes, Paulo/0000-0001-6330-3314; Araya, Ricardo/0000-0002-0420-5148; de Almeida Lopes Fernandes, Ivan Filipe/0000-0002-4236-4393; Diez-Canseco, Francisco/0000-0002-7611-8190; Cavero, Victoria/0000-0003-4858-7165; Toyama, Mauricio/0000-0001-5554-357X; Miranda, J. Jaime/0000-0002-4738-5468				Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Arjadi R, 2018, LANCET PSYCHIAT, V5, P707, DOI 10.1016/S2215-0366(18)30223-2; Brandt LR, 2019, JMIR MENT HEALTH, V6, DOI 10.2196/11701; Carter H, 2021, J PSYCHIATR RES, V133, P223, DOI 10.1016/j.jpsychires.2020.12.016; Chibanda D, 2016, JAMA-J AM MED ASSOC, V316, P2618, DOI 10.1001/jama.2016.19102; Coley RY, 2020, PSYCHIAT SERV, V71, P312, DOI 10.1176/appi.ps.201900295; Cuijpers P, 2020, LANCET PSYCHIAT, V7, P925, DOI [10.1016/j.S2215-0366(20)30036-5, 10.1016/S2215-0366(20)30036-5]; Ekers D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100100; Firth J, 2017, WORLD PSYCHIATRY, V16, P287, DOI 10.1002/wps.20472; Gold SM, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0200-2; Graham AK, 2019, JAMA PSYCHIAT, V76, P1223, DOI 10.1001/jamapsychiatry.2019.2075; Islam SMS, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022637; Jimenez-Molina A, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00664; Kounali D, 2022, PSYCHOL MED, V52, P1875, DOI 10.1017/S0033291720003700; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuehn BM, 2020, JAMA-J AM MED ASSOC, V324, P1933, DOI 10.1001/jama.2020.22085; Macinko J, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.8; McMillan D, 2010, J AFFECT DISORDERS, V127, P122, DOI 10.1016/j.jad.2010.04.030; Menezes P, 2019, JMIR MENT HEALTH, V6, DOI 10.2196/11698; Mohr DC, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7725; Mohr DC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1602; Naslund JA, 2017, LANCET PSYCHIAT, V4, P486, DOI 10.1016/S2215-0366(17)30096-2; Pan American Health Organization, 2018, BURD MENT DIS REG AM; Patel V, 2017, LANCET, V389, P176, DOI 10.1016/S0140-6736(16)31589-6; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Prabhakaran D, 2019, CIRCULATION, V139, P380, DOI 10.1161/CIRCULATIONAHA.118.038192; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rojas G, 2007, LANCET, V370, P1629, DOI 10.1016/S0140-6736(07)61685-7; Sawyer A, 2019, J MED INTERNET RES, V21, DOI 10.2196/13689; Singla DR, 2020, BEHAV RES THER, V130, DOI 10.1016/j.brat.2019.04.010; Torous John, 2019, Mhealth, V5, P19, DOI 10.21037/mhealth.2019.06.04; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; World Health Organization, 2000, WHO DAS 2 WHO DIS; World Health Organization, 2017, DEP OTH COMM MENT DI	34	7	7	6	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1852	1862		10.1001/jama.2021.4348	http://dx.doi.org/10.1001/jama.2021.4348			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SB7YR	33974019	Green Published, Bronze			2022-12-28	WOS:000650205000014
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: How will a waiver on vaccine patents affect global supply?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, BBC NEWS 0507; Office of the United States Trade Representative, 2021, STAT AMB KATH TAI CO; WHO, 2021, DIR GEN OP ON SHAR W	3	13	13	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2021	373								n1182	10.1136/bmj.n1182	http://dx.doi.org/10.1136/bmj.n1182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RA	33972288	Bronze			2022-12-28	WOS:000649709400001
J	Edwards, TL; Nowicki, S; Marzeion, B; Hock, R; Goelzer, H; Seroussi, H; Jourdain, NC; Slater, DA; Turner, FE; Smith, CJ; McKenna, CM; Simon, E; Abe-Ouchi, A; Gregory, JM; Larour, E; Lipscomb, WH; Payne, AJ; Shepherd, A; Agosta, C; Alexander, P; Albrecht, T; Anderson, B; Asay-Davis, X; Aschwanden, A; Barthel, A; Bliss, A; Calov, R; Chambers, C; Champollion, N; Choi, Y; Cullather, R; Cuzzone, J; Dumas, C; Felikson, D; Fettweis, X; Fujita, K; Galton-Fenzi, BK; Gladstone, R; Golledge, NR; Greve, R; Hattermann, T; Hoffman, MJ; Humbert, A; Huss, M; Huybrechts, P; Immerzeel, W; Kleiner, T; Kraaijenbrink, P; Le Clec'h, S; Lee, VC; Leguy, GR; Little, CM; Lowry, DP; Malles, JH; Martin, DF; Maussion, F; Morlighem, M; O'Neill, JF; Nias, I; Pattyn, F; Pelle, T; Price, SF; Quiquet, A; Radic, V; Reese, R; Rounce, DR; Ruckamp, M; Sakai, A; Shafer, C; Schlegel, NJ; Shannon, S; Smith, RS; Straneo, F; Sun, SN; Tarasov, L; Trusel, LD; Van Breedam, J; van de Wal, R; van den Broeke, M; Winkelmann, R; Zekollari, H; Zhao, C; Zhang, T; Zwinger, T				Edwards, Tamsin L.; Nowicki, Sophie; Marzeion, Ben; Hock, Regine; Goelzer, Heiko; Seroussi, Helene; Jourdain, Nicolas C.; Slater, Donald A.; Turner, Fiona E.; Smith, Christopher J.; McKenna, Christine M.; Simon, Erika; Abe-Ouchi, Ayako; Gregory, Jonathan M.; Larour, Eric; Lipscomb, William H.; Payne, Antony J.; Shepherd, Andrew; Agosta, Cecile; Alexander, Patrick; Albrecht, Torsten; Anderson, Brian; Asay-Davis, Xylar; Aschwanden, Andy; Barthel, Alice; Bliss, Andrew; Calov, Reinhard; Chambers, Christopher; Champollion, Nicolas; Choi, Youngmin; Cullather, Richard; Cuzzone, Joshua; Dumas, Christophe; Felikson, Denis; Fettweis, Xavier; Fujita, Koji; Galton-Fenzi, Benjamin K.; Gladstone, Rupert; Golledge, Nicholas R.; Greve, Ralf; Hattermann, Tore; Hoffman, Matthew J.; Humbert, Angelika; Huss, Matthias; Huybrechts, Philippe; Immerzeel, Walter; Kleiner, Thomas; Kraaijenbrink, Philip; Le Clec'h, Sebastien; Lee, Victoria; Leguy, Gunter R.; Little, Christopher M.; Lowry, Daniel P.; Malles, Jan-Hendrik; Martin, Daniel F.; Maussion, Fabien; Morlighem, Mathieu; O'Neill, James F.; Nias, Isabel; Pattyn, Frank; Pelle, Tyler; Price, Stephen F.; Quiquet, Aure'lien; Radic, Valentina; Reese, Ronja; Rounce, David R.; Ruckamp, Martin; Sakai, Akiko; Shafer, Courtney; Schlegel, Nicole-Jeanne; Shannon, Sarah; Smith, Robin S.; Straneo, Fiammetta; Sun, Sainan; Tarasov, Lev; Trusel, Luke D.; Van Breedam, Jonas; van de Wal, Roderik; van den Broeke, Michiel; Winkelmann, Ricarda; Zekollari, Harry; Zhao, Chen; Zhang, Tong; Zwinger, Thomas			Projected land ice contributions to twenty-first-century sea level rise	NATURE			English	Article							GLOBAL SENSITIVITY-ANALYSIS; SPATIAL SENSITIVITIES; ENVIRONMENTAL-CHANGE; MASS RESPONSE; SHEET; GREENLAND; ANTARCTICA; EMULATION; MELT; UNCERTAINTY	Efficient statistical emulation of melting land ice under various climate scenarios to 2100 indicates a contribution from melting land ice to sea level increase of at least 13 centimetres sea level equivalent. The land ice contribution to global mean sea level rise has not yet been predicted(1) using ice sheet and glacier models for the latest set of socio-economic scenarios, nor using coordinated exploration of uncertainties arising from the various computer models involved. Two recent international projects generated a large suite of projections using multiple models(2-8), but primarily used previous-generation scenarios(9) and climate models(10), and could not fully explore known uncertainties. Here we estimate probability distributions for these projections under the new scenarios(11,12) using statistical emulation of the ice sheet and glacier models. We find that limiting global warming to 1.5 degrees Celsius would halve the land ice contribution to twenty-first-century sea level rise, relative to current emissions pledges. The median decreases from 25 to 13 centimetres sea level equivalent (SLE) by 2100, with glaciers responsible for half the sea level contribution. The projected Antarctic contribution does not show a clear response to the emissions scenario, owing to uncertainties in the competing processes of increasing ice loss and snowfall accumulation in a warming climate. However, under risk-averse (pessimistic) assumptions, Antarctic ice loss could be five times higher, increasing the median land ice contribution to 42 centimetres SLE under current policies and pledges, with the 95th percentile projection exceeding half a metre even under 1.5 degrees Celsius warming. This would severely limit the possibility of mitigating future coastal flooding. Given this large range (between 13 centimetres SLE using the main projections under 1.5 degrees Celsius warming and 42 centimetres SLE using risk-averse projections under current pledges), adaptation planning for twenty-first-century sea level rise must account for a factor-of-three uncertainty in the land ice contribution until climate policies and the Antarctic response are further constrained.	[Edwards, Tamsin L.; Turner, Fiona E.; O'Neill, James F.] Kings Coll London, Dept Geog, London, England; [Nowicki, Sophie; Simon, Erika; Cullather, Richard; Felikson, Denis; Nias, Isabel] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Nowicki, Sophie] SUNY Buffalo, Dept Geol, Buffalo, NY USA; [Nowicki, Sophie] SUNY Buffalo, RENEW Inst, Buffalo, NY USA; [Marzeion, Ben; Champollion, Nicolas] Univ Bremen, Inst Geog, Bremen, Germany; [Marzeion, Ben] Univ Bremen, MARUM Ctr Marine Environm Sci, Bremen, Germany; [Hock, Regine; Goelzer, Heiko; Aschwanden, Andy; Rounce, David R.; van den Broeke, Michiel] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; [Hock, Regine] Univ Oslo, Dept Geosci, Oslo, Norway; [Hock, Regine] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, Utrecht, Netherlands; [Goelzer, Heiko; Pattyn, Frank; Sun, Sainan; Zekollari, Harry] Univ Libre Bruxelles, Lab Glaciol, Brussels, Belgium; [Goelzer, Heiko] Bjerknes Ctr Climate Res, NORCE Norwegian Res Ctr, Bergen, Norway; [Seroussi, Helene; Larour, Eric; Choi, Youngmin; Cuzzone, Joshua; Schlegel, Nicole-Jeanne] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Jourdain, Nicolas C.; Champollion, Nicolas] Univ Grenoble Alpes, CNRS, Inst Geosci Environm, G INP,IRD, Grenoble, France; [Slater, Donald A.; Straneo, Fiammetta] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Slater, Donald A.] Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland; [Slater, Donald A.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Smith, Christopher J.; McKenna, Christine M.; Abe-Ouchi, Ayako] Univ Leeds, Priestley Int Ctr Climate, Leeds, W Yorkshire, England; [Smith, Christopher J.] Int Inst Appl Syst Anal IIASA, Laxenburg, Austria; [Abe-Ouchi, Ayako] Univ Tokyo, Atmosphere & Ocean Res Inst, Tokyo, Japan; [Gregory, Jonathan M.; Smith, Robin S.] Univ Reading, Natl Ctr Atmospher Sci, Reading, Berks, England; [Gregory, Jonathan M.] Hadley Ctr, Met Off, Exeter, Devon, England; [Lipscomb, William H.; Leguy, Gunter R.] Natl Ctr Atmospher Res, Climate & Global Dynam Lab, POB 3000, Boulder, CO 80307 USA; [Payne, Antony J.; Shannon, Sarah] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [Shepherd, Andrew] Univ Leeds, Sch Earth & Environm, Ctr Polar Observat & Modelling, Leeds, W Yorkshire, England; [Agosta, Cecile; Dumas, Christophe; Quiquet, Aure'lien] Univ Paris Saclay, Lab Sci Climat & Environm, LSCE IPSL, CEA CNRS UVSQ, Gif Sur Yvette, France; [Alexander, Patrick] Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA; [Alexander, Patrick; Anderson, Brian] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Albrecht, Torsten; Calov, Reinhard; Reese, Ronja; Winkelmann, Ricarda] Potsdam Inst Climate Impact Res PIK, Leibniz Assoc, Potsdam, Germany; [Golledge, Nicholas R.] Victoria Univ Wellington, Antarctic Res Ctr, Wellington, New Zealand; [Asay-Davis, Xylar; Barthel, Alice; Hoffman, Matthew J.; Price, Stephen F.; Zhang, Tong] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Bliss, Andrew] Colorado State Univ, Dept Anthropol & Geog, Ft Collins, CO 80523 USA; [Chambers, Christopher; Greve, Ralf] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido, Japan; [Choi, Youngmin; Morlighem, Mathieu; Pelle, Tyler] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA; [Felikson, Denis] Univ Space Res Assoc, Goddard Earth Sci Technol & Res Studies & Invest, Columbia, MD USA; [Fettweis, Xavier] Univ Liege, Dept Geog, Lab Climatol, Liege, Belgium; [Fujita, Koji; Sakai, Akiko] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi, Japan; [Galton-Fenzi, Benjamin K.] Australian Antarctic Div, Kingston, Tas, Australia; [Galton-Fenzi, Benjamin K.; Zhao, Chen] Univ Tasmania, Australian Antarctic Program Partnership, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Gladstone, Rupert] Univ Lapland, Arctic Ctr, Rovaniemi, Finland; [Greve, Ralf] Hokkaido Univ, Arctic Res Ctr, Sapporo, Hokkaido, Japan; [Hattermann, Tore] Norwegian Polar Res Inst, Tromso, Norway; [Hattermann, Tore] Univ Tromso, Dept Phys & Technol, Energy & Climate Grp, Arctic Univ, Tromso, Norway; [Humbert, Angelika; Kleiner, Thomas; Ruckamp, Martin] Alfred Wegener Inst, Helmholtz Zentrum Polar & Meeresforsch, Bremerhaven, Germany; [Humbert, Angelika] Univ Bremen, Dept Geosci, Bremen, Germany; [Huss, Matthias; Zekollari, Harry] Swiss Fed Inst Technol, Lab Hydraul Hydrol & Glaciol VAW, Zurich, Switzerland; [Huss, Matthias; Malles, Jan-Hendrik] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Huss, Matthias; van de Wal, Roderik] Univ Fribourg, Dept Geosci, Fribourg, Switzerland; [Huybrechts, Philippe; Le Clec'h, Sebastien; Van Breedam, Jonas] Vrije Univ Brussel, Earth Syst Sci, Brussels, Belgium; [Huybrechts, Philippe; Le Clec'h, Sebastien; Van Breedam, Jonas] Vrije Univ Brussel, Dept Geografie, Brussels, Belgium; [Immerzeel, Walter; Kraaijenbrink, Philip] Univ Utrecht, Dept Phys Geog, Utrecht, Netherlands; [Lee, Victoria] Univ Bristol, Sch Geog Sci, Ctr Polar Observat & Modelling, Bristol, Avon, England; [Little, Christopher M.] Atmospher & Environm Res, Lexington, MA USA; [Lowry, Daniel P.] GNS Sci, Lower Hutt, New Zealand; [Martin, Daniel F.; Shafer, Courtney] Lawrence Berkeley Natl Lab, Computat Res Div, Berkeley, CA USA; [Maussion, Fabien] Univ Innsbruck, Dept Atmospher & Cryospher Sci, Innsbruck, Austria; [Nias, Isabel] Univ Liverpool, Sch Environm Sci, Liverpool, Merseyside, England; [Radic, Valentina] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC, Canada; [Rounce, David R.] Carnegie Mellon Univ, Dept Civil & Environm Engn, Pittsburgh, PA 15213 USA; [Tarasov, Lev] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada; [Trusel, Luke D.] Penn State Univ, Dept Geog, University Pk, PA 16802 USA; [Winkelmann, Ricarda] Univ Potsdam, Dept Phys & Astron, Potsdam, Germany; [Zekollari, Harry] Delft Univ Technol, Dept Geosci & Remote Sensing, Delft, Netherlands; [Zhang, Tong] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource, Beijing, Peoples R China; [Zwinger, Thomas] CSC IT Ctr Sci, Espoo, Finland	University of London; King's College London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Bremen; University of Bremen; University of Alaska System; University of Alaska Fairbanks; University of Oslo; Utrecht University; Universite Libre de Bruxelles; Bjerknes Centre for Climate Research; Norwegian Research Centre (NORCE); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Recherche pour le Developpement (IRD); University of California System; University of California San Diego; Scripps Institution of Oceanography; University of St Andrews; University of Edinburgh; University of Leeds; International Institute for Applied Systems Analysis (IIASA); University of Tokyo; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Reading; Met Office - UK; Hadley Centre; National Center Atmospheric Research (NCAR) - USA; University of Bristol; University of Leeds; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Potsdam Institut fur Klimafolgenforschung; Victoria University Wellington; United States Department of Energy (DOE); Los Alamos National Laboratory; Colorado State University; Hokkaido University; University of California System; University of California Irvine; Universities Space Research Association (USRA); University of Liege; Nagoya University; Australian Antarctic Division; University of Tasmania; University of Lapland; Hokkaido University; Norwegian Polar Institute; UiT The Arctic University of Tromso; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Fribourg; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Utrecht University; University of Bristol; Atmospheric & Environmental Research; GNS Science - New Zealand; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Innsbruck; University of Liverpool; University of British Columbia; Carnegie Mellon University; Memorial University Newfoundland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Potsdam; Delft University of Technology; Beijing Normal University	Edwards, TL (corresponding author), Kings Coll London, Dept Geog, London, England.	tamsin.edwards@kcl.ac.uk	Gregory, Jonathan/J-2939-2016; Barthel, Alice/AHE-2973-2022; Zwinger, Thomas/H-5163-2018; Maussion, Fabien/B-9814-2013; Greve, Ralf/G-2336-2010; Lipscomb, William/AAR-8668-2021; Felikson, Denis/M-2397-2016; Albrecht, Torsten/J-8259-2019; Goelzer, Heiko/M-2367-2016; Quiquet, Aurélien/P-6180-2014; Morlighem, Mathieu/O-9942-2014; Smith, Christopher/AHD-0991-2022; Zhao, Chen/S-2693-2019; Sakai, Akiko/M-5413-2013; Fujita, Koji/E-6104-2010; van de wal, roderik/D-1705-2011; Van den Broeke, Michiel R./F-7867-2011; Marzeion, Ben/G-6514-2013; Seroussi, Helene/AAX-5342-2021; Jourdain, Nicolas/B-6899-2015; Huybrechts, Philippe/J-5278-2013; Price, Stephen/E-1568-2013	Gregory, Jonathan/0000-0003-1296-8644; Barthel, Alice/0000-0002-2481-8646; Zwinger, Thomas/0000-0003-3360-4401; Maussion, Fabien/0000-0002-3211-506X; Greve, Ralf/0000-0002-1341-4777; Felikson, Denis/0000-0002-3785-5112; Albrecht, Torsten/0000-0001-7459-2860; Goelzer, Heiko/0000-0002-5878-9599; Quiquet, Aurélien/0000-0001-6207-3043; Morlighem, Mathieu/0000-0001-5219-1310; Smith, Christopher/0000-0003-0599-4633; Zhao, Chen/0000-0003-0368-1334; Sakai, Akiko/0000-0002-6320-6212; Fujita, Koji/0000-0003-3753-4981; van de wal, roderik/0000-0003-2543-3892; Van den Broeke, Michiel R./0000-0003-4662-7565; Marzeion, Ben/0000-0002-6185-3539; Seroussi, Helene/0000-0001-9201-1644; McKenna, Christine/0000-0002-9677-4582; Slater, Donald/0000-0001-8394-6149; Schlegel, Nicole-Jeanne/0000-0001-8035-448X; Malles, Jan-Hendrik/0000-0002-4208-704X; Reese, Ronja/0000-0001-7625-040X; Zekollari, Harry/0000-0002-7443-4034; Sun, Sainan/0000-0002-1614-2658; Humbert, Angelika/0000-0002-0244-8760; Jourdain, Nicolas/0000-0002-1372-2235; Turner, Fiona/0000-0002-5919-153X; Van Breedam, Jonas/0000-0003-1504-9520; Huybrechts, Philippe/0000-0003-1406-0525; Nias, Isabel/0000-0002-5657-8691; Edwards, Tamsin/0000-0002-4760-4704; Martin, Daniel/0000-0003-4488-2538; Price, Stephen/0000-0001-6878-2553				Alevropoulos-Borrill AV, 2020, CRYOSPHERE, V14, P1245, DOI 10.5194/tc-14-1245-2020; Andrianakis I, 2012, COMPUT STAT DATA AN, V56, P4215, DOI 10.1016/j.csda.2012.04.020; Araya-Melo PA, 2015, CLIM PAST, V11, P45, DOI 10.5194/cp-11-45-2015; Barthel A, 2020, CRYOSPHERE, V14, P855, DOI 10.5194/tc-14-855-2020; Bastos LS, 2009, TECHNOMETRICS, V51, P425, DOI 10.1198/TECH.2009.08019; Bell RE, 2017, NATURE, V544, P344, DOI 10.1038/nature22048; Biemans H, 2019, NAT SUSTAIN, V2, P594, DOI 10.1038/s41893-019-0305-3; Bounceur N, 2015, EARTH SYST DYNAM, V6, P205, DOI 10.5194/esd-6-205-2015; Bowman KW, 2018, GEOPHYS RES LETT, V45, P13050, DOI 10.1029/2018GL080082; Bulthuis K, 2019, CRYOSPHERE, V13, P1349, DOI 10.5194/tc-13-1349-2019; Clerc F, 2019, GEOPHYS RES LETT, V46, P12108, DOI 10.1029/2019GL084183; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Edwards TL, 2019, NATURE, V566, P58, DOI 10.1038/s41586-019-0901-4; Eyring V, 2016, GEOSCI MODEL DEV, V9, P1937, DOI 10.5194/gmd-9-1937-2016; Farinotti D, 2019, NAT GEOSCI, V12, P168, DOI 10.1038/s41561-019-0300-3; Favier L, 2019, GEOSCI MODEL DEV, V12, P2255, DOI 10.5194/gmd-12-2255-2019; Forster PM, 2020, NAT CLIM CHANGE, V10, P7, DOI 10.1038/s41558-019-0660-0; Goelzer H, 2020, CRYOSPHERE, V14, P3071, DOI 10.5194/tc-14-3071-2020; Goelzer H, 2020, CRYOSPHERE, V14, P1747, DOI 10.5194/tc-14-1747-2020; Goelzer H, 2018, CRYOSPHERE, V12, P1433, DOI 10.5194/tc-12-1433-2018; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Golledge NR, 2019, NATURE, V566, P65, DOI 10.1038/s41586-019-0889-9; Gramacy RB, 2012, STAT COMPUT, V22, P713, DOI 10.1007/s11222-010-9224-x; Gu MY, 2019, R J, V11, P112, DOI 10.32614/RJ-2019-011; Hock R, 2019, J GLACIOL, V65, P453, DOI 10.1017/jog.2019.22; IPCC, 2018, SUMMARY POLICYMAKERS; Jourdain NC, 2020, CRYOSPHERE, V14, P3111, DOI 10.5194/tc-14-3111-2020; Levermann A, 2020, EARTH SYST DYNAM, V11, P35, DOI 10.5194/esd-11-35-2020; Lord NS, 2017, CLIM PAST, V13, P1539, DOI 10.5194/cp-13-1539-2017; Marzeion B, 2020, EARTHS FUTURE, V8, DOI 10.1029/2019EF001470; McKenna CM, 2021, NAT CLIM CHANGE, V11, DOI 10.1038/s41558-020-00957-9; Meehl GA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1981; Meredith M., 2019, IPCC SPECIAL REPORT; Mottram R, 2021, CRYOSPHERE, V15, P3751, DOI 10.5194/tc-15-3751-2021; Nauels A, 2017, GEOSCI MODEL DEV, V10, P2495, DOI 10.5194/gmd-10-2495-2017; Naughten KA, 2018, J CLIMATE, V31, P5243, DOI 10.1175/JCLI-D-17-0854.1; Nowicki S, 2020, CRYOSPHERE, V14, P2331, DOI 10.5194/tc-14-2331-2020; Nowicki S, 2013, J GEOPHYS RES-EARTH, V118, P1025, DOI 10.1002/jgrf.20076; Nowicki S, 2013, J GEOPHYS RES-EARTH, V118, P1002, DOI 10.1002/jgrf.20081; Nowicki SMJ, 2016, GEOSCI MODEL DEV, V9, P4521, DOI 10.5194/gmd-9-4521-2016; O'Hagan A, 2006, RELIAB ENG SYST SAFE, V91, P1290, DOI 10.1016/j.ress.2005.11.025; O'Neill BC, 2016, GEOSCI MODEL DEV, V9, P3461, DOI 10.5194/gmd-9-3461-2016; Oppenheimer M., 2019, IPCC SPECIAL REPORT, DOI DOI 10.1126/SCIENCE.AAM6284; Palmer MD, 2020, EARTHS FUTURE, V8, DOI 10.1029/2019EF001413; Payne A., GEOPHYS RES LETT; Price SF, 2011, P NATL ACAD SCI USA, V108, P8978, DOI 10.1073/pnas.1017313108; Reese R, 2020, CRYOSPHERE, V14, P3097, DOI 10.5194/tc-14-3097-2020; Rougier J, 2009, J CLIMATE, V22, P3540, DOI 10.1175/2008JCLI2533.1; Roussel ML, 2020, CRYOSPHERE, V14, P2715, DOI 10.5194/tc-14-2715-2020; Saito F, 2016, CRYOSPHERE, V10, P43, DOI 10.5194/tc-10-43-2016; Salter JM, 2016, ENVIRONMETRICS, V27, P507, DOI 10.1002/env.2405; Seroussi H, 2020, CRYOSPHERE, V14, P3033, DOI 10.5194/tc-14-3033-2020; Seroussi H, 2019, CRYOSPHERE, V13, P1441, DOI 10.5194/tc-13-1441-2019; Shepherd A, 2020, NATURE, V579, P233, DOI 10.1038/s41586-019-1855-2; Shepherd A, 2018, NATURE, V558, P219, DOI 10.1038/s41586-018-0179-y; Silverman B., 1986, DENSITY ESTIMATION S, V175; Slater DA, 2020, CRYOSPHERE, V14, P985, DOI 10.5194/tc-14-985-2020; Slater DA, 2019, CRYOSPHERE, V13, P2489, DOI 10.5194/tc-13-2489-2019; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trusel LD, 2015, NAT GEOSCI, V8, P927, DOI [10.1038/ngeo2563, 10.1038/NGEO2563]; van Beers WCM, 2003, J OPER RES SOC, V54, P255, DOI 10.1057/palgrave.jors.2601492; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; van Vuuren DP, 2017, GLOBAL ENVIRON CHANG, V42, P148, DOI 10.1016/j.gloenvcha.2016.10.009; Williamson D, 2015, CLIM DYNAM, V45, P1299, DOI 10.1007/s00382-014-2378-z; Williamson D, 2014, SIAM-ASA J UNCERTAIN, V2, P1, DOI 10.1137/120900915; Williamson DB, 2019, B AM METEOROL SOC, V100, P2571, DOI 10.1175/BAMS-D-19-0131.1	67	63	64	52	127	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					74	+		10.1038/s41586-021-03302-y	http://dx.doi.org/10.1038/s41586-021-03302-y			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RY0YD	33953415	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000647642900014
J	Gau, SY				Gau, Shuo-Yan			Association Between Bariatric Surgery and All-Cause Mortality	ANNALS OF INTERNAL MEDICINE			English	Letter									[Gau, Shuo-Yan] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	Chung Shan Medical University	Gau, SY (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.		Gau, Shuo-Yan/ABA-7848-2021	Gau, Shuo-Yan/0000-0001-8897-5635				Doumouras AG, 2020, ANN INTERN MED, V173, P694, DOI 10.7326/M19-3925	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					730	730		10.7326/L20-1242	http://dx.doi.org/10.7326/L20-1242			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33999683				2022-12-28	WOS:000652604800044
J	Leff, L; Schoen, RE				Leff, Laurel; Schoen, Robert E.			Fighting Prejudice and Absorbing Refugees From Nazism: The National Committee for the Resettlement of Foreign Physicians, 1939-1945	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EMIGRE PHYSICIAN	In the 1930s and 1940s, the medical profession reacted with hostility and erected formidable barriers to refugee physicians from Nazi-dominated Europe who sought to practice medicine in the United States. Yet, refugee physicians ultimately succeeded, with 77% of them working as doctors by 1945 and 98.6% by 1947. Although physician skills are readily transferable, and the United States had a genuine need for doctors after World War II drew 55 000 physicians into the military, refugee physicians' success can be attributed to the courageous physician leaders who lobbied on their behalf and the creation of the National Committee for the Resettlement of Foreign Physicians-an organization that helped immigrant physicians pass licensing examinations, identify locations for employment, and overcome barriers to integration into American society.	[Leff, Laurel] Northeastern Univ, Sch Journalism, Coll Arts Media & Design, 102 Lake Hall, Boston, MA 02115 USA; [Schoen, Robert E.] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Mezzanine Level,C Wing,PUH,200 Lothrop St, Pittsburgh, PA 15213 USA	Northeastern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schoen, RE (corresponding author), Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Mezzanine Level,C Wing,PUH,200 Lothrop St, Pittsburgh, PA 15213 USA.	rschoen@pitt.edu		Schoen, Robert/0000-0001-7153-2766				American Council for Emigr, AM COUNCIL EMIGRES P, P35; [Anonymous], National Refugee Service Collection, 675 folder, box 33; [Anonymous], 1938, FED B, V24, P227; [Anonymous], 1938, JAMA-J AM MED ASSOC, V111, P1102, DOI [10.1001/jama.1938.02790380044012, DOI 10.1001/JAMA.1938.02790380044012]; [Anonymous], 1938, P COUNC SOC; [Anonymous], The staff. National Refugee Service Collection, 8 folder, box 4; [Anonymous], 1939, B NUMB ON NAT COMM R; Aub J, PIONEER MODERN MED, V1; Berlant J.L., 1975, PROFESSION MONOPOLY; Bevan AD, 1936, J ASSOC AM MED COLL, V11, P377; Biele H., 1941, COMMUNICATION 0506; Biele H., 1944, COMMUNICATION 0508; Bierring WL, 1934, AM MED ASS B, V292, P18; Boas E., 1940, COMMUNICATION 0202; Boston Committee on Medical Emigr, 1938, COMMUNICATION 1027; Brody D, 1969, JEWISH EXPERIENCE AM, P337; Cobb S, 1939, COMMUNICATION 0211; Cohn A., 1942, COMMUNICATION 0114; Cox C., 1939, COMMUNICATION 1108; Davie MR, 1947, REFUGEES AM REPORT C, P41; Deckert Margot, MARG DECK FIL; Edsall DL, 1940, J AMER MED ASSOC, V114, P1068; Edsall DL, 1939, J AMER MED ASSOC, V112, P1986, DOI 10.1001/jama.1939.02800190100026; Edsall DL, 1939, J AMER MED ASSOC, V112, P570, DOI 10.1001/jama.1939.02800060086025; Edsall DL, 1941, J AMER MED ASSOC, V117, P1881, DOI 10.1001/jama.1941.72820480006012; Edsall DL, 1940, COMMUNICATION 0110; Edsall J, 1964, HARVARD MED SCH; Fine J, 1938, COMMUNICATION 0531; Goldwasser E., 1939, COMMUNICATION 0515; Graef I., 1942, COMMUNICATION 0116; Greenleigh AD, 1939, COMMUNICATION 0920; Halterman S., 1939, COMMUNICATION 1106; Harrison RB, 1940, JAMA-J AM MED ASSOC, V114, P1580, DOI [10.1001/jama.1940.62810160019035, DOI 10.1001/JAMA.1940.62810160019035]; Jordan C., 1939, COMMUNICATION 0905; Kohler ED, RELICENSING CENTRAL; Lazaron M., JEWISH STUDENT MED; Ludmerer KM, 1999, TIME HEAL AM MED ED, P95; Motion for the Boston Committee on Medical Emigres, 1938, JP CHAMBERLAIN PAPER; New York Committee of the National Committee for the Resettlement of Foreign Physicians, 1939, SOL PROBL REF PHYS; Ohio State Medical Board, MIN OH STAT MED BOAR; Page C., MEMORANDUM; Pratt JH, 1940, FED B, V26, P106; Preston JW, 1939, COMMUNICATION 0419; Rau L., 1940, COMMUNICATION 0913; RAYACK E, 1967, PROFESSIONAL POWER A; Rockefeller University, ALFR COHN COLL FOLD; Shryock RH, 1967, MED LICENSING AM 165, P91; Tanenbaum D, 1939, COMMUNICATION 1108; Tanenbaum D., 1939, COMMUNICATION 0728; Warburg B, 1940, COMMUNICATION 0105	50	0	0	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					680	+		10.7326/M20-6002	http://dx.doi.org/10.7326/M20-6002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33999678				2022-12-28	WOS:000652604800027
J	Mathieson, S; Bagg, MK; Schoene, M; Maher, CG				Mathieson, Stephanie; Bagg, Matthew K.; Schoene, Mark; Maher, Christopher G.			Nonpharmacologic and Pharmacologic Management of Acute Pain From Non-Low Back, Musculoskeletal Injuries in Adults	ANNALS OF INTERNAL MEDICINE			English	Letter									[Mathieson, Stephanie; Maher, Christopher G.] Univ Sydney, Inst Musculoskeletal Hlth, Camperdown, NSW, Australia; [Bagg, Matthew K.] Univ New South Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Schoene, Mark] BackLetter Lippincott Williams & Wilkins, Philadelphia, PA USA	University of Sydney; Neuroscience Research Australia; University of New South Wales Sydney	Mathieson, S (corresponding author), Univ Sydney, Inst Musculoskeletal Hlth, Camperdown, NSW, Australia.		Maher, Christopher/AAC-6267-2019; Mathieson, Stephanie/H-4067-2019; Bagg, Matthew/GSN-4849-2022	Maher, Christopher/0000-0002-1628-7857; Mathieson, Stephanie/0000-0002-7335-8842; Bagg, Matthew/0000-0002-4812-3814				Busse JW, 2020, ANN INTERN MED, V173, P730, DOI 10.7326/M19-3601; Qaseem A, 2020, ANN INTERN MED, V173, P739, DOI 10.7326/M19-3602; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					732	733		10.7326/L21-0060	http://dx.doi.org/10.7326/L21-0060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33999672				2022-12-28	WOS:000652604800048
J	McCarron, RM; Shapiro, B; Rawles, J; Luo, J				McCarron, Robert M.; Shapiro, Bryan; Rawles, Jody; Luo, John			In the Clinic Depression	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERSISTENT PULMONARY-HYPERTENSION; SEROTONIN-REUPTAKE INHIBITORS; MAJOR DEPRESSION; PRACTICE GUIDELINE; AMERICAN-COLLEGE; COLLABORATIVE CARE; ANTIDEPRESSANTS; DISORDER; RISK; PREGNANCY		[McCarron, Robert M.; Shapiro, Bryan; Rawles, Jody; Luo, John] Univ Calif Irvine, Irvine, CA 92697 USA	University of California System; University of California Irvine	McCarron, RM (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.			Luo, John/0000-0001-8327-4573	American College of Physicians	American College of Physicians	American College of Physicians.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anglin R, 2014, AM J GASTROENTEROL, V109, P810, DOI 10.1038/ajg.2014.82; [Anonymous], MED CARE; Appleton KM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004692.pub4; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Biesheuvel-Leliefeld KEM, 2015, J AFFECT DISORDERS, V174, P400, DOI 10.1016/j.jad.2014.12.016; Bloom D.E., 2012, GLOBAL EC BURDEN NON; BRODY DS, 1995, GEN HOSP PSYCHIAT, V17, P93, DOI 10.1016/0163-8343(94)00093-S; Carvalho AF, 2016, PSYCHOTHER PSYCHOSOM, V85, P270, DOI 10.1159/000447034; Casper RC, 2015, J NERV MENT DIS, V203, P167, DOI 10.1097/NMD.0000000000000258; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chisholm D, 2016, LANCET PSYCHIAT, V3, P415, DOI 10.1016/S2215-0366(16)30024-4; Cipriani Andrea, 2018, Focus (Am Psychiatr Publ), V16, P420, DOI 10.1176/appi.focus.16407; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Conner A, 2019, ANN INTERN MED, V171, P885, DOI 10.7326/M19-1324; Dubicka B, 2006, BRIT J PSYCHIAT, V189, P393, DOI 10.1192/bjp.bp.105.011833; Fortney JC, 2007, J GEN INTERN MED, V22, P1086, DOI 10.1007/s11606-007-0201-9; Gartlehner G, 2016, ANN INTERN MED, V164, P331, DOI 10.7326/M15-1813; Gonzalez HM, 2010, ARCH GEN PSYCHIAT, V67, P37, DOI 10.1001/archgenpsychiatry.2009.168; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Guidi J, 2011, PSYCHOL MED, V41, P321, DOI 10.1017/S0033291710000826; Hedegaard Holly, 2018, NCHS Data Brief, P1; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V313, P2142, DOI 10.1001/jama.2015.5605; Kim J, 2019, NEW ENGL J MED, V381, P1, DOI 10.1056/NEJMp1903305; Lam RW, 2016, JAMA PSYCHIAT, V73, P56, DOI 10.1001/jamapsychiatry.2015.2235; Levis B, 2020, JAMA-J AM MED ASSOC, V323, P2290, DOI 10.1001/jama.2020.6504; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lu CY, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3596; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3; Moscicki EK, 1997, PSYCHIAT CLIN N AM, V20, P499, DOI 10.1016/S0193-953X(05)70327-0; Paykel ES, 1999, ARCH GEN PSYCHIAT, V56, P829, DOI 10.1001/archpsyc.56.9.829; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Qaseem A, 2008, ANN INTERN MED, V149, P725, DOI 10.7326/0003-4819-149-10-200811180-00007; Qaseem A, 2016, ANN INTERN MED, V164, P350, DOI 10.7326/M15-2570; Raue PJ, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0466-8; Ren JJ, 2014, PROG NEURO-PSYCHOPH, V51, P181, DOI 10.1016/j.pnpbp.2014.02.004; Reynolds CF, 2006, NEW ENGL J MED, V354, P1130, DOI 10.1056/NEJMoa052619; Riddell CA, 2018, ANN INTERN MED, V168, P712, DOI 10.7326/M17-2976; RUSH AJ, 1993, AM FAM PHYSICIAN, V47, P1776; Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu; Sheehan D.V., 1998, J CLIN PSYCHIAT, V59, P22; Shelton RC, 2008, ACTA PSYCHIAT SCAND, V117, P253, DOI 10.1111/j.1600-0447.2007.01130.x; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Smith A, 2020, OBSTET MED, V13, P55, DOI 10.1177/1753495X19843015; Spier S A, 1998, Depress Anxiety, V7, P73, DOI 10.1002/(SICI)1520-6394(1998)7:2<73::AID-DA4>3.0.CO;2-6; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; Targownik LE, 2009, AM J GASTROENTEROL, V104, P1475, DOI 10.1038/ajg.2009.128; Taylor MJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003382.pub3; Terre L, 2003, PSYCHOTHER PSYCHOSOM, V72, P261, DOI 10.1159/000071897; Thachil AF, 2007, J AFFECT DISORDERS, V97, P23, DOI 10.1016/j.jad.2006.06.021; The American Psychiatric Association, PRACTICE GUIDELINE T, V3; Titov Nickolai, 2011, Cognitive Behaviour Therapy, V40, P126, DOI 10.1080/16506073.2010.550059; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Unutzer J, 2012, PRIMARY CARE, V39, P415, DOI 10.1016/j.pop.2012.03.010; Unutzer J, 2008, AM J MANAG CARE, V14, P95; Vaiva G, 2006, BRIT MED J, V332, P1241, DOI 10.1136/bmj.332.7552.1241; Voineskos D, 2020, NEUROPSYCH DIS TREAT, V16, P221, DOI 10.2147/NDT.S198774; Wang JH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017173; Wang S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001681; World Medical Association, 2013, JAMA-J AM MED ASSOC; Ziegelstein RC, 2007, AM J MED, V120, P525, DOI 10.1016/j.amjmed.2006.10.026	64	37	39	14	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					ITC65	ITC79		10.7326/AITC202105180	http://dx.doi.org/10.7326/AITC202105180			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SF2QB	33971098				2022-12-28	WOS:000652604800004
J	Yan, CW; Li, H				Yan, Chaowu; Li, Hua			Preliminary Investigation of In situ Thrombus Within Patent Foramen Ovale in Patients With and Without Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Yan, Chaowu] Fuwai Hosp, Dept Struct Heart Dis, 167 Beilishi Rd, Beijing 100037, Peoples R China; [Li, Hua] Beijing Tongren Hosp, Dept Cardiol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Capital Medical University	Yan, CW (corresponding author), Fuwai Hosp, Dept Struct Heart Dis, 167 Beilishi Rd, Beijing 100037, Peoples R China.	chaowuyan@163.com						Ali ZA, 2017, JACC-CARDIOVASC INTE, V10, P2473, DOI 10.1016/j.jcin.2017.09.042; Elgendy AY, 2020, JAMA NEUROL, V77, P878, DOI 10.1001/jamaneurol.2020.0458; Fracassi F, 2019, J AM COLL CARDIOL, V73, P2253, DOI 10.1016/j.jacc.2018.10.093; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Mojadidi MK, 2018, J AM COLL CARDIOL, V71, P1035, DOI 10.1016/j.jacc.2017.12.059; Pristipino C, 2019, EUR HEART J, V40, P3182, DOI 10.1093/eurheartj/ehy649	6	5	5	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2116	2118		10.1001/jama.2021.4359	http://dx.doi.org/10.1001/jama.2021.4359			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032839	Bronze, Green Published			2022-12-28	WOS:000655647300028
J	Coombes, R				Coombes, Rebecca			Doctors' duty to declare their interests should be enforced, says GMC	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Feldman HR, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019952; Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2726; Rimmer A, 2021, BMJ-BRIT MED J, P373	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2021	373								n1329	10.1136/bmj.n1329	http://dx.doi.org/10.1136/bmj.n1329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK9UC	34031033				2022-12-28	WOS:000656562600006
J	Morse, I				Morse, Ian			A DEAD BATTERY DILEMMA	SCIENCE			English	Editorial Material																			0	15	15	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					780	783		10.1126/science.372.6544.780	http://dx.doi.org/10.1126/science.372.6544.780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016763				2022-12-28	WOS:000653997000020
J	Rich, MK; Vigneron, N; Libourel, C; Keller, J; Xue, L; Hajheidari, M; Radhakrishnan, GV; Le Ru, A; Diop, SI; Potente, G; Conti, E; Duijsings, D; Batut, A; Le Faouder, P; Kodama, K; Kyozuka, J; Sallet, E; Becard, G; Rodriguez-Franco, M; Ott, T; Bertrand-Michel, J; Oldroyd, GED; Szovenyi, P; Bucher, M; Delaux, PM				Rich, Melanie K.; Vigneron, Nicolas; Libourel, Cyril; Keller, Jean; Xue, Li; Hajheidari, Mohsen; Radhakrishnan, Guru, V; Le Ru, Aurelie; Diop, Seydina Issa; Potente, Giacomo; Conti, Elena; Duijsings, Danny; Batut, Aurelie; Le Faouder, Pauline; Kodama, Kyoichi; Kyozuka, Junko; Sallet, Erika; Becard, Guillaume; Rodriguez-Franco, Marta; Ott, Thomas; Bertrand-Michel, Justine; Oldroyd, Giles E. D.; Szovenyi, Peter; Bucher, Marcel; Delaux, Pierre-Marc			Lipid exchanges drove the evolution of mutualism during plant terrestrialization	SCIENCE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ EXPERIMENTS; TRANSCRIPTION FACTORS; RHIZOPHAGUS-IRREGULARIS; MYCORRHIZAL SYMBIOSIS; ARBUSCULAR MYCORRHIZA; ALIGNMENT; FUNGI; GENE; BIOSYNTHESIS	Symbiosis with arbuscular mycorrhizal fungi (AMF) improves plant nutrition in most land plants, and its contribution to the colonization of land by plants has been hypothesized. Here, we identify a conserved transcriptomic response to AMF among land plants, including the activation of lipid metabolism. Using gain of function, we show the transfer of lipids from the liverwort Marchantia paleacea to AMF and its direct regulation by the transcription factor WRINKLED (WRI). Arbuscules, the nutrient-exchange structures, were not formed in loss-of-function wri mutants in M. paleacea, leading to aborted mutualism. Our results show the orthology of the symbiotic transfer of lipids across land plants and demonstrate that mutualism with arbuscular mycorrhizal fungi was present in the most recent ancestor of land plants 450 million years ago.	[Rich, Melanie K.; Vigneron, Nicolas; Libourel, Cyril; Keller, Jean; Becard, Guillaume; Delaux, Pierre-Marc] Univ Toulouse, Lab Rech Sci Vegetales LRSV, UPS, CNRS, F-31326 Castanet Tolosan, France; [Xue, Li; Hajheidari, Mohsen; Bucher, Marcel] Univ Cologne, Cologne Bioctr, Inst Plant Sci, Cluster Excellence Plant Sci, D-50674 Cologne, Germany; [Xue, Li] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Zhejiang, Peoples R China; [Radhakrishnan, Guru, V; Oldroyd, Giles E. D.] John Innes Ctr, Norwich NR4 7UH, Norfolk, England; [Le Ru, Aurelie] Federat Rech 3450, Plateforme Imagerie, Pole Biotechnol Vegetale, F-31326 Castanet Tolosan, France; [Diop, Seydina Issa; Potente, Giacomo; Conti, Elena; Szovenyi, Peter] Univ Zurich, Dept Systemat & Evolutionary Bot, CH-8008 Zurich, Switzerland; [Diop, Seydina Issa; Potente, Giacomo; Conti, Elena; Szovenyi, Peter] Zurich Basel Plant Sci Ctr, CH-8092 Zurich, Switzerland; [Duijsings, Danny] BaseClear BV, NL-2333 Leiden, Netherlands; [Batut, Aurelie; Le Faouder, Pauline; Bertrand-Michel, Justine] MetaToulLipid Facil, INSERM, UMR1048, F-31432 Toulouse, France; [Kodama, Kyoichi; Kyozuka, Junko] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan; [Sallet, Erika] Univ Toulouse, Lab Plant Microbe Interact LIPM, CNRS, INRA, F-31326 Castanet Tolosan, France; [Rodriguez-Franco, Marta; Ott, Thomas] Univ Freiburg, Fac Biol, Cell Biol, D-79104 Freiburg, Germany; [Ott, Thomas] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, D-79104 Freiburg, Germany; [Oldroyd, Giles E. D.] Univ Cambridge, Crop Sci Ctr, Cambridge CB2 3EA, England	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Cologne; Zhejiang Normal University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); Tohoku University; Centre National de la Recherche Scientifique (CNRS); INRAE; University of Freiburg; University of Freiburg; University of Cambridge	Delaux, PM (corresponding author), Univ Toulouse, Lab Rech Sci Vegetales LRSV, UPS, CNRS, F-31326 Castanet Tolosan, France.	pierre-marc.delaux@lrsv.ups.tlse.fr	Bucher, Marcel/D-4596-2013; Oldroyd, Giles/ABD-8143-2021	Bucher, Marcel/0000-0003-1680-9413; Oldroyd, Giles/0000-0002-5245-6355; Kodama, Kyoichi/0000-0001-6988-1772; Libourel, Cyril/0000-0002-4271-9596; Vigneron, Nicolas/0000-0002-0619-2993; Rodriguez Franco, Marta/0000-0003-1183-2075; Potente, Giacomo/0000-0002-4343-3952; AURELIE, LE RU/0000-0002-0236-791X; Rich, Melanie/0000-0001-6109-1290; Sallet, Erika/0000-0003-4637-473X; Xue, Li/0000-0002-9367-0155	Bill and Melinda Gates Foundation; UK Foreign, Commonwealth and Development Office as Engineering Nitrogen Symbiosis for Africa [OPP1172165]; Agence Nationale de la Recherche (ANR) grant EVOLSYM [ANR-17-CE20-0006-01]; Universite Paul Sabatier ATP2016 grant; URPP Evolution in Action of the University of Zurich; Forschungskredit (University of Zurich); Swiss National Science Foundation [160004, 131726]; EU's Horizon 2020 Research and Innovation Programme (PlantHUB) [722338]; Georges and Antoine Claraz Foundation; German Research Foundation (DFG) under Germany's Excellence Strategy [CIBSS - EXC-2189, 39093984]; DFG grant [INST 39/1153-1]; German Science Foundation [BU-2250/12-1]; German Ministry of Education and Research (BMBF) [031B0200];  [MetaboHUB-ANR-11-INBS-0010]; BBSRC [BB/S011005/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Foreign, Commonwealth and Development Office as Engineering Nitrogen Symbiosis for Africa; Agence Nationale de la Recherche (ANR) grant EVOLSYM(French National Research Agency (ANR)); Universite Paul Sabatier ATP2016 grant; URPP Evolution in Action of the University of Zurich; Forschungskredit (University of Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU's Horizon 2020 Research and Innovation Programme (PlantHUB); Georges and Antoine Claraz Foundation; German Research Foundation (DFG) under Germany's Excellence Strategy(German Research Foundation (DFG)); DFG grant(German Research Foundation (DFG)); German Science Foundation(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Bill and Melinda Gates Foundation; the UK Foreign, Commonwealth and Development Office as Engineering Nitrogen Symbiosis for Africa (OPP1172165) to G.E.D.O., P.-M.D., and T.O.; Agence Nationale de la Recherche (ANR) grant EVOLSYM (ANR-17-CE20-0006-01); Universite Paul Sabatier ATP2016 grant to P.-M.D.; the MetaboHUB-ANR-11-INBS-0010 grant to J.B.-M.; the URPP Evolution in Action of the University of Zurich (P.S. and I.S.D.); funding from the Forschungskredit (University of Zurich; P.S. and I.S.D.); Swiss National Science Foundation grants 160004 and 131726 (P.S.); the EU's Horizon 2020 Research and Innovation Programme (PlantHUB-No. 722338; I.S.D., G.P., P.S., E.C., and D.U.); and the Georges and Antoine Claraz Foundation (G.P., I.S.D., and P.S.). This work was also supported by the German Research Foundation (DFG) under Germany's Excellence Strategy (CIBSS -EXC-2189 -Project ID 39093984). The TEM (funded by DFG grant INST 39/1153-1) is operated by the University of Freiburg, Faculty of Biology, as a partner unit within the Microscopy and Image Analysis Platform (MIAP) and the Life Imaging Center (LIC), Freiburg. This research was supported by the German Science Foundation grant BU-2250/12-1 (M.B.) and by the German Ministry of Education and Research (BMBF, project no. 031B0200 A to M.B.) within the frame of RECONSTRUCT. The Laboratoire de Recherche en Sciences Vegetales (LRSV) and the Laboratory of Plant-Microbe Interactions (LIPM) belong to the TULIP Laboratoire d'Excellence (ANR-10-LABX-41).	Althoff F, 2014, TRANSGENIC RES, V23, P235, DOI 10.1007/s11248-013-9746-z; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2018, GENOTOUL BIOINFORMAT, DOI [10.15454/1.5572369328961167E12, DOI 10.15454/1.5572369328961167E12]; Arseneau JR, 2017, MOL ECOL RESOUR, V17, P686, DOI 10.1111/1755-0998.12616; Balzergue C, 2011, J EXP BOT, V62, P1049, DOI 10.1093/jxb/erq335; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; BARRANS A, 1994, J BIOL CHEM, V269, P11572; Beerling DJ, 2007, EMERALD PLANET PLANT; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bravo A, 2017, NEW PHYTOL, V214, P1631, DOI 10.1111/nph.14533; Cabau C, 2017, PEERJ, V5, DOI 10.7717/peerj.2988; Calabrese S, 2017, PLANT CELL PHYSIOL, V58, P1003, DOI 10.1093/pcp/pcx044; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carey S. B., 2020, CERATODON PURPURES G; Delaux PM, 2015, P NATL ACAD SCI USA, V112, P13390, DOI 10.1073/pnas.1515426112; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Dipp-Alvarez M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00017; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Emms DM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1832-y; FANG YC, 1983, NEW PHYTOL, V95, P107, DOI 10.1111/j.1469-8137.1983.tb03473.x; Fiorilli V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00636; Foissac S, 2008, CURR BIOINFORM, V3, P87, DOI 10.2174/157489308784340702; Fukuda N, 2013, PLANT MOL BIOL, V82, P473, DOI 10.1007/s11103-013-0075-7; GenoToul Bioinformatics Facility, 2018, GENOTOUL BIOINFO, DOI 10.15454/1.5572369328961167E12; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Humphreys CP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1105; Jiang YN, 2018, MOL PLANT, V11, P1344, DOI 10.1016/j.molp.2018.09.006; Jiang YN, 2017, SCIENCE, V356, P1172, DOI 10.1126/science.aam9970; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Keymer A, 2017, ELIFE, V6, DOI [10.7554/eLife.29107, 10.7554/eLife.29107.001]; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Laetsch D. R., 2017, F1000RESEARCH, V6, P1287, DOI [10.12688/f1000research.12232.1, DOI 10.12688/F1000RESEARCH.12232.1]; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leebens-Mack JH, 2019, NATURE, V574, P679, DOI 10.1038/s41586-019-1693-2; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li H, 2016, BIOINFORMATICS, V32, P2103, DOI 10.1093/bioinformatics/btw152; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; LILLINGTON JM, 1981, CLIN CHIM ACTA, V111, P91, DOI 10.1016/0009-8981(81)90425-3; Luginbuehl LH, 2017, SCIENCE, V356, P1175, DOI 10.1126/science.aan0081; Lutzoni F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07849-9; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miart F, 2014, PLANT J, V77, P71, DOI 10.1111/tpj.12362; Mistry J, 2021, NUCLEIC ACIDS RES, V49, pD412, DOI 10.1093/nar/gkaa913; Morris JL, 2018, P NATL ACAD SCI USA, V115, pE2274, DOI 10.1073/pnas.1719588115; Nagar R., 2018, PROTOCOLSIO, DOI [10.17504/protocols.io.n5ydg7w, DOI 10.17504/PROTOCOLS.IO.N5YDG7W]; ONO K, 1979, PLANT SCI LETT, V14, P225, DOI 10.1016/0304-4211(79)90074-9; Patron N, 2015, NEW PHYTOL, V208, P13, DOI 10.1111/nph.13532; Pecrix Y, 2018, NAT PLANTS, V4, P1017, DOI 10.1038/s41477-018-0286-7; Pertea Geo, 2020, F1000Res, V9, P304, DOI 10.12688/f1000research.23297.1; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; Radhakrishnan GV, 2020, NAT PLANTS, V6, P280, DOI 10.1038/s41477-020-0613-7; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Rensing SA, 2020, CELL, V181, P964, DOI 10.1016/j.cell.2020.05.011; Rich MK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3988-8; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roux, 2021, CURR BIOL, V31, P1570; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P91, DOI 10.1016/B978-012370526-6.50005-2; To A, 2012, PLANT CELL, V24, P5007, DOI 10.1105/tpc.112.106120; Vangelisti A, 2020, MYCORRHIZA, V30, P373, DOI 10.1007/s00572-020-00950-2; Vaser R, 2017, GENOME RES, V27, P737, DOI 10.1101/gr.214270.116; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wewer V, 2014, PLANT J, V79, P398, DOI 10.1111/tpj.12566; Xue L, 2018, P NATL ACAD SCI USA, V115, pE9239, DOI 10.1073/pnas.1812275115; Xue L, 2015, PLANT PHYSIOL, V167, P854, DOI 10.1104/pp.114.255430	77	39	39	69	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					864	+		10.1126/science.abg0929	http://dx.doi.org/10.1126/science.abg0929			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016782	Green Submitted			2022-12-28	WOS:000653997000048
J	Yang, QM; Wang, YH; Qiao, YS; Gau, M; Carroll, PJ; Walsh, PJ; Schelter, EJ				Yang, Qiaomu; Wang, Yu-Heng; Qiao, Yusen; Gau, Michael; Carroll, Patrick J.; Walsh, Patrick J.; Schelter, Eric J.			Photocatalytic C-H activation and the subtle role of chlorine radical complexation in reactivity	SCIENCE			English	Article							VISIBLE-LIGHT; CHARGE-TRANSFER; METHANE; PHOTOCHEMISTRY; HYDROCARBONS; COPPER(II); BORYLATION; ATOMS	The functionalization of methane, ethane, and other alkanes derived from fossil fuels is a central goal in the chemical enterprise. Recently, a photocatalytic system comprising [(CeCl5)-Cl-IV(OR)]2(-) [Ce-IV, cerium(IV); OR, -OCH3 or -OCCl2CH3] was disclosed. The system was reportedly capable of alkane activation by alkoxy radicals (RO center dot) formed by Ce-IV-OR bond photolysis. In this work, we present evidence that the reported carbon-hydrogen (C-H) activation of alkanes is instead mediated by the photocatalyst [NEt4](2)[CeCl6] (NEt4+, tetraethylammonium), and RO center dot are not intermediates. Spectroscopic analyses and kinetics were investigated for C-H activation to identify chlorine radical (Cl center dot) generation as the rate-limiting step. Density functional theory calculations support the formation of [Cl center dot][alcohol] adducts when alcohols are present, which can manifest a masked RO center dot character. This result serves as an important cautionary note for interpretation of radical trapping experiments.	[Yang, Qiaomu; Wang, Yu-Heng; Qiao, Yusen; Gau, Michael; Carroll, Patrick J.; Walsh, Patrick J.; Schelter, Eric J.] Univ Penn, P Roy & Diana T Vagelos Labs, Dept Chem, 231 South 34th St, Philadelphia, PA 19104 USA	University of Pennsylvania	Walsh, PJ; Schelter, EJ (corresponding author), Univ Penn, P Roy & Diana T Vagelos Labs, Dept Chem, 231 South 34th St, Philadelphia, PA 19104 USA.	pwalsh@sas.upenn.edu; schelter@sas.upenn.edu		Wang, Yu-Heng/0000-0002-5655-7604; Gau, Michael/0000-0002-4790-6980	Vagelos Institute for Energy Science and Technology (VIEST); Center for Actinide Science and Technology (CAST), an Energy Frontier Research Center (EFRC) - US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0016568]; NSF [CHE-1902509]; University of Pennsylvania	Vagelos Institute for Energy Science and Technology (VIEST); Center for Actinide Science and Technology (CAST), an Energy Frontier Research Center (EFRC) - US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); University of Pennsylvania	The project was supported by Vagelos Institute for Energy Science and Technology (VIEST), including support for Y.H.W.; Q.Y. was supported as part of the Center for Actinide Science and Technology (CAST), an Energy Frontier Research Center (EFRC) funded by the US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), under award number DE-SC0016568. P.J.W. thanks the NSF (CHE-1902509) for financial support. We also thank the University of Pennsylvania for support of this work.	Alfassi ZB, 1996, J PHYS CHEM-US, V100, P15961, DOI 10.1021/jp961628s; Alkorta I, 1998, BER BUNSEN PHYS CHEM, V102, P429, DOI 10.1002/bbpc.19981020323; An Q, 2020, J AM CHEM SOC, V142, P6216, DOI 10.1021/jacs.0c00212; Andrienko G., 2017, CHEMCRAFT GRAPHICAL; [Anonymous], 2009, SHELXTL; [Anonymous], 2009, SAINT; BUHLER RE, 1967, NATURE, V214, P1220, DOI 10.1038/2141220a0; CERVONE E, 1981, J PHOTOCHEM, V15, P203, DOI 10.1016/0047-2670(81)87004-9; Chen YL, 2020, CHEM-US, V6, P266, DOI 10.1016/j.chempr.2019.11.009; Cook AK, 2016, SCIENCE, V351, P1421, DOI 10.1126/science.aad9289; COSTANZO LL, 1983, J PHOTOCHEM, V21, P45, DOI 10.1016/0047-2670(83)80006-9; Frisch M. J., 2016, GAUSSIAN 16 REV B 01; GILBERT BC, 1988, J CHEM SOC FARAD T 1, V84, P3319, DOI 10.1039/f19888403319; Gorelsky SI., 2017, AOMIX PROGRAM MOL OR; Gunsalus NJ, 2017, CHEM REV, V117, P8521, DOI 10.1021/acs.chemrev.6b00739; Guo JJ, 2018, TETRAHEDRON LETT, V59, P2103, DOI 10.1016/j.tetlet.2018.04.060; Guo JJ, 2016, ANGEW CHEM INT EDIT, V55, P15319, DOI 10.1002/anie.201609035; Hammerum S, 2009, J AM CHEM SOC, V131, P8627, DOI 10.1021/ja901854t; Hu AH, 2018, J AM CHEM SOC, V140, P13580, DOI 10.1021/jacs.8b08781; Hu AH, 2018, SCIENCE, V361, P668, DOI 10.1126/science.aat9750; Hu AH, 2018, J AM CHEM SOC, V140, P1612, DOI 10.1021/jacs.7b13131; Huang HM, 2019, CHEM SOC REV, V48, P4626, DOI 10.1039/c8cs00947c; Institute for Theoretical Chemistry University of Cologne, 2014, EN CONS PSEUD STUTTG; Jodkowski JT, 1998, J PHYS CHEM A, V102, P9230, DOI 10.1021/jp980846d; LANNUNG A, 1960, ACTA CHEM SCAND, V14, P1124, DOI 10.3891/acta.chem.scand.14-1124; Laudadio G, 2020, SCIENCE, V369, P92, DOI 10.1126/science.abb4688; Liebov NS, 2019, CHEMCATCHEM, V11, P5045, DOI 10.1002/cctc.201901175; Meng XG, 2019, CHEM-US, V5, P2296, DOI 10.1016/j.chempr.2019.05.008; Mereshchenko AS, 2016, J PHYS CHEM A, V120, P1833, DOI 10.1021/acs.jpca.5b12509; Mereshchenko AS, 2012, J PHYS CHEM A, V116, P2791, DOI 10.1021/jp208532u; O'Reilly ME, 2017, ACS CENTRAL SCI, V3, P1174, DOI 10.1021/acscentsci.7b00342; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; Qiao YS, 2018, ACCOUNTS CHEM RES, V51, P2926, DOI 10.1021/acs.accounts.8b00336; Qiao YS, 2018, ANGEW CHEM INT EDIT, V57, P10999, DOI 10.1002/anie.201804022; Quant M, 2005, THESIS CALIFORNIA ST; RABJOHN N, 1955, J AM CHEM SOC, V77, P2907, DOI 10.1021/ja01615a081; Ravi M, 2017, ANGEW CHEM INT EDIT, V56, P16464, DOI 10.1002/anie.201702550; Rohe S, 2018, ANGEW CHEM INT EDIT, V57, P15664, DOI 10.1002/anie.201810187; RUSSELL GA, 1957, J AM CHEM SOC, V79, P2977, DOI 10.1021/ja01568a085; RUSSELL GA, 1958, J AM CHEM SOC, V80, P4987, DOI 10.1021/ja01551a056; Schwach P, 2017, CHEM REV, V117, P8497, DOI 10.1021/acs.chemrev.6b00715; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith KT, 2016, SCIENCE, V351, P1424, DOI 10.1126/science.aad9730; Troian-Gautier L, 2019, CHEM REV, V119, P4628, DOI 10.1021/acs.chemrev.8b00732; Tsao ML, 2003, J AM CHEM SOC, V125, P8390, DOI 10.1021/ja035095u; Wang L, 2010, J ATMOS CHEM, V65, P73, DOI 10.1007/s10874-011-9182-5; Wenger OS, 2018, J AM CHEM SOC, V140, P13522, DOI 10.1021/jacs.8b08822; Yin HL, 2016, J AM CHEM SOC, V138, P16266, DOI 10.1021/jacs.6b05712; Zhang KN, 2019, J AM CHEM SOC, V141, P10556, DOI 10.1021/jacs.9b05932	50	67	66	60	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					847	+		10.1126/science.abd8408	http://dx.doi.org/10.1126/science.abd8408			138	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016778				2022-12-28	WOS:000653997000044
J	Mahase, E				Mahase, Elisabeth			Gaza: Israeli airstrikes kill doctors and damage healthcare facilities	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ang S, 2021, BMJ-BRIT MED J; [Anonymous], 2021, PAL EM SIT UPD; [Anonymous], 2021, NY TIMES        0517; [Anonymous], 2021, MED SANS FRONTI 0517; [Anonymous], 2021, UN NEWS; [Anonymous], 2021, MIDDLE E EYE    0517; [Anonymous], 2020, REUTERS 0518	7	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2021	373								n1300	10.1136/bmj.n1300	http://dx.doi.org/10.1136/bmj.n1300			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5TH	34016591				2022-12-28	WOS:000655596600006
J	Lin, JS; Perdue, LA; Henrikson, NB; Bean, SI; Blasi, PR				Lin, Jennifer S.; Perdue, Leslie A.; Henrikson, Nora B.; Bean, Sarah I.; Blasi, Paula R.			Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; RISK PREDICTION MODELS; COMPUTED TOMOGRAPHIC COLONOGRAPHY; ONCE-ONLY SIGMOIDOSCOPY; BASE-LINE FINDINGS; CT COLONOGRAPHY; IMMUNOCHEMICAL TEST; FLEXIBLE SIGMOIDOSCOPY; EXTRACOLONIC FINDINGS	ImportanceColorectal cancer (CRC) remains a significant cause of morbidity and mortality in the US. ObjectiveTo systematically review the effectiveness, test accuracy, and harms of screening for CRC to inform the US Preventive Services Task Force. Data SourcesMEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials for relevant studies published from January 1, 2015, to December 4, 2019; surveillance through March 26, 2021. Study SelectionEnglish-language studies conducted in asymptomatic populations at general risk of CRC. Data Extraction and SynthesisTwo reviewers independently appraised the articles and extracted relevant study data from fair- or good-quality studies. Random-effects meta-analyses were conducted. Main Outcomes and MeasuresColorectal cancer incidence and mortality, test accuracy in detecting cancers or adenomas, and serious adverse events. ResultsThe review included 33 studies (n=10776276) on the effectiveness of screening, 59 (n=3491045) on the test performance of screening tests, and 131 (n=26987366) on the harms of screening. In randomized clinical trials (4 trials, n=458002), intention to screen with 1- or 2-time flexible sigmoidoscopy vs no screening was associated with a decrease in CRC-specific mortality (incidence rate ratio, 0.74 [95% CI, 0.68-0.80]). Annual or biennial guaiac fecal occult blood test (gFOBT) vs no screening (5 trials, n=419966) was associated with a reduction of CRC-specific mortality after 2 to 9 rounds of screening (relative risk at 19.5 years, 0.91 [95% CI, 0.84-0.98]; relative risk at 30 years, 0.78 [95% CI, 0.65-0.93]). In observational studies, receipt of screening colonoscopy (2 studies, n=436927) or fecal immunochemical test (FIT) (1 study, n=5.4 million) vs no screening was associated with lower risk of CRC incidence or mortality. Nine studies (n=6497) evaluated the test accuracy of screening computed tomography (CT) colonography, 4 of which also reported the test accuracy of colonoscopy; pooled sensitivity to detect adenomas 6 mm or larger was similar between CT colonography with bowel prep (0.86) and colonoscopy (0.89). In pooled values, commonly evaluated FITs (14 studies, n=45403) (sensitivity, 0.74; specificity, 0.94) and stool DNA with FIT (4 studies, n=12424) (sensitivity, 0.93; specificity, 0.85) performed better than high-sensitivity gFOBT (2 studies, n=3503) (sensitivity, 0.50-0.75; specificity, 0.96-0.98) to detect cancers. Serious harms of screening colonoscopy included perforations (3.1/10000 procedures) and major bleeding (14.6/10000 procedures). CT colonography may have harms resulting from low-dose ionizing radiation. It is unclear if detection of extracolonic findings on CT colonography is a net benefit or harm. Conclusions and RelevanceThere are several options to screen for colorectal cancer, each with a different level of evidence demonstrating its ability to reduce cancer mortality, its ability to detect cancer or precursor lesions, and its risk of harms. This systematic review to support the 2021 US Preventive Services Task Force Recommendation Statement on screening for colorectal cancer summarizes published evidence on the benefits and harms of screening for colorectal cancer in asymptomatic, community-dwelling adults.	[Lin, Jennifer S.; Perdue, Leslie A.; Henrikson, Nora B.; Bean, Sarah I.; Blasi, Paula R.] Kaiser Permanente, Ctr Hlth Res, Permanente Evidence Based Practice Ctr, Portland, OR USA	Kaiser Permanente	Lin, JS (corresponding author), Kaiser Permanente Northwest, Ctr Hlth Res, Kaiser Permanente Evidence Based Practice Ctr, 3800 N Interstate Ave, Portland, OR 97227 USA.	jennifer.s.lin@kpchr.org			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2015-00007-I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2015-00007-I, Task Order 6, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the US Preventive Services Task Force (USPSTF).	Adeyemo A, 2014, DIS COLON RECTUM, V57, P110, DOI 10.1097/DCR.0000000000000002; Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; An S, 2008, AM J ROENTGENOL, V191, pW100, DOI 10.2214/AJR.07.3367; [Anonymous], 2018, PROCEDURE MANUAL; [Anonymous], 2014, SUMMARY SAFETY EFFEC; Ansari M., 2014, METHODS GUIDE EFFECT, V10, P314; Arana-Arri E, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3555-3; Arora G, 2009, GASTROINTEST ENDOSC, V69, P654, DOI 10.1016/j.gie.2008.09.008; Atkin W, 2017, LANCET, V389, P1299, DOI 10.1016/S0140-6736(17)30396-3; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Bair D, 2009, CAN J GASTROENTEROL, V23, P41, DOI 10.1155/2009/831029; Basson MD, 2018, JAMA SURG, V153, P90, DOI 10.1001/jamasurg.2017.3790; Berhane C, 2009, AM SURGEON, V75, P699; Berry DP, 1997, BRIT J SURG, V84, P1274; Bielawska B, 2018, GASTROENTEROLOGY, V154, P77, DOI 10.1053/j.gastro.2017.08.043; Bielawska B, 2014, CLIN GASTROENTEROL H, V12, P85, DOI 10.1016/j.cgh.2013.06.030; Binefa G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19532; Blotiere PO, 2014, CLIN RES HEPATOL GAS, V38, P112, DOI 10.1016/j.clinre.2013.10.005; Bokemeyer B, 2009, EUR J GASTROEN HEPAT, V21, P650, DOI 10.1097/MEG.0b013e32830b8acf; Bosch LJW, 2019, AM J GASTROENTEROL, V114, P1909, DOI 10.14309/ajg.0000000000000445; Brenner H, 2018, CLIN EPIDEMIOL, V10, P381, DOI 10.2147/CLEP.S155548; Brenner H, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.37; Brenner H, 2017, CLIN EPIDEMIOL, V9, P377, DOI 10.2147/CLEP.S136565; Brenner H, 2017, INT J CANCER, V140, P2015, DOI 10.1002/ijc.30629; Brenner H, 2013, EUR J CANCER, V49, P3049, DOI 10.1016/j.ejca.2013.04.023; Brenner H, 2010, AM J GASTROENTEROL, V105, P2457, DOI 10.1038/ajg.2010.301; Brenner H, 2010, INT J CANCER, V127, P1643, DOI 10.1002/ijc.25154; Bretthauer M, 2016, JAMA INTERN MED, V176, P894, DOI 10.1001/jamainternmed.2016.0960; Brevinge H, 1997, INT J COLORECTAL DIS, V12, P291, DOI 10.1007/s003840050108; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Cash BD, 2012, AM J ROENTGENOL, V199, pW27, DOI 10.2214/AJR.11.7729; Castells A, 2015, DIGEST DIS SCI, V60, P672, DOI 10.1007/s10620-014-3446-2; Castiglione G, 2007, BRIT J CANCER, V96, P1750, DOI 10.1038/sj.bjc.6603759; Castro G, 2013, CANCER-AM CANCER SOC, V119, P2849, DOI 10.1002/cncr.28159; Chang LC, 2017, CLIN GASTROENTEROL H, V15, P872, DOI 10.1016/j.cgh.2016.07.029; Chen CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004414; Chen HD, 2017, CLIN GASTROENTEROL H, V15, P1547, DOI 10.1016/j.cgh.2016.10.018; Chen LS, 2011, LANCET ONCOL, V12, P551, DOI 10.1016/S1470-2045(11)70101-2; Chen SLS, 2018, CANCER EPIDEM BIOMAR, V27, P704, DOI 10.1158/1055-9965.EPI-17-0387; Chen YY, 2014, ADV DIG MED, V1, P74, DOI 10.1016/j.aidm.2013.09.003; Cheng TI, 2002, J FORMOS MED ASSOC, V101, P685; Chiang TH, 2014, GASTROENTEROLOGY, V147, P1317, DOI 10.1053/j.gastro.2014.08.043; Chin M, 2005, AM J GASTROENTEROL, V100, P2771, DOI 10.1111/j.1572-0241.2005.00337.x; Chiu HM, 2016, GASTROENTEROLOGY, V150, P617, DOI 10.1053/j.gastro.2015.11.042; Chiu HM, 2015, CANCER-AM CANCER SOC, V121, P3221, DOI 10.1002/cncr.29462; Chiu HM, 2013, CLIN GASTROENTEROL H, V11, P832, DOI 10.1016/j.cgh.2013.01.013; Chukmaitov A, 2019, INT J COLORECTAL DIS, V34, P1203, DOI 10.1007/s00384-019-03304-3; Chukmaitov A, 2016, DIS COLON RECTUM, V59, P677, DOI 10.1097/DCR.0000000000000603; Chukmaitov A, 2013, GASTROINTEST ENDOSC, V77, P436, DOI 10.1016/j.gie.2012.11.012; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Cooper GS, 2018, CANCER-AM CANCER SOC, V124, P3876, DOI 10.1002/cncr.31660; Cooper GS, 2013, JAMA INTERN MED, V173, P551, DOI 10.1001/jamainternmed.2013.2908; Cotterill M, 2005, CAN FAM PHYSICIAN, V51, P1224; Crispin A, 2009, ENDOSCOPY, V41, P1018, DOI 10.1055/s-0029-1215214; Dancourt V, 2008, EUR J CANCER, V44, P2254, DOI 10.1016/j.ejca.2008.06.041; de Wijkerslooth TR, 2012, AM J GASTROENTEROL, V107, P1570, DOI 10.1038/ajg.2012.249; Deng L, 2017, METABOLITES, V7, DOI 10.3390/metabo7030032; Denters MJ, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-28; Derbyshire E, 2018, ENDOSCOPY, V50, P861, DOI 10.1055/a-0584-7138; Derbyshire E, 2017, ENDOSCOPY, V49, P899, DOI 10.1055/s-0043-113442; Dominitz JA, 2013, GASTROENTEROLOGY, V144, P298, DOI 10.1053/j.gastro.2012.10.038; Doroudi M, 2017, CANCER-AM CANCER SOC, V123, P4815, DOI 10.1002/cncr.31034; Dube C, 2019, LANCET GASTROENTEROL, V4, P577, DOI 10.1016/S2468-1253(19)30191-8; Durbin JM, 2012, CLIN NEPHROL, V77, P204, DOI 10.5414/CN107242; Edwards JT, 2004, RADIOLOGY, V230, P459, DOI 10.1148/radiol.2302021422; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Faivre J, 2012, EUR J CANCER, V48, P2969, DOI 10.1016/j.ejca.2012.04.007; Faivre J, 2012, DIGEST LIVER DIS, V44, P700, DOI 10.1016/j.dld.2012.03.015; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; Fletcher JG, 2013, AM J ROENTGENOL, V201, P787, DOI 10.2214/AJR.12.9225; Flicker MS, 2008, J COMPUT ASSIST TOMO, V32, P497, DOI 10.1097/RCT.0b013e3181692091; Forbes GM, 2006, MED J AUSTRALIA, V184, P546, DOI 10.5694/j.1326-5377.2006.tb00377.x; Forsberg A, 2017, SCAND J GASTROENTERO, V52, P1042, DOI 10.1080/00365521.2017.1334812; Garcia M, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/672410; Garcia-Albeniz X, 2017, ANN INTERN MED, V166, P18, DOI 10.7326/M16-0758; Gies A, 2019, CANCERS, V11, DOI 10.3390/cancers11010120; Gies A, 2018, UNITED EUR GASTROENT, V6, P1223, DOI 10.1177/2050640618784053; Gies A, 2018, GASTROENTEROLOGY, V154, P93, DOI 10.1053/j.gastro.2017.09.018; Gluecker TM, 2003, GASTROENTEROLOGY, V124, P911, DOI 10.1053/gast.2003.50158; Gondal G, 2003, SCAND J GASTROENTERO, V38, P635, DOI 10.1080/00365520310003002; Graser A, 2009, GUT, V58, P241, DOI 10.1136/gut.2008.156448; Grazzini G, 2004, EUR J CANCER PREV, V13, P19, DOI 10.1097/00008469-200402000-00004; Grobbee EJ, 2017, GUT, V66, P1975, DOI 10.1136/gutjnl-2016-311819; Grobbee EJ, 2020, CLIN GASTROENTEROL H, V18, P667, DOI 10.1016/j.cgh.2019.08.015; Grobbee EJ, 2017, UNITED EUR GASTROENT, V5, P448, DOI 10.1177/2050640616659998; Grossberg LB, 2020, DIGEST DIS SCI, V65, P1964, DOI 10.1007/s10620-019-05962-3; Grossberg LB, 2018, GASTROINTEST ENDOSC, V87, P517, DOI 10.1016/j.gie.2017.08.019; Hamdani U, 2013, WORLD J GASTROENTERO, V19, P3596, DOI 10.3748/wjg.v19.i23.3596; Hara AK, 2000, RADIOLOGY, V215, P353, DOI 10.1148/radiology.215.2.r00ap33353; Haug U, 2011, BRIT J CANCER, V104, P1779, DOI 10.1038/bjc.2011.160; Haug U, 2017, GUT, V66, P1262, DOI 10.1136/gutjnl-2015-310102; Hernandez V, 2014, WORLD J GASTROENTERO, V20, P1038, DOI 10.3748/wjg.v20.i4.1038; Ho JM, 2012, CAN J GASTROENTEROL, V26, P436, DOI 10.1155/2012/238387; Hoff G, 1996, SCAND J GASTROENTERO, V31, P1006, DOI 10.3109/00365529609003121; Hoff G, 2001, EUR J CANCER PREV, V10, P131, DOI 10.1097/00008469-200104000-00003; Hoff G, 2017, ENDOSCOPY, V49, P745, DOI 10.1055/s-0043-105265; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Holme O, 2018, ANN INTERN MED, V168, P775, DOI 10.7326/M17-1441; Holme O, 2015, GUT, V64, P929, DOI 10.1136/gutjnl-2014-307793; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Hsieh Teng-Kuei, 2009, Acta Anaesthesiol Taiwan, V47, P162, DOI 10.1016/S1875-4597(09)60049-7; Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005; Iafrate F, 2013, DIGEST LIVER DIS, V45, P645, DOI 10.1016/j.dld.2013.02.020; Ibanez J, 2018, GASTROENT HEPAT-BARC, V41, P553, DOI 10.1016/j.gastrohep.2018.06.007; Imperiale TF, 2021, CANCER PREV RES, V14, P489, DOI 10.1158/1940-6207.CAPR-20-0294; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Itoh M, 1996, J Med Screen, V3, P66; Jain Ankur, 2002, Hawaii Med J, V61, P118; Jodal HC, 2018, GASTROENTEROLOGY, V155, P1787, DOI 10.1053/j.gastro.2018.08.035; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Johnson CD, 2007, AM J ROENTGENOL, V189, P672, DOI 10.2214/AJR.07.2354; Johnson CD, 2012, RADIOLOGY, V263, P401, DOI 10.1148/radiol.12102177; Johnson DA, 2017, CLIN GASTROENTEROL H, V15, P883, DOI 10.1016/j.cgh.2016.12.015; Jung YS, 2017, J GASTROEN HEPATOL, V32, P1003, DOI 10.1111/jgh.13634; Juul JS, 2018, SCAND J PRIM HEALTH, V36, P281, DOI 10.1080/02813432.2018.1487378; Kamath AS, 2009, J GASTROINTEST SURG, V13, P2136, DOI 10.1007/s11605-009-1064-7; Kang HY, 2008, DIGESTION, V78, P218, DOI 10.1159/000190811; Kapidzic A, 2017, GUT, V66, P118, DOI 10.1136/gutjnl-2014-308957; KEWENTER J, 1994, SCAND J GASTROENTERO, V29, P468, DOI 10.3109/00365529409096840; Kewenter J, 1996, DIS COLON RECTUM, V39, P676, DOI 10.1007/BF02056949; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Kim DH, 2010, RADIOLOGY, V254, P493, DOI 10.1148/radiol.09091478; Kim JS, 2013, SURG ENDOSC, V27, P501, DOI 10.1007/s00464-012-2465-3; Kim NH, 2017, DIGEST LIVER DIS, V49, P557, DOI 10.1016/j.dld.2016.12.020; Kim YS, 2008, J CLIN GASTROENTEROL, V42, P791, DOI 10.1097/MCG.0b013e31811edcb7; Kim YS, 2008, J GASTROEN HEPATOL, V23, pE49, DOI 10.1111/j.1440-1746.2007.05060.x; Knudsen AB, 2021, AHRQ PUBLICATION, V20-05271-EF-2; Knudsen AB, 2021, JAMA-J AM MED ASSOC, V325, P1998, DOI 10.1001/jama.2021.5746; Ko CW, 2007, GASTROINTEST ENDOSC, V65, P648, DOI 10.1016/j.gie.2006.06.020; Ko CW, 2010, CLIN GASTROENTEROL H, V8, P166, DOI 10.1016/j.cgh.2009.10.007; Kobiela J, 2020, CLIN GASTROENTEROL H, V18, P1501, DOI 10.1016/j.cgh.2019.09.010; Korman LY, 2003, GASTROINTEST ENDOSC, V58, P554, DOI 10.1067/S0016-5107(03)01890-X; Koskenvuo L, 2019, BRIT J SURG, V106, P436, DOI 10.1002/bjs.11011; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Kubisch CH, 2016, CLIN GASTROENTEROL H, V14, P1612, DOI 10.1016/j.cgh.2016.04.008; Laanani M, 2019, CLIN GASTROENTEROL H, V17, P719, DOI 10.1016/j.cgh.2018.08.005; Laiyemo AO, 2015, J GEN INTERN MED, V30, P1447, DOI 10.1007/s11606-015-3297-3; Larson ME, 2019, ABDOM RADIOL, V44, P31, DOI 10.1007/s00261-018-1708-8; Launoy GD, 2005, INT J CANCER, V115, P493, DOI 10.1002/ijc.20921; Layton JB, 2014, CLIN GASTROENTEROL H, V12, P1514, DOI 10.1016/j.cgh.2014.01.034; Lee YH, 2015, CLIN CHEM LAB MED, V53, pE69, DOI 10.1515/cclm-2014-0442; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Lefere P, 2013, EUR J RADIOL, V82, pE262, DOI 10.1016/j.ejrad.2013.02.010; Levi Z, 2011, INT J CANCER, V128, P2415, DOI 10.1002/ijc.25574; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Levin TR, 2002, GASTROENTEROLOGY, V123, P1786, DOI 10.1053/gast.2002.37064; Levy BT, 2014, J MED SCREEN, V21, P133, DOI 10.1177/0969141314541109; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Liles EG., 2017, CANC TREAT RES COMM, V10, P27, DOI DOI 10.1016/J.CTARC.2016.12.004; Liles EG, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4402-x; Lin JS, 2016, JAMA-J AM MED ASSOC, V315, P2576, DOI 10.1001/jama.2016.3332; Lin JS., 2016, AHRQ PUBLICATION, V14-05203-EF-1; Lin JS, 2021, SCREENING COLORECTAL; Lin JS., 2021, AHRQ PUBLICATION, V20-05271-EF-1; Lindholm E, 2008, BRIT J SURG, V95, P1029, DOI 10.1002/bjs.6136; Loffeld RJLF, 2011, ENDOSCOPY, V43, P240, DOI 10.1055/s-0030-1255939; Lord SJ, 2006, ANN INTERN MED, V144, P850, DOI 10.7326/0003-4819-144-11-200606060-00011; Lorenzo-Zuniga V, 2010, COLORECTAL DIS, V12, pE273, DOI 10.1111/j.1463-1318.2009.02146.x; Macari M, 2004, RADIOLOGY, V230, P629, DOI 10.1148/radiol.2303021624; Macari M, 2011, RADIOLOGY, V259, P767, DOI 10.1148/radiol.11102144; Malila N, 2011, J MED SCREEN, V18, P18, DOI 10.1258/jms.2010.010036; Malila N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2261; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mansmann U, 2008, DTSCH ARZTEBL INT, V105, P434, DOI 10.3238/arztebl.2008.0434; Mikkelsen EM, 2018, CLIN EPIDEMIOL, V10, P1649, DOI 10.2147/CLEP.S181204; Miles A, 2003, CANCER EPIDEM BIOMAR, V12, P651; Miller EA, 2019, LANCET GASTROENTEROL, V4, P101, DOI 10.1016/S2468-1253(18)30358-3; Mlakar DN, 2018, RADIOL ONCOL, V52, P413, DOI 10.2478/raon-2018-0025; Moreno CC, 2018, CLIN COLORECTAL CANC, V17, pE363, DOI 10.1016/j.clcc.2018.02.007; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Morikawa T, 2007, AM J GASTROENTEROL, V102, P2259, DOI 10.1111/j.1572-0241.2007.01404.x; Nakama H, 1996, J Med Screen, V3, P63; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P228; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Ng SC, 2013, ALIMENT PHARM THER, V38, P835, DOI 10.1111/apt.12446; Niedermaier T, 2018, EPIDEMIOLOGY, V29, P397, DOI 10.1097/EDE.0000000000000795; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; O'Connor SD, 2011, AM J ROENTGENOL, V197, P139, DOI 10.2214/AJR.10.5920; Parente F, 2013, ENDOSCOPY, V45, P27, DOI 10.1055/s-0032-1325800; Park DI, 2010, AM J GASTROENTEROL, V105, P2017, DOI 10.1038/ajg.2010.179; Parra-Blanco A, 2006, WORLD J GASTROENTERO, V12, P6161, DOI 10.3748/wjg.v12.i38.6161; Passamonti B, 2018, GUT, V67, P485, DOI 10.1136/gutjnl-2016-312716; Pedersen BG, 2003, GUT, V52, P1744; Peng ZY, 2018, CELL MOL BIOL, V64, P77, DOI 10.14715/cmb/2018.64.6.14; Penz D, 2020, GASTROINTEST ENDOSC, V91, P135, DOI 10.1016/j.gie.2019.08.038; Pickhardt PJ, 2008, RADIOLOGY, V249, P151, DOI 10.1148/radiol.2491072148; Pickhardt PJ, 2007, DIS COLON RECTUM, V50, P56, DOI 10.1007/s10350-006-0806-9; Pickhardt PJ, 2011, AM J ROENTGENOL, V196, pW400, DOI 10.2214/AJR.10.5392; Pickhardt PJ, 2010, ACAD RADIOL, V17, P784, DOI 10.1016/j.acra.2010.01.010; Pickhardt PJ, 2010, RADIOLOGY, V255, P83, DOI 10.1148/radiol.09090939; Pickhardt PJ, 2006, RADIOLOGY, V239, P313, DOI 10.1148/radiol.2392052002; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Pinsky PF, 2019, J MED SCREEN, V26, P127, DOI 10.1177/0969141319839097; Pitkaniemi J, 2015, BMJ OPEN GASTROENTER, V2, DOI 10.1136/bmjgast-2015-000034; Polter Daniel E, 2015, Proc (Bayl Univ Med Cent), V28, P3; Pooler BD, 2016, AM J ROENTGENOL, V207, P996, DOI 10.2214/AJR.16.16275; Pooler BD, 2016, AM J ROENTGENOL, V206, P313, DOI 10.2214/AJR.15.15193; Potter NT, 2014, CLIN CHEM, V60, P1183, DOI 10.1373/clinchem.2013.221044; Pox CP, 2012, GASTROENTEROLOGY, V142, P1460, DOI 10.1053/j.gastro.2012.03.022; Quallick MR, 2009, GASTROINTEST ENDOSC, V69, P960, DOI 10.1016/j.gie.2008.11.011; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Randel KR, 2021, GASTROENTEROLOGY, V160, P1085, DOI 10.1053/j.gastro.2020.11.037; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rasmussen M, 1999, SCAND J GASTROENTERO, V34, P73; Rathgaber SW, 2006, GASTROINTEST ENDOSC, V64, P556, DOI 10.1016/j.gie.2006.03.014; Redwood DG, 2016, MAYO CLIN PROC, V91, P61, DOI 10.1016/j.mayocp.2015.10.008; Regge D, 2017, GUT, V66, P1434, DOI 10.1136/gutjnl-2015-311278; Regula J, 2008, NEW ENGL J MED, V358, P88; Rex DK, 2015, GASTROENTEROLOGY, V148, P948, DOI 10.1053/j.gastro.2015.01.025; Rim JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03134-9; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Rutter CM, 2012, CANCER CAUSE CONTROL, V23, P289, DOI 10.1007/s10552-011-9878-5; Sagawa T, 2012, WORLD J GASTROENTERO, V18, P4898, DOI 10.3748/wjg.v18.i35.4898; Sali L, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv319; Santare D, 2016, EUR J GASTROEN HEPAT, V28, P904, DOI 10.1097/MEG.0000000000000650; Saraste D, 2016, J MED SCREEN, V23, P135, DOI 10.1177/0969141315625701; Schoen RE, 2015, GASTROENTEROLOGY, V149, P1438, DOI 10.1053/j.gastro.2015.07.055; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Scholefield JH, 2012, GUT, V61, P1036, DOI 10.1136/gutjnl-2011-300774; Schreuders EH, 2019, LANCET GASTROENTEROL, V4, P622, DOI 10.1016/S2468-1253(19)30176-1; Segnan N, 2002, J NATL CANCER I, V94, P1763; Segnan N, 2005, JNCI-J NATL CANCER I, V97, P347, DOI 10.1093/jnci/dji050; Segnan N, 2007, GASTROENTEROLOGY, V132, P2304, DOI 10.1053/j.gastro.2007.03.030; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Selby K, 2018, ANN INTERN MED, V169, P439, DOI 10.7326/M18-0244; Senore C, 2018, RADIOLOGY, V286, P885, DOI 10.1148/radiol.2017170228; Senore C, 2011, J MED SCREEN, V18, P128, DOI 10.1258/jms.2011.010135; Shapiro JA, 2017, AM J GASTROENTEROL, V112, P1728, DOI 10.1038/ajg.2017.285; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Sieg A, 2001, GASTROINTEST ENDOSC, V53, P620, DOI 10.1067/mge.2001.114422; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Siegel RL, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw322; Singh H, 2009, GASTROINTEST ENDOSC, V69, P665, DOI 10.1016/j.gie.2008.09.046; Smith T, 2019, GUT, V68, P672, DOI 10.1136/gutjnl-2017-315730; Sohn Dae Kyung, 2005, Cancer Res Treat, V37, P20, DOI 10.4143/crt.2005.37.1.20; Sosna J, 2006, RADIOLOGY, V239, P457, DOI 10.1148/radiol.2392050287; Steele RJC, 2020, J MED SCREEN, V27, P59, DOI 10.1177/0969141319879955; Stegeman I, 2015, CANCER EPIDEMIOL, V39, P388, DOI 10.1016/j.canep.2015.03.012; Stock C, 2013, GASTROINTEST ENDOSC, V77, P419, DOI 10.1016/j.gie.2012.10.028; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Strul H, 2006, AM J GASTROENTEROL, V101, P255, DOI 10.1111/j.1572-0241.2006.00430.x; Suissa A, 2012, Diagn Ther Endosc, V2012, P612542, DOI 10.1155/2012/612542; Tam Michael S, 2013, Perm J, V17, P17, DOI 10.7812/TPP/12-095; Taya M, 2019, ABDOM RADIOL, V44, P429, DOI 10.1007/s00261-018-1753-3; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; THOMAS W, 1995, AM J EPIDEMIOL, V142, P176, DOI 10.1093/oxfordjournals.aje.a117616; Thulin T, 2019, UNITED EUR GASTROENT, V7, P130, DOI 10.1177/2050640618809782; Toes-Zoutendijk E, 2020, CLIN GASTROENTEROL H, V18, P1493, DOI 10.1016/j.cgh.2019.08.021; Usher-Smith JA, 2018, BRIT J CANCER, V118, P750, DOI 10.1038/bjc.2017.463; Usher-Smith JA, 2016, CANCER PREV RES, V9, P13, DOI 10.1158/1940-6207.CAPR-15-0274; van der Vlugt M, 2017, GASTROENTEROLOGY, V153, P439, DOI 10.1053/j.gastro.2017.05.004; van Roon AHC, 2013, GUT, V62, P409, DOI 10.1136/gutjnl-2011-301583; van Roon AHC, 2011, CLIN GASTROENTEROL H, V9, P333, DOI 10.1016/j.cgh.2010.12.012; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Veerappan GR, 2010, AM J ROENTGENOL, V195, P677, DOI 10.2214/AJR.09.3779; Verne JECW, 1998, BRIT MED J, V317, P182, DOI 10.1136/bmj.317.7152.182; Viiala CH, 2007, MED J AUSTRALIA, V187, P274, DOI 10.5694/j.1326-5377.2007.tb01241.x; Voska M, 2019, GASTROENT RES PRACT, V2019, DOI 10.1155/2019/5975438; Wallace MB, 1999, AM J MED, V107, P214, DOI 10.1016/S0002-9343(99)00225-9; Wang HL, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.2; Wang L, 2018, GASTROENTEROLOGY, V154, P540, DOI 10.1053/j.gastro.2017.10.006; Wang PQ, 2018, GUT, V67, P1626, DOI 10.1136/gutjnl-2017-315308; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Weissfeld JL, 2005, JNCI-J NATL CANCER I, V97, P989, DOI 10.1093/jnci/dji175; White A, 2017, MMWR-MORBID MORTAL W, V66, P1, DOI 10.15585/mmwr.mm6608a1; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Wilen HR, 2019, SCAND J GASTROENTERO, V54, P303, DOI 10.1080/00365521.2019.1585569; Win AK, 2012, CANCER EPIDEM BIOMAR, V21, P398, DOI 10.1158/1055-9965.EPI-11-0771; Wong MCS, 2015, CLIN GASTROENTEROL H, V13, P1472, DOI 10.1016/j.cgh.2015.02.021; Xirasagar S, 2010, MED CARE, V48, P703, DOI 10.1097/MLR.0b013e3181e358a3; Zafar Hanna M, 2014, Prev Med Rep, V1, P3; Zalis ME, 2005, RADIOLOGY, V236, P3, DOI 10.1148/radiol.2361041926; Zalis ME, 2012, ANN INTERN MED, V156, P692, DOI 10.7326/0003-4819-156-10-201205150-00005; Zubero MB, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00175; Zwink N, 2017, DTSCH ARZTEBL INT, V114, P321, DOI 10.3238/arztebl.2017.0321	283	60	60	9	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1978	1997		10.1001/jama.2021.4417	http://dx.doi.org/10.1001/jama.2021.4417			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003220	Bronze			2022-12-28	WOS:000652675100012
J	Pearce, F				Pearce, Fred			WHEN THE LEVEES BREAK Researchers are learning where, when, and why rivers leap from their channels in deadly avulsions	SCIENCE			English	Editorial Material																			0	3	3	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					676	679		10.1126/science.372.6543.676	http://dx.doi.org/10.1126/science.372.6543.676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SD1KE	33986164				2022-12-28	WOS:000651125300024
J	Couturaud, F; Sanchez, O; Bertoletti, L				Couturaud, Francis; Sanchez, Olivier; Bertoletti, Laurent			Pulmonary Embolism Prevalence Among Hospitalized Patients With COPD Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Couturaud, Francis] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, Brest, France; [Sanchez, Olivier] Univ Paris, Hop Europeen Georges Pompidou, Paris, France; [Bertoletti, Laurent] Univ Jean Monnet, Ctr Hosp Univ St Etienne, St Etienne, France	CHU Brest; Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne	Couturaud, F (corresponding author), CHRU Brest, Dept Med Interne & Pneumol, Hop Cavale Blanche, F-29609 Brest, France.	francis.couturaud@chu-brest.fr		Couturaud, Francis/0000-0002-1855-8032; BERTOLETTI, Laurent/0000-0001-8214-3010				Bertoletti L, 2011, EUR RESPIR J, V37, P219, DOI 10.1183/09031936.00128410; Bertoletti L, 2021, EUR J INTERN MED, V84, P14, DOI 10.1016/j.ejim.2020.12.013; Couturaud F, 2021, JAMA-J AM MED ASSOC, V325, P59, DOI 10.1001/jama.2020.23567; Jimenez D, 2019, CLIN CARDIOL, V42, P346, DOI 10.1002/clc.23161; Perrier A, 2006, NEW ENGL J MED, V354, P2383, DOI 10.1056/NEJMe068076; van der Pol LM, 2019, NEW ENGL J MED, V380, P1139, DOI 10.1056/NEJMoa1813865	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1903	1903		10.1001/jama.2021.3247	http://dx.doi.org/10.1001/jama.2021.3247			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974023				2022-12-28	WOS:000650205000024
J	Franciosi, AN; McCarthy, C				Franciosi, Alessandro N.; McCarthy, Cormac			Pulmonary Embolism Prevalence Among Hospitalized Patients With COPD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							YIELD		[Franciosi, Alessandro N.] Univ British Columbia, Vancouver, BC, Canada; [McCarthy, Cormac] Univ Coll Dublin, Dublin, Ireland	University of British Columbia; University College Dublin	McCarthy, C (corresponding author), St Vincents Univ Hosp, UCD Sch Med, Educ & Res Ctr, Elm Pk, Dublin 4, Ireland.	cormac.mccarthy@ucd.ie		McCarthy, Cormac/0000-0003-2896-5210				Chong J, 2018, JAMA INTERN MED, V178, P412, DOI 10.1001/jamainternmed.2017.7552; Couturaud F, 2021, JAMA-J AM MED ASSOC, V325, P59, DOI 10.1001/jama.2020.23567; Wang RC, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.26930; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Yan ZH, 2017, RADIOLOGY, V282, P717, DOI 10.1148/radiol.2016151985	5	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1902	1903		10.1001/jama.2021.3244	http://dx.doi.org/10.1001/jama.2021.3244			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974025				2022-12-28	WOS:000650205000023
J	Sue, KL; Fiellin, DA				Sue, Kimberly L.; Fiellin, David A.			Bringing Harm Reduction into Health Policy - Combating the Overdose Crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Bringing Harm Reduction into Health Policy In the face of increasing drug-related morbidity and mortality, the Biden administration could signal a change in federal strategy by fully endorsing harm reduction as a valid, evidence-based policy to improve the health of people who use drugs.	[Sue, Kimberly L.; Fiellin, David A.] Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Sue, Kimberly L.; Fiellin, David A.] Yale Sch Med, Program Addict Med, New Haven, CT 06510 USA; [Fiellin, David A.] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Fiellin, David A.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Sue, Kimberly L.] Natl Harm Reduct Coalit, New York, NY 10016 USA	Yale University; Yale University; Yale University; Yale University	Sue, KL (corresponding author), Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Sue, KL (corresponding author), Yale Sch Med, Program Addict Med, New Haven, CT 06510 USA.; Sue, KL (corresponding author), Natl Harm Reduct Coalit, New York, NY 10016 USA.			Sue, Kimberly/0000-0002-5594-9198				[Anonymous], 2017, NAL OV PREV LAWS PRE; Bensinger P, 2016, HEROIN EPIDEMIC NOW; Dasgupta S, 2019, AIDS BEHAV, V23, P3257, DOI 10.1007/s10461-019-02600-x; National Harm Reduction Coalition, PRINC HARM RED	4	2	2	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					1781	1783		10.1056/NEJMp2103274	http://dx.doi.org/10.1056/NEJMp2103274		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD6UF	33983692				2022-12-28	WOS:000649041100001
J	Enserink, M				Enserink, Martin			SEA OF DOUBTS	SCIENCE			English	Editorial Material															Science Fund for Investigative Reporting	Science Fund for Investigative Reporting	This story was supported by the Science Fund for Investigative Reporting.		0	3	3	4	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					560	565		10.1126/science.372.6542.560	http://dx.doi.org/10.1126/science.372.6542.560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA2AW	33958459				2022-12-28	WOS:000649103500021
J	Katz, LA				Katz, Laura A.			Illuminating the first bacteria	SCIENCE			English	Editorial Material							TREE; ORIGIN		[Katz, Laura A.] Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA	Smith College	Katz, LA (corresponding author), Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA.			Katz, Laura/0000-0002-9138-4702	National Science Foundation [OCE-1924570, DEB-1651908, DEB-1541511]; National Institutes of Health [R15HG010409]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank A.Cote-L'Heureux and several other colleagues for thought-provoking conversations on this topic. L.A.K. is supported by grants from the National Science Foundation (OCE-1924570, DEB-1651908, and DEB-1541511) and National Institutes of Health (R15HG010409).	Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P7, DOI 10.1099/00207713-52-1-7; Coleman G.A., 2021, SCIENCE, V372; Collens AB, 2021, J HERED, V112, P140, DOI 10.1093/jhered/esaa060; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gribaldo S, 2009, RES MICROBIOL, V160, P513, DOI 10.1016/j.resmic.2009.07.006; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Javaux EJ, 2019, NATURE, V572, P451, DOI 10.1038/s41586-019-1436-4; Lake JA, 2009, PHILOS T R SOC B, V364, P2177, DOI 10.1098/rstb.2009.0035; Martin WF, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00817; Miyata M, 2020, GENES CELLS, V25, P6, DOI 10.1111/gtc.12737; Sousa FL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0088; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779	15	1	1	4	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					574	575		10.1126/science.abh2814	http://dx.doi.org/10.1126/science.abh2814			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA2AW	33958464				2022-12-28	WOS:000649103500026
J	Qaseem, A; Yost, J; Forciea, MA; Jokela, JA; Miller, MC; Obley, A; Humphrey, LL				Qaseem, Amir; Yost, Jennifer; Forciea, Mary Ann; Jokela, Janet A.; Miller, Matthew C.; Obley, Adam; Humphrey, Linda L.		Amer Coll Phys	The Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article								In response to the COVID-19 pandemic, the Scientific Medical Policy Committee (SMPC) of the American College of Physicians (ACP) began developing "practice points" to provide clinical advice based on the best available evidence for the public, patients, clinicians, and public health professionals. As one of the first organizations in the United States to develop evidence-based clinical guidelines, ACP continues to lead and advance the science of evidence-based medicine by implementing new methods to rapidly publish practice points and maintain them as living advice that regularly assesses and incorporates new evidence. The overarching aim of practice points is to answer targeted key questions for which there is a timely need to synthesize evidence for decision making. The SMPC believes these methods can potentially be adapted to address various clinical and public health topics beyond the COVID-19 pandemic. This article presents an overview of the SMPC's living, rapid practice points development process, which includes a rapid systematic review, use of the GRADE (Grading of Recommendations Assessment, Development and Evaluation) method, use of stringent policies on the disclosure of interests and management of conflicts of interest, incorporating a public (nonclinician) perspective, and maintenance of the documents as living through ongoing surveillance and synthesis of new evidence as it emerges.	[Qaseem, Amir] Coll Phys, Philadelphia, PA USA; [Yost, Jennifer] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Yost, Jennifer] Villanova Univ, Villanova, PA 19085 USA; [Forciea, Mary Ann; Miller, Matthew C.] Penn Med, Philadelphia, PA USA; [Jokela, Janet A.] Univ Illinois, Coll Med Urbana Champaign, Champaign, IL USA; [Obley, Adam] Portland VA Med Ctr, Portland, OR USA; [Humphrey, Linda L.] Portland VA Med Ctr, Portland, OR USA; [Humphrey, Linda L.] Oregon Hlth & Sci Univ, Portland, OR USA	American College of Physicians; Villanova University; University of Pennsylvania; Pennsylvania Medicine; University of Illinois System; University of Illinois Urbana-Champaign; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Qaseem, Amir/0000-0001-6866-7985; Miller, Matthew/0000-0001-7267-4897; Forciea, Mary Ann/0000-0002-1999-1145; Yost, Jennifer/0000-0002-3170-1956	ACP	ACP	Financial support for the development of this article comes exclusively from the ACP operating budget.	Akl EA, 2017, J CLIN EPIDEMIOL, V91, P47, DOI 10.1016/j.jclinepi.2017.08.009; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Kowalski SC, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0327-8; Qaseem A, 2019, ANN INTERN MED, V171, P354, DOI 10.7326/M18-3279; Qaseem A, 2019, ANN INTERN MED, V170, P863, DOI 10.7326/M18-3290; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Santesso N, 2020, J CLIN EPIDEMIOL, V119, P126, DOI 10.1016/j.jclinepi.2019.10.014; Schunemann H, GRADE HDB	8	9	9	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG	2021	174	8					1126	+		10.7326/M20-7641	http://dx.doi.org/10.7326/M20-7641			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP3IW	34029483	Green Published			2022-12-28	WOS:000695277800023
J	Marand, AP; Chen, ZL; Gallavotti, A; Schmitz, RJ				Marand, Alexandre P.; Chen, Zongliang; Gallavotti, Andrea; Schmitz, Robert J.			A cis-regulatory atlas in maize at single-cell resolution	CELL			English	Article							GENE-EXPRESSION; TRANSCRIPTION-FACTOR; ENHANCER EVOLUTION; BUNDLE-SHEATH; PLANT; GENOME; ACCESSIBILITY; PROTEINS; ARCHITECTURE; MESOPHYLL	cis-regulatory elements (CREs) encode the genomic blueprints of spatiotemporal gene expression programs enabling highly specialized cell functions. Using single-cell genomics in six maize organs, we determined the cis- and trans-regulatory factors defining diverse cell identities and coordinating chromatin organization by profiling transcription factor (TF) combinatorics, identifying TFs with non-cell-autonomous activity, and uncovering TFs underlying higher-order chromatin interactions. Cell-type-specific CREs were enriched for enhancer activity and within unmethylated long terminal repeat retrotransposons. Moreover, we found cell-type-specific CREs are hotspots for phenotype-associated genetic variants and were targeted by selection during modern maize breeding, highlighting the biological implications of this CRE atlas. Through comparison of maize and Arabidopsis thaliana developmental trajectories, we identified TFs and CREs with conserved and divergent chromatin dynamics, showcasing extensive evolution of gene regulatory networks. In addition to this rich dataset, we developed single-cell analysis software, Socrates, which can be used to understand cis-regulatory variation in any species.	[Marand, Alexandre P.; Schmitz, Robert J.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Chen, Zongliang; Gallavotti, Andrea] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Gallavotti, Andrea] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA	University System of Georgia; University of Georgia; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Marand, AP; Schmitz, RJ (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	marand@uga.edu; schmitz@uga.edu	Chen, Zongliang/AAS-7932-2021; Chen, Zongliang/AEM-2036-2022	Chen, Zongliang/0000-0003-1469-3699; Schmitz, Robert/0000-0001-7538-6663	NSF [IOS-1856627, IOS1802848, IOS-1916804]; UGA Office of Research; NSF postdoctoral fellowship in biology [DBI-1905869]; NSF collaborative awards [IOS-2026554, IOS-2026561]	NSF(National Science Foundation (NSF)); UGA Office of Research; NSF postdoctoral fellowship in biology; NSF collaborative awards(National Science Foundation (NSF))	We would like to acknowledge Dr. Zefu Lu, Dr. William Ricci, Tyler Earp, and Julie Nelson from the UGA flow cytometry core; Noah Workman and Julia Portocarrero from the GGBC; and the GACRC for providing valuable assistance. This study was funded with support from the NSF (IOS-1856627 and IOS1802848) and the UGA Office of Research to R.J.S., the NSF (IOS-1916804) to A.G., and an NSF postdoctoral fellowship in biology (DBI-1905869) to A.P.M. A.G. and R.J.S. are also supported by NSF collaborative awards to support this research (IOS-2026554 and IOS-2026561).	Alpert A, 2018, NAT METHODS, V15, P267, DOI [10.1038/NMETH.4628, 10.1038/nmeth.4628]; Andersson R, 2020, NAT REV GENET, V21, P71, DOI 10.1038/s41576-019-0173-8; Baker RF, 2016, PLANT PHYSIOL, V172, P1876, DOI 10.1104/pp.16.00884; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Cai YC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20940-y; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang YM, 2012, PLANT PHYSIOL, V160, P165, DOI 10.1104/pp.112.203810; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Chuck GS, 2014, P NATL ACAD SCI USA, V111, P18775, DOI 10.1073/pnas.1407401112; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Corces M.R., 2018, NETWORK, V362; Crisp PA, 2020, P NATL ACAD SCI USA, V117, P23991, DOI 10.1073/pnas.2010250117; Cusanovich DA, 2018, CELL, V174, P1309, DOI 10.1016/j.cell.2018.06.052; Deal RB, 2011, NAT PROTOC, V6, P56, DOI 10.1038/nprot.2010.175; Dong PF, 2017, MOL PLANT, V10, P1497, DOI 10.1016/j.molp.2017.11.005; Dorrity M.W., 2020, REGULATORY LANDSCAPE; Emms DM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1832-y; Fang R., 2020, 615179 BIORXIV, P615179; Farmer A., 2020, IMPACT CHROMATIN REM; Gage JL, 2018, GENETICS, V210, P1125, DOI 10.1534/genetics.118.301487; Galli M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06977-6; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Gate RE, 2018, NAT GENET, V50, P1140, DOI 10.1038/s41588-018-0156-2; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Granja J.M., 2020, ARCHR INTEGRATIVE SC; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Heger P, 2012, P NATL ACAD SCI USA, V109, P17507, DOI 10.1073/pnas.1111941109; Hekselman I, 2020, NAT REV GENET, V21, P137, DOI 10.1038/s41576-019-0200-9; Hofmeister BT, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2160-z; Hubley R., 2013, REPEATMASKER OPEN 40; Jiang HL, 2009, PLANT SIGNAL BEHAV, V4, P464, DOI [10.4161/psb.4.5.8543, 10.1104/pp.109.135269]; Jiang KN, 2010, PLANTA, V231, P411, DOI 10.1007/s00425-009-1059-3; Jiao YP, 2017, NATURE, V546, P524, DOI 10.1038/nature22971; Kajala K., 2020, INNOVATION CONSERVAT; Karaaslan ES, 2020, NAT PLANTS, V6, P1250, DOI 10.1038/s41477-020-00766-0; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; LANGDALE JA, 1989, DEV BIOL, V133, P128, DOI 10.1016/0012-1606(89)90304-7; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu C, 2017, NAT PLANTS, V3, P742, DOI 10.1038/s41477-017-0005-9; Liu C, 2016, GENOME RES, V26, P1057, DOI 10.1101/gr.204032.116; Liu L, 2021, NAT PLANTS, V7, P287, DOI 10.1038/s41477-021-00858-5; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marand AP, 2017, BBA-GENE REGUL MECH, V1860, P131, DOI 10.1016/j.bbagrm.2016.06.006; Miyashima S, 2019, NATURE, V565, P490, DOI 10.1038/s41586-018-0839-y; Morneau D, 2021, NAT REV METHOD PRIME, V1, DOI 10.1038/s43586-020-00008-9; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Nelms B, 2019, SCIENCE, V364, P52, DOI 10.1126/science.aav6428; Ngan CY, 2020, NAT GENET, V52, P264, DOI 10.1038/s41588-020-0581-x; Noshay J.M., 2020, CIS REGULATORY ELEME; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; Oka R., 2020, PLANTS DISTAL REGULA; Oka R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1273-4; Peng Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10602-5; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pliner HA, 2018, MOL CELL, V71, P858, DOI 10.1016/j.molcel.2018.06.044; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2009, R LANG ENV STAT COMP; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rebeiz M, 2017, CURR OPIN GENET DEV, V45, P115, DOI 10.1016/j.gde.2017.04.006; Ricci WA, 2019, NAT PLANTS, V5, P1237, DOI 10.1038/s41477-019-0547-0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Leal D, 2017, CELL, V171, P470, DOI 10.1016/j.cell.2017.08.030; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Savaldi-Goldstein S, 2007, NATURE, V446, P199, DOI 10.1038/nature05618; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Stitzer M.C., 2019, 559922 BIORXIV, P559922; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun YH, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02063-7; Tatematsu K, 2008, PLANT J, V53, P42, DOI 10.1111/j.1365-313X.2007.03308.x; ten Hove CA, 2008, CURR OPIN PLANT BIOL, V11, P34, DOI 10.1016/j.pbi.2007.11.001; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Verweij W, 2016, PLANT CELL, V28, P786, DOI 10.1105/tpc.15.00608; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Wallace JG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004845; Wallner ES, 2017, CURR BIOL, V27, P1241, DOI 10.1016/j.cub.2017.03.014; Wang BB, 2020, NAT GENET, V52, P565, DOI 10.1038/s41588-020-0616-3; Welch JD, 2019, CELL, V177, P1873, DOI 10.1016/j.cell.2019.05.006; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Xiao J, 2017, NAT GENET, V49, P1546, DOI 10.1038/ng.3937; Yamaguchi M, 2010, PLANT CELL, V22, P1249, DOI 10.1105/tpc.108.064048; You Y, 2019, PLANT CELL, V31, P325, DOI 10.1105/tpc.17.00714; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao HN, 2018, PLANT PHYSIOL, V176, P2789, DOI 10.1104/pp.17.01467; Zheng LL, 2015, J EXP BOT, V66, P3917, DOI 10.1093/jxb/erv192	92	62	62	29	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					3041	+		10.1016/j.cell.2021.04.014	http://dx.doi.org/10.1016/j.cell.2021.04.014		MAY 2021	35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	33964211	Bronze, Green Submitted			2022-12-28	WOS:000656965600018
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Local councils initiate surge vaccination to tackle B.1.617.2 variant	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, PLANS ANNOUNCED SPEE; [Anonymous], 2021, BBC NEWS        0521; [Anonymous], 2021, NHS BWD CCG; Iacobucci G, 2020, MILITARY MED RES, V2021, P373, DOI DOI 10.1186/s40779-020-0233-6; MERVIS J, 1991, SCIENTIST, V5, P1; Saito S, 2007, J ASSIST REPROD GEN, V24, P379, DOI 10.1007/s10815-007-9140-y; SPI-M-O, 2021, CONS STAT COVID 19	7	9	10	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2021	373								n1361	10.1136/bmj.n1361	http://dx.doi.org/10.1136/bmj.n1361			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SM4OV	34035001	Bronze			2022-12-28	WOS:000657587800005
J	Rubin, R				Rubin, Rita			Improving Maternal Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2038	2038		10.1001/jama.2021.7584	http://dx.doi.org/10.1001/jama.2021.7584			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032843				2022-12-28	WOS:000655647300005
J	McGeorge, E; James, J; Abraham, N				McGeorge, Elizabeth; James, Jo; Abraham, Nicola			The art of medicine The intergenerational project: creating space for play in health care	LANCET			English	Editorial Material									[McGeorge, Elizabeth; James, Jo] Imperial Coll Healthcare NHS Trust, London W2 1NY, England; [Abraham, Nicola] Royal Cent Sch Speech & Drama, London, England	Imperial College London	McGeorge, E (corresponding author), Imperial Coll Healthcare NHS Trust, London W2 1NY, England.	e.mcgeorge@nhs.net							0	0	0	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1876	1877						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF1XN	34022977	Green Accepted			2022-12-28	WOS:000652556000011
J	Bouwmeester, HJ				Bouwmeester, Harro J.			Plant lipids enticed fungi to mutualism	SCIENCE			English	Editorial Material							MYCORRHIZAL SYMBIOSIS; STRIGOLACTONE		[Bouwmeester, Harro J.] Univ Amsterdam, Swammerdam Inst Life Sci, Plant Hormone Biol Grp, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands	University of Amsterdam	Bouwmeester, HJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Plant Hormone Biol Grp, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	h.j.bouwmeester@uva.nl	Bouwmeester, Harro J/C-1414-2008		Dutch Research Council (NWO/OCW) [024.004.014]; European Research Council [670211]	Dutch Research Council (NWO/OCW); European Research Council(European Research Council (ERC)European Commission)	H.J.B. is funded by the Dutch Research Council (NWO/OCW) for the MiCRop Consortium program"Harnessing the second genome of plants"(grant 024.004.014) and by the European Research Council through ERCAdvanced grant CHEMCOMRHIZO (670211).	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Baud S, 2009, PLANT J, V60, P933, DOI 10.1111/j.1365-313X.2009.04011.x; Chen HH, 2017, J AGR FOOD CHEM, V65, P8099, DOI 10.1021/acs.jafc.7b03495; Choi J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16021-1; Jiang YN, 2017, SCIENCE, V356, P1172, DOI 10.1126/science.aam9970; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Lopez-Raez JA, 2011, J PLANT PHYSIOL, V168, P294, DOI 10.1016/j.jplph.2010.08.011; Luginbuehl LH, 2017, SCIENCE, V356, P1175, DOI 10.1126/science.aan0081; Radhakrishnan GV, 2020, NAT PLANTS, V6, P280, DOI 10.1038/s41477-020-0613-7; Rich MK, 2021, SCIENCE, V372, P864, DOI 10.1126/science.abg0929; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Wang YT, 2018, J EXP BOT, V69, P2219, DOI 10.1093/jxb/ery091; Waters MT, 2017, ANNU REV PLANT BIOL, V68, P291, DOI 10.1146/annurev-arplant-042916-040925; Xue L, 2018, P NATL ACAD SCI USA, V115, pE9239, DOI 10.1073/pnas.1812275115	14	0	0	8	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					789	790		10.1126/science.abi8016	http://dx.doi.org/10.1126/science.abi8016			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016767	Green Published			2022-12-28	WOS:000653997000024
J	Richerson, PJ; Gavrilets, S; de Waal, FBM				Richerson, Peter J.; Gavrilets, Sergey; de Waal, Frans B. M.			Modern theories of human evolution foreshadowed by Darwin's Descent of Man	SCIENCE			English	Review							CLIMATE-CHANGE; STONE TOOLS; LANGUAGE; CULTURE; DYNAMICS; CHIMPANZEE; HISTORY; AGRICULTURE; COOPERATION; CHALLENGES	Charles Darwin's The Descent of Man, published 150 years ago, laid the grounds for scientific studies into human origins and evolution. Three of his insights have been reinforced by modern science. The first is that we share many characteristics (genetic, developmental, physiological, morphological, cognitive, and psychological) with our closest relatives, the anthropoid apes. The second is that humans have a talent for high-level cooperation reinforced by morality and social norms. The third is that we have greatly expanded the social learning capacity that we see already in other primates. Darwin's emphasis on the role of culture deserves special attention because during an increasingly unstable Pleistocene environment, cultural accumulation allowed changes in life history; increased cognition; and the appearance of language, social norms, and institutions.	[Richerson, Peter J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Gavrilets, Sergey] Univ Tennessee, Natl Inst Math & Biol Synth, Dept Ecol & Evolutionary Biol, Dept Math,Ctr Dynam Social Complex, Knoxville, TN 37996 USA; [de Waal, Frans B. M.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	University of California System; University of California Davis; University of Tennessee System; University of Tennessee Knoxville; Emory University	Gavrilets, S (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth, Dept Ecol & Evolutionary Biol, Dept Math,Ctr Dynam Social Complex, Knoxville, TN 37996 USA.	gavrila@utk.edu		Richerson, Peter/0000-0002-7233-358X	U.S. Army Research Office [W911NF-14-1-0637, W911NF-18-1-0138]; Office of Naval Research [W911NF-17-1-0150]; National Institute for Mathematical and Biological Synthesis through NSF [EF-0830858]	U.S. Army Research Office; Office of Naval Research(Office of Naval Research); National Institute for Mathematical and Biological Synthesis through NSF	S.G. was supported by the U.S. Army Research Office grants W911NF-14-1-0637 and W911NF-18-1-0138, the Office of Naval Research grant W911NF-17-1-0150, and the National Institute for Mathematical and Biological Synthesis through NSF award EF-0830858.	AISNER R, 1992, ANIM BEHAV, V44, P327, DOI 10.1016/0003-3472(92)90038-B; Alexander R.D., 1990, DID HUMANS EVOLVE RE; [Anonymous], 2005, UNFOLDING LANGUAGE; Apicella CL, 2019, CURR BIOL, V29, pR447, DOI 10.1016/j.cub.2019.03.036; Atkinson EG, 2018, CELL, V174, P1424, DOI 10.1016/j.cell.2018.06.048; Atkinson QD, 2005, SYST BIOL, V54, P513, DOI 10.1080/10635150590950317; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Barlow G. L, 2015, ARCHAEOLOGY E ASIA R; Boas F, 1909, RELATION DARWI UNPUB; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Brewer J, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0070; Bromham L, 2015, P NATL ACAD SCI USA, V112, P2097, DOI 10.1073/pnas.1419704112; Brosnan SF, 2014, SCIENCE, V346, P314, DOI 10.1126/science.1251776; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burkart J, 2018, INTERACT STUD, V19, P136, DOI 10.1075/is.17026.bur; Campbell D. T., 1965, SOCIAL CHANGE DEV AR, P19; Chapais Bernard, 2008, PRIMEVAL KINSHIP PAI, DOI DOI 10.1111/btp.12564; Christiansen M. H, 2013, CULTURAL EVOLUTION, P87; Churchland P.S., 2019, CONSCIENCE ORIGINS M; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Collins P.W., 1965, MAN CULTURE ANIMALS, V78; Cress D, 2011, BASIC POLITICAL WRIT; Currie TE, 2016, STRUNGMANN FORUM REP, P201; Curry OS, 2019, CURR ANTHROPOL, V60, P47, DOI 10.1086/701478; Darwin C., 1859, ORIGIN SPECIES MEANS; Darwin C., 1871, P475; de Boer B, 2019, J SPEECH LANG HEAR R, V62, P2932, DOI 10.1044/2019_JSLHR-S-CSMC7-18-0293; de Boer B, 2017, PSYCHON B REV, V24, P158, DOI 10.3758/s13423-016-1130-6; de Waal F., 2001, APE SUSHI MASTER CUL; De Waal F., 2016, ARE WE SMART ENOUGH; de Waal FBM, 2017, NAT REV NEUROSCI, V18, P498, DOI 10.1038/nrn.2017.72; de Waal FBM, 2014, BEHAVIOUR, V151, P185, DOI 10.1163/1568539X-00003146; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; Degler C., 1991, SEARCH HUMAN NATURE; Ditlevsen PD, 1996, NATURE, V379, P810, DOI 10.1038/379810a0; Dobzhansky T, 1962, MANKIND EVOLVING EVO; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P289, DOI 10.1006/jhev.2000.0466; Engels F., 1876, DIALECTICS NATURE; Ensminger J, 2014, EXPERIMENTING WITH SOCIAL NORMS: FAIRNESS AND PUNISHMENT IN CROSS-CULTURAL PERSPECTIVE, P1; Fehr E, 2018, NAT HUM BEHAV, V2, P458, DOI 10.1038/s41562-018-0385-5; Feldman MW, 1996, TRENDS ECOL EVOL, V11, P453, DOI 10.1016/0169-5347(96)10052-5; Fry DouglasP., 2013, WAR PEACE HUMAN NATU; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Galway-Witham J, 2019, J QUATERNARY SCI, V34, P355, DOI 10.1002/jqs.3137; Gavrilets S., 2004, MONOGRAPHS POPULATIO; Gavrilets S., 2020, EVOL HUM SCI, V2, pe60, DOI [10.1017/ehs.2020.58, DOI 10.1017/EHS.2020.58]; Gavrilets S, 2006, P NATL ACAD SCI USA, V103, P16823, DOI 10.1073/pnas.0601428103; Gavrilets S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1067; Gelfand M., 2011, ADV CULTURE PSYCHOL, P5, DOI DOI 10.1093/ACPROF:OSO/9780195380392.001.0001; GERARD RW, 1956, BEHAV SCI, V1, P6; Gomez A, 2017, NAT HUM BEHAV, V1, P673, DOI 10.1038/s41562-017-0193-3; Goni M. F. Sanchez, 2020, EVOLUTION HUM SCI, V2, pE55, DOI [10.1017/ehs.2020.56, DOI 10.1017/EHS.2020.56]; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2015, MORAL BRAIN: A MULTIDISCIPLINARY PERSPECTIVE, P197; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hammond RA, 2006, J CONFLICT RESOLUT, V50, P926, DOI 10.1177/0022002706293470; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 2016, SECRET OF OUR SUCCESS: HOW CULTURE IS DRIVING HUMAN EVOLUTION, DOMESTICATING OUR SPECIES, AND MAKING US SMARTER, P1; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hill KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102806; Hirata S, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P487; Hodgson G. M, 2004, EVOLUTION I EC AGENC; Hoehl S, 2019, DEV REV, V51, P90, DOI 10.1016/j.dr.2018.12.002; House BR, 2020, NAT HUM BEHAV, V4, P36, DOI 10.1038/s41562-019-0734-z; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Hurford J.R., 2007, ORIGINS MEANING; Huxley J., 1942, P1; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Jowett G.S., 2018, PROPAGANDA PERSUASIO; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kohler W., 1925, MENTALITY APES; Kropotkin P., 1902, MUTUAL AID FACTOR EV; Krupenye C, 2016, SCIENCE, V354, P110, DOI 10.1126/science.aaf8110; Labov W, 2001, PRINCIPLES LINGUISTI, V29; Laland K., 2017, DARWINS UNFINISHED S; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Leonardi M, 2012, INT DAIRY J, V22, P88, DOI 10.1016/j.idairyj.2011.10.010; Lewis HS, 2001, CURR ANTHROPOL, V42, P381, DOI 10.1086/320474; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Macedo S, 2006, PRIMATES AND PHILOSOPHERS: HOW MORALITY EVOLVED, P1; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; McDonald MM, 2012, PHILOS T R SOC B, V367, P670, DOI 10.1098/rstb.2011.0301; McElreath R, 2003, CURR ANTHROPOL, V44, P122, DOI 10.1086/345689; McGrew WC, 2010, SCIENCE, V328, P579, DOI 10.1126/science.1187921; Mercader J, 2002, SCIENCE, V296, P1452, DOI 10.1126/science.1070268; Mesoudi A, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0712; Miller G. F., 2000, MATING MIND SEXUAL C; Muthukrishna M, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006504; Nakahashi W, 2018, POPUL ECOL, V60, P127, DOI 10.1007/s10144-018-0610-0; Origgi G., 2000, EVOLUTION HUMAN MIND, P140, DOI 10.1017/CBO9780511611926.008; Orr H.A, 2004, SPECIATION, V37; Panksepp J., 2004, AFFECTIVE NEUROSCIEN; Petr M, 2020, SCIENCE, V369, P1653, DOI 10.1126/science.abb6460; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Richards R. J., 1988, EVOLUTIONARY PROGR, P129; Richards Robert J., 2016, DEBATING DARWIN; Richerson P., 2009, CLIODYNAMICS, DOI [10.2139/ssrn.1368756, DOI 10.21237/C7CLIO3112453]; Richerson P., 1978, J SOC BIOL STRUCT, V1, P127, DOI [10.1016/S0140-1750(78)80002-5, DOI 10.1016/S0140-1750(78)80002-5]; Richerson P. J., 2001, ORIGIN HUMAN SOCIAL, V110, P197; Richerson P. J., 2005, HDB EVOLUTION EVOLUT, V2, P223; Richerson P, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X1400106X; Richerson PJ, 2010, BIOLINGUISTICS, V4, P289; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Richerson PJ, 1999, HUM NATURE-INT BIOS, V10, P253, DOI 10.1007/s12110-999-1004-y; Ross CT, 2014, CURR OPIN GENET DEV, V29, P103, DOI 10.1016/j.gde.2014.08.014; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Shennan S, 2018, CAMB WOR ARCHAEOL, P1, DOI 10.1017/9781108386029; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; Singh M, 2017, HUM NATURE-INT BIOS, V28, P457, DOI 10.1007/s12110-017-9298-7; Stevens CJ, 2017, LANG DYN CHANG, V7, P152, DOI 10.1163/22105832-00702001; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; van Schaik CP., 2016, PRIMATE ORIGINS HUMA; Warneken F, 2018, ANNU REV PSYCHOL, V69, P205, DOI 10.1146/annurev-psych-122216-011813; WASHBURN S. L., 1959, HUMAN BIOL, V31, P21; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Whitehead H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10293-y; Whiten A, 2019, ANNU REV ECOL EVOL S, V50, P27, DOI 10.1146/annurev-ecolsys-110218-025040; Whiten A, 2017, P NATL ACAD SCI USA, V114, P7790, DOI 10.1073/pnas.1620733114; Whiten A, 2017, ANNU REV PSYCHOL, V68, P129, DOI 10.1146/annurev-psych-010416-044108; Wiessner P., 1998, HIST VINES ENGA NETW; Will M., 2019, MODERN HUMAN ORIGINS, P25; Williams-Hatala EM, 2018, J HUM EVOL, V119, P14, DOI 10.1016/j.jhevol.2018.02.008; Wrangham R, 2009, CATCHING FIRE COOKIN, P1; Wrangham R. W., 2019, GOODNESS PARADOX STR, VFirst	133	17	17	14	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					806	+	eaba3776	10.1126/science.aba3776	http://dx.doi.org/10.1126/science.aba3776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SH2WJ	34016754				2022-12-28	WOS:000653997000034
J	Ho, JSY; Zhu, ZY; Marazzi, I				Ho, Jessica Sook Yuin; Zhu, Zeyu; Marazzi, Ivan			Unconventional viral gene expression mechanisms as therapeutic targets	NATURE			English	Review							HEPATITIS-C-VIRUS; RIBOSOME ENTRY SITE; OPEN READING FRAMES; OVERLAPPING CODING SEQUENCES; MESSENGER-RNA; INFLUENZA-VIRUS; SENDAI-VIRUS; TRANSLATION INITIATION; CRYPTIC EPITOPES; V-PROTEIN	Unlike the human genome that comprises mostly noncoding and regulatory sequences, viruses have evolved under the constraints of maintaining a small genome size while expanding the efficiency of their coding and regulatory sequences. As a result, viruses use strategies of transcription and translation in which one or more of the steps in the conventional gene-protein production line are altered. These alternative strategies of viral gene expression (also known as gene recoding) can be uniquely brought about by dedicated viral enzymes or by co-opting host factors (known as host dependencies). Targeting these unique enzymatic activities and host factors exposes vulnerabilities of a virus and provides a paradigm for the design of novel antiviral therapies. In this Review, we describe the types and mechanisms of unconventional gene and protein expression in viruses, and provide a perspective on how future basic mechanistic work could inform translational efforts that are aimed at viral eradication.	[Ho, Jessica Sook Yuin; Zhu, Zeyu; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Marazzi, Ivan] Icahn Sch Med Mt Sinai, Global Hearth & Emerging Pathogens Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Marazzi, I (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Marazzi, I (corresponding author), Icahn Sch Med Mt Sinai, Global Hearth & Emerging Pathogens Inst, New York, NY 10029 USA.	ivan.marazzi@mssm.edu		Ho, Jessica Sook Yuin/0000-0003-2234-2602	Burroughs Wellcome Fund [1017892]; NIH/NIAID [U01AI150748]; Chan Zuckerberg Initiative [2018-191895]	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chan Zuckerberg Initiative	I.M. is supported by Burroughs Wellcome Fund 1017892, NIH/NIAID-U01AI150748 and Chan Zuckerberg Initiative 2018-191895	Ahmadian G, 2000, EMBO J, V19, P2681, DOI 10.1093/emboj/19.11.2681; AHOLA T, 1995, P NATL ACAD SCI USA, V92, P507, DOI 10.1073/pnas.92.2.507; Artarini A, 2019, ANTIVIR RES, V168, P187, DOI 10.1016/j.antiviral.2019.06.003; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530; Bansal A, 2015, JAIDS-J ACQ IMM DEF, V70, P1, DOI 10.1097/QAI.0000000000000700; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Baranov PV, 2005, VIROLOGY, V332, P498, DOI 10.1016/j.virol.2004.11.038; Barr JN, 2001, J VIROL, V75, P6901, DOI 10.1128/JVI.75.15.6901-6913.2001; Batra R, 2016, NAT STRUCT MOL BIOL, V23, P1101, DOI 10.1038/nsmb.3310; Bet A, 2014, JAIDS-J ACQ IMM DEF, V65, P142, DOI 10.1097/QAI.0b013e3182a9917e; Biswas P, 2004, J VIROL, V78, P2082, DOI 10.1128/JVI.78.4.2082-2087.2004; BOECK R, 1992, J VIROL, V66, P1765, DOI 10.1128/JVI.66.3.1765-1768.1992; Bogdanow B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13520-8; Bojkova D, 2020, NATURE, V583, P469, DOI 10.1038/s41586-020-2332-7; Bonenfant G, 2019, J VIROL, V93, DOI [10.1128/JVI.00520-19, 10.1128/jvi.00520-19]; Boudreault S, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1543; Brierley I, 1997, J MOL BIOL, V270, P360, DOI 10.1006/jmbi.1997.1134; Cai ZN, 2021, BRIEF BIOINFORM, V22, P2182, DOI 10.1093/bib/bbaa052; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; CARROLL R, 1993, J VIROL, V67, P1433, DOI 10.1128/JVI.67.3.1433-1440.1993; CASSAN M, 1994, J VIROL, V68, P1501, DOI 10.1128/JVI.68.3.1501-1508.1994; Chen A, 2005, NUCLEIC ACIDS RES, V33, P1169, DOI 10.1093/nar/gki251; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chung WY, 2007, PLOS COMPUT BIOL, V3, P855, DOI 10.1371/journal.pcbi.0030091; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Corcelette S, 2000, NUCLEIC ACIDS RES, V28, P1625, DOI 10.1093/nar/28.7.1625; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; de Farias ST, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00125; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; DEGNIN CR, 1993, J VIROL, V67, P5514, DOI 10.1128/JVI.67.9.5514-5521.1993; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Depledge DP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08734-9; Dhillon P, 2018, J VIROL, V92, DOI 10.1128/JVI.00612-18; Di H, 2017, P NATL ACAD SCI USA, V114, pE8895, DOI 10.1073/pnas.1706696114; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Dibrov SM, 2012, P NATL ACAD SCI USA, V109, P5223, DOI 10.1073/pnas.1118699109; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Dillon PJ, 2007, J VIROL, V81, P11116, DOI 10.1128/JVI.01360-07; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Dolan BP, 2010, J IMMUNOL, V184, P1419, DOI 10.4049/jimmunol.0901907; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dulude D, 2006, VIROLOGY, V345, P127, DOI 10.1016/j.virol.2005.08.048; Dulude D, 2002, NUCLEIC ACIDS RES, V30, P5094, DOI 10.1093/nar/gkf657; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Finkel Yaara, 2021, Nature, V589, P125, DOI 10.1038/s41586-020-2739-1; Firth AE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-75; Firth AE, 2005, BIOINFORMATICS, V21, P282, DOI 10.1093/bioinformatics/bti007; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033; Fukao K, 2019, J ANTIMICROB CHEMOTH, V74, P654, DOI 10.1093/jac/dky462; FULLER F, 1983, J GEN VIROL, V64, P1705, DOI 10.1099/0022-1317-64-8-1705; FUTTERER J, 1993, CELL, V73, P789, DOI 10.1016/0092-8674(93)90257-Q; Gainey MD, 2008, J VIROL, V82, P828, DOI 10.1128/JVI.02023-07; Garcia-Miranda P, 2016, J VIROL, V90, P6906, DOI 10.1128/JVI.00149-16; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Gould PS, 2005, J BIOL CHEM, V280, P21972, DOI 10.1074/jbc.M502276200; Griffiths A, 2005, P NATL ACAD SCI USA, V102, P9667, DOI 10.1073/pnas.0504132102; Gu WF, 2015, RNA, V21, P2067, DOI 10.1261/rna.054221.115; Guedj J, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002535; GUPTA KC, 1988, J BIOL CHEM, V263, P8553; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Hausmann S, 1999, J VIROL, V73, P5568, DOI 10.1128/JVI.73.7.5568-5576.1999; Hayden FG, 2019, CURR OPIN INFECT DIS, V32, P176, DOI 10.1097/QCO.0000000000000532; Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017; Ho JSY, 2020, CELL, V181, P1502, DOI 10.1016/j.cell.2020.05.035; HOFMANN MA, 1993, P NATL ACAD SCI USA, V90, P11733, DOI 10.1073/pnas.90.24.11733; Hofmann Wolf Peter, 2009, V189, P321, DOI 10.1007/978-3-540-79086-0_12; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Irigoyen N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005473; Iseni F, 2002, RNA, V8, P1056, DOI 10.1017/S1355838202029977; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Jeudy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003122; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Jiang T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156906; Jin XP, 2003, J BIOL CHEM, V278, P25716, DOI 10.1074/jbc.M300316200; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Kang ST, 2013, J VIROL, V87, P13263, DOI 10.1128/JVI.01732-13; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Kim H, 2018, VIRAL IMMUNOL, V31, P174, DOI 10.1089/vim.2017.0141; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Kolakofsky D, 2004, VIROLOGY, V318, P463, DOI 10.1016/j.virol.2003.10.031; Kolupaeva VG, 2003, MOL CELL BIOL, V23, P687, DOI 10.1128/MCB.23.2.687-698.2003; Koppstein D, 2015, NUCLEIC ACIDS RES, V43, P5052, DOI 10.1093/nar/gkv333; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krause-Kyora B, 2018, ELIFE, V7, DOI 10.7554/eLife.36666; Latorre P, 1998, MOL CELL BIOL, V18, P5021, DOI 10.1128/MCB.18.9.5021; LEE BJ, 1989, J BIOL CHEM, V264, P9724; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Lin JC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010075; Loughran G, 2011, P NATL ACAD SCI USA, V108, pE1111, DOI 10.1073/pnas.1102932108; Luke GA, 2008, J GEN VIROL, V89, P1036, DOI 10.1099/vir.0.83428-0; Lulla V, 2019, NAT MICROBIOL, V4, P280, DOI 10.1038/s41564-018-0297-1; Machkovech HM, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007518; Majzoub K, 2014, CELL, V159, P1086, DOI 10.1016/j.cell.2014.10.041; Maness NJ, 2010, J IMMUNOL, V184, P67, DOI 10.4049/jimmunol.0903118; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Meyers G, 2003, J BIOL CHEM, V278, P34051, DOI 10.1074/jbc.M304874200; Michel AM, 2012, GENOME RES, V22, P2219, DOI 10.1101/gr.133249.111; Mishin VP, 2019, EMERG INFECT DIS, V25, P1969, DOI 10.3201/eid2510.190607; Mohamadi M, 2020, J MED VIROL, V92, P2930, DOI 10.1002/jmv.26091; Mokhtari RB, 2017, ONCOTARGET, V8, P38022, DOI 10.18632/oncotarget.16723; Muhlemann B, 2018, NATURE, V557, P418, DOI 10.1038/s41586-018-0097-z; Neme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-117; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; Noshi T, 2018, ANTIVIR RES, V160, P109, DOI 10.1016/j.antiviral.2018.10.008; Ogino T, 2007, MOL CELL, V25, P85, DOI 10.1016/j.molcel.2006.11.013; Olspert A, 2015, EMBO REP, V16, P995, DOI 10.15252/embr.201540509; Omoto S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27890-4; Park SJ, 2011, J AM CHEM SOC, V133, P10094, DOI 10.1021/ja1098325; Parsons J, 2009, NAT CHEM BIOL, V5, P823, DOI 10.1038/nchembio.217; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Peng BJ, 2018, J VIROL, V92, DOI 10.1128/JVI.00711-18; Penno C, 2017, NUCLEIC ACIDS RES, V45, P10156, DOI 10.1093/nar/gkx690; Plant EP, 2010, J VIROL, V84, P4330, DOI 10.1128/JVI.02480-09; Pooggin MM, 1999, J GEN VIROL, V80, P2217, DOI 10.1099/0022-1317-80-8-2217; PRATS AC, 1989, J MOL BIOL, V205, P363, DOI 10.1016/0022-2836(89)90347-1; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Ratinier M, 2008, J GEN VIROL, V89, P1569, DOI 10.1099/vir.0.83614-0; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Rialdi A, 2017, CELL, V169, P679, DOI 10.1016/j.cell.2017.04.021; Ritchie DB, 2014, J AM CHEM SOC, V136, P2196, DOI 10.1021/ja410344b; Ritchie DB, 2012, P NATL ACAD SCI USA, V109, P16167, DOI 10.1073/pnas.1204114109; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schlub TE, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa009; Scholthof HB, 2006, NAT REV MICROBIOL, V4, P405, DOI 10.1038/nrmicro1395; Schueren F, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006196; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; Seif M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02711; Selman M, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.38; Seth PP, 2005, J MED CHEM, V48, P7099, DOI 10.1021/jm050815o; Shabman RS, 2014, MBIO, V5, DOI 10.1128/mBio.02011-14; Shabman RS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003147; Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028; Sharma P, 2012, NUCLEIC ACIDS RES, V40, P3143, DOI 10.1093/nar/gkr1176; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Shih SR, 1996, EMBO J, V15, P5415, DOI 10.1002/j.1460-2075.1996.tb00925.x; Shirako Y, 1998, J VIROL, V72, P1677, DOI 10.1128/JVI.72.2.1677-1682.1998; Sikora D, 2017, VIROLOGY, V509, P167, DOI 10.1016/j.virol.2017.06.020; Simmonds P, 2019, NAT REV MICROBIOL, V17, P321, DOI 10.1038/s41579-018-0120-2; Soler M, 2004, ANTIVIR THER, V9, P953; Stacey SN, 2000, J VIROL, V74, P7284, DOI 10.1128/JVI.74.16.7284-7297.2000; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Su MC, 2005, NUCLEIC ACIDS RES, V33, P4265, DOI 10.1093/nar/gki731; Suzuki Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005357; Sweeney TR, 2014, EMBO J, V33, P76, DOI 10.1002/embj.201386124; TERWILLIGER EF, 1989, P NATL ACAD SCI USA, V86, P5163, DOI 10.1073/pnas.86.13.5163; THOMAS SM, 1988, CELL, V54, P891, DOI 10.1016/S0092-8674(88)91285-8; Tremblay MP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3029-z; Tsai PL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003460; Ullah Hemayet, 2019, Oncotarget, V10, P3209, DOI 10.18632/oncotarget.26907; Urbanski LM, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1476; van Knippenberg I, 2010, J GEN VIROL, V91, P2002, DOI 10.1099/vir.0.021774-0; Vera-Otarola J, 2012, J VIROL, V86, P2176, DOI 10.1128/JVI.06223-11; Vetsika EK, 2011, J IMMUNOTHER, V34, P641, DOI 10.1097/CJI.0b013e31823284a6; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Vulliemoz D, 2001, J VIROL, V75, P4506, DOI 10.1128/JVI.75.10.4506-4518.2001; Wang XL, 2019, CELL, V176, P625, DOI 10.1016/j.cell.2018.12.030; Watanabe Y, 2019, BBA-GEN SUBJECTS, V1863, P1480, DOI 10.1016/j.bbagen.2019.05.012; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wise H. M, 2019, ALTERNATIVE AUG CODO, DOI [10.1101/738427, DOI 10.1101/738427]; Wise HM, 2011, NUCLEIC ACIDS RES, V39, P7775, DOI 10.1093/nar/gkr487; Worthington RJ, 2013, TRENDS BIOTECHNOL, V31, P177, DOI 10.1016/j.tibtech.2012.12.006; Wu HY, 2014, J VIROL, V88, P846, DOI 10.1128/JVI.02831-13; Yamamoto H, 2015, EMBO J, V34, P3042, DOI 10.15252/embj.201592469; Young SK, 2016, J BIOL CHEM, V291, P16927, DOI 10.1074/jbc.R116.733899; Yueh A, 1996, GENE DEV, V10, P1557, DOI 10.1101/gad.10.12.1557; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zanker DJ, 2019, J IMMUNOL, V202, P3370, DOI 10.4049/jimmunol.1900070; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0; Zhang H, 1999, ANTIMICROB AGENTS CH, V43, P347, DOI 10.1128/AAC.43.2.347; Zhao J, 2020, GENOM PROTEOM BIOINF, V18, P129, DOI 10.1016/j.gpb.2020.03.001; Zhao JW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10246-5; Zhao N, 2018, NAT STRUCT MOL BIOL, V25, P885, DOI 10.1038/s41594-018-0124-7	187	15	16	6	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					362	371		10.1038/s41586-021-03511-5	http://dx.doi.org/10.1038/s41586-021-03511-5			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE7VT	34012080	Bronze			2022-12-28	WOS:000652278400012
J	Buresh, M; Stern, R; Rastegar, D				Buresh, Megan; Stern, Robert; Rastegar, Darius			Treatment of opioid use disorder in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEPATITIS-C VIRUS; BUPRENORPHINE MAINTENANCE TREATMENT; EXTENDED-RELEASE NALTREXONE; RANDOMIZED CONTROLLED-TRIAL; INVOLVED OVERDOSE DEATHS; HIV TREATMENT OUTCOMES; INJECTING DRUG-USERS; QUALITY-OF-LIFE; METHADONE-MAINTENANCE; DEPENDENT PATIENTS	Opioid use disorder (OUD) is a common, treatable chronic disease that can be effectively managed in primary care settings. Untreated OUD is associated with considerable morbidity and mortality-notably, overdose, infectious complications of injecting drug use, and profoundly diminished quality of life. Withdrawal management and medication tapers are ineffective and are associated with increased rates of relapse and death. Pharmacotherapy is the evidence based mainstay of OUD treatment, and many studies support its integration into primary care settings. Evidence is strongest for the opioid agonists buprenorphine and methadone, which randomized controlled trials have shown to decrease illicit opioid use and mortality. Discontinuation of opioid agonist therapy is associated with increased rates of relapse and mortality. Less evidence is available for the opioid antagonist extended release naltrexone, with a meta-analysis of randomized controlled trials showing decreased illicit opioid use but no effect on mortality. Treating OUD in primary care settings is cost effective, improves outcomes for both OUD and other medical comorbidities, and is highly acceptable to patients. Evidence on whether behavioral interventions improve outcomes for patients receiving pharmacotherapy is mixed, with guidelines promoting voluntary engagement in psychosocial supports, including counseling. Further work is needed to promote the integration of OUD treatment into primary care and to overcome regulatory barriers to integrating methadone into primary care treatment in the US.	[Buresh, Megan; Stern, Robert; Rastegar, Darius] Johns Hopkins Univ, Sch Med, Dept Addict Med, Baltimore, MD 21218 USA; [Buresh, Megan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Buresh, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Addict Med, Baltimore, MD 21218 USA.; Buresh, M (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	mburesh2@jhmi.edu						Accurso AJ, 2016, J SUBST ABUSE TREAT, V61, P74, DOI 10.1016/j.jsat.2015.09.004; Akiyama MJ, 2019, ANN INTERN MED, V170, P594, DOI 10.7326/M18-1715; Alderks C. E., 2013, TRENDS USE METHADONE; Alford DP, 2011, ARCH INTERN MED, V171, P425, DOI 10.1001/archinternmed.2010.541; Altice FL, 2011, JAIDS-J ACQ IMM DEF, V56, pS22, DOI 10.1097/QAI.0b013e318209751e; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2020, J ADDICT MED, V14, P1, DOI 10.1097/ADM.0000000000000633; Antoine D, 2021, AM J ADDICTION, V30, P83, DOI 10.1111/ajad.13069; Artenie AA, 2019, CAN MED ASSOC J, V191, pE462, DOI 10.1503/cmaj.181506; Astals M, 2008, SUBST USE MISUSE, V43, P612, DOI 10.1080/10826080701204813; Bailey GL, 2013, J SUBST ABUSE TREAT, V45, P302, DOI 10.1016/j.jsat.2013.04.002; Barry DT, 2007, J GEN INTERN MED, V22, P242, DOI 10.1007/s11606-006-0050-y; Basu S, 2006, CLIN INFECT DIS, V42, P716, DOI 10.1086/500200; Behar E, 2018, PREV MED, V114, P79, DOI 10.1016/j.ypmed.2018.06.005; Behar E, 2015, DRUG ALCOHOL DEPEN, V148, P209, DOI 10.1016/j.drugalcdep.2014.12.009; Bernstein J, 2005, DRUG ALCOHOL DEPEN, V77, P49, DOI 10.1016/j.drugalcdep.2004.07.006; Bertholet N, 2020, DRUG ALCOHOL DEPEN, V213, DOI 10.1016/j.drugalcdep.2020.108001; Bickel WK, 2008, EXP CLIN PSYCHOPHARM, V16, P132, DOI 10.1037/1064-1297.16.2.132; Bizzarri J, 2005, SUBST USE MISUSE, V40, P1765, DOI 10.1080/10826080500260800; Bloom-Foster J, 2020, J ALTERN COMPLEM MED, V26, P34, DOI 10.1089/acm.2019.0242; Brands B, 2003, J ADDICT DIS, V22, P19, DOI 10.1300/J069v22n03_03; Brown JL, 2017, J SUBST ABUSE TREAT, V76, P77, DOI 10.1016/j.jsat.2017.01.017; Butler SF, 2007, PAIN, V130, P144, DOI 10.1016/j.pain.2007.01.014; Canadian Research Initiative in Substance Misuse, 2018, NAT GUID CLIN MAN OP; CAPLEHORN JRM, 1994, INT J ADDICT, V29, P1361, DOI 10.3109/10826089409048714; Carrieri PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112328; Carroll KM, 2017, AM J PSYCHIAT, V174, P738, DOI 10.1176/appi.ajp.2016.16070792; Center for Substance Abuse Treatment. Substance Abuse Treatment: Group Therapy, 2005, SUBSTANCE ABUSE TREA, V41; Centers for Disease Control National Center for Health Statistics., 2020, NAT VIT STAT RAP REL; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Chou R, 2019, ANN INTERN MED, V171, P427, DOI 10.7326/M19-1488; Christensen DR, 2014, J CONSULT CLIN PSYCH, V82, P964, DOI 10.1037/a0037496; Clark RE, 2014, HEALTH SERV RES, V49, P1964, DOI 10.1111/1475-6773.12201; Coe MA, 2019, J ADDICT MED, V13, P93, DOI 10.1097/ADM.0000000000000457; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; Correia CJ, 2006, PSYCHOPHARMACOLOGY, V189, P297, DOI 10.1007/s00213-006-0571-4; Cousins G, 2017, DRUG ALCOHOL DEPEN, V173, P126, DOI 10.1016/j.drugalcdep.2016.12.009; Cousins G, 2016, ADDICTION, V111, P73, DOI 10.1111/add.13087; Coviello DM, 2011, J SUBST ABUSE TREAT, V40, P165, DOI 10.1016/j.jsat.2010.09.007; Cunningham EB, 2020, CLIN INFECT DIS, V71, pE115, DOI 10.1093/cid/ciz1089; D'Onofrio G, 2017, J GEN INTERN MED, V32, P660, DOI 10.1007/s11606-017-3993-2; Davison JW, 2006, J ADDICT DIS, V25, P27, DOI 10.1300/J069v25n04_03; Degenhardt L, 2018, LANCET PSYCHIAT, V5, P987, DOI 10.1016/S2215-0366(18)30337-7; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Dey P, 2002, J PUBLIC HEALTH MED, V24, P38, DOI 10.1093/pubmed/24.1.38; DOLE VP, 1967, ARCH INTERN MED, V120, P19, DOI 10.1001/archinte.120.1.19; Dowell D, 2017, JAMA-J AM MED ASSOC, V318, P1065, DOI 10.1001/jama.2017.9308; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Drucker E, 2007, ADDICT DISORD TREAT, V6, P121, DOI 10.1097/ADT.0b013e31802b4ea1; Dunlap LJ, 2018, J SUBST ABUSE TREAT, V94, P81, DOI 10.1016/j.jsat.2018.07.014; Dupouy J, 2017, ANN FAM MED, V15, P355, DOI 10.1370/afm.2098; Edelman EJ, 2014, DRUG ALCOHOL DEPEN, V139, P79, DOI 10.1016/j.drugalcdep.2014.03.006; Faggiano F., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002208; Fanucchi L, 2019, CURR HIV-AIDS REP, V16, P1, DOI [10.1007/s11904-019-00436-7, 10.1007/s1190]; Fareed A, 2012, J ADDICT DIS, V31, P8, DOI 10.1080/10550887.2011.642758; Fatseas M, 2007, Curr Psychiatry Rep, V9, P358, DOI 10.1007/s11920-007-0046-2; Fiellin DA, 2001, JAMA-J AM MED ASSOC, V286, P1724, DOI 10.1001/jama.286.14.1724; Fiellin DA, 2008, AM J ADDICTION, V17, P116, DOI 10.1080/10550490701860971; Fiellin DA, 2006, NEW ENGL J MED, V355, P365, DOI 10.1056/NEJMoa055255; Fiellin DA, 2014, JAMA INTERN MED, V174, P1947, DOI 10.1001/jamainternmed.2014.5302; Fiellin DA, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.07.005; Fiellin DA, 2011, JAIDS-J ACQ IMM DEF, V56, pS33, DOI 10.1097/QAI.0b013e3182097537; Fox AD, 2016, SUBST ABUS, V37, P70, DOI 10.1080/08897077.2015.1088496; Fox AD, 2012, SUBST ABUS, V33, P361, DOI 10.1080/08897077.2011.638734; Gibson AE, 2003, MED J AUSTRALIA, V179, P38, DOI 10.5694/j.1326-5377.2003.tb05417.x; Goldman JE, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-018-0276-0; Gossop M, 1999, BRIT J GEN PRACT, V49, P31; Gossop M, 2003, J SUBST ABUSE TREAT, V24, P313, DOI 10.1016/S0740-5472(03)00040-0; Grebely J, 2018, LANCET GASTROENTEROL, V3, P153, DOI 10.1016/S2468-1253(17)30404-1; Gunderson EW, 2010, ADDICT BEHAV, V35, P537, DOI 10.1016/j.addbeh.2010.01.001; Haddad MS, 2015, J URBAN HEALTH, V92, P193, DOI 10.1007/s11524-014-9924-1; Haight BR, 2019, LANCET, V393, P778, DOI 10.1016/S0140-6736(18)32259-1; Hammig R, 2016, SUBST ABUSE REHABIL, V7, P99, DOI 10.2147/SAR.S109919; Herget Greg, 2005, HIV AIDS Policy Law Rev, V10, P23; Hickman M, 2018, ADDICTION, V113, P1461, DOI 10.1111/add.14188; Hser YI, 2014, ADDICTION, V109, P79, DOI 10.1111/add.12333; Hsu YJ, 2019, POPUL HEALTH MANAG, V22, P292, DOI 10.1089/pop.2018.0163; Hurley SF, 1997, LANCET, V349, P1797, DOI 10.1016/S0140-6736(96)11380-5; Jansson LM, 2009, BREASTFEED MED, V4, P225, DOI 10.1089/bfm.2009.9987; Jarlais DCD, 1996, LANCET, V348, P987, DOI 10.1016/S0140-6736(96)02536-6; Jarvis BP, 2018, ADDICTION, V113, P1188, DOI 10.1111/add.14180; Jarvis M, 2017, J ADDICT MED, V11, P163, DOI 10.1097/ADM.0000000000000323; Jones CM, 2015, AM J PUBLIC HEALTH, V105, pE55, DOI 10.2105/AJPH.2015.302664; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Kampman K, 2015, J ADDICT MED, V9, P358, DOI 10.1097/ADM.0000000000000166; Kaner EFS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Knisely JS, 2008, J SUBST ABUSE TREAT, V35, P380, DOI 10.1016/j.jsat.2008.02.001; Komaromy M, 2016, SUBST ABUS, V37, P20, DOI 10.1080/08897077.2015.1129388; Korthuis PT, 2017, ANN INTERN MED, V166, P268, DOI 10.7326/M16-2149; Korthuis PT, 2012, JAIDS-J ACQ IMM DEF, V61, P171, DOI 10.1097/QAI.0b013e31826741aa; Krans EE, 2018, ADDICT BEHAV, V86, P124, DOI 10.1016/j.addbeh.2018.05.016; Krans EE, 2015, CLIN OBSTET GYNECOL, V58, P370, DOI 10.1097/GRF.0000000000000098; Krawczyk N, 2020, ADDICTION, V115, P1683, DOI 10.1111/add.14991; Krist AH, 2020, JAMA-J AM MED ASSOC, V323, P2301, DOI 10.1001/jama.2020.8020; Krupitsky E, 2011, LANCET, V377, P1506, DOI 10.1016/S0140-6736(11)60358-9; LaBelle CT, 2016, J SUBST ABUSE TREAT, V60, P6, DOI 10.1016/j.jsat.2015.06.010; Lagisetty PA, 2019, JAMA PSYCHIAT, V76, P979, DOI 10.1001/jamapsychiatry.2019.0876; Lanier D., 2008, SCREENING PRIMARY CA; Lee JD, 2018, LANCET, V391, P309, DOI 10.1016/S0140-6736(17)32812-X; Liebschutz JM, 2014, JAMA INTERN MED, V174, P1369, DOI 10.1001/jamainternmed.2014.2556; Ling W, 2020, J SUBST ABUSE TREAT, V110, P1, DOI 10.1016/j.jsat.2019.11.004; Ling W, 2013, ADDICTION, V108, P1788, DOI 10.1111/add.12266; Lofwall MR, 2018, JAMA INTERN MED, V178, P764, DOI 10.1001/jamainternmed.2018.1052; Low AJ, 2016, CLIN INFECT DIS, V63, P1094, DOI 10.1093/cid/ciw416; Mark TL, 2019, J SUBST ABUSE TREAT, V103, P58, DOI 10.1016/j.jsat.2019.05.001; Mascola MA, 2017, OBSTET GYNECOL, V130, pE81, DOI 10.1097/AOG.0000000000002235; Mattick RP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub4; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; MCAULIFFE WE, 1990, J PSYCHOACTIVE DRUGS, V22, P197, DOI 10.1080/02791072.1990.10472544; McKnight S, 2016, AM J PERINAT, V33, P495, DOI 10.1055/s-0035-1566295; McNeely J, 2000, J URBAN HEALTH, V77, P96, DOI 10.1007/BF02350965; Mintzer IL, 2007, ANN FAM MED, V5, P146, DOI 10.1370/afm.665; Miotto K, 2012, J ADDICT MED, V6, P68, DOI 10.1097/ADM.0b013e318233d621; Morgan JR, 2019, DRUG ALCOHOL DEPEN, V200, P34, DOI 10.1016/j.drugalcdep.2019.02.031; Mullen L, 2012, AM J DRUG ALCOHOL AB, V38, P551, DOI 10.3109/00952990.2012.694516; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; OCONNOR PG, 1995, J GEN INTERN MED, V10, P255, DOI 10.1007/BF02599882; OCONNOR PG, 1992, J GEN INTERN MED, V7, P532, DOI 10.1007/BF02599459; OConnor PG, 1996, AM J DRUG ALCOHOL AB, V22, P523, DOI 10.3109/00952999609001678; Olfson M, 2019, JAMA-J AM MED ASSOC, V322, P2340, DOI 10.1001/jama.2019.16566; Palepua A, 2006, DRUG ALCOHOL DEPEN, V84, P188, DOI 10.1016/j.drugalcdep.2006.02.003; Patnode CD, 2020, JAMA-J AM MED ASSOC, V323, P2310, DOI 10.1001/jama.2019.21381; Potier C, 2014, DRUG ALCOHOL DEPEN, V145, P48, DOI 10.1016/j.drugalcdep.2014.10.012; Primary Care Collaborative, 2019, VERM HUB SPOK HLTH H; Reif S, 2014, PSYCHIAT SERV, V65, P301, DOI 10.1176/appi.ps.201300242; Rich KM, 2018, CURR HIV-AIDS REP, V15, P266, DOI 10.1007/s11904-018-0396-x; Roncero C, 2016, PSYCHIAT RES, V243, P174, DOI 10.1016/j.psychres.2016.06.024; Rosenthal ES, 2020, CLIN INFECT DIS, V71, P1715, DOI 10.1093/cid/ciaa105; Roux P, 2016, ADDICTION, V111, P94, DOI 10.1111/add.13089; Roux P, 2013, PAIN, V154, P1442, DOI 10.1016/j.pain.2013.05.004; Roy-Byrne P, 2014, JAMA-J AM MED ASSOC, V312, P492, DOI 10.1001/jama.2014.7860; Saitz R, 2014, JAMA-J AM MED ASSOC, V312, P502, DOI 10.1001/jama.2014.7862; Schiff DM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5734; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; Schottenfeld RS, 2005, AM J PSYCHIAT, V162, P340, DOI 10.1176/appi.ajp.162.2.340; Sibai M, 2020, AM J DRUG ALCOHOL AB, V46, P289, DOI 10.1080/00952990.2019.1700265; Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463; Soeffing JM, 2009, J SUBST ABUSE TREAT, V37, P426, DOI 10.1016/j.jsat.2009.05.003; Sordo L, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1550; Stein MD, 2007, J ADDICT DIS, V26, P1, DOI 10.1300/J069v26n02_01; Stein MD, 2015, J SUBST ABUSE TREAT, V59, P99, DOI 10.1016/j.jsat.2015.07.002; Streck JM, 2018, EXP CLIN PSYCHOPHARM, V26, P403, DOI 10.1037/pha0000199; Substance Abuse and Mental Health Services Administration, 2018, TREATMENT IMPROVEMEN, V63; Substance Abuse and Mental Health Services Administration, 2019, KEY SUBSTANCE USE ME; Substances Abuse and Mental Health Services Administration, 2020, METH; Sullivan M, 2017, AM J PSYCHIAT, V174, P459, DOI 10.1176/appi.ajp.2016.16050548; Sullivan MA, 2019, AM J PSYCHIAT, V176, P129, DOI 10.1176/appi.ajp.2018.17070732; Suzuki Joji, 2014, J Opioid Manag, V10, P159, DOI 10.5055/jom.2014.0204; Terplan M, 2018, OBSTET GYNECOL, V131, P803, DOI 10.1097/AOG.0000000000002562; Tiet QQ, 2015, JAMA INTERN MED, V175, P1371, DOI 10.1001/jamainternmed.2015.2438; Timko C, 2006, ADDICTION, V101, P678, DOI 10.1111/j.1360-0443.2006.01391.x; Tuchman E, 2006, ADDICT DISORD TREAT, V5, P43, DOI 10.1097/01.adt.0000210713.80198.d1; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; US Department of Health and Human Services, 2019, HHS GUID CLIN APPR D; US Preventive Serv Task Force, 2020, JAMA-J AM MED ASSOC, V323, P970, DOI 10.1001/jama.2020.1123; Vowles KE, 2015, PAIN, V156, P569, DOI 10.1097/01.j.pain.0000460357.01998.f1; Weinstein ZM, 2017, J SUBST ABUSE TREAT, V74, P65, DOI 10.1016/j.jsat.2016.12.010; Weisner C, 2001, JAMA-J AM MED ASSOC, V286, P1715, DOI 10.1001/jama.286.14.1715; Weiss L, 2008, 17 INT AIDS C 3 8 AU; Weiss L, 2011, JAIDS-J ACQ IMM DEF, V56, pS68, DOI 10.1097/QAI.0b013e31820a8226; Weiss RD, 2011, ARCH GEN PSYCHIAT, V68, P1238, DOI 10.1001/archgenpsychiatry.2011.121; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wilson N, 2020, MMWR-MORBID MORTAL W, V69, P290, DOI 10.15585/mmwr.mm6911a4; Wright NMJ, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-3; Zaller Nickolas D, 2010, J Opioid Manag, V6, P365; Zanis DA, 1998, DRUG ALCOHOL DEPEN, V52, P257, DOI 10.1016/S0376-8716(98)00097-0	167	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2021	373								n784	10.1136/bmj.n784	http://dx.doi.org/10.1136/bmj.n784			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ5SO	34011512				2022-12-28	WOS:000655594700011
J	Iacobucci, G				Iacobucci, Gareth			GMC sets targets to end disproportionate complaints against ethnic minority doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		GMC, FAIR REF; GMC, DIFFER ATT	2	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2021	373								n1269	10.1136/bmj.n1269	http://dx.doi.org/10.1136/bmj.n1269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SL5PR	34006527				2022-12-28	WOS:000656970600005
J	Hill, JH; Round, JL				Hill, Jennifer H.; Round, June L.			SnapShot: Microbiota effects on host physiology	CELL			English	Editorial Material									[Hill, Jennifer H.; Round, June L.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Hill, JH (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA.								0	17	18	13	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2796	2796		10.1016/j.cell.2021.04.026	http://dx.doi.org/10.1016/j.cell.2021.04.026		MAY 2021	1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33989551	Bronze			2022-12-28	WOS:000652830800022
J	Mingrone, G; Bornstein, SR				Mingrone, Geltrude; Bornstein, Stefan R.			Gain in survival after metabolic-bariatric surgery	LANCET			English	Editorial Material							POPULATION-BASED COHORT; LIFE EXPECTANCY; MORTALITY		[Mingrone, Geltrude] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Med & Surg Sci, I-00168 Rome, Italy; [Mingrone, Geltrude; Bornstein, Stefan R.] Kings Coll London, Fac Life Sci & Med, Div Diabet & Nutr Sci, London, England; [Bornstein, Stefan R.] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Dept Med 3, Dresden, Germany	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of London; King's College London; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Mingrone, G (corresponding author), Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Med & Surg Sci, I-00168 Rome, Italy.; Mingrone, G (corresponding author), Kings Coll London, Fac Life Sci & Med, Div Diabet & Nutr Sci, London, England.	geltrude.mingrone@unicatt.it						Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/s2213-8587(18)30288-2, 10.1016/S2213-8587(18)30288-2]; Blonde L, 2017, DIABETES VASC DIS RE, V14, P172, DOI 10.1177/1479164116679775; Carlsson LMS, 2020, NEW ENGL J MED, V383, P1535, DOI 10.1056/NEJMoa2002449; Del Re AC, 2014, OBESITY, V22, P1968, DOI 10.1002/oby.20810; Mingrone G, 2021, LANCET, V397, P293, DOI 10.1016/S0140-6736(20)32649-0; Rawshani A, 2018, NEW ENGL J MED, V379, P633, DOI 10.1056/NEJMoa1800256; Svensson E, 2017, DIABETES CARE, V40, P800, DOI 10.2337/dc16-2271; Syn NL, 2021, LANCET, V397, P1830, DOI 10.1016/S0140-6736(21)00591-2; Ward ZJ, 2019, NEW ENGL J MED, V381, P2440, DOI 10.1056/NEJMsa1909301; Wright AK, 2017, DIABETES CARE, V40, P338, DOI 10.2337/dc16-1616	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2021	397	10287					1785	1787		10.1016/S0140-6736(21)00952-1	http://dx.doi.org/10.1016/S0140-6736(21)00952-1		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD0HD	33965072				2022-12-28	WOS:000651041900005
J	Xue, X; Patra, B; van Dijk, JPG; Samkharadze, N; Subramanian, S; Corna, A; Wuetz, BP; Jeon, C; Sheikh, F; Juarez-Hernandez, E; Esparza, BP; Rampurawala, H; Carlton, B; Ravikumar, S; Nieva, C; Kim, S; Lee, HJ; Sammak, A; Scappucci, G; Veldhorst, M; Sebastiano, F; Babaie, M; Pellerano, S; Charbon, E; Vandersypen, LMK				Xue, Xiao; Patra, Bishnu; van Dijk, Jeroen P. G.; Samkharadze, Nodar; Subramanian, Sushil; Corna, Andrea; Paquelet Wuetz, Brian; Jeon, Charles; Sheikh, Farhana; Juarez-Hernandez, Esdras; Esparza, Brando Perez; Rampurawala, Huzaifa; Carlton, Brent; Ravikumar, Surej; Nieva, Carlos; Kim, Sungwon; Lee, Hyung-Jin; Sammak, Amir; Scappucci, Giordano; Veldhorst, Menno; Sebastiano, Fabio; Babaie, Masoud; Pellerano, Stefano; Charbon, Edoardo; Vandersypen, Lieven M. K.			CMOS-based cryogenic control of silicon quantum circuits	NATURE			English	Article							CHIP; DESIGN	The most promising quantum algorithms require quantum processors that host millions of quantum bits when targeting practical applications(1). A key challenge towards large-scale quantum computation is the interconnect complexity. In current solid-state qubit implementations, an important interconnect bottleneck appears between the quantum chip in a dilution refrigerator and the room-temperature electronics. Advanced lithography supports the fabrication of both control electronics and qubits in silicon using technology compatible with complementary metal oxide semiconductors (CMOS)(2). When the electronics are designed to operate at cryogenic temperatures, they can ultimately be integrated with the qubits on the same die or package, overcoming the 'wiring bottleneck'(3-6). Here we report a cryogenic CMOS control chip operating at 3 kelvin, which outputs tailored microwave bursts to drive silicon quantum bits cooled to 20 millikelvin. We first benchmark the control chip and find an electrical performance consistent with qubit operations of 99.99 per cent fidelity, assuming ideal qubits. Next, we use it to coherently control actual qubits encoded in the spin of single electrons confined in silicon quantum dots(7-9) and find that the cryogenic control chip achieves the same fidelity as commercial instruments at room temperature. Furthermore, we demonstrate the capabilities of the control chip by programming a number of benchmarking protocols, as well as the Deutsch-Josza algorithm(10), on a two-qubit quantum processor. These results open up the way towards a fully integrated, scalable silicon-based quantum computer. A cryogenic CMOS control chip operating at 3 K is used to demonstrate coherent control and simple algorithms on silicon qubits operating at 20 mK.	[Xue, Xiao; Patra, Bishnu; van Dijk, Jeroen P. G.; Samkharadze, Nodar; Corna, Andrea; Paquelet Wuetz, Brian; Sammak, Amir; Scappucci, Giordano; Veldhorst, Menno; Sebastiano, Fabio; Babaie, Masoud; Charbon, Edoardo; Vandersypen, Lieven M. K.] Delft Univ Technol, QuTech, Delft, Netherlands; [Xue, Xiao; Patra, Bishnu; van Dijk, Jeroen P. G.; Corna, Andrea; Paquelet Wuetz, Brian; Scappucci, Giordano; Veldhorst, Menno; Charbon, Edoardo; Vandersypen, Lieven M. K.] Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands; [Patra, Bishnu; van Dijk, Jeroen P. G.; Sebastiano, Fabio; Babaie, Masoud] Delft Univ Technol, Dept Quantum & Comp Engn, Delft, Netherlands; [Samkharadze, Nodar; Sammak, Amir] Netherlands Org Appl Sci Res TNO, Delft, Netherlands; [Subramanian, Sushil; Jeon, Charles; Sheikh, Farhana; Rampurawala, Huzaifa; Carlton, Brent; Ravikumar, Surej; Nieva, Carlos; Kim, Sungwon; Lee, Hyung-Jin; Pellerano, Stefano; Charbon, Edoardo; Vandersypen, Lieven M. K.] Intel Corp, Hillsboro, OR USA; [Juarez-Hernandez, Esdras; Esparza, Brando Perez] Intel Guadalajara, Zapopan, Mexico; [Charbon, Edoardo] Ecole Polytech Fed Lausanne EPFL, Lausanne, Switzerland	Delft University of Technology; Delft University of Technology; Delft University of Technology; Netherlands Organization Applied Science Research; Intel Corporation; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Charbon, E; Vandersypen, LMK (corresponding author), Delft Univ Technol, QuTech, Delft, Netherlands.; Charbon, E; Vandersypen, LMK (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands.; Charbon, E; Vandersypen, LMK (corresponding author), Intel Corp, Hillsboro, OR USA.; Charbon, E (corresponding author), Ecole Polytech Fed Lausanne EPFL, Lausanne, Switzerland.	edoardo.charbon@epfl.ch; l.m.k.vandersypen@tudelft.nl	Patra, Bishnu/Z-1649-2019; Wuetz, Brian Paquelet/AAW-4170-2021	Patra, Bishnu/0000-0003-1913-1337; Wuetz, Brian Paquelet/0000-0003-2139-1306; Sheikh, Farhana/0000-0001-5078-0816; Jeon, Charles/0000-0001-8753-5080; Corna, Andrea/0000-0003-2028-3995				Altepeter JB, 2005, ADV ATOM MOL OPT PHY, V52, P105, DOI 10.1016/S1049-250X(05)52003-2; Arute F, 2019, NATURE, V574, P505, DOI 10.1038/s41586-019-1666-5; Bardin JC, 2019, IEEE J SOLID-ST CIRC, V54, P3043, DOI 10.1109/JSSC.2019.2937234; Batey G, 2014, J PHYS CONF SER, V568, DOI 10.1088/1742-6596/568/3/032014; Beckers A, 2018, IEEE J ELECTRON DEVI, V6, P1007, DOI 10.1109/JEDS.2018.2817458; Bonen S, 2019, IEEE ELECTR DEVICE L, V40, P127, DOI 10.1109/LED.2018.2880303; Boter JM, 2019, INT EL DEVICES MEET; DEUTSCH D, 1992, P ROY SOC LOND A MAT, V439, P553, DOI 10.1098/rspa.1992.0167; Ekanayake SR, 2010, IEEE T ELECTRON DEV, V57, P539, DOI 10.1109/TED.2009.2037381; Esmailiyan A, 2020, IEEE SOLID-ST CIRC L, V3, P354, DOI 10.1109/LSSC.2020.3018707; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Geck L, 2020, QUANTUM SCI TECHNOL, V5, DOI 10.1088/2058-9565/ab5e07; Green MA, 2015, IOP CONF SER-MAT SCI, V101, DOI 10.1088/1757-899X/101/1/012001; Hart PAT, 2020, IEEE J ELECTRON DEVI, V8, P797, DOI 10.1109/JEDS.2020.2988730; Huang W, 2019, NATURE, V569, P532, DOI 10.1038/s41586-019-1197-0; Lawrie WIL, 2020, APPL PHYS LETT, V116, DOI 10.1063/5.0002013; Le Guevel L, 2020, ISSCC DIG TECH PAP I, P306, DOI 10.1109/ISSCC19947.2020.9063090; Meunier T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.121403; Mukhanov O, 2019, INT EL DEVICES MEET; Patra B, 2020, IEEE J ELECTRON DEVI, V8, P448, DOI 10.1109/JEDS.2020.2986722; Patra B, 2020, ISSCC DIG TECH PAP I, P304, DOI 10.1109/ISSCC19947.2020.9063109; Patra B, 2018, IEEE J SOLID-ST CIRC, V53, P309, DOI 10.1109/JSSC.2017.2737549; Petit L, 2020, NATURE, V580, P355, DOI 10.1038/s41586-020-2170-7; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Pillarisetty R, 2018, INT EL DEVICES MEET; Pioro-Ladriere M, 2008, NAT PHYS, V4, P776, DOI 10.1038/nphys1053; Preskill J, 2018, QUANTUM-AUSTRIA, V2, DOI 10.22331/q-2018-08-06-79; Reed M., 2013, THESIS YALE U; Sabbagh D, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.014013; SAUL PH, 1988, IEEE J SOLID-ST CIRC, V23, P819, DOI 10.1109/4.323; Srinivasa V, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.196803; Svore KM, 2006, COMPUTER, V39, P74, DOI 10.1109/MC.2006.4; Urdampilleta M, 2019, NAT NANOTECHNOL, V14, P737, DOI 10.1038/s41565-019-0443-9; van Dijk JPG, 2020, IEEE T CIRCUITS-I, V67, P5380, DOI 10.1109/TCSI.2020.3019413; Van Meter Rodney, 2013, Communications of the ACM, V56, P73, DOI 10.1145/2494568; Vandersypen LMK, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0038-y; Vandersypen LMK, 2004, REV MOD PHYS, V76, P1037, DOI 10.1103/RevModPhys.76.1037; Xu Y, 2020, APPL PHYS LETT, V117, DOI 10.1063/5.0012883; Xue X, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021006; Zajac DM, 2018, SCIENCE, V359, P439, DOI 10.1126/science.aao5965; ZINNER E, 1980, SCANNING, V3, P57, DOI 10.1002/sca.4950030202	46	50	50	16	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					205	+		10.1038/s41586-021-03469-4	http://dx.doi.org/10.1038/s41586-021-03469-4			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33981049	Green Published, Green Submitted			2022-12-28	WOS:000649848600010
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Fever, chills, and aches more common when AstraZeneca and Pfizer vaccines are mixed, early data show	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Heath P, 2021, SINGLE BLIND RANDOMI; Shaw RH, 2021, LANCET, V397, P2043, DOI [10.1016/S0140-6736(21)01158-2, 10.1016/S0140-6736(21)01115-6]	2	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1216	10.1136/bmj.n1216	http://dx.doi.org/10.1136/bmj.n1216			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9GP	33980548	Bronze			2022-12-28	WOS:000653055200007
J	Shepherd, A				Shepherd, Alison			Fashion forward face masks on display	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1191	10.1136/bmj.n1191	http://dx.doi.org/10.1136/bmj.n1191			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2ZO	33980504				2022-12-28	WOS:000651243600003
J	Morgan, M				Morgan, Matt			Matt Morgan: Covid helped me travel, with colleagues as guides	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Univ Hosp Wales, Cardiff, Wales	Cardiff University	Morgan, M (corresponding author), Univ Hosp Wales, Cardiff, Wales.	mmorgan@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1177	10.1136/bmj.n1177	http://dx.doi.org/10.1136/bmj.n1177			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975890	Bronze			2022-12-28	WOS:000649711400002
J	Costanzo, M; Hou, J; Messier, V; Nelson, J; Rahman, M; VanderSluis, B; Wang, W; Pons, C; Ross, C; Usaj, M; San Luis, BJ; Shuteriqi, E; Koch, EN; Aloy, P; Myers, CL; Boone, C; Andrews, B				Costanzo, Michael; Hou, Jing; Messier, Vincent; Nelson, Justin; Rahman, Mahfuzur; VanderSluis, Benjamin; Wang, Wen; Pons, Carles; Ross, Catherine; Usaj, Matej; San Luis, Bryan-Joseph; Shuteriqi, Emira; Koch, Elizabeth N.; Aloy, Patrick; Myers, Chad L.; Boone, Charles; Andrews, Brenda			Environmental robustness of the global yeast genetic interaction network	SCIENCE			English	Article							MISSING HERITABILITY; PROTEIN COMPLEXES; GENOME; LANDSCAPE; FITNESS; DELETION; DATABASE; HSP90; MAP	Phenotypes associated with genetic variants can be altered by interactions with other genetic variants (GxG), with the environment (GxE), or both (GxGxE). Yeast genetic interactions have been mapped on a global scale, but the environmental influence on the plasticity of genetic networks has not been examined systematically. To assess environmental rewiring of genetic networks, we examined 14 diverse conditions and scored 30,000 functionally representative yeast gene pairs for dynamic, differential interactions. Different conditions revealed novel differential interactions, which often uncovered functional connections between distantly related gene pairs. However, the majority of observed genetic interactions remained unchanged in different conditions, suggesting that the global yeast genetic interaction network is robust to environmental perturbation and captures the fundamental functional architecture of a eukaryotic cell.	[Costanzo, Michael; Hou, Jing; Messier, Vincent; Ross, Catherine; Usaj, Matej; San Luis, Bryan-Joseph; Shuteriqi, Emira; Boone, Charles; Andrews, Brenda] Univ Toronto, Donnelly Ctr, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Nelson, Justin; Rahman, Mahfuzur; VanderSluis, Benjamin; Wang, Wen; Koch, Elizabeth N.; Myers, Chad L.] Univ Minnesota Twin Cities, Dept Comp Sci & Engn, 200 Union St, Minneapolis, MN 55455 USA; [Nelson, Justin; Rahman, Mahfuzur; Myers, Chad L.] Univ Minnesota Twin Cities, Program Biomed Informat & Computat Biol, 200 Union St, Minneapolis, MN 55455 USA; [Pons, Carles; Aloy, Patrick] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Aloy, Patrick] Inst Catalana Recerca & Estudis Avacats ICREA, Barcelona, Spain; [Boone, Charles; Andrews, Brenda] Univ Toronto, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Boone, Charles] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama, Japan	University of Toronto; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Toronto; RIKEN	Boone, C; Andrews, B (corresponding author), Univ Toronto, Donnelly Ctr, 160 Coll St, Toronto, ON M5S 3E1, Canada.; Myers, CL (corresponding author), Univ Minnesota Twin Cities, Dept Comp Sci & Engn, 200 Union St, Minneapolis, MN 55455 USA.; Myers, CL (corresponding author), Univ Minnesota Twin Cities, Program Biomed Informat & Computat Biol, 200 Union St, Minneapolis, MN 55455 USA.; Boone, C; Andrews, B (corresponding author), Univ Toronto, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada.; Boone, C (corresponding author), RIKEN Ctr Sustainable Resource Sci, Wako, Saitama, Japan.	chadm@umn.edu; charlie.boone@utoronto.ca; brenda.andrews@utoronto.ca	Pons, Carles/B-6841-2016; Usaj, Matej/J-5454-2015; Wang, Wen/E-6320-2012	Pons, Carles/0000-0002-9131-9089; Ross, Catherine/0000-0002-3327-306X; Costanzo, Michael/0000-0002-7906-2604; Hou, Jing/0000-0003-2940-9670; Rahman, AHM Mahfuzur/0000-0002-9226-3988; Usaj, Matej/0000-0003-0675-2847; Messier, Vincent/0000-0003-0476-5425; Wang, Wen/0000-0002-5812-6744	National Institutes of Health [R01HG005853, R01HG005084]; Canadian Institutes of Health Research [FDN-143264, FDN-143265]; National Science Foundation [DBI\0953881]; Ramon y Cajal fellowship [RYC-2017-22959]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); Ramon y Cajal fellowship(Spanish Government)	This work was primarily supported by the National Institutes of Health (R01HG005853) (to B.A., C.B., and C.L.M.), Canadian Institutes of Health Research (FDN-143264 and FDN-143265) (to C.B. and B.A.), National Institutes of Health (R01HG005084) (to C.L.M.), the National Science Foundation (DBI\0953881) (to C.L.M.), and a Ramon y Cajal fellowship (RYC-2017-22959) (to C.P.). Computing resources and data storage services were partially provided by the Minnesota Supercomputing Institute and the UMN Office of Information Technology, respectively. C.B. is a fellow of the Canadian Institute for Advanced Research (CIFAR).	Aitchison JD, 2012, GENETICS, V190, P855, DOI 10.1534/genetics.111.127803; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Baryshnikova A, 2016, CELL SYST, V2, P412, DOI 10.1016/j.cels.2016.04.014; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Bean GJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r123; Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Bloom JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9712; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Costanzo M, 2019, CELL, V177, P85, DOI 10.1016/j.cell.2019.01.033; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Deshpande R., 2017, BIORXIV, DOI [10.1101/159632, DOI 10.1101/159632]; Dilcher M, 2001, J BIOL CHEM, V276, P34537, DOI 10.1074/jbc.M101551200; Fang G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12131-7; Forsberg SKG, 2017, NAT GENET, V49, P497, DOI 10.1038/ng.3800; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guenole A, 2013, MOL CELL, V49, P346, DOI 10.1016/j.molcel.2012.11.023; Hoose SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002590; Hou J, 2019, P NATL ACAD SCI USA, V116, P5045, DOI 10.1073/pnas.1820915116; Huang W., 2016, PLOS GENET, V12, DOI DOI 10.1371/JOURNAL.PGEN.1006421; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Jaffe M, 2019, GENOME RES, V29, P668, DOI 10.1101/gr.246603.118; Kaliszewski P, 2008, ACTA BIOCHIM POL, V55, P649; Kim JJ, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00020; Koch EN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r57; Kofoed M, 2015, G3-GENES GENOM GENET, V5, P1879, DOI 10.1534/g3.115.019174; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; Kramer MH, 2017, MOL CELL, V65, P761, DOI 10.1016/j.molcel.2016.12.024; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuzmin E, 2018, SCIENCE, V360, DOI 10.1126/science.aao1729; Kuzmin E, 2014, METHODS MOL BIOL, V1205, P143, DOI 10.1007/978-1-4939-1363-3_10; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Martin H, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145606; Meldal BHM, 2019, NUCLEIC ACIDS RES, V47, pD550, DOI 10.1093/nar/gky1001; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mullis MN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06023-5; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Phillips P. C., 2000, EPISTASIS EVOLUTIONA; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rizzolo K, 2017, CELL REP, V20, P2735, DOI 10.1016/j.celrep.2017.08.074; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schell R., 2020, GENETIC ARCHITECTURE, DOI [10.1101/2020.04.03.024547, DOI 10.1101/2020.04.03.024547]; Schell R., 2020, 024547 BIORXIV; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Usaj M, 2017, G3-GENES GENOM GENET, V7, P1539, DOI 10.1534/g3.117.040220; van Leeuwen J, 2016, SCIENCE, V354, DOI 10.1126/science.aag0839; Wang W, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006973; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	71	13	13	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					589	+	abf8424	10.1126/science.abf8424	http://dx.doi.org/10.1126/science.abf8424			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958448	Green Accepted, Green Submitted			2022-12-28	WOS:000649103500036
J	Keynejad, R; Baker, N; Lindenberg, U; Pitt, K; Boyle, A; Hawcroft, C				Keynejad, Roxanne; Baker, Natasha; Lindenberg, Ursula; Pitt, Katherine; Boyle, Adrian; Hawcroft, Claire			Identifying and responding to domestic violence and abuse in healthcare settings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTIMATE PARTNER VIOLENCE; RISK-ASSESSMENT; WOMEN; CONSEQUENCES; PREVALENCE; PROGRAM		[Keynejad, Roxanne; Baker, Natasha] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, Sect Womens Mental Hlth, London, England; [Lindenberg, Ursula] VOICES, Bath, Avon, England; [Pitt, Katherine] Wellspring Surg, Nottingham, England; [Boyle, Adrian] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Hawcroft, Claire] Univ Bristol, Bristol Med Sch, Ctr Acad Primary Care, Bristol, Avon, England	University of London; King's College London; University of Cambridge; University of Bristol	Keynejad, R (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, Sect Womens Mental Hlth, London, England.	roxanne.1.keynejad@kcl.ac.uk	, RoxanneKeynejad/N-6276-2018	, RoxanneKeynejad/0000-0003-4434-3526				[Anonymous], 2021, J ECON GEOGR, DOI DOI 10.1093/JEG/LBAB007; Bacchus L, 2004, BJOG-INT J OBSTET GY, V111, P441, DOI 10.1111/j.1471-0528.2004.00108.x; Battaglia TA, 2003, J GEN INTERN MED, V18, P617, DOI 10.1046/j.1525-1497.2003.21013.x; Beynon CE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-473; Bowen E, 2005, BJOG-INT J OBSTET GY, V112, P1083, DOI 10.1111/j.1471-0528.2005.00653.x; Boyle A, 2006, EMERG MED J, V23, P604, DOI 10.1136/emj.2005.031260; Boyle A, 2006, BRIT J GEN PRACT, V56, P258; Boyle A, 2005, J EPIDEMIOL COMMUN H, V59, P909, DOI 10.1136/jech.2004.028597; Boyle A, 2003, EMERG MED J, V20, P438, DOI 10.1136/emj.20.5.438; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Daoud N, 2012, AM J PUBLIC HEALTH, V102, P1893, DOI 10.2105/AJPH.2012.300843; Department of Health, 2012, STRIK BAL PRACT GUID; Dheensa S., 2020, RECORDING SHARING IN; Feder G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13160; Feder G, 2017, GUIDANCE RECORDING D; Feder G, 2011, LANCET, V378, P1788, DOI 10.1016/S0140-6736(11)61179-3; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Fraser E, 2020, IMPACT COVID 19 PAND; Garcia-Moreno C, 2013, PREVALENCE HLTH EFFE; General Medical Council, 2017, CONF GOOD PRACT HAND; Ghandour RM, 2015, J WOMENS HEALTH, V24, P57, DOI 10.1089/jwh.2014.4885; Graham-Harrison Emma, 2020, THE GUARDIAN 0319; Hall M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001581; Halliwell G, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4621-0; Herrenkohl TI, 2008, TRAUMA VIOLENCE ABUS, V9, P84, DOI 10.1177/1524838008314797; Hester M, 2013, EUR J CRIMINOL, V10, P623, DOI 10.1177/1477370813479078; Holly J., 2017, MAPPING MAZE SERVICE; Howarth E, 2016, NIHR J LIB, DOI [10.3310/phr04100, DOI 10.3310/PHR04100, 10.3310/phr04100,1-342]; Hutchinson S, 2014, REBUILDING SHATTERED; IRISi, 2020, GUID GEN PRACT TEAMS; Kelley J, 2019, RECOGNISE RESPOND ST; Kelly J., 2020, BBC NEWS; Khalifeh H, 2015, PSYCHOL MED, V45, P875, DOI 10.1017/S0033291714001962; Lewis G, 2001, WHY MOTHERS REPORT C; McCulloch J., 2016, REV FAMILY VIOLENCE; McLindon E, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0588-y; Morrison J, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000589; National Institute for Health and Care Excellence, 2014, DOM VIOL AB; Office for National Statistics, 2020, DOM AB ENGL WAL OV; Oracle, 2008, JAV LANG KEYW; Parr JM, 2006, SOC SCI MED, V62, P1237, DOI 10.1016/j.socscimed.2005.07.016; Reducing the Risk, 2020, REDUCING RISK DOMEST; Reisenhofer SA, 2019, J INTERPERS VIOLENCE, V34, P337, DOI 10.1177/0886260516640781; Richardson J, 2002, BRIT MED J, V324, P274, DOI 10.1136/bmj.324.7332.274; Roesch E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1712; Rose D, 2011, BRIT J PSYCHIAT, V198, P189, DOI 10.1192/bjp.bp.109.072389; Royal College of General Practitioners, 2020, COVID 19 SAF; Rutherford A, 2007, J EPIDEMIOL COMMUN H, V61, P676, DOI 10.1136/jech.2005.043711; SafeLives, 2017, YOUR CHOIC HON BAS V; Sherif D., 2020, COVID 19 SURGE DOMES; Smith JM, 2020, VIOLENCE AGAINST WOM, V26, P1267, DOI 10.1177/1077801219863876; Snider C, 2009, ACAD EMERG MED, V16, P1208, DOI 10.1111/j.1553-2712.2009.00457.x; Turner E, 2019, BRIT J CRIMINOL, V59, P1013, DOI 10.1093/bjc/azy074; UK Home Office, 2013, INF LOC AR CHANG DEF; Van der Kolk B. A, 2015, BODY KEEPS SCORE MIN; Walby S., 2004, HOME OFFICE RES STUD; Welch J., 2014, ABC DOMESTIC SEXUAL; World Health Organisation, 2013, RESPONDING INTIMATE; World Health Organization, 2019, RESP WOM PREV VIOL W; World Health Organization, 2021, VIOL WOM; World Health Organization, 2013, GLOB REG EST VIOL WO; World Health Organization, 2019, CAR WOM SUBJ VIOL AW; World Health Organization, 2014, HLTH CAR WOM SUBJ IN; World Health Organization & Pan American Health Organization, 2012, UNDERSTANDING ADDRES	67	4	4	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2021	373								n1047	10.1136/bmj.n1047	http://dx.doi.org/10.1136/bmj.n1047			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SB0QT	33962911				2022-12-28	WOS:000649708700003
J	Chibueze, JO; Sakemi, H; Ohmura, T; Machida, M; Akamatsu, H; Akahori, T; Nakanishi, H; Parekh, V; van Rooyen, R; Takeuchi, TT				Chibueze, James O.; Sakemi, Haruka; Ohmura, Takumi; Machida, Mami; Akamatsu, Hiroki; Akahori, Takuya; Nakanishi, Hiroyuki; Parekh, Viral; van Rooyen, Ruby; Takeuchi, Tsutomu T.			Jets from MRC 0600-399 bent by magnetic fields in the cluster Abell 3376	NATURE			English	Article							COLD FRONTS; X-RAY; CHANDRA OBSERVATION; MERGING CLUSTER; GALAXY CLUSTERS; SIMULATIONS; GAS; SUBCLUSTER; CORES	Galaxy clusters are known to harbour magnetic fields, the nature of which remains unresolved. Intra-cluster magnetic fields can be observed at the density contact discontinuity formed by cool and dense plasma running into hot ambient plasma(1,2), and the discontinuity exists(3) near the second-brightest galaxy(4), MRC 0600-399, in the merging galaxy cluster Abell 3376 (redshift 0.0461). Elongated X-ray emission in the east-west direction shows a comet-like structure that reaches the megaparsec scale(5). Previous radio observations(6,7) detected the bent jets from MRC 0600-399, moving in same direction as the sub-cluster, against ram pressure. Here we report radio(8,9) observations of MRC 0600-399 that have 3.4 and 11 times higher resolution and sensitivity, respectively, than the previous results(6). In contrast to typical jets(10,11), MRC 0600-399 shows a 90-degree bend at the contact discontinuity, and the collimated jets extend over 100 kiloparsecs from the point of the bend. We see diffuse, elongated emission that we name 'double-scythe' structures. The spectral index flattens downstream of the bend point, indicating cosmic-ray reacceleration. High-resolution numerical simulations reveal that the ordered magnetic field along the discontinuity has an important role in the change of jet direction. The morphology of the double-scythe jets is consistent with the simulations. Our results provide insights into the effect of magnetic fields on the evolution of the member galaxies and intra-cluster medium of galaxy clusters. Radio observations of the cluster Abell 3376, combined with numerical modelling, attribute the bent jets associated with the second-brightest galaxy in the cluster to an ordered magnetic field at the discontinuity.	[Chibueze, James O.] Northwest Univ, Ctr Space Res, Potchefstroom campus, Potchefstroom, South Africa; [Chibueze, James O.] Univ Nigeria, Fac Phys Sci, Dept Phys & Astron, Nsukka, Nigeria; [Sakemi, Haruka; Ohmura, Takumi] Kyushu Univ, Grad Sch Sci, Fukuoka, Japan; [Machida, Mami] Natl Astron Observ Japan, Div Sci, Tokyo, Japan; [Akamatsu, Hiroki] SRON Netherlands Inst Space Res, Utrecht, Netherlands; [Akahori, Takuya] Natl Astron Observ Japan, Mizusawa VLBI Observ, Tokyo, Japan; [Nakanishi, Hiroyuki] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima, Japan; [Parekh, Viral; van Rooyen, Ruby] South African Radio Astron Observ, Cape Town, South Africa; [Parekh, Viral] Rhodes Univ, Dept Phys & Elect, Makhanda, South Africa; [Takeuchi, Tsutomu T.] Nagoya Univ, Div Particle & Astrophys Sci, Nagoya, Aichi, Japan; [Takeuchi, Tsutomu T.] Inst Stat Math, Res Ctr Stat Machine Learning, Tokyo, Japan; [Ohmura, Takumi] Univ Tokyo, Inst Cosm Ray Res, Chiba, Japan; [Akahori, Takuya] Jodrel Bank Observ, Sq Kilometre Array Org, Operat Div, Macclesfield, Cheshire, England	University of Nigeria; Kyushu University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kagoshima University; Rhodes University; Nagoya University; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; University of Tokyo	Chibueze, JO (corresponding author), Northwest Univ, Ctr Space Res, Potchefstroom campus, Potchefstroom, South Africa.; Chibueze, JO (corresponding author), Univ Nigeria, Fac Phys Sci, Dept Phys & Astron, Nsukka, Nigeria.; Sakemi, H; Ohmura, T (corresponding author), Kyushu Univ, Grad Sch Sci, Fukuoka, Japan.; Ohmura, T (corresponding author), Univ Tokyo, Inst Cosm Ray Res, Chiba, Japan.	james.chibueze@nwu.ac.za; sakemi@phys.kyushu-u.ac.jp; ohmura@phys.kyushu-u.ac.jp	Chibueze, James O./AAI-5422-2020; Parekh, Viral/AAS-6300-2021; Chibueze, James Okwe/AAD-9381-2022	Chibueze, James O./0000-0002-9875-7436; Sakemi, Haruka/0000-0002-4037-1346				Asai N, 2007, ASTROPHYS J, V663, P816, DOI 10.1086/518235; Bagchi J, 2006, SCIENCE, V314, P791, DOI 10.1126/science.1131189; Bicknell GV, 2018, MON NOT R ASTRON SOC, V475, P3493, DOI 10.1093/mnras/sty070; Cavagnolo KW, 2009, ASTROPHYS J SUPPL S, V182, P12, DOI 10.1088/0067-0049/182/1/12; Chen HQ, 2017, ASTROPHYS J, V838, DOI 10.3847/1538-4357/aa64de; Donnert J, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-018-0556-8; Durret F, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322082; Eckert D, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118281; Hallman EJ, 2004, ASTROPHYS J, V610, pL81, DOI 10.1086/423449; Hickish J, 2016, J ASTRON INSTRUM, V5, DOI 10.1142/S2251171716410014; Jonas J., 2016, MEERKAT SCI PATHWAY, V1; JONES TW, 1979, ASTROPHYS J, V234, P818, DOI 10.1086/157561; Kale R, 2012, MON NOT R ASTRON SOC, V426, P1204, DOI 10.1111/j.1365-2966.2012.21519.x; Kenyon JS, 2018, MON NOT R ASTRON SOC, V478, P2399, DOI 10.1093/mnras/sty1221; Koide S, 1996, ASTROPHYS J, V464, P724, DOI 10.1086/177359; Komarov S, 2020, MON NOT R ASTRON SOC, V497, P1434, DOI 10.1093/mnras/staa1986; Lal DV, 2020, ASTRON J, V160, DOI 10.3847/1538-3881/abacd1; Machado REG, 2013, MON NOT R ASTRON SOC, V430, P3249, DOI 10.1093/mnras/stt127; Markevitch M, 2000, ASTROPHYS J, V541, P542, DOI 10.1086/309470; Markevitch M, 2007, PHYS REP, V443, P1, DOI 10.1016/j.physrep.2007.01.001; Matsumoto Y, 2019, PUBL ASTRON SOC JPN, V71, DOI 10.1093/pasj/psz064; Mauch T, 2020, ASTROPHYS J, V888, DOI 10.3847/1538-4357/ab5d2d; McMullin JP, 2007, ASTR SOC P, V376, P127; Nolting C, 2019, ASTROPHYS J, V876, DOI 10.3847/1538-4357/ab16d6; Offringa AR, 2014, MON NOT R ASTRON SOC, V444, P606, DOI 10.1093/mnras/stu1368; Offringa AR, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118497; OWEN FN, 1976, ASTROPHYS J, V205, pL1, DOI 10.1086/182077; Rybicki G.B., 1985, RAD PROCESSES ASTROP, DOI DOI 10.1002/9783527618170.CH5; Sheardown A, 2019, ASTROPHYS J, V874, DOI 10.3847/1538-4357/ab0c06; Tajima T., 2018, PLASMA ASTROPHYSICS, DOI [10.1201/9780429498299, DOI 10.1201/9780429498299]; Takizawa M, 2005, ASTROPHYS J, V629, P791, DOI 10.1086/431927; Urdampilleta I, 2018, ASTRON ASTROPHYS, V618, DOI 10.1051/0004-6361/201732496; Vikhlinin A, 2001, ASTROPHYS J, V551, P160, DOI 10.1086/320078; Walker SA, 2018, NAT ASTRON, V2, P292, DOI 10.1038/s41550-018-0401-8; Wang QHS, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/1/99; Werner N, 2016, MON NOT R ASTRON SOC, V455, P846, DOI 10.1093/mnras/stv2358; ZuHone JA, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/16; ZuHone JA, 2016, J PLASMA PHYS, V82, DOI 10.1017/S0022377816000544	39	8	8	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					47	+		10.1038/s41586-021-03434-1	http://dx.doi.org/10.1038/s41586-021-03434-1			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RY0YD	33953411	Green Submitted			2022-12-28	WOS:000647642900009
J	Battiston, S; Monasterolo, I; Riahi, K; van Ruijven, BJ				Battiston, Stefano; Monasterolo, Irene; Riahi, Keywan; van Ruijven, Bas J.			Accounting for finance is key for climate mitigation pathways	SCIENCE			English	Editorial Material							MODELS		[Battiston, Stefano] Univ Zurich, Dept Banking & Finance, Zurich, Switzerland; [Battiston, Stefano] Ca Foscari Univ Venice, Dept Econ, Venice, Italy; [Monasterolo, Irene] Vienna Univ Econ & Business, Vienna, Austria; [Monasterolo, Irene] Boston Univ, Global Dev Policy Ctr, Boston, MA 02215 USA; [Monasterolo, Irene; Riahi, Keywan; van Ruijven, Bas J.] Int Inst Appl Syst Anal, Laxenburg, Austria; [Riahi, Keywan] Graz Univ Technol, Graz, Austria	University of Zurich; Universita Ca Foscari Venezia; Vienna University of Economics & Business; Boston University; International Institute for Applied Systems Analysis (IIASA); Graz University of Technology	Battiston, S (corresponding author), Univ Zurich, Dept Banking & Finance, Zurich, Switzerland.; Battiston, S (corresponding author), Ca Foscari Univ Venice, Dept Econ, Venice, Italy.	stefano.battiston@uzh.ch	van Ruijven, Bas/G-8106-2011; battiston, stefano/I-2624-2012	van Ruijven, Bas/0000-0003-1232-5892; battiston, stefano/0000-0002-0051-973X	foundation G+B SchwyzerWiniker-Stiftung; European Union's Horizon 2020 research and innovation programme [821010, 821471]; 11th ACRP call project GreenFin [KR18ACOK14634]	foundation G+B SchwyzerWiniker-Stiftung; European Union's Horizon 2020 research and innovation programme; 11th ACRP call project GreenFin	S.B. received funding from the foundation G+B SchwyzerWiniker-Stiftung. I.M. received funding from the 11th ACRP call project GreenFin (grant agreement no.KR18ACOK14634) and from the European Union's Horizon 2020 research and innovation programme under grant 821010 (CASCADES). K.R. and B.J.v.R. received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement 821471 (ENGAGE).	Battiston S, 2017, NAT CLIM CHANGE, V7, P283, DOI [10.1038/nclimate3255, 10.1038/NCLIMATE3255]; Chen Y, 2017, CNS NEUROL DISORD-DR, V16, P5, DOI 10.2174/1871527314666161124115531; Dunz N, 2021, J FINANC STABIL, V54, DOI 10.1016/j.jfs.2021.100872; IPCC, 2018, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Keppo I, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/abe5d8; McCollum DL, 2018, NAT ENERGY, V3, P589, DOI 10.1038/s41560-018-0179-z; McGlade C, 2015, NATURE, V517, P187, DOI 10.1038/nature14016; NGFS, 2020, GUID SUP INT CLIM RE; Pollitt H, 2018, CLIM POLICY, V18, P184, DOI 10.1080/14693062.2016.1277685; Rogge KS, 2018, ENVIRON SCI POLICY, V87, P74, DOI 10.1016/j.envsci.2018.05.009; Roncoroni A, 2021, J FINANC STABIL, V54, DOI 10.1016/j.jfs.2021.100870; UNEP-FI, 2021, DEC DISR UND FIN RIS; Weyant J, 2017, REV ENV ECON POLICY, V11, P115, DOI 10.1093/reep/rew018	13	19	19	8	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2021	372	6545					918	920		10.1126/science.abf3877	http://dx.doi.org/10.1126/science.abf3877			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SK7YO	34016742	Bronze, Green Accepted			2022-12-28	WOS:000656432400030
J	Woolston, C				Woolston, Chris			HOW COVID-19 HAS STOMPED ON RESEARCHER MOBILITY	NATURE			English	Editorial Material						Careers; Policy; SARS-CoV-2; Infection		It could take years to reveal the true impact of closed borders, cancelled travel plans and vaccine delays. It could take years to reveal the true impact of closed borders, cancelled travel plans and vaccine delays.											0	1	1	5	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					613	615		10.1038/d41586-021-01389-x	http://dx.doi.org/10.1038/d41586-021-01389-x			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SG0BP	34021275				2022-12-28	WOS:000653111800001
J	Goldenberg, JZ; Johnston, BC				Goldenberg, Joshua Z.; Johnston, Bradley C.			Low and very low carbohydrate diets for diabetes remission	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Dietary interventions that restrict carbohydrate intake for the management of diabetes are of particular interest to researchers, healthcare providers, and patients. Based on evidence of moderate to low certainty from 23 randomized trials (n=1357), evidence synthesis suggests that patients who adhere to low or very low carbohydrate diets for six months might achieve diabetes remission without adverse consequences. But the definition of low and very low carbohydrate diets, the long term health effects of carbohydrate restricted diets, and the working definitions of diabetes remission are debated, requiring further investigation, particularly for longer term health outcomes based on evidence from randomized trials. Definition of low or very low carbohydrate diets Carbohydrate restriction has a long history of use in the management of diabetes, and authoritative organizations have recently highlighted the potential benefits and harms of low carbohydrate diets.1 The definition of such diets can, however, vary widely and can be confusing to both patients and providers.2 Over the past few decades, the average carbohydrate intake for adults in the United States has been estimated to range between 39% and 51% of daily kilocalories (subsequently referred to as calories).2 Historically, authoritative organizations have recommended carbohydrate intake varying from 45% to 65% of daily calories. Diets with a carbohydrate intake of less than 45% of daily calories therefore have been commonly considered as carbohydrate restricted.3 What is meant by a low carbohydrate diet can vary depending on the reference source. For example, a formal definition was proposed in 2015, defining a low carbohydrate diet as one where less than 26% of daily calories are derived from carbohydrates (<130 g/day),3 yet in its review of the literature the 2019 American Diabetes Association consensus statement on nutrition therapy for diabetes and prediabetes describes "a low-carbohydrate eating pattern as reducing carbohydrates to 26-45% of total calories" (<225 g/day of a 2000 calorie diet).1 The definitions of very low carbohydrate diets also vary (eg, thresholds ranging from <10% to <26% of	[Goldenberg, Joshua Z.; Johnston, Bradley C.] Texas A&M Univ, Dept Nutr, College Stn, TX 77843 USA; [Goldenberg, Joshua Z.] Natl Univ Nat Med, Hetfgott Res Inst, Portland, OR USA; [Johnston, Bradley C.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada	Texas A&M University System; Texas A&M University College Station; McMaster University	Johnston, BC (corresponding author), Texas A&M Univ, Dept Nutr, College Stn, TX 77843 USA.; Johnston, BC (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.	bradley.johnston@tamu.edu						Adam-Perrot A, 2006, OBES REV, V7, P49, DOI 10.1111/j.1467-789X.2006.00222.x; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Captieux M, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003396; Cohen E, 2015, NUTRITION, V31, P727, DOI 10.1016/j.nut.2015.02.007; DuBroff R, 2021, BMJ EVID-BASED MED, V26, P3, DOI 10.1136/bmjebm-2019-111180; Evert AB, 2019, DIABETES CARE, V42, P731, DOI 10.2337/dci19-0014; Feinman RD, 2015, NUTRITION, V31, P1, DOI 10.1016/j.nut.2014.06.011; Goldenberg JZ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4743; Ludwig DS, 2020, J NUTR, V150, P1354, DOI 10.1093/jn/nxz308; Seidelmann SB, 2018, LANCET PUBLIC HEALTH, V3, pE419, DOI 10.1016/S2468-2667(18)30135-X	10	2	2	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2021	373								n262	10.1136/bmj.n262	http://dx.doi.org/10.1136/bmj.n262			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK9UC	34031034	Bronze			2022-12-28	WOS:000656562600009
J	McHugh, MD; Aiken, LH; Sloane, DM; Windsor, C; Douglas, C; Yates, P				McHugh, Matthew D.; Aiken, Linda H.; Sloane, Douglas M.; Windsor, Carol; Douglas, Clint; Yates, Patsy			Effects of nurse-to-patient ratio legislation on nurse staffing and patient mortality, readmissions, and length of stay: a prospective study in a panel of hospitals	LANCET			English	Article							CHARLSON COMORBIDITY INDEX; WORK ENVIRONMENTS; CALIFORNIA; EDUCATION; COUNTRIES; OUTCOMES; MANDATE	Background Substantial evidence indicates that patient outcomes are more favourable in hospitals with better nurse staffing. One policy designed to achieve better staffing is minimum nurse-to-patient ratio mandates, but such policies have rarely been implemented or evaluated. In 2016, Queensland (Australia) implemented minimum nurse-to-patient ratios in selected hospitals. We aimed to assess the effects of this policy on staffing levels and patient outcomes and whether both were associated. Methods For this prospective panel study, we compared Queensland hospitals subject to the ratio policy (27 intervention hospitals) and those that discharged similar patients but were not subject to ratios (28 comparison hospitals) at two timepoints: before implementation of ratios (baseline) and 2 years after implementation (post-implementation). We used standardised Queensland Hospital Admitted Patient Data, linked with death records, to obtain data on patient characteristics and outcomes (30-day mortality, 7-day readmissions, and length of stay [LOS]) for medical-surgical patients and survey data from 17 010 medical-surgical nurses in the study hospitals before and after policy implementation. Survey data from nurses were used to measure nurse staffing and, after linking with standardised patient data, to estimate the differential change in outcomes between patients in intervention and comparison hospitals, and determine whether nurse staffing changes were related to it. Findings We included 231 902 patients (142 986 in intervention hospitals and 88 916 in comparison hospitals) assessed at baseline (2016) and 257 253 patients (160 167 in intervention hospitals and 97 086 in comparison hospitals) assessed in the post-implementation period (2018). After implementation, mortality rates were not significantly higher than at baseline in comparison hospitals (adjusted odds ratio [OR] 1.07, 95% CI 0.97-1.17, p=0.18), but were significantly lower than at baseline in intervention hospitals (0.89, 0.84-0.95, p=0.0003). From baseline to post-implementation, readmissions increased in comparison hospitals (1.06, 1.01-1.12, p=0.015), but not in intervention hospitals (1.00, 0.95-1.04, p=0.92). Although LOS decreased in both groups post-implementation, the reduction was more pronounced in intervention hospitals than in comparison hospitals (adjusted incident rate ratio [IRR] 0.95, 95% CI 0.92-0.99, p=0.010). Staffing changed in hospitals from baseline to post-implementation: of the 36 hospitals with reliable staffing measures, 30 (83%) had more than 4.5 patients per nurse at baseline, with the number decreasing to 21 (58%) post-implementation. The majority of change was at intervention hospitals, and staffing improvements by one patient per nurse produced reductions in mortality (OR 0.93, 95% CI 0.86-0.99, p=0.045), readmissions (0.93, 0.89-0.97, p<0.0001), and LOS (IRR 0.97, 0.94-0.99, p=0.035). In addition to producing better outcomes, the costs avoided due to fewer readmissions and shorter LOS were more than twice the cost of the additional nurse staffing. Interpretation Minimum nurse-to-patient ratio policies are a feasible approach to improve nurse staffing and patient outcomes with good return on investment. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[McHugh, Matthew D.; Aiken, Linda H.; Sloane, Douglas M.] Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Philadelphia, PA 19104 USA; [Windsor, Carol; Douglas, Clint; Yates, Patsy] Queensland Univ Technol, Sch Nursing, Kelvin Grove, Qld, Australia; [Windsor, Carol; Douglas, Clint; Yates, Patsy] Queensland Univ Technol, Fac Hlth, Ctr Healthcare Transformat, Brisbane, Qld, Australia; [Douglas, Clint] Royal Brisbane & Womens Hosp, Metro North Hosp & Hlth Serv, Herston, Qld, Australia	University of Pennsylvania; Queensland University of Technology (QUT); Queensland University of Technology (QUT); Royal Brisbane & Women's Hospital	McHugh, MD (corresponding author), Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Philadelphia, PA 19104 USA.	mchughm@nursing.upenn.edu		Yates, Patsy/0000-0001-8946-8504; Douglas, Clint/0000-0003-4131-5044	Queensland Health, National Institutes of Health, National Institute of Nursing Research	Queensland Health, National Institutes of Health, National Institute of Nursing Research	Queensland Health, National Institutes of Health, National Institute of Nursing Research.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Aiken LH, 2014, LANCET, V383, P1824, DOI 10.1016/S0140-6736(13)62631-8; Aiken LH, 2011, MED CARE, V49, P1047, DOI 10.1097/MLR.0b013e3182330b6e; Aiken LH, 2010, HEALTH SERV RES, V45, P904, DOI 10.1111/j.1475-6773.2010.01114.x; AIKEN M, 1968, AM SOCIOL REV, V33, P912, DOI 10.2307/2092683; Ball JE, 2018, INT J NURS STUD, V78, P10, DOI 10.1016/j.ijnurstu.2017.08.004; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen Michelle, 2018, NATION; Cho E, 2015, INT J NURS STUD, V52, P535, DOI 10.1016/j.ijnurstu.2014.08.006; Dillman D.A., 2014, TAILORED DESIGN METH; Duffield C, 2011, APPL NURS RES, V24, P244, DOI 10.1016/j.apnr.2009.12.004; Fairbrother M, 2014, POLIT SCI RES METH, V2, P119, DOI 10.1017/psrm.2013.24; Gerdtz M F, 2007, J Nurs Manag, V15, P64, DOI 10.1111/j.1365-2934.2006.00657.x; International Council of Nurses, 2018, EV BAS SAF NURS STAF; KAHN KL, 1988, JAMA-J AM MED ASSOC, V260, P3625, DOI 10.1001/jama.260.24.3625; Lasater KB, 2021, BMJ QUAL SAF, V30, P639, DOI 10.1136/bmjqs-2020-011512; Lasater KB, 2021, MED CARE, V59, P444, DOI 10.1097/MLR.0000000000001519; Lasater KB, 2021, AM J INFECT CONTROL, V49, P868, DOI 10.1016/j.ajic.2020.12.002; Lasater KB, 2019, MED CARE, V57, P742, DOI 10.1097/MLR.0000000000001167; Lasater KB, 2016, INT J QUAL HEALTH C, V28, P253, DOI 10.1093/intqhc/mzw007; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Massey DouglasS., 2013, ANN AM ACAD POLIT SS, P645; McHugh MD, 2011, HEALTH AFFAIR, V30, P1299, DOI 10.1377/hlthaff.2010.1118; Nantsupawat A, 2011, J NURS SCHOLARSHIP, V43, P426, DOI 10.1111/j.1547-5069.2011.01419.x; National Research Council, 2013, NONRESPONSE SOCIAL S; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Pensions DfWa, 2021, ANN REP FISC YEAR 20; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Queensland Health, 2020, WAG RAT NURS STREAM; Rafferty AM, 2007, INT J NURS STUD, V44, P175, DOI 10.1016/j.ijnurstu.2006.08.003; Silber JH, 2016, JAMA SURG, V151, P527, DOI 10.1001/jamasurg.2015.4908; Sloane DM, 2018, MED CARE, V56, P1001, DOI 10.1097/MLR.0000000000001002; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Twigg D, 2011, INT J NURS STUD, V48, P540, DOI 10.1016/j.ijnurstu.2010.07.013; Van den Heede K, 2020, HEALTH POLICY, V124, P1064, DOI 10.1016/j.healthpol.2020.08.003; WHO, 2021, 20 YEAR NURS MIDW	36	47	47	5	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1905	1913		10.1016/S0140-6736(21)00768-6	http://dx.doi.org/10.1016/S0140-6736(21)00768-6		MAY 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SF1XN	33989553	Green Published			2022-12-28	WOS:000652556000026
J	Overpeck, JT; Breshears, DD				Overpeck, Jonathan T.; Breshears, David D.			The growing challenge of vegetation change	SCIENCE			English	Editorial Material							TERRESTRIAL		[Overpeck, Jonathan T.] Univ Michigan, Sch Environm & Sustainabil, Ann Arbor, MI 48109 USA; [Breshears, David D.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA	University of Michigan System; University of Michigan; University of Arizona	Overpeck, JT (corresponding author), Univ Michigan, Sch Environm & Sustainabil, Ann Arbor, MI 48109 USA.	overpeck@umich.edu; daveb@email.arizona.edu	Breshears, David D./B-9318-2009; Breshears, David D/GSN-3920-2022	Breshears, David D./0000-0001-6601-0058; 				Anderegg WRL, 2020, SCIENCE, V368, P1327, DOI 10.1126/science.aaz7005; Curtis PG, 2018, SCIENCE, V361, P1108, DOI 10.1126/science.aau3445; Duane A, 2021, CLIMATIC CHANGE, V165, DOI 10.1007/s10584-021-03066-4; Garner AJ, 2018, EARTHS FUTURE, V6, P1603, DOI 10.1029/2018EF000991; Hartmann H, 2018, NEW PHYTOL, V218, P15, DOI 10.1111/nph.15048; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Mottl O, 2021, SCIENCE, V372, P860, DOI 10.1126/science.abg1685; Nolan C, 2018, SCIENCE, V361, P920, DOI 10.1126/science.aan5360; Ruddiman WF, 2013, ANNU REV EARTH PL SC, V41, P45, DOI 10.1146/annurev-earth-050212-123944; Ruthrof KX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31236-5; Stephens SL, 2018, BIOSCIENCE, V68, P77, DOI 10.1093/biosci/bix146; Turner WR, 2007, BIOSCIENCE, V57, P868, DOI 10.1641/B571009; United Nations Climate Change Conference, 2021, C PART COP 26 1 12 N; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	15	10	10	15	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					786	787		10.1126/science.abi9902	http://dx.doi.org/10.1126/science.abi9902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016765				2022-12-28	WOS:000653997000022
J	Bilimoria, KY; Barnard, C				Bilimoria, Karl Y.; Barnard, Cynthia			An Evolving Hospital Quality Star Rating System From CMS Aligning the Stars	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAID SERVICES; CENTERS		[Bilimoria, Karl Y.; Barnard, Cynthia] Northwestern Med, Dept Surg, Surg Outcomes & Qual Improvement Ctr SOQIC, Chicago, IL 60611 USA; [Bilimoria, Karl Y.; Barnard, Cynthia] Northwestern Med, Dept Qual Strategies, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bilimoria, KY (corresponding author), Northwestern Med, Dept Surg, Surg Outcomes & Qual Improvement Ctr SOQIC, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu						Abdullah-Mclaughlin, 2021, CMS WEBINAR 0203; Bilimoria KY, 2016, JAMA-J AM MED ASSOC, V316, P1761, DOI 10.1001/jama.2016.13679; Bilimoria KY., 2019, NEJM CATALYST, DOI [10.1056/CAT.19.0629, DOI 10.1056/CAT.19.0629]; Chung JW, 2019, HEALTH AFFAIR, V38, P1523, DOI 10.1377/hlthaff.2018.05345; DeLancey JO, 2017, JAMA-J AM MED ASSOC, V317, P2015, DOI 10.1001/jama.2017.3148; Department of Health and Human Services Office of the Inspector General, 2017, CMS VAL HOSP INP QUA; Hu JH, 2017, AM J MED QUAL, V32, P605, DOI 10.1177/1062860616684012; The Center for Medicare & Medicaid Services,, OV HOSP QUAL STAR RA	8	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2021	325	21					2151	2152		10.1001/jama.2021.6946	http://dx.doi.org/10.1001/jama.2021.6946		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UK2NJ	33999111				2022-12-28	WOS:000652627900001
J	Dyer, O				Dyer, Owen			Covid-19: India sees record deaths as "black fungus" spreads fear	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, INDIA TODAY; BBC, 2021, BBC; Hoffmann M, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109415; Sharma D., 2021, HINDUSTAN TIMES; Slater J, 2021, WASHINGTON POST; Soutik B., 2021, BBC NEWS; Tyagi Kanika, 2021, Diabetes Metab Syndr, V15, P1007, DOI 10.1016/j.dsx.2021.05.001; World Health Organization, 2021, WEEKL EP UPD COV 19	8	24	24	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2021	373								n1238	10.1136/bmj.n1238	http://dx.doi.org/10.1136/bmj.n1238			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3HS	33985993	Bronze			2022-12-28	WOS:000652650700004
J	Franco, B; Blumenstock, T; Cho, C; Clarisse, L; Clerbaux, C; Coheur, PF; De Maziere, M; De Smedt, I; Dorn, HP; Emmerichs, T; Fuchs, H; Gkatzelis, G; Griffith, DWT; Gromov, S; Hannigan, JW; Hase, F; Hohaus, T; Jones, N; Kerkweg, A; Kiendler-Scharr, A; Lutsch, E; Mahieu, E; Novelli, A; Ortega, I; Paton-Walsh, C; Pommier, M; Pozzer, A; Reimer, D; Rosanka, S; Sander, R; Schneider, M; Strong, K; Tillmann, R; Van Roozendael, M; Vereecken, L; Vigouroux, C; Wahner, A; Taraborrelli, D				Franco, B.; Blumenstock, T.; Cho, C.; Clarisse, L.; Clerbaux, C.; Coheur, P. -F.; De Maziere, M.; De Smedt, I.; Dorn, H. -P.; Emmerichs, T.; Fuchs, H.; Gkatzelis, G.; Griffith, D. W. T.; Gromov, S.; Hannigan, J. W.; Hase, F.; Hohaus, T.; Jones, N.; Kerkweg, A.; Kiendler-Scharr, A.; Lutsch, E.; Mahieu, E.; Novelli, A.; Ortega, I.; Paton-Walsh, C.; Pommier, M.; Pozzer, A.; Reimer, D.; Rosanka, S.; Sander, R.; Schneider, M.; Strong, K.; Tillmann, R.; Van Roozendael, M.; Vereecken, L.; Vigouroux, C.; Wahner, A.; Taraborrelli, D.			Ubiquitous atmospheric production of organic acids mediated by cloud droplets	NATURE			English	Article							BIOMASS BURNING EMISSIONS; OH-INITIATED OXIDATION; FORMIC-ACID; CYCLE 2; CHEMISTRY; MECHANISM; MODEL; INVERSION; AEROSOLS; KINETICS	The oxidation of hydrated formaldehyde from cloud droplets is the dominant source of atmospheric formic acid, increasing atmospheric acidity by reducing cloud and rainwater pH. Atmospheric acidity is increasingly determined by carbon dioxide and organic acids(1-3). Among the latter, formic acid facilitates the nucleation of cloud droplets(4) and contributes to the acidity of clouds and rainwater(1,5). At present, chemistry-climate models greatly underestimate the atmospheric burden of formic acid, because key processes related to its sources and sinks remain poorly understood(2,6-9). Here we present atmospheric chamber experiments that show that formaldehyde is efficiently converted to gaseous formic acid via a multiphase pathway that involves its hydrated form, methanediol. In warm cloud droplets, methanediol undergoes fast outgassing but slow dehydration. Using a chemistry-climate model, we estimate that the gas-phase oxidation of methanediol produces up to four times more formic acid than all other known chemical sources combined. Our findings reconcile model predictions and measurements of formic acid abundance. The additional formic acid burden increases atmospheric acidity by reducing the pH of clouds and rainwater by up to 0.3. The diol mechanism presented here probably applies to other aldehydes and may help to explain the high atmospheric levels of other organic acids that affect aerosol growth and cloud evolution.	[Franco, B.; Cho, C.; Dorn, H. -P.; Emmerichs, T.; Fuchs, H.; Gkatzelis, G.; Hohaus, T.; Kerkweg, A.; Kiendler-Scharr, A.; Novelli, A.; Reimer, D.; Rosanka, S.; Tillmann, R.; Vereecken, L.; Wahner, A.; Taraborrelli, D.] Forschungszentrum Julich, Inst Energy & Climate Res, IEK Troposphere 8, Julich, Germany; [Franco, B.; Clarisse, L.; Clerbaux, C.; Coheur, P. -F.] Univ Libre Bruxelles ULB, Spect Quantum Chem & Atmospher Remote Sensing, Brussels, Belgium; [Blumenstock, T.; Hase, F.; Schneider, M.] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Karlsruhe, Germany; [Clerbaux, C.; Pommier, M.] Sorbonne Univ, CNRS, UVSQ, LATMOS IPSL, Paris, France; [De Maziere, M.; De Smedt, I.; Van Roozendael, M.; Vigouroux, C.] Royal Belgian Inst Space Aeron, Brussels, Belgium; [Griffith, D. W. T.; Jones, N.; Paton-Walsh, C.] Univ Wollongong, Sch Earth Atmospher & Life Sci, Ctr Atmospher Chem, Wollongong, NSW, Australia; [Gromov, S.; Pozzer, A.; Sander, R.] Max Planck Inst Chem, Mainz, Germany; [Gromov, S.] Roshydromet & RAS, Inst Global Climate & Ecol, Moscow, Russia; [Hannigan, J. W.; Ortega, I.] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Lutsch, E.; Strong, K.] Univ Toronto, Dept Phys, Toronto, ON, Canada; [Mahieu, E.] Univ Liege, Inst Astrophys & Geophys, Liege, Belgium; [Pommier, M.] Ricardo Energy & Environm, Harwell, Berks, England	Helmholtz Association; Research Center Julich; Universite Libre de Bruxelles; Helmholtz Association; Karlsruhe Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; University of Wollongong; Max Planck Society; National Center Atmospheric Research (NCAR) - USA; University of Toronto; University of Liege	Franco, B; Taraborrelli, D (corresponding author), Forschungszentrum Julich, Inst Energy & Climate Res, IEK Troposphere 8, Julich, Germany.; Franco, B (corresponding author), Univ Libre Bruxelles ULB, Spect Quantum Chem & Atmospher Remote Sensing, Brussels, Belgium.	bfranco@ulb.ac.be; d.taraborrelli@fz-juelich.de	Clarisse, Lieven/GQQ-4657-2022; Pozzer, Andrea/L-4872-2013; Jones, Nicholas B/G-5575-2011; Kerkweg, Astrid/AAE-9829-2019; Rosanka, Simon/Q-2607-2018; Tillmann, Ralf/I-9203-2012; Vereecken, Luc/D-5025-2016; Gkatzelis, Georgios I./R-1057-2016; Jones, Nicholas/AFU-3135-2022; Taraborrelli, Domenico/O-8668-2015; Lutsch, Erik/AAB-7031-2022; Dorn, Hans-Peter/B-3054-2009; Fuchs, Hendrik/I-9157-2012; FZJUELICH, SAPHIR/O-2271-2017; Novelli, Anna/D-2262-2012; Strong, Kimberly/D-2563-2012; Franco, Bruno/F-9595-2017; Paton-Walsh, Clare/B-2774-2009; Emmerichs, Tamara/Q-2615-2018; Sander, Rolf/A-5725-2011; Gromov, Sergey/G-1224-2013	Clarisse, Lieven/0000-0002-8805-2141; Pozzer, Andrea/0000-0003-2440-6104; Jones, Nicholas B/0000-0002-0111-2368; Rosanka, Simon/0000-0001-5929-163X; Tillmann, Ralf/0000-0003-0648-6622; Vereecken, Luc/0000-0001-7845-684X; Gkatzelis, Georgios I./0000-0002-4608-3695; Jones, Nicholas/0000-0002-0111-2368; Taraborrelli, Domenico/0000-0003-2213-6307; Dorn, Hans-Peter/0000-0001-5945-7708; Fuchs, Hendrik/0000-0003-1263-0061; Novelli, Anna/0000-0003-2077-7573; Strong, Kimberly/0000-0001-9947-1053; Franco, Bruno/0000-0003-0736-458X; Mahieu, Emmanuel/0000-0002-5251-0286; de smedt, isabelle/0000-0002-3541-7725; Paton-Walsh, Clare/0000-0003-1156-4138; Ortega, Ivan/0000-0002-0067-617X; Emmerichs, Tamara/0000-0002-0165-9574; Sander, Rolf/0000-0001-6479-2092; Pommier, Matthieu/0000-0002-3694-0083; Gromov, Sergey/0000-0002-2542-3005				Akagi SK, 2011, ATMOS CHEM PHYS, V11, P4039, DOI 10.5194/acp-11-4039-2011; Alwe HD, 2019, GEOPHYS RES LETT, V46, P2940, DOI 10.1029/2018GL081526; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Assaf E, 2017, ENVIRON SCI TECHNOL, V51, P2170, DOI 10.1021/acs.est.6b06265; Bergamaschi P, 2000, J GEOPHYS RES-ATMOS, V105, P1929, DOI 10.1029/1999JD900819; Butkovskaya NI, 2006, J PHYS CHEM A, V110, P6833, DOI 10.1021/jp056345r; Butkovskaya NI, 2006, J PHYS CHEM A, V110, P13492, DOI 10.1021/jp064993k; Cabrera-Perez D, 2016, ATMOS CHEM PHYS, V16, P6931, DOI 10.5194/acp-16-6931-2016; Caravan RL, 2020, P NATL ACAD SCI USA, V117, P9733, DOI 10.1073/pnas.1916711117; Chaliyakunnel S, 2016, ENVIRON SCI TECHNOL, V50, P5631, DOI 10.1021/acs.est.5b06385; CHAMEIDES WL, 1983, NATURE, V304, P427, DOI 10.1038/304427a0; Chebbi A, 1996, ATMOS ENVIRON, V30, P4233, DOI 10.1016/1352-2310(96)00102-1; Chen X, 2019, ATMOS CHEM PHYS, V19, P9097, DOI 10.5194/acp-19-9097-2019; Clerbaux C, 2009, ATMOS CHEM PHYS, V9, P6041, DOI 10.5194/acp-9-6041-2009; Deckert R, 2011, GEOSCI MODEL DEV, V4, P195, DOI 10.5194/gmd-4-195-2011; Doussin JF, 2013, ATMOS CHEM PHYS, V13, P11625, DOI 10.5194/acp-13-11625-2013; Franco B, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2019GL086239; Franco B, 2018, J GEOPHYS RES-ATMOS, V123, P13963, DOI 10.1029/2018JD029633; GALLOWAY JN, 1982, J GEOPHYS RES-OCEANS, V87, P8771, DOI 10.1029/JC087iC11p08771; Iuga C, 2011, J PHYS CHEM A, V115, P5138, DOI 10.1021/jp201517p; JACOB DJ, 1986, J GEOPHYS RES-ATMOS, V91, P9807, DOI 10.1029/JD091iD09p09807; Jarecka D, 2013, J ATMOS SCI, V70, P2751, DOI 10.1175/JAS-D-13-042.1; Jockel P, 2010, GEOSCI MODEL DEV, V3, P717, DOI 10.5194/gmd-3-717-2010; Kaiser JW, 2012, BIOGEOSCIENCES, V9, P527, DOI 10.5194/bg-9-527-2012; Keene WC, 2015, J ATMOS SCI, V72, P2947, DOI 10.1175/JAS-D-14-0378.1; Kjaer HA, 2016, ENVIRON SCI TECHNOL, V50, P10485, DOI 10.1021/acs.est.6b00026; Krause D., 2018, J LARGE SCALE RES FA, V4, P132, DOI [10.17815/jlsrf-4-121-1, DOI 10.17815/JLSRF-4-121-1]; Lamarque JF, 2010, ATMOS CHEM PHYS, V10, P7017, DOI 10.5194/acp-10-7017-2010; Liu Z, 2018, PHYS CHEM CHEM PHYS, V20, P6970, DOI 10.1039/c7cp08421h; Millet DB, 2015, ATMOS CHEM PHYS, V15, P6283, DOI 10.5194/acp-15-6283-2015; Muller JF, 2019, GEOSCI MODEL DEV, V12, P2307, DOI 10.5194/gmd-12-2307-2019; Mungall EL, 2018, ATMOS CHEM PHYS, V18, P10237, DOI 10.5194/acp-18-10237-2018; Paulot F, 2011, ATMOS CHEM PHYS, V11, P1989, DOI 10.5194/acp-11-1989-2011; Pommier M, 2016, ATMOS CHEM PHYS, V16, P8963, DOI 10.5194/acp-16-8963-2016; Sander R, 1999, SURV GEOPHYS, V20, P1, DOI 10.1023/A:1006501706704; Sander R, 2019, GEOSCI MODEL DEV, V12, P1365, DOI 10.5194/gmd-12-1365-2019; Shaw MF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04824-2; So S, 2014, ENVIRON SCI TECHNOL, V48, P6694, DOI 10.1021/es500319q; Stavrakou T, 2012, NAT GEOSCI, V5, P26, DOI [10.1038/NGEO1354, 10.1038/ngeo1354]; Tost H, 2006, ATMOS CHEM PHYS, V6, P5475, DOI 10.5194/acp-6-5475-2006; Tost H, 2006, ATMOS CHEM PHYS, V6, P565, DOI 10.5194/acp-6-565-2006; Vereecken L, 2017, PHYS CHEM CHEM PHYS, V19, P31599, DOI 10.1039/c7cp05541b; Wang SN, 2020, ENVIRON SCI TECHNOL, V54, P7798, DOI 10.1021/acs.est.0c00526; Winkelman JGM, 2002, CHEM ENG SCI, V57, P4067, DOI 10.1016/S0009-2509(02)00358-5; Yu SC, 2000, ATMOS RES, V53, P185, DOI 10.1016/S0169-8095(00)00037-5; Yuan B, 2015, ATMOS CHEM PHYS, V15, P1975, DOI 10.5194/acp-15-1975-2015	46	26	26	19	66	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					233	+		10.1038/s41586-021-03462-x	http://dx.doi.org/10.1038/s41586-021-03462-x			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33981052	Green Published, hybrid			2022-12-28	WOS:000649848600015
J	Kennedy, SH; Dherange, BD; Berger, KJ; Levin, MD				Kennedy, Sean H.; Dherange, Balu D.; Berger, Kathleen J.; Levin, Mark D.			Skeletal editing through direct nitrogen deletion of secondary amines	NATURE			English	Article							REARRANGEMENT; OXIDATION	Nitrogen is 'deleted' from secondary amines using anomeric amide reagents, which react with the amine to form an isodiazene, after which nitrogen gas is released and the resulting carbon radicals combine to form a carbon-carbon bond. Synthetic chemistry aims to build up molecular complexity from simple feedstocks(1). However, the ability to exert precise changes that manipulate the connectivity of the molecular skeleton itself remains limited, despite possessing substantial potential to expand the accessible chemical space(2,3). Here we report a reaction that 'deletes' nitrogen from organic molecules. We show that N-pivaloyloxy-N-alkoxyamides, a subclass of anomeric amides, promote the intermolecular activation of secondary aliphatic amines to yield intramolecular carbon-carbon coupling products. Mechanistic experiments indicate that the reactions proceed via isodiazene intermediates that extrude the nitrogen atom as dinitrogen, producing short-lived diradicals that rapidly couple to form the new carbon-carbon bond. The reaction shows broad functional-group tolerance, which enables the translation of routine amine synthesis protocols into a strategy for carbon-carbon bond constructions and ring syntheses. This is highlighted by the use of this reaction in the syntheses and skeletal editing of bioactive compounds.	[Kennedy, Sean H.; Dherange, Balu D.; Berger, Kathleen J.; Levin, Mark D.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA	University of Chicago	Levin, MD (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	marklevin@uchicago.edu	Dherange, Balu/GQQ-7208-2022; Dherange, Balu/AAP-8671-2020	Dherange, Balu/0000-0002-4123-5012; Berger, Kathleen/0000-0002-7959-6331; Kennedy, Sean/0000-0002-7422-3114				AYER WA, 1968, ALKALOIDS, V11, P459; Banert K, 2018, J ORG CHEM, V83, P5138, DOI 10.1021/acs.joc.8b00496; Barrett TN, 2011, J NAT PROD, V74, P1980, DOI 10.1021/np200596q; Berger KJ, 2021, ORG BIOMOL CHEM, V19, P11, DOI 10.1039/d0ob01807d; Blakemore DC, 2018, NAT CHEM, V10, P383, DOI 10.1038/s41557-018-0021-z; Brow DG, 2016, J MED CHEM, V59, P4443, DOI 10.1021/acs.jmedchem.5b01409; Brown H. C., 1958, J AM CHEM SOC, V80, P4979, DOI DOI 10.1021/JA01551A055; Cao ZC, 2017, J AM CHEM SOC, V139, P6546, DOI 10.1021/jacs.7b02326; Carpenter BK, 1998, ANGEW CHEM INT EDIT, V37, P3341, DOI 10.1002/(SICI)1521-3773(19981231)37:24<3340::AID-ANIE3340>3.0.CO;2-1; Cernak T, 2016, CHEM SOC REV, V45, P546, DOI 10.1039/c5cs00628g; Chandrasekaran R. Y., 2005, US patent US2005171181A1, Patent No. [2005171181A1, 2005171181]; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; DEALMEIDA MV, 1995, J AM CHEM SOC, V117, P4870, DOI 10.1021/ja00122a018; Donald JR, 2017, CHEM-EUR J, V23, P8780, DOI 10.1002/chem.201700467; Fier PS, 2019, J AM CHEM SOC, V141, P18416, DOI 10.1021/jacs.9b10985; Glover SA, 2005, CAN J CHEM, V83, P1492, DOI 10.1139/V05-150; Glover SA, 2002, J CHEM SOC PERK T 2, P1728, DOI 10.1039/b111250n; Glover SA, 1998, TETRAHEDRON, V54, P7229, DOI 10.1016/S0040-4020(98)00197-5; HERK L, 1961, J AM CHEM SOC, V83, P2998, DOI 10.1021/ja01475a005; HINMAN RL, 1959, J AM CHEM SOC, V81, P3294, DOI 10.1021/ja01522a036; HINSBERG WD, 1978, J AM CHEM SOC, V100, P1608, DOI 10.1021/ja00473a051; Hu Y, 2017, J MED CHEM, V60, P1238, DOI 10.1021/acs.jmedchem.6b01437; Huigens RW, 2013, NAT CHEM, V5, P195, DOI [10.1038/nchem.1549, 10.1038/NCHEM.1549]; Kuznetsov M. A., 1989, RUSS CHEM REV+, V58, P732; LEMAL DM, 1965, J AM CHEM SOC, V87, P393, DOI 10.1021/ja01080a052; Mahjour B, 2020, NATURE, V580, P71, DOI 10.1038/s41586-020-2142-y; Moy B, 2007, NAT REV DRUG DISCOV, V6, P431, DOI 10.1038/nrd2332; MUNCH G, 1994, J NEURAL TRANSM-PARK, V8, P193, DOI 10.1007/BF02260940; Newcomb M., 2012, CHEM BIOL MAT, V1st; Nwachukwu CI, 2020, J ORG CHEM, V85, P9979, DOI 10.1021/acs.joc.0c01274; Plunkett S, 2019, J AM CHEM SOC, V141, P2257, DOI 10.1021/jacs.9b00111; Procopiou G, 2013, ORG LETT, V15, P2030, DOI 10.1021/ol400720b; Roque JB, 2018, NATURE, V564, P244, DOI 10.1038/s41586-018-0700-3; Silva Jr L. F., 2013, STEREOSELECTIVE SYNT, V1; Smaligo AJ, 2019, SCIENCE, V364, P681, DOI 10.1126/science.aaw4212; Strick BF, 2011, J AM CHEM SOC, V133, P14252, DOI 10.1021/ja2066219; Szpilman AM, 2010, ANGEW CHEM INT EDIT, V49, P9592, DOI 10.1002/anie.200904761; Taylor E. C., 2015, SUCCESSFUL DRUG DISC, P157; URRY WH, 1957, J AM CHEM SOC, V79, P6568, DOI 10.1021/ja01581a064; Wager TT, 2011, J MED CHEM, V54, P7602, DOI 10.1021/jm200939b; Xu Y, 2019, NATURE, V567, P373, DOI 10.1038/s41586-019-0926-8; Zou XD, 2017, J ORG CHEM, V82, P4677, DOI 10.1021/acs.joc.7b00308	42	45	45	13	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					223	+		10.1038/s41586-021-03448-9	http://dx.doi.org/10.1038/s41586-021-03448-9			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33981048				2022-12-28	WOS:000649848600013
J	Seltzer, AM; Ng, J; Aeschbach, W; Kipfer, R; Kulongoski, JT; Severinghaus, JP; Stute, M				Seltzer, Alan M.; Ng, Jessica; Aeschbach, Werner; Kipfer, Rolf; Kulongoski, Justin T.; Severinghaus, Jeffrey P.; Stute, Martin			Widespread six degrees Celsius cooling on land during the Last Glacial Maximum	NATURE			English	Article							DISSOLVED NOBLE-GASES; GROUNDWATER RECHARGE; PALEOCLIMATE RECORD; 40 KYR; CLIMATE; TEMPERATURE; AQUIFER; PALEOTEMPERATURES; RECONSTRUCTION; SENSITIVITY	The magnitude of global cooling during the Last Glacial Maximum (LGM, the coldest multimillennial interval of the last glacial period) is an important constraint for evaluating estimates of Earth's climate sensitivity(1,2). Reliable LGM temperatures come from high-latitude ice cores(3,4), but substantial disagreement exists between proxy records in the low latitudes(1,5-8), where quantitative low-elevation records on land are scarce. Filling this data gap, noble gases in ancient groundwater record past land surface temperatures through a direct physical relationship that is rooted in their temperature-dependent solubility in water(9,10). Dissolved noble gases are suitable tracers of LGM temperature because of their complete insensitivity to biological and chemical processes and the ubiquity of LGM-aged groundwater around the globe(11,12). However, although several individual noble gas studies have found substantial tropical LGM cooling(13-16), they have used different methodologies and provide limited spatial coverage. Here we use noble gases in groundwater to show that the low-altitude, low-to-mid-latitude land surface (45 degrees south to 35 degrees north) cooled by 5.8 +/- 0.6 degrees Celsius (mean +/- 95% confidence interval) during the LGM. Our analysis includes four decades of groundwater noble gas data from six continents, along with new records from the tropics, all of which were interpreted using the same physical framework. Our land-based result broadly supports a recent reconstruction based on marine proxy data assimilation(1) that suggested greater climate sensitivity than previous estimates(5-7). Analyses and modelling of noble gases in groundwater show that the mean annual surface temperatures of low-altitude, low-to-mid-latitude land masses were about 6 degrees C cooler during the Last Glacial Maximum than during the Late Holocene.	[Seltzer, Alan M.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA; [Ng, Jessica; Kulongoski, Justin T.; Severinghaus, Jeffrey P.] Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA USA; [Aeschbach, Werner] Heidelberg Univ, Inst Environm Phys, Heidelberg, Germany; [Kipfer, Rolf] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Water Resources & Drinking Water, Dubendorf, Switzerland; [Kipfer, Rolf] ETHZ, Inst Biogeochem & Pollutant Dynam, Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Kipfer, Rolf] ETHZ, Inst Geochem & Petrol, Swiss Fed Inst Technol, Dept Earth Sci, Zurich, Switzerland; [Stute, Martin] Lamont Doherty Earth Observ, Geochem Div, Palisades, NY USA; [Stute, Martin] Barnard Coll, Environm Sci Dept, New York, NY USA	Woods Hole Oceanographic Institution; University of California System; University of California San Diego; Scripps Institution of Oceanography; Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Columbia University	Seltzer, AM (corresponding author), Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA.	aseltzer@whoi.edu	Aeschbach, Werner/C-1026-2008	Aeschbach, Werner/0000-0003-0917-1239; Seltzer, Alan/0000-0003-2870-1215; Stute, Martin/0000-0002-8453-9067				Abouelmagd A, 2014, QUATERNARY RES, V81, P158, DOI 10.1016/j.yqres.2013.10.017; Aeschbach-Hertig W, 2000, NATURE, V405, P1040, DOI 10.1038/35016542; Aeschbach-Hertig W, 2002, GEOCHIM COSMOCHIM AC, V66, P797, DOI 10.1016/S0016-7037(01)00804-3; Aeschbach-Hertig W, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006454; Alvarado JAC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038826; ANDREWS JN, 1979, J HYDROL, V41, P233, DOI 10.1016/0022-1694(79)90064-7; Annan JD, 2013, CLIM PAST, V9, P367, DOI 10.5194/cp-9-367-2013; Bartlein PJ, 2011, CLIM DYNAM, V37, P775, DOI 10.1007/s00382-010-0904-1; Befus KM, 2017, GEOPHYS RES LETT, V44, P5511, DOI 10.1002/2017GL073322; Bereiter B, 2018, NATURE, V553, P39, DOI 10.1038/nature25152; Beyerle U, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016310; Beyerle U, 1998, SCIENCE, V282, P731, DOI 10.1126/science.282.5389.731; Blaser PC, 2010, J QUATERNARY SCI, V25, P1038, DOI 10.1002/jqs.1391; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; Carreira, 1998, PALEOAGUAS AVEIRO; Castro MC, 2007, EARTH PLANET SC LETT, V257, P170, DOI 10.1016/j.epsl.2007.02.030; Cey BD, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010438; Chang J.-H., 1958, GROUND TEMPERATURE; Clark JF, 1997, WATER RESOUR RES, V33, P281, DOI 10.1029/96WR03017; Clark JF, 1998, J HYDROL, V211, P151, DOI 10.1016/S0022-1694(98)00233-9; Edmunds WM, 2006, APPL GEOCHEM, V21, P2148, DOI 10.1016/j.apgeochem.2006.07.016; Farrera I, 1999, CLIM DYNAM, V15, P823, DOI 10.1007/s003820050317; Freundt F, 2013, CHEM GEOL, V339, P283, DOI 10.1016/j.chemgeo.2012.07.026; Ghadiri E, 2018, EARTH PLANET SC LETT, V495, P192, DOI 10.1016/j.epsl.2018.05.019; Hall CM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010951; Hall CM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023582; Han LF, 2016, EARTH-SCI REV, V152, P119, DOI 10.1016/j.earscirev.2015.11.004; HEATON THE, 1986, QUATERNARY RES, V25, P79, DOI 10.1016/0033-5894(86)90045-1; Hersbach H, 2020, Q J ROY METEOR SOC, V146, P1999, DOI 10.1002/qj.3803; Jasechko S, 2017, NAT GEOSCI, V10, P425, DOI [10.1038/NGEO2943, 10.1038/ngeo2943]; Jenkins WJ, 2019, MAR CHEM, V211, P94, DOI 10.1016/j.marchem.2019.03.007; Joshi MM, 2008, CLIM DYNAM, V30, P455, DOI 10.1007/s00382-007-0306-1; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Jung M, 2018, ENVIRON MODELL SOFTW, V103, P120, DOI 10.1016/j.envsoft.2018.02.004; Jung M, 2013, CHEM GEOL, V339, P291, DOI 10.1016/j.chemgeo.2012.08.006; Kendrick MA., 2013, NOBLE GASEGEOCHEMI, P319, DOI [10.1007/978-3-642-28836-4_11, DOI 10.1007/978-3-642-28836-4_11]; Kipfer R, 2002, REV MINERAL GEOCHEM, V47, P615, DOI 10.2138/rmg.2002.47.14; Klein AG, 1999, QUATERNARY SCI REV, V18, P63, DOI 10.1016/S0277-3791(98)00095-X; Klump S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006280; Klump S, 2008, GEOLOGY, V36, P395, DOI 10.1130/G24604A.1; Klump S, 2007, GEOCHIM COSMOCHIM AC, V71, P1385, DOI 10.1016/j.gca.2006.12.006; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Kreuzer AM, 2009, CHEM GEOL, V259, P168, DOI 10.1016/j.chemgeo.2008.11.001; Kulongoski JT, 2009, QUATERNARY SCI REV, V28, P2465, DOI 10.1016/j.quascirev.2009.05.008; Kulongoski JT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019238; Loomis SE, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600815; Ma L, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021766; MANABE S, 1991, J CLIMATE, V4, P785, DOI 10.1175/1520-0442(1991)004<0785:TROACO>2.0.CO;2; Masbruch MD, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012100; MAZOR E, 1972, GEOCHIM COSMOCHIM AC, V36, P1321, DOI 10.1016/0016-7037(72)90065-8; McIntyre A., 1976, Science, V191, P1131, DOI 10.1126/science.191.4232.1131; MELIERES MA, 1991, GLOBAL PLANET CHANGE, V89, P333, DOI 10.1016/0921-8181(91)90115-D; Pepin RO, 2002, REV MINERAL GEOCHEM, V47, P191, DOI 10.2138/rmg.2002.47.7; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Porter SC, 2001, QUATERNARY SCI REV, V20, P1067, DOI 10.1016/S0277-3791(00)00178-5; Powers LA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022014; Prentice IC, 2011, NEW PHYTOL, V189, P988, DOI 10.1111/j.1469-8137.2010.03620.x; RIND D, 1985, QUATERNARY RES, V24, P1, DOI 10.1016/0033-5894(85)90080-8; Saraceno J, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6853-6; Schmittner A, 2011, SCIENCE, V334, P1385, DOI 10.1126/science.1203513; SCHWANDER J, 1989, PHYS CH EAR, V8, P53; Seltzer AM, 2015, EARTH PLANET SC LETT, V431, P206, DOI 10.1016/j.epsl.2015.09.032; Seltzer AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13693-2; Seltzer AM, 2017, WATER RESOUR RES, V53, P2716, DOI 10.1002/2016WR019655; Sonntag, 1992, ISOTOPES NOBLE GASES, P111; Steiger NJ, 2014, J CLIMATE, V27, P426, DOI 10.1175/JCLI-D-12-00693.1; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; STUTE M, 1992, SCIENCE, V256, P1000, DOI 10.1126/science.256.5059.1000; STUTE M, 1995, QUATERNARY RES, V43, P209, DOI 10.1006/qres.1995.1021; STUTE M, 1989, RADIOCARBON, V31, P902; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; Stute M., 1993, PROTEOM, P89, DOI [DOI 10.1016/J.CBD.2016.06.005, DOI 10.1029/GM078P0089]; Stute M., 1998, P SERIES INT ATOMIC, P307; Sundal A, 2019, SCI TOTAL ENVIRON, V660, P1219, DOI 10.1016/j.scitotenv.2018.12.456; Sutton RT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028164; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Tierney JE, 2020, NATURE, V584, P569, DOI 10.1038/s41586-020-2617-x; Trabelsi R, 2020, QUATERN INT, V547, P208, DOI 10.1016/j.quaint.2019.04.001; Varsanyi I, 2011, APPL GEOCHEM, V26, P91, DOI 10.1016/j.apgeochem.2010.11.006; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Weyhenmeyer CE, 2000, SCIENCE, V287, P842, DOI 10.1126/science.287.5454.842; Wieser, 2011, IMPRINTS CLIMATIC EN; Wieser M., 2013, Isotopes in Hydrology, Marine Ecosystems and Climate Change Studies. Proceedings of the International Symposium, P7; Zhu C, 2010, GEOLOGY, V38, P83, DOI 10.1130/G30369.1	84	27	27	8	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					228	+		10.1038/s41586-021-03467-6	http://dx.doi.org/10.1038/s41586-021-03467-6			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33981051	Green Accepted, Green Submitted			2022-12-28	WOS:000649848600014
J	Feinmann, J				Feinmann, Jane			How covid-19 revealed the scandal of medical oxygen supplies worldwide	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], 2021, NEW VAR COR 50 MOR I; Clinton Health Access Initiative, 2021, INV OXYG CLOS ACC GA; Davies M, 2020, LACK OXYGEN LEAVES P; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hossain S., SOMALIA USED WHOS CO; Kaunain K, 2021, INDIAN EXPRESS; Lalwani V, 2021, SCROLL; Lawn JE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000389; PATH, COV 19 OX NEEDS TRAC; Stein F, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002786; WHO, 2021, COVID 19 OX EM IMP M; WHO, PNEUM IS LEAD CAUS D; World Health Organization, 2020, COVID 19 TECHN SPEC	13	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1166	10.1136/bmj.n1166	http://dx.doi.org/10.1136/bmj.n1166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9GP	33980538	Bronze			2022-12-28	WOS:000653055200004
J	Choiniere, JN; Neenan, JM; Schmitz, L; Ford, DP; Chapelle, KEJ; Balanoff, AM; Sipla, JS; Georgi, JA; Walsh, SA; Norell, MA; Xu, X; Clark, JM; Benson, RBJ				Choiniere, Jonah N.; Neenan, James M.; Schmitz, Lars; Ford, David P.; Chapelle, Kimberley E. J.; Balanoff, Amy M.; Sipla, Justin S.; Georgi, Justin A.; Walsh, Stig A.; Norell, Mark A.; Xu, Xing; Clark, James M.; Benson, Roger B. J.			Evolution of vision and hearing modalities in theropod dinosaurs	SCIENCE			English	Article							BIRDS; ECOMORPHOLOGY; DIVERSITY; PATTERNS; INSIGHTS; REPTILES; ANATOMY	Owls and nightbirds are nocturnal hunters of active prey that combine visual and hearing adaptations to overcome limits on sensory performance in low light. Such sensory innovations are unknown in nonavialan theropod dinosaurs and are poorly characterized on the line that leads to birds. We investigate morphofunctional proxies of vision and hearing in living and extinct theropods and demonstrate deep evolutionary divergences of sensory modalities. Nocturnal predation evolved early in the nonavialan lineage Alvarezsauroidea, signaled by extreme low-light vision and increases in hearing sensitivity. The Late Cretaceous alvarezsauroid Shuvuuia deserti had even further specialized hearing acuity, rivaling that of today's barn owl. This combination of sensory adaptations evolved independently in dinosaurs long before the modern bird radiation and provides a notable example of convergence between dinosaurs and mammals.	[Choiniere, Jonah N.; Neenan, James M.; Ford, David P.; Chapelle, Kimberley E. J.; Benson, Roger B. J.] Univ Witwatersrand, Evolutionary Studies Inst, 1 Jan Smuts Ave, ZA-2000 Johannesburg, South Africa; [Neenan, James M.] Univ Oxford, Museum Nat Hist, Parks Rd, Oxford OX1 3PW, England; [Schmitz, Lars] Claremont McKenna Coll, WM Keck Sci Dept, 925 N Mills Ave, Claremont, CA 91711 USA; [Schmitz, Lars] Scripps Coll, 925 N Mills Ave, Claremont, CA 91711 USA; [Schmitz, Lars] Pitzer Coll, 925 N Mills Ave, Claremont, CA 91711 USA; [Schmitz, Lars] Los Angeles Cty Museum Nat Hist, Dinosaur Inst, 900 Exposit Blvd, Los Angeles, CA 90007 USA; [Chapelle, Kimberley E. J.; Balanoff, Amy M.; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, Cent Pk West & 79th St, New York, NY 10024 USA; [Balanoff, Amy M.] Johns Hopkins Univ, Dept Psychol & Brain Sci, 3400 North Charles St, Baltimore, MD 21218 USA; [Sipla, Justin S.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, 51 Newton Rd,100 Bowen Sci Bldg, Iowa City, IA 52242 USA; [Georgi, Justin A.] Midwestern Univ, Coll Grad Studies, Dept Anat, 19555 N 59th Ave, Glendale, AZ 85308 USA; [Walsh, Stig A.] Natl Museums Scotland, Dept Nat Sci, Chambers St, Edinburgh EH1 1JF, Midlothian, Scotland; [Walsh, Stig A.] Univ Edinburgh, Sch Geosci, Grant Inst, Hutton Rd, Edinburgh EH9 3FE, Midlothian, Scotland; [Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, 142 Xizhimenwai St, Beijing 100044, Peoples R China; [Xu, Xing] Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Beijing 100044, Peoples R China; [Clark, James M.] George Washington Univ, Dept Biol Sci, 2029 G St NW, Washington, DC 20052 USA; [Benson, Roger B. J.] Univ Oxford, Dept Earth Sci, South Parks Rd, Oxford OX1 3AN, England	University of Witwatersrand; University of Oxford; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Claremont Colleges; Scripps College; Claremont Colleges; Pitzer College; American Museum of Natural History (AMNH); Johns Hopkins University; University of Iowa; Midwestern University; University of Edinburgh; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; George Washington University; University of Oxford	Benson, RBJ (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, 1 Jan Smuts Ave, ZA-2000 Johannesburg, South Africa.; Benson, RBJ (corresponding author), Univ Oxford, Dept Earth Sci, South Parks Rd, Oxford OX1 3AN, England.	roger.benson@earth.ox.ac.uk	Chapelle, Kimberley/ABD-7871-2020; Neenan, James/A-3941-2012	Chapelle, Kimberley/0000-0002-9991-0439; Balanoff, Amy/0000-0003-4030-3818; Sipla, Justin/0000-0001-8171-8126; Neenan, James/0000-0002-8215-5748; Choiniere, Jonah/0000-0002-1008-0687	European Union [677774]; Leverhulme Trust [ECF-2017-360]; NERC [NE/H012176/1]; National Research Foundation of South Africa [118994, 98800, 95449]; Kalbfleish Fellowship through the Richard Gilder Graduate School of the American Museum of Natural History; National Natural Science Foundation of China [41688103]; Strategic Priority, Research Program of the Chinese Academy of Sciences [XDB18000000]; National Science Foundation of the USA [DEB 1801224, EAR 1636753]; Paleontological Scientific Trust; DSI/NSF Center of Excellence Paleosciences; Jurassic Foundation; Institute for Global/Local Action & Study, Pitzer College	European Union(European Commission); Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Research Foundation of South Africa(National Research Foundation - South Africa); Kalbfleish Fellowship through the Richard Gilder Graduate School of the American Museum of Natural History; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority, Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of the USA(National Science Foundation (NSF)); Paleontological Scientific Trust; DSI/NSF Center of Excellence Paleosciences; Jurassic Foundation; Institute for Global/Local Action & Study, Pitzer College	Funding was received from the European Union's Horizon 2020 research and innovation program 2014-2018, starting grant (R.B. J.B., 677774); Leverhulme Trust (J.M. N., ECF-2017-360); NERC (S.A.W., NE/H012176/1); National Research Foundation of South Africa (J.N. C.; 118994, 98800, and 95449); Kalbfleish Fellowship through the Richard Gilder Graduate School of the American Museum of Natural History (J.N.C. and K.E. J.C.); the National Natural Science Foundation of China (X.X., 41688103); Strategic Priority, Research Program of the Chinese Academy of Sciences (X.X., XDB18000000); National Science Foundation of the USA (A. M.B., M.A.N., and J. M.C.; DEB 1801224 and EAR 1636753); Paleontological Scientific Trust (J. N.C. and K.E. J.C.); DSI/NSF Center of Excellence Paleosciences (J.N.C. and K.E.J.C.); Jurassic Foundation (J.S.S. and J.A.G.); and Institute for Global/Local Action & Study, Pitzer College (L.S.).	Agnolin FL, 2012, CRETACEOUS RES, V35, P33, DOI 10.1016/j.cretres.2011.11.014; Andres B, 2012, EARTH ENV SCI T R SO, V103, P383, DOI 10.1017/S1755691013000303; Bapst D.W., 2014, MODERN PHYLOGENETIC, P515, DOI [10.1007/978-3-662-43550-2_22, DOI 10.1007/978-3-662-43550-2_22]; Barrett PM, 2014, ANNU REV EARTH PL SC, V42, P207, DOI 10.1146/annurev-earth-042711-105515; Benson R., 2021, **DATA OBJECT**, DOI [10.17605/OSF.IO/TEQ73, DOI 10.17605/OSF.IO/TEQ73]; Benson R., OSF; Benson RBJ, 2017, J ANAT, V231, P990, DOI 10.1111/joa.12726; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benson RBJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4567; Choiniere Jonah N., 2014, American Museum Novitates, V3816, P1; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Davies KTJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061998; Ekdale EG, 2016, J ANAT, V228, P324, DOI 10.1111/joa.12308; Evers SW, 2019, ZOOL J LINN SOC-LOND, V187, P800, DOI 10.1093/zoolinnean/zlz063; Gaston KJ, 2019, AM NAT, V193, P481, DOI 10.1086/702250; Gleich O, 2005, NATURWISSENSCHAFTEN, V92, P595, DOI 10.1007/s00114-005-0050-5; Gleich O, 2011, HEARING RES, V273, P80, DOI 10.1016/j.heares.2010.01.009; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; KONISHI M, 1973, AM SCI, V61, P414; Lautenschlager S, 2014, J VERTEBR PALEONTOL, V34, P1263, DOI 10.1080/02724634.2014.874529; Longrich NR, 2009, CRETACEOUS RES, V30, P239, DOI 10.1016/j.cretres.2008.07.005; Luo ZX, 2016, SPRINGER HANDB AUDIT, V59, P139, DOI 10.1007/978-3-319-46661-3_6; Martin GR, 2012, J ORNITHOL, V153, pS23, DOI 10.1007/s10336-011-0771-5; Muller J, 2018, ANNU REV EARTH PL SC, V46, P495, DOI 10.1146/annurev-earth-082517-010120; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Payne R. S., 1958, Natural History New York, V67, P316; PAYNE RS, 1971, J EXP BIOL, V54, P535; Perle A., 1994, AM MUS NOVIT, V3105, P1; Pinheiro J., 2019, R PACKAGE VERSION 3; R Core Team, 2013, R PROJECT STAT COMPU, DOI 10.9774/GLEAF.978-1-909493-38-4_2; Schlosser G, 2018, INTEGR COMP BIOL, V58, P301, DOI 10.1093/icb/icy024; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Schmitz L, 2010, VISION RES, V50, P936, DOI 10.1016/j.visres.2010.03.009; Schmitz L, 2009, J MORPHOL, V270, P759, DOI 10.1002/jmor.10720; Senter P, 2005, PALEOBIOLOGY, V31, P373, DOI 10.1666/0094-8373(2005)031[0373:FITSFO]2.0.CO;2; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Wu YH, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2185; Xu X, 2018, CURR BIOL, V28, P2853, DOI 10.1016/j.cub.2018.07.057; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zelenitsky DK, 2011, P ROY SOC B-BIOL SCI, V278, P3625, DOI 10.1098/rspb.2011.0238; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009	47	11	11	6	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					610	+		10.1126/science.abe7941	http://dx.doi.org/10.1126/science.abe7941			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958472	Green Submitted			2022-12-28	WOS:000649103500041
J	Lau, HK; Clerk, AA				Lau, Hoi-Kwan; Clerk, Aashish A.			Macroscale entanglement and measurement	SCIENCE			English	Editorial Material									[Lau, Hoi-Kwan] Simon Fraser Univ, Dept Phys, Burnaby, BC, Canada; [Clerk, Aashish A.] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA	Simon Fraser University; University of Chicago	Clerk, AA (corresponding author), Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA.	aaclerk@uchicago.edu						Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Braginsky V. B., 1992, QUANTUM MEASUREMENT; Clerk AA, 2020, NAT PHYS, V16, P257, DOI 10.1038/s41567-020-0797-9; de Lepinay L.Mercier, 2021, SCIENCE, V372, P625; Kotler S, 2021, SCIENCE, V372, P622, DOI 10.1126/science.abf2998; Lecocq F, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041037; Moller CB, 2017, NATURE, V547, P191, DOI 10.1038/nature22980; Ockeloen-Korppi CF, 2018, NATURE, V556, P478, DOI 10.1038/s41586-018-0038-x; Ockeloen-Korppi CF, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.140401; Polzik ES, 2015, ANN PHYS-BERLIN, V527, pA15, DOI 10.1002/andp.201400099; Riedinger R, 2018, NATURE, V556, P473, DOI 10.1038/s41586-018-0036-z; Shomroni I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10024-3; Suh J, 2014, SCIENCE, V344, P1262, DOI 10.1126/science.1253258; Tsang M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031016; Woolley MJ, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063846	15	2	2	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					570	571		10.1126/science.abh3419	http://dx.doi.org/10.1126/science.abh3419			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA2AW	33958461				2022-12-28	WOS:000649103500023
J	Speakman, JR; Hall, KD				Speakman, John R.; Hall, Kevin D.			Carbohydrates, insulin, and obesity	SCIENCE			English	Editorial Material							ENERGY-EXPENDITURE; WEIGHT-LOSS; LOW-FAT; OVERWEIGHT; SECRETION; DIET		[Speakman, John R.] Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Energy Metab & Reprod, Shenzhen, Peoples R China; [Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China; [Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Speakman, John R.] CAS Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China; [Hall, Kevin D.] NIDDK, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Aberdeen; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Speakman, JR (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Energy Metab & Reprod, Shenzhen, Peoples R China.; Speakman, JR (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.; Speakman, JR (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.; Speakman, JR (corresponding author), CAS Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China.	j.speakman@abdn.ac.uk; kevinh@niddk.nih.gov	Hall, Kevin/F-2383-2010	Hall, Kevin/0000-0003-4062-3133	1000 Talents Program; Chinese Academy of Sciences President's International Fellowship Initiative (PIFI); UK Royal Society; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases	1000 Talents Program; Chinese Academy of Sciences President's International Fellowship Initiative (PIFI); UK Royal Society(Royal Society of London); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	J.R.S.is supported by the 1000 Talents Program, a professorial fellowship from the Chinese Academy of Sciences President's International Fellowship Initiative (PIFI), and a Wolfson Research Merit Award from the UK Royal Society. K.D.H. is supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.	Carpentier AC, 2021, AM J PHYSIOL-ENDOC M, V320, pE653, DOI 10.1152/ajpendo.00620.2020; Ebbeling CB, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4583; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Gardner CD, 2018, JAMA-J AM MED ASSOC, V319, P667, DOI 10.1001/jama.2018.0245; Guo JE, 2019, OBESITY, V27, P420, DOI 10.1002/oby.22389; Hall KD, 2021, NAT MED, V27, P344, DOI 10.1038/s41591-020-01209-1; Hall KD, 2019, INT J OBESITY, V43, P2350, DOI 10.1038/s41366-019-0456-3; Hall KD, 2016, AM J CLIN NUTR, V104, P324, DOI 10.3945/ajcn.116.133561; Hall KD, 2015, CELL METAB, V22, P427, DOI 10.1016/j.cmet.2015.07.021; Hu SM, 2020, MOL METAB, V32, P27, DOI 10.1016/j.molmet.2019.11.010; Huang ZX, 2020, OBESITY, V28, P2098, DOI 10.1002/oby.22955; Ludwig DS, 2018, JAMA INTERN MED, V178, P1098, DOI 10.1001/jamainternmed.2018.2933; Shimy KJ, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa062; Templeman NM, 2017, J ENDOCRINOL, V232, pR173, DOI [10.1530/JOE-16-0449, 10.1530/joe-16-0449]; Trico D, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124912	15	16	16	10	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					577	578		10.1126/science.aav0448	http://dx.doi.org/10.1126/science.aav0448			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA2AW	33958466				2022-12-28	WOS:000649103500028
J	Martinon-Torres, M; d'Errico, F; Santos, E; Gallo, AA; Amano, N; Archer, W; Armitage, SJ; Arsuaga, JL; de Castro, JMB; Blinkhorn, J; Crowther, A; Douka, K; Dubernet, S; Faulkner, P; Fernandez-Colon, P; Kourampas, N; Garcia, JG; Larreina, D; Le Bourdonnec, FX; MacLeod, G; Martin-Frances, L; Massilani, D; Mercader, J; Miller, JM; Ndiema, E; Notario, B; Marti, AP; Prendergast, ME; Queffelec, A; Rigaud, S; Roberts, P; Shoaee, MJ; Shipton, C; Simpson, I; Boivin, N; Petraglia, MD				Martinon-Torres, Maria; d'Errico, Francesco; Santos, Elena; Alvaro Gallo, Ana; Amano, Noel; Archer, William; Armitage, Simon J.; Arsuaga, Juan Luis; de Castro, Jose Maria Bermudez; Blinkhorn, James; Crowther, Alison; Douka, Katerina; Dubernet, Stephan; Faulkner, Patrick; Fernandez-Colon, Pilar; Kourampas, Nikos; Gonzalez Garcia, Jorge; Larreina, David; Le Bourdonnec, Francois-Xavier; MacLeod, George; Martin-Frances, Laura; Massilani, Diyendo; Mercader, Julio; Miller, Jennifer M.; Ndiema, Emmanuel; Notario, Belen; Pitarch Marti, Africa; Prendergast, Mary E.; Queffelec, Alain; Rigaud, Solange; Roberts, Patrick; Shoaee, Mohammad Javad; Shipton, Ceri; Simpson, Ian; Boivin, Nicole; Petraglia, Michael D.			Earliest known human burial in Africa	NATURE			English	Article							MIDDLE PALEOLITHIC BURIAL; MOLAR ENAMEL THICKNESS; PERSONAL ORNAMENTS; LOS HUESOS; STONE-AGE; MORPHOMETRIC-ANALYSIS; GENOME SEQUENCE; DENTAL REMAINS; ATAPUERCA-SIMA; ANCIENT BONES	The earliest known human burial in Africa, that of a young child, is dated to around 78,000 years ago. The origin and evolution of hominin mortuary practices are topics of intense interest and debate(1-3). Human burials dated to the Middle Stone Age (MSA) are exceedingly rare in Africa and unknown in East Africa(1-6). Here we describe the partial skeleton of a roughly 2.5- to 3.0-year-old child dating to 78.3 +/- 4.1 thousand years ago, which was recovered in the MSA layers of Panga ya Saidi (PYS), a cave site in the tropical upland coast of Kenya(7,8). Recent excavations have revealed a pit feature containing a child in a flexed position. Geochemical, granulometric and micromorphological analyses of the burial pit content and encasing archaeological layers indicate that the pit was deliberately excavated. Taphonomical evidence, such as the strict articulation or good anatomical association of the skeletal elements and histological evidence of putrefaction, support the in-place decomposition of the fresh body. The presence of little or no displacement of the unstable joints during decomposition points to an interment in a filled space (grave earth), making the PYS finding the oldest known human burial in Africa. The morphological assessment of the partial skeleton is consistent with its assignment to Homo sapiens, although the preservation of some primitive features in the dentition supports increasing evidence for non-gradual assembly of modern traits during the emergence of our species. The PYS burial sheds light on how MSA populations interacted with the dead.	[Martinon-Torres, Maria; Alvaro Gallo, Ana; de Castro, Jose Maria Bermudez; Fernandez-Colon, Pilar; Larreina, David; Martin-Frances, Laura; Notario, Belen] CENIEH Natl Res Ctr Human Evolut, Burgos, Spain; [Martinon-Torres, Maria; de Castro, Jose Maria Bermudez; Martin-Frances, Laura] UCL, Anthropol Dept, London, England; [d'Errico, Francesco; Pitarch Marti, Africa; Queffelec, Alain; Rigaud, Solange] Univ Bordeaux, Prehistoire Actuel Culture Environm & Anthropol P, CNRS, UMR 5199, Talence, France; [d'Errico, Francesco; Armitage, Simon J.] Univ Bergen, SFF Ctr Early Sapiens Behav SapienCE, Bergen, Norway; [Santos, Elena; Arsuaga, Juan Luis] Inst Salud Carlos III, Ctr Mixto UCM ISCIII Evoluc & Comportamiento Hum, Madrid, Spain; [Santos, Elena] Univ Alcala, Catedra Otoacust Evolut & Paleoantropol, Dept Ciencias Vida, HM Hosp, Alcala De Henares, Spain; [Amano, Noel; Blinkhorn, James; Crowther, Alison; Douka, Katerina; Faulkner, Patrick; Mercader, Julio; Miller, Jennifer M.; Ndiema, Emmanuel; Roberts, Patrick; Shoaee, Mohammad Javad; Boivin, Nicole; Petraglia, Michael D.] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Archer, William] Natl Museum, Dept Archaeol & Anthropol, Bloemfontein, South Africa; [Archer, William] Univ Cape Town, Dept Archaeol, Cape Town, South Africa; [Archer, William] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Armitage, Simon J.; Blinkhorn, James] Univ London, Dept Geog, Royal Holloway, Egham, Surrey, England; [Arsuaga, Juan Luis] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Blinkhorn, James] Max Planck Inst Sci Human Hist, Pan African Evolut Res Grp, Jena, Germany; [Crowther, Alison; Roberts, Patrick; Boivin, Nicole; Petraglia, Michael D.] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Douka, Katerina] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Dubernet, Stephan; Le Bourdonnec, Francois-Xavier] Univ Bordeaux Montaigne, Ctr Rech Phys Appl Archeol, IRAMAT CRP2A Inst Rech Archeomateriaux, CNRS,Maison Archeol,UMR 5060, Pessac, France; [Faulkner, Patrick] Univ Sydney, Dept Archaeol, Fac Arts & Social Sci, Sydney, NSW, Australia; [Kourampas, Nikos; Simpson, Ian] Univ Edinburgh, Ctr Open Learning, Edinburgh, Midlothian, Scotland; [Kourampas, Nikos; MacLeod, George] Univ Stirling, Biol & Environm Sci, Stirling, Scotland; [Gonzalez Garcia, Jorge] Univ S Florida, Digital Heritage & Humanities Collect, Tampa, FL 33620 USA; [Massilani, Diyendo] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Mercader, Julio; Boivin, Nicole] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB, Canada; [Ndiema, Emmanuel] Natl Museums Kenya, Dept Earth Sci, Nairobi, Kenya; [Pitarch Marti, Africa] Univ Barcelona, Fac Geog & Hist, Dept Hist & Arqueol, Seminari Estudis & Recerques Prehistor SERP, Barcelona, Spain; [Prendergast, Mary E.] Rice Univ, Dept Anthropol, Houston, TX USA; [Shipton, Ceri] UCL, Inst Archaeol, London, England; [Shipton, Ceri] Australian Natl Univ, Ctr Excellence Australian Biodivers & Herita, Canberra, ACT, Australia; [Boivin, Nicole] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA; [Petraglia, Michael D.] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; [Petraglia, Michael D.] Griffith Univ, Australian Res Ctr Human Evolut ARCHE, Brisbane, Qld, Australia	Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Bergen; Instituto de Salud Carlos III; Universidad de Alcala; University of Cape Town; Max Planck Society; University of London; Royal Holloway University London; Complutense University of Madrid; University of Queensland; University of Oxford; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Orleans; Universite de Technologie de Belfort-Montbeliard (UTBM); CNRS - Institute for Humanities & Social Sciences (INSHS); University of Sydney; University of Edinburgh; University of Stirling; State University System of Florida; University of South Florida; Max Planck Society; University of Calgary; University of Barcelona; Rice University; University of London; University College London; Australian National University; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; Griffith University	Martinon-Torres, M (corresponding author), CENIEH Natl Res Ctr Human Evolut, Burgos, Spain.; Martinon-Torres, M (corresponding author), UCL, Anthropol Dept, London, England.; Boivin, N; Petraglia, MD (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany.; Boivin, N; Petraglia, MD (corresponding author), Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia.; Boivin, N (corresponding author), Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB, Canada.; Boivin, N (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA.; Petraglia, MD (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA.; Petraglia, MD (corresponding author), Griffith Univ, Australian Res Ctr Human Evolut ARCHE, Brisbane, Qld, Australia.	maria.martinon@cenieh.es; boivin@shh.mpg.de; petraglia@shh.mpg.de	Petraglia, Michael/ABA-9748-2021; Armitage, Simon J/K-7471-2015; Rigaud, Solange/ABF-4684-2021; Amano, Noel/AGQ-3028-2022; Crowther, Alison/AAR-9872-2021; Santos, Elena/H-5558-2015; Le Bourdonnec, François-Xavier/G-3824-2018; Douka, Katerina/L-3287-2014; Crowther, Alison/B-7854-2016; Alvaro Gallo, Ana/H-9229-2015	Armitage, Simon J/0000-0003-1480-9188; Rigaud, Solange/0000-0002-9108-200X; Amano, Noel/0000-0002-7871-2230; Santos, Elena/0000-0002-6012-6313; Le Bourdonnec, François-Xavier/0000-0002-1051-5337; Roberts, Patrick/0000-0002-4403-7548; Douka, Katerina/0000-0002-0558-0011; Fernandez-Colon, Pilar/0000-0002-2779-9428; Crowther, Alison/0000-0002-2394-1917; Archer, Will/0000-0003-1174-0605; Martin-Frances Martin de la Fuente, Laura/0000-0001-5853-5014; Pitarch Marti, Africa/0000-0002-8396-9487; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; Dubernet, Stephan/0000-0003-4278-3501; Alvaro Gallo, Ana/0000-0002-1523-7831; Martinon-Torres, Maria/0000-0002-2750-4554; Massilani, Diyendo/0000-0003-2661-4468; BOIVIN, NICOLE/0000-0002-7783-4199; Queffelec, Alain/0000-0002-9763-7600; Petraglia, Michael/0000-0003-2522-5727				AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Babay S, 2015, J MOL STRUCT, V1085, P286, DOI 10.1016/j.molstruc.2014.12.067; Backwell L, 2020, PALAEOGEOGR PALAEOCL, V560, DOI 10.1016/j.palaeo.2020.109989; Bailey S.E., 2006, P191, DOI 10.1007/978-1-4020-5121-0_10; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bayle P., 2011, WISSENSCHAFTLICHE SC, P29; BEAUMONT PB, 1978, S AFR J SCI, V74, P409; Bellot-Gurlet L, 2009, J NANO RES-SW, V8, P147, DOI 10.4028/www.scientific.net/JNanoR.8.147; Blaizot F, 2011, ESPACES FUNERAIRES H; Blegen N, 2015, QUATERNARY SCI REV, V122, P89, DOI 10.1016/j.quascirev.2015.04.024; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Brooks AS, 2018, SCIENCE, V360, P90, DOI 10.1126/science.aao2646; Bullock P., 1985, Handbook for soil thin section description.; Carbonell E, 2006, CR PALEVOL, V5, P155, DOI 10.1016/j.crpv.2005.11.010; Carlsen O., 1987, DENT MORPHOLOGY CLAS; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; Cooke HBS, 1945, MAN, V45, P6, DOI 10.2307/2793006; D'Errico F, 2020, J HUM EVOL, V141, DOI 10.1016/j.jhevol.2019.102737; d'Errico F, 2016, J HUM EVOL, V93, P91, DOI 10.1016/j.jhevol.2016.01.002; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; de Castro JMB, 2001, J HUM EVOL, V41, P195, DOI 10.1006/jhev.2001.0491; Defleur A, 1993, SEPULTURES MOUSTERIE; Dirks PHGM, 2015, ELIFE, V4, DOI 10.7554/eLife.09561; Downs R. T., 2006, 19 GEN M INT MIN ASS, pO03; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Du J, 2012, MIXDIST FINITE MIXTU; Duday A., 2006, SOCIAL ARCHAEOLOGY F, P30; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx033; Gargett RH, 1999, J HUM EVOL, V37, P27, DOI 10.1006/jhev.1999.0301; Glocke I, 2017, GENOME RES, V27, P1230, DOI 10.1101/gr.219675.116; Graham R. D, 1988, MANGANESE SOILS PLAN, P75, DOI DOI 10.1007/978-94-009-2817-6_6; Grine FE, 2000, J HUM EVOL, V38, P129, DOI 10.1006/jhev.1999.0353; Grove  M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237528; Guo YJ, 2017, J QUATERNARY SCI, V32, P540, DOI 10.1002/jqs.2949; HACKETT CJ, 1981, MED SCI LAW, V21, P243, DOI 10.1177/002580248102100403; Hanesch M, 2009, GEOPHYS J INT, V177, P941, DOI 10.1111/j.1365-246X.2009.04122.x; HEDGES REM, 1995, J ARCHAEOL SCI, V22, P201, DOI 10.1006/jasc.1995.0022; Henshilwood CS, 2018, NATURE, V562, P115, DOI 10.1038/s41586-018-0514-3; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Hollund HI, 2012, INT J OSTEOARCHAEOL, V22, P537, DOI 10.1002/oa.1273; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; International Organization for Standardization, 2009, 133202009 ISO; Jans MME, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P397, DOI 10.1007/978-3-540-77598-0_20; Jones RM, 2003, AM LAB, V35, P44; Julien CM, 2004, SPECTROCHIM ACTA A, V60, P689, DOI 10.1016/S1386-1425(03)00279-8; Kapandii I. A, 1972, PHYSL ARTICULAIRE SC, V3; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Knusel CJ, 2014, J SOC ARCHAEOL, V14, P26, DOI 10.1177/1469605313518869; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Lefevre J, 1973, B MEM SOC ANTHRO PAR, V10, P301, DOI [10.3406/bmsap.1973.2076, DOI 10.3406/BMSAP.1973.2076]; Li B, 2020, QUAT GEOCHRONOL, V58, DOI 10.1016/j.quageo.2020.101066; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin-Albaladejo M, 2017, QUATERN INT, V433, P156, DOI 10.1016/j.quaint.2015.11.126; Martin-Fernandez JA, 2003, MATH GEOL, V35, P253, DOI 10.1023/A:1023866030544; de Pinillos MM, 2017, QUATERN INT, V433, P189, DOI 10.1016/j.quaint.2015.08.050; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; Martinon-Torres M, 2008, J HUM EVOL, V55, P249, DOI 10.1016/j.jhevol.2007.12.008; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Maureille B, 2001, PALEO, V13, P183, DOI DOI 10.4000/PALEO.1043; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Millard A., 2001, HDB ARCHAEOLOGICAL S, P637; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Mounier A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11213-w; Nelson G. C., 2008, TECHNIQUE APPL DENT, P425; Olejniczak AJ, 2005, S AFR J SCI, V101, P219; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Paulissen E, 2010, Chert Quarrying, Lithic Technology and Human Burial at the Palaeolithic Site of Taramsa 1, Upper Egypt, V5; Pettitt P, 2011, PALAEOLITHIC ORIGINS OF HUMAN BURIAL, P1; Marti AP, 2017, J ANTHROPOL ARCHAEOL, V48, P102, DOI 10.1016/j.jaa.2017.07.002; Prendergast ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182565; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Renaud G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku699; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; Roberts P, 2020, PALAEOGEOGR PALAEOCL, V537, DOI 10.1016/j.palaeo.2019.109438; Rohland N, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0050-5; Scerri EML, 2019, NAT ECOL EVOL, V3, P1370, DOI 10.1038/s41559-019-0992-1; Scerri EML, 2018, TRENDS ECOL EVOL, V33, P582, DOI 10.1016/j.tree.2018.05.005; Scheuer L., 2000, HUMAN OSTEOLOGY ARCH, P9; Scolan H., 2012, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V24, P69, DOI 10.1007/s13219-011-0047-x; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; Shipton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04057-3; Sitzia L, 2019, QUATERNARY RES, V92, P33, DOI 10.1017/qua.2018.144; Skoglund P, 2017, CELL, V171, P59, DOI 10.1016/j.cell.2017.08.049; Slon V, 2017, SCIENCE, V356, P605, DOI 10.1126/science.aam9695; Slon V, 2016, QUATERN INT, V398, P210, DOI 10.1016/j.quaint.2015.03.039; Steele Teresa E., 2019, Paleoanthropology, P24; Stiner Mary C., 2017, Biology Theory, V12, P248, DOI 10.1007/s13752-017-0275-5; Stoops G, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P1; Stoops G., 2003, GUIDELINES ANAL DESC; Thompson IA, 2005, ENVIRON MICROBIOL, V7, P1480, DOI 10.1111/j.1462-2920.2005.00842.x; Tobias P. V., 1991, SKULLS ENDOCASTS TEE, VIV; Toussaint M, 2010, J HUM EVOL, V58, P56, DOI 10.1016/j.jhevol.2009.09.006; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; Vermeersch PM, 1998, ANTIQUITY, V72, P475, DOI 10.1017/S0003598X00086919; Vermeersch PM., 1986, PAEORIENT, V12, P61, DOI [10.3406/paleo.1986.4399, DOI 10.3406/PALEO.1986.4399]; Wadley L., 2020, OXFORD HDB AFRICAN A, P15; WHITE TD, 1986, AM J PHYS ANTHROPOL, V69, P503, DOI 10.1002/ajpa.1330690410; Zanolli C, 2017, CR PALEVOL, V16, P702, DOI 10.1016/j.crpv.2017.05.002; Zilhao J., 2016, DEATH RITUALS SOCIAL, P27	112	19	19	6	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					95	+		10.1038/s41586-021-03457-8	http://dx.doi.org/10.1038/s41586-021-03457-8			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RY0YD	33953416	Green Submitted, Green Published			2022-12-28	WOS:000647642900017
J	Hurwitz, LM; Pinsky, PF; Trabert, B				Hurwitz, Lauren M.; Pinsky, Paul F.; Trabert, Britton			General population screening for ovarian cancer	LANCET			English	Editorial Material							COLLABORATIVE TRIAL; MORTALITY		[Hurwitz, Lauren M.; Trabert, Britton] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA; [Pinsky, Paul F.] NCI, Canc Prevent Div, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hurwitz, LM (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA.	lauren.hurwitz@nih.gov	Trabert, Britton/F-8051-2015	Trabert, Britton/0000-0002-1539-6090				Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Menon U, 2021, LANCET, V397, P2182, DOI 10.1016/S0140-6736(21)00731-5; Menon U, 2015, J CLIN ONCOL, V33, P2062, DOI 10.1200/JCO.2014.59.4945; Nebgen DR, 2019, CURR ONCOL REP, V21, DOI 10.1007/s11912-019-0816-0; Pinsky PF, 2016, GYNECOL ONCOL, V143, P270, DOI 10.1016/j.ygyno.2016.08.334; Rebbeck TR, 2018, CANCER DISCOV, V8, P803, DOI 10.1158/2159-8290.CD-17-1415; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654	8	8	8	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2021	397	10290					2128	2130		10.1016/S0140-6736(21)01061-8	http://dx.doi.org/10.1016/S0140-6736(21)01061-8		JUN 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SM8DI	33991478				2022-12-28	WOS:000657828600003
J	Richardson, H				Richardson, Heather			HOW WASTE WATER IS HELPING SOUTH AFRICA FIGHT COVID-19	NATURE			English	Editorial Material						SARS-CoV-2; Epidemiology; Developing world; Water resources		Detecting the coronavirus in samples from treatment plants could give early warning of outbreaks and new variants. Detecting the coronavirus in samples from treatment plants could give early warning of outbreaks and new variants.											0	3	3	5	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					616	617		10.1038/d41586-021-01399-9	http://dx.doi.org/10.1038/d41586-021-01399-9			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SG9LQ	34031580	Bronze			2022-12-28	WOS:000653761800001
J	Emanuel, EJ; Mostashari, F; Navathe, AS				Emanuel, Ezekiel J.; Mostashari, Farzad; Navathe, Amol S.			Designing a Successful Primary Care Physician Capitation Model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel J.] Univ Penn, Healthcare Transformat Inst, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Mostashari, Farzad; Navathe, Amol S.] Aledade Inc, Bethesda, MD USA; [Navathe, Amol S.] Cresencz VA Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Healthcare Transformat Inst, 423 Guardian Dr,Blockley Hall,Ste 1412, Philadelphia, PA 19104 USA.; Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,Ste 1412, Philadelphia, PA 19104 USA.	MEHPchair@upenn.edu						[Anonymous], MOR PERF HLTH CAR SY; Bailit MH, 2017, STANDARDIZING MEASUR; Donaldson MS, 1996, PRIM CAR AM HLTH NEW, P31; Larry A Green Center, QUICK COVID 19 PRIMA; Larry A. Green Center, QUICK COVID 19 PRIMA; Meyer G, COMMONWEALTH FUND TA; Navathe AS, 2019, JAMA-J AM MED ASSOC, V322, P57, DOI 10.1001/jama.2019.8113; Navathe AS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7950	8	3	3	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2043	2044		10.1001/jama.2021.5133	http://dx.doi.org/10.1001/jama.2021.5133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	33978678				2022-12-28	WOS:000655647300014
J	Anderson, M; O'Neill, C; Clark, JM; Street, A; Woods, M; Johnston-Webber, C; Charlesworth, A; Whyte, M; Foster, M; Majeed, A; Pitchforth, E; Mossialos, E; Asaria, M; McGuire, A				Anderson, Michael; O'Neill, Ciaran; Clark, Jill Macleod; Street, Andrew; Woods, Michael; Johnston-Webber, Charlotte; Charlesworth, Anita; Whyte, Moira; Foster, Margaret; Majeed, Azeem; Pitchforth, Emma; Mossialos, Elias; Asaria, Miqdad; McGuire, Alistair			Securing a sustainable and fit-for-purpose UK health and care workforce	LANCET			English	Review							COMMUNITY PHARMACISTS; DOCTORS; MULTIMORBIDITY; REAPPRAISAL; PRESCRIBERS; POPULATION; CHALLENGES; EDUCATION; POLICIES; NURSES	Approximately 13% of the total UK workforce is employed in the health and care sector. Despite substantial workforce planning efforts, the effectiveness of this planning has been criticised. Education, training, and workforce plans have typically considered each health-care profession in isolation and have not adequately responded to changing health and care needs. The results are persistent vacancies, poor morale, and low retention. Areas of particular concern highlighted in this Health Policy paper include primary care, mental health, nursing, clinical and non-clinical support, and social care. Responses to workforce shortfalls have included a high reliance on foreign and temporary staff, smallscale changes in skill mix, and enhanced recruitment drives. Impending challenges for the UK health and care workforce include growing multimorbidity, an increasing shortfall in the supply of unpaid carers, and the relative decline of the attractiveness of the National Health Service (NHS) as an employer internationally. We argue that to secure a sustainable and fit-for-purpose health and care workforce, integrated workforce approaches need to be developed alongside reforms to education and training that reflect changes in roles and skill mix, as well as the trend towards multidisciplinary working. Enhancing career development opportunities, promoting staff wellbeing, and tackling discrimination in the NHS are all needed to improve recruitment, retention, and morale of staff. An urgent priority is to offer sufficient aftercare and support to staff who have been exposed to high-risk situations and traumatic experiences during the COVID-19 pandemic. In response to growing calls to recognise and reward health and care staff, growth in pay must at least keep pace with projected rises in average earnings, which in turn will require linking future NHS funding allocations to rises in pay. Through illustrative projections, we show that, to sustain annual growth in the workforce at approximately 2.4%, increases in NHS expenditure of 4% annually in real terms will be required. Above all, a radical long-term strategic vision is needed to ensure that the future NHS workforce is fit for purpose.	[Anderson, Michael; Street, Andrew; Woods, Michael; Johnston-Webber, Charlotte; Pitchforth, Emma; Mossialos, Elias; Asaria, Miqdad; McGuire, Alistair] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England; [O'Neill, Ciaran] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Clark, Jill Macleod] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Charlesworth, Anita] Hlth Fdn, London, England; [Charlesworth, Anita] Univ Birmingham, Coll Social Sci, Hlth Serv Management Ctr, Birmingham, W Midlands, England; [Whyte, Moira] Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland; [Foster, Margaret] NHS Wales Shared Serv Partnership, Cardiff, Wales; [Majeed, Azeem] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Pitchforth, Emma] Univ Exeter, Coll Med & Hlth, Exeter, Devon, England	University of London; London School Economics & Political Science; Queens University Belfast; University of Southampton; University of Birmingham; University of Edinburgh; Imperial College London; University of Exeter	Anderson, M (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.	m.anderson5@lse.ac.uk	Mossialos, Elias/ABE-1301-2021; Asaria, Miqdad/T-9980-2019	Asaria, Miqdad/0000-0002-3538-4417; Majeed, Azeem/0000-0002-2357-9858	LSE Knowledge and Exchange Impact (KEI) fund from Higher Education Innovation Fund (HEIF)	LSE Knowledge and Exchange Impact (KEI) fund from Higher Education Innovation Fund (HEIF)	We would like to acknowledge the assistance of Josephine Lloyd who contributed to the analysis of health and care workforce strategies in England, Scotland, Wales, and Northern Ireland. We would also like to express our gratitude to all stakeholders who engaged with the Commission throughout our consultation. Funding for the LSE-Lancet Commission on the future of the NHS was granted by the LSE Knowledge and Exchange Impact (KEI) fund, which was created using funds from the Higher Education Innovation Fund (HEIF). The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	A'Campo LEI, 2010, QUAL LIFE RES, V19, P55, DOI 10.1007/s11136-009-9559-y; Ajaz A, 2016, BJPSYCH BULL, V40, P97, DOI 10.1192/pb.bp.115.053140; Albreht Tit, 2016, J Comorb, V6, P12, DOI 10.15256/joc.2016.6.73; [Anonymous], 2018, LANCET, V391, P1637, DOI 10.1016/S0140-6736(18)30941-3; [Anonymous], 2020, CARERS WEEK JUN; [Anonymous], 2016, MAKING IT WORK HARNE; Ashcroft DM, 2015, DRUG SAFETY, V38, P833, DOI 10.1007/s40264-015-0320-x; Bahler C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0698-2; Baker C, 2020, NHS STAFF OVERSEAS S; Beard J., 2020, CHANCELLOR DELIVERS; Beech J., 2019, CLOSING GAP KEY AREA; Blewitt N, 2018, PICTURE PRIMARY CARE; Bolton P., 2018, TUITION FEE STAT; Booth R., 2020, AGENCY STAFF WERE SP; Bostock N., 2019, PENSION TAXES FORCE; Brimblecombe N., 2018, UNPAID CARE ENGLAND; British Medical Association, 2020, HIDD IMP COVID 19 PA; Brown RM, 2014, SOC ISS POLICY REV, V8, P74, DOI 10.1111/sipr.12002; Brown Tom, 2019, BJPsych Int, V16, P1, DOI 10.1192/bji.2017.29; Buchan J, 2015, INT NURS REV, V62, P162, DOI 10.1111/inr.12169; Buchan J, 2017, RISING PRESSURE NHS; Buchan J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2543; Buchan J, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-29; Buckner L., 2015, VALUING CARERS 2015; Cancer Research UK, 2018, SEC CANC WORKF BEST; Carduff E., 2014, BMJ SUPPORTIVE PALLI, V4, pA17, DOI 10.1136/bmjspcare-2014-000654.45; Cavendish C., 2013, SOCIAL MOVEMENTS LAW; Charlesworth A, 2021, LANCET, V397, P2012, DOI 10.1016/S0140-6736(21)00230-0; Choudry A, 2017, BJPSYCH BULL, V41, P345, DOI 10.1192/pb.bp.116.055269; Cope LC, 2016, THER ADV DRUG SAF, V7, P165, DOI 10.1177/2042098616646726; Coull Alison, 2013, Br J Community Nurs, V18, P234; Courtenay M, 2011, BRIT J DERMATOL, V164, P396, DOI 10.1111/j.1365-2133.2010.10119.x; Courtenay Molly, 2018, Nurs Stand, V33, P40, DOI 10.7748/ns.2018.e11078; Courtin E, 2014, HEALTH POLICY, V118, P84, DOI 10.1016/j.healthpol.2014.07.013; Cumming I, 2017, SECURING FUTURE WORK; Curtis LA, 2018, UNIT COSTS HLTH SOCI; Department of Health and Social Care. HM Treasury Hunt J, 2018, PRIME MINISTER SETS; DHSC, 2019, REG MED ASS PROF UK; Digital NHS, 2018, AD SOC CAR ACT FIN R; Dolton P, 2018, BREXIT HLTH SOCIAL C; Dromey J., 2018, FAIR CARE WORKFORCE; El-Osta A, 2019, SELFCARE, V10, P38; England Golf, 2017, GROW GAM GOLF ENGL S; Fenton W, 2020, STATE ADULT SOCIAL C; Fletcher E, 2019, BJGP OPEN, V3; Francis R., 2013, INDEPENDENT REPORT R; Francis-Devine B, 2021, PUBLIC SECTOR PAY; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Gerada C, 2018, BRIT J GEN PRACT, V68, P168, DOI 10.3399/bjgp18X695345; Gerlinger T., 2018, GERMANY IMPROVING ST; Gibson J., 2018, 9 NATL GP WORKLIFE S; Graham-Clarke E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196471; Greenaway D, 2013, SECURING FUTURE EXCE; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Harvey S.L., 2009, MENTAL HLTH HLTH CAR; Hasardzhiev Stanimir, 2016, J Comorb, V6, P28, DOI 10.15256/joc.2016.6.75; Health Education England, 2017, PSYCH NAT RECR FILL; Health Education England, 2019, TRAIN NURS ASS NUMB; Health Education England, 2017, RET PRACT ALL HLTH P; Health Education England, 2018, RET NURS PRACT PROGR; Hussey R., 2018, PARLIAMENTARY REV HL; Improvement NHS, OP WORKF PLANN SELF; Independent Mental Health Taskforce, 2016, 5 YEAR FORW VIEW MEN; Information Services Division, 2019, NHS SCOTL WORKF Q EN; International Labour Organization, 2018, 08171 ILO; Ipsos MORI, 2017, RECRUITMENT RETENTIO; Jackson B, 2017, BRIT J GEN PRACT, V67, pE785, DOI 10.3399/bjgp17X693113; Johnson P, 2018, SECURING FUTURE FUND; Jones-Berry S., 2018, WHY MANY ONE FOUR NU; Joyce CM, 2004, MED J AUSTRALIA, V180, P343, DOI 10.5694/j.1326-5377.2004.tb05972.x; Katlic MR, 2019, JAMA-J AM MED ASSOC, V321, P449, DOI 10.1001/jama.2018.22216; Keep M., 2020, BARNETT FORMULA; Kingston A, 2018, AGE AGEING, V47, P374, DOI 10.1093/ageing/afx201; Lara Montero A, 2017, INVESTING SOCIAL SER; Latter S, 2012, J HEALTH SERV RES PO, V17, P149, DOI 10.1258/jhsrp.2012.011090; Laurant M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub3; Lorenz-Dant K, 2020, INT EXAMPLES MEASURE; LSE-Lancet Commission, 2021, LANCET, DOI [10.1016/S0140-6736(21)00232-4, DOI 10.1016/S0140-6736(21)00232-4]; Majeed A, 2020, BRIT J GEN PRACT, V70, P268, DOI 10.3399/bjgp20X709925; McColl D., 2019, GETTING FAIRER DEAL; Medical Schools Council, 2018, SURVEY MED CLIN ACAD; Migration Advisory Committee, 2018, EEA MIGR UK FIN REP; Mitchell G., 2019, NMC CONSIDERS ADV NU; Moberly Tom, 2018, BMJ, V360, pk1367, DOI 10.1136/bmj.k1367; Morse A., 2018, ADULT SOCIAL CARE WO; Mossialos E, 2015, HEALTH POLICY, V119, P628, DOI 10.1016/j.healthpol.2015.02.007; Mossialos E, 2013, HEALTH POLICY, V111, P135, DOI 10.1016/j.healthpol.2013.04.003; Mulley A. G., 2012, PATIENTS PREFERENCES; Naqvi H., 2020, ITS LONGER ENOUGH KN; NHS Digital, 2018, DAT WRITT COMPL NHS; NHS Digital, 2018, NURS HLTH VIS JOIN L; NHS Digital, 2020, GEN PRACT WORKF SER; NHS digital, 2018, NARR NHS GEND DIV ME; NHS Digital, 2018, SUPPL INF REL STAB I; NHS Employers, 2020, NHS TERMS COND AFC P; NHS Employers, 2018, 32018 NHS EMPL; NHS Employers, 2018, DEV COUNTR RECR; NHS Employers, 2018, FRAM AGR; NHS England, 2020, 1000S FORM NHS STAFF; NHS England, 2016, GEN PRACT FORW VIEW; NHS England, PRIM CAR NETW; NHS England, 2019, INTERIM NHS PEOPLE P; NHS England, 2020, NHS WORKF RAC EQ STA; NHS England, 2018, GEND PAY REP; NHS Improvement, 2019, PERF NHS PROV SECT Y; NHS Wales, RET PRACT NURS MIDW; Niezen MGH, 2014, HEALTH POLICY, V117, P151, DOI 10.1016/j.healthpol.2014.04.016; Northern Ireland Department of Health, 2020, NO IR HLTH SOC CAR H; Northern Ireland Department of Health, 2019, NO IR HLTH SOC CAR H; Northern Ireland Department of Health, 2018, W BELF BEN NEW GP PR; Northern Ireland Practice & Education Council for Nursing and Midwifery, RET PRACT; Nursing and Midwifery Council, 2018, STAND PROF REG NURS; Nursing & Midwifery Council, REG DAT REP; Office for Budget Responsibility, 2019, FISC RISKS REP; Okuno T, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-01364-4; Ono T, 2013, HLTH WORKFORCE PLANN; Organisation for Economic Co-operation and Development, 2019, WOM AR WELL REPR HLT; Organisation for Economic Co-operation and Development, 2019, REC TRENDS INT MIGR; Palmer W., 2019, IS NUMBER GPS FALLIN; Panagioti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135947; Parmar J, 2020, HEALTH SOC CARE COMM, V28, P716, DOI 10.1111/hsc.12928; Patel P., 2020, COMMUNICATION 1023; Payne RA, 2013, CAN MED ASSOC J, V185, pE221, DOI 10.1503/cmaj.121349; Pearson K., 2019, NHS STAFF LEARNERS M; Pickard L, 2018, HEALTH SOC CARE COMM, V26, pE132, DOI 10.1111/hsc.12486; Pickard L, 2012, AGEING SOC, V32, P1147, DOI 10.1017/S0144686X11000833; Public Health England, 2020, UNDERSTANDING IMPACT; Rogers S., 2020, NHS BURSARY; Rolewicz L, 2019, NHS WORKFORCE NUMBER; Ross S, 2020, WORKFORCE RACE INEQU; Roth DL, 2015, GERONTOLOGIST, V55, P309, DOI 10.1093/geront/gnu177; Royal College of Nursing, 2018, RCN BRIEF STAFF LEV; Royal College of Physicians, 2016, WHO ARE PHYS ASS; Royal College of Physicians, 2018, FOC PHYS CENS CONS P; Royal Society for Public Health, 2015, RETH PUBL HLTH WORKF; Salt H, 2019, REPORT NHS EMPLOYERS; Sansom A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019849; Scottish Social Services Council, 2020, STAFF VAC CAR SERV 2; Sheikh A, 2021, LANCET DIGIT HEALTH, V3, pE383, DOI 10.1016/S2589-7500(21)00005-4; Sizmur S., 2018, RISKS CARE QUALITY S, P24; Skills for Health, 2016, HEALTHC SUPP WORKF C; Smith Fay, 2018, Future Healthc J, V5, P192, DOI 10.7861/futurehosp.5-3-192; Smith W., 2014, TALENT CARE NATL STR; Stewart Derek C, 2009, Int J Pharm Pract, V17, P89; Storey C, 2009, J ADV NURS, V65, P1596, DOI 10.1111/j.1365-2648.2009.05036.x; Swinford S., 2020, 4 MILLION PUBLIC SEC; The Local Government Data Unit Wales, 2019, SOC WORK WORKF PLANN; The Psychological Professions Network, 2018, DEL EXP PSYCH PROF; The Scottish Government, 2017, 2018 GEN MED SERV CO; Thompson J, 2019, PRACTICAL GUIDE CURR; Topol EJ, 2019, TOPOL REV PREPARING; UCAS, 2019, 2019 END CYCL REP; UK Department of Health, 2017, EXP UND MED ED CONS; UK Department of Health & Social Care, 2019, ANN REP ACC 2018 19, P2018; UK Department of Health & Social Care, 2019, NEW IND SCHEM GEN PR; UK Department of Health & Social Care, 2017, NHS BURS REF; UK Department of Health & Social Care NHS England and NHS Improvement Pharmaceutical Services Negotiating Committee, 2019, COMM PHARM CONTR FRA; UK Home Office, 2018, UKS FUT SKILLS BAS I; UK Office for National Statistics, 2013, 2011 CENS AN UNP CAR; UK Office for National Statistics, 2019, INT MIGR HLTH CAR WO; UK Office for National Statistics, EST POP UK ENGL WAL; Uthaman T, 2016, PROC SINGAP HEALTHC, V25, P50, DOI 10.1177/2010105815610138; Wagner SL, 2016, INT J OCCUP ENV MED, V7, P1, DOI 10.15171/ijoem.2016.607; Ward D, 2019, AVERAGE PAY CARE WOR; Watt G, 2017, BRIT J GEN PRACT, V67, P280, DOI 10.3399/bjgp17X691289; Webber F, 2019, RACE CLASS, V60, P76, DOI 10.1177/0306396819825788; WHO Regional Office for Europe, 2018, TOOLK SUST HLTH WORK; Willis G., 2015, SHAPE CARING REV FUT; World Health Organization, 2010, WHO GLOB COD PRACT I; Zhang HM, 2020, J CLIN TRANSL ENDOCR, V22, DOI 10.1016/j.jcte.2020.100240; Zulman DM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007771	171	21	21	3	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1992	2011		10.1016/S0140-6736(21)00231-2	http://dx.doi.org/10.1016/S0140-6736(21)00231-2		MAY 2021	20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SF1XN	33965066	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000652556000030
J	Hammoud, MM; Standiford, TC; Carmody, JB				Hammoud, Maya M.; Standiford, Taylor C.; Carmody, J. Bryan			The 2020-2021 Residency Application Cycle Lessons Learned and Lingering Problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COVID-19		[Hammoud, Maya M.; Standiford, Taylor C.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Carmody, J. Bryan] Eastern Virginia Med Sch, Norfolk, VA 23501 USA	University of Michigan System; University of Michigan; Eastern Virginia Medical School	Hammoud, MM (corresponding author), Univ Michigan, Sch Med, Dept Obstet & Gynecol, Voigtlander Womens Hosp, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	immaya@umich.edu						Association of American Medical Colleges, 2019, MED SCH GRAD QUEST 2; Carmody JB, 2021, CUREUS, V13, DOI 10.7759/cureus.13804; Chang CWD, 2021, LARYNGOSCOPE, V131, pE744, DOI 10.1002/lary.29151; Hammoud MM, 2020, JAMA-J AM MED ASSOC, V324, P29, DOI 10.1001/jama.2020.8911; Hammoud MM, 2020, JAMA-J AM MED ASSOC, V323, P503, DOI 10.1001/jama.2019.21212; Polanco-Santana JC, 2021, J SURG EDUC, V78, P1524, DOI 10.1016/j.jsurg.2021.02.005; Quillen DA, 2021, OPHTHALMOLOGY, V128, P181, DOI 10.1016/j.ophtha.2020.07.012; Rubright JD, 2019, ACAD MED, V94, P364, DOI 10.1097/ACM.0000000000002366; The National Resident Matching Program, DATA REPORTS; Winterton M, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0805-z	10	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2021	325	22					2249	2250		10.1001/jama.2021.5708	http://dx.doi.org/10.1001/jama.2021.5708		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS1CN	34019077				2022-12-28	WOS:000652627800002
J	Dyer, C				Dyer, Clare			Homeopathy UK told to take down articles saying remedies can help depression and asthma	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2021	373								n1296	10.1136/bmj.n1296	http://dx.doi.org/10.1136/bmj.n1296			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5TH	34016649				2022-12-28	WOS:000655596600004
J	Manfroid, J; Hutsemekers, D; Jehin, E				Manfroid, J.; Hutsemekers, D.; Jehin, E.			Iron and nickel atoms in cometary atmospheres even far from the Sun	NATURE			English	Article							IKEYA-SEKI; INTERPLANETARY DUST; CARBON-MONOXIDE; VAPOR-PRESSURE; EMISSION; SPECTRA; HISTORY; FLUORESCENCE; NUCLEUS; SODIUM	In comets, iron and nickel are found in refractory dust particles or in metallic and sulfide grains(1). So far, no iron- or nickel-bearing molecules have been observed in the gaseous coma of comets(2). Iron and a few other heavy atoms, such as copper and cobalt, have been observed only in two exceptional objects: the Great Comet of 18823 and, almost a century later, C/1965 S1 (Ikeya-Seki)(4-9). These sungrazing comets approached the Sun so closely that refractory materials sublimated, and their relative abundance of nickel to iron was similar to that of the Sun and meteorites(7). More recently, the presence of iron vapour was inferred from the properties of a faint tail in comet C/2006 P1 (McNaught) at perihelion(10), but neither iron nor nickel was reported in the gaseous coma of comet 67P/Churyumov-Gerasimenko by the in situ Rosetta mission(11). Here we report that neutral Fe I and Ni I emission lines are ubiquitous in cometary atmospheres, even far from the Sun, as revealed by high-resolution ultraviolet-optical spectra of a large sample of comets of various compositions and dynamical origins. The abundances of both species appear to be of the same order of magnitude, contrasting the typical Solar System abundance ratio.	[Manfroid, J.; Hutsemekers, D.; Jehin, E.] Univ Liege, STAR Inst, Liege, Belgium	University of Liege	Manfroid, J (corresponding author), Univ Liege, STAR Inst, Liege, Belgium.	jmanfroid@gmail.com						AHEARN MF, 1984, ASTRON J, V89, P579, DOI 10.1086/113552; Altwegg K., 2017, P INT ASTR UN, V13, P153; Arpigny C, 2003, SCIENCE, V301, P1522, DOI 10.1126/science.1086711; Berger EL, 2011, GEOCHIM COSMOCHIM AC, V75, P3501, DOI 10.1016/j.gca.2011.03.026; Bhardwaj A, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/13; Biver N, 2019, ASTRON ASTROPHYS, V630, DOI 10.1051/0004-6361/201834960; Biver N, 2018, ASTRON ASTROPHYS, V619, DOI 10.1051/0004-6361/201833449; BLOCH MR, 1980, NATURWISSENSCHAFTEN, V67, P562, DOI 10.1007/BF00450669; Bockelee-Morvan D, 2017, MON NOT R ASTRON SOC, V469, pS443, DOI 10.1093/mnras/stx1950; Bockelee-Morvan D, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0252; Bohnhardt H, 2008, ASTROPHYS J LETT, V683, pL71, DOI 10.1086/591446; Boury A, 1979, LIEG INT ASTR C, V22, P189; BRADLEY JP, 1994, SCIENCE, V265, P925, DOI 10.1126/science.265.5174.925; COCHRAN AL, 1993, ICARUS, V105, P235, DOI 10.1006/icar.1993.1121; Combi MR, 1997, ICARUS, V130, P336, DOI 10.1006/icar.1997.5832; de Val-Borro M, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322284; DiSanti MA, 2007, ASTROPHYS J, V661, pL101, DOI 10.1086/518716; DiSanti MA, 2006, ASTROPHYS J, V650, P470, DOI 10.1086/507118; DUFAY J, 1965, ASTROPHYS J, V142, P1698, DOI 10.1086/148467; Faggi S, 2019, ASTRON J, V158, DOI 10.3847/1538-3881/ab4f6e; Fulle M, 2007, ASTROPHYS J, V661, pL93, DOI 10.1086/518719; GILBERT AG, 1974, J ELECTROCHEM SOC, V121, P832, DOI 10.1149/1.2401930; GROSSMAN L, 1974, REV GEOPHYS, V12, P71, DOI 10.1029/RG012i001p00071; Guzik P, 2021, NATURE, V593, P375, DOI 10.1038/s41586-021-03485-4; Hensley BS, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/2/134; HUEBNER WF, 1970, ASTRON ASTROPHYS, V5, P286; Ip WH, 1998, ASTROPHYS J, V496, pL47, DOI 10.1086/311241; Ishii HA, 2008, SCIENCE, V319, P447, DOI 10.1126/science.1150683; Klotz A, 1996, PLANET SPACE SCI, V44, P957, DOI 10.1016/0032-0633(96)00026-8; LARIMER JW, 1970, GEOCHIM COSMOCHIM AC, V34, P367, DOI 10.1016/0016-7037(70)90112-2; Levison HF, 1996, ASTR SOC P, V107, P173; Lewis J., 2004, PHYS CHEM SOLAR SYST; Lodders K., 2020, OXFORD RES ENCY PLAN, DOI 10.1093/acrefore/9780190647926.013.145; Lohse J. G, 1882, COPERNICUS INT J AST, V2, P225; Lupu RE, 2007, ASTROPHYS J, V670, P1473, DOI 10.1086/522328; Mulligan W. O, 1978, P RA WELCH FDN C CHE, P9; Paganini L, 2012, ASTEROIDS COMETS MET, V1667, P6331; Paganini L, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/1/15; PRESTON GW, 1967, ASTROPHYS J, V147, P718, DOI 10.1086/149049; Prialnik D, 2004, SPACE SCI S, P359; Raghuram S., 2021, MON NOT R ASTRON SOC, V501, P4035, DOI DOI 10.1093/MNRAS/STAA3885; Roth NX, 2020, ASTRON J, V159, DOI 10.3847/1538-3881/ab536b; Schleicher DG, 2010, ASTRON J, V140, P973, DOI 10.1088/0004-6256/140/4/973; SCHLEICHER DG, 1988, ASTROPHYS J, V331, P1058, DOI 10.1086/166622; SLAUGHTE.CD, 1969, ASTRON J, V74, P929, DOI 10.1086/110884; Smith KE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10866-x; STULL DR, 1947, IND ENG CHEM, V39, P517, DOI 10.1021/ie50448a022; Tarakeshwar P, 2019, ASTROPHYS J, V879, DOI 10.3847/1538-4357/ab22b7; THACKERAY AD, 1966, ASTROPHYS J, V143, P276, DOI 10.1086/148506; Weaver H., 2010, IAU CIRC, V9183, P1; Wilkening L. L, 1982, IAU C 61 COMET DISCO, P85; Womack M, 2017, PUBL ASTRON SOC PAC, V129, DOI 10.1088/1538-3873/129/973/031001; Wurz P, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525980; YAMAMOTO T, 1983, ASTRON ASTROPHYS, V122, P171; YAMAMOTO T, 1985, ASTRON ASTROPHYS, V142, P31; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	57	10	10	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					372	+		10.1038/s41586-021-03435-0	http://dx.doi.org/10.1038/s41586-021-03435-0			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE7VT	34012081	Green Submitted			2022-12-28	WOS:000652278400013
J	Bezruki, A; Moon, S				Bezruki, Anna; Moon, Suerie			Post-covid reforms: can we avoid fighting the last war?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bezruki, Anna; Moon, Suerie] Grad Inst Int & Dev Studies, Geneva, Switzerland; [Moon, Suerie] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Moon, S (corresponding author), Grad Inst Int & Dev Studies, Geneva, Switzerland.; Moon, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	Suerie.moon@graduateinstitute.ch	Bezruki, Anna/HCG-9137-2022	Moon, Suerie/0000-0001-8504-1212				ACT Accelerator, 2020, URG PRI FIN REQ 10 N; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Chapman N, 2020, POLICY CURES RES; Craven J, 2021, REGULATORY FOCUS; Economist Intelligence Unit, 2020, COV 19 HLTH FUND TRA; FIND, 2021, COST RAP COVID 19 TE; FIND, SARS COV 2 DIAGN PIP; FIND The Global Fund., 2020, ACC COVID 19 TOOLS A; Fraser N., 2021, PREPRINTING PANDEMIC, DOI [10.1101/2020.05.22.111294, DOI 10.1101/2020.05.22.111294]; GAVI The Vaccine Alliance, 2021, COV GLOB SUPPLY FOR; Haider N, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820002046; Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734; Independent Oversight and Advisory Committee for the WHO Emergencies Programme, 2021, 74 WORLD HLTH ASS; Independent Panel for Pandemic Preparedness Response, COVID 19 MAK LAST PA; International Monetary Fund, 2020, WTO IMF HEADS CALL L; International Trade Centre, 2020, COV 19 TEMP TRAD MEA; Johansson MA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002549; Lachapelle F., COVID 19 PREPRINTS T, DOI [10.1101/2020.09.04.20188771, DOI 10.1101/2020.09.04.20188771]; Milken Institute, 2021, COVID 19 TREATM VACC; Moon S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j280; Otsuki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163418; Pattani R, 2015, CAN MED ASSOC J, V187, P166, DOI 10.1503/cmaj.141488; Policy Cures Research, 2020, COVID 19 R D TRACK A; Ren G, 2020, HLTH POLICY WATCH; Rhymer W, 2017, B WORLD HEALTH ORGAN, V95, P10, DOI 10.2471/BLT.16.171579; Tejpar ALI., 2017, CAN YEARB INT LAW, V54, P366, DOI [10.1017/cyl.2017.18, DOI 10.1017/CYL.2017.18]; UN WTO., 2020, COV 19 REL TRAV REST; WHO, 2020, GLOB PARTHN MAK AVA; WHO, 2020, HOW WHOIS FUND; WHO, JO EXT EVAL JEE MISS; WHO, REP REV COMM FUNCT I; WHO Director General, 2021, COVID 19 RESP; World Health Organization, 2020, COV ANN ADD DEALS AC; World Health Organization, 2020, UPD WHO REC INT TRAF; World Health Organization (WHO), 2020, STATEMENT 2 M INT HL; World Trade Organization, 2020, COVID 19 MEAS AFF TR; Yamanis T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005077	37	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2021	373								n1184	10.1136/bmj.n1184	http://dx.doi.org/10.1136/bmj.n1184			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5SO	34011498	Bronze, Green Published			2022-12-28	WOS:000655594700006
J	Jaklevic, MC				Jaklevic, Mary Chris			Trends Identified in Foodborne Illnesses From Leafy Greens	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1932	1932		10.1001/jama.2021.7165	http://dx.doi.org/10.1001/jama.2021.7165			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003234				2022-12-28	WOS:000652675100020
J	Sacks, CA				Sacks, Chana A.			Herpes-Associated Erythema Multiforme	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Herpes-Associated Erythema Multiforme A 32-year-old man presented with itchy lesions on his palms that appeared several days after oral infection with herpes simplex virus. A diagnosis of herpes-associated erythema multiforme was made.						Puerta-Pena, Mario/0000-0001-6273-0613; Velasco-Tamariz, Virginia/0000-0003-4009-0525					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					1848	1848		10.1056/NEJMicm2033090	http://dx.doi.org/10.1056/NEJMicm2033090			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD6UF	33979491				2022-12-28	WOS:000651509400012
J	Wibowo, MC; Yang, Z; Borry, M; Hubner, A; Huang, KD; Tierney, BT; Zimmerman, S; Barajas-Olmos, F; Contreras-Cubas, C; Garcia-Ortiz, H; Martinez-Hernandez, A; Luber, JM; Kirstahler, P; Blohm, T; Smiley, FE; Arnold, R; Ballal, SA; Pamp, SJ; Russ, J; Maixner, F; Rota-Stabelli, O; Segata, N; Reinhard, K; Orozco, L; Warinner, C; Snow, M; LeBlanc, S; Kostic, AD				Wibowo, Marsha C.; Yang, Zhen; Borry, Maxime; Huebner, Alexander; Huang, Kun D.; Tierney, Braden T.; Zimmerman, Samuel; Barajas-Olmos, Francisco; Contreras-Cubas, Cecilia; Garcia-Ortiz, Humberto; Martinez-Hernandez, Angelica; Luber, Jacob M.; Kirstahler, Philipp; Blohm, Tre; Smiley, Francis E.; Arnold, Richard; Ballal, Sonia A.; Pamp, Sunje Johanna; Russ, Julia; Maixner, Frank; Rota-Stabelli, Omar; Segata, Nicola; Reinhard, Karl; Orozco, Lorena; Warinner, Christina; Snow, Meradeth; LeBlanc, Steven; Kostic, Aleksandar D.			Reconstruction of ancient microbial genomes from the human gut	NATURE			English	Article							LOS MUERTOS CHIQUITOS; RIO ZAPE VALLEY; LA CUEVA; DNA; DIET; SEQUENCE; DURANGO; TOOL; NEANDERTHAL; EVOLUTION	Loss of gut microbial diversity(1-6) in industrial populations is associated with chronic diseases(7), underscoring the importance of studying our ancestral gut microbiome. However, relatively little is known about the composition of pre-industrial gut microbiomes. Here we performed a large-scale de novo assembly of microbial genomes from palaeofaeces. From eight authenticated human palaeofaeces samples (1,000-2,000 years old) with well-preserved DNA from southwestern USA and Mexico, we reconstructed 498 medium- and high-quality microbial genomes. Among the 181 genomes with the strongest evidence of being ancient and of human gut origin, 39% represent previously undescribed species-level genome bins. Tip dating suggests an approximate diversification timeline for the key human symbiont Methanobrevibacter smithii. In comparison to 789 present-day human gut microbiome samples from eight countries, the palaeofaeces samples are more similar to non-industrialized than industrialized human gut microbiomes. Functional profiling of the palaeofaeces samples reveals a markedly lower abundance of antibiotic-resistance and mucin-degrading genes, as well as enrichment of mobile genetic elements relative to industrial gut microbiomes. This study facilitates the discovery and characterization of previously undescribed gut microorganisms from ancient microbiomes and the investigation of the evolutionary history of the human gut microbiota through genome reconstruction from palaeofaeces.	[Wibowo, Marsha C.; Yang, Zhen; Tierney, Braden T.; Zimmerman, Samuel; Luber, Jacob M.; Kostic, Aleksandar D.] Joslin Diabet Ctr, Sect Pathophysiol & Mol Pharmacol, Boston, MA 02215 USA; [Wibowo, Marsha C.; Yang, Zhen; Tierney, Braden T.; Zimmerman, Samuel; Luber, Jacob M.; Kostic, Aleksandar D.] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Yang, Zhen] Univ Waterloo, Dept Combinator & Optimizat, Waterloo, ON, Canada; [Borry, Maxime; Huebner, Alexander; Warinner, Christina] Max Planck Inst Sci Human Hist, Dept Archaeogenet, Jena, Germany; [Huang, Kun D.; Segata, Nicola] Univ Trento, CIBIO Dept, Trento, Italy; [Huang, Kun D.; Rota-Stabelli, Omar] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy; [Tierney, Braden T.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Barajas-Olmos, Francisco; Contreras-Cubas, Cecilia; Garcia-Ortiz, Humberto; Martinez-Hernandez, Angelica; Orozco, Lorena] Inst Nacl Med Genom, Secretaria Salud, Immunogen & Metab Dis Lab, Mexico City, DF, Mexico; [Luber, Jacob M.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kirstahler, Philipp; Pamp, Sunje Johanna] Tech Univ Denmark, Res Grp Genom Epidemiol, Natl Food Inst, Lyngby, Denmark; [Blohm, Tre; Snow, Meradeth] Univ Montana, Dept Anthropol, Missoula, MT 59812 USA; [Smiley, Francis E.] No Arizona Univ, Dept Anthropol, Flagstaff, AZ 86011 USA; [Arnold, Richard] Pahrump Paiute Tribe & Consolidated Grp Tribes &, Pahrump, NV USA; [Ballal, Sonia A.] Boston Childrens Hosp, Dept Gastroenterol Hepatol & Nutr, Boston, MA USA; [Russ, Julia] Univ Nebraska Lincoln, Ctr Biotechnol, Morrison Microscopy Core Res Facil, Lincoln, NE USA; [Maixner, Frank] EURAC Res, Inst Mummy Studies, Bolzano, Italy; [Rota-Stabelli, Omar] Univ Trento, Ctr Agr Food Environm C3A, Trento, Italy; [Reinhard, Karl] Univ Nebraska Lincoln, Sch Nat Resources, Lincoln, NE USA; [Warinner, Christina] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Warinner, Christina] Friedrich Schiller Univ, Fac Biol Sci, Jena, Germany; [LeBlanc, Steven] Harvard Univ, Peabody Museum Archaeol & Ethnol, Cambridge, MA 02138 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Waterloo; University of Trento; Fondazione Edmund Mach; Harvard University; Harvard Medical School; Instituto Nacional de Medicina Genomica; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Technical University of Denmark; University of Montana System; University of Montana; Northern Arizona University; Harvard University; Boston Children's Hospital; University of Nebraska System; University of Nebraska Lincoln; European Academy of Bozen-Bolzano; University of Trento; University of Nebraska System; University of Nebraska Lincoln; Harvard University; Friedrich Schiller University of Jena; Harvard University	Kostic, AD (corresponding author), Joslin Diabet Ctr, Sect Pathophysiol & Mol Pharmacol, Boston, MA 02215 USA.; Kostic, AD (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.	aleksandar.kostic@joslin.harvard.edu	Barajas, Francisco/GLV-6617-2022; Pamp, Sunje Johanna/H-8787-2012	Tierney, Braden/0000-0002-7533-8802; Pamp, Sunje Johanna/0000-0002-6236-1763; Barajas-Olmos, Francisco/0000-0001-5064-6203; Kostic, Aleksandar/0000-0002-0837-4360; Warinner, Christina/0000-0002-4528-5877; Garcia-Ortiz, Humberto/0000-0002-0453-980X; Maixner, Frank/0000-0003-2846-8994; Wibowo, Marsha Christanvia/0000-0001-7678-5447; Hubner, Alexander/0000-0003-3572-9996	American Diabetes Association (ADA) Pathway to Stop Diabetes Initiator Award [1-17-INI-13]; Smith Family Foundation Award for Excellence in Biomedical Research; American Heart Association (AHA) Predoctoral Fellowship [19PRE34430165]; European Research Council grant ERC-STG Project MetaPG; Werner Siemens Stiftung; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC 2051, 390713860]; NIH [P30DK036836-30]	American Diabetes Association (ADA) Pathway to Stop Diabetes Initiator Award; Smith Family Foundation Award for Excellence in Biomedical Research; American Heart Association (AHA) Predoctoral Fellowship(American Heart Association); European Research Council grant ERC-STG Project MetaPG; Werner Siemens Stiftung; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge and appreciate those individuals whose genetics and microorganisms were analysed for this research, as well as present-day individuals with associated genetic or cultural heritage. We thank members of the A.D.K. laboratory, especially T. A. Chavkin and M. Tran for discussion and reading of the manuscript, and L.-D. Pham for assistance with construction of sequencing libraries; J. A. Fellows Yates and A. B. Rohrlach for discussion, advice on metagenomic analysis and reading of the manuscript; Y.-H. Tseng for guidance and members of the Y.-H. Tseng laboratory for discussions; M. L. Taylor and R. J. Wheeler from the Robert S. Peabody Institute of Archaeology for their roles in initiating and assisting with consultation with Native American communities. Parasite-related sequence analysis was performed using the DeiC National Life Science Supercomputer at the Technical University of Denmark. This research was supported by the American Diabetes Association (ADA) Pathway to Stop Diabetes Initiator Award 1-17-INI-13 (A.D.K.), a Smith Family Foundation Award for Excellence in Biomedical Research (A.D.K.), the American Heart Association (AHA) Predoctoral Fellowship 19PRE34430165 (M.C.W.), a European Research Council grant ERC-STG Project MetaPG (N.S.), Werner Siemens Stiftung (M.B. and C.W.) and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy EXC 2051, Project-ID 390713860 (A.H. and C.W.). Support was also provided by NIH grant no. P30DK036836-30 (principal investigator, G. L. King).	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Almeida A, 2021, NAT BIOTECHNOL, V39, P105, DOI 10.1038/s41587-020-0603-3; Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Androy J., 2003, AGR MOBILITY BASKETM; Angelakis E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32191; Asnicar F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16366-7; Baele G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-85; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Battillo J. M., 2017, THESIS SE METHODIST; Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; Blaser MJ, 2017, NAT REV IMMUNOL, V17, P461, DOI 10.1038/nri.2017.77; Borry M, 2020, PEERJ, V8, DOI 10.7717/peerj.9001; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bowers RM, 2017, NAT BIOTECHNOL, V35, P725, DOI 10.1038/nbt.3893; Brealey JC, 2020, MOL BIOL EVOL, V37, P3003, DOI 10.1093/molbev/msaa135; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brito IL, 2016, NATURE, V535, P435, DOI 10.1038/nature18927; BROOKS RH, 1962, AM ANTIQUITY, V27, P356, DOI 10.2307/277801; Bushnell B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185056; Chaumeil PA, 2020, BIOINFORMATICS, V36, P1925, DOI 10.1093/bioinformatics/btz848; Crandall JJ., 2012, LANDSC VIOLENCE, V2, P12; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Duchene S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000094; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fragiadakis GK, 2019, GUT MICROBES, V10, P216, DOI 10.1080/19490976.2018.1494103; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Garrison E, 2012, HAPLOTYPE BASED VARI; Gaynes R, 2017, EMERG INFECT DIS, V23, P849, DOI 10.3201/eid2305.161556; Grun R, 2005, J HUM EVOL, V49, P316, DOI 10.1016/j.jhevol.2005.04.006; Guernsey S. J, 1931, EXPLORATIONS NE ARIZ; Hagan RW, 2020, AM J PHYS ANTHROPOL, V171, P275, DOI 10.1002/ajpa.23978; Hammerl EE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133710; Hershkovitz I, 2018, SCIENCE, V359, P456, DOI 10.1126/science.aap8369; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jain C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07641-9; Jimenez FA, 2012, J PARASITOL, V98, P304, DOI 10.1645/GE-2915.1; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kang DWD, 2019, PEERJ, V7, DOI 10.7717/peerj.7359; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kirstahler P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22416-4; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luber JM, 2018, BIOINFORMATICS, V34, P1565, DOI 10.1093/bioinformatics/btx787; Manara S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1923-9; Mann AE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28091-9; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Morrow JJ, 2016, J PARASITOL, V102, P429, DOI 10.1645/15-916; Morss N., 1931, **DROPPED REF**, VXII; Nayfach S, 2019, NATURE, V568, P505, DOI 10.1038/s41586-019-1058-x; Neukamm J, 2020, DAMAGEPROFILER FAST, DOI [10.1101/2020.10.01.322206, DOI 10.1101/2020.10.01.322206]; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Olm MR, 2017, ISME J, V11, P2864, DOI 10.1038/ismej.2017.126; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Pasolli E, 2017, NAT METHODS, V14, P1023, DOI 10.1038/nmeth.4468; Pucu E, 2020, ARCHAEOL ANTHROP SCI, V12, DOI 10.1007/s12520-019-00950-0; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055; Reinhard K, 2019, ARCHAEOL ANTHROP SCI, V11, P6017, DOI 10.1007/s12520-019-00946-w; Reinhard KJ, 2006, AM SCI, V94, P254, DOI 10.1511/2006.59.996; Renaud G, 2017, BIOINFORMATICS, V33, P577, DOI 10.1093/bioinformatics/btw670; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Santiago-Rodriguez TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138135; Santiago-Torres M, 2017, EUR J CLIN NUTR, V71, P395, DOI 10.1038/ejcn.2016.211; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Schuenemann VJ, 2013, SCIENCE, V341, P179, DOI 10.1126/science.1238286; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shapiro B, 2012, METHODS MOL BIOL, V840, P1, DOI 10.1007/978-1-61779-516-9; Slon V, 2017, SCIENCE, V356, P605, DOI 10.1126/science.aam9695; Smiley F. E., 1997, ANIMAS LA PLATA ARCH, P43; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Sonnenburg ED, 2019, NAT REV MICROBIOL, V17, P383, DOI 10.1038/s41579-019-0191-8; Sonnenburg JL, 2019, SCIENCE, V366, P444, DOI 10.1126/science.aaw9255; Spangler J. D., 2018, CRIMSON COWBOYS REMA; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tett A, 2019, CELL HOST MICROBE, V26, P666, DOI 10.1016/j.chom.2019.08.018; Tito RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051146; Tito RY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003703; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Vagene AJ, 2018, NAT ECOL EVOL, V2, P520, DOI 10.1038/s41559-017-0446-6; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479	107	50	50	32	79	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2021	594	7862					234	+		10.1038/s41586-021-03532-0	http://dx.doi.org/10.1038/s41586-021-03532-0		MAY 2021	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SQ0ZC	33981035	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000650200300003
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: "Exhausted" GPs need more support for future crises, says leader	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Confederation, 2021, REST PRIM CAR 10 KEY; NHS Digital, 2021, APP GEN PRACT MARCH	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1206	10.1136/bmj.n1206	http://dx.doi.org/10.1136/bmj.n1206			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975911				2022-12-28	WOS:000649711400011
J	Speaker, SL; Pfoh, ER; Pappas, MA; Hu, B; Rothberg, MB				Speaker, Sidra L.; Pfoh, Elizabeth R.; Pappas, Matthew A.; Hu, Bo; Rothberg, Michael B.			Oral Temperature of Noninfected Hospitalized Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BODY-TEMPERATURE		[Speaker, Sidra L.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Pfoh, Elizabeth R.; Pappas, Matthew A.; Rothberg, Michael B.] Cleveland Clin, Ctr Value Based Care Res, Cleveland, OH 44106 USA; [Hu, Bo] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Rothberg, MB (corresponding author), Cleveland Clin, Dept Internal Med & Geriatr, 9500 Euclid Ave,G10, Cleveland, OH 44195 USA.	rothbem@ccf.org						Arora VM, 2019, J HOSP MED, V14, P38, DOI 10.12788/jhm.3091; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; MACKOWIAK PA, 1992, JAMA-J AM MED ASSOC, V268, P1578, DOI 10.1001/jama.268.12.1578; Obermeyer Z, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5468; Protsiv M, 2020, ELIFE, V9, DOI 10.7554/eLife.49555; Sund-Levander M, 2002, SCAND J CARING SCI, V16, P122, DOI 10.1046/j.1471-6712.2002.00069.x	6	2	2	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1899	1901		10.1001/jama.2021.1541	http://dx.doi.org/10.1001/jama.2021.1541			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974027	Green Published, Bronze			2022-12-28	WOS:000650205000021
J	Chen, LYC; Skinnider, BF; Wilson, D; Fajgenbaum, DC				Chen, Luke Y. C.; Skinnider, Brian F.; Wilson, Don; Fajgenbaum, David C.			Adrenalitis and anasarca in idiopathic multicentric Castleman's disease	LANCET			English	Editorial Material									[Chen, Luke Y. C.] Univ British Columbia, Div Haematol, Vancouver, BC V5Z 1M9, Canada; [Chen, Luke Y. C.] Univ British Columbia, Ctr Hlth Scholarship, Vancouver, BC, Canada; [Skinnider, Brian F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Wilson, Don] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Wilson, Don] British Columbia Canc Agcy, Vancouver Ctr, Funct Imaging Program, Vancouver, BC, Canada; [Fajgenbaum, David C.] Univ Penn, Perelman Sch Med, Ctr Cytokine Storm Treatment & Lab, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of Pennsylvania; Pennsylvania Medicine	Chen, LYC (corresponding author), Univ British Columbia, Div Haematol, Vancouver, BC V5Z 1M9, Canada.	lchen2@bccancer.bc.ca	Chen, Luke Yu Chung/I-6027-2019	Chen, Luke Yu Chung/0000-0002-9551-2951	NHLBI NIH HHS [R01 HL141408] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))			0	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1749	1749						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33965090	Green Accepted			2022-12-28	WOS:000647813600029
J	Ferry, G				Ferry, Georgina			A woman's place Monica Lewin: surgeon to victims of political violence in Jamaica	LANCET			English	Editorial Material												mgf@georginaferry.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1701	1701						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33965077				2022-12-28	WOS:000647813600012
J	Morgan, OW; Aguilera, X; Ammon, A; Amuasi, J; Fall, IS; Frieden, T; Heymann, D; Ihekweazu, C; Jeong, EK; Leung, GM; Mahon, B; Nkengasong, J; Qamar, FN; Schuchat, A; Wieler, LH; Dowell, SF				Morgan, Oliver W.; Aguilera, Ximena; Ammon, Andrea; Amuasi, John; Fall, Ibrahima Soce; Frieden, Tom; Heymann, David; Ihekweazu, Chikwe; Jeong, Eun-kyeong; Leung, Gabriel M.; Mahon, Barbara; Nkengasong, John; Qamar, Farah Naz; Schuchat, Anne; Wieler, Lothar H.; Dowell, Scott F.			Disease surveillance for the COVID-19 era: time for bold changes	LANCET			English	Editorial Material									[Morgan, Oliver W.] WHO, Hlth Emergency Informat & Risk Assessment, CH-1211 Geneva, Switzerland; [Aguilera, Ximena] Univ Desarrollo Chile, Ctr Epidemiol & Hlth Policy, Santiago, Chile; [Ammon, Andrea] European Ctr Dis Prevent & Control, Solna, Sweden; [Amuasi, John] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Global Hlth & Infect Dis Res Grp, Kumasi, Ghana; [Fall, Ibrahima Soce] WHO, Emergency Response, Geneva, Switzerland; [Frieden, Tom] Resolve Save Lives, New York, NY USA; [Heymann, David] London Sch Hyg & Trop Med, Infect Dis Epidemiol, London, England; [Ihekweazu, Chikwe] Nigeria Ctr Dis Control, Abuja, Nigeria; [Jeong, Eun-kyeong] Korea Dis Control & Prevent Agcy, Cheongju, Chungcheongbuk, South Korea; [Leung, Gabriel M.] Univ Hong Kong, LKS Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China; [Mahon, Barbara; Dowell, Scott F.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Nkengasong, John] Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia; [Qamar, Farah Naz] Aga Khan Univ, Nairobi, Kenya; [Schuchat, Anne] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Wieler, Lothar H.] Robert Koch Inst, Berlin, Germany	World Health Organization; Universidad del Desarrollo; European Centre for Disease Prevention & Control; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of Hong Kong; Bill & Melinda Gates Foundation; Aga Khan University; Centers for Disease Control & Prevention - USA; Robert Koch Institute	Morgan, OW (corresponding author), WHO, Hlth Emergency Informat & Risk Assessment, CH-1211 Geneva, Switzerland.	omorgan@who.int	aguilera, ximena/P-7682-2019; Aguilera, Ximena Paz/D-9861-2014	aguilera, ximena/0000-0002-8153-6733; Aguilera, Ximena Paz/0000-0002-8153-6733				Arvisais-Anhalt S, 2021, CLIN INFECT DIS, V72, P920, DOI 10.1093/cid/ciaa1686; Lewis D, 2020, NATURE, V588, P384, DOI 10.1038/d41586-020-03518-4; Mwananyanda L, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n334; Nkengasong J, 2020, LANCET GLOB HEALTH, V8, pE35, DOI 10.1016/S2214-109X(19)30397-3; Thacker Stephen B, 2012, MMWR Suppl, V61, P3; Tian Nan, 2019, TRENDS WORLD MILITAR; Wadman M, 2021, SCIENCE, V371, P657, DOI 10.1126/science.371.6530.657; Wilson M., 2021, NOT LAST PANDEMIC IN; World Health Organization, 2021, SCORE HLTH DAT TECHN; World Health Organization, 2021, SARS COV 2 GEN SEQ P	10	14	14	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2021	397	10292					2317	2319		10.1016/S0140-6736(21)01096-5	http://dx.doi.org/10.1016/S0140-6736(21)01096-5		JUN 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SU4QL	34000258	Green Published, Bronze			2022-12-28	WOS:000663124100007
J	Wise, J				Wise, Jacqui			Covid-19: UK cases of variant from India rise by 160% in a week	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ash S, 2021, BBC NEWS        0520; COG-UK, VAR VOC INV VUI DET; Harrison D, 2021, LANCASHIRE TELEGRAPH; Public Health England, 2021, VAR DISTR CAS DAT MA; Scientific Advisory Group for Emerg encies, 2021, SAGE 89 MIN COR COVI	5	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2021	373								n1315	10.1136/bmj.n1315	http://dx.doi.org/10.1136/bmj.n1315			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7ZT	34020965	Bronze			2022-12-28	WOS:000656435600007
J	Dyer, C				Dyer, Clare			Women harmed by faulty breast implants should be compensated, says French court	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2021	373								n1307	10.1136/bmj.n1307	http://dx.doi.org/10.1136/bmj.n1307			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5TH	34016643				2022-12-28	WOS:000655596600009
J	O'Connell, J; O'Keeffe, DT				O'Connell, James; O'Keeffe, Derek T.			Contact Tracing for Covid-19-A Digital Inoculation against Future Pandemics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Contact Tracing for Covid-19 Automation using geolocation tracking allowed South Korea to trace contacts of people infected with SARS-CoV-2 reaching back to 14 days before symptom onset or diagnosis. By the end of 2020, there were at least 65 advanced digital contact-tracing systems worldwide.	[O'Connell, James; O'Keeffe, Derek T.] Natl Univ Ireland Galway, Sch Med, Coll Med Nursing & Hlth Sci, Galway, Ireland; [O'Connell, James; O'Keeffe, Derek T.] Natl Univ Ireland Galway, Lambe Inst Translat Res, Hlth Innovat Via Engn Lab, Curam, Galway, Ireland; [O'Keeffe, Derek T.] Univ Hosp Galway, Saolta, Galway, Ireland; [O'Keeffe, Derek T.] Univ Limerick, Irish Software Res Ctr, Lero, Limerick, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Limerick	O'Connell, J (corresponding author), Natl Univ Ireland Galway, Sch Med, Coll Med Nursing & Hlth Sci, Galway, Ireland.; O'Connell, J (corresponding author), Natl Univ Ireland Galway, Lambe Inst Translat Res, Hlth Innovat Via Engn Lab, Curam, Galway, Ireland.			O'Keeffe, Derek/0000-0001-8501-2382; O'Connell, James/0000-0003-1553-4489				Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Johnson, 2020, MIT TECHNOL REV; Lewis Dyani, 2021, Nature, V591, P18, DOI 10.1038/d41586-021-00451-y; Tal I, 2021, WHY 61 US ARE WILLIN; Valentino-DeVries J., 2018, NEW YORK TIMES	5	14	14	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2021	385	6					484	487		10.1056/NEJMp2102256	http://dx.doi.org/10.1056/NEJMp2102256		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TZ7DN	34010529	Bronze			2022-12-28	WOS:000653202000001
J	Healton, EB; Treanor, WM; DeGioia, JJ; Girard, VW				Healton, Edward B.; Treanor, William M.; DeGioia, John J.; Girard, Vicki W.			Training Future Health Justice Leaders - A Role for Medical-Legal Partnerships	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERPROFESSIONAL EDUCATION	Training Future Health Justice Leaders Medical-legal partnerships integrate lawyers directly into health care teams to help patients address health-harming legal needs. Schools could integrate these partnerships into education and training to support the next generation of health justice leaders.	[Healton, Edward B.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Treanor, William M.; Girard, Vicki W.] Georgetown Univ, Law Ctr, Washington, DC USA; [DeGioia, John J.] Georgetown Univ, Washington, DC USA	Georgetown University; Georgetown University; Georgetown University	Healton, EB (corresponding author), Georgetown Univ, Med Ctr, Washington, DC 20007 USA.			Girard, Vicki/0000-0001-9974-9705				Dow A, 2017, NEW ENGL J MED, V377, P803, DOI 10.1056/NEJMp1705665; Girard VW, 2020, J LEGAL MED, V40, P265, DOI 10.1080/01947648.2020.1819485; Minor LB, 2020, FORTUNE MAGAZINE; Regenstein M, 2018, HEALTH AFFAIR, V37, P378, DOI 10.1377/hlthaff.2017.1264; Tobin-Tyler E, 2016, ACAD MED, V91, P761, DOI 10.1097/ACM.0000000000000943	5	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					1879	1881		10.1056/NEJMp2100530	http://dx.doi.org/10.1056/NEJMp2100530		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ4AW	34014050				2022-12-28	WOS:000652580300001
J	Bernal, JL; Andrews, N; Gower, C; Robertson, C; Stowe, J; Tessier, E; Simmons, R; Cottrell, S; Roberts, R; O'Doherty, M; Brown, K; Cameron, C; Stockton, D; McMenamin, J; Ramsay, M				Bernal, Jamie Lopez; Andrews, Nick; Gower, Charlotte; Robertson, Chris; Stowe, Julia; Tessier, Elise; Simmons, Ruth; Cottrell, Simon; Roberts, Richard; O'Doherty, Mark; Brown, Kevin; Cameron, Claire; Stockton, Diane; McMenamin, Jim; Ramsay, Mary			Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REGIMEN	OBjECTIVE To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including the UK variant of concern B.1.1.7), admissions to hospital, and deaths. DESIGN Test negative case-control study. SETTING Community testing for covid-19 in England. PARTICIPANTS 156 930 adults aged 70 years and older who reported symptoms of covid-19 between 8 December 2020 and 19 February 2021 and were successfully linked to vaccination data in the National Immunisation Management System. INTERVENTIONS Vaccination with BNT162b2 or ChAdOx1-S. MAIN OUTCOME MEASURES Primary outcomes were polymerase chain reaction confirmed symptomatic SARS-CoV-2 infections, admissions to hospital for covid-19, and deaths with covid-19. RESULTS Participants aged 80 years and older vaccinated with BNT162b2 before 4 January 2021 had a higher odds of testing positive for covid-19 in the first nine days after vaccination (odds ratio up to 1.48, 95% confidence interval 1.23 to 1.77), indicating that those initially targeted had a higher underlying risk of infection. Vaccine effectiveness was therefore compared with the baseline post-vaccination period. Vaccine effects were noted 10 to 13 days after vaccination, reaching a vaccine effectiveness of 70% (95% confidence interval 59% to 78%), then plateauing. From 14 days after the second dose a vaccination effectiveness of 89% (85% to 93%) was found compared with the increased baseline risk. Participants aged 70 years and older vaccinated from 4 January (when ChAdOx1-S delivery commenced) had a similar underlying risk of covid-19 to unvaccinated individuals. With BNT162b2, vaccine effectiveness reached 61% (51% to 69%) from 28 to 34 days after vaccination, then plateaued. With ChAdOx1-S, effects were seen from 14 to 20 days after vaccination, reaching an effectiveness of 60% (41% to 73%) from 28 to 34 days, increasing to 73% (27% to 90%) from day 35 onwards. On top of the protection against symptomatic disease, a further 43% (33% to 52%) reduced risk of emergency hospital admission and 51% (37% to 62%) reduced risk of death was observed in those who had received one dose of BNT162b2. Participants who had received one dose of ChAdOx1-S had a further 37% (3% to 59%) reduced risk of emergency hospital admission. Follow-up was insufficient to assess the effect of ChAdOx1-S on mortality. Combined with the effect against symptomatic disease, a single dose of either vaccine was about 80% effective at preventing admission to hospital with covid-19 and a single dose of BNT162b2 was 85% effective at preventing death with covid-19. CONCLUSION Vaccination with either one dose of BNT162b2 or ChAdOx1-S was associated with a significant reduction in symptomatic covid-19 in older adults, and with further protection against severe disease. Both vaccines showed similar effects. Protection was maintained for the duration of follow-up (>6 weeks). A second dose of BNT162b2 was associated with further protection against symptomatic disease. A clear effect of the vaccines against the B.1.1.7 variant was found.	[Bernal, Jamie Lopez; Andrews, Nick; Gower, Charlotte; Stowe, Julia; Tessier, Elise; Simmons, Ruth; Brown, Kevin; Ramsay, Mary] Publ Hlth England, London, England; [Bernal, Jamie Lopez; Andrews, Nick; Robertson, Chris; Ramsay, Mary] London Sch Hyg & Trop Med, NIHR Hlth Protect Res Unit Vaccines & Immunisat, London, England; [Bernal, Jamie Lopez] Imperial Coll London, NIHR Hlth Protect Res Unit Resp Infect, London, England; [Robertson, Chris] Univ Strathclyde, Glasgow, Lanark, Scotland; [Cottrell, Simon; Roberts, Richard] Publ Hlth Wales, Cardiff, Wales; [O'Doherty, Mark] Publ Hlth Agcy Northern Ireland, Belfast, Antrim, North Ireland; [Cameron, Claire; Stockton, Diane; McMenamin, Jim] Hlth Protect Scotland, Glasgow, Lanark, Scotland	Public Health England; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of Strathclyde	Bernal, JL (corresponding author), Publ Hlth England, London, England.; Bernal, JL (corresponding author), London Sch Hyg & Trop Med, NIHR Hlth Protect Res Unit Vaccines & Immunisat, London, England.; Bernal, JL (corresponding author), Imperial Coll London, NIHR Hlth Protect Res Unit Resp Infect, London, England.	jamie.lopezbernal2@phe.gov.uk		Stowe, Julia/0000-0002-3999-6461; Lopez Bernal, Jamie/0000-0002-1301-5653; Tessier, Elise/0000-0002-2712-7971				Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Care Quality Commission, 2021, CQC CAR DIR; Chodick G, 2021, EFFECTIVENESS 1 DOSE, V2021; Davies NG, 2020, ESTIMATED TRANSMISSI; De Serres G, 2013, Euro Surveill, V18; Department of Health and Social Care, 2020, DET METH SOURC COVID; Department of Health and Social Care, 2021, JOINT COMM VACC IMM; European Centre for Disease Prevention and Control, 2020, THREAT ASS BRIEF RAP; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Hunter PR, 2021, ESTIMATING EFFECTIVE; Jackson ML, 2017, NEW ENGL J MED, V377, P534, DOI [10.1056/NEJMoa1700153, 10.1056/nejmoa1700153]; Joint Committee on Vaccination and Immunisation, OPT COVID 19 VACC PR; Kuypers J, 2005, J CLIN VIROL, V33, P299, DOI 10.1016/j.jcv.2004.11.023; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Medicines and Healthcare products Regulatory Agency, 2020, VACC BNT162B2 COND A; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Pebody R, 2019, EUROSURVEILLANCE, V24, P23, DOI 10.2807/1560-7917.ES.2019.24.31.1800488; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Public Health England, 2021, INV NOV SARS COV 2 V, DOI DOI 10.1371/journal.pbio.3001236; Public Health England, 2020, NEUROLOGICA BLO 0615; Public Health England, 2020, TECHN SUMM PUBL HLTH; Public Health England, INV NOV SARS COV 2 V; Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1; Ramsay M., 2020, COVID 19 GREEN BOOK; Schwartz LM, 2017, VACCINE, V35, P184, DOI 10.1016/j.vaccine.2016.10.077; Shukarev G, 2017, HUM VACC IMMUNOTHER, V13, P266, DOI 10.1080/21645515.2017.1264755; Singanayagam A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.32.2001483; Skowronski DM, 2021, NEW ENGL J MED, V384, P1576, DOI 10.1056/NEJMc2036242; Voysey M, SINGLE DOSE ADM INFL, P2021, DOI [10.2139/ssrn.3777268, DOI 10.2139/SSRN.3777268]; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; World Health Organization, 2020, DES VACC EFF TRIALS	32	440	447	8	52	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2021	373								n1088	10.1136/bmj.n1088	http://dx.doi.org/10.1136/bmj.n1088			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3HS	33985964	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000652650700008
J	Limb, M				Limb, Matthew			Queen's speech "lacks detail" on safe staffing, public health, social care reform, and covid inquiry	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1218	10.1136/bmj.n1218	http://dx.doi.org/10.1136/bmj.n1218			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9GP	33980580				2022-12-28	WOS:000653055200003
J	Xiong, W				Xiong, Wei			Pulmonary Embolism Prevalence Among Hospitalized Patients With COPD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Xiong, Wei] Xinhua Hosp, Dept Pulm & Crit Care Med, Shanghai, Peoples R China		Xiong, W (corresponding author), 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.	xiongwei@xinhuamed.com.cn	Xiong, Wei/AAA-3363-2020; Franciosi, Alessandro N/ABA-8274-2021; Franciosi, Alex/GYE-2835-2022	Xiong, Wei/0000-0003-2126-8535; Franciosi, Alex/0000-0002-4241-8718				Couturaud F, 2021, JAMA-J AM MED ASSOC, V325, P59, DOI 10.1001/jama.2020.23567; Dentali F, 2020, EUR J INTERN MED, V80, P54, DOI 10.1016/j.ejim.2020.05.006; Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405; Shen JH, 2016, J THROMB THROMBOLYS, V41, P482, DOI 10.1007/s11239-015-1250-2; Xiong W, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01483-0	5	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1901	+		10.1001/jama.2021.3241	http://dx.doi.org/10.1001/jama.2021.3241			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974026				2022-12-28	WOS:000650205000022
J	van Tulleken, C				van Tulleken, Christoffer			Covid-19: Sputnik vaccine rockets, thanks to Lancet boost	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EFFICACY; SAFETY		[van Tulleken, Christoffer] UCL, London, England	University of London; University College London	van Tulleken, C (corresponding author), UCL, London, England.	c.vantulleken@ucl.ac.uk			MRC [MR/J011533/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2021, LANCET REG HEALTH-EU, V2, DOI 10.1016/j.lanepe.2021.100077; [Anonymous], 2020, LANCET DIGIT HEALTH, DOI DOI 10.1016/S2589-7500(20)30198; Baraniuk C, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n743; Bucci E, 2020, LANCET, V396, pE53, DOI 10.1016/S0140-6736(20)31960-7; Cattivi Scienziati, 2020, NOT CONC; Cattivi Scienziati, 2021, MOR CONC SPUTN VACC; Department of error, 2021, LANCET, V397, P98, DOI [10.1016/S0140-6736(20)32719-7, DOI 10.1016/S0140-6736(20)32719-7]; Department of error, 2021, LANCET, V397, P670, DOI [10.1016/S0140-6736(21)00398-6, DOI 10.1016/S0140-6736(21)00398-6]; Doshi P, 2020, STAT, P17; Doshi P, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4037; Doshi P, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1991; Jones I, 2021, LANCET, V397, P642, DOI 10.1016/S0140-6736(21)00191-4; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; Logunov DY, 2020, LANCET, V396, pE54, DOI 10.1016/S0140-6736(20)31970-X; Logunov DY, 2020, LANCET, V396, P887, DOI 10.1016/S0140-6736(20)31866-3; Russian Direct Investment Fund, 2020, M PRES RUSS GOV MEMB; Smith R, 2006, J ROY SOC MED, V99, P178, DOI 10.1258/jrsm.99.4.178; Sputnik V., LANCET; State Register of Medicines, 2020, REG CERT; Su S, 2021, NAT REV MICROBIOL, V19, P211, DOI 10.1038/s41579-020-00462-y; Vlassov V., 2021, COMMENTARY PUBLICATI	21	15	15	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2021	373								n1108	10.1136/bmj.n1108	http://dx.doi.org/10.1136/bmj.n1108			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YV	33958384	Bronze			2022-12-28	WOS:000651241700010
J	Kleele, T; Rey, T; Winter, J; Zaganelli, S; Mahecic, D; Lambert, HP; Ruberto, FP; Nemir, M; Wai, T; Pedrazzini, T; Manley, S				Kleele, Tatjana; Rey, Timo; Winter, Julius; Zaganelli, Sofia; Mahecic, Dora; Lambert, Helene Perreten; Ruberto, Francesco Paolo; Nemir, Mohamed; Wai, Timothy; Pedrazzini, Thierry; Manley, Suliana			Distinct fission signatures predict mitochondrial degradation or biogenesis	NATURE			English	Article							DYNAMIN-RELATED PROTEIN-1; IMAGE; CA2+; MITOPHAGY; CELLS; INCREASES; MID51; MID49; DRP1; MFF	Mitochondrial fission is ahighly regulated process that, when disrupted, can alter metabolism, proliferation and apoptosis(1-3). Dysregulation has been linked to neurodegeneration(3,4), cardiovascular disease(3) and cancer(5). Key components of the fission machinery include the endoplasmic reticulum(6) and actin(7), which initiate constriction before dynamin-related protein 1 (DRP1)(8) binds to the outer mitochondrial membrane via adaptor proteins(9-11), to drive scission(12). In the mitochondrial life cycle, fission enables both biogenesis of new mitochondria and clearance of dysfunctional mitochondria through mitophagy(1,13). Current models of fission regulation cannot explain how those dual fates are decided. However, uncovering fate determinants is challenging, as fission is unpredictable, and mitochondrial morphology is heterogeneous, with ultrastructuralfeatures that are below the diffraction limit. Here, we used live-cell structured illumination microscopy to capture mitochondrial dynamics. By analysing hundreds of fissions in African green monkey Cos-7 cells and mouse cardiomyocytes, we discovered two functionally and mechanistically distinct types of fission. Division at the periphery enables damaged material to be shed into smaller mitochondria destined for mitophagy, whereas division at the midzone leads to the proliferation of mitochondria. Both types are mediated by DRP1, but endoplasmic reticulum- and actin-mediated pre-constriction and the adaptor MFF govern only midzone fission. Peripheral fission is preceded by lysosomal contact and is regulated by the mitochondrial outer membrane protein FIS1. These distinct molecular mechanisms explain how cells independently regulate fission, leading to distinct mitochondrial fates.	[Kleele, Tatjana; Rey, Timo; Winter, Julius; Zaganelli, Sofia; Mahecic, Dora; Lambert, Helene Perreten; Manley, Suliana] Ecole Polytech Fed Lausanne EPFL, Inst Phys, Lausanne, Switzerland; [Ruberto, Francesco Paolo; Nemir, Mohamed; Pedrazzini, Thierry] Univ Lausanne, Med Sch, Dept Cardiovasc Med, Expt Cardiol Unit, Lausanne, Switzerland; [Wai, Timothy] Inst Pasteur, CNRS, UMR 3691, Mitochondrial Biol Grp, Paris, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kleele, T; Manley, S (corresponding author), Ecole Polytech Fed Lausanne EPFL, Inst Phys, Lausanne, Switzerland.	tatjana.kleele@epfl.ch; suliana.manley@epfl.ch	; Manley, Suliana/D-3818-2012	Pedrazzini, Thierry/0000-0002-7969-8725; Kleele, Tatjana/0000-0001-5320-7337; Rey, Timo/0000-0002-2124-937X; Mahecic, Dora/0000-0003-1004-4771; ZAGANELLI, SOFIA/0000-0002-2815-3231; Winter, Julius/0000-0001-6702-1330; Manley, Suliana/0000-0002-4755-4778	National Centre of Competence in Research Chemical Biology; European Research Council [CoG 819823]; Swiss National Science Foundation [182429, CRSII5_173738, 31003A_182322]; European Molecular Biology Organization [ALTF-739-2016]; Munich Cluster for Systems Neurology (SyNergy)	National Centre of Competence in Research Chemical Biology; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Munich Cluster for Systems Neurology (SyNergy)	We thank C. Cottiny and M. Colomer for experimental and technical assistance, M.-C. Croisier and G. Knott from the BioEM (EPFL) for carrying out the electron microscopy, T. Laroche (BIOP, EPFL) for imaging support and M. Ryan for the MEF lines. We thank T. Misgeld, J.-C. Martinou and P. Ramdya for feedback on the manuscript. Research in S.M.'s laboratory is supported by the National Centre of Competence in Research Chemical Biology, the European Research Council (CoG 819823, Piko) and the Swiss National Science Foundation (182429). T.K. received funding from the European Molecular Biology Organization (ALTF-739-2016) and the Munich Cluster for Systems Neurology (SyNergy). This work is supported in part by grants from the Swiss National Science Foundation to T.P. (no. CRSII5_173738 and no. 31003A_182322).	Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Chang F, 2014, ANNU REV CELL DEV BI, V30, P317, DOI 10.1146/annurev-cellbio-100913-013357; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hirabayahi Y, 2017, SCIENCE, V358, P623, DOI 10.1126/science.aan6009; HOLMES TJ, 1989, APPL OPTICS, V28, P4930, DOI 10.1364/AO.28.004930; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Ji WK, 2015, ELIFE, V4, DOI [10.7554/eLife.11553.001, 10.7554/eLife.11553]; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kimura W, 2014, ANTIOXID REDOX SIGN, V21, P1660, DOI 10.1089/ars.2014.6029; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549; Ma JT, 2019, J CANCER, V10, P4045, DOI 10.7150/jca.29756; Mahecic D, 2020, NAT METHODS, V17, P726, DOI 10.1038/s41592-020-0859-z; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Minin AA, 2006, J CELL SCI, V119, P659, DOI 10.1242/jcs.02762; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Osellame LD, 2016, J CELL SCI, V129, P2170, DOI 10.1242/jcs.185165; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rey T, 2020, NAT CELL BIOL, V22, P1180, DOI 10.1038/s41556-020-00584-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang WZ, 2016, NAT MED, V22, P54, DOI 10.1038/nm.3983; Wolf DM, 2019, EMBO J, V38, DOI 10.15252/embj.2018101056; Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Xian HX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10096-1; York AG, 2013, NAT METHODS, V10, P1122, DOI [10.1038/NMETH.2687, 10.1038/nmeth.2687]; Yu R, 2019, EMBO J, V38, DOI 10.15252/embj.201899748; Zamora M, 2015, BIOCHEM PHARMACOL, V98, P16, DOI 10.1016/j.bcp.2015.06.032	52	94	94	35	126	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					435	+		10.1038/s41586-021-03510-6	http://dx.doi.org/10.1038/s41586-021-03510-6		MAY 2021	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE2PC	33953403	Green Submitted, Green Published			2022-12-28	WOS:000647555000004
J	Bhatt, PR; Scaiola, A; Loughran, G; Leibundgut, M; Kratzel, A; Meurs, R; Dreos, R; O'Connor, KM; McMillan, A; Bode, JW; Thiel, V; Gatfield, D; Atkins, JF; Ban, NN				Bhatt, Pramod R.; Scaiola, Alain; Loughran, Gary; Leibundgut, Marc; Kratzel, Annika; Meurs, Romane; Dreos, Rene; O'Connor, Kate M.; McMillan, Angus; Bode, Jeffrey W.; Thiel, Volker; Gatfield, David; Atkins, John F.; Ban, Nenad			Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome	SCIENCE			English	Article							SARS-CORONAVIRUS; CRYSTAL-STRUCTURE; IN-VITRO; VISUALIZATION; SIGNAL; CONSERVATION; FEATURES; PLATFORM; SYSTEM; LIGAND	Programmed ribosomal frameshifting is a key event during translation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA genome that allows synthesis of the viral RNA-dependent RNA polymerase and downstream proteins. Here, we present the cryo-electron microscopy structure of a translating mammalian ribosome primed for frameshifting on the viral RNA. The viral RNA adopts a pseudoknot structure that lodges at the entry to the ribosomal messenger RNA (mRNA) channel to generate tension in the mRNA and promote frameshifting, whereas the nascent viral polyprotein forms distinct interactions with the ribosomal tunnel. Biochemical experiments validate the structural observations and reveal mechanistic and regulatory features that influence frameshifting efficiency. Finally, we compare compounds previously shown to reduce frameshifting with respect to their ability to inhibit SARS-CoV-2 replication, establishing coronavirus frameshifting as a target for antiviral intervention.	[Bhatt, Pramod R.; Scaiola, Alain; Leibundgut, Marc; Ban, Nenad] Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Zurich, Switzerland; [Bhatt, Pramod R.; Loughran, Gary; O'Connor, Kate M.; Atkins, John F.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork T12 XF62, Ireland; [Bhatt, Pramod R.; Atkins, John F.] Univ Coll Cork, Sch Microbiol, Cork T12 K8AF, Ireland; [Kratzel, Annika; Thiel, Volker] Univ Bern, Inst Virol & Immunol, Bern, Switzerland; [Kratzel, Annika; Thiel, Volker] Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland; [Kratzel, Annika] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Meurs, Romane; Dreos, Rene; Gatfield, David] Univ Lausanne, Ctr Integrat Genom, Genopode, CH-1015 Lausanne, Switzerland; [McMillan, Angus; Bode, Jeffrey W.] Swiss Fed Inst Technol, Lab Organ Chem, Dept Chem & Appl Biosci, Zurich, Switzerland; [Atkins, John F.] MRC Lab Mol Biol, Cambridge CB2 0QH, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University College Cork; University College Cork; University of Bern; University of Bern; University of Bern; University of Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; MRC Laboratory Molecular Biology	Ban, NN (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Zurich, Switzerland.; Atkins, JF (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cork T12 XF62, Ireland.; Atkins, JF (corresponding author), Univ Coll Cork, Sch Microbiol, Cork T12 K8AF, Ireland.; Atkins, JF (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	j.atkins@ucc.le; ban@mol.biol.ethz.ch	Loughran, Gary/AAQ-8791-2020; Gatfield, David/C-2354-2011	Loughran, Gary/0000-0002-2683-5597; McMillan, Angus/0000-0002-8883-1380; O'Connor, Kate/0000-0002-4862-4918; Scaiola, Alain/0000-0003-3233-3910; Meurs, Romane/0000-0003-3115-2501; Thiel, Volker/0000-0002-5783-0887; Gatfield, David/0000-0001-5114-2824; Dreos, Rene/0000-0002-0816-7775	Swiss National Science Foundation (SNSF) through the National Center of Excellence in RNA and Disease [31003A_182341, 310030_173085, 182880]; Federal Ministry of Education and Research, Germany (BMBF; grant RAPID) [01KI1723A]; Irish Research Council Advanced Laureate [IRCLA/2019/74]; Carbery Group Ltd.	Swiss National Science Foundation (SNSF) through the National Center of Excellence in RNA and Disease(Swiss National Science Foundation (SNSF)); Federal Ministry of Education and Research, Germany (BMBF; grant RAPID)(Federal Ministry of Education & Research (BMBF)); Irish Research Council Advanced Laureate(Irish Research Council for Science, Engineering and Technology); Carbery Group Ltd.	This work was supported by the Swiss National Science Foundation (SNSF) to N.B. and V.T. (grants 31003A_182341 and 310030_173085) through the National Center of Excellence in RNA and Disease (project funding 182880) to N.B., V.T., and D.G.; by the Federal Ministry of Education and Research, Germany (BMBF; grant RAPID, #01KI1723A) to A.K. and V.T.; and by the Irish Research Council Advanced Laureate (IRCLA/2019/74) to J.F.A., who thanks G. F. Fitzgerald for funds from Carbery Group Ltd.	Amiri H, 2019, RNA, V25, P364, DOI 10.1261/rna.068965.118; Arpat AB, 2020, GENOME RES, V30, P985, DOI 10.1101/gr.257741.119; Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530; Bao C, 2020, ELIFE, V9, DOI 10.7554/eLife.55799; Baranov PV, 2005, VIROLOGY, V332, P498, DOI 10.1016/j.virol.2004.11.038; Bouvet M, 2014, J BIOL CHEM, V289, P25783, DOI 10.1074/jbc.M114.577353; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Brown A, 2015, NATURE, V524, P493, DOI 10.1038/nature14896; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Chandrasekaran V, 2019, NAT STRUCT MOL BIOL, V26, P1132, DOI 10.1038/s41594-019-0331-x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6969; Doring K, 2017, CELL, V170, P298, DOI 10.1016/j.cell.2017.06.038; Dos Ramos F, 2004, BIOCHEM SOC T, V32, P1081; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finkel Yaara, 2021, Nature, V589, P125, DOI 10.1038/s41586-020-2739-1; George V. G., 1996, P3, DOI 10.1016/B978-012465330-6/50002-6; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Han Px, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107610; Harrington HR, 2020, J BIOL CHEM, V295, P6798, DOI 10.1074/jbc.RA120.012706; Huston NC, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.041; Irigoyen N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005473; Joseph JS, 2006, J VIROL, V80, P7894, DOI 10.1128/JVI.00467-06; KEITH G, 1978, BIOCHIM BIOPHYS ACTA, V517, P133, DOI 10.1016/0005-2787(78)90041-2; Kelly JA, 2020, J BIOL CHEM, V295, P10741, DOI 10.1074/jbc.AC120.013449; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lan, 2020, INSIGHTS SECONDARY S, DOI [10.1101/2020.06.29.178343, DOI 10.1101/2020.06.29.178343]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li WF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18765-2; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lin ZR, 2012, NUCLEIC ACIDS RES, V40, P8674, DOI 10.1093/nar/gks629; Loughran G, 2017, RNA, V23, P1285, DOI 10.1261/rna.061051.117; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McGlincy NJ, 2017, METHODS, V126, P112, DOI 10.1016/j.ymeth.2017.05.028; Meydan S, 2020, MOL CELL, V79, P588, DOI 10.1016/j.molcel.2020.06.010; Moriarty NW, 2019, ACTA CRYSTALLOGR D, V75, P16, DOI 10.1107/S205979831801519X; Mutterer J, 2013, J MICROSC-OXFORD, V252, P89, DOI 10.1111/jmi.12069; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Natchiar SK, 2017, NATURE, V551, P472, DOI 10.1038/nature24482; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Park SJ, 2011, J AM CHEM SOC, V133, P10094, DOI 10.1021/ja1098325; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plant EP, 2005, PLOS BIOL, V3, P1012, DOI 10.1371/journal.pbio.0030172; Plant EP, 2010, J VIROL, V84, P4330, DOI 10.1128/JVI.02480-09; Punjani A, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107702; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Puray-Chavez Maritza, 2021, bioRxiv, DOI 10.1101/2020.11.03.367516; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rangan R, 2020, RNA, V26, P937, DOI 10.1261/rna.076141.120; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shao SC, 2016, CELL, V167, P1229, DOI 10.1016/j.cell.2016.10.046; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinha NK, 2020, ELIFE, V9, DOI 10.7554/eLife.58828; Smith EC, 2015, J VIROL, V89, P6418, DOI 10.1128/JVI.00110-15; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Su MC, 2005, NUCLEIC ACIDS RES, V33, P4265, DOI 10.1093/nar/gki731; Sun Yu, 2020, bioRxiv, DOI 10.1101/2020.10.21.349225; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Taoka M, 2018, NUCLEIC ACIDS RES, V46, P9289, DOI 10.1093/nar/gky811; Terwilliger TC, 2018, ACTA CRYSTALLOGR D, V74, P545, DOI 10.1107/S2059798318004655; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Kaiming, 2020, bioRxiv, DOI 10.1101/2020.07.18.209270; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	78	67	69	12	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2021	372	6548			SI		1306	+		10.1126/science.abf3546	http://dx.doi.org/10.1126/science.abf3546			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SY0WR	34029205	Green Submitted, Green Published			2022-12-28	WOS:000665616000028
J	Horby, PW; Landray, MJ				Horby, Peter W.; Landray, Martin J.		RECOVERY Collaborative Grp	Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial	LANCET			English	Article								Background Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. Methods This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]) is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. The trial is underway at 177 NHS hospitals from across the UK. Eligible and consenting patients were randomly assigned (1:1) to receive either usual care alone (usual care group) or usual care plus high-titre convalescent plasma (convalescent plasma group). The primary outcome was 28-day mortality, analysed on an intention-to-treat basis. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings Between May 28, 2020, and Jan 15, 2021, 11558 (71%) of 16287 patients enrolled in RECOVERY were eligible to receive convalescent plasma and were assigned to either the convalescent plasma group or the usual care group. There was no significant difference in 28-day mortality between the two groups: 1399 (24%) of 5795 patients in the convalescent plasma group and 1408 (24%) of 5763 patients in the usual care group died within 28 days (rate ratio 1.00, 95% CI 0.93-1.07; p=0.95). The 28-day mortality rate ratio was similar in all prespecified subgroups of patients, including in those patients without detectable SARS-CoV-2 antibodies at randomisation. Allocation to convalescent plasma had no significant effect on the proportion of patients discharged from hospital within 28 days (3832 [66%] patients in the convalescent plasma group vs 3822 [66%] patients in the usual care group; rate ratio 0.99, 95% CI 0.94-1.03; p=0.57). Among those not on invasive mechanical ventilation at randomisation, there was no significant difference in the proportion of patients meeting the composite endpoint of progression to invasive mechanical ventilation or death (1568 [29%] of 5493 patients in the convalescent plasma group vs 1568 [29%] of 5448 patients in the usual care group; rate ratio 0.99, 95% CI 0.93-1.05; p=0.79). Interpretation In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Horby, Peter W.; Landray, Martin J.] RECOVERY Cent Coordinating Off, Oxford OX3 7LF, England		Horby, PW; Landray, MJ (corresponding author), RECOVERY Cent Coordinating Off, Oxford OX3 7LF, England.	recoverytrial@ndph.ox.ac.uk	Ahmed, Naseer/C-8119-2019; Shanahan, Thomas/AAP-3822-2020; Chan, Xin Hui S/ABA-5004-2021; Tso, Simon/N-2422-2014; Evans, D Gareth/AAB-4308-2022; Tageldin, Amr/CAF-8726-2022; mcgrath, brendan a/D-7202-2013; Rivera-Ortega, Pilar/X-7083-2019; Pessoa-Amorim, Guilherme/AAV-4151-2021; Gkrania-Klotsas, Effrossyni/AAT-8424-2021; Caplin, Ben/AAH-1641-2019; Kelly, Michael Eamon/AAF-1917-2021; Darton, Thomas/H-2816-2017; Fawke, Joe/ABA-9407-2021; Montgomery, Hugh/C-2592-2008; moon, james/F-1031-2014; Faust, Saul/J-9779-2014; Gibbison, Ben/J-6611-2014; Pearse, Rupert/H-5426-2011; Porter, Joanna/C-7162-2009; Payne, Brendan/I-1233-2016; Kudsk-Iversen, Soren/Y-9391-2018; Llewelyn, Martin/A-7194-2011; Skene, Imogen/D-6153-2018	Ahmed, Naseer/0000-0002-0960-1123; Shanahan, Thomas/0000-0001-5613-2545; Chan, Xin Hui S/0000-0002-9941-6975; Tso, Simon/0000-0001-9221-7618; Evans, D Gareth/0000-0002-8482-5784; mcgrath, brendan a/0000-0003-3048-3480; Rivera-Ortega, Pilar/0000-0002-7960-8822; Pessoa-Amorim, Guilherme/0000-0002-4050-6191; Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; Caplin, Ben/0000-0001-9544-164X; Darton, Thomas/0000-0003-2209-9956; Fawke, Joe/0000-0002-5267-7107; Bibby, Anna/0000-0001-7386-7754; Aujayeb, Avinash/0000-0002-0859-5550; Burden, Christy/0000-0001-6409-5238; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Montgomery, Hugh/0000-0001-8797-5019; Abu-Arafeh, Ahmad/0000-0003-2464-3871; Cathie, Katrina/0000-0001-5074-0769; Christides, Alexander/0000-0002-9476-9827; Adamali, Huzaifa/0000-0002-8230-175X; Barnett-Vanes, Ashton/0000-0002-8088-1068; Chapman, Laura/0000-0001-6174-9435; Gupta-Wright, Ankur/0000-0002-5150-2970; Hawcutt, Dan/0000-0002-8120-6507; Lillie, Patrick/0000-0002-4811-4774; Nadeem, Iftikhar/0000-0002-8644-925X; Whittaker, Elizabeth/0000-0002-7944-8793; Razvi, Salman/0000-0002-9047-1556; Peto, Leon/0000-0002-4100-2163; Lowsby, Richard/0000-0001-9940-191X; Forton, Julian/0000-0002-0580-0432; Mentzer, Alexander/0000-0002-4502-2209; Staplin, Natalie/0000-0003-4482-4418; Shelley, Ben/0000-0001-6771-9659; Dey, Vishal/0000-0002-5108-4158; Gregory, Katherine/0000-0002-0610-5386; Smith, Christopher/0000-0001-7369-2034; Murray, Clare/0000-0002-8961-8055; vatish, manu/0000-0002-6012-2574; Quenby, Siobhan/0000-0003-3221-5471; Welters, Ingeborg/0000-0002-3408-8798; Roehr, Charles Christoph/0000-0001-7965-4637; moon, james/0000-0001-8071-1491; Faust, Saul/0000-0003-3410-7642; Parmar, Chetan/0000-0002-1238-6524; Roddick, Alistair/0000-0002-4184-2541; Pickford, Hayleah/0000-0002-1906-5467; Kametas, Nicholas/0000-0002-7992-6038; Lewis, Joseph/0000-0002-3837-5188; Sekhar, Mallika/0000-0002-5783-1855; Iliodromiti, Stamatina/0000-0001-6453-6654; Harwood, Catherine/0000-0002-1375-0965; Pathan, Nazima/0000-0001-7656-9453; Underwood, Jonathan/0000-0001-6963-2821; Kapil, Vikas/0000-0001-5778-6188; Lim, Wei Shen/0000-0002-7694-3051; Parekh, Dhruv/0000-0002-1508-8362; Taynton, Thomas/0000-0001-7771-9564; Hartshorn, Stuart/0000-0003-0419-1564; Baillie, John Kenneth/0000-0001-5258-793X; Scott, Alex/0000-0001-6719-0417; Emberson, Jonathan/0000-0001-7792-9422; Mutch, Callum/0000-0001-9788-0179; Last, Anna/0000-0001-8730-9323; , Satvinder Kaur/0000-0003-0808-9612; Puxty, Kathryn/0000-0002-5742-6171; Behrouzi, Roya/0000-0002-1978-6539; Gorick, Hugh/0000-0003-3089-9830; Brankin-Frisby, Thomas/0000-0003-2184-8580; Dark, Paul/0000-0003-3309-0164; Orton, Christopher/0000-0002-9167-5462; Esmail, Hanif/0000-0002-4278-9316; Dobbie, Laurence J./0000-0003-1908-848X; Bhagani, Sanjay/0000-0003-2557-4337; Hodson, Kenneth/0000-0003-3091-6952; Noba, Lyrics/0000-0002-5389-7937; Grandjean, Louis/0000-0002-1457-8327; brightling, chris/0000-0002-9345-4903; Fairbairn, Tim/0000-0003-1491-6231; Linden, Dermot/0000-0003-0552-1115; Jhanji, Shaman/0000-0002-1116-628X; Vidler, Jennifer/0000-0003-2996-3014; Gibbison, Ben/0000-0003-3635-6212; Collini, Paul/0000-0001-6696-6826; Pearse, Rupert/0000-0002-4373-5934; Adams, Richard/0000-0003-3915-7243; Barker, Joseph/0000-0002-5483-9608; Merrick, Blair/0000-0002-6061-6064; Pastika, Libor/0000-0001-6892-6553; Crook, Derrick/0000-0002-0590-2850; Porter, Joanna/0000-0002-7307-169X; Haynes, Richard/0000-0002-1179-0023; Cavazza, Anna/0000-0003-3720-0463; Murray, Eleanor/0000-0002-4837-4840; Bassett, John/0000-0002-8815-6012; Jethwa, Kishan/0000-0003-1715-9256; Lord, Robert/0000-0001-9008-2502; Dixon, Giles/0000-0001-9787-0739; Linares, Christian Alexander/0000-0002-2473-8873; Sahdev, Nikhil/0000-0003-2291-5044; Hormis, Anil/0000-0001-5510-7639; Green, Christopher/0000-0002-1984-4014; Bancroft, Elizabeth/0000-0002-5482-5660; imray, chris/0000-0001-8451-4102; Bukhari, Marwan/0000-0003-4311-5222; Foley, Paul/0000-0002-4856-832X; Rowan, Kathryn/0000-0001-8217-5602; Lason, Wojciech/0000-0002-1036-6108; Ustianowski, Andrew/0000-0002-6134-7855; O'Sullivan, Eoin/0000-0002-7709-6595; mumford, andrew/0000-0002-5523-511X; Payne, Brendan/0000-0002-3101-3512; Hodgson, Luke/0000-0002-8278-9513; Dhaliwal, Kevin/0000-0002-3925-3174; Landray, Martin/0000-0001-6646-827X; Kudsk-Iversen, Soren/0000-0002-7112-3548; Hum, Ryan Malcolm/0000-0003-0801-6974; de Silva, Thushan/0000-0002-6498-9212; Rickman, Hannah/0000-0002-3502-0744; Horby, Peter/0000-0002-9822-1586; , Prof Dr Muhammad Shahid Iqbal/0000-0003-0245-5976; Estcourt, Lise/0000-0003-4309-9162; Sarkar, Rahuldeb/0000-0002-4343-8526; Cooper, Jamie/0000-0003-3812-7026; Naisbitt, Michael/0000-0003-1560-6235; Hinshaw, Kim/0000-0003-0468-4326; CARTER, Michael/0000-0003-3403-4746; Shah, Pallav/0000-0002-9052-4638; Newman, Tom/0000-0002-7987-9948; Mazzella, Andrea/0000-0003-1560-7465; Llewelyn, Martin/0000-0002-6811-1124; Bachar, Roudi/0000-0001-8113-7110; Ireland, Aidan Taeke/0000-0001-9513-2302; So, Beng/0000-0003-4356-532X; Downey, Damian/0000-0002-6471-549X; Brannigan, Jamie/0000-0003-1697-403X; Blencowe, Natalie/0000-0002-6111-2175; Glaysher, Sharon/0000-0002-9584-0621; Montgomery, Alan/0000-0003-0450-1606; Jajbhay, Danyal/0000-0002-3475-9651; Nigel, Brunskill/0000-0002-7109-7108; King, Scott/0000-0001-6821-9234; Soiza, Roy/0000-0002-1397-4272; Willis, Joanna/0000-0003-3260-4311; Dimitri, Paul/0000-0001-7625-6713; Spata, Enti/0000-0002-7207-2076; Hannah, Jennifer/0000-0002-3491-6653; Skene, Imogen/0000-0001-5215-2899; de Vere, Natasha/0000-0001-9593-6925; Pfeffer, Paul/0000-0003-0369-2885; Vallabhaneni, Pramodh/0000-0002-4887-8651; Spears, Mark/0000-0003-4381-5819; Hoggett, Lee/0000-0003-1135-6232; Rokadiya, Sakib/0000-0003-2955-4907; Milligan, Iain D/0000-0002-6501-5524; Ali, Mohammad/0000-0002-4765-615X; McKnight, Gerard/0000-0003-1546-7853; Denis, Emmanuelle/0000-0001-8463-1341; Patel, Manish/0000-0003-3012-7507; Peters, Mark/0000-0003-3653-4808; Lindsay, Charlotte/0000-0002-7283-857X; Welch, Hugh/0000-0001-6906-2718; De Sousa, Paulo/0000-0003-3011-4116; Burton, Ben/0000-0001-9579-9078; Gibani, Malick/0000-0003-1781-0053; Drysdale, Simon/0000-0002-6350-6557; Crocombe, Dominic/0000-0002-1401-6930; Cole, Joby/0000-0002-5258-5835; Colton, Hayley/0000-0002-3287-4103; Ramasamy, Maheshi Nirmala/0000-0002-2119-951X; Chaudhuri, Nazia/0000-0003-3325-6996; Roberts, David/0000-0003-0648-6585; Iftikhar, Hina/0000-0003-2138-1415; Ripley, David/0000-0001-8460-9873; Campbell, Mark/0000-0002-9759-0232; Tridente, Ascanio/0000-0003-1500-447X; Kelly, Dominic/0000-0002-6063-8896; Gorog, Diana/0000-0002-9286-1451	NHS Blood and Transplant; Scottish National Blood Transfusion Service; Welsh Blood Service; Northern Ireland Blood Transfusion Service; Public Health England; Department of Health Social Care; ntensive Care National Audit & Research Centre; Public Health Scotland; National Records Service of Scotland; UK Research and Innovation (UKRI); NIHR [MC_PC_19056]; Department of Health and Social Care (DHSC); UKRI; NIHR COVID-19 Rapid Response Grant (COV19-RECPLA); NIHR Oxford Biomedical Research Centre; Wellcome Trust; Bill & Melinda Gates Foundation; Department for International Development, Health Data Research UK; Medical Research Council Population Health Research Unit; NIHR Health Protection Unit in Emerging and Zoonotic Infections; NHS Blood and Transplant Research and Development Funding; EU's Horizon 2020 research and innovation programme [SUPPORT-E - 101015756]; UK Medical Research Council [MC_UU_0002/14]; NIHR Senior Research Fellowship [NIHR-SRF-2015-08-001]; NIHR Nottingham Biomedical Research Centre; DHSC; EU SoHo Grant; NIHR Clinical Trials Unit Support Funding; NHS DigiTrials	NHS Blood and Transplant; Scottish National Blood Transfusion Service; Welsh Blood Service; Northern Ireland Blood Transfusion Service; Public Health England; Department of Health Social Care; ntensive Care National Audit & Research Centre; Public Health Scotland; National Records Service of Scotland; UK Research and Innovation (UKRI)(UK Research & Innovation (UKRI)); NIHR(National Institute for Health Research (NIHR)); Department of Health and Social Care (DHSC); UKRI(UK Research & Innovation (UKRI)); NIHR COVID-19 Rapid Response Grant (COV19-RECPLA); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Department for International Development, Health Data Research UK; Medical Research Council Population Health Research Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Health Protection Unit in Emerging and Zoonotic Infections; NHS Blood and Transplant Research and Development Funding; EU's Horizon 2020 research and innovation programme; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Senior Research Fellowship; NIHR Nottingham Biomedical Research Centre; DHSC; EU SoHo Grant; NIHR Clinical Trials Unit Support Funding; NHS DigiTrials	We would like to thank the thousands of patients who participated in this trial. We would also like to thank the many doctors, nurses, pharmacists, other allied health professionals, and research administrators at 177 NHS hospital organisations across the whole of the UK, supported by staff at the National Institute of Health Research (NIHR) Clinical Research Network, NHS DigiTrials, NHS Blood and Transplant, the Scottish National Blood Transfusion Service, the Welsh Blood Service, the Northern Ireland Blood Transfusion Service, Public Health England, Department of Health & Social Care, the Intensive Care National Audit & Research Centre, Public Health Scotland, National Records Service of Scotland, the Secure Anonymised Information Linkage at University of Swansea, Swansea, UK, and the NHS in England, Scotland, Wales and Northern Ireland. The RECOVERY trial is supported by a grant to the University of Oxford from UK Research and Innovation (UKRI) and NIHR (MC_PC_19056), by the Department of Health and Social Care (DHSC), UKRI, and NIHR COVID-19 Rapid Response Grant (COV19-RECPLA), and by core funding provided by NIHR Oxford Biomedical Research Centre, the Wellcome Trust, the Bill & Melinda Gates Foundation, the Department for International Development, Health Data Research UK, the Medical Research Council Population Health Research Unit, the NIHR Health Protection Unit in Emerging and Zoonotic Infections, NHS Blood and Transplant Research and Development Funding, EU's Horizon 2020 research and innovation programme (SUPPORT-E -101015756), and NIHR Clinical Trials Unit Support Funding. TJ is supported by a grant from UK Medical Research Council (MC_UU_0002/14) and an NIHR Senior Research Fellowship (NIHR-SRF-2015-08-001). WSL is supported by core funding provided by NIHR Nottingham Biomedical Research Centre. AbbVie contributed some supplies of lopinavir-ritonavir for use in this trial. Tocilizumab was provided free of charge for this trial by Roche. REGN-COV2 was provided free of charge for this trial by Regeneron. The collection of plasma was funded by the DHSC through core funding and funding under COVID-19 and EU SoHo Grant. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, NHS Blood and Transplant, the DHSC, or the EU.	Agarwal A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3939; AlQahtani M, 2020, MEDRXIV, DOI [10.1101/2020.11.02.20224303, DOI 10.1101/2020.11.02.20224303]; Avendano-Sola C., 2020, CONVALESCENT PLASMA, DOI [https://doi.org/10.1101/2020.08.26.20182444, 10.1101/2020.08.26.20182444, DOI 10.1101/2020.08.26.20182444]; Bajpai M., 2020, PREPRINT, DOI [10.25.20219337, 10.1101/2020.10.25.20219337, DOI 10.1101/2020.10.25.20219337]; Balcells ME, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003415; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Devasenapathy N, 2020, CAN MED ASSOC J, V192, pE745, DOI 10.1503/cmaj.200642; Gharbharan A, 2020, CONVALESCENT PLASMA, DOI 10.1101/2020.07.01.20139857; Harvala H, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.28.2001260; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Joyner MJ, 2021, NEW ENGL J MED, V384, P1015, DOI 10.1056/NEJMoa2031893; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Li KN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19943-y; Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; O'Donnell MR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI150646; Patel EU, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02257-20; Ray Y., 2020, INFECT DIS EXCEPT HI, V2020, p11.25.20237883, DOI 10.1101/2020.11.25.20237883; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304; Stoesser N, 2020, LANCET INFECT DIS, V20, P1390, DOI 10.1016/S1473-3099(20)30634-4; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; US Department of Health and Human Services Food and Drug Administration, 2021, LETT AUTH REISS CONV; Valdivia A, 2021, EUR J CLIN MICROBIOL, V40, P485, DOI 10.1007/s10096-020-04128-8; Walker GJ, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020247	29	268	270	6	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 29	2021	397	10289					2049	2059		10.1016/S0140-6736(21)00897-7	http://dx.doi.org/10.1016/S0140-6736(21)00897-7		MAY 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK5LX	34000257	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000656257800023
J	Slomski, A				Slomski, Anita			Patient Navigation Reduces Substance Abuse Disorder Readmissions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2039	2039		10.1001/jama.2021.7723	http://dx.doi.org/10.1001/jama.2021.7723			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ6MR	34032830				2022-12-28	WOS:000655647300010
J	Chen, Z; Jiang, Y; Shao, YT; Holtz, ME; Odstrcil, M; Guizar-Sicairos, M; Hanke, I; Ganschow, S; Schlom, DG; Muller, DA				Chen, Zhen; Jiang, Yi; Shao, Yu-Tsun; Holtz, Megan E.; Odstrcil, Michal; Guizar-Sicairos, Manuel; Hanke, Isabelle; Ganschow, Steffen; Schlom, Darrell G.; Muller, David A.			Electron ptychography achieves atomic-resolution limits set by lattice vibrations	SCIENCE			English	Article							X-RAY; TRANSMISSION MICROSCOPY; DIFFRACTION; ORTHOSCANDATE; SCATTERING; DETECTOR; DEPTH	Transmission electron microscopes use electrons with wavelengths of a few picometers, potentially capable of imaging individual atoms in solids at a resolution ultimately set by the intrinsic size of an atom. However, owing to lens aberrations and multiple scattering of electrons in the sample, the image resolution is reduced by a factor of 3 to 10. By inversely solving the multiple scattering problem and overcoming the electron-probe aberrations using electron ptychography, we demonstrate an instrumental blurring of less than 20 picometers and a linear phase response in thick samples. The measured widths of atomic columns are limited by thermal fluctuations of the atoms. Our method is also capable of locating embedded atomic dopant atoms in all three dimensions with subnanometer precision from only a single projection measurement.	[Chen, Zhen; Shao, Yu-Tsun; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Jiang, Yi] Argonne Natl Lab, Adv Photon Source, Lemont, IL 60439 USA; [Holtz, Megan E.; Schlom, Darrell G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Odstrcil, Michal; Guizar-Sicairos, Manuel] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Hanke, Isabelle; Ganschow, Steffen; Schlom, Darrell G.] Leibniz Inst Kristallzuchtung, Max Born Str 2, D-12489 Berlin, Germany; [Schlom, Darrell G.; Muller, David A.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Holtz, Megan E.] Colorado Sch Mines, Departure Met & Mat Engn, Golden, CO 80401 USA; [Odstrcil, Michal] Carl Zeiss SMT, Carl Zeiss Str 22, D-73447 Oberkochen, Germany	Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Leibniz Institut fur Kristallzuchtung (IKZ); Colorado School of Mines; Carl Zeiss AG	Chen, Z; Muller, DA (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.; Muller, DA (corresponding author), Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA.	zhen.chen@cornell.edu; david.a.muller@cornell.edu	Muller, David/A-7745-2010; Guizar-Sicairos, Manuel/AAB-3793-2019	Muller, David/0000-0003-4129-0473; Guizar-Sicairos, Manuel/0000-0002-8293-3634	National Science Foundation [DMR-1719875]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation under grant DMR-1539918 (PARADIM Materials Innovation Platform in-house program). Electron microscopy performed at the Cornell Center for Materials Research was supported by the National Science Foundation under grant DMR-1719875.	Allen LJ, 2015, ULTRAMICROSCOPY, V151, P11, DOI 10.1016/j.ultramic.2014.10.011; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Born M., 1989, PRINCIPLES OPTICS EL; Brown HG, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.266102; Chen Z., 2021, PARADIM; Chen Z., 2021, ZENODO, DOI [10.5281/zenodo.4659690, DOI 10.5281/ZENODO.4659690]; Chen Z, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16688-6; Close R, 2015, ULTRAMICROSCOPY, V159, P124, DOI 10.1016/j.ultramic.2015.09.002; COWLEY JM, 1957, ACTA CRYSTALLOGR, V10, P609, DOI 10.1107/S0365110X57002194; Donatelli JJ, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.065502; DOYLE PA, 1968, ACTA CRYSTALL A-CRYS, VA 24, P390, DOI 10.1107/S0567739468000756; Erni R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096101; Gao S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00150-1; Gesing TM, 2009, Z KRIST-NEW CRYST ST, V224, P365, DOI 10.1524/ncrs.2009.0159; Godden TM, 2014, OPT EXPRESS, V22, P12513, DOI 10.1364/OE.22.012513; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; HOPPE W, 1969, ACTA CRYSTALL A-CRYS, VA 25, P495, DOI 10.1107/S0567739469001045; HYTCH MJ, 1994, ULTRAMICROSCOPY, V53, P191, DOI 10.1016/0304-3991(94)90034-5; Jia CL, 2004, MICROSC MICROANAL, V10, P174, DOI 10.1017/S1431927604040425; Jiang B, 2003, MICROSC MICROANAL, V9, P457, DOI 10.1017/S1431927603030381; Jiang Y., 2018, MICROSC MICROANAL, V24, P192, DOI DOI 10.1017/S1431927618001459; Jiang Y, 2018, NATURE, V559, P343, DOI 10.1038/s41586-018-0298-5; Kirkland E.J., 2010, ADV COMPUTING ELECT, V2nd; Liferovich RP, 2004, J SOLID STATE CHEM, V177, P2188, DOI 10.1016/j.jssc.2004.02.025; Maiden AM, 2012, J OPT SOC AM A, V29, P1606, DOI 10.1364/JOSAA.29.001606; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Mir JA, 2017, ULTRAMICROSCOPY, V182, P44, DOI 10.1016/j.ultramic.2017.06.010; O'Keefe MA, 2008, ULTRAMICROSCOPY, V108, P196, DOI 10.1016/j.ultramic.2007.07.009; Odstrcil M, 2018, OPT EXPRESS, V26, P3108, DOI 10.1364/OE.26.003108; Ophus C., 2014, MICROSC MICROANAL, V20, P62, DOI [DOI 10.1017/S1431927614002037, 10.1017/S1431927614002037]; Pelz PM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07488-y; Pennycook TJ, 2015, ULTRAMICROSCOPY, V151, P160, DOI 10.1016/j.ultramic.2014.09.013; Reimer, 1989, TRANSMISSION ELECT M; Rodenburg JM, 2007, ULTRAMICROSCOPY, V107, P227, DOI 10.1016/j.ultramic.2006.07.007; Rodenburg JM, 2004, APPL PHYS LETT, V85, P4795, DOI 10.1063/1.1823034; RODENBURG JM, 1992, PHILOS T R SOC A, V339, P521, DOI 10.1098/rsta.1992.0050; Sawada H, 2009, J ELECTRON MICROSC, V58, P357, DOI 10.1093/jmicro/dfp030; Schloz M, 2020, OPT EXPRESS, V28, P28306, DOI 10.1364/OE.396925; Song JM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40413-z; Spence J C H, 1992, ELECT MICRODIFFRACTI, pp86; Suzuki A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.053903; Tate MW, 2016, MICROSC MICROANAL, V22, P237, DOI 10.1017/S1431927615015664; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Thibault P, 2013, NATURE, V494, P68, DOI 10.1038/nature11806; Tsai EHR, 2016, OPT EXPRESS, V24, P29090, DOI 10.1364/OE.24.029089; Uecker R, 2006, J CRYST GROWTH, V295, P84, DOI 10.1016/j.jcrysgro.2006.07.018; Voyles PM, 2002, NATURE, V416, P826, DOI 10.1038/416826a; Wakonig K, 2020, J APPL CRYSTALLOGR, V53, P574, DOI 10.1107/S1600576720001776; WEICKENMEIER A, 1991, ACTA CRYSTALLOGR A, V47, P590, DOI 10.1107/S0108767391004804; Xin HL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2828990; Xin HL, 2009, J ELECTRON MICROSC, V58, P157, DOI 10.1093/jmicro/dfn029; Yang H, 2017, ULTRAMICROSCOPY, V180, P173, DOI 10.1016/j.ultramic.2017.02.006; Yankovich AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5155; Zhou D, 2016, ULTRAMICROSCOPY, V160, P110, DOI 10.1016/j.ultramic.2015.10.008; Zhou LQ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16391-6; ZUO JM, 1992, ULTRAMICROSCOPY, V41, P211, DOI 10.1016/0304-3991(92)90110-6; Zuo JM, 1998, MATER T JIM, V39, P938, DOI 10.2320/matertrans1989.39.938	57	37	37	31	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					826	+	abg2533	10.1126/science.abg2533	http://dx.doi.org/10.1126/science.abg2533			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016774	Green Accepted, Green Submitted			2022-12-28	WOS:000653997000039
J	Sobirey, L; Luick, N; Bohlen, M; Biss, H; Moritz, H; Lompe, T				Sobirey, Lennart; Luick, Niclas; Bohlen, Markus; Biss, Hauke; Moritz, Henning; Lompe, Thomas			Observation of superfluidity in a strongly correlated two-dimensional Fermi gas	SCIENCE			English	Article							TEMPERATURE	Understanding how strongly correlated two-dimensional (2D) systems can give rise to unconventional superconductivity with high critical temperatures is one of the major unsolved problems in condensed matter physics. Ultracold 2D Fermi gases have emerged as clean and controllable model systems to study the interplay of strong correlations and reduced dimensionality, but direct evidence of superfluidity in these systems has been missing. We demonstrate superfluidity in an ultracold 2D Fermi gas by moving a periodic potential through the system and observing no dissipation below a critical velocity v(c). We measure v(c) as a function of interaction strength and find a maximum in the crossover regime between bosonic and fermionic superfluidity. Our measurements enable systematic studies of the influence of reduced dimensionality on fermionic superfluidity.	[Sobirey, Lennart; Luick, Niclas; Bohlen, Markus; Biss, Hauke; Moritz, Henning; Lompe, Thomas] Univ Hamburg, Inst Laserphys, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Sobirey, Lennart; Luick, Niclas; Bohlen, Markus; Biss, Hauke; Moritz, Henning; Lompe, Thomas] Univ Hamburg, Hamburg Ctr Ultrafast Imaging, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Bohlen, Markus] ENS PSL Res Univ, Lab Kastler Brossel, CNRS, Sorbonne Univ,Coll France, 24 Rue Lhomond, F-75005 Paris, France	University of Hamburg; University of Hamburg; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Sobirey, L (corresponding author), Univ Hamburg, Inst Laserphys, Luruper Chaussee 149, D-22761 Hamburg, Germany.; Sobirey, L (corresponding author), Univ Hamburg, Hamburg Ctr Ultrafast Imaging, Luruper Chaussee 149, D-22761 Hamburg, Germany.	lsobirey@physnet.uni-hamburg.de	Moritz, Henning/E-7919-2010	Moritz, Henning/0000-0002-4854-5806; Biss, Hauke/0000-0002-7067-214X; Lompe, Thomas/0000-0002-7880-1639; Sobirey, Lennart/0000-0002-5567-9327; Luick, Niclas/0000-0003-3283-8695; Bohlen, Markus/0000-0003-4108-0409	European Union [335431]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) SFB-925 [170620586]; excellence cluster "Advanced Imaging of Matter" EXC 2056 [390715994]; Labex ICFP of Ecole Normale Superieure Paris	European Union(European Commission); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) SFB-925(German Research Foundation (DFG)); excellence cluster "Advanced Imaging of Matter" EXC 2056; Labex ICFP of Ecole Normale Superieure Paris	This work was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant 335431 and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) SFB-925 project 170620586 and the excellence cluster "Advanced Imaging of Matter" EXC 2056 project 390715994. M.B. acknowledges support by Labex ICFP of Ecole Normale Superieure Paris.	Astrakharchik GE, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.013608; Bauer M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.135302; Bighin G, 2018, INT J MOD PHYS B, V32, DOI 10.1142/S0217979218400222; Boettcher I, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.045303; Bohlen M, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.240403; Chung MC, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123012; Combescot R, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042717; Desbuquois R, 2012, NAT PHYS, V8, P645, DOI [10.1038/nphys2378, 10.1038/NPHYS2378]; Fenech K, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.045302; Frohlich B, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105301; Ha LC, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.055301; Holten M, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.120401; Hueck K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.060402; Hueck K, 2017, OPT EXPRESS, V25, P8670, DOI 10.1364/OE.25.008670; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Kondo T, 2011, NAT PHYS, V7, P21, DOI 10.1038/NPHYS1851; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Landau L, 1941, PHYS REV, V60, P356, DOI 10.1103/PhysRev.60.356; Levinsen J., 2015, ANN REV COLD ATOMS M, V3, P1; Luick N, 2020, SCIENCE, V369, P89, DOI 10.1126/science.aaz2342; Makhalov V, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.045301; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; Miller DE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.070402; Mitra D, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.093601; Mulkerin BC, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.053608; Murthy PA, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.010401; Murthy PA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043611; Murthy PA, 2018, SCIENCE, V359, P452, DOI 10.1126/science.aan5950; Ong W, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.110403; Peppler T, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.120402; PETHICK CJ, 1966, PHYSICA, V32, P1905, DOI 10.1016/0031-8914(66)90157-1; Petrov DS, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012706; Raman C, 1999, PHYS REV LETT, V83, P2502, DOI 10.1103/PhysRevLett.83.2502; Ries MG, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.230401; Shi H, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.033603; Singh V. P., 2020, ARXIV201000013CONDMA; Sobirey L., 2021, OBSERVATION SUPERFLU, DOI [10.5281/zenodo.4613154, DOI 10.5281/ZENODO.4613154]; Sommer AT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.045302; Tononi A., 2020, ARXIV200906491CONDMA; Turlapov AV, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa7ad9; Weimer W, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.095301; Zurn G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135301	42	18	19	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					844	+		10.1126/science.abc8793	http://dx.doi.org/10.1126/science.abc8793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016777	Green Submitted			2022-12-28	WOS:000653997000043
J	Leung, N; Bridoux, F; Nasr, SH				Leung, Nelson; Bridoux, Frank; Nasr, Samih H.			Monoclonal Gammopathy of Renal Significance	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHAIN DEPOSITION DISEASE; UNDETERMINED SIGNIFICANCE MGUS; WALDENSTROM MACROGLOBULINEMIA; FANCONI-SYNDROME; NATURAL-HISTORY; MECHANISMS; BORTEZOMIB; CYCLOPHOSPHAMIDE; TRANSPLANTATION; GLOMERULOPATHY	Monoclonal Gammopathy of Renal Significance Monoclonal gammopathy of renal significance is a B-cell or plasma-cell clonal disorder that does not meet the criteria for cancer but produces a monoclonal immunoglobulin that leads to kidney injury or disease. This review discusses pathogenesis, evaluation, and management.	[Leung, Nelson] Mayo Clin, Div Nephrol, Rochester, MN USA; [Leung, Nelson] Mayo Clin, Div Hypertens & Hematol, Rochester, MN USA; [Nasr, Samih H.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Bridoux, Frank] Univ Poitiers, Dept Nephrol, Poitiers, France; [Bridoux, Frank] Univ Poitiers, Ctr Invest Clin INSERM 1402, Ctr Reference Amylose & Autres Malad Depot Immuno, Ctr Hosp Univ, Poitiers, France; [Bridoux, Frank] Univ Limoges, CNRS, UMR7276, Limoges, France	Mayo Clinic; Mayo Clinic; Mayo Clinic; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Limoges	Leung, N (corresponding author), 200 First St SW, Rochester, MN 55905 USA.	leung.nelson@mayo.edu		Leung, Nelson/0000-0002-5651-1411				Abeykoon JP, 2019, LEUKEMIA, V33, P531, DOI 10.1038/s41375-018-0262-2; Angel-Korman A, 2020, KIDNEY INT REP, V5, P485, DOI 10.1016/j.ekir.2020.01.011; Angel-Korman A, 2020, TRANSPLANTATION, V104, P2035, DOI 10.1097/TP.0000000000003170; Bhutani G, 2015, MAYO CLIN PROC, V90, P587, DOI 10.1016/j.mayocp.2015.01.024; Borza DB, 2005, AM J KIDNEY DIS, V45, P397, DOI 10.1053/j.ajkd.2004.09.029; Bridoux F, 2002, KIDNEY INT, V62, P1764, DOI 10.1046/j.1523-1755.2002.00628.x; Bridoux F, 2017, KIDNEY INT, V91, P423, DOI 10.1016/j.kint.2016.09.004; Chauvet S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02260; Chauvet S, 2017, BLOOD, V129, P1437, DOI 10.1182/blood-2016-08-737163; Cohen C, 2015, KIDNEY INT, V88, P1135, DOI 10.1038/ki.2015.201; de Seigneux S, 2010, AM J KIDNEY DIS, V56, P117, DOI 10.1053/j.ajkd.2010.03.010; Dimopoulos MA, 2009, J CLIN ONCOL, V27, P120, DOI 10.1200/JCO.2008.17.7865; Dooley MA, 2011, NEW ENGL J MED, V365, P1886, DOI 10.1056/NEJMoa1014460; Fermand JP, 2018, BLOOD, V132, P1478, DOI 10.1182/blood-2018-04-839480; Fermand JP, 2013, BLOOD, V122, P3583, DOI 10.1182/blood-2013-05-495929; Fervenza FC, 2019, NEW ENGL J MED, V381, P36, DOI 10.1056/NEJMoa1814427; Gilmore BA, 2019, CL LYMPH MYELOM LEUK, V19, pE251, DOI 10.1016/j.clml.2019.02.008; Gumber R, 2018, KIDNEY INT, V94, P199, DOI 10.1016/j.kint.2018.02.020; Hallek M, 2018, BLOOD, V131, P2745, DOI 10.1182/blood-2017-09-806398; HEILMAN RL, 1992, AM J KIDNEY DIS, V20, P34, DOI 10.1016/S0272-6386(12)80314-3; Heybeli C, 2021, KIDNEY INT, V99, P707, DOI 10.1016/j.kint.2020.06.036; Higgins L, 2018, CLIN J AM SOC NEPHRO, V13, P1037, DOI 10.2215/CJN.13041117; Joly F, 2019, BLOOD, V133, P576, DOI 10.1182/blood-2018-09-872028; Klomjit N, 2020, J AM SOC NEPHROL, V31, P2400, DOI 10.1681/ASN.2020010054; Kourelis TV, 2016, AM J HEMATOL, V91, P1123, DOI 10.1002/ajh.24528; Kumar S, 2016, LANCET ONCOL, V17, pE328, DOI 10.1016/S1470-2045(16)30206-6; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; KYLE RA, 1978, AM J MED, V64, P814, DOI 10.1016/0002-9343(78)90522-3; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Kyle RA, 2012, BLOOD, V119, P4462, DOI 10.1182/blood-2011-10-384768; Leung N, 2004, AM J KIDNEY DIS, V43, P147, DOI 10.1053/j.ajkd.2003.09.020; Leung N, 2020, CL LYMPH MYELOM LEUK, V20, pE488, DOI 10.1016/j.clml.2020.03.013; Leung N, 2019, NAT REV NEPHROL, V15, P45, DOI 10.1038/s41581-018-0077-4; Leung N, 2018, HAEMATOLOGICA, V103, pE135, DOI 10.3324/haematol.2017.183749; Leung N, 2016, CLIN CHEM LAB MED, V54, P929, DOI 10.1515/cclm-2015-0994; Leung N, 2012, BLOOD, V120, P4292, DOI 10.1182/blood-2012-07-445304; Luciani A, 2016, J AM SOC NEPHROL, V27, P2049, DOI 10.1681/ASN.2015050581; Ma CX, 2004, BLOOD, V104, P40, DOI 10.1182/blood-2003-10-3400; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Merlini G, 2007, CONTRIB NEPHROL, V153, P66; Mikhael JR, 2012, BLOOD, V119, P4391, DOI 10.1182/blood-2011-11-390930; Muchtar E, 2019, MAYO CLIN PROC, V94, P472, DOI 10.1016/j.mayocp.2018.08.006; Muchtar E, 2019, LEUKEMIA, V33, P527, DOI 10.1038/s41375-018-0258-y; Nasr SH, 2012, NEPHROL DIAL TRANSPL, V27, P4137, DOI 10.1093/ndt/gfs348; Nasr SH, 2012, CLIN J AM SOC NEPHRO, V7, P231, DOI 10.2215/CJN.08640811; Paueksakon P, 2003, AM J KIDNEY DIS, V42, P87, DOI 10.1016/S0272-6386(03)00412-8; Pinney JH, 2011, J CLIN ONCOL, V29, P674, DOI 10.1200/JCO.2010.30.5235; Pozzi C, 2003, AM J KIDNEY DIS, V42, P1154, DOI 10.1053/j.ajkd.2003.08.040; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Rezk T, 2017, KIDNEY INT, V92, P1476, DOI 10.1016/j.kint.2017.05.004; Roeker LE, 2013, LEUKEMIA, V27, P1391, DOI 10.1038/leu.2013.34; Said SM, 2018, KIDNEY INT, V94, P159, DOI 10.1016/j.kint.2018.01.028; SANDERS PW, 1992, J CLIN INVEST, V89, P630, DOI 10.1172/JCI115629; Sayed RH, 2015, BLOOD, V126, P2805, DOI 10.1182/blood-2015-07-658872; Sidiqi MH, 2020, BLOOD CANCER J, V10, DOI 10.1038/s41408-020-0321-6; Specks U, 2013, NEW ENGL J MED, V369, P417, DOI 10.1056/NEJMoa1213277; Staron A, 2020, BLOOD ADV, V4, P880, DOI 10.1182/bloodadvances.2019001331; Steiner N, 2018, ONCOTARGET, V9, P2344, DOI 10.18632/oncotarget.23412; Stokes MB, 2016, J AM SOC NEPHROL, V27, P1555, DOI 10.1681/ASN.2015020185; Strati P, 2015, HAEMATOLOGICA, V100, P1180, DOI 10.3324/haematol.2015.128793; Swaminathan S, 2006, CLIN J AM SOC NEPHRO, V1, P483, DOI 10.2215/CJN.00710805; Sy-Go JPT, 2021, J NEPHROL, V34, P949, DOI 10.1007/s40620-020-00927-6; Therneau TM, 2012, MAYO CLIN PROC, V87, P1071, DOI 10.1016/j.mayocp.2012.06.014; Vignon M, 2017, LEUKEMIA, V31, P123, DOI 10.1038/leu.2016.195; Yadav P, 2020, BLOOD CANCER J, V10, DOI 10.1038/s41408-020-0295-4; Ziogas DC, 2017, LEUKEMIA LYMPHOMA, V58, P1832, DOI 10.1080/10428194.2016.1267349	66	23	23	7	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					1931	1941		10.1056/NEJMra1810907	http://dx.doi.org/10.1056/NEJMra1810907			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ4AW	34010532				2022-12-28	WOS:000655474700012
J	Musunuru, K; Chadwick, AC; Mizoguchi, T; Garcia, SP; DeNizio, JE; Reiss, CW; Wang, K; Iyer, S; Dutta, C; Clendaniel, V; Amaonye, M; Beach, A; Berth, K; Biswas, S; Braun, MC; Chen, HM; Colace, TV; Ganey, JD; Gangopadhyay, SA; Garrity, R; Kasiewicz, LN; Lavoie, J; Madsen, JA; Matsumoto, Y; Mazzola, AM; Nasrullah, YS; Nneji, J; Ren, H; Sanjeev, A; Shay, M; Stahley, MR; Fan, SHY; Tam, YK; Gaudelli, NM; Ciaramella, G; Stolz, LE; Malyala, P; Cheng, CJ; Rajeev, KG; Rohde, E; Bellinger, AM; Kathiresan, S				Musunuru, Kiran; Chadwick, Alexandra C.; Mizoguchi, Taiji; Garcia, Sara P.; DeNizio, Jamie E.; Reiss, Caroline W.; Wang, Kui; Iyer, Sowmya; Dutta, Chaitali; Clendaniel, Victoria; Amaonye, Michael; Beach, Aaron; Berth, Kathleen; Biswas, Souvik; Braun, Maurine C.; Chen, Huei-Mei; Colace, Thomas, V; Ganey, John D.; Gangopadhyay, Soumyashree A.; Garrity, Ryan; Kasiewicz, Lisa N.; Lavoie, Jennifer; Madsen, James A.; Matsumoto, Yuri; Mazzola, Anne Marie; Nasrullah, Yusuf S.; Nneji, Joseph; Ren, Huilan; Sanjeev, Athul; Shay, Madeleine; Stahley, Mary R.; Fan, Steven H. Y.; Tam, Ying K.; Gaudelli, Nicole M.; Ciaramella, Giuseppe; Stolz, Leslie E.; Malyala, Padma; Cheng, Christopher J.; Rajeev, Kallanthottathil G.; Rohde, Ellen; Bellinger, Andrew M.; Kathiresan, Sekar			In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates	NATURE			English	Article							GENOMIC DNA; ENDONUCLEASE; MUTATIONS; LDL	Gene-editing technologies, which include the CRISPR-Cas nucleases(1-3) and CRISPR base editors(4,5), have the potential to permanently modify disease-causing genes in patients(6). The demonstration of durable editing in target organs of nonhuman primates is a key step before in vivo administration of gene editors to patients in clinical trials. Here we demonstrate that CRISPR base editors that are delivered in vivo using lipid nanoparticles can efficiently and precisely modify disease-related genes in living cynomolgus monkeys (Macaca fascicularis). We observed a near-complete knockdown of PCSK9 in the liver after a single infusion of lipid nanoparticles, with concomitant reductions in blood levels of PCSK9 and low-density lipoprotein cholesterol of approximately 90% and about 60%, respectively; all of these changes remained stable for at least 8 months after a single-dose treatment. In addition to supporting a 'once-and-done' approach to the reduction of low-density lipoprotein cholesterol and the treatment of atherosclerotic cardiovascular disease (the leading cause of death worldwide(7)), our results provide a proof-of-concept for how CRISPR base editors can be productively applied to make precise single-nucleotide changes in therapeutic target genes in the liver, and potentially in other organs.	[Musunuru, Kiran] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Musunuru, Kiran] Univ Penn, Dept Med, Perelman Sch Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA; [Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Chadwick, Alexandra C.; Mizoguchi, Taiji; Garcia, Sara P.; DeNizio, Jamie E.; Reiss, Caroline W.; Wang, Kui; Iyer, Sowmya; Dutta, Chaitali; Clendaniel, Victoria; Amaonye, Michael; Beach, Aaron; Berth, Kathleen; Biswas, Souvik; Braun, Maurine C.; Chen, Huei-Mei; Colace, Thomas, V; Ganey, John D.; Gangopadhyay, Soumyashree A.; Garrity, Ryan; Kasiewicz, Lisa N.; Lavoie, Jennifer; Madsen, James A.; Matsumoto, Yuri; Mazzola, Anne Marie; Nasrullah, Yusuf S.; Nneji, Joseph; Ren, Huilan; Sanjeev, Athul; Shay, Madeleine; Stahley, Mary R.; Stolz, Leslie E.; Malyala, Padma; Cheng, Christopher J.; Rajeev, Kallanthottathil G.; Rohde, Ellen; Bellinger, Andrew M.; Kathiresan, Sekar] Verve Therapeut, Cambridge, MA 02139 USA; [Fan, Steven H. Y.; Tam, Ying K.] Acuitas Therapeut, Vancouver, BC, Canada; [Gaudelli, Nicole M.; Ciaramella, Giuseppe] Beam Therapeut, Cambridge, MA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Kathiresan, S (corresponding author), Verve Therapeut, Cambridge, MA 02139 USA.	skathiresan@vervetx.com	Gangopadhyay, Soumyashree/J-1172-2019	Garcia, Sara/0000-0003-3312-6454; Mazzola, Anne Marie/0000-0003-3300-0245; Reiss, Caroline/0000-0002-6385-1879; Clendaniel, Victoria/0000-0002-2969-4443; Musunuru, Kiran/0000-0003-3298-0368	Verve Therapeutics; Acuitas Therapeutics; Beam Therapeutics	Verve Therapeutics; Acuitas Therapeutics; Beam Therapeutics	Conception and design of the work was performed and supported by Verve Therapeutics. Acquisition, analysis and interpretation of the data was performed and supported by Verve Therapeutics, with some aspects being performed on behalf or at the direction of Verve Therapeutics. Acuitas Therapeutics supported the work by providing Verve Therapeutics with LNP reagents and manufacturing the LNP formulations. Beam Therapeutics supported the work by developing the ABE8.8-m protein sequence. We are grateful to J. K. Joung for critical reading of the manuscript.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brandts J, 2020, CIRCULATION, V141, P873, DOI 10.1161/CIRCULATIONAHA.119.043406; Chadwick AC, 2017, ARTERIOSCL THROM VAS, V37, P1741, DOI 10.1161/ATVBAHA.117.309881; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Concordet JP, 2018, NUCLEIC ACIDS RES, V46, pW242, DOI 10.1093/nar/gky354; Conway A, 2019, MOL THER, V27, P866, DOI 10.1016/j.ymthe.2019.03.003; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doudna JA, 2020, NATURE, V578, P229, DOI 10.1038/s41586-020-1978-5; Finn JD, 2018, CELL REP, V22, P2227, DOI 10.1016/j.celrep.2018.02.014; Gaudelli NM, 2020, NAT BIOTECHNOL, V38, P892, DOI 10.1038/s41587-020-0491-6; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Grunewald J, 2019, NATURE, V569, P433, DOI 10.1038/s41586-019-1161-z; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hines DM, 2018, VASC HEALTH RISK MAN, V14, P409, DOI 10.2147/VHRM.S180496; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2019, NAT BIOTECHNOL, V37, P430, DOI 10.1038/s41587-019-0050-1; Koblan LW, 2021, NATURE, V589, P608, DOI 10.1038/s41586-020-03086-7; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang PP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07988-z; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Petri, 2021, GLOBAL SCALE CRISPR, DOI [10.1101/2021.04.05, DOI 10.1101/2021.04.05]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao AS, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002162; Ray KK, 2017, NEW ENGL J MED, V376, P1430, DOI 10.1056/NEJMoa1615758; Rodriguez F, 2019, JAMA CARDIOL, V4, P206, DOI 10.1001/jamacardio.2018.4936; Rossidis AC, 2018, NAT MED, V24, P1513, DOI 10.1038/s41591-018-0184-6; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Ryu SM, 2018, NAT BIOTECHNOL, V36, P536, DOI 10.1038/nbt.4148; Song CQ, 2020, NAT BIOMED ENG, V4, P125, DOI 10.1038/s41551-019-0357-8; Strecker J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08224-4; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Villiger L, 2021, NAT BIOMED ENG, V5, DOI 10.1038/s41551-020-00671-z; Villiger L, 2018, NAT MED, V24, P1519, DOI 10.1038/s41591-018-0209-1; Wang LL, 2021, MOL THER, V29, P2019, DOI 10.1016/j.ymthe.2021.02.020; Yin H, 2017, NAT BIOTECHNOL, V35, P1179, DOI 10.1038/nbt.4005; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zafrir B, 2021, J CLIN LIPIDOL, V15, P202, DOI 10.1016/j.jacl.2020.11.004; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488; Zhou CY, 2019, NATURE, V571, P275, DOI 10.1038/s41586-019-1314-0	50	156	160	54	159	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					429	+		10.1038/s41586-021-03534-y	http://dx.doi.org/10.1038/s41586-021-03534-y			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE7VT	34012082				2022-12-28	WOS:000652278400019
J	Witze, A				Witze, Alexandra			NASA REBOOTS ITS ROLE IN FIGHTING CLIMATE CHANGE	NATURE			English	News Item																			0	0	0	2	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					324	+		10.1038/d41586-021-01230-5	http://dx.doi.org/10.1038/d41586-021-01230-5			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE2PC	33963332				2022-12-28	WOS:000651914000005
J	Yeku, OO; Medford, AJ; Fenves, AZ; Uljon, SN				Yeku, Oladapo O.; Medford, Arielle J.; Fenves, Andrew Z.; Uljon, Sacha N.			Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LACTIC-ACIDOSIS; METFORMIN	A Woman with Nausea, Diarrhea, and Acute Kidney Failure A 76-year-old woman with a history of type 2 diabetes, obstructive sleep apnea, coronary artery disease, and heart failure with reduced ejection fraction presented with nausea, abdominal cramps, and nonbloody diarrhea. The blood level of creatinine was 7.66 mg per deciliter, and the level of lactic acid was 7.4 mmol per liter. A diagnosis was made.	[Yeku, Oladapo O.; Medford, Arielle J.; Fenves, Andrew Z.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Uljon, Sacha N.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yeku, Oladapo O.; Medford, Arielle J.; Fenves, Andrew Z.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Uljon, Sacha N.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Yeku, OO (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Yeku, OO (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							Calello DP, 2015, CRIT CARE MED, V43, P1716, DOI 10.1097/CCM.0000000000001002; Council on Children With Disabilities and Medical Home Implementation-Project Advisory Committee, 2014, PEDIATRICS, V133, pe1451; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Kajbaf F, 2016, CLIN PHARMACOKINET, V55, P439, DOI 10.1007/s40262-015-0323-x; Kajbaf F, 2014, PHARMACOEPIDEM DR S, V23, P1123, DOI 10.1002/pds.3689; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Lalau JD, 1999, DRUG SAFETY, V20, P377, DOI 10.2165/00002018-199920040-00006; Pearlman BL, 1996, AM J MED, V101, P109, DOI 10.1016/S0002-9343(97)89422-3; Shen XW, 2014, INT UROL NEPHROL, V46, P1909, DOI 10.1007/s11255-014-0742-x	9	0	0	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					1943	1950		10.1056/NEJMcpc2100274	http://dx.doi.org/10.1056/NEJMcpc2100274			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ4AW	34010534				2022-12-28	WOS:000655474700014
J	Krishna, G; Howard, S				Krishna, Geetanjali; Howard, Sally			Covid-19: How India's doctors found their voice in the country's devastating second wave	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sal@sallyhoward.net						Ahmed A, 2021, REUTERS         0420; Banka R, 2021, HINDUSTAN TIMES 0424; Indian Ministry of Health and Family Welfare, GOV IND ANN LIB ACC; KALRA A, REUTERS; Krishnan, 2021, DW; Mascarenhas Anuradha, 2021, INDIAN EXPRESS; Press Information Bureau Delhi, 2021, GOV IND; Sengar MS, 2021, NDTV; Wallen, 2021, TELEGRAPH; Wangchuk RN, 2021, BETTER INDIA	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2021	373								n1253	10.1136/bmj.n1253	http://dx.doi.org/10.1136/bmj.n1253			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5SO	34011510	Bronze			2022-12-28	WOS:000655594700004
J	Rimmer, A				Rimmer, Abi			How can I refocus on my career after the pandemic?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Working through an extremely difficult period has left some doctors with an opportunity to assess their career options. Abi Rimmer hears what next steps might be useful at this stage											0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2021	373								n1209	10.1136/bmj.n1209	http://dx.doi.org/10.1136/bmj.n1209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9HR	34001540	Bronze			2022-12-28	WOS:000653058000001
J	Whitlock, RP; Belley-Cote, EP; Paparella, D; Healey, JS; Brady, K; Sharma, M; Reents, W; Budera, P; Baddour, AJ; Fila, P; Devereaux, PJ; Bogachev-Prokophiev, A; Boening, A; Teoh, KHT; Tagarakis, GI; Slaughter, MS; Royse, AG; McGuinness, S; Alings, M; Punjabi, PP; Mazer, CD; Folkeringa, RJ; Colli, A; Avezum, A; Nakamya, J; Balasubramanian, K; Vincent, J; Voisine, P; Lamy, A; Yusuf, S; Connolly, SJ				Whitlock, Richard P.; Belley-Cote, Emilie P.; Paparella, Domenico; Healey, Jeff S.; Brady, Katheryn; Sharma, Mukul; Reents, Wilko; Budera, Petr; Baddour, Andony J.; Fila, Petr; Devereaux, P. J.; Bogachev-Prokophiev, Alexander; Boening, Andreas; Teoh, Kevin H. T.; Tagarakis, Georgios I.; Slaughter, Mark S.; Royse, Alistair G.; McGuinness, Shay; Alings, Marco; Punjabi, Prakash P.; Mazer, C. David; Folkeringa, Richard J.; Colli, Andrea; Avezum, Alvaro; Nakamya, Juliet; Balasubramanian, Kumar; Vincent, Jessica; Voisine, Pierre; Lamy, Andre; Yusuf, Salim; Connolly, Stuart J.		LAAOS III Investigators	Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIBRILLATION; METAANALYSIS	BACKGROUND Surgical occlusion of the left atrial appendage has been hypothesized to prevent ischemic stroke in patients with atrial fibrillation, but this has not been proved. The procedure can be performed during cardiac surgery undertaken for other reasons. METHODS We conducted a multicenter, randomized trial involving participants with atrial fibrillation and a CHA(2)DS(2)-VASc score of at least 2 (on a scale from 0 to 9, with higher scores indicating greater risk of stroke) who were scheduled to undergo cardiac surgery for another indication. The participants were randomly assigned to undergo or not undergo occlusion of the left atrial appendage during surgery; all the participants were expected to receive usual care, including oral anticoagulation, during follow-up. The primary outcome was the occurrence of ischemic stroke (including transient ischemic attack with positive neuroimaging) or systemic embolism. The participants, research personnel, and primary care physicians (other than the surgeons) were unaware of the trial-group assignments. RESULTS The primary analysis population included 2379 participants in the occlusion group and 2391 in the no-occlusion group, with a mean age of 71 years and a mean CHA(2)DS(2)-VASc score of 4.2. The participants were followed for a mean of 3.8 years. A total of 92.1% of the participants received the assigned procedure, and at 3 years, 76.8% of the participants continued to receive oral anticoagulation. Stroke or systemic embolism occurred in 114 participants (4.8%) in the occlusion group and in 168 (7.0%) in the no-occlusion group (hazard ratio, 0.67; 95% confidence interval, 0.53 to 0.85; P=0.001). The incidence of perioperative bleeding, heart failure, or death did not differ significantly between the trial groups. CONCLUSIONS Among participants with atrial fibrillation who had undergone cardiac surgery, most of whom continued to receive ongoing antithrombotic therapy, the risk of ischemic stroke or systemic embolism was lower with concomitant left atrial appendage occlusion performed during the surgery than without it.	[Whitlock, Richard P.; Belley-Cote, Emilie P.; Healey, Jeff S.; Sharma, Mukul; Devereaux, P. J.; Nakamya, Juliet; Balasubramanian, Kumar; Lamy, Andre; Yusuf, Salim; Connolly, Stuart J.] McMaster Univ, Hamilton, ON, Canada; [Whitlock, Richard P.; Belley-Cote, Emilie P.; Healey, Jeff S.; Brady, Katheryn; Sharma, Mukul; Devereaux, P. J.; Vincent, Jessica; Lamy, Andre; Yusuf, Salim; Connolly, Stuart J.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Whitlock, Richard P.; Belley-Cote, Emilie P.; Healey, Jeff S.; Brady, Katheryn; Sharma, Mukul; Devereaux, P. J.; Nakamya, Juliet; Balasubramanian, Kumar; Vincent, Jessica; Lamy, Andre; Yusuf, Salim; Connolly, Stuart J.] Populat Hlth Res Inst, Hamilton, ON, Canada; [Teoh, Kevin H. T.] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [Mazer, C. David] Univ Toronto, Toronto, ON, Canada; [Mazer, C. David] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Voisine, Pierre] Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Paparella, Domenico] Univ Foggia, Foggia, Italy; [Paparella, Domenico] Santa Maria Hosp, Grp Villa Maria Care & Res, Bari, Italy; [Colli, Andrea] Univ Pisa, Pisa, Italy; [Reents, Wilko] Rhon Klinikum Campus Bad Neustadt, Bad Neustadt an der Saale, Germany; [Boening, Andreas] Univ Hosp Giessen, Giessen, Germany; [Budera, Petr] Inst Clin & Expt Med, Prague, Czech Republic; [Fila, Petr] Ctr Cardiovasc Surg & Transplant, Brno, Czech Republic; [Baddour, Andony J.] G Papanikolaou Hosp, Thessaloniki, Greece; [Tagarakis, Georgios I.] Aristotle Univ Thessaloniki, Thessaloniki, Greece; [Bogachev-Prokophiev, Alexander] E Meshalkin Natl Med Res Ctr, Novosibirsk, Russia; [Slaughter, Mark S.] Univ Louisville, Louisville, KY 40292 USA; [Royse, Alistair G.] Univ Melbourne, Melbourne, Vic, Australia; [Royse, Alistair G.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [McGuinness, Shay] Auckland City Hosp, Auckland, New Zealand; [Alings, Marco] Amphia Ziekenhuis, Breda, Netherlands; [Folkeringa, Richard J.] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Punjabi, Prakash P.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Avezum, Alvaro] Hosp Alemao Oswaldo Cruz, Int Res Ctr, Sao Paulo, Brazil	McMaster University; McMaster University; Population Health Research Institute; Southlake Regional Health Centre; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Quebec Heart & Lung Institute; University of Foggia; University of Pisa; Rhon-Klinikum AG; University Hospital of Giessen & Marburg; Institute for Clinical & Experimental Medicine (IKEM); George Papanikolaou General Hospital of Thessaloniki; Aristotle University of Thessaloniki; Meshalkin National Medical Research Center; University of Louisville; University of Melbourne; Royal Melbourne Hospital; Auckland City Hospital; Amphia Hospital; Medical Center Leeuwarden; Imperial College London	Whitlock, RP (corresponding author), Hamilton Gen Hosp, David Braley Res Inst, 237 Barton St, Hamilton, ON L8L 2X2, Canada.	richard.whitlock@phri.ca	LAMY, ANDRE/AAS-3855-2021; Gago, Marta G Fuentes/AAT-5448-2021; Sharifulin, Ravil/F-6318-2017; Devereaux, PJ/AAY-1757-2021; Whitlock, Richard/AAQ-1593-2021; Fila, Petr/AAD-5867-2019	Gago, Marta G Fuentes/0000-0002-3006-4721; Sharifulin, Ravil/0000-0002-8832-2447; Whitlock, Richard/0000-0002-6863-5884; Fila, Petr/0000-0002-1519-2469; Kyriazis, Mr Panagiotis Grigorios/0000-0003-3833-7752; Sanetra, Krzysztof/0000-0002-0534-4983; Mazer, Cyril David/0000-0003-2566-4308; Jasinski, Marek/0000-0002-9989-7748; Cavicchiolo, Andrea Gualtiero/0000-0001-5729-2874; Punjabi, Prof Prakash P/0000-0002-6587-1603; Yusuf, Salim/0000-0003-4776-5601; Marto, Joao Pedro/0000-0003-2277-5950; McGuinness, Shay/0000-0003-0620-4787	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Request for Applications Program-Research Strategic Initiatives of Hamilton Health Sciences; Canadian Network and Centre for Trials Internationally; McMaster University Surgical Associates; Canadian Stroke Prevention Intervention Network; Hamilton Health Sciences Research Institute through the Population Health Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Request for Applications Program-Research Strategic Initiatives of Hamilton Health Sciences; Canadian Network and Centre for Trials Internationally; McMaster University Surgical Associates; Canadian Stroke Prevention Intervention Network; Hamilton Health Sciences Research Institute through the Population Health Research Institute	Supported by the Canadian Institutes of Health Research, the Canadian Stroke Prevention Intervention Network, Hamilton Health Sciences Research Institute through the Population Health Research Institute, the Heart and Stroke Foundation of Canada, the Request for Applications Program-Research Strategic Initiatives of Hamilton Health Sciences, the Canadian Network and Centre for Trials Internationally, and McMaster University Surgical Associates.	Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Fuster Valentin, 2006, Rev Esp Cardiol, V59, P1329; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Jones WJ, 2001, STROKE, V32, P2232, DOI 10.1161/hs1001.096191; Lakkireddy D, 2018, J AM COLL CARDIOL, V71, P135, DOI 10.1016/j.jacc.2017.10.092; Mahmood E, 2020, CIRCULATION, V142, P20, DOI 10.1161/CIRCULATIONAHA.119.044642; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Perreault S, 2020, PHARMACOTHERAPY, V40, P40, DOI 10.1002/phar.2350; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Salazar JD, 2001, ANN THORAC SURG, V72, P1195, DOI 10.1016/S0003-4975(01)02929-0; Whitlock R, 2014, ANN CARDIOTHORAC SUR, V3, P45, DOI 10.3978/j.issn.2225-319X.2013.12.06; Wilber DJ, 2018, J AM COLL CARDIOL, V71, P145, DOI 10.1016/j.jacc.2017.11.030; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	17	119	119	4	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2021	384	22					2081	2091		10.1056/NEJMoa2101897	http://dx.doi.org/10.1056/NEJMoa2101897		MAY 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SO5MH	33999547	Green Published, Bronze			2022-12-28	WOS:000652582300001
J	Iacobucci, G				Iacobucci, Gareth			GPs should return to offering face-to-face appointments without prior triage, says NHS	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Donnelly L., 2021, TELEGRAPH; Macfarlane J., 2021, MAIL ONLINE; NHS England, 2021, LETT UPD STAND OP PR; Royal College of General Practitioners, GEN PRACT COVID 19 R	4	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2021	373								n1251	10.1136/bmj.n1251	http://dx.doi.org/10.1136/bmj.n1251			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9HX	33990340				2022-12-28	WOS:000653058600008
J	Datoo, MS; Natama, MH; Some, A; Traore, O; Rouamba, T; Bellamy, D; Yameogo, P; Valia, D; Tegneri, M; Ouedraogo, F; Soma, R; Sawadogo, S; Sorgho, F; Derra, K; Rouamba, E; Orindi, B; Lopez, FR; Flaxman, A; Cappuccini, F; Kailath, R; Elias, S; Mukhopadhyay, E; Noe, A; Cairns, M; Lawrie, A; Roberts, R; Valea, I; Sorgho, H; Williams, N; Glenn, G; Fries, L; Reimer, J; Ewer, KJ; Shaligram, U; Hill, AVS; Tinto, H				Datoo, Mehreen S.; Natama, Magloire H.; Some, Athanase; Traore, Ousmane; Rouamba, Toussaint; Bellamy, Duncan; Yameogo, Prisca; Valia, Daniel; Tegneri, Moubarak; Ouedraogo, Florence; Soma, Rachidatou; Sawadogo, Seydou; Sorgho, Faizatou; Derra, Karim; Rouamba, Eli; Orindi, Benedict; Lopez, Fernando Ramos; Flaxman, Amy; Cappuccini, Federica; Kailath, Reshma; Elias, Sean; Mukhopadhyay, Ekta; Noe, Andres; Cairns, Matthew; Lawrie, Alison; Roberts, Rachel; Valea, Innocent; Sorgho, Hermann; Williams, Nicola; Glenn, Gregory; Fries, Louis; Reimer, Jenny; Ewer, Katie J.; Shaligram, Umesh; Hill, Adrian V. S.; Tinto, Halidou			Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial	LANCET			English	Article							IMMUNE-RESPONSES; PHASE-3 TRIAL; RTS,S/AS01; AFRICA; SAFETY	Background Stalled progress in controlling Plasmodium falciparum malaria highlights the need for an effective and deployable vaccine. RTS,S/AS01, the most effective malaria vaccine candidate to date, demonstrated 56% efficacy over 12 months in African children. We therefore assessed a new candidate vaccine for safety and efficacy. Methods In this double-blind, randomised, controlled, phase 2b trial, the low-dose circumsporozoite protein-based vaccine R21, with two different doses of adjuvant Matrix-M (MM), was given to children aged 5-17 months in Nanoro, Burkina Faso-a highly seasonal malaria transmission setting. Three vaccinations were administered at 4-week intervals before the malaria season, with a fourth dose 1 year later. All vaccines were administered intramuscularly into the thigh. Group 1 received 5 mu g R21 plus 25 mu g MM, group 2 received 5 mu g R21 plus 50 mu g MM, and group 3, the control group, received rabies vaccinations. Children were randomly assigned (1:1:1) to groups 1-3. An independent statistician generated a random allocation list, using block randomisation with variable block sizes, which was used to assign participants. Participants, their families, and the local study team were all masked to group allocation. Only the pharmacists preparing the vaccine were unmasked to group allocation. Vaccine safety, immunogenicity, and efficacy were evaluated over 1 year. The primary objective assessed protective efficacy of R21 plus MM (R21/MM) from 14 days after the third vaccination to 6 months. Primary analyses of vaccine efficacy were based on a modified intention-to-treat population, which included all participants who received three vaccinations, allowing for inclusion of participants who received the wrong vaccine at any timepoint. This trial is registered with ClinicalTrials.gov, NCT03896724. Findings From May 7 to June 13, 2019, 498 children aged 5-17 months were screened, and 48 were excluded. 450 children were enrolled and received at least one vaccination. 150 children were allocated to group 1, 150 children were allocated to group 2, and 150 children were allocated to group 3. The final vaccination of the primary series was administered on Aug 7, 2019. R21/MM had a favourable safety profile and was well tolerated. The majority of adverse events were mild, with the most common event being fever. None of the seven serious adverse events were attributed to the vaccine. At the 6-month primary efficacy analysis, 43 (29%) of 146 participants in group 1, 38 (26%) of 146 participants in group 2, and 105 (71%) of 147 participants in group 3 developed clinical malaria. Vaccine efficacy was 74% (95% CI 63-82) in group 1 and 77% (67-84) in group 2 at 6 months. At 1 year, vaccine efficacy remained high, at 77% (67-84) in group 1. Participants vaccinated with R21/MM showed high titres of malaria-specific anti-Asn-Ala-Asn-Pro (NANP) antibodies 28 days after the third vaccination, which were almost doubled with the higher adjuvant dose. Titres waned but were boosted to levels similar to peak titres after the primary series of vaccinations after a fourth dose administered 1 year later. Interpretation R21/MM appears safe and very immunogenic in African children, and shows promising high-level efficacy. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Datoo, Mehreen S.; Lopez, Fernando Ramos; Lawrie, Alison; Roberts, Rachel; Hill, Adrian V. S.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Jenner Inst, Oxford, England; [Datoo, Mehreen S.; Lopez, Fernando Ramos; Lawrie, Alison; Roberts, Rachel; Hill, Adrian V. S.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Natama, Magloire H.; Some, Athanase; Traore, Ousmane; Rouamba, Toussaint; Yameogo, Prisca; Valia, Daniel; Tegneri, Moubarak; Ouedraogo, Florence; Soma, Rachidatou; Sawadogo, Seydou; Sorgho, Faizatou; Derra, Karim; Rouamba, Eli; Valea, Innocent; Sorgho, Hermann; Tinto, Halidou] Inst Rech Sci Sante, Unite Rech Clin Nanoro, Nanoro, Burkina Faso; [Bellamy, Duncan; Flaxman, Amy; Cappuccini, Federica; Kailath, Reshma; Elias, Sean; Mukhopadhyay, Ekta; Noe, Andres; Ewer, Katie J.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst Labs, Oxford, England; [Williams, Nicola] Univ Oxford, Dept Primary Care, Oxford, England; [Orindi, Benedict] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Cairns, Matthew] London Sch Hyg & Trop Med, London, England; [Glenn, Gregory; Fries, Louis] Novavax, Gaithersburg, MD USA; [Reimer, Jenny] Novavax, Uppsala, Sweden; [Shaligram, Umesh] Serum Inst India, Pune, Maharashtra, India	University of Oxford; Jenner Institute; University of Oxford; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Serum Institute of India	Tinto, H (corresponding author), Inst Rech Sci Sante, Unite Rech Clin Nanoro, Nanoro, Burkina Faso.; Hill, AVS (corresponding author), Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England.	adrian.hill@ndin.ox.ac.uk; tintoh@crun.bf	Traore, Ousmane/J-3573-2019; Noé, Andrés/AAU-9612-2020; Ewer, Katie J/B-4328-2011; Derra, Karim/AAC-1323-2022; Rouamba, Toussaint/ABG-2448-2021; Valea, Innocent/ABE-6694-2020	Traore, Ousmane/0000-0003-1873-6473; Noé, Andrés/0000-0002-6408-7032; Ewer, Katie J/0000-0001-9827-9836; Derra, Karim/0000-0002-2090-9698; Rouamba, Toussaint/0000-0003-0594-3887; Ramos Lopez, Fernando/0000-0002-9997-7879; Shaligram, Umesh/0000-0002-2301-2595; Bellamy, Duncan/0000-0003-3614-0032	European & Developing Countries Clinical Trials Partnership; Wellcome Trust; National Institute for Health Research Oxford Biomedical Research Centre	European & Developing Countries Clinical Trials Partnership; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR))	The European & Developing Countries Clinical Trials Partnership, Wellcome Trust, and National Institute for Health Research Oxford Biomedical Research Centre.	Adepoju P, 2019, LANCET, V393, P1685, DOI 10.1016/S0140-6736(19)30937-7; Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; [Anonymous], 2015, LANCET INFECT DIS, V15, P1450; Bengtsson KL, 2013, EXPERT REV VACCINES, V12, P821, DOI 10.1586/14760584.2013.814822; Cairns ME, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003214; Chandramohan D, BMJ OPEN; Collins KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46621; Datoo MS, 2020, AM J TROP MED HYG, V103, P469; Gessner BD, 2016, LANCET, V387, P1376, DOI 10.1016/S0140-6736(16)30081-2; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; Klein SL, 2016, MBIO, V7, DOI 10.1128/mBio.00514-16; Leroux-Roels G, 2014, HUM VACC IMMUNOTHER, V10, P2211, DOI 10.4161/hv.29375; Magnusson SE, 2013, VACCINE, V31, P1725, DOI 10.1016/j.vaccine.2013.01.039; Mendoza YG, 2019, HUM VACC IMMUNOTHER, V15, P2386, DOI 10.1080/21645515.2019.1586040; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moorthy VS, 2013, LANCET, V382, P1700, DOI 10.1016/S0140-6736(13)62238-2; Natama HM, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2315-4; Njau IW, 2020, AM J TROP MED HYG, V103, P226; Nkumama IN, 2017, TRENDS PARASITOL, V33, P128, DOI 10.1016/j.pt.2016.11.006; Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257; Portnoff AD, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8010099; Rampling T, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0084-2; Regules JA, 2011, EXPERT REV VACCINES, V10, P589, DOI [10.1586/erv.11.57, 10.1586/ERV.11.57]; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tinto HD, 2019, LANCET INFECT DIS, V19, P821, DOI 10.1016/S1473-3099(19)30300-7; Vaidyanathan G, 2020, NATURE, V585, P167, DOI 10.1038/d41586-020-02507-x; Vekemans J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-221; Venkatraman N, 2019, PHASE 1 ASSESSMENTS, DOI [10.1101/19009282, DOI 10.1101/19009282]; Venkatraman N, 2017, AM J TROP MED HYG, V97, P594; WHO, 2012, POLICY RECOMMENDATIO	31	93	95	6	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2021	397	10287					1809	1818		10.1016/S0140-6736(21)00943-0	http://dx.doi.org/10.1016/S0140-6736(21)00943-0		MAY 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD0HD	33964223	Green Published			2022-12-28	WOS:000651041900027
J	Dai, ZH; Yadavalli, SK; Chen, M; Abbaspourtamijani, A; Qi, Y; Padture, NP				Dai, Zhenghong; Yadavalli, Srinivas K.; Chen, Min; Abbaspourtamijani, Ali; Qi, Yue; Padture, Nitin P.			Interfacial toughening with self-assembled monolayers enhances perovskite solar cell reliability	SCIENCE			English	Article							TOTAL-ENERGY CALCULATIONS; HALIDE PEROVSKITES; STABILITY; BEHAVIOR; PASSIVATION; EFFICIENCY; SURFACE	Iodine-terminated self-assembled monolayer (I-SAM) was used in perovskite solar cells (PSCs) to achieve a 50% increase of adhesion toughness at the interface between the electron transport layer (ETL) and the halide perovskite thin film to enhance mechanical reliability. Treatment with I-SAM also increased the power conversion efficiency from 20.2% to 21.4%, reduced hysteresis, and improved operational stability with a projected T80 (time to 80% initial efficiency retained) increasing from similar to 700 hours to 4000 hours under 1-sun illumination and with continuous maximum power point tracking. Operational stability-tested PSC without SAMs revealed extensive irreversible morphological degradation at the ETL/perovskite interface, including voids formation and delamination, whereas PSCs with I-SAM exhibited minimal damage accumulation. This difference was attributed to a combination of a decrease in hydroxyl groups at the interface and the higher interfacial toughness.	[Dai, Zhenghong; Yadavalli, Srinivas K.; Chen, Min; Abbaspourtamijani, Ali; Qi, Yue; Padture, Nitin P.] Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University	Padture, NP (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	nitin_padture@brown.edu	Dai, Zhenghong/GQQ-3190-2022; Padture, Nitin P/A-9746-2009; Abbaspourtamijani, Ali/AAP-6818-2021	Padture, Nitin P/0000-0001-6622-8559; Abbaspourtamijani, Ali/0000-0003-4867-0487; Qi, Yue/0000-0001-5331-1193	Office of Naval Research [N00014-17-1-2232, N00014-20-1-2574]; National Science Foundation (NSF) [1538893]; NSF Center for Synthetic Organic Electrochemistry [2002158]	Office of Naval Research(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Center for Synthetic Organic Electrochemistry	The work of Z.D., S.K.Y., M.C., and N.P.P was supported by the Office of Naval Research (grants N00014-17-1-2232 and N00014-20-1-2574) and the National Science Foundation (NSF; grant 1538893). The work of A.A. and Y. Q. was supported by NSF Center for Synthetic Organic Electrochemistry (grant 2002158).	Abate A, 2014, NANO LETT, V14, P3247, DOI 10.1021/nl500627x; Bi DQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06709-w; Cavallo G, 2016, CHEM REV, V116, P2478, DOI 10.1021/acs.chemrev.5b00484; Dai ZH, 2020, SCRIPTA MATER, V185, P47, DOI 10.1016/j.scriptamat.2020.03.044; Dong QS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21292-3; Dunlap-Shohl WA, 2019, CHEM REV, V119, P3193, DOI 10.1021/acs.chemrev.8b00318; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Gutwald M, 2020, SOL ENERG MAT SOL C, V209, DOI 10.1016/j.solmat.2020.110433; Howarth AJ, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.18; Jena AK, 2019, CHEM REV, V119, P3036, DOI 10.1021/acs.chemrev.8b00539; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Jeong S, 2020, ADV MATER INTERFACES, V7, DOI 10.1002/admi.202001425; Jiang Q, 2017, NAT ENERGY, V2, P1, DOI [10.1038/nenergy.2016.177, 10.1038/NENERGY.2016.177]; Khenkin MV, 2020, NAT ENERGY, V5, P35, DOI 10.1038/s41560-019-0529-5; Kim JH, 2017, MRS BULL, V42, P115, DOI 10.1557/mrs.2017.3; Kim SY, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.202002606; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Liu JX, 2020, PHYS CHEM CHEM PHYS, V22, P19718, DOI 10.1039/d0cp02896g; Liu LF, 2015, J AM CHEM SOC, V137, P1790, DOI 10.1021/ja5125594; Liu ZH, 2020, NAT ENERGY, V5, P596, DOI 10.1038/s41560-020-0653-2; Noguera C., 1996, PHYS CHEM OXIDE SURF; O'Brien PJ, 2013, NAT MATER, V12, P118, DOI [10.1038/NMAT3465, 10.1038/nmat3465]; Park N.-G., 2016, ORGANIC INORGANIC HA; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Qi Y, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.235401; Ramirez C, 2018, SCRIPTA MATER, V150, P36, DOI 10.1016/j.scriptamat.2018.02.022; Rolston N, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201702116; Rolston N, 2016, EXTREME MECH LETT, V9, P353, DOI 10.1016/j.eml.2016.06.006; Rong YG, 2018, SCIENCE, V361, DOI 10.1126/science.aat8235; Saliba M, 2018, JOULE, V2, P1019, DOI 10.1016/j.joule.2018.05.005; Saliba M, 2016, ENERG ENVIRON SCI, V9, P1989, DOI 10.1039/c5ee03874j; Schulz P, 2019, CHEM REV, V119, P3349, DOI 10.1021/acs.chemrev.8b00558; Snaith HJ, 2018, NAT MATER, V17, P372, DOI 10.1038/s41563-018-0071-z; Song S, 2021, ADV ENERGY MATER, V11, DOI 10.1002/aenm.202003382; Tamijani AA, 2016, J PHYS CHEM C, V120, P18126, DOI 10.1021/acs.jpcc.6b05949; Tong JH, 2021, MATTER-US, V4, P1365, DOI 10.1016/j.matt.2021.01.003; Tumen-Ulzii G, 2020, COMMUN MATER, V1, DOI 10.1038/s43246-020-0028-z; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Watson BL, 2017, ENERG ENVIRON SCI, V10, P2500, DOI 10.1039/c7ee02185b; Watson BL, 2016, ACS APPL MATER INTER, V8, P25896, DOI 10.1021/acsami.6b06164; Weller MT, 2015, J PHYS CHEM LETT, V6, P3209, DOI 10.1021/acs.jpclett.5b01432; Yadavalli SK, 2020, ACTA MATER, V187, P112, DOI 10.1016/j.actamat.2020.01.040; Yang G, 2017, J MATER CHEM A, V5, P1658, DOI 10.1039/c6ta08783c; Yun JH, 2015, J MATER CHEM A, V3, P22176, DOI 10.1039/c5ta06008g	46	138	137	144	526	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					618	+		10.1126/science.abf5602	http://dx.doi.org/10.1126/science.abf5602			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958474				2022-12-28	WOS:000649103500043
J	Thyssen, JP; Thomsen, SF				Thyssen, Jacob P.; Thomsen, Simon F.			Treatment of atopic dermatitis with biologics and Janus kinase inhibitors	LANCET			English	Editorial Material							PLACEBO; ADULTS		[Thyssen, Jacob P.; Thomsen, Simon F.] Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Thyssen, JP (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark.	jacob.pontoppidan.thyssen@regionh.dk						Akinlade B, 2019, BRIT J DERMATOL, V181, P459, DOI 10.1111/bjd.17869; Andersen YMF, 2017, J AM ACAD DERMATOL, V76, P274, DOI 10.1016/j.jaad.2016.08.047; de Bruin-Weller M, 2018, BRIT J DERMATOL, V178, P1083, DOI 10.1111/bjd.16156; Egeberg A, 2019, J AM ACAD DERMATOL, V81, P943, DOI 10.1016/j.jaad.2019.06.018; Guttman-Yassky E, 2021, LANCET, V397, P2151, DOI 10.1016/S0140-6736(21)00588-2; Kabashima K, 2020, NEW ENGL J MED, V383, P141, DOI 10.1056/NEJMoa1917006; Ratchataswan T, 2021, J ALLER CL IMM-PRACT, V9, P1053, DOI 10.1016/j.jaip.2020.11.034; Reich K, 2021, LANCET, V397, P2169, DOI 10.1016/S0140-6736(21)00589-4; Reich K, 2020, JAMA DERMATOL, V156, P1333, DOI 10.1001/jamadermatol.2020.3260; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Silverberg JI, 2021, BRIT J DERMATOL, V184, P450, DOI 10.1111/bjd.19573; Silverberg JI, 2021, BRIT J DERMATOL, V184, P888, DOI 10.1111/bjd.19457; Silverberg JI, 2020, JAMA DERMATOL, V156, P863, DOI 10.1001/jamadermatol.2020.1406; Simpson EL, 2020, BRIT J DERMATOL, V183, P242, DOI 10.1111/bjd.18898; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Simpson EL, 2020, LANCET, V396, P255, DOI 10.1016/S0140-6736(20)30732-7; Wollenberg A, 2021, BRIT J DERMATOL, V184, P437, DOI 10.1111/bjd.19574	17	3	3	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2021	397	10290					2126	2128		10.1016/S0140-6736(21)00717-0	http://dx.doi.org/10.1016/S0140-6736(21)00717-0		JUN 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SM8DI	34023007				2022-12-28	WOS:000657828600002
J	Jones, WS; Mulder, H; Wruck, LM; Pencina, MJ; Kripalani, S; Munoz, D; Crenshaw, DL; Effron, MB; Re, RN; Gupta, K; Anderson, RD; Pepine, CJ; Handberg, EM; Manning, BR; Jain, SK; Girotra, S; Riley, D; DeWalt, DA; Whittle, J; Goldberg, YH; Roger, VL; Hess, R; Benziger, CP; Farrehi, P; Zhou, L; Ford, DE; Haynes, K; VanWormer, JJ; Knowlton, KU; Kraschnewski, JL; Polonsky, TS; Fintel, DJ; Ahmad, FS; McClay, JC; Campbell, JR; Bell, DS; Fonarow, GC; Bradley, SM; Paranjape, A; Roe, MT; Robertson, HR; Curtis, LH; Sharlow, AG; Berdan, LG; Hammill, BG; Harris, DF; Qualls, LG; Marquis-Gravel, G; Modrow, MF; Marcus, GM; Carton, TW; Nauman, E; Waitman, LR; Kho, AN; Shenkman, EA; McTigue, KM; Kaushal, R; Masoudi, FA; Antman, EM; Davidson, DR; Edgley, K; Merritt, JG; Brown, LS; Zemon, DN; McCormick, TE; Alikhaani, JD; Gregoire, KC; Rothman, RL; Harrington, RA; Hernandez, AF				Jones, W. Schuyler; Mulder, Hillary; Wruck, Lisa M.; Pencina, Michael J.; Kripalani, Sunil; Munoz, Daniel; Crenshaw, David L.; Effron, Mark B.; Re, Richard N.; Gupta, Kamal; Anderson, R. David; Pepine, Carl J.; Handberg, Eileen M.; Manning, Brittney R.; Jain, Sandeep K.; Girotra, Saket; Riley, Danielle; DeWalt, Darren A.; Whittle, Jeff; Goldberg, Ythan H.; Roger, Veronique L.; Hess, Rachel; Benziger, Catherine P.; Farrehi, Peter; Zhou, Li; Ford, Daniel E.; Haynes, Kevin; VanWormer, Jeffrey J.; Knowlton, Kirk U.; Kraschnewski, Jennifer L.; Polonsky, Tamar S.; Fintel, Dan J.; Ahmad, Faraz S.; McClay, James C.; Campbell, James R.; Bell, Douglas S.; Fonarow, Gregg C.; Bradley, Steven M.; Paranjape, Anuradha; Roe, Matthew T.; Robertson, Holly R.; Curtis, Lesley H.; Sharlow, Amber G.; Berdan, Lisa G.; Hammill, Bradley G.; Harris, Debra F.; Qualls, Laura G.; Marquis-Gravel, Guillaume; Modrow, Madelaine F.; Marcus, Gregory M.; Carton, Thomas W.; Nauman, Elizabeth; Waitman, Lemuel R.; Kho, Abel N.; Shenkman, Elizabeth A.; McTigue, Kathleen M.; Kaushal, Rainu; Masoudi, Frederick A.; Antman, Elliott M.; Davidson, Desiree R.; Edgley, Kevin; Merritt, James G.; Brown, Linda S.; Zemon, Doris N.; McCormick, Thomas E.; Alikhaani, Jacqueline D.; Gregoire, Kenneth C.; Rothman, Russell L.; Harrington, Robert A.; Hernandez, Adrian F.		ADAPTABLE Team	Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROME; ASSOCIATION; PATTERNS; OUTCOMES	Background The appropriate dose of aspirin to lower the risk of death, myocardial infarction, and stroke and to minimize major bleeding in patients with established atherosclerotic cardiovascular disease is a subject of controversy. Methods Using an open-label, pragmatic design, we randomly assigned patients with established atherosclerotic cardiovascular disease to a strategy of 81 mg or 325 mg of aspirin per day. The primary effectiveness outcome was a composite of death from any cause, hospitalization for myocardial infarction, or hospitalization for stroke, assessed in a time-to-event analysis. The primary safety outcome was hospitalization for major bleeding, also assessed in a time-to-event analysis. Results A total of 15,076 patients were followed for a median of 26.2 months (interquartile range [IQR], 19.0 to 34.9). Before randomization, 13,537 (96.0% of those with available information on previous aspirin use) were already taking aspirin, and 85.3% of these patients were previously taking 81 mg of daily aspirin. Death, hospitalization for myocardial infarction, or hospitalization for stroke occurred in 590 patients (estimated percentage, 7.28%) in the 81-mg group and 569 patients (estimated percentage, 7.51%) in the 325-mg group (hazard ratio, 1.02; 95% confidence interval [CI], 0.91 to 1.14). Hospitalization for major bleeding occurred in 53 patients (estimated percentage, 0.63%) in the 81-mg group and 44 patients (estimated percentage, 0.60%) in the 325-mg group (hazard ratio, 1.18; 95% CI, 0.79 to 1.77). Patients assigned to 325 mg had a higher incidence of dose switching than those assigned to 81 mg (41.6% vs. 7.1%) and fewer median days of exposure to the assigned dose (434 days [IQR, 139 to 737] vs. 650 days [IQR, 415 to 922]). Conclusions In this pragmatic trial involving patients with established cardiovascular disease, there was substantial dose switching to 81 mg of daily aspirin and no significant differences in cardiovascular events or major bleeding between patients assigned to 81 mg and those assigned to 325 mg of aspirin daily. (Funded by the Patient-Centered Outcomes Research Institute; ADAPTABLE ClinicalTrials.gov number, NCT02697916.) Aspirin Dosing in Cardiovascular Disease In an open-label, pragmatic trial, patients with cardiovascular disease were randomly assigned to a strategy of 81 mg or 325 mg of aspirin daily. A substantial proportion of those assigned to the 325-mg dose switched to the 81-mg dose, and there were no significant differences in cardiovascular events or major bleeding between the two groups.	[Jones, W. Schuyler; Mulder, Hillary; Wruck, Lisa M.; Pencina, Michael J.; Roe, Matthew T.; Robertson, Holly R.; Curtis, Lesley H.; Sharlow, Amber G.; Berdan, Lisa G.; Hammill, Bradley G.; Harris, Debra F.; Qualls, Laura G.; Marquis-Gravel, Guillaume; Hernandez, Adrian F.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [DeWalt, Darren A.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Zhou, Li] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Kripalani, Sunil; Munoz, Daniel; Crenshaw, David L.; Rothman, Russell L.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Effron, Mark B.; Re, Richard N.] Ochsner Hlth, New Orleans, LA USA; [Carton, Thomas W.; Nauman, Elizabeth] Louisiana Publ Hlth Inst, New Orleans, LA USA; [Gupta, Kamal] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Anderson, R. David; Pepine, Carl J.; Handberg, Eileen M.; Manning, Brittney R.; Shenkman, Elizabeth A.] Univ Florida, Gainesville, FL USA; [Jain, Sandeep K.; McTigue, Kathleen M.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Kraschnewski, Jennifer L.] Penn State Coll Med, Hershey, PA USA; [Paranjape, Anuradha] Temple Univ, Philadelphia, PA 19122 USA; [Girotra, Saket; Riley, Danielle] Univ Iowa, Iowa City, IA USA; [Whittle, Jeff] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [VanWormer, Jeffrey J.] Marshfield Clin Res Inst, Marshfield, WI USA; [Goldberg, Ythan H.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Kaushal, Rainu] Weill Cornell Med, New York, NY USA; [Kaushal, Rainu] New York Presbyterian Hosp, New York, NY USA; [Roger, Veronique L.] Mayo Clin, Rochester, MN USA; [Benziger, Catherine P.] Essentia Hlth Heart & Vasc Ctr, Duluth, MN USA; [Bradley, Steven M.] Allina Hlth, Minneapolis, MN USA; [Bradley, Steven M.] Minneapolis Heart Inst, Minneapolis, MN USA; [Hess, Rachel] Univ Utah, Sch Med, Salt Lake City, UT USA; [Knowlton, Kirk U.] Intermt Med Ctr Heart Inst, Salt Lake City, UT USA; [Farrehi, Peter] Univ Michigan, Ann Arbor, MI 48109 USA; [Ford, Daniel E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Haynes, Kevin] HealthCore, Wilmington, DE USA; [Polonsky, Tamar S.] Univ Chicago Med, Chicago, IL USA; [Fintel, Dan J.; Ahmad, Faraz S.; Kho, Abel N.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [McClay, James C.; Campbell, James R.] Univ Nebraska Med Ctr, Omaha, NE USA; [Bell, Douglas S.; Fonarow, Gregg C.] Univ Calif Los Angeles, Los Angeles, CA USA; [Modrow, Madelaine F.; Marcus, Gregory M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Harrington, Robert A.] Stanford Univ, Sch Med, Stanford, CA USA; [Waitman, Lemuel R.] Univ Missouri, Sch Med, Columbia, MO USA; [Masoudi, Frederick A.] Univ Colorado, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Antman, Elliott M.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center; Vanderbilt University; University of Kansas; University of Kansas Medical Center; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Iowa; Medical College of Wisconsin; Yeshiva University; Albert Einstein College of Medicine; Cornell University; NewYork-Presbyterian Hospital; Mayo Clinic; Allina Health System; Minneapolis Heart Institute Foundation; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; University of Michigan System; University of Michigan; Johns Hopkins University; Northwestern University; Feinberg School of Medicine; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; Stanford University; University of Missouri System; University of Missouri Columbia; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jones, WS (corresponding author), Duke Univ Hlth Syst, Div Cardiol, DUMC 3330, Durham, NC 27710 USA.	schuyler.jones@duke.edu	Effron, Mark B./P-9300-2015; Roger, Veronique/AAV-5951-2020; Bradley, Steven/AID-7839-2022; Sandu, Oana/AAH-4771-2019	Effron, Mark B./0000-0003-4050-5030; Sandu, Oana/0000-0002-4198-7249; Girotra, Saket/0000-0002-4784-4513; Whittle, Jeff/0000-0002-9544-838X; Rothman, Russsell/0000-0002-1506-3990; Shenkman, Elizabeth/0000-0003-4903-1804; Pepine, Carl/0000-0002-6011-681X; Marcus, Gregory/0000-0001-5197-7696; Clariday, Laura/0000-0001-5291-2982				Ahmad FS, 2020, CIRC-CARDIOVASC QUAL, V13, P355, DOI 10.1161/CIRCOUTCOMES.119.006292; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Bowman L, 2018, NEW ENGL J MED, V379, P1529, DOI 10.1056/NEJMoa1804988; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Fishman E, 2018, CONT CLIN TRIAL COMM, V12, P154, DOI 10.1016/j.conctc.2018.11.001; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Gaziano JM, 2018, LANCET, V392, P1036, DOI 10.1016/S0140-6736(18)31924-X; Hall HM, 2014, CIRC-CARDIOVASC QUAL, V7, P701, DOI 10.1161/CIRCOUTCOMES.113.000822; Hernandez AF, 2015, ANN INTERN MED, V163, P635, DOI 10.7326/M15-1460; Kohli P, 2014, J AM COLL CARDIOL, V63, P225, DOI 10.1016/j.jacc.2013.09.023; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Mahaffey KW, 2014, AM J CARDIOL, V113, P936, DOI 10.1016/j.amjcard.2013.11.052; Marquis-Gravel G, 2020, JAMA CARDIOL, V5, P598, DOI 10.1001/jamacardio.2020.0116; Marquis-Gravel G, 2019, CIRCULATION, V140, P1115, DOI 10.1161/CIRCULATIONAHA.119.040205; McNeil JJ, 2018, NEW ENGL J MED, V379, P1509, DOI 10.1056/NEJMoa1805819; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Xian Y, 2015, CIRCULATION, V132, P174, DOI 10.1161/CIRCULATIONAHA.114.014992	21	57	58	5	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2021	384	21					1981	1990		10.1056/NEJMoa2102137Copyright<(c)>2021Massachusetts	http://dx.doi.org/10.1056/NEJMoa2102137Copyright<(c)>2021Massachusetts			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SY1GA	33999548				2022-12-28	WOS:000665641200015
J	Turban, JL; Kraschel, KL; Cohen, IG				Turban, Jack L.; Kraschel, Katherine L.; Cohen, I. Glenn			Legislation to Criminalize Gender-Affirming Medical Care for Transgender Youth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Turban, Jack L.] Stanford Univ, Div Child & Adolescent Psychiat, Sch Med, Stanford, CA 94305 USA; [Kraschel, Katherine L.] Yale Law Sch, Solomon Ctr Hlth Law & Policy, New Haven, CT USA; [Cohen, I. Glenn] Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Boston, MA USA	Stanford University; Yale University; Harvard University	Turban, JL (corresponding author), 401 Quarry Rd, Palo Alto, CA 94304 USA.	jturban@stanford.edu						Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Hembree WC, 2018, J CLIN ENDOCR METAB, V103, P699, DOI [10.1210/jc.2017-02548, 10.1210/jc.2017-01658]; Johns MM, 2019, MMWR-MORBID MORTAL W, V68, P67, DOI 10.15585/mmwr.mm6803a3; Jung I, 2015, ROUT INT HANDB, P115; Kidd KM, 2021, J ADOLESCENT HEALTH, V68, P1082, DOI 10.1016/j.jadohealth.2020.09.010; Rafferty J, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-2162; Szemanski A, 2020, HARV J LAW GEND, V43, P137	7	16	16	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2021	325	22					2251	2252		10.1001/jama.2021.7764	http://dx.doi.org/10.1001/jama.2021.7764		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS1CN	34028489				2022-12-28	WOS:000655670500004
J	Perry, M; Betty, SK; Downes, N; Andrews, N; Mackenzie, S				Perry, Mark; Betty, Sophia Kemmis; Downes, Nicole; Andrews, Neil; Mackenzie, Simon		Guideline Comm	Atrial fibrillation: diagnosis and management-summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Perry, Mark; Betty, Sophia Kemmis; Downes, Nicole] Royal Coll Physicians, London NW1 4LE, England; [Andrews, Neil] Portsmouth Hosp Univ NHS Trust, Portsmouth, Hants, England; [Mackenzie, Simon] NHS England, London, England; [Mackenzie, Simon] NHS Improvement, London, England	Royal College of Physicians	Perry, M (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	mark.perry@rcp.ac.uk						Medicines and Healthcare products Regulatory Agency, DIR ACT OR ANT DOACS; National Institute for Health and Care Excellence, 2009, MED ADH INV PAT DEC; National Institute for Health and Care Excellence, 2021, ATRIAL FIBRILLATION; National Institute for Health and Care Excellence, 2011, ALCOHOL USE DISORDER; National Institute for Health and Care Excellence, 2012, MED ADHERENCE INVOLV, Patent No. [CG138, 138]; National Institute for Health and Care Excellence, NICE PATHW ATR FIBR; National Institute for Health and Care Excellence, 2019, HYPERTENSION ADULTS; NICE, 2015, MED OPT SAF EFF US M	8	13	13	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2021	373								n1150	10.1136/bmj.n1150	http://dx.doi.org/10.1136/bmj.n1150			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7ZT	34020968	Green Accepted			2022-12-28	WOS:000656435600013
J	Gashu, D; Nalivata, PC; Amede, T; Ander, EL; Bailey, EH; Botoman, L; Chagumaira, C; Gameda, S; Haefele, SM; Hailu, K; Joy, EJM; Kalimbira, AA; Kumssa, DB; Lark, RM; Ligowe, IS; McGrath, SP; Milne, AE; Mossa, AW; Munthali, M; Towett, EK; Walsh, MG; Wilson, L; Young, SD; Broadley, MR				Gashu, D.; Nalivata, P. C.; Amede, T.; Ander, E. L.; Bailey, E. H.; Botoman, L.; Chagumaira, C.; Gameda, S.; Haefele, S. M.; Hailu, K.; Joy, E. J. M.; Kalimbira, A. A.; Kumssa, D. B.; Lark, R. M.; Ligowe, I. S.; McGrath, S. P.; Milne, A. E.; Mossa, A. W.; Munthali, M.; Towett, E. K.; Walsh, M. G.; Wilson, L.; Young, S. D.; Broadley, M. R.			The nutritional quality of cereals varies geospatially in Ethiopia and Malawi	NATURE			English	Article							SOIL; DEFICIENCY; SELENIUM; BIOFORTIFICATION; IMPACT; COPPER; ZINC; IRON	Micronutrient deficiencies (MNDs) remain widespread among people in sub-Saharan Africa(1-5), where access to sufficient food from plant and animal sources that is rich in micronutrients (vitamins and minerals) is limited due to socioeconomic and geographical reasons(4-6). Here we report the micronutrient composition (calcium, iron, selenium and zinc) of staple cereal grains for most of the cereal production areas in Ethiopia and Malawi. We show that there is geospatial variation in the composition of micronutrients that is nutritionally important at subnational scales. Soil and environmental covariates of grain micronutrient concentrations included soil pH, soil organic matter, temperature, rainfall and topography, which were specific to micronutrient and crop type. For rural households consuming locally sourced food-including many smallholder farming communities-the location of residence can be the largest influencing factor in determining the dietary intake of micronutrients from cereals. Positive relationships between the concentration of selenium in grain and biomarkers of selenium dietary status occur in both countries. Surveillance of MNDs on the basis of biomarkers of status and dietary intakes from national- and regional-scale food-composition data(1-7) could be improved using subnational data on the composition of grain micronutrients. Beyond dietary diversification, interventions to alleviate MNDs, such as food fortification(8,9) and biofortification to increase the micronutrient concentrations in crops(10,11), should account for geographical effects that can be larger in magnitude than intervention outcomes.	[Gashu, D.; Hailu, K.] Addis Ababa Univ, Ctr Food Sci & Nutr, Addis Ababa, Ethiopia; [Nalivata, P. C.; Botoman, L.; Chagumaira, C.; Kalimbira, A. A.; Ligowe, I. S.] Lilongwe Univ Agr & Nat Resources LUANAR, Lilongwe, Malawi; [Amede, T.] Int Crop Res Inst Semiarid Trop ICRISAT, Addis Ababa, Ethiopia; [Ander, E. L.] British Geol Survey, Ctr Environm Geochem, Keyworth, Notts, England; [Bailey, E. H.; Chagumaira, C.; Kumssa, D. B.; Lark, R. M.; Mossa, A. W.; Wilson, L.; Young, S. D.; Broadley, M. R.] Univ Nottingham, Sch Biosci, Loughborough, England; [Botoman, L.; Ligowe, I. S.; Munthali, M.] Dept Agr Res Serv, Lilongwe, Malawi; [Chagumaira, C.; Lark, R. M.] Univ Nottingham, Future Food Beacon, Loughborough, England; [Chagumaira, C.; Haefele, S. M.; McGrath, S. P.; Milne, A. E.] Rothamsted Res, Sustainable Agr Sci Dept, Harpenden, Herts, England; [Gameda, S.] Int Maize & Wheat Improvement Ctr CIMMYT, Addis Ababa, Ethiopia; [Hailu, K.] Addis Ababa Sci & Technol Univ, Dept Food Sci & Appl Nutr, Addis Ababa, Ethiopia; [Joy, E. J. M.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Towett, E. K.] World Agroforestry ICRAF, Nairobi, Kenya; [Walsh, M. G.] Selian Agr Res Inst, Africa Soil Informat Serv, Arusha, Tanzania	Addis Ababa University; Lilongwe University of Agriculture & Natural Resources; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Nottingham; University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Addis Ababa University; University of London; London School of Hygiene & Tropical Medicine; CGIAR; World Agroforestry (ICRAF)	Broadley, MR (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, England.	martin.broadley@nottingham.ac.uk	Ander, E.L./D-2009-2013; Milne, Alice/HGE-7308-2022; Broadley, Martin/AAW-4638-2021; Chagumaira, Christopher/GQY-5939-2022; broadley, martin r/E-9081-2011; Haefele, Stephan M/E-1256-2017; McGrath, Steve P/B-5127-2008; Kumssa, Diriba/AAR-7547-2020; Chagumaira, Christopher/AAI-7239-2020; Bailey, Elizabeth/N-4888-2016	Ander, E.L./0000-0003-3901-1949; Broadley, Martin/0000-0003-3964-7226; broadley, martin r/0000-0003-3964-7226; Haefele, Stephan M/0000-0003-0389-8373; McGrath, Steve P/0000-0003-0952-8947; Kumssa, Diriba/0000-0002-5869-4864; Chagumaira, Christopher/0000-0003-0590-0350; Mossa, Abdul Wahab/0000-0002-9540-2023; Gashu, Dawd/0000-0002-6067-4432; Milne, Alice/0000-0002-4509-0578; Bailey, Elizabeth/0000-0002-5266-3792	GeoNutrition projects - Bill & Melinda Gates Foundation [INV-009129]; UKRI Biotechnology and Biological Sciences Research Council (BBSRC)/Global Challenges Research Fund (GCRF) [BB/P023126/1]; Royal Society-UK Foreign, Commonwealth & Development Office (FCDO) [AQ140000]; BBSRC Institute Strategic Project Soil to Nutrition [BBS/E/C/000I0310]; NERC [bgs06003] Funding Source: UKRI	GeoNutrition projects - Bill & Melinda Gates Foundation; UKRI Biotechnology and Biological Sciences Research Council (BBSRC)/Global Challenges Research Fund (GCRF)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society-UK Foreign, Commonwealth & Development Office (FCDO); BBSRC Institute Strategic Project Soil to Nutrition; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by GeoNutrition projects funded by the Bill & Melinda Gates Foundation (INV-009129) and the UKRI Biotechnology and Biological Sciences Research Council (BBSRC)/Global Challenges Research Fund (GCRF) (BB/P023126/1). The funders were not involved in the study design; the collection, management, analysis, and interpretation of data; the writing of the paper or the decision to submit the paper for publication. The boundaries, denominations and any other information shown on these maps do not imply any judgment about the legal status of any territory or constitute any official endorsement or acceptance of any boundaries on the part of any Government. We acknowledge the contributions made to this research by the participating farmers and field sampling teams. In Ethiopia, field sampling teams were from the Amhara, Oromia and Tigray Regional Bureau of Agriculture. In Malawi, field sampling teams were from the Department of Agricultural Research Services and Lilongwe University of Agriculture and Natural Resources. Training support for field activities in Malawi was facilitated by funding from the Royal Society-UK Foreign, Commonwealth & Development Office (FCDO), under project AQ140000, "Strengthening African capacity in soil geochemistry for agriculture and health". Mineral analytical support was provided by B. Broadley, K. Davis, P. Muleya, S. Vasquez Reina, S. Dunham, J. Carter and J. Hernandez with support from BBSRC Institute Strategic Project Soil to Nutrition (BBS/E/C/000I0310). E.L.A.'s contribution is published with the permission of the Director of the British Geological Survey (UKRI). The CHELSA project is acknowledged for making the downscaled climate data available from https://climatedataguide.ucar.edu/.	AfSIS, 2015, NEW CROPL RUR SETTL; Allen LH, 2002, J NUTR, V132, p813S, DOI 10.1093/jn/132.4.813S; Allen LH, 2020, ADV NUTR, V11, P469, DOI 10.1093/advances/nmz096; Badigannavar A, 2018, J CEREAL SCI, V84, P1, DOI 10.1016/j.jcs.2018.09.014; Barrett CB, 2015, NAT GEOSCI, V8, P907, DOI [10.1038/ngeo2591, 10.1038/NGEO2591]; Belay A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061565; Bermudez OI, 2012, FOOD NUTR BULL, V33, pS208, DOI 10.1177/15648265120333S209; Bevis LEM, 2020, J DEV ECON, V143, DOI 10.1016/j.jdeveco.2019.102377; Bevis LE, 2021, ENVIRON GEOCHEM HLTH, V43, P1867, DOI 10.1007/s10653-020-00698-w; Bouis HE, 2017, GLOB FOOD SECUR-AGR, V12, P49, DOI 10.1016/j.gfs.2017.01.009; Brys G, 2004, J COMPUT GRAPH STAT, V13, P996, DOI 10.1198/106186004X12632; Caulfeld L. E., 2006, DIS CONTROL PRIORITI, P551; Chilimba A. D. C., 2015, BMC NUTR, V1, P42, DOI DOI 10.1186/S40795-015-0036-4; Chilimba ADC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00072; CRESSIE N, 1980, J INT ASS MATH GEOL, V12, P115, DOI 10.1007/BF01035243; Das JK, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-67; Deville JC, 2004, BIOMETRIKA, V91, P893, DOI 10.1093/biomet/91.4.893; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Dowd PA., 1984, GEOSTATISTICS NATURA, P91, DOI [10.1007/978-94-009-3699-7_6, DOI 10.1007/978-94-009-3699-7...6]; ESA, LAND COV CCI DAT VER; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; FAO, 2017, FAOSTAT DAT; FAYE B, 1991, TROP ANIM HEALTH PRO, V23, P172, DOI 10.1007/BF02357001; Fordyce F.M., 2013, ESSENTIALS MED GEOLO, P375, DOI 10.1007/978-94-007-4375-5_16; Gabaza M, 2018, J CEREAL SCI, V82, P223, DOI 10.1016/j.jcs.2018.06.007; Gashu D, 2020, SCI TOTAL ENVIRON, V733, DOI 10.1016/j.scitotenv.2020.139231; Gashu D, 2019, BIOL TRACE ELEM RES, V189, P354, DOI 10.1007/s12011-018-1489-5; Gneiting T, 2013, BERNOULLI, V19, P1327, DOI 10.3150/12-BEJSP06; Godecke T, 2018, GLOB FOOD SECUR-AGR, V17, P21, DOI 10.1016/j.gfs.2018.03.004; Grafstrom A., 2016, BALANCED SPATIALLY B; Grafstrom A, 2014, SCAND J STAT, V41, P277, DOI 10.1111/sjos.12016; Hurst R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01425; Jones GD, 2017, P NATL ACAD SCI USA, V114, P2848, DOI 10.1073/pnas.1611576114; Joy EJM, 2015, SCI TOTAL ENVIRON, V505, P587, DOI 10.1016/j.scitotenv.2014.10.038; Joy EJM, 2014, PHYSIOL PLANTARUM, V151, P208, DOI 10.1111/ppl.12144; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Khokhar JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192026; King JC, 2016, J NUTR, V146, p858S, DOI 10.3945/jn.115.220079; Kohler IH, 2019, PLANT J, V97, P872, DOI 10.1111/tpj.14166; Kumssa DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep10974; Lark RM, 2006, EUR J SOIL SCI, V57, P787, DOI 10.1111/j.1365-2389.2005.00768.x; Lark RM, 2018, GEODERMA, V319, P89, DOI 10.1016/j.geoderma.2017.12.022; Lark RM, 2017, EUR J SOIL SCI, V68, P221, DOI 10.1111/ejss.12413; Lark RM, 2014, GEODERMA, V226, P64, DOI 10.1016/j.geoderma.2014.03.002; Lark RM, 2000, EUR J SOIL SCI, V51, P137, DOI 10.1046/j.1365-2389.2000.00280.x; Ligowe IS, 2020, P NUTR SOC, V79, P457, DOI 10.1017/S0029665120006904; Manzeke MG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42828-0; Maqbool MA, 2019, PLANT BREEDING, V138, P1, DOI 10.1111/pbr.12658; Marks KJ, 2018, GLOB HEALTH-SCI PRAC, V6, P354, DOI 10.9745/GHSP-D-17-00427; Matheron G., 1962, TRAITE GEOSTATISTIQU, V1; Nelson G, 2018, NAT SUSTAIN, V1, P773, DOI 10.1038/s41893-018-0192-z; Pawlowsky-Glahn V., 2004, GEOSTATISTICS COMPUT; Phiri FP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43013-z; R Development Core Team, 2009, R LANG ENV STAT COMP; Rawlins BG, 2005, SOIL USE MANAGE, V21, P353, DOI 10.1079/SUM2005335; Smith MR, 2018, NAT CLIM CHANGE, V8, P834, DOI 10.1038/s41558-018-0253-3; The DHS Program, 2017, MAL DEM HLTH SURV 20; VANDERPAS JB, 1990, AM J CLIN NUTR, V52, P1087, DOI 10.1093/ajcn/52.6.1087; Velu G., 2015, ADV FOOD TECHNOLOGY, V1, P73, DOI DOI 10.17140/AFTNSOJ-1-112; Walsh M., 2020, GEOSURVEY DATA PREDI; Walvoort DJJ, 2010, COMPUT GEOSCI-UK, V36, P1261, DOI 10.1016/j.cageo.2010.04.005; Webster R., 2007, GEOSTATISTICS ENV SC; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Wood SA, 2018, AGR ECOSYST ENVIRON, V266, P100, DOI 10.1016/j.agee.2018.07.025; Yamazaki D, 2017, GEOPHYS RES LETT, V44, P5844, DOI 10.1002/2017GL072874; Zia MH, 2020, FRONT SUSTAIN FOOD S, V4, DOI 10.3389/fsufs.2020.00135	67	43	43	28	108	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					71	+		10.1038/s41586-021-03559-3	http://dx.doi.org/10.1038/s41586-021-03559-3		MAY 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM2RM	34012114	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000652172000001
J	Doshi, P				Doshi, Peter			Covid-19 vaccines: In the rush for regulatory approval, do we need more data?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pdoshi@bmj.com						Avorn J, 2020, JAMA-J AM MED ASSOC, V324, P1284, DOI 10.1001/jama.2020.17101; Doshi P, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4037; European Medicines Agency, EMA156892021CORR1202; European Medicines Agency, EMA7073832020CORR120; European Medicines Agency, 2006, EMEACHMPVWP164653200, P18; European Medicines Agency, 2021, EMA1584242021; Goodman S, 2020, CONSIDERATIONS PLACE; Kaplan K., 2020, LOS ANGELES TIMES; Kesselheim AS, 2021, HEALTH AFFAIR, V40, P25, DOI 10.1377/hlthaff.2020.01620; Krause P, 2020, LANCET, V396, P741, DOI 10.1016/S0140-6736(20)31821-3; Lenzer J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4956; Mehrotra DV, 2021, ANN INTERN MED, V174, P221, DOI 10.7326/M20-6169; Meissner HC, 2021, JAMA-J AM MED ASSOC, V325, P721, DOI 10.1001/jama.2020.26792; Moderna TX. Inc, 2021, MOD COV 19 VACC EUA; Musumeci M., 2021, KEY QUESTIONS COVID; Nania R., 2020, FDA COMMISSIONER S H; Pfizer, SARS COV2 MRNA VACC; US Food and Drug Administration, 2020, 161 VACC REL BIOL PR; US Food and Drug Administration, 2020, DEV AUTH LIC VACC PR; US Food and Drug Administration, FAQS EM US AUTH EUAS, P2021; US Food and Drug Administration, 2020, DEV LIC VACC PREV CO; US Food and Drug Administration, 2020, 162 VACC REL BIOL PR; Zuckerman DM, 2021, AM J PUBLIC HEALTH, V111, P1065, DOI 10.2105/AJPH.2021.306273	23	13	13	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2021	373								n1244	10.1136/bmj.n1244	http://dx.doi.org/10.1136/bmj.n1244			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SL5PR	34006591	Bronze			2022-12-28	WOS:000656970600006
J	Wise, J				Wise, Jacqui			Covid-19: Second vaccine doses expedited in areas of England where new variant is high	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Independent SAGE, 2021, 6 POINT PLAN DEAL B; Public Health England, 2021, SARS COV2 VAR DAT UP; Scientific Advisory Group for Emergencies, 2021, SAGE 89 MIN COR COVI	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2021	373								n1266	10.1136/bmj.n1266	http://dx.doi.org/10.1136/bmj.n1266			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9HR	34001501	Bronze			2022-12-28	WOS:000653058000002
J	Loomba, R; Friedman, SL; Shulman, GI				Loomba, Rohit; Friedman, Scott L.; Shulman, Gerald, I			Mechanisms and disease consequences of nonalcoholic fatty liver disease	CELL			English	Review							HEPATIC INSULIN-RESISTANCE; ENDOPLASMIC-RETICULUM STRESS; ADIPOSE-TISSUE INFLAMMATION; ELEMENT-BINDING PROTEIN; DE-NOVO LIPOGENESIS; GLUCOSE-TRANSPORT-PHOSPHORYLATION; GENOME-WIDE ASSOCIATION; C3 GENE VARIANTS; HEPATOCELLULAR-CARCINOMA; STELLATE CELLS	Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. Here we provide an in-depth discussion of the underlying pathogenetic mechanisms that lead to progressive liver injury, including the metabolic origins of NAFLD, the effect of NAFLD on hepatic glucose and lipid metabolism, bile acid toxicity, macrophage dysfunction, and hepatic stellate cell activation, and consider the role of genetic, epigenetic, and environmental factors that promote fibrosis progression and risk of hepatocellular carcinoma in NASH.	[Loomba, Rohit] Univ Calif San Diego, NAFLD Res Ctr, Div Gastroenterol, Dept Med, La Jolla, CA 92093 USA; [Friedman, Scott L.] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY 10029 USA; [Shulman, Gerald, I] Yale Sch Med, Yale Diabet Res Ctr, Dept Internal Med, New Haven, CT 06520 USA; [Shulman, Gerald, I] Yale Sch Med, Yale Diabet Res Ctr, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Yale University; Yale University	Loomba, R (corresponding author), Univ Calif San Diego, NAFLD Res Ctr, Div Gastroenterol, Dept Med, La Jolla, CA 92093 USA.; Friedman, SL (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY 10029 USA.; Shulman, GI (corresponding author), Yale Sch Med, Yale Diabet Res Ctr, Dept Internal Med, New Haven, CT 06520 USA.; Shulman, GI (corresponding author), Yale Sch Med, Yale Diabet Res Ctr, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.	roleemba@ucsd.edu; scott.friedman@mssm.edu; gerald.shulman@yale.edu		Shulman, Gerald/0000-0003-1529-5668; Friedman, Scott/0000-0003-1178-6195	Department of Health and Human Services (NIH/NIDDK/NHLBI/NIEHS/NCATS) [R01 DK56621, DK128289, R01 DK113984, R01 DK114793, R01 DK116774, R01 DK119968, RC2 DK120534, P30 DK045735, UL1 TR001442, U01 DK061734, R01 DK106419, R01 DK121378, R01 DK124318, P30 DK120515, P01 HL147835, P42 ES01033]	Department of Health and Human Services (NIH/NIDDK/NHLBI/NIEHS/NCATS)	The authors received funding support from the Department of Health and Human Services (NIH/NIDDK/NHLBI/NIEHS/NCATS): R01 DK56621 and DK128289 (to S.L.F.); R01 DK113984, R01 DK114793, R01 DK116774, R01 DK119968, RC2 DK120534, and P30 DK045735 (to G.I.S.); and P42 ES01033, UL1 TR001442, U01 DK061734, R01 DK106419, R01 DK121378, R01 DK124318, P30 DK120515, and P01 HL147835 (to R.L.).	Abul-Husn NS, 2018, NEW ENGL J MED, V378, P1096, DOI 10.1056/NEJMoa1712191; Abulizi A, 2020, J LIPID RES, V61, P1565, DOI 10.1194/jlr.RA119000586; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Adorini L, 2012, DRUG DISCOV TODAY, V17, P988, DOI 10.1016/j.drudis.2012.05.012; Alegre F, 2017, SEMIN LIVER DIS, V37, P119, DOI 10.1055/s-0037-1601350; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; An  P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16092-0; Andersson DP, 2017, OBES SURG, V27, P1115, DOI 10.1007/s11695-017-2576-y; Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7; Anstee QM, 2016, GASTROENTEROLOGY, V150, P1728, DOI 10.1053/j.gastro.2016.01.037; Arab JP, 2017, HEPATOLOGY, V65, P350, DOI 10.1002/hep.28709; Asrani SK, 2014, J HEPATOL, V60, P934, DOI 10.1016/j.jhep.2013.12.016; Barcena-Varela M, 2021, GUT, V70, P388, DOI 10.1136/gutjnl-2019-320205; Barry AE, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00709; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; BasuRay S, 2017, HEPATOLOGY, V66, P1111, DOI 10.1002/hep.29273; Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192; BAYOUMI A, 2020, TRENDS GENET, V36, P429, DOI DOI 10.1016/j.tig.2020.03.003; Beaven SW, 2013, CELL METAB, V18, P106, DOI 10.1016/j.cmet.2013.04.021; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Beier JI, 2018, J HEPATOL, V68, P643, DOI 10.1016/j.jhep.2018.01.017; Benhamouche-Trouillet S, 2016, GUT, V65, P1781, DOI 10.1136/gutjnl-2015-310044; Berkan-Kawinska A, 2020, CURR MED RES OPIN, V36, P235, DOI 10.1080/03007995.2019.1683817; Betancourt-Garcia MM, 2017, OBES SURG, V27, P236, DOI 10.1007/s11695-016-2440-5; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bin Ramli MN, 2020, GASTROENTEROLOGY, V159, P1471, DOI 10.1053/j.gastro.2020.06.010; Bindesboll C, 2015, J LIPID RES, V56, P771, DOI 10.1194/jlr.M049130; Boren J, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.144079; Borji M, 2019, BIOCHEM GENET, V57, P507, DOI 10.1007/s10528-019-09905-5; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Brady GF, 2018, HEPATOLOGY, V67, P1710, DOI 10.1002/hep.29522; Brenachot X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02074-2; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brumbaugh DE, 2013, J PEDIATR-US, V162, P930, DOI 10.1016/j.jpeds.2012.11.017; Bruschi FV, 2017, HEPATOLOGY, V65, P1875, DOI 10.1002/hep.29041; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Bugianesi E, 2004, HEPATOLOGY, V39, P179, DOI 10.1002/hep.20023; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calvente CJ, 2019, J CLIN INVEST, V129, P4091, DOI 10.1172/JCI122258; Camporez JP, 2017, P NATL ACAD SCI USA, V114, pE11285, DOI 10.1073/pnas.1716990115; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42801; Caussy C, 2017, J CLIN INVEST, V127, P2697, DOI 10.1172/JCI93465; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chalasani NP, 2021, CLIN GASTROENTEROL H, V19, P2597, DOI 10.1016/j.cgh.2020.08.065; Chan AWH, 2017, J GASTROEN HEPATOL, V32, P667, DOI 10.1111/jgh.13536; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Chavez-Talavera O, 2017, GASTROENTEROLOGY, V152, P1679, DOI 10.1053/j.gastro.2017.01.055; Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073; Chen JZ, 2019, J CELL BIOCHEM, V120, P2713, DOI 10.1002/jcb.27635; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Chennamsetty I, 2016, CELL REP, V17, P527, DOI 10.1016/j.celrep.2016.09.005; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Chong YC, 2019, ONCOGENE, V38, P2206, DOI 10.1038/s41388-018-0585-5; Chu Huikuan, 2018, Liver Res, V2, P43, DOI 10.1016/j.livres.2017.11.005; Chu X, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1490-y; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Coombes JD, 2016, BBA-MOL BASIS DIS, V1862, P135, DOI 10.1016/j.bbadis.2015.10.028; Cornell L, 2015, CLIN CANCER RES, V21, P925, DOI 10.1158/1078-0432.CCR-14-0842; Couillard B, 1999, ARTERIOSCL THROM VAS, V19, P2448; Csak T, 2014, LIVER INT, V34, P1402, DOI 10.1111/liv.12537; Cui J, 2016, HEPATOLOGY, V64, P1547, DOI 10.1002/hep.28674; Cuthbertson DJ, 2017, INT J OBESITY, V41, P853, DOI 10.1038/ijo.2017.4; Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x; Da Silva HE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19753-9; de I'Hortet AC, 2019, CELL METAB, V30, P385, DOI 10.1016/j.cmet.2019.06.017; Deczkowska A, 2020, CELL, V181, P1207, DOI 10.1016/j.cell.2020.05.003; Dehnad A, 2020, J CLIN INVEST, V130, P4320, DOI 10.1172/JCI133051; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Ding JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13729; Donati B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04991-0; Dong ZX, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.21; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Doycheva I, 2020, J CLIN EXP HEPATOL, V10, P296, DOI 10.1016/j.jceh.2019.11.004; Du K, 2018, GASTROENTEROLOGY, V154, P1465, DOI 10.1053/j.gastro.2017.12.022; du Plessis J, 2015, GASTROENTEROLOGY, V149, P635, DOI 10.1053/j.gastro.2015.05.044; Du ZP, 2020, LAB INVEST, V100, P1042, DOI 10.1038/s41374-020-0425-4; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011; Elbadawy M, 2020, BIOMATERIALS, V237, DOI 10.1016/j.biomaterials.2020.119823; Erion DM, 2013, ENDOCRINOLOGY, V154, P36, DOI 10.1210/en.2012-1725; Eslam M, 2019, TRENDS PHARMACOL SCI, V40, P506, DOI 10.1016/j.tips.2019.05.002; Eslam M, 2018, J HEPATOL, V68, P268, DOI 10.1016/j.jhep.2017.09.003; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Fabbrini E, 2010, GASTROENTEROLOGY, V139, P448, DOI 10.1053/j.gastro.2010.04.056; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fan YB, 2016, GASTROENTEROLOGY, V150, P1208, DOI 10.1053/j.gastro.2016.01.005; Fang QH, 2019, HEPATOL RES, V49, P743, DOI 10.1111/hepr.13330; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; Feaver RE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90954; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; Fondevila MF, 2021, HEPATOLOGY, V73, P606, DOI 10.1002/hep.31290; Fuchs CD, 2016, SEMIN LIVER DIS, V36, P69, DOI 10.1055/s-0036-1571296; Fukuo Y, 2014, HEPATOL RES, V44, P1026, DOI 10.1111/hepr.12282; Gai ZB, 2018, MOL PHARMACOL, V94, P802, DOI 10.1124/mol.117.111047; Gautheron J, 2014, EMBO MOL MED, V6, P1062, DOI 10.15252/emmm.201403856; Ge XD, 2018, HEPATOLOGY, V68, P2380, DOI 10.1002/hep.30093; Ghorpade DS, 2018, NATURE, V555, P673, DOI 10.1038/nature26138; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Gomes AL, 2016, CANCER CELL, V30, P161, DOI 10.1016/j.ccell.2016.05.020; Gonzalez-Teran B, 2016, EMBO J, V35, P536, DOI 10.15252/embj.201591857; Grohmann M, 2018, CELL, V175, P1289, DOI 10.1016/j.cell.2018.09.053; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guillot A, 2014, HEPATOLOGY, V59, P296, DOI 10.1002/hep.26598; Guo L, 2017, J CLIN INVEST, V127, P4449, DOI 10.1172/JCI96324; Guo QQ, 2019, J HEPATOL, V71, P1193, DOI 10.1016/j.jhep.2019.07.019; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hammoutene A, 2019, J HEPATOL, V70, P1278, DOI 10.1016/j.jhep.2019.02.012; Han CY, 2018, CELL REP, V24, P2985, DOI 10.1016/j.celrep.2018.07.068; Han YH, 2019, J CLIN INVEST, V129, P1684, DOI 10.1172/JCI124219; Han YH, 2017, CELL REP, V20, P124, DOI 10.1016/j.celrep.2017.06.017; Handy JA, 2011, BIOCHEM J, V440, P385, DOI 10.1042/BJ20102148; Hanson A, 2019, CYTOKINE, V123, DOI 10.1016/j.cyto.2019.154789; Hassan MM, 2013, MOL CARCINOGEN, V52, P139, DOI 10.1002/mc.22057; Heinrich B, 2021, GASTROENTEROLOGY, V160, P331, DOI 10.1053/j.gastro.2020.09.031; Helsley RN, 2019, ELIFE, V8, DOI 10.7554/eLife.49882; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Herman MA, 2016, TRENDS ENDOCRIN MET, V27, P719, DOI 10.1016/j.tem.2016.06.005; Hernandez-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Hicks DF, 2017, SCI REP-UK, V7, DOI 10.1038/srep42563; Hirsova P, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2283-9; Hirsova P, 2017, HEPATOL COMMUN, V1, P648, DOI 10.1002/hep4.1069; Hirsova P, 2016, GASTROENTEROLOGY, V150, P956, DOI 10.1053/j.gastro.2015.12.037; Hirsova P, 2015, CELL MOL GASTROENTER, V1, P17, DOI 10.1016/j.jcmgh.2014.11.005; Holland ML, 2016, SCIENCE, V353, P495, DOI 10.1126/science.aaf7040; Horwath JA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90170; Hoyles L, 2018, NAT MED, V24, P1070, DOI 10.1038/s41591-018-0061-3; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Hwang YC, 2015, INT J OBESITY, V39, P1365, DOI 10.1038/ijo.2015.75; Ibrahim SH, 2018, GUT, V67, P963, DOI 10.1136/gutjnl-2017-315691; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ilyas G, 2019, ALCOHOL CLIN EXP RES, V43, P1403, DOI 10.1111/acer.14041; Iqbal J, 2020, ADV EXP MED BIOL, V1276, P37, DOI 10.1007/978-981-15-6082-8_4; Irimia JM, 2017, J BIOL CHEM, V292, P10455, DOI 10.1074/jbc.M117.786525; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Kanda T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041525; Kazankov K, 2019, NAT REV GASTRO HEPAT, V16, P145, DOI 10.1038/s41575-018-0082-x; Keitel V, 2018, SEMIN LIVER DIS, V38, P333, DOI 10.1055/s-0038-1669940; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007; Khan RS, 2019, HEPATOLOGY, V70, P711, DOI 10.1002/hep.30429; Kim D, 2017, CLIN GASTROENTEROL H, V15, P474, DOI 10.1016/j.cgh.2016.08.028; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim JY, 2018, CELL, V175, P133, DOI 10.1016/j.cell.2018.08.020; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kopec AK, 2017, J CLIN INVEST, V127, P3152, DOI [10.1172/JCI92744, 10.1172/jci92744]; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Krenkel O, 2020, GUT, V69, P551, DOI 10.1136/gutjnl-2019-318382; Krenkel O, 2018, HEPATOLOGY, V67, P1270, DOI 10.1002/hep.29544; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Kumar DP, 2019, HEPATOLOGY, V69, P1520, DOI 10.1002/hep.30346; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Kumashiro N, 2013, HEPATOLOGY, V57, P1763, DOI 10.1002/hep.26170; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lafoz E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040929; Lally JSV, 2019, CELL METAB, V29, P174, DOI 10.1016/j.cmet.2018.08.020; Lawlor DA, 2012, NAT REV ENDOCRINOL, V8, P679, DOI 10.1038/nrendo.2012.176; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lebensztejn DM, 2016, ACTA BIOCHIM POL, V63, P459, DOI 10.18388/abp.2015_1252; Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee J, 2017, MOL ASPECTS MED, V54, P78, DOI 10.1016/j.mam.2016.11.008; Lee YA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07338-z; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; LEVINE R, 1956, DIABETES, V5, P209, DOI 10.2337/diab.5.3.209; Lewis GF, 1996, DIABETES, V45, P454, DOI 10.2337/diabetes.45.4.454; Li BH, 2017, TRANSL RES, V180, P103, DOI 10.1016/j.trsl.2016.08.006; Li JZ, 2012, J CLIN INVEST, V122, P4130, DOI 10.1172/JCI65179; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li YH, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00567; Liang JQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06931-6; Liang N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09524-z; Lin YC, 2016, J HEPATOL, V65, P1209, DOI 10.1016/j.jhep.2016.06.029; Liu DB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9840; Liu YL, 2014, J HEPATOL, V61, P75, DOI 10.1016/j.jhep.2014.02.030; Liu ZP, 2020, J HEPATOL, V73, P263, DOI 10.1016/j.jhep.2020.03.006; Loomba R, 2020, GASTROENTEROLOGY, V158, P1822, DOI 10.1053/j.gastro.2019.12.053; Loomba R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96685; Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001; Loomba R, 2015, GASTROENTEROLOGY, V149, P1784, DOI 10.1053/j.gastro.2015.08.011; Loomba R, 2015, J LIPID RES, V56, P185, DOI 10.1194/jlr.P055640; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lopez-Vicario C, 2015, P NATL ACAD SCI USA, V112, P536, DOI 10.1073/pnas.1422590112; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Luo XJ, 2018, GASTROENTEROLOGY, V155, P1971, DOI 10.1053/j.gastro.2018.09.010; Luukkonen PK, 2017, J HEPATOL, V67, P128, DOI 10.1016/j.jhep.2017.02.014; Luukkonen PK, 2016, J HEPATOL, V65, P1263, DOI 10.1016/j.jhep.2016.07.045; Luukkonen PK, 2016, J HEPATOL, V64, P1167, DOI 10.1016/j.jhep.2016.01.002; Lyu K, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.139946; Lyu K, 2020, CELL METAB, V32, P654, DOI 10.1016/j.cmet.2020.08.001; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Ma HY, 2020, J HEPATOL, V72, P946, DOI 10.1016/j.jhep.2019.12.016; Ma YL, 2019, HEPATOLOGY, V69, P1504, DOI 10.1002/hep.30350; Machado MV, 2015, GUT, V64, P1148, DOI 10.1136/gutjnl-2014-307362; Machado MV, 2015, J HEPATOL, V63, P962, DOI 10.1016/j.jhep.2015.05.031; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Magkos F, 2010, OBESITY, V18, P1510, DOI 10.1038/oby.2010.90; Mahdessian H, 2014, P NATL ACAD SCI USA, V111, P8913, DOI 10.1073/pnas.1323785111; Malehmir M, 2019, NAT MED, V25, P641, DOI 10.1038/s41591-019-0379-5; Mallat A, 2008, DIABETES METAB, V34, P680, DOI 10.1016/S1262-3636(08)74604-4; Mancina RM, 2015, J CLIN ENDOCR METAB, V100, pE821, DOI 10.1210/jc.2014-4464; Mancina RM, 2016, GASTROENTEROLOGY, V150, P1219, DOI 10.1053/j.gastro.2016.01.032; Marcher AB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39112-6; Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502; Masarone M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9547613; Maurel M, 2014, CANCER CELL, V26, P301, DOI 10.1016/j.ccr.2014.08.007; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; McIlvride S, 2019, AM J PHYSIOL-ENDOC M, V317, pE399, DOI 10.1152/ajpendo.00407.2018; Metwally M, 2019, J HEPATOL, V70, P494, DOI 10.1016/j.jhep.2018.10.021; Mirea AM, 2018, TRENDS MOL MED, V24, P458, DOI 10.1016/j.molmed.2018.03.005; Mitsche MA, 2018, J BIOL CHEM, V293, P6958, DOI 10.1074/jbc.RA118.002333; Mittal S, 2016, CLIN GASTROENTEROL H, V14, P124, DOI 10.1016/j.cgh.2015.07.019; Moran-Salvador E, 2019, GASTROENTEROLOGY, V157, P1398, DOI 10.1053/j.gastro.2019.07.029; Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022; Musso G, 2018, TRENDS PHARMACOL SCI, V39, P387, DOI 10.1016/j.tips.2018.01.003; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Nair S, 2002, HEPATOLOGY, V36, P150, DOI 10.1053/jhep.2002.33713; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Nakagawa S, 2016, CANCER CELL, V30, P879, DOI 10.1016/j.ccell.2016.11.004; Nati M, 2016, REV ENDOCR METAB DIS, V17, P29, DOI 10.1007/s11154-016-9339-2; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Negro F, 2020, LIVER INT, V40, P72, DOI 10.1111/liv.14362; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Nguyen Jennifer, 2018, Oncotarget, V9, P29495, DOI 10.18632/oncotarget.25685; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Nozaki Y, 2020, P NATL ACAD SCI USA, V117, P8166, DOI 10.1073/pnas.1921694117; Oh TG, 2020, CELL METAB, V32, P878, DOI 10.1016/j.cmet.2020.06.005; Ouchi R, 2019, CELL METAB, V30, P374, DOI 10.1016/j.cmet.2019.05.007; Ouyang XS, 2018, CELL METAB, V27, P339, DOI 10.1016/j.cmet.2018.01.007; Page A, 2016, J HEPATOL, V64, P661, DOI 10.1016/j.jhep.2015.11.024; Palmer AK, 2016, EXP GERONTOL, V86, P97, DOI 10.1016/j.exger.2016.02.013; Palmer ND, 2013, HEPATOLOGY, V58, P966, DOI 10.1002/hep.26440; Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Peter A, 2012, INT J OBESITY, V36, P774, DOI 10.1038/ijo.2011.154; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Petersen KF, 1998, J CLIN INVEST, V101, P1203, DOI 10.1172/JCI579; Petersen KF, 2001, DIABETES, V50, P1263, DOI 10.2337/diabetes.50.6.1263; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Petta S, 2017, HEPATOLOGY, V66, P1885, DOI 10.1002/hep.29395; Pfister D, 2021, NATURE; Piccinin E, 2019, NAT REV GASTRO HEPAT, V16, P160, DOI 10.1038/s41575-018-0089-3; Pingitore P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071629; Pingitore P, 2014, BBA-MOL CELL BIOL L, V1841, P574, DOI 10.1016/j.bbalip.2013.12.006; Pirazzi C, 2014, HUM MOL GENET, V23, P4077, DOI 10.1093/hmg/ddu121; Piscaglia F, 2016, HEPATOLOGY, V63, P827, DOI 10.1002/hep.28368; Planas-Paz L, 2019, CELL STEM CELL, V25, P39, DOI 10.1016/j.stem.2019.04.005; Polyzos SA, 2016, DIABETOLOGIA, V59, P30, DOI 10.1007/s00125-015-3769-3; Previs SF, 1999, AM J PHYSIOL-ENDOC M, V277, pE154, DOI 10.1152/ajpendo.1999.277.1.E154; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Rabol R, 2011, P NATL ACAD SCI USA, V108, P13705, DOI 10.1073/pnas.1110105108; Raddatz K, 2011, DIABETOLOGIA, V54, P1447, DOI 10.1007/s00125-011-2073-0; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Raman M, 2013, CLIN GASTROENTEROL H, V11, P868, DOI 10.1016/j.cgh.2013.02.015; Ramnath D, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120274; Rangwala F, 2011, J PATHOL, V224, P401, DOI 10.1002/path.2888; Rau M, 2016, J IMMUNOL, V196, P97, DOI 10.4049/jimmunol.1501175; Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846; REBUFFESCRIVE M, 1990, METABOLISM, V39, P1021, DOI 10.1016/0026-0495(90)90160-E; Reddy JK, 2001, AM J PHYSIOL-GASTR L, V281, pG1333, DOI 10.1152/ajpgi.2001.281.6.G1333; Reig M, 2019, TRANSPLANTATION, V103, P39, DOI 10.1097/TP.0000000000002361; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Roh YS, 2018, ADV EXP MED BIOL, V1061, P45, DOI 10.1007/978-981-10-8684-7_4; Rokusz A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176518; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; ROTHMAN DL, 1995, P NATL ACAD SCI USA, V92, P983, DOI 10.1073/pnas.92.4.983; Rusu V, 2017, CELL, V170, P199, DOI 10.1016/j.cell.2017.06.011; Sakasai-Sakai A., 2019, NUTRIENTS, V11, P11; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Santoro N, 2012, HEPATOLOGY, V55, P781, DOI 10.1002/hep.24806; Sanyal AJ, 2019, HEPATOLOGY, V70, P1913, DOI 10.1002/hep.30664; Sanyal Arun J, 2015, Trans Am Clin Climatol Assoc, V126, P271; Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150; Saxena NK, 2015, TRENDS ENDOCRIN MET, V26, P153, DOI 10.1016/j.tem.2015.01.002; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Schulien I, 2019, CELL DEATH DIFFER, V26, P1688, DOI 10.1038/s41418-018-0239-8; Schumacher JD, 2020, HEPATOLOGY, V71, P670, DOI 10.1002/hep.30810; Schuppan D, 2018, J HEPATOL, V68, P238, DOI 10.1016/j.jhep.2017.11.012; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Schwabe RF, 2020, GASTROENTEROLOGY, V158, P1913, DOI 10.1053/j.gastro.2019.11.311; Schwabe RF, 2018, NAT REV GASTRO HEPAT, V15, P738, DOI 10.1038/s41575-018-0065-y; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Schwimmer JB, 2019, GASTROENTEROLOGY, V157, P1109, DOI 10.1053/j.gastro.2019.06.028; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Sharifnia T, 2015, AM J PHYSIOL-GASTR L, V309, pG270, DOI 10.1152/ajpgi.00304.2014; Sharpton SR, 2019, CLIN GASTROENTEROL H, V17, P296, DOI 10.1016/j.cgh.2018.08.065; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sia D, 2017, GASTROENTEROLOGY, V153, P812, DOI 10.1053/j.gastro.2017.06.007; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Smagris E, 2016, J BIOL CHEM, V291, P10659, DOI 10.1074/jbc.M116.719955; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; Somm E, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91809; Song JD, 2020, CELL METAB, V32, P726, DOI 10.1016/j.cmet.2020.09.008; Song ZL, 2021, HEPATOLOGY, V73, P1594, DOI 10.1002/hep.31582; Sookoian S, 2019, SEMIN LIVER DIS, V39, P124, DOI 10.1055/s-0039-1679920; Spengler EK, 2015, MAYO CLIN PROC, V90, P1233, DOI 10.1016/j.mayocp.2015.06.013; Stender S, 2020, HEPATOLOGY, V71, P777, DOI 10.1002/hep.31113; Stender S, 2017, NAT GENET, V49, P842, DOI 10.1038/ng.3855; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stols-Goncalves D, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1151-4; Sun XL, 2020, CELL METAB, V31, P189, DOI 10.1016/j.cmet.2019.10.014; Sydor S, 2020, CLIN TRANSL GASTROEN, V11, DOI 10.14309/ctg.0000000000000131; Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599; Szabo G, 2015, CLIN RES HEPATOL GAS, V39, pS18, DOI 10.1016/j.clinre.2015.06.012; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tanaka S, 2013, J GASTROENTEROL, V48, P1249, DOI 10.1007/s00535-012-0739-0; ter Horst KW, 2021, DIABETES CARE, V44, P489, DOI 10.2337/dc20-1644; ter Horst KW, 2017, CELL REP, V19, P1997, DOI 10.1016/j.celrep.2017.05.035; Thabet K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12757; Thangapandi VR, 2021, GUT, V70, P940, DOI 10.1136/gutjnl-2020-320853; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Tomita K, 2014, HEPATOLOGY, V59, P154, DOI 10.1002/hep.26604; Tomita K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28786; Torres DM, 2012, CLIN GASTROENTEROL H, V10, P837, DOI 10.1016/j.cgh.2012.03.011; Trepo E, 2020, J HEPATOL, V72, P1196, DOI 10.1016/j.jhep.2020.02.020; Trepo E, 2014, HEPATOLOGY, V59, P2170, DOI 10.1002/hep.26767; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Vacca M, 2020, NAT METAB, V2, P514, DOI 10.1038/s42255-020-0214-9; Valladolid-Acebes I, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abc2931; van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; von Felden J, 2020, GUT, V69, P2025, DOI 10.1136/gutjnl-2019-320282; Wang PX, 2017, NAT MED, V23, P439, DOI 10.1038/nm.4290; Wang XB, 2020, CELL METAB, V31, P969, DOI 10.1016/j.cmet.2020.03.010; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wang XD, 2014, GUT, V63, P1805, DOI 10.1136/gutjnl-2013-306373; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Watanabe A, 2009, AM J PHYSIOL-GASTR L, V296, pG1248, DOI 10.1152/ajpgi.90223.2008; Wattacheril J, 2017, J PEDIATR-US, V190, P100, DOI 10.1016/j.jpeds.2017.08.004; Wehmeyer MH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003887; Weinstein G, 2018, JAMA NEUROL, V75, P97, DOI 10.1001/jamaneurol.2017.3229; Wesolowski SR, 2017, NAT REV GASTRO HEPAT, V14, P81, DOI 10.1038/nrgastro.2016.160; Widjaja AA, 2019, GASTROENTEROLOGY, V157, P777, DOI 10.1053/j.gastro.2019.05.002; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034; Wooden B, 2017, GASTROENTEROLOGY, V152, P53, DOI 10.1053/j.gastro.2016.09.065; Wu TJ, 2012, TRANSPL P, V44, P1055, DOI 10.1016/j.transproceed.2012.03.029; Wueest S, 2016, DIABETES, V65, P140, DOI 10.2337/db15-0941; Xie GH, 2013, HEPATOLOGY, V58, P1801, DOI 10.1002/hep.26511; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028; Xu B, 2018, J HEPATOL, V68, P773, DOI 10.1016/j.jhep.2017.11.040; Xu DW, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01428; Yang J, 2019, INT J CANCER, V144, P533, DOI 10.1002/ijc.31910; Yang JM, 2019, 2019 20TH IEEE/ACIS INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, ARTIFICIAL INTELLIGENCE, NETWORKING AND PARALLEL/DISTRIBUTED COMPUTING (SNPD), P3, DOI 10.1109/SNPD.2019.8935837; Yang JD, 2020, HEPATOLOGY, V71, P907, DOI 10.1002/hep.30858; Yang L, 2017, CELL MOL GASTROENTER, V3, P469, DOI 10.1016/j.jcmgh.2016.12.004; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Ye DW, 2016, J HEPATOL, V65, P988, DOI 10.1016/j.jhep.2016.05.041; Ye DW, 2012, GUT, V61, P1058, DOI 10.1136/gutjnl-2011-300269; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Yoshitaka H, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006712; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; Younossi Z, 2019, CLIN GASTROENTEROL H, V17, P748, DOI 10.1016/j.cgh.2018.05.057; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zarrinpar A, 2016, GUT, V65, P1546, DOI 10.1136/gutjnl-2015-309456; Zeng N, 2018, MOL CELL ENDOCRINOL, V474, P260, DOI 10.1016/j.mce.2018.03.016; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893; Zhang DY, 2016, GUT, V65, P1754, DOI 10.1136/gutjnl-2015-309655; Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30029; Zhang P, 2018, NAT MED, V24, P84, DOI 10.1038/nm.4453; Zhang RN, 2016, DIGEST DIS SCI, V61, P2284, DOI 10.1007/s10620-016-4120-7; Zhu CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0344; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	399	231	233	193	373	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2537	2564		10.1016/j.cell.2021.04.015	http://dx.doi.org/10.1016/j.cell.2021.04.015		MAY 2021	28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33989548	Bronze			2022-12-28	WOS:000652830800004
J	Menzies-Gow, A; Corren, J; Bourdin, A; Chupp, G; Israel, E; Wechsler, ME; Brightling, CE; Griffiths, JM; Hellqvist, A; Bowen, K; Kaur, P; Almqvist, G; Ponnarambil, S; Colice, G				Menzies-Gow, Andrew; Corren, Jonathan; Bourdin, Arnaud; Chupp, Geoffrey; Israel, Elliot; Wechsler, Michael E.; Brightling, Christopher E.; Griffiths, Janet M.; Hellqvist, Asa; Bowen, Karin; Kaur, Primal; Almqvist, Gun; Ponnarambil, Sandhia; Colice, Gene			Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN EPITHELIAL-CELLS; TSLP; BENRALIZUMAB; INFLAMMATION; EFFICACY; ANTIBODY	Tezepelumab in Severe, Uncontrolled Asthma Tezepelumab is a monoclonal antibody that blocks thymic stromal lymphopoietin, an epithelial-cell-derived cytokine implicated in the pathogenesis of asthma. This randomized, placebo-controlled clinical trial showed a reduction in the annualized rate of asthma exacerbations among patients with severe, uncontrolled asthma treated with tezepelumab. Background Tezepelumab is a human monoclonal antibody that blocks thymic stromal lymphopoietin, an epithelial-cell-derived cytokine implicated in the pathogenesis of asthma. The efficacy and safety of tezepelumab in patients with severe, uncontrolled asthma require further assessment. Methods We conducted a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. Patients (12 to 80 years of age) were randomly assigned to receive tezepelumab (210 mg) or placebo subcutaneously every 4 weeks for 52 weeks. The primary end point was the annualized rate of asthma exacerbations over a period of 52 weeks. This end point was also assessed in patients with baseline blood eosinophil counts of less than 300 cells per microliter. Secondary end points included the forced expiratory volume in 1 second (FEV1) and scores on the Asthma Control Questionnaire-6 (ACQ-6; range, 0 [no impairment] to 6 [maximum impairment]), Asthma Quality of Life Questionnaire (AQLQ; range, 1 [maximum impairment] to 7 [no impairment]), and Asthma Symptom Diary (ASD; range, 0 [no symptoms] to 4 [worst possible symptoms]). Results Overall, 1061 patients underwent randomization (529 were assigned to receive tezepelumab and 532 to receive placebo). The annualized rate of asthma exacerbations was 0.93 (95% confidence interval [CI], 0.80 to 1.07) with tezepelumab and 2.10 (95% CI, 1.84 to 2.39) with placebo (rate ratio, 0.44; 95% CI, 0.37 to 0.53; P<0.001). In patients with a blood eosinophil count of less than 300 cells per microliter, the annualized rate was 1.02 (95% CI, 0.84 to 1.23) with tezepelumab and 1.73 (95% CI, 1.46 to 2.05) with placebo (rate ratio, 0.59; 95% CI, 0.46 to 0.75; P<0.001). At week 52, improvements were greater with tezepelumab than with placebo with respect to the prebronchodilator FEV1 (0.23 vs. 0.09 liters; difference, 0.13 liters; 95% CI, 0.08 to 0.18; P<0.001) and scores on the ACQ-6 (-1.55 vs. -1.22; difference, -0.33; 95% CI, -0.46 to -0.20; P<0.001), AQLQ (1.49 vs. 1.15; difference, 0.34; 95% CI, 0.20 to 0.47; P<0.001), and ASD (-0.71 vs. -0.59; difference, -0.12; 95% CI, -0.19 to -0.04; P=0.002). The frequencies and types of adverse events did not differ meaningfully between the two groups. Conclusions Patients with severe, uncontrolled asthma who received tezepelumab had fewer exacerbations and better lung function, asthma control, and health-related quality of life than those who received placebo. (Funded by AstraZeneca and Amgen; NAVIGATOR ClinicalTrials.gov number, .)	[Menzies-Gow, Andrew] Royal Brompton Hosp, Sydney St, London SW3 6NP, England; [Brightling, Christopher E.] Univ Leicester, Natl Inst Hlth Res, Biomed Res Ctr, Leicester, Leics, England; [Ponnarambil, Sandhia] AstraZeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Cambridge, England; [Corren, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kaur, Primal] Amgen Inc, Global Dev, Thousand Oaks, CA USA; [Bourdin, Arnaud] Univ Montpellier, Physiol & Med Expt Coeur & Muscles, CHU Montpellier, INSERM,CNRS, Montpellier, France; [Chupp, Geoffrey] Yale Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New Haven, CT USA; [Israel, Elliot] Harvard Med Sch, Brigham & Womens Hosp, Div Pulm & Crit Care Med & Allergy & Immunol, Boston, MA 02115 USA; [Wechsler, Michael E.] Natl Jewish Hlth, Denver, CO USA; [Griffiths, Janet M.] AstraZeneca, BioPharmaceut R&D, Translat Sci & Expt Med Res & Early Dev Resp & Im, Gaithersburg, MD USA; [Bowen, Karin] AstraZeneca, BioPharmaceut R&D, Biometr, Gaithersburg, MD USA; [Colice, Gene] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Gaithersburg, MD USA; [Hellqvist, Asa] AstraZeneca, BioPharmaceut R&D, Biometr, Gothenburg, Sweden; [Almqvist, Gun] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Gothenburg, Sweden	Royal Brompton Hospital; University of Leicester; AstraZeneca; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Amgen; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Jewish Health; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Menzies-Gow, A (corresponding author), Royal Brompton Hosp, Sydney St, London SW3 6NP, England.	a.menzies-gow@rbht.nhs.uk		brightling, chris/0000-0002-9345-4903				Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; American Thoracic Society, ASTHM CONTR QUEST; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Bleecker ER, 2016, LANCET, V388, P2115, DOI 10.1016/S0140-6736(16)31324-1; Carr TF, 2018, AM J RESP CRIT CARE, V197, P22, DOI 10.1164/rccm.201611-2232PP; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Chen S, 2018, CURR MED RES OPIN, V34, P2075, DOI 10.1080/03007995.2018.1505352; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; ClinicalTrials.gov, EV DUP PAT PERS ASTH; Corren J, 2020, ANN ALLERG ASTHMA IM, V125, pS5; Corren J, 2019, J ALLERGY CLIN IMMUN, V199, pA2621; Corren J, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.congress-2020.2269; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]; Gauvreau GM, 2020, EXPERT OPIN THER TAR, V24, P777, DOI 10.1080/14728222.2020.1783242; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Global Initiative for Asthma, 2020, 2020 GINA MAIN REP G 2020 GINA MAIN REP G; Globe G, 2016, J ALLERGY CLIN IMMUN, V4; Globe G, 2019, J PATIENT-REP OUTCOM, V3, DOI 10.1186/s41687-019-0109-2; Globe G, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0217-5; Hinks TSC, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.00528-2020; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Liang Y, 2019, J ALLERGY CLIN IMMUN, V144; Liu S, 2018, J ALLERGY CLIN IMMUN, V141; Ly N, 2021, J CLIN PHARMACOL, V61, P901, DOI 10.1002/jcph.1803; Menzies-Gow A, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01526-6; Ortega HG, 2016, LANCET RESP MED, V4, P549, DOI 10.1016/S2213-2600(16)30031-5; PHAM T, 2019, AM J RESP CRIT CARE, V199; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tanaka J, 2009, CLIN EXP ALLERGY, V39, P89, DOI 10.1111/j.1365-2222.2008.03151.x; Tepper RS, 2012, J ALLERGY CLIN IMMUN, V129, pS65, DOI 10.1016/j.jaci.2011.12.986	35	134	135	10	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					1800	1809		10.1056/NEJMoa2034975	http://dx.doi.org/10.1056/NEJMoa2034975			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD6UF	33979488	Green Submitted, Bronze			2022-12-28	WOS:000651509400008
J	Kulkarni, K; Asif, A; Dias, J				Kulkarni, Kunal; Asif, Aqua; Dias, Joseph			Wrist pain that should not be missed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCAPHOID FRACTURES; MANAGEMENT; WAIST; COST		[Kulkarni, Kunal; Asif, Aqua; Dias, Joseph] Univ Hosp Leicester NHS Trust, AToMS Acad Team Musculoskeletal Surg, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester	Kulkarni, K (corresponding author), Univ Hosp Leicester NHS Trust, AToMS Acad Team Musculoskeletal Surg, Leicester, Leics, England.	kunalkulkarni@doctors.org.uk	Kulkarni, Kunal/GYI-9096-2022; Asif, Aqua/GQB-5625-2022; Asif, Aqua/ABH-3414-2021	Kulkarni, Kunal/0000-0002-9405-0273; Asif, Aqua/0000-0003-3233-7428; Asif, Aqua/0000-0003-3233-7428				CLAY NR, 1991, J BONE JOINT SURG BR, V73, P828, DOI 10.1302/0301-620X.73B5.1894676; DIAS JJ, 1990, J BONE JOINT SURG BR, V72, P98, DOI 10.1302/0301-620X.72B1.2298805; Dias JJ, 2020, LANCET, V396, P390, DOI 10.1016/S0140-6736(20)30931-4; Duckworth AD, 2012, J BONE JOINT SURG BR, V94B, P961, DOI 10.1302/0301-620X.94B7.28704; Grewal R, 2013, J HAND SURG-AM, V38A, P872, DOI 10.1016/j.jhsa.2013.01.032; Harrison W, 2015, EUR J EMERG MED, V22, P142, DOI 10.1097/MEJ.0000000000000152; National Institute for Health and Care Excellence, 2016, FRACT NONC ASS MAN; Rua T, 2019, BONE JOINT J, V101B, P984, DOI 10.1302/0301-620X.101B8.BJJ-2018-1590.R1; Singh HP, 2012, INJURY, V43, P933, DOI 10.1016/j.injury.2012.02.012; VENDER MI, 1987, J HAND SURG-AM, V12A, P514, DOI 10.1016/S0363-5023(87)80198-3	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1067	10.1136/bmj.n1067	http://dx.doi.org/10.1136/bmj.n1067			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2ZO	33980541				2022-12-28	WOS:000651243600002
J	Nabavi, N				Nabavi, Nikki			Screening for ovarian cancer is ruled out after trial found it did not reduce deaths	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															NIHR Health Technology Assessment Programme; Cancer Research UK; Eve Appeal	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Eve Appeal	The UKCTOCS trial was funded by the NIHR Health Technology Assessment Programme and the charities Cancer Research UK and the Eve Appeal.	Menon U, 2021, LANCET, V397, P2182, DOI 10.1016/S0140-6736(21)00731-5	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2021	373								n1223	10.1136/bmj.n1223	http://dx.doi.org/10.1136/bmj.n1223			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9GP	33980585				2022-12-28	WOS:000653055200002
J	Chapman, MS; Ranzoni, AM; Myers, B; Williams, N; Coorens, THH; Mitchell, E; Butler, T; Dawson, KJ; Hooks, Y; Moore, L; Nangalia, J; Robinson, PS; Yoshida, K; Hook, E; Campbell, PJ; Cvejic, A				Spencer Chapman, Michael; Ranzoni, Anna Maria; Myers, Brynelle; Williams, Nicholas; Coorens, Tim H. H.; Mitchell, Emily; Butler, Timothy; Dawson, Kevin J.; Hooks, Yvette; Moore, Luiza; Nangalia, Jyoti; Robinson, Philip S.; Yoshida, Kenichi; Hook, Elizabeth; Campbell, Peter J.; Cvejic, Ana			Lineage tracing of human development through somatic mutations	NATURE			English	Article							STEM-CELLS; YOLK-SAC; MOUSE; DIFFERENTIATION; HEMATOPOIESIS; COMMITMENT; MESODERM	The ontogeny of the human haematopoietic system during fetal development has previously been characterized mainly through careful microscopic observations(1). Here we reconstruct a phylogenetic tree of blood development using whole-genome sequencing of 511 single-cell-derived haematopoietic colonies from healthy human fetuses at 8 and 18 weeks after conception, coupled with deep targeted sequencing of tissues of known embryonic origin. We found that, in healthy fetuses, individual haematopoietic progenitors acquire tens of somatic mutations by 18 weeks after conception. We used these mutations as barcodes and timed the divergence of embryonic and extra-embryonic tissues during development, and estimated the number of blood antecedents at different stages of embryonic development. Our data support a hypoblast origin of the extra-embryonic mesoderm and primitive blood in humans.	[Spencer Chapman, Michael; Ranzoni, Anna Maria; Myers, Brynelle; Williams, Nicholas; Coorens, Tim H. H.; Mitchell, Emily; Butler, Timothy; Dawson, Kevin J.; Hooks, Yvette; Moore, Luiza; Nangalia, Jyoti; Robinson, Philip S.; Yoshida, Kenichi; Campbell, Peter J.; Cvejic, Ana] Wellcome Trust Sanger Inst, Hinxton, England; [Spencer Chapman, Michael] Imperial Coll Healthcare NHS Trust, Dept Haematol, Hammersmith Hosp, London, England; [Spencer Chapman, Michael; Mitchell, Emily] Cambridge Univ Hosp NHS Fdn Trust, Dept Haematol, Cambridge, England; [Ranzoni, Anna Maria; Myers, Brynelle; Mitchell, Emily; Nangalia, Jyoti; Campbell, Peter J.; Cvejic, Ana] Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge, England; [Ranzoni, Anna Maria; Myers, Brynelle; Nangalia, Jyoti; Cvejic, Ana] Univ Cambridge, Dept Haematol, Cambridge, England; [Moore, Luiza; Hook, Elizabeth] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England; [Robinson, Philip S.] Univ Cambridge, Dept Paediat, Cambridge, England	Wellcome Trust Sanger Institute; Imperial College London; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Campbell, PJ; Cvejic, A (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.; Campbell, PJ; Cvejic, A (corresponding author), Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge, England.; Cvejic, A (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.	pc8@sanger.ac.uk; as889@cam.ac.uk		Coorens, Tim/0000-0002-5826-3554; Butler, Timothy/0000-0001-5803-1035; Spencer Chapman, Michael/0000-0002-5320-8193; Williams, Nicholas/0000-0003-3989-9167; Ranzoni, Anna Maria/0000-0002-2573-1382; Moore, Luiza/0000-0001-5315-516X	European Research Council [677501]; EMBO Young Investigator Award; Wellcome Trust; MRC [203151/Z/16/Z]; Wellcome Clinical PhD Fellowship	European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Clinical PhD Fellowship	The study was supported by European Research Council project 677501 - ZF_Blood (to A.C. and A.M.R.), an EMBO Young Investigator Award (to A.C.) and core support grants from the Wellcome Trust to the Wellcome Sanger Institute and both Wellcome and the MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute (203151/Z/16/Z). M.S.C. was supported by a Wellcome Clinical PhD Fellowship. We thank the Wellcome Sanger Institute (WSI) Cytometry Core Facility for their help with single-cell index sorting; the WSI DNA pipelines for their contribution to sequencing the data; the WSI Cancer, Ageing and Somatic Mutation programme IT and sample teams for their bioinformatic and logistical support; J. Eliasova (scientific illustrator, WSI) for her support and help with the illustrations; and the Human Developmental Biology Resource (HDBR) for providing samples.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Barcena A, 2011, TRANSFUSION, V51, p94S, DOI 10.1111/j.1537-2995.2011.03372.x; Baron CS, 2019, NAT REV MOL CELL BIO, V20, P753, DOI 10.1038/s41580-019-0186-3; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Charbord P, 1996, BLOOD, V87, P4109, DOI 10.1182/blood.V87.10.4109.bloodjournal87104109; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Coorens THH, 2019, SCIENCE, V366, P1247, DOI 10.1126/science.aax1323; Hoang DT, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1131-3; Don PK, 2013, P NATL ACAD SCI USA, V110, P14699, DOI 10.1073/pnas.1221792110; Ellis P, 2021, NAT PROTOC, V16, P841, DOI 10.1038/s41596-020-00437-6; ENDERS AC, 1988, AM J ANAT, V181, P327, DOI 10.1002/aja.1001810402; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Ivanovs A, 2017, DEVELOPMENT, V144, P2323, DOI 10.1242/dev.134866; Jones D., 2016, CURR PROTOC BIOINFOR, V56, p15.10.1, DOI 10.1002/cpbi.20; Ju YS, 2017, NATURE, V543, P714, DOI 10.1038/nature21703; Kelemen E., 1979, ATLAS HUMAN HEMOPOIE; Lee-Six H, 2018, NATURE, V561, P473, DOI 10.1038/s41586-018-0497-0; LUCKETT WP, 1978, AM J ANAT, V152, P59, DOI 10.1002/aja.1001520106; Mole MA, 2020, CURR TOP DEV BIOL, V136, P113, DOI 10.1016/bs.ctdb.2019.10.002; OpenStax, 2016, ANATOMY PHYSL; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Raine Keiran M, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi1507s52; Rossant J, 2017, CELL STEM CELL, V20, P18, DOI 10.1016/j.stem.2016.12.004; Schulz KN, 2019, NAT REV GENET, V20, P221, DOI 10.1038/s41576-018-0087-x; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Silver L, 1997, BLOOD, V89, P1154, DOI 10.1182/blood.V89.4.1154; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Wu JY, 2018, NATURE, V557, P256, DOI 10.1038/s41586-018-0080-8; Xiang LF, 2020, NATURE, V577, P537, DOI 10.1038/s41586-019-1875-y; Ye AY, 2018, GENOME RES, V28, P943, DOI 10.1101/gr.230003.117; Yoshida K, 2020, NATURE, V578, P266, DOI 10.1038/s41586-020-1961-1	33	32	32	0	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 1	2021	595	7865					85	+		10.1038/s41586-021-03548-6	http://dx.doi.org/10.1038/s41586-021-03548-6		MAY 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC5EM	33981037				2022-12-28	WOS:000650200300002
J	Guo, JC; Smith, SM				Guo, Jingchuan; Smith, Steven M.			Newer drug treatments for type 2 diabetes Guidance developed in partnership with patients recommends a risk based approach	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RECEPTOR AGONISTS		[Guo, Jingchuan; Smith, Steven M.] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL 32611 USA; [Smith, Steven M.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Smith, SM (corresponding author), Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL 32611 USA.; Smith, SM (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA.	ssmith@cop.ufl.edu						Alicic RZ, 2017, CLIN J AM SOC NEPHRO, V12, P2032, DOI 10.2215/CJN.11491116; Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS111, DOI 10.2337/dc21-S009; Cosentino F., 2020, EUR HEART J, V41, P255, DOI [10.1093/eurheartj/ehz486, DOI 10.1093/eurheartj/ehz486]; Das SR, 2020, J AM COLL CARDIOL, V76, P1117, DOI 10.1016/j.jacc.2020.05.037; Dave CV, 2020, DIABETES CARE, V43, P921, DOI 10.2337/dc19-1943; Einarson TR, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0728-6; International Diabetes Federation, 2019, IDF DIAB ALT; Jia WP, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3158; Kristensen SL, 2019, LANCET DIABETES ENDO, V7, P776, DOI 10.1016/S2213-8587(19)30249-9; Lee K, 2009, GLOB INST, P1; Li SY, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1091; Marx N, 2021, LANCET DIABETES ENDO, V9, P46, DOI 10.1016/S2213-8587(20)30343-0; McGuire DK, 2021, JAMA CARDIOL, V6, P148, DOI 10.1001/jamacardio.2020.4511; Rangaswami J, 2020, CIRCULATION, V142, pE265, DOI 10.1161/CIR.0000000000000920; Schernthaner G, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01154-w; The National Institute for Health and Care Excellence (NICE), 2020, ABD AORT AN DIAGN MA; Vaduganathan M, 2019, J AM COLL CARDIOL, V73, P1596, DOI 10.1016/j.jacc.2019.01.029	17	1	1	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1171	10.1136/bmj.n1171	http://dx.doi.org/10.1136/bmj.n1171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975861				2022-12-28	WOS:000649711400001
J	Harris, KM; Woolf, SH; Gaskin, DJ				Harris, Kathleen Mullan; Woolf, Steven H.; Gaskin, Darrell J.			High and Rising Working-Age Mortality in the US A Report From the National Academy of Sciences, Engineering, and Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; OBESITY; RATES	This Viewpoint summarizes a 2021 report from the National Academy of Sciences, Engineering, and Medicine (NASEM) that details declining life expectancy among working-age adults in the US from drug and alcohol use, suicide, and cardiometabolic diseases, mortality disparities by race/ethnicity, socioeconomic status, and geography, and implications for health policy.	[Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC 27515 USA; [Harris, Kathleen Mullan] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [Woolf, Steven H.] Virginia Commonwealth Univ, Sch Med, Dept Family Med & Populat Hlth, Richmond, VA USA; [Woolf, Steven H.] Virginia Commonwealth Univ, Ctr Soc & Hlth, Richmond, VA USA; [Gaskin, Darrell J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Gaskin, Darrell J.] Johns Hopkins Univ, Ctr Hlth Dispar Solut, Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Virginia Commonwealth University; Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Harris, KM (corresponding author), Carolina Populat Ctr, 123 W Franklin St, Chapel Hill, NC 27516 USA.	kathie_harris@unc.edu						Harris KM., 2021, HIGH RISING MORTALIT; Kerr WC, 2017, AM J PREV MED, V52, P469, DOI 10.1016/j.amepre.2016.09.021; Masters RK, 2013, AM J PUBLIC HEALTH, V103, P1895, DOI 10.2105/AJPH.2013.301379; Monnat S.M., 2020, RURAL FAMILIES COMMU; Preston SH, 2018, P NATL ACAD SCI USA, V115, P957, DOI 10.1073/pnas.1716802115; Rossen LM, 2020, MMWR-MORBID MORTAL W, V69, P1522, DOI [10.1101/2020.06.06.20120857v1.full.pdf, 10.15585/mmwr.mm6942e2]; Williams DR, 2019, ANNU REV PUBL HEALTH, V40, P105, DOI 10.1146/annurev-publhealth-040218-043750; Woolf SH, 2019, JAMA-J AM MED ASSOC, V322, P1996, DOI 10.1001/jama.2019.16932	8	11	11	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2045	2046		10.1001/jama.2021.4073	http://dx.doi.org/10.1001/jama.2021.4073		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	33970196				2022-12-28	WOS:000650215500001
J	Almecija, S; Hammond, AS; Thompson, NE; Pugh, KD; Moya-Sola, S; Alba, DM				Almecija, Sergio; Hammond, Ashley S.; Thompson, Nathan E.; Pugh, Kelsey D.; Moya-Sola, Salvador; Alba, David M.			Fossil apes and human evolution	SCIENCE			English	Review							MIOCENE GREAT APE; HUMAN BIPEDALISM; SKULL MATERIAL; AFRICAN APES; HOMINID; ORIGINS; HOMINOIDS; PRIMATES; LOCOMOTION; CHIMPANZEE	Humans diverged from apes (chimpanzees, specifically) toward the end of the Miocene similar to 9.3 million to 6.5 million years ago. Understanding the origins of the human lineage (hominins) requires reconstructing the morphology, behavior, and environment of the chimpanzee-human last common ancestor. Modern hominoids (that is, humans and apes) share multiple features (for example, an orthograde body plan facilitating upright positional behaviors). However, the fossil record indicates that living hominoids constitute narrow representatives of an ancient radiation of more widely distributed, diverse species, none of which exhibit the entire suite of locomotor adaptations present in the extant relatives. Hence, some modern ape similarities might have evolved in parallel in response to similar selection pressures. Current evidence suggests that hominins originated in Africa from Miocene ape ancestors unlike any living species.	[Almecija, Sergio; Hammond, Ashley S.; Pugh, Kelsey D.] Amer Museum Nat Hist AMNH, Div Anthropol, New York, NY 10024 USA; [Almecija, Sergio; Hammond, Ashley S.; Pugh, Kelsey D.] New York Consortium Evolutionary Primatol AMNH, New York, NY 10024 USA; [Almecija, Sergio; Moya-Sola, Salvador; Alba, David M.] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont ICP, Barcelona 08193, Spain; [Thompson, Nathan E.] Coll Osteopath Med, Dept Anat, New York Inst Technol NYIT, Old Westbury, NY 11568 USA; [Moya-Sola, Salvador] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona 08010, Spain; [Moya-Sola, Salvador] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol Biol, Barcelona 08193, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); New York Institute Technology; ICREA; Autonomous University of Barcelona	Almecija, S (corresponding author), Amer Museum Nat Hist AMNH, Div Anthropol, New York, NY 10024 USA.; Almecija, S (corresponding author), New York Consortium Evolutionary Primatol AMNH, New York, NY 10024 USA.; Almecija, S (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont ICP, Barcelona 08193, Spain.	salmecija@amnh.org	Alba, David/G-9716-2015	Alba, David/0000-0002-8886-5580; Pugh, Kelsey/0000-0001-8029-0623; Almecija, Sergio/0000-0003-1373-1497	Agencia Estatal de Investigacion (AEI/FEDER EU) [CGL2016-76431-P, CGL2017-82654-P]; Generalitat de Catalunya (CERCA Programme); Generalitat de Catalunya [2017 SGR 86, 2017 SGR 116 GRC]	Agencia Estatal de Investigacion (AEI/FEDER EU); Generalitat de Catalunya (CERCA Programme); Generalitat de Catalunya(Generalitat de Catalunya)	This research has been funded by the Agencia Estatal de Investigacion (CGL2016-76431-P and CGL2017-82654-P, AEI/FEDER EU) and the Generalitat de Catalunya (CERCA Programme and consolidated research groups 2017 SGR 86 and 2017 SGR 116 GRC).	Alba DM, 2015, SCIENCE, V350, DOI 10.1126/science.aab2625; Alba DM, 2012, EVOL ANTHROPOL, V21, P254, DOI 10.1002/evan.21312; Alba DM, 2010, J ANTHROPOL SCI, V88, P11; Alba DM, 2003, J HUM EVOL, V44, P225, DOI 10.1016/S0047-2484(02)00207-5; Almecija S., 2017, NERVOUS SYSTEMS NONH, V3, P299; Almecija S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8717; Almecija S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3888; Andrews P., 1976, Gibbon and Siamang, V4, P167; ANDREWS P, 1982, NATURE, V297, P541, DOI 10.1038/297541a0; ANDREWS P, 1987, J HUM EVOL, V16, P101, DOI 10.1016/0047-2484(87)90062-5; Andrews P., 2005, INTERPRETING ESSAYS; Andrews P., 2016, APES VIEW HUMAN EVOL; Andrews P.J., 1987, Bulletin of the British Museum (Natural History) Geology, V41, P383; Andrews P, 2007, FOLIA PRIMATOL, V78, P328, DOI 10.1159/000105148; Andrews P, 2020, FOLIA PRIMATOL, V91, P122, DOI 10.1159/000501557; Barnosky AD, 2017, SCIENCE, V355, DOI 10.1126/science.aah4787; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; Begun DR, 2016, REAL PLANET OF THE APES: A NEW STORY OF HUMAN ORIGINS, P1; Begun DR, 2001, HOM EVOLUT CLIMAT CH, V2, P231; BENEFIT BR, 1995, ANNU REV ANTHROPOL, V24, P237; Bohme M, 2020, NATURE, V586, pE4, DOI 10.1038/s41586-020-2737-3; Bohme M, 2019, NATURE, V575, P489, DOI 10.1038/s41586-019-1731-0; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Cartmill M., 1985, P73; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; Catalano SA, 2015, SYST BIOL, V64, P294, DOI 10.1093/sysbio/syu107; Cerling Thure E., 2010, Science (Washington D C), V328, P1105, DOI 10.1126/science.1185274; Chaimanee Y, 2019, J HUM EVOL, V134, DOI 10.1016/j.jhevol.2019.06.007; CLARK WE, 1964, FOSSIL EVIDENCE HUMA; CONROY GC, 1992, NATURE, V356, P144, DOI 10.1038/356144a0; COPPENS Y, 1994, SCI AM, V270, P88, DOI 10.1038/scientificamerican0594-88; Cote SM, 2004, CR PALEVOL, V3, P323, DOI 10.1016/j.crpv.2004.03.006; Currey JD, 2002, BONES STRUCTURE MECH; Dainton M, 1999, J HUM EVOL, V36, P171, DOI 10.1006/jhev.1998.0265; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; Darwin C., 1859, ORIGIN SPECIES PRESE; Darwin C., 1871, P475; DEBONIS L, 1990, NATURE, V345, P712, DOI 10.1038/345712a0; DELSON E, 1986, J HUM EVOL, V15, P523, DOI 10.1016/S0047-2484(86)80071-9; DELSON E, 1977, J HUM EVOL, V6, P263, DOI 10.1016/S0047-2484(77)80051-1; Demes B, 1998, AM J PHYS ANTHROPOL, V106, P87, DOI 10.1002/(SICI)1096-8644(199805)106:1<87::AID-AJPA6>3.0.CO;2-A; DeSilva J, 2006, J HUM EVOL, V50, P687, DOI 10.1016/j.jhevol.2006.01.008; Dominguez-Rodrigo M, 2014, CURR ANTHROPOL, V55, P59, DOI 10.1086/674530; Dubois E., 1896, J ANTHR I G B IREL, V25, P240, DOI DOI 10.2307/2842246; Erikson G. E., 1963, P135; Fer I, 2017, PALAEOGEOGR PALAEOCL, V467, P120, DOI 10.1016/j.palaeo.2016.04.007; Fleagle J.G., 1981, Symposia of the Zoological Society of London, P359; Fuss J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177127; Gebo DL, 1997, SCIENCE, V276, P401, DOI 10.1126/science.276.5311.401; Goloboff PA, 2018, PALAEONTOLOGY, V61, P625, DOI 10.1111/pala.12353; GOODALL J, 1964, NATURE, V201, P1264, DOI 10.1038/2011264a0; GOODMAN M, 1962, ANN NY ACAD SCI, V102, P219, DOI 10.1111/j.1749-6632.1962.tb13641.x; GOODMAN M, 1983, NATURE, V303, P546, DOI 10.1038/303546a0; GOODMAN M, 1990, J MOL EVOL, V30, P260, DOI 10.1007/BF02099995; Gregory WK, 1927, Q REV BIOL, V2, P549, DOI 10.1086/394289; Haeckel E, 1868, NATURLICHE SCHOPFUNG; Hammond AS, 2020, P NATL ACAD SCI USA, V117, P278, DOI 10.1073/pnas.1911896116; Hammond AS, 2017, ANAT REC, V300, P828, DOI 10.1002/ar.23545; Hammond AS, 2016, AM J PHYS ANTHROPOL, V160, P529, DOI 10.1002/ajpa.22990; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Harrison T, 2010, SCIENCE, V327, P532, DOI 10.1126/science.1184703; Hennig W., 1966, P263; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; HUNT KD, 1994, J HUM EVOL, V26, P183, DOI 10.1006/jhev.1994.1011; Hunt KD, 2016, J ANAT, V228, P630, DOI 10.1111/joa.12454; Huxley T., 1863, EVIDENCE MANS PLACE; INOUYE SE, 1992, J HUM EVOL, V23, P107, DOI 10.1016/0047-2484(92)90103-G; Ishida H., 1984, AFR STUD MONOGR, V2, P73; Jablonski NG, 2000, J HUM EVOL, V39, P131, DOI 10.1006/jhev.2000.0405; JOHANSON DC, 1976, NATURE, V260, P293, DOI 10.1038/260293a0; JR WLS, 1949, Q REV BIOL, V24, P200, DOI DOI 10.1086/397067; Kaya F, 2018, NAT ECOL EVOL, V2, P241, DOI 10.1038/s41559-017-0414-1; Keith A, 1923, Br Med J, V1, P499; Kelley J, 2012, P NATL ACAD SCI USA, V109, P6882, DOI 10.1073/pnas.1201330109; Kivell TL, 2016, J ANAT, V228, P569, DOI 10.1111/joa.12446; Kohler M, 1997, P NATL ACAD SCI USA, V94, P11747, DOI 10.1073/pnas.94.21.11747; Kunimatsu Y, 2007, P NATL ACAD SCI USA, V104, P19220, DOI 10.1073/pnas.0706190104; Landau Marie, 1993, NARRATIVES HUMAN EVO; LANYON LE, 1992, BONE, V13, pS17, DOI 10.1016/8756-3282(92)90191-X; Larson SG, 1998, EVOL ANTHROPOL, V6, P87, DOI 10.1002/(SICI)1520-6505(1998)6:3<87::AID-EVAN3>3.0.CO;2-T; Lartet E., 1856, CR HEBD ACAD SCI, V43, P219; LEAKEY LSB, 1970, P NATL ACAD SCI USA, V67, P746, DOI 10.1073/pnas.67.2.746; LEAKEY LSB, 1967, NATURE, V213, P155, DOI 10.1038/213155a0; LEAKEY LSB, 1959, NATURE, V184, P491, DOI 10.1038/184491a0; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; Lewis GE, 1934, AM J SCI, V27, P161; Linnaeus C, 1758, SYSTEMA NATURAE REGN, V1, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; Maclatchy L, 2004, EVOL ANTHROPOL, V13, P90, DOI 10.1002/evan.10133; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Maslin MA, 2014, QUATERNARY SCI REV, V101, P1, DOI 10.1016/j.quascirev.2014.06.012; McBrearty S, 2005, NATURE, V437, P105, DOI 10.1038/nature04008; McNulty Kieran P., 2010, Evolution Education and Outreach, V3, P322; McNutt EJ, 2018, EVOL ANTHROPOL, V27, P197, DOI 10.1002/evan.21713; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; MIYAMOTO MM, 1987, SCIENCE, V238, P369, DOI 10.1126/science.3116671; Moorjani P, 2016, P NATL ACAD SCI USA, V113, P10607, DOI 10.1073/pnas.1600374113; Morton DJ, 1926, J MORPHOL PHYSIOL, V43, P147, DOI 10.1002/jmor.1050430108; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Moya-Sola S., AM J PHYS ANTHR, V139, P126; MoyaSola S, 1996, NATURE, V379, P156, DOI 10.1038/379156a0; Nakatsukasa M, 2016, DEV PRIMATOL-PROG PR, P485, DOI 10.1007/978-1-4939-3646-5_17; Nakatsukasa M, 2009, EVOL ANTHROPOL, V18, P103, DOI 10.1002/evan.20208; Nengo I, 2017, NATURE, V548, P169, DOI 10.1038/nature23456; Nyakatura JA, 2019, NATURE, V565, P351, DOI 10.1038/s41586-018-0851-2; Osborn HF, 1930, SCIENCE, V71, P1, DOI 10.1126/science.71.1827.1; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; Pickford M, 2005, ANTHROPOL SCI, V113, P95, DOI 10.1537/ase.04S014; Pickford M, 2002, C R PALEVOL, V1, P191, DOI 10.1016/S1631-0683(02)00028-3; Pickford Martin, 2006, Beitraege zur Palaeontologie, V30, P361; Pickford M, 2009, CR PALEVOL, V8, P413, DOI 10.1016/j.crpv.2008.11.003; Pilbeam D, 2004, CR PALEVOL, V3, P305, DOI 10.1016/j.crpv.2004.01.006; Pilbeam D, 1996, MOL PHYLOGENET EVOL, V5, P155, DOI 10.1006/mpev.1996.0010; PILBEAM D, 1982, NATURE, V295, P232, DOI 10.1038/295232a0; PILBEAM D, 1990, NATURE, V348, P237, DOI 10.1038/348237a0; Pilbeam D. R., 2017, CHIMPANZEES HUMAN EV, P22; PLAVCAN JM, 1995, J HUM EVOL, V28, P245, DOI 10.1006/jhev.1995.1019; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Potts R, 2004, AM J PRIMATOL, V62, P209, DOI 10.1002/ajp.20016; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Pugh KD, 2020, THESIS CITY U NY; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; Rose M.D., 1991, P37; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Saers JPP, 2016, J HUM EVOL, V97, P97, DOI 10.1016/j.jhevol.2016.05.012; SARICH VM, 1967, SCIENCE, V158, P1200, DOI 10.1126/science.158.3805.1200; SCHULTZ A. H., 1930, HUMAN BIOL, V2, P303; Schultz AH, 1936, Q REV BIOL, V11, P259, DOI 10.1086/394508; Sellers WI, 2014, BIOL OPEN, V3, P656, DOI 10.1242/bio.20148086; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Senut B, 1997, CR ACAD SCI II A, V325, P741, DOI 10.1016/S1251-8050(97)89119-7; SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980; SIMONS EL, 1965, FOLIA PRIMATOL, V3, P81, DOI 10.1159/000155026; SIMONS ELWYN L., 1961, POSTILLA [YALE PEABODY MUS], V57, P1; Smith GE., 1924, EVOLUTION MAN ESSAYS; Smith RJ, 2016, EVOL ANTHROPOL, V25, P276, DOI 10.1002/evan.21495; SOLA SM, 1993, NATURE, V365, P543, DOI 10.1038/365543a0; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Stern J., 1975, YEARB PHYS ANTHROPOL, V19, P59; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Thompson NE, 2017, J HUM EVOL, V110, P18, DOI 10.1016/j.jhevol.2017.05.012; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Tuttle R. H., 1975, PHYLOGENY PRIMATES, P447; van der Valk T, 2021, NATURE, V591, P265, DOI 10.1038/s41586-021-03224-9; Wallace IJ, 2015, BONE, V72, P1, DOI 10.1016/j.bone.2014.11.013; WARD CV, 1993, AM J PHYS ANTHROPOL, V90, P77, DOI 10.1002/ajpa.1330900106; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Washburn S., 1973, YEARB PHYS ANTHROPOL, V17, P67; Washburn S. L., 1967, P ROYAL ANTHR I GREA, V1967, P21; WASHBURN SL, 1960, SCI AM, V203, P63; WEINER J. S., 1953, BULL BRIT MUS [NAT HIST] GEOL, V2, P139; Weinert H, 1932, URSPRUNG MENSCHHEIT; Welker F, 2019, NATURE, V576, P262, DOI 10.1038/s41586-019-1728-8; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Williams BA, 2007, J HUM EVOL, V52, P480, DOI 10.1016/j.jhevol.2006.11.011; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Wood Z, 2019, BONE, V127, P635, DOI 10.1016/j.bone.2019.08.002; Wrangham R, 2001, DEV PRIMATOL-PROG PR, P5; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZIHLMAN AL, 1978, NATURE, V275, P744, DOI 10.1038/275744a0; ZUCKERKANDL E, 1960, P NATL ACAD SCI USA, V46, P1349, DOI 10.1073/pnas.46.10.1349	169	21	21	14	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					587	+	abb4363	10.1126/science.abb4363	http://dx.doi.org/10.1126/science.abb4363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA2AW	33958446	Green Submitted			2022-12-28	WOS:000649103500034
J	Tong, SYC				Tong, Steven Y. C.			Inpatient Notes: Clinical Pearls-Methicillin-Resistant Staphylococcus aureus Bacteremia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								A 35-year-old man presented with worsening lumbar back pain over 10 days. He had a history of active injection drug use. On examination, his temperature was 38.9 degrees C, heart rate was 120 beats/min, blood pressure was 115/65 mm Hg, and respiratory rate was 24 breaths/min. No cardiac murmurs were evident. He exhibited tenderness to palpation in the lumbar region. Neurologic examination was normal. Two sets of blood cultures were obtained, and both isolated gram-positive cocci in clusters. Magnetic resonance imaging showed discitis of the L1 to L2 intervertebral disk and an epidural collection anterior to the theca fromT12 to L2 without compression of the spinal cord. A neurosurgical consultant recommended observation and medical therapy in the absence of neurologic signs or radiologic evidence of spinal cord compression.	[Tong, Steven Y. C.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Tong, Steven Y. C.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia	Royal Melbourne Hospital; University of Melbourne	Tong, SYC (corresponding author), Doherty Inst, 792 Elizabeth St, Melbourne, Vic 3000, Australia.	steven.tong@mh.org.au	Tong, Steven/N-2353-2013	Tong, Steven/0000-0002-1368-8356				Goto M, 2017, JAMA INTERN MED, V177, P1489, DOI 10.1001/jamainternmed.2017.3958; Iversen K, 2019, NEW ENGL J MED, V380, P415, DOI 10.1056/NEJMoa1808312; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Rybak MJ, 2020, CLIN INFECT DIS, V71, P1361, DOI 10.1093/cid/ciaa303; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					HO2	HO3		10.7326/M21-1491	http://dx.doi.org/10.7326/M21-1491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33999686				2022-12-28	WOS:000652604800001
J	Kuehn, BM				Kuehn, Bridget M.			Sexually Transmitted Disease Cases Continue to Break Records	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2040	2040		10.1001/jama.2021.6937	http://dx.doi.org/10.1001/jama.2021.6937			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032822				2022-12-28	WOS:000655647300012
J	O'Dowd, A				O'Dowd, Adrian			Why I ... lunch with the team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2021	373								n1235	10.1136/bmj.n1235	http://dx.doi.org/10.1136/bmj.n1235			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK9UC	34031035	Bronze			2022-12-28	WOS:000656562600005
J	Anderson, M; Pitchforth, E; Asaria, M; Brayne, C; Casadei, B; Charlesworth, A; Coulter, A; Franklin, BD; Donaldson, C; Drummond, M; Dunnell, K; Foster, M; Hussey, R; Johnson, P; Johnston-Webber, C; Knapp, M; Lavery, G; Longley, M; Clark, JM; Majeed, A; McKee, M; Newton, JN; O'Neill, C; Raine, R; Richards, M; Sheikh, A; Smith, P; Street, A; Taylor, D; Watt, RG; Whyte, M; Woods, M; McGuire, A; Mossialos, E				Anderson, Michael; Pitchforth, Emma; Asaria, Miqdad; Brayne, Carol; Casadei, Barbara; Charlesworth, Anita; Coulter, Angela; Franklin, Bryony Dean; Donaldson, Cam; Drummond, Michael; Dunnell, Karen; Foster, Margaret; Hussey, Ruth; Johnson, Paul; Johnston-Webber, Charlotte; Knapp, Martin; Lavery, Gavin; Longley, Marcus; Clark, Jill Macleod; Majeed, Azeem; McKee, Martin; Newton, John N.; O'Neill, Ciaran; Raine, Rosalind; Richards, Mike; Sheikh, Aziz; Smith, Peter; Street, Andrew; Taylor, David; Watt, Richard G.; Whyte, Moira; Woods, Michael; McGuire, Alistair; Mossialos, Elias			LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19	LANCET			English	Review							PUBLIC-HEALTH; QUALITY IMPROVEMENT; ATRIAL-FIBRILLATION; COST-EFFECTIVENESS; INTEGRATED CARE; LIFE EXPECTANCY; SOCIAL CARE; ENGLAND; IMPACT; INEQUALITIES		[Anderson, Michael; Asaria, Miqdad; Johnston-Webber, Charlotte; Knapp, Martin; Richards, Mike; Street, Andrew; Woods, Michael; McGuire, Alistair; Mossialos, Elias] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England; [Pitchforth, Emma] Univ Exeter, Coll Med & Hlth, Exeter, Devon, England; [Brayne, Carol] Univ Cambridge, Cambridge Publ Hlth, Cambridge, England; [Casadei, Barbara] John Radcliffe Hosp, Radcliffe Dept Med, BHF Ctr Res Excellence, NIHR Biomed Res Ctr, Oxford, England; [Coulter, Angela] Univ Oxford, Green Templeton Coll, Oxford, England; [Charlesworth, Anita; Hussey, Ruth; Richards, Mike] Hlth Fdn, London, England; [Charlesworth, Anita] Univ Birmingham, Coll Social Sci, Hlth Serv Management Ctr, Birmingham, W Midlands, England; [Coulter, Angela] Univ Southern Denmark, Dept Reg Hlth Res, Fac Hlth Sci, Odense, Denmark; [Franklin, Bryony Dean; Taylor, David] UCL Sch Pharm, London, England; [Watt, Richard G.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Raine, Rosalind] UCL, Dept Appl Hlth Res, London, England; [Franklin, Bryony Dean] Imperial Coll Healthcare NHSTrust, NIHR Imperial Patient Safety Translat Res Ctr, London, England; [Donaldson, Cam] Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow, Lanark, Scotland; [Drummond, Michael; Smith, Peter] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Foster, Margaret] Natl Hlth Serv Wales Shared Serv Partnership, Cardiff, Wales; [Johnson, Paul] Inst Fiscal Studies, London, England; [Lavery, Gavin] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Longley, Marcus] Univ South Wales, Welsh Inst Hlth & Social Care, Pontypridd, M Glam, Wales; [Clark, Jill Macleod] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Majeed, Azeem] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Smith, Peter] Imperial Coll London, Ctr Hlth Econ & Policy Innovat, London, England; [Mossialos, Elias] Imperial Coll London, Inst Global Hlth Innovat, London, England; [McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Newton, John N.] Publ Hlth England, London, England; [O'Neill, Ciaran] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Sheikh, Aziz] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland; [Whyte, Moira] Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland	University of London; London School Economics & Political Science; University of Exeter; University of Cambridge; University of Oxford; University of Oxford; University of Birmingham; University of Southern Denmark; University of London; University College London; University of London; University College London; University of London; University College London; Glasgow Caledonian University; University of York - UK; University of London; London School Economics & Political Science; University of South Wales; University of Southampton; Imperial College London; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Public Health England; Queens University Belfast; University of Edinburgh; University of Edinburgh	Mossialos, E (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.	e.a.mossialos@lse.ac.uk	Newton, John/HCH-8693-2022; Mossialos, Elias/ABE-1301-2021; Asaria, Miqdad/T-9980-2019	Asaria, Miqdad/0000-0002-3538-4417; Majeed, Azeem/0000-0002-2357-9858; Brayne, Carol/0000-0001-5307-663X; Raine, Rosalind/0000-0003-0904-749X; Watt, Richard/0000-0001-6229-8584; Knapp, Martin/0000-0003-1427-0215; Casadei, Barbara/0000-0002-6801-1617; Newton, John/0000-0002-5641-6457; Smith, Peter/0000-0003-0058-7588	LSE Knowledge and Exchange Impact fund from the Higher Education Innovation Fund	LSE Knowledge and Exchange Impact fund from the Higher Education Innovation Fund	We thank Josephine Lloyd and Jenna Kerns, who both provided administrative and analytical support throughout stages of this Commission. We thank all stakeholders who engaged with this Commission throughout our consultation. We thank Aoife Molloy (NHS England and NHS Improvement, London, UK) for producing panel 8 at the request of this Commission. Funding for the LSE-Lancet Commission on the future of the NHS was granted by the LSE Knowledge and Exchange Impact fund, which was created by use of funding from the Higher Education Innovation Fund. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Abel-Smith B., 1964, HOSPITALS 1800 1948; ABELSMITH B, 1988, MILBANK Q, V66, P694, DOI 10.2307/3349936; Academy of Medical Royal Colleges, 2018, PLEAS WRIT ME WRIT O; Academy of Medical Sciences, 2016, IMPR HLTH PUBL 2040; Adam S., 2019, HIGH ARE OUR TAXES D; Adebowale V, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m568; Airoldi M, 2014, MED DECIS MAKING, V34, P965, DOI 10.1177/0272989X14546376; Alzheimer's Society, 2020, CAR HOM LEFT FEND TH; Anandaciva S, 2018, LEADERSHIP TODAYS NH; Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P317, DOI 10.2471/BLT.07.050112; Anderson C, 2019, RES SOC ADMIN PHARM, V15, P338, DOI 10.1016/j.sapharm.2018.06.001; Anderson M, 2021, LANCET, V397, P1992, DOI 10.1016/S0140-6736(21)00231-2; [Anonymous], **DATA OBJECT**; [Anonymous], 2020, DEATHS INV COVID 19; [Anonymous], 2018, SCOTL DIG HLTH CAR S; [Anonymous], **DATA OBJECT**; [Anonymous], 2019, PUBL EXP STAT AN 201; [Anonymous], 2018, PROP REG EUR PARL CO; [Anonymous], 2019, DIR EFF ILL TAX CHAN; [Anonymous], **DATA OBJECT**; [Anonymous], 2005, PHARM J; [Anonymous], **DATA OBJECT**; [Anonymous], OECD STAT; Appleby J, 2017, ROOT CAUSES QUALITY; Appleby J, 2020, PUBLIC SATISFACTION; Appleby J, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6237; Armiento R, 2018, J PAEDIAT CHILD HLTH, V54, P7; Armstrong N, 2018, SOC SCI MED, V198, P157, DOI 10.1016/j.socscimed.2017.12.033; Armstrong S, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5680; Asaria M, 2016, J EPIDEMIOL COMMUN H, V70, P990, DOI 10.1136/jech-2016-207447; Ashcroft DM, 2015, DRUG SAFETY, V38, P833, DOI 10.1007/s40264-015-0320-x; Association of the British Pharmaceutical Industry, INT COMP UK COMP WOR; ATKINSON AB, 1995, EUR ECON REV, V39, P723, DOI 10.1016/0014-2921(94)00079-F; Atkinson AB, 1999, EC CONSEQUENCES ROLL; Bacon S, 2020, J MED INTERNET RES, V22, DOI 10.2196/15603; Baig MM, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0760-1; Baker M, 2016, BRIT J GEN PRACT, V66, P508, DOI 10.3399/bjgp16X687169; Bakker J., 2020, LIVES RISK DUE 50 DR; Bansal N, 2012, BRIT J CANCER, V106, P1361, DOI 10.1038/bjc.2012.83; Baqir W, 2015, EUR J HOSP PHARM, V22, P79, DOI 10.1136/ejhpharm-2014-000486; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barr B, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3310; Bate A., 2017, NHS COMMISSIONING SP; Bauer A, 2016, DP2913 PSSRU; Bernal JAL, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002427; Bevan G, 2014, 4 HLTH SYSTEMS UK DO; Beveridge W, 2000, B WORLD HEALTH ORGAN, V78, P847; Bidmead E, 2016, DIGIT HEALTH, V2, DOI 10.1177/2055207616668431; Blackburn P., 2017, HLTH COVER UK MARKET; Boffey D, 2020, UK MISS 3 CHANC JOIN; Bonell C, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3827; Bouget D, 2016, WORKLIFE BALANCE MEA; Briggs A., 2020, NHS TEST TRACE JOURN; Brimblecombe N., 2018, UNPAID CARE ENGLAND; Brodersen J, 2018, BMJ EVID-BASED MED, V23, P1, DOI 10.1136/ebmed-2017-110886; Brown RM, 2014, SOC ISS POLICY REV, V8, P74, DOI 10.1111/sipr.12002; Buchan BW, 2014, CLIN MICROBIOL REV, V27, P783, DOI 10.1128/CMR.00003-14; Buckner L., 2015, VALUING CARERS 2015; Burgess M, 2020, WHY NHS COVID 19 CON; Burki T, 2020, LANCET, V395, P1602, DOI 10.1016/S0140-6736(20)31199-5; Butler P., 2020, MILLION VOLUNTEER HE; Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001; Camacho EM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012514; Campbell D., 2020, GPS VERDICT SHIELDIN; Campos PA, 2019, HEALTH SYST REFORM, V5, P224, DOI 10.1080/23288604.2019.1625251; Cancer Research UK, 2020, CANC RES UKS RESP HL; Care Quality Commission, 2014, POND SEA CHILDR TRAN; Carlhed R, 2006, AM HEART J, V152, P1175, DOI 10.1016/j.ahj.2006.07.028; Carter P, 2020, EUR HEART J, V41, P2516, DOI 10.1093/eurheartj/ehaa342; Cashin C., 2017, EARMARKING HLTH THEO; Cassell A, 2018, BRIT J GEN PRACT, V68, pE245, DOI 10.3399/bjgp18X695465; Cattan S., 2019, HLTH EFFECTS SURE ST; Center of Health Economics at the University of York, CCG IN IND; Challen R, 2019, BMJ QUAL SAF, V28, P231, DOI 10.1136/bmjqs-2018-008370; Chang WH, 2013, J STROKE, V15, P174, DOI 10.5853/jos.2013.15.3.174; Charles A., 2017, READ ALL IT MEDIA CO; Charlesworth A, 2021, LANCET, V397, P2012, DOI 10.1016/S0140-6736(21)00230-0; Cockwell P, 2020, LANCET, V395, P662, DOI 10.1016/S0140-6736(19)32977-0; Commission on Funding of Care and Support, 2011, FAIRER CARE FUNDING; Cookson R, 2018, SOC SCI MED, V198, P148, DOI 10.1016/j.socscimed.2018.01.004; Cookson R, 2016, FISC STUD, V37, P371, DOI 10.1111/j.1475-5890.2016.12109; Corbett J, 2017, FUTURE HLTH FINDINGS; Coronini-Cronberg S, 2012, AM J PUBLIC HEALTH, V102, P2141, DOI 10.2105/AJPH.2012.300946; Coulter A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010523.pub2; Courtin E, 2014, HEALTH POLICY, V118, P84, DOI 10.1016/j.healthpol.2014.07.013; Crampton P, 2016, CLIN TEACH, V13, P102, DOI 10.1111/tct.12385; Cresswell K, 2018, J MED INTERNET RES, V20, DOI 10.2196/10410; Crosbie PA, 2019, THORAX, V74, P405, DOI 10.1136/thoraxjnl-2017-211377; Cumberlege J., 2020, 1 NO HARM REPORT IND; Cutler DM, 1998, NBER FR HLTH POL RES, V1, P1; Cylus J, 2020, MAKING EC CASE INVES; Darzi A., 2018, BETTER HLTH CARE ALL; Dayan M, 2018, NHS 70 GOOD IS NHS; de Lusignan S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006021; Department for Business, 2019, GRAND CHALL MISS; Department for Education, 2020, REL ED REL SEX ED RS; Department of Health, 2020, NO IR HLTH SOC CAR H; Department of Health and Social Care, 2018, SOC CAR CHARG LOC AU; Department of Health and Social Care, 2015, NHS CONST ENGL; Department of Health & Social Care, 2015, PUBL HLTH FORM LOC A; Department of Health & Social Care NHS England NHS Improvement Pharmaceutical Services Negotiating Committee, 2019, NHS LONG TERM PLAN; Dergiades T, 2020, EFFECTIVENESS GOVT P; Devakumar D, 2020, LANCET, V395, pE112, DOI 10.1016/S0140-6736(20)31371-4; Devakumar D, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1662; Devins D, 2017, MAXIMISING LOCAL IMP; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Dixon J., 2015, EQUITY PROVISION PAL; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Dixon-Woods Mary, 2016, Future Hosp J, V3, P191, DOI 10.7861/futurehosp.3-3-191; Djuric U, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0022-1; Donaldson C, 2010, QJM-INT J MED, V103, P801, DOI 10.1093/qjmed/hcq086; Donaldson C, 2005, EC HLTH CARE FINANCI, V2nd; Drew DA, 2020, SCIENCE, V368, P1362, DOI 10.1126/science.abc0473; Dreyer K, 2019, DESCRIPTIVE ANAL HLT; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; du Vaure CB, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010119; Dundar U, 2014, TOP STROKE REHABIL, V21, P453, DOI 10.1310/tsr2106-453; Dunkley I, 2019, FRONTLINE GASTROENTE, V10, P24, DOI 10.1136/flgastro-2017-100950; Edwards RT, 2016, J CHILD SERV, V11, P54, DOI 10.1108/JCS-02-2015-0005; El-Yousfi S, 2019, BRIT DENT J, V227, P143, DOI 10.1038/s41415-019-0529-7; Elliot I., 2016, POVERTY MENTAL HLTH; Emilsson L, 2015, J INTERN MED, V277, P94, DOI 10.1111/joim.12303; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; Essen A, 2018, HEALTH POLICY TECHN, V7, P44, DOI 10.1016/j.hlpt.2017.11.003; European Commission, 2019, TASK SHIFT HLTH REP; European Medicines Agency, ADV THER MED PROD OV; European Observatory on Health Systems and Policies, 2014, FACETS PUBLIC HLTH E; Evans RG, 1997, J HEALTH POLIT POLIC, V22, P427, DOI 10.1215/03616878-22-2-427; Evans S., 2018, DATE SET NEW CONTRAC; Fahy N, 2017, LANCET, V390, P2110, DOI 10.1016/S0140-6736(17)31926-8; Fertility Fairness, IVF PROV ENGL; Finch D, 2018, TAKING OUR HLTH GRAN; Flear M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m400; Fonhus MS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012472.pub2; Foster D., 2020, ADULT SOCIAL CARE FU; Fredriksson M, 2017, INT J QUAL HEALTH C, V29, P909, DOI 10.1093/intqhc/mzx132; Gadsby EW, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4122-1; Gann B., 2018, DIGITAL INCLUSION HL; Garrow V., 2016, PRESENTEEISM REV CUR; Germain S, 2020, FEM LEGAL STUD, V28, P301, DOI 10.1007/s10691-020-09437-z; Gilson L, 2016, HEALTH SYST REFORM, V2, P187, DOI 10.1080/23288604.2016.1217367; Godlee F, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2303; Good Things Foundation, 2016, HLTH DIG EV WID DIG; Gorsky M, 2014, J PUBLIC HEALTH-UK, V36, P546, DOI 10.1093/pubmed/fdt131; Gorsky M, 2008, SOC HIST MED, V21, P437, DOI 10.1093/shm/hkn064; Government Statistical Service, HLTH CAR STAT LANDSC; Government Statistical Service, ENGL HLTH STAT STEER; Gower M., 2020, CORONAVIRUS CALLS EA; GP Patient Survey, SEE YOUR GP PRACT IS; Graham-Clarke E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196471; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Greer SL, 2016, BRIT MED BULL, V118, P17, DOI 10.1093/bmb/ldw013; Greer SL, 2004, TERRITORIAL POLITICS; Guets W, 2020, PHARMACOECONOMICS, V38, P341, DOI 10.1007/s40273-019-00874-6; Gurung B, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1738-9; Ham C., 2009, HLTH POLICY BRITAIN, V6th; Hanson S, 2019, SOC SCI MED, V220, P150, DOI 10.1016/j.socscimed.2018.11.009; Hartmann-Boyce J, 2020, SUPPORTING PEOPLE LO; Health and Social Care Northern Ireland, HLTH SOC CAR TRUSTS; Health and Social Care Northern Ireland, NI EL CAR REC; Health Data Research UK, 2019, DIG INN HUB PROSP; Health Education England, 2018, COMMUNITY PHARM WORK; Health Quality Improvement Partnership, A Z NAT CLIN AUD; Higgins V, 2016, ENVIRON PLANN A, V48, P1133, DOI 10.1177/0308518X16633471; Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4; Horton R, 2020, LANCET, V395, P1022, DOI 10.1016/S0140-6736(20)30727-3; House of Lords Select Committee on the Long-term Sustainability of the NHS, 2017, REP SESS 2016 17 LON; Hudson B, 2019, POLICY DES PRACT, V2, P1, DOI 10.1080/25741292.2018.1540378; Humphries R, 2015, HEALTH POLICY, V119, P856, DOI 10.1016/j.healthpol.2015.04.010; Huntley AL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010933; Hupe PL, 2016, PUBLIC POLICY ADMIN, V31, P103, DOI 10.1177/0952076715598828; Hutchinson CV, 2005, CLIN LAB HAEMATOL, V27, P357, DOI 10.1111/j.1365-2257.2005.00727.x; Ilyas A, 2017, BRIT J PSYCHIAT, V211, P194, DOI 10.1192/bjp.bp.117.203240; Improvement National Health Service, 2018, DEV PAT SAF INC MAN; Institute of Medicine, 1994, WORK DEF HLTH SERV R; Jackson B. D. J., 2011, WHAT IS INNOVATION E; James K Lynette, 2013, Int J Pharm Pract, V21, P92, DOI 10.1111/j.2042-7174.2012.00238.x; Johnston MC, 2019, EUR J PUBLIC HEALTH, V29, P182, DOI 10.1093/eurpub/cky098; Joint Royal Colleges of Training Board, 2017, SHAP TRAIN PHYS TRAI; Jones Molly Morgan, 2017, Rand Health Q, V6, P13; Joyce R, 2019, INEQUALITIES TWENTYF; Kamal R, 2020, DOES HLTH SPENDING U; Kingston A, 2018, AGE AGEING, V47, P374, DOI 10.1093/ageing/afx201; Kirkup B., 2020, LIFE DEATH E DIXON C; Klein R, 1985, Health Aff (Millwood), V4, P41, DOI 10.1377/hlthaff.4.1.41; Klein R, 2013, IN THEIR OWN WORDS: A JOURNEY TO THE STEWARDSHIP OF THE PRACTICE IN EDUCATION, P75; Knapp M., SHOULD WE PAY SOCIAL; Knapp M, 2017, WRITTEN EVIDENCE SUB; Knapp M., 2011, MENTAL HLTH PROMOTIO; Knapp M, 2013, WORLD PSYCHIATRY, V12, P60, DOI 10.1002/wps.20017; Latter S, 2012, J HEALTH SERV RES PO, V17, P149, DOI 10.1258/jhsrp.2012.011090; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Laurant M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub3; Lavigne Maxime, 2019, Healthc Manage Forum, V32, P173, DOI 10.1177/0840470419848428; Lee T, 2018, SECURING FUTURE FUND; Lewis M, 2015, LONDON J PRIM CARE, V7, P49, DOI 10.1080/17571472.2015.11494377; Limb M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2982; Lincoln P, 2019, RETURN INVESTMENT CA; Lintern S., 2020, CORONAVIRUS TESTING; Local Government Association, 2020, COMMUNICATION 0327; Lopes MA, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0028-0; Lordan G, 2018, HLTH MINDS INTERIM P; Luigetti R., 2016, WHO DRUG INFORM, V30, P558; Lynn LA, 2019, PATIENT SAF SURG, V13, DOI 10.1186/s13037-019-0188-2; MACK SO, 1988, BIOL REPROD, V38, P270, DOI 10.1095/biolreprod38.2.270; MacMahon SC., 2018, MULTIMORBIDITY PRIOR; Malhotra A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2308; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; Marmot M, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.2.31; Marshall L, 2014, NHS PAYMENT SYSTEM E; Marshall M, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1195; Martin S, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036411; Mason Anne, 2005, Eur J Health Econ, VSuppl, P18; Masters R, 2017, J EPIDEMIOL COMMUN H, V71, P827, DOI 10.1136/jech-2016-208141; McKee M, 2021, LANCET, V397, P1979, DOI 10.1016/S0140-6736(21)00229-4; McKee M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2052; McKee M, 2019, EUR J PUBLIC HEALTH, V29, P3, DOI 10.1093/eurpub/ckz160; McKee M, 2011, LANCET, V378, P536, DOI 10.1016/S0140-6736(11)60241-9; McKenna H., 2017, TERENCE MCKENNA HALL; Medical Schools Council, 2018, SURVEY MED CLIN ACAD; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Miani Celine, 2015, Rand Health Q, V5, P2; Millard C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6821; Minchole A, 2019, NAT MED, V25, P22, DOI 10.1038/s41591-018-0306-1; Mitton C, 2009, PRIORITY SETTING TOO; Monbiot G., 2020, GOVT SECRETIVE COVID; Mossialos E, 2000, BMJ-BRIT MED J, V320, P197, DOI 10.1136/bmj.320.7229.197; Mountford J, 2012, BMJ QUAL SAF, V21, P519, DOI 10.1136/bmjqs-2012-000859; Muir D., 2017, NEGLECT MENTAL HLTH; Naik G, 2012, BRIT J GEN PRACT, V62, P213, DOI 10.3399/bjgp12X636236; National Audit Office, 2014, MAKING EARMARKED FUN; National Health Service, 2019, PERF NHS PROV SECT Y; National Health Service, EV BAS INT PROGR; National Health Service, 2020, DEL NET ZER NAT HLTH; National Health Service Business Services Authority, NHS PAYM DENT 2018 2; National Health Service Business Services Authority, CAT PUBL INS PORT; National Health Service Confederation, 2020, GETTING NHS BACK TRA; National Health Service Digital, 2021, NHS VACANCY STAT ENG; National Health Service Digital, 2020, APP GEN PRACT REP; National Health Service Digital, SNOMED CT; National Health Service Digital, 2016, MENTAL HLTH WELLBEIN; National Health Service Digital, 2020, GEN PRACT WORKF; National Health Service Digital, SAF HAV DIR; National Health Service Digital, 2020, NHS WORKF STAT JAN 2; National Health Service England, 2020, STAND OP PROC SOP GE; National Health Service England, 2019, STAND GEN MED SERV C; National Health Service England, 2020, 1000 FORM NHS STAFF; National Health Service England, 2020, IMP ACT 2 PHAS NHS R; National Health Service England, 2020, CLIN GUID MAN ESS CA; National Health Service England, CONS LED REF TREATM; National Health Service England, OP API POL; National Health Service England, IN UNPLN HOSP CHRON; National Health Service England, 2021, GET FREE PCR TEST CH; National Health Service England, 2020, NHS WORKF RAC EQ STN; National Health Service England, 2019, 5 YEAR FRAM GP CONTR; National Health Service England, 2019, INT NHS PEOPL PLAN; National Health Service England, 2020, A E ATT EM ADM; National Health Service England, 2019, PRIM CAR NETW BRIEF; National Health Service England, 2020, NEW REQ TEST PAT BEI; National Health Service England, 2014, 5 YEAR FORW VIEW; National Health Service England Sustainable Development Unit, 2016, SEC HLTH RET REAL FI; National Health Service RightCare, ATL; National Health Service Scotland, 2019, PRIM CAR DENT SCOTL; National Health Service Scotland, 2017, REAL REAL MED CHIEF; National Health Service Sustainable Development Unit, 2018, NAT RES FOOTPR 2018; National Health Service Wales, 2019, CARD ATL VAR; National Health Service Wales, 2009, NHS WAL WHY WE AR CH; National Institute for Health and Care Excellence, MED TECHN EV PROGR; National Institute for Health and Care Excellence, DIAGN ASS PROR; National Institute for Health and Care Excellence, EV STAND FRAM DIG HL; National Institute for Health and Care Excellence, WHAT WE DO; National Institute for Health Research, 2020, ANN REP 2018 19; Naylor C., 2016, BRINGING TOGETHER PH; Nazroo JY, 2003, AM J PUBLIC HEALTH, V93, P277, DOI 10.2105/AJPH.93.2.277; Needs & Redistribution Technical Working Group, 2018, DISC PAP REG PUBL HL; Newham JJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027301; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; NHS Public Health England, 2017, FAC FACTS SHAP FUT D; NHS Scotland, HIGHL ISL MED SER; Nicholson BD, 2015, BRIT J GEN PRACT, V65, P156, DOI 10.3399/bjgp15X684229; Niezen MGH, 2014, HEALTH POLICY, V117, P151, DOI 10.1016/j.healthpol.2014.04.016; Northern Health Science Alliance, 2020, CONN HLTH CIT IMP SU; Northern Ireland Statistics and Research Agency, 2020, FAM PRACT SERV STAT; Novak SM, 2013, CLIN LAB MED, V33, P567, DOI 10.1016/j.cll.2013.03.002; Nuki P., 2020, EXERCISE CYGNUS UNCO; O'Toole F., 2020, CORONAVIRUS HAS EXPO; Ocloo J, 2016, BMJ QUAL SAF, V25, P626, DOI 10.1136/bmjqs-2015-004839; Office for Budget Responsibility, 2021, EC FISC OUTL; Office for National Statisitics, 2017, PROJ DAT PER COH LIF; Office for National Statistics, 2016, INT MIGR ENGL WAL YE; Office for National Statistics, 2013, FULL STOR GEND GAP U; Office for National Statistics, 2020, EST POP UK ENGL WAL; Office for National Statistics, 2019, PROJ PER COH LIF TAB; Office for National Statistics, 2020, COR COVID 19 REL DEA; Office for National Statistics, 2019, EXPLORING UKS DIGITA; Ono T, 2013, HLTH WORKFORCE PLANN; Organisation for Economic Co-operation and Development, **NON-TRADITIONAL**; Oung C, 2020, MUCH SOCIAL CARE DOE; Oxman AD, 2005, J ROY SOC MED, V98, P563, DOI 10.1258/jrsm.98.12.563; Paddison CAM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006172; Palmer B., 2019, IS NUMBER GPS FALLIN; Park AL, 2016, EARLY INTERV PSYCHIA, V10, P144, DOI 10.1111/eip.12149; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Peacock S, 2006, BRIT MED J, V332, P482, DOI 10.1136/bmj.332.7539.482; Peacock SJ, 2007, SOC SCI MED, V64, P897, DOI 10.1016/j.socscimed.2006.09.029; Pearson K., 2019, NHS STAFF LEARNERS M; Peckham S., 2015, HLTH SERV DELIV RES, V3, P1, DOI [DOI 10.3310/HSDR03290, 10.3310/hsdr03290]; Peckham S, 2008, PUBLIC HEALTH, V122, P99, DOI 10.1016/j.puhe.2007.05.003; Phekoo K, 2014, OVERVIEW SELF ASSESS; Pickard L, 2015, J SOC POLICY, V44, P567, DOI 10.1017/S0047279415000069; Pimpin L, 2018, FISCAL PRICING POLIC; Pitchforth Emma, 2015, Future Hosp J, V2, P173, DOI 10.7861/futurehosp.2-3-173; Prime Minister's Office, 2020, OUR PLAN REB UK GOV; Public Health England, 2017, PUBL HLTH OUTC FRAM; Public Health England, 2020, UNDERSTANDING IMPACT; Public Health England, 2014, NAT CANC INT NETW CA; Public Health England, 2017, EX GYGN REP; Public Health England, 2018, PREC CAR MAK CAS; Public Health England, 2018, LOCAL ACTION HLTH IN; Public Health England, 2019, PUBLIC HLTH MATTERS; Public Health England, 2016, LOC WELLB LOC GROWTH; Public Health Scotland, 2019, NHS SCOTL WORKF INF; Public Health Scotland, 2020, A E ACT WAIT TIM; Public Health Scotland, SCOTT ATL HEALTHC VA; Public Health Scotland, 2020, EV IMP MIN UN PRIC M; Public Health Wales, 2017, NAT FOC GLOB RESP OU; Rawlinson K., 2020, CORONAVIRUS PPE ALL; Reed S., 2019, BUILDING HLTH COMMUN; Richards M, 2020, NAT CANCER, V1, P565, DOI 10.1038/s43018-020-0074-y; Rimmer A, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2678; Rizzo A, 2016, ARTIFICIAL INTELLIGENCE IN BEHAVIORAL AND MENTAL HEALTH CARE, P53, DOI 10.1016/B978-0-12-420248-1.00003-9; Robertson S, 2018, TRANSL RES, V194, P19, DOI 10.1016/j.trsl.2017.10.010; Rodriguez-Ruiz A, 2019, JNCI-J NATL CANCER I, V111, P916, DOI 10.1093/jnci/djy222; Rolnick JA, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1780; Roth DL, 2015, GERONTOLOGIST, V55, P309, DOI 10.1093/geront/gnu177; Royal College of General Practitioners, 2020, COMM PALL END LIF BE; Royal College of Pathologists, 2018, M PATH DEM HIST WORK; Royal College of Radiologists, 2019, CLIN RAD UK WORKF CE; Royal Society DELVE Initiative, 2020, 3 ROYAL SOC DELVE IN; Royal Society for Public Health, 2017, EV INT MEAS PUBL HLT; Royal Society for Public Health, IMP PATHW EV INT; Rubin J, 2016, ARE BETTER HLTH OUTC; Rudolf M, 2019, PEDIATR OBES, V14, DOI 10.1111/ijpo.12529; Russell Jill, 2011, BMJ, V342, pd3279, DOI 10.1136/bmj.d3279; Salisbury C, 2018, SHOULD HLTH POLICY R; Sassi F, 2019, LANCET, V393, P745, DOI 10.1016/S0140-6736(19)30253-3; Saville M, 2018, CURR ONCOL, V25, pE27, DOI 10.3747/co.25.3915; Schmahl W., 1998, GLOBALIZATION TECHNO, P179; Schneider EC, 2017, INT COMP REFLECTS FL; Schneider H, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4652; Schrank S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031030; Scobie S, 2020, LEARN HEALTH SYST, V4, DOI 10.1002/lrh2.10209; Scottish Government, 2017, GMS CONTR 2018; Shaw JA, 2017, J HEALTH ORGAN MANAG, V31, P82, DOI 10.1108/JHOM-06-2016-0123; Sheikh A, 2021, LANCET DIGIT HEALTH, V3, pE383, DOI 10.1016/S2589-7500(21)00005-4; Sheldon T, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2534; Shen J, 2013, COMMUNITY DENT ORAL, V41, P481, DOI 10.1111/cdoe.12071; Shenbagaraj L, 2019, FRONTLINE GASTROENTE, V10, P7, DOI 10.1136/flgastro-2018-100970; Simonet D, 2015, ADMIN SOC, V47, P802, DOI 10.1177/0095399713485001; Simpson CR, 2020, LANCET INFECT DIS, V20, P767, DOI 10.1016/S1473-3099(20)30398-4; Simpson Colin R, 2020, BMJ Open, V10, pe039097, DOI 10.1136/bmjopen-2020-039097; Skills for Care, 2020, STATE ADULT SOCIAL C; Smith CF, 2019, FAM PRACT, V36, P255, DOI 10.1093/fampra/cmy069; Smith J, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4013-5; Smittenaar CR, 2016, BRIT J CANCER, V115, P1147, DOI 10.1038/bjc.2016.304; Sng Y, 2019, EUR J HOSP PHARM, V26, P157, DOI 10.1136/ejhpharm-2017-001424; Sparring V, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3621-9; Spiegelhalter D, 2017, ANNU REV STAT APPL, V4, P31, DOI 10.1146/annurev-statistics-010814-020148; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Stanfill MH, 2010, J AM MED INFORM ASSN, V17, P646, DOI 10.1136/jamia.2009.001024; StatsWales, NURS MIDW HLTH VIS S; Steinberg BA, 2018, JAMA-J AM MED ASSOC, V320, P139, DOI 10.1001/jama.2018.8513; Stevens S., 2020, COMMUNICATION 0609; Stewart H, 2020, NO IRELAND JOINS REJ; Stewart Kevin, 2016, Future Hosp J, V3, P203, DOI 10.7861/futurehosp.3-3-203; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Stokes-Lampard H., 2018, COMMUNICATION 0928; Strehlenert H, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4591-2; Stroke Association, 2020, WHAT DOES COR MEAN S; Sustainable Scotland Network, 2018, GUIDANCE COMPLETING; Tapper J, 2020, LOCAL OFFICIALS KEPT; Tetlow G, 2018, UNDERSTANDING EC IMP; The Academy of Medical Sciences, 2020, SURV RES UND PEOPL M; The Health Foundation, 2018, IS REC FUND ANN EN N; The Health Foundation, 2019, ANCH LOC COMM NHS OR; The Health Foundation All-Party Parliamentary Health Group, 2016, HLTH LIF ALL CAS CRO; The Health Informatics Service, 2017, EN DIG REQ RES ALL 2; The Institute for Government, 2020, COR LOCKD RUL EACH P; The Learning Healthcare Project, E LOND PAT REC; The Queen's Nursing Institute, 2020, EXP CAR HOM STAFF CO; The Royal College of Surgeons of England, 2014, IS ACC SURG POSTC LO; Thomas A., 2020, JOINT BIOSECURITY CT; Thomas S, 2017, UPDATED META REV EVI; Thompson S., 2018, NHS WAS NOT SOLELY M; Thomson S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3759; Thorlby R, 2018, NHS 70 WHATS PROBLEM; Tidy EJ, 2018, BRIT J GEN PRACT, V68, P360, DOI 10.3399/bjgp18X698021; Time to Change, 2019, OUR IMP 2018 19; Timewise, 2018, TIMEWISE; Ting DSW, 2018, NAT MED, V24, P539, DOI 10.1038/s41591-018-0029-3; Titmuss, 1958, ESSAYS WELFARE STATE; Tizhoosh Hamid Reza, 2018, J Pathol Inform, V9, P38, DOI 10.4103/jpi.jpi_53_18; Topol EJ, 2019, TOPOL REV PREPARING; Torjesen I, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2883; Tridico P, 2018, ECON LABOUR RELAT RE, V29, P118, DOI 10.1177/1035304618758941; Tsiachristas A, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2472; Turienzo CF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009044; Turnbull S, 2020, J MED INTERNET RES, V22, DOI 10.2196/17849; UK Clinical Research Collaboration, AB UKCRC; UK Clinical Research Collaboration, 2020, UK HLTH RES AN 2018; UK Government, 2021, INTEGRATION INNOVATI; UK Government, 2020, 2 9 BILL FUND STRENG; UK Government, 2019, DEP HLTH SOCIAL CARE; UK Government, 2020, NEXT PHAS NHS COR CO; UK Government, 2019, IMPL SUST DEV GOALS; UK Government, 2020, COR COVID 19 UK TEST; UK Government, 2021, J HARR MARKS OFF LAU; UK Government, 2019, VOLUNTARY NATL REV P; UK Government, 2018, DENT CONTR REF PROT; UK Government, 2020, GUID NOT NEW ASS ROU; United Nations, 2020, HHS; US Renal Data System, 2018, 2018 USRDS ANN DAT R; Vallace P., 2020, COMPOSITION SCI ADVI; van der Aa Maartje J, 2017, J Comorb, V7, P11, DOI 10.15256/joc.2017.7.97; van Doorslaer E, 1999, J HEALTH ECON, V18, P291, DOI 10.1016/S0167-6296(98)00043-5; Van Greuningen M, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-21; van Schalkwyk MCI, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5300; van Twillert M., 2019, SHORTAGES GEN PRACTI; VANDEVEN WPMM, 1992, DEV HLTH EC, V1, P23; Verhaegh KJ, 2014, HEALTH AFFAIR, V33, P1531, DOI 10.1377/hlthaff.2014.0160; Viner R, 2018, CHILD HLTH 2030 ENGL; Vize R, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1934; Vodicka E, 2013, J MED INTERNET RES, V15, P186, DOI 10.2196/jmir.2670; Wachter RM, 2016, MAKING IT WORK HARNE; Wagstaff A., 2013, SOCIAL HLTH INSURANC, DOI [10.1596/1813-9450-4821, DOI 10.1596/1813-9450-4821]; Wagstaff A, 2018, LANCET GLOB HEALTH, V6, pE169, DOI [10.1016/S2214-109X(17)30486-2, 10.1016/s2214-109x(17)30486-2, 10.1016/S2214-109X(17)30429-1]; Wallace J, 2019, WELLBEING POL POL, P33, DOI 10.1007/978-3-030-02230-3_2; Walshe K, 2018, DEVOLVING HLTH SOCIA; Walshe K, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1495; Wanless D., 2002, SECURING OUR FUTURE; Watt T, 2018, SOCIAL CARE FUNDING; Watts N, 2018, LANCET, V392, P2479, DOI 10.1016/S0140-6736(18)32594-7; Wellings D., 2017, WHAT DOES PUBLIC THI; Wellings D, 2020, PUBLIC SATISFACTION; Welsh Government, 2019, NHS DENT STAT WAL 20; Wenzl M, 2015, BRIT MED BULL, V115, P5, DOI 10.1093/bmb/ldv031; Westwood M, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0944-z; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2017, SUST DEV WAL OTH REG; WHO, HLTH SYSTEMS STRENGT; WHO, UNIVERSAL HLTH COVER; WHO Regional Office for Europe, 2016, STRENGTH PEOPL CENTR; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Willis M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-032412; Willis TA, 2016, PUBLIC HEALTH, V136, P101, DOI 10.1016/j.puhe.2016.04.006; Wittenberg R, 2018, PROJECTIONS DEMAND E; Wohland P, 2015, ETHNIC HEALTH, V20, P341, DOI 10.1080/13557858.2014.921892; World Bank, 2020, POV DISTR IMP COVID; World Health Organization, 2016, GLOB HLTH OBS DAT RE; Wouters OJ, 2020, JAMA HLTH FORUM; Wouters OJ, 2016, HEALTH ECON POLICY L, V11, P321, DOI 10.1017/S1744133116000025; Woznitza N, 2014, J MED RADIAT SCI, V61, P66, DOI 10.1002/jmrs.51; Yamin CK, 2011, ARCH INTERN MED, V171, P568, DOI 10.1001/archinternmed.2011.34; Yokotani K, 2018, COMPUT HUM BEHAV, V85, P135, DOI 10.1016/j.chb.2018.03.045	468	28	28	3	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1915	1978		10.1016/S0140-6736(21)00232-4	http://dx.doi.org/10.1016/S0140-6736(21)00232-4		MAY 2021	64	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SF1XN	33965070	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000652556000028
J	Dyer, O				Dyer, Owen			US obstetrician who performed unnecessary surgery is sentenced to 59 years	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2021	373								n1317	10.1136/bmj.n1317	http://dx.doi.org/10.1136/bmj.n1317			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7ZT	34020966				2022-12-28	WOS:000656435600009
J	Chiou, J; Geusz, RJ; Okino, ML; Han, JY; Miller, M; Melton, R; Beebe, E; Benaglio, P; Huang, SA; Korgaonkar, K; Heller, S; Kleger, A; Preissl, S; Gorkin, DU; Sander, M; Gaulton, KJ				Chiou, Joshua; Geusz, Ryan J.; Okino, Mei-Lin; Han, Jee Yun; Miller, Michael; Melton, Rebecca; Beebe, Elisha; Benaglio, Paola; Huang, Serina; Korgaonkar, Katha; Heller, Sandra; Kleger, Alexander; Preissl, Sebastian; Gorkin, David U.; Sander, Maike; Gaulton, Kyle J.			Interpreting type 1 diabetes risk with genetics and single-cell epigenomics	NATURE			English	Article							GENOME-WIDE ASSOCIATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; SUSCEPTIBILITY LOCI; COMMON VARIANTS; MUTATIONS; PATHOPHYSIOLOGY; COLOCALIZATION; ACCESSIBILITY; ANNOTATION	Genetic risk variants that have been identified in genome-wide association studies of complex diseases are primarily non-coding(1). Translating these risk variants into mechanistic insights requires detailed maps of gene regulation in disease-relevant cell types(2). Here we combined two approaches: a genome-wide association study of type 1 diabetes (T1D) using 520,580 samples, and the identification of candidate cis-regulatory elements (cCREs) in pancreas and peripheral blood mononuclear cells using single-nucleus assay for transposase-accessible chromatin with sequencing (snATAC-seq) of 131,554 nuclei. Risk variants for T1D were enriched in cCREs that were active in T cells and other cell types, including acinar and ductal cells of the exocrine pancreas. Risk variants at multiple T1D signals overlapped with exocrine-specific cCREs that were linked to genes with exocrine-specific expression. At the CFTR locus, the T1D risk variant rs7795896 mapped to a ductal-specific cCRE that regulated CFTR; the risk allele reduced transcription factor binding, enhancer activity and CFTR expression in ductal cells. These findings support a role for the exocrine pancreas in the pathogenesis of T1D and highlight the power of large-scale genome-wide association studies and single-cell epigenomics for understanding the cellular origins of complex disease.	[Chiou, Joshua; Geusz, Ryan J.; Melton, Rebecca] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Okino, Mei-Lin; Beebe, Elisha; Benaglio, Paola; Huang, Serina; Korgaonkar, Katha; Sander, Maike; Gaulton, Kyle J.] Univ Calif San Diego, Pediat Diabet Res Ctr, Dept Pediat, La Jolla, CA 92093 USA; [Han, Jee Yun; Miller, Michael; Preissl, Sebastian; Gorkin, David U.] Univ Calif San Diego, Ctr Epigenom, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Heller, Sandra; Kleger, Alexander] Univ Ulm, Dept Internal Med 1, Ulm, Germany; [Sander, Maike] Univ Calif San Diego, Dept Cell & Mol Biol, La Jolla, CA 92093 USA; [Sander, Maike; Gaulton, Kyle J.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Chiou, Joshua] Pfizer Worldwide Res, Internal Med Res Unit, Cambridge, MA 02139 USA; [Gorkin, David U.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ulm University; University of California System; University of California San Diego; University of California System; University of California San Diego; Pfizer; Emory University	Chiou, J (corresponding author), Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA.; Gaulton, KJ (corresponding author), Univ Calif San Diego, Pediat Diabet Res Ctr, Dept Pediat, La Jolla, CA 92093 USA.; Gaulton, KJ (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.; Chiou, J (corresponding author), Pfizer Worldwide Res, Internal Med Res Unit, Cambridge, MA 02139 USA.	joshua.chiou@pfizer.com; kgaulton@health.ucsd.edu		Chiou, Joshua/0000-0002-4618-0647; Heller, Sandra/0000-0002-8704-2646	NIH [DK112155, DK120429, DK122607, T32 GM008666]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants DK112155, DK120429 and DK122607 to K.J.G. and M.S., and T32 GM008666 to R.J.G. We thank S. Kuan for assistance with sequencing. Additional acknowledgements for each cohort are listed in the Supplementary Information.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Amemiya HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45839-z; Arda HE, 2018, CELL SYST, V7, P310, DOI 10.1016/j.cels.2018.07.007; Aylward A., 2018, HUM MOL GENET; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Calderon D, 2019, NAT GENET, V51, P1494, DOI 10.1038/s41588-019-0505-9; Campbell-Thompson M, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0653-y; Camunas-Soler J, 2020, CELL METAB, V31, P1017, DOI 10.1016/j.cmet.2020.04.005; Chiou J, 2021, NAT GENET, V53, P455, DOI 10.1038/s41588-021-00823-0; Claussnitzer M, 2020, NATURE, V577, P179, DOI 10.1038/s41586-019-1879-7; Cousminer DL, 2013, HUM MOL GENET, V22, P2735, DOI 10.1093/hmg/ddt104; Cusanovich DA, 2018, CELL, V174, P1309, DOI 10.1016/j.cell.2018.06.052; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Day FR, 2017, NAT GENET, V49, P834, DOI 10.1038/ng.3841; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Diaferia GR, 2016, EMBO J, V35, P595, DOI 10.15252/embj.201592404; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Evangelou M, 2014, GENET EPIDEMIOL, V38, P661, DOI 10.1002/gepi.21853; Fasolino M., 2021, BIORXIV, DOI [10.1101/2021.01.28.428598, DOI 10.1101/2021.01.28.428598, DOI 10.1101/2021.10.15.464577]; Felix JF, 2016, HUM MOL GENET, V25, P389, DOI 10.1093/hmg/ddv472; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Franzen O, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz046; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gibson-Corley KN, 2016, J PATHOL, V238, P311, DOI 10.1002/path.4634; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hart NJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98240; Horikoshi M, 2016, NATURE, V538, P248, DOI 10.1038/nature19806; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Jansen PR, 2019, NAT GENET, V51, P394, DOI 10.1038/s41588-018-0333-3; Ji SG, 2017, NAT GENET, V49, P269, DOI 10.1038/ng.3745; Jiang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02662-2; Jin Y, 2016, NAT GENET, V48, P1418, DOI 10.1038/ng.3680; Johansson BB, 2018, PANCREATOLOGY, V18, P12, DOI 10.1016/j.pan.2017.12.001; Katsarou Anastasia, 2017, Nat Rev Dis Primers, V3, P17016, DOI 10.1038/nrdp.2017.16; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lopez-Isac E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12760-y; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McWilliams RR, 2010, CANCER, V116, P203, DOI [10.1002/cncr.24697, 10.1002/cncr.25465]; Namkung W, 2003, J BIOL CHEM, V278, P200, DOI 10.1074/jbc.M207199200; Navis A, 2015, DEV BIOL, V399, P237, DOI 10.1016/j.ydbio.2014.12.034; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3; Noone PG, 2001, GASTROENTEROLOGY, V121, P1310, DOI 10.1053/gast.2001.29673; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pliner HA, 2018, MOL CELL, V71, P858, DOI 10.1016/j.molcel.2018.06.044; Preissl S, 2018, NAT NEUROSCI, V21, P432, DOI 10.1038/s41593-018-0079-3; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Stahl EA, 2019, NAT GENET, V51, P793, DOI 10.1038/s41588-019-0397-8; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Tachmazidou I, 2019, NAT GENET, V51, P230, DOI 10.1038/s41588-018-0327-1; Taliun D, 2021, NATURE, V590, DOI 10.1038/s41586-021-03205-y; Teumer A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06356-1; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Valle A, 2013, DIABETES, V62, P2072, DOI 10.2337/db12-1345; van der Valk RJP, 2015, HUM MOL GENET, V24, P1155, DOI 10.1093/hmg/ddu510; Virostko J, 2019, DIABETES CARE, V42, P248, DOI 10.2337/dc18-1507; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wang XR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08023-x; Watson HJ, 2019, NAT GENET, V51, P1207, DOI 10.1038/s41588-019-0439-2; Wheeler E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002383; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wingender E, 2015, NUCLEIC ACIDS RES, V43, pD97, DOI 10.1093/nar/gku1064; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolpin BM, 2014, NAT GENET, V46, P994, DOI 10.1038/ng.3052; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Wuttke M, 2019, NAT GENET, V51, P957, DOI 10.1038/s41588-019-0407-x; Xin Y, 2018, DIABETES, V67, P1783, DOI 10.2337/db18-0365; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y	104	45	45	8	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 17	2021	594	7863					398	+		10.1038/s41586-021-03552-w	http://dx.doi.org/10.1038/s41586-021-03552-w		MAY 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SU1FZ	34012112				2022-12-28	WOS:000652172000004
J	Puymirat, E; Cayla, G; Simon, T; Steg, PG; Montalescot, G; Durand-Zaleski, I; le Bras, A; Gallet, R; Khalife, K; Morelle, JF; Motreff, P; Lemesle, G; Dillinger, JG; Lhermusier, T; Silvain, J; Roule, V; Labeque, JN; Range, G; Ducrocq, G; Cottin, Y; Blanchard, D; Nelson, AC; De Bruyne, B; Chatellier, G; Danchin, N				Puymirat, Etienne; Cayla, Guillaume; Simon, Tabassome; Steg, Philippe G.; Montalescot, Gilles; Durand-Zaleski, Isabelle; le Bras, Alicia; Gallet, Romain; Khalife, Khalife; Morelle, Jean-Francois; Motreff, Pascal; Lemesle, Gilles; Dillinger, Jean-Guillaume; Lhermusier, Thibault; Silvain, Johanne; Roule, Vincent; Labeque, Jean-Noel; Range, Gregoire; Ducrocq, Gregory; Cottin, Yves; Blanchard, Didier; Charles Nelson, Anais; De Bruyne, Bernard; Chatellier, Gilles; Danchin, Nicolas		FLOWER-MI Study Investigators	Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FRACTIONAL FLOW RESERVE; ST-SEGMENT ELEVATION; PERCUTANEOUS CORONARY INTERVENTION; 5-YEAR FOLLOW-UP; RANDOMIZED-TRIAL; REVASCULARIZATION; MANAGEMENT; ANGIOPLASTY; GUIDELINES; LESION	BACKGROUND In patients with ST-elevation myocardial infarction (STEMI) who have multivessel disease, percutaneous coronary intervention (PCI) for nonculprit lesions (complete revascularization) is superior to treatment of the culprit lesion alone. However, whether complete revascularization that is guided by fractional flow reserve (FFR) is superior to an angiography-guided procedure is unclear. METHODS In this multicenter trial, we randomly assigned patients with STEMI and multivessel disease who had undergone successful PCI of the infarct-related artery to receive complete revascularization guided by either FFR or angiography. The primary outcome was a composite of death from any cause, nonfatal myocardial infarction, or unplanned hospitalization leading to urgent revascularization at 1 year. RESULTS The mean (+/- SD) number of stents that were placed per patient for nonculprit lesions was 1.01 +/- 0.99 in the FFR-guided group and 1.50 +/- 0.86 in the angiography-guided group. During follow-up, a primary outcome event occurred in 32 of 586 patients (5.5%) in the FFR-guided group and in 24 of 577 patients (4.2%) in the angiography-guided group (hazard ratio, 1.32; 95% confidence interval, 0.78 to 2.23; P=0.31). Death occurred in 9 patients (1.5%) in the FFR-guided group and in 10 (1.7%) in the angiography-guided group; nonfatal myocardial infarction in 18 (3.1%) and 10 (1.7%), respectively; and unplanned hospitalization leading to urgent revascularization in 15 (2.6%) and 11 (1.9%), respectively. CONCLUSIONS In patients with STEMI undergoing complete revascularization, an FFR-guided strategy did not have a significant benefit over an angiography-guided strategy with respect to the risk of death, myocardial infarction, or urgent revascularization at 1 year. However, given the wide confidence intervals for the estimate of effect, the findings do not allow for a conclusive interpretation.	[Puymirat, Etienne; Blanchard, Didier; Danchin, Nicolas] Univ Paris, Hop Europeen Georges Pompidou, Paris Ctr Rech Cardiovasc, Dept Cardiol,INSERM,AP HP, Paris, France; [Simon, Tabassome] Sorbonne Univ, Hop St Antoine, Dept Clin Pharmacol, AP HP,INSERM,Unite 698, Paris, France; [Simon, Tabassome] Sorbonne Univ, INSERM, Unite Rech Clin, Unite 698, Paris, France; [Steg, Philippe G.] Univ Paris, INSERM, Unite 1148, Paris, France; [Steg, Philippe G.] Hop Bichat Claude Bernard, AP HP, Paris, France; [Montalescot, Gilles; Silvain, Johanne] Sorbonne Univ, Hop Pitie Salpetriere, ACTION Study Grp, Inst Cardiol,AP HP,INSERM,UMRS 1166, Paris, France; [Durand-Zaleski, Isabelle; le Bras, Alicia] Hop Hotel Dieu, AP HP, Clin Res Unit Eco Ile France, Paris, France; [Dillinger, Jean-Guillaume] Univ Paris, Hop Lariboisiere, AP HP, Dept Cardiol,INSERM,Unite 942, Paris, France; [Ducrocq, Gregory] Univ Paris, French Alliance Cardiovasc Trials, Lab Vasc Translat Sci, Dept Cardiol,Hop Bichat,AP HP,INSERM,Unite 1148, Paris, France; [Charles Nelson, Anais; Chatellier, Gilles] George Pompidou European Hosp, AP HP, Clin Res Unit, INSERM, Paris, France; [Charles Nelson, Anais; Chatellier, Gilles] George Pompidou European Hosp, AP HP, INSERM, Ctr Invest Clin 1418, Paris, France; [Puymirat, Etienne; Simon, Tabassome; Steg, Philippe G.; Lemesle, Gilles; Blanchard, Didier; Chatellier, Gilles; Danchin, Nicolas] French Alliance Cardiovasc Trials, Paris, France; [Cayla, Guillaume] CHU Nimes, Nimes, France; [Gallet, Romain] Univ Paris Est Creteil, Hopitaux Univ Henri Mondor, AP HP, Serv Cardiol, Creteil, France; [Gallet, Romain] Ecole Natl Vet Alfort, INSERM, Mondor Inst Biomed Res, Unite 955,Equipe 03, Maisons Alfort, France; [Khalife, Khalife] Hop Bon Secours, Metz, France; [Morelle, Jean-Francois] Clin St Martin, Caen, France; [Roule, Vincent] Caen Univ Hosp, Cardiol Dept, Caen, France; [Motreff, Pascal] Univ Clermont Auvergne, CHU Clermont Ferrand, Dept Cardiol, CNRS,UMR 6602, Clermont Ferrand, France; [Motreff, Pascal] CHU Lille, Heart & Lung Inst, Cardiac Intens Care Unit, Lille, France; [Lemesle, Gilles] Univ Hosp Lille, Inst Pasteur Lille, Heart & Lung Inst, INSERM,Unite 1011, Lille, France; [Lhermusier, Thibault] Rangueil Univ Hosp, Dept Cardiol, Intens Cardiac Care Unit, Toulouse, France; [Lhermusier, Thibault] Toulouse III Paul Sabatier Univ, Med Sch, Toulouse, France; [Labeque, Jean-Noel] Ctr Hosp Cote Basque, Grp Cooperat Saintaire Cardiol Cote Basque, Bayonne, France; [Range, Gregoire] Hop Chartres, Cardiol Dept, Chartres, Eure & Loir, France; [Cottin, Yves] Univ Bourgogne Franche Comte, Physiopathol & Epidemiol Cerebro Cardiovasc, Equipe Accueil, EA 7460, Dijon, France; [Cottin, Yves] Univ Hosp Ctr Dijon Bourgogne, Cardiol Dept, Dijon, France; [De Bruyne, Bernard] Cardiovasc Ctr Aalst, Aalst, Belgium; [De Bruyne, Bernard] Lausanne Univ Ctr Hosp, Dept Cardiol, Lausanne, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Ecole Nationale Veterinaire d'Alfort (ENVA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHR Metz-Thionville; CHU de Caen NORMANDIE; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Bourgogne; Cardiovascular Center Aalst	Puymirat, E (corresponding author), Hop Europeen Georges Pompidou, Dept Cardiol, 20 Rue Leblanc, F-75015 Paris, France.	etienne.puymirat@aphp.fr		STEG, Philippe Gabriel/0000-0001-6896-2941; Puymirat, Etienne/0000-0002-0533-9682; LE BRAS, Alicia/0000-0001-9426-0206	French Ministry of Health; Abbott	French Ministry of Health; Abbott(Abbott Laboratories)	Supported by a grant from the French Ministry of Health and an unrestricted grant from Abbott.	Altman DG, 1991, PRACTICAL STAT MED R; Bogaty P, 2020, NEW ENGL J MED, V382, P1568, DOI [10.1056/NEJMoa1907775, 10.1056/NEJMc2000278]; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Jeger R, 2014, INT J CARDIOL, V172, P76, DOI 10.1016/j.ijcard.2013.12.083; Layland J, 2015, EUR HEART J, V36, P100, DOI 10.1093/eurheartj/ehu338; Ntalianis A, 2010, JACC-CARDIOVASC INTE, V3, P1274, DOI 10.1016/j.jcin.2010.08.025; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Puymirat E, 2020, AM HEART J, V222, P1, DOI 10.1016/j.ahj.2019.12.015; Puymirat E, 2012, JAMA-J AM MED ASSOC, V308, P998, DOI 10.1001/2012.jama.11348; Smits PC, 2017, NEW ENGL J MED, V376, P1234, DOI 10.1056/NEJMoa1701067; Szummer K, 2017, EUR HEART J, V38, P3056, DOI 10.1093/eurheartj/ehx515; Thim T, 2020, JACC-CARDIOVASC INTE, V13, pE96, DOI 10.1016/j.jcin.2020.02.030; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; van Nunen LX, 2015, LANCET, V386, P1853, DOI 10.1016/S0140-6736(15)00057-4; Wald DS, 2020, EUR HEART J-QUAL CAR, V6, P186, DOI 10.1093/ehjqcco/qcaa012; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	23	65	67	2	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2021	385	4					297	308		10.1056/NEJMoa2104650	http://dx.doi.org/10.1056/NEJMoa2104650		MAY 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TN5VF	33999545	Bronze			2022-12-28	WOS:000652592600001
J	Ben-Moshe, A; da Silva, A; Muller, A; Abu-Odeh, A; Harrison, P; Waelder, J; Niroui, F; Ophus, C; Minor, AM; Asta, M; Theis, W; Ercius, P; Alivisatos, AP				Ben-Moshe, Assaf; da Silva, Alessandra; Mueller, Alexander; Abu-Odeh, Anas; Harrison, Patrick; Waelder, Jacob; Niroui, Farnaz; Ophus, Colin; Minor, Andrew M.; Asta, Mark; Theis, Wolfgang; Ercius, Peter; Alivisatos, A. Paul			The chain of chirality transfer in tellurium nanocrystals	SCIENCE			English	Article							GROWTH; DRIVEN; CRYSTALLIZATION; DISLOCATIONS; CRYSTALS	Despite persistent and extensive observations of crystals with chiral shapes, the mechanisms underlying their formation are not well understood. Although past studies suggest that chiral shapes can form because of crystallization in the presence of chiral additives, or because of an intrinsic tendency that stems from the crystal structure, there are many cases in which these explanations are not suitable or have not been tested. Here, an investigation of model tellurium nanocrystals provides insights into the chain of chirality transfer between crystal structure and shape. We show that this transfer is mediated by screw dislocations, and shape chirality is not an outcome of the chiral crystal structure or ligands.	[Ben-Moshe, Assaf; Abu-Odeh, Anas; Asta, Mark; Alivisatos, A. Paul] Ernest Orlando Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Ben-Moshe, Assaf; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [da Silva, Alessandra; Harrison, Patrick; Theis, Wolfgang] Univ Birmingham, Nanoscale Phys Res Lab, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Mueller, Alexander; Ophus, Colin; Minor, Andrew M.; Ercius, Peter] Ernest Orlando Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Mol Foundry, Berkeley, CA 94720 USA; [Mueller, Alexander; Abu-Odeh, Anas; Minor, Andrew M.; Asta, Mark] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Waelder, Jacob] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Niroui, Farnaz] Univ Calif Berkeley, Miller Res Inst, Berkeley, CA 94720 USA; [Alivisatos, A. Paul] Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Ben-Moshe, Assaf] Weizmanu Inst Sci, Dept Phys Complex Syst, IL-7610001 Rehovot, Israel; [Waelder, Jacob] Univ Michigan, Appl Phys Program, Ann Arbor, MI 48109 USA; [Niroui, Farnaz] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Birmingham; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT)	Alivisatos, AP (corresponding author), Ernest Orlando Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.; Alivisatos, AP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Alivisatos, AP (corresponding author), Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA.	paul.alivisatos@berkeley.edu	Ercius, Peter/AAN-2870-2020; Theis, Wolfgang/AAA-3195-2022	Ercius, Peter/0000-0002-6762-9976; Harrison, Patrick/0000-0001-9798-8710; Theis, Wolfgang/0000-0002-4074-8318; da Silva, Alessandra/0000-0003-0465-504X; Ophus, Colin/0000-0003-2348-8558; Ben Moshe, ASSAF/0000-0001-7348-8586; Minor, Andrew/0000-0003-3606-8309; Asta, Mark/0000-0002-8968-321X; Waelder, Jacob/0000-0002-1986-9457	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division within the Characterization of Functional Nanomachines Program [DE-AC02-05-CH11231, KC1203]; U.S. Department of Energy [DE-AC02-05CH11231]; U.S. Department of Energy, Office of Science, Office of Workforce Development for Teachers and Scientists (WDTS) under the Science Undergraduate Laboratory Internship (SULI) program; Miller Research Institute; Fulbright fellowship; Brazilian National Council of Technological and Scientific Development (CNPq); National Science Foundation Graduate Research Fellowship Program [DGE 1752814]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division within the Damage-Tolerance in Structural Materials (KC 13) program [DE-AC02-05-CH11231]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division within the Characterization of Functional Nanomachines Program(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Workforce Development for Teachers and Scientists (WDTS) under the Science Undergraduate Laboratory Internship (SULI) program(United States Department of Energy (DOE)); Miller Research Institute; Fulbright fellowship; Brazilian National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division within the Damage-Tolerance in Structural Materials (KC 13) program(United States Department of Energy (DOE))	This work was primarily supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, under contract DE-AC02-05-CH11231 within the Characterization of Functional Nanomachines Program (KC1203). Work at the Molecular Foundry, Lawrence Berkeley National Laboratory, was supported by the U.S. Department of Energy under contract DE-AC02-05CH11231. J.W. acknowledges support from the U.S. Department of Energy, Office of Science, Office of Workforce Development for Teachers and Scientists (WDTS) under the Science Undergraduate Laboratory Internship (SULI) program. F.N. was supported by the Miller Research Institute. A.B.-M. acknowledges support from a Fulbright fellowship. A.d.S. acknowledges funding from the Brazilian National Council of Technological and Scientific Development (CNPq). A.A. and M.A. acknowledge support for the computational modeling from a fellowship through the National Science Foundation Graduate Research Fellowship Program (grant DGE 1752814), and the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, under contract DE-AC02-05-CH11231 within the Damage-Tolerance in Structural Materials (KC 13) program, respectively.	Addadi L, 2003, CRYSTENGCOMM, P140, DOI 10.1039/b304061e; Anderson P. M., 2017, THEORY DISLOCATIONS, V3rd; Ben-Moshe A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5302; Ben-Moshe A, 2013, CHEM SOC REV, V42, P7028, DOI 10.1039/c3cs60139k; Ben-Moshe A, 2013, ANGEW CHEM INT EDIT, V52, P1275, DOI 10.1002/anie.201207489; Bierman MJ, 2008, SCIENCE, V320, P1060, DOI 10.1126/science.1157131; Chernov N, 2005, J MATH IMAGING VIS, V23, P239, DOI 10.1007/s10851-005-0482-8; dasilvaale, 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4587925, DOI 10.5281/ZENODO.4587925]; dasilvaale, 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4587925, DOI 10.5281/ZENODO.4587925]; DIPERSIO J, 1967, J PHYS-PARIS, V28, P661, DOI 10.1051/jphys:01967002808-9066100; Dong ZY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15388-5; Ernst KH, 2013, SURF SCI, V613, P1, DOI 10.1016/j.susc.2013.03.014; Escaig B, 1974, J PHYS C, V35; Gal J, 2008, CHIRALITY, V20, P5, DOI 10.1002/chir.20494; Gammer C, 2015, ULTRAMICROSCOPY, V155, P1, DOI 10.1016/j.ultramic.2015.03.015; Hazen RM, 2003, NAT MATER, V2, P367, DOI 10.1038/nmat879; Ismail-Beigi S, 2000, PHYS REV LETT, V84, P1499, DOI 10.1103/PhysRevLett.84.1499; Jansen J, 2013, ULTRAMICROSCOPY, V125, P59, DOI 10.1016/j.ultramic.2012.09.010; Kim GH, 1996, MICROSC RES TECHNIQ, V33, P510, DOI 10.1002/(SICI)1097-0029(19960415)33:6<510::AID-JEMT6>3.0.CO;2-O; Liu Y, 2019, NATURE, V570, P358, DOI 10.1038/s41586-019-1308-y; Meng F, 2013, ACCOUNTS CHEM RES, V46, P1616, DOI 10.1021/ar400003q; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Morin SA, 2010, SCIENCE, V328, P476, DOI 10.1126/science.1182977; Ophus C, 2019, MICROSC MICROANAL, V25, P563, DOI 10.1017/S1431927619000497; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Pasteur L., 1848, ANN CHIM PHYS, V24, P442; Persson K, 2016, **DATA OBJECT**, DOI [10.17188/1193780, DOI 10.17188/1193780]; Rauch EF, 2014, EUR PHYS J-APPL PHYS, V66, DOI 10.1051/epjap/2014130556; Shtukenberg AG, 2015, CRYST GROWTH DES, V15, P921, DOI 10.1021/cg501485e; Shtukenberg AG, 2014, ANGEW CHEM INT EDIT, V53, P672, DOI 10.1002/anie.201301223; STROH AN, 1958, PHILOS MAG, V3, P625, DOI 10.1080/14786435808565804; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Sung B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03745-4; Tizei LHG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.195503; Wang PP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14312; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Wen CY, 2000, J CRYST GROWTH, V213, P150, DOI 10.1016/S0022-0248(00)00317-1; Yeom J, 2015, NAT MATER, V14, P66, DOI [10.1038/NMAT4125, 10.1038/nmat4125]; Zhu J, 2008, NAT NANOTECHNOL, V3, P477, DOI 10.1038/nnano.2008.179	39	25	25	25	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					729	+		10.1126/science.abf9645	http://dx.doi.org/10.1126/science.abf9645			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986178	Green Submitted, Green Accepted			2022-12-28	WOS:000651125300048
J	Ye, LH; Li, X				Ye, Luhan; Li, Xin			A dynamic stability design strategy for lithium metal solid state batteries	NATURE			English	Article							MECHANICAL CONSTRICTION; CATHODE; ANODE	A multi-layered electrolyte, in which a less stable electrolyte is sandwiched between two electrolyte layers that are more stable, can inhibit the growth of lithium dendrites in highly pressurized solid-state lithium metal batteries. A solid-state electrolyte is expected to suppress lithium (Li) dendrite penetration with high mechanical strength(1-4). However, in practice it still remains challenging to realise a lithium metal anode for batteries, because micrometre- or submicrometre-sized cracks in ceramic pellets can frequently be generated during battery assembly or long-time cycling(3,5). Once cracks form, lithium dendrite penetration is inevitable(6,7). Here we describe a solid-state battery design with a hierarchy of interface stabilities (to lithium metal responses), to achieve an ultrahigh current density with no lithium dendrite penetration. Our multilayer design has the structure of a less-stable electrolyte sandwiched between more-stable solid electrolytes, which prevents any lithium dendrite growth through well localized decompositions in the less stable electrolyte layer. A mechanism analogous to the expansion screw effect is proposed, whereby any cracks are filled by dynamically generated decompositions that are also well constrained, probably by the 'anchoring' effect the decompositions induce. The cycling performance of the lithium metal anode paired with a LiNi0.8Mn0.1Co0.1O2 cathode is very stable, with an 82 per cent capacity retention after 10,000 cycles at a 20C rate (8.6 milliamps per centimetre squared) and 81.3 per cent capacity retention after 2,000 cycles at a 1.5C rate (0.64 milliamps per centimetre squared). Our design also enables a specific power of 110.6 kilowatts per kilogram and specific energy up to 631.1 watt hours per kilogram at the micrometre-sized cathode material level.	[Ye, Luhan; Li, Xin] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University	Li, X (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	lixin@seas.harvard.edu		Ye, Luhan/0000-0002-2684-424X; Li, Xin/0000-0001-9390-0830				Adeli P, 2019, ANGEW CHEM INT EDIT, V58, P8681, DOI 10.1002/anie.201814222; Auvergniot J, 2017, CHEM MATER, V29, P3883, DOI 10.1021/acs.chemmater.6b04990; Chen YM, 2020, NATURE, V578, P251, DOI 10.1038/s41586-020-1972-y; Fitzhugh W, 2019, J MATER CHEM A, V7, P23604, DOI 10.1039/c9ta05248h; Fitzhugh W, 2019, SMALL, V15, DOI 10.1002/smll.201901470; Goodenough JB, 2013, J AM CHEM SOC, V135, P1167, DOI 10.1021/ja3091438; Jin S, 2016, ADV MATER, V28, P9094, DOI 10.1002/adma.201602704; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/NMAT3066, 10.1038/nmat3066]; Kang B, 2009, NATURE, V458, P190, DOI 10.1038/nature07853; Kasemchainan J, 2019, NAT MATER, V18, P1105, DOI 10.1038/s41563-019-0438-9; Kato Y, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2016.30; Krauskopf T, 2020, CHEM REV, V120, P7745, DOI 10.1021/acs.chemrev.0c00431; Lee YG, 2020, NAT ENERGY, V5, P299, DOI 10.1038/s41560-020-0575-z; Liu J, 2019, NAT ENERGY, V4, P180, DOI 10.1038/s41560-019-0338-x; Qi Y, 2020, JOULE, V4, P2599, DOI 10.1016/j.joule.2020.10.009; Sallard S, 2020, ACS APPL ENERG MATER, V3, P8646, DOI 10.1021/acsaem.0c01235; Saroha R, 2017, APPL SURF SCI, V394, P25, DOI 10.1016/j.apsusc.2016.09.105; Schwietert TK, 2020, NAT MATER, V19, P428, DOI 10.1038/s41563-019-0576-0; Su YB, 2020, ENERG ENVIRON SCI, V13, P908, DOI 10.1039/c9ee04007b; Tu QS, 2020, CELL REP PHYS SCI, V1, DOI 10.1016/j.xcrp.2020.100106; Wang S, 2019, ANGEW CHEM INT EDIT, V58, P8039, DOI 10.1002/anie.201901938; Wenzel S, 2018, SOLID STATE IONICS, V318, P102, DOI 10.1016/j.ssi.2017.07.005; Wenzel S, 2016, CHEM MATER, V28, P2400, DOI 10.1021/acs.chemmater.6b00610; Wu F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06123-2; Xin FX, 2019, ACS APPL MATER INTER, V11, P34889, DOI 10.1021/acsami.9b09696; Xu C, 2021, NAT MATER, V20, P84, DOI 10.1038/s41563-020-0767-8; Ye LH, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.202001569	27	144	142	198	576	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					218	+		10.1038/s41586-021-03486-3	http://dx.doi.org/10.1038/s41586-021-03486-3			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33981053				2022-12-28	WOS:000649848600012
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Government must invest in primary care to aid pandemic recovery, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1139	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1208	10.1136/bmj.n1208	http://dx.doi.org/10.1136/bmj.n1208			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975859	Bronze			2022-12-28	WOS:000649711400003
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: General practice on the brink	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1139; NHS Digital, 2021, APP GEN PRACT MARCH	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2021	373								n1187	10.1136/bmj.n1187	http://dx.doi.org/10.1136/bmj.n1187			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RU	33975889	Bronze			2022-12-28	WOS:000649711400007
J	Fralick, M; Sarma, S				Fralick, Michael; Sarma, Shohinee			Thyrotoxic Periodic Paralysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fralick, Michael; Sarma, Shohinee] Univ Toronto, Toronto, ON, Canada	University of Toronto	Fralick, M (corresponding author), Univ Toronto, Toronto, ON, Canada.	mike.fralick@mail.utoronto.ca		Sarma, Shohinee/0000-0001-6018-6036					0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					E71	E71		10.1056/NEJMicm2030770	http://dx.doi.org/10.1056/NEJMicm2030770		MAY 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD6UF	33983691				2022-12-28	WOS:000649041400001
J	Slomski, A				Slomski, Anita			Shorter Antibiotic Therapy Safe for Inpatients With Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2039	2039		10.1001/jama.2021.7721	http://dx.doi.org/10.1001/jama.2021.7721			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032831				2022-12-28	WOS:000655647300009
J	Sparrow, AK; Brosseau, LM; Harrison, RJ; Osterholm, MT				Sparrow, Annie K.; Brosseau, Lisa M.; Harrison, Robert J.; Osterholm, Michael T.			Protecting Olympic Participants from Covid-19-The Urgent Need for a Risk-Management Approach	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sparrow, Annie K.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Brosseau, Lisa M.; Osterholm, Michael T.] Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN USA; [Osterholm, Michael T.] Univ Minnesota, Div Environm Hlth Sci, Sch Publ Hlth, Minneapolis, MN USA; [Harrison, Robert J.] Univ Calif San Francisco, Div Occupat & Environm Med, San Francisco, CA 94143 USA	Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Sparrow, AK (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA.							International Olympic Committee and International Paralympic Committee, 2021, PLAYB ATHL OFF; Mack CD, 2021, MMWR-MORBID MORTAL W, V70, P130, DOI [10.15585/mmwr.mm7004e2externalicon, 10.15585/mmwr.mm7004e2]; Thermo Fisher scientific, 2021, SCI BRIEF SARS COV 2; World Health Organization, 2020, COVID 19 WHY IS IT M; World Health Organization, 2016, WHO CONV INT HLTH RE WHO CONV INT HLTH RE	5	18	18	3	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2021	385	1					E2	E2		10.1056/NEJMp2108567	http://dx.doi.org/10.1056/NEJMp2108567		MAY 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WU5EV	34033274	Bronze			2022-12-28	WOS:000656567200001
J	Samarasekera, U				Samarasekera, Udani			Yee-Sin Leo: a leader in Singapore's fight against infectious diseases	LANCET			English	Biographical-Item																		LEO YS, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1873	1873						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF1XN	34022976	Green Published, Bronze			2022-12-28	WOS:000652556000009
J	Iacobucci, G				Iacobucci, Gareth			GP leaders pass vote of no confidence in NHS England over appointments letter	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2021, GP LEAD DEL DAMN VOT; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1276; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1251; NHS England, 2021, GUID STAND OP PROC G; NHS England, 2021, LETT UPD STAND PROC	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2021	373								n1311	10.1136/bmj.n1311	http://dx.doi.org/10.1136/bmj.n1311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7ZT	34020983				2022-12-28	WOS:000656435600002
J	Mottl, O; Flantua, SGA; Bhatta, KP; Felde, VA; Giesecke, T; Goring, S; Grimm, EC; Haberle, S; Hooghiemstra, H; Ivory, S; Kunes, P; Wolters, S; Seddon, AWR; Williams, JW				Mottl, Ondrej; Flantua, Suzette G. A.; Bhatta, Kuber P.; Felde, Vivian A.; Giesecke, Thomas; Goring, Simon; Grimm, Eric C.; Haberle, Simon; Hooghiemstra, Henry; Ivory, Sarah; Kunes, Petr; Wolters, Steffen; Seddon, Alistair W. R.; Williams, John W.			Global acceleration in rates of vegetation change over the past 18,000 years	SCIENCE			English	Article							LAST GLACIAL MAXIMUM; NORTH-AMERICA; SOUTH-AMERICA; LAND-USE; CLIMATE; DATABASE; TRANSFORMATION; MIDHOLOCENE; ECOSYSTEMS; MEGAFAUNA	Global vegetation over the past 18,000 years has been transformed first by the climate changes that accompanied the last deglaciation and again by increasing human pressures; however, the magnitude and patterns of rates of vegetation change are poorly understood globally. Using a compilation of 1181 fossil pollen sequences and newly developed statistical methods, we detect a worldwide acceleration in the rates of vegetation compositional change beginning between 4.6 and 2.9 thousand years ago that is globally unprecedented over the past 18,000 years in both magnitude and extent. Late Holocene rates of change equal or exceed the deglacial rates for all continents, which suggests that the scale of human effects on terrestrial ecosystems exceeds even the climate-driven transformations of the last deglaciation. The acceleration of biodiversity change demonstrated in ecological datasets from the past century began millennia ago.	[Mottl, Ondrej; Flantua, Suzette G. A.; Bhatta, Kuber P.; Felde, Vivian A.; Seddon, Alistair W. R.] Univ Bergen, Dept Biol Sci, N-5020 Bergen, Norway; [Flantua, Suzette G. A.; Felde, Vivian A.; Seddon, Alistair W. R.] Univ Bergen, Bjerknes Ctr Climate Res, N-5020 Bergen, Norway; [Giesecke, Thomas] Univ Utrecht, Dept Phys Geog, NL-3508 TC Utrecht, Netherlands; [Goring, Simon; Williams, John W.] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Goring, Simon; Williams, John W.] Univ Wisconsin, Ctr Climat Res, Madison, WI USA; [Grimm, Eric C.] Univ Minnesota, Dept Earth & Environm Sci, Minneapolis, MN USA; [Haberle, Simon] Australian Natl Univ, Dept Archaeol & Nat Hist, Canberra, ACT 2601, Australia; [Haberle, Simon] Australian Natl Univ, Ctr Excellence Australian Biodivers & Heritage, Australian Res Council, Canberra, ACT 2601, Australia; [Hooghiemstra, Henry] Univ Amsterdam, Dept Ecosyst & Landscape Dynam, NL-1098 XH Amsterdam, Netherlands; [Ivory, Sarah] Penn State Univ, Dept Geosci, Earth & Environm Syst Inst EESI, University Pk, PA 16802 USA; [Kunes, Petr] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Wolters, Steffen] Lower Saxony Inst Hist Coastal Res, Wilhelmshaven, Germany	University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; Utrecht University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Australian National University; Australian National University; University of Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Charles University Prague	Mottl, O; Flantua, SGA (corresponding author), Univ Bergen, Dept Biol Sci, N-5020 Bergen, Norway.; Flantua, SGA (corresponding author), Univ Bergen, Bjerknes Ctr Climate Res, N-5020 Bergen, Norway.	ondrej.mottl@gmail.com; s.g.a.flantua@gmail.com	Flantua, Suzette/AAY-7004-2021; Mottl, Ondřej/AAC-7606-2019; Kuneš, Petr/C-7099-2008; Giesecke, Thomas/A-2450-2013	Flantua, Suzette/0000-0001-6526-3037; Mottl, Ondřej/0000-0002-9796-5081; Kuneš, Petr/0000-0001-9605-8204; Ivory, Sarah/0000-0003-4709-4406; Haberle, Simon/0000-0001-5802-6535; Bhatta, Kuber Prasad/0000-0001-7837-1395; Wolters, Steffen/0000-0003-3727-1982; Giesecke, Thomas/0000-0002-5132-1061	European Research Council (ERC) under the European Union [741413]; National Science Foundation [1550707, 1550805, 1948926]; Belmont Forum [1929476]	European Research Council (ERC) under the European Union(European Research Council (ERC)); National Science Foundation(National Science Foundation (NSF)); Belmont Forum	O.M., S.G.A.F., K.P.B., V.A.F., and A.W.R.S. acknowledge support from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 741413) to H. J. B. Birks. Neotoma development has been supported by the National Science Foundation (1550707, 1550805, and 1948926) and Belmont Forum (1929476).	Ahmed M, 2013, NAT GEOSCI, V6, P339, DOI [10.1038/NGEO1797, 10.1038/ngeo1797]; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Bevan A, 2017, P NATL ACAD SCI USA, V114, pE10524, DOI 10.1073/pnas.1709190114; Blois JL, 2011, QUATERNARY SCI REV, V30, P1926, DOI 10.1016/j.quascirev.2011.04.017; Blowes SA, 2019, SCIENCE, V366, P339, DOI 10.1126/science.aaw1620; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Charrad M, 2014, J STAT SOFTW, V61, P1; Dornelas M, 2018, GLOBAL ECOL BIOGEOGR, V27, P760, DOI 10.1111/geb.12729; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Flantua SGA, 2016, CLIM PAST, V12, P483, DOI 10.5194/cp-12-483-2016; Flantua SGA, 2016, CLIM PAST, V12, P387, DOI 10.5194/cp-12-387-2016; Flantua S. G. A., 2021, LATIN AM, DOI [10.6084/m9.figshare.13049735, DOI 10.6084/M9.FIGSHARE.13049735]; Flantua SGA, 2015, REV PALAEOBOT PALYNO, V223, P104, DOI 10.1016/j.revpalbo.2015.09.008; Fordham DA, 2020, SCIENCE, V369, P1072, DOI 10.1126/science.abc5654; Gavin DG, 2003, QUATERNARY RES, V60, P356, DOI 10.1016/S0033-5894(03)00088-7; Giesecke T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13233-y; Giesecke T, 2017, J BIOGEOGR, V44, P1441, DOI 10.1111/jbi.12974; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goring Simon, 2015, Open Quaternary, V1, P2, DOI 10.5334/oq.ab; Groot MHM, 2011, CLIM PAST, V7, P299, DOI 10.5194/cp-7-299-2011; Haslett J, 2008, J R STAT SOC C-APPL, V57, P399, DOI 10.1111/j.1467-9876.2008.00623.x; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Lotter AF, 1992, CLIM DYNAM, V6, P233, DOI 10.1007/BF00193536; MacDonald GM, 2008, PHILOS T R SOC B, V363, P2285, DOI 10.1098/rstb.2007.2200; Malhi Y, 2016, P NATL ACAD SCI USA, V113, P838, DOI 10.1073/pnas.1502540113; Marchant R, 2018, EARTH-SCI REV, V178, P322, DOI 10.1016/j.earscirev.2017.12.010; Marquer L, 2017, QUATERNARY SCI REV, V171, P20, DOI 10.1016/j.quascirev.2017.07.001; Marsicek J, 2018, NATURE, V554, P92, DOI 10.1038/nature25464; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Mayle FE, 2009, DEV PALEOENVIRON RES, V14, P89, DOI 10.1007/978-90-481-2672-9_4; McAndrews J.H., 1984, MCINTYRE SITE ARCHAE, P161; McGill BJ, 2015, TRENDS ECOL EVOL, V30, P104, DOI 10.1016/j.tree.2014.11.006; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Mottl O., 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4650239, DOI 10.5281/ZENODO.4650239]; Mottl O., 2021, 20201216422943 BIORX, DOI [10.1101/2020.12.16.422943, DOI 10.1101/2020.12.16.422943]; Munoz SE, 2010, P NATL ACAD SCI USA, V107, P22008, DOI 10.1073/pnas.1005764107; Munoz SE, 2010, HOLOCENE, V20, P967, DOI 10.1177/0959683610362815; Nolan C, 2018, SCIENCE, V361, P920, DOI 10.1126/science.aan5360; Oswald WW, 2020, NAT SUSTAIN, V3, P241, DOI 10.1038/s41893-019-0466-0; OVERPECK JT, 1985, QUATERNARY RES, V23, P87, DOI 10.1016/0033-5894(85)90074-2; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; PRENTICE IC, 1980, REV PALAEOBOT PALYNO, V31, P71, DOI 10.1016/0034-6667(80)90023-8; Ramankutty N, 1999, GLOBAL ECOL BIOGEOGR, V8, P381, DOI 10.1046/j.1365-2699.1999.00141.x; Riris P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43086-w; Roos CI, 2020, NAT SUSTAIN, V3, P898, DOI 10.1038/s41893-020-0579-5; Russell E. W. B., 1998, PEOPLE LAND TIME LIN; Seddon AWR, 2015, HOLOCENE, V25, P25, DOI 10.1177/0959683614556383; Shanahan TM, 2015, NAT GEOSCI, V8, P140, DOI [10.1038/ngeo2329, 10.1038/NGEO2329]; Shirkhorshidi AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144059; Simpson GL, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00149; Stephens L, 2019, SCIENCE, V365, P897, DOI 10.1126/science.aax1192; Tierney JE, 2020, NATURE, V584, P569, DOI 10.1038/s41586-020-2617-x; Trenberth KE, 2015, NAT CLIM CHANGE, V5, P725, DOI 10.1038/NCLIMATE2657; Vincens A, 2007, REV PALAEOBOT PALYNO, V145, P135, DOI 10.1016/j.revpalbo.2006.09.004; Wilkinson L., 2005, GRAMMAR GRAPHICS; Williams JW, 2018, QUATERNARY RES, V89, P156, DOI 10.1017/qua.2017.105; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Woodbridge J, 2021, J ECOL, V109, P1396, DOI 10.1111/1365-2745.13565; Wu HB, 2007, CLIM DYNAM, V29, P211, DOI 10.1007/s00382-007-0231-3; Zhang HW, 2019, QUATERNARY, V2, DOI 10.3390/quat2030026	64	45	47	43	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					860	+		10.1126/science.abg1685	http://dx.doi.org/10.1126/science.abg1685			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	34016781	Green Submitted			2022-12-28	WOS:000653997000047
J	Kuehn, BM				Kuehn, Bridget M.			Rare PEG Allergy Triggered Postvaccination Anaphylaxis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1931	1931		10.1001/jama.2021.7215	http://dx.doi.org/10.1001/jama.2021.7215			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003216				2022-12-28	WOS:000652675100022
J	Kuehn, BM				Kuehn, Bridget M.			Pandemic Contributes to Worse Pregnancy Outcomes Worldwide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1931	1931		10.1001/jama.2021.6448	http://dx.doi.org/10.1001/jama.2021.6448			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	34003217				2022-12-28	WOS:000652675100021
J	Best, J				Best, Jo			Who is hacking the NHS during a pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jo.best@journalist.com						[Anonymous], 2019, IMPR CYB SEC NHS; Department of Health and Social Care, 2018, LESS LEARN REV WANNA; Keen CE, 2019, APPL RADIOL; Murphy M, 2021, TELEGRAPH; National Cyber Security Centre, 2020, ADV APT GROUPS TARG; NHS Digital, 2020, SOLARWINDS OR SUPPL; O'Dowd A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2357; Security Intelligence, 2020, IBM UNC GLOB PHISH C	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2021	373								n1230	10.1136/bmj.n1230	http://dx.doi.org/10.1136/bmj.n1230			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF9HX	33990351				2022-12-28	WOS:000653058600005
J	Peterson, TJ; Saft, M; Peel, MC; John, A				Peterson, Tim J.; Saft, M.; Peel, M. C.; John, A.			Watersheds may not recover from drought	SCIENCE			English	Article							HIDDEN MARKOV MODEL; GLOBAL DROUGHT; CLIMATE; RUNOFF; SHIFTS; RESILIENCE	The Millennium Drought (southeastern Australia) provided a natural experiment to challenge the assumption that watershed streamflow always recovers from drought. Seven years after the drought, the runoff (as a fraction of precipitation) had not recovered in 37% of watersheds, and the number of recovered watersheds was not increasing. When recovery did occur, it was not explained by watershed wetness. For those watersheds not recovered, similar to 80% showed no evidence of recovering soon, suggesting persistence within a low-runoff state. The post-drought precipitation not going to runoff was found to be likely going to increased evapotranspiration per unit of precipitation. These findings show that watersheds can have a finite resilience to disturbances and suggest that hydrological droughts can persist indefinitely after meteorological droughts.	[Peterson, Tim J.] Monash Univ, Dept Civil Engn, Clayton, Vic, Australia; [Peterson, Tim J.; Saft, M.; Peel, M. C.; John, A.] Univ Melbourne, Dept Infrastruct Engn, Parkville, Vic, Australia	Monash University; University of Melbourne	Peterson, TJ (corresponding author), Monash Univ, Dept Civil Engn, Clayton, Vic, Australia.; Peterson, TJ (corresponding author), Univ Melbourne, Dept Infrastruct Engn, Parkville, Vic, Australia.	tim.peterson@monash.edu	Peel, Murray C/F-4621-2014; Peterson, Tim/D-4683-2015; Saft, Margarita/J-3856-2017	Peel, Murray C/0000-0002-3255-3692; John, Andrew/0000-0002-6919-3221; Peterson, Tim/0000-0002-1885-0826; Saft, Margarita/0000-0002-4011-4761	Victorian Government Department of Environment, Land, Water and Planning under the Victorian Water and Climate Initiative; Australian Research Council [FT120100130, LP180100796]	Victorian Government Department of Environment, Land, Water and Planning under the Victorian Water and Climate Initiative; Australian Research Council(Australian Research Council)	The majority of funding was received from the Victorian Government Department of Environment, Land, Water and Planning under the Victorian Water and Climate Initiative with recent supplemental support from the Australian Research Council (FT120100130 and LP180100796).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ault TR, 2020, SCIENCE, V368, P256, DOI 10.1126/science.aaz5492; Avanzi F, 2020, HYDROL EARTH SYST SC, V24, P4317, DOI 10.5194/hess-24-4317-2020; Box GEP, 2008, WILEY SERIES PROBABI; Brodribb TJ, 2020, SCIENCE, V368, P261, DOI 10.1126/science.aat7631; Brooks PD, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009762; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Caplan JS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6635; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Fowler KJA, 2016, WATER RESOUR RES, V52, P1820, DOI 10.1002/2015WR018068; Grafton RQ, 2019, NAT SUSTAIN, V2, P907, DOI 10.1038/s41893-019-0376-1; Han JT, 2020, WATER RESOUR RES, V56, DOI 10.1029/2020WR027392; Lambert MF, 2003, HYDROL EARTH SYST SC, V7, P652, DOI 10.5194/hess-7-652-2003; Lowe L, 2005, AUSTRALAS J WAT RESO, V9, P13, DOI 10.1080/13241583.2005.11465260; Ma XL, 2015, J GEOPHYS RES-BIOGEO, V120, P2036, DOI 10.1002/2015JG003144; Mullen KM, 2011, J STAT SOFTW, V40, P1; NATHAN RJ, 1990, WATER RESOUR RES, V26, P1465, DOI 10.1029/WR026i007p01465; Newton AC, 2016, CONSERV LETT, V9, P369, DOI 10.1111/conl.12227; Peterson TJ, 2014, WATER RESOUR RES, V50, P3010, DOI 10.1002/2012WR013004; Peterson TJ, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006886; Peterson TJ, 2020, HYDROL PROCESS, V34, DOI 10.1002/hyp.13637; Potter NJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010333; Saft M, 2015, WATER RESOUR RES, V51, P2444, DOI 10.1002/2014WR015348; Sawada Y, 2016, J GEOPHYS RES-BIOGEO, V121, P2312, DOI 10.1002/2016JG003356; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Thyer M, 2003, J HYDROL, V275, P12, DOI 10.1016/S0022-1694(02)00412-2; Tian W, 2018, J HYDROL, V565, P95, DOI 10.1016/j.jhydrol.2018.08.015; Troch PA, 2009, HYDROL PROCESS, V23, P2409, DOI 10.1002/hyp.7358; Ukkola AM, 2016, NAT CLIM CHANGE, V6, P75, DOI [10.1038/NCLIMATE2831, 10.1038/nclimate2831]; van Dijk AIJM, 2013, WATER RESOUR RES, V49, P1040, DOI 10.1002/wrcr.20123; Van Loon AF, 2012, HYDROL EARTH SYST SC, V16, P1915, DOI 10.5194/hess-16-1915-2012; Van Loon AF, 2015, WIRES WATER, V2, P359, DOI 10.1002/wat2.1085; Wei ZW, 2017, GEOPHYS RES LETT, V44, P2792, DOI 10.1002/2016GL072235; White M, A RYLAH I ENV RES TE, V311; Xu L, 2019, INT J CLIMATOL, V39, P2375, DOI 10.1002/joc.5958; Yang YT, 2017, WATER RESOUR RES, V53, P4821, DOI 10.1002/2017WR020683; Zucchini W, 2009, MONOGR STAT APPL PRO, V110, P3	38	45	45	30	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					745	+		10.1126/science.abd5085	http://dx.doi.org/10.1126/science.abd5085			428	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986181				2022-12-28	WOS:000651125300052
J	Gewin, V				Gewin, Virginia			HOW TO BLOW THE WHISTLE ON AN ACADEMIC BULLY	NATURE			English	Editorial Material																		Mahmoudi M, 2020, BIOIMPACTS, V10, P139, DOI 10.34172/bi.2020.17; OLAYACASTRO A, 2018, NATURE, V563, P616; PLANCK M, 2019, NATURE, V575, P403; PLANCK M, 2019, NATURE, V571, P14	4	4	4	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					299	301		10.1038/d41586-021-01252-z	http://dx.doi.org/10.1038/d41586-021-01252-z			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA6OC	33976423	Bronze			2022-12-28	WOS:000649420400019
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: NHS to trial rapid diagnostics and Saturday clinics to tackle elective care backlog	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, REST REC REST GETT U; NHS Confederation, 2021, COMMUNICATION	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2021	373								n1243	10.1136/bmj.n1243	http://dx.doi.org/10.1136/bmj.n1243			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3HS	33985984	Bronze			2022-12-28	WOS:000652650700001
J	Robbins, MS				Robbins, Matthew S.			Diagnosis and Management of Headache: A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY STANDARDS SUBCOMMITTEE; IDIOPATHIC INTRACRANIAL HYPERTENSION; EPISODIC MIGRAINE PREVENTION; AMERICAN ACADEMY; DOUBLE-BLIND; CARDIOVASCULAR-DISEASE; CONSENSUS STATEMENT; 5-HT1B/1D AGONISTS; CLUSTER HEADACHE; ADULTS REPORT	ImportanceApproximately 90% of people in the US experience headache during their lifetime. Migraine is the second leading cause of years lived with disability worldwide. ObservationsPrimary headache disorders are defined as headaches that are unrelated to an underlying medical condition and are categorized into 4 groups: migraine, tension-type headache, trigeminal autonomic cephalalgias, and other primary headache disorders. Studies evaluating prevalence in more than 100000 people reported that tension-type headache affected 38% of the population, while migraine affected 12% and was the most disabling. Secondary headache disorders are defined as headaches due to an underlying medical condition and are classified according to whether they are due to vascular, neoplastic, infectious, or intracranial pressure/volume causes. Patients presenting with headache should be evaluated to determine whether their headache is most likely a primary or a secondary headache disorder. They should be evaluated for symptoms or signs that suggest an urgent medical problem such as an abrupt onset, neurologic signs, age 50 years and older, presence of cancer or immunosuppression, and provocation by physical activities or postural changes. Acute migraine treatment includes acetaminophen, nonsteroidal anti-inflammatory drugs, and combination products that include caffeine. Patients not responsive to these treatments may require migraine-specific treatments including triptans (5-HT1B/D agonists), which eliminate pain in 20% to 30% of patients by 2 hours, but are accompanied by adverse effects such as transient flushing, tightness, or tingling in the upper body in 25% of patients. Patients with or at high risk for cardiovascular disease should avoid triptans because of vasoconstrictive properties. Acute treatments with gepants, antagonists to receptors for the inflammatory neuropeptide calcitonin gene-related peptide, such as rimegepant or ubrogepant, can eliminate headache symptoms for 2 hours in 20% of patients but have adverse effects of nausea and dry mouth in 1% to 4% of patients. A 5-HT1F agonist, lasmiditan, is also available for acute migraine treatment and appears safe in patients with cardiovascular risk factors. Preventive treatments include antihypertensives, antiepileptics, antidepressants, calcitonin gene-related peptide monoclonal antibodies, and onabotulinumtoxinA, which reduce migraine by 1 to 3 days per month relative to placebo. Conclusions and RelevanceHeadache disorders affect approximately 90% of people during their lifetime. Among primary headache disorders, migraine is most debilitating and can be treated acutely with analgesics, nonsteroidal anti-inflammatory drugs, triptans, gepants, and lasmiditan. This narrative review summarizes the clinical characteristics, pathophysiology, diagnosis, and acute and preventive treatment options for primary headache disorders (migraine, tension-type headache, trigeminal autonomic cephalalgias) and secondary causes.	[Robbins, Matthew S.] Weill Cornell Med Coll, Dept Neurol, New York, NY USA	Cornell University	Robbins, MS (corresponding author), Weill Cornell Med, 520 E 70th St,Starr Pavil 607, New York, NY 10021 USA.	mar9391@med.cornell.edu						Ailani J, 2020, HEADACHE, V60, P141, DOI 10.1111/head.13682; Ashina M, 2020, CEPHALALGIA, V40, P241, DOI 10.1177/0333102420905132; Ashina M, 2018, CEPHALALGIA, V38, P1611, DOI 10.1177/0333102418788347; Bendtsen L, 2010, EUR J NEUROL, V17, P1318, DOI 10.1111/j.1468-1331.2010.03070.x; Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Bigal ME, 2008, HEADACHE, V48, P1157, DOI 10.1111/j.1526-4610.2008.01217.x; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Buse DC, 2010, J NEUROL NEUROSUR PS, V81, P428, DOI 10.1136/jnnp.2009.192492; Buse DC, 2019, HEADACHE, V59, P306, DOI 10.1111/head.13459; Croop R, 2019, LANCET, V394, P737, DOI 10.1016/S0140-6736(19)31606-X; de Dhaem OB, 2020, HEADACHE, V60, P478, DOI 10.1111/head.13752; Detke HC, 2018, NEUROLOGY, V91, pE2211, DOI 10.1212/WNL.0000000000006640; Diener HC, 2019, LANCET NEUROL, V18, P891, DOI 10.1016/S1474-4422(19)30146-2; Digre KB, 2019, HEADACHE, V59, P1, DOI 10.1111/head.13456; Dodick D, 2004, HEADACHE, V44, P414, DOI 10.1111/j.1526-4610.2004.04078.x; Dodick DW, 2019, NEW ENGL J MED, V381, P2230, DOI 10.1056/NEJMoa1813049; Dodick DW, 2018, JAMA-J AM MED ASSOC, V319, P1999, DOI 10.1001/jama.2018.4853; Dodick DW, 2018, CEPHALALGIA, V38, P1026, DOI 10.1177/0333102418759786; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Dodick DW., 2003, ADV STUD MED, V3, P87; Ephross SA, 2014, HEADACHE, V54, P1158, DOI 10.1111/head.12375; Evans RW, 2020, HEADACHE, V60, P318, DOI 10.1111/head.13720; Evans RW, 2010, HEADACHE, V50, P1089, DOI 10.1111/j.1526-4610.2010.01691.x; Expert Panel on Neurologic Imaging, 2019, J Am Coll Radiol, V16, pS364, DOI 10.1016/j.jacr.2019.05.030; Favier I, 2007, ARCH NEUROL-CHICAGO, V64, P25, DOI 10.1001/archneur.64.1.25; Ferrari MD, 2001, LANCET, V358, P1668, DOI 10.1016/S0140-6736(01)06711-3; Ferrari MD, 2019, LANCET, V394, P1030, DOI 10.1016/S0140-6736(19)31946-4; Fischera M, 2008, CEPHALALGIA, V28, P614, DOI 10.1111/j.1468-2982.2008.01592.x; Friedman DI, 2017, HEADACHE, V57, P1195, DOI 10.1111/head.13153; Friedman DI, 2013, NEUROLOGY, V81, P1159, DOI 10.1212/WNL.0b013e3182a55f17; Garza Ivan, 2006, Neuropsychiatr Dis Treat, V2, P281, DOI 10.2147/nedt.2006.2.3.281; Giffin NJ, 2016, NEUROLOGY, V87, P309, DOI 10.1212/WNL.0000000000002789; Goadsby PJ, 2019, NEW ENGL J MED, V381, P132, DOI 10.1056/NEJMoa1813440; Goadsby PJ, 2019, BRAIN, V142, P1894, DOI 10.1093/brain/awz134; Goadsby PJ, 2017, NEW ENGL J MED, V377, P2123, DOI 10.1056/NEJMoa1705848; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; Goncalves AL, 2016, J NEUROL NEUROSUR PS, V87, P1127, DOI 10.1136/jnnp-2016-313458; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; Holroyd KA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4871; Iljazi A, 2020, CEPHALALGIA, V40, P818, DOI 10.1177/0333102420911461; Kranz PG, 2019, NEUROIMAG CLIN N AM, V29, P581, DOI 10.1016/j.nic.2019.07.006; Kuca B, 2018, NEUROLOGY, V91, pE2222, DOI 10.1212/WNL.0000000000006641; Kurth T, 2020, JAMA-J AM MED ASSOC, V323, P2281, DOI 10.1001/jama.2020.7172; Linde K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007587.pub2; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Lipton RB, 2000, HEADACHE, V40, P783, DOI 10.1046/j.1526-4610.2000.00143.x; Lipton RB, 2020, NEUROLOGY, V94, pE1365, DOI 10.1212/WNL.0000000000009169; Lipton RB, 2019, JAMA-J AM MED ASSOC, V322, P1887, DOI 10.1001/jama.2019.16711; Lipton RB, 2019, NEW ENGL J MED, V381, P142, DOI 10.1056/NEJMoa1811090; Lipton RB, 2016, HEADACHE, V56, P1635, DOI 10.1111/head.12941; Loder E, 2010, NEW ENGL J MED, V363, P63, DOI 10.1056/NEJMct0910887; Manack A, 2011, NEUROLOGY, V76, P711, DOI 10.1212/WNL.0b013e31820d8af2; Marmura MJ, 2015, HEADACHE, V55, P3, DOI 10.1111/head.12499; McCluskey G, 2018, EUR J NEUROL, V25, P1218, DOI 10.1111/ene.13739; Minen MT, 2020, HEADACHE, V60, P1093, DOI 10.1111/head.13790; Munjal S, 2020, HEADACHE, V60, P416, DOI 10.1111/head.13708; Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202; Orlova Y, 2018, JAMA NEUROL, V75, P566, DOI 10.1001/jamaneurol.2017.5144; Pavlovic JM, 2017, J NEUROSCI RES, V95, P587, DOI 10.1002/jnr.23903; Pavlovic JM, 2014, HEADACHE, V54, P1670, DOI 10.1111/head.12468; Pringsheim T, 2012, CAN J NEUROL SCI, V39, pS1; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; Reuter U, 2018, LANCET, V392, P2280, DOI 10.1016/S0140-6736(18)32534-0; Robbins MS, 2010, NEUROLOGY, V74, P1358, DOI 10.1212/WNL.0b013e3181dad5de; Robbins MS, 2020, NEUROLOGY, V95, P866, DOI 10.1212/WNL.0000000000010634; Robbins MS, 2016, HEADACHE, V56, P1093, DOI 10.1111/head.12866; Robbins MS, 2015, NEUROLOGY, V85, P1024, DOI 10.1212/WNL.0000000000001954; Robbins MS, 2014, HEADACHE, V54, P1441, DOI 10.1111/head.12442; Robbins MS, 2010, DRUG AGING, V27, P377, DOI 10.2165/11315980-000000000-00000; Robbins MS, 2010, SEMIN NEUROL, V30, P107, DOI 10.1055/s-0030-1249220; Rothrock JF, 2019, HEADACHE, V59, P1700, DOI 10.1111/head.13653; Sacco S, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0815-1; Schievink Wouter I, 2007, J Headache Pain, V8, P325, DOI 10.1007/s10194-007-0421-8; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Seng EK, 2019, HEADACHE, V59, P1448, DOI 10.1111/head.13657; Shapiro RE, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1044-6; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 2017, NEW ENGL J MED, V377, P2113, DOI 10.1056/NEJMoa1709038; Singh RBH, 2019, HEADACHE, V59, P33, DOI 10.1111/head.13586; Skljarevski V, 2018, CEPHALALGIA, V38, P1442, DOI 10.1177/0333102418779543; Smith JH, 2014, HEADACHE, V54, P1273, DOI 10.1111/head.12425; Stauffer VL, 2018, JAMA NEUROL, V75, P1080, DOI 10.1001/jamaneurol.2018.1212; Stovner LJ, 2014, CEPHALALGIA, V34, P523, DOI 10.1177/0333102413515348; Szperka CL, 2020, HEADACHE, V60, P833, DOI 10.1111/head.13810; Tepper S, 2017, LANCET NEUROL, V16, P425, DOI 10.1016/S1474-4422(17)30083-2; Tepper SJ, 2019, NEUROLOGY, V92, pE2309, DOI 10.1212/WNL.0000000000007497; Do TP, 2019, NEUROLOGY, V92, P134, DOI 10.1212/WNL.0000000000006697; Valentinis L, 2010, CEPHALALGIA, V30, P389, DOI 10.1111/j.1468-2982.2009.01970.x; Vgontzas A, 2018, HEADACHE, V58, P845, DOI 10.1111/head.13279; Wall M, 2014, JAMA-J AM MED ASSOC, V311, P1641, DOI 10.1001/jama.2014.3312; Wells RE, 2021, JAMA INTERN MED, V181, P317, DOI 10.1001/jamainternmed.2020.7090; Young WB, 2013, NEUROL PRACT, P125	93	31	33	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1874	1885		10.1001/jama.2021.1640	http://dx.doi.org/10.1001/jama.2021.1640			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33974014				2022-12-28	WOS:000650205000016
J	Baraniuk, C				Baraniuk, Chris			Where are we with drug treatments for covid-19?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												chrisbaraniuk@gmail.com						Dyer O, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4057; Kupferschmidt K., 2021, SCIENCE; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1422; Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1077; Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3472; National Institute for Health Research, 2021, RECOVERY TRIAL SHOWS; NHS England, 2021, COV TREATM DEV NHS S; NHS England, 2020, COV 19 THER CORT INC; NHS England, 2021, INT CLIN COMM POL TO; RECOVERY, 2021, **NON-TRADITIONAL**; Wadvalla BA, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n747; Yu L-M, 2021, INHALED BUDESONIDE C, DOI [10.1101/2021.04.10.21254672, DOI 10.1101/2021.04.10.21254672]	12	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2021	373								n1109	10.1136/bmj.n1109	http://dx.doi.org/10.1136/bmj.n1109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QT	33962913	Bronze			2022-12-28	WOS:000649708700010
J	Arnold, DT; Milne, A; Samms, E; Stadon, L; Maskell, NA; Hamilton, FW				Arnold, David T.; Milne, Alice; Samms, Emma; Stadon, Louise; Maskell, Nick A.; Hamilton, Fergus W.			Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series	ANNALS OF INTERNAL MEDICINE			English	Letter									[Arnold, David T.; Milne, Alice; Stadon, Louise; Maskell, Nick A.; Hamilton, Fergus W.] North Bristol NHS Trust, Bristol, Avon, England	North Bristol NHS Trust	Maskell, NA (corresponding author), Southmead Hosp, Acad Resp Unit, Clin Res Ctr, Bristol BS10 5NB, Avon, England.	nick.maskell@bristol.ac.uk		maskell, nick/0000-0002-1276-6500; Hamilton, Fergus/0000-0002-9760-4059; Arnold, David/0000-0003-3158-7740; Milne, Alice/0000-0002-1543-6355				Arnold DT, 2021, THORAX, V76, P399, DOI 10.1136/thoraxjnl-2020-216086; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Maglinte GA, 2012, J CLIN EPIDEMIOL, V65, P497, DOI 10.1016/j.jclinepi.2011.09.008; Menni C, 2021, LANCET INFECT DIS, V21, P939, DOI 10.1016/S1473-3099(21)00224-3; Vaughan A, 2020, NEW SCI, V245, P12, DOI 10.1016/S0262-4079(20)32025-X	5	25	25	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP	2021	174	9					1334	+		10.7326/M21-1976	http://dx.doi.org/10.7326/M21-1976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XA5GQ	34029484	Green Published			2022-12-28	WOS:000720675500042
J	Chou, SH; McWilliams, A; Murphy, S; Sitammagari, K; Liu, TL; Hole, C; Kowalkowski, M				Chou, Shih-Hsiung; McWilliams, Andrew; Murphy, Stephanie; Sitammagari, Kranthi; Liu, Tsai-Ling; Hole, Colleen; Kowalkowski, Marc			Factors Associated With Risk for Care Escalation Among Patients With COVID-19 Receiving Home-Based Hospital Care	ANNALS OF INTERNAL MEDICINE			English	Letter									[Chou, Shih-Hsiung; McWilliams, Andrew; Murphy, Stephanie; Sitammagari, Kranthi; Liu, Tsai-Ling; Hole, Colleen; Kowalkowski, Marc] Atrium Hlth, Charlotte, NC USA		Chou, SH (corresponding author), Ctr Outcomes Res & Evaluat CORE, 1300 Scott Ave,Suite 126, Charlotte, NC 28204 USA.	Shih-Hsiung.Chou@atriumhealth.org	Sitammagari, Kranthi/A-1981-2019	Sitammagari, Kranthi/0000-0002-1553-2742; Liu, Tsai-Ling/0000-0001-6661-082X; Chou, Shih-Hsiung/0000-0001-5414-1958; Hole, Colleen/0000-0002-4863-5043; Kowalkowski, Marc/0000-0003-2624-4209				Associated Press, 2021, ASS PRESS; Berkowitz SA, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2021209; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Sitammagari K, 2021, ANN INTERN MED, V174, P192, DOI 10.7326/M20-4076; WYNANTS L, 2020, BMJ-BRIT MED J, V369	5	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG	2021	174	8					1188	+		10.7326/M21-0409	http://dx.doi.org/10.7326/M21-0409			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP3IW	33971099	Green Published			2022-12-28	WOS:000695277800040
J	Bi, GZ; Su, M; Li, N; Liang, Y; Dang, S; Xu, JC; Hu, MJ; Wang, JZ; Zou, MX; Deng, YA; Li, QY; Huang, SJ; Li, JJ; Chai, JJ; He, KM; Chen, YH; Zhou, JM				Bi, Guozhi; Su, Min; Li, Nan; Liang, Yu; Dang, Song; Xu, Jiachao; Hu, Meijuan; Wang, Jizong; Zou, Minxia; Deng, Yanan; Li, Qiyu; Huang, Shijia; Li, Jiejie; Chai, Jijie; He, Kangmin; Chen, Yu-hang; Zhou, Jian-Min			The ZAR1 resistosome is a calcium-permeable channel triggering plant immune signaling	CELL			English	Article							SINGLE-MOLECULE ANALYSIS; DISEASE RESISTANCE GENE; PLASMA-MEMBRANE; OXIDATIVE BURST; ARABIDOPSIS; EFFECTOR; DYNAMICS; PROTEIN; PSEUDOKINASE; RECOGNITION	Nucleotide-binding, leucine-rich repeat receptors (NLRs) are major immune receptors in plants and animals. Upon activation, the Arabidopsis NLR protein ZAR1 forms a pentameric resistosome in vitro and triggers immune responses and cell death in plants. In this study, we employed single-molecule imaging to show that the activated ZAR1 protein can form pentameric complexes in the plasma membrane, The ZAR1 resistosome displayed ion channel activity in Xenopus oocytes in a manner dependent on a conserved acidic residue Glu11 situated in the channel pore. Pre-assembled ZAR1 resistosome was readily incorporated into planar lipid-bilayers and displayed calcium-permeable cation-selective channel activity. Furthermore, we show that activation of ZAR1 in the plant cell led to Glu11 -dependent Ca2+ influx, perturbation of subcellular structures, production of reactive oxygen species, and cell death. The results thus support that the ZAR1 resisto-some acts as a calcium-permeable cation channel to trigger immunity and cell death.	[Bi, Guozhi; Hu, Meijuan; Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Su, Min; Li, Nan; Liang, Yu; Dang, Song; Xu, Jiachao; Deng, Yanan; Li, Qiyu; He, Kangmin; Chen, Yu-hang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [He, Kangmin; Chen, Yu-hang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Jizong] Peking Univ, Sch Adv Agr Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Zou, Minxia; Li, Jiejie] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Zou, Minxia; Li, Jiejie] Beijing Normal Univ, Coll Life Sci, Key Lab Cell Proliferat & Regulat, Minist Educ, Beijing 100875, Peoples R China; [Huang, Shijia; Chai, Jijie] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Ctr Plant Biol,Sch Life Sci, Beijing 100084, Peoples R China; [Chai, Jijie] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Chai, Jijie] Univ Cologne, Inst Biochem, Zuelpicher Str 47, D-50674 Cologne, Germany; [He, Kangmin; Chen, Yu-hang; Zhou, Jian-Min] Chinese Acad Sci, Innovat Acad Seed Design, Beijing 100101, Peoples R China; [Zhou, Jian-Min] Univ Chinese Acad Sci, CAS Ctr Excellence Biot Interact, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Beijing Normal University; Beijing Normal University; Tsinghua University; Max Planck Society; University of Cologne; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, JM (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China.; He, KM; Chen, YH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; He, KM; Chen, YH (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Chai, JJ (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Ctr Plant Biol,Sch Life Sci, Beijing 100084, Peoples R China.; Chai, JJ (corresponding author), Max Planck Inst Plant Breeding Res, Cologne, Germany.; Chai, JJ (corresponding author), Univ Cologne, Inst Biochem, Zuelpicher Str 47, D-50674 Cologne, Germany.; He, KM; Chen, YH; Zhou, JM (corresponding author), Chinese Acad Sci, Innovat Acad Seed Design, Beijing 100101, Peoples R China.; Zhou, JM (corresponding author), Univ Chinese Acad Sci, CAS Ctr Excellence Biot Interact, Beijing 100049, Peoples R China.	chaijj@tsinghua.edu.cn; kmhe@genetics.ac.cn; yuhang.chen@genetics.ac.cn; jmzhou@genetics.ac.cn	Li, Nan/ABF-1880-2021; bi, guozhi/CAG-5945-2022	bi, guozhi/0000-0002-7232-8887; Deng, Yanan/0000-0002-1383-4368; Wang, Jizong/0000-0003-1085-5347; Hu, Meijuan/0000-0001-5326-0816	National Natural Science Foundation of China [31830019, 31521001, 91957106, 31970659, 31900222, 32000557, 22004129]; National Key Research and Development Program of China [2020YFA0509903, 2016YFA0500503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	We thank Paul Schulze-Lefert and Sheng Yang He for helpful discussions and Yan Guo and Hai-Lei Wei for providing genetic materials. The work was supported by the National Natural Science Foundation of China (31830019 and 31521001 to J.-M.Z, 91957106 and 31970659 to K.H., 31900222 to G.B., 32000557 to N.L., and 22004129 to J.X.) and the National Key Research and Development Program of China (2020YFA0509903 and 2016YFA0500503 to Y.-h.C.).	Adachi H, 2019, ELIFE, V8, DOI 10.7554/eLife.49956; Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Bentham AR, 2018, PLANT CELL PHYSIOL, V59, P2398, DOI 10.1093/pcp/pcy185; Burdett H, 2019, CELL HOST MICROBE, V26, P193, DOI 10.1016/j.chom.2019.07.020; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Chen YH, 2010, NATURE, V467, P1074, DOI 10.1038/nature09487; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Demidchik V, 2018, NEW PHYTOL, V220, P49, DOI 10.1111/nph.15266; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; FRIEL DD, 1989, P NATL ACAD SCI USA, V86, P5207, DOI 10.1073/pnas.86.13.5207; Ghosh D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07111; Gillespie D, 2009, BIOPHYS J, V97, P2212, DOI 10.1016/j.bpj.2009.08.009; GOPRIMEMEZGOPRI.L, 2000, MOL CELL, V5, P1003; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; HALL JE, 1984, BIOPHYS J, V45, P233, DOI 10.1016/S0006-3495(84)84151-X; Hara-Nishimura I, 2011, CELL DEATH DIFFER, V18, P1298, DOI 10.1038/cdd.2011.70; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hatsugai N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00234; Hatsugai N, 2009, GENE DEV, V23, P2496, DOI 10.1101/gad.1825209; He KM, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201908142; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Hu MJ, 2020, MOL PLANT, V13, P793, DOI 10.1016/j.molp.2020.03.004; Jacobson K, 2019, CELL, V177, P806, DOI 10.1016/j.cell.2019.04.018; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Jubic LM, 2019, CURR OPIN PLANT BIOL, V50, P82, DOI 10.1016/j.pbi.2019.03.013; Kamoun S., 2020, JURASSIC NLR CONSERV, DOI 10. 12.333484; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Laflamme B, 2020, SCIENCE, V367, P763, DOI 10.1126/science.aax4079; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Lewis JD, 2008, J BACTERIOL, V190, P2880, DOI 10.1128/JB.01702-07; Lewis JD, 2013, P NATL ACAD SCI USA, V110, P18722, DOI 10.1073/pnas.1315520110; Lewis JD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000894; Li XJ, 2011, PLANT CELL, V23, P3780, DOI 10.1105/tpc.111.091454; Liu X, 2020, ANNU REV IMMUNOL, V38, P455, DOI 10.1146/annurev-immunol-111319-023800; Ma SC, 2020, SCIENCE, V370, P1184, DOI 10.1126/science.abe3069; Ma WB, 2006, PLOS GENET, V2, P2131, DOI 10.1371/journal.pgen.0020209; Martel A, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.01290; Martin R, 2020, SCIENCE, V370, P1185, DOI 10.1126/science.abd9993; Miura Kota, 2020, F1000Res, V9, P1494, DOI 10.12688/f1000research.27171.1; Mukhtar MS, 2016, CURR BIOL, V26, pR608, DOI 10.1016/j.cub.2016.02.051; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Pitsili E, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036483; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Redinbo M., 2021, PLANT IMMUNE RECEPTO, DOI [10.1101/2021.02.25.431980, DOI 10.1101/2021.02.25.431980]; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schultink A, 2019, NEW PHYTOL, V221, P1001, DOI 10.1111/nph.15411; Segami S, 2014, PLANT CELL, V26, P3416, DOI 10.1105/tpc.114.127571; Seto D, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.27; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Thor K, 2020, NATURE, V585, P569, DOI 10.1038/s41586-020-2702-1; Tian W, 2020, NAT PLANTS, V6, P750, DOI 10.1038/s41477-020-0667-6; Tian W, 2019, NATURE, V572, P131, DOI 10.1038/s41586-019-1413-y; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Wang GX, 2015, CELL HOST MICROBE, V18, P285, DOI 10.1016/j.chom.2015.08.004; Wang JC, 2019, CELL RES, V29, P820, DOI 10.1038/s41422-019-0219-7; Wang JZ, 2019, SCIENCE, V364, P44, DOI 10.1126/science.aav5870; Wang XH, 2019, P NATL ACAD SCI USA, V116, P4238, DOI 10.1073/pnas.1817271116; Wei HL, 2015, CELL HOST MICROBE, V17, P752, DOI 10.1016/j.chom.2015.05.007; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Xia BQ, 2016, CELL RES, V26, P517, DOI 10.1038/cr.2016.26; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu X, 2019, CURR BIOL, V29, P3778, DOI 10.1016/j.cub.2019.09.018; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang YY, 2018, CELL RES, V28, P9, DOI 10.1038/cr.2017.133; Zhou JM, 2020, CELL, V181, P978, DOI 10.1016/j.cell.2020.04.028	76	122	127	64	177	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2021	184	13					3528	+		10.1016/j.cell.2021.05.003	http://dx.doi.org/10.1016/j.cell.2021.05.003		JUN 2021	26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SX9WL	33984278	Bronze			2022-12-28	WOS:000665547300017
J	Williams, WB; Meyerhoff, RR; Edwards, RJ; Li, H; Manne, K; Nicely, NI; Henderson, R; Zhou, Y; Janowska, K; Mansouri, K; Gobeil, S; Evangelous, T; Hora, B; Berry, M; Abuahmad, AY; Sprenz, J; Deyton, M; Stalls, V; Kopp, M; Hsu, AL; Borgnia, MJ; Stewart-Jones, GBE; Lee, MS; Bronkema, N; Moody, MA; Wiehe, K; Bradley, T; Alam, SM; Parks, RJ; Foulger, A; Oguin, T; Sempowski, GD; Bonsignori, M; LaBranche, CC; Montefiori, DC; Seaman, M; Santra, S; Perfect, J; Francica, JR; Lynn, GM; Aussedat, B; Walkowicz, WE; Laga, R; Kelsoe, G; Saunders, KO; Fera, D; Kwong, PD; Seder, RA; Bartesaghi, A; Shaw, GM; Acharya, P; Haynes, BF				Williams, Wilton B.; Meyerhoff, R. Ryan; Edwards, R. J.; Li, Hui; Manne, Kartik; Nicely, Nathan, I; Henderson, Rory; Zhou, Ye; Janowska, Katarzyna; Mansouri, Katayoun; Gobeil, Sophie; Evangelous, Tyler; Hora, Bhavna; Berry, Madison; Abuahmad, A. Yousef; Sprenz, Jordan; Deyton, Margaret; Stalls, Victoria; Kopp, Megan; Hsu, Allen L.; Borgnia, Mario J.; Stewart-Jones, Guillaume B. E.; Lee, Matthew S.; Bronkema, Naomi; Moody, M. Anthony; Wiehe, Kevin; Bradley, Todd; Alam, S. Munir; Parks, Robert J.; Foulger, Andrew; Oguin, Thomas; Sempowski, Gregory D.; Bonsignori, Mattia; LaBranche, Celia C.; Montefiori, David C.; Seaman, Michael; Santra, Sampa; Perfect, John; Francica, Joseph R.; Lynn, Geoffrey M.; Aussedat, Baptiste; Walkowicz, William E.; Laga, Richard; Kelsoe, Garnett; Saunders, Kevin O.; Fera, Daniela; Kwong, Peter D.; Seder, Robert A.; Bartesaghi, Alberto; Shaw, George M.; Acharya, Priyamvada; Haynes, Barton F.			Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies	CELL			English	Article							BROADLY NEUTRALIZING ANTIBODIES; CELL ANTIGEN RECEPTOR; HIV-1 ENV; CANDIDA-ALBICANS; ENVELOPE GLYCANS; 2G12 RECOGNIZES; B-CELLS; POTENT; COMPLEX; EPITOPE	Natural antibodies (Abs) can target host glycans on the surface of pathogens. We studied the evolution of glycan-reactive B cells of rhesus macaques and humans using glycosylated HIV-1 envelope (Env) as a model antigen. 2G12 is a broadly neutralizing Ab (bnAb) that targets a conserved glycan patch on Env of geographically diverse HIV-1 strains using a unique heavy-chain (VH) domain-swapped architecture that results in fragment antigen-binding (Fab) dimerization. Here, we describe HIV-1 Env Fab-dimerized glycan (FDG)-reactive bnAbs without VH-swapped domains from simian-human immunodeficiency virus (SHIV)-infected macaques. FDG Abs also recognized cell-surface glycans on diverse pathogens, including yeast and severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) spike. FDG precursors were expanded by glycan-bearing immunogens in macaques and were abundant in HIV-1-naive humans. Moreover, FDG precursors were predominately mutated IgM(+) IgD(+)CD27(+), thus suggesting that they originated from a pool of antigen-experienced IgM(+) or marginal zone B cells.	[Williams, Wilton B.; Meyerhoff, R. Ryan; Edwards, R. J.; Manne, Kartik; Nicely, Nathan, I; Henderson, Rory; Janowska, Katarzyna; Mansouri, Katayoun; Gobeil, Sophie; Evangelous, Tyler; Hora, Bhavna; Berry, Madison; Abuahmad, A. Yousef; Sprenz, Jordan; Deyton, Margaret; Stalls, Victoria; Kopp, Megan; Moody, M. Anthony; Wiehe, Kevin; Bradley, Todd; Alam, S. Munir; Parks, Robert J.; Foulger, Andrew; Oguin, Thomas; Sempowski, Gregory D.; Bonsignori, Mattia; Montefiori, David C.; Kelsoe, Garnett; Saunders, Kevin O.; Acharya, Priyamvada; Haynes, Barton F.] Duke Human Vaccine Inst, Durham, NC 27710 USA; [Williams, Wilton B.; Meyerhoff, R. Ryan; Edwards, R. J.; Henderson, Rory; Wiehe, Kevin; Alam, S. Munir; Sempowski, Gregory D.; Bonsignori, Mattia; Perfect, John; Haynes, Barton F.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Moody, M. Anthony; Kelsoe, Garnett; Saunders, Kevin O.; Haynes, Barton F.] Duke Univ, Dept Immunol, Durham, NC 27710 USA; [LaBranche, Celia C.; Montefiori, David C.; Saunders, Kevin O.; Acharya, Priyamvada] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Moody, M. Anthony] Duke Univ, Dept Pediat, Durham, NC 27710 USA; [Li, Hui; Shaw, George M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hsu, Allen L.; Borgnia, Mario J.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Stewart-Jones, Guillaume B. E.; Francica, Joseph R.; Lynn, Geoffrey M.; Kwong, Peter D.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Lee, Matthew S.] Boston Childrens Hosp, Boston, MA 02115 USA; [Lee, Matthew S.] Harvard Med Sch, Boston, MA 02115 USA; [Bronkema, Naomi; Fera, Daniela] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA; [Seaman, Michael; Santra, Sampa] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Seaman, Michael; Santra, Sampa] Harvard Med Sch, Boston, MA 02215 USA; [Aussedat, Baptiste; Walkowicz, William E.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Laga, Richard] Czech Acad Sci, Inst Macromol Chem, Prague, Czech Republic; [Lynn, Geoffrey M.] Avidea Technol Inc, Baltimore, MD USA; [Zhou, Ye; Bartesaghi, Alberto] Duke Univ, Dept Comp Sci, Durham, NC 27708 USA; [Bartesaghi, Alberto] Duke Univ, Dept Biochem, Durham, NC 27705 USA; [Bartesaghi, Alberto] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA; [Nicely, Nathan, I] Univ N Carolina, Chapel Hill, NC 27599 USA; [Bradley, Todd] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Aussedat, Baptiste; Walkowicz, William E.] Chemitope Glycopeptide, Brooklyn, NY 11220 USA; [Meyerhoff, R. Ryan] Duke Univ, Dept Radiol, Div Intervent Radiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Swarthmore College; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Children's Mercy Hospital; Duke University	Williams, WB (corresponding author), Duke Human Vaccine Inst, Durham, NC 27710 USA.	wilton.williams@duke.edu; priyamvada.acharya@duke.edu; hayne002@mc.duke.edu	Laga, Richard/G-3627-2014; , PEP-MX Core/AGV-4051-2022	Manne, Kartik/0000-0002-7218-4852; Kelsoe, Garnett/0000-0002-8770-040X; Aussedat, Baptiste/0000-0002-8828-8963; Meyerhoff, Ryan/0000-0003-1253-2250; Sempowski, Gregory/0000-0003-0391-6594; Zhou, Ye/0000-0002-0489-3614; Acharya, Priyamvada/0000-0002-0089-277X; Nicely, Nathan/0000-0002-0025-2377; Oguin, Thomas/0000-0001-8959-4025; Mansouri, Katayoun/0000-0001-6232-7330; Edwards, Robert/0000-0003-4446-1194; Stalls, Victoria/0000-0002-1878-0581	NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program [U24 GM129539]; Simons Foundation [SF349247]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NIH, NIAID, DAIDS grants Center for HIV/Vaccine Immunology-Immunogen Discovery (CHAVI-ID) [UM1-AI100645]; Consortia for HIV/AIDS Vaccine Development (CHAVD) [UM-1AI44371]; NIH [R01-AI145687, R01-AI140897, R01-AI128832, R01-AI120801]; Translating Duke Health Initiative; MSTP [T32GM007171]; NIAID [F30-AI22982-0, P01-AI131251]; DARPA [N6600109-C-2082]; NIH/NIAID [UC6AI058607, HHSN272201800004C]; Duke CFAR; Intramural Research Program of the VRC, NIAID, NIH; amfAR; Swarthmore College Startup and Faculty Research Funds [109502-61-RKVA]	NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH, NIAID, DAIDS grants Center for HIV/Vaccine Immunology-Immunogen Discovery (CHAVI-ID); Consortia for HIV/AIDS Vaccine Development (CHAVD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translating Duke Health Initiative; MSTP; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Duke CFAR; Intramural Research Program of the VRC, NIAID, NIH; amfAR; Swarthmore College Startup and Faculty Research Funds	We thank the DHVI teams from Program Management, Computational Biology, and the Biostatistics Center for their support. Thomas B. Kepler provided computational support, and Charles Giamberardino and Jennifer Tenor generated heat-killed yeast antigens. The following individuals provided technical assistance: Andy (Shi) Huang, Shi-Mao Xia, Melissa Cooper, Kara Anasti, Maggie Barr, Callie Vivian, Giovanna Hernandez, Esther Lee, Aja Sanzone, and Paige Rawls. Cryo-EM data were collected at the Shared Materials Instrumentation Facility at Duke University and National Center for CryoEM Access and Training and the Simons Electron Microscopy Center located at the New York Structural Biology Center, supported by the NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program (U24 GM129539) and by grants from the Simons Foundation (SF349247). The adjuvant GLASE was provided by Infectious Disease Research Institute, Seattle, WA 98102, USA; Christopher Fox and Steve Reed. The use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences (contract W-31-109-Eng-38). This study utilized the computational resources offered by Duke Research Computing (https://rc.duke.edu).This work was funded by NIH, NIAID, DAIDS grants Center for HIV/Vaccine Immunology-Immunogen Discovery (CHAVI-ID) (UM1-AI100645) and Consortia for HIV/AIDS Vaccine Development (CHAVD) (UM-1AI44371) to B.F.H.; NIH (R01-AI145687 to P.A., R01-AI140897 to W.B.W., R01-AI128832 to G.K., and R01-AI120801 to K.O.S.); Translating Duke Health Initiative (to P.A.); MSTP (T32GM007171 to R.R.M.); NIAID (F30-AI22982-0 to R.R.M. and P01-AI131251 to G.M.S.); DARPA (N6600109-C-2082 to G.D.S.); NIH/NIAID (UC6AI058607 to G.D.S. and HHSN272201800004C to C.C.L.); Duke CFAR; Intramural Research Program of the VRC, NIAID, NIH (to G.B.E.S.-J. and P.D.K.); and amfAR and Swarthmore College Startup and Faculty Research Funds (109502-61-RKVA to D.F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam SM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7521; Alam SM, 2013, J VIROL, V87, P1554, DOI 10.1128/JVI.00718-12; Alexander J, 2000, J IMMUNOL, V164, P1625, DOI 10.4049/jimmunol.164.3.1625; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Baumgarth N, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00324; Blazkova J, 2019, J CLIN INVEST, V129, P4832, DOI 10.1172/JCI125955; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Bonsignori M, 2018, IMMUNITY, V49, P1162, DOI 10.1016/j.immuni.2018.10.015; Bonsignori M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7514; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Bradley T, 2018, CELL, V175, P387, DOI 10.1016/j.cell.2018.08.064; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Buchner C, 2014, JOVE-J VIS EXP, DOI 10.3791/51211; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954; CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056; Chuang GY, 2019, STRUCTURE, V27, P196, DOI 10.1016/j.str.2018.10.007; Corcoran MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13642; Crispin M, 2018, ANNU REV BIOPHYS, V47, P499, DOI 10.1146/annurev-biophys-060414-034156; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Daniels CN, 2019, ADV IMMUNOL, V143, P11, DOI 10.1016/bs.ai.2019.08.002; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Doores KJ, 2015, FEBS J, V282, P4679, DOI 10.1111/febs.13530; Doores KJ, 2013, J VIROL, V87, P2234, DOI 10.1128/JVI.02820-12; Doores KJ, 2010, J VIROL, V84, P10690, DOI 10.1128/JVI.01110-10; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Edwards RJ, 2021, NAT STRUCT MOL BIOL, V28, P128, DOI 10.1038/s41594-020-00547-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fera D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03565-6; Francica JR, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000328; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Hall RA, 2013, MOL MICROBIOL, V90, P1147, DOI 10.1111/mmi.12426; Havenar-Daughton C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0381; Haynes BF, 2014, SCIENCE, V344, P588, DOI 10.1126/science.1254990; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Holodick NE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00872; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huber M, 2010, J VIROL, V84, P10700, DOI 10.1128/JVI.01111-10; Ichikawa D, 2015, J IMMUNOL, V194, P606, DOI 10.4049/jimmunol.1402383; Imkeller K, 2018, SCIENCE, V360, P1358, DOI 10.1126/science.aar5304; Kepler TB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00170; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; LaBranche CC, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008026; LALOR PA, 1989, EUR J IMMUNOL, V19, P507, DOI 10.1002/eji.1830190315; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee CCD, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009407; Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Liu MF, 2015, J VIROL, V89, P784, DOI 10.1128/JVI.02378-14; Lynn GM, 2015, NAT BIOTECHNOL, V33, P1201, DOI 10.1038/nbt.3371; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Masuoka J, 2004, CLIN MICROBIOL REV, V17, P281, DOI 10.1128/CMR.17.2.281-310.2004; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moody MA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag0851; Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; New JS, 2016, IMMUNOL REV, V270, P32, DOI 10.1111/imr.12397; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plath F, 2016, MABS-AUSTIN, V8, P928, DOI 10.1080/19420862.2016.1168960; Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Quach TD, 2016, J IMMUNOL, V196, P1060, DOI 10.4049/jimmunol.1501843; Ramesh A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01407; Roark RS, 2021, SCIENCE, V371, P142, DOI 10.1126/science.abd2638; Roskin KM, 2020, NAT IMMUNOL, V21, P199, DOI 10.1038/s41590-019-0581-0; Rouge L, 2020, SCIENCE, V367, P1224, DOI 10.1126/science.aaz9356; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Saunders KO, 2019, SCIENCE, V366, P1215, DOI 10.1126/science.aay7199; Saunders KO, 2017, CELL REP, V21, P3681, DOI 10.1016/j.celrep.2017.12.028; Saunders KO, 2017, CELL REP, V18, P2175, DOI 10.1016/j.celrep.2017.02.003; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seabright GE, 2020, STRUCTURE, V28, P897, DOI 10.1016/j.str.2020.04.022; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; SHACKELFORD DA, 1983, J IMMUNOL, V130, P274; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Stanfield RL, 2015, GLYCOBIOLOGY, V25, P412, DOI 10.1093/glycob/cwu123; Steichen JM, 2019, SCIENCE, V366, P1216, DOI 10.1126/science.aax4380; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Taylor WR, 1997, PROTEIN ENG, V10, P743, DOI 10.1093/protein/10.7.743; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger Thomas C, 2020, Nat Methods, V17, P923, DOI 10.1038/s41592-020-0914-9; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Williams LD, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2200; Williams WB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01336-3; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Wu YJ, 2013, CELL REP, V5, P1443, DOI 10.1016/j.celrep.2013.11.015; Yang JY, 2010, FEBS LETT, V584, P4872, DOI 10.1016/j.febslet.2010.09.045; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Yu JS, 2010, J VIROL METHODS, V168, P248, DOI 10.1016/j.jviromet.2010.04.025; Zhang RJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf0618; ZHENG GX, 2017, NATURE, V0008	120	28	28	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					2955	+		10.1016/j.cell.2021.04.042	http://dx.doi.org/10.1016/j.cell.2021.04.042		MAY 2021	43	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	34019795	Green Published, Bronze			2022-12-28	WOS:000656965600013
J	Adler, AI; Latimer, NR				Adler, Amanda I.; Latimer, Nicholas R.			Adjusting for Nonadherence or Stopping Treatments in Randomized Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROGRESSION-FREE SURVIVAL; CANCER		[Adler, Amanda I.] Univ Oxford, Diabet Trials Unit, Oxford, England; [Adler, Amanda I.] Natl Inst Hlth & Clin Excellence, London, England; [Latimer, Nicholas R.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Oxford; National Institute for Health & Care Excellence; University of Sheffield	Adler, AI (corresponding author), Univ Oxford, Churchill Hosp, Diabet Trials Unit, Old Rd, Oxford OX3 7LJ, England.	amanda.adler@dtu.ox.ac.uk						Detry MA, 2014, JAMA-J AM MED ASSOC, V312, P85, DOI 10.1001/jama.2014.7523; Hernan MA, 2001, J AM STAT ASSOC, V96, P440, DOI 10.1198/016214501753168154; Lakdawalla DN, 2015, JAMA ONCOL, V1, P196, DOI 10.1001/jamaoncol.2015.0203; Latimer NR, 2017, STAT METHODS MED RES, V26, P724, DOI 10.1177/0962280214557578; Latimer NR, 2014, 16 NICE DSU U SHEFF; Manson JE, 2016, JAMA-J AM MED ASSOC, V315, P2273, DOI 10.1001/jama.2016.3676; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Shyr Y, 2015, JAMA ONCOL, V1, P202, DOI 10.1001/jamaoncol.2015.0407	9	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2110	2111		10.1001/jama.2021.2433	http://dx.doi.org/10.1001/jama.2021.2433			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	34032845				2022-12-28	WOS:000655647300025
J	Dyer, C				Dyer, Clare			Cardiologist from Poland must improve his English before he resumes practice, says tribunal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2021	373								n1331	10.1136/bmj.n1331	http://dx.doi.org/10.1136/bmj.n1331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WX9WC	34031046				2022-12-28	WOS:000718937900001
J	Tanne, JH				Tanne, Janice Hopkins			American Medical Association confronts its racist past with plan for a more equal future	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		American Medical Association, 2021, ORG STRAT PLAN EMB R; Tanne JH, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n851	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2021	373								n1314	10.1136/bmj.n1314	http://dx.doi.org/10.1136/bmj.n1314			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7ZT	34020970				2022-12-28	WOS:000656435600001
J	Ullman, AJ; Davidson, PM				Ullman, Amanda J.; Davidson, Patricia M.			Patient safety: the value of the nurse	LANCET			English	Editorial Material							MORTALITY		[Ullman, Amanda J.] Univ Queensland, Sch Nursing Midwifery & Social Work, South Brisbane, Qld 4101, Australia; [Ullman, Amanda J.] Childrens Hlth Queensland Hosp & Hlth Serv, Ctr Childrens Hlth Res, South Brisbane, Qld 4101, Australia; [Davidson, Patricia M.] Univ Wollongong, Vice Chancellors Unit, Wollongong, NSW, Australia	University of Queensland; University of Wollongong	Ullman, AJ (corresponding author), Univ Queensland, Sch Nursing Midwifery & Social Work, South Brisbane, Qld 4101, Australia.; Ullman, AJ (corresponding author), Childrens Hlth Queensland Hosp & Hlth Serv, Ctr Childrens Hlth Res, South Brisbane, Qld 4101, Australia.	a.ullman@uq.edu.au		Davidson, Patricia M./0000-0003-2050-1534				Aiken LH, 2014, LANCET, V383, P1824, DOI 10.1016/S0140-6736(13)62631-8; Daly J, 2020, J CLIN NURS, V29, P2751, DOI 10.1111/jocn.15305; Davidson PM, 2020, J CLIN NURS, V29, P2758, DOI 10.1111/jocn.15297; Kelly DM, 2014, CRIT CARE MED, V42, P1089, DOI 10.1097/CCM.0000000000000127; McHugh MD, 2021, LANCET, V397, P1905, DOI 10.1016/S0140-6736(21)00768-6; McHugh MD, 2013, MED CARE, V51, P382, DOI [10.1097/01.NNA.0000435145.39337.d5, 10.1097/MLR.0b013e3182726cc5]; Padula WV, 2021, J PATIENT SAF, V17, P51, DOI 10.1097/PTS.0000000000000623; Stokes-Parish J, 2020, J NURS SCHOLARSHIP, V52, P462, DOI 10.1111/jnu.12591; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Zurn Pascal, 2004, Hum Resour Health, V2, P13, DOI 10.1186/1478-4491-2-13	10	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1861	1863		10.1016/S0140-6736(21)00981-8	http://dx.doi.org/10.1016/S0140-6736(21)00981-8		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SF1XN	33989554				2022-12-28	WOS:000652556000003
J	Lewis, CE; Fine, LJ; Beddhu, S; Cheung, AK; Cushman, WC; Cutler, JA; Evans, GW; Johnson, KC; Kitzman, DW; Oparil, S; Rahman, M; Reboussin, DM; Rocco, MV; Sink, KM; Snyder, JK; Whelton, PK; Williamson, JD; Wright, JT; Ambrosius, WT				Lewis, Cora E.; Fine, Lawrence J.; Beddhu, Srinivasan; Cheung, Alfred K.; Cushman, William C.; Cutler, Jeffrey A.; Evans, Gregory W.; Johnson, Karen C.; Kitzman, Dalane W.; Oparil, Suzanne; Rahman, Mahboob; Reboussin, David M.; Rocco, Michael V.; Sink, Kaycee M.; Snyder, Joni K.; Whelton, Paul K.; Williamson, Jeff D.; Wright, Jackson T., Jr.; Ambrosius, Walter T.		SPRINT Res Grp	Final Report of a Trial of Intensive versus Standard Blood-Pressure Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-FAILURE; KIDNEY; SPRINT; DESIGN	Background In a previously reported randomized trial of standard and intensive systolic blood-pressure control, data on some outcome events had yet to be adjudicated and post-trial follow-up data had not yet been collected. Methods We randomly assigned 9361 participants who were at increased risk for cardiovascular disease but did not have diabetes or previous stroke to adhere to an intensive treatment target (systolic blood pressure, <120 mm Hg) or a standard treatment target (systolic blood pressure, <140 mm Hg). The primary outcome was a composite of myocardial infarction, other acute coronary syndromes, stroke, acute decompensated heart failure, or death from cardiovascular causes. Additional primary outcome events occurring through the end of the intervention period (August 20, 2015) were adjudicated after data lock for the primary analysis. We also analyzed post-trial observational follow-up data through July 29, 2016. Results At a median of 3.33 years of follow-up, the rate of the primary outcome and all-cause mortality during the trial were significantly lower in the intensive-treatment group than in the standard-treatment group (rate of the primary outcome, 1.77% per year vs. 2.40% per year; hazard ratio, 0.73; 95% confidence interval [CI], 0.63 to 0.86; all-cause mortality, 1.06% per year vs. 1.41% per year; hazard ratio, 0.75; 95% CI, 0.61 to 0.92). Serious adverse events of hypotension, electrolyte abnormalities, acute kidney injury or failure, and syncope were significantly more frequent in the intensive-treatment group. When trial and post-trial follow-up data were combined (3.88 years in total), similar patterns were found for treatment benefit and adverse events; however, rates of heart failure no longer differed between the groups. Conclusions Among patients who were at increased cardiovascular risk, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of major adverse cardiovascular events and lower all-cause mortality than targeting a systolic blood pressure of less than 140 mm Hg, both during receipt of the randomly assigned therapy and after the trial. Rates of some adverse events were higher in the intensive-treatment group. (Funded by the National Institutes of Health; SPRINT ClinicalTrials.gov number, NCT01206062.) Intensive or Standard Blood-Pressure Control In confirmation of a previous preliminary report, among patients who were at increased cardiovascular risk, targeting a systolic blood pressure less than 120 mm Hg, as compared with less than 140 mm Hg, resulted in lower rates of major adverse cardiovascular events, both during receipt of the randomly assigned therapy and after the trial.	[Lewis, Cora E.] Univ Alabama, Sch Med, Dept Epidemiol, Birmingham, W Midlands, England; [Lewis, Cora E.] Univ Alabama, Sch Med, Div Prevent Med, Birmingham, W Midlands, England; [Rahman, Mahboob] Univ Alabama, Sch Med, Div Cardiovasc Dis, Birmingham, W Midlands, England; [Fine, Lawrence J.; Cutler, Jeffrey A.; Snyder, Joni K.] NHLBI, Clin Applicat & Prevent Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Beddhu, Srinivasan; Cheung, Alfred K.] Univ Utah, Div Nephrol & Hypertens, Salt Lake City, UT USA; [Beddhu, Srinivasan; Cheung, Alfred K.] Vet Affairs Salt Lake City Hlth Care Syst, Med Serv, Salt Lake City, UT USA; [Cushman, William C.; Johnson, Karen C.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Cushman, William C.] Vet Affairs Med Ctr, Med Serv, Memphis, TN USA; [Reboussin, David M.; Ambrosius, Walter T.] Wake Forest Sch Med, Dept Biostat & Data Sci, Winston Salem, NC 27101 USA; [Sink, Kaycee M.; Williamson, Jeff D.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC 27101 USA; [Sink, Kaycee M.; Williamson, Jeff D.] Wake Forest Sch Med, Sticht Ctr Hlth Aging & Alzheimers Prevent, Winston Salem, NC 27101 USA; [Sink, Kaycee M.; Williamson, Jeff D.] Wake Forest Sch Med, Div Geriatr Med, Winston Salem, NC 27101 USA; [Rahman, Mahboob] Case Western Reserve Univ, Div Nephrol & Hypertens, Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Rahman, Mahboob; Wright, Jackson T., Jr.] Case Western Reserve Univ, Div Nephrol & Hypertens, Univ Hosp Cleveland Med Ctr, Cleveland, OH 44106 USA; [Rahman, Mahboob; Wright, Jackson T., Jr.] Case Western Reserve Univ, Univ Hosp Cleveland Med Ctr, Div Nephrol & Hypertens, Cleveland, OH 44106 USA; [Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA	Aston University; Aston University; Aston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University Hospitals of Cleveland; Tulane University	Lewis, CE (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, 1720 2nd Ave S, Birmingham, AL 35294 USA.	celewis@ubmc.edu	Dwyer, Jamie/A-4799-2015	Dwyer, Jamie/0000-0002-8402-8961; Rahbari-Oskoui, Frederic/0000-0001-8933-4880	NCATS NIH HHS [UL1 TR002548, UL1 TR000075, UL1 TR000064, UL1 TR000093, UL1 TR000105, UL1 TR000005, UL1 TR000433, UL1 TR000073, UL1 TR000445, UL1 TR000439, UL1 TR000003, U54 TR000123, UL1 TR001064, UL1 TR000002, UL1 TR000050] Funding Source: Medline; NCRR NIH HHS [UL1 RR025755, UL1 RR025771, UL1 RR025752, UL1 RR024134] Funding Source: Medline; NIA NIH HHS [P30 AG049638] Funding Source: Medline; NIGMS NIH HHS [P30 GM103337] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambrosius WT, 2014, CLIN TRIALS, V11, P532, DOI 10.1177/1740774514537404; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], 2017, N Engl J Med, V377, P2506, DOI 10.1056/NEJMx170008; [Anonymous], PROJECT DETAILS SPRI; [Anonymous], 2012, BLOOD PRESS INT TRIA; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Beddhu S, 2017, ANN INTERN MED, V167, P375, DOI 10.7326/M16-2966; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Holtkamp FA, 2011, KIDNEY INT, V80, P282, DOI 10.1038/ki.2011.79; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Johnson KC, 2018, HYPERTENSION, V71, P848, DOI 10.1161/HYPERTENSIONAHA.117.10479; Kjeldsen SE, 2016, BLOOD PRESSURE, V25, P63, DOI 10.3109/08037051.2015.1130775; Malhotra R, 2019, AM J KIDNEY DIS, V73, P21, DOI 10.1053/j.ajkd.2018.07.015; Peralta CA, 2016, CIRCULATION, V133, P584, DOI 10.1161/CIRCULATIONAHA.115.019657; Rocco MV, 2018, AM J KIDNEY DIS, V71, P352, DOI 10.1053/j.ajkd.2017.08.021; Rosamond WD, 2012, CIRC-HEART FAIL, V5, P152, DOI 10.1161/CIRCHEARTFAILURE.111.963199; Sink KM, 2018, J AM GERIATR SOC, V66, P679, DOI 10.1111/jgs.15236; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Upadhya B, 2019, JACC-HEART FAIL, V7, P1032, DOI 10.1016/j.jchf.2019.08.018	19	96	97	3	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					1921	1930		10.1056/NEJMoa1901281	http://dx.doi.org/10.1056/NEJMoa1901281			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ4AW	34010531	Bronze			2022-12-28	WOS:000655474700011
J	Rimmer, A				Rimmer, Abi			Briefing: Why do we need a mandatory register of doctors' interests?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com						Association of the British Pharmaceutical Industry, 2020, DISCL UK FURTH DET 2; Base Transparence Sante, BAS DON PUBL TRANSP; Chew M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7197; Fabbri A, 2018, INT J HEALTH POLICY, V7, P504, DOI 10.15171/ijhpm.2018.20; Grundy Q, 2018, HEALTH POLICY, V122, P509, DOI 10.1016/j.healthpol.2018.03.015; Independent Medicines and Medical Devices Safety Review, 2020, 1 NO HARM REP IND ME; Independent Medicines and Medical Devices Safety Review, 2018, ESPRESSO 1105; Joint Committee on Vaccination and Immunistion, 2013, COD PRACT; NHS England, 2017, MAN CONFL INT NHS; Rimmer A, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n933	10	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2021	373								n1280	10.1136/bmj.n1280	http://dx.doi.org/10.1136/bmj.n1280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ5TH	34016582	Bronze			2022-12-28	WOS:000655596600005
J	Islam, N; Shkolnikov, VM; Acosta, RJ; Klimkin, I; Kawachi, I; Irizarry, RA; Alicandro, G; Khunti, K; Yates, T; Jdanov, DA; White, M; Lewington, S; Lacey, B				Islam, Nazrul; Shkolnikov, Vladimir M.; Acosta, Rolando J.; Klimkin, Ilya; Kawachi, Ichiro; Irizarry, Rafael A.; Alicandro, Gianfranco; Khunti, Kamlesh; Yates, Tom; Jdanov, Dmitri A.; White, Martin; Lewington, Sarah; Lacey, Ben			Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MORTALITY; HEALTH; IMPACT; ALGORITHM	Objective To estimate the direct and indirect effects of the covid-19 pandemic on mortality in 2020 in 29 high income countries with reliable and complete age and sex disaggregated mortality data. Design Time series study of high income countries. Setting Austria, Belgium, Czech Republic, Denmark, England and Wales, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Latvia, Lithuania, the Netherlands, New Zealand, Northern Ireland, Norway, Poland, Portugal, Scotland, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, and United States. Participants Mortality data from the Short-term Mortality Fluctuations data series of the Human Mortality Database for 2016-20, harmonised and disaggregated by age and sex. Interventions Covid-19 pandemic and associated policy measures. Main outcome measures Weekly excess deaths (observed deaths versus expected deaths predicted by model) in 2020, by sex and age (0-14, 15-64, 65-74, 75-84, and =85 years), estimated using an over-dispersed Poisson regression model that accounts for temporal trends and seasonal variability in mortality. Results An estimated 979?000 (95% confidence interval 954?000 to 1?001?000) excess deaths occurred in 2020 in the 29 high income countries analysed. All countries had excess deaths in 2020, except New Zealand, Norway, and Denmark. The five countries with the highest absolute number of excess deaths were the US (458?000, 454?000 to 461?000), Italy (89?100, 87?500 to 90?700), England and Wales (85?400, 83?900 to 86?800), Spain (84?100, 82?800 to 85?300), and Poland (60?100, 58?800 to 61?300). New Zealand had lower overall mortality than expected (-2500, -2900 to -2100). In many countries, the estimated number of excess deaths substantially exceeded the number of reported deaths from covid-19. The highest excess death rates (per 100?000) in men were in Lithuania (285, 259 to 311), Poland (191, 184 to 197), Spain (179, 174 to 184), Hungary (174, 161 to 188), and Italy (168, 163 to 173); the highest rates in women were in Lithuania (210, 185 to 234), Spain (180, 175 to 185), Hungary (169, 156 to 182), Slovenia (158, 132 to 184), and Belgium (151, 141 to 162). Little evidence was found of subsequent compensatory reductions following excess mortality. Conclusion Approximately one million excess deaths occurred in 2020 in these 29 high income countries. Age standardised excess death rates were higher in men than women in almost all countries. Excess deaths substantially exceeded reported deaths from covid-19 in many countries, indicating that determining the full impact of the pandemic on mortality requires assessment of excess deaths. Many countries had lower deaths than expected in children <15 years. Sex inequality in mortality widened further in most countries in 2020.	[Islam, Nazrul; Lewington, Sarah; Lacey, Ben] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Islam, Nazrul; Lewington, Sarah; Lacey, Ben] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England; [Islam, Nazrul; White, Martin] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Shkolnikov, Vladimir M.; Jdanov, Dmitri A.] Max Planck Inst Demog Res, Rostock, Germany; [Shkolnikov, Vladimir M.; Klimkin, Ilya; Jdanov, Dmitri A.] Natl Res Univ Higher Sch Econ, Int Lab Populat & Hlth, Moscow, Russia; [Acosta, Rolando J.; Irizarry, Rafael A.] Harvard Univ, Harvard TH Chan Sch Publ, Dept Biostat, Boston, MA 02115 USA; [Kawachi, Ichiro] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Irizarry, Rafael A.] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA; [Alicandro, Gianfranco] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Khunti, Kamlesh; Yates, Tom] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Khunti, Kamlesh] Leicester Gen Hosp, NIHR Appl Res Collaborat East Midlands, Leicester, Leics, England; [Yates, Tom] Univ Hosp Leicester NHS Trust, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England; [Yates, Tom] Univ Leicester, Leicester, Leics, England; [Lewington, Sarah] Univ Oxford, Nuffield Dept Populat Hlth, MRC Populat Hlth Res Unit, Oxford, England	University of Oxford; University of Oxford; University of Cambridge; Max Planck Society; HSE University (National Research University Higher School of Economics); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; University of Milan; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester; University of Oxford	Islam, N (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England.; Islam, N (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England.; Islam, N (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.	nazrul.islam@ndph.ox.ac.uk	Jdanov, Dmitri/F-9425-2014; Klimkin, Ilya/AAN-7047-2021; /ABC-9527-2021; Islam, Nazrul/E-8592-2015	Jdanov, Dmitri/0000-0003-4633-2011; Islam, Nazrul/0000-0003-3982-4325; Khunti, Kamlesh/0000-0003-2343-7099; White, Martin/0000-0002-1861-6757; Yates, Thomas/0000-0002-5724-5178	Nuffield Department of Population Health (NDPH), University of Oxford; UK Biobank; NIHR Oxford Biomedical Research Centre; BHF Centre of Research Excellence, Oxford; Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence from British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council (MRC); National Institute for Health Research (NIHR); Wellcome Trust under UKCRC; MRC [MC_UU_12015/6, MC_UU_00006/7]; National Research University Higher School of Economics; National Institutes of Health [R35GM131802, T32ES007142]; NIHR Applied Research Collaboration East Midlands (ARC EM); NIHR Leicester Biomedical Research Centre (BRC); NIHR Leicester BRC; UKRI (MRC)-DHSC (NIHR) COVID-19 Rapid Response Rolling Call [MR/V020536/1]; HDR-UK [HDRUK2020.138]; US Centers for Disease Control and Prevention Foundation; Amgen	Nuffield Department of Population Health (NDPH), University of Oxford; UK Biobank; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); BHF Centre of Research Excellence, Oxford; Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence from British Heart Foundation; Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Wellcome Trust under UKCRC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research University Higher School of Economics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Applied Research Collaboration East Midlands (ARC EM); NIHR Leicester Biomedical Research Centre (BRC); NIHR Leicester BRC; UKRI (MRC)-DHSC (NIHR) COVID-19 Rapid Response Rolling Call(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HDR-UK; US Centers for Disease Control and Prevention Foundation; Amgen(Amgen)	No specific funding was received for this study.NI receives salary support from the Nuffield Department of Population Health (NDPH), University of Oxford. BL acknowledges support from UK Biobank, the NIHR Oxford Biomedical Research Centre, and the BHF Centre of Research Excellence, Oxford. MW is supported by the Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council (MRC), National Institute for Health Research (NIHR), and Wellcome Trust, under the auspices of the UKCRC. MW is also supported by the MRC (grant Nos MC_UU_12015/6 and MC_UU_00006/7). IKlimkin was fully supported, and VMS and JDA were partially supported, by the Basic Research Program of the National Research University Higher School of Economics. RAI and RJA are supported by the National Institutes of Health (R35GM131802 and T32ES007142, respectively). KK and TY are supported by the NIHR Applied Research Collaboration East Midlands (ARC EM) and the NIHR Leicester Biomedical Research Centre (BRC). Covid-19 research by TY is supported by the NIHR Leicester BRC and grants from the UKRI (MRC)-DHSC (NIHR) COVID-19 Rapid Response Rolling Call (MR/V020536/1) and from HDR-UK (HDRUK2020.138). The BMJ open access fee was supported by research funding from the US Centers for Disease Control and Prevention Foundation (with support from Amgen). Employers/sponsors had no role in the design, analysis, or dissemination of the study. The views expressed in this article are those of the authors and not necessarily those of the entities the authors are affiliated with and/or supported by.	Acosta RJ, 2020, MONITORING HLTH SYST; Alicandro G, 2020, LANCET, V396, pE27, DOI 10.1016/S0140-6736(20)31865-1; Baker MG, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4907; Baker MG, 2020, MED J AUSTRALIA, V213, P198, DOI 10.5694/mja2.50735; Baker MG, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2025203; Ball S, 2020, HEART, V106, P1890, DOI 10.1136/heartjnl-2020-317870; Barbieri M, 2015, INT J EPIDEMIOL, V44, P1549, DOI 10.1093/ije/dyv105; Barone E, 2021, EXPERTS ARE TRYING F; Barr P, 2021, UKS EXCESS DEATH TOL; Bauchner H, 2020, JAMA-J AM MED ASSOC, V324, P1504, DOI 10.1001/jama.2020.20016; Beaney T, 2020, J ROY SOC MED, V113, P329, DOI 10.1177/0141076820956802; Bhopal R, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1366; Bhopal SS, 2020, LANCET, V396, P532, DOI 10.1016/S0140-6736(20)31748-7; Bondy H, 2020, 39 COVID 19 DEATHS H; Centers for Disease Control and Prevention, PROV COVID 19 DEATH; Centers for Disease Control and Prevention, 10 LEAD CAUS DEATH I; Centers for Disease Control and Prevention, NVSS PROV COVID 19 D; Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896; Chen K, 2020, LANCET PLANET HEALTH, V4, pE210, DOI 10.1016/S2542-5196(20)30107-8; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Cross SH, 2019, NEW ENGL J MED, V381, P2369, DOI 10.1056/NEJMc1911892; Diderichsen F, 2021, INT J HEALTH SERV, V51, P417, DOI 10.1177/0020731421994848; Fanning Patricia J, 2010, INFLUENZA INEQUALITY; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Figliozzi S, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13362; Fry CV., 2019, NEVER LET GOOD CRISI; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Godderis L, 2020, OCCUP ENVIRON MED, V77, P511, DOI 10.1136/oemed-2020-106645; Gorges RJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.37431; Grantz KH, 2016, P NATL ACAD SCI USA, V113, P13839, DOI 10.1073/pnas.1612838113; Han E, 2020, LANCET, V396, P1525, DOI 10.1016/S0140-6736(20)32007-9; Hohle M, 2008, COMPUT STAT DATA AN, V52, P4357, DOI 10.1016/j.csda.2008.02.015; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Human Mortality Database, 2020, HUMAN MORTALITY DATA; Ing EB, 2020, OCCUP MED-OXFORD, V70, P370, DOI 10.1093/occmed/kqaa088; Islam N, 2021, EUR J PUBLIC HEALTH, V31, P280, DOI 10.1093/eurpub/ckab009; Islam N, 2021, J EPIDEMIOL COMMUN H, V75, P496, DOI 10.1136/jech-2020-215626; Islam N, 2020, EUR J PUBLIC HEALTH, V30, P847, DOI 10.1093/eurpub/ckaa150; Islam N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2743; Kang J, 2020, AM J INFECT CONTROL, V48, P1080, DOI 10.1016/j.ajic.2020.06.003; Karlinsky Ariel, 2021, medRxiv, DOI 10.1101/2021.01.27.21250604; Khunti K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2503; Klimkin I., 2021, CALCULATION WEEK SPE, DOI [10.4054/MPIDR-WP-2021-004, DOI 10.4054/MPIDR-WP-2021-004]; Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0; Kontopantelis E, 2021, J EPIDEMIOL COMMUN H, V75, P213, DOI 10.1136/jech-2020-214764; Kung S, 2021, LANCET, V397, P25, DOI 10.1016/S0140-6736(20)32647-7; KUNST AE, 1993, AM J EPIDEMIOL, V137, P331, DOI 10.1093/oxfordjournals.aje.a116680; Lee E, COMPENDIUM GOOD PRAC; Legido-Quigley H, 2020, LANCET, V395, P848, DOI 10.1016/S0140-6736(20)30551-1; Leung CC, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30520-1; Mafham MM, 2020, LANCET, V396, P381, DOI 10.1016/S0140-6736(20)31356-8; Mansfield KE, 2021, LANCET DIGIT HEALTH, V3, pE217, DOI [10.1016/S2589-7500(21)00017-0, 10.1016/S2589-7500(21)00017-0ac.uk]; Marmot M., 2011, FAIR SOC HLTH LIVES; Morris EJA, 2021, LANCET GASTROENTEROL, V6, P199, DOI 10.1016/S2468-1253(21)00005-4; Nafilyan V, 2021, J ROY SOC MED, V114, P182, DOI 10.1177/0141076821999973; National Center for Health Statistic Table 39, HLTH US 2019; National Center for Health Statistics, 2021, EXC DEATHS ASS COVID; Nemeth L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246663; Noufaily A, 2013, STAT MED, V32, P1206, DOI 10.1002/sim.5595; Office for National Statistics, DEATHS REG WEEKL ENG; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Platt L, 2020, ARE SOME ETHNIC GROU; Prasad R, 2020, CORONAVIRUS BAD IS C; Public Health England, 2020, EXC MORT ENGL WEEK E; Publications Office of the EU, 2013, REV EUR STAND POP RE, DOI [10.2785/11470, DOI 10.2785/11470]; Qureshi AI, 2020, ACCIDENT ANAL PREV, V146, DOI 10.1016/j.aap.2020.105747; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Razieh C, 2021, EUR J PUBLIC HEALTH, V31, P639, DOI 10.1093/eurpub/ckab041; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Rizzi S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025324118; Rossen LM, 2020, MMWR-MORBID MORTAL W, V69, P1522, DOI [10.1101/2020.06.06.20120857v1.full.pdf, 10.15585/mmwr.mm6942e2]; Roy A, 2020, MOST IMPORTANT CORON; Scortichini M., 2020, INT J EPIDEMIOL, V49, P1909, DOI [10.1093/ije/dyaa169, DOI 10.1093/IJE/DYAA169]; Son JY, 2020, SCI TOTAL ENVIRON, V744, DOI 10.1016/j.scitotenv.2020.141012; Stang A, 2020, J INFECTION, V81, P797, DOI 10.1016/j.jinf.2020.09.012; Statistics Korea, PREL RES BIRTH DEATH; Tilles D, 2021, POLAND RECORDED MORE; Wilmoth J.R., 2021, METHODS PROTOCOL HUM; Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P1562, DOI 10.1001/jama.2020.19545; World Economic Forum, GLOBAL GENDER GAP RE; Yates T, 2021, OBESITY, V29, P1223, DOI 10.1002/oby.23178	81	135	138	10	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2021	373								n1137	10.1136/bmj.n1137	http://dx.doi.org/10.1136/bmj.n1137			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ5SO	34011491	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000655594700014
J	Mathew, R				Mathew, Rammya			Rammya Mathew: Digital access has opened the floodgates to patient demand	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rammya.mathew@nhs.net						Charlesworth A, 2014, J HEALTH SERV RES PO, V19, P129, DOI 10.1177/1355819614531940; King's Fund, 2019, MUCH NHS BUDGET IS S; London School of Hygiene & Tropical Medicine, 2021, WEB PRACT POL POL GE; Siddique H, 2019, GUARDIAN        0812	4	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2021	373								n1246	10.1136/bmj.n1246	http://dx.doi.org/10.1136/bmj.n1246			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SL5PR	34006532	Bronze			2022-12-28	WOS:000656970600003
J	Chen, Z; Liu, Y; Zhang, H; Liu, ZR; Tian, H; Sun, YQ; Zhang, M; Zhou, Y; Sun, JR; Xie, YW				Chen, Zheng; Liu, Yuan; Zhang, Hui; Liu, Zhongran; Tian, He; Sun, Yanqiu; Zhang, Meng; Zhou, Yi; Sun, Jirong; Xie, Yanwu			Electric field control of superconductivity at the LaAlO3/KTaO3(111) interface	SCIENCE			English	Article							QUANTUM PHASE-TRANSITIONS; INSULATOR TRANSITION; METAL TRANSITION; CARRIER DENSITY; MODULATION; DISORDER; KTAO3	The oxide interface between LaAlO3 and KTaO3(111) can harbor a superconducting state. We report that by applying a gate voltage (V-G) across KTaO3, the interface can be continuously tuned from superconducting into insulating states, yielding a dome-shaped T-c-V-G dependence, where T-c is the transition temperature. The electric gating has only a minor effect on carrier density but a strong one on mobility. We interpret the tuning of mobility in terms of change in the spatial profile of the carriers in the interface and hence, effective disorder. As the temperature is decreased, the resistance saturates at the lowest temperature on both superconducting and insulating sides, suggesting the emergence of a quantum metallic state associated with a failed superconductor and/or fragile insulator.	[Chen, Zheng; Liu, Yuan; Sun, Yanqiu; Zhang, Meng; Xie, Yanwu] Zhejiang Univ, Interdisciplinary Ctr Quantum Informat, State Key Lab Modern Opt Instrumentat, Hangzhou 310027, Peoples R China; [Chen, Zheng; Liu, Yuan; Sun, Yanqiu; Zhang, Meng; Xie, Yanwu] Zhejiang Univ, Zhejiang Prov Key Lab Quantum Technol & Device, Dept Phys, Hangzhou 310027, Peoples R China; [Zhang, Hui] Beihang Univ, Sch Integrated Circuit Sci & Engn, Beijing 100191, Peoples R China; [Liu, Zhongran; Tian, He] Zhejiang Univ, Ctr Electron Microscope, Sch Mat Sci & Engn, State Key Lab Silicon Mat, Hangzhou 310027, Peoples R China; [Zhou, Yi; Sun, Jirong] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Zhou, Yi; Sun, Jirong] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Zhou, Yi; Sun, Jirong] Songshan Lake Mat Lab, Dongguan 523808, Guangdong, Peoples R China; [Zhou, Yi] Univ Chinese Acad Sci, Kavli Inst Theoret Sci, Beijing 100190, Peoples R China; [Zhou, Yi] Univ Chinese Acad Sci, CAS Ctr Excellence Topol Quantum Computat, Beijing 100190, Peoples R China; [Sun, Jirong] Univ Chinese Acad Sci, Sch Phys Sci, Beijing 100049, Peoples R China; [Xie, Yanwu] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Peoples R China	Zhejiang University; Zhejiang University; Beihang University; Zhejiang University; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Physics, CAS; Songshan Lake Materials Laboratory; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing University	Xie, YW (corresponding author), Zhejiang Univ, Interdisciplinary Ctr Quantum Informat, State Key Lab Modern Opt Instrumentat, Hangzhou 310027, Peoples R China.; Xie, YW (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Quantum Technol & Device, Dept Phys, Hangzhou 310027, Peoples R China.; Zhou, Y; Sun, JR (corresponding author), Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China.; Zhou, Y; Sun, JR (corresponding author), Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.; Zhou, Y; Sun, JR (corresponding author), Songshan Lake Mat Lab, Dongguan 523808, Guangdong, Peoples R China.; Zhou, Y (corresponding author), Univ Chinese Acad Sci, Kavli Inst Theoret Sci, Beijing 100190, Peoples R China.; Zhou, Y (corresponding author), Univ Chinese Acad Sci, CAS Ctr Excellence Topol Quantum Computat, Beijing 100190, Peoples R China.; Sun, JR (corresponding author), Univ Chinese Acad Sci, Sch Phys Sci, Beijing 100049, Peoples R China.; Xie, YW (corresponding author), Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Peoples R China.	yizhou@iphy.ac.cn; jrsun@lphy.ac.cn; ywxie@zju.edu.cn	Liu, Zhongran/AAS-7882-2020; Zhou, Yi/A-8147-2010	Zhou, Yi/0000-0003-0423-7964; Xie, Yanwu/0000-0002-8447-9455; Liu, Yuan/0000-0003-0382-6986; Zhang, Meng/0000-0001-7609-6393	National Key Research and Development Program of China [2017YFA0303002, 2016YFA0300202, 2016YFA0300204, 2016YFA0300701]; National Natural Science Foundation of China [11934016, 11774306]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB28000000]; Key R&D Program of Zhejiang Province, China [2021C01002, 2020C01019]; Fundamental Research Funds for the Central Universities of China; Science Center of the National Science Foundation of China [52088101]; Project for Innovative Research Team of National Natural Science Foundation of China [11921004]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Key R&D Program of Zhejiang Province, China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Science Center of the National Science Foundation of China; Project for Innovative Research Team of National Natural Science Foundation of China	This work was supported by the National Key Research and Development Program of China (grant nos. 2017YFA0303002, 2016YFA0300202, 2016YFA0300204, 2016YFA0300701); National Natural Science Foundation of China (grant nos. 11934016, 11774306); the Strategic Priority Research Program of Chinese Academy of Sciences (grant no. XDB28000000); the Key R&D Program of Zhejiang Province, China (2021C01002, 2020C01019); and the Fundamental Research Funds for the Central Universities of China. J.S. thanks the support of the Science Center of the National Science Foundation of China (52088101) and the Project for Innovative Research Team of National Natural Science Foundation of China (11921004).	Ahn CH, 1999, SCIENCE, V284, P1152, DOI 10.1126/science.284.5417.1152; Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878; Bell C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.226802; Biscaras J, 2013, NAT MATER, V12, P542, DOI [10.1038/nmat3624, 10.1038/NMAT3624]; Biscaras J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1084; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Checkelsky JG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206801; Chen ZY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06444-2; Chen ZY, 2016, NANO LETT, V16, P6130, DOI 10.1021/acs.nanolett.6b02348; Christiansen C, 2002, PHYS REV LETT, V88, DOI [10.1103/PhysRevLett.88.037004, 10.1103/PhysRevB.88.037004]; FISHER MPA, 1990, PHYS REV LETT, V65, P923, DOI 10.1103/PhysRevLett.65.923; FUJII Y, 1976, J PHYS SOC JPN, V41, P888, DOI 10.1143/JPSJ.41.888; Goldman AM, 2010, INT J MOD PHYS B, V24, P4081, DOI 10.1142/S0217979210056451; Kapitulnik A, 2019, REV MOD PHYS, V91, DOI 10.1103/RevModPhys.91.011002; Liu CJ, 2021, SCIENCE, V371, P716, DOI 10.1126/science.aba5511; Markovic N, 1999, PHYS REV B, V60, P4320, DOI 10.1103/PhysRevB.60.4320; Mason N, 1999, PHYS REV LETT, V82, P5341, DOI 10.1103/PhysRevLett.82.5341; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Richter C, 2013, NATURE, V502, P528, DOI 10.1038/nature12494; Sacepe B, 2020, NAT PHYS, V16, P734, DOI 10.1038/s41567-020-0905-x; Saito Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03275-z; Saito Y, 2015, SCIENCE, V350, P409, DOI 10.1126/science.1259440; Spivak B, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.214523; Tamir I, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3826; THOMPSON JR, 1982, J LOW TEMP PHYS, V47, P467, DOI 10.1007/BF00683987; Tsen AW, 2016, NAT PHYS, V12, P208, DOI 10.1038/NPHYS3579; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Ueno K, 2011, NAT NANOTECHNOL, V6, P408, DOI [10.1038/nnano.2011.78, 10.1038/NNANO.2011.78]; Xie Y., 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4626213, DOI 10.5281/ZENODO.4626213]; Xing Y, 2015, SCIENCE, V350, P542, DOI 10.1126/science.aaa7154; Yang C, 2019, SCIENCE, V366, P1505, DOI 10.1126/science.aax5798; YAZDANI A, 1995, PHYS REV LETT, V74, P3037, DOI 10.1103/PhysRevLett.74.3037; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/NMAT2587, 10.1038/nmat2587]; Zhang H, 2017, ACS APPL MATER INTER, V9, P36456, DOI 10.1021/acsami.7b12814; Zou K, 2015, APL MATER, V3, DOI 10.1063/1.4914310	39	32	32	55	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					721	U444		10.1126/science.abb3848	http://dx.doi.org/10.1126/science.abb3848			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33986177	Green Submitted			2022-12-28	WOS:000651125300046
J	Wymant, C; Ferretti, L; Tsallis, D; Charalambides, M; Abeler-Dorner, L; Bonsall, D; Hinch, R; Kendall, M; Milsom, L; Ayres, M; Holmes, C; Briers, M; Fraser, C				Wymant, Chris; Ferretti, Luca; Tsallis, Daphne; Charalambides, Marcos; Abeler-Dorner, Lucie; Bonsall, David; Hinch, Robert; Kendall, Michelle; Milsom, Luke; Ayres, Matthew; Holmes, Chris; Briers, Mark; Fraser, Christophe			The epidemiological impact of the NHS COVID-19 app	NATURE			English	Article								The COVID-19 pandemic has seen the emergence of digital contact tracing to help to prevent the spread of the disease. A mobile phone app records proximity events between app users, and when a user tests positive for COVID-19, their recent contacts can be notified instantly. Theoretical evidence has supported this new public health intervention(1-6), but its epidemiological impact has remained uncertain(7). Here we investigate the impact of the National Health Service (NHS) COVID-19 app for England and Wales, from its launch on 24 September 2020 to the end of December 2020. It was used regularly by approximately 16.5 million users (28% of the total population), and sent approximately 1.7 million exposure notifications: 4.2 per index case consenting to contact tracing. We estimated that the fraction of individuals notified by the app who subsequently showed symptoms and tested positive (the secondary attack rate (SAR)) was 6%, similar to the SAR for manually traced close contacts. We estimated the number of cases averted by the app using two complementary approaches: modelling based on the notifications and SAR gave an estimate of 284,000 (central 95% range of sensitivity analyses 108,000-450,000), and statistical comparison of matched neighbouring local authorities gave an estimate of 594,000 (95% confidence interval 317,000-914,000). Approximately one case was averted for each case consenting to notification of their contacts. We estimated that for every percentage point increase in app uptake, the number of cases could be reduced by 0.8% (using modelling) or 2.3% (using statistical analysis). These findings support the continued development and deployment of such apps in populations that are awaiting full protection from vaccines.	[Wymant, Chris; Ferretti, Luca; Abeler-Dorner, Lucie; Bonsall, David; Hinch, Robert; Kendall, Michelle; Holmes, Chris; Fraser, Christophe] Univ Oxford, Big Data Inst, Nuffield Dept Med, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Tsallis, Daphne] Zuhlke Engn Ltd, London, England; [Charalambides, Marcos; Ayres, Matthew; Holmes, Chris; Briers, Mark] Alan Turing Inst, London, England; [Kendall, Michelle] Univ Warwick, Dept Stat, Coventry, W Midlands, England; [Milsom, Luke] Univ Oxford, Dept Econ, Oxford, England; [Holmes, Chris] Univ Oxford, Dept Stat, Oxford, England	University of Oxford; University of Warwick; University of Oxford; University of Oxford	Fraser, C (corresponding author), Univ Oxford, Big Data Inst, Nuffield Dept Med, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England.	christophe.fraser@bdi.ox.ac.uk	Fraser, Christophe/A-8109-2008	Fraser, Christophe/0000-0003-2399-9657; Michalsen Tsallis, Daphne/0000-0002-0968-2744; Hinch, Robert/0000-0003-3169-698X	Li Ka Shing Foundation; UK Department of Health and Social Care (DHSC)	Li Ka Shing Foundation; UK Department of Health and Social Care (DHSC)	We thank R. Hayes, M. Kraemer, S. Bhatt, S. Mishra, J. Scott, S. Flaxman, A. Gandy, C. Jewell and W. Probert for helpful comments. This work was funded by a Li Ka Shing Foundation award to C.F., and by research grant funding from the UK Department of Health and Social Care (DHSC) to M.B., C.H. and C.F. The funders had no role in the design and conduct of the analysis.	Abueg M, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00422-7; [Anonymous], 2020, INV NOV SARS COV 2 V; Colizza V, 2021, NAT MED, V27, P361, DOI 10.1038/s41591-021-01236-6; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Donnarumma H., 2020, CORONAVIRUS COVID 19; Endo A., 2021, WELLCOME OPEN RES, V5, P239, DOI 10.12688/wellcomeopenres.16344.3; Fancourt D., 2020, COVID 19 SOCIAL STUD; Farronato C., 2020, HARVARD BUS REV; Ferretti L., 2020, TIMING COVID 19 TRAN, DOI [DOI 10.1101/2020.09.04.20188516, 10.1101/2020.09.04.20188516, 10.2139/ssrn.3716879, DOI 10.1101/2020.09.04.20188516V2]; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Galanti M., 2020, IMPORTANCE CONTINUED, DOI [10.1101/2020.12.23.20248784, DOI 10.1101/2020.12.23.20248784]; Google & Apple, 2020, EXP NOT US TECHN HEL; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Hinch R., 2020, MEDRXIV, DOI [10.1101/2020.09.16.20195925, DOI 10.1101/2020.09.16.20195925]; Keeling M. J., 2021, VACCINATION NONPHARM, DOI [10.1101/2020.12.27.20248896, DOI 10.1101/2020.12.27.20248896]; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Lambert A., 2020, MATH RIGOROUS ASSESS, DOI [10.1101/2020.05.04.20091009, DOI 10.1101/2020.05.04.20091009]; Lovett T., INFERRING PROXIMITY; Lunz D, 2021, EPIDEMICS-NETH, V34, DOI 10.1016/j.epidem.2020.100428; Riley S., 2020, MEDRXIV20248244; Rodriguez P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20817-6; Salathe M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.20457, 10.4414/smw.2020.20457]; Smith L.E., 2020, ADHERENCE TEST TRACE, DOI [DOI 10.1101/2020.09.15.20191957, 10.1101/2020.09.15.20191957]; Troncoso C., 2020, ARXIV; Vohringer H., 2020, LINEAGE SPECIFIC GRO; Volz E, 2021, NATURE, V593, P266, DOI 10.1038/s41586-021-03470-x	28	73	74	4	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 17	2021	594	7863					408	+		10.1038/s41586-021-03606-z	http://dx.doi.org/10.1038/s41586-021-03606-z		MAY 2021	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SU1FZ	33979832	Bronze			2022-12-28	WOS:000659479400001
J	Cruz-Silva, R; Elias, AL				Cruz-Silva, Rodolfo; Elias, Ana Laura			Reversible fusion-fission fibers	SCIENCE			English	Editorial Material							GRAPHENE		[Cruz-Silva, Rodolfo] Shinshu Univ, Res Initiat Supramaterials & Aqua Global Innovat, Nagano, Japan; [Elias, Ana Laura] SUNY Binghamton, Dept Phys, Binghamton, NY 13902 USA	Shinshu University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Elias, AL (corresponding author), SUNY Binghamton, Dept Phys, Binghamton, NY 13902 USA.	alelias@binghamton.edu	Cruz-Silva, Rodolfo/A-2149-2012	Cruz-Silva, Rodolfo/0000-0002-6120-9524; Elias, Ana Laura/0000-0002-4119-6084				Alberts B, 2008, MOL BIOL CELL; Chang D, 2021, SCIENCE, V372, P614, DOI 10.1126/science.abb6640; Cruz-Silva R, 2014, ACS NANO, V8, P5959, DOI 10.1021/nn501098d; Demirel MC, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201704990; Kvavadze E, 2009, SCIENCE, V325, P1359, DOI 10.1126/science.1175404; Liu ZF, 2015, SCIENCE, V349, P400, DOI 10.1126/science.aaa7952; Rideau E, 2018, CHEM SOC REV, V47, DOI 10.1039/c8cs00162f; Xin GQ, 2015, SCIENCE, V349, P1083, DOI 10.1126/science.aaa6502; Xu Z, 2014, ACCOUNTS CHEM RES, V47, P1267, DOI 10.1021/ar4002813	9	0	0	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					573	573		10.1126/science.abh2283	http://dx.doi.org/10.1126/science.abh2283			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA2AW	33958463				2022-12-28	WOS:000649103500025
J	Garcia-Finana, M; Buchan, IE				Garcia-Finana, Marta; Buchan, Iain E.			Rapid antigen testing in COVID-19 responses	SCIENCE			English	Editorial Material									[Garcia-Finana, Marta; Buchan, Iain E.] Univ Liverpool, Inst Populat Hlth, Waterhouse Bldg, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Garcia-Finana, M (corresponding author), Univ Liverpool, Inst Populat Hlth, Waterhouse Bldg, Liverpool L69 3BX, Merseyside, England.	martaf@liverpool.ac.uk; buchan@liverpool.ac.uk	Buchan, Iain/H-5767-2013	Buchan, Iain/0000-0003-3392-1650; Garcia-Finana, Professor Marta/0000-0003-4939-0575	UK Department of Health and Social Care	UK Department of Health and Social Care	I.E.B. and M.G.-F. received grant funding from the UK Department of Health and Social Care to evaluate the Liverpool community testing pilot. I.E.B. reports fees from AstraZeneca as chief data scientist adviser through Liverpool University and a senior investigator grant from the National Institute for Health Research (NIHR) outside the submitted work.	Buchan I., 2020, LIVERPOOL COVID 19 C; Crozier A, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n208; Green M.A., 2021, MEDRXIV, DOI [10.1101/2021.02.10.21251256, DOI 10.1101/2021.02.10.21251256]; Kmietowicz Z, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n81; Lee L. Y.W., 2021, MEDRXIV, DOI [10.1101/2021.03.31.21254687, DOI 10.1101/2021.03.31.21254687]; Lee L. Y.W., 2021, MEDRXIV, DOI [10.1101/2021.03.31.21254687, DOI 10.1101/2021.03.31.21254687]; Marks M, 2021, LANCET INFECT DIS, V21, P629, DOI 10.1016/S1473-3099(20)30985-3; Mina MJ, 2021, LANCET, V397, P1425, DOI 10.1016/S0140-6736(21)00425-6; NHS Cheshire and Merseyside, 2021, COMB INT POP HLTH AC; Nnoaham K., 2021, EVALUATION LATERAL F; Pavelka M, 2021, SCIENCE, V372, P635, DOI 10.1126/science.abf9648; Peeling R.W., 2021, LANCET, DOI [10.1016/S1473-3099(21)00152-3, DOI 10.1016/S1473-3099(21)00152-3]; Peto T., 2021, COVID 19 RAPID ANTIG, DOI [10.1101/2021.01.13.21249563, DOI 10.1101/2021.01.13.21249563]; Tulloch J., 2021, SSRN, DOI [10.2139/ssrn.3822257, DOI 10.2139/SSRN.3822257]	14	10	10	12	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					571	572		10.1126/science.abi6680	http://dx.doi.org/10.1126/science.abi6680			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SA2AW	33958462				2022-12-28	WOS:000649103500024
J	Kotler, S; Peterson, GA; Shojaee, E; Lecocq, F; Cicak, K; Kwiatkowski, A; Geller, S; Glancy, S; Knill, E; Simmonds, RW; Aumentado, J; Teufel, JD				Kotler, Shlomi; Peterson, Gabriel A.; Shojaee, Ezad; Lecocq, Florent; Cicak, Katarina; Kwiatkowski, Alex; Geller, Shawn; Glancy, Scott; Knill, Emanuel; Simmonds, Raymond W.; Aumentado, Jose; Teufel, John D.			Direct observation of deterministic macroscopic entanglement	SCIENCE			English	Article							QUANTUM INFORMATION; CRITERION	Quantum entanglement of mechanical systems emerges when distinct objects move with such a high degree of correlation that they can no longer be described separately. Although quantum mechanics presumably applies to objects of all sizes, directly observing entanglement becomes challenging as masses increase, requiring measurement and control with a vanishingly small error. Here, using pulsed electromechanics, we deterministically entangle two mechanical drumheads with masses of 70 picograms. Through nearly quantum-limited measurements of the position and momentum quadratures of both drums, we perform quantum state tomography and thereby directly observe entanglement. Such entangled macroscopic systems are poised to serve in fundamental tests of quantum mechanics, enable sensing beyond the standard quantum limit, and function as long-lived nodes of future quantum networks.	[Kotler, Shlomi; Peterson, Gabriel A.; Shojaee, Ezad; Lecocq, Florent; Cicak, Katarina; Kwiatkowski, Alex; Geller, Shawn; Glancy, Scott; Knill, Emanuel; Simmonds, Raymond W.; Aumentado, Jose; Teufel, John D.] NIST, Boulder, CO 80305 USA; [Kotler, Shlomi; Peterson, Gabriel A.; Shojaee, Ezad; Lecocq, Florent; Kwiatkowski, Alex; Geller, Shawn] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Knill, Emanuel] Univ Colorado, Ctr Theory Quantum Matter, Boulder, CO 80309 USA; [Kotler, Shlomi] Hebrew Univ Jerusalem, Dept Appl Phys, IL-9190401 Jerusalem, Israel	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Hebrew University of Jerusalem	Kotler, S (corresponding author), NIST, Boulder, CO 80305 USA.; Kotler, S (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.; Kotler, S (corresponding author), Hebrew Univ Jerusalem, Dept Appl Phys, IL-9190401 Jerusalem, Israel.	shlomi.kotler@mail.huji.ac.il	Teufel, John D/A-8898-2010; KOTLER, SHLOMI/I-4393-2014; Lecocq, Florent/A-9613-2015	Teufel, John D/0000-0002-1873-9941; Geller, Shawn/0000-0002-9932-734X; KOTLER, SHLOMI/0000-0002-0191-5777; Lecocq, Florent/0000-0002-3950-0024; Cicak, Katarina/0000-0002-3211-6636; Simmonds, Raymond/0000-0003-2217-2965; Glancy, Scott/0000-0003-3137-2125; Kwiatkowski, Alex/0000-0003-1296-589X	NIST from the U.S. Department of Commerce [70NANB18H006]; University of Colorado Boulder from the U.S. Department of Commerce [70NANB18H006]	NIST from the U.S. Department of Commerce; University of Colorado Boulder from the U.S. Department of Commerce	At the time this work was performed, S.K., E.S. F.L., A.K., and S.Geller were supported as Associates in the Professional Research Experience Program (PREP) operated jointly by NIST and the University of Colorado Boulder under Award no. 70NANB18H006 from the U.S. Department of Commerce.	Barzanjeh S, 2019, NATURE, V570, P480, DOI 10.1038/s41586-019-1320-2; Bowen W. P., 2015, QUANTUM OPTOMECHANIC; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Buchmann LF, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.013851; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Chen JX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14768-1; Delaney RD, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.183603; Duan LM, 2000, PHYS REV LETT, V84, P2722, DOI 10.1103/PhysRevLett.84.2722; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Hartmann MJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.200503; Hofer SG, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052327; Jia XJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250503; Jost JD, 2009, NATURE, V459, P683, DOI 10.1038/nature08006; Lecocq F, 2015, NAT PHYS, V11, P635, DOI [10.1038/NPHYS3365, 10.1038/nphys3365]; Li J, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/10/103037; Mancini S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.120401; Ockeloen-Korppi CF, 2018, NATURE, V556, P478, DOI 10.1038/s41586-018-0038-x; Palomaki TA, 2013, SCIENCE, V342, P710, DOI 10.1126/science.1244563; Palomaki TA, 2013, NATURE, V495, P210, DOI 10.1038/nature11915; Pinard M, 2005, EUROPHYS LETT, V72, P747, DOI 10.1209/epl/i2005-10317-6; Reed AP, 2017, NAT PHYS, V13, P1163, DOI 10.1038/NPHYS4251; Reid MD, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.120402; Riedinger R, 2018, NATURE, V556, P473, DOI 10.1038/s41586-018-0036-z; Safavi-Naeini AH, 2019, OPTICA, V6, P213, DOI 10.1364/OPTICA.6.000213; Schnabel R, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.012126; Serafini A, 2004, J PHYS B-AT MOL OPT, V37, pL21, DOI 10.1088/0953-4075/37/2/L02; Simon R, 2000, PHYS REV LETT, V84, P2726, DOI 10.1103/PhysRevLett.84.2726; Tan HT, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.033829; Teo YS, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.042322; Teufel JD, 2011, NATURE, V471, P204, DOI 10.1038/nature09898; Thomas RA, 2021, NAT PHYS, V17, P228, DOI 10.1038/s41567-020-1031-5; Wang YD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.253601	32	54	54	9	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2021	372	6542					622	+		10.1126/science.abf2998	http://dx.doi.org/10.1126/science.abf2998			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA2AW	33958475	Green Submitted			2022-12-28	WOS:000649103500044
J	Wang, EY; Mao, TY; Klein, J; Dai, YL; Huck, JD; Jaycox, JR; Liu, FM; Zhou, T; Israelow, B; Wong, P; Coppi, A; Lucas, C; Silva, J; Oh, JE; Song, E; Perotti, ES; Zheng, NS; Fischer, S; Campbell, M; Fournier, JB; Wyllie, AL; Vogels, CBF; Ott, IM; Kalinich, CC; Petrone, ME; Watkins, AE; Dela Cruz, C; Farhadian, SF; Schulz, WL; Ma, SG; Grubaugh, ND; Ko, AI; Iwasaki, A; Ring, AM				Wang, Eric Y.; Mao, Tianyang; Klein, Jon; Dai, Yile; Huck, John D.; Jaycox, Jillian R.; Liu, Feimei; Zhou, Ting; Israelow, Benjamin; Wong, Patrick; Coppi, Andreas; Lucas, Carolina; Silva, Julio; Oh, Ji Eun; Song, Eric; Perotti, Emily S.; Zheng, Neil S.; Fischer, Suzanne; Campbell, Melissa; Fournier, John B.; Wyllie, Anne L.; Vogels, Chantal B. F.; Ott, Isabel M.; Kalinich, Chaney C.; Petrone, Mary E.; Watkins, Anne E.; Dela Cruz, Charles; Farhadian, Shelli F.; Schulz, Wade L.; Ma, Shuangge; Grubaugh, Nathan D.; Ko, Albert I.; Iwasaki, Akiko; Ring, Aaron M.		Yale IMPACT Team	Diverse functional autoantibodies in patients with COVID-19	NATURE			English	Article								COVID-19 manifests with a wide spectrum of clinical phenotypes that are characterized by exaggerated and misdirected host immune responses(1-6). Although pathological innate immune activation is well-documented in severe disease(1), the effect of autoantibodies on disease progression is less well-defined. Here we use a high-throughput autoantibody discovery technique known as rapid extracellular antigen profiling(7) to screen a cohort of 194 individuals infected with SARS-CoV-2, comprising 172 patients with COVID-19 and 22 healthcare workers with mild disease or asymptomatic infection, for autoantibodies against 2,770 extracellular and secreted proteins (members of the exoproteome). We found that patients with COVID-19 exhibit marked increases in autoantibody reactivities as compared to uninfected individuals, and show a high prevalence of autoantibodies against immunomodulatory proteins (including cytokines, chemokines, complement components and cell-surface proteins). We established that these autoantibodies perturb immune function and impair virological control by inhibiting immunoreceptor signalling and by altering peripheral immune cell composition, and found that mouse surrogates of these autoantibodies increase disease severity in a mouse model of SARS-CoV-2 infection. Our analysis of autoantibodies against tissue-associated antigens revealed associations with specific clinical characteristics. Our findings suggest a pathological role for exoproteome-directed autoantibodies in COVID-19, with diverse effects on immune functionality and associations with clinical outcomes.	[Wang, Eric Y.; Mao, Tianyang; Klein, Jon; Dai, Yile; Huck, John D.; Jaycox, Jillian R.; Liu, Feimei; Zhou, Ting; Israelow, Benjamin; Wong, Patrick; Lucas, Carolina; Silva, Julio; Oh, Ji Eun; Song, Eric; Perotti, Emily S.; Zheng, Neil S.; Fischer, Suzanne; Iwasaki, Akiko; Ring, Aaron M.] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Coppi, Andreas; Schulz, Wade L.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Campbell, Melissa; Fournier, John B.; Farhadian, Shelli F.; Ko, Albert I.] Yale Sch Med, Dept Internal Med Infect Dis, New Haven, CT USA; [Wyllie, Anne L.; Vogels, Chantal B. F.; Ott, Isabel M.; Kalinich, Chaney C.; Petrone, Mary E.; Watkins, Anne E.; Grubaugh, Nathan D.; Ko, Albert I.; Iwasaki, Akiko] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Dela Cruz, Charles] Yale Sch Med, Sect Pulm & Crit Care Med, Dept Med, New Haven, CT USA; [Schulz, Wade L.] Yale Sch Med, Dept Lab Med, New Haven, CT USA; [Ma, Shuangge] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ring, Aaron M.] Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Iwasaki, A; Ring, AM (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.; Iwasaki, A (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Ring, AM (corresponding author), Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	akiko.iwasaki@yale.edu; aaron.ring@yale.edu	Ko, Albert/P-2343-2015	Ko, Albert/0000-0001-9023-2339; Mao, Tianyang/0000-0001-9251-8592; Ott, Isabel/0000-0002-7134-0956; Obaid, Abeer/0000-0002-9846-1045; Wyllie, Anne/0000-0001-6015-0279; Wang, Eric/0000-0002-6120-5136; Velazquez, Sofia/0000-0001-5954-3518; Liu, Feimei/0000-0003-2663-6544; Zhou, Ting/0000-0001-8783-8380; Klein, Jonathan/0000-0002-3552-7684; Rose, Kadi-Ann/0000-0003-4664-2757; Watkins, Anne/0000-0002-0399-8238	Mathers Family Foundation; Ludwig Family Foundation; Yale Cancer Center Support Grant [3P30CA016359-40S4]; Beatrice Neuwirth Foundation; Yale Schools of Medicine and Public Health; NIAID [U19 AI08992]; Yale COVID-19 Research Resource Fund; NIH Director's Early Independence Award [DP5OD023088]; Pew-Stewart Award; Robert T. McCluskey Foundation; Yale Interdisciplinary Immunology Training Program [T32AI007019]; Yale Medical Scientist Training Program [T32GM007205]	Mathers Family Foundation; Ludwig Family Foundation; Yale Cancer Center Support Grant; Beatrice Neuwirth Foundation; Yale Schools of Medicine and Public Health; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Yale COVID-19 Research Resource Fund; NIH Director's Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew-Stewart Award; Robert T. McCluskey Foundation; Yale Interdisciplinary Immunology Training Program; Yale Medical Scientist Training Program	We thank all members of the laboratories of A.M.R. and A.I., as well as E. Meffre, J. Craft and K. O'Connor, for helpful conversation and technical assistance; M. Linehan and H. Dong for logistical assistance; H. P. Young for technical assistance with data management; N. K. Savalia and T. J. Shelby for discussion regarding statistical techniques; and L. Steinman for helpful discussions about autoantibodies to HCRTR2. This work was supported by the Mathers Family Foundation (to A.M.R. and A.I.), the Ludwig Family Foundation (to A.M.R. and A.I.), a supplement to the Yale Cancer Center Support Grant 3P30CA016359-40S4 (to A.M.R.), the Beatrice Neuwirth Foundation, Yale Schools of Medicine and Public Health and NIAID grant U19 AI08992. IMPACT received support from the Yale COVID-19 Research Resource Fund. A.M.R. is additionally supported by an NIH Director's Early Independence Award (DP5OD023088), a Pew-Stewart Award, and the Robert T. McCluskey Foundation. T.M. and Y.D. are supported by the Yale Interdisciplinary Immunology Training Program T32AI007019. J.K. and J.R.J. are supported by the Yale Medical Scientist Training Program T32GM007205. Schematics in Fig. 3a, Extended Data Figs. 1a, 7a were created with Biorender.com.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Chang S. E., NEW ONSET IGG AUTOAN, DOI [10.1101/2021.01.27.21250559(2021, DOI 10.1101/2021.01.27.21250559(2021]; Cheng LL, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23618; Combes Alexis J, 2020, bioRxiv, DOI [10.1038/s41586-021-03234-7, 10.1101/2020.10.28.359935]; Garcia-Beltran Wilfredo F, 2021, Cell, V184, P476, DOI 10.1016/j.cell.2020.12.015; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mann ER, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6197; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Maucourant C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6832; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; McPadden J., CLIN CHARACTERISTICS, DOI [10.1101/2020.07.19.20157305 (2020), DOI 10.1101/2020.07.19.20157305(2020), 10.1101/2020.07.19.20157305(2020)]; McPadden J, 2019, J MED INTERNET RES, V21, DOI 10.2196/13043; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z; Nixon JP, 2015, AGEING RES REV, V20, P63, DOI 10.1016/j.arr.2014.11.001; Orzalli MH, 2018, MOL CELL, V71, P825, DOI 10.1016/j.molcel.2018.07.009; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodrigues TS, 2021, J EXP MED, V218, DOI 10.1084/jem.20201707; Schulz WL, 2020, J MED INTERNET RES, V22, DOI 10.2196/18707; Song ER, 2021, J EXP MED, V218, DOI 10.1084/jem.20202135; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414; Trapnell BC, 2002, ANNU REV PHYSIOL, V64, P775, DOI 10.1146/annurev.physiol.64.090601.113847; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Vogels CBF, 2020, NAT MICROBIOL, V5, P1299, DOI 10.1038/s41564-020-0761-6; Wang E. Y., REAP PLATFORM IDENTI, DOI [10.1101/2021.02.11.430703(2021, DOI 10.1101/2021.02.11.430703(2021]; Wang GY, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa153; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Woodruff M.C., 2020, CLIN IDENTIFIABLE AU, DOI [10.21.20216192, DOI 10.1101/2020.10.21.20216192]; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Zheng J, 2021, NATURE, V589, P603, DOI 10.1038/s41586-020-2943-z; Zhou T, 2020, NATURE, V583, P609, DOI 10.1038/s41586-020-2422-6; Zhou YQ, 2020, CTS-CLIN TRANSL SCI, V13, P1077, DOI 10.1111/cts.12805; Zuo Y, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd3876	39	289	289	12	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 8	2021	595	7866					283	+		10.1038/s41586-021-03631-y	http://dx.doi.org/10.1038/s41586-021-03631-y		MAY 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE9OU	33330894	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000659479600001
